data_2jna_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jna _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.528 ' O ' ' HB3' ' B' ' 261' ' ' SER . . . . . . . . 0 N--CA 1.465 0.282 0 CA-C-O 121.134 0.492 . . . . 0.0 110.823 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.439 ' CD ' ' HD3' ' B' ' 257' ' ' ARG . 2.2 tp10 -147.0 -138.88 0.09 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -176.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.651 ' HB2' ' H ' ' B' ' 223' ' ' GLU . 0.0 OUTLIER 72.73 156.73 0.17 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 122.6 0.36 . . . . 0.0 111.64 176.348 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.3 m -114.5 147.72 17.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 121.055 0.455 . . . . 0.0 110.905 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.42 ' O ' HG13 ' A' ' 30' ' ' ILE . 19.9 t -100.29 -166.79 1.36 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.28 0.562 . . . . 0.0 111.017 -177.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -66.5 -44.1 83.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.535 -173.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.627 ' HG2' ' OE1' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -63.59 -44.72 93.19 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.891 -173.736 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.627 ' OE1' ' HG2' ' A' ' 28' ' ' GLN . 2.3 mp0 -62.98 -40.95 99.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.619 0.247 . . . . 0.0 110.846 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 26' ' ' SER . 97.4 mt -59.01 -49.9 81.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.841 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.3 t -73.43 -24.85 60.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.362 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.426 ' HB2' ' O ' ' A' ' 28' ' ' GLN . 33.7 t-80 -85.92 -57.81 2.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.686 0.279 . . . . 0.0 111.287 -174.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -81.77 -10.74 59.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.193 -175.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt 59.54 76.43 0.36 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.338 0.59 . . . . 0.0 110.113 -175.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.1 mt -82.39 159.39 23.01 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.892 -176.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.1 t -81.88 111.71 18.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.081 -176.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.54 ' HD3' ' CE2' ' A' ' 91' ' ' TYR . 15.0 tptm -71.5 111.19 6.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.67 175.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.401 HG21 ' HB ' ' A' ' 90' ' ' VAL . 3.2 m -104.66 6.95 10.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.871 0.367 . . . . 0.0 111.667 -176.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 133.37 -168.44 23.08 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.549 175.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 47.7 m -136.54 132.93 35.88 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.4 pt -111.43 134.22 54.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.257 0.551 . . . . 0.0 110.861 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -114.62 121.05 42.22 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.565 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.563 ' HB ' ' HB1' ' A' ' 86' ' ' ALA . 24.3 t -93.35 107.51 19.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.8 t -110.62 110.54 21.28 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.549 -176.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.5 ' HG2' HG12 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -116.79 152.63 33.99 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.236 -176.53 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.8 t -126.03 124.79 41.46 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.875 -0.416 . . . . 0.0 109.875 175.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.33 -145.92 25.79 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.456 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.84 52.53 0.72 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.877 -175.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.455 ' HB2' ' CG ' ' A' ' 45' ' ' GLN . 14.5 mm100 -71.96 -41.79 67.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.298 0.571 . . . . 0.0 109.619 175.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.534 HG21 ' HB2' ' A' ' 55' ' ' ASP . 49.3 mm -97.93 125.4 51.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.73 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.1 m -103.26 -39.74 6.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.199 -176.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.42 ' HB2' ' HD2' ' A' ' 53' ' ' PRO . 51.4 p -131.87 162.56 55.72 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.462 -176.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.42 ' HD2' ' HB2' ' A' ' 52' ' ' SER . 17.0 Cg_endo -57.49 -27.02 74.53 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.633 2.222 . . . . 0.0 111.44 176.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.579 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 2.5 m -59.08 -45.92 89.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.545 177.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.534 ' HB2' HG21 ' A' ' 50' ' ' ILE . 36.2 m-20 -64.85 -35.84 82.43 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.561 -178.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 67.2 tp -61.46 -47.2 86.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.847 175.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -58.08 -41.12 82.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.068 177.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.579 ' HG2' ' O ' ' A' ' 54' ' ' SER . 14.1 mm-40 -55.6 -50.47 70.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.281 0.562 . . . . 0.0 110.68 177.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 59' ' ' LYS . 73.2 mmtt -69.71 -35.14 74.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.323 -177.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.2 mt -62.58 -44.32 96.61 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.54 176.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.7 t -66.6 -39.83 88.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.068 0.461 . . . . 0.0 110.237 177.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -57.03 -48.72 77.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.905 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 87.4 mt -71.83 -40.49 69.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.618 -176.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.62 -38.11 89.89 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -176.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -59.56 -42.71 93.05 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.271 0.558 . . . . 0.0 110.336 178.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.73 -7.78 58.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.425 -177.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.424 ' HD3' ' HA ' ' A' ' 67' ' ' LYS . 30.2 mmtm -97.38 -19.98 18.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.788 0.328 . . . . 0.0 111.408 178.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.79 34.47 9.06 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.335 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.45 ' HA3' HG11 ' A' ' 90' ' ' VAL . . . -129.32 138.49 10.28 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 177.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' B' ' 222' ' ' ALA . 87.9 mttt -85.01 -28.99 25.35 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.74 0.27 . . . . 0.0 111.463 -174.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -129.56 141.3 51.0 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -176.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.572 ' CD2' ' HB3' ' B' ' 222' ' ' ALA . 13.8 p90 -105.07 168.0 9.34 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 171.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -138.94 105.84 5.41 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.907 172.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 33.5 mt -69.96 124.5 26.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.238 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 31.4 pt -110.94 -17.59 8.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.989 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -171.89 101.22 0.18 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.509 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.551 ' HA ' ' HA ' ' A' ' 86' ' ' ALA . . . -107.69 101.64 10.93 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 171.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -136.96 167.1 22.13 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.104 0.478 . . . . 0.0 111.373 -172.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -90.37 145.58 24.84 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.821 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -129.35 80.53 1.97 Allowed 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 173.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.5 -117.73 9.2 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.827 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -83.12 -2.2 10.64 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.812 2.341 . . . . 0.0 112.045 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -112.42 165.04 12.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.989 -177.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -125.89 121.92 34.57 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.046 175.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -117.23 111.01 18.83 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.866 0.365 . . . . 0.0 110.579 -176.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.563 ' HB1' ' HB ' ' A' ' 43' ' ' VAL . . . -110.59 116.32 31.15 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.08 0.467 . . . . 0.0 110.495 176.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.6 t -102.39 118.17 48.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.311 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -135.94 136.65 40.6 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.592 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.538 ' HB3' ' HE3' ' A' ' 37' ' ' LYS . 40.9 mt-10 -91.83 149.87 21.36 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.45 HG11 ' HA3' ' A' ' 69' ' ' GLY . 5.6 t -107.48 132.72 54.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.35 -177.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.54 ' CE2' ' HD3' ' A' ' 37' ' ' LYS . 95.8 m-85 -133.21 146.3 51.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.162 0.506 . . . . 0.0 111.196 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -123.31 160.47 26.62 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.402 176.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 . . . . . 0 C--O 1.237 0.442 0 CA-C-O 120.673 0.273 . . . . 0.0 110.814 -177.698 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 222' ' ' ALA . . . . . 0.572 ' HB3' ' CD2' ' A' ' 72' ' ' TYR . . . . . . . . 0 CA--C 1.517 -0.314 0 N-CA-C 110.585 -0.154 . . . . 0.0 110.585 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 223' ' ' GLU . . . . . 0.651 ' H ' ' HB2' ' A' ' 24' ' ' GLN . 40.5 tt0 -172.88 101.83 0.13 Allowed 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -176.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 224' ' ' GLN . . . . . 0.61 ' HA ' ' HD1' ' B' ' 271' ' ' TYR . 0.0 OUTLIER -174.04 158.71 3.15 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 122.919 0.488 . . . . 0.0 109.807 175.754 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . 0.476 HG21 ' CD1' ' B' ' 235' ' ' LEU . 24.1 m -117.03 146.11 21.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 120.543 0.211 . . . . 0.0 110.672 178.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 78.1 p -91.49 -166.8 1.65 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.952 0.406 . . . . 0.0 110.67 -177.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -67.13 -29.17 68.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.173 -176.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -73.02 -50.87 20.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.072 -174.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -59.8 -39.11 83.89 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.048 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 87.8 mt -60.4 -49.22 85.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.781 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 15.2 m -72.82 -32.2 65.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.093 -177.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -78.76 -55.18 5.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.455 -175.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -83.23 -23.44 32.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.562 -174.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm 64.34 80.81 0.22 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.424 0.631 . . . . 0.0 110.308 -176.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . 0.476 ' CD1' HG21 ' B' ' 225' ' ' VAL . 63.1 mt -83.79 -178.41 7.0 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.108 -175.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 44.5 t -100.12 109.71 25.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.11 178.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 52.6 tttm -82.0 114.01 20.28 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 238' ' ' VAL . . . . . 0.5 HG22 ' HB ' ' B' ' 290' ' ' VAL . 14.5 m -104.36 7.57 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -170.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 131.34 -153.38 20.37 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 119.934 -1.127 . . . . 0.0 113.499 175.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 240' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' B' ' 289' ' ' GLU . 6.9 m -137.95 141.43 40.54 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 122.205 0.202 . . . . 0.0 110.846 -175.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 37.4 pt -127.67 148.65 32.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 171.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -144.54 141.0 29.18 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.559 0.695 . . . . 0.0 111.717 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 243' ' ' VAL . . . . . 0.603 ' O ' ' HA ' ' B' ' 285' ' ' GLU . 61.3 t -92.99 129.54 43.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.284 176.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 5.8 t -153.07 74.99 1.06 Allowed 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 245' ' ' GLN . . . . . 0.551 ' HB3' ' HG3' ' B' ' 249' ' ' GLN . 0.8 OUTLIER -116.7 168.36 10.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.646 -177.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 246' ' ' SER . . . . . 0.421 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 21.0 p -83.77 101.12 11.37 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.727 -177.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 42.62 -92.04 0.01 OUTLIER Glycine 0 N--CA 1.463 0.48 0 N-CA-C 115.817 1.087 . . . . 0.0 115.817 167.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -71.71 10.92 3.66 Favored Glycine 0 CA--C 1.519 0.329 0 N-CA-C 114.809 0.683 . . . . 0.0 114.809 -168.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . 0.551 ' HG3' ' HB3' ' B' ' 245' ' ' GLN . 13.3 mm100 -73.24 -21.1 60.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.664 0.732 . . . . 0.0 110.012 175.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 250' ' ' ILE . . . . . 0.401 HD11 ' HA ' ' B' ' 256' ' ' LEU . 46.9 mm -114.89 103.08 14.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.49 178.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 41.2 t -88.97 -16.9 30.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.653 0.264 . . . . 0.0 111.416 -177.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 252' ' ' SER . . . . . 0.548 ' HB2' ' HD2' ' B' ' 253' ' ' PRO . 89.4 p -163.92 165.78 13.07 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -178.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . 0.548 ' HD2' ' HB2' ' B' ' 252' ' ' SER . 9.4 Cg_endo -52.56 -32.0 51.79 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.821 2.347 . . . . 0.0 112.243 176.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 254' ' ' SER . . . . . 0.492 ' O ' ' HG3' ' B' ' 258' ' ' GLU . 5.1 m -59.28 -47.43 85.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.35 177.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.07 -43.71 74.15 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.879 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . 0.401 ' HA ' HD11 ' B' ' 250' ' ' ILE . 57.4 tp -57.7 -56.17 25.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.426 -175.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 257' ' ' ARG . . . . . 0.533 ' HA ' HD11 ' B' ' 260' ' ' LEU . 6.3 ppt_? -66.69 -31.18 71.68 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.34 -176.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 258' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' B' ' 254' ' ' SER . 44.2 mt-10 -63.14 -26.78 68.98 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.868 0.366 . . . . 0.0 111.03 177.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 259' ' ' LYS . . . . . 0.429 ' HA ' ' HD3' ' B' ' 259' ' ' LYS . 66.1 mmtt -88.28 -22.91 23.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.93 0.395 . . . . 0.0 110.52 177.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 260' ' ' LEU . . . . . 0.533 HD11 ' HA ' ' B' ' 257' ' ' ARG . 89.2 mt -74.13 -48.42 29.57 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.501 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 261' ' ' SER . . . . . 0.528 ' HB3' ' O ' ' A' ' 22' ' ' ALA . 2.7 p -65.78 -30.99 71.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.862 0.363 . . . . 0.0 110.542 176.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -56.48 -45.4 80.96 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.053 175.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 263' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' B' ' 259' ' ' LYS . 84.1 mt -74.74 -34.52 62.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.843 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -64.31 -38.7 91.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.214 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -62.95 -43.86 97.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.694 177.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -64.01 -34.38 77.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.635 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 12.8 mmtt -73.03 -46.94 49.03 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.852 177.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 99.23 32.8 5.67 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -176.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -104.48 171.99 19.89 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.568 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -111.83 -24.86 9.76 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.851 0.358 . . . . 0.0 111.423 -177.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 271' ' ' TYR . . . . . 0.61 ' HD1' ' HA ' ' B' ' 224' ' ' GLN . 24.0 m-85 -144.01 160.52 40.72 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 272' ' ' TYR . . . . . 0.421 ' HH ' ' HA ' ' A' ' 23' ' ' GLU . 38.9 p90 -137.55 129.17 28.41 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.047 0.451 . . . . 0.0 110.068 173.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -98.46 102.59 14.38 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.914 -177.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 274' ' ' ILE . . . . . 0.485 HG12 ' HB3' ' B' ' 288' ' ' ALA . 57.0 mt -67.25 129.74 32.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.821 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 19.0 pt -116.97 -26.84 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.807 -176.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -144.49 139.95 28.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.157 -177.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -154.79 117.5 4.34 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.222 177.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.91 156.77 36.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.928 0.394 . . . . 0.0 110.78 -177.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -88.8 117.43 27.79 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 167.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -92.77 14.48 17.15 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.492 0.663 . . . . 0.0 109.976 -175.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 129.93 -119.96 2.98 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 -175.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.93 -13.3 15.92 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.445 2.097 . . . . 0.0 111.765 173.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -106.82 142.96 35.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.665 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -104.1 130.8 51.82 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 285' ' ' GLU . . . . . 0.603 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 52.1 mt-10 -118.96 122.06 41.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.278 -176.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 286' ' ' ALA . . . . . 0.458 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -132.67 116.25 16.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.167 174.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 40.4 t -109.02 127.53 65.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.81 0.338 . . . . 0.0 111.067 -174.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 288' ' ' ALA . . . . . 0.485 ' HB3' HG12 ' B' ' 274' ' ' ILE . . . -139.25 133.53 31.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.957 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 289' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' B' ' 240' ' ' THR . 31.9 mt-10 -93.06 135.39 34.28 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 290' ' ' VAL . . . . . 0.5 ' HB ' HG22 ' B' ' 238' ' ' VAL . 3.8 t -92.96 138.87 19.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.037 0.446 . . . . 0.0 111.27 -168.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -130.02 149.38 51.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.478 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 292' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -114.68 159.78 20.11 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 171.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 . . . . . 0 N--CA 1.474 0.747 0 CA-C-O 121.492 0.663 . . . . 0.0 112.116 -174.609 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.612 ' HB2' ' CD2' ' B' ' 272' ' ' TYR . . . . . . . . 0 C--O 1.234 0.268 0 CA-C-O 120.9 0.381 . . . . 0.0 111.942 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.926 ' HB3' ' HE1' ' A' ' 71' ' ' TYR . 26.8 mt-10 -149.28 105.28 3.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.683 -179.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.553 ' CB ' ' HB2' ' B' ' 224' ' ' GLN . 0.0 OUTLIER -162.3 156.1 21.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.262 178.844 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.0 m -101.69 128.32 54.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.037 0.446 . . . . 0.0 110.887 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.534 ' O ' HG13 ' A' ' 30' ' ' ILE . 1.5 m -64.99 151.33 46.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.877 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.527 ' HB2' ' CE1' ' A' ' 73' ' ' HIS . 88.7 tttt -57.85 -40.52 80.31 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.128 0.489 . . . . 0.0 109.724 176.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -61.14 -39.06 88.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.408 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.543 ' HA ' ' HB3' ' A' ' 32' ' ' HIS . 20.6 mm-40 -76.94 -26.98 54.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.503 -177.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.534 HG13 ' O ' ' A' ' 26' ' ' SER . 86.0 mt -60.88 -45.07 98.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 173.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.4 m -73.42 -31.83 64.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.879 175.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.543 ' HB3' ' HA ' ' A' ' 29' ' ' GLU . 23.7 t-160 -65.82 -54.86 21.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.286 -177.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -92.67 -8.74 43.16 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.376 -177.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm 59.31 70.56 0.64 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.452 0.644 . . . . 0.0 110.592 -178.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 94.1 mt -76.31 163.0 27.44 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.306 -176.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 85.1 t -93.37 126.42 45.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.271 -177.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.537 ' HE3' ' HB3' ' A' ' 89' ' ' GLU . 21.7 tptm -70.12 116.76 10.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.651 175.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.2 m -122.84 26.0 3.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -174.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.12 -175.36 16.94 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.109 -1.043 . . . . 0.0 113.252 174.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 61.7 m -135.29 129.55 33.72 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 30.5 pt -104.48 138.62 28.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 175.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -135.02 122.23 21.54 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.197 0.522 . . . . 0.0 111.092 -173.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 59.0 t -93.45 121.69 44.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.062 176.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.2 t -141.23 30.79 1.76 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.752 0.786 . . . . 0.0 109.134 -177.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -91.24 160.55 15.47 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.773 -175.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.2 t -64.06 157.84 24.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.075 176.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.06 -20.14 33.5 Favored Glycine 0 C--O 1.228 -0.271 0 CA-C-N 116.039 -0.528 . . . . 0.0 113.314 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.26 -20.64 75.28 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.884 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -101.46 -2.04 31.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.893 0.377 . . . . 0.0 110.88 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.1 mm -130.8 75.23 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 171.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.0 t -96.46 -14.01 22.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.875 -168.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.1 m -155.43 160.0 31.22 Favored Pre-proline 0 C--N 1.322 -0.598 0 O-C-N 122.365 -0.209 . . . . 0.0 110.784 -176.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.5 -36.26 86.98 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.589 2.193 . . . . 0.0 111.623 175.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.56 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 0.1 OUTLIER -63.27 -44.36 95.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.648 0.737 . . . . 0.0 109.698 174.071 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -64.38 -27.74 69.21 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.136 -177.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.6 tp -61.59 -52.68 63.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.683 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -65.79 -28.13 68.79 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.432 -176.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.56 ' HG2' ' O ' ' A' ' 54' ' ' SER . 38.8 mm-40 -62.6 -34.62 77.38 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.974 0.416 . . . . 0.0 110.223 -178.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -83.25 -38.33 22.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.764 176.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.813 HD11 ' HH ' ' A' ' 72' ' ' TYR . 96.3 mt -61.78 -48.48 80.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.255 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.2 p -64.52 -36.4 84.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.021 0.439 . . . . 0.0 110.473 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -64.29 -40.38 95.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.193 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 86.2 mt -69.54 -44.79 70.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.9 177.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.61 -37.33 83.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.99 0.424 . . . . 0.0 110.652 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -66.68 -37.78 85.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.808 177.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.9 -34.96 78.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.772 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -80.65 -45.03 17.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.177 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 118.24 41.88 0.62 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.534 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.498 ' HA3' ' CG1' ' A' ' 90' ' ' VAL . . . -124.38 151.68 17.26 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.413 -0.899 . . . . 0.0 113.043 -177.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -81.04 -43.58 19.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.834 0.35 . . . . 0.0 110.44 176.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.926 ' HE1' ' HB3' ' A' ' 23' ' ' GLU . 78.9 m-85 -137.96 175.61 9.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.264 -174.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.813 ' HH ' HD11 ' A' ' 60' ' ' LEU . 0.6 OUTLIER -149.85 168.25 24.28 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -177.13 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.527 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 19.2 t-80 -135.05 126.1 27.79 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.49 -0.484 . . . . 0.0 109.812 172.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.0 mp -72.77 123.37 27.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.017 -178.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 33.1 pt -104.88 -31.13 2.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.386 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.469 ' HB3' ' NH1' ' A' ' 78' ' ' ARG . . . -161.82 117.9 2.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.025 -177.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -131.92 122.28 25.37 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.385 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.469 ' NH1' ' HB3' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -156.46 142.24 17.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.044 0.449 . . . . 0.0 110.888 -178.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -72.07 145.62 48.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.905 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -139.6 100.38 3.95 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 61.97 -123.87 32.57 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.991 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -88.29 6.6 4.8 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.994 2.463 . . . . 0.0 112.569 178.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -119.76 158.92 25.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.046 0.45 . . . . 0.0 111.123 -176.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -113.57 111.65 22.23 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.564 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.55 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 25.9 mm-40 -96.26 111.45 23.51 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.612 -176.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.507 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -124.99 115.17 20.13 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.754 177.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.2 t -105.64 124.86 60.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.499 -178.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.442 ' CB ' ' HD2' ' A' ' 72' ' ' TYR . . . -141.0 149.2 41.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.2 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.537 ' HB3' ' HE3' ' A' ' 37' ' ' LYS . 7.4 mt-10 -108.67 143.61 37.54 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.263 -178.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.498 ' CG1' ' HA3' ' A' ' 69' ' ' GLY . 11.4 t -95.04 137.57 23.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.642 -172.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -133.71 136.98 45.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.894 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -122.42 172.78 8.09 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.578 176.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.673 177.301 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 222' ' ' ALA . . . . . 0.414 ' HB2' ' CD1' ' A' ' 72' ' ' TYR . . . . . . . . 0 N--CA 1.463 0.222 0 CA-C-O 121.237 0.542 . . . . 0.0 111.588 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -161.12 125.5 3.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.839 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 224' ' ' GLN . . . . . 0.553 ' HB2' ' CB ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -159.3 167.97 27.59 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.782 176.845 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . 0.425 HG12 HD11 ' B' ' 235' ' ' LEU . 6.8 m -135.18 123.63 39.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.984 0.421 . . . . 0.0 110.353 174.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 226' ' ' SER . . . . . 0.416 ' O ' HG13 ' B' ' 230' ' ' ILE . 9.3 t -105.72 -171.72 1.96 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.581 178.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . 0.417 ' HE2' ' CA ' ' B' ' 227' ' ' LYS . 0.0 OUTLIER -55.33 -33.83 63.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.769 -175.092 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -70.74 -49.65 44.56 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.264 0.554 . . . . 0.0 110.365 -176.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 229' ' ' GLU . . . . . 0.402 ' O ' ' HD1' ' B' ' 233' ' ' PHE . 1.8 mp0 -72.13 -48.44 43.66 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.459 -176.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.516 HG12 HD13 ' B' ' 235' ' ' LEU . 89.9 mt -54.54 -49.68 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 -174.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 59.1 m -72.56 -21.17 61.2 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -176.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -89.12 -35.92 16.01 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.893 -177.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 233' ' ' PHE . . . . . 0.402 ' HD1' ' O ' ' B' ' 229' ' ' GLU . 81.7 m-85 -89.9 -15.02 32.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.377 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 234' ' ' LYS . . . . . 0.445 ' HB3' ' HE3' ' B' ' 234' ' ' LYS . 25.9 mmmt 59.79 77.55 0.31 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.225 0.536 . . . . 0.0 111.545 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . 0.516 HD13 HG12 ' B' ' 230' ' ' ILE . 94.4 mt -88.21 163.46 16.13 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.389 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 47.4 t -96.28 118.36 42.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.82 178.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -91.29 111.97 23.69 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 238' ' ' VAL . . . . . 0.42 HG22 ' HB ' ' B' ' 290' ' ' VAL . 2.6 m -90.28 -25.01 5.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -176.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 161.8 -156.29 27.78 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.046 -1.073 . . . . 0.0 112.863 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 87.4 m -139.7 131.45 27.43 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 122.476 0.311 . . . . 0.0 110.353 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 22.3 pt -103.98 143.11 16.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.008 0.432 . . . . 0.0 110.13 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -116.02 128.76 55.97 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.881 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 243' ' ' VAL . . . . . 0.553 ' HB ' ' HB1' ' B' ' 286' ' ' ALA . 58.0 t -96.8 124.31 49.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.613 177.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 23.2 t -153.35 88.77 1.31 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.895 0.379 . . . . 0.0 110.138 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 245' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -142.4 157.65 44.55 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 246' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' B' ' 283' ' ' ASN . 25.8 t -62.48 153.18 32.38 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.694 0.283 . . . . 0.0 110.385 177.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -60.51 -17.54 48.31 Favored Glycine 0 C--N 1.332 0.353 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.807 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.04 -23.33 69.5 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.362 176.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -88.98 -47.65 7.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.098 0.475 . . . . 0.0 110.547 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 44.9 mm -107.55 100.42 10.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.968 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 22.3 t -112.11 -11.43 13.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.993 0.425 . . . . 0.0 111.085 -175.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 78.8 p -149.33 163.66 24.23 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.399 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.72 -31.63 94.43 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.476 2.117 . . . . 0.0 111.639 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 254' ' ' SER . . . . . 0.546 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 8.1 t -65.49 -40.12 92.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.106 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -64.48 -38.46 91.11 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.297 0.57 . . . . 0.0 109.978 177.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 48.5 tp -60.24 -44.69 95.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.847 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 257' ' ' ARG . . . . . 0.463 ' HD3' ' OE1' ' A' ' 23' ' ' GLU . 0.3 OUTLIER -66.44 -34.76 78.66 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.787 -0.188 . . . . 0.0 110.712 -177.032 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 258' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' B' ' 254' ' ' SER . 67.7 mm-40 -59.54 -45.56 91.44 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-O 121.311 0.576 . . . . 0.0 109.604 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 259' ' ' LYS . . . . . 0.467 ' O ' ' HG ' ' B' ' 263' ' ' LEU . 38.8 tptt -72.91 -40.18 65.71 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.834 -178.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 81.1 mt -64.53 -48.73 73.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.346 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 49.4 m -64.56 -29.8 70.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.706 0.289 . . . . 0.0 110.541 178.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -64.34 -51.44 63.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.997 0.427 . . . . 0.0 110.248 174.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 263' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' B' ' 259' ' ' LYS . 86.8 mt -65.45 -36.58 84.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.922 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.53 -39.51 81.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.856 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -62.54 -35.54 79.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.149 0.5 . . . . 0.0 110.626 177.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -76.37 -11.35 59.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.932 -177.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -114.99 -27.04 7.5 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.817 0.341 . . . . 0.0 111.372 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 91.61 64.93 1.15 Allowed Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.5 176.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -137.82 156.94 23.99 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.611 175.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . 0.853 ' HD3' ' HB2' ' B' ' 293' ' ' ASP . 10.3 mtpm? -104.39 -12.67 16.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.824 0.312 . . . . 0.0 111.321 -178.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 271' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -146.37 159.96 42.69 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 272' ' ' TYR . . . . . 0.612 ' CD2' ' HB2' ' A' ' 22' ' ' ALA . 0.3 OUTLIER -132.37 163.52 28.51 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.165 171.42 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -128.58 101.93 6.38 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 175.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 274' ' ' ILE . . . . . 0.5 HG12 ' HB3' ' B' ' 288' ' ' ALA . 49.6 mt -82.23 118.04 29.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.083 0.468 . . . . 0.0 110.267 -177.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 16.9 pt -103.19 -39.27 5.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.457 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 276' ' ' ALA . . . . . 0.51 ' HB1' ' HB ' ' B' ' 287' ' ' VAL . . . -119.92 143.95 47.7 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.783 0.325 . . . . 0.0 111.417 -175.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -157.98 114.52 2.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.421 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 278' ' ' ARG . . . . . 0.455 ' HG2' ' HB2' ' B' ' 285' ' ' GLU . 0.0 OUTLIER -151.35 150.91 31.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.949 0.404 . . . . 0.0 111.147 -175.639 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -93.4 109.56 21.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.846 176.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 280' ' ' HIS . . . . . 0.417 ' HB2' ' CG ' ' B' ' 285' ' ' GLU . 4.7 t60 -69.26 -22.96 63.8 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 150.15 -110.66 0.48 Allowed Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -69.52 -15.82 38.19 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 122.319 2.013 . . . . 0.0 111.43 171.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 283' ' ' ASN . . . . . 0.561 ' HA ' ' HA ' ' B' ' 246' ' ' SER . 41.1 m-80 -111.85 151.82 28.65 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.464 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -107.88 133.78 51.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.41 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 285' ' ' GLU . . . . . 0.455 ' HB2' ' HG2' ' B' ' 278' ' ' ARG . 50.4 mm-40 -117.67 122.23 42.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.941 -175.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 286' ' ' ALA . . . . . 0.553 ' HB1' ' HB ' ' B' ' 243' ' ' VAL . . . -136.55 145.86 45.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.811 0.339 . . . . 0.0 110.673 177.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 287' ' ' VAL . . . . . 0.51 ' HB ' ' HB1' ' B' ' 276' ' ' ALA . 59.2 t -126.29 118.06 50.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.445 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 288' ' ' ALA . . . . . 0.5 ' HB3' HG12 ' B' ' 274' ' ' ILE . . . -129.09 136.16 49.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.054 -177.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -91.21 136.83 32.82 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 290' ' ' VAL . . . . . 0.42 ' HB ' HG22 ' B' ' 238' ' ' VAL . 12.7 t -97.91 127.36 50.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.748 0.309 . . . . 0.0 110.411 -176.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -120.75 134.5 55.28 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.265 0.555 . . . . 0.0 110.998 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 292' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -95.33 159.15 15.14 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 176.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 293' ' ' ASP . . . . . 0.853 ' HB2' ' HD3' ' B' ' 270' ' ' LYS . 3.2 t70 . . . . . 0 C--N 1.32 -0.696 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.492 -174.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.29 0 CA-C-O 120.591 0.234 . . . . 0.0 110.603 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.518 ' HB3' ' HG3' ' B' ' 257' ' ' ARG . 6.1 pt-20 -161.4 124.86 3.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.693 0.759 . . . . 0.0 111.796 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.764 ' HG3' ' HG3' ' B' ' 224' ' ' GLN . 0.0 OUTLIER -141.35 143.5 34.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.769 -173.54 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.535 HG21 ' HB2' ' A' ' 73' ' ' HIS . 3.5 m -103.19 126.84 57.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.364 0.602 . . . . 0.0 111.401 176.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.658 ' HB2' ' OE1' ' A' ' 28' ' ' GLN . 1.3 p -92.5 159.12 15.67 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.478 178.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.517 ' HA ' HD11 ' A' ' 30' ' ' ILE . 15.9 ttpp -69.67 -26.19 64.26 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.153 0.502 . . . . 0.0 109.688 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.658 ' OE1' ' HB2' ' A' ' 26' ' ' SER . 19.6 mp0 -59.9 -49.53 77.34 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.078 175.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.568 ' HA ' ' HB3' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -71.23 -25.76 62.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.948 -1.023 . . . . 0.0 112.347 -177.043 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.517 HD11 ' HA ' ' A' ' 27' ' ' LYS . 72.6 mt -52.93 -55.69 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.778 0.323 . . . . 0.0 110.503 177.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.9 t -73.59 -31.53 63.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.082 0.468 . . . . 0.0 110.564 176.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.568 ' HB3' ' HA ' ' A' ' 29' ' ' GLU . 15.1 t-160 -63.55 -51.37 65.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.901 -173.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -111.38 4.53 19.05 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 121.208 -0.197 . . . . 0.0 111.494 -176.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm 56.64 79.01 0.19 Allowed 'General case' 0 N--CA 1.465 0.29 0 O-C-N 123.696 0.622 . . . . 0.0 110.841 -177.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.506 HD11 HG12 ' A' ' 30' ' ' ILE . 91.0 mt -75.55 152.9 37.68 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.934 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.9 t -92.14 101.1 12.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.452 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.53 ' HE3' ' HB3' ' A' ' 89' ' ' GLU . 22.9 tptm -75.1 113.66 12.69 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.691 178.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.8 m -99.55 -9.37 8.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.134 0.492 . . . . 0.0 111.31 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 142.75 -179.75 20.16 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.432 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 21.3 m -131.09 126.69 36.43 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.1 pt -106.8 160.62 6.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.031 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -141.56 141.6 33.52 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.731 0.777 . . . . 0.0 111.8 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.661 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 53.5 t -94.13 135.33 28.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.943 179.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 10.0 t -150.38 86.7 1.42 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.121 0.486 . . . . 0.0 109.972 178.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.83 148.44 42.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.97 178.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.7 t -100.7 124.91 46.97 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.62 -177.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.45 -157.72 22.59 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.272 175.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.27 50.5 4.1 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.344 -0.455 . . . . 0.0 113.755 -172.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -75.42 -38.32 59.89 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 172.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' A' ' 56' ' ' LEU . 47.4 mm -105.24 95.03 3.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.541 176.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.3 t -108.58 -36.39 6.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.394 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.8 m -107.46 144.38 29.11 Favored Pre-proline 0 N--CA 1.448 -0.568 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.408 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.621 ' HG3' ' HB3' ' B' ' 233' ' ' PHE . 34.8 Cg_exo -56.99 -39.92 87.86 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.908 2.405 . . . . 0.0 111.707 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.1 t -62.37 -40.54 96.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.834 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -67.31 -34.79 78.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.941 -174.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.536 ' HA ' HD12 ' A' ' 50' ' ' ILE . 58.4 tp -57.89 -55.89 29.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.472 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.479 ' HA ' HD12 ' A' ' 60' ' ' LEU . 7.8 ppt_? -70.84 -24.55 62.55 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.285 -177.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -58.67 -34.82 71.68 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.95 0.405 . . . . 0.0 110.495 171.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -78.51 -36.55 44.76 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.41 175.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.479 HD12 ' HA ' ' A' ' 57' ' ' ARG . 97.0 mt -62.24 -48.77 78.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.146 -178.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.4 p -68.68 -42.15 78.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.741 0.305 . . . . 0.0 110.781 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -54.41 -42.83 70.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.988 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 94.2 mt -76.06 -51.06 13.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.883 178.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.47 -45.34 69.25 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -172.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.87 -42.63 94.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.113 0.482 . . . . 0.0 110.053 -176.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.41 -12.84 60.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.457 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -78.05 -22.99 48.31 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 175.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.72 59.98 0.7 Allowed Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.842 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.473 ' HA2' ' OD1' ' A' ' 92' ' ' ASN . . . -135.56 176.25 20.25 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.851 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -116.69 -30.18 5.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 117.04 0.42 . . . . 0.0 111.331 176.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -142.2 163.72 32.11 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.494 ' CE1' ' HB3' ' B' ' 224' ' ' GLN . 12.1 p90 -136.71 152.45 50.38 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.946 172.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.535 ' HB2' HG21 ' A' ' 25' ' ' VAL . 46.9 t-80 -131.53 108.88 9.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.166 -174.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.501 HD12 ' HB2' ' B' ' 226' ' ' SER . 69.0 mt -79.56 127.59 39.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.829 0.347 . . . . 0.0 110.672 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.4 pt -101.03 -29.37 3.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.49 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -159.84 141.46 12.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.905 0.383 . . . . 0.0 111.299 -177.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -142.95 126.53 16.87 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.49 147.45 34.54 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.373 0.606 . . . . 0.0 112.223 -175.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -93.71 104.81 16.89 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 169.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -87.55 11.45 14.89 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.314 0.578 . . . . 0.0 110.484 -171.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 120.27 -113.42 2.42 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 111.309 -0.717 . . . . 0.0 111.309 -178.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -73.79 -11.19 23.8 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.449 2.1 . . . . 0.0 112.172 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -122.17 140.54 52.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.92 0.391 . . . . 0.0 110.758 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.419 ' O ' ' HA ' ' A' ' 44' ' ' SER . 84.0 t80 -103.15 130.5 50.35 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 175.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.661 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 63.0 mt-10 -124.57 114.86 19.95 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.278 -175.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -121.18 121.24 37.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.325 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.6 t -105.34 120.46 56.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.659 0.266 . . . . 0.0 110.821 -176.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.476 ' HB2' HG12 ' A' ' 74' ' ' ILE . . . -131.57 137.73 48.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.082 0.468 . . . . 0.0 111.274 -177.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.53 ' HB3' ' HE3' ' A' ' 37' ' ' LYS . 30.4 mt-10 -91.73 145.68 24.38 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.586 177.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 18.3 t -105.25 129.84 57.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -125.38 134.96 51.97 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.496 0.665 . . . . 0.0 112.024 -177.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.473 ' OD1' ' HA2' ' A' ' 69' ' ' GLY . 56.0 m-20 -109.72 179.45 4.12 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.234 169.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 39.9 p30 . . . . . 0 C--N 1.317 -0.821 0 CA-C-O 120.812 0.339 . . . . 0.0 110.191 175.828 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.189 0 CA-C-O 120.235 0.064 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 223' ' ' GLU . . . . . 0.458 ' OE2' ' HD3' ' A' ' 57' ' ' ARG . 4.7 mm-40 -147.34 125.54 12.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.998 0.428 . . . . 0.0 111.282 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 224' ' ' GLN . . . . . 0.764 ' HG3' ' HG3' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -147.38 138.56 23.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.782 -174.431 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . 0.413 HG11 ' HB2' ' B' ' 271' ' ' TYR . 12.3 m -94.95 136.03 27.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.226 0.536 . . . . 0.0 110.414 175.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 226' ' ' SER . . . . . 0.501 ' HB2' HD12 ' A' ' 74' ' ' ILE . 28.4 t -82.78 148.01 28.06 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.229 -175.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . 0.514 ' HD3' ' O ' ' B' ' 227' ' ' LYS . 12.6 tmtt? -69.57 -36.69 76.54 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -65.16 -36.11 83.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.458 177.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 229' ' ' GLU . . . . . 0.582 ' HA ' ' HB3' ' B' ' 232' ' ' HIS . 0.0 OUTLIER -68.66 -25.63 64.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.649 -178.557 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 73.8 mt -56.15 -53.06 43.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 174.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 46.2 t -73.62 -31.19 63.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.059 177.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 232' ' ' HIS . . . . . 0.582 ' HB3' ' HA ' ' B' ' 229' ' ' GLU . 22.1 t-160 -72.57 -46.82 52.5 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.658 -173.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 233' ' ' PHE . . . . . 0.621 ' HB3' ' HG3' ' A' ' 53' ' ' PRO . 82.5 m-85 -111.49 6.45 20.19 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -175.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm 56.25 51.68 11.31 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.36 0.412 . . . . 0.0 110.587 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 89.9 mt -57.2 140.2 50.37 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.693 -176.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 75.0 t -79.86 117.72 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.635 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -81.41 105.68 12.77 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.806 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 238' ' ' VAL . . . . . 0.433 ' CG1' ' HB2' ' B' ' 292' ' ' ASN . 36.0 m -87.05 -16.11 9.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.799 -0.361 . . . . 0.0 111.792 -175.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 160.98 145.09 4.19 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 119.883 -1.151 . . . . 0.0 113.077 177.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 240' ' ' THR . . . . . 0.532 HG23 ' HG2' ' B' ' 289' ' ' GLU . 24.8 m -97.78 122.32 40.74 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 174.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 24.0 pt -103.58 131.71 51.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.303 0.573 . . . . 0.0 110.849 -177.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -102.27 112.48 25.18 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.628 176.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 243' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 87.6 t -95.55 108.92 21.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.199 176.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 244' ' ' SER . . . . . 0.521 ' HA ' ' O ' ' B' ' 284' ' ' PHE . 7.9 t -127.9 94.19 3.87 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.323 0.582 . . . . 0.0 109.632 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 245' ' ' GLN . . . . . 0.529 ' HB2' ' HB3' ' B' ' 284' ' ' PHE . 0.0 OUTLIER -86.28 147.45 26.07 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.396 -177.204 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 22.8 t -101.31 102.48 13.34 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 177.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 94.65 177.25 38.4 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.441 -0.663 . . . . 0.0 111.441 -174.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -79.3 66.28 3.49 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.819 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -76.2 -21.02 56.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.163 0.506 . . . . 0.0 110.879 -177.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 50.0 mm -98.75 122.17 50.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 176.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 1.9 m -109.94 -53.8 2.63 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.287 0.565 . . . . 0.0 110.231 -176.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 16.0 m -114.91 163.08 20.74 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.493 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.6 -29.14 59.26 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.463 2.109 . . . . 0.0 111.979 176.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 254' ' ' SER . . . . . 0.559 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 1.6 p -60.52 -44.09 96.43 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.568 177.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -56.43 -45.33 80.79 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.24 0.543 . . . . 0.0 110.225 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 46.6 tp -68.32 -39.41 81.98 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.55 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 257' ' ' ARG . . . . . 0.518 ' HG3' ' HB3' ' A' ' 23' ' ' GLU . 6.7 ttp85 -60.33 -46.8 88.63 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.759 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 258' ' ' GLU . . . . . 0.559 ' HG2' ' O ' ' B' ' 254' ' ' SER . 33.7 mm-40 -57.99 -42.98 86.28 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.598 -178.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 259' ' ' LYS . . . . . 0.536 ' O ' ' HG ' ' B' ' 263' ' ' LEU . 75.4 mmtt -64.12 -48.25 76.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.446 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 97.6 mt -66.67 -38.75 87.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.414 -176.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 29.5 t -65.35 -38.92 91.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.841 0.353 . . . . 0.0 110.095 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -63.16 -47.11 84.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.254 0.55 . . . . 0.0 110.145 177.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 263' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' B' ' 259' ' ' LYS . 85.1 mt -64.05 -42.62 96.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.967 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -58.9 -48.29 81.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.335 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -62.83 -43.98 97.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.256 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -68.1 -37.79 81.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.925 0.393 . . . . 0.0 111.338 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -78.86 -3.73 46.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.408 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 76.17 48.5 9.56 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.141 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -128.47 -179.66 16.03 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.681 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . 0.787 ' HZ2' ' HB3' ' B' ' 270' ' ' LYS . 7.9 mtpm? -115.88 -63.57 1.43 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.723 0.296 . . . . 0.0 110.608 -178.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 271' ' ' TYR . . . . . 0.413 ' HB2' HG11 ' B' ' 225' ' ' VAL . 13.9 m-85 -122.99 174.38 7.22 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 272' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -139.01 166.79 23.57 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.663 -175.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -141.49 125.49 17.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.849 175.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 274' ' ' ILE . . . . . . . . . . . . . 84.9 mt -82.75 140.11 16.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.412 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 19.1 pt -125.12 -22.29 2.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -152.66 109.1 3.41 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.738 0.304 . . . . 0.0 110.596 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -132.23 121.17 23.21 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.832 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 278' ' ' ARG . . . . . 0.423 ' N ' ' HD2' ' B' ' 278' ' ' ARG . 0.0 OUTLIER -141.64 130.76 23.35 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.334 0.587 . . . . 0.0 111.256 -178.025 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -75.39 106.24 6.82 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 174.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -80.73 -24.93 38.39 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.458 -172.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 113.12 -89.75 0.53 Allowed Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -70.28 -12.65 32.28 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.42 2.08 . . . . 0.0 111.353 174.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -140.29 170.54 15.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.562 177.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 284' ' ' PHE . . . . . 0.529 ' HB3' ' HB2' ' B' ' 245' ' ' GLN . 72.9 t80 -131.89 119.87 21.77 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 285' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -109.45 111.21 22.62 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 123.108 0.255 . . . . 0.0 110.395 -175.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 286' ' ' ALA . . . . . 0.562 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -123.83 117.16 24.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.983 0.42 . . . . 0.0 110.838 174.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 38.3 t -105.21 118.28 52.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.277 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -140.36 150.1 43.53 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.148 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 289' ' ' GLU . . . . . 0.532 ' HG2' HG23 ' B' ' 240' ' ' THR . 32.6 mt-10 -109.85 143.18 40.1 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 177.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 290' ' ' VAL . . . . . 0.431 ' O ' HG22 ' B' ' 238' ' ' VAL . 17.2 t -102.42 141.09 19.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 291' ' ' TYR . . . . . 0.411 ' CD2' HG21 ' B' ' 225' ' ' VAL . 71.6 m-85 -128.04 149.62 50.3 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.776 0.322 . . . . 0.0 110.346 -178.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 292' ' ' ASN . . . . . 0.433 ' HB2' ' CG1' ' B' ' 238' ' ' VAL . 5.5 t-20 -104.7 24.58 11.56 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.245 0.545 . . . . 0.0 111.163 -176.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 . . . . . 0 C--N 1.317 -0.807 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.31 179.997 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.099 0 CA-C-O 121.021 0.439 . . . . 0.0 111.515 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.459 ' H ' ' HB2' ' B' ' 223' ' ' GLU . 33.7 mt-10 -150.4 99.37 2.77 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.574 -175.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.8 156.21 5.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.649 176.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.459 ' HB ' ' HB2' ' A' ' 29' ' ' GLU . 19.6 m -122.79 143.38 35.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.185 177.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.489 ' O ' HG13 ' A' ' 30' ' ' ILE . 94.9 p -93.78 -167.6 1.72 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.918 0.39 . . . . 0.0 110.738 -176.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -62.18 -38.53 89.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.624 -174.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.524 ' HB2' ' OE2' ' A' ' 29' ' ' GLU . 0.9 OUTLIER -62.17 -49.98 73.66 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.096 0.474 . . . . 0.0 110.601 -176.416 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.524 ' OE2' ' HB2' ' A' ' 28' ' ' GLN . 1.8 mp0 -62.32 -40.86 97.72 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.251 -177.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.511 HG12 HD11 ' A' ' 35' ' ' LEU . 80.8 mt -55.35 -48.28 77.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 121.048 0.452 . . . . 0.0 110.712 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.9 m -73.28 -41.61 63.4 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.749 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 12.6 t60 -76.99 -32.28 57.09 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.79 0.292 . . . . 0.0 111.79 -171.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -101.87 -2.78 29.15 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 121.352 -0.139 . . . . 0.0 111.257 -178.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt 44.68 100.02 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 122.294 1.045 . . . . 0.0 113.76 -171.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.511 HD11 HG12 ' A' ' 30' ' ' ILE . 91.7 mt -104.67 152.82 22.02 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.106 -1.406 . . . . 0.0 111.368 -176.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.1 t -88.09 105.66 15.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.932 -175.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.589 ' HZ1' ' CD ' ' A' ' 89' ' ' GLU . 25.4 tttp -73.87 118.49 16.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.956 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 26.8 m -100.05 -21.9 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -178.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.58 -171.83 34.23 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.43 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 27.2 m -125.17 139.49 53.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.666 0.269 . . . . 0.0 110.659 -178.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.3 pt -114.7 143.88 23.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 175.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -126.18 131.12 52.07 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.105 0.479 . . . . 0.0 111.359 -173.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 95.9 t -93.89 125.67 46.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.084 173.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -153.16 88.96 1.33 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.863 0.364 . . . . 0.0 110.135 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -138.46 163.45 31.91 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.884 177.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.551 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 4.0 p -66.05 148.92 51.07 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.122 0.487 . . . . 0.0 111.835 -178.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.88 114.42 6.03 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.934 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 137.62 -39.38 1.61 Allowed Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 -175.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -70.24 -29.29 66.06 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.465 0.65 . . . . 0.0 109.632 175.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.414 HD12 ' HG3' ' A' ' 59' ' ' LYS . 46.1 mm -118.38 109.19 26.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.728 174.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.5 t -116.18 -44.53 2.89 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.041 0.448 . . . . 0.0 110.23 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.2 m -104.06 157.14 34.61 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.073 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.931 ' HG3' HD21 ' B' ' 235' ' ' LEU . 22.1 Cg_endo -61.08 -28.79 86.3 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.411 2.074 . . . . 0.0 110.857 175.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.636 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 0.8 OUTLIER -60.34 -45.29 93.99 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.118 176.12 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.487 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 71.8 m-20 -54.93 -46.88 75.0 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.117 0.484 . . . . 0.0 110.25 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 59.2 tp -57.14 -47.82 80.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.898 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.51 -31.49 68.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.91 -176.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.636 ' HG2' ' O ' ' A' ' 54' ' ' SER . 57.7 mm-40 -63.2 -43.16 98.95 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.982 0.42 . . . . 0.0 110.013 176.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.487 ' HG2' ' O ' ' A' ' 55' ' ' ASP . 31.5 mmmt -67.24 -45.6 76.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.562 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 87.5 mt -65.24 -38.82 91.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.509 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.4 t -63.47 -35.75 81.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.96 0.409 . . . . 0.0 110.316 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -59.75 -42.88 94.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.251 176.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 87.3 mt -74.74 -33.68 62.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.936 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.93 -40.17 94.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.449 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -61.21 -35.82 78.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.373 176.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.59 2.49 29.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.579 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.42 ' HD3' ' HA ' ' A' ' 67' ' ' LYS . 42.9 mmtm -122.08 -0.05 9.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.911 0.386 . . . . 0.0 110.687 176.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 60.73 40.5 98.17 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.631 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -108.2 135.56 12.91 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.007 -178.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -77.68 -25.7 49.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.365 0.602 . . . . 0.0 110.021 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -152.93 175.44 12.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.215 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -147.65 170.22 17.98 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.925 -176.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -135.42 114.23 11.95 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 119.994 -0.683 . . . . 0.0 110.915 174.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.463 ' HA ' ' HA ' ' A' ' 88' ' ' ALA . 55.8 mt -78.39 127.53 38.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.777 177.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 23.2 pt -100.92 -35.2 4.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.585 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -156.32 144.86 20.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.817 0.341 . . . . 0.0 111.424 -177.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -147.14 124.67 11.7 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.07 152.21 40.68 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.888 0.375 . . . . 0.0 111.213 -174.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -86.0 118.88 25.75 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.488 170.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -80.11 -22.13 42.5 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 128.4 -86.28 0.32 Allowed Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 -175.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.551 ' O ' ' HA ' ' A' ' 46' ' ' SER . 70.1 Cg_endo -74.73 -24.0 13.86 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.16 1.907 . . . . 0.0 111.374 172.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.458 ' OD1' ' HG2' ' A' ' 82' ' ' PRO . 1.1 m120 -119.57 150.15 40.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.323 -176.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -108.13 121.67 45.33 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 170.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.677 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 46.2 mt-10 -117.71 118.98 33.57 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.206 0.527 . . . . 0.0 111.782 -174.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -121.36 132.13 54.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.992 176.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.1 t -111.54 112.85 42.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.997 0.427 . . . . 0.0 110.421 -178.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 74' ' ' ILE . . . -125.13 135.57 52.78 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.223 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.589 ' CD ' ' HZ1' ' A' ' 37' ' ' LYS . 33.2 mt-10 -106.0 134.96 48.29 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 26.2 t -90.66 132.19 35.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -175.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -123.25 125.73 45.61 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.167 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.68 147.39 25.26 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 174.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.061 -178.769 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.317 0 CA-C-O 121.264 0.554 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 223' ' ' GLU . . . . . 0.459 ' HB2' ' H ' ' A' ' 23' ' ' GLU . 4.2 mm-40 -127.07 89.14 2.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.274 -173.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 224' ' ' GLN . . . . . 0.63 ' HA ' ' HB3' ' B' ' 271' ' ' TYR . 0.0 OUTLIER -176.62 155.73 1.38 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.285 169.264 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 20.3 m -125.88 150.85 31.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.272 175.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 226' ' ' SER . . . . . 0.445 ' O ' HG13 ' B' ' 230' ' ' ILE . 12.7 t -83.74 171.61 13.02 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . 0.493 ' HA ' HD13 ' B' ' 230' ' ' ILE . 74.3 tttt -68.74 -19.55 64.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.343 -173.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 228' ' ' GLN . . . . . 0.434 ' HB2' ' OE1' ' B' ' 229' ' ' GLU . 0.6 OUTLIER -65.75 -50.36 65.07 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 177.315 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 229' ' ' GLU . . . . . 0.434 ' OE1' ' HB2' ' B' ' 228' ' ' GLN . 1.9 mp0 -64.58 -41.33 96.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.444 178.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.493 HD13 ' HA ' ' B' ' 227' ' ' LYS . 87.4 mt -56.84 -46.46 83.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.898 178.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 16.5 m -73.14 -21.29 60.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.458 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 -85.48 -48.03 9.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.806 -176.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -91.19 -7.81 50.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.033 -177.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 57.95 64.56 1.5 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.082 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . 0.931 HD21 ' HG3' ' A' ' 53' ' ' PRO . 60.4 mt -75.21 147.26 40.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.236 -178.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 46.8 t -88.55 119.09 35.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.08 -175.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -80.53 117.56 21.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.12 175.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 2.0 m -80.26 -39.48 19.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.841 177.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 179.37 -173.27 45.26 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.991 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 33.3 m -115.22 129.81 56.74 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.245 -0.279 . . . . 0.0 110.245 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 24.2 pt -104.08 132.66 50.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.006 0.431 . . . . 0.0 110.177 175.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -117.55 123.08 45.38 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.582 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 243' ' ' VAL . . . . . 0.691 ' O ' ' HA ' ' B' ' 285' ' ' GLU . 41.9 t -92.6 120.42 41.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 173.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 15.9 t -150.97 87.16 1.39 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.345 0.593 . . . . 0.0 109.511 -177.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 245' ' ' GLN . . . . . 0.535 ' HG3' ' HB2' ' B' ' 249' ' ' GLN . 6.3 pm0 -138.62 173.62 11.39 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.734 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 8.6 t -85.39 176.21 8.41 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.735 0.302 . . . . 0.0 110.275 -176.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.69 52.42 1.57 Allowed Glycine 0 CA--C 1.521 0.439 0 CA-C-N 116.098 -0.501 . . . . 0.0 113.246 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -141.28 -39.78 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 176.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . 0.535 ' HB2' ' HG3' ' B' ' 245' ' ' GLN . 77.3 mt-30 -80.03 -15.13 57.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.587 -0.306 . . . . 0.0 110.518 175.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 250' ' ' ILE . . . . . 0.57 ' HA ' ' OD2' ' B' ' 255' ' ' ASP . 47.4 mm -131.76 110.22 16.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 175.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 8.5 t -118.25 -27.98 5.91 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.606 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 252' ' ' SER . . . . . 0.536 ' HB3' ' HD2' ' B' ' 253' ' ' PRO . 50.6 m -152.22 164.72 19.36 Favored Pre-proline 0 C--N 1.327 -0.383 0 O-C-N 122.357 -0.214 . . . . 0.0 110.62 -175.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . 0.536 ' HD2' ' HB3' ' B' ' 252' ' ' SER . 12.3 Cg_endo -56.95 -43.9 49.76 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.8 2.333 . . . . 0.0 112.503 178.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 254' ' ' SER . . . . . . . . . . . . . 4.3 p -64.14 -30.46 71.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.361 0.6 . . . . 0.0 110.726 177.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 255' ' ' ASP . . . . . 0.57 ' OD2' ' HA ' ' B' ' 250' ' ' ILE . 28.1 t70 -75.75 -37.1 59.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.458 177.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 60.6 tp -61.64 -47.54 84.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.945 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 257' ' ' ARG . . . . . 0.506 ' HA ' HD12 ' B' ' 260' ' ' LEU . 2.0 ppt_? -59.19 -25.38 63.9 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -175.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 258' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -63.0 -47.5 82.86 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.169 0.509 . . . . 0.0 110.372 176.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 259' ' ' LYS . . . . . 0.515 ' N ' ' HD2' ' B' ' 259' ' ' LYS . 12.2 mptt -74.16 -26.23 60.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.559 -175.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 260' ' ' LEU . . . . . 0.506 HD12 ' HA ' ' B' ' 257' ' ' ARG . 95.9 mt -67.79 -48.21 66.94 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.479 176.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 14.4 t -66.1 -37.59 86.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.891 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -51.2 -49.4 61.09 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.083 176.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 263' ' ' LEU . . . . . . . . . . . . . 87.7 mt -74.48 -30.39 61.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.547 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.42 -40.95 81.01 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -177.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -63.48 -35.48 80.58 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.24 0.543 . . . . 0.0 110.42 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -74.59 -6.74 50.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.471 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -116.16 -2.84 12.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.84 176.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 66.29 51.09 46.28 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.158 -0.544 . . . . 0.0 112.854 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -138.92 169.35 24.46 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.172 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . 0.434 ' HB3' ' OE1' ' B' ' 223' ' ' GLU . 46.0 mtmt -105.56 -66.56 0.98 Allowed 'General case' 0 C--O 1.223 -0.334 0 CA-C-O 121.017 0.437 . . . . 0.0 110.923 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 271' ' ' TYR . . . . . 0.63 ' HB3' ' HA ' ' B' ' 224' ' ' GLN . 16.0 m-85 -92.41 152.66 19.6 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -174.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 272' ' ' TYR . . . . . 0.566 ' O ' ' HG3' ' B' ' 224' ' ' GLN . 2.8 p90 -134.69 118.28 16.96 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.352 0.596 . . . . 0.0 110.203 175.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 273' ' ' HIS . . . . . 0.502 ' HA ' ' OE1' ' B' ' 224' ' ' GLN . 32.7 t-80 -87.84 101.21 13.49 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 274' ' ' ILE . . . . . 0.49 HG12 ' HB3' ' B' ' 288' ' ' ALA . 58.5 mt -74.17 106.44 4.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.314 -178.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 19.4 pt -85.66 -33.36 7.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.588 -175.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -151.58 124.13 8.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.703 0.287 . . . . 0.0 111.193 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -130.47 118.43 21.12 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 174.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -133.67 164.96 26.05 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.384 0.612 . . . . 0.0 111.064 -175.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -99.14 123.28 43.31 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.027 178.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 280' ' ' HIS . . . . . 0.457 ' HB3' ' HB2' ' B' ' 283' ' ' ASN . 12.1 t-80 -103.07 28.95 5.82 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.198 0.523 . . . . 0.0 110.067 -174.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 93.0 -108.3 3.64 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -178.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -83.23 4.3 7.16 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.666 2.244 . . . . 0.0 111.518 175.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 283' ' ' ASN . . . . . 0.457 ' HB2' ' HB3' ' B' ' 280' ' ' HIS . 15.6 m120 -126.16 142.02 51.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.484 -177.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -103.61 129.03 50.81 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 173.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 285' ' ' GLU . . . . . 0.691 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 31.2 mt-10 -121.95 113.97 20.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.787 0.327 . . . . 0.0 111.651 -178.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 286' ' ' ALA . . . . . 0.519 ' HB1' ' HB ' ' B' ' 243' ' ' VAL . . . -117.59 127.97 54.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.554 175.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 32.1 t -110.09 116.43 52.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.23 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 288' ' ' ALA . . . . . 0.517 ' HB1' ' HB2' ' B' ' 272' ' ' TYR . . . -128.31 139.24 52.52 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.131 0.491 . . . . 0.0 111.783 -177.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -91.9 123.46 35.29 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.352 177.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 16.5 t -90.78 127.4 43.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.461 -176.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -123.49 139.83 53.62 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.018 -177.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 292' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -106.39 165.77 11.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.106 172.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 . . . . . 0 C--O 1.236 0.38 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 175.98 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.332 0 CA-C-O 121.387 0.613 . . . . 0.0 111.369 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.697 ' HB3' ' HE2' ' A' ' 71' ' ' TYR . 42.8 mt-10 -133.88 160.67 36.95 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.38 176.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.58 ' CG ' ' HG3' ' B' ' 224' ' ' GLN . 0.0 OUTLIER 174.66 142.88 0.05 Allowed 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.539 0.525 . . . . 0.0 110.424 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.2 m -123.97 125.2 70.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 169.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.431 ' O ' HG13 ' A' ' 30' ' ' ILE . 8.2 t -99.38 -167.93 1.54 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.025 0.44 . . . . 0.0 110.915 -175.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.401 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -71.26 -36.62 71.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.321 -175.169 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -64.54 -50.33 67.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.058 -173.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -59.17 -36.07 74.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.426 -177.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 26' ' ' SER . 79.2 mt -57.19 -56.05 17.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.93 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.6 m -73.77 -30.51 62.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.749 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 17.6 t-160 -79.08 -51.84 9.01 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -174.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -93.03 -7.81 44.7 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 121.18 -0.208 . . . . 0.0 111.467 -174.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt 59.66 65.12 1.19 Allowed 'General case' 0 N--CA 1.463 0.212 0 O-C-N 123.555 0.534 . . . . 0.0 110.656 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.4 mt -65.47 144.49 57.0 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.54 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.482 ' HB ' ' HB3' ' A' ' 92' ' ' ASN . 95.3 t -73.23 112.56 9.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.06 0.457 . . . . 0.0 110.477 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.605 ' HD3' ' CE1' ' A' ' 91' ' ' TYR . 19.3 tptm -78.75 112.98 16.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.125 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.476 HG22 ' HA3' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -97.99 -13.19 8.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.816 -178.675 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 145.48 -170.81 26.71 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.293 -0.956 . . . . 0.0 112.571 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.479 HG21 ' HG2' ' A' ' 89' ' ' GLU . 52.2 m -137.17 139.38 41.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.632 0.253 . . . . 0.0 110.432 -178.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 34.5 pt -121.97 155.65 26.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.743 0.306 . . . . 0.0 110.201 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -141.18 140.53 34.05 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.218 0.533 . . . . 0.0 110.728 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 44.1 t -94.6 126.31 47.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.313 -0.858 . . . . 0.0 108.775 173.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.7 p -138.69 35.83 2.21 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.848 0.832 . . . . 0.0 108.894 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -99.75 159.73 14.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.942 -175.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.55 ' HA ' ' HA ' ' A' ' 83' ' ' ASN . 22.7 t -73.31 172.09 11.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.829 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.96 22.07 1.55 Allowed Glycine 0 CA--C 1.52 0.363 0 CA-C-N 116.178 -0.464 . . . . 0.0 113.366 -177.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -103.96 -21.78 9.33 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 173.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -102.41 -20.22 14.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.339 0.59 . . . . 0.0 109.63 178.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.3 mm -125.58 98.05 4.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.17 172.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.8 m -103.26 -66.54 0.93 Allowed 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.651 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.527 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 23.5 m -108.24 165.0 13.51 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.527 ' HD2' ' HB3' ' A' ' 52' ' ' SER . 11.2 Cg_endo -55.14 -32.49 80.2 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.581 2.188 . . . . 0.0 111.88 178.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.591 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 7.9 m -60.76 -43.25 98.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.896 177.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.505 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 18.3 m-20 -63.39 -36.49 83.88 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.536 -178.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.7 tp -60.86 -46.73 89.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.496 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.434 ' HD2' ' HG2' ' B' ' 223' ' ' GLU . 23.5 ttp180 -60.63 -42.65 97.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.44 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.591 ' HG2' ' O ' ' A' ' 54' ' ' SER . 31.3 mm-40 -63.05 -34.84 78.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.841 -179.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' ' 55' ' ' ASP . 42.9 mmtm -75.29 -43.54 50.6 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.806 0.336 . . . . 0.0 110.707 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.1 mt -62.69 -46.38 88.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.066 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.7 p -64.76 -40.05 94.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.994 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -58.8 -44.15 90.71 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.797 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.7 mt -74.49 -36.03 63.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.511 -179.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.38 -47.09 74.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.815 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -64.35 -35.36 80.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.069 0.462 . . . . 0.0 110.487 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -78.64 4.78 12.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.55 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.7 mmtm -119.45 3.95 11.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.779 0.323 . . . . 0.0 111.563 176.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.46 -17.46 58.41 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.215 174.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.476 ' HA3' HG22 ' A' ' 38' ' ' VAL . . . -92.47 179.73 40.51 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.846 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.549 ' HE2' ' HA ' ' A' ' 70' ' ' LYS . 9.2 mmpt? -122.18 -59.13 1.67 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.672 0.272 . . . . 0.0 110.456 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.697 ' HE2' ' HB3' ' A' ' 23' ' ' GLU . 95.2 m-85 -91.67 167.35 12.26 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.545 -175.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -146.3 157.65 43.82 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.794 0.33 . . . . 0.0 110.912 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.429 ' CD2' ' HA ' ' A' ' 26' ' ' SER . 40.6 t-80 -127.48 102.88 7.06 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.098 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.43 ' HA ' ' HA ' ' A' ' 88' ' ' ALA . 63.9 mt -63.81 127.24 23.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.466 176.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.4 pt -113.45 -14.6 10.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.857 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.448 ' HB3' ' HB ' ' A' ' 87' ' ' VAL . . . -150.2 123.83 9.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.733 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' B' ' 228' ' ' GLN . . . -135.34 108.34 7.63 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.445 HH11 ' HD3' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -149.6 171.98 15.77 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.578 -174.668 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -119.5 140.1 51.04 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -130.36 96.69 4.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.017 0.437 . . . . 0.0 110.08 -178.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 60.8 -125.36 38.09 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -175.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -90.6 20.51 0.97 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.852 2.368 . . . . 0.0 112.348 175.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.55 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 38.4 m-80 -123.86 151.88 42.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.361 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.422 ' CE2' ' HB3' ' A' ' 86' ' ' ALA . 83.6 t80 -111.21 120.45 42.32 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.049 178.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.569 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 26.2 mm-40 -102.03 110.62 22.64 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.403 -177.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.422 ' HB3' ' CE2' ' A' ' 84' ' ' PHE . . . -128.38 114.99 17.55 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.808 0.337 . . . . 0.0 110.768 177.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.448 ' HB ' ' HB3' ' A' ' 76' ' ' ALA . 48.3 t -105.68 117.37 51.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 120.77 0.319 . . . . 0.0 110.344 -178.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 74' ' ' ILE . . . -131.84 133.09 44.29 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.455 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.556 ' HB3' ' HE3' ' A' ' 37' ' ' LYS . 29.8 mt-10 -92.0 135.26 34.09 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.9 t -91.42 127.72 43.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -175.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.605 ' CE1' ' HD3' ' A' ' 37' ' ' LYS . 77.1 m-85 -128.14 136.98 51.89 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.336 0.589 . . . . 0.0 110.879 -178.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.482 ' HB3' ' HB ' ' A' ' 36' ' ' VAL . 8.0 t-20 -95.15 -176.86 3.94 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 174.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.4 t70 . . . . . 0 CA--C 1.538 0.498 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.609 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.242 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 223' ' ' GLU . . . . . 0.434 ' HG2' ' HD2' ' A' ' 57' ' ' ARG . 28.9 mt-10 -138.8 164.96 28.25 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 173.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 224' ' ' GLN . . . . . 0.58 ' HG3' ' CG ' ' A' ' 24' ' ' GLN . 26.1 tt0 179.6 146.99 0.22 Allowed 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.405 0.441 . . . . 0.0 111.247 175.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . 0.504 ' N ' ' HG2' ' B' ' 224' ' ' GLN . 17.2 m -141.94 139.73 30.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 167.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 226' ' ' SER . . . . . 0.709 ' HA ' ' CD2' ' B' ' 273' ' ' HIS . 4.5 m -109.21 -89.81 0.47 Allowed 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.954 -0.299 . . . . 0.0 111.658 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . 0.428 ' HZ1' ' CD ' ' B' ' 289' ' ' GLU . 14.5 mmtm -154.66 -41.83 0.09 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.079 0.466 . . . . 0.0 109.774 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 228' ' ' GLN . . . . . 0.444 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -63.39 -44.19 95.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.191 -178.254 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -65.62 -40.0 92.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.6 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.535 HG22 ' HB2' ' B' ' 235' ' ' LEU . 77.6 mt -66.82 -38.05 80.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.497 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 30.7 t -71.38 -25.66 62.46 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.956 177.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -87.86 -46.69 9.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.983 -175.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 233' ' ' PHE . . . . . 0.462 ' CD1' ' HD3' ' A' ' 53' ' ' PRO . 68.6 m-85 -94.09 -7.39 42.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.401 -177.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt 61.08 74.1 0.46 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.523 174.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . 0.535 ' HB2' HG22 ' B' ' 230' ' ' ILE . 68.1 mt -88.89 176.41 7.04 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.808 0.337 . . . . 0.0 111.211 -177.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 59.4 t -101.89 123.71 55.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.057 -177.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 237' ' ' LYS . . . . . 0.648 ' HD3' ' CZ ' ' B' ' 291' ' ' TYR . 18.9 tptm -82.74 111.85 19.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.763 177.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 238' ' ' VAL . . . . . 0.44 HG21 HG12 ' B' ' 290' ' ' VAL . 0.4 OUTLIER -104.84 14.37 7.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -176.113 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 128.2 -162.53 21.94 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.279 -0.963 . . . . 0.0 113.216 173.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 89.4 m -149.08 135.61 19.46 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 26.7 pt -110.18 146.07 15.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.311 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -130.56 114.94 16.09 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.715 -178.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 243' ' ' VAL . . . . . 0.538 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 76.7 t -94.4 109.34 21.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.287 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 10.2 p -119.71 105.34 11.06 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 176.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 245' ' ' GLN . . . . . 0.436 ' HB3' ' OE1' ' B' ' 249' ' ' GLN . 75.3 mt-30 -111.5 -174.78 2.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.865 -172.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 23.4 m -151.79 102.8 2.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.426 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 102.93 -164.48 16.02 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.423 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -83.85 58.45 5.01 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.228 -0.511 . . . . 0.0 112.704 -176.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . 0.436 ' OE1' ' HB3' ' B' ' 245' ' ' GLN . 53.9 mt-30 -80.27 -15.81 56.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.875 0.369 . . . . 0.0 110.395 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 250' ' ' ILE . . . . . 0.498 HD12 ' HA ' ' B' ' 256' ' ' LEU . 47.9 mm -113.59 114.34 46.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 173.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 16.3 t -108.07 -13.95 14.83 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.146 -176.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 252' ' ' SER . . . . . 0.439 ' O ' ' HB3' ' B' ' 255' ' ' ASP . 46.7 m -152.71 158.65 33.11 Favored Pre-proline 0 C--N 1.326 -0.415 0 O-C-N 122.382 -0.199 . . . . 0.0 110.617 -177.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -58.66 -50.49 9.2 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.809 2.34 . . . . 0.0 111.876 175.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 254' ' ' SER . . . . . 0.688 ' O ' ' HG3' ' B' ' 257' ' ' ARG . 41.4 t -58.31 -36.35 73.22 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.02 0.438 . . . . 0.0 110.629 174.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 255' ' ' ASP . . . . . 0.439 ' HB3' ' O ' ' B' ' 252' ' ' SER . 20.2 t0 -60.78 -43.62 97.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.355 178.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . 0.498 ' HA ' HD12 ' B' ' 250' ' ' ILE . 55.3 tp -61.51 -44.4 97.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.278 178.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 257' ' ' ARG . . . . . 0.688 ' HG3' ' O ' ' B' ' 254' ' ' SER . 0.7 OUTLIER -66.26 -30.91 71.43 Favored 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 120.411 -0.515 . . . . 0.0 110.372 -177.346 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 258' ' ' GLU . . . . . 0.5 ' HG3' ' O ' ' B' ' 254' ' ' SER . 49.5 mt-10 -68.76 -27.06 65.57 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.946 0.403 . . . . 0.0 110.651 178.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -75.01 -34.35 61.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.27 0.557 . . . . 0.0 110.273 174.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 260' ' ' LEU . . . . . 0.442 ' CD1' HD11 ' B' ' 274' ' ' ILE . 79.1 mt -74.04 -46.71 41.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.421 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 25.0 m -60.39 -34.21 73.58 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.108 175.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -54.81 -48.64 72.5 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.085 0.469 . . . . 0.0 110.589 176.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 263' ' ' LEU . . . . . 0.402 ' O ' ' HB2' ' B' ' 267' ' ' LYS . 86.6 mt -73.82 -38.13 64.65 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.171 -178.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.59 -44.68 61.7 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -177.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -67.77 -39.65 84.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.275 -178.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -72.36 -24.03 61.21 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.03 177.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 267' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' B' ' 263' ' ' LEU . 11.8 mmtt -78.21 -50.35 12.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.591 177.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 118.88 33.09 1.2 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.686 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -132.66 133.07 6.88 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 176.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -93.52 8.5 40.46 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -167.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 271' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -146.78 146.67 30.34 Favored 'General case' 0 C--N 1.33 -0.239 0 O-C-N 122.312 -0.242 . . . . 0.0 110.675 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 272' ' ' TYR . . . . . 0.449 ' CE1' ' HB3' ' A' ' 24' ' ' GLN . 37.1 p90 -141.19 159.87 41.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.877 0.37 . . . . 0.0 110.965 177.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 273' ' ' HIS . . . . . 0.709 ' CD2' ' HA ' ' B' ' 226' ' ' SER . 12.4 t-80 -136.14 111.97 9.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.567 -178.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 274' ' ' ILE . . . . . 0.442 HD11 ' CD1' ' B' ' 260' ' ' LEU . 77.4 mt -78.26 113.29 17.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.872 0.368 . . . . 0.0 110.456 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 9.0 pt -97.09 -27.2 3.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.294 -178.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -150.07 130.71 14.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.467 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 277' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' B' ' 285' ' ' GLU . . . -153.37 117.9 4.95 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -157.56 175.48 13.88 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.064 0.459 . . . . 0.0 110.795 -178.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -109.24 124.75 51.38 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.325 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -112.74 87.67 2.64 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 173.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 69.84 -124.71 15.14 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 -175.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -84.37 -3.28 10.11 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.656 2.237 . . . . 0.0 112.036 175.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -100.2 116.5 32.35 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.082 -174.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -90.52 126.44 35.93 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 175.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 285' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' B' ' 277' ' ' ALA . 9.2 mm-40 -116.02 110.54 19.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.781 -176.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 286' ' ' ALA . . . . . 0.538 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -118.86 115.72 24.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.857 0.361 . . . . 0.0 111.092 174.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 27.2 t -110.21 124.34 66.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.268 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -135.93 148.08 48.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.236 0.541 . . . . 0.0 111.673 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 289' ' ' GLU . . . . . 0.525 ' HB3' ' HE3' ' B' ' 237' ' ' LYS . 31.8 mt-10 -89.73 143.58 26.69 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 290' ' ' VAL . . . . . 0.44 HG12 HG21 ' B' ' 238' ' ' VAL . 10.6 t -107.79 123.31 63.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 291' ' ' TYR . . . . . 0.648 ' CZ ' ' HD3' ' B' ' 237' ' ' LYS . 77.0 m-85 -127.31 148.88 50.23 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.253 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 292' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -124.12 162.64 23.14 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 11.9 p30 . . . . . 0 C--N 1.329 -0.326 0 CA-C-O 121.584 0.707 . . . . 0.0 112.336 -174.578 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 -0.219 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.493 ' HB2' ' CE1' ' A' ' 71' ' ' TYR . 8.7 pt-20 -165.29 125.43 1.86 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -169.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.616 ' HA ' ' HB3' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -161.71 159.08 26.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.506 174.522 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.479 HG22 ' HB2' ' A' ' 71' ' ' TYR . 17.1 m -128.32 130.91 69.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.353 174.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.49 ' O ' HG13 ' A' ' 30' ' ' ILE . 15.4 m -97.56 173.95 6.89 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.382 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -66.58 -15.16 63.22 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.556 -174.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.449 ' HB2' ' OE1' ' A' ' 29' ' ' GLU . 41.9 mt-30 -71.57 -50.81 27.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.405 0.621 . . . . 0.0 109.527 177.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.463 ' OE1' ' HB2' ' A' ' 26' ' ' SER . 1.9 mp0 -70.44 -41.28 73.05 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.901 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 26' ' ' SER . 94.7 mt -56.21 -48.67 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.353 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.1 m -72.34 -30.12 64.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.08 0.467 . . . . 0.0 110.727 -177.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -74.87 -40.85 60.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.498 -177.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -96.88 -0.01 48.43 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -175.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm 57.87 51.45 9.08 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.03 0.443 . . . . 0.0 110.033 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.838 HD23 ' HG2' ' B' ' 253' ' ' PRO . 56.4 mt -68.62 169.58 10.83 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.622 0.725 . . . . 0.0 112.78 -172.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.7 t -100.04 117.88 45.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.293 -175.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.407 ' HE2' ' OE1' ' A' ' 89' ' ' GLU . 60.8 tttm -83.14 107.65 15.85 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 176.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.5 m -90.69 -11.68 9.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -175.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 138.07 -168.02 24.71 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 119.892 -1.147 . . . . 0.0 113.092 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 24.0 m -123.55 144.54 49.5 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -178.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.6 pt -110.84 157.54 11.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.674 0.273 . . . . 0.0 110.439 178.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -117.98 136.71 53.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.126 0.489 . . . . 0.0 111.921 -171.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.583 ' HB ' ' HB2' ' A' ' 86' ' ' ALA . 85.5 t -122.45 113.45 38.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.849 169.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.0 t -150.85 77.2 1.27 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.186 0.517 . . . . 0.0 110.053 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -137.73 163.64 30.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.992 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.511 ' HA ' ' HA ' ' A' ' 83' ' ' ASN . 26.4 t -73.18 163.83 27.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.643 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.97 -16.97 58.02 Favored Glycine 0 C--N 1.333 0.393 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.48 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.46 -19.63 68.95 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.215 176.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -102.0 -28.37 12.41 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.676 0.274 . . . . 0.0 111.01 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 43.5 mm -119.35 107.33 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-O 121.219 0.533 . . . . 0.0 110.479 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.8 m -128.98 -28.64 2.38 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.967 -178.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.8 m -121.68 156.08 59.16 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.192 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.433 ' HG2' ' HB2' ' B' ' 293' ' ' ASP . 32.5 Cg_exo -59.88 -24.43 76.08 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.729 2.286 . . . . 0.0 112.087 177.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.513 ' O ' ' HG3' ' A' ' 58' ' ' GLU . 24.1 p -62.76 -39.91 95.63 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.471 177.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.568 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 16.3 m-20 -61.69 -51.79 66.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.304 -175.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.429 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 57.6 tp -57.03 -44.82 83.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.653 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.5 ttp180 -53.25 -53.59 48.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.516 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.513 ' HG3' ' O ' ' A' ' 54' ' ' SER . 72.4 mt-10 -67.5 -27.27 66.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.021 -171.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.568 ' HG2' ' O ' ' A' ' 55' ' ' ASP . 46.9 mmtt -71.05 -45.64 63.47 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 56' ' ' LEU . 82.1 mt -65.53 -43.86 88.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.227 -176.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.9 p -62.88 -41.47 99.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.74 0.305 . . . . 0.0 111.383 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -64.67 -46.36 82.76 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.173 0.511 . . . . 0.0 110.223 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 59' ' ' LYS . 81.2 mt -67.87 -34.74 77.26 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.464 -178.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.72 -46.73 77.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.693 -178.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -67.38 -25.81 66.15 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.84 0.352 . . . . 0.0 110.992 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.77 -28.96 68.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.261 0.553 . . . . 0.0 110.237 176.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -86.18 -13.43 47.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.742 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.76 -9.04 73.8 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.914 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.24 172.5 54.41 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 121.221 -0.514 . . . . 0.0 112.146 -178.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -117.35 -62.8 1.52 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.966 0.412 . . . . 0.0 110.671 -176.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.616 ' HB3' ' HA ' ' A' ' 24' ' ' GLN . 4.5 m-85 -98.17 148.1 23.91 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -176.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.428 ' CE2' ' HA ' ' B' ' 223' ' ' GLU . 32.7 p90 -121.8 156.98 32.04 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 177.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -135.25 115.93 13.85 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.569 -177.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.6 mp -73.31 132.06 33.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 26.6 pt -117.37 -27.74 2.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.589 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -152.96 133.53 13.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.616 0.245 . . . . 0.0 110.684 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.493 ' HB3' ' HG3' ' B' ' 228' ' ' GLN . . . -150.55 142.74 24.14 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -164.87 147.99 8.56 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.033 0.444 . . . . 0.0 111.048 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -78.29 111.33 14.16 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 169.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -115.06 82.14 1.69 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.049 0.452 . . . . 0.0 110.349 -174.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.04 -128.75 8.74 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.6 -178.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -81.43 -6.15 12.7 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.572 2.181 . . . . 0.0 112.893 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.511 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 81.9 m-20 -121.07 154.52 36.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.079 0.466 . . . . 0.0 111.276 -175.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -104.29 118.39 36.51 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.585 176.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -102.4 124.92 48.83 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.05 -176.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.583 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . . . -137.36 129.8 29.72 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.231 0.539 . . . . 0.0 110.917 178.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.9 t -113.24 118.83 59.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.973 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.59 138.24 39.34 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.121 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 40' ' ' THR . 51.1 mt-10 -98.96 153.91 18.47 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 178.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.9 t -112.27 138.45 41.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -125.26 148.57 48.61 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.086 0.47 . . . . 0.0 110.595 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -118.27 164.73 14.76 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.508 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.6 t0 . . . . . 0 C--N 1.329 -0.317 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.591 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.301 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 223' ' ' GLU . . . . . 0.428 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 10.8 pt-20 -173.0 140.65 0.92 Allowed 'General case' 0 C--O 1.235 0.31 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -167.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 224' ' ' GLN . . . . . 0.476 ' HA ' ' HB3' ' B' ' 271' ' ' TYR . 0.0 OUTLIER -175.57 156.73 1.97 Allowed 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.612 173.365 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 28.3 m -116.45 141.51 33.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.769 0.319 . . . . 0.0 110.811 177.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 47.9 t -83.83 -92.96 0.07 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.111 -176.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . 0.408 ' HA ' HD12 ' B' ' 230' ' ' ILE . 26.2 ttpt -151.48 -39.68 0.12 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.962 0.411 . . . . 0.0 110.895 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 228' ' ' GLN . . . . . 0.493 ' HG3' ' HB3' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -63.75 -35.09 79.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.424 179.876 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 229' ' ' GLU . . . . . 0.465 ' OE1' ' HG2' ' B' ' 228' ' ' GLN . 2.4 mp0 -69.68 -37.93 76.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.831 176.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.512 HG12 HD12 ' B' ' 235' ' ' LEU . 63.3 mt -59.05 -45.18 92.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.642 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 16.5 m -73.13 -37.68 66.57 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.861 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -70.37 -48.54 55.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.435 -176.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -94.45 5.43 51.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.438 -175.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt 55.68 45.13 25.22 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.92 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . 0.557 HD21 ' HA ' ' B' ' 293' ' ' ASP . 72.7 mt -58.27 148.82 26.04 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.509 -175.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 61.9 t -97.29 117.92 42.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.01 -174.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -80.82 113.63 19.15 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.14 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 18.9 m -85.89 -34.94 8.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -176.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 166.02 179.77 39.72 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.637 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 240' ' ' THR . . . . . 0.452 HG23 ' HG2' ' B' ' 289' ' ' GLU . 54.3 m -113.45 135.84 53.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.698 0.285 . . . . 0.0 110.583 -178.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 30.1 pt -107.77 131.19 58.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 171.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -120.19 113.79 20.96 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.997 -174.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 243' ' ' VAL . . . . . 0.55 ' HB ' ' HB2' ' B' ' 286' ' ' ALA . 84.2 t -95.12 119.61 43.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.353 -177.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 22.6 t -115.64 86.1 2.4 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 170.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 245' ' ' GLN . . . . . 0.54 ' HG2' HG12 ' B' ' 250' ' ' ILE . 0.3 OUTLIER -81.63 106.47 13.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.946 -173.22 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 13.9 m -88.13 103.69 15.98 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.68 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 94.69 -162.69 24.42 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.146 174.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -82.54 63.73 4.39 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.554 -0.355 . . . . 0.0 113.591 -173.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . 0.489 ' HB2' ' HG3' ' B' ' 245' ' ' GLN . 72.6 mt-30 -96.09 -2.8 45.88 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.126 0.488 . . . . 0.0 109.911 172.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 250' ' ' ILE . . . . . 0.54 HG12 ' HG2' ' B' ' 245' ' ' GLN . 48.9 mm -128.36 125.54 64.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.116 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 1.1 m -112.09 -57.79 2.22 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.457 0.646 . . . . 0.0 109.668 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 252' ' ' SER . . . . . 0.485 ' HB3' ' HD2' ' B' ' 253' ' ' PRO . 50.7 m -127.01 175.12 3.55 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.362 176.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . 0.838 ' HG2' HD23 ' A' ' 35' ' ' LEU . 52.2 Cg_exo -55.09 -28.63 61.56 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.288 1.992 . . . . 0.0 112.315 175.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 254' ' ' SER . . . . . 0.565 ' O ' ' HB3' ' B' ' 257' ' ' ARG . 56.3 m -65.74 -26.19 67.62 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.777 178.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 255' ' ' ASP . . . . . 0.573 ' O ' ' HD3' ' B' ' 259' ' ' LYS . 2.6 m-20 -70.82 -49.39 46.84 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.154 0.502 . . . . 0.0 109.661 176.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 41.2 tp -62.5 -31.31 72.04 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.024 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 257' ' ' ARG . . . . . 0.565 ' HB3' ' O ' ' B' ' 254' ' ' SER . 50.7 ttt85 -51.19 -51.4 54.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.117 175.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 258' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -59.72 -51.99 67.41 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.138 0.494 . . . . 0.0 110.317 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 259' ' ' LYS . . . . . 0.573 ' HD3' ' O ' ' B' ' 255' ' ' ASP . 12.1 mptt -59.56 -43.7 93.5 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.245 -174.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 260' ' ' LEU . . . . . 0.501 HD13 ' CE2' ' B' ' 272' ' ' TYR . 96.5 mt -74.26 -43.62 56.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.179 -177.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 32.9 t -63.39 -37.97 89.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.677 0.275 . . . . 0.0 110.482 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -60.95 -52.96 62.8 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.46 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 263' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' B' ' 259' ' ' LYS . 81.1 mt -68.84 -40.19 79.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.282 -176.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -61.25 -52.53 64.36 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -175.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -69.48 -32.25 71.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.875 0.369 . . . . 0.0 110.413 -176.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -68.1 -24.23 65.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.007 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -84.96 0.4 51.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.531 176.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 74.82 34.16 53.78 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.798 -178.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . 0.42 ' HA2' ' OD1' ' B' ' 292' ' ' ASN . . . -127.79 163.83 21.35 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 121.051 -0.595 . . . . 0.0 111.957 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . 0.764 ' HA ' ' HZ3' ' B' ' 270' ' ' LYS . 1.0 OUTLIER -108.34 -66.55 1.03 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.782 0.325 . . . . 0.0 111.276 178.427 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 271' ' ' TYR . . . . . 0.476 ' HB3' ' HA ' ' B' ' 224' ' ' GLN . 4.9 m-85 -92.61 140.79 29.18 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -173.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 272' ' ' TYR . . . . . 0.501 ' CE2' HD13 ' B' ' 260' ' ' LEU . 55.0 p90 -125.17 131.38 53.23 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 176.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -104.34 107.91 19.06 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.114 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 274' ' ' ILE . . . . . . . . . . . . . 69.6 mt -70.21 123.14 23.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.191 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 34.0 pt -100.17 -26.55 3.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.706 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -153.76 123.71 6.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.826 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -143.58 117.97 9.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.261 178.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.8 159.02 13.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.948 0.404 . . . . 0.0 111.404 -177.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -84.65 138.58 32.6 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 172.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -114.7 26.84 9.87 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 173.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 115.49 -125.94 6.92 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -175.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.16 -10.5 22.69 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.457 2.104 . . . . 0.0 111.481 175.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 283' ' ' ASN . . . . . 0.451 ' HA ' ' O ' ' B' ' 245' ' ' GLN . 80.3 m-20 -109.64 125.54 52.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.817 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 284' ' ' PHE . . . . . 0.436 ' CE2' ' HB3' ' B' ' 286' ' ' ALA . 71.6 t80 -101.46 121.99 42.95 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.387 178.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 285' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -98.13 113.82 25.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.096 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 286' ' ' ALA . . . . . 0.55 ' HB2' ' HB ' ' B' ' 243' ' ' VAL . . . -125.63 116.02 21.05 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.867 0.365 . . . . 0.0 110.158 172.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 21.4 t -113.3 114.68 47.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.247 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -129.35 133.65 47.52 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.451 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 289' ' ' GLU . . . . . 0.452 ' HG2' HG23 ' B' ' 240' ' ' THR . 14.1 mt-10 -106.48 128.17 53.87 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 25.0 t -90.31 135.63 25.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.102 0.477 . . . . 0.0 111.202 -171.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -127.26 133.68 50.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.676 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 292' ' ' ASN . . . . . 0.42 ' OD1' ' HA2' ' B' ' 269' ' ' GLY . 54.2 m-20 -106.16 161.6 14.38 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.305 174.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 293' ' ' ASP . . . . . 0.557 ' HA ' HD21 ' B' ' 235' ' ' LEU . 9.3 p-10 . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.618 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.139 0 CA-C-O 121.295 0.569 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.505 ' O ' ' HB2' ' A' ' 24' ' ' GLN . 30.9 mt-10 -140.42 165.64 26.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.54 176.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.505 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER 174.69 136.63 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 O-C-N 123.791 0.682 . . . . 0.0 109.775 171.017 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.0 m -128.24 116.0 40.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.167 0.508 . . . . 0.0 110.479 173.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.438 ' O ' HG13 ' A' ' 30' ' ' ILE . 0.7 OUTLIER -91.29 169.89 10.44 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.099 -178.91 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.5 mmtp -68.99 -20.24 64.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.472 -177.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.11 -49.8 66.25 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 177.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -66.39 -43.89 84.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.317 176.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.499 HG12 HD13 ' A' ' 35' ' ' LEU . 90.2 mt -58.6 -46.84 89.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.437 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.9 t -72.88 -26.63 61.51 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.999 0.428 . . . . 0.0 110.611 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -73.83 -51.37 16.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.08 -177.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -85.47 -13.52 48.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.95 -178.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt 62.74 68.17 0.66 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.989 -176.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.525 HD21 ' HG2' ' B' ' 253' ' ' PRO . 63.0 mt -79.79 162.63 24.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.463 -176.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.6 m -96.29 131.28 43.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.947 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -85.12 118.51 24.72 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.89 177.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.402 HG11 ' HD2' ' A' ' 67' ' ' LYS . 20.8 t -78.76 -26.73 13.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 157.48 164.88 14.3 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.705 176.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 88.4 m -107.27 118.2 36.08 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 173.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.6 pt -107.52 170.44 2.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -178.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -143.42 143.85 31.79 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.924 0.868 . . . . 0.0 111.682 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 82.2 t -93.55 128.79 44.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 114.323 -1.308 . . . . 0.0 108.668 174.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -156.12 72.4 0.77 Allowed 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -178.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.424 ' O ' ' HA ' ' A' ' 83' ' ' ASN . 0.6 OUTLIER -103.11 148.37 25.82 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.097 -176.432 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.7 p -105.67 112.2 25.19 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.338 -176.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.28 -147.04 18.28 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.73 -0.747 . . . . 0.0 113.116 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -90.26 38.09 3.27 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.133 -0.556 . . . . 0.0 112.823 -173.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -76.4 -31.26 57.86 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.438 HD13 ' HA ' ' A' ' 56' ' ' LEU . 44.7 mm -114.43 95.23 3.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 171.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.8 t -103.41 -43.48 5.4 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.211 0.529 . . . . 0.0 109.831 -177.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 17.8 m -113.74 159.17 36.76 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.385 176.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -57.18 -26.35 69.14 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.386 2.057 . . . . 0.0 111.947 177.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.403 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 3.8 p -73.24 -22.72 60.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.508 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -71.45 -34.54 70.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.326 0.584 . . . . 0.0 109.715 177.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.438 ' HA ' HD13 ' A' ' 50' ' ' ILE . 51.6 tp -66.25 -48.19 71.32 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.57 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.499 ' HD3' ' OE1' ' B' ' 223' ' ' GLU . 0.2 OUTLIER -64.21 -30.52 71.57 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.223 -178.217 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.442 ' HG3' ' NE ' ' A' ' 57' ' ' ARG . 36.1 mt-10 -67.64 -41.25 84.18 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.1 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -66.81 -45.34 78.65 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.823 0.344 . . . . 0.0 110.635 177.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.4 mt -64.48 -41.34 96.54 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.033 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.6 t -65.94 -39.04 90.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.154 0.502 . . . . 0.0 110.256 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -63.4 -42.67 98.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.883 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 97.5 mt -69.64 -32.69 71.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.804 178.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.87 -40.54 95.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.039 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -63.0 -40.38 97.61 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.912 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.79 -44.01 87.01 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.823 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.402 ' HD2' HG11 ' A' ' 38' ' ' VAL . 40.7 mmtt -74.11 -33.44 63.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.813 177.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 94.2 36.46 5.69 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.08 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -100.38 166.68 19.85 Favored Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.607 ' HZ3' ' HB3' ' A' ' 93' ' ' ASP . 51.7 mtmt -123.12 2.75 9.28 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.96 0.38 . . . . 0.0 111.587 -176.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.515 ' HE2' ' HB2' ' A' ' 93' ' ' ASP . 6.9 m-85 -153.96 166.02 34.28 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 177.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -150.65 157.46 43.0 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 171.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -146.1 117.64 8.03 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.041 -176.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.473 HG13 ' HB2' ' A' ' 88' ' ' ALA . 3.7 mp -83.64 131.35 34.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 178.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 9.9 pt -107.62 -21.63 5.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.592 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -150.52 139.26 20.75 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.171 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -151.15 113.01 4.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.749 0.309 . . . . 0.0 110.561 -178.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.59 150.7 51.62 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.415 0.626 . . . . 0.0 111.194 -177.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -93.99 102.72 14.81 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.272 176.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -102.54 77.32 1.61 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.367 -175.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.83 -125.6 35.27 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.292 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -82.67 5.46 6.38 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.874 2.383 . . . . 0.0 112.734 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.424 ' HA ' ' O ' ' A' ' 45' ' ' GLN . 58.5 m-80 -122.51 120.03 32.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.961 0.41 . . . . 0.0 110.628 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -85.32 116.42 23.65 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 177.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.52 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 19.3 mm-40 -106.94 114.49 28.61 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.833 -175.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.513 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -135.26 121.16 19.78 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.617 0.246 . . . . 0.0 110.96 176.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.6 t -95.77 120.42 45.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -177.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.473 ' HB2' HG13 ' A' ' 74' ' ' ILE . . . -126.05 143.62 51.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.198 0.523 . . . . 0.0 111.349 -175.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.447 ' HB3' ' CE1' ' A' ' 91' ' ' TYR . 41.4 mt-10 -103.3 140.71 37.05 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.547 178.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.3 t -107.81 119.21 57.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 176.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.447 ' CE1' ' HB3' ' A' ' 89' ' ' GLU . 72.1 m-85 -123.77 152.81 41.78 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.193 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -115.69 155.87 26.95 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.063 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.607 ' HB3' ' HZ3' ' A' ' 70' ' ' LYS . 19.7 t70 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.078 -177.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.292 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 223' ' ' GLU . . . . . 0.827 ' HG2' ' HE1' ' B' ' 271' ' ' TYR . 12.7 tt0 -164.43 125.27 2.12 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.371 0.605 . . . . 0.0 111.076 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 224' ' ' GLN . . . . . 0.413 HE21 ' C ' ' B' ' 224' ' ' GLN . 0.0 OUTLIER -164.93 150.61 9.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.571 -170.235 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . 0.532 HG22 ' HB3' ' B' ' 271' ' ' TYR . 17.9 m -127.02 128.84 71.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 172.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 226' ' ' SER . . . . . 0.797 ' HA ' ' CD2' ' B' ' 273' ' ' HIS . 11.5 t -92.84 173.17 7.89 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.089 0.471 . . . . 0.0 110.547 -178.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . 0.5 ' HA ' HD12 ' B' ' 230' ' ' ILE . 47.4 tttm -64.16 -28.64 69.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.874 -172.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -66.49 -50.46 63.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.291 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 229' ' ' GLU . . . . . 0.473 ' OE1' ' HB3' ' B' ' 226' ' ' SER . 1.9 mp0 -65.36 -38.0 88.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.651 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.509 HG12 HD11 ' B' ' 235' ' ' LEU . 97.1 mt -55.86 -53.92 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.232 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 68.6 m -73.45 -21.01 60.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.713 0.292 . . . . 0.0 111.517 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -75.04 -45.05 44.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.564 0.221 . . . . 0.0 110.99 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -100.75 -12.42 19.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.347 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? 64.41 91.15 0.08 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.139 -175.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . 0.509 HD11 HG12 ' B' ' 230' ' ' ILE . 88.6 mt -96.87 166.24 11.72 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.43 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 52.1 t -93.22 115.06 31.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.582 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -84.77 111.76 19.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.081 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 238' ' ' VAL . . . . . 0.417 HG21 ' HB ' ' B' ' 290' ' ' VAL . 1.2 m -88.35 -30.15 5.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -176.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 168.21 -147.53 11.58 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 119.964 -1.112 . . . . 0.0 113.085 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 29.0 m -141.17 138.1 33.16 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 122.598 0.359 . . . . 0.0 110.377 -176.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 241' ' ' ILE . . . . . 0.489 HG13 ' HB2' ' B' ' 288' ' ' ALA . 2.4 pt -105.29 137.61 34.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.139 0.495 . . . . 0.0 110.514 177.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -109.69 123.23 49.14 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.707 -172.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 243' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' B' ' 285' ' ' GLU . 89.2 t -100.95 117.4 46.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 172.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 34.4 m -155.37 76.61 0.97 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.787 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 245' ' ' GLN . . . . . 0.414 ' O ' ' HA ' ' B' ' 283' ' ' ASN . 0.9 OUTLIER -103.79 142.77 33.8 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.834 -177.706 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 246' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' B' ' 282' ' ' PRO . 17.2 m -80.97 117.74 21.85 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.06 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 90.53 -165.71 31.27 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.582 176.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -87.08 53.12 4.45 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.319 -0.467 . . . . 0.0 112.454 -177.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -72.21 -25.32 61.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.252 0.549 . . . . 0.0 109.797 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 39.4 mm -105.91 90.84 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 175.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 9.4 t -92.94 -23.63 18.67 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.219 0.533 . . . . 0.0 109.961 -176.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 7.1 p -141.14 157.2 67.3 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.141 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . 0.525 ' HG2' HD21 ' A' ' 35' ' ' LEU . 68.5 Cg_exo -53.22 -30.78 52.7 Favored 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 123.017 2.478 . . . . 0.0 113.08 178.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 254' ' ' SER . . . . . 0.587 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 6.9 p -59.44 -41.22 89.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.833 -0.167 . . . . 0.0 110.902 176.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -58.36 -44.19 88.7 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.427 0.632 . . . . 0.0 109.764 176.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 49.2 tp -61.48 -44.57 96.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.272 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 257' ' ' ARG . . . . . 0.456 ' HD2' ' HG2' ' A' ' 23' ' ' GLU . 3.1 ttp180 -61.71 -46.67 88.69 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.549 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 258' ' ' GLU . . . . . 0.587 ' HG2' ' O ' ' B' ' 254' ' ' SER . 9.9 mm-40 -58.12 -47.08 84.38 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.959 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -66.39 -47.86 71.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.13 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 53.2 mt -62.86 -47.63 82.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.841 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 35.0 p -63.98 -39.07 93.29 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.84 0.352 . . . . 0.0 110.707 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -62.09 -48.46 80.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.433 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 263' ' ' LEU . . . . . 0.579 ' O ' ' HG2' ' B' ' 267' ' ' LYS . 96.2 mt -65.44 -37.35 86.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.055 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -69.07 -49.45 57.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.286 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -63.51 -33.29 75.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.878 0.37 . . . . 0.0 110.815 -178.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -66.79 -29.31 69.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.737 178.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 267' ' ' LYS . . . . . 0.579 ' HG2' ' O ' ' B' ' 263' ' ' LEU . 48.3 mmtm -82.07 -25.06 34.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.137 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 113.41 -5.68 24.85 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.866 -178.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . 0.492 ' HA2' ' OD1' ' B' ' 292' ' ' ASN . . . -77.41 145.69 30.79 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.183 -0.532 . . . . 0.0 111.812 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . 0.583 ' HE2' ' HA ' ' B' ' 270' ' ' LYS . 9.7 mmpt? -107.5 -23.64 12.09 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.854 0.359 . . . . 0.0 110.893 -177.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 271' ' ' TYR . . . . . 0.827 ' HE1' ' HG2' ' B' ' 223' ' ' GLU . 99.4 m-85 -133.46 157.06 46.54 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.348 -178.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 272' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -151.07 167.46 27.61 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.688 174.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 273' ' ' HIS . . . . . 0.797 ' CD2' ' HA ' ' B' ' 226' ' ' SER . 49.1 t-80 -143.15 117.27 9.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.863 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 274' ' ' ILE . . . . . 0.452 ' HA ' ' HA ' ' B' ' 288' ' ' ALA . 61.8 mt -67.4 137.1 25.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.191 178.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 25.8 pt -110.91 -26.74 3.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.129 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -158.55 140.44 13.78 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.842 0.354 . . . . 0.0 111.016 -178.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -140.25 129.35 23.58 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -137.53 150.81 47.8 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.394 0.616 . . . . 0.0 111.195 -175.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -101.72 123.76 46.24 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.479 -175.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 280' ' ' HIS . . . . . 0.439 ' HB2' ' O ' ' B' ' 283' ' ' ASN . 10.1 m170 -125.33 154.72 41.36 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 163.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . -65.92 -57.59 10.59 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.715 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 282' ' ' PRO . . . . . 0.562 ' O ' ' HA ' ' B' ' 246' ' ' SER . 60.4 Cg_endo -72.07 -29.73 14.38 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.136 1.891 . . . . 0.0 112.958 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 283' ' ' ASN . . . . . 0.513 HD21 ' C ' ' B' ' 282' ' ' PRO . 0.9 OUTLIER -132.49 129.38 39.1 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 122.326 -0.234 . . . . 0.0 111.126 -175.609 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -91.17 120.46 32.12 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 171.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 285' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 46.6 mt-10 -118.61 130.82 56.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.288 0.566 . . . . 0.0 112.411 -170.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 286' ' ' ALA . . . . . 0.434 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -149.27 143.7 26.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.128 176.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 41.0 t -123.38 124.91 70.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.397 -178.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 288' ' ' ALA . . . . . 0.489 ' HB2' HG13 ' B' ' 241' ' ' ILE . . . -132.24 141.48 49.05 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.941 0.401 . . . . 0.0 111.153 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -92.01 132.52 36.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.64 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 290' ' ' VAL . . . . . 0.417 ' HB ' HG21 ' B' ' 238' ' ' VAL . 6.0 t -97.99 131.89 44.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 120.832 0.349 . . . . 0.0 110.455 -176.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -127.99 143.91 51.09 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.32 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 292' ' ' ASN . . . . . 0.492 ' OD1' ' HA2' ' B' ' 269' ' ' GLY . 1.5 m120 -112.14 179.71 3.92 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.559 0.695 . . . . 0.0 112.157 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.322 -0.599 0 CA-C-N 114.014 -1.448 . . . . 0.0 110.032 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.211 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -133.94 104.11 6.12 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.176 -170.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.662 ' HA ' ' HB3' ' A' ' 71' ' ' TYR . 0.0 OUTLIER 175.13 167.64 0.3 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.816 0.341 . . . . 0.0 111.27 176.217 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.425 ' H ' ' CD ' ' A' ' 24' ' ' GLN . 28.3 m -127.51 139.77 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.068 0.547 . . . . 0.0 110.174 175.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.9 p -89.46 -93.65 0.11 Allowed 'General case' 0 C--N 1.322 -0.611 0 O-C-N 121.768 -0.582 . . . . 0.0 112.29 -174.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -131.68 -46.75 0.96 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.757 0.313 . . . . 0.0 111.044 -175.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -64.85 -47.39 78.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.516 -177.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -55.12 -47.81 74.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.608 -176.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.453 HG12 HD13 ' A' ' 35' ' ' LEU . 59.8 mt -58.02 -48.55 83.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.08 0.467 . . . . 0.0 111.147 -178.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.9 m -72.8 -33.83 66.51 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.344 -177.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -81.97 -34.88 29.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.956 -173.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.76 ' HB3' ' HG3' ' B' ' 253' ' ' PRO . 71.1 m-85 -101.77 -8.14 21.96 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.708 -176.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm 60.71 70.44 0.62 Allowed 'General case' 0 N--CA 1.466 0.343 0 O-C-N 123.559 0.537 . . . . 0.0 110.367 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.453 HD13 HG12 ' A' ' 30' ' ' ILE . 87.5 mt -82.12 163.16 22.18 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.799 -175.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 51.8 t -91.74 108.69 20.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.818 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -81.64 105.19 12.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.761 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.43 HG22 ' HB ' ' A' ' 90' ' ' VAL . 4.8 m -86.72 -20.4 7.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -172.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.59 -151.0 22.58 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 119.622 -1.275 . . . . 0.0 113.181 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.413 HG23 ' HG2' ' A' ' 89' ' ' GLU . 4.7 m -137.5 145.84 43.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.656 0.265 . . . . 0.0 110.73 -174.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.403 HD11 HD23 ' A' ' 60' ' ' LEU . 12.2 pt -127.83 144.95 35.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 174.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -125.95 138.62 53.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.084 0.469 . . . . 0.0 111.797 -175.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 90.4 t -97.57 110.26 25.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.198 171.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.4 p -138.46 74.99 1.5 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.361 0.601 . . . . 0.0 109.65 175.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.65 166.54 22.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.307 -177.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.1 t -73.78 164.65 26.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.75 -177.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.06 5.24 6.7 Favored Glycine 0 CA--C 1.519 0.324 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.729 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.49 -5.27 55.75 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.927 174.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -108.35 -15.75 14.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.819 0.342 . . . . 0.0 110.81 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.559 HD13 ' HA ' ' A' ' 56' ' ' LEU . 45.1 mm -125.43 107.72 18.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.1 m -101.58 -42.01 6.38 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.015 -174.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.416 ' H ' ' HB3' ' A' ' 55' ' ' ASP . 80.5 p -138.94 169.46 12.45 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.288 -175.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.892 ' HG2' HD21 ' B' ' 235' ' ' LEU . 42.1 Cg_exo -58.54 -36.02 97.91 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.354 2.036 . . . . 0.0 111.639 174.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.568 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -64.76 -44.59 89.59 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.6 175.212 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.527 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 38.9 t0 -66.88 -30.66 70.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.312 0.577 . . . . 0.0 110.179 179.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.559 ' HA ' HD13 ' A' ' 50' ' ' ILE . 63.9 tp -63.5 -51.16 66.74 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.933 176.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.568 ' HG3' ' O ' ' A' ' 54' ' ' SER . 6.2 ppt_? -68.45 -25.71 65.14 Favored 'General case' 0 C--O 1.225 -0.202 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.452 -178.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.527 ' HB2' ' O ' ' A' ' 55' ' ' ASP . 6.0 mm-40 -51.77 -51.5 55.86 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.295 0.569 . . . . 0.0 110.698 174.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.489 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 12.4 mptt -65.03 -45.11 86.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.204 -176.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.444 HD21 HG22 ' A' ' 43' ' ' VAL . 86.7 mt -71.45 -36.03 71.1 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.517 -177.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.485 ' HA ' ' HB3' ' B' ' 222' ' ' ALA . 6.9 t -62.94 -44.16 96.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.254 0.55 . . . . 0.0 109.523 176.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -63.39 -40.7 97.93 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.699 177.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 59' ' ' LYS . 84.7 mt -66.68 -44.68 81.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.079 178.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.7 -47.48 85.49 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.856 0.36 . . . . 0.0 110.673 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -58.24 -40.57 82.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.277 178.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.03 -25.29 58.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.817 -177.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -83.77 -47.55 11.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.935 0.398 . . . . 0.0 111.238 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 125.6 34.93 0.63 Allowed Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.498 -175.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.452 ' HA2' ' OD1' ' A' ' 92' ' ' ASN . . . -134.13 161.34 24.37 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.403 ' O ' ' HB1' ' B' ' 222' ' ' ALA . 24.8 mtpp -108.3 -71.74 0.75 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.866 0.333 . . . . 0.0 111.409 -178.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.662 ' HB3' ' HA ' ' A' ' 24' ' ' GLN . 2.3 m-85 -93.22 157.23 16.37 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 -173.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.524 ' CD2' ' HB2' ' B' ' 222' ' ' ALA . 45.6 p90 -146.45 133.68 20.55 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.293 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -102.62 119.11 38.27 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.159 -178.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.9 mp -77.04 124.53 35.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 30.3 pt -105.99 -21.71 5.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.925 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -152.61 135.92 15.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.696 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -149.03 111.4 4.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.163 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -149.86 173.63 13.56 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.918 0.389 . . . . 0.0 111.073 -176.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.84 148.76 26.3 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.242 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -100.92 -20.47 15.44 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.508 0.671 . . . . 0.0 109.212 175.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 143.06 -99.4 0.22 Allowed Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -176.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -74.28 -18.78 20.39 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.772 2.315 . . . . 0.0 111.232 171.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -116.47 159.64 21.75 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.623 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -115.74 138.31 51.24 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.621 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 42.1 mt-10 -123.98 117.4 24.66 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.209 0.528 . . . . 0.0 111.24 -176.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.512 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . . . -129.03 139.46 52.05 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.629 178.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.7 t -118.77 119.44 61.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.128 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.433 ' HB2' ' HD1' ' A' ' 72' ' ' TYR . . . -135.78 138.82 43.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.782 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.413 ' HG2' HG23 ' A' ' 40' ' ' THR . 3.2 mt-10 -104.0 139.53 39.0 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.43 ' HB ' HG22 ' A' ' 38' ' ' VAL . 8.5 t -97.5 134.83 34.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.144 -170.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -130.4 139.08 50.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.28 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.452 ' OD1' ' HA2' ' A' ' 69' ' ' GLY . 78.9 m-20 -101.37 -178.99 3.9 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.161 173.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.721 174.635 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 222' ' ' ALA . . . . . 0.524 ' HB2' ' CD2' ' A' ' 72' ' ' TYR . . . . . . . . 0 N--CA 1.451 -0.425 0 CA-C-O 121.804 0.812 . . . . 0.0 108.813 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 223' ' ' GLU . . . . . 0.513 ' HG3' ' HD3' ' A' ' 57' ' ' ARG . 4.4 mp0 -124.37 96.55 4.95 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.389 -166.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 224' ' ' GLN . . . . . 0.636 ' HB3' ' HG3' ' A' ' 24' ' ' GLN . 0.6 OUTLIER -173.02 148.65 1.76 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.246 -178.557 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . 0.496 HG23 ' CD1' ' B' ' 235' ' ' LEU . 16.6 m -128.7 137.34 57.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.046 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 226' ' ' SER . . . . . 0.525 ' HA ' ' CD2' ' B' ' 273' ' ' HIS . 8.7 t -96.24 176.78 5.94 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 120.976 0.417 . . . . 0.0 110.301 -178.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -65.31 -28.93 69.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.437 -173.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.18 -50.32 68.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.043 0.449 . . . . 0.0 110.283 -178.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -65.44 -42.72 92.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.459 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.517 HG12 HD11 ' B' ' 235' ' ' LEU . 88.5 mt -63.34 -34.36 66.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.965 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 31.4 t -69.57 -21.24 63.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.0 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 29.2 t-80 -98.17 -45.73 6.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.836 0.351 . . . . 0.0 110.921 -177.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -86.2 -20.95 27.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.835 -176.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm 59.57 80.76 0.19 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.351 0.596 . . . . 0.0 111.612 -177.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . 0.892 HD21 ' HG2' ' A' ' 53' ' ' PRO . 40.9 mt -83.24 -168.92 2.28 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.754 178.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 59.0 t -109.82 109.21 27.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.088 0.471 . . . . 0.0 111.089 -178.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 237' ' ' LYS . . . . . 0.552 ' HE3' ' HB3' ' B' ' 289' ' ' GLU . 23.1 tptm -73.97 112.67 10.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.789 175.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 3.8 m -100.05 -4.41 9.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -175.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 136.07 -171.82 22.62 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 119.979 -1.105 . . . . 0.0 112.999 176.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 240' ' ' THR . . . . . 0.502 HG23 ' HG2' ' B' ' 289' ' ' GLU . 29.8 m -128.63 134.26 48.51 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -178.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 32.8 pt -107.86 137.62 38.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.945 0.402 . . . . 0.0 110.386 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -111.58 115.12 28.63 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.839 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 243' ' ' VAL . . . . . 0.511 ' HB ' ' HB2' ' B' ' 286' ' ' ALA . 34.9 t -94.05 109.35 21.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.108 -178.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 23.1 t -110.06 98.36 7.65 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 245' ' ' GLN . . . . . 0.635 ' O ' ' HA ' ' B' ' 283' ' ' ASN . 0.7 OUTLIER -87.89 148.39 24.64 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.946 -177.892 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 51.1 m -126.32 107.04 9.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.209 0.528 . . . . 0.0 111.056 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 101.05 -141.38 15.32 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.322 177.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -107.85 42.29 1.98 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.329 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -63.51 -46.44 86.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.752 0.311 . . . . 0.0 110.365 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 250' ' ' ILE . . . . . 0.565 HG12 ' HG2' ' B' ' 245' ' ' GLN . 47.2 mm -77.56 99.89 2.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.392 0.615 . . . . 0.0 109.585 177.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 5.7 m -100.68 -26.01 13.95 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.691 -174.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 1.9 m -136.52 162.36 56.65 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -177.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . 0.76 ' HG3' ' HB3' ' A' ' 33' ' ' PHE . 48.0 Cg_exo -56.06 -36.38 96.08 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.241 1.961 . . . . 0.0 111.537 175.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 254' ' ' SER . . . . . . . . . . . . . 4.3 m -69.25 -24.26 63.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.653 -178.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.17 -34.93 74.27 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.013 0.435 . . . . 0.0 111.523 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . 0.459 ' O ' ' HG ' ' B' ' 260' ' ' LEU . 22.3 tp -65.11 -38.52 90.96 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.749 -177.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 257' ' ' ARG . . . . . 0.428 HH21 ' CD ' ' B' ' 258' ' ' GLU . 2.9 ttp85 -63.83 -35.82 81.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.996 0.427 . . . . 0.0 110.424 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 258' ' ' GLU . . . . . 0.428 ' CD ' HH21 ' B' ' 257' ' ' ARG . 17.0 mm-40 -62.27 -43.06 99.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.249 -178.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -71.79 -34.74 69.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.041 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 260' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' B' ' 256' ' ' LEU . 95.2 mt -69.18 -46.2 68.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.003 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 24.2 p -65.47 -34.75 79.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.802 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -54.18 -51.11 65.39 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.247 0.546 . . . . 0.0 110.439 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 263' ' ' LEU . . . . . 0.471 ' O ' ' HG2' ' B' ' 267' ' ' LYS . 98.2 mt -71.79 -41.69 68.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.172 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -63.84 -32.12 73.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.822 0.344 . . . . 0.0 111.486 -178.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -71.9 -44.27 64.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.814 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -67.0 -30.82 71.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.265 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 267' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' B' ' 263' ' ' LEU . 74.3 mmtt -79.52 -55.82 4.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.002 0.43 . . . . 0.0 110.095 176.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 114.64 48.08 0.56 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.252 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -97.95 -169.63 32.3 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.478 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . 0.42 ' HB2' ' HA ' ' B' ' 292' ' ' ASN . 4.4 tptp -131.53 -29.9 1.72 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.709 0.29 . . . . 0.0 110.882 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 271' ' ' TYR . . . . . 0.424 ' HB3' ' HA ' ' B' ' 224' ' ' GLN . 6.4 m-85 -147.95 173.53 12.78 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 177.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 272' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.65 167.18 22.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.766 0.317 . . . . 0.0 110.796 174.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 273' ' ' HIS . . . . . 0.525 ' CD2' ' HA ' ' B' ' 226' ' ' SER . 19.5 t-80 -148.04 103.5 3.48 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.184 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 274' ' ' ILE . . . . . 0.48 HG13 ' HB2' ' B' ' 288' ' ' ALA . 4.2 mp -70.25 135.23 28.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 31.2 pt -113.99 -28.87 2.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.699 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -157.7 146.97 19.8 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.645 0.259 . . . . 0.0 110.956 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -156.37 139.26 15.29 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 278' ' ' ARG . . . . . 0.442 ' N ' ' HD2' ' B' ' 278' ' ' ARG . 0.0 OUTLIER -155.92 136.39 13.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.969 0.414 . . . . 0.0 111.214 -179.157 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -88.72 102.64 15.18 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 171.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -114.84 103.72 11.23 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 73.6 -134.49 19.24 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.667 -176.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -82.95 -9.16 10.86 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.589 2.193 . . . . 0.0 111.877 176.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 283' ' ' ASN . . . . . 0.635 ' HA ' ' O ' ' B' ' 245' ' ' GLN . 93.4 m-20 -101.37 113.48 26.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.463 -175.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -87.4 107.47 18.55 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 170.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 285' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -100.8 113.67 26.78 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.06 -175.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 286' ' ' ALA . . . . . 0.511 ' HB2' ' HB ' ' B' ' 243' ' ' VAL . . . -117.94 124.24 47.76 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.49 178.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 24.5 t -106.27 112.81 41.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.159 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 288' ' ' ALA . . . . . 0.48 ' HB2' HG13 ' B' ' 274' ' ' ILE . . . -125.63 132.54 52.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.274 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 289' ' ' GLU . . . . . 0.552 ' HB3' ' HE3' ' B' ' 237' ' ' LYS . 18.1 mt-10 -94.83 138.88 32.05 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 21.9 t -103.64 138.93 26.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.972 0.415 . . . . 0.0 110.408 -174.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -128.15 152.18 48.34 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.336 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 292' ' ' ASN . . . . . 0.42 ' HA ' ' HB2' ' B' ' 270' ' ' LYS . 12.2 t-20 -120.01 163.4 17.68 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 174.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 16.1 t70 . . . . . 0 C--N 1.326 -0.42 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -176.875 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.379 0 CA-C-O 120.508 0.194 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.427 ' HA ' ' OH ' ' B' ' 272' ' ' TYR . 0.5 OUTLIER -161.23 121.98 2.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.051 0.453 . . . . 0.0 111.84 -178.812 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 1.059 ' HG3' ' HG3' ' B' ' 224' ' ' GLN . 6.4 tm0? -150.35 144.34 25.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.777 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.2 m -126.78 152.27 34.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 172.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.612 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 6.9 m -108.38 -79.77 0.58 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.074 0.464 . . . . 0.0 110.746 -178.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -165.68 -48.25 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -176.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.406 ' HG3' ' CD ' ' A' ' 29' ' ' GLU . 5.2 pt20 -56.95 -36.44 70.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.058 176.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.406 ' CD ' ' HG3' ' A' ' 28' ' ' GLN . 25.6 mp0 -72.73 -40.1 66.37 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.544 HG22 ' HB2' ' A' ' 35' ' ' LEU . 87.8 mt -61.72 -48.58 88.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.247 -178.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.4 m -68.44 -21.37 64.65 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.259 -177.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -92.97 -43.57 8.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.529 -176.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.556 ' HB3' ' HD3' ' B' ' 253' ' ' PRO . 82.9 m-85 -98.61 -2.91 37.38 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -175.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.7 mptt 65.06 90.1 0.09 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.394 0.616 . . . . 0.0 111.894 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.544 ' HB2' HG22 ' A' ' 30' ' ' ILE . 97.2 mt -121.54 147.86 45.24 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.804 176.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.3 t -103.38 125.09 57.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.912 0.387 . . . . 0.0 111.399 -174.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -69.67 111.57 5.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.092 173.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.1 m -94.8 -8.29 9.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.874 -177.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.34 -160.2 29.36 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.179 -1.01 . . . . 0.0 112.785 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.456 ' HG1' ' HG2' ' A' ' 89' ' ' GLU . 64.6 m -145.15 135.94 24.56 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 122.596 0.358 . . . . 0.0 110.247 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.7 pt -104.68 143.28 16.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 176.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -122.88 123.51 41.15 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.013 0.435 . . . . 0.0 111.346 -175.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.679 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 67.4 t -97.26 130.72 45.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.294 174.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.9 t -157.68 40.97 0.29 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.49 ' NE2' HG13 ' A' ' 43' ' ' VAL . 0.9 OUTLIER -81.57 158.32 24.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.646 -172.119 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.426 ' HA ' HD21 ' A' ' 83' ' ' ASN . 10.8 t -99.7 87.12 3.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.932 -172.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.61 -84.19 0.55 Allowed Glycine 0 C--O 1.224 -0.524 0 N-CA-C 114.582 0.593 . . . . 0.0 114.582 170.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -49.94 -42.35 38.43 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 114.923 0.729 . . . . 0.0 114.923 -168.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.418 ' OE1' ' HG2' ' A' ' 45' ' ' GLN . 63.8 mt-30 -71.03 -18.03 62.6 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -174.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.7 mm -129.43 123.93 58.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.62 0.248 . . . . 0.0 110.79 -175.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.7 t -140.25 -51.47 0.49 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.017 0.437 . . . . 0.0 110.814 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.525 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 46.4 m -128.41 172.63 6.64 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 178.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.817 ' HD3' ' HB3' ' B' ' 233' ' ' PHE . 59.3 Cg_exo -51.7 -34.96 55.98 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.49 2.126 . . . . 0.0 111.97 178.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.549 ' O ' ' HG3' ' A' ' 58' ' ' GLU . 16.7 p -58.34 -56.72 18.42 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.072 179.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -58.7 -37.67 76.6 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.876 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 61.9 tp -64.12 -52.55 58.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.121 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 53' ' ' PRO . 7.4 ppt_? -69.85 -25.91 63.96 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.501 -177.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.549 ' HG3' ' O ' ' A' ' 54' ' ' SER . 38.8 mt-10 -62.61 -40.84 98.21 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 120.835 0.35 . . . . 0.0 110.24 173.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -74.31 -38.52 63.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.611 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.6 mt -64.5 -48.88 73.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.707 -177.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.461 ' HB2' ' HG2' ' B' ' 223' ' ' GLU . 17.0 t -65.92 -35.55 80.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.858 0.361 . . . . 0.0 110.483 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -60.74 -42.12 96.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.15 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 93.4 mt -75.02 -32.71 61.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.293 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.57 -41.7 68.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.281 -178.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -58.93 -41.72 88.02 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 176.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.75 -4.99 30.8 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.855 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -104.71 -9.36 18.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.191 0.52 . . . . 0.0 110.178 174.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.54 26.12 72.49 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.312 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -112.53 146.65 18.26 Favored Glycine 0 C--O 1.225 -0.447 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.764 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -97.19 -14.17 21.61 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -172.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.16 144.12 32.07 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -176.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.47 ' CD2' ' HB3' ' B' ' 222' ' ' ALA . 15.5 p90 -129.91 157.51 42.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.82 0.343 . . . . 0.0 110.13 172.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.612 ' CD2' ' HA ' ' A' ' 26' ' ' SER . 8.1 t-160 -128.74 109.34 11.22 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.868 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.516 HG12 ' HB3' ' A' ' 88' ' ' ALA . 57.6 mt -75.95 116.68 19.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.314 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.4 pt -107.15 -15.54 8.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.803 -176.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -153.25 142.5 21.51 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.616 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -162.77 139.35 7.52 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.9 152.12 22.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.753 0.311 . . . . 0.0 110.701 178.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -89.9 107.54 19.17 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 171.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -112.51 84.91 2.06 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.092 0.473 . . . . 0.0 110.301 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.18 -123.29 20.74 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.264 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -84.28 -3.57 10.2 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.845 2.363 . . . . 0.0 112.864 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.426 HD21 ' HA ' ' A' ' 46' ' ' SER . 10.7 m120 -119.26 128.9 54.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.748 0.309 . . . . 0.0 110.611 -176.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -93.14 123.46 36.42 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 173.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.679 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 43.1 mt-10 -108.5 129.07 55.29 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.879 0.371 . . . . 0.0 111.066 -176.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.491 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . . . -138.28 132.58 31.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.231 177.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.3 t -114.21 112.87 41.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.012 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.516 ' HB3' HG12 ' A' ' 74' ' ' ILE . . . -128.04 129.09 46.12 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.724 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.456 ' HG2' ' HG1' ' A' ' 40' ' ' THR . 26.5 mt-10 -91.88 139.15 30.95 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.6 t -100.39 136.76 30.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -176.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -124.19 150.88 44.7 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.291 0.567 . . . . 0.0 111.127 -177.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -130.33 158.64 39.25 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.464 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 120.766 0.317 . . . . 0.0 110.317 178.717 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 222' ' ' ALA . . . . . 0.47 ' HB3' ' CD2' ' A' ' 72' ' ' TYR . . . . . . . . 0 C--O 1.231 0.117 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 223' ' ' GLU . . . . . 0.928 ' HB3' ' HE2' ' B' ' 271' ' ' TYR . 28.2 mt-10 -144.42 124.36 13.52 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.737 173.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 224' ' ' GLN . . . . . 1.059 ' HG3' ' HG3' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -153.69 146.42 24.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.867 -172.813 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . 0.51 ' HB ' HD12 ' B' ' 235' ' ' LEU . 11.6 m -116.26 126.56 73.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 170.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 226' ' ' SER . . . . . 0.425 ' O ' HG13 ' B' ' 230' ' ' ILE . 6.7 t -95.99 -167.33 1.57 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.374 0.607 . . . . 0.0 111.523 -173.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . 0.439 ' HA ' HD12 ' B' ' 230' ' ' ILE . 2.2 tmtp? -75.67 -28.91 58.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.831 -172.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -72.86 -43.73 62.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.088 0.47 . . . . 0.0 110.539 -177.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -61.8 -26.94 68.41 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.459 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.467 HG12 HD11 ' B' ' 235' ' ' LEU . 69.9 mt -57.83 -57.23 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.096 0.474 . . . . 0.0 110.253 176.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 11.2 m -73.69 -50.61 20.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.05 -177.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -76.24 -38.59 56.11 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -170.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 233' ' ' PHE . . . . . 0.817 ' HB3' ' HD3' ' A' ' 53' ' ' PRO . 37.7 m-85 -102.71 -5.8 23.35 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -173.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt 67.01 92.01 0.08 Allowed 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.853 0.721 . . . . 0.0 110.996 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . 0.51 HD12 ' HB ' ' B' ' 225' ' ' VAL . 28.1 mt -97.23 141.06 30.8 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.023 178.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 21.7 t -66.64 -50.14 68.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.237 -178.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 237' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' B' ' 291' ' ' TYR . 50.7 tttm 65.78 120.39 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.901 -175.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 38.1 t -91.14 -46.62 14.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.43 -177.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.73 -152.03 16.57 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.871 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 21.3 m -127.62 140.09 52.32 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 241' ' ' ILE . . . . . 0.46 HG23 HG21 ' B' ' 290' ' ' VAL . 19.2 pt -113.08 141.88 27.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.887 0.375 . . . . 0.0 110.683 176.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -120.21 126.54 50.88 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.835 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 243' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' B' ' 285' ' ' GLU . 88.1 t -94.02 132.25 38.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.061 175.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 11.0 p -152.93 64.3 0.78 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.442 0.639 . . . . 0.0 110.776 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 245' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -97.95 143.85 28.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.295 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 6.2 t -86.62 36.84 0.72 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.357 0.598 . . . . 0.0 110.412 -174.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 88.0 167.94 43.89 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.227 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . 82.35 -49.35 4.13 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.821 176.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -71.26 -18.49 62.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.839 0.352 . . . . 0.0 111.201 -178.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 250' ' ' ILE . . . . . 0.452 ' HA ' ' HB3' ' B' ' 255' ' ' ASP . 40.8 mm -126.61 107.59 17.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 34.7 t -135.52 3.5 3.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.601 0.239 . . . . 0.0 111.129 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 252' ' ' SER . . . . . 0.527 ' HB2' ' HD2' ' B' ' 253' ' ' PRO . 95.7 p -158.38 167.21 14.89 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -178.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . 0.556 ' HD3' ' HB3' ' A' ' 33' ' ' PHE . 15.9 Cg_endo -59.14 -37.8 90.13 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.261 1.974 . . . . 0.0 111.019 173.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 254' ' ' SER . . . . . 0.564 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 15.3 m -60.75 -46.13 91.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.682 176.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 255' ' ' ASP . . . . . 0.452 ' HB3' ' HA ' ' B' ' 250' ' ' ILE . 24.9 m-20 -55.12 -50.11 70.07 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.663 0.268 . . . . 0.0 110.786 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . 0.471 ' O ' ' HG ' ' B' ' 260' ' ' LEU . 57.0 tp -60.01 -45.94 91.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.068 178.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -57.27 -48.24 79.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.962 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 258' ' ' GLU . . . . . 0.564 ' HG2' ' O ' ' B' ' 254' ' ' SER . 43.8 mm-40 -58.13 -39.49 78.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.475 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 259' ' ' LYS . . . . . 0.419 ' O ' ' HG ' ' B' ' 263' ' ' LEU . 13.5 mptt -77.28 -35.48 55.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.395 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 260' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' B' ' 256' ' ' LEU . 87.7 mt -64.97 -47.41 77.68 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.501 0.191 . . . . 0.0 110.965 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 6.1 m -61.85 -30.79 71.09 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.205 0.526 . . . . 0.0 110.274 177.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -70.07 -52.76 21.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.753 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 263' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' B' ' 259' ' ' LYS . 88.0 mt -64.08 -36.9 85.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.263 -176.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -66.24 -38.3 87.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.279 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -72.38 -36.7 68.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.439 -177.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -63.27 -30.2 71.39 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.806 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -72.2 -32.9 67.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.352 175.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 117.46 -3.59 17.98 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.234 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -99.44 -153.59 27.86 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.594 -177.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm -150.53 -60.17 0.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.771 0.32 . . . . 0.0 111.049 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 271' ' ' TYR . . . . . 0.928 ' HE2' ' HB3' ' B' ' 223' ' ' GLU . 62.1 m-85 -90.41 148.1 23.01 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -172.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 272' ' ' TYR . . . . . 0.427 ' OH ' ' HA ' ' A' ' 23' ' ' GLU . 10.0 p90 -147.08 167.59 23.69 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.906 0.384 . . . . 0.0 111.423 -174.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 273' ' ' HIS . . . . . 0.512 ' HA ' ' OE1' ' A' ' 24' ' ' GLN . 0.6 OUTLIER -139.47 113.35 8.65 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.878 177.529 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 274' ' ' ILE . . . . . . . . . . . . . 4.4 mp -70.67 121.63 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 30.1 pt -102.43 -24.53 4.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.526 -178.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -153.85 140.73 19.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.863 -178.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -144.79 123.51 12.58 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.779 177.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 6.1 ptt180 -129.2 134.5 48.03 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.084 0.468 . . . . 0.0 110.691 -178.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -99.21 89.89 4.39 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 173.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -92.77 85.42 5.21 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.058 -173.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 62.08 -116.1 8.89 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.725 176.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.49 -16.57 21.54 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.716 2.277 . . . . 0.0 112.808 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 -105.99 162.89 13.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.176 0.512 . . . . 0.0 110.952 -175.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -132.12 104.7 6.94 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 171.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 285' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 21.4 mp0 -107.13 134.08 50.78 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.063 0.459 . . . . 0.0 110.843 -176.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 286' ' ' ALA . . . . . . . . . . . . . . . -137.19 147.08 45.63 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.585 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 32.8 t -123.25 122.53 65.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.947 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -131.84 143.62 50.31 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.937 0.399 . . . . 0.0 111.069 -178.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -91.56 123.94 35.35 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.824 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 290' ' ' VAL . . . . . 0.46 HG21 HG23 ' B' ' 241' ' ' ILE . 53.5 t -94.34 129.36 44.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.884 0.373 . . . . 0.0 110.851 -177.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 291' ' ' TYR . . . . . 0.513 ' HA ' ' HA ' ' B' ' 237' ' ' LYS . 64.0 m-85 -121.79 171.06 9.16 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.058 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 292' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -123.09 157.47 32.79 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 174.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 36.7 t70 . . . . . 0 C--N 1.32 -0.691 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.625 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.738 ' HA ' ' HG3' ' B' ' 223' ' ' GLU . . . . . . . . 0 N--CA 1.453 -0.275 0 CA-C-O 120.446 0.165 . . . . 0.0 110.97 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.539 ' HG3' ' HB2' ' B' ' 257' ' ' ARG . 17.0 tt0 80.9 104.97 0.07 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 124.37 1.043 . . . . 0.0 110.358 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.496 ' HA ' ' HB3' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -162.18 154.11 18.87 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.39 -174.333 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.1 m -106.79 139.27 28.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.854 0.359 . . . . 0.0 110.877 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.674 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 7.4 t -93.98 -86.11 0.28 Allowed 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.328 -175.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -157.97 -49.15 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.225 -176.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -58.56 -40.42 83.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.067 0.461 . . . . 0.0 110.53 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -64.87 -37.89 89.13 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.664 178.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.524 HG12 HD11 ' A' ' 35' ' ' LEU . 58.5 mt -66.72 -39.46 83.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.442 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.9 m -68.81 -35.03 76.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.086 0.47 . . . . 0.0 110.86 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -85.87 -45.17 11.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.416 -174.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -92.24 -19.38 22.26 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -175.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.444 ' NZ ' ' HB2' ' A' ' 34' ' ' LYS . 0.2 OUTLIER 65.83 85.18 0.14 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.127 0.489 . . . . 0.0 111.388 -177.614 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.524 HD11 HG12 ' A' ' 30' ' ' ILE . 67.7 mt -94.35 175.67 6.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.676 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.7 t -105.97 123.6 60.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.33 -175.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.496 ' HZ1' ' CD ' ' A' ' 89' ' ' GLU . 35.8 tttp -81.4 112.35 18.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.191 176.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.2 m -107.48 22.4 3.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -173.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 120.9 -164.8 14.11 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.306 -0.949 . . . . 0.0 112.897 174.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.527 HG23 ' HG2' ' A' ' 89' ' ' GLU . 12.9 m -140.06 134.69 31.71 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 -176.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.7 pt -107.21 151.05 9.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 174.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -125.52 123.04 38.27 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.033 0.444 . . . . 0.0 111.628 -174.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.565 ' HB ' ' HB2' ' A' ' 86' ' ' ALA . 73.0 t -99.1 117.68 44.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.348 172.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 63.5 p -145.98 72.81 1.31 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.245 0.545 . . . . 0.0 109.718 176.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.414 HE22 HG11 ' A' ' 43' ' ' VAL . 0.7 OUTLIER -100.5 148.77 24.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.03 -176.706 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.413 ' HA ' HD21 ' A' ' 83' ' ' ASN . 17.4 m -86.4 56.64 4.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.594 -176.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.82 -71.05 2.79 Favored Glycine 0 C--O 1.227 -0.337 0 C-N-CA 121.261 -0.495 . . . . 0.0 114.129 173.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -54.01 -28.71 41.65 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 115.164 0.825 . . . . 0.0 115.164 -169.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -78.61 -14.57 59.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.59 0.695 . . . . 0.0 111.606 -177.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.0 mm -120.32 107.53 21.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.163 0.506 . . . . 0.0 110.185 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.2 m -114.52 -45.13 3.03 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.576 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 87.7 p -124.78 164.28 32.01 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.739 177.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.753 ' HB2' ' HB2' ' B' ' 293' ' ' ASP . 24.2 Cg_exo -64.34 -20.19 66.27 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.28 1.986 . . . . 0.0 111.644 174.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.502 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 75.2 m -69.06 -42.75 75.85 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.084 173.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -62.87 -39.11 93.41 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.217 0.532 . . . . 0.0 109.717 176.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 61.7 tp -60.36 -41.36 93.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.964 176.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.447 ' HD2' ' OE1' ' B' ' 223' ' ' GLU . 9.5 ttp85 -61.3 -43.86 98.18 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.552 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.502 ' HG2' ' O ' ' A' ' 54' ' ' SER . 22.9 mm-40 -53.49 -50.78 64.63 Favored 'General case' 0 C--N 1.332 -0.165 0 O-C-N 123.51 0.506 . . . . 0.0 110.616 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.481 ' HA ' ' HG2' ' A' ' 62' ' ' GLU . 4.3 mptp? -67.44 -41.62 84.45 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.573 -178.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 85.0 mt -63.34 -34.16 77.1 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.005 0.431 . . . . 0.0 110.482 177.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.6 t -70.6 -52.46 21.33 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.724 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.481 ' HG2' ' HA ' ' A' ' 59' ' ' LYS . 13.0 pt-20 -65.26 -31.46 72.63 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -175.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 82.9 mt -66.98 -47.07 72.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.84 0.353 . . . . 0.0 111.172 177.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.526 ' O ' ' HG3' ' A' ' 67' ' ' LYS . . . -74.01 -43.9 56.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.608 -177.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -59.57 -51.52 69.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.548 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.9 -18.97 64.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.038 -176.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.526 ' HG3' ' O ' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -91.19 -13.92 32.0 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.439 -179.285 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.64 44.35 4.91 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.212 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -130.07 151.76 19.49 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.097 -0.573 . . . . 0.0 111.813 177.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' B' ' 222' ' ' ALA . 17.7 mmtp -88.4 -72.78 0.52 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.86 0.362 . . . . 0.0 111.543 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.496 ' HB3' ' HA ' ' A' ' 24' ' ' GLN . 0.4 OUTLIER -108.19 169.82 8.39 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -173.128 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -140.68 167.51 22.0 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.674 ' CD2' ' HA ' ' A' ' 26' ' ' SER . 4.8 t-80 -139.08 110.59 7.04 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.753 174.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 59.8 mt -65.89 113.93 2.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.804 176.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 31.8 pt -97.73 -26.31 3.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.966 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -156.21 131.69 9.5 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.328 178.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -135.65 98.81 4.02 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -125.32 165.69 17.9 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.513 -173.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -109.69 129.33 55.61 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.963 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -100.5 18.39 19.21 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.335 0.588 . . . . 0.0 109.647 -178.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 110.25 -98.93 1.13 Allowed Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.463 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.83 -13.86 11.49 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.522 2.148 . . . . 0.0 112.103 176.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.413 HD21 ' HA ' ' A' ' 46' ' ' SER . 13.5 m120 -114.34 139.26 49.61 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.019 -176.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -99.83 115.8 30.42 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 172.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.506 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 50.5 mt-10 -107.18 111.14 23.42 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.946 0.403 . . . . 0.0 110.73 -175.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.565 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . . . -120.38 117.34 27.49 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.258 177.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.5 t -98.61 112.97 32.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.034 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -126.46 123.89 38.88 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.017 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.527 ' HG2' HG23 ' A' ' 40' ' ' THR . 10.4 mt-10 -93.46 143.99 25.77 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.6 t -96.6 130.43 45.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.894 0.378 . . . . 0.0 110.356 -171.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -125.61 133.88 52.09 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.821 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -107.48 161.44 14.83 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.2 t70 . . . . . 0 C--O 1.238 0.476 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -179.37 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 222' ' ' ALA . . . . . 0.44 ' HB2' ' O ' ' A' ' 70' ' ' LYS . . . . . . . . 0 N--CA 1.453 -0.324 0 N-CA-C 110.243 -0.281 . . . . 0.0 110.243 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 223' ' ' GLU . . . . . 0.738 ' HG3' ' HA ' ' A' ' 22' ' ' ALA . 0.9 OUTLIER -170.36 124.7 0.72 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -176.212 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 224' ' ' GLN . . . . . 0.473 ' HA ' ' HB3' ' B' ' 271' ' ' TYR . 0.0 OUTLIER -171.48 149.26 2.65 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.325 177.463 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 29.0 m -114.77 151.42 16.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.513 176.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 226' ' ' SER . . . . . 0.612 ' HA ' ' CD2' ' B' ' 273' ' ' HIS . 57.5 p -113.59 -96.21 0.45 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -136.05 -36.05 0.76 Allowed 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.61 -43.1 89.5 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.443 0.639 . . . . 0.0 109.98 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 229' ' ' GLU . . . . . 0.484 ' H ' ' CD ' ' B' ' 229' ' ' GLU . 3.2 mp0 -58.72 -45.22 90.08 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.448 177.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.5 ' HA ' ' HG ' ' B' ' 235' ' ' LEU . 55.7 mt -63.44 -39.3 84.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.528 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 15.2 m -69.82 -23.13 63.26 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.086 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -93.5 -57.6 2.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.602 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -90.05 -14.38 33.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.157 -170.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt 59.07 82.78 0.14 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.252 0.549 . . . . 0.0 110.082 -175.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . 0.54 HD21 ' HA ' ' B' ' 293' ' ' ASP . 55.1 mt -80.32 178.8 8.04 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.477 -171.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . 0.544 ' HB ' ' HB2' ' B' ' 292' ' ' ASN . 40.8 t -103.61 109.35 26.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.135 -0.938 . . . . 0.0 110.288 -178.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -76.33 125.75 29.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.711 -176.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 238' ' ' VAL . . . . . 0.691 HG13 ' HD2' ' B' ' 267' ' ' LYS . 4.1 t -100.73 -17.53 6.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-O 121.334 0.588 . . . . 0.0 110.847 -176.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 115.81 162.64 13.38 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.391 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.04 145.07 31.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.046 0.45 . . . . 0.0 111.505 -177.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 32.2 pt -126.87 132.04 70.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 169.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -117.45 132.39 56.57 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.993 0.901 . . . . 0.0 111.477 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 243' ' ' VAL . . . . . 0.53 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 66.5 t -93.99 131.0 42.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 114.528 -1.214 . . . . 0.0 109.999 -177.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 15.4 t -148.06 95.74 2.53 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 176.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 245' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.91 152.37 50.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.124 176.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 15.3 m -76.94 162.72 27.36 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.012 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -58.72 106.11 0.8 Allowed Glycine 0 C--N 1.331 0.275 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.916 176.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . 151.92 -50.41 0.52 Allowed Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -174.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -78.13 -28.99 48.59 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 173.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 42.8 mm -121.27 123.43 69.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.675 171.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 22.2 t -149.88 -38.72 0.14 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.95 0.405 . . . . 0.0 110.379 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 252' ' ' SER . . . . . 0.451 ' HB3' ' HD2' ' B' ' 253' ' ' PRO . 16.5 m -113.16 161.53 26.47 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.152 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' B' ' 252' ' ' SER . 13.7 Cg_endo -57.78 -20.89 45.48 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.675 2.25 . . . . 0.0 112.189 177.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 254' ' ' SER . . . . . 0.619 ' HA ' ' NH1' ' B' ' 257' ' ' ARG . 22.6 t -65.94 -51.08 61.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.522 177.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 255' ' ' ASP . . . . . 0.448 ' O ' ' HG2' ' B' ' 259' ' ' LYS . 9.3 m-20 -54.47 -45.4 73.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.383 -173.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 49.3 tp -60.3 -60.61 3.54 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.234 -174.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 257' ' ' ARG . . . . . 0.619 ' NH1' ' HA ' ' B' ' 254' ' ' SER . 0.0 OUTLIER -68.03 -25.92 65.62 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -174.636 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 258' ' ' GLU . . . . . 0.485 ' HG3' ' O ' ' B' ' 254' ' ' SER . 53.8 mt-10 -70.18 -32.19 70.0 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.398 179.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 259' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' B' ' 255' ' ' ASP . 74.8 mmtt -73.03 -44.21 61.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.986 0.422 . . . . 0.0 109.965 174.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.32 -48.26 82.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.612 -177.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 41.0 m -60.88 -35.34 76.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.677 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -68.37 -41.76 80.15 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.008 0.432 . . . . 0.0 110.529 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 263' ' ' LEU . . . . . . . . . . . . . 98.1 mt -67.46 -44.18 79.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.008 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -61.44 -41.99 98.06 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.158 177.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -54.03 -53.87 47.0 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.306 176.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -64.01 -31.18 72.28 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.048 0.451 . . . . 0.0 111.02 -177.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 267' ' ' LYS . . . . . 0.691 ' HD2' HG13 ' B' ' 238' ' ' VAL . 32.7 mmtt -62.5 -38.7 90.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.21 176.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 94.9 15.33 45.98 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -170.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . 0.482 ' HA2' ' ND2' ' B' ' 292' ' ' ASN . . . -106.87 146.76 16.1 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . 0.588 ' O ' ' HB1' ' A' ' 22' ' ' ALA . 54.8 mtpt -79.66 -68.28 0.68 Allowed 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 121.133 -0.227 . . . . 0.0 111.415 -176.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 271' ' ' TYR . . . . . 0.568 ' HE2' ' HB3' ' B' ' 293' ' ' ASP . 9.9 m-85 -97.93 154.41 17.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.101 0.477 . . . . 0.0 110.631 -173.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 272' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -122.62 136.42 54.88 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 175.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 273' ' ' HIS . . . . . 0.612 ' CD2' ' HA ' ' B' ' 226' ' ' SER . 12.3 t-80 -110.98 101.79 10.32 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.667 0.27 . . . . 0.0 110.745 -176.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 274' ' ' ILE . . . . . . . . . . . . . 68.5 mt -70.16 122.12 21.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 176.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 61.5 mt -97.85 -52.65 8.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.152 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -140.73 147.52 39.31 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.968 -177.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -144.53 138.68 27.7 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -152.38 151.41 30.79 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.038 0.447 . . . . 0.0 110.811 -176.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -97.25 120.24 37.25 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 175.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -129.95 107.54 9.44 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.006 0.432 . . . . 0.0 110.813 -174.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 66.82 -127.62 28.29 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.787 -178.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -92.21 3.54 3.84 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.767 2.311 . . . . 0.0 112.472 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -118.58 149.86 40.63 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.129 0.49 . . . . 0.0 111.415 -174.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -99.9 123.3 44.0 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.515 173.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 285' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 21.1 mm-40 -107.75 121.21 44.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.457 -176.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 286' ' ' ALA . . . . . 0.53 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -128.75 134.48 48.43 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 121.106 -0.238 . . . . 0.0 110.827 176.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 65.0 t -116.52 117.53 55.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.832 0.349 . . . . 0.0 110.386 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -133.28 142.99 48.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.467 -178.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -99.26 131.43 45.29 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.982 175.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 290' ' ' VAL . . . . . 0.558 ' HB ' ' HB ' ' B' ' 238' ' ' VAL . 32.7 t -90.09 133.81 30.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 176.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -132.58 134.12 44.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.993 0.425 . . . . 0.0 111.354 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 292' ' ' ASN . . . . . 0.544 ' HB2' ' HB ' ' B' ' 236' ' ' VAL . 23.2 m120 -90.73 123.71 34.53 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 165.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 293' ' ' ASP . . . . . 0.753 ' HB2' ' HB2' ' A' ' 53' ' ' PRO . 5.3 p-10 . . . . . 0 C--N 1.318 -0.79 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.432 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.437 ' HB3' ' HE1' ' A' ' 71' ' ' TYR . 30.9 mt-10 -144.43 -158.8 0.92 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.691 -175.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.637 ' HA ' ' CD1' ' A' ' 71' ' ' TYR . 0.0 OUTLIER 86.98 145.62 0.05 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.857 1.263 . . . . 0.0 111.447 178.437 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.413 HG21 ' CD1' ' A' ' 35' ' ' LEU . 31.1 m -109.82 140.98 26.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.356 -178.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.577 ' HA ' ' HD2' ' A' ' 73' ' ' HIS . 6.3 m -86.81 -174.08 4.78 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.296 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -69.92 -35.3 74.45 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -169.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.478 HE21 ' HB2' ' A' ' 26' ' ' SER . 0.5 OUTLIER -73.21 -33.93 65.65 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.561 -177.198 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.432 ' OE1' ' HB2' ' A' ' 26' ' ' SER . 3.0 mp0 -63.58 -45.03 92.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.099 0.476 . . . . 0.0 109.907 175.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.476 HG12 HD11 ' A' ' 35' ' ' LEU . 81.4 mt -56.76 -40.31 69.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.756 177.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.1 m -71.94 -20.74 61.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.305 -178.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -88.29 -42.19 12.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.476 -178.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -89.56 -9.31 50.31 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 121.064 -0.255 . . . . 0.0 111.372 -178.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? 54.84 54.78 8.61 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.293 0.568 . . . . 0.0 110.237 -176.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.476 HD11 HG12 ' A' ' 30' ' ' ILE . 89.6 mt -66.17 145.93 55.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.44 -176.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.7 m -73.71 135.91 26.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.719 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.5 tttm -96.89 122.58 40.02 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.365 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.24 -47.11 20.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.973 0.416 . . . . 0.0 110.237 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 171.45 173.86 38.7 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.066 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 86.9 m -101.26 121.28 41.6 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.619 0.247 . . . . 0.0 110.467 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.1 pt -106.77 144.09 16.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 176.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -128.43 131.57 48.44 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.533 0.682 . . . . 0.0 110.882 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 70.7 t -93.99 128.5 45.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 114.255 -1.339 . . . . 0.0 109.311 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.0 t -150.35 78.17 1.32 Allowed 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.631 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 0.6 OUTLIER -103.1 130.68 50.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.997 -179.141 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.9 t -92.14 102.61 15.14 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.009 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.54 -130.21 10.18 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.055 -0.593 . . . . 0.0 114.405 171.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.91 34.06 2.59 Favored Glycine 0 C--N 1.331 0.26 0 N-CA-C 114.329 0.492 . . . . 0.0 114.329 -167.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.631 ' HB2' ' HB3' ' A' ' 45' ' ' GLN . 15.2 mm100 -82.68 -28.33 30.67 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 172.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.523 HD13 ' HA ' ' A' ' 56' ' ' LEU . 49.6 mm -122.95 112.1 32.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.407 176.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.0 m -118.46 -1.27 11.26 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.311 -176.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 40.4 m -155.93 148.46 17.82 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -58.73 -31.49 95.07 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.426 2.084 . . . . 0.0 111.21 176.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.547 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 2.8 p -69.72 -35.1 74.74 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.212 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -75.76 -32.1 59.81 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.879 0.371 . . . . 0.0 110.422 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.523 ' HA ' HD13 ' A' ' 50' ' ' ILE . 68.4 tp -59.59 -50.21 74.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.049 178.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.558 ' HD2' ' CD ' ' B' ' 223' ' ' GLU . 26.5 ptt85 -67.35 -32.8 73.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.952 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.547 ' HG2' ' O ' ' A' ' 54' ' ' SER . 9.5 mm-40 -55.5 -42.64 74.72 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.162 0.506 . . . . 0.0 110.006 176.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.486 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 13.7 mptt -58.76 -44.91 90.71 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.591 175.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.452 HD11 HD11 ' A' ' 74' ' ' ILE . 74.5 mt -64.89 -41.88 95.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.972 -176.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.4 m -60.18 -40.01 88.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.163 0.506 . . . . 0.0 110.168 175.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -69.04 -40.37 78.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.891 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 59' ' ' LYS . 87.9 mt -66.26 -37.49 85.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.221 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.96 -39.08 93.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.885 0.374 . . . . 0.0 110.523 178.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -68.04 -35.77 78.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.849 177.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.12 -32.7 70.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.285 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.412 ' HD3' ' HA ' ' A' ' 67' ' ' LYS . 71.5 mmtt -87.34 -26.54 23.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.882 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.53 43.96 3.3 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.511 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -120.44 -170.84 14.33 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.81 -0.709 . . . . 0.0 111.776 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -123.26 -36.08 2.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.966 0.412 . . . . 0.0 110.591 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.637 ' CD1' ' HA ' ' A' ' 24' ' ' GLN . 71.7 m-85 -132.6 166.74 21.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.007 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.571 ' HH ' ' HA ' ' B' ' 223' ' ' GLU . 48.0 p90 -148.96 131.3 15.61 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.577 ' HD2' ' HA ' ' A' ' 26' ' ' SER . 58.8 t-80 -109.72 105.61 14.93 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.078 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.497 ' HB ' ' OG ' ' B' ' 226' ' ' SER . 60.6 mt -67.77 130.89 33.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.272 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 33.5 pt -114.17 -16.27 9.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.15 -178.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.512 ' HB3' ' HB ' ' A' ' 87' ' ' VAL . . . -147.94 137.31 22.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.056 -176.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -156.51 103.54 2.13 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.41 145.97 35.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.776 0.322 . . . . 0.0 111.032 -176.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -82.14 124.96 30.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.199 0.523 . . . . 0.0 110.816 176.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.0 t-160 -100.19 50.61 0.9 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 175.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.14 -130.83 10.14 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 110.321 -1.111 . . . . 0.0 110.321 -170.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -79.61 6.0 5.47 Favored 'Trans proline' 0 N--CA 1.464 -0.229 0 C-N-CA 122.483 2.122 . . . . 0.0 111.499 173.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -108.96 121.93 46.16 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.284 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.483 ' CE2' ' HB3' ' A' ' 86' ' ' ALA . 70.1 t80 -93.36 122.77 36.11 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.964 -176.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 25.9 mm-40 -112.36 115.3 28.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.249 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.492 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . . . -132.31 134.67 45.51 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.591 0.234 . . . . 0.0 111.057 178.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.512 ' HB ' ' HB3' ' A' ' 76' ' ' ALA . 97.2 t -114.46 121.86 67.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.939 0.4 . . . . 0.0 110.075 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 74' ' ' ILE . . . -125.19 138.07 54.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.165 -177.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.05 116.92 29.4 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.776 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.7 t -86.3 126.02 40.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.833 0.349 . . . . 0.0 110.655 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -123.52 156.51 35.5 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.986 178.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -110.19 172.65 6.74 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 16.8 t70 . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.299 -175.494 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.325 0 CA-C-O 120.517 0.199 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 223' ' ' GLU . . . . . 0.571 ' HA ' ' HH ' ' A' ' 72' ' ' TYR . 11.0 tp10 -164.97 135.72 3.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.213 -177.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 224' ' ' GLN . . . . . 0.432 ' HB2' ' O ' ' B' ' 223' ' ' GLU . 0.0 OUTLIER 170.76 139.98 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.811 0.694 . . . . 0.0 110.588 -179.827 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 17.8 m -109.33 132.18 58.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.943 172.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 226' ' ' SER . . . . . 0.554 ' O ' HG13 ' B' ' 230' ' ' ILE . 5.8 m -88.69 172.8 8.99 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.846 0.355 . . . . 0.0 111.068 -175.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . 0.522 ' HA ' HD13 ' B' ' 230' ' ' ILE . 5.5 mmtt -57.47 -32.65 67.18 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.76 -174.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -68.56 -51.5 42.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.334 -177.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -63.24 -35.52 80.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.015 -177.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.554 HG13 ' O ' ' B' ' 226' ' ' SER . 82.3 mt -57.08 -52.29 58.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.846 178.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 18.3 m -74.18 -24.32 59.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.785 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 20.0 t-160 -75.17 -48.71 22.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.34 -175.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -96.72 -3.16 43.0 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.047 -177.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm 62.92 72.27 0.49 Allowed 'General case' 0 N--CA 1.463 0.224 0 O-C-N 123.67 0.606 . . . . 0.0 111.59 176.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . 0.514 HD11 HG12 ' B' ' 230' ' ' ILE . 69.6 mt -73.35 174.4 8.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.997 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 69.5 t -93.11 -49.19 13.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.644 -176.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 237' ' ' LYS . . . . . 0.574 ' HA ' ' HA ' ' B' ' 291' ' ' TYR . 60.0 tttm 69.97 139.92 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 O-C-N 123.877 0.735 . . . . 0.0 111.734 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 238' ' ' VAL . . . . . 0.524 HG12 ' HB2' ' B' ' 292' ' ' ASN . 3.3 m -111.15 -50.83 6.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . -178.65 -142.08 4.64 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.011 -1.09 . . . . 0.0 113.056 -177.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 63.4 m -134.38 145.36 48.89 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 122.621 0.368 . . . . 0.0 110.716 -176.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 20.5 pt -117.91 131.59 70.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 170.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -123.05 114.44 20.38 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.06 0.457 . . . . 0.0 110.338 -175.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 243' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 82.0 t -94.0 115.19 32.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.433 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 19.2 m -110.69 87.41 2.52 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 174.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 245' ' ' GLN . . . . . 0.488 ' HB3' ' HB3' ' B' ' 284' ' ' PHE . 0.0 OUTLIER -107.55 179.61 4.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.57 0.7 . . . . 0.0 111.53 -172.451 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 33.2 t -108.63 153.31 23.58 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 166.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -58.23 -29.07 62.38 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 121.17 -0.538 . . . . 0.0 113.768 -175.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -73.49 -11.83 80.16 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 121.043 -0.599 . . . . 0.0 113.908 -174.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -94.02 -6.81 44.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 117.482 0.641 . . . . 0.0 111.158 -178.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 47.2 mm -119.73 108.09 22.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.248 -178.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 23.7 t -121.72 -47.62 2.19 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.267 0.556 . . . . 0.0 109.998 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 3.9 m -113.28 156.6 42.87 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.435 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -57.89 -30.31 89.19 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.393 2.062 . . . . 0.0 111.748 176.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 254' ' ' SER . . . . . 0.486 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 18.8 m -63.16 -33.83 76.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.15 177.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -64.62 -45.89 84.95 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.137 0.494 . . . . 0.0 110.222 -178.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 54.3 tp -66.62 -39.39 88.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.941 177.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 257' ' ' ARG . . . . . 0.428 HH11 ' CD ' ' A' ' 23' ' ' GLU . 7.5 tmm_? -58.05 -42.07 84.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.076 178.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 258' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' B' ' 254' ' ' SER . 69.7 mm-40 -57.94 -29.54 65.24 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.57 178.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -85.64 -47.95 9.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.945 0.402 . . . . 0.0 110.658 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 96.0 mt -66.1 -49.72 66.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.119 -174.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 14.6 m -66.88 -33.23 75.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.825 0.345 . . . . 0.0 110.857 -176.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -62.48 -45.68 91.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.264 0.554 . . . . 0.0 110.287 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 263' ' ' LEU . . . . . 0.618 ' O ' ' HG2' ' B' ' 267' ' ' LYS . 92.3 mt -74.39 -44.88 50.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.002 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -59.02 -48.92 79.83 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -175.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -66.87 -31.47 72.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.873 0.368 . . . . 0.0 110.547 -178.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -69.3 -19.23 63.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.9 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 267' ' ' LYS . . . . . 0.618 ' HG2' ' O ' ' B' ' 263' ' ' LEU . 74.2 mmtt -84.76 -20.48 30.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.083 0.468 . . . . 0.0 110.141 177.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 107.23 -3.94 35.29 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.548 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -90.25 153.26 22.7 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.157 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -111.98 -9.98 13.98 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -177.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 271' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -135.79 162.22 33.4 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 272' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -151.24 167.48 27.69 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.414 170.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 273' ' ' HIS . . . . . 0.453 ' CD2' ' HA ' ' B' ' 226' ' ' SER . 47.5 t-80 -135.47 108.55 7.68 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 172.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 274' ' ' ILE . . . . . 0.555 ' HB ' ' HG ' ' A' ' 26' ' ' SER . 62.3 mt -65.21 130.54 30.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 29.4 pt -108.58 -21.29 5.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.658 -175.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -159.76 112.84 2.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.973 -179.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 277' ' ' ALA . . . . . 0.4 ' HB3' ' HG3' ' A' ' 29' ' ' GLU . . . -133.46 103.49 5.96 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 176.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -147.22 175.1 11.01 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.482 -171.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.19 108.47 19.11 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.17 -178.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 33.8 t-80 -90.64 69.83 6.71 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 175.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 75.67 -122.38 6.68 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 -174.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -79.71 -3.81 13.09 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.568 2.179 . . . . 0.0 112.19 175.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -94.99 140.92 29.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.419 -177.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 284' ' ' PHE . . . . . 0.488 ' HB3' ' HB3' ' B' ' 245' ' ' GLN . 71.3 t80 -113.53 110.23 19.92 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 174.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 285' ' ' GLU . . . . . 0.505 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 18.2 mm-40 -105.58 110.98 23.5 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.922 -178.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 286' ' ' ALA . . . . . 0.533 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -111.95 115.13 28.45 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.981 0.42 . . . . 0.0 110.062 172.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 24.4 t -114.12 119.77 62.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.759 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 288' ' ' ALA . . . . . 0.433 ' HB1' HG12 ' B' ' 274' ' ' ILE . . . -131.5 141.64 49.8 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.866 0.365 . . . . 0.0 110.869 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -91.36 124.96 35.94 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 290' ' ' VAL . . . . . 0.441 ' HB ' HG23 ' B' ' 238' ' ' VAL . 11.2 t -89.63 123.44 41.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.028 0.442 . . . . 0.0 109.997 -176.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 291' ' ' TYR . . . . . 0.574 ' HA ' ' HA ' ' B' ' 237' ' ' LYS . 98.3 m-85 -112.3 124.22 51.99 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.905 -176.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 292' ' ' ASN . . . . . 0.524 ' HB2' HG12 ' B' ' 238' ' ' VAL . 10.6 t-20 -91.86 156.47 17.47 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 174.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 19.8 t70 . . . . . 0 C--N 1.323 -0.545 0 O-C-N 123.48 0.488 . . . . 0.0 110.953 -177.053 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' B' ' 223' ' ' GLU . . . . . . . . 0 CA--C 1.521 -0.142 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.91 ' HA ' ' HH ' ' B' ' 272' ' ' TYR . 16.2 pt-20 -177.39 141.44 0.31 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.629 ' HB3' ' HG3' ' B' ' 224' ' ' GLN . 0.0 OUTLIER -179.67 151.37 0.45 Allowed 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.31 174.264 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.499 ' HB ' ' CG ' ' A' ' 29' ' ' GLU . 11.6 m -112.58 146.35 17.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.77 0.319 . . . . 0.0 110.443 178.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.9 p -89.77 -156.67 0.42 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.438 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.472 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 12.8 tmtt? -80.01 -35.95 36.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.82 0.343 . . . . 0.0 110.676 -175.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -60.0 -50.42 73.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.213 -170.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.499 ' CG ' ' HB ' ' A' ' 25' ' ' VAL . 3.2 pm0 -76.15 -29.16 57.67 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.506 -174.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.548 HG12 HD13 ' A' ' 35' ' ' LEU . 69.2 mt -61.8 -43.68 97.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.011 0.434 . . . . 0.0 109.848 177.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.4 m -73.05 -34.16 66.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.191 177.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 35.1 t-80 -80.04 -36.33 35.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.778 -172.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -103.13 -10.46 18.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.47 0.176 . . . . 0.0 111.341 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt 58.55 83.96 0.11 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.339 -177.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.993 HD12 ' HH ' ' A' ' 71' ' ' TYR . 92.3 mt -93.53 155.37 17.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.8 -178.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.5 t -87.77 117.91 32.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.148 -176.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -82.24 115.15 21.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.025 177.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.421 ' CG1' ' HB2' ' A' ' 92' ' ' ASN . 6.4 m -97.12 15.0 3.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.075 0.464 . . . . 0.0 111.279 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 128.48 -158.1 21.59 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.65 -0.785 . . . . 0.0 113.006 174.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.5 m -144.96 139.74 27.74 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -178.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.6 pt -117.82 150.3 19.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -130.79 132.71 45.43 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.164 0.507 . . . . 0.0 111.486 -175.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 73.0 t -95.09 123.82 47.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.963 172.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.2 p -151.32 75.92 1.2 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.011 0.434 . . . . 0.0 111.23 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 14.9 mp0 -111.7 156.83 21.27 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.976 0.417 . . . . 0.0 111.084 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 64.4 m -89.47 67.76 7.7 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.975 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.6 -78.18 1.03 Allowed Glycine 0 CA--C 1.521 0.428 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.801 175.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.93 51.55 3.16 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 114.86 0.704 . . . . 0.0 114.86 -169.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -137.62 1.32 2.34 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 168.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.558 HD12 ' HA ' ' A' ' 56' ' ' LEU . 49.7 mm -126.62 107.64 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.081 174.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.3 p -95.55 -29.54 14.31 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.58 -174.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.4 m -147.83 165.88 17.37 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.847 -174.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.49 -46.4 21.18 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.207 1.938 . . . . 0.0 111.325 174.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.461 ' O ' ' HG3' ' A' ' 58' ' ' GLU . 48.4 t -59.49 -34.82 73.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.666 175.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.4 ' OD2' ' HA ' ' A' ' 50' ' ' ILE . 34.9 t70 -66.98 -41.0 87.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.949 0.404 . . . . 0.0 110.002 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.558 ' HA ' HD12 ' A' ' 50' ' ' ILE . 58.5 tp -59.69 -44.61 93.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.317 0.58 . . . . 0.0 109.789 173.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.39 -34.15 77.1 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.003 178.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 54' ' ' SER . 50.2 mt-10 -59.87 -45.49 92.3 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.779 -0.191 . . . . 0.0 110.577 177.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -60.92 -43.54 98.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.918 0.389 . . . . 0.0 110.821 176.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.47 -48.18 76.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.52 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.48 ' HB3' ' O ' ' B' ' 222' ' ' ALA . 18.8 p -70.29 -33.08 71.14 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.075 -176.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -60.95 -48.74 80.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.561 177.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.8 mt -65.46 -35.09 79.88 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.613 178.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.16 -41.99 80.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.863 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -62.13 -38.15 87.84 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.577 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.28 -39.02 85.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.923 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.4 mmtp -74.64 -29.38 61.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.001 0.429 . . . . 0.0 110.74 176.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.31 26.77 11.64 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.759 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -101.03 147.56 17.86 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.131 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 67.6 mttt -93.18 -4.16 52.59 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.825 0.345 . . . . 0.0 111.501 -172.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.993 ' HH ' HD12 ' A' ' 35' ' ' LEU . 22.3 p90 -165.32 164.6 19.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.486 -177.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.413 ' O ' ' HG3' ' A' ' 24' ' ' GLN . 25.3 p90 -131.78 133.06 44.33 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.508 -178.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.409 ' HB3' ' HB2' ' A' ' 89' ' ' GLU . 17.0 t-80 -100.22 102.5 13.8 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.494 -175.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.414 ' H ' HD13 ' A' ' 74' ' ' ILE . 5.3 mp -72.3 122.94 25.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 30.7 pt -111.49 -24.02 4.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.089 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -155.72 125.19 6.32 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.001 0.429 . . . . 0.0 111.202 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.16 119.68 23.36 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 175.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -139.62 155.1 47.63 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.463 0.649 . . . . 0.0 111.973 -171.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -110.54 112.11 23.8 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.538 177.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -78.12 -27.01 48.21 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 123.28 -85.16 0.37 Allowed Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -176.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.91 -20.42 29.42 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.456 2.104 . . . . 0.0 111.474 173.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -123.12 145.7 48.36 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.825 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -102.88 124.85 49.17 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 170.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.542 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 51.6 mt-10 -123.28 115.91 22.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.062 0.458 . . . . 0.0 111.099 -171.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.532 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . . . -127.85 134.37 49.41 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.042 179.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.8 t -114.36 116.27 52.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.155 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -131.65 137.79 48.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.089 0.471 . . . . 0.0 111.087 -178.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.409 ' HB2' ' HB3' ' A' ' 73' ' ' HIS . 30.0 mt-10 -91.48 150.61 21.15 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 17.6 t -113.06 130.64 66.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 177.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.753 ' HB2' ' CE1' ' A' ' 71' ' ' TYR . 52.3 m-85 -121.21 147.71 45.25 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.128 0.489 . . . . 0.0 110.107 177.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.421 ' HB2' ' CG1' ' A' ' 38' ' ' VAL . 1.5 t-20 -95.35 18.73 11.94 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.583 -168.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 45.2 t0 . . . . . 0 N--CA 1.476 0.866 0 CA-C-O 121.672 0.749 . . . . 0.0 110.299 -178.754 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 222' ' ' ALA . . . . . 0.48 ' O ' ' HB3' ' A' ' 61' ' ' SER . . . . . . . . 0 CA--C 1.521 -0.151 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 223' ' ' GLU . . . . . 0.464 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 7.2 pt-20 -168.54 122.69 0.89 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.062 0.458 . . . . 0.0 111.513 178.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 224' ' ' GLN . . . . . 0.629 ' HG3' ' HB3' ' A' ' 24' ' ' GLN . 0.7 OUTLIER -171.07 154.24 4.02 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.352 179.615 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 23.8 m -131.94 130.69 61.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.71 0.29 . . . . 0.0 111.032 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 226' ' ' SER . . . . . 0.66 ' HA ' ' HD2' ' B' ' 273' ' ' HIS . 77.3 p -88.87 179.8 6.12 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.45 -28.72 70.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.441 0.162 . . . . 0.0 111.312 -172.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -64.28 -50.65 67.08 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -61.65 -46.14 91.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.317 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.424 HG12 HD12 ' B' ' 235' ' ' LEU . 90.9 mt -55.8 -48.82 77.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.273 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 14.7 m -73.25 -35.11 66.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.88 0.371 . . . . 0.0 111.433 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -77.95 -33.53 51.53 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.37 -174.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -99.05 -9.41 23.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.399 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt 58.64 70.75 0.63 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.263 0.554 . . . . 0.0 110.691 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . 0.424 HD12 HG12 ' B' ' 230' ' ' ILE . 74.0 mt -82.99 -177.94 6.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.946 -175.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 57.0 t -105.88 123.65 60.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.599 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -86.89 123.34 31.91 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 177.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 18.9 t -96.09 -38.82 8.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.444 -173.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 165.74 154.04 7.95 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.168 -1.015 . . . . 0.0 112.582 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 240' ' ' THR . . . . . 0.509 HG22 ' HG2' ' B' ' 289' ' ' GLU . 17.9 m -92.01 136.62 33.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.549 0.214 . . . . 0.0 110.542 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 36.5 pt -120.17 168.44 12.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.008 0.432 . . . . 0.0 110.949 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -144.72 133.13 21.9 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.19 174.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 243' ' ' VAL . . . . . 0.534 HG22 HD13 ' B' ' 263' ' ' LEU . 43.9 t -104.49 108.53 25.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.16 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 244' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' B' ' 284' ' ' PHE . 8.2 t -139.36 106.79 5.54 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.113 0.482 . . . . 0.0 110.115 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 245' ' ' GLN . . . . . 0.541 ' HB3' ' OE1' ' B' ' 249' ' ' GLN . 1.0 OUTLIER -132.1 -177.25 4.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.327 178.306 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 246' ' ' SER . . . . . 0.444 ' HB3' ' HG3' ' B' ' 249' ' ' GLN . 47.4 t -72.42 150.71 43.12 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.655 173.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -65.1 -16.26 61.86 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.727 177.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -77.56 -16.2 80.52 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.14 175.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . 0.541 ' OE1' ' HB3' ' B' ' 245' ' ' GLN . 38.9 mt-30 -92.03 -45.16 8.46 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 50.3 mm -97.33 93.22 3.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.814 0.816 . . . . 0.0 109.842 175.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 20.1 m -118.68 -15.7 9.47 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.049 -176.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 19.9 m -127.72 142.7 45.04 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.75 -39.64 80.18 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.536 2.157 . . . . 0.0 111.828 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 254' ' ' SER . . . . . 0.427 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 4.7 m -62.47 -29.85 70.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.17 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -74.84 -34.78 62.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.004 0.431 . . . . 0.0 110.632 -176.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . 0.42 ' O ' ' HG ' ' B' ' 260' ' ' LEU . 66.1 tp -61.86 -42.5 99.13 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.953 176.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -58.4 -35.56 72.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.981 178.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 258' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' B' ' 254' ' ' SER . 25.1 mm-40 -57.98 -50.87 71.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.333 177.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -66.87 -39.38 87.51 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.337 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 260' ' ' LEU . . . . . 0.485 ' HB3' ' CZ ' ' B' ' 272' ' ' TYR . 97.6 mt -58.11 -45.9 86.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.082 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 22.9 t -66.06 -44.16 85.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.298 0.571 . . . . 0.0 110.27 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -58.43 -42.78 88.05 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.642 -177.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 263' ' ' LEU . . . . . 0.534 HD13 HG22 ' B' ' 243' ' ' VAL . 83.7 mt -73.09 -30.33 63.58 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.866 -178.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -65.88 -50.98 62.55 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.717 0.294 . . . . 0.0 110.915 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -59.86 -38.1 81.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.949 0.404 . . . . 0.0 110.777 176.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -64.21 -22.31 66.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.496 -178.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 267' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' B' ' 267' ' ' LYS . 63.3 mmtt -87.48 -14.61 39.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.504 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 90.95 19.39 43.35 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.423 -175.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -117.63 -166.12 13.84 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . 0.416 ' O ' ' HB1' ' A' ' 22' ' ' ALA . 50.4 mttp -130.19 -66.51 0.77 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.722 0.296 . . . . 0.0 110.533 -178.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 271' ' ' TYR . . . . . 0.515 ' HB3' ' HA ' ' B' ' 224' ' ' GLN . 5.7 m-85 -90.56 153.65 20.19 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -175.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 272' ' ' TYR . . . . . 0.91 ' HH ' ' HA ' ' A' ' 23' ' ' GLU . 27.5 p90 -132.85 129.42 38.42 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.264 0.554 . . . . 0.0 110.759 178.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 273' ' ' HIS . . . . . 0.66 ' HD2' ' HA ' ' B' ' 226' ' ' SER . 55.9 t-80 -101.87 103.19 13.86 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.845 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 274' ' ' ILE . . . . . . . . . . . . . 59.1 mt -67.5 135.7 28.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.408 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 17.8 pt -115.52 -26.51 2.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -157.21 136.96 12.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.532 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -148.11 129.37 14.69 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.512 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.72 173.61 14.41 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.5 149.73 40.81 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.955 0.407 . . . . 0.0 110.318 171.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -95.51 -0.8 51.77 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.657 -178.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 113.86 -90.5 0.54 Allowed Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.323 -174.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.59 -14.62 22.14 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.852 2.368 . . . . 0.0 112.166 177.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -135.03 156.52 48.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.976 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 284' ' ' PHE . . . . . 0.546 ' O ' ' HA ' ' B' ' 244' ' ' SER . 82.7 t80 -110.83 145.63 37.85 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 285' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -138.67 110.1 6.99 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.924 0.393 . . . . 0.0 111.497 -177.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 286' ' ' ALA . . . . . 0.463 ' HB2' ' HB ' ' B' ' 243' ' ' VAL . . . -125.16 145.03 50.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.75 175.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 88.3 t -127.56 131.76 69.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.912 0.387 . . . . 0.0 110.347 177.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -142.57 156.28 45.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.246 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 289' ' ' GLU . . . . . 0.509 ' HG2' HG22 ' B' ' 240' ' ' THR . 35.5 mt-10 -112.76 128.28 56.38 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 58.4 t -89.02 131.42 36.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.943 0.402 . . . . 0.0 110.979 -176.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -125.23 159.7 30.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.284 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 292' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -118.52 161.79 19.44 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 4.6 t70 . . . . . 0 N--CA 1.471 0.608 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -170.395 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.482 ' HB2' ' HA ' ' B' ' 261' ' ' SER . . . . . . . . 0 C--O 1.233 0.203 0 CA-C-O 120.894 0.378 . . . . 0.0 110.859 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -151.72 179.41 8.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.612 -176.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.575 ' HA ' ' HB2' ' A' ' 71' ' ' TYR . 0.0 OUTLIER 81.79 167.78 0.13 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.791 0.836 . . . . 0.0 111.765 171.919 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.419 HG13 ' CZ ' ' B' ' 257' ' ' ARG . 31.0 m -126.4 171.97 14.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.47 -178.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.514 ' HB2' ' HB ' ' B' ' 274' ' ' ILE . 10.8 t -112.66 -149.73 0.45 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.519 ' HA ' HD11 ' A' ' 30' ' ' ILE . 18.2 ttpt -97.86 -17.15 19.46 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 122.088 -0.382 . . . . 0.0 110.44 178.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -62.95 -42.53 99.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.951 -176.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.635 ' HG2' HH22 ' B' ' 257' ' ' ARG . 3.4 mp0 -68.83 -31.18 69.97 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.495 178.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.519 HD11 ' HA ' ' A' ' 27' ' ' LYS . 62.7 mt -64.68 -51.29 69.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.443 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.8 m -69.44 -27.87 65.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.407 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 22.2 m170 -84.1 -58.11 2.91 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.979 0.362 . . . . 0.0 111.979 -178.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -99.17 -11.75 21.08 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -169.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.434 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 3.8 mppt? 60.12 84.56 0.12 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.233 0.54 . . . . 0.0 110.799 -177.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 90.4 mt -73.81 151.44 40.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.031 -177.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 63.1 t -91.22 108.86 20.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.025 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -83.61 130.48 34.98 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.208 0.528 . . . . 0.0 110.836 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.472 HG12 ' HB2' ' A' ' 92' ' ' ASN . 6.4 m -92.03 -20.94 6.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.847 178.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.27 171.27 22.39 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.608 178.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 35.0 m -106.43 129.57 54.38 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.8 pt -102.92 151.46 6.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -128.49 123.77 34.43 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.095 0.474 . . . . 0.0 110.663 -171.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.746 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 57.3 t -93.54 109.05 21.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 174.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.6 t -141.38 78.71 1.65 Allowed 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -106.7 138.52 42.73 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.984 -177.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.0 m -83.66 94.15 8.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.865 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.89 -169.72 13.06 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.521 178.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.28 55.64 4.36 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.412 -0.423 . . . . 0.0 113.383 -176.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -75.94 -21.23 57.26 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.406 0.622 . . . . 0.0 109.421 173.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.1 mm -119.46 98.63 6.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.148 -0.933 . . . . 0.0 108.65 172.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 77.2 p -111.56 -40.93 4.21 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.229 -173.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.409 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 12.6 m -119.54 161.72 36.08 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.65 -177.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 52' ' ' SER . 9.3 Cg_endo -53.38 -29.47 48.36 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.728 2.285 . . . . 0.0 111.78 176.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.528 ' HA ' ' NE ' ' A' ' 57' ' ' ARG . 23.7 m -59.04 -38.92 80.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.621 177.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.453 ' O ' ' HD3' ' A' ' 59' ' ' LYS . 59.5 m-20 -63.54 -53.23 55.07 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -174.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 23.1 tp -54.92 -49.71 70.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.258 -173.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.528 ' NE ' ' HA ' ' A' ' 54' ' ' SER . 25.7 ptt180 -63.34 -42.68 98.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.355 -178.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 54' ' ' SER . 43.3 mt-10 -69.54 -46.89 65.42 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.672 0.272 . . . . 0.0 111.161 -176.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.453 ' HD3' ' O ' ' A' ' 55' ' ' ASP . 14.5 mptt -59.77 -45.86 90.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.527 178.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.528 HD22 ' CG2' ' A' ' 43' ' ' VAL . 79.7 mt -75.04 -30.82 61.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.146 -175.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.7 m -60.48 -41.43 94.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.023 0.439 . . . . 0.0 110.312 174.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -63.66 -46.94 83.31 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.402 177.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 88.6 mt -69.5 -48.48 60.49 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.862 -177.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.2 -50.93 68.35 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -174.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -63.88 -37.36 87.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.909 0.385 . . . . 0.0 111.004 -176.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.95 -19.34 62.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.439 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -85.04 -5.73 59.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.955 0.407 . . . . 0.0 110.866 177.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.97 -28.45 13.04 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.351 177.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.513 ' HA3' HG13 ' A' ' 90' ' ' VAL . . . -79.84 179.42 53.2 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.911 -0.662 . . . . 0.0 111.789 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.826 ' HA ' ' HZ1' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -112.43 -72.85 0.69 Allowed 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.162 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.575 ' HB2' ' HA ' ' A' ' 24' ' ' GLN . 0.6 OUTLIER -96.5 155.65 16.68 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.845 -176.349 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.744 ' CD1' ' HB1' ' B' ' 222' ' ' ALA . 3.9 p90 -109.34 170.94 7.74 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.259 -177.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 23.6 t-80 -141.0 103.38 4.46 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.419 HD11 ' H ' ' A' ' 74' ' ' ILE . 2.9 mp -65.12 132.01 30.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.029 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 32.1 pt -133.02 -5.76 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.686 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.403 ' HB1' ' HB ' ' A' ' 87' ' ' VAL . . . -165.92 144.73 5.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.739 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -158.56 137.9 11.64 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 177.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.444 HH11 ' HD2' ' A' ' 78' ' ' ARG . 7.4 ptp180 -166.15 141.15 4.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.945 0.402 . . . . 0.0 111.363 -178.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -77.93 96.19 4.97 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 170.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -90.44 77.5 6.52 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.677 -177.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.1 -120.42 13.68 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -175.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -86.33 -0.68 8.34 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.518 2.145 . . . . 0.0 111.869 176.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -107.96 110.41 22.13 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.57 -176.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -79.44 104.33 9.98 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 173.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.746 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 23.3 mt-10 -104.06 123.14 46.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.191 0.519 . . . . 0.0 111.484 -175.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.496 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -130.82 126.84 37.33 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.856 176.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.403 ' HB ' ' HB1' ' A' ' 76' ' ' ALA . 41.9 t -105.62 121.53 57.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.428 -176.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.47 135.95 32.49 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.794 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 40' ' ' THR . 29.3 mt-10 -96.35 150.17 20.88 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.513 HG13 ' HA3' ' A' ' 69' ' ' GLY . 8.2 t -110.56 133.59 55.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 -179.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.478 ' HB2' ' HE1' ' A' ' 71' ' ' TYR . 54.1 m-85 -116.77 151.1 37.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.25 0.547 . . . . 0.0 110.889 -178.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.472 ' HB2' HG12 ' A' ' 38' ' ' VAL . 8.2 t-20 -106.13 21.96 16.49 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.926 -177.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.2 t70 . . . . . 0 C--N 1.323 -0.58 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.174 -175.312 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 222' ' ' ALA . . . . . 0.744 ' HB1' ' CD1' ' A' ' 72' ' ' TYR . . . . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 223' ' ' GLU . . . . . 0.842 ' HB3' ' HE1' ' B' ' 271' ' ' TYR . 30.0 mt-10 -143.98 105.63 4.3 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 224' ' ' GLN . . . . . 0.573 ' HB2' ' HB2' ' A' ' 24' ' ' GLN . 0.0 OUTLIER 173.56 179.87 0.09 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.298 0.639 . . . . 0.0 109.287 172.273 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . 0.523 HG13 HD11 ' B' ' 235' ' ' LEU . 15.8 m -138.84 157.86 29.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 120.622 0.248 . . . . 0.0 110.774 178.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 226' ' ' SER . . . . . 0.503 ' HA ' ' CD2' ' B' ' 273' ' ' HIS . 81.2 p -110.2 -92.88 0.44 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.072 178.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . 0.487 ' C ' ' HD3' ' B' ' 227' ' ' LYS . 8.1 tmtm? -133.42 -52.99 0.89 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.813 0.34 . . . . 0.0 110.959 -176.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 228' ' ' GLN . . . . . 0.43 ' NE2' ' H ' ' B' ' 228' ' ' GLN . 1.9 mp0 -59.96 -45.43 92.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.278 -172.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 229' ' ' GLU . . . . . 0.538 ' H ' ' CD ' ' B' ' 229' ' ' GLU . 2.0 mp0 -60.58 -45.12 95.14 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.991 -177.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.521 HG12 HD13 ' B' ' 235' ' ' LEU . 49.1 mt -60.72 -49.77 83.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.119 -176.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 25.4 m -67.21 -21.26 65.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.465 -177.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -94.21 -44.07 8.15 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.597 -174.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -92.34 -8.73 44.21 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -175.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 10.6 mmmm 63.03 75.62 0.39 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.088 0.471 . . . . 0.0 111.042 176.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . 0.523 HD11 HG13 ' B' ' 225' ' ' VAL . 68.6 mt -83.77 161.68 20.9 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.293 0.568 . . . . 0.0 111.574 -177.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 65.2 t -95.63 129.18 46.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.348 176.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -102.32 146.07 28.57 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 238' ' ' VAL . . . . . 0.495 HG13 ' HB2' ' B' ' 292' ' ' ASN . 2.5 m -127.4 9.36 3.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 133.62 -161.92 24.32 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 119.942 -1.123 . . . . 0.0 113.191 174.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 240' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' B' ' 289' ' ' GLU . 29.2 m -140.18 133.35 29.63 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 33.3 pt -109.49 147.37 13.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.214 0.531 . . . . 0.0 111.031 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -112.82 118.06 33.89 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.25 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 243' ' ' VAL . . . . . 0.586 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 22.1 t -93.83 113.46 28.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 176.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 47.7 t -125.38 100.97 6.74 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.72 0.295 . . . . 0.0 110.228 -176.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 245' ' ' GLN . . . . . 0.573 ' HB3' ' HB2' ' B' ' 249' ' ' GLN . 9.2 mm-40 -90.63 -175.94 4.57 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.611 0.72 . . . . 0.0 111.453 -177.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 68.6 m -143.49 113.45 7.18 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.699 176.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 66.3 -118.85 11.6 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.135 177.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -98.3 42.2 2.11 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.181 -0.533 . . . . 0.0 113.49 -172.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . 0.83 HE21 ' HA ' ' B' ' 249' ' ' GLN . 0.0 OUTLIER -77.78 -22.19 50.56 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 173.687 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 250' ' ' ILE . . . . . 0.551 HG12 ' HG3' ' B' ' 245' ' ' GLN . 43.8 mm -121.51 96.36 4.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.34 175.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 39.4 t -96.64 -24.31 16.06 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.321 0.581 . . . . 0.0 109.583 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 73.8 p -138.23 162.85 51.4 Favored Pre-proline 0 N--CA 1.447 -0.625 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.65 -179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.93 -22.59 74.61 Favored 'Trans proline' 0 C--O 1.238 0.482 0 C-N-CA 122.019 1.813 . . . . 0.0 111.263 173.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 254' ' ' SER . . . . . . . . . . . . . 2.3 m -66.09 -42.79 88.83 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.566 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 255' ' ' ASP . . . . . 0.466 ' O ' ' HG2' ' B' ' 259' ' ' LYS . 30.1 m-20 -54.92 -39.01 68.37 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.013 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . 0.414 ' O ' ' HG ' ' B' ' 260' ' ' LEU . 45.2 tp -58.83 -42.58 89.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.848 -178.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 257' ' ' ARG . . . . . 0.635 HH22 ' HG2' ' A' ' 29' ' ' GLU . 0.1 OUTLIER -67.92 -31.37 71.1 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.154 0.502 . . . . 0.0 110.028 -179.161 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 258' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' B' ' 255' ' ' ASP . 52.7 mm-40 -61.18 -41.45 96.83 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.424 178.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 259' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' B' ' 255' ' ' ASP . 16.0 mmmt -77.15 -42.04 39.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.766 -179.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 260' ' ' LEU . . . . . 0.452 HD11 ' CE2' ' B' ' 272' ' ' TYR . 97.3 mt -60.33 -42.96 96.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.768 -177.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 261' ' ' SER . . . . . 0.482 ' HA ' ' HB2' ' A' ' 22' ' ' ALA . 67.8 m -58.32 -48.97 78.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.955 0.407 . . . . 0.0 110.988 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -64.33 -41.89 96.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.023 -177.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 263' ' ' LEU . . . . . 0.442 ' O ' ' HG2' ' B' ' 267' ' ' LYS . 94.0 mt -74.12 -51.04 16.88 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -176.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -66.99 -48.14 69.36 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -172.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -67.09 -32.37 73.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.944 0.402 . . . . 0.0 110.62 -174.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -82.68 -9.91 59.16 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.245 -177.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 267' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' B' ' 263' ' ' LEU . 67.6 mmtt -87.48 -2.41 58.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.677 0.275 . . . . 0.0 111.279 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 91.98 7.85 63.88 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.031 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -108.75 -174.45 21.53 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 176.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . 0.614 ' HE2' ' HA ' ' B' ' 270' ' ' LYS . 8.4 mmpt? -127.41 -62.91 1.07 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.942 0.401 . . . . 0.0 110.876 -178.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 271' ' ' TYR . . . . . 0.842 ' HE1' ' HB3' ' B' ' 223' ' ' GLU . 90.1 m-85 -102.43 173.33 6.4 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.125 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 272' ' ' TYR . . . . . 0.452 ' CE2' HD11 ' B' ' 260' ' ' LEU . 17.6 p90 -149.87 169.4 21.21 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.519 -178.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 273' ' ' HIS . . . . . 0.503 ' CD2' ' HA ' ' B' ' 226' ' ' SER . 11.2 t-160 -139.63 110.01 6.59 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.813 0.34 . . . . 0.0 110.622 174.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 274' ' ' ILE . . . . . 0.514 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 47.6 mt -70.69 113.19 6.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.063 175.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 25.2 pt -100.04 -23.56 4.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.814 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -160.52 146.6 15.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.358 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 277' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' B' ' 285' ' ' GLU . . . -157.03 111.03 2.66 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 177.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.31 150.46 50.67 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.651 -174.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -84.81 95.8 9.09 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 172.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 17.3 t-80 -91.61 84.85 5.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.055 0.455 . . . . 0.0 109.932 -177.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 66.76 -125.48 25.61 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.386 -175.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -85.15 -8.56 8.83 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.598 2.199 . . . . 0.0 111.965 175.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 283' ' ' ASN . . . . . 0.409 ' HA ' ' O ' ' B' ' 245' ' ' GLN . 15.1 m120 -103.81 109.98 21.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.676 -177.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 284' ' ' PHE . . . . . 0.494 ' HB3' ' HB2' ' B' ' 245' ' ' GLN . 78.3 t80 -78.76 120.02 22.81 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 175.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 285' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' B' ' 277' ' ' ALA . 97.2 mt-10 -108.72 110.92 22.45 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.41 0.444 . . . . 0.0 111.155 -176.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 286' ' ' ALA . . . . . 0.586 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -111.53 123.14 49.61 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 172.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 28.5 t -105.12 113.31 41.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.312 -178.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -130.84 128.81 41.4 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.678 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 289' ' ' GLU . . . . . 0.538 ' HA ' ' HA ' ' B' ' 240' ' ' THR . 17.2 mt-10 -92.38 135.46 34.02 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 23.6 t -97.67 137.84 24.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.142 0.496 . . . . 0.0 111.496 -170.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -118.3 149.5 41.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.159 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 292' ' ' ASN . . . . . 0.495 ' HB2' HG13 ' B' ' 238' ' ' VAL . 8.0 t-20 -95.37 21.95 7.48 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.881 -171.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 293' ' ' ASP . . . . . 0.443 ' HB3' ' O ' ' B' ' 292' ' ' ASN . 10.8 t70 . . . . . 0 N--CA 1.474 0.775 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.562 172.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.127 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 178.95 104.65 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.584 178.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.592 ' HB2' ' HB3' ' B' ' 224' ' ' GLN . 0.0 OUTLIER -162.14 155.64 20.87 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 122.052 -0.405 . . . . 0.0 110.873 -179.341 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.8 m -115.75 143.93 24.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.966 174.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.617 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 11.8 t -108.05 -90.45 0.44 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -174.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.413 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 10.7 tmtt? -145.88 -45.73 0.21 Allowed 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -173.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.413 ' CB ' ' HB1' ' B' ' 277' ' ' ALA . 27.7 mm-40 -54.58 -49.85 69.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.996 -174.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.477 ' H ' ' CD ' ' A' ' 29' ' ' GLU . 0.9 OUTLIER -68.85 -43.75 74.8 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.713 -176.129 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.525 HG12 HD11 ' A' ' 35' ' ' LEU . 54.7 mt -62.1 -43.64 98.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.66 -175.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.4 m -72.6 -24.38 61.07 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.928 0.394 . . . . 0.0 111.274 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -91.56 -32.85 15.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.533 -173.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -110.1 -12.5 14.5 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -177.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt 65.93 82.98 0.17 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.165 0.507 . . . . 0.0 111.719 -178.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.525 HD11 HG12 ' A' ' 30' ' ' ILE . 22.0 mt -89.88 147.91 23.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.2 177.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.1 m -85.03 122.36 38.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.711 -177.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.1 ttmm -85.54 117.53 24.5 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 177.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.1 t -78.39 -28.08 14.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.155 0.502 . . . . 0.0 109.939 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 167.45 -175.99 42.35 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.854 179.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.6 m -130.28 123.47 30.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.055 0.455 . . . . 0.0 110.243 178.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.422 HD12 HD11 ' A' ' 63' ' ' LEU . 25.3 pt -120.28 166.07 15.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.413 -176.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.7 p30 -145.77 147.53 31.98 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.491 0.663 . . . . 0.0 111.169 176.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.609 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 75.0 t -94.56 142.64 13.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.551 177.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.6 t -159.6 79.73 0.72 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.189 0.519 . . . . 0.0 109.765 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -113.8 150.04 34.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.358 178.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.7 t -111.61 112.73 24.65 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.622 -175.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.61 -144.93 17.45 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.226 176.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.3 74.54 1.68 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 121.603 -0.332 . . . . 0.0 113.781 -173.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -121.65 -36.73 2.99 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.154 0.502 . . . . 0.0 109.796 169.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.435 HG22 ' HB2' ' A' ' 55' ' ' ASP . 72.1 mt -133.52 123.01 45.35 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.493 176.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.7 m -143.64 -27.98 0.54 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.0 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.3 p -113.73 154.87 45.68 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 175.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.74 -25.0 58.28 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.824 2.349 . . . . 0.0 112.879 -176.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.612 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 11.8 p -67.24 -40.9 86.35 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.92 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.435 ' HB2' HG22 ' A' ' 50' ' ' ILE . 37.3 m-20 -58.63 -41.78 86.76 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.117 0.485 . . . . 0.0 110.624 -176.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 45.2 tp -63.23 -45.76 90.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.307 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.482 ' HD2' ' OE2' ' B' ' 223' ' ' GLU . 42.9 ttp180 -61.32 -40.5 94.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.983 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.612 ' HG2' ' O ' ' A' ' 54' ' ' SER . 9.4 mm-40 -59.18 -30.98 68.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.454 -177.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.421 ' O ' ' HB3' ' A' ' 62' ' ' GLU . 4.3 mptp? -93.86 -37.09 11.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.775 -177.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 86.5 mt -70.42 -39.7 74.27 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.019 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.0 t -69.2 -34.7 75.29 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 176.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.421 ' HB3' ' O ' ' A' ' 59' ' ' LYS . 34.4 tt0 -56.8 -49.32 75.68 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.87 177.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.422 HD11 HD12 ' A' ' 41' ' ' ILE . 73.8 mt -74.43 -30.36 61.88 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.742 -178.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.82 -50.98 53.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.433 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -68.23 -25.43 65.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.158 0.504 . . . . 0.0 110.41 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.45 -42.29 59.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.13 178.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.441 ' HD3' ' HA ' ' A' ' 67' ' ' LYS . 59.0 mmtt -77.13 -35.66 56.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.394 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.57 59.94 0.63 Allowed Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.605 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.638 ' HA2' ' HA ' ' A' ' 92' ' ' ASN . . . -143.93 160.87 27.82 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 177.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -107.63 -15.71 14.52 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.777 0.289 . . . . 0.0 111.267 -175.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -140.47 145.63 37.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.642 0.258 . . . . 0.0 110.362 -177.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.445 ' O ' ' HG2' ' A' ' 24' ' ' GLN . 21.4 p90 -116.53 168.08 10.48 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 171.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.617 ' CD2' ' HA ' ' A' ' 26' ' ' SER . 10.0 t-160 -140.0 108.21 5.79 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.204 178.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 76.6 mt -71.76 118.59 16.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.188 177.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.9 pt -114.89 -18.58 7.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -152.92 100.42 2.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.826 0.345 . . . . 0.0 111.235 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -115.31 115.12 26.11 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -138.08 160.3 39.74 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.252 0.548 . . . . 0.0 111.614 -172.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -104.7 103.93 13.65 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.738 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.487 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 2.6 t-160 -94.75 56.88 2.09 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -176.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.67 -122.82 5.83 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.769 -0.933 . . . . 0.0 110.769 -175.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -83.94 10.52 3.66 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.372 2.048 . . . . 0.0 111.7 174.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.487 ' HB2' ' HB3' ' A' ' 80' ' ' HIS . 17.3 m-80 -113.48 127.27 56.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.282 -176.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -97.67 111.88 23.98 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.609 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 42.0 mt-10 -116.12 119.83 37.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.04 0.448 . . . . 0.0 110.957 -177.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -130.12 118.25 21.19 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.507 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.1 t -95.27 127.74 47.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 73' ' ' HIS . . . -136.62 144.72 44.23 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.389 -175.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -91.57 147.27 23.13 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 176.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 43.9 t -106.46 122.02 59.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -121.31 139.1 53.87 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.817 0.342 . . . . 0.0 110.079 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.638 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 26.2 t-20 -77.4 -89.42 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.202 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.5 t70 . . . . . 0 C--N 1.327 -0.404 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 178.417 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 222' ' ' ALA . . . . . 0.413 ' HB3' ' HD2' ' A' ' 72' ' ' TYR . . . . . . . . 0 C--O 1.234 0.257 0 CA-C-O 121.72 0.772 . . . . 0.0 112.656 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 223' ' ' GLU . . . . . 0.519 ' O ' ' HB2' ' A' ' 24' ' ' GLN . 34.7 mt-10 -139.98 -156.46 0.68 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.631 -178.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 224' ' ' GLN . . . . . 0.592 ' HB3' ' HB2' ' A' ' 24' ' ' GLN . 0.8 OUTLIER 68.76 144.32 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.034 0.534 . . . . 0.0 112.352 176.503 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 2.4 m -118.87 172.87 5.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.686 -177.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 226' ' ' SER . . . . . 0.529 ' HA ' ' CD2' ' B' ' 273' ' ' HIS . 13.4 t -101.8 -96.02 0.28 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -176.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -142.53 -41.21 0.33 Allowed 'General case' 0 C--O 1.233 0.236 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -173.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -62.78 -30.7 71.66 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.76 0.79 . . . . 0.0 110.023 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -70.99 -34.52 71.46 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.625 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.499 HG22 ' HB2' ' B' ' 235' ' ' LEU . 56.4 mt -59.27 -43.38 89.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.153 0.502 . . . . 0.0 109.988 177.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 42.6 t -63.48 -30.15 71.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.668 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -84.54 -46.49 11.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.96 -176.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -93.89 -14.28 26.22 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -171.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? 62.52 88.91 0.09 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.289 0.566 . . . . 0.0 110.798 -176.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . 0.585 HD13 ' HE1' ' B' ' 271' ' ' TYR . 81.6 mt -108.9 155.43 20.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.08 -177.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 73.3 t -115.19 113.02 42.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.535 -172.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.2 140.05 58.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.91 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 1.9 m -122.85 5.78 5.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 138.62 -160.17 25.54 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.173 -1.013 . . . . 0.0 112.788 176.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 240' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' B' ' 289' ' ' GLU . 8.8 m -140.54 146.14 37.7 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -176.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 241' ' ' ILE . . . . . 0.51 ' HB ' HD13 ' B' ' 263' ' ' LEU . 26.4 pt -113.19 143.98 21.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 174.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -127.15 123.05 35.82 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.223 0.535 . . . . 0.0 110.684 -174.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 243' ' ' VAL . . . . . 0.582 ' HB ' ' HB2' ' B' ' 286' ' ' ALA . 75.3 t -100.15 116.14 42.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.448 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 72.7 m -135.96 87.87 2.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.332 177.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 245' ' ' GLN . . . . . 0.402 HE22 HG12 ' B' ' 243' ' ' VAL . 0.0 OUTLIER -142.43 163.11 33.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.575 179.714 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 37.7 t -78.14 174.68 10.9 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.208 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -70.4 4.6 8.52 Favored Glycine 0 CA--C 1.521 0.408 0 CA-C-N 116.363 -0.38 . . . . 0.0 113.041 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -80.55 -35.54 25.55 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.453 174.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -94.66 -21.5 18.75 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.924 0.393 . . . . 0.0 110.581 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 42.0 mm -119.45 99.29 7.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 176.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 16.7 t -130.9 -52.94 1.05 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.851 0.358 . . . . 0.0 110.524 -177.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 252' ' ' SER . . . . . 0.438 ' HB3' ' HD2' ' B' ' 253' ' ' PRO . 23.1 m -109.9 159.71 30.77 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.213 178.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' B' ' 252' ' ' SER . 11.1 Cg_endo -55.87 -39.78 89.08 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.826 2.351 . . . . 0.0 112.841 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 254' ' ' SER . . . . . 0.495 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 66.7 m -60.98 -31.87 71.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.211 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -64.13 -50.19 69.22 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.061 0.458 . . . . 0.0 110.249 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 48.6 tp -62.05 -38.38 88.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.541 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -56.99 -51.03 70.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.754 178.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 258' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' B' ' 254' ' ' SER . 10.2 mm-40 -63.9 -38.9 92.81 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.934 -178.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -63.99 -46.36 84.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.628 178.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 94.6 mt -65.89 -38.88 89.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.711 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 47.3 t -62.42 -40.08 95.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.432 176.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -60.85 -43.24 98.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.42 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 263' ' ' LEU . . . . . 0.51 HD13 ' HB ' ' B' ' 241' ' ' ILE . 94.1 mt -74.06 -39.49 63.44 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.392 -178.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -64.67 -44.56 90.0 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.73 0.3 . . . . 0.0 111.447 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -68.72 -31.73 71.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.078 0.466 . . . . 0.0 110.174 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -67.06 -35.78 80.59 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.779 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -75.57 -37.21 60.08 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.024 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 89.25 31.98 11.13 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.374 -176.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -94.3 -176.9 38.98 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.568 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . 0.403 ' HG2' HD21 ' B' ' 292' ' ' ASN . 30.1 mmtp -112.1 -12.94 13.62 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.426 -177.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 271' ' ' TYR . . . . . 0.585 ' HE1' HD13 ' B' ' 235' ' ' LEU . 43.5 p90 -167.52 175.71 6.97 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 173.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 272' ' ' TYR . . . . . 0.486 ' H ' ' HG3' ' B' ' 224' ' ' GLN . 43.9 p90 -133.04 123.93 26.71 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 273' ' ' HIS . . . . . 0.529 ' CD2' ' HA ' ' B' ' 226' ' ' SER . 6.1 t-160 -95.04 102.12 13.91 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.095 -0.642 . . . . 0.0 110.257 -177.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 274' ' ' ILE . . . . . . . . . . . . . 62.1 mt -66.36 111.63 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.185 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 20.0 pt -103.2 -35.66 3.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -178.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -159.76 113.86 2.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.003 0.43 . . . . 0.0 111.365 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 277' ' ' ALA . . . . . 0.53 ' HA ' ' HA ' ' B' ' 286' ' ' ALA . . . -122.37 107.43 12.07 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 174.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -128.18 138.54 52.52 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.644 0.735 . . . . 0.0 111.55 -169.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -78.88 133.63 36.96 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.363 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -134.08 101.1 4.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.009 0.433 . . . . 0.0 110.704 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 64.46 -129.49 36.84 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.858 -178.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -88.71 8.38 3.99 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.235 2.624 . . . . 0.0 112.489 178.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -124.57 155.77 38.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.965 0.412 . . . . 0.0 110.726 -177.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 284' ' ' PHE . . . . . 0.498 ' CE2' ' HB3' ' B' ' 286' ' ' ALA . 83.2 t80 -111.62 125.17 53.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.241 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 285' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 8.3 mm-40 -109.7 110.86 22.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.282 -178.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 286' ' ' ALA . . . . . 0.582 ' HB2' ' HB ' ' B' ' 243' ' ' VAL . . . -119.82 125.51 48.73 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.329 179.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 25.8 t -111.65 118.62 57.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.364 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -135.19 135.92 41.39 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.868 177.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 289' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' B' ' 240' ' ' THR . 2.4 mt-10 -98.3 140.43 32.59 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -178.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 40.3 t -101.4 129.66 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -176.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 291' ' ' TYR . . . . . 0.556 ' HB2' ' CZ ' ' B' ' 271' ' ' TYR . 50.4 m-85 -120.14 150.51 40.5 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.403 0.62 . . . . 0.0 110.512 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 292' ' ' ASN . . . . . 0.403 HD21 ' HG2' ' B' ' 270' ' ' LYS . 3.1 t-20 -120.74 179.45 4.34 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.75 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 2.1 p30 . . . . . 0 C--N 1.318 -0.774 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 174.928 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.445 ' CB ' ' HA ' ' B' ' 261' ' ' SER . . . . . . . . 0 N--CA 1.466 0.365 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.51 ' HG2' ' HA ' ' B' ' 222' ' ' ALA . 8.6 tp10 -155.51 165.51 36.37 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.161 -179.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.469 ' HB3' ' HB2' ' B' ' 224' ' ' GLN . 0.0 OUTLIER 76.23 156.47 0.18 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.662 0.785 . . . . 0.0 111.168 176.876 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.9 m -117.92 174.42 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 121.157 0.503 . . . . 0.0 111.636 -174.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.42 ' HB3' ' HB ' ' B' ' 274' ' ' ILE . 69.0 p -79.4 -172.4 3.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.232 0.539 . . . . 0.0 111.542 -173.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.47 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 14.2 tmtt? -86.11 -29.37 23.38 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 171.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.453 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 1.0 OUTLIER -58.25 -50.1 74.77 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.287 179.875 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.548 ' HA ' ' HB3' ' A' ' 32' ' ' HIS . 0.4 OUTLIER -61.66 -26.99 68.36 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.315 -177.181 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.482 HG12 ' OH ' ' A' ' 71' ' ' TYR . 57.8 mt -61.0 -54.66 32.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.011 0.434 . . . . 0.0 110.047 176.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.2 m -73.48 -26.99 61.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.684 177.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.548 ' HB3' ' HA ' ' A' ' 29' ' ' GLU . 12.2 t-160 -68.31 -48.48 64.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.336 -175.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -104.52 -5.06 21.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.793 -176.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt 58.75 78.04 0.27 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.337 0.589 . . . . 0.0 110.77 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.8 mt -92.72 168.47 11.18 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.937 -176.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.9 t -96.99 138.23 22.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.792 -176.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -97.34 127.09 43.0 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.417 HG13 ' HB2' ' A' ' 92' ' ' ASN . 6.8 m -101.53 -45.78 11.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -175.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -174.66 175.0 46.88 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 119.689 -1.243 . . . . 0.0 113.362 -178.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.543 HG23 ' HG2' ' A' ' 89' ' ' GLU . 15.6 m -112.6 141.44 46.37 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 122.617 0.367 . . . . 0.0 110.421 -178.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.6 pt -120.14 144.64 28.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.816 0.341 . . . . 0.0 110.688 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -115.14 118.95 34.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.408 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.569 ' HB ' ' HB1' ' A' ' 86' ' ' ALA . 61.2 t -95.18 109.5 22.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.695 176.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.8 m -138.4 96.14 3.12 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.479 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -129.01 134.43 48.14 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.637 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.9 t -78.93 64.26 3.83 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.09 0.471 . . . . 0.0 111.126 -177.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.65 -69.93 2.3 Favored Glycine 0 CA--C 1.521 0.459 0 CA-C-N 115.86 -0.609 . . . . 0.0 114.412 172.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -50.83 -30.34 21.59 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 115.831 1.092 . . . . 0.0 115.831 -167.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -78.17 -27.01 47.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.831 0.816 . . . . 0.0 112.178 -175.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.496 HD13 ' HA ' ' A' ' 56' ' ' LEU . 49.7 mm -125.28 117.08 48.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 110.555 -0.165 . . . . 0.0 110.555 -175.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.6 t -119.19 -54.56 2.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.02 0.438 . . . . 0.0 110.329 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.503 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 4.9 m -105.85 164.35 15.19 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.817 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.557 ' HG3' HD21 ' B' ' 235' ' ' LEU . 18.4 Cg_endo -60.52 -28.26 86.35 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.482 2.121 . . . . 0.0 111.57 177.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.416 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -68.82 -28.81 67.07 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.2 178.62 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -70.76 -44.9 65.78 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.337 0.589 . . . . 0.0 109.444 175.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.496 ' HA ' HD13 ' A' ' 50' ' ' ILE . 55.5 tp -65.35 -40.0 93.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.542 -175.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.416 ' HG3' ' O ' ' A' ' 54' ' ' SER . 3.0 ppt_? -61.28 -37.02 81.64 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -175.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -67.64 -37.98 83.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.945 0.402 . . . . 0.0 110.277 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -67.92 -40.18 83.41 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.215 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.571 HD11 ' CE2' ' A' ' 72' ' ' TYR . 81.6 mt -71.89 -39.21 69.75 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.102 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.5 t -65.29 -39.13 92.15 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -57.11 -42.71 81.35 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.009 177.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 97.9 mt -71.68 -46.02 60.12 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.411 -178.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.81 -42.32 86.11 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -175.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -63.37 -24.06 67.68 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.796 0.331 . . . . 0.0 111.623 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.23 -13.79 37.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.906 0.384 . . . . 0.0 111.335 178.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -90.02 -42.68 11.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.094 0.473 . . . . 0.0 110.409 178.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.67 65.27 0.65 Allowed Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.724 -178.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -145.35 169.65 26.9 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.067 177.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.416 ' HD2' HH12 ' B' ' 257' ' ' ARG . 31.7 mmtp -92.17 -15.13 28.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.716 0.293 . . . . 0.0 111.087 -178.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.635 ' HA ' ' CB ' ' B' ' 222' ' ' ALA . 31.6 p90 -165.26 175.79 8.93 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -177.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.571 ' CE2' HD11 ' A' ' 60' ' ' LEU . 54.6 p90 -135.36 136.54 41.57 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 175.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -110.54 115.83 30.31 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.489 -177.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.431 HD13 ' H ' ' A' ' 74' ' ' ILE . 4.8 mp -72.53 136.03 26.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 32.2 pt -117.26 -21.78 4.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.736 0.303 . . . . 0.0 111.196 178.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -159.4 147.89 17.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.714 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -162.06 141.5 9.71 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -166.77 154.81 9.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.036 0.446 . . . . 0.0 111.403 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -88.6 118.32 28.17 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 168.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -107.15 91.93 3.87 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.19 -120.09 12.91 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -172.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -94.43 6.6 2.43 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.074 2.516 . . . . 0.0 112.341 175.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.489 ' N ' HD21 ' A' ' 83' ' ' ASN . 0.8 OUTLIER -103.55 143.51 32.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.705 0.288 . . . . 0.0 110.679 -178.241 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -103.06 114.25 28.39 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -111.91 127.34 55.82 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.842 -177.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.569 ' HB1' ' HB ' ' A' ' 43' ' ' VAL . . . -141.08 133.48 28.3 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.924 0.392 . . . . 0.0 110.126 175.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.3 t -116.16 118.03 57.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.072 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -133.5 145.54 50.27 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.851 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.543 ' HG2' HG23 ' A' ' 40' ' ' THR . 10.4 mt-10 -117.5 136.77 53.0 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 26.0 t -95.52 135.95 28.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.676 -171.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 71' ' ' TYR . 79.5 m-85 -119.2 149.06 42.38 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.211 0.529 . . . . 0.0 110.41 178.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.417 ' HB2' HG13 ' A' ' 38' ' ' VAL . 18.1 t-20 -95.74 167.36 11.32 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.482 -176.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.7 t70 . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.298 -178.994 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 222' ' ' ALA . . . . . 0.635 ' CB ' ' HA ' ' A' ' 71' ' ' TYR . . . . . . . . 0 N--CA 1.45 -0.425 0 CA-C-O 120.419 0.152 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 223' ' ' GLU . . . . . 0.523 ' HA ' ' OH ' ' A' ' 72' ' ' TYR . 10.2 pt-20 177.54 133.46 0.06 Allowed 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.896 0.747 . . . . 0.0 111.941 -177.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 224' ' ' GLN . . . . . 0.469 ' HB2' ' HB3' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -172.22 157.86 4.32 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.657 0.783 . . . . 0.0 109.064 179.789 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . 0.444 HG21 HD12 ' B' ' 235' ' ' LEU . 18.6 m -109.55 133.09 55.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.729 0.3 . . . . 0.0 111.109 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 226' ' ' SER . . . . . 0.519 ' O ' HG13 ' B' ' 230' ' ' ILE . 83.3 p -90.56 -174.28 4.05 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 178.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -56.46 -37.42 70.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.397 -177.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -64.8 -50.45 66.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.702 -177.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -60.82 -41.06 94.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.171 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.519 HG13 ' O ' ' B' ' 226' ' ' SER . 83.5 mt -55.52 -51.79 53.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.921 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 35.3 m -72.09 -28.76 63.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.382 -178.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -78.26 -47.99 16.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.708 -175.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -92.04 4.33 53.31 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -173.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm 57.75 41.0 25.82 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.101 0.477 . . . . 0.0 111.022 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . 0.557 HD21 ' HG3' ' A' ' 53' ' ' PRO . 89.4 mt -63.01 125.66 24.75 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.838 -176.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . 0.435 ' CG2' ' HB3' ' B' ' 292' ' ' ASN . 17.0 m -78.79 132.94 31.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.569 -175.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 41.9 tttm -78.4 117.58 19.75 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.44 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 27.0 t -84.3 -35.92 11.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.003 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 164.91 -178.65 39.94 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.226 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 42.1 m -109.69 135.46 50.6 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 18.4 pt -110.05 134.31 52.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.99 0.424 . . . . 0.0 110.511 175.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -120.5 114.33 21.61 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.952 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 243' ' ' VAL . . . . . 0.527 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 5.3 t -102.4 113.38 38.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.15 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 23.3 t -111.72 103.11 11.38 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.938 0.399 . . . . 0.0 110.032 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 245' ' ' GLN . . . . . 0.536 ' HG2' HG12 ' B' ' 250' ' ' ILE . 0.6 OUTLIER -99.96 143.38 30.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.784 -177.247 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 41.1 t -97.69 72.88 2.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.991 0.424 . . . . 0.0 110.859 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 69.43 -92.36 0.33 Allowed Glycine 0 CA--C 1.518 0.269 0 CA-C-N 115.676 -0.693 . . . . 0.0 114.158 172.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -79.89 50.86 3.97 Favored Glycine 0 CA--C 1.517 0.21 0 N-CA-C 114.195 0.438 . . . . 0.0 114.195 -169.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . 0.463 ' HB2' ' HG3' ' B' ' 245' ' ' GLN . 78.7 mt-30 -131.66 -0.07 3.93 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.17 0.51 . . . . 0.0 109.761 173.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 250' ' ' ILE . . . . . 0.536 HG12 ' HG2' ' B' ' 245' ' ' GLN . 45.0 mm -132.01 119.74 41.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.551 178.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 3.4 m -135.08 -50.68 0.76 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.227 -177.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.25 163.68 16.43 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.305 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.27 -37.75 94.21 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.342 2.028 . . . . 0.0 111.954 176.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 254' ' ' SER . . . . . . . . . . . . . 54.8 m -68.31 -25.9 65.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.831 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -64.42 -32.01 73.46 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.616 0.246 . . . . 0.0 110.581 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 56.3 tp -86.93 -38.51 16.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.929 0.395 . . . . 0.0 109.981 176.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 257' ' ' ARG . . . . . 0.416 HH12 ' HD2' ' A' ' 70' ' ' LYS . 77.6 ttt180 -50.72 -43.53 57.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.799 179.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 258' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -55.48 -48.57 74.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.657 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -72.9 -32.42 65.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.815 0.341 . . . . 0.0 111.041 -174.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 92.0 mt -65.22 -46.23 81.5 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.871 -178.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 261' ' ' SER . . . . . 0.445 ' HA ' ' CB ' ' A' ' 22' ' ' ALA . 17.6 m -67.18 -36.77 82.48 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.871 177.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -57.56 -52.13 66.68 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.169 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 263' ' ' LEU . . . . . 0.404 HD11 HG21 ' B' ' 243' ' ' VAL . 89.8 mt -73.21 -30.82 63.78 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -174.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.5 -38.51 68.12 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 121.149 -0.22 . . . . 0.0 111.33 -176.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -70.35 -32.89 70.79 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.989 0.423 . . . . 0.0 110.07 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -68.65 -22.73 64.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.321 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -96.36 -11.18 26.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.672 0.272 . . . . 0.0 111.004 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 80.03 53.35 4.24 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.634 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.04 -178.88 18.74 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.012 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 22.3 mmmt -117.22 -46.87 2.69 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.922 0.391 . . . . 0.0 110.722 177.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 271' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -138.23 164.82 28.25 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 272' ' ' TYR . . . . . 0.429 ' HE1' ' N ' ' A' ' 23' ' ' GLU . 11.1 p90 -144.49 142.14 30.04 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.564 -174.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 22.0 t-80 -114.36 104.85 12.47 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.85 -178.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 274' ' ' ILE . . . . . 0.42 ' HB ' ' HB3' ' A' ' 26' ' ' SER . 57.4 mt -68.03 105.37 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.228 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 19.1 pt -77.98 -40.49 26.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.393 -176.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -153.45 131.45 11.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.126 0.489 . . . . 0.0 111.51 -177.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -120.58 103.56 9.25 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 174.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -127.23 126.82 43.4 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.331 0.586 . . . . 0.0 110.603 -172.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -88.89 126.55 35.43 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.308 0.575 . . . . 0.0 110.487 -176.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -97.39 81.2 2.96 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.121 -176.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 61.16 -120.18 21.7 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.057 -176.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 282' ' ' PRO . . . . . 0.473 ' C ' HD21 ' B' ' 283' ' ' ASN . 89.2 Cg_endo -83.06 10.55 3.6 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.799 2.332 . . . . 0.0 112.211 177.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 283' ' ' ASN . . . . . 0.473 HD21 ' C ' ' B' ' 282' ' ' PRO . 1.0 OUTLIER -121.08 166.53 13.78 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.893 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 284' ' ' PHE . . . . . 0.448 ' CE2' ' HB1' ' B' ' 286' ' ' ALA . 51.1 t80 -131.7 127.47 36.95 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.425 0.155 . . . . 0.0 110.686 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 285' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -111.26 110.51 21.03 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.443 -178.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 286' ' ' ALA . . . . . 0.527 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -107.29 120.24 41.61 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.612 0.244 . . . . 0.0 110.788 176.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 17.7 t -116.13 123.12 70.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.816 0.341 . . . . 0.0 110.577 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -136.6 144.47 44.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.945 0.402 . . . . 0.0 111.588 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -92.98 123.66 36.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.705 176.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 48.9 t -91.13 128.33 42.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.75 0.31 . . . . 0.0 110.467 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -123.48 156.34 35.78 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.11 0.481 . . . . 0.0 111.032 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 292' ' ' ASN . . . . . 0.435 ' HB3' ' CG2' ' B' ' 236' ' ' VAL . 6.9 t-20 -117.21 159.35 22.79 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 4.1 p30 . . . . . 0 C--N 1.327 -0.408 0 O-C-N 123.102 0.251 . . . . 0.0 111.161 -177.901 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.524 ' HB3' ' CD2' ' B' ' 272' ' ' TYR . . . . . . . . 0 N--CA 1.453 -0.301 0 CA-C-O 120.36 0.124 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.611 ' HB3' ' HE1' ' A' ' 71' ' ' TYR . 10.8 mt-10 -160.33 110.97 1.85 Allowed 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -177.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.632 ' HB2' ' HB3' ' B' ' 224' ' ' GLN . 0.9 OUTLIER -173.58 141.35 0.86 Allowed 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.469 174.501 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.2 m -105.76 116.11 48.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.081 0.467 . . . . 0.0 110.929 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.656 ' HA ' ' HD2' ' A' ' 73' ' ' HIS . 15.9 t -82.13 172.76 12.82 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.778 0.323 . . . . 0.0 110.147 -177.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.527 ' HA ' ' HB ' ' A' ' 30' ' ' ILE . 29.1 mmmt -67.3 -19.33 65.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.26 -173.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 17.7 mp0 -65.47 -51.57 59.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.902 0.382 . . . . 0.0 110.31 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.512 ' OE2' ' HB3' ' A' ' 26' ' ' SER . 2.3 pm0 -76.84 -28.03 55.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.087 177.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.527 ' HB ' ' HA ' ' A' ' 27' ' ' LYS . 77.7 mt -60.0 -46.59 93.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.725 0.298 . . . . 0.0 110.204 174.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.6 m -73.8 -21.83 60.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.207 178.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -86.72 -46.17 10.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.423 -175.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -94.49 -13.87 25.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.07 -178.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm 62.01 76.06 0.38 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.525 0.679 . . . . 0.0 110.579 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.454 HD13 HG12 ' A' ' 30' ' ' ILE . 71.6 mt -87.52 177.01 7.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.869 -172.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.471 ' HB ' ' HB2' ' A' ' 92' ' ' ASN . 28.9 t -104.0 115.34 45.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.472 -174.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.1 ttmm -80.88 121.16 25.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.654 0.264 . . . . 0.0 110.588 177.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.6 HG23 ' OD1' ' A' ' 92' ' ' ASN . 2.2 t -78.78 -34.42 17.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.572 0.701 . . . . 0.0 109.344 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 160.32 -159.51 30.89 Favored Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.961 -177.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.5 m -137.5 126.44 24.19 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.5 pt -103.96 136.46 37.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.087 0.47 . . . . 0.0 111.089 -177.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -117.01 122.58 44.62 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.974 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 88.3 t -94.25 138.11 21.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.345 175.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.4 t -156.99 80.37 0.92 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.195 0.522 . . . . 0.0 110.247 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -125.4 159.75 31.1 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 176.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.536 ' HA ' ' HA ' ' A' ' 83' ' ' ASN . 22.6 t -64.59 158.95 22.94 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 176.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.88 50.82 1.9 Allowed Glycine 0 C--N 1.333 0.363 0 CA-C-N 116.358 -0.383 . . . . 0.0 112.843 -178.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -142.17 -36.84 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 177.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -69.66 -30.13 67.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.291 0.567 . . . . 0.0 110.036 175.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.3 mm -108.24 96.1 4.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 173.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.3 t -106.28 -2.03 22.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.954 0.407 . . . . 0.0 110.991 -174.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 93.4 p -162.19 164.4 17.33 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.213 -178.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.74 -25.86 81.88 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.237 1.958 . . . . 0.0 111.213 172.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.464 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 17.1 m -66.65 -45.4 79.09 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.6 178.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.483 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 26.5 m-20 -57.61 -45.54 85.2 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.227 0.537 . . . . 0.0 109.945 177.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 54.4 tp -64.57 -39.58 94.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.048 -178.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -60.32 -46.21 90.69 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.702 -178.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 54' ' ' SER . 8.5 mm-40 -63.53 -26.99 68.96 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.927 -177.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.508 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 29.3 mmmt -78.2 -53.67 7.08 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.524 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.0 mt -63.67 -41.86 98.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.72 -174.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.9 p -63.23 -45.71 90.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.668 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -60.61 -45.26 94.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.911 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 59' ' ' LYS . 92.1 mt -63.75 -40.27 96.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.066 -178.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.1 -43.85 77.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.863 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -63.2 -44.99 93.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.404 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.8 -22.25 61.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.976 -177.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -80.04 -12.17 59.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.691 0.281 . . . . 0.0 110.911 176.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 94.92 16.65 40.78 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.404 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.424 ' HA3' HG21 ' A' ' 38' ' ' VAL . . . -112.53 -158.15 13.65 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.875 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.815 ' HD2' ' HB2' ' A' ' 93' ' ' ASP . 93.2 mttt -138.92 -61.46 0.56 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.096 0.474 . . . . 0.0 110.795 177.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.611 ' HE1' ' HB3' ' A' ' 23' ' ' GLU . 56.8 m-85 -97.8 156.98 16.33 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.901 -171.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.47 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 26.3 p90 -142.81 123.24 13.94 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.191 178.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.656 ' HD2' ' HA ' ' A' ' 26' ' ' SER . 48.2 t-80 -96.06 109.07 21.55 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.14 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.437 HD11 ' H ' ' A' ' 74' ' ' ILE . 4.5 mp -73.69 104.8 2.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 30.0 pt -85.65 -20.55 8.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.723 -178.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -160.0 120.78 3.05 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.12 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -124.7 96.2 4.8 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 175.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.1 -178.99 4.25 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.292 -174.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.83 157.41 17.49 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 176.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.537 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 4.3 t-160 -124.08 63.16 1.08 Allowed 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 174.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.48 -114.6 4.5 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.213 -175.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -83.76 20.9 1.12 Allowed 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.684 2.256 . . . . 0.0 112.015 174.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.537 ' HB2' ' HB3' ' A' ' 80' ' ' HIS . 31.0 m-80 -131.27 164.21 26.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.116 -177.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -124.1 129.96 51.74 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 175.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 81.8 mt-10 -127.86 116.89 20.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.129 0.49 . . . . 0.0 111.465 -176.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -114.31 128.79 56.53 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.312 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.0 t -108.76 115.86 50.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.905 179.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.433 ' HB2' ' HB2' ' A' ' 72' ' ' TYR . . . -125.99 136.65 53.23 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.933 0.397 . . . . 0.0 111.544 -176.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' A' ' 72' ' ' TYR . 45.9 mt-10 -91.76 118.63 30.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.82 177.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.5 t -86.3 128.65 39.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.434 -178.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -124.92 147.36 48.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.09 0.472 . . . . 0.0 110.608 178.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.6 ' OD1' HG23 ' A' ' 38' ' ' VAL . 21.5 m120 -82.52 163.1 21.76 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.139 178.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.815 ' HB2' ' HD2' ' A' ' 70' ' ' LYS . 38.0 t0 . . . . . 0 C--N 1.319 -0.757 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 169.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.381 0 CA-C-O 121.033 0.444 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -151.43 -156.66 0.73 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.126 -168.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 224' ' ' GLN . . . . . 0.674 ' HA ' ' HB3' ' B' ' 271' ' ' TYR . 0.0 OUTLIER 82.23 145.79 0.08 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.899 0.88 . . . . 0.0 111.495 172.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 23.7 m -115.97 154.36 17.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.208 -176.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 19.7 m -99.03 -102.79 0.22 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.883 -178.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -124.16 -57.54 1.59 Allowed 'General case' 0 C--N 1.326 -0.413 0 O-C-N 122.011 -0.43 . . . . 0.0 111.31 -170.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -62.04 -38.08 87.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.025 0.44 . . . . 0.0 110.878 -175.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -61.72 -36.08 79.91 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.01 -177.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.416 HD13 ' CZ ' ' B' ' 291' ' ' TYR . 66.7 mt -60.49 -53.08 53.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.79 -178.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 23.2 t -72.85 -21.33 60.96 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.171 -176.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -87.87 -44.48 11.04 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -176.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -95.32 -18.43 20.8 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.582 0.216 . . . . 0.0 111.582 -177.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 5.7 mmmm 63.17 77.29 0.33 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.501 0.667 . . . . 0.0 111.489 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 87.9 mt -93.94 140.75 29.32 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.502 175.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 27.2 m -76.88 127.07 38.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.106 0.479 . . . . 0.0 111.0 -177.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 237' ' ' LYS . . . . . 0.516 ' HE2' ' HB3' ' B' ' 289' ' ' GLU . 57.9 tttm -84.95 107.12 16.93 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.936 178.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 48.8 t -67.28 -35.19 73.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.607 -177.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 168.79 -149.32 13.61 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.313 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 38.3 m -139.74 140.81 36.83 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 -178.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 18.2 pt -121.14 139.01 49.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.097 0.475 . . . . 0.0 110.677 178.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -127.68 113.59 16.23 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 243' ' ' VAL . . . . . 0.405 ' HB ' ' HB2' ' B' ' 286' ' ' ALA . 2.3 t -100.69 108.41 23.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.21 -175.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 26.5 t -99.32 109.42 22.04 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 177.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 245' ' ' GLN . . . . . 0.609 ' CA ' HE21 ' B' ' 245' ' ' GLN . 0.0 OUTLIER -99.71 158.25 15.91 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 121.358 0.599 . . . . 0.0 110.669 179.302 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 1.5 p -91.48 11.04 25.31 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.539 175.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 94.83 -61.02 1.68 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.796 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -78.29 50.57 3.47 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 121.2 -0.524 . . . . 0.0 113.103 -178.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -137.03 -14.48 1.57 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.828 0.346 . . . . 0.0 110.533 177.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 39.5 mm -125.56 99.15 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.73 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 23.1 t -98.38 -25.47 14.81 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.355 0.597 . . . . 0.0 109.65 178.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 252' ' ' SER . . . . . 0.527 ' HB3' ' HD2' ' B' ' 253' ' ' PRO . 49.8 m -151.49 165.7 16.81 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.747 178.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . 0.527 ' HD2' ' HB3' ' B' ' 252' ' ' SER . 11.3 Cg_endo -55.41 -25.69 49.63 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.756 2.304 . . . . 0.0 112.113 177.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 254' ' ' SER . . . . . 0.544 ' O ' ' HG3' ' B' ' 258' ' ' GLU . 30.0 t -54.15 -36.29 63.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.142 174.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -74.32 -40.16 62.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.905 0.383 . . . . 0.0 110.614 -177.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 42.7 tp -60.9 -45.45 94.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.211 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 257' ' ' ARG . . . . . 0.497 ' HD3' ' OH ' ' A' ' 71' ' ' TYR . 13.1 ptt180 -63.72 -30.99 72.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.796 0.331 . . . . 0.0 111.158 -178.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 258' ' ' GLU . . . . . 0.544 ' HG3' ' O ' ' B' ' 254' ' ' SER . 56.5 mt-10 -72.41 -36.49 68.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.854 0.359 . . . . 0.0 110.462 -179.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -74.67 -40.1 61.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.966 178.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 93.3 mt -66.35 -43.89 84.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.746 -177.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 22.0 p -68.15 -34.15 75.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.751 0.31 . . . . 0.0 110.521 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -54.93 -44.76 74.57 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.573 0.701 . . . . 0.0 109.966 176.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 263' ' ' LEU . . . . . 0.578 ' O ' ' HG2' ' B' ' 267' ' ' LYS . 68.9 mt -74.69 -41.73 59.69 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.995 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -60.17 -47.86 84.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.271 -174.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -70.7 -29.96 66.39 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.624 -177.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -66.49 -23.53 66.27 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.373 0.606 . . . . 0.0 110.538 176.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 267' ' ' LYS . . . . . 0.578 ' HG2' ' O ' ' B' ' 263' ' ' LEU . 73.3 mmtt -89.43 -21.76 22.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.869 176.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 88.27 25.3 31.47 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.802 -177.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -100.14 -165.28 28.82 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.124 -179.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 22.2 mmtp -132.66 -67.56 0.64 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.194 0.521 . . . . 0.0 109.708 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 271' ' ' TYR . . . . . 0.674 ' HB3' ' HA ' ' B' ' 224' ' ' GLN . 7.7 m-85 -101.23 145.29 29.02 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.165 -176.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 272' ' ' TYR . . . . . 0.524 ' CD2' ' HB3' ' A' ' 22' ' ' ALA . 10.9 p90 -104.46 169.47 8.45 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 175.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 273' ' ' HIS . . . . . 0.438 ' HB3' ' HB2' ' B' ' 289' ' ' GLU . 10.7 t-160 -138.03 101.47 4.43 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.402 172.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 274' ' ' ILE . . . . . 0.454 HD11 ' OE1' ' A' ' 29' ' ' GLU . 63.3 mt -71.33 123.02 24.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.155 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 22.5 pt -114.08 -28.67 2.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.592 -176.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -152.06 107.13 3.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.954 0.407 . . . . 0.0 111.531 -178.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -105.37 96.65 6.66 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 173.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -127.38 137.51 52.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.206 0.527 . . . . 0.0 111.331 -170.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -88.06 119.75 28.74 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.095 0.474 . . . . 0.0 110.707 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -98.62 78.65 2.39 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 69.5 -126.42 18.78 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 -175.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.74 6.47 4.5 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 122.614 2.209 . . . . 0.0 112.257 177.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -112.34 151.49 29.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.184 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 284' ' ' PHE . . . . . 0.453 ' HB3' ' HB2' ' B' ' 245' ' ' GLN . 52.0 t80 -115.67 113.0 22.93 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 175.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 285' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -102.37 110.39 22.32 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.293 -0.412 . . . . 0.0 109.993 -177.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 286' ' ' ALA . . . . . 0.405 ' HB2' ' HB ' ' B' ' 243' ' ' VAL . . . -102.35 114.91 29.49 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.79 0.328 . . . . 0.0 110.52 176.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 29.4 t -105.75 120.93 57.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.218 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -138.83 152.21 47.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.019 0.438 . . . . 0.0 111.364 -178.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 289' ' ' GLU . . . . . 0.516 ' HB3' ' HE2' ' B' ' 237' ' ' LYS . 31.1 mt-10 -91.74 157.99 16.61 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 175.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 39.9 t -115.11 125.43 72.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 177.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 291' ' ' TYR . . . . . 0.416 ' CZ ' HD13 ' B' ' 230' ' ' ILE . 93.5 m-85 -125.02 155.34 39.87 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.236 0.541 . . . . 0.0 110.716 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 292' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -118.91 156.62 29.2 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 2.3 p30 . . . . . 0 N--CA 1.466 0.325 0 CA-C-O 120.662 0.267 . . . . 0.0 110.897 -178.871 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.587 ' HA ' ' OE2' ' B' ' 223' ' ' GLU . . . . . . . . 0 N--CA 1.464 0.241 0 CA-C-O 121.277 0.561 . . . . 0.0 109.984 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.713 ' O ' ' HB3' ' A' ' 24' ' ' GLN . 9.2 tp10 -133.74 178.75 6.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.349 -171.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.713 ' HB3' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER 96.45 134.9 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.95 1.3 . . . . 0.0 111.985 176.851 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.43 ' N ' ' HG2' ' A' ' 24' ' ' GLN . 21.2 m -109.98 155.74 11.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.07 -0.968 . . . . 0.0 108.721 172.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.621 ' HB3' ' OE1' ' A' ' 28' ' ' GLN . 7.0 t -98.29 -176.85 3.52 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.26 -178.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.578 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 5.0 tmtt? -65.08 -27.87 69.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.464 -169.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.621 ' OE1' ' HB3' ' A' ' 26' ' ' SER . 15.8 mp0 -59.34 -49.51 77.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.021 0.439 . . . . 0.0 110.356 -178.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.593 ' HA ' ' HB3' ' A' ' 32' ' ' HIS . 12.8 mm-40 -75.25 -25.62 58.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.102 -173.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.528 HD11 ' HA ' ' A' ' 27' ' ' LYS . 63.8 mt -57.53 -52.93 51.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.204 0.526 . . . . 0.0 109.912 175.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.8 m -73.87 -24.02 59.68 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.001 177.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.593 ' HB3' ' HA ' ' A' ' 29' ' ' GLU . 21.8 t-160 -69.72 -52.58 24.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.136 -177.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -97.59 2.95 50.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.301 -176.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt 56.17 59.05 3.9 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 123.624 0.577 . . . . 0.0 111.03 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.3 mt -62.44 138.04 58.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.654 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.8 t -65.09 -37.17 79.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.541 -174.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.0 tttm 66.28 114.94 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 O-C-N 124.227 0.954 . . . . 0.0 111.118 -178.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.2 m -82.66 -39.45 15.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.859 -0.337 . . . . 0.0 111.741 -177.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 173.12 -155.67 23.12 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.266 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.487 HG23 ' HG2' ' A' ' 89' ' ' GLU . 46.8 m -141.97 131.06 23.25 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.706 0.289 . . . . 0.0 110.337 -178.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.9 pt -120.91 173.3 6.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -150.29 152.2 34.13 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.558 0.694 . . . . 0.0 112.112 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.607 HG12 ' NE2' ' A' ' 45' ' ' GLN . 69.2 t -94.64 128.67 45.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.521 171.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.4 t -143.34 46.11 1.52 Allowed 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.607 ' NE2' HG12 ' A' ' 43' ' ' VAL . 1.0 OUTLIER -93.42 145.05 24.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.033 -175.089 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.3 m -82.1 80.97 8.2 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.956 -174.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.23 -77.29 0.58 Allowed Glycine 0 CA--C 1.521 0.434 0 N-CA-C 114.872 0.709 . . . . 0.0 114.872 168.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -58.56 -19.85 43.5 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 114.743 0.657 . . . . 0.0 114.743 -168.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.416 ' HB2' ' HB3' ' A' ' 45' ' ' GLN . 15.9 mm-40 -79.35 -21.77 45.37 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 117.356 0.578 . . . . 0.0 111.169 -178.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 40.3 mm -123.44 88.22 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.7 t -105.76 -30.64 9.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.635 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.7 m -127.47 158.38 69.92 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.373 -177.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.28 -32.52 81.31 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.726 2.284 . . . . 0.0 112.088 176.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.579 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 11.5 p -64.28 -40.68 96.45 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.145 178.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -54.96 -30.97 60.13 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.733 0.301 . . . . 0.0 111.457 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 40.4 tp -56.59 -55.91 27.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.774 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -73.21 -29.8 63.06 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.047 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.579 ' HG2' ' O ' ' A' ' 54' ' ' SER . 22.8 mm-40 -62.05 -48.31 80.83 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.214 0.531 . . . . 0.0 110.837 179.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -73.12 -37.94 66.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.336 -178.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.462 HD13 ' CE1' ' A' ' 72' ' ' TYR . 37.6 mt -72.08 -35.51 69.25 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.732 -178.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.9 m -62.6 -42.74 99.75 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 120.874 -0.331 . . . . 0.0 110.31 173.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -56.18 -39.65 72.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.356 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 86.6 mt -76.42 -51.34 12.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.669 178.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.86 -32.16 72.48 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.294 -171.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -58.03 -49.49 76.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.946 0.403 . . . . 0.0 110.611 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.49 -25.25 63.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.612 -178.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -75.87 -19.62 58.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.023 0.439 . . . . 0.0 110.581 178.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.55 38.46 9.7 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.291 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -105.51 161.62 14.56 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.414 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.577 ' HG3' ' OD2' ' A' ' 93' ' ' ASP . 35.4 mmtp -98.73 -48.66 4.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.276 0.56 . . . . 0.0 110.387 178.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.527 ' HE2' ' HD2' ' B' ' 257' ' ' ARG . 1.5 p90 -147.63 168.28 22.42 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.39 -178.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.462 ' CE1' HD13 ' A' ' 60' ' ' LEU . 45.8 p90 -142.14 166.96 23.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.901 -178.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -137.7 109.43 7.08 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.313 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.509 HG12 ' HB1' ' A' ' 88' ' ' ALA . 83.6 mt -69.62 130.31 34.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 176.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.9 pt -109.55 -25.88 3.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.29 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -150.0 129.37 12.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.628 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -144.28 138.12 27.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.255 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.492 ' HD3' ' HB2' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -166.52 157.77 12.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.547 179.848 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -91.47 122.68 34.28 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 168.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -115.35 96.73 5.8 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.82 -125.25 9.0 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -172.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.444 ' HD2' ' ND2' ' A' ' 83' ' ' ASN . 94.9 Cg_endo -94.83 14.94 1.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.019 2.479 . . . . 0.0 112.497 175.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.444 ' ND2' ' HD2' ' A' ' 82' ' ' PRO . 12.6 m-80 -114.87 150.69 35.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.704 0.288 . . . . 0.0 110.947 -176.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -109.43 108.17 18.59 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 174.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.52 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 5.0 mm-40 -100.62 112.34 24.71 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.057 -175.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.459 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -130.57 116.55 18.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.855 0.359 . . . . 0.0 111.318 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.2 t -96.55 123.35 48.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.782 0.325 . . . . 0.0 110.649 -177.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.509 ' HB1' HG12 ' A' ' 74' ' ' ILE . . . -135.35 129.0 32.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.007 0.432 . . . . 0.0 111.307 -177.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.487 ' HG2' HG23 ' A' ' 40' ' ' THR . 21.1 mt-10 -92.34 137.01 32.73 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 23.1 t -99.89 134.5 39.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 120.896 0.379 . . . . 0.0 110.33 -176.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -124.69 149.35 47.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.237 -177.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.565 ' OD1' ' HG2' ' A' ' 70' ' ' LYS . 18.2 m-20 -123.53 150.85 43.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.393 176.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.577 ' OD2' ' HG3' ' A' ' 70' ' ' LYS . 5.8 m-20 . . . . . 0 C--O 1.238 0.464 0 O-C-N 123.687 0.617 . . . . 0.0 110.359 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.951 0.405 . . . . 0.0 111.65 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 223' ' ' GLU . . . . . 0.587 ' OE2' ' HA ' ' A' ' 22' ' ' ALA . 8.7 pt-20 -150.78 169.58 21.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.502 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 224' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' B' ' 223' ' ' GLU . 0.8 OUTLIER 177.4 137.08 0.07 Allowed 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.781 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 5.7 m -133.55 107.28 10.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.07 0.462 . . . . 0.0 110.195 173.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 226' ' ' SER . . . . . 0.5 ' O ' HG13 ' B' ' 230' ' ' ILE . 8.5 t -89.71 171.08 9.9 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -178.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -66.45 -18.18 65.22 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -171.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -72.07 -47.56 50.64 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 176.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 229' ' ' GLU . . . . . 0.438 ' OE1' ' HB3' ' B' ' 226' ' ' SER . 2.0 mp0 -67.4 -41.04 85.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.159 176.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.525 HG12 HD12 ' B' ' 235' ' ' LEU . 98.1 mt -59.01 -48.01 88.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.448 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 35.5 p -72.78 -25.01 61.01 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.007 0.432 . . . . 0.0 110.959 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 26.4 t-80 -75.71 -50.17 16.12 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.284 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -88.62 -16.89 31.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.319 -177.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 60.06 79.77 0.23 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.543 0.687 . . . . 0.0 110.177 -177.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . 0.525 HD12 HG12 ' B' ' 230' ' ' ILE . 82.9 mt -82.57 177.48 8.69 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.002 -175.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 61.3 t -105.96 138.8 29.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.727 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 237' ' ' LYS . . . . . 0.422 ' HE2' ' O ' ' B' ' 239' ' ' GLY . 20.2 tptm -104.74 128.9 53.0 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.774 -179.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 238' ' ' VAL . . . . . 0.406 HG11 ' HB2' ' B' ' 292' ' ' ASN . 2.6 m -91.3 -45.33 14.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.297 176.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 239' ' ' GLY . . . . . 0.422 ' O ' ' HE2' ' B' ' 237' ' ' LYS . . . 166.02 -178.7 40.57 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.115 -177.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 34.9 m -106.69 137.93 43.81 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.466 -0.198 . . . . 0.0 110.466 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 29.7 pt -105.53 137.44 35.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.878 0.37 . . . . 0.0 110.435 175.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -115.64 114.17 24.53 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.431 -177.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 243' ' ' VAL . . . . . 0.518 ' HB ' ' HB2' ' B' ' 286' ' ' ALA . 54.9 t -101.9 125.4 56.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.901 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 23.1 t -146.91 106.4 3.92 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.874 0.369 . . . . 0.0 110.44 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 245' ' ' GLN . . . . . 0.489 ' HG3' ' HB2' ' B' ' 249' ' ' GLN . 0.0 OUTLIER -156.33 168.05 28.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.391 178.363 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 22.6 t -92.16 -174.3 3.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.828 0.347 . . . . 0.0 110.413 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -69.64 -3.1 39.67 Favored Glycine 0 C--N 1.33 0.2 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.771 -178.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -74.45 -27.59 65.29 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.701 -0.762 . . . . 0.0 111.613 174.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . 0.489 ' HB2' ' HG3' ' B' ' 245' ' ' GLN . 64.7 mt-30 -102.16 -36.79 8.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.56 0.219 . . . . 0.0 110.586 177.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 250' ' ' ILE . . . . . 0.401 HG12 ' HG3' ' B' ' 245' ' ' GLN . 47.6 mm -115.4 99.97 9.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.857 0.36 . . . . 0.0 110.791 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 21.5 t -122.68 -42.74 2.3 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.999 175.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 252' ' ' SER . . . . . 0.521 ' HB3' ' HD2' ' B' ' 253' ' ' PRO . 32.3 m -111.23 162.33 21.35 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.776 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . 0.521 ' HD2' ' HB3' ' B' ' 252' ' ' SER . 13.1 Cg_endo -57.83 -35.25 98.88 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.775 2.316 . . . . 0.0 112.754 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 254' ' ' SER . . . . . 0.404 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 5.3 p -63.27 -34.39 77.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.149 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -58.84 -51.57 69.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.662 -176.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 55.4 tp -63.66 -37.92 89.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.029 -177.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 257' ' ' ARG . . . . . 0.527 ' HD2' ' HE2' ' A' ' 71' ' ' TYR . 81.3 mtp180 -59.43 -39.92 85.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.719 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 258' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' B' ' 254' ' ' SER . 21.2 mm-40 -65.46 -30.98 71.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.857 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -79.74 -48.36 13.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.113 -177.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.69 -46.25 86.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.904 -174.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 18.4 p -61.28 -41.18 96.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.224 0.535 . . . . 0.0 110.763 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -61.5 -51.0 70.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.156 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 263' ' ' LEU . . . . . . . . . . . . . 95.9 mt -67.65 -31.42 71.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.68 -175.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.88 -50.75 47.05 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -175.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -71.98 -25.31 61.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.872 0.368 . . . . 0.0 110.106 -177.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -67.8 -34.24 76.37 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.287 0.565 . . . . 0.0 110.552 176.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -81.79 -9.68 59.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.362 177.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 268' ' ' GLY . . . . . 0.472 ' O ' ' HE2' ' B' ' 270' ' ' LYS . . . 96.37 5.92 58.94 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.168 175.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . 0.456 ' HA3' HG12 ' B' ' 290' ' ' VAL . . . -89.45 154.94 24.58 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.685 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . 0.472 ' HE2' ' O ' ' B' ' 268' ' ' GLY . 48.6 mmtt -119.74 -2.54 10.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.951 0.405 . . . . 0.0 110.55 -175.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 271' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -143.55 154.6 43.77 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 175.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 272' ' ' TYR . . . . . 0.419 ' CD1' ' HB1' ' A' ' 22' ' ' ALA . 7.3 p90 -151.31 157.85 43.05 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.994 174.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -138.89 112.13 8.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.865 -178.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 274' ' ' ILE . . . . . 0.555 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 55.6 mt -69.24 120.76 17.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.536 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 22.0 pt -97.87 -36.94 6.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.149 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -145.45 100.44 3.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.925 0.393 . . . . 0.0 111.598 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -104.57 100.57 10.24 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 174.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 278' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' B' ' 285' ' ' GLU . 10.0 ptm180 -118.68 111.96 19.19 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.838 0.827 . . . . 0.0 111.787 -169.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -77.75 96.78 4.99 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.666 173.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 17.1 t-160 -96.62 97.83 9.7 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.691 -175.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 77.39 -137.26 20.1 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -174.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -83.08 -4.36 11.17 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.462 2.108 . . . . 0.0 111.872 174.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -103.66 154.33 19.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.173 -176.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 284' ' ' PHE . . . . . 0.458 ' CE2' ' HB3' ' B' ' 286' ' ' ALA . 84.1 t80 -114.74 124.75 52.58 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.913 0.387 . . . . 0.0 110.238 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 285' ' ' GLU . . . . . 0.461 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 36.2 mt-10 -123.72 116.65 23.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.151 -179.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 286' ' ' ALA . . . . . 0.518 ' HB2' ' HB ' ' B' ' 243' ' ' VAL . . . -118.07 130.15 55.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.119 0.485 . . . . 0.0 111.722 -175.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 35.2 t -110.93 120.73 62.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.031 174.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -133.13 140.86 47.84 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.11 0.481 . . . . 0.0 111.517 -177.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -91.75 119.27 31.43 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.497 177.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 290' ' ' VAL . . . . . 0.456 HG12 ' HA3' ' B' ' 269' ' ' GLY . 15.4 t -94.98 130.41 43.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -117.35 157.81 25.49 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.375 0.607 . . . . 0.0 110.634 -176.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 292' ' ' ASN . . . . . 0.406 ' HB2' HG11 ' B' ' 238' ' ' VAL . 6.3 t-20 -120.37 164.38 16.43 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 174.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 9.5 t70 . . . . . 0 C--N 1.32 -0.688 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -176.985 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.683 ' HB1' ' CD1' ' B' ' 272' ' ' TYR . . . . . . . . 0 CA--C 1.519 -0.248 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.497 ' O ' ' HE1' ' B' ' 272' ' ' TYR . 0.0 OUTLIER -138.23 -171.67 3.09 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.883 -171.116 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.551 ' CD ' ' HG3' ' B' ' 224' ' ' GLN . 0.0 OUTLIER 75.24 154.69 0.16 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.627 0.771 . . . . 0.0 111.615 176.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.8 m -114.77 164.56 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.854 -176.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.546 ' HB2' ' HB ' ' B' ' 274' ' ' ILE . 16.8 t -74.95 164.32 26.69 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.005 0.431 . . . . 0.0 111.267 -174.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -66.61 -28.91 68.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.281 176.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -60.67 -37.97 83.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.403 176.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.581 ' HA ' ' HB3' ' A' ' 32' ' ' HIS . 15.4 mm-40 -72.52 -26.21 61.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.908 -175.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.432 ' HA ' HD13 ' A' ' 35' ' ' LEU . 56.5 mt -60.79 -48.09 90.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 173.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.2 m -73.92 -21.15 60.16 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.1 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.581 ' HB3' ' HA ' ' A' ' 29' ' ' GLU . 22.8 t-160 -80.89 -54.21 5.79 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.402 -175.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -93.24 -20.05 20.81 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -176.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.85 84.99 0.13 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.191 0.519 . . . . 0.0 110.513 -175.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.552 HD23 ' HE1' ' A' ' 71' ' ' TYR . 5.8 mp -91.08 175.48 6.93 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.433 -176.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -99.38 129.51 49.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.253 -173.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.448 ' HZ2' ' CD ' ' A' ' 89' ' ' GLU . 35.3 tptt -70.48 126.46 29.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.416 179.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.94 8.88 5.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.952 0.406 . . . . 0.0 111.483 175.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.75 -170.0 15.97 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.8 174.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 53.3 m -133.38 131.05 39.58 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.616 HG13 ' HB1' ' A' ' 88' ' ' ALA . 26.1 pt -104.23 132.33 51.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 176.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -123.28 127.72 48.96 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.136 0.493 . . . . 0.0 110.686 -175.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.655 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 88.7 t -93.01 123.26 45.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.171 175.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.5 t -146.35 74.4 1.36 Allowed 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 176.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -124.37 178.75 5.22 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.051 -178.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.8 t -86.27 168.47 13.88 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.85 176.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.26 -16.52 54.07 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.492 178.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.24 -17.83 74.45 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.123 -0.561 . . . . 0.0 112.349 177.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -111.61 -26.85 8.81 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.12 0.486 . . . . 0.0 110.353 176.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.469 HD12 ' HA ' ' A' ' 56' ' ' LEU . 43.1 mm -117.41 92.13 2.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.34 175.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.8 t -113.79 -62.33 1.61 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.347 -177.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.8 m -101.56 165.02 14.8 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.827 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -53.0 -38.4 79.98 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.423 2.082 . . . . 0.0 111.567 174.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.8 p -67.71 -38.53 83.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.448 177.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -59.88 -46.89 87.89 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.154 0.502 . . . . 0.0 109.932 176.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.469 ' HA ' HD12 ' A' ' 50' ' ' ILE . 60.4 tp -61.28 -45.74 93.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.19 176.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.672 ' HD2' ' OE2' ' B' ' 223' ' ' GLU . 3.7 ttp180 -53.41 -48.36 68.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.203 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -55.52 -45.76 77.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.14 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -70.74 -35.23 72.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.06 -178.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.7 mt -66.04 -48.65 70.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.062 0.458 . . . . 0.0 110.635 176.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.5 t -64.03 -38.11 89.87 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.226 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -58.17 -43.88 87.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.95 178.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 93.5 mt -70.32 -38.03 74.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.277 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.95 93.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.063 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -63.11 -31.94 73.2 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.099 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.47 -24.01 61.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.32 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 28.3 mmtm -100.17 -13.42 18.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.557 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.09 38.82 73.47 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.108 -179.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.1 146.3 18.19 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.567 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.46 ' HG2' ' OD2' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -89.89 -2.18 58.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.633 0.254 . . . . 0.0 111.442 -176.497 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.552 ' HE1' HD23 ' A' ' 35' ' ' LEU . 10.4 p90 -167.4 174.88 7.61 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 169.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.532 ' O ' ' HG3' ' A' ' 24' ' ' GLN . 44.0 p90 -148.25 130.74 15.77 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 175.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -111.43 109.67 19.75 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.385 -0.526 . . . . 0.0 109.97 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.542 ' HA ' ' HA ' ' A' ' 88' ' ' ALA . 68.2 mt -68.75 127.15 30.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 177.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 26.8 pt -102.3 -37.24 4.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.03 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.23 136.03 36.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.241 -178.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -147.69 134.12 19.68 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.454 ' HD3' ' HB2' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -154.72 147.34 24.21 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.999 0.428 . . . . 0.0 110.286 179.192 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -94.11 92.6 7.37 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 177.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -87.59 80.13 8.1 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.44 -173.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.62 -121.92 16.05 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.961 -178.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -86.2 -1.46 8.56 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.951 2.434 . . . . 0.0 112.442 177.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -117.45 122.42 43.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.318 -178.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.44 ' CD2' HG23 ' A' ' 50' ' ' ILE . 88.5 t80 -92.53 128.04 38.23 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 177.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.655 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 48.4 mt-10 -112.22 117.09 31.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.708 -179.107 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.517 ' HB1' ' HB ' ' A' ' 43' ' ' VAL . . . -120.99 118.67 30.44 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.194 175.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.6 t -100.95 111.5 30.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.616 ' HB1' HG13 ' A' ' 41' ' ' ILE . . . -117.38 132.45 56.58 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.05 0.452 . . . . 0.0 110.957 -177.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.475 ' HB3' ' CE2' ' A' ' 91' ' ' TYR . 11.0 mm-40 -92.14 128.23 37.91 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.116 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.1 t -102.37 125.86 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -178.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.527 ' HB2' ' HH ' ' A' ' 71' ' ' TYR . 92.9 m-85 -129.54 142.67 50.71 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.0 0.429 . . . . 0.0 110.386 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -111.85 170.32 8.23 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.014 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.46 ' OD2' ' HG2' ' A' ' 70' ' ' LYS . 13.2 m-20 . . . . . 0 C--N 1.322 -0.608 0 CA-C-O 121.085 0.469 . . . . 0.0 111.006 -176.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.503 0 CA-C-O 120.769 0.319 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 223' ' ' GLU . . . . . 0.672 ' OE2' ' HD2' ' A' ' 57' ' ' ARG . 9.8 tp10 -162.04 120.45 2.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.818 -178.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 224' ' ' GLN . . . . . 0.551 ' HG3' ' CD ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -169.95 139.29 1.86 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.041 0.448 . . . . 0.0 112.067 -179.093 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 14.1 m -113.84 128.83 70.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.032 170.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 226' ' ' SER . . . . . 0.463 ' HB2' ' HG2' ' B' ' 229' ' ' GLU . 12.5 m -77.59 157.42 30.29 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.683 -178.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -68.31 -30.39 69.36 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -62.22 -35.75 79.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.687 176.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 229' ' ' GLU . . . . . 0.463 ' HG2' ' HB2' ' B' ' 226' ' ' SER . 36.6 mm-40 -71.34 -25.3 62.34 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.405 -178.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.497 HG12 HD12 ' B' ' 235' ' ' LEU . 56.8 mt -60.97 -45.17 98.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.828 175.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 5.1 m -73.07 -21.66 60.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.568 176.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -78.11 -52.04 9.35 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.579 -173.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -113.22 -4.59 13.72 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -175.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.88 84.92 0.12 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.421 0.629 . . . . 0.0 110.119 -171.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . 0.497 HD12 HG12 ' B' ' 230' ' ' ILE . 87.9 mt -79.32 138.84 37.87 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.031 -176.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 57.2 t -72.92 106.4 2.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.626 -178.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -79.23 116.88 19.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.105 0.478 . . . . 0.0 110.317 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 3.0 t -81.36 -40.89 18.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.825 -178.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 169.05 -149.98 14.73 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.47 -178.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 41.6 m -139.42 127.63 22.58 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 241' ' ' ILE . . . . . 0.443 HG21 HG21 ' B' ' 290' ' ' VAL . 2.4 pp -103.32 131.96 50.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.123 0.487 . . . . 0.0 109.931 178.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -116.19 120.19 38.19 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.058 -177.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 243' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' B' ' 285' ' ' GLU . 57.9 t -94.16 132.2 38.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.408 178.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 46.5 m -127.87 88.55 2.79 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 172.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 245' ' ' GLN . . . . . 0.556 ' HG2' HG12 ' B' ' 250' ' ' ILE . 0.7 OUTLIER -80.88 107.82 14.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.076 -173.474 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 53.1 p -84.99 102.74 13.42 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.853 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 92.52 -163.73 27.58 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.798 176.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -85.61 64.67 4.09 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 121.275 -0.488 . . . . 0.0 113.443 -172.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . 0.527 ' HB2' ' HG3' ' B' ' 245' ' ' GLN . 64.8 mt-30 -93.95 -3.06 52.28 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.01 0.433 . . . . 0.0 110.195 173.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 250' ' ' ILE . . . . . 0.556 HG12 ' HG2' ' B' ' 245' ' ' GLN . 38.7 mm -125.68 99.22 5.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.091 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 33.0 t -93.58 -46.36 7.32 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.098 0.475 . . . . 0.0 109.799 175.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 20.0 m -123.64 167.63 14.58 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.212 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.13 -26.77 61.89 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.574 2.183 . . . . 0.0 112.01 173.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 254' ' ' SER . . . . . . . . . . . . . 19.9 m -64.78 -39.45 93.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.625 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.04 -46.76 82.17 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.301 177.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 55.3 tp -57.58 -43.85 84.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.701 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 257' ' ' ARG . . . . . 0.483 ' HD2' ' CD ' ' A' ' 23' ' ' GLU . 10.7 ttp180 -53.71 -52.32 60.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.266 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 258' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -60.29 -27.1 67.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.814 -173.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 259' ' ' LYS . . . . . 0.416 ' O ' ' HG ' ' B' ' 263' ' ' LEU . 14.4 mptt -80.47 -39.65 27.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.976 0.417 . . . . 0.0 110.851 176.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 95.6 mt -71.28 -47.34 57.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.73 -175.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 2.8 m -58.93 -34.83 72.18 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.314 0.578 . . . . 0.0 110.658 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -66.39 -47.81 72.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.421 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 263' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' B' ' 259' ' ' LYS . 90.6 mt -64.96 -32.41 74.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.629 -175.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -60.86 -42.58 98.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.597 -177.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -61.29 -49.39 77.22 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.43 -177.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -68.92 -15.12 63.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.852 -175.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 267' ' ' LYS . . . . . 0.437 ' HD3' ' HA ' ' B' ' 267' ' ' LYS . 31.4 mmtp -100.87 -0.86 36.07 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.088 178.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 74.42 28.11 64.35 Favored Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.218 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -101.27 162.76 17.98 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.066 -178.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . 0.522 ' HA ' ' HZ2' ' B' ' 270' ' ' LYS . 0.0 OUTLIER -117.15 -59.94 1.89 Allowed 'General case' 0 C--N 1.32 -0.716 0 O-C-N 122.66 -0.317 . . . . 0.0 110.754 179.426 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 271' ' ' TYR . . . . . 0.618 ' HE2' ' HB2' ' B' ' 293' ' ' ASP . 6.0 m-85 -117.19 162.94 17.06 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 272' ' ' TYR . . . . . 0.683 ' CD1' ' HB1' ' A' ' 22' ' ' ALA . 0.1 OUTLIER -148.74 158.75 44.37 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.183 0.516 . . . . 0.0 110.994 -179.123 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -128.17 107.78 10.07 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.256 -178.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 274' ' ' ILE . . . . . 0.546 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 4.5 mp -77.46 120.47 28.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.611 -174.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 14.4 pt -111.42 -26.45 3.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -176.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 276' ' ' ALA . . . . . 0.56 ' HB1' ' HB ' ' B' ' 287' ' ' VAL . . . -134.9 145.74 48.52 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.192 -177.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 277' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' B' ' 285' ' ' GLU . . . -169.47 117.66 0.62 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.856 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.13 139.11 15.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.83 0.348 . . . . 0.0 110.992 -178.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 279' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' B' ' 284' ' ' PHE . 3.3 mp0 -76.7 91.08 3.43 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 174.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -87.01 89.31 7.95 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 -176.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 66.44 -118.76 11.33 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.511 -174.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -90.54 -2.12 5.18 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.896 2.398 . . . . 0.0 112.733 177.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 283' ' ' ASN . . . . . 0.547 ' HA ' ' O ' ' B' ' 245' ' ' GLN . 59.1 m-80 -118.87 115.87 25.3 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.018 0.437 . . . . 0.0 111.127 -176.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 284' ' ' PHE . . . . . 0.434 ' HA ' ' HA ' ' B' ' 279' ' ' GLU . 70.0 t80 -79.06 113.92 17.57 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 175.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 285' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 48.3 mt-10 -99.27 114.13 26.79 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.853 -176.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 286' ' ' ALA . . . . . 0.471 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -114.26 135.09 54.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.473 174.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 287' ' ' VAL . . . . . 0.56 ' HB ' ' HB1' ' B' ' 276' ' ' ALA . 37.4 t -125.41 128.48 72.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 110.081 -0.341 . . . . 0.0 110.081 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -134.74 151.13 50.74 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.965 0.412 . . . . 0.0 111.54 -178.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 289' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' B' ' 272' ' ' TYR . 21.8 mt-10 -90.62 119.92 31.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.141 178.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 290' ' ' VAL . . . . . 0.443 HG21 HG21 ' B' ' 241' ' ' ILE . 39.1 t -94.15 124.15 46.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.511 0.196 . . . . 0.0 111.211 -175.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -129.27 151.29 50.09 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.469 0.652 . . . . 0.0 111.658 -178.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 292' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -106.76 155.19 19.96 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.949 173.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 293' ' ' ASP . . . . . 0.618 ' HB2' ' HE2' ' B' ' 271' ' ' TYR . 25.7 t70 . . . . . 0 C--N 1.322 -0.59 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 165.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.454 ' O ' ' HD3' ' B' ' 257' ' ' ARG . . . . . . . . 0 N--CA 1.467 0.382 0 CA-C-O 121.276 0.56 . . . . 0.0 112.002 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.695 ' HG2' ' H ' ' B' ' 222' ' ' ALA . 9.8 tp10 -150.17 179.74 7.85 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.361 -178.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.765 ' HA ' ' HB2' ' A' ' 71' ' ' TYR . 0.0 OUTLIER 85.44 140.08 0.06 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.074 0.95 . . . . 0.0 111.529 176.712 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.495 HG21 ' CZ ' ' A' ' 71' ' ' TYR . 5.0 m -117.06 173.35 4.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.48 176.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.551 ' HB3' ' HB ' ' B' ' 274' ' ' ILE . 92.3 p -97.99 -175.75 3.24 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.097 0.475 . . . . 0.0 111.039 -175.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.0 tmmt? -71.48 -19.74 62.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.099 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -66.51 -45.91 77.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.6 -178.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -65.64 -44.69 85.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.502 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.0 mt -53.77 -46.47 62.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.688 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.3 m -68.4 -38.4 81.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.549 -176.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 25.8 m80 -80.86 -44.99 17.53 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -174.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.429 ' CD1' ' HD3' ' B' ' 253' ' ' PRO . 97.8 m-85 -93.22 -19.9 20.97 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -173.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm 61.35 82.72 0.16 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.184 0.516 . . . . 0.0 110.617 -177.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.572 HD21 ' HG3' ' B' ' 253' ' ' PRO . 96.5 mt -85.31 173.38 10.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.415 -176.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.1 t -95.97 124.78 48.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.608 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -84.58 115.49 22.65 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.161 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -94.68 -3.84 10.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.157 0.503 . . . . 0.0 111.141 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 120.83 155.25 9.51 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.976 174.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 27.4 m -81.16 150.3 28.75 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 177.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.3 pt -116.35 134.22 60.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.001 0.429 . . . . 0.0 110.006 172.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -124.12 116.04 22.11 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.122 -178.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 3.2 t -109.87 109.51 28.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.513 -178.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.8 p -92.48 91.92 7.84 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 175.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.559 ' HG2' HG12 ' A' ' 50' ' ' ILE . 0.9 OUTLIER -97.58 147.66 24.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.669 -170.641 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.9 t -96.84 154.8 17.08 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 172.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.92 78.32 0.39 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.338 178.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -175.76 -37.83 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 121.146 -0.549 . . . . 0.0 112.553 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -81.73 -23.85 36.48 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 122.57 -0.37 . . . . 0.0 111.255 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.559 HG12 ' HG2' ' A' ' 45' ' ' GLN . 49.3 mm -112.7 109.71 29.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.6 t -107.12 -45.94 4.02 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.204 0.526 . . . . 0.0 109.711 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.533 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 22.0 m -126.06 165.96 24.32 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.837 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.533 ' HD2' ' HB3' ' A' ' 52' ' ' SER . 10.7 Cg_endo -54.69 -26.4 46.65 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.631 2.221 . . . . 0.0 111.981 177.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.588 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 2.3 m -55.67 -51.86 65.8 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.752 176.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -59.62 -42.17 92.07 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.234 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 56.9 tp -61.5 -46.58 89.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.908 -177.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 21.5 ttp180 -58.66 -44.51 90.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.455 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.588 ' HG2' ' O ' ' A' ' 54' ' ' SER . 19.0 mm-40 -62.32 -45.35 93.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.854 -178.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -67.33 -36.86 82.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.362 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.0 mt -68.26 -43.0 78.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.977 0.418 . . . . 0.0 110.515 177.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.4 m -68.49 -30.53 69.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.575 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -58.01 -46.67 84.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.055 0.455 . . . . 0.0 110.46 177.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 98.5 mt -74.55 -37.0 63.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.898 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.72 -32.64 74.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.091 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -60.33 -41.72 94.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.917 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.05 -16.62 56.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.078 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -89.52 -15.22 33.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.548 177.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 57.68 48.98 77.83 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 -175.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -92.66 171.14 32.97 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.877 -175.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.467 ' CB ' ' HA ' ' A' ' 92' ' ' ASN . 56.7 tptt -99.89 -47.18 5.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.535 0.683 . . . . 0.0 109.811 178.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.765 ' HB2' ' HA ' ' A' ' 24' ' ' GLN . 35.1 p90 -150.96 177.15 10.43 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.794 -178.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -142.62 126.05 16.69 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.247 0.546 . . . . 0.0 110.166 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -106.61 101.0 10.48 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.281 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.569 ' HB ' ' HB2' ' B' ' 226' ' ' SER . 69.7 mt -72.44 120.11 20.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.139 0.495 . . . . 0.0 110.514 -176.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.6 pt -94.99 -35.38 6.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.22 -178.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.97 110.88 5.02 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.995 0.426 . . . . 0.0 111.601 -177.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -107.86 88.43 2.73 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 172.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.521 ' CG ' ' HB2' ' A' ' 85' ' ' GLU . 6.2 ptp180 -95.86 121.49 37.64 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.874 0.845 . . . . 0.0 112.196 -166.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -70.64 100.47 1.85 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.71 172.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 23.8 t-80 -88.16 14.74 8.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.062 0.458 . . . . 0.0 110.46 -177.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.85 -106.5 3.18 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.75 -5.9 16.39 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.579 2.186 . . . . 0.0 111.193 173.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -123.02 156.8 34.09 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.172 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -128.49 120.97 27.83 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.521 ' HB2' ' CG ' ' A' ' 78' ' ' ARG . 41.3 mt-10 -110.3 110.94 21.94 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.787 -177.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.36 118.12 32.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.035 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.9 t -112.82 112.79 41.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.934 176.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.507 ' HB1' HG12 ' A' ' 74' ' ' ILE . . . -127.76 141.71 51.51 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.962 0.41 . . . . 0.0 111.895 -176.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -91.85 116.47 28.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.79 177.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.6 t -100.34 125.01 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-O 121.117 0.484 . . . . 0.0 110.067 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.517 ' HB2' ' CE1' ' A' ' 71' ' ' TYR . 64.7 m-85 -123.84 159.51 29.43 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.911 177.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.467 ' HA ' ' CB ' ' A' ' 70' ' ' LYS . 10.3 t-20 -120.52 174.07 6.78 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 175.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 . . . . . 0 C--O 1.235 0.335 0 CA-C-O 120.764 0.316 . . . . 0.0 110.222 176.427 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 222' ' ' ALA . . . . . 0.695 ' H ' ' HG2' ' A' ' 23' ' ' GLU . . . . . . . . 0 N--CA 1.465 0.321 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -167.61 110.57 0.65 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.926 174.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 224' ' ' GLN . . . . . 0.519 ' HG3' ' CD ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -161.94 148.09 13.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.033 -175.817 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . 0.435 HG22 ' HB3' ' B' ' 271' ' ' TYR . 18.7 m -126.78 128.69 71.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 166.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 226' ' ' SER . . . . . 0.569 ' HB2' ' HB ' ' A' ' 74' ' ' ILE . 6.3 t -87.86 178.98 6.55 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.776 0.322 . . . . 0.0 110.158 -177.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . 0.408 ' HA ' HD13 ' B' ' 230' ' ' ILE . 23.0 tptp -66.98 -23.91 65.99 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.293 -170.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -72.0 -50.32 29.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.939 0.399 . . . . 0.0 110.127 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -65.06 -38.64 91.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.784 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.494 HG13 ' O ' ' B' ' 226' ' ' SER . 97.4 mt -54.88 -54.0 27.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.032 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 56.8 m -73.44 -22.08 60.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.76 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -79.88 -44.5 20.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.693 0.282 . . . . 0.0 110.547 -177.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -89.48 -8.59 52.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.97 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt 60.28 51.72 5.32 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.528 -178.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.42 149.66 47.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.874 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . 0.438 HG21 ' HB3' ' B' ' 292' ' ' ASN . 16.0 m -86.46 124.34 40.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.375 0.607 . . . . 0.0 111.491 -177.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -75.6 128.13 34.58 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.511 176.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 40.5 t -92.69 -44.44 13.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.253 0.549 . . . . 0.0 110.337 -179.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 177.11 -157.35 22.21 Favored Glycine 0 N--CA 1.442 -0.94 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.442 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 59.3 m -135.22 137.47 42.65 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 22.7 pt -117.61 142.61 31.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 175.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -132.9 138.5 47.0 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.692 0.758 . . . . 0.0 111.772 -177.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 243' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' B' ' 285' ' ' GLU . 59.7 t -102.75 134.68 43.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.221 177.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 7.2 t -149.21 47.82 0.98 Allowed 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 245' ' ' GLN . . . . . 0.513 ' NE2' HG11 ' B' ' 243' ' ' VAL . 0.9 OUTLIER -103.63 159.22 15.8 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.738 -177.071 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 246' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' B' ' 283' ' ' ASN . 19.1 m -89.18 171.06 10.09 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.247 -177.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -54.61 115.4 5.35 Favored Glycine 0 C--N 1.333 0.389 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.084 176.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . 134.31 -43.57 1.25 Allowed Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 -176.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . 0.459 ' HB2' ' HB3' ' B' ' 245' ' ' GLN . 11.5 mm100 -73.29 -23.81 60.33 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 49.9 mm -114.29 111.63 36.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 171.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 19.7 m -104.03 -19.09 14.31 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.612 -175.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 252' ' ' SER . . . . . 0.483 ' HB3' ' HD2' ' B' ' 253' ' ' PRO . 38.6 m -154.99 163.51 24.21 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -176.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . 0.572 ' HG3' HD21 ' A' ' 35' ' ' LEU . 19.1 Cg_endo -61.64 -41.98 35.7 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.256 1.971 . . . . 0.0 111.246 175.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 254' ' ' SER . . . . . 0.423 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 27.5 m -75.28 -18.74 60.0 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.762 177.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 255' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' B' ' 258' ' ' GLU . 35.2 t70 -71.56 -33.57 69.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.204 0.526 . . . . 0.0 109.723 176.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 63.2 tp -59.44 -43.22 93.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.461 172.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 257' ' ' ARG . . . . . 0.454 ' HD3' ' O ' ' A' ' 22' ' ' ALA . 1.8 tmm_? -62.24 -39.12 91.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.807 178.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 258' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' B' ' 254' ' ' SER . 13.5 mm-40 -52.43 -52.32 54.59 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.911 0.386 . . . . 0.0 110.328 176.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -62.31 -42.86 99.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.128 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 260' ' ' LEU . . . . . 0.495 HD12 ' CE2' ' B' ' 272' ' ' TYR . 96.0 mt -67.9 -43.82 78.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.82 -176.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 17.0 p -64.7 -31.23 72.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.999 0.428 . . . . 0.0 110.683 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -65.73 -42.42 91.04 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.21 178.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 263' ' ' LEU . . . . . . . . . . . . . 94.6 mt -73.21 -37.71 66.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.128 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -59.5 -39.31 83.4 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.575 -178.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -61.29 -40.0 92.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.182 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -74.7 -19.15 60.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.657 -176.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -93.25 -36.18 12.72 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.946 0.403 . . . . 0.0 110.904 179.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 106.13 55.91 0.67 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.559 177.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -142.64 150.8 22.53 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.366 -0.921 . . . . 0.0 111.857 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . 0.907 ' HD3' ' HB2' ' B' ' 293' ' ' ASP . 45.6 mtpt -94.52 -37.81 11.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.426 0.632 . . . . 0.0 110.268 177.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 271' ' ' TYR . . . . . 0.435 ' HB3' HG22 ' B' ' 225' ' ' VAL . 16.7 m-85 -117.75 150.31 39.33 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.747 -172.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 272' ' ' TYR . . . . . 0.495 ' CE2' HD12 ' B' ' 260' ' ' LEU . 21.6 p90 -145.2 155.02 43.01 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 175.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -136.49 109.79 7.85 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -177.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 274' ' ' ILE . . . . . 0.551 ' HB ' ' HB3' ' A' ' 26' ' ' SER . 60.8 mt -65.4 127.2 26.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.076 177.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 22.7 pt -108.25 -28.26 2.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.777 0.322 . . . . 0.0 111.769 -177.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -152.71 108.84 3.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.922 -178.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 277' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' B' ' 286' ' ' ALA . . . -124.53 102.89 7.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.091 0.472 . . . . 0.0 109.921 178.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.53 132.02 54.47 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.543 0.687 . . . . 0.0 111.311 -174.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.1 115.53 15.9 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 171.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 280' ' ' HIS . . . . . 0.457 ' HB2' ' HG3' ' B' ' 285' ' ' GLU . 7.1 t-160 -103.54 25.51 9.6 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.189 0.519 . . . . 0.0 110.109 -171.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 103.35 -106.44 2.86 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.982 -0.627 . . . . 0.0 111.732 -177.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -75.45 -24.57 12.0 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.993 2.462 . . . . 0.0 112.045 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 283' ' ' ASN . . . . . 0.465 ' HA ' ' HA ' ' B' ' 246' ' ' SER . 53.2 m-80 -116.18 148.21 40.61 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.944 -177.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -107.22 115.31 29.94 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.58 176.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 285' ' ' GLU . . . . . 0.551 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 1.0 OUTLIER -101.52 110.85 22.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.959 -175.095 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 286' ' ' ALA . . . . . 0.455 ' HB2' ' HB ' ' B' ' 243' ' ' VAL . . . -125.95 116.52 21.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.782 0.325 . . . . 0.0 111.604 -177.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 46.3 t -103.46 124.47 57.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.328 178.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -130.08 141.2 50.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.929 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -92.47 133.42 35.93 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.046 178.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 44.8 t -98.0 125.06 51.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.622 -178.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -123.68 142.98 50.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.1 0.476 . . . . 0.0 110.581 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 292' ' ' ASN . . . . . 0.438 ' HB3' HG21 ' B' ' 236' ' ' VAL . 14.8 t-20 -92.2 167.33 12.11 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 293' ' ' ASP . . . . . 0.907 ' HB2' ' HD3' ' B' ' 270' ' ' LYS . 13.6 t70 . . . . . 0 C--N 1.328 -0.346 0 CA-C-O 121.143 0.497 . . . . 0.0 110.093 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.486 ' O ' ' HD3' ' B' ' 257' ' ' ARG . . . . . . . . 0 C--O 1.234 0.28 0 N-CA-C 110.456 -0.202 . . . . 0.0 110.456 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 24' ' ' GLN . 8.4 pt-20 -176.46 114.71 0.11 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.107 0.48 . . . . 0.0 112.289 178.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.774 ' HB3' ' CB ' ' B' ' 224' ' ' GLN . 22.2 tm0? 173.81 141.0 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.136 176.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.46 HG23 HD13 ' A' ' 35' ' ' LEU . 31.3 m -120.7 155.08 24.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 121.099 0.476 . . . . 0.0 111.883 -174.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 72.6 p -96.33 -93.09 0.21 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.429 -174.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.473 ' C ' ' HD3' ' A' ' 27' ' ' LYS . 10.8 tmtt? -123.12 -66.61 1.0 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 122.168 -0.333 . . . . 0.0 111.873 -174.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.5 -28.53 69.9 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -170.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -65.32 -42.78 92.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.968 0.414 . . . . 0.0 110.064 176.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.417 HG12 ' CD1' ' A' ' 35' ' ' LEU . 28.0 mt -64.57 -44.94 96.81 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.897 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.3 m -67.35 -30.47 70.3 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.846 -0.341 . . . . 0.0 111.335 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -72.45 -48.25 42.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.583 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.407 ' C ' ' H ' ' A' ' 35' ' ' LEU . 87.0 m-85 -98.68 4.16 47.85 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.324 -176.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt 71.85 -45.95 0.63 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.978 0.911 . . . . 0.0 112.028 177.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.514 HD21 ' HA ' ' A' ' 93' ' ' ASP . 19.3 mt 58.71 164.25 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.208 1.003 . . . . 0.0 112.604 -172.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 76.3 t -97.5 -47.68 12.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.658 -175.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.57 ' HA ' ' HA ' ' A' ' 91' ' ' TYR . 63.5 tttm 70.39 126.49 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 O-C-N 124.159 0.912 . . . . 0.0 111.082 -177.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.0 m -114.28 -30.06 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -175.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 169.47 -161.99 35.51 Favored Glycine 0 C--O 1.227 -0.305 0 C-N-CA 119.303 -1.427 . . . . 0.0 113.656 -178.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.534 HG22 ' HG2' ' A' ' 89' ' ' GLU . 6.4 m -123.07 143.88 49.66 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 122.473 0.309 . . . . 0.0 110.441 -176.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.9 pt -118.92 139.5 46.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 172.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -122.02 114.4 20.9 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.724 -175.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.579 ' HB ' ' HB1' ' A' ' 86' ' ' ALA . 43.0 t -105.63 115.33 47.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 68.7 p -148.28 99.27 3.02 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.731 0.301 . . . . 0.0 110.996 -174.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -142.15 157.11 45.25 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.064 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.583 ' HA ' ' HA ' ' A' ' 83' ' ' ASN . 19.9 t -71.38 173.44 7.85 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 120.666 0.27 . . . . 0.0 110.313 178.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.78 55.16 2.57 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 113.165 -176.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -141.52 -37.3 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 176.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -83.41 -14.81 51.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.09 0.471 . . . . 0.0 110.59 177.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.1 mm -130.34 132.57 64.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 176.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.3 m -134.84 -35.03 0.88 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.055 0.455 . . . . 0.0 111.584 -177.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.583 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 28.1 m -142.11 168.48 13.49 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -177.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.583 ' HD2' ' HB3' ' A' ' 52' ' ' SER . 10.8 Cg_endo -54.55 -31.05 67.93 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.543 2.162 . . . . 0.0 112.637 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.4 m -61.87 -34.51 76.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.664 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -62.88 -52.81 61.65 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.338 0.59 . . . . 0.0 109.881 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 57.4 tp -63.4 -30.37 71.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.276 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -62.08 -31.79 72.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.955 -178.302 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -74.93 -46.87 32.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.8 0.333 . . . . 0.0 110.358 175.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.543 ' HA ' ' HG2' ' A' ' 62' ' ' GLU . 1.9 mptp? -62.97 -40.39 97.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.195 -175.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.3 mt -61.6 -37.12 82.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.824 0.345 . . . . 0.0 110.748 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.534 ' HA ' ' HB3' ' B' ' 222' ' ' ALA . 19.5 m -75.95 -43.28 45.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.45 -178.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.543 ' HG2' ' HA ' ' A' ' 59' ' ' LYS . 16.8 pt-20 -69.44 -36.72 76.93 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 121.151 -0.219 . . . . 0.0 111.221 -175.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 87.4 mt -74.9 -49.36 20.59 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -178.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.24 -44.1 89.27 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -174.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -65.68 -34.9 79.29 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.997 0.427 . . . . 0.0 110.72 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.11 -8.86 57.65 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.428 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -106.48 2.24 26.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.804 176.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.05 58.57 4.31 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.967 178.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -131.17 -178.04 15.23 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.28 178.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -130.29 -37.07 1.45 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.165 0.507 . . . . 0.0 110.007 177.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.551 ' HB3' ' HA ' ' A' ' 24' ' ' GLN . 11.4 m-85 -127.23 169.53 13.39 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.417 ' O ' ' HG2' ' A' ' 24' ' ' GLN . 25.7 p90 -142.63 167.28 22.47 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 173.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -134.45 109.26 8.62 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.818 175.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 54.2 mt -68.65 129.81 33.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.833 176.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.5 pt -123.33 -14.78 5.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.741 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -157.45 107.3 2.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.505 0.193 . . . . 0.0 111.191 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -132.6 105.35 7.16 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.785 0.326 . . . . 0.0 110.187 176.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.439 HH11 ' HD3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -153.47 146.9 24.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.942 -177.529 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -77.79 109.07 11.48 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.636 174.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -101.84 87.95 3.25 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.74 -134.66 13.6 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -175.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -83.61 1.2 9.06 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.65 2.233 . . . . 0.0 112.386 176.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.583 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 44.6 m-80 -115.08 143.15 45.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.051 0.453 . . . . 0.0 111.491 -177.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.505 ' O ' ' HA ' ' A' ' 44' ' ' SER . 66.6 t80 -93.99 120.11 33.79 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.783 176.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -105.26 118.8 37.46 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.512 -177.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.579 ' HB1' ' HB ' ' A' ' 43' ' ' VAL . . . -132.34 115.73 15.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.166 0.507 . . . . 0.0 110.696 176.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 44.6 t -111.81 122.58 66.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.019 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.28 142.09 33.9 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.413 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.534 ' HG2' HG22 ' A' ' 40' ' ' THR . 10.9 mt-10 -103.75 140.24 37.9 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.68 -0.408 . . . . 0.0 109.977 176.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 36.5 t -90.52 125.05 43.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.054 0.454 . . . . 0.0 110.369 -175.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 37' ' ' LYS . 54.9 m-85 -111.5 114.23 27.19 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.657 -178.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -86.36 146.47 26.46 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 171.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.514 ' HA ' HD21 ' A' ' 35' ' ' LEU . 2.7 p-10 . . . . . 0 C--N 1.318 -0.788 0 C-N-CA 121.13 -0.228 . . . . 0.0 110.494 -174.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 222' ' ' ALA . . . . . 0.534 ' HB3' ' HA ' ' A' ' 61' ' ' SER . . . . . . . . 0 C--O 1.236 0.359 0 N-CA-C 110.523 -0.177 . . . . 0.0 110.523 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -170.55 116.65 0.49 Allowed 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 224' ' ' GLN . . . . . 0.774 ' CB ' ' HB3' ' A' ' 24' ' ' GLN . 0.0 OUTLIER 177.31 167.46 0.6 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.449 -1.25 . . . . 0.0 107.96 176.95 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . 0.466 ' H ' ' CD ' ' B' ' 224' ' ' GLN . 27.9 m -121.54 147.17 25.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.3 0.571 . . . . 0.0 111.508 -177.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 84.1 p -105.89 -157.47 0.61 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.487 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . 0.489 ' C ' ' HD3' ' B' ' 227' ' ' LYS . 12.1 tmtt? -67.07 -40.8 87.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.753 0.311 . . . . 0.0 110.277 -178.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -59.19 -49.26 78.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.631 -173.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -63.46 -39.42 94.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.574 -177.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 77.8 mt -59.25 -56.9 14.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.652 0.263 . . . . 0.0 111.358 -177.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 5.7 p -73.31 -21.59 60.53 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -174.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -98.09 -38.76 9.22 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.429 -0.508 . . . . 0.0 112.198 -176.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 233' ' ' PHE . . . . . 0.482 ' CD1' ' HD3' ' A' ' 53' ' ' PRO . 57.7 m-85 -99.4 4.64 46.32 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -174.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt 58.63 40.52 23.39 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.302 0.376 . . . . 0.0 110.915 174.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . 0.455 HD12 HG22 ' B' ' 225' ' ' VAL . 84.7 mt -55.44 150.5 11.64 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.278 0.561 . . . . 0.0 112.456 -173.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 22.1 t -94.08 110.31 23.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.838 -176.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -83.29 114.99 21.77 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 177.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -86.06 -28.93 6.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.457 -178.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 178.44 -170.17 42.11 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.423 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 7.5 m -133.71 140.46 47.03 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 28.1 pt -124.1 148.06 28.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.941 0.401 . . . . 0.0 110.416 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -134.74 142.36 46.73 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.477 0.656 . . . . 0.0 111.533 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 243' ' ' VAL . . . . . 0.627 HG11 ' NE2' ' B' ' 245' ' ' GLN . 67.9 t -106.66 123.64 61.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.695 -178.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 10.6 t -143.05 69.6 1.31 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 176.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 245' ' ' GLN . . . . . 0.627 ' NE2' HG11 ' B' ' 243' ' ' VAL . 1.3 mp0 -109.42 153.43 24.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.97 -174.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 57.8 m -83.06 43.32 0.86 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.49 -174.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . 0.445 ' C ' ' H ' ' B' ' 249' ' ' GLN . . . 78.47 -41.25 2.06 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.922 -0.656 . . . . 0.0 113.731 174.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -73.57 27.63 0.88 Allowed Glycine 0 CA--C 1.519 0.34 0 CA-C-N 116.888 0.344 . . . . 0.0 113.652 -176.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . 0.52 ' HG3' ' HG2' ' B' ' 245' ' ' GLN . 23.8 mm-40 -130.85 -3.62 4.07 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 176.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 44.9 mm -133.71 132.3 56.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.337 -179.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 23.2 m -133.45 -58.26 0.88 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.24 -177.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 252' ' ' SER . . . . . 0.535 ' HB3' ' HD2' ' B' ' 253' ' ' PRO . 7.2 m -113.72 168.87 7.18 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . 0.535 ' HD2' ' HB3' ' B' ' 252' ' ' SER . 11.6 Cg_endo -57.1 -24.47 58.5 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.293 1.996 . . . . 0.0 112.213 175.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 254' ' ' SER . . . . . 0.545 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 1.5 p -70.2 -37.12 75.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.139 176.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -61.93 -37.43 84.66 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.792 0.329 . . . . 0.0 110.895 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 51.9 tp -59.02 -42.01 89.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.52 177.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 257' ' ' ARG . . . . . 0.56 ' C ' ' HD2' ' B' ' 257' ' ' ARG . 3.9 tmm_? -64.13 -47.07 81.39 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.859 177.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 258' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' B' ' 254' ' ' SER . 28.8 mm-40 -54.02 -48.85 70.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.349 -176.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -70.17 -35.25 73.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.732 0.301 . . . . 0.0 111.24 -177.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 81.9 mt -72.66 -40.5 66.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.178 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 17.0 t -68.54 -31.97 71.58 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 177.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -57.36 -51.65 68.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.242 175.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 263' ' ' LEU . . . . . . . . . . . . . 74.5 mt -71.17 -41.18 70.71 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.958 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -63.52 -44.39 94.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.721 -177.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -66.31 -34.21 77.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.896 0.379 . . . . 0.0 110.48 -178.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -68.94 -20.09 64.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.285 0.565 . . . . 0.0 110.821 176.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 4.8 mmpm? -94.81 -2.41 50.93 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.664 176.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 77.35 16.06 80.84 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.168 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . 0.553 ' HA3' ' CG1' ' B' ' 290' ' ' VAL . . . -93.85 148.99 19.24 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.017 -178.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -110.73 3.42 19.15 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.247 0.546 . . . . 0.0 110.073 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 271' ' ' TYR . . . . . 0.696 ' HD1' ' HA ' ' B' ' 224' ' ' GLN . 9.2 m-85 -147.75 141.45 25.61 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 -177.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 272' ' ' TYR . . . . . 0.451 ' CE2' HD13 ' B' ' 274' ' ' ILE . 34.2 p90 -126.66 111.11 13.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.472 0.654 . . . . 0.0 110.06 178.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -92.1 101.75 14.28 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.171 -174.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 274' ' ' ILE . . . . . 0.451 HD13 ' CE2' ' B' ' 272' ' ' TYR . 4.6 mp -72.35 131.59 34.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.82 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 28.4 pt -117.64 -28.45 2.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.727 0.299 . . . . 0.0 111.511 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -156.97 137.84 13.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.832 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -155.51 120.81 4.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.506 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 278' ' ' ARG . . . . . 0.468 ' HE ' ' HB3' ' B' ' 278' ' ' ARG . 0.0 OUTLIER -145.04 155.02 43.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.0 0.428 . . . . 0.0 110.942 -178.853 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -79.19 134.87 36.68 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.208 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -122.01 72.68 1.05 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.001 0.429 . . . . 0.0 110.059 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 64.11 -120.38 19.54 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.659 -177.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.11 -2.3 12.27 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.737 2.292 . . . . 0.0 112.259 176.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -114.41 166.08 12.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.28 -177.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -129.39 122.28 29.12 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.936 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 285' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -105.28 119.7 39.72 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.32 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 286' ' ' ALA . . . . . 0.525 ' HB1' ' HB ' ' B' ' 243' ' ' VAL . . . -136.68 146.83 46.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.692 0.282 . . . . 0.0 111.154 177.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 37.0 t -128.79 128.86 68.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 177.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -137.27 144.92 42.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.004 0.43 . . . . 0.0 110.988 -179.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 289' ' ' GLU . . . . . 0.41 ' HB2' ' HE1' ' B' ' 291' ' ' TYR . 25.5 mt-10 -96.1 150.09 20.89 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.891 178.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 290' ' ' VAL . . . . . 0.553 ' CG1' ' HA3' ' B' ' 269' ' ' GLY . 12.8 t -111.93 123.97 68.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 291' ' ' TYR . . . . . 0.41 ' HE1' ' HB2' ' B' ' 289' ' ' GLU . 65.9 m-85 -124.29 151.69 43.94 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.229 0.538 . . . . 0.0 111.618 -177.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 292' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -117.65 161.4 19.72 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.105 170.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.467 0.402 0 O-C-N 123.439 0.462 . . . . 0.0 111.551 175.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.48 1.069 0 CA-C-O 120.584 0.23 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -83.64 100.91 11.14 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -92.98 109.35 20.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.009 -175.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 70.5 mtt-85 -124.36 108.67 12.43 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.883 176.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 pp -73.36 95.09 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.685 0.755 . . . . 0.0 111.277 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 27.6 pt -128.5 -176.72 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.22 -175.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 68.39 107.88 0.05 Allowed 'General case' 0 N--CA 1.465 0.293 0 O-C-N 124.09 0.869 . . . . 0.0 112.274 175.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -144.43 109.37 5.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.069 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -116.3 113.15 22.58 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.963 0.411 . . . . 0.0 111.22 -175.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -102.15 34.67 2.64 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.318 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.3 mt -65.4 124.92 23.55 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.723 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -147.32 143.32 27.96 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.278 -177.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.6 m 73.62 115.61 0.06 Allowed 'General case' 0 C--O 1.233 0.22 0 O-C-N 124.048 0.843 . . . . 0.0 112.656 175.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.3 p -143.78 88.42 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.109 172.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.479 ' HB1' ' CE2' ' A' ' 17' ' ' PHE . . . -93.84 119.83 33.3 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.293 -172.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.1 p -103.57 88.71 3.15 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.423 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.479 ' CE2' ' HB1' ' A' ' 15' ' ' ALA . 71.8 m-85 -108.17 -80.45 0.57 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.399 177.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.5 m 54.92 22.12 4.1 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 123.722 0.639 . . . . 0.0 111.689 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.7 m -83.64 90.64 7.31 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.012 0.434 . . . . 0.0 110.221 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 61.6 mt -99.64 -163.73 1.06 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.635 -176.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -135.5 159.81 40.43 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 177.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.528 ' O ' ' HB3' ' B' ' 261' ' ' SER . . . 70.65 108.31 0.06 Allowed 'General case' 0 N--CA 1.465 0.282 0 O-C-N 124.085 0.866 . . . . 0.0 110.823 -177.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.493 ' HG2' ' HB2' ' B' ' 221' ' ' ALA . 2.2 tp10 -147.0 -138.88 0.09 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -176.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.651 ' HB2' ' H ' ' B' ' 223' ' ' GLU . 0.0 OUTLIER 72.73 156.73 0.17 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 122.6 0.36 . . . . 0.0 111.64 176.348 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.3 m -114.5 147.72 17.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 121.055 0.455 . . . . 0.0 110.905 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.42 ' O ' HG13 ' A' ' 30' ' ' ILE . 19.9 t -100.29 -166.79 1.36 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.28 0.562 . . . . 0.0 111.017 -177.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -66.5 -44.1 83.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.535 -173.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.627 ' HG2' ' OE1' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -63.59 -44.72 93.19 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.891 -173.736 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.627 ' OE1' ' HG2' ' A' ' 28' ' ' GLN . 2.3 mp0 -62.98 -40.95 99.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.619 0.247 . . . . 0.0 110.846 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 26' ' ' SER . 97.4 mt -59.01 -49.9 81.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.841 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.3 t -73.43 -24.85 60.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.362 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.426 ' HB2' ' O ' ' A' ' 28' ' ' GLN . 33.7 t-80 -85.92 -57.81 2.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.686 0.279 . . . . 0.0 111.287 -174.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -81.77 -10.74 59.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.193 -175.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt 59.54 76.43 0.36 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.338 0.59 . . . . 0.0 110.113 -175.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.1 mt -82.39 159.39 23.01 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.892 -176.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.519 HG11 ' HE3' ' A' ' 96' ' ' LYS . 48.1 t -81.88 111.71 18.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.081 -176.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.54 ' HD3' ' CE2' ' A' ' 91' ' ' TYR . 15.0 tptm -71.5 111.19 6.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.67 175.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.401 HG21 ' HB ' ' A' ' 90' ' ' VAL . 3.2 m -104.66 6.95 10.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.871 0.367 . . . . 0.0 111.667 -176.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 133.37 -168.44 23.08 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.549 175.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 47.7 m -136.54 132.93 35.88 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.4 pt -111.43 134.22 54.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.257 0.551 . . . . 0.0 110.861 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -114.62 121.05 42.22 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.565 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.563 ' HB ' ' HB1' ' A' ' 86' ' ' ALA . 24.3 t -93.35 107.51 19.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.8 t -110.62 110.54 21.28 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.549 -176.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.5 ' HG2' HG12 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -116.79 152.63 33.99 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.236 -176.53 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.8 t -126.03 124.79 41.46 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.875 -0.416 . . . . 0.0 109.875 175.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.33 -145.92 25.79 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.456 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.84 52.53 0.72 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.877 -175.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.455 ' HB2' ' CG ' ' A' ' 45' ' ' GLN . 14.5 mm100 -71.96 -41.79 67.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.298 0.571 . . . . 0.0 109.619 175.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.534 HG21 ' HB2' ' A' ' 55' ' ' ASP . 49.3 mm -97.93 125.4 51.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.73 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.1 m -103.26 -39.74 6.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.199 -176.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.42 ' HB2' ' HD2' ' A' ' 53' ' ' PRO . 51.4 p -131.87 162.56 55.72 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.462 -176.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.42 ' HD2' ' HB2' ' A' ' 52' ' ' SER . 17.0 Cg_endo -57.49 -27.02 74.53 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.633 2.222 . . . . 0.0 111.44 176.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.579 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 2.5 m -59.08 -45.92 89.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.545 177.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.534 ' HB2' HG21 ' A' ' 50' ' ' ILE . 36.2 m-20 -64.85 -35.84 82.43 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.561 -178.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 67.2 tp -61.46 -47.2 86.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.847 175.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.403 HH22 ' HB3' ' B' ' 298' ' ' GLU . 7.4 ttm180 -58.08 -41.12 82.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.068 177.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.579 ' HG2' ' O ' ' A' ' 54' ' ' SER . 14.1 mm-40 -55.6 -50.47 70.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.281 0.562 . . . . 0.0 110.68 177.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 59' ' ' LYS . 73.2 mmtt -69.71 -35.14 74.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.323 -177.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.2 mt -62.58 -44.32 96.61 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.54 176.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.7 t -66.6 -39.83 88.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.068 0.461 . . . . 0.0 110.237 177.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -57.03 -48.72 77.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.905 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 87.4 mt -71.83 -40.49 69.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.618 -176.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.62 -38.11 89.89 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -176.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -59.56 -42.71 93.05 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.271 0.558 . . . . 0.0 110.336 178.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.73 -7.78 58.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.425 -177.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.424 ' HD3' ' HA ' ' A' ' 67' ' ' LYS . 30.2 mmtm -97.38 -19.98 18.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.788 0.328 . . . . 0.0 111.408 178.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.79 34.47 9.06 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.335 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.45 ' HA3' HG11 ' A' ' 90' ' ' VAL . . . -129.32 138.49 10.28 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 177.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.716 ' HA ' ' HB2' ' B' ' 220' ' ' LEU . 87.9 mttt -85.01 -28.99 25.35 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.74 0.27 . . . . 0.0 111.463 -174.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -129.56 141.3 51.0 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -176.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.572 ' CD2' ' HB3' ' B' ' 222' ' ' ALA . 13.8 p90 -105.07 168.0 9.34 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 171.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -138.94 105.84 5.41 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.907 172.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 33.5 mt -69.96 124.5 26.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.238 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 31.4 pt -110.94 -17.59 8.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.989 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -171.89 101.22 0.18 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.509 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.551 ' HA ' ' HA ' ' A' ' 86' ' ' ALA . . . -107.69 101.64 10.93 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 171.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -136.96 167.1 22.13 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.104 0.478 . . . . 0.0 111.373 -172.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -90.37 145.58 24.84 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.821 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -129.35 80.53 1.97 Allowed 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 173.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.5 -117.73 9.2 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.827 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -83.12 -2.2 10.64 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.812 2.341 . . . . 0.0 112.045 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -112.42 165.04 12.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.989 -177.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -125.89 121.92 34.57 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.046 175.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -117.23 111.01 18.83 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.866 0.365 . . . . 0.0 110.579 -176.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.563 ' HB1' ' HB ' ' A' ' 43' ' ' VAL . . . -110.59 116.32 31.15 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.08 0.467 . . . . 0.0 110.495 176.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.6 t -102.39 118.17 48.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.311 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -135.94 136.65 40.6 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.592 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.538 ' HB3' ' HE3' ' A' ' 37' ' ' LYS . 40.9 mt-10 -91.83 149.87 21.36 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.45 HG11 ' HA3' ' A' ' 69' ' ' GLY . 5.6 t -107.48 132.72 54.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.35 -177.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.54 ' CE2' ' HD3' ' A' ' 37' ' ' LYS . 95.8 m-85 -133.21 146.3 51.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.162 0.506 . . . . 0.0 111.196 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -123.31 160.47 26.62 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.402 176.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -56.46 145.74 26.73 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 120.673 0.273 . . . . 0.0 110.814 -177.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.56 70.75 1.32 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.279 0.561 . . . . 0.0 110.39 177.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.441 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 8.7 t -175.26 -26.37 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.42 -177.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.519 ' HE3' HG11 ' A' ' 36' ' ' VAL . 28.4 mmtp 73.49 -0.83 3.25 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 122.996 0.519 . . . . 0.0 112.371 175.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 87.7 mt -99.88 -169.82 1.8 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.731 0.301 . . . . 0.0 110.441 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.63 ' CD ' ' H ' ' A' ' 99' ' ' HIS . 0.6 OUTLIER -139.46 -172.21 3.31 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -178.382 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.63 ' H ' ' CD ' ' A' ' 98' ' ' GLU . 32.8 t60 -82.77 1.61 38.06 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.228 0.537 . . . . 0.0 109.738 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -115.04 155.85 26.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.284 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -115.5 117.42 30.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.63 0.252 . . . . 0.0 110.997 -178.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 72.69 125.77 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.366 -0.834 . . . . 0.0 113.131 174.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -140.84 -42.29 0.39 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 168.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 . . . . . 0 C--N 1.324 -0.527 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.699 174.281 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . 0.554 ' HG3' ' H ' ' B' ' 203' ' ' LYS . 38.7 tptt 66.56 177.13 0.23 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.24 -178.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . 0.554 ' H ' ' HG3' ' B' ' 202' ' ' LYS . 56.2 mtpt -121.11 171.69 8.5 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 177.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 62.09 95.41 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.931 0.769 . . . . 0.0 110.207 -176.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 10.4 tt -104.41 -36.31 3.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.132 -176.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 48.7 mm 68.74 109.04 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 O-C-N 123.563 0.539 . . . . 0.0 111.004 -177.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -77.14 176.66 8.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.036 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -82.96 30.84 0.44 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.981 0.42 . . . . 0.0 111.322 -177.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -79.84 -24.58 41.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.143 177.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 210' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -82.68 113.71 20.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.349 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 87.7 mt -67.79 -29.02 68.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.356 -175.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -119.26 102.34 8.63 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.932 0.396 . . . . 0.0 111.141 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 213' ' ' THR . . . . . . . . . . . . . 33.4 p -110.5 102.93 11.5 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.831 175.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 214' ' ' VAL . . . . . . . . . . . . . 28.9 m -112.85 135.62 51.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.167 0.508 . . . . 0.0 111.624 -175.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -139.88 120.29 14.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.466 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 50.8 m -96.05 -175.81 3.5 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.182 176.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 217' ' ' PHE . . . . . 0.48 ' HD2' ' H ' ' B' ' 218' ' ' SER . 2.5 p90 41.54 -99.38 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.772 0.829 . . . . 0.0 112.734 -176.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 218' ' ' SER . . . . . 0.48 ' H ' ' HD2' ' B' ' 217' ' ' PHE . 45.6 m 62.22 27.43 16.46 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 122.74 0.416 . . . . 0.0 111.673 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 6.4 t 39.5 87.81 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.274 1.029 . . . . 0.0 113.282 178.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.716 ' HB2' ' HA ' ' A' ' 70' ' ' LYS . 2.4 pt? -68.71 165.94 18.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.351 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . 0.493 ' HB2' ' HG2' ' A' ' 23' ' ' GLU . . . -135.47 69.17 1.44 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.444 176.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . 0.572 ' HB3' ' CD2' ' A' ' 72' ' ' TYR . . . -113.08 118.32 34.44 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.585 -175.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . 0.651 ' H ' ' HB2' ' A' ' 24' ' ' GLN . 40.5 tt0 -172.88 101.83 0.13 Allowed 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -176.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 224' ' ' GLN . . . . . 0.61 ' HA ' ' HD1' ' B' ' 271' ' ' TYR . 0.0 OUTLIER -174.04 158.71 3.15 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 122.919 0.488 . . . . 0.0 109.807 175.754 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . 0.476 HG21 ' CD1' ' B' ' 235' ' ' LEU . 24.1 m -117.03 146.11 21.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 120.543 0.211 . . . . 0.0 110.672 178.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 78.1 p -91.49 -166.8 1.65 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.952 0.406 . . . . 0.0 110.67 -177.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -67.13 -29.17 68.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.173 -176.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -73.02 -50.87 20.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.072 -174.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -59.8 -39.11 83.89 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.048 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 87.8 mt -60.4 -49.22 85.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.781 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 15.2 m -72.82 -32.2 65.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.093 -177.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -78.76 -55.18 5.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.455 -175.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -83.23 -23.44 32.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.562 -174.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm 64.34 80.81 0.22 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.424 0.631 . . . . 0.0 110.308 -176.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . 0.476 ' CD1' HG21 ' B' ' 225' ' ' VAL . 63.1 mt -83.79 -178.41 7.0 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.108 -175.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 44.5 t -100.12 109.71 25.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.11 178.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 52.6 tttm -82.0 114.01 20.28 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 238' ' ' VAL . . . . . 0.5 HG22 ' HB ' ' B' ' 290' ' ' VAL . 14.5 m -104.36 7.57 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -170.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 131.34 -153.38 20.37 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 119.934 -1.127 . . . . 0.0 113.499 175.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 240' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' B' ' 289' ' ' GLU . 6.9 m -137.95 141.43 40.54 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 122.205 0.202 . . . . 0.0 110.846 -175.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 37.4 pt -127.67 148.65 32.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 171.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -144.54 141.0 29.18 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.559 0.695 . . . . 0.0 111.717 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 243' ' ' VAL . . . . . 0.603 ' O ' ' HA ' ' B' ' 285' ' ' GLU . 61.3 t -92.99 129.54 43.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.284 176.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 5.8 t -153.07 74.99 1.06 Allowed 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 245' ' ' GLN . . . . . 0.551 ' HB3' ' HG3' ' B' ' 249' ' ' GLN . 0.8 OUTLIER -116.7 168.36 10.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.646 -177.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 246' ' ' SER . . . . . 0.421 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 21.0 p -83.77 101.12 11.37 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.727 -177.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 42.62 -92.04 0.01 OUTLIER Glycine 0 N--CA 1.463 0.48 0 N-CA-C 115.817 1.087 . . . . 0.0 115.817 167.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -71.71 10.92 3.66 Favored Glycine 0 CA--C 1.519 0.329 0 N-CA-C 114.809 0.683 . . . . 0.0 114.809 -168.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . 0.551 ' HG3' ' HB3' ' B' ' 245' ' ' GLN . 13.3 mm100 -73.24 -21.1 60.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.664 0.732 . . . . 0.0 110.012 175.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 250' ' ' ILE . . . . . 0.401 HD11 ' HA ' ' B' ' 256' ' ' LEU . 46.9 mm -114.89 103.08 14.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.49 178.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 41.2 t -88.97 -16.9 30.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.653 0.264 . . . . 0.0 111.416 -177.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 252' ' ' SER . . . . . 0.548 ' HB2' ' HD2' ' B' ' 253' ' ' PRO . 89.4 p -163.92 165.78 13.07 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -178.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . 0.548 ' HD2' ' HB2' ' B' ' 252' ' ' SER . 9.4 Cg_endo -52.56 -32.0 51.79 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.821 2.347 . . . . 0.0 112.243 176.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 254' ' ' SER . . . . . 0.492 ' O ' ' HG3' ' B' ' 258' ' ' GLU . 5.1 m -59.28 -47.43 85.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.35 177.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.07 -43.71 74.15 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.879 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . 0.401 ' HA ' HD11 ' B' ' 250' ' ' ILE . 57.4 tp -57.7 -56.17 25.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.426 -175.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 257' ' ' ARG . . . . . 0.533 ' HA ' HD11 ' B' ' 260' ' ' LEU . 6.3 ppt_? -66.69 -31.18 71.68 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.34 -176.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 258' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' B' ' 254' ' ' SER . 44.2 mt-10 -63.14 -26.78 68.98 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.868 0.366 . . . . 0.0 111.03 177.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 259' ' ' LYS . . . . . 0.429 ' HA ' ' HD3' ' B' ' 259' ' ' LYS . 66.1 mmtt -88.28 -22.91 23.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.93 0.395 . . . . 0.0 110.52 177.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 260' ' ' LEU . . . . . 0.533 HD11 ' HA ' ' B' ' 257' ' ' ARG . 89.2 mt -74.13 -48.42 29.57 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.501 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 261' ' ' SER . . . . . 0.528 ' HB3' ' O ' ' A' ' 22' ' ' ALA . 2.7 p -65.78 -30.99 71.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.862 0.363 . . . . 0.0 110.542 176.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -56.48 -45.4 80.96 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.053 175.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 263' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' B' ' 259' ' ' LYS . 84.1 mt -74.74 -34.52 62.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.843 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -64.31 -38.7 91.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.214 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -62.95 -43.86 97.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.694 177.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -64.01 -34.38 77.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.635 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 12.8 mmtt -73.03 -46.94 49.03 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.852 177.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 99.23 32.8 5.67 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -176.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -104.48 171.99 19.89 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.568 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -111.83 -24.86 9.76 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.851 0.358 . . . . 0.0 111.423 -177.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 271' ' ' TYR . . . . . 0.61 ' HD1' ' HA ' ' B' ' 224' ' ' GLN . 24.0 m-85 -144.01 160.52 40.72 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 272' ' ' TYR . . . . . 0.421 ' HH ' ' HA ' ' A' ' 23' ' ' GLU . 38.9 p90 -137.55 129.17 28.41 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.047 0.451 . . . . 0.0 110.068 173.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -98.46 102.59 14.38 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.914 -177.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 274' ' ' ILE . . . . . 0.485 HG12 ' HB3' ' B' ' 288' ' ' ALA . 57.0 mt -67.25 129.74 32.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.821 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 19.0 pt -116.97 -26.84 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.807 -176.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -144.49 139.95 28.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.157 -177.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -154.79 117.5 4.34 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.222 177.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.91 156.77 36.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.928 0.394 . . . . 0.0 110.78 -177.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -88.8 117.43 27.79 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 167.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -92.77 14.48 17.15 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.492 0.663 . . . . 0.0 109.976 -175.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 129.93 -119.96 2.98 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 -175.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.93 -13.3 15.92 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.445 2.097 . . . . 0.0 111.765 173.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -106.82 142.96 35.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.665 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -104.1 130.8 51.82 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 285' ' ' GLU . . . . . 0.603 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 52.1 mt-10 -118.96 122.06 41.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.278 -176.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 286' ' ' ALA . . . . . 0.458 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -132.67 116.25 16.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.167 174.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 40.4 t -109.02 127.53 65.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.81 0.338 . . . . 0.0 111.067 -174.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 288' ' ' ALA . . . . . 0.485 ' HB3' HG12 ' B' ' 274' ' ' ILE . . . -139.25 133.53 31.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.957 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 289' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' B' ' 240' ' ' THR . 31.9 mt-10 -93.06 135.39 34.28 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 290' ' ' VAL . . . . . 0.5 ' HB ' HG22 ' B' ' 238' ' ' VAL . 3.8 t -92.96 138.87 19.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.037 0.446 . . . . 0.0 111.27 -168.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -130.02 149.38 51.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.478 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 292' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -114.68 159.78 20.11 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 171.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -57.61 -95.16 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.492 0.663 . . . . 0.0 112.116 -174.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 294' ' ' ALA . . . . . . . . . . . . . . . -130.8 4.94 4.58 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.799 0.809 . . . . 0.0 109.147 176.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 295' ' ' THR . . . . . . . . . . . . . 14.5 t -161.49 -176.43 5.34 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.151 -1.386 . . . . 0.0 107.611 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 29.7 ttpp -86.47 99.46 11.67 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.308 -176.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 297' ' ' LEU . . . . . . . . . . . . . 94.7 mt 71.76 107.58 0.07 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.993 171.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 298' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' B' ' 299' ' ' HIS . 4.4 tm-20 -86.29 157.72 19.85 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 172.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 299' ' ' HIS . . . . . 0.453 ' HB2' ' O ' ' B' ' 298' ' ' GLU . 47.0 m-70 71.9 87.76 0.11 Allowed 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.344 0.658 . . . . 0.0 110.279 -172.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 300' ' ' HIS . . . . . . . . . . . . . 11.8 p80 -78.72 37.17 0.28 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.747 -1.115 . . . . 0.0 113.218 -171.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 301' ' ' HIS . . . . . . . . . . . . . 23.4 t60 -147.53 78.19 1.46 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.948 0.404 . . . . 0.0 110.107 171.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 302' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -153.71 18.72 0.53 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.065 177.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -80.24 137.44 36.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.476 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 15.5 p80 . . . . . 0 C--N 1.322 -0.621 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.349 -177.997 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.1 tpp . . . . . 0 N--CA 1.482 1.144 0 CA-C-O 120.626 0.251 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.412 ' HE2' ' HB3' ' A' ' 2' ' ' LYS . 45.6 mtpt -113.21 -38.53 4.41 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 175.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -74.52 93.3 2.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.099 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -68.57 119.45 13.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.879 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.4 pp -84.49 165.67 2.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.323 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.2 pt -106.41 100.47 10.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.407 0.623 . . . . 0.0 111.513 -177.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -138.54 134.46 33.91 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.068 178.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -81.05 -35.61 31.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.036 -176.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 60.16 69.89 0.67 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.04 -178.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 36.7 tp -84.83 96.54 9.33 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.114 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.3 mt -76.4 -44.97 33.78 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.339 -177.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.07 72.59 0.46 Allowed 'General case' 0 N--CA 1.465 0.318 0 O-C-N 123.761 0.663 . . . . 0.0 111.02 -177.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.5 m -125.76 140.93 52.27 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.842 -175.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.6 p -61.97 141.47 17.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.15 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.61 108.76 4.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.058 177.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.3 m -84.15 -37.35 22.04 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.225 -176.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -156.18 154.8 31.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.455 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.8 m -124.56 109.57 13.38 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.613 177.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.1 p -76.93 -41.04 44.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.069 0.461 . . . . 0.0 110.957 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 54.1 tp -132.47 107.68 8.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.54 176.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.637 ' HB1' ' HA ' ' B' ' 270' ' ' LYS . . . -168.12 133.1 1.78 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.235 -178.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.612 ' HB2' ' CD2' ' B' ' 272' ' ' TYR . . . 64.04 86.89 0.12 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.942 173.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.926 ' HB3' ' HE1' ' A' ' 71' ' ' TYR . 26.8 mt-10 -149.28 105.28 3.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.683 -179.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.553 ' CB ' ' HB2' ' B' ' 224' ' ' GLN . 0.0 OUTLIER -162.3 156.1 21.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.262 178.844 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.0 m -101.69 128.32 54.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.037 0.446 . . . . 0.0 110.887 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.534 ' O ' HG13 ' A' ' 30' ' ' ILE . 1.5 m -64.99 151.33 46.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.877 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.527 ' HB2' ' CE1' ' A' ' 73' ' ' HIS . 88.7 tttt -57.85 -40.52 80.31 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.128 0.489 . . . . 0.0 109.724 176.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -61.14 -39.06 88.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.408 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.543 ' HA ' ' HB3' ' A' ' 32' ' ' HIS . 20.6 mm-40 -76.94 -26.98 54.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.503 -177.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.534 HG13 ' O ' ' A' ' 26' ' ' SER . 86.0 mt -60.88 -45.07 98.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 173.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.4 m -73.42 -31.83 64.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.879 175.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.543 ' HB3' ' HA ' ' A' ' 29' ' ' GLU . 23.7 t-160 -65.82 -54.86 21.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.286 -177.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -92.67 -8.74 43.16 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.376 -177.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm 59.31 70.56 0.64 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.452 0.644 . . . . 0.0 110.592 -178.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 94.1 mt -76.31 163.0 27.44 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.306 -176.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.458 HG21 ' HA ' ' A' ' 94' ' ' ALA . 85.1 t -93.37 126.42 45.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.271 -177.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.537 ' HE3' ' HB3' ' A' ' 89' ' ' GLU . 21.7 tptm -70.12 116.76 10.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.651 175.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.2 m -122.84 26.0 3.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -174.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.12 -175.36 16.94 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.109 -1.043 . . . . 0.0 113.252 174.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 61.7 m -135.29 129.55 33.72 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 30.5 pt -104.48 138.62 28.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 175.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -135.02 122.23 21.54 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.197 0.522 . . . . 0.0 111.092 -173.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 59.0 t -93.45 121.69 44.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.062 176.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.2 t -141.23 30.79 1.76 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.752 0.786 . . . . 0.0 109.134 -177.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -91.24 160.55 15.47 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.773 -175.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.2 t -64.06 157.84 24.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.075 176.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.06 -20.14 33.5 Favored Glycine 0 C--O 1.228 -0.271 0 CA-C-N 116.039 -0.528 . . . . 0.0 113.314 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.26 -20.64 75.28 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.884 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -101.46 -2.04 31.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.893 0.377 . . . . 0.0 110.88 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.1 mm -130.8 75.23 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 171.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.0 t -96.46 -14.01 22.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.875 -168.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.1 m -155.43 160.0 31.22 Favored Pre-proline 0 C--N 1.322 -0.598 0 O-C-N 122.365 -0.209 . . . . 0.0 110.784 -176.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.5 -36.26 86.98 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.589 2.193 . . . . 0.0 111.623 175.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.56 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 0.1 OUTLIER -63.27 -44.36 95.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.648 0.737 . . . . 0.0 109.698 174.071 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -64.38 -27.74 69.21 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.136 -177.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.6 tp -61.59 -52.68 63.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.683 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -65.79 -28.13 68.79 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.432 -176.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.56 ' HG2' ' O ' ' A' ' 54' ' ' SER . 38.8 mm-40 -62.6 -34.62 77.38 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.974 0.416 . . . . 0.0 110.223 -178.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -83.25 -38.33 22.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.764 176.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.813 HD11 ' HH ' ' A' ' 72' ' ' TYR . 96.3 mt -61.78 -48.48 80.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.255 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.2 p -64.52 -36.4 84.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.021 0.439 . . . . 0.0 110.473 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -64.29 -40.38 95.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.193 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 86.2 mt -69.54 -44.79 70.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.9 177.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.61 -37.33 83.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.99 0.424 . . . . 0.0 110.652 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.706 ' HA ' HG23 ' B' ' 219' ' ' THR . 22.8 t70 -66.68 -37.78 85.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.808 177.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.9 -34.96 78.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.772 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -80.65 -45.03 17.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.177 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 118.24 41.88 0.62 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.534 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.498 ' HA3' ' CG1' ' A' ' 90' ' ' VAL . . . -124.38 151.68 17.26 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.413 -0.899 . . . . 0.0 113.043 -177.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -81.04 -43.58 19.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.834 0.35 . . . . 0.0 110.44 176.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.926 ' HE1' ' HB3' ' A' ' 23' ' ' GLU . 78.9 m-85 -137.96 175.61 9.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.264 -174.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.813 ' HH ' HD11 ' A' ' 60' ' ' LEU . 0.6 OUTLIER -149.85 168.25 24.28 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -177.13 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.527 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 19.2 t-80 -135.05 126.1 27.79 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.49 -0.484 . . . . 0.0 109.812 172.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.0 mp -72.77 123.37 27.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.017 -178.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 33.1 pt -104.88 -31.13 2.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.386 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.469 ' HB3' ' NH1' ' A' ' 78' ' ' ARG . . . -161.82 117.9 2.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.025 -177.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -131.92 122.28 25.37 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.385 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.469 ' NH1' ' HB3' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -156.46 142.24 17.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.044 0.449 . . . . 0.0 110.888 -178.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -72.07 145.62 48.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.905 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -139.6 100.38 3.95 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 61.97 -123.87 32.57 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.991 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -88.29 6.6 4.8 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.994 2.463 . . . . 0.0 112.569 178.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -119.76 158.92 25.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.046 0.45 . . . . 0.0 111.123 -176.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -113.57 111.65 22.23 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.564 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.55 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 25.9 mm-40 -96.26 111.45 23.51 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.612 -176.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.507 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -124.99 115.17 20.13 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.754 177.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.2 t -105.64 124.86 60.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.499 -178.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.442 ' CB ' ' HD2' ' A' ' 72' ' ' TYR . . . -141.0 149.2 41.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.2 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.537 ' HB3' ' HE3' ' A' ' 37' ' ' LYS . 7.4 mt-10 -108.67 143.61 37.54 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.263 -178.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.498 ' CG1' ' HA3' ' A' ' 69' ' ' GLY . 11.4 t -95.04 137.57 23.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.642 -172.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -133.71 136.98 45.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.894 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -122.42 172.78 8.09 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.578 176.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -61.16 161.4 8.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.673 177.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.458 ' HA ' HG21 ' A' ' 36' ' ' VAL . . . -83.4 14.79 3.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.684 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.8 t -131.95 139.07 48.57 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.269 -178.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.513 ' HB3' ' HB1' ' B' ' 215' ' ' ALA . 0.1 OUTLIER -124.82 125.09 43.45 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 17.3 mt -139.55 6.68 2.3 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.41 -0.516 . . . . 0.0 112.328 -168.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.557 ' OE2' ' HB3' ' B' ' 215' ' ' ALA . 5.3 pm0 -90.35 79.33 6.32 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 122.173 0.987 . . . . 0.0 110.389 176.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -66.99 123.82 21.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.467 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -144.11 -178.61 6.03 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.091 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -56.14 133.12 51.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.698 -176.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -73.88 80.44 1.64 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.562 175.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 31.4 t-80 -80.49 143.35 33.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.939 -176.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 7.0 p-80 . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.857 173.985 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 201' ' ' MET . . . . . 0.425 ' N ' ' SD ' ' B' ' 201' ' ' MET . 1.6 mpt? . . . . . 0 N--CA 1.48 1.054 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -131.49 22.3 4.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.182 0.515 . . . . 0.0 110.544 -173.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -71.97 103.57 3.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.515 0.674 . . . . 0.0 110.668 178.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -147.16 105.37 3.76 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.285 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 8.1 tp -120.01 132.65 69.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.337 0.589 . . . . 0.0 111.079 -174.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 21.3 pt -121.67 129.26 75.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.753 176.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -96.37 8.16 44.68 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.349 -176.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -62.95 133.33 54.46 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.639 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -87.3 -175.28 5.22 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.926 -177.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 210' ' ' LEU . . . . . 0.85 ' HG ' ' H ' ' B' ' 211' ' ' LEU . 21.1 tp 66.71 -169.25 0.2 Allowed 'General case' 0 CA--C 1.534 0.344 0 O-C-N 123.699 0.624 . . . . 0.0 110.294 178.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . 0.85 ' H ' ' HG ' ' B' ' 210' ' ' LEU . 83.2 mt 60.01 43.88 14.0 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.158 0.504 . . . . 0.0 110.964 -178.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -84.23 144.15 29.12 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 173.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 213' ' ' THR . . . . . . . . . . . . . 19.0 m -148.92 -68.91 0.22 Allowed 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.725 -176.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 214' ' ' VAL . . . . . . . . . . . . . 30.6 m -109.07 171.99 2.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.266 0.555 . . . . 0.0 111.756 -174.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . 0.557 ' HB3' ' OE2' ' A' ' 98' ' ' GLU . . . -101.27 -169.29 1.67 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.491 176.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 50.9 m -157.16 -81.4 0.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -177.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -143.93 162.92 34.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.762 0.315 . . . . 0.0 111.063 -175.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 218' ' ' SER . . . . . . . . . . . . . 71.1 m -150.28 129.74 12.99 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.168 176.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 219' ' ' THR . . . . . 0.706 HG23 ' HA ' ' A' ' 65' ' ' ASP . 57.9 p -101.38 157.28 16.91 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.651 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 26.2 tp -143.27 -74.52 0.27 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.272 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -144.95 -78.47 0.19 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 121.266 -0.173 . . . . 0.0 111.359 -177.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . 0.414 ' HB2' ' CD1' ' A' ' 72' ' ' TYR . . . 71.03 92.69 0.08 Allowed 'General case' 0 N--CA 1.463 0.222 0 O-C-N 124.008 0.817 . . . . 0.0 111.588 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -161.12 125.5 3.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.839 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 224' ' ' GLN . . . . . 0.553 ' HB2' ' CB ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -159.3 167.97 27.59 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.782 176.845 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . 0.425 HG12 HD11 ' B' ' 235' ' ' LEU . 6.8 m -135.18 123.63 39.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.984 0.421 . . . . 0.0 110.353 174.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 226' ' ' SER . . . . . 0.416 ' O ' HG13 ' B' ' 230' ' ' ILE . 9.3 t -105.72 -171.72 1.96 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.581 178.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . 0.417 ' HE2' ' CA ' ' B' ' 227' ' ' LYS . 0.0 OUTLIER -55.33 -33.83 63.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.769 -175.092 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -70.74 -49.65 44.56 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.264 0.554 . . . . 0.0 110.365 -176.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 229' ' ' GLU . . . . . 0.402 ' O ' ' HD1' ' B' ' 233' ' ' PHE . 1.8 mp0 -72.13 -48.44 43.66 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.459 -176.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.516 HG12 HD13 ' B' ' 235' ' ' LEU . 89.9 mt -54.54 -49.68 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 -174.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 59.1 m -72.56 -21.17 61.2 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -176.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -89.12 -35.92 16.01 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.893 -177.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . 0.402 ' HD1' ' O ' ' B' ' 229' ' ' GLU . 81.7 m-85 -89.9 -15.02 32.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.377 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 234' ' ' LYS . . . . . 0.445 ' HB3' ' HE3' ' B' ' 234' ' ' LYS . 25.9 mmmt 59.79 77.55 0.31 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.225 0.536 . . . . 0.0 111.545 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . 0.516 HD13 HG12 ' B' ' 230' ' ' ILE . 94.4 mt -88.21 163.46 16.13 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.389 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 47.4 t -96.28 118.36 42.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.82 178.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -91.29 111.97 23.69 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 238' ' ' VAL . . . . . 0.42 HG22 ' HB ' ' B' ' 290' ' ' VAL . 2.6 m -90.28 -25.01 5.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -176.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 161.8 -156.29 27.78 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.046 -1.073 . . . . 0.0 112.863 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 87.4 m -139.7 131.45 27.43 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 122.476 0.311 . . . . 0.0 110.353 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 22.3 pt -103.98 143.11 16.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.008 0.432 . . . . 0.0 110.13 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -116.02 128.76 55.97 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.881 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 243' ' ' VAL . . . . . 0.553 ' HB ' ' HB1' ' B' ' 286' ' ' ALA . 58.0 t -96.8 124.31 49.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.613 177.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 23.2 t -153.35 88.77 1.31 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.895 0.379 . . . . 0.0 110.138 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 245' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -142.4 157.65 44.55 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 246' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' B' ' 283' ' ' ASN . 25.8 t -62.48 153.18 32.38 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.694 0.283 . . . . 0.0 110.385 177.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -60.51 -17.54 48.31 Favored Glycine 0 C--N 1.332 0.353 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.807 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.04 -23.33 69.5 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.362 176.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -88.98 -47.65 7.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.098 0.475 . . . . 0.0 110.547 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 44.9 mm -107.55 100.42 10.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.968 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 22.3 t -112.11 -11.43 13.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.993 0.425 . . . . 0.0 111.085 -175.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 78.8 p -149.33 163.66 24.23 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.399 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.72 -31.63 94.43 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.476 2.117 . . . . 0.0 111.639 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 254' ' ' SER . . . . . 0.546 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 8.1 t -65.49 -40.12 92.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.106 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -64.48 -38.46 91.11 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.297 0.57 . . . . 0.0 109.978 177.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 48.5 tp -60.24 -44.69 95.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.847 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 257' ' ' ARG . . . . . 0.463 ' HD3' ' OE1' ' A' ' 23' ' ' GLU . 0.3 OUTLIER -66.44 -34.76 78.66 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.787 -0.188 . . . . 0.0 110.712 -177.032 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 258' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' B' ' 254' ' ' SER . 67.7 mm-40 -59.54 -45.56 91.44 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-O 121.311 0.576 . . . . 0.0 109.604 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 259' ' ' LYS . . . . . 0.467 ' O ' ' HG ' ' B' ' 263' ' ' LEU . 38.8 tptt -72.91 -40.18 65.71 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.834 -178.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 81.1 mt -64.53 -48.73 73.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.346 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 49.4 m -64.56 -29.8 70.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.706 0.289 . . . . 0.0 110.541 178.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -64.34 -51.44 63.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.997 0.427 . . . . 0.0 110.248 174.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 263' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' B' ' 259' ' ' LYS . 86.8 mt -65.45 -36.58 84.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.922 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.53 -39.51 81.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.856 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -62.54 -35.54 79.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.149 0.5 . . . . 0.0 110.626 177.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -76.37 -11.35 59.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.932 -177.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -114.99 -27.04 7.5 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.817 0.341 . . . . 0.0 111.372 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 91.61 64.93 1.15 Allowed Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.5 176.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -137.82 156.94 23.99 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.611 175.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . 0.853 ' HD3' ' HB2' ' B' ' 293' ' ' ASP . 10.3 mtpm? -104.39 -12.67 16.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.824 0.312 . . . . 0.0 111.321 -178.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 271' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -146.37 159.96 42.69 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 272' ' ' TYR . . . . . 0.612 ' CD2' ' HB2' ' A' ' 22' ' ' ALA . 0.3 OUTLIER -132.37 163.52 28.51 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.165 171.42 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -128.58 101.93 6.38 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 175.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 274' ' ' ILE . . . . . 0.5 HG12 ' HB3' ' B' ' 288' ' ' ALA . 49.6 mt -82.23 118.04 29.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.083 0.468 . . . . 0.0 110.267 -177.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 16.9 pt -103.19 -39.27 5.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.457 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . 0.51 ' HB1' ' HB ' ' B' ' 287' ' ' VAL . . . -119.92 143.95 47.7 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.783 0.325 . . . . 0.0 111.417 -175.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -157.98 114.52 2.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.421 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 278' ' ' ARG . . . . . 0.455 ' HG2' ' HB2' ' B' ' 285' ' ' GLU . 0.0 OUTLIER -151.35 150.91 31.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.949 0.404 . . . . 0.0 111.147 -175.639 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -93.4 109.56 21.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.846 176.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 280' ' ' HIS . . . . . 0.417 ' HB2' ' CG ' ' B' ' 285' ' ' GLU . 4.7 t60 -69.26 -22.96 63.8 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 150.15 -110.66 0.48 Allowed Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -69.52 -15.82 38.19 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 122.319 2.013 . . . . 0.0 111.43 171.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 283' ' ' ASN . . . . . 0.561 ' HA ' ' HA ' ' B' ' 246' ' ' SER . 41.1 m-80 -111.85 151.82 28.65 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.464 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -107.88 133.78 51.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.41 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 285' ' ' GLU . . . . . 0.455 ' HB2' ' HG2' ' B' ' 278' ' ' ARG . 50.4 mm-40 -117.67 122.23 42.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.941 -175.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 286' ' ' ALA . . . . . 0.553 ' HB1' ' HB ' ' B' ' 243' ' ' VAL . . . -136.55 145.86 45.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.811 0.339 . . . . 0.0 110.673 177.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 287' ' ' VAL . . . . . 0.51 ' HB ' ' HB1' ' B' ' 276' ' ' ALA . 59.2 t -126.29 118.06 50.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.445 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 288' ' ' ALA . . . . . 0.5 ' HB3' HG12 ' B' ' 274' ' ' ILE . . . -129.09 136.16 49.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.054 -177.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -91.21 136.83 32.82 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 290' ' ' VAL . . . . . 0.42 ' HB ' HG22 ' B' ' 238' ' ' VAL . 12.7 t -97.91 127.36 50.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.748 0.309 . . . . 0.0 110.411 -176.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -120.75 134.5 55.28 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.265 0.555 . . . . 0.0 110.998 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 292' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -95.33 159.15 15.14 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 176.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 293' ' ' ASP . . . . . 0.853 ' HB2' ' HD3' ' B' ' 270' ' ' LYS . 3.2 t70 -82.56 150.89 26.66 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.492 -174.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 294' ' ' ALA . . . . . . . . . . . . . . . -78.66 73.51 5.21 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.218 0.532 . . . . 0.0 110.401 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 295' ' ' THR . . . . . . . . . . . . . 6.4 t -174.93 -41.07 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.101 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt 60.92 20.92 11.19 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.502 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 297' ' ' LEU . . . . . . . . . . . . . 90.1 mt -114.26 111.96 22.35 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.993 0.425 . . . . 0.0 110.98 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 298' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -76.92 158.55 30.63 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 299' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -63.69 -62.35 1.71 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -176.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 300' ' ' HIS . . . . . . . . . . . . . 34.2 p-80 -169.3 128.89 1.04 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.912 0.387 . . . . 0.0 111.37 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 301' ' ' HIS . . . . . . . . . . . . . 36.0 p-80 -170.59 143.43 2.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.111 176.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 302' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -97.01 121.77 39.26 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 174.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -123.72 77.91 1.56 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -178.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 5.7 t60 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.527 -179.691 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.619 ' HG3' ' H ' ' A' ' 2' ' ' LYS . 11.5 tpt . . . . . 0 N--CA 1.482 1.163 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.619 ' H ' ' HG3' ' A' ' 1' ' ' MET . 11.7 mptt -83.51 -84.28 0.13 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.103 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt 47.47 52.87 11.81 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 122.176 0.989 . . . . 0.0 108.436 -170.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -76.83 4.07 10.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.198 -1.365 . . . . 0.0 113.184 -164.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 58.4 mt -90.23 92.11 3.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.026 0.441 . . . . 0.0 110.324 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.5 pt -127.1 126.85 68.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.467 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.448 ' C ' ' H ' ' A' ' 9' ' ' ALA . . . -161.58 -73.35 0.06 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.733 -178.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 70.1 -35.87 0.33 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.632 0.773 . . . . 0.0 112.368 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.448 ' H ' ' C ' ' A' ' 7' ' ' ALA . . . -73.95 95.9 2.56 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.841 0.353 . . . . 0.0 111.394 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 59.6 tp -104.39 96.66 6.77 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 174.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.46 122.34 33.96 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.736 -176.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.35 90.07 7.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.319 0.581 . . . . 0.0 111.037 -178.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.8 m -107.43 98.8 8.37 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.23 172.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.0 p -138.91 140.51 38.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.981 0.42 . . . . 0.0 110.556 -175.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.52 145.03 28.31 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.44 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.6 m -76.79 90.19 3.45 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.178 178.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.443 ' CE2' ' HB3' ' B' ' 304' ' ' HIS . 56.1 t80 -80.19 146.57 31.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.05 -176.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.8 m -61.3 167.5 3.16 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.227 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.4 ' C ' HD13 ' A' ' 20' ' ' LEU . 8.8 t -98.21 140.7 32.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.129 0.49 . . . . 0.0 111.014 -175.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.4 HD13 ' C ' ' A' ' 19' ' ' THR . 8.6 mp -125.64 28.38 6.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.037 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' B' ' 223' ' ' GLU . . . -98.2 22.22 9.83 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.826 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.3 97.12 8.14 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.603 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.518 ' HB3' ' HG3' ' B' ' 257' ' ' ARG . 6.1 pt-20 -161.4 124.86 3.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.693 0.759 . . . . 0.0 111.796 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.764 ' HG3' ' HG3' ' B' ' 224' ' ' GLN . 0.0 OUTLIER -141.35 143.5 34.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.769 -173.54 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.535 HG21 ' HB2' ' A' ' 73' ' ' HIS . 3.5 m -103.19 126.84 57.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.364 0.602 . . . . 0.0 111.401 176.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.658 ' HB2' ' OE1' ' A' ' 28' ' ' GLN . 1.3 p -92.5 159.12 15.67 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.478 178.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.517 ' HA ' HD11 ' A' ' 30' ' ' ILE . 15.9 ttpp -69.67 -26.19 64.26 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.153 0.502 . . . . 0.0 109.688 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.658 ' OE1' ' HB2' ' A' ' 26' ' ' SER . 19.6 mp0 -59.9 -49.53 77.34 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.078 175.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.568 ' HA ' ' HB3' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -71.23 -25.76 62.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.948 -1.023 . . . . 0.0 112.347 -177.043 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.517 HD11 ' HA ' ' A' ' 27' ' ' LYS . 72.6 mt -52.93 -55.69 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.778 0.323 . . . . 0.0 110.503 177.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.9 t -73.59 -31.53 63.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.082 0.468 . . . . 0.0 110.564 176.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.568 ' HB3' ' HA ' ' A' ' 29' ' ' GLU . 15.1 t-160 -63.55 -51.37 65.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.901 -173.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -111.38 4.53 19.05 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 121.208 -0.197 . . . . 0.0 111.494 -176.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm 56.64 79.01 0.19 Allowed 'General case' 0 N--CA 1.465 0.29 0 O-C-N 123.696 0.622 . . . . 0.0 110.841 -177.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.506 HD11 HG12 ' A' ' 30' ' ' ILE . 91.0 mt -75.55 152.9 37.68 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.934 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.444 HG13 ' HG3' ' A' ' 98' ' ' GLU . 57.9 t -92.14 101.1 12.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.452 -178.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.53 ' HE3' ' HB3' ' A' ' 89' ' ' GLU . 22.9 tptm -75.1 113.66 12.69 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.691 178.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.8 m -99.55 -9.37 8.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.134 0.492 . . . . 0.0 111.31 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 142.75 -179.75 20.16 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.432 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 21.3 m -131.09 126.69 36.43 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.1 pt -106.8 160.62 6.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.031 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -141.56 141.6 33.52 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.731 0.777 . . . . 0.0 111.8 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.661 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 53.5 t -94.13 135.33 28.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.943 179.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 10.0 t -150.38 86.7 1.42 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.121 0.486 . . . . 0.0 109.972 178.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.83 148.44 42.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.97 178.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.7 t -100.7 124.91 46.97 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.62 -177.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.45 -157.72 22.59 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.272 175.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.27 50.5 4.1 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.344 -0.455 . . . . 0.0 113.755 -172.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -75.42 -38.32 59.89 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 172.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' A' ' 56' ' ' LEU . 47.4 mm -105.24 95.03 3.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.541 176.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.3 t -108.58 -36.39 6.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.394 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.8 m -107.46 144.38 29.11 Favored Pre-proline 0 N--CA 1.448 -0.568 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.408 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.621 ' HG3' ' HB3' ' B' ' 233' ' ' PHE . 34.8 Cg_exo -56.99 -39.92 87.86 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.908 2.405 . . . . 0.0 111.707 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.1 t -62.37 -40.54 96.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.834 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -67.31 -34.79 78.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.941 -174.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.536 ' HA ' HD12 ' A' ' 50' ' ' ILE . 58.4 tp -57.89 -55.89 29.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.472 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.479 ' HA ' HD12 ' A' ' 60' ' ' LEU . 7.8 ppt_? -70.84 -24.55 62.55 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.285 -177.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -58.67 -34.82 71.68 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.95 0.405 . . . . 0.0 110.495 171.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -78.51 -36.55 44.76 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.41 175.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.479 HD12 ' HA ' ' A' ' 57' ' ' ARG . 97.0 mt -62.24 -48.77 78.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.146 -178.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.4 p -68.68 -42.15 78.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.741 0.305 . . . . 0.0 110.781 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.836 ' HG2' ' HB1' ' B' ' 215' ' ' ALA . 37.7 tt0 -54.41 -42.83 70.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.988 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.46 HD23 ' HB3' ' B' ' 215' ' ' ALA . 94.2 mt -76.06 -51.06 13.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.883 178.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.47 -45.34 69.25 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -172.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.87 -42.63 94.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.113 0.482 . . . . 0.0 110.053 -176.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.41 -12.84 60.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.457 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.611 ' HG2' HG22 ' B' ' 213' ' ' THR . 5.4 tmtt? -78.05 -22.99 48.31 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 175.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.72 59.98 0.7 Allowed Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.842 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.473 ' HA2' ' OD1' ' A' ' 92' ' ' ASN . . . -135.56 176.25 20.25 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.851 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -116.69 -30.18 5.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 117.04 0.42 . . . . 0.0 111.331 176.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -142.2 163.72 32.11 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.494 ' CE1' ' HB3' ' B' ' 224' ' ' GLN . 12.1 p90 -136.71 152.45 50.38 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.946 172.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.535 ' HB2' HG21 ' A' ' 25' ' ' VAL . 46.9 t-80 -131.53 108.88 9.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.166 -174.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.501 HD12 ' HB2' ' B' ' 226' ' ' SER . 69.0 mt -79.56 127.59 39.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.829 0.347 . . . . 0.0 110.672 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.4 pt -101.03 -29.37 3.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.49 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -159.84 141.46 12.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.905 0.383 . . . . 0.0 111.299 -177.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -142.95 126.53 16.87 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.49 147.45 34.54 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.373 0.606 . . . . 0.0 112.223 -175.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -93.71 104.81 16.89 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 169.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -87.55 11.45 14.89 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.314 0.578 . . . . 0.0 110.484 -171.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 120.27 -113.42 2.42 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 111.309 -0.717 . . . . 0.0 111.309 -178.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -73.79 -11.19 23.8 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.449 2.1 . . . . 0.0 112.172 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -122.17 140.54 52.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.92 0.391 . . . . 0.0 110.758 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.419 ' O ' ' HA ' ' A' ' 44' ' ' SER . 84.0 t80 -103.15 130.5 50.35 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 175.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.661 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 63.0 mt-10 -124.57 114.86 19.95 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.278 -175.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -121.18 121.24 37.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.325 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.6 t -105.34 120.46 56.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.659 0.266 . . . . 0.0 110.821 -176.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.476 ' HB2' HG12 ' A' ' 74' ' ' ILE . . . -131.57 137.73 48.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.082 0.468 . . . . 0.0 111.274 -177.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.53 ' HB3' ' HE3' ' A' ' 37' ' ' LYS . 30.4 mt-10 -91.73 145.68 24.38 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.586 177.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 18.3 t -105.25 129.84 57.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -125.38 134.96 51.97 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.496 0.665 . . . . 0.0 112.024 -177.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.473 ' OD1' ' HA2' ' A' ' 69' ' ' GLY . 56.0 m-20 -109.72 179.45 4.12 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.234 169.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.406 ' OD1' HG21 ' A' ' 95' ' ' THR . 39.9 p30 -124.23 174.56 7.61 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.812 0.339 . . . . 0.0 110.191 175.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.85 21.77 0.11 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -173.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.406 HG21 ' OD1' ' A' ' 93' ' ' ASP . 6.9 t -122.77 3.53 9.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.706 0.765 . . . . 0.0 109.987 178.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -80.73 -170.57 2.7 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.836 175.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.3 pp -96.02 19.92 10.89 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.2 0.524 . . . . 0.0 111.047 -174.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.444 ' HG3' HG13 ' A' ' 36' ' ' VAL . 1.6 mm-40 -81.24 34.65 0.37 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.336 -174.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 41.75 85.35 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.955 0.883 . . . . 0.0 111.708 -173.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -77.97 148.26 34.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.965 -1.016 . . . . 0.0 112.112 -171.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -73.84 144.11 45.63 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.882 169.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 -59.26 120.1 8.62 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 65.7 t-80 -139.99 143.94 36.73 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.638 -172.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 38.0 m80 . . . . . 0 C--N 1.326 -0.419 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 171.008 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 201' ' ' MET . . . . . 0.415 ' HA ' ' HD3' ' A' ' 27' ' ' LYS . 72.9 mtm . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . 0.508 ' HB3' HD13 ' B' ' 205' ' ' ILE . 32.3 mmmt -101.84 111.74 24.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.811 0.339 . . . . 0.0 110.878 -178.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -112.2 172.28 7.01 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.177 177.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 68.9 mtp180 64.51 18.51 11.4 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.492 0.495 . . . . 0.0 112.243 174.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 205' ' ' ILE . . . . . 0.508 HD13 ' HB3' ' B' ' 202' ' ' LYS . 71.4 mt -71.38 -51.62 32.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.131 0.491 . . . . 0.0 110.452 177.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 43.9 pt -99.42 153.2 4.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.18 -178.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -145.25 -47.55 0.23 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.777 175.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -87.55 83.54 7.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.187 177.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -162.97 130.44 3.63 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.695 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 210' ' ' LEU . . . . . . . . . . . . . 50.1 tp -153.91 97.36 2.07 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 86.7 mt -120.18 100.06 6.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.034 0.445 . . . . 0.0 111.823 -171.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.57 95.02 6.18 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 171.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 213' ' ' THR . . . . . 0.611 HG22 ' HG2' ' A' ' 67' ' ' LYS . 13.5 p -79.13 160.74 26.88 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.534 -175.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 214' ' ' VAL . . . . . . . . . . . . . 40.5 t -70.57 100.61 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.897 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . 0.836 ' HB1' ' HG2' ' A' ' 62' ' ' GLU . . . -70.76 129.55 39.4 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.042 -177.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 50.1 m -84.01 161.13 20.84 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 175.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -71.75 88.04 0.99 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.793 0.33 . . . . 0.0 111.768 -174.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 218' ' ' SER . . . . . . . . . . . . . 3.1 t 60.98 89.94 0.07 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.051 174.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 9.3 m -115.49 119.03 34.86 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 39.7 tp -116.95 110.45 18.31 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -169.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -153.35 -58.01 0.13 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.577 170.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -80.38 118.76 22.3 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.906 177.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . 0.458 ' OE2' ' HD3' ' A' ' 57' ' ' ARG . 4.7 mm-40 -147.34 125.54 12.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.998 0.428 . . . . 0.0 111.282 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 224' ' ' GLN . . . . . 0.764 ' HG3' ' HG3' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -147.38 138.56 23.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.782 -174.431 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . 0.413 HG11 ' HB2' ' B' ' 271' ' ' TYR . 12.3 m -94.95 136.03 27.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.226 0.536 . . . . 0.0 110.414 175.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 226' ' ' SER . . . . . 0.501 ' HB2' HD12 ' A' ' 74' ' ' ILE . 28.4 t -82.78 148.01 28.06 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.229 -175.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . 0.514 ' HD3' ' O ' ' B' ' 227' ' ' LYS . 12.6 tmtt? -69.57 -36.69 76.54 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -65.16 -36.11 83.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.458 177.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 229' ' ' GLU . . . . . 0.582 ' HA ' ' HB3' ' B' ' 232' ' ' HIS . 0.0 OUTLIER -68.66 -25.63 64.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.649 -178.557 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 73.8 mt -56.15 -53.06 43.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 174.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 46.2 t -73.62 -31.19 63.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.059 177.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 232' ' ' HIS . . . . . 0.582 ' HB3' ' HA ' ' B' ' 229' ' ' GLU . 22.1 t-160 -72.57 -46.82 52.5 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.658 -173.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . 0.621 ' HB3' ' HG3' ' A' ' 53' ' ' PRO . 82.5 m-85 -111.49 6.45 20.19 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -175.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm 56.25 51.68 11.31 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.36 0.412 . . . . 0.0 110.587 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . 0.792 ' HA ' ' HB1' ' B' ' 294' ' ' ALA . 89.9 mt -57.2 140.2 50.37 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.693 -176.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . 0.524 HG22 ' HA ' ' B' ' 294' ' ' ALA . 75.0 t -79.86 117.72 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.635 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -81.41 105.68 12.77 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.806 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 238' ' ' VAL . . . . . 0.433 ' CG1' ' HB2' ' B' ' 292' ' ' ASN . 36.0 m -87.05 -16.11 9.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.799 -0.361 . . . . 0.0 111.792 -175.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 160.98 145.09 4.19 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 119.883 -1.151 . . . . 0.0 113.077 177.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 240' ' ' THR . . . . . 0.532 HG23 ' HG2' ' B' ' 289' ' ' GLU . 24.8 m -97.78 122.32 40.74 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 174.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 24.0 pt -103.58 131.71 51.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.303 0.573 . . . . 0.0 110.849 -177.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -102.27 112.48 25.18 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.628 176.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 243' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 87.6 t -95.55 108.92 21.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.199 176.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 244' ' ' SER . . . . . 0.521 ' HA ' ' O ' ' B' ' 284' ' ' PHE . 7.9 t -127.9 94.19 3.87 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.323 0.582 . . . . 0.0 109.632 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 245' ' ' GLN . . . . . 0.529 ' HB2' ' HB3' ' B' ' 284' ' ' PHE . 0.0 OUTLIER -86.28 147.45 26.07 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.396 -177.204 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 22.8 t -101.31 102.48 13.34 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 177.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 94.65 177.25 38.4 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.441 -0.663 . . . . 0.0 111.441 -174.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -79.3 66.28 3.49 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.819 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -76.2 -21.02 56.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.163 0.506 . . . . 0.0 110.879 -177.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 50.0 mm -98.75 122.17 50.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 176.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 1.9 m -109.94 -53.8 2.63 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.287 0.565 . . . . 0.0 110.231 -176.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 16.0 m -114.91 163.08 20.74 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.493 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.6 -29.14 59.26 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.463 2.109 . . . . 0.0 111.979 176.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 254' ' ' SER . . . . . 0.559 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 1.6 p -60.52 -44.09 96.43 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.568 177.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -56.43 -45.33 80.79 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.24 0.543 . . . . 0.0 110.225 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 46.6 tp -68.32 -39.41 81.98 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.55 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 257' ' ' ARG . . . . . 0.518 ' HG3' ' HB3' ' A' ' 23' ' ' GLU . 6.7 ttp85 -60.33 -46.8 88.63 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.759 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 258' ' ' GLU . . . . . 0.559 ' HG2' ' O ' ' B' ' 254' ' ' SER . 33.7 mm-40 -57.99 -42.98 86.28 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.598 -178.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 259' ' ' LYS . . . . . 0.536 ' O ' ' HG ' ' B' ' 263' ' ' LEU . 75.4 mmtt -64.12 -48.25 76.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.446 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 97.6 mt -66.67 -38.75 87.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.414 -176.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 29.5 t -65.35 -38.92 91.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.841 0.353 . . . . 0.0 110.095 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -63.16 -47.11 84.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.254 0.55 . . . . 0.0 110.145 177.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 263' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' B' ' 259' ' ' LYS . 85.1 mt -64.05 -42.62 96.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.967 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -58.9 -48.29 81.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.335 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -62.83 -43.98 97.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.256 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -68.1 -37.79 81.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.925 0.393 . . . . 0.0 111.338 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -78.86 -3.73 46.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.408 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 76.17 48.5 9.56 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.141 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -128.47 -179.66 16.03 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.681 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . 0.787 ' HZ2' ' HB3' ' B' ' 270' ' ' LYS . 7.9 mtpm? -115.88 -63.57 1.43 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.723 0.296 . . . . 0.0 110.608 -178.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 271' ' ' TYR . . . . . 0.413 ' HB2' HG11 ' B' ' 225' ' ' VAL . 13.9 m-85 -122.99 174.38 7.22 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 272' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -139.01 166.79 23.57 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.663 -175.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -141.49 125.49 17.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.849 175.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 274' ' ' ILE . . . . . . . . . . . . . 84.9 mt -82.75 140.11 16.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.412 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 19.1 pt -125.12 -22.29 2.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -152.66 109.1 3.41 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.738 0.304 . . . . 0.0 110.596 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -132.23 121.17 23.21 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.832 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 278' ' ' ARG . . . . . 0.423 ' N ' ' HD2' ' B' ' 278' ' ' ARG . 0.0 OUTLIER -141.64 130.76 23.35 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.334 0.587 . . . . 0.0 111.256 -178.025 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -75.39 106.24 6.82 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 174.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -80.73 -24.93 38.39 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.458 -172.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 113.12 -89.75 0.53 Allowed Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -70.28 -12.65 32.28 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.42 2.08 . . . . 0.0 111.353 174.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -140.29 170.54 15.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.562 177.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 284' ' ' PHE . . . . . 0.529 ' HB3' ' HB2' ' B' ' 245' ' ' GLN . 72.9 t80 -131.89 119.87 21.77 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 285' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -109.45 111.21 22.62 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 123.108 0.255 . . . . 0.0 110.395 -175.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 286' ' ' ALA . . . . . 0.562 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -123.83 117.16 24.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.983 0.42 . . . . 0.0 110.838 174.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 38.3 t -105.21 118.28 52.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.277 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -140.36 150.1 43.53 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.148 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 289' ' ' GLU . . . . . 0.532 ' HG2' HG23 ' B' ' 240' ' ' THR . 32.6 mt-10 -109.85 143.18 40.1 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 177.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 290' ' ' VAL . . . . . 0.431 ' O ' HG22 ' B' ' 238' ' ' VAL . 17.2 t -102.42 141.09 19.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 291' ' ' TYR . . . . . 0.411 ' CD2' HG21 ' B' ' 225' ' ' VAL . 71.6 m-85 -128.04 149.62 50.3 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.776 0.322 . . . . 0.0 110.346 -178.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 292' ' ' ASN . . . . . 0.433 ' HB2' ' CG1' ' B' ' 238' ' ' VAL . 5.5 t-20 -104.7 24.58 11.56 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.245 0.545 . . . . 0.0 111.163 -176.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 64.58 9.45 5.11 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.31 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 294' ' ' ALA . . . . . 0.792 ' HB1' ' HA ' ' B' ' 235' ' ' LEU . . . 68.76 18.65 8.64 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.373 0.669 . . . . 0.0 112.514 178.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 295' ' ' THR . . . . . 0.491 ' C ' ' H ' ' B' ' 297' ' ' LEU . 6.3 t -112.21 -34.28 5.97 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.371 -0.531 . . . . 0.0 112.044 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 296' ' ' LYS . . . . . 0.519 ' HD3' ' O ' ' B' ' 296' ' ' LYS . 1.7 tmtp? 73.99 -20.68 0.3 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.632 0.773 . . . . 0.0 110.834 -177.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 297' ' ' LEU . . . . . 0.491 ' H ' ' C ' ' B' ' 295' ' ' THR . 74.4 mt -105.17 -167.52 1.35 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.977 178.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 298' ' ' GLU . . . . . 0.869 ' HG2' ' H ' ' B' ' 299' ' ' HIS . 9.2 tt0 68.92 -179.22 0.23 Allowed 'General case' 0 CA--C 1.536 0.416 0 O-C-N 123.642 0.589 . . . . 0.0 110.843 177.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 299' ' ' HIS . . . . . 0.869 ' H ' ' HG2' ' B' ' 298' ' ' GLU . 4.7 p80 -172.97 -36.31 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.556 176.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 300' ' ' HIS . . . . . . . . . . . . . 16.1 m170 47.96 72.32 0.28 Allowed 'General case' 0 N--CA 1.471 0.585 0 O-C-N 123.602 0.564 . . . . 0.0 111.504 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 301' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -179.32 103.43 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -178.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 302' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -72.74 -42.55 63.96 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.157 -171.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -154.2 -165.09 2.0 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.996 -176.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 304' ' ' HIS . . . . . 0.443 ' HB3' ' CE2' ' A' ' 17' ' ' PHE . 5.1 p80 . . . . . 0 C--N 1.325 -0.478 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.1 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.56 ' O ' ' HG2' ' A' ' 2' ' ' LYS . 14.7 tpt . . . . . 0 N--CA 1.481 1.081 0 N-CA-C 110.803 -0.073 . . . . 0.0 110.803 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.56 ' HG2' ' O ' ' A' ' 1' ' ' MET . 12.8 ptpt 65.15 141.26 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.76 1.224 . . . . 0.0 112.087 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -142.49 -26.9 0.62 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.778 175.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 64.53 -171.07 0.18 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.295 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.4 tt -156.5 115.31 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.505 0.669 . . . . 0.0 110.76 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.401 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.0 mp -101.62 99.03 7.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 176.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -93.45 134.11 36.04 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.644 -177.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 72.07 163.56 0.27 Allowed 'General case' 0 C--O 1.234 0.262 0 O-C-N 124.202 0.939 . . . . 0.0 111.157 -177.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -169.74 170.36 7.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.149 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.424 ' HG ' HD11 ' B' ' 297' ' ' LEU . 27.2 tp -100.03 86.28 3.22 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.0 mp -74.44 -37.13 63.37 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.159 -176.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.802 ' HB2' HD13 ' B' ' 297' ' ' LEU . . . 70.91 155.08 0.14 Allowed 'General case' 0 N--CA 1.467 0.406 0 O-C-N 124.272 0.983 . . . . 0.0 110.321 -170.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.6 m -75.74 74.12 2.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.342 0.591 . . . . 0.0 110.984 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.8 t -138.6 -59.68 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.192 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 62.44 -168.6 0.19 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.846 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.7 m -114.89 -62.81 1.55 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 174.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 47.6 t80 48.46 -89.04 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.136 0.974 . . . . 0.0 112.895 177.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.7 t -81.64 -17.88 46.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.853 0.359 . . . . 0.0 110.578 -175.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.0 m -77.69 107.04 9.89 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.128 178.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.8 mt -69.13 104.27 2.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.042 0.449 . . . . 0.0 110.06 178.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.491 ' HA ' ' HG3' ' B' ' 223' ' ' GLU . . . -151.5 -175.03 5.02 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.645 -178.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 61.25 66.62 0.86 Allowed 'General case' 0 C--N 1.332 -0.175 0 O-C-N 123.695 0.622 . . . . 0.0 111.515 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.459 ' H ' ' HB2' ' B' ' 223' ' ' GLU . 33.7 mt-10 -150.4 99.37 2.77 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.574 -175.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.8 156.21 5.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.649 176.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.459 ' HB ' ' HB2' ' A' ' 29' ' ' GLU . 19.6 m -122.79 143.38 35.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.185 177.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.489 ' O ' HG13 ' A' ' 30' ' ' ILE . 94.9 p -93.78 -167.6 1.72 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.918 0.39 . . . . 0.0 110.738 -176.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -62.18 -38.53 89.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.624 -174.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.524 ' HB2' ' OE2' ' A' ' 29' ' ' GLU . 0.9 OUTLIER -62.17 -49.98 73.66 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.096 0.474 . . . . 0.0 110.601 -176.416 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.524 ' OE2' ' HB2' ' A' ' 28' ' ' GLN . 1.8 mp0 -62.32 -40.86 97.72 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.251 -177.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.511 HG12 HD11 ' A' ' 35' ' ' LEU . 80.8 mt -55.35 -48.28 77.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 121.048 0.452 . . . . 0.0 110.712 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.9 m -73.28 -41.61 63.4 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.749 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 12.6 t60 -76.99 -32.28 57.09 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.79 0.292 . . . . 0.0 111.79 -171.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -101.87 -2.78 29.15 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 121.352 -0.139 . . . . 0.0 111.257 -178.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt 44.68 100.02 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 122.294 1.045 . . . . 0.0 113.76 -171.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.511 HD11 HG12 ' A' ' 30' ' ' ILE . 91.7 mt -104.67 152.82 22.02 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.106 -1.406 . . . . 0.0 111.368 -176.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.1 t -88.09 105.66 15.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.932 -175.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.589 ' HZ1' ' CD ' ' A' ' 89' ' ' GLU . 25.4 tttp -73.87 118.49 16.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.956 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 26.8 m -100.05 -21.9 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -178.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.58 -171.83 34.23 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.43 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 27.2 m -125.17 139.49 53.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.666 0.269 . . . . 0.0 110.659 -178.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.3 pt -114.7 143.88 23.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 175.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -126.18 131.12 52.07 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.105 0.479 . . . . 0.0 111.359 -173.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 95.9 t -93.89 125.67 46.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.084 173.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -153.16 88.96 1.33 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.863 0.364 . . . . 0.0 110.135 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -138.46 163.45 31.91 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.884 177.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.551 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 4.0 p -66.05 148.92 51.07 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.122 0.487 . . . . 0.0 111.835 -178.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.88 114.42 6.03 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.934 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 137.62 -39.38 1.61 Allowed Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 -175.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -70.24 -29.29 66.06 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.465 0.65 . . . . 0.0 109.632 175.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.414 HD12 ' HG3' ' A' ' 59' ' ' LYS . 46.1 mm -118.38 109.19 26.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.728 174.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.5 t -116.18 -44.53 2.89 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.041 0.448 . . . . 0.0 110.23 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.2 m -104.06 157.14 34.61 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.073 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.931 ' HG3' HD21 ' B' ' 235' ' ' LEU . 22.1 Cg_endo -61.08 -28.79 86.3 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.411 2.074 . . . . 0.0 110.857 175.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.636 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 0.8 OUTLIER -60.34 -45.29 93.99 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.118 176.12 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.487 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 71.8 m-20 -54.93 -46.88 75.0 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.117 0.484 . . . . 0.0 110.25 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 59.2 tp -57.14 -47.82 80.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.898 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.51 -31.49 68.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.91 -176.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.636 ' HG2' ' O ' ' A' ' 54' ' ' SER . 57.7 mm-40 -63.2 -43.16 98.95 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.982 0.42 . . . . 0.0 110.013 176.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.487 ' HG2' ' O ' ' A' ' 55' ' ' ASP . 31.5 mmmt -67.24 -45.6 76.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.562 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 87.5 mt -65.24 -38.82 91.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.509 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.4 t -63.47 -35.75 81.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.96 0.409 . . . . 0.0 110.316 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -59.75 -42.88 94.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.251 176.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 87.3 mt -74.74 -33.68 62.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.936 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.93 -40.17 94.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.449 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -61.21 -35.82 78.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.373 176.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.59 2.49 29.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.579 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.42 ' HD3' ' HA ' ' A' ' 67' ' ' LYS . 42.9 mmtm -122.08 -0.05 9.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.911 0.386 . . . . 0.0 110.687 176.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 60.73 40.5 98.17 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.631 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -108.2 135.56 12.91 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.007 -178.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.79 ' HD3' HG23 ' B' ' 219' ' ' THR . 74.6 mmtt -77.68 -25.7 49.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.365 0.602 . . . . 0.0 110.021 177.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -152.93 175.44 12.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.215 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -147.65 170.22 17.98 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.925 -176.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -135.42 114.23 11.95 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 119.994 -0.683 . . . . 0.0 110.915 174.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.463 ' HA ' ' HA ' ' A' ' 88' ' ' ALA . 55.8 mt -78.39 127.53 38.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.777 177.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 23.2 pt -100.92 -35.2 4.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.585 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -156.32 144.86 20.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.817 0.341 . . . . 0.0 111.424 -177.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -147.14 124.67 11.7 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.07 152.21 40.68 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.888 0.375 . . . . 0.0 111.213 -174.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -86.0 118.88 25.75 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.488 170.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -80.11 -22.13 42.5 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 128.4 -86.28 0.32 Allowed Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 -175.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.551 ' O ' ' HA ' ' A' ' 46' ' ' SER . 70.1 Cg_endo -74.73 -24.0 13.86 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.16 1.907 . . . . 0.0 111.374 172.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.458 ' OD1' ' HG2' ' A' ' 82' ' ' PRO . 1.1 m120 -119.57 150.15 40.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.323 -176.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -108.13 121.67 45.33 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 170.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.677 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 46.2 mt-10 -117.71 118.98 33.57 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.206 0.527 . . . . 0.0 111.782 -174.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -121.36 132.13 54.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.992 176.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.1 t -111.54 112.85 42.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.997 0.427 . . . . 0.0 110.421 -178.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 74' ' ' ILE . . . -125.13 135.57 52.78 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.223 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.589 ' CD ' ' HZ1' ' A' ' 37' ' ' LYS . 33.2 mt-10 -106.0 134.96 48.29 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 26.2 t -90.66 132.19 35.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -175.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -123.25 125.73 45.61 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.167 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.68 147.39 25.26 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 174.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.49 ' C ' ' H ' ' A' ' 95' ' ' THR . 2.1 m-20 -53.5 147.82 10.27 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.061 -178.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.458 ' O ' ' HB3' ' A' ' 104' ' ' HIS . . . -73.49 46.84 0.21 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 166.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.49 ' H ' ' C ' ' A' ' 93' ' ' ASP . 31.1 m -151.43 -50.11 0.12 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.947 -172.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -69.66 -32.74 71.58 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.235 -178.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 78.2 mt -116.32 24.13 11.6 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.286 0.565 . . . . 0.0 110.294 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.46 ' CD ' ' HD1' ' A' ' 100' ' ' HIS . 0.4 OUTLIER -116.28 141.27 48.37 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.139 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 35.1 t-80 -146.72 75.61 1.4 Allowed 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.547 -175.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.46 ' HD1' ' CD ' ' A' ' 98' ' ' GLU . 14.5 m80 -90.52 -49.84 6.28 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 169.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -112.53 -84.0 0.59 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 176.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 14.5 t-160 -128.97 -41.63 1.44 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -143.09 161.15 38.95 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.964 -1.016 . . . . 0.0 108.53 170.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.458 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 57.5 t-80 . . . . . 0 C--N 1.311 -1.068 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 171.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 15.7 tpt . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 120.574 0.226 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -133.57 122.12 23.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.594 0.235 . . . . 0.0 110.619 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 92.8 mttt 60.2 67.96 0.81 Allowed 'General case' 0 N--CA 1.465 0.301 0 O-C-N 124.037 0.836 . . . . 0.0 112.802 177.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -135.1 101.87 5.01 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 170.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 205' ' ' ILE . . . . . 0.611 HG21 HG23 ' B' ' 206' ' ' ILE . 4.4 mp -119.93 -73.04 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.722 -178.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . 0.611 HG23 HG21 ' B' ' 205' ' ' ILE . 32.2 pt -128.41 174.55 11.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.825 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -118.33 -11.85 9.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.597 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . 63.86 18.42 11.16 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.425 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -89.87 140.85 29.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.097 -178.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 210' ' ' LEU . . . . . . . . . . . . . 8.7 mp 65.79 24.7 11.4 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.248 176.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 97.9 mt -64.76 -58.69 5.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.283 0.563 . . . . 0.0 109.488 173.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -132.21 -60.79 0.89 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.4 -0.818 . . . . 0.0 108.84 171.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 213' ' ' THR . . . . . 0.721 HG22 ' H ' ' B' ' 214' ' ' VAL . 1.2 m 64.91 -160.64 0.28 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.438 172.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 214' ' ' VAL . . . . . 0.721 ' H ' HG22 ' B' ' 213' ' ' THR . 47.8 t 67.51 94.03 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-O 121.262 0.554 . . . . 0.0 111.225 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -155.18 85.87 1.09 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.73 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 15.0 m -78.4 84.12 4.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.109 -173.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -107.33 151.94 24.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.349 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 218' ' ' SER . . . . . . . . . . . . . 8.4 t -91.58 124.73 35.97 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.786 0.327 . . . . 0.0 110.845 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 219' ' ' THR . . . . . 0.79 HG23 ' HD3' ' A' ' 70' ' ' LYS . 89.1 m -159.2 109.43 1.97 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.379 175.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 6.3 mp -86.31 96.18 9.89 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.658 -0.417 . . . . 0.0 109.91 173.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -140.14 -139.99 0.13 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.041 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . 68.73 91.12 0.09 Allowed 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.64 0.588 . . . . 0.0 111.154 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . 0.491 ' HG3' ' HA ' ' A' ' 21' ' ' ALA . 4.2 mm-40 -127.07 89.14 2.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.274 -173.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 224' ' ' GLN . . . . . 0.63 ' HA ' ' HB3' ' B' ' 271' ' ' TYR . 0.0 OUTLIER -176.62 155.73 1.38 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.285 169.264 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 20.3 m -125.88 150.85 31.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.272 175.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 226' ' ' SER . . . . . 0.445 ' O ' HG13 ' B' ' 230' ' ' ILE . 12.7 t -83.74 171.61 13.02 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . 0.493 ' HA ' HD13 ' B' ' 230' ' ' ILE . 74.3 tttt -68.74 -19.55 64.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.343 -173.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 228' ' ' GLN . . . . . 0.434 ' HB2' ' OE1' ' B' ' 229' ' ' GLU . 0.6 OUTLIER -65.75 -50.36 65.07 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 177.315 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 229' ' ' GLU . . . . . 0.434 ' OE1' ' HB2' ' B' ' 228' ' ' GLN . 1.9 mp0 -64.58 -41.33 96.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.444 178.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.493 HD13 ' HA ' ' B' ' 227' ' ' LYS . 87.4 mt -56.84 -46.46 83.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.898 178.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 16.5 m -73.14 -21.29 60.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.458 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 -85.48 -48.03 9.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.806 -176.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -91.19 -7.81 50.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.033 -177.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 57.95 64.56 1.5 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.082 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . 0.931 HD21 ' HG3' ' A' ' 53' ' ' PRO . 60.4 mt -75.21 147.26 40.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.236 -178.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 46.8 t -88.55 119.09 35.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.08 -175.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -80.53 117.56 21.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.12 175.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 2.0 m -80.26 -39.48 19.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.841 177.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 179.37 -173.27 45.26 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.991 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 33.3 m -115.22 129.81 56.74 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.245 -0.279 . . . . 0.0 110.245 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 24.2 pt -104.08 132.66 50.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.006 0.431 . . . . 0.0 110.177 175.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -117.55 123.08 45.38 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.582 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 243' ' ' VAL . . . . . 0.691 ' O ' ' HA ' ' B' ' 285' ' ' GLU . 41.9 t -92.6 120.42 41.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 173.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 15.9 t -150.97 87.16 1.39 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.345 0.593 . . . . 0.0 109.511 -177.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 245' ' ' GLN . . . . . 0.535 ' HG3' ' HB2' ' B' ' 249' ' ' GLN . 6.3 pm0 -138.62 173.62 11.39 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.734 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 8.6 t -85.39 176.21 8.41 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.735 0.302 . . . . 0.0 110.275 -176.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.69 52.42 1.57 Allowed Glycine 0 CA--C 1.521 0.439 0 CA-C-N 116.098 -0.501 . . . . 0.0 113.246 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -141.28 -39.78 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 176.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . 0.535 ' HB2' ' HG3' ' B' ' 245' ' ' GLN . 77.3 mt-30 -80.03 -15.13 57.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.587 -0.306 . . . . 0.0 110.518 175.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 250' ' ' ILE . . . . . 0.57 ' HA ' ' OD2' ' B' ' 255' ' ' ASP . 47.4 mm -131.76 110.22 16.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 175.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 8.5 t -118.25 -27.98 5.91 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.606 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 252' ' ' SER . . . . . 0.536 ' HB3' ' HD2' ' B' ' 253' ' ' PRO . 50.6 m -152.22 164.72 19.36 Favored Pre-proline 0 C--N 1.327 -0.383 0 O-C-N 122.357 -0.214 . . . . 0.0 110.62 -175.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . 0.536 ' HD2' ' HB3' ' B' ' 252' ' ' SER . 12.3 Cg_endo -56.95 -43.9 49.76 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.8 2.333 . . . . 0.0 112.503 178.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 254' ' ' SER . . . . . . . . . . . . . 4.3 p -64.14 -30.46 71.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.361 0.6 . . . . 0.0 110.726 177.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.57 ' OD2' ' HA ' ' B' ' 250' ' ' ILE . 28.1 t70 -75.75 -37.1 59.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.458 177.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 60.6 tp -61.64 -47.54 84.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.945 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 257' ' ' ARG . . . . . 0.506 ' HA ' HD12 ' B' ' 260' ' ' LEU . 2.0 ppt_? -59.19 -25.38 63.9 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -175.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 258' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -63.0 -47.5 82.86 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.169 0.509 . . . . 0.0 110.372 176.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 259' ' ' LYS . . . . . 0.515 ' N ' ' HD2' ' B' ' 259' ' ' LYS . 12.2 mptt -74.16 -26.23 60.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.559 -175.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 260' ' ' LEU . . . . . 0.506 HD12 ' HA ' ' B' ' 257' ' ' ARG . 95.9 mt -67.79 -48.21 66.94 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.479 176.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 14.4 t -66.1 -37.59 86.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.891 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -51.2 -49.4 61.09 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.083 176.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 263' ' ' LEU . . . . . . . . . . . . . 87.7 mt -74.48 -30.39 61.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.547 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.42 -40.95 81.01 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -177.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -63.48 -35.48 80.58 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.24 0.543 . . . . 0.0 110.42 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -74.59 -6.74 50.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.471 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -116.16 -2.84 12.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.84 176.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 66.29 51.09 46.28 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.158 -0.544 . . . . 0.0 112.854 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -138.92 169.35 24.46 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.172 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . 0.434 ' HB3' ' OE1' ' B' ' 223' ' ' GLU . 46.0 mtmt -105.56 -66.56 0.98 Allowed 'General case' 0 C--O 1.223 -0.334 0 CA-C-O 121.017 0.437 . . . . 0.0 110.923 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 271' ' ' TYR . . . . . 0.63 ' HB3' ' HA ' ' B' ' 224' ' ' GLN . 16.0 m-85 -92.41 152.66 19.6 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -174.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 272' ' ' TYR . . . . . 0.566 ' O ' ' HG3' ' B' ' 224' ' ' GLN . 2.8 p90 -134.69 118.28 16.96 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.352 0.596 . . . . 0.0 110.203 175.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 273' ' ' HIS . . . . . 0.502 ' HA ' ' OE1' ' B' ' 224' ' ' GLN . 32.7 t-80 -87.84 101.21 13.49 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 274' ' ' ILE . . . . . 0.49 HG12 ' HB3' ' B' ' 288' ' ' ALA . 58.5 mt -74.17 106.44 4.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.314 -178.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 19.4 pt -85.66 -33.36 7.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.588 -175.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -151.58 124.13 8.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.703 0.287 . . . . 0.0 111.193 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -130.47 118.43 21.12 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 174.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -133.67 164.96 26.05 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.384 0.612 . . . . 0.0 111.064 -175.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -99.14 123.28 43.31 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.027 178.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 280' ' ' HIS . . . . . 0.457 ' HB3' ' HB2' ' B' ' 283' ' ' ASN . 12.1 t-80 -103.07 28.95 5.82 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.198 0.523 . . . . 0.0 110.067 -174.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 93.0 -108.3 3.64 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -178.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -83.23 4.3 7.16 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.666 2.244 . . . . 0.0 111.518 175.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 283' ' ' ASN . . . . . 0.457 ' HB2' ' HB3' ' B' ' 280' ' ' HIS . 15.6 m120 -126.16 142.02 51.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.484 -177.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -103.61 129.03 50.81 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 173.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 285' ' ' GLU . . . . . 0.691 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 31.2 mt-10 -121.95 113.97 20.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.787 0.327 . . . . 0.0 111.651 -178.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 286' ' ' ALA . . . . . 0.519 ' HB1' ' HB ' ' B' ' 243' ' ' VAL . . . -117.59 127.97 54.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.554 175.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 32.1 t -110.09 116.43 52.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.23 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 288' ' ' ALA . . . . . 0.517 ' HB1' ' HB2' ' B' ' 272' ' ' TYR . . . -128.31 139.24 52.52 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.131 0.491 . . . . 0.0 111.783 -177.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -91.9 123.46 35.29 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.352 177.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 16.5 t -90.78 127.4 43.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.461 -176.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -123.49 139.83 53.62 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.018 -177.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 292' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -106.39 165.77 11.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.106 172.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -60.48 152.1 26.65 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 175.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 294' ' ' ALA . . . . . . . . . . . . . . . -73.03 77.05 1.21 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.076 0.465 . . . . 0.0 110.534 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 295' ' ' THR . . . . . . . . . . . . . 11.2 t 179.72 -28.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.695 -178.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 296' ' ' LYS . . . . . 0.713 ' HD2' ' HG ' ' B' ' 297' ' ' LEU . 2.1 tmmm? -80.07 91.78 5.54 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 297' ' ' LEU . . . . . 0.802 HD13 ' HB2' ' A' ' 12' ' ' ALA . 75.4 mt 74.17 91.72 0.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.644 -1.162 . . . . 0.0 112.995 172.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 298' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -100.99 35.74 2.14 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 166.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 299' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -63.96 136.45 57.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.352 -1.294 . . . . 0.0 110.406 -175.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 300' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -69.52 103.95 2.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.081 0.467 . . . . 0.0 110.157 -179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 301' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -69.78 99.88 1.43 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.606 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 302' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -85.39 -13.19 50.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.847 176.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -120.48 104.11 9.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.559 175.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 60.6 t60 . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.071 -177.164 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.868 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.1 mttm 61.85 84.14 0.14 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.584 0.707 . . . . 0.0 111.548 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -98.04 108.77 21.55 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.917 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.0 tpt180 -125.03 115.51 20.65 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 177.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 60.3 mt 64.42 92.71 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.272 0 O-C-N 123.701 0.625 . . . . 0.0 110.737 -174.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 40.7 pt -138.37 179.03 3.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.708 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 56.26 50.7 12.88 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.923 175.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -113.22 145.87 40.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.36 178.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -141.93 110.97 6.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.832 0.348 . . . . 0.0 111.53 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 24.7 tp -137.6 41.86 2.35 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.735 0.779 . . . . 0.0 109.437 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.437 HD22 ' H ' ' B' ' 242' ' ' ASN . 0.3 OUTLIER -79.35 94.61 5.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.013 -177.696 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.42 116.47 4.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.417 177.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.6 t -173.47 134.39 0.51 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.162 177.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 56.4 t -107.94 101.79 13.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.869 0.366 . . . . 0.0 110.404 177.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -164.82 170.49 15.37 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.865 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.5 p -120.16 78.76 1.38 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.332 0.587 . . . . 0.0 110.484 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.606 ' HB3' ' OD2' ' B' ' 265' ' ' ASP . 65.8 m-85 -131.25 146.99 52.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.142 178.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.898 ' HA ' ' HA ' ' B' ' 262' ' ' GLU . 34.5 m -155.53 -25.34 0.11 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -177.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.4 p -141.36 116.88 10.22 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -174.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 59.4 tp -165.77 -53.56 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.329 176.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -153.67 -165.01 2.02 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.236 177.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 73.5 91.53 0.08 Allowed 'General case' 0 C--O 1.235 0.332 0 O-C-N 123.756 0.66 . . . . 0.0 111.369 176.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.697 ' HB3' ' HE2' ' A' ' 71' ' ' TYR . 42.8 mt-10 -133.88 160.67 36.95 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.38 176.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.58 ' CG ' ' HG3' ' B' ' 224' ' ' GLN . 0.0 OUTLIER 174.66 142.88 0.05 Allowed 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.539 0.525 . . . . 0.0 110.424 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.2 m -123.97 125.2 70.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 169.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.431 ' O ' HG13 ' A' ' 30' ' ' ILE . 8.2 t -99.38 -167.93 1.54 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.025 0.44 . . . . 0.0 110.915 -175.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.401 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -71.26 -36.62 71.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.321 -175.169 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -64.54 -50.33 67.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.058 -173.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -59.17 -36.07 74.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.426 -177.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 26' ' ' SER . 79.2 mt -57.19 -56.05 17.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.93 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.6 m -73.77 -30.51 62.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.749 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 17.6 t-160 -79.08 -51.84 9.01 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -174.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -93.03 -7.81 44.7 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 121.18 -0.208 . . . . 0.0 111.467 -174.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt 59.66 65.12 1.19 Allowed 'General case' 0 N--CA 1.463 0.212 0 O-C-N 123.555 0.534 . . . . 0.0 110.656 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.4 mt -65.47 144.49 57.0 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.54 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.482 ' HB ' ' HB3' ' A' ' 92' ' ' ASN . 95.3 t -73.23 112.56 9.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.06 0.457 . . . . 0.0 110.477 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.605 ' HD3' ' CE1' ' A' ' 91' ' ' TYR . 19.3 tptm -78.75 112.98 16.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.125 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.476 HG22 ' HA3' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -97.99 -13.19 8.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.816 -178.675 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 145.48 -170.81 26.71 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.293 -0.956 . . . . 0.0 112.571 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.479 HG21 ' HG2' ' A' ' 89' ' ' GLU . 52.2 m -137.17 139.38 41.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.632 0.253 . . . . 0.0 110.432 -178.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 34.5 pt -121.97 155.65 26.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.743 0.306 . . . . 0.0 110.201 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -141.18 140.53 34.05 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.218 0.533 . . . . 0.0 110.728 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 44.1 t -94.6 126.31 47.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.313 -0.858 . . . . 0.0 108.775 173.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.7 p -138.69 35.83 2.21 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.848 0.832 . . . . 0.0 108.894 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -99.75 159.73 14.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.942 -175.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.55 ' HA ' ' HA ' ' A' ' 83' ' ' ASN . 22.7 t -73.31 172.09 11.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.829 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.96 22.07 1.55 Allowed Glycine 0 CA--C 1.52 0.363 0 CA-C-N 116.178 -0.464 . . . . 0.0 113.366 -177.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -103.96 -21.78 9.33 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 173.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -102.41 -20.22 14.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.339 0.59 . . . . 0.0 109.63 178.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.3 mm -125.58 98.05 4.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.17 172.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.8 m -103.26 -66.54 0.93 Allowed 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.651 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.527 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 23.5 m -108.24 165.0 13.51 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.527 ' HD2' ' HB3' ' A' ' 52' ' ' SER . 11.2 Cg_endo -55.14 -32.49 80.2 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.581 2.188 . . . . 0.0 111.88 178.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.591 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 7.9 m -60.76 -43.25 98.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.896 177.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.505 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 18.3 m-20 -63.39 -36.49 83.88 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.536 -178.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.7 tp -60.86 -46.73 89.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.496 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.434 ' HD2' ' HG2' ' B' ' 223' ' ' GLU . 23.5 ttp180 -60.63 -42.65 97.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.44 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.591 ' HG2' ' O ' ' A' ' 54' ' ' SER . 31.3 mm-40 -63.05 -34.84 78.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.841 -179.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' ' 55' ' ' ASP . 42.9 mmtm -75.29 -43.54 50.6 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.806 0.336 . . . . 0.0 110.707 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.1 mt -62.69 -46.38 88.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.066 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.7 p -64.76 -40.05 94.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.994 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -58.8 -44.15 90.71 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.797 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.7 mt -74.49 -36.03 63.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.511 -179.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.38 -47.09 74.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.815 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -64.35 -35.36 80.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.069 0.462 . . . . 0.0 110.487 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -78.64 4.78 12.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.55 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.7 mmtm -119.45 3.95 11.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.779 0.323 . . . . 0.0 111.563 176.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.46 -17.46 58.41 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.215 174.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.476 ' HA3' HG22 ' A' ' 38' ' ' VAL . . . -92.47 179.73 40.51 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.846 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.549 ' HE2' ' HA ' ' A' ' 70' ' ' LYS . 9.2 mmpt? -122.18 -59.13 1.67 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.672 0.272 . . . . 0.0 110.456 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.697 ' HE2' ' HB3' ' A' ' 23' ' ' GLU . 95.2 m-85 -91.67 167.35 12.26 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.545 -175.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -146.3 157.65 43.82 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.794 0.33 . . . . 0.0 110.912 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.429 ' CD2' ' HA ' ' A' ' 26' ' ' SER . 40.6 t-80 -127.48 102.88 7.06 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.098 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.43 ' HA ' ' HA ' ' A' ' 88' ' ' ALA . 63.9 mt -63.81 127.24 23.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.466 176.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.4 pt -113.45 -14.6 10.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.857 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.448 ' HB3' ' HB ' ' A' ' 87' ' ' VAL . . . -150.2 123.83 9.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.733 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' B' ' 228' ' ' GLN . . . -135.34 108.34 7.63 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.445 HH11 ' HD3' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -149.6 171.98 15.77 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.578 -174.668 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -119.5 140.1 51.04 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -130.36 96.69 4.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.017 0.437 . . . . 0.0 110.08 -178.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 60.8 -125.36 38.09 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -175.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -90.6 20.51 0.97 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.852 2.368 . . . . 0.0 112.348 175.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.55 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 38.4 m-80 -123.86 151.88 42.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.361 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.422 ' CE2' ' HB3' ' A' ' 86' ' ' ALA . 83.6 t80 -111.21 120.45 42.32 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.049 178.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.569 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 26.2 mm-40 -102.03 110.62 22.64 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.403 -177.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.422 ' HB3' ' CE2' ' A' ' 84' ' ' PHE . . . -128.38 114.99 17.55 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.808 0.337 . . . . 0.0 110.768 177.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.448 ' HB ' ' HB3' ' A' ' 76' ' ' ALA . 48.3 t -105.68 117.37 51.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 120.77 0.319 . . . . 0.0 110.344 -178.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 74' ' ' ILE . . . -131.84 133.09 44.29 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.455 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.556 ' HB3' ' HE3' ' A' ' 37' ' ' LYS . 29.8 mt-10 -92.0 135.26 34.09 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.9 t -91.42 127.72 43.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -175.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.605 ' CE1' ' HD3' ' A' ' 37' ' ' LYS . 77.1 m-85 -128.14 136.98 51.89 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.336 0.589 . . . . 0.0 110.879 -178.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.482 ' HB3' ' HB ' ' A' ' 36' ' ' VAL . 8.0 t-20 -95.15 -176.86 3.94 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 174.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.439 ' CG ' ' H ' ' A' ' 94' ' ' ALA . 12.4 t70 -71.82 -166.97 0.24 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.439 ' H ' ' CG ' ' A' ' 93' ' ' ASP . . . -98.42 6.95 46.81 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 121.844 -0.535 . . . . 0.0 110.563 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.7 t -112.5 159.96 18.27 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.545 -178.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -131.77 9.14 4.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.744 177.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 85.8 mt -101.95 101.99 12.48 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.045 -173.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -117.38 -98.81 0.45 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 56.4 m80 -155.38 -47.48 0.08 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 175.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -129.3 95.17 3.96 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.358 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.403 ' O ' ' HB2' ' A' ' 102' ' ' HIS . 51.0 p-80 -124.71 38.65 4.15 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.119 -173.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.403 ' HB2' ' O ' ' A' ' 101' ' ' HIS . 91.9 m-70 70.38 -170.94 0.17 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.654 -177.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 22.6 p-80 -116.66 159.81 21.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.708 0.289 . . . . 0.0 110.321 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 . . . . . 0 C--N 1.322 -0.626 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.762 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 51.4 ttm . . . . . 0 N--CA 1.477 0.889 0 CA-C-O 120.99 0.424 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -125.4 -28.36 3.35 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 175.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -74.2 110.81 8.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.632 176.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -161.42 99.14 1.16 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.834 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 205' ' ' ILE . . . . . 0.763 HG12 HG13 ' B' ' 206' ' ' ILE . 14.7 tt -91.59 143.65 10.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.893 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . 0.763 HG13 HG12 ' B' ' 205' ' ' ILE . 73.8 mt 71.85 114.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 123.383 0.673 . . . . 0.0 112.19 177.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -140.05 108.56 5.88 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.14 175.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -90.63 102.9 15.64 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.354 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -89.76 -45.99 8.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.738 -174.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 210' ' ' LEU . . . . . . . . . . . . . 31.6 tp -83.99 74.61 10.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.292 0.568 . . . . 0.0 111.003 -176.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 67.8 mt -131.86 104.48 6.89 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.06 175.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -83.24 139.69 32.96 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.099 176.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 213' ' ' THR . . . . . 0.635 HG21 ' H ' ' B' ' 215' ' ' ALA . 29.0 m -133.48 130.78 39.04 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.986 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 214' ' ' VAL . . . . . . . . . . . . . 26.9 m -87.41 10.83 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.122 0.487 . . . . 0.0 110.979 -178.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . 0.635 ' H ' HG21 ' B' ' 213' ' ' THR . . . -80.34 99.91 8.15 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.979 176.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 49.8 m -145.03 98.75 3.22 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.787 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -133.19 149.71 52.02 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 218' ' ' SER . . . . . . . . . . . . . 9.5 m -66.32 92.93 0.2 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.052 0.453 . . . . 0.0 110.023 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 14.9 t -101.01 141.99 33.12 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.798 -175.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 59.5 tp -106.47 83.02 1.81 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 177.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . 0.587 ' HA ' ' OE2' ' A' ' 23' ' ' GLU . . . -172.16 34.56 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.922 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -157.71 82.01 0.88 Allowed 'General case' 0 C--O 1.234 0.242 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -171.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . 0.434 ' HG2' ' HD2' ' A' ' 57' ' ' ARG . 28.9 mt-10 -138.8 164.96 28.25 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 173.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 224' ' ' GLN . . . . . 0.58 ' HG3' ' CG ' ' A' ' 24' ' ' GLN . 26.1 tt0 179.6 146.99 0.22 Allowed 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.405 0.441 . . . . 0.0 111.247 175.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . 0.504 ' N ' ' HG2' ' B' ' 224' ' ' GLN . 17.2 m -141.94 139.73 30.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 167.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 226' ' ' SER . . . . . 0.709 ' HA ' ' CD2' ' B' ' 273' ' ' HIS . 4.5 m -109.21 -89.81 0.47 Allowed 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.954 -0.299 . . . . 0.0 111.658 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . 0.428 ' HZ1' ' CD ' ' B' ' 289' ' ' GLU . 14.5 mmtm -154.66 -41.83 0.09 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.079 0.466 . . . . 0.0 109.774 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 228' ' ' GLN . . . . . 0.444 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -63.39 -44.19 95.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.191 -178.254 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -65.62 -40.0 92.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.6 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.535 HG22 ' HB2' ' B' ' 235' ' ' LEU . 77.6 mt -66.82 -38.05 80.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.497 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 30.7 t -71.38 -25.66 62.46 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.956 177.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -87.86 -46.69 9.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.983 -175.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . 0.462 ' CD1' ' HD3' ' A' ' 53' ' ' PRO . 68.6 m-85 -94.09 -7.39 42.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.401 -177.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt 61.08 74.1 0.46 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.523 174.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . 0.535 ' HB2' HG22 ' B' ' 230' ' ' ILE . 68.1 mt -88.89 176.41 7.04 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.808 0.337 . . . . 0.0 111.211 -177.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 59.4 t -101.89 123.71 55.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.057 -177.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 237' ' ' LYS . . . . . 0.648 ' HD3' ' CZ ' ' B' ' 291' ' ' TYR . 18.9 tptm -82.74 111.85 19.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.763 177.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 238' ' ' VAL . . . . . 0.44 HG21 HG12 ' B' ' 290' ' ' VAL . 0.4 OUTLIER -104.84 14.37 7.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -176.113 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 128.2 -162.53 21.94 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.279 -0.963 . . . . 0.0 113.216 173.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 89.4 m -149.08 135.61 19.46 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 26.7 pt -110.18 146.07 15.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.311 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 242' ' ' ASN . . . . . 0.437 ' H ' HD22 ' A' ' 11' ' ' LEU . 37.6 t-20 -130.56 114.94 16.09 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.715 -178.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 243' ' ' VAL . . . . . 0.538 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 76.7 t -94.4 109.34 21.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.287 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 10.2 p -119.71 105.34 11.06 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 176.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 245' ' ' GLN . . . . . 0.436 ' HB3' ' OE1' ' B' ' 249' ' ' GLN . 75.3 mt-30 -111.5 -174.78 2.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.865 -172.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 23.4 m -151.79 102.8 2.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.426 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 102.93 -164.48 16.02 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.423 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -83.85 58.45 5.01 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.228 -0.511 . . . . 0.0 112.704 -176.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . 0.436 ' OE1' ' HB3' ' B' ' 245' ' ' GLN . 53.9 mt-30 -80.27 -15.81 56.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.875 0.369 . . . . 0.0 110.395 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 250' ' ' ILE . . . . . 0.498 HD12 ' HA ' ' B' ' 256' ' ' LEU . 47.9 mm -113.59 114.34 46.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 173.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 16.3 t -108.07 -13.95 14.83 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.146 -176.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 252' ' ' SER . . . . . 0.439 ' O ' ' HB3' ' B' ' 255' ' ' ASP . 46.7 m -152.71 158.65 33.11 Favored Pre-proline 0 C--N 1.326 -0.415 0 O-C-N 122.382 -0.199 . . . . 0.0 110.617 -177.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -58.66 -50.49 9.2 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.809 2.34 . . . . 0.0 111.876 175.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 254' ' ' SER . . . . . 0.688 ' O ' ' HG3' ' B' ' 257' ' ' ARG . 41.4 t -58.31 -36.35 73.22 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.02 0.438 . . . . 0.0 110.629 174.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.439 ' HB3' ' O ' ' B' ' 252' ' ' SER . 20.2 t0 -60.78 -43.62 97.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.355 178.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . 0.498 ' HA ' HD12 ' B' ' 250' ' ' ILE . 55.3 tp -61.51 -44.4 97.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.278 178.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 257' ' ' ARG . . . . . 0.688 ' HG3' ' O ' ' B' ' 254' ' ' SER . 0.7 OUTLIER -66.26 -30.91 71.43 Favored 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 120.411 -0.515 . . . . 0.0 110.372 -177.346 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 258' ' ' GLU . . . . . 0.5 ' HG3' ' O ' ' B' ' 254' ' ' SER . 49.5 mt-10 -68.76 -27.06 65.57 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.946 0.403 . . . . 0.0 110.651 178.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -75.01 -34.35 61.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.27 0.557 . . . . 0.0 110.273 174.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 260' ' ' LEU . . . . . 0.442 ' CD1' HD11 ' B' ' 274' ' ' ILE . 79.1 mt -74.04 -46.71 41.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.421 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 25.0 m -60.39 -34.21 73.58 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.108 175.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 262' ' ' GLU . . . . . 0.898 ' HA ' ' HA ' ' A' ' 18' ' ' SER . 34.6 tt0 -54.81 -48.64 72.5 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.085 0.469 . . . . 0.0 110.589 176.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 263' ' ' LEU . . . . . 0.402 ' O ' ' HB2' ' B' ' 267' ' ' LYS . 86.6 mt -73.82 -38.13 64.65 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.171 -178.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.59 -44.68 61.7 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -177.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 265' ' ' ASP . . . . . 0.606 ' OD2' ' HB3' ' A' ' 17' ' ' PHE . 25.0 t0 -67.77 -39.65 84.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.275 -178.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -72.36 -24.03 61.21 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.03 177.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 267' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' B' ' 263' ' ' LEU . 11.8 mmtt -78.21 -50.35 12.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.591 177.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 268' ' ' GLY . . . . . 0.431 ' HA3' ' NE2' ' B' ' 302' ' ' HIS . . . 118.88 33.09 1.2 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.686 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -132.66 133.07 6.88 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 176.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -93.52 8.5 40.46 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -167.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 271' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -146.78 146.67 30.34 Favored 'General case' 0 C--N 1.33 -0.239 0 O-C-N 122.312 -0.242 . . . . 0.0 110.675 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 272' ' ' TYR . . . . . 0.449 ' CE1' ' HB3' ' A' ' 24' ' ' GLN . 37.1 p90 -141.19 159.87 41.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.877 0.37 . . . . 0.0 110.965 177.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 273' ' ' HIS . . . . . 0.709 ' CD2' ' HA ' ' B' ' 226' ' ' SER . 12.4 t-80 -136.14 111.97 9.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.567 -178.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 274' ' ' ILE . . . . . 0.442 HD11 ' CD1' ' B' ' 260' ' ' LEU . 77.4 mt -78.26 113.29 17.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.872 0.368 . . . . 0.0 110.456 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 9.0 pt -97.09 -27.2 3.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.294 -178.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -150.07 130.71 14.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.467 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 277' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' B' ' 285' ' ' GLU . . . -153.37 117.9 4.95 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -157.56 175.48 13.88 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.064 0.459 . . . . 0.0 110.795 -178.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -109.24 124.75 51.38 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.325 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -112.74 87.67 2.64 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 173.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 69.84 -124.71 15.14 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 -175.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -84.37 -3.28 10.11 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.656 2.237 . . . . 0.0 112.036 175.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -100.2 116.5 32.35 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.082 -174.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -90.52 126.44 35.93 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 175.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 285' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' B' ' 277' ' ' ALA . 9.2 mm-40 -116.02 110.54 19.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.781 -176.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 286' ' ' ALA . . . . . 0.538 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -118.86 115.72 24.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.857 0.361 . . . . 0.0 111.092 174.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 27.2 t -110.21 124.34 66.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.268 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -135.93 148.08 48.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.236 0.541 . . . . 0.0 111.673 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 289' ' ' GLU . . . . . 0.525 ' HB3' ' HE3' ' B' ' 237' ' ' LYS . 31.8 mt-10 -89.73 143.58 26.69 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 290' ' ' VAL . . . . . 0.44 HG12 HG21 ' B' ' 238' ' ' VAL . 10.6 t -107.79 123.31 63.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 291' ' ' TYR . . . . . 0.648 ' CZ ' ' HD3' ' B' ' 237' ' ' LYS . 77.0 m-85 -127.31 148.88 50.23 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.253 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 292' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -124.12 162.64 23.14 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 11.9 p30 -63.95 151.54 42.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.584 0.707 . . . . 0.0 112.336 -174.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 294' ' ' ALA . . . . . 0.468 ' HB3' ' HA ' ' B' ' 235' ' ' LEU . . . -85.25 58.57 5.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.595 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 295' ' ' THR . . . . . . . . . . . . . 7.3 t -161.89 -25.44 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.578 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 97.3 mttt 73.21 72.44 0.13 Allowed 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.682 170.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 297' ' ' LEU . . . . . . . . . . . . . 71.9 mt -134.01 96.7 3.69 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.611 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 298' ' ' GLU . . . . . 0.638 ' HG3' ' HB2' ' B' ' 302' ' ' HIS . 2.5 tm-20 -90.3 156.71 18.08 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 299' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -69.99 -29.04 66.03 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.012 0.434 . . . . 0.0 110.605 -172.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 300' ' ' HIS . . . . . 0.428 ' H ' ' CD ' ' B' ' 298' ' ' GLU . 2.7 m-70 -107.03 -104.61 0.34 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.346 -0.388 . . . . 0.0 109.987 170.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 301' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -156.02 97.27 1.79 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 302' ' ' HIS . . . . . 0.638 ' HB2' ' HG3' ' B' ' 298' ' ' GLU . 28.6 t-80 -81.4 141.14 34.23 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.872 0.368 . . . . 0.0 111.329 -172.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 34.9 t60 -71.45 120.75 17.48 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.012 175.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 7.3 p80 . . . . . 0 C--N 1.321 -0.654 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.038 177.746 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.481 1.079 0 CA-C-O 120.641 0.258 . . . . 0.0 110.601 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -127.6 158.92 36.2 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 -177.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.698 ' HD3' HG22 ' B' ' 287' ' ' VAL . 52.0 mttp -121.25 -77.4 0.58 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.584 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . 29.1 mmt180 -141.82 -33.08 0.51 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.11 177.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 63.4 mt 64.18 88.17 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.317 -177.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 72.2 mt 66.82 -81.06 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.271 -175.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.584 ' HB3' ' HB3' ' A' ' 4' ' ' ARG . . . 66.1 147.56 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.839 0.828 . . . . 0.0 112.899 177.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -106.89 101.05 10.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.261 173.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.94 137.53 41.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.57 -175.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -90.31 143.8 26.42 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.573 176.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.2 tp -123.07 141.99 51.36 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.757 0.313 . . . . 0.0 110.343 -177.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -93.46 110.93 22.49 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.317 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.9 p -83.91 86.63 7.14 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.35 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.0 m -132.84 -169.6 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.311 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.01 67.48 1.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.249 0.547 . . . . 0.0 111.56 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.1 m -119.23 111.02 17.7 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.891 176.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -135.62 -76.25 0.44 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.534 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.474 ' O ' ' HB ' ' A' ' 19' ' ' THR . 20.3 m 56.26 -103.38 0.18 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.552 -175.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 18' ' ' SER . 8.8 t 163.9 -41.03 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 123.504 0.722 . . . . 0.0 109.062 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.564 HD12 HH21 ' B' ' 257' ' ' ARG . 83.9 mt -147.24 -125.46 0.06 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 62.68 49.07 3.97 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.268 0.556 . . . . 0.0 110.906 176.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -177.96 90.59 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.594 -1.184 . . . . 0.0 108.626 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.493 ' HB2' ' CE1' ' A' ' 71' ' ' TYR . 8.7 pt-20 -165.29 125.43 1.86 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -169.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.616 ' HA ' ' HB3' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -161.71 159.08 26.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.506 174.522 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.479 HG22 ' HB2' ' A' ' 71' ' ' TYR . 17.1 m -128.32 130.91 69.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.353 174.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.49 ' O ' HG13 ' A' ' 30' ' ' ILE . 15.4 m -97.56 173.95 6.89 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.382 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -66.58 -15.16 63.22 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.556 -174.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.449 ' HB2' ' OE1' ' A' ' 29' ' ' GLU . 41.9 mt-30 -71.57 -50.81 27.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.405 0.621 . . . . 0.0 109.527 177.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.463 ' OE1' ' HB2' ' A' ' 26' ' ' SER . 1.9 mp0 -70.44 -41.28 73.05 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.901 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 26' ' ' SER . 94.7 mt -56.21 -48.67 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.353 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.1 m -72.34 -30.12 64.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.08 0.467 . . . . 0.0 110.727 -177.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -74.87 -40.85 60.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.498 -177.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -96.88 -0.01 48.43 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -175.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm 57.87 51.45 9.08 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.03 0.443 . . . . 0.0 110.033 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.838 HD23 ' HG2' ' B' ' 253' ' ' PRO . 56.4 mt -68.62 169.58 10.83 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.622 0.725 . . . . 0.0 112.78 -172.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.7 t -100.04 117.88 45.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.293 -175.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.407 ' HE2' ' OE1' ' A' ' 89' ' ' GLU . 60.8 tttm -83.14 107.65 15.85 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 176.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.5 m -90.69 -11.68 9.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -175.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 138.07 -168.02 24.71 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 119.892 -1.147 . . . . 0.0 113.092 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 24.0 m -123.55 144.54 49.5 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -178.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.6 pt -110.84 157.54 11.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.674 0.273 . . . . 0.0 110.439 178.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -117.98 136.71 53.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.126 0.489 . . . . 0.0 111.921 -171.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.583 ' HB ' ' HB2' ' A' ' 86' ' ' ALA . 85.5 t -122.45 113.45 38.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.849 169.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.0 t -150.85 77.2 1.27 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.186 0.517 . . . . 0.0 110.053 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -137.73 163.64 30.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.992 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.511 ' HA ' ' HA ' ' A' ' 83' ' ' ASN . 26.4 t -73.18 163.83 27.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.643 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.97 -16.97 58.02 Favored Glycine 0 C--N 1.333 0.393 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.48 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.46 -19.63 68.95 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.215 176.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -102.0 -28.37 12.41 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.676 0.274 . . . . 0.0 111.01 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 43.5 mm -119.35 107.33 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-O 121.219 0.533 . . . . 0.0 110.479 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.8 m -128.98 -28.64 2.38 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.967 -178.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.8 m -121.68 156.08 59.16 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.192 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.433 ' HG2' ' HB2' ' B' ' 293' ' ' ASP . 32.5 Cg_exo -59.88 -24.43 76.08 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.729 2.286 . . . . 0.0 112.087 177.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.513 ' O ' ' HG3' ' A' ' 58' ' ' GLU . 24.1 p -62.76 -39.91 95.63 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.471 177.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.568 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 16.3 m-20 -61.69 -51.79 66.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.304 -175.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.429 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 57.6 tp -57.03 -44.82 83.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.653 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.5 ttp180 -53.25 -53.59 48.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.516 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.513 ' HG3' ' O ' ' A' ' 54' ' ' SER . 72.4 mt-10 -67.5 -27.27 66.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.021 -171.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.568 ' HG2' ' O ' ' A' ' 55' ' ' ASP . 46.9 mmtt -71.05 -45.64 63.47 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 56' ' ' LEU . 82.1 mt -65.53 -43.86 88.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.227 -176.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.9 p -62.88 -41.47 99.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.74 0.305 . . . . 0.0 111.383 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -64.67 -46.36 82.76 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.173 0.511 . . . . 0.0 110.223 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 59' ' ' LYS . 81.2 mt -67.87 -34.74 77.26 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.464 -178.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.72 -46.73 77.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.693 -178.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -67.38 -25.81 66.15 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.84 0.352 . . . . 0.0 110.992 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.77 -28.96 68.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.261 0.553 . . . . 0.0 110.237 176.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -86.18 -13.43 47.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.742 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.76 -9.04 73.8 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.914 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.24 172.5 54.41 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 121.221 -0.514 . . . . 0.0 112.146 -178.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -117.35 -62.8 1.52 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.966 0.412 . . . . 0.0 110.671 -176.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.616 ' HB3' ' HA ' ' A' ' 24' ' ' GLN . 4.5 m-85 -98.17 148.1 23.91 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -176.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.428 ' CE2' ' HA ' ' B' ' 223' ' ' GLU . 32.7 p90 -121.8 156.98 32.04 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 177.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -135.25 115.93 13.85 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.569 -177.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.6 mp -73.31 132.06 33.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.511 HD11 ' HA ' ' B' ' 205' ' ' ILE . 26.6 pt -117.37 -27.74 2.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.589 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -152.96 133.53 13.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.616 0.245 . . . . 0.0 110.684 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.493 ' HB3' ' HG3' ' B' ' 228' ' ' GLN . . . -150.55 142.74 24.14 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -164.87 147.99 8.56 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.033 0.444 . . . . 0.0 111.048 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -78.29 111.33 14.16 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 169.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -115.06 82.14 1.69 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.049 0.452 . . . . 0.0 110.349 -174.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.04 -128.75 8.74 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.6 -178.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -81.43 -6.15 12.7 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.572 2.181 . . . . 0.0 112.893 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.511 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 81.9 m-20 -121.07 154.52 36.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.079 0.466 . . . . 0.0 111.276 -175.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -104.29 118.39 36.51 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.585 176.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -102.4 124.92 48.83 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.05 -176.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.583 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . . . -137.36 129.8 29.72 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.231 0.539 . . . . 0.0 110.917 178.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.9 t -113.24 118.83 59.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.973 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.59 138.24 39.34 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.121 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 40' ' ' THR . 51.1 mt-10 -98.96 153.91 18.47 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 178.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.9 t -112.27 138.45 41.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -125.26 148.57 48.61 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.086 0.47 . . . . 0.0 110.595 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -118.27 164.73 14.76 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.508 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -74.44 150.8 39.77 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.41 25.85 0.59 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.774 0.321 . . . . 0.0 111.845 -171.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.1 t -103.11 -12.72 17.18 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.09 0.471 . . . . 0.0 111.128 -176.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.46 ' HB3' ' HZ2' ' A' ' 96' ' ' LYS . 9.7 mtpm? -86.12 179.45 6.95 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.407 -176.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.4 pp -86.15 -1.79 57.75 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 113.099 0.778 . . . . 0.0 113.099 -167.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -55.41 126.26 24.34 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 63.7 m80 -66.5 106.22 1.7 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.994 -171.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 56.2 p-80 -139.62 -16.78 1.01 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.772 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 43.2 m80 65.87 177.33 0.21 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.848 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -143.64 98.02 3.17 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.483 0.659 . . . . 0.0 109.992 173.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 63.1 t60 -55.61 127.81 31.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.767 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 . . . . . 0 C--N 1.325 -0.496 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.883 175.633 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 201' ' ' MET . . . . . 0.688 ' SD ' ' HG3' ' B' ' 202' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . 0.688 ' HG3' ' SD ' ' B' ' 201' ' ' MET . 85.6 mttt 72.27 134.65 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 O-C-N 124.058 0.849 . . . . 0.0 111.981 -176.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -105.82 68.1 0.77 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.678 170.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 38.9 ptt85 -75.81 145.79 40.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.992 177.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 205' ' ' ILE . . . . . 0.511 ' HA ' HD11 ' A' ' 75' ' ' ILE . 24.0 pt -125.21 136.99 59.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.017 0.437 . . . . 0.0 111.234 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 60.5 mt -121.54 90.89 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 173.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -93.25 80.72 4.45 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.034 0.445 . . . . 0.0 110.867 -176.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -116.77 93.99 4.42 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.043 177.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -115.18 107.77 15.73 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.234 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 210' ' ' LEU . . . . . . . . . . . . . 31.7 tp -126.74 100.33 6.14 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.361 -175.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 11.0 mp 70.2 143.02 0.05 Allowed 'General case' 0 N--CA 1.469 0.522 0 O-C-N 124.03 0.831 . . . . 0.0 112.223 177.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -85.75 176.61 8.04 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.898 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 213' ' ' THR . . . . . . . . . . . . . 12.5 t -115.68 169.86 8.88 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 214' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.2 134.65 29.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 177.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -73.86 88.66 1.82 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.236 0.541 . . . . 0.0 111.327 -175.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 36.0 m -143.74 152.9 41.84 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.151 176.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -151.28 150.81 30.99 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.924 0.392 . . . . 0.0 110.576 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 218' ' ' SER . . . . . . . . . . . . . 3.1 m -118.22 159.49 23.23 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.981 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 2.8 p -76.54 79.31 3.23 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.317 0.58 . . . . 0.0 110.642 176.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 86.8 mt -104.76 179.63 4.21 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.492 -177.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -126.11 107.1 10.07 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.567 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . 178.71 109.37 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . 0.428 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 10.8 pt-20 -173.0 140.65 0.92 Allowed 'General case' 0 C--O 1.235 0.31 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -167.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 224' ' ' GLN . . . . . 0.476 ' HA ' ' HB3' ' B' ' 271' ' ' TYR . 0.0 OUTLIER -175.57 156.73 1.97 Allowed 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.612 173.365 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 28.3 m -116.45 141.51 33.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.769 0.319 . . . . 0.0 110.811 177.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 47.9 t -83.83 -92.96 0.07 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.111 -176.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . 0.408 ' HA ' HD12 ' B' ' 230' ' ' ILE . 26.2 ttpt -151.48 -39.68 0.12 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.962 0.411 . . . . 0.0 110.895 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 228' ' ' GLN . . . . . 0.493 ' HG3' ' HB3' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -63.75 -35.09 79.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.424 179.876 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 229' ' ' GLU . . . . . 0.465 ' OE1' ' HG2' ' B' ' 228' ' ' GLN . 2.4 mp0 -69.68 -37.93 76.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.831 176.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.512 HG12 HD12 ' B' ' 235' ' ' LEU . 63.3 mt -59.05 -45.18 92.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.642 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 16.5 m -73.13 -37.68 66.57 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.861 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -70.37 -48.54 55.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.435 -176.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -94.45 5.43 51.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.438 -175.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt 55.68 45.13 25.22 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.92 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . 0.557 HD21 ' HA ' ' B' ' 293' ' ' ASP . 72.7 mt -58.27 148.82 26.04 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.509 -175.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 61.9 t -97.29 117.92 42.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.01 -174.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -80.82 113.63 19.15 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.14 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 18.9 m -85.89 -34.94 8.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -176.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 166.02 179.77 39.72 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.637 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 240' ' ' THR . . . . . 0.452 HG23 ' HG2' ' B' ' 289' ' ' GLU . 54.3 m -113.45 135.84 53.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.698 0.285 . . . . 0.0 110.583 -178.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 30.1 pt -107.77 131.19 58.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 171.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -120.19 113.79 20.96 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.997 -174.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 243' ' ' VAL . . . . . 0.55 ' HB ' ' HB2' ' B' ' 286' ' ' ALA . 84.2 t -95.12 119.61 43.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.353 -177.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 22.6 t -115.64 86.1 2.4 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 170.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 245' ' ' GLN . . . . . 0.54 ' HG2' HG12 ' B' ' 250' ' ' ILE . 0.3 OUTLIER -81.63 106.47 13.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.946 -173.22 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 13.9 m -88.13 103.69 15.98 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.68 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 94.69 -162.69 24.42 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.146 174.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -82.54 63.73 4.39 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.554 -0.355 . . . . 0.0 113.591 -173.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . 0.489 ' HB2' ' HG3' ' B' ' 245' ' ' GLN . 72.6 mt-30 -96.09 -2.8 45.88 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.126 0.488 . . . . 0.0 109.911 172.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 250' ' ' ILE . . . . . 0.54 HG12 ' HG2' ' B' ' 245' ' ' GLN . 48.9 mm -128.36 125.54 64.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.116 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 1.1 m -112.09 -57.79 2.22 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.457 0.646 . . . . 0.0 109.668 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 252' ' ' SER . . . . . 0.485 ' HB3' ' HD2' ' B' ' 253' ' ' PRO . 50.7 m -127.01 175.12 3.55 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.362 176.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . 0.838 ' HG2' HD23 ' A' ' 35' ' ' LEU . 52.2 Cg_exo -55.09 -28.63 61.56 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.288 1.992 . . . . 0.0 112.315 175.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 254' ' ' SER . . . . . 0.565 ' O ' ' HB3' ' B' ' 257' ' ' ARG . 56.3 m -65.74 -26.19 67.62 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.777 178.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.573 ' O ' ' HD3' ' B' ' 259' ' ' LYS . 2.6 m-20 -70.82 -49.39 46.84 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.154 0.502 . . . . 0.0 109.661 176.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 41.2 tp -62.5 -31.31 72.04 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.024 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 257' ' ' ARG . . . . . 0.565 ' HB3' ' O ' ' B' ' 254' ' ' SER . 50.7 ttt85 -51.19 -51.4 54.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.117 175.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 258' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -59.72 -51.99 67.41 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.138 0.494 . . . . 0.0 110.317 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 259' ' ' LYS . . . . . 0.573 ' HD3' ' O ' ' B' ' 255' ' ' ASP . 12.1 mptt -59.56 -43.7 93.5 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.245 -174.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 260' ' ' LEU . . . . . 0.501 HD13 ' CE2' ' B' ' 272' ' ' TYR . 96.5 mt -74.26 -43.62 56.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.179 -177.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 32.9 t -63.39 -37.97 89.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.677 0.275 . . . . 0.0 110.482 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -60.95 -52.96 62.8 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.46 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 263' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' B' ' 259' ' ' LYS . 81.1 mt -68.84 -40.19 79.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.282 -176.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -61.25 -52.53 64.36 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -175.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -69.48 -32.25 71.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.875 0.369 . . . . 0.0 110.413 -176.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -68.1 -24.23 65.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.007 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -84.96 0.4 51.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.531 176.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 74.82 34.16 53.78 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.798 -178.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . 0.42 ' HA2' ' OD1' ' B' ' 292' ' ' ASN . . . -127.79 163.83 21.35 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 121.051 -0.595 . . . . 0.0 111.957 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . 0.764 ' HA ' ' HZ3' ' B' ' 270' ' ' LYS . 1.0 OUTLIER -108.34 -66.55 1.03 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.782 0.325 . . . . 0.0 111.276 178.427 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 271' ' ' TYR . . . . . 0.476 ' HB3' ' HA ' ' B' ' 224' ' ' GLN . 4.9 m-85 -92.61 140.79 29.18 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -173.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 272' ' ' TYR . . . . . 0.501 ' CE2' HD13 ' B' ' 260' ' ' LEU . 55.0 p90 -125.17 131.38 53.23 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 176.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -104.34 107.91 19.06 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.114 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 274' ' ' ILE . . . . . . . . . . . . . 69.6 mt -70.21 123.14 23.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.191 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 34.0 pt -100.17 -26.55 3.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.706 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -153.76 123.71 6.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.826 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -143.58 117.97 9.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.261 178.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.8 159.02 13.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.948 0.404 . . . . 0.0 111.404 -177.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -84.65 138.58 32.6 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 172.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -114.7 26.84 9.87 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 173.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 115.49 -125.94 6.92 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -175.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.16 -10.5 22.69 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.457 2.104 . . . . 0.0 111.481 175.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 283' ' ' ASN . . . . . 0.451 ' HA ' ' O ' ' B' ' 245' ' ' GLN . 80.3 m-20 -109.64 125.54 52.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.817 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 284' ' ' PHE . . . . . 0.436 ' CE2' ' HB3' ' B' ' 286' ' ' ALA . 71.6 t80 -101.46 121.99 42.95 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.387 178.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 285' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -98.13 113.82 25.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.096 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 286' ' ' ALA . . . . . 0.55 ' HB2' ' HB ' ' B' ' 243' ' ' VAL . . . -125.63 116.02 21.05 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.867 0.365 . . . . 0.0 110.158 172.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 287' ' ' VAL . . . . . 0.698 HG22 ' HD3' ' A' ' 3' ' ' LYS . 21.4 t -113.3 114.68 47.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.247 -178.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -129.35 133.65 47.52 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.451 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 289' ' ' GLU . . . . . 0.452 ' HG2' HG23 ' B' ' 240' ' ' THR . 14.1 mt-10 -106.48 128.17 53.87 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 25.0 t -90.31 135.63 25.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.102 0.477 . . . . 0.0 111.202 -171.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -127.26 133.68 50.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.676 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 292' ' ' ASN . . . . . 0.42 ' OD1' ' HA2' ' B' ' 269' ' ' GLY . 54.2 m-20 -106.16 161.6 14.38 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.305 174.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 293' ' ' ASP . . . . . 0.557 ' HA ' HD21 ' B' ' 235' ' ' LEU . 9.3 p-10 -64.2 -62.2 1.76 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.618 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 294' ' ' ALA . . . . . 0.467 ' H ' ' CG ' ' B' ' 293' ' ' ASP . . . 176.22 6.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.208 0.603 . . . . 0.0 112.236 177.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 295' ' ' THR . . . . . 0.544 HG22 ' OD1' ' B' ' 293' ' ' ASP . 8.9 t -96.04 -47.76 5.96 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.815 -0.553 . . . . 0.0 112.213 -174.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 12.2 mmmt 68.83 -52.24 0.57 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.957 0.503 . . . . 0.0 111.513 -174.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 297' ' ' LEU . . . . . . . . . . . . . 73.9 mt -85.57 -179.56 6.92 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.434 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 298' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 61.65 90.09 0.07 Allowed 'General case' 0 C--N 1.331 -0.212 0 O-C-N 123.882 0.739 . . . . 0.0 110.367 -174.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 299' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -80.23 72.24 7.05 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 176.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 300' ' ' HIS . . . . . . . . . . . . . 5.5 t60 74.24 -52.97 0.69 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.055 -175.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 301' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -154.2 110.06 3.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.736 0.303 . . . . 0.0 110.805 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 302' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -149.88 81.83 1.39 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 174.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 62.54 81.31 0.2 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.15 -174.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 . . . . . 0 C--N 1.322 -0.589 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.006 -177.533 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.7 ttp . . . . . 0 N--CA 1.481 1.084 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -75.5 14.62 0.58 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -149.9 119.59 7.02 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.53 -172.21 2.04 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.912 176.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.62 137.67 56.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.048 0.452 . . . . 0.0 110.186 -176.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.8 tt -129.97 114.91 31.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.345 0.593 . . . . 0.0 110.06 177.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -119.09 -174.01 2.62 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.305 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 60.84 63.05 1.35 Allowed 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.92 0.762 . . . . 0.0 111.236 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.01 128.11 35.19 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.766 178.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 80.5 mt -80.34 73.22 7.22 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.711 -177.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 98.2 mt -119.81 128.97 54.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.054 178.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.81 118.28 23.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.491 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.468 ' HB ' ' HE1' ' B' ' 301' ' ' HIS . 11.1 p -58.0 134.87 56.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.917 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.1 m -88.51 174.36 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.251 176.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.65 104.68 2.04 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.073 0.463 . . . . 0.0 110.319 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.1 p -128.57 154.14 46.49 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.981 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -84.62 150.92 24.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.971 0.415 . . . . 0.0 111.253 -174.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.2 m -100.53 174.73 5.95 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 173.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.409 HG22 ' NH1' ' A' ' 57' ' ' ARG . 18.8 p -78.39 141.16 38.55 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.044 0.449 . . . . 0.0 110.997 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.632 HD23 HH22 ' B' ' 257' ' ' ARG . 51.4 tp -82.71 80.28 8.86 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 175.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.473 ' HB3' ' OE2' ' B' ' 223' ' ' GLU . . . -95.54 -159.07 0.69 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.508 -174.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 67.6 73.6 0.32 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.968 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.505 ' O ' ' HB2' ' A' ' 24' ' ' GLN . 30.9 mt-10 -140.42 165.64 26.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.54 176.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.505 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER 174.69 136.63 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 O-C-N 123.791 0.682 . . . . 0.0 109.775 171.017 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.0 m -128.24 116.0 40.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.167 0.508 . . . . 0.0 110.479 173.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.438 ' O ' HG13 ' A' ' 30' ' ' ILE . 0.7 OUTLIER -91.29 169.89 10.44 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.099 -178.91 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.5 mmtp -68.99 -20.24 64.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.472 -177.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.11 -49.8 66.25 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 177.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -66.39 -43.89 84.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.317 176.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.499 HG12 HD13 ' A' ' 35' ' ' LEU . 90.2 mt -58.6 -46.84 89.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.437 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.9 t -72.88 -26.63 61.51 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.999 0.428 . . . . 0.0 110.611 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -73.83 -51.37 16.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.08 -177.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -85.47 -13.52 48.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.95 -178.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt 62.74 68.17 0.66 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.989 -176.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.525 HD21 ' HG2' ' B' ' 253' ' ' PRO . 63.0 mt -79.79 162.63 24.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.463 -176.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.437 HG11 ' HE2' ' A' ' 96' ' ' LYS . 15.6 m -96.29 131.28 43.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.947 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -85.12 118.51 24.72 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.89 177.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.402 HG11 ' HD2' ' A' ' 67' ' ' LYS . 20.8 t -78.76 -26.73 13.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 157.48 164.88 14.3 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.705 176.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 88.4 m -107.27 118.2 36.08 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 173.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.6 pt -107.52 170.44 2.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -178.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -143.42 143.85 31.79 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.924 0.868 . . . . 0.0 111.682 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 82.2 t -93.55 128.79 44.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 114.323 -1.308 . . . . 0.0 108.668 174.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -156.12 72.4 0.77 Allowed 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -178.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.424 ' O ' ' HA ' ' A' ' 83' ' ' ASN . 0.6 OUTLIER -103.11 148.37 25.82 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.097 -176.432 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.7 p -105.67 112.2 25.19 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.338 -176.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.28 -147.04 18.28 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.73 -0.747 . . . . 0.0 113.116 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -90.26 38.09 3.27 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.133 -0.556 . . . . 0.0 112.823 -173.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -76.4 -31.26 57.86 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.438 HD13 ' HA ' ' A' ' 56' ' ' LEU . 44.7 mm -114.43 95.23 3.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 171.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.8 t -103.41 -43.48 5.4 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.211 0.529 . . . . 0.0 109.831 -177.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 17.8 m -113.74 159.17 36.76 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.385 176.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -57.18 -26.35 69.14 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.386 2.057 . . . . 0.0 111.947 177.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.403 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 3.8 p -73.24 -22.72 60.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.508 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -71.45 -34.54 70.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.326 0.584 . . . . 0.0 109.715 177.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.438 ' HA ' HD13 ' A' ' 50' ' ' ILE . 51.6 tp -66.25 -48.19 71.32 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.57 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.499 ' HD3' ' OE1' ' B' ' 223' ' ' GLU . 0.2 OUTLIER -64.21 -30.52 71.57 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.223 -178.217 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.442 ' HG3' ' NE ' ' A' ' 57' ' ' ARG . 36.1 mt-10 -67.64 -41.25 84.18 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.1 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -66.81 -45.34 78.65 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.823 0.344 . . . . 0.0 110.635 177.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.4 mt -64.48 -41.34 96.54 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.033 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.6 t -65.94 -39.04 90.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.154 0.502 . . . . 0.0 110.256 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -63.4 -42.67 98.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.883 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 97.5 mt -69.64 -32.69 71.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.804 178.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.87 -40.54 95.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.039 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -63.0 -40.38 97.61 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.912 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.79 -44.01 87.01 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.823 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.402 ' HD2' HG11 ' A' ' 38' ' ' VAL . 40.7 mmtt -74.11 -33.44 63.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.813 177.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.473 ' HA3' ' CE1' ' A' ' 99' ' ' HIS . . . 94.2 36.46 5.69 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.08 -179.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -100.38 166.68 19.85 Favored Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.607 ' HZ3' ' HB3' ' A' ' 93' ' ' ASP . 51.7 mtmt -123.12 2.75 9.28 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.96 0.38 . . . . 0.0 111.587 -176.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.515 ' HE2' ' HB2' ' A' ' 93' ' ' ASP . 6.9 m-85 -153.96 166.02 34.28 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 177.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -150.65 157.46 43.0 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 171.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -146.1 117.64 8.03 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.041 -176.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.473 HG13 ' HB2' ' A' ' 88' ' ' ALA . 3.7 mp -83.64 131.35 34.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 178.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 9.9 pt -107.62 -21.63 5.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.592 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -150.52 139.26 20.75 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.171 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -151.15 113.01 4.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.749 0.309 . . . . 0.0 110.561 -178.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.59 150.7 51.62 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.415 0.626 . . . . 0.0 111.194 -177.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -93.99 102.72 14.81 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.272 176.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -102.54 77.32 1.61 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.367 -175.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.83 -125.6 35.27 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.292 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -82.67 5.46 6.38 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.874 2.383 . . . . 0.0 112.734 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.424 ' HA ' ' O ' ' A' ' 45' ' ' GLN . 58.5 m-80 -122.51 120.03 32.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.961 0.41 . . . . 0.0 110.628 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -85.32 116.42 23.65 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 177.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.52 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 19.3 mm-40 -106.94 114.49 28.61 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.833 -175.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.513 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -135.26 121.16 19.78 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.617 0.246 . . . . 0.0 110.96 176.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.6 t -95.77 120.42 45.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -177.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.473 ' HB2' HG13 ' A' ' 74' ' ' ILE . . . -126.05 143.62 51.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.198 0.523 . . . . 0.0 111.349 -175.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.447 ' HB3' ' CE1' ' A' ' 91' ' ' TYR . 41.4 mt-10 -103.3 140.71 37.05 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.547 178.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.3 t -107.81 119.21 57.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 176.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.447 ' CE1' ' HB3' ' A' ' 89' ' ' GLU . 72.1 m-85 -123.77 152.81 41.78 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.193 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.531 ' HB3' ' HB ' ' A' ' 95' ' ' THR . 2.1 m-20 -115.69 155.87 26.95 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.063 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.607 ' HB3' ' HZ3' ' A' ' 70' ' ' LYS . 19.7 t70 -79.44 67.66 5.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.078 -177.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 56.63 22.29 6.6 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.596 -175.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.545 HG22 ' CB ' ' A' ' 98' ' ' GLU . 72.0 m -62.84 112.52 2.59 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 121.889 0.852 . . . . 0.0 112.261 -175.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.437 ' HE2' HG11 ' A' ' 36' ' ' VAL . 73.4 mmtt -131.67 103.44 6.37 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.328 -1.306 . . . . 0.0 109.158 174.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 93.6 mt 67.3 16.85 10.18 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.145 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.545 ' CB ' HG22 ' A' ' 95' ' ' THR . 47.6 tt0 -53.76 -53.89 45.91 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 172.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.473 ' CE1' ' HA3' ' A' ' 68' ' ' GLY . 10.4 p80 -116.6 129.49 56.2 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 166.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 60.5 m-70 -80.9 -28.05 36.02 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -167.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.444 ' CE1' ' HB3' ' B' ' 215' ' ' ALA . 3.3 t-160 61.78 96.08 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -174.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -67.86 72.96 0.17 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.478 -175.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 169.12 -37.49 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.067 0.947 . . . . 0.0 108.945 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 6.1 t60 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.271 -170.855 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.126 0 CA-C-O 120.7 0.286 . . . . 0.0 110.306 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -83.94 100.67 11.17 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 174.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -114.73 108.61 17.01 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.541 0.686 . . . . 0.0 111.052 -177.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -86.09 107.54 17.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.238 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 2.9 pp -70.27 153.09 8.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.402 -176.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 8.6 tt -145.19 107.68 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.477 0.656 . . . . 0.0 110.853 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -108.8 93.68 4.65 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.198 177.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -143.94 66.63 1.28 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.002 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -136.4 111.14 8.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.883 175.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 210' ' ' LEU . . . . . . . . . . . . . 6.0 mp -110.88 -3.2 15.76 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.409 -174.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -114.09 112.86 23.9 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.076 0.465 . . . . 0.0 111.353 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -104.98 -167.0 1.29 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.048 174.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 213' ' ' THR . . . . . . . . . . . . . 14.7 t -166.57 151.08 7.55 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 177.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 214' ' ' VAL . . . . . . . . . . . . . 60.2 t -110.26 107.99 24.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.02 0.438 . . . . 0.0 110.839 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . 0.444 ' HB3' ' CE1' ' A' ' 101' ' ' HIS . . . -144.64 85.91 1.79 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.028 175.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 49.0 m -91.38 109.61 20.89 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.907 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 217' ' ' PHE . . . . . 0.435 ' HE1' ' HB1' ' B' ' 215' ' ' ALA . 79.5 m-85 -117.09 -72.57 0.68 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.688 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 218' ' ' SER . . . . . . . . . . . . . 47.8 t -179.96 128.04 0.08 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.255 -177.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 9.0 t -67.04 158.59 30.65 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.403 176.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 60.6 tp -157.97 -49.64 0.07 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.989 -177.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -135.79 100.94 4.6 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.019 178.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . 178.43 85.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 O-C-N 123.856 0.723 . . . . 0.0 110.169 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . 0.827 ' HG2' ' HE1' ' B' ' 271' ' ' TYR . 12.7 tt0 -164.43 125.27 2.12 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.371 0.605 . . . . 0.0 111.076 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 224' ' ' GLN . . . . . 0.413 HE21 ' C ' ' B' ' 224' ' ' GLN . 0.0 OUTLIER -164.93 150.61 9.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.571 -170.235 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . 0.532 HG22 ' HB3' ' B' ' 271' ' ' TYR . 17.9 m -127.02 128.84 71.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 172.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 226' ' ' SER . . . . . 0.797 ' HA ' ' CD2' ' B' ' 273' ' ' HIS . 11.5 t -92.84 173.17 7.89 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.089 0.471 . . . . 0.0 110.547 -178.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . 0.5 ' HA ' HD12 ' B' ' 230' ' ' ILE . 47.4 tttm -64.16 -28.64 69.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.874 -172.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -66.49 -50.46 63.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.291 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 229' ' ' GLU . . . . . 0.473 ' OE1' ' HB3' ' B' ' 226' ' ' SER . 1.9 mp0 -65.36 -38.0 88.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.651 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.509 HG12 HD11 ' B' ' 235' ' ' LEU . 97.1 mt -55.86 -53.92 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.232 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 68.6 m -73.45 -21.01 60.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.713 0.292 . . . . 0.0 111.517 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -75.04 -45.05 44.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.564 0.221 . . . . 0.0 110.99 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -100.75 -12.42 19.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.347 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? 64.41 91.15 0.08 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.139 -175.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . 0.509 HD11 HG12 ' B' ' 230' ' ' ILE . 88.6 mt -96.87 166.24 11.72 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.43 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 52.1 t -93.22 115.06 31.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.582 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -84.77 111.76 19.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.081 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 238' ' ' VAL . . . . . 0.417 HG21 ' HB ' ' B' ' 290' ' ' VAL . 1.2 m -88.35 -30.15 5.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -176.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 168.21 -147.53 11.58 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 119.964 -1.112 . . . . 0.0 113.085 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 29.0 m -141.17 138.1 33.16 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 122.598 0.359 . . . . 0.0 110.377 -176.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 241' ' ' ILE . . . . . 0.489 HG13 ' HB2' ' B' ' 288' ' ' ALA . 2.4 pt -105.29 137.61 34.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.139 0.495 . . . . 0.0 110.514 177.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -109.69 123.23 49.14 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.707 -172.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 243' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' B' ' 285' ' ' GLU . 89.2 t -100.95 117.4 46.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 172.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 34.4 m -155.37 76.61 0.97 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.787 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 245' ' ' GLN . . . . . 0.414 ' O ' ' HA ' ' B' ' 283' ' ' ASN . 0.9 OUTLIER -103.79 142.77 33.8 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.834 -177.706 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 246' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' B' ' 282' ' ' PRO . 17.2 m -80.97 117.74 21.85 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.06 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 90.53 -165.71 31.27 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.582 176.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -87.08 53.12 4.45 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.319 -0.467 . . . . 0.0 112.454 -177.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -72.21 -25.32 61.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.252 0.549 . . . . 0.0 109.797 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 39.4 mm -105.91 90.84 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 175.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 9.4 t -92.94 -23.63 18.67 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.219 0.533 . . . . 0.0 109.961 -176.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 7.1 p -141.14 157.2 67.3 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.141 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . 0.525 ' HG2' HD21 ' A' ' 35' ' ' LEU . 68.5 Cg_exo -53.22 -30.78 52.7 Favored 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 123.017 2.478 . . . . 0.0 113.08 178.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 254' ' ' SER . . . . . 0.587 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 6.9 p -59.44 -41.22 89.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.833 -0.167 . . . . 0.0 110.902 176.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -58.36 -44.19 88.7 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.427 0.632 . . . . 0.0 109.764 176.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 49.2 tp -61.48 -44.57 96.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.272 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 257' ' ' ARG . . . . . 0.632 HH22 HD23 ' A' ' 20' ' ' LEU . 3.1 ttp180 -61.71 -46.67 88.69 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.549 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 258' ' ' GLU . . . . . 0.587 ' HG2' ' O ' ' B' ' 254' ' ' SER . 9.9 mm-40 -58.12 -47.08 84.38 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.959 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -66.39 -47.86 71.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.13 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 53.2 mt -62.86 -47.63 82.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.841 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 35.0 p -63.98 -39.07 93.29 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.84 0.352 . . . . 0.0 110.707 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -62.09 -48.46 80.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.433 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 263' ' ' LEU . . . . . 0.579 ' O ' ' HG2' ' B' ' 267' ' ' LYS . 96.2 mt -65.44 -37.35 86.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.055 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -69.07 -49.45 57.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.286 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -63.51 -33.29 75.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.878 0.37 . . . . 0.0 110.815 -178.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -66.79 -29.31 69.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.737 178.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 267' ' ' LYS . . . . . 0.579 ' HG2' ' O ' ' B' ' 263' ' ' LEU . 48.3 mmtm -82.07 -25.06 34.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.137 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 113.41 -5.68 24.85 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.866 -178.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . 0.492 ' HA2' ' OD1' ' B' ' 292' ' ' ASN . . . -77.41 145.69 30.79 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.183 -0.532 . . . . 0.0 111.812 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . 0.583 ' HE2' ' HA ' ' B' ' 270' ' ' LYS . 9.7 mmpt? -107.5 -23.64 12.09 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.854 0.359 . . . . 0.0 110.893 -177.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 271' ' ' TYR . . . . . 0.827 ' HE1' ' HG2' ' B' ' 223' ' ' GLU . 99.4 m-85 -133.46 157.06 46.54 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.348 -178.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 272' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -151.07 167.46 27.61 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.688 174.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 273' ' ' HIS . . . . . 0.797 ' CD2' ' HA ' ' B' ' 226' ' ' SER . 49.1 t-80 -143.15 117.27 9.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.863 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 274' ' ' ILE . . . . . 0.452 ' HA ' ' HA ' ' B' ' 288' ' ' ALA . 61.8 mt -67.4 137.1 25.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.191 178.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 25.8 pt -110.91 -26.74 3.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.129 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -158.55 140.44 13.78 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.842 0.354 . . . . 0.0 111.016 -178.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -140.25 129.35 23.58 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -137.53 150.81 47.8 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.394 0.616 . . . . 0.0 111.195 -175.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -101.72 123.76 46.24 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.479 -175.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 280' ' ' HIS . . . . . 0.439 ' HB2' ' O ' ' B' ' 283' ' ' ASN . 10.1 m170 -125.33 154.72 41.36 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 163.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . -65.92 -57.59 10.59 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.715 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . 0.562 ' O ' ' HA ' ' B' ' 246' ' ' SER . 60.4 Cg_endo -72.07 -29.73 14.38 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.136 1.891 . . . . 0.0 112.958 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 283' ' ' ASN . . . . . 0.513 HD21 ' C ' ' B' ' 282' ' ' PRO . 0.9 OUTLIER -132.49 129.38 39.1 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 122.326 -0.234 . . . . 0.0 111.126 -175.609 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -91.17 120.46 32.12 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 171.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 285' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 46.6 mt-10 -118.61 130.82 56.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.288 0.566 . . . . 0.0 112.411 -170.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 286' ' ' ALA . . . . . 0.434 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -149.27 143.7 26.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.128 176.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 41.0 t -123.38 124.91 70.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.397 -178.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 288' ' ' ALA . . . . . 0.489 ' HB2' HG13 ' B' ' 241' ' ' ILE . . . -132.24 141.48 49.05 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.941 0.401 . . . . 0.0 111.153 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -92.01 132.52 36.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.64 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 290' ' ' VAL . . . . . 0.417 ' HB ' HG21 ' B' ' 238' ' ' VAL . 6.0 t -97.99 131.89 44.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 120.832 0.349 . . . . 0.0 110.455 -176.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -127.99 143.91 51.09 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.32 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 292' ' ' ASN . . . . . 0.492 ' OD1' ' HA2' ' B' ' 269' ' ' GLY . 1.5 m120 -112.14 179.71 3.92 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.559 0.695 . . . . 0.0 112.157 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.21 133.55 44.5 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.014 -1.448 . . . . 0.0 110.032 177.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 294' ' ' ALA . . . . . 0.47 ' O ' ' HB ' ' B' ' 295' ' ' THR . . . -73.19 70.17 1.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.052 0.453 . . . . 0.0 110.323 178.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 295' ' ' THR . . . . . 0.47 ' HB ' ' O ' ' B' ' 294' ' ' ALA . 9.3 t 166.47 -21.01 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.173 -175.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 296' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' B' ' 295' ' ' THR . 98.5 mttt 71.15 -173.49 0.17 Allowed 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.128 0.571 . . . . 0.0 110.413 -176.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 297' ' ' LEU . . . . . . . . . . . . . 96.1 mt 63.18 -171.46 0.17 Allowed 'General case' 0 N--CA 1.464 0.261 0 O-C-N 123.486 0.491 . . . . 0.0 109.989 -173.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 298' ' ' GLU . . . . . 0.466 ' HB3' ' CG ' ' B' ' 302' ' ' HIS . 11.4 mm-40 51.28 32.25 8.01 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 176.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 299' ' ' HIS . . . . . . . . . . . . . 22.8 m170 -63.76 -29.49 70.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.21 0.528 . . . . 0.0 110.282 177.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 300' ' ' HIS . . . . . . . . . . . . . 11.2 p80 -135.0 157.27 47.37 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.473 -0.785 . . . . 0.0 108.968 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 301' ' ' HIS . . . . . 0.468 ' HE1' ' HB ' ' A' ' 13' ' ' THR . 19.3 t-80 65.1 22.94 12.37 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.279 0.562 . . . . 0.0 110.286 175.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 302' ' ' HIS . . . . . 0.466 ' CG ' ' HB3' ' B' ' 298' ' ' GLU . 9.5 t-160 -82.8 82.37 8.14 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.902 -177.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 303' ' ' HIS . . . . . 0.438 ' O ' ' HB2' ' B' ' 304' ' ' HIS . 52.9 t60 -99.63 80.17 2.34 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.968 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 304' ' ' HIS . . . . . 0.438 ' HB2' ' O ' ' B' ' 303' ' ' HIS . 4.9 t-80 . . . . . 0 N--CA 1.462 0.16 0 O-C-N 123.798 0.687 . . . . 0.0 109.776 176.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.3 mtm . . . . . 0 N--CA 1.48 1.039 0 CA-C-O 120.717 0.294 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -78.79 -33.34 46.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.898 0.38 . . . . 0.0 111.144 -176.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -91.23 103.97 16.57 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.37 0.605 . . . . 0.0 111.658 -171.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -108.8 133.86 52.29 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 165.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.8 pt -73.16 148.55 8.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.718 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.853 ' H ' HD12 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -73.34 69.2 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.655 0.741 . . . . 0.0 111.574 -176.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.35 91.72 7.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.736 175.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.98 3.4 8.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.751 -176.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.12 106.64 2.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.893 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.7 tt -145.08 112.17 6.0 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.481 ' O ' HD12 ' A' ' 11' ' ' LEU . 1.5 pp -143.44 142.7 31.3 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.653 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.17 86.59 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 O-C-N 124.103 0.877 . . . . 0.0 112.538 176.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.58 ' HA ' ' HD2' ' B' ' 300' ' ' HIS . 63.0 m -88.03 86.6 7.14 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.124 0.487 . . . . 0.0 110.766 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.3 t -95.26 72.14 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.79 177.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -177.94 105.79 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.302 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.3 m -81.15 100.21 8.95 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.168 0.509 . . . . 0.0 110.917 -178.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -132.08 130.56 41.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.517 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.4 m 57.07 67.19 1.02 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.401 0.619 . . . . 0.0 110.192 -174.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.5 p -85.23 69.62 10.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.736 -175.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.453 ' O ' ' HG ' ' A' ' 20' ' ' LEU . 1.8 pt? -158.98 88.58 0.9 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.543 174.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -173.2 55.46 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.289 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -175.91 66.58 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.733 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.522 ' HG2' ' HB2' ' B' ' 221' ' ' ALA . 12.4 mp0 -133.94 104.11 6.12 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.176 -170.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.662 ' HA ' ' HB3' ' A' ' 71' ' ' TYR . 0.0 OUTLIER 175.13 167.64 0.3 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.816 0.341 . . . . 0.0 111.27 176.217 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.425 ' H ' ' CD ' ' A' ' 24' ' ' GLN . 28.3 m -127.51 139.77 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.068 0.547 . . . . 0.0 110.174 175.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.9 p -89.46 -93.65 0.11 Allowed 'General case' 0 C--N 1.322 -0.611 0 O-C-N 121.768 -0.582 . . . . 0.0 112.29 -174.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -131.68 -46.75 0.96 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.757 0.313 . . . . 0.0 111.044 -175.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -64.85 -47.39 78.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.516 -177.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -55.12 -47.81 74.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.608 -176.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.453 HG12 HD13 ' A' ' 35' ' ' LEU . 59.8 mt -58.02 -48.55 83.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.08 0.467 . . . . 0.0 111.147 -178.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.9 m -72.8 -33.83 66.51 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.344 -177.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -81.97 -34.88 29.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.956 -173.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.76 ' HB3' ' HG3' ' B' ' 253' ' ' PRO . 71.1 m-85 -101.77 -8.14 21.96 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.708 -176.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.543 ' HE3' ' HA ' ' B' ' 205' ' ' ILE . 13.3 mmmm 60.71 70.44 0.62 Allowed 'General case' 0 N--CA 1.466 0.343 0 O-C-N 123.559 0.537 . . . . 0.0 110.367 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.453 HD13 HG12 ' A' ' 30' ' ' ILE . 87.5 mt -82.12 163.16 22.18 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.799 -175.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 51.8 t -91.74 108.69 20.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.818 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -81.64 105.19 12.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.761 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.43 HG22 ' HB ' ' A' ' 90' ' ' VAL . 4.8 m -86.72 -20.4 7.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -172.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.59 -151.0 22.58 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 119.622 -1.275 . . . . 0.0 113.181 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.413 HG23 ' HG2' ' A' ' 89' ' ' GLU . 4.7 m -137.5 145.84 43.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.656 0.265 . . . . 0.0 110.73 -174.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.403 HD11 HD23 ' A' ' 60' ' ' LEU . 12.2 pt -127.83 144.95 35.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 174.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -125.95 138.62 53.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.084 0.469 . . . . 0.0 111.797 -175.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 90.4 t -97.57 110.26 25.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.198 171.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.4 p -138.46 74.99 1.5 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.361 0.601 . . . . 0.0 109.65 175.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.65 166.54 22.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.307 -177.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.1 t -73.78 164.65 26.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.75 -177.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.06 5.24 6.7 Favored Glycine 0 CA--C 1.519 0.324 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.729 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.49 -5.27 55.75 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.927 174.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -108.35 -15.75 14.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.819 0.342 . . . . 0.0 110.81 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.559 HD13 ' HA ' ' A' ' 56' ' ' LEU . 45.1 mm -125.43 107.72 18.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.1 m -101.58 -42.01 6.38 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.015 -174.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.416 ' H ' ' HB3' ' A' ' 55' ' ' ASP . 80.5 p -138.94 169.46 12.45 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.288 -175.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.892 ' HG2' HD21 ' B' ' 235' ' ' LEU . 42.1 Cg_exo -58.54 -36.02 97.91 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.354 2.036 . . . . 0.0 111.639 174.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.568 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -64.76 -44.59 89.59 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.6 175.212 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.527 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 38.9 t0 -66.88 -30.66 70.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.312 0.577 . . . . 0.0 110.179 179.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.559 ' HA ' HD13 ' A' ' 50' ' ' ILE . 63.9 tp -63.5 -51.16 66.74 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.933 176.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.568 ' HG3' ' O ' ' A' ' 54' ' ' SER . 6.2 ppt_? -68.45 -25.71 65.14 Favored 'General case' 0 C--O 1.225 -0.202 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.452 -178.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.527 ' HB2' ' O ' ' A' ' 55' ' ' ASP . 6.0 mm-40 -51.77 -51.5 55.86 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.295 0.569 . . . . 0.0 110.698 174.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.489 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 12.4 mptt -65.03 -45.11 86.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.204 -176.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.444 HD21 HG22 ' A' ' 43' ' ' VAL . 86.7 mt -71.45 -36.03 71.1 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.517 -177.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.485 ' HA ' ' HB3' ' B' ' 222' ' ' ALA . 6.9 t -62.94 -44.16 96.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.254 0.55 . . . . 0.0 109.523 176.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -63.39 -40.7 97.93 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.699 177.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 59' ' ' LYS . 84.7 mt -66.68 -44.68 81.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.079 178.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.7 -47.48 85.49 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.856 0.36 . . . . 0.0 110.673 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.541 ' HB2' ' HB3' ' B' ' 220' ' ' LEU . 10.0 t70 -58.24 -40.57 82.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.277 178.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.03 -25.29 58.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.817 -177.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -83.77 -47.55 11.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.935 0.398 . . . . 0.0 111.238 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.429 ' C ' HD23 ' A' ' 97' ' ' LEU . . . 125.6 34.93 0.63 Allowed Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.498 -175.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.452 ' HA2' ' OD1' ' A' ' 92' ' ' ASN . . . -134.13 161.34 24.37 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.559 ' HE2' ' HB2' ' A' ' 99' ' ' HIS . 24.8 mtpp -108.3 -71.74 0.75 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.866 0.333 . . . . 0.0 111.409 -178.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.662 ' HB3' ' HA ' ' A' ' 24' ' ' GLN . 2.3 m-85 -93.22 157.23 16.37 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 -173.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.524 ' CD2' ' HB2' ' B' ' 222' ' ' ALA . 45.6 p90 -146.45 133.68 20.55 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.293 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -102.62 119.11 38.27 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.159 -178.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.9 mp -77.04 124.53 35.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 30.3 pt -105.99 -21.71 5.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.925 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -152.61 135.92 15.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.696 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -149.03 111.4 4.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.163 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -149.86 173.63 13.56 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.918 0.389 . . . . 0.0 111.073 -176.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.84 148.76 26.3 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.242 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -100.92 -20.47 15.44 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.508 0.671 . . . . 0.0 109.212 175.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 143.06 -99.4 0.22 Allowed Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -176.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -74.28 -18.78 20.39 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.772 2.315 . . . . 0.0 111.232 171.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -116.47 159.64 21.75 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.623 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -115.74 138.31 51.24 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.621 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 42.1 mt-10 -123.98 117.4 24.66 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.209 0.528 . . . . 0.0 111.24 -176.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.512 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . . . -129.03 139.46 52.05 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.629 178.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.7 t -118.77 119.44 61.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.128 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.433 ' HB2' ' HD1' ' A' ' 72' ' ' TYR . . . -135.78 138.82 43.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.782 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.413 ' HG2' HG23 ' A' ' 40' ' ' THR . 3.2 mt-10 -104.0 139.53 39.0 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.43 ' HB ' HG22 ' A' ' 38' ' ' VAL . 8.5 t -97.5 134.83 34.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.144 -170.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -130.4 139.08 50.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.28 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.452 ' OD1' ' HA2' ' A' ' 69' ' ' GLY . 78.9 m-20 -101.37 -178.99 3.9 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.161 173.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -70.64 -156.05 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.721 174.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -83.33 16.85 2.31 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.408 0.623 . . . . 0.0 109.908 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.2 t -154.31 -162.05 1.34 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.126 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -78.9 -157.57 0.12 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.638 0.256 . . . . 0.0 110.834 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.429 HD23 ' C ' ' A' ' 68' ' ' GLY . 54.5 mt -72.98 40.83 0.09 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 122.964 0.506 . . . . 0.0 111.887 -177.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -90.07 -61.18 1.74 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.148 -175.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.559 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . 21.7 t-80 63.06 -82.86 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 O-C-N 123.602 0.564 . . . . 0.0 109.709 -170.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 28.17 87.64 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.557 1.143 . . . . 0.0 113.33 175.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -77.61 123.11 26.2 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.132 0.491 . . . . 0.0 110.848 -176.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -75.27 142.44 43.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.358 174.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -86.42 137.05 32.87 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.94 0.4 . . . . 0.0 110.761 -178.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.5 t60 . . . . . 0 C--N 1.324 -0.529 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.687 -178.525 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 201' ' ' MET . . . . . 0.446 ' O ' ' HB2' ' B' ' 202' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.93 0 CA-C-O 121.125 0.488 . . . . 0.0 110.509 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' B' ' 201' ' ' MET . 5.3 mptp? 71.66 160.74 0.23 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.103 -178.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? 66.7 112.85 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.471 -176.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -97.88 142.1 30.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.432 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 205' ' ' ILE . . . . . 0.543 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 12.1 tt -101.95 123.61 55.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.016 0.436 . . . . 0.0 110.29 178.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 7.8 tt -131.45 125.83 57.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.592 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 207' ' ' ALA . . . . . 0.7 ' HB2' HD23 ' B' ' 210' ' ' LEU . . . -81.6 87.64 6.25 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.529 178.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -95.2 131.17 41.53 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.008 -178.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . 61.09 73.57 0.48 Allowed 'General case' 0 C--O 1.234 0.246 0 O-C-N 123.937 0.773 . . . . 0.0 112.033 177.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 210' ' ' LEU . . . . . 0.7 HD23 ' HB2' ' B' ' 207' ' ' ALA . 88.1 mt -85.26 83.68 7.91 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.014 176.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 48.5 tp -110.91 110.77 21.49 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.056 -177.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -158.22 104.04 1.84 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.902 178.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 213' ' ' THR . . . . . 0.443 ' O ' ' HB ' ' B' ' 214' ' ' VAL . 2.3 m -62.81 -74.05 0.1 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.819 -178.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 214' ' ' VAL . . . . . 0.443 ' HB ' ' O ' ' B' ' 213' ' ' THR . 13.8 p 173.92 -34.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.287 0 O-C-N 123.424 0.453 . . . . 0.0 110.27 178.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . 66.19 178.89 0.21 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.611 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 23.2 m -117.96 -37.01 3.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.973 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -102.8 99.8 9.76 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 173.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 218' ' ' SER . . . . . . . . . . . . . 21.6 m -129.37 167.53 17.62 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.354 -174.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 58.9 p -131.45 117.31 18.66 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.984 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.541 ' HB3' ' HB2' ' A' ' 65' ' ' ASP . 0.2 OUTLIER -64.11 -85.89 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.093 177.541 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . 0.537 ' H ' ' CD1' ' B' ' 220' ' ' LEU . . . 64.2 65.7 0.66 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.611 0.72 . . . . 0.0 109.818 -174.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . 0.524 ' HB2' ' CD2' ' A' ' 72' ' ' TYR . . . -128.19 61.03 1.46 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.456 -1.247 . . . . 0.0 108.813 -175.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . 0.513 ' HG3' ' HD3' ' A' ' 57' ' ' ARG . 4.4 mp0 -124.37 96.55 4.95 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.389 -166.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 224' ' ' GLN . . . . . 0.636 ' HB3' ' HG3' ' A' ' 24' ' ' GLN . 0.6 OUTLIER -173.02 148.65 1.76 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.246 -178.557 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . 0.496 HG23 ' CD1' ' B' ' 235' ' ' LEU . 16.6 m -128.7 137.34 57.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.046 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 226' ' ' SER . . . . . 0.525 ' HA ' ' CD2' ' B' ' 273' ' ' HIS . 8.7 t -96.24 176.78 5.94 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 120.976 0.417 . . . . 0.0 110.301 -178.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -65.31 -28.93 69.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.437 -173.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.18 -50.32 68.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.043 0.449 . . . . 0.0 110.283 -178.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -65.44 -42.72 92.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.459 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.517 HG12 HD11 ' B' ' 235' ' ' LEU . 88.5 mt -63.34 -34.36 66.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.965 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 31.4 t -69.57 -21.24 63.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.0 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 29.2 t-80 -98.17 -45.73 6.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.836 0.351 . . . . 0.0 110.921 -177.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -86.2 -20.95 27.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.835 -176.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm 59.57 80.76 0.19 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.351 0.596 . . . . 0.0 111.612 -177.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . 0.892 HD21 ' HG2' ' A' ' 53' ' ' PRO . 40.9 mt -83.24 -168.92 2.28 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.754 178.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 59.0 t -109.82 109.21 27.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.088 0.471 . . . . 0.0 111.089 -178.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 237' ' ' LYS . . . . . 0.552 ' HE3' ' HB3' ' B' ' 289' ' ' GLU . 23.1 tptm -73.97 112.67 10.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.789 175.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 3.8 m -100.05 -4.41 9.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -175.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 136.07 -171.82 22.62 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 119.979 -1.105 . . . . 0.0 112.999 176.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 240' ' ' THR . . . . . 0.502 HG23 ' HG2' ' B' ' 289' ' ' GLU . 29.8 m -128.63 134.26 48.51 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -178.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 32.8 pt -107.86 137.62 38.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.945 0.402 . . . . 0.0 110.386 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -111.58 115.12 28.63 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.839 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 243' ' ' VAL . . . . . 0.511 ' HB ' ' HB2' ' B' ' 286' ' ' ALA . 34.9 t -94.05 109.35 21.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.108 -178.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 23.1 t -110.06 98.36 7.65 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 245' ' ' GLN . . . . . 0.635 ' O ' ' HA ' ' B' ' 283' ' ' ASN . 0.7 OUTLIER -87.89 148.39 24.64 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.946 -177.892 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 51.1 m -126.32 107.04 9.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.209 0.528 . . . . 0.0 111.056 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 101.05 -141.38 15.32 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.322 177.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -107.85 42.29 1.98 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.329 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -63.51 -46.44 86.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.752 0.311 . . . . 0.0 110.365 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 250' ' ' ILE . . . . . 0.565 HG12 ' HG2' ' B' ' 245' ' ' GLN . 47.2 mm -77.56 99.89 2.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.392 0.615 . . . . 0.0 109.585 177.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 5.7 m -100.68 -26.01 13.95 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.691 -174.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 1.9 m -136.52 162.36 56.65 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -177.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . 0.76 ' HG3' ' HB3' ' A' ' 33' ' ' PHE . 48.0 Cg_exo -56.06 -36.38 96.08 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.241 1.961 . . . . 0.0 111.537 175.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 254' ' ' SER . . . . . 0.418 ' HB3' ' CD2' ' A' ' 99' ' ' HIS . 4.3 m -69.25 -24.26 63.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.653 -178.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.17 -34.93 74.27 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.013 0.435 . . . . 0.0 111.523 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . 0.459 ' O ' ' HG ' ' B' ' 260' ' ' LEU . 22.3 tp -65.11 -38.52 90.96 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.749 -177.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 257' ' ' ARG . . . . . 0.428 HH21 ' CD ' ' B' ' 258' ' ' GLU . 2.9 ttp85 -63.83 -35.82 81.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.996 0.427 . . . . 0.0 110.424 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 258' ' ' GLU . . . . . 0.428 ' CD ' HH21 ' B' ' 257' ' ' ARG . 17.0 mm-40 -62.27 -43.06 99.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.249 -178.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -71.79 -34.74 69.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.041 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 260' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' B' ' 256' ' ' LEU . 95.2 mt -69.18 -46.2 68.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.003 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 24.2 p -65.47 -34.75 79.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.802 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -54.18 -51.11 65.39 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.247 0.546 . . . . 0.0 110.439 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 263' ' ' LEU . . . . . 0.471 ' O ' ' HG2' ' B' ' 267' ' ' LYS . 98.2 mt -71.79 -41.69 68.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.172 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -63.84 -32.12 73.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.822 0.344 . . . . 0.0 111.486 -178.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -71.9 -44.27 64.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.814 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -67.0 -30.82 71.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.265 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 267' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' B' ' 263' ' ' LEU . 74.3 mmtt -79.52 -55.82 4.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.002 0.43 . . . . 0.0 110.095 176.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 114.64 48.08 0.56 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.252 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -97.95 -169.63 32.3 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.478 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . 0.42 ' HB2' ' HA ' ' B' ' 292' ' ' ASN . 4.4 tptp -131.53 -29.9 1.72 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.709 0.29 . . . . 0.0 110.882 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 271' ' ' TYR . . . . . 0.424 ' HB3' ' HA ' ' B' ' 224' ' ' GLN . 6.4 m-85 -147.95 173.53 12.78 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 177.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 272' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.65 167.18 22.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.766 0.317 . . . . 0.0 110.796 174.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 273' ' ' HIS . . . . . 0.525 ' CD2' ' HA ' ' B' ' 226' ' ' SER . 19.5 t-80 -148.04 103.5 3.48 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.184 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 274' ' ' ILE . . . . . 0.48 HG13 ' HB2' ' B' ' 288' ' ' ALA . 4.2 mp -70.25 135.23 28.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 31.2 pt -113.99 -28.87 2.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.699 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -157.7 146.97 19.8 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.645 0.259 . . . . 0.0 110.956 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -156.37 139.26 15.29 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 278' ' ' ARG . . . . . 0.442 ' N ' ' HD2' ' B' ' 278' ' ' ARG . 0.0 OUTLIER -155.92 136.39 13.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.969 0.414 . . . . 0.0 111.214 -179.157 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -88.72 102.64 15.18 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 171.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -114.84 103.72 11.23 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 73.6 -134.49 19.24 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.667 -176.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -82.95 -9.16 10.86 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.589 2.193 . . . . 0.0 111.877 176.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 283' ' ' ASN . . . . . 0.635 ' HA ' ' O ' ' B' ' 245' ' ' GLN . 93.4 m-20 -101.37 113.48 26.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.463 -175.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -87.4 107.47 18.55 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 170.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 285' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -100.8 113.67 26.78 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.06 -175.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 286' ' ' ALA . . . . . 0.511 ' HB2' ' HB ' ' B' ' 243' ' ' VAL . . . -117.94 124.24 47.76 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.49 178.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 24.5 t -106.27 112.81 41.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.159 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 288' ' ' ALA . . . . . 0.48 ' HB2' HG13 ' B' ' 274' ' ' ILE . . . -125.63 132.54 52.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.274 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 289' ' ' GLU . . . . . 0.552 ' HB3' ' HE3' ' B' ' 237' ' ' LYS . 18.1 mt-10 -94.83 138.88 32.05 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 21.9 t -103.64 138.93 26.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.972 0.415 . . . . 0.0 110.408 -174.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -128.15 152.18 48.34 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.336 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 292' ' ' ASN . . . . . 0.42 ' HA ' ' HB2' ' B' ' 270' ' ' LYS . 12.2 t-20 -120.01 163.4 17.68 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 174.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -66.38 170.75 5.6 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -176.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 294' ' ' ALA . . . . . . . . . . . . . . . -73.33 9.12 1.4 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.994 0.426 . . . . 0.0 111.815 -174.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 295' ' ' THR . . . . . . . . . . . . . 13.8 t -125.91 -8.73 6.63 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.381 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt 57.22 -162.81 0.19 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.186 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 297' ' ' LEU . . . . . 0.434 HD23 ' CE1' ' B' ' 304' ' ' HIS . 36.8 mt 67.95 -161.97 0.21 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.021 170.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 298' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 54.49 69.46 0.72 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.36 -176.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 299' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 179.75 -53.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.84 175.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 300' ' ' HIS . . . . . 0.58 ' HD2' ' HA ' ' A' ' 13' ' ' THR . 61.7 t-80 -92.55 102.64 15.08 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 174.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 301' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -70.56 143.35 51.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.227 -177.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 302' ' ' HIS . . . . . . . . . . . . . 9.4 t-80 73.58 170.14 0.31 Allowed 'General case' 0 N--CA 1.468 0.437 0 O-C-N 124.173 0.921 . . . . 0.0 111.508 176.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 71.62 35.25 1.47 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.803 0.841 . . . . 0.0 110.001 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 304' ' ' HIS . . . . . 0.434 ' CE1' HD23 ' B' ' 297' ' ' LEU . 55.2 m-70 . . . . . 0 C--N 1.326 -0.428 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.656 175.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtt . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.814 0.34 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -97.86 6.05 48.28 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -174.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -75.5 112.13 11.51 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 177.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -118.57 101.87 8.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.074 0.464 . . . . 0.0 110.225 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.1 tt -171.21 120.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.315 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.3 pt -125.92 37.36 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.221 0.534 . . . . 0.0 111.243 -177.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.59 90.37 8.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.633 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -139.01 91.46 2.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.52 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -149.83 152.27 34.87 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.585 -178.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 54.2 tp -162.25 129.34 3.77 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.366 177.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 41.3 tp -105.95 97.64 7.43 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 175.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.01 137.65 34.82 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.982 -176.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.6 m 67.48 77.94 0.25 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.695 0.76 . . . . 0.0 110.909 178.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.6 t -107.4 -47.91 8.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.324 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -108.75 100.8 9.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.571 175.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.4 m -83.11 56.99 3.71 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.817 -174.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.5 t80 66.1 -73.43 0.07 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.861 176.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.8 t -146.32 116.57 7.43 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.6 t -136.55 132.81 35.7 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.216 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.1 mt -99.83 142.86 30.74 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.882 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -154.32 66.76 0.71 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.209 -0.905 . . . . 0.0 108.817 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -161.72 84.9 0.62 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.033 -170.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.427 ' HA ' ' OH ' ' B' ' 272' ' ' TYR . 0.5 OUTLIER -161.23 121.98 2.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.051 0.453 . . . . 0.0 111.84 -178.812 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 1.059 ' HG3' ' HG3' ' B' ' 224' ' ' GLN . 6.4 tm0? -150.35 144.34 25.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.777 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.2 m -126.78 152.27 34.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 172.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.612 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 6.9 m -108.38 -79.77 0.58 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.074 0.464 . . . . 0.0 110.746 -178.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -165.68 -48.25 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -176.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.406 ' HG3' ' CD ' ' A' ' 29' ' ' GLU . 5.2 pt20 -56.95 -36.44 70.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.058 176.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.406 ' CD ' ' HG3' ' A' ' 28' ' ' GLN . 25.6 mp0 -72.73 -40.1 66.37 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.544 HG22 ' HB2' ' A' ' 35' ' ' LEU . 87.8 mt -61.72 -48.58 88.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.247 -178.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.4 m -68.44 -21.37 64.65 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.259 -177.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -92.97 -43.57 8.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.529 -176.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.556 ' HB3' ' HD3' ' B' ' 253' ' ' PRO . 82.9 m-85 -98.61 -2.91 37.38 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -175.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.7 mptt 65.06 90.1 0.09 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.394 0.616 . . . . 0.0 111.894 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.544 ' HB2' HG22 ' A' ' 30' ' ' ILE . 97.2 mt -121.54 147.86 45.24 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.804 176.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.3 t -103.38 125.09 57.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.912 0.387 . . . . 0.0 111.399 -174.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -69.67 111.57 5.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.092 173.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.1 m -94.8 -8.29 9.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.874 -177.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.34 -160.2 29.36 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.179 -1.01 . . . . 0.0 112.785 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.456 ' HG1' ' HG2' ' A' ' 89' ' ' GLU . 64.6 m -145.15 135.94 24.56 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 122.596 0.358 . . . . 0.0 110.247 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.7 pt -104.68 143.28 16.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 176.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -122.88 123.51 41.15 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.013 0.435 . . . . 0.0 111.346 -175.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.679 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 67.4 t -97.26 130.72 45.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.294 174.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.9 t -157.68 40.97 0.29 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.49 ' NE2' HG13 ' A' ' 43' ' ' VAL . 0.9 OUTLIER -81.57 158.32 24.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.646 -172.119 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.426 ' HA ' HD21 ' A' ' 83' ' ' ASN . 10.8 t -99.7 87.12 3.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.932 -172.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.61 -84.19 0.55 Allowed Glycine 0 C--O 1.224 -0.524 0 N-CA-C 114.582 0.593 . . . . 0.0 114.582 170.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -49.94 -42.35 38.43 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 114.923 0.729 . . . . 0.0 114.923 -168.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.418 ' OE1' ' HG2' ' A' ' 45' ' ' GLN . 63.8 mt-30 -71.03 -18.03 62.6 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -174.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.7 mm -129.43 123.93 58.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.62 0.248 . . . . 0.0 110.79 -175.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.7 t -140.25 -51.47 0.49 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.017 0.437 . . . . 0.0 110.814 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.525 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 46.4 m -128.41 172.63 6.64 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 178.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.817 ' HD3' ' HB3' ' B' ' 233' ' ' PHE . 59.3 Cg_exo -51.7 -34.96 55.98 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.49 2.126 . . . . 0.0 111.97 178.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.549 ' O ' ' HG3' ' A' ' 58' ' ' GLU . 16.7 p -58.34 -56.72 18.42 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.072 179.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -58.7 -37.67 76.6 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.876 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 61.9 tp -64.12 -52.55 58.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.121 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 53' ' ' PRO . 7.4 ppt_? -69.85 -25.91 63.96 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.501 -177.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.549 ' HG3' ' O ' ' A' ' 54' ' ' SER . 38.8 mt-10 -62.61 -40.84 98.21 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 120.835 0.35 . . . . 0.0 110.24 173.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -74.31 -38.52 63.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.611 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.6 mt -64.5 -48.88 73.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.707 -177.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.461 ' HB2' ' HG2' ' B' ' 223' ' ' GLU . 17.0 t -65.92 -35.55 80.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.858 0.361 . . . . 0.0 110.483 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -60.74 -42.12 96.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.15 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 93.4 mt -75.02 -32.71 61.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.293 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.57 -41.7 68.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.281 -178.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.593 ' OD2' ' HB2' ' B' ' 218' ' ' SER . 9.2 t0 -58.93 -41.72 88.02 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 176.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.502 ' HA ' ' OG ' ' B' ' 216' ' ' SER . . . -71.75 -4.99 30.8 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.855 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -104.71 -9.36 18.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.191 0.52 . . . . 0.0 110.178 174.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.54 26.12 72.49 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.312 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' B' ' 221' ' ' ALA . . . -112.53 146.65 18.26 Favored Glycine 0 C--O 1.225 -0.447 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.764 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -97.19 -14.17 21.61 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -172.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.16 144.12 32.07 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -176.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.47 ' CD2' ' HB3' ' B' ' 222' ' ' ALA . 15.5 p90 -129.91 157.51 42.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.82 0.343 . . . . 0.0 110.13 172.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.612 ' CD2' ' HA ' ' A' ' 26' ' ' SER . 8.1 t-160 -128.74 109.34 11.22 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.868 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.516 HG12 ' HB3' ' A' ' 88' ' ' ALA . 57.6 mt -75.95 116.68 19.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.314 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.4 pt -107.15 -15.54 8.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.803 -176.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -153.25 142.5 21.51 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.616 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -162.77 139.35 7.52 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.9 152.12 22.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.753 0.311 . . . . 0.0 110.701 178.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -89.9 107.54 19.17 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 171.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -112.51 84.91 2.06 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.092 0.473 . . . . 0.0 110.301 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.18 -123.29 20.74 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.264 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -84.28 -3.57 10.2 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.845 2.363 . . . . 0.0 112.864 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.426 HD21 ' HA ' ' A' ' 46' ' ' SER . 10.7 m120 -119.26 128.9 54.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.748 0.309 . . . . 0.0 110.611 -176.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -93.14 123.46 36.42 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 173.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.679 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 43.1 mt-10 -108.5 129.07 55.29 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.879 0.371 . . . . 0.0 111.066 -176.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.491 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . . . -138.28 132.58 31.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.231 177.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.3 t -114.21 112.87 41.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.012 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.516 ' HB3' HG12 ' A' ' 74' ' ' ILE . . . -128.04 129.09 46.12 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.724 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.456 ' HG2' ' HG1' ' A' ' 40' ' ' THR . 26.5 mt-10 -91.88 139.15 30.95 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.6 t -100.39 136.76 30.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -176.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -124.19 150.88 44.7 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.291 0.567 . . . . 0.0 111.127 -177.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -130.33 158.64 39.25 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.464 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -69.49 169.12 13.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.766 0.317 . . . . 0.0 110.317 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -77.1 73.48 3.68 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.259 0.552 . . . . 0.0 110.674 178.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.9 t -170.05 -35.63 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.717 179.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm 67.59 -72.34 0.09 Allowed 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.622 0.576 . . . . 0.0 112.198 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 96.1 mt -137.36 -174.18 3.68 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.479 -176.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -91.62 -29.67 16.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.286 0.565 . . . . 0.0 109.482 175.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.458 ' O ' ' HB2' ' A' ' 100' ' ' HIS . 3.4 t60 -81.3 115.47 20.69 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.458 ' HB2' ' O ' ' A' ' 99' ' ' HIS . 33.7 m170 73.13 165.66 0.3 Allowed 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.916 0.76 . . . . 0.0 110.156 -168.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -157.84 126.42 5.58 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -122.59 125.72 46.25 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.451 -173.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -100.35 175.69 5.62 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 173.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 84.2 t60 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.73 -0.214 . . . . 0.0 110.469 177.985 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 47.9 ttm . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 120.541 0.21 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -77.61 98.94 5.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.769 0.318 . . . . 0.0 110.277 177.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . 0.425 ' HD3' ' HA ' ' B' ' 203' ' ' LYS . 27.4 mmtp -135.29 135.59 40.95 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.014 175.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -77.0 168.52 19.96 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.848 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 67.8 mt -77.33 105.85 6.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.033 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 50.7 mm -92.81 105.22 16.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.887 177.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -107.27 9.01 30.16 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.012 -176.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -81.32 80.61 7.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.165 0.507 . . . . 0.0 111.161 -178.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -140.1 141.78 36.13 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.132 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 210' ' ' LEU . . . . . . . . . . . . . 95.9 mt -121.29 140.08 52.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.782 0.325 . . . . 0.0 110.695 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . 0.781 ' H ' HD23 ' B' ' 211' ' ' LEU . 1.7 pt? -87.7 110.94 20.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.104 0.478 . . . . 0.0 110.108 177.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -153.44 115.79 4.39 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.885 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 213' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.14 95.91 4.88 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.458 178.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 214' ' ' VAL . . . . . . . . . . . . . 27.3 m -86.94 163.75 2.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.452 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.39 91.65 0.12 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.962 0.41 . . . . 0.0 110.77 178.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 216' ' ' SER . . . . . 0.502 ' OG ' ' HA ' ' A' ' 66' ' ' ALA . 13.9 m -95.2 159.52 14.97 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.363 -178.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -160.4 32.12 0.16 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -173.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 218' ' ' SER . . . . . 0.593 ' HB2' ' OD2' ' A' ' 65' ' ' ASP . 4.8 m -71.75 -77.87 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 119.329 -0.367 . . . . 0.0 110.666 -175.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 2.3 m 146.39 -58.33 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.118 1.367 . . . . 0.0 109.113 178.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -149.82 106.34 3.51 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 69' ' ' GLY . . . -126.14 117.3 22.85 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.947 -175.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . 0.47 ' HB3' ' CD2' ' A' ' 72' ' ' TYR . . . 68.52 109.93 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 O-C-N 124.187 0.93 . . . . 0.0 112.814 174.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . 0.928 ' HB3' ' HE2' ' B' ' 271' ' ' TYR . 28.2 mt-10 -144.42 124.36 13.52 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.737 173.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 224' ' ' GLN . . . . . 1.059 ' HG3' ' HG3' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -153.69 146.42 24.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.867 -172.813 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . 0.51 ' HB ' HD12 ' B' ' 235' ' ' LEU . 11.6 m -116.26 126.56 73.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 170.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 226' ' ' SER . . . . . 0.425 ' O ' HG13 ' B' ' 230' ' ' ILE . 6.7 t -95.99 -167.33 1.57 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.374 0.607 . . . . 0.0 111.523 -173.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . 0.439 ' HA ' HD12 ' B' ' 230' ' ' ILE . 2.2 tmtp? -75.67 -28.91 58.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.831 -172.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -72.86 -43.73 62.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.088 0.47 . . . . 0.0 110.539 -177.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -61.8 -26.94 68.41 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.459 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.467 HG12 HD11 ' B' ' 235' ' ' LEU . 69.9 mt -57.83 -57.23 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.096 0.474 . . . . 0.0 110.253 176.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 11.2 m -73.69 -50.61 20.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.05 -177.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -76.24 -38.59 56.11 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -170.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . 0.817 ' HB3' ' HD3' ' A' ' 53' ' ' PRO . 37.7 m-85 -102.71 -5.8 23.35 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -173.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt 67.01 92.01 0.08 Allowed 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.853 0.721 . . . . 0.0 110.996 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . 0.51 HD12 ' HB ' ' B' ' 225' ' ' VAL . 28.1 mt -97.23 141.06 30.8 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.023 178.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 21.7 t -66.64 -50.14 68.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.237 -178.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 237' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' B' ' 291' ' ' TYR . 50.7 tttm 65.78 120.39 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.901 -175.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 38.1 t -91.14 -46.62 14.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.43 -177.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.73 -152.03 16.57 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.871 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 21.3 m -127.62 140.09 52.32 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 241' ' ' ILE . . . . . 0.46 HG23 HG21 ' B' ' 290' ' ' VAL . 19.2 pt -113.08 141.88 27.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.887 0.375 . . . . 0.0 110.683 176.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -120.21 126.54 50.88 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.835 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 243' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' B' ' 285' ' ' GLU . 88.1 t -94.02 132.25 38.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.061 175.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 11.0 p -152.93 64.3 0.78 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.442 0.639 . . . . 0.0 110.776 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 245' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -97.95 143.85 28.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.295 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 6.2 t -86.62 36.84 0.72 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.357 0.598 . . . . 0.0 110.412 -174.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 88.0 167.94 43.89 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.227 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . 82.35 -49.35 4.13 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.821 176.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -71.26 -18.49 62.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.839 0.352 . . . . 0.0 111.201 -178.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 250' ' ' ILE . . . . . 0.452 ' HA ' ' HB3' ' B' ' 255' ' ' ASP . 40.8 mm -126.61 107.59 17.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 34.7 t -135.52 3.5 3.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.601 0.239 . . . . 0.0 111.129 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 252' ' ' SER . . . . . 0.527 ' HB2' ' HD2' ' B' ' 253' ' ' PRO . 95.7 p -158.38 167.21 14.89 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -178.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . 0.556 ' HD3' ' HB3' ' A' ' 33' ' ' PHE . 15.9 Cg_endo -59.14 -37.8 90.13 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.261 1.974 . . . . 0.0 111.019 173.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 254' ' ' SER . . . . . 0.564 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 15.3 m -60.75 -46.13 91.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.682 176.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.452 ' HB3' ' HA ' ' B' ' 250' ' ' ILE . 24.9 m-20 -55.12 -50.11 70.07 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.663 0.268 . . . . 0.0 110.786 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . 0.471 ' O ' ' HG ' ' B' ' 260' ' ' LEU . 57.0 tp -60.01 -45.94 91.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.068 178.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -57.27 -48.24 79.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.962 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 258' ' ' GLU . . . . . 0.564 ' HG2' ' O ' ' B' ' 254' ' ' SER . 43.8 mm-40 -58.13 -39.49 78.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.475 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 259' ' ' LYS . . . . . 0.419 ' O ' ' HG ' ' B' ' 263' ' ' LEU . 13.5 mptt -77.28 -35.48 55.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.395 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 260' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' B' ' 256' ' ' LEU . 87.7 mt -64.97 -47.41 77.68 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.501 0.191 . . . . 0.0 110.965 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 6.1 m -61.85 -30.79 71.09 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.205 0.526 . . . . 0.0 110.274 177.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -70.07 -52.76 21.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.753 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 263' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' B' ' 259' ' ' LYS . 88.0 mt -64.08 -36.9 85.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.263 -176.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -66.24 -38.3 87.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.279 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -72.38 -36.7 68.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.439 -177.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -63.27 -30.2 71.39 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.806 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -72.2 -32.9 67.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.352 175.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 117.46 -3.59 17.98 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.234 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -99.44 -153.59 27.86 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.594 -177.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm -150.53 -60.17 0.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.771 0.32 . . . . 0.0 111.049 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 271' ' ' TYR . . . . . 0.928 ' HE2' ' HB3' ' B' ' 223' ' ' GLU . 62.1 m-85 -90.41 148.1 23.01 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -172.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 272' ' ' TYR . . . . . 0.427 ' OH ' ' HA ' ' A' ' 23' ' ' GLU . 10.0 p90 -147.08 167.59 23.69 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.906 0.384 . . . . 0.0 111.423 -174.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 273' ' ' HIS . . . . . 0.512 ' HA ' ' OE1' ' A' ' 24' ' ' GLN . 0.6 OUTLIER -139.47 113.35 8.65 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.878 177.529 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 274' ' ' ILE . . . . . . . . . . . . . 4.4 mp -70.67 121.63 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 30.1 pt -102.43 -24.53 4.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.526 -178.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -153.85 140.73 19.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.863 -178.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -144.79 123.51 12.58 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.779 177.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 6.1 ptt180 -129.2 134.5 48.03 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.084 0.468 . . . . 0.0 110.691 -178.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -99.21 89.89 4.39 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 173.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -92.77 85.42 5.21 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.058 -173.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 62.08 -116.1 8.89 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.725 176.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.49 -16.57 21.54 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.716 2.277 . . . . 0.0 112.808 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 -105.99 162.89 13.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.176 0.512 . . . . 0.0 110.952 -175.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -132.12 104.7 6.94 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 171.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 285' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 21.4 mp0 -107.13 134.08 50.78 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.063 0.459 . . . . 0.0 110.843 -176.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 286' ' ' ALA . . . . . . . . . . . . . . . -137.19 147.08 45.63 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.585 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 32.8 t -123.25 122.53 65.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.947 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -131.84 143.62 50.31 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.937 0.399 . . . . 0.0 111.069 -178.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -91.56 123.94 35.35 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.824 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 290' ' ' VAL . . . . . 0.46 HG21 HG23 ' B' ' 241' ' ' ILE . 53.5 t -94.34 129.36 44.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.884 0.373 . . . . 0.0 110.851 -177.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 291' ' ' TYR . . . . . 0.513 ' HA ' ' HA ' ' B' ' 237' ' ' LYS . 64.0 m-85 -121.79 171.06 9.16 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.058 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 292' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -123.09 157.47 32.79 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 174.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -72.84 141.57 47.98 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 294' ' ' ALA . . . . . 0.438 ' HB1' ' HD2' ' A' ' 53' ' ' PRO . . . -74.08 79.71 1.73 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.343 0.592 . . . . 0.0 111.081 -175.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 295' ' ' THR . . . . . . . . . . . . . 8.9 t -166.7 -34.86 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.142 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -81.91 89.22 6.35 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.051 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 297' ' ' LEU . . . . . . . . . . . . . 56.4 mt -149.5 160.23 43.64 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.779 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 298' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -72.51 -61.01 1.95 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.95 0.405 . . . . 0.0 110.05 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 299' ' ' HIS . . . . . . . . . . . . . 37.5 m-70 -92.79 118.46 31.12 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.833 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 300' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -80.52 112.82 18.22 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.331 0.586 . . . . 0.0 110.909 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 301' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -137.16 143.87 42.65 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 175.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 302' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 70.36 96.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 O-C-N 124.019 0.825 . . . . 0.0 110.502 -176.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 13.4 t60 75.91 91.27 0.07 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.35 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.337 178.498 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.402 ' HD2' ' HA ' ' A' ' 2' ' ' LYS . 33.2 tptt -89.49 147.66 23.87 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -179.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.07 69.17 3.32 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.05 0.452 . . . . 0.0 112.129 -176.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -100.54 -35.59 9.48 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.72 0.295 . . . . 0.0 111.21 179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 pp -83.4 117.28 28.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.459 0.647 . . . . 0.0 112.593 -171.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.2 pp -134.05 156.47 40.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.237 174.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -121.58 153.43 38.06 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.887 0.375 . . . . 0.0 111.011 -177.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.01 101.56 13.03 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.544 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.0 137.82 32.02 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.686 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.2 mp -91.76 147.24 23.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.993 0.425 . . . . 0.0 110.55 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -83.46 159.47 21.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.913 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -158.18 154.61 27.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.615 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 33.9 p -84.01 -83.53 0.15 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.964 0.165 . . . . 0.0 111.174 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.578 HG13 HG12 ' B' ' 238' ' ' VAL . 59.1 t 64.34 108.32 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 121.632 0.73 . . . . 0.0 112.029 178.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -118.91 97.27 5.62 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.167 175.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.684 ' HB3' ' HA3' ' B' ' 268' ' ' GLY . 23.0 t -112.62 -179.7 3.74 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.933 -178.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -62.06 124.59 21.22 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.96 0.41 . . . . 0.0 110.781 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.8 p -75.18 110.69 9.72 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.372 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.8 t -158.96 87.43 0.86 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.965 175.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.757 ' HB3' ' HB2' ' B' ' 265' ' ' ASP . 3.8 pp -58.2 140.64 52.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.108 -178.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -156.14 78.85 0.97 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.104 176.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.738 ' HA ' ' HG3' ' B' ' 223' ' ' GLU . . . -163.35 -135.21 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.97 -171.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.539 ' HG3' ' HB2' ' B' ' 257' ' ' ARG . 17.0 tt0 80.9 104.97 0.07 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 124.37 1.043 . . . . 0.0 110.358 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.496 ' HA ' ' HB3' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -162.18 154.11 18.87 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.39 -174.333 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.1 m -106.79 139.27 28.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.854 0.359 . . . . 0.0 110.877 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.674 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 7.4 t -93.98 -86.11 0.28 Allowed 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.328 -175.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -157.97 -49.15 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.225 -176.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -58.56 -40.42 83.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.067 0.461 . . . . 0.0 110.53 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -64.87 -37.89 89.13 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.664 178.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.524 HG12 HD11 ' A' ' 35' ' ' LEU . 58.5 mt -66.72 -39.46 83.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.442 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.9 m -68.81 -35.03 76.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.086 0.47 . . . . 0.0 110.86 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -85.87 -45.17 11.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.416 -174.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -92.24 -19.38 22.26 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -175.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.444 ' NZ ' ' HB2' ' A' ' 34' ' ' LYS . 0.2 OUTLIER 65.83 85.18 0.14 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.127 0.489 . . . . 0.0 111.388 -177.614 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.524 HD11 HG12 ' A' ' 30' ' ' ILE . 67.7 mt -94.35 175.67 6.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.676 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.674 HG22 ' HE3' ' A' ' 96' ' ' LYS . 40.7 t -105.97 123.6 60.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.33 -175.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.496 ' HZ1' ' CD ' ' A' ' 89' ' ' GLU . 35.8 tttp -81.4 112.35 18.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.191 176.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.2 m -107.48 22.4 3.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -173.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 120.9 -164.8 14.11 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.306 -0.949 . . . . 0.0 112.897 174.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.527 HG23 ' HG2' ' A' ' 89' ' ' GLU . 12.9 m -140.06 134.69 31.71 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 -176.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.7 pt -107.21 151.05 9.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 174.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -125.52 123.04 38.27 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.033 0.444 . . . . 0.0 111.628 -174.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.565 ' HB ' ' HB2' ' A' ' 86' ' ' ALA . 73.0 t -99.1 117.68 44.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.348 172.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 63.5 p -145.98 72.81 1.31 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.245 0.545 . . . . 0.0 109.718 176.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.414 HE22 HG11 ' A' ' 43' ' ' VAL . 0.7 OUTLIER -100.5 148.77 24.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.03 -176.706 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.413 ' HA ' HD21 ' A' ' 83' ' ' ASN . 17.4 m -86.4 56.64 4.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.594 -176.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.82 -71.05 2.79 Favored Glycine 0 C--O 1.227 -0.337 0 C-N-CA 121.261 -0.495 . . . . 0.0 114.129 173.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -54.01 -28.71 41.65 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 115.164 0.825 . . . . 0.0 115.164 -169.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -78.61 -14.57 59.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.59 0.695 . . . . 0.0 111.606 -177.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.0 mm -120.32 107.53 21.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.163 0.506 . . . . 0.0 110.185 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.2 m -114.52 -45.13 3.03 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.576 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 87.7 p -124.78 164.28 32.01 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.739 177.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.753 ' HB2' ' HB2' ' B' ' 293' ' ' ASP . 24.2 Cg_exo -64.34 -20.19 66.27 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.28 1.986 . . . . 0.0 111.644 174.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.502 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 75.2 m -69.06 -42.75 75.85 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.084 173.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -62.87 -39.11 93.41 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.217 0.532 . . . . 0.0 109.717 176.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 61.7 tp -60.36 -41.36 93.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.964 176.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.447 ' HD2' ' OE1' ' B' ' 223' ' ' GLU . 9.5 ttp85 -61.3 -43.86 98.18 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.552 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.502 ' HG2' ' O ' ' A' ' 54' ' ' SER . 22.9 mm-40 -53.49 -50.78 64.63 Favored 'General case' 0 C--N 1.332 -0.165 0 O-C-N 123.51 0.506 . . . . 0.0 110.616 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.481 ' HA ' ' HG2' ' A' ' 62' ' ' GLU . 4.3 mptp? -67.44 -41.62 84.45 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.573 -178.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 85.0 mt -63.34 -34.16 77.1 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.005 0.431 . . . . 0.0 110.482 177.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.6 t -70.6 -52.46 21.33 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.724 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.726 ' HA ' ' O ' ' B' ' 217' ' ' PHE . 13.0 pt-20 -65.26 -31.46 72.63 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -175.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 82.9 mt -66.98 -47.07 72.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.84 0.353 . . . . 0.0 111.172 177.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.526 ' O ' ' HG3' ' A' ' 67' ' ' LYS . . . -74.01 -43.9 56.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.608 -177.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -59.57 -51.52 69.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.548 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.9 -18.97 64.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.038 -176.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.526 ' HG3' ' O ' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -91.19 -13.92 32.0 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.439 -179.285 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.64 44.35 4.91 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.212 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -130.07 151.76 19.49 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.097 -0.573 . . . . 0.0 111.813 177.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' B' ' 222' ' ' ALA . 17.7 mmtp -88.4 -72.78 0.52 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.86 0.362 . . . . 0.0 111.543 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.496 ' HB3' ' HA ' ' A' ' 24' ' ' GLN . 0.4 OUTLIER -108.19 169.82 8.39 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -173.128 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -140.68 167.51 22.0 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.674 ' CD2' ' HA ' ' A' ' 26' ' ' SER . 4.8 t-80 -139.08 110.59 7.04 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.753 174.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 59.8 mt -65.89 113.93 2.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.804 176.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 31.8 pt -97.73 -26.31 3.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.966 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -156.21 131.69 9.5 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.328 178.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -135.65 98.81 4.02 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.497 HH11 ' HB2' ' B' ' 207' ' ' ALA . 13.3 ptm180 -125.32 165.69 17.9 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.513 -173.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -109.69 129.33 55.61 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.963 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -100.5 18.39 19.21 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.335 0.588 . . . . 0.0 109.647 -178.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 110.25 -98.93 1.13 Allowed Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.463 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.83 -13.86 11.49 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.522 2.148 . . . . 0.0 112.103 176.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.413 HD21 ' HA ' ' A' ' 46' ' ' SER . 13.5 m120 -114.34 139.26 49.61 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.019 -176.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -99.83 115.8 30.42 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 172.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.506 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 50.5 mt-10 -107.18 111.14 23.42 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.946 0.403 . . . . 0.0 110.73 -175.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.565 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . . . -120.38 117.34 27.49 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.258 177.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.5 t -98.61 112.97 32.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.034 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -126.46 123.89 38.88 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.017 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.527 ' HG2' HG23 ' A' ' 40' ' ' THR . 10.4 mt-10 -93.46 143.99 25.77 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.6 t -96.6 130.43 45.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.894 0.378 . . . . 0.0 110.356 -171.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -125.61 133.88 52.09 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.821 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -107.48 161.44 14.83 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -64.84 164.04 13.14 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.442 ' O ' ' HB ' ' A' ' 95' ' ' THR . . . -75.92 65.37 1.99 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.153 0.501 . . . . 0.0 110.549 -177.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.442 ' HB ' ' O ' ' A' ' 94' ' ' ALA . 9.6 t 168.82 -21.4 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.438 -177.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.674 ' HE3' HG22 ' A' ' 36' ' ' VAL . 7.8 mptt 60.92 -117.5 0.73 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.959 -177.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 95' ' ' THR . 83.4 mt 70.81 151.96 0.11 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 122.057 0.932 . . . . 0.0 113.191 174.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.458 ' OE1' ' HB2' ' A' ' 100' ' ' HIS . 1.7 tm-20 -147.63 138.4 23.35 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -73.93 -20.39 60.39 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -168.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.458 ' HB2' ' OE1' ' A' ' 98' ' ' GLU . 47.1 m80 -93.84 -2.89 52.84 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 173.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 58.44 90.93 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.158 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -140.46 141.93 35.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.911 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -152.67 148.01 26.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.977 170.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 . . . . . 0 C--N 1.321 -0.633 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -179.651 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 201' ' ' MET . . . . . 0.431 ' N ' ' SD ' ' B' ' 201' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 56.5 mmtt -148.93 -65.97 0.23 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.293 0.568 . . . . 0.0 110.721 -178.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 45.2 pttt -102.68 114.07 28.0 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.878 -173.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -118.34 27.49 8.92 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.386 175.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 44.1 mm -84.28 -64.66 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.712 -174.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 47.0 mm -68.97 128.04 31.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.31 -174.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 207' ' ' ALA . . . . . 0.497 ' HB2' HH11 ' A' ' 78' ' ' ARG . . . -164.82 102.27 0.79 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.299 178.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -148.15 126.89 12.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.505 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -109.89 106.46 16.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.166 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 210' ' ' LEU . . . . . . . . . . . . . 5.5 tt -96.02 -46.23 6.59 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 177.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 90.2 mt 73.27 146.95 0.08 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.625 175.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -154.91 179.12 9.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.914 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 213' ' ' THR . . . . . . . . . . . . . 39.4 p -67.55 138.76 56.74 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 177.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 214' ' ' VAL . . . . . . . . . . . . . 43.6 t -95.84 -48.87 12.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.177 -175.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . 59.34 -156.98 0.33 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.446 -175.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 16.1 t -151.03 83.35 1.33 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.099 0.475 . . . . 0.0 110.547 177.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 217' ' ' PHE . . . . . 0.726 ' O ' ' HA ' ' A' ' 62' ' ' GLU . 91.8 m-85 -140.73 111.11 6.73 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 175.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 218' ' ' SER . . . . . . . . . . . . . 3.3 p -125.66 116.5 21.78 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.105 0.478 . . . . 0.0 111.512 -176.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 4.2 m -121.76 149.41 43.33 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.702 176.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.403 ' HA ' ' OE2' ' B' ' 223' ' ' GLU . 6.6 mp -71.45 106.88 4.11 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . 178.65 -19.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.961 -174.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . 0.44 ' HB2' ' O ' ' A' ' 70' ' ' LYS . . . -129.16 92.2 3.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.243 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . 0.738 ' HG3' ' HA ' ' A' ' 22' ' ' ALA . 0.9 OUTLIER -170.36 124.7 0.72 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -176.212 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 224' ' ' GLN . . . . . 0.473 ' HA ' ' HB3' ' B' ' 271' ' ' TYR . 0.0 OUTLIER -171.48 149.26 2.65 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.325 177.463 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 29.0 m -114.77 151.42 16.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.513 176.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 226' ' ' SER . . . . . 0.612 ' HA ' ' CD2' ' B' ' 273' ' ' HIS . 57.5 p -113.59 -96.21 0.45 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -136.05 -36.05 0.76 Allowed 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.61 -43.1 89.5 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.443 0.639 . . . . 0.0 109.98 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 229' ' ' GLU . . . . . 0.484 ' H ' ' CD ' ' B' ' 229' ' ' GLU . 3.2 mp0 -58.72 -45.22 90.08 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.448 177.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.5 ' HA ' ' HG ' ' B' ' 235' ' ' LEU . 55.7 mt -63.44 -39.3 84.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.528 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 15.2 m -69.82 -23.13 63.26 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.086 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -93.5 -57.6 2.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.602 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -90.05 -14.38 33.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.157 -170.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt 59.07 82.78 0.14 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.252 0.549 . . . . 0.0 110.082 -175.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . 0.54 HD21 ' HA ' ' B' ' 293' ' ' ASP . 55.1 mt -80.32 178.8 8.04 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.477 -171.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . 0.544 ' HB ' ' HB2' ' B' ' 292' ' ' ASN . 40.8 t -103.61 109.35 26.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.135 -0.938 . . . . 0.0 110.288 -178.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -76.33 125.75 29.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.711 -176.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 238' ' ' VAL . . . . . 0.691 HG13 ' HD2' ' B' ' 267' ' ' LYS . 4.1 t -100.73 -17.53 6.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-O 121.334 0.588 . . . . 0.0 110.847 -176.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 115.81 162.64 13.38 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.391 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.04 145.07 31.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.046 0.45 . . . . 0.0 111.505 -177.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 32.2 pt -126.87 132.04 70.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 169.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -117.45 132.39 56.57 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.993 0.901 . . . . 0.0 111.477 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 243' ' ' VAL . . . . . 0.53 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 66.5 t -93.99 131.0 42.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 114.528 -1.214 . . . . 0.0 109.999 -177.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 15.4 t -148.06 95.74 2.53 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 176.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 245' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.91 152.37 50.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.124 176.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 15.3 m -76.94 162.72 27.36 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.012 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -58.72 106.11 0.8 Allowed Glycine 0 C--N 1.331 0.275 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.916 176.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . 151.92 -50.41 0.52 Allowed Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -174.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -78.13 -28.99 48.59 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 173.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 42.8 mm -121.27 123.43 69.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.675 171.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 22.2 t -149.88 -38.72 0.14 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.95 0.405 . . . . 0.0 110.379 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 252' ' ' SER . . . . . 0.451 ' HB3' ' HD2' ' B' ' 253' ' ' PRO . 16.5 m -113.16 161.53 26.47 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.152 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' B' ' 252' ' ' SER . 13.7 Cg_endo -57.78 -20.89 45.48 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.675 2.25 . . . . 0.0 112.189 177.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 254' ' ' SER . . . . . 0.619 ' HA ' ' NH1' ' B' ' 257' ' ' ARG . 22.6 t -65.94 -51.08 61.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.522 177.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.448 ' O ' ' HG2' ' B' ' 259' ' ' LYS . 9.3 m-20 -54.47 -45.4 73.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.383 -173.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 49.3 tp -60.3 -60.61 3.54 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.234 -174.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 257' ' ' ARG . . . . . 0.619 ' NH1' ' HA ' ' B' ' 254' ' ' SER . 0.0 OUTLIER -68.03 -25.92 65.62 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -174.636 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 258' ' ' GLU . . . . . 0.485 ' HG3' ' O ' ' B' ' 254' ' ' SER . 53.8 mt-10 -70.18 -32.19 70.0 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.398 179.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 259' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' B' ' 255' ' ' ASP . 74.8 mmtt -73.03 -44.21 61.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.986 0.422 . . . . 0.0 109.965 174.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.32 -48.26 82.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.612 -177.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 41.0 m -60.88 -35.34 76.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.677 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -68.37 -41.76 80.15 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.008 0.432 . . . . 0.0 110.529 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 263' ' ' LEU . . . . . . . . . . . . . 98.1 mt -67.46 -44.18 79.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.008 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -61.44 -41.99 98.06 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.158 177.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 265' ' ' ASP . . . . . 0.757 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 26.6 t70 -54.03 -53.87 47.0 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.306 176.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -64.01 -31.18 72.28 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.048 0.451 . . . . 0.0 111.02 -177.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 267' ' ' LYS . . . . . 0.691 ' HD2' HG13 ' B' ' 238' ' ' VAL . 32.7 mmtt -62.5 -38.7 90.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.21 176.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 268' ' ' GLY . . . . . 0.684 ' HA3' ' HB3' ' A' ' 16' ' ' SER . . . 94.9 15.33 45.98 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -170.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . 0.482 ' HA2' ' ND2' ' B' ' 292' ' ' ASN . . . -106.87 146.76 16.1 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . 0.588 ' O ' ' HB1' ' A' ' 22' ' ' ALA . 54.8 mtpt -79.66 -68.28 0.68 Allowed 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 121.133 -0.227 . . . . 0.0 111.415 -176.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 271' ' ' TYR . . . . . 0.568 ' HE2' ' HB3' ' B' ' 293' ' ' ASP . 9.9 m-85 -97.93 154.41 17.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.101 0.477 . . . . 0.0 110.631 -173.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 272' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -122.62 136.42 54.88 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 175.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 273' ' ' HIS . . . . . 0.612 ' CD2' ' HA ' ' B' ' 226' ' ' SER . 12.3 t-80 -110.98 101.79 10.32 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.667 0.27 . . . . 0.0 110.745 -176.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 274' ' ' ILE . . . . . . . . . . . . . 68.5 mt -70.16 122.12 21.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 176.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 61.5 mt -97.85 -52.65 8.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.152 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -140.73 147.52 39.31 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.968 -177.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -144.53 138.68 27.7 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -152.38 151.41 30.79 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.038 0.447 . . . . 0.0 110.811 -176.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -97.25 120.24 37.25 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 175.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -129.95 107.54 9.44 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.006 0.432 . . . . 0.0 110.813 -174.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 66.82 -127.62 28.29 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.787 -178.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -92.21 3.54 3.84 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.767 2.311 . . . . 0.0 112.472 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -118.58 149.86 40.63 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.129 0.49 . . . . 0.0 111.415 -174.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -99.9 123.3 44.0 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.515 173.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 285' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 21.1 mm-40 -107.75 121.21 44.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.457 -176.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 286' ' ' ALA . . . . . 0.53 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -128.75 134.48 48.43 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 121.106 -0.238 . . . . 0.0 110.827 176.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 65.0 t -116.52 117.53 55.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.832 0.349 . . . . 0.0 110.386 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -133.28 142.99 48.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.467 -178.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -99.26 131.43 45.29 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.982 175.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 290' ' ' VAL . . . . . 0.558 ' HB ' ' HB ' ' B' ' 238' ' ' VAL . 32.7 t -90.09 133.81 30.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 176.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -132.58 134.12 44.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.993 0.425 . . . . 0.0 111.354 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 292' ' ' ASN . . . . . 0.544 ' HB2' ' HB ' ' B' ' 236' ' ' VAL . 23.2 m120 -90.73 123.71 34.53 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 165.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 293' ' ' ASP . . . . . 0.753 ' HB2' ' HB2' ' A' ' 53' ' ' PRO . 5.3 p-10 -71.45 163.91 26.8 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 294' ' ' ALA . . . . . 0.468 ' H ' ' HG2' ' A' ' 53' ' ' PRO . . . -71.73 77.99 0.85 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.975 0.417 . . . . 0.0 111.063 -177.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 295' ' ' THR . . . . . . . . . . . . . 8.5 t -133.72 105.16 6.67 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 122.485 1.136 . . . . 0.0 110.998 176.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -151.44 15.37 0.69 Allowed 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.079 -1.418 . . . . 0.0 108.375 177.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 297' ' ' LEU . . . . . . . . . . . . . 74.3 mt -114.47 141.22 47.97 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.523 -173.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 298' ' ' GLU . . . . . 0.504 ' CD ' ' H ' ' B' ' 299' ' ' HIS . 0.5 OUTLIER -77.72 163.85 25.79 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.099 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 299' ' ' HIS . . . . . 0.504 ' H ' ' CD ' ' B' ' 298' ' ' GLU . 77.9 m-70 -75.72 -25.61 56.76 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 176.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 300' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 64.64 34.46 9.79 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.174 170.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 301' ' ' HIS . . . . . . . . . . . . . 42.6 t-80 -167.24 -53.54 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.388 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 302' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -144.44 102.66 3.86 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.092 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -70.91 -53.12 16.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.487 -175.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 20.6 t-80 . . . . . 0 C--N 1.324 -0.515 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 -178.645 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.0 tpp . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -144.97 111.25 5.6 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -60.27 -44.52 95.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.375 -176.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 61.47 -170.02 0.16 Allowed 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.476 0.485 . . . . 0.0 110.699 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 51.4 mm 71.25 -69.49 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.227 172.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.9 mt 64.25 94.09 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.573 0.701 . . . . 0.0 110.044 -172.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -138.58 -142.93 0.16 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.078 -176.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 68.92 30.83 4.47 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 122.989 0.515 . . . . 0.0 110.944 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.91 133.43 39.25 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.678 177.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.5 tp -102.73 109.9 21.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.932 0.396 . . . . 0.0 111.248 -176.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.57 122.23 43.45 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 175.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -98.49 107.16 19.55 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.859 0.361 . . . . 0.0 111.121 -175.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.3 m -123.8 98.39 5.79 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.128 0.489 . . . . 0.0 110.605 178.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.9 m -102.92 -174.15 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.049 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -151.55 166.54 30.85 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.201 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.9 t -84.5 117.98 24.02 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 177.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -81.02 -83.33 0.11 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -171.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 71.8 m 59.18 27.88 17.02 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.488 0.661 . . . . 0.0 110.574 -172.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.48 ' HB ' HD21 ' A' ' 20' ' ' LEU . 44.6 p -104.64 -157.39 0.61 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.755 177.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.486 ' H ' HD21 ' A' ' 20' ' ' LEU . 2.0 pt? -52.75 125.68 17.55 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 171.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -130.67 149.79 52.16 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.644 -177.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.76 92.52 2.49 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 176.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.437 ' HB3' ' HE1' ' A' ' 71' ' ' TYR . 30.9 mt-10 -144.43 -158.8 0.92 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.691 -175.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.637 ' HA ' ' CD1' ' A' ' 71' ' ' TYR . 0.0 OUTLIER 86.98 145.62 0.05 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.857 1.263 . . . . 0.0 111.447 178.437 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.413 HG21 ' CD1' ' A' ' 35' ' ' LEU . 31.1 m -109.82 140.98 26.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.356 -178.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.577 ' HA ' ' HD2' ' A' ' 73' ' ' HIS . 6.3 m -86.81 -174.08 4.78 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.296 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -69.92 -35.3 74.45 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -169.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.478 HE21 ' HB2' ' A' ' 26' ' ' SER . 0.5 OUTLIER -73.21 -33.93 65.65 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.561 -177.198 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.432 ' OE1' ' HB2' ' A' ' 26' ' ' SER . 3.0 mp0 -63.58 -45.03 92.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.099 0.476 . . . . 0.0 109.907 175.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.476 HG12 HD11 ' A' ' 35' ' ' LEU . 81.4 mt -56.76 -40.31 69.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.756 177.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.1 m -71.94 -20.74 61.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.305 -178.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -88.29 -42.19 12.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.476 -178.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -89.56 -9.31 50.31 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 121.064 -0.255 . . . . 0.0 111.372 -178.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? 54.84 54.78 8.61 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.293 0.568 . . . . 0.0 110.237 -176.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.476 HD11 HG12 ' A' ' 30' ' ' ILE . 89.6 mt -66.17 145.93 55.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.44 -176.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.7 m -73.71 135.91 26.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.719 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.5 tttm -96.89 122.58 40.02 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.365 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.24 -47.11 20.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.973 0.416 . . . . 0.0 110.237 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 171.45 173.86 38.7 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.066 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 86.9 m -101.26 121.28 41.6 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.619 0.247 . . . . 0.0 110.467 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.1 pt -106.77 144.09 16.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 176.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -128.43 131.57 48.44 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.533 0.682 . . . . 0.0 110.882 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 70.7 t -93.99 128.5 45.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 114.255 -1.339 . . . . 0.0 109.311 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.0 t -150.35 78.17 1.32 Allowed 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.631 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 0.6 OUTLIER -103.1 130.68 50.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.997 -179.141 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.9 t -92.14 102.61 15.14 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.009 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.54 -130.21 10.18 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.055 -0.593 . . . . 0.0 114.405 171.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.91 34.06 2.59 Favored Glycine 0 C--N 1.331 0.26 0 N-CA-C 114.329 0.492 . . . . 0.0 114.329 -167.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.631 ' HB2' ' HB3' ' A' ' 45' ' ' GLN . 15.2 mm100 -82.68 -28.33 30.67 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 172.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.523 HD13 ' HA ' ' A' ' 56' ' ' LEU . 49.6 mm -122.95 112.1 32.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.407 176.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.589 ' HB2' ' HA ' ' B' ' 302' ' ' HIS . 15.0 m -118.46 -1.27 11.26 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.311 -176.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 40.4 m -155.93 148.46 17.82 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -58.73 -31.49 95.07 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.426 2.084 . . . . 0.0 111.21 176.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.547 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 2.8 p -69.72 -35.1 74.74 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.212 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -75.76 -32.1 59.81 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.879 0.371 . . . . 0.0 110.422 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.523 ' HA ' HD13 ' A' ' 50' ' ' ILE . 68.4 tp -59.59 -50.21 74.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.049 178.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.558 ' HD2' ' CD ' ' B' ' 223' ' ' GLU . 26.5 ptt85 -67.35 -32.8 73.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.952 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.547 ' HG2' ' O ' ' A' ' 54' ' ' SER . 9.5 mm-40 -55.5 -42.64 74.72 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.162 0.506 . . . . 0.0 110.006 176.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.486 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 13.7 mptt -58.76 -44.91 90.71 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.591 175.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.452 HD11 HD11 ' A' ' 74' ' ' ILE . 74.5 mt -64.89 -41.88 95.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.972 -176.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.4 m -60.18 -40.01 88.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.163 0.506 . . . . 0.0 110.168 175.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -69.04 -40.37 78.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.891 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 59' ' ' LYS . 87.9 mt -66.26 -37.49 85.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.221 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.96 -39.08 93.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.885 0.374 . . . . 0.0 110.523 178.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -68.04 -35.77 78.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.849 177.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.12 -32.7 70.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.285 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.412 ' HD3' ' HA ' ' A' ' 67' ' ' LYS . 71.5 mmtt -87.34 -26.54 23.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.882 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.53 43.96 3.3 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.511 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -120.44 -170.84 14.33 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.81 -0.709 . . . . 0.0 111.776 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -123.26 -36.08 2.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.966 0.412 . . . . 0.0 110.591 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.637 ' CD1' ' HA ' ' A' ' 24' ' ' GLN . 71.7 m-85 -132.6 166.74 21.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.007 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.571 ' HH ' ' HA ' ' B' ' 223' ' ' GLU . 48.0 p90 -148.96 131.3 15.61 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.577 ' HD2' ' HA ' ' A' ' 26' ' ' SER . 58.8 t-80 -109.72 105.61 14.93 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.078 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.497 ' HB ' ' OG ' ' B' ' 226' ' ' SER . 60.6 mt -67.77 130.89 33.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.272 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 33.5 pt -114.17 -16.27 9.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.15 -178.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.512 ' HB3' ' HB ' ' A' ' 87' ' ' VAL . . . -147.94 137.31 22.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.056 -176.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -156.51 103.54 2.13 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.41 145.97 35.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.776 0.322 . . . . 0.0 111.032 -176.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -82.14 124.96 30.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.199 0.523 . . . . 0.0 110.816 176.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.0 t-160 -100.19 50.61 0.9 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 175.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.14 -130.83 10.14 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 110.321 -1.111 . . . . 0.0 110.321 -170.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -79.61 6.0 5.47 Favored 'Trans proline' 0 N--CA 1.464 -0.229 0 C-N-CA 122.483 2.122 . . . . 0.0 111.499 173.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -108.96 121.93 46.16 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.284 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.483 ' CE2' ' HB3' ' A' ' 86' ' ' ALA . 70.1 t80 -93.36 122.77 36.11 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.964 -176.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 25.9 mm-40 -112.36 115.3 28.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.249 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.492 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . . . -132.31 134.67 45.51 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.591 0.234 . . . . 0.0 111.057 178.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.512 ' HB ' ' HB3' ' A' ' 76' ' ' ALA . 97.2 t -114.46 121.86 67.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.939 0.4 . . . . 0.0 110.075 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 74' ' ' ILE . . . -125.19 138.07 54.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.165 -177.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.05 116.92 29.4 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.776 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.7 t -86.3 126.02 40.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.833 0.349 . . . . 0.0 110.655 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -123.52 156.51 35.5 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.986 178.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -110.19 172.65 6.74 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.454 ' C ' ' H ' ' A' ' 95' ' ' THR . 16.8 t70 -61.24 -31.94 71.73 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.299 -175.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 71.08 -9.78 0.83 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.565 0.746 . . . . 0.0 112.178 178.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.454 ' H ' ' C ' ' A' ' 93' ' ' ASP . 6.9 m -118.76 -39.94 2.92 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.122 175.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 97.0 mttt 70.03 35.21 2.27 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.783 176.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 96.5 mt -122.98 97.46 5.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.22 173.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.456 ' OE2' ' HD2' ' A' ' 99' ' ' HIS . 11.4 tm-20 -97.28 -73.62 0.6 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.572 -176.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.456 ' HD2' ' OE2' ' A' ' 98' ' ' GLU . 27.9 m-70 -151.78 146.21 25.56 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 173.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -79.95 78.23 6.58 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 174.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -143.05 117.76 9.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.595 0.712 . . . . 0.0 111.418 -178.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 41.8 t60 -99.1 102.74 14.53 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.873 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 69.4 t60 -103.92 85.48 2.42 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.811 0.338 . . . . 0.0 110.263 178.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 83.6 t60 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.928 178.229 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 120.834 0.35 . . . . 0.0 110.507 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -136.32 103.63 5.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.938 -177.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -132.78 150.41 52.16 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.952 175.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? 70.67 -83.16 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.994 0.809 . . . . 0.0 111.581 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 64.0 mt 60.54 84.23 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -169.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 21.7 pt -91.06 128.82 42.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.419 -174.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -89.27 86.13 6.77 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 175.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -148.14 160.65 42.69 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.213 -176.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . 0.466 ' HB2' ' HB ' ' B' ' 213' ' ' THR . . . -143.31 -50.68 0.34 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.66 177.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 210' ' ' LEU . . . . . . . . . . . . . 6.8 mp 55.91 28.52 12.69 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.045 -178.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 95.0 mt 71.68 -5.87 1.56 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.651 0.781 . . . . 0.0 111.679 -178.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -93.54 20.87 6.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.236 0.541 . . . . 0.0 110.76 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 213' ' ' THR . . . . . 0.466 ' HB ' ' HB2' ' B' ' 209' ' ' ALA . 11.1 t -65.79 -11.28 44.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.482 -177.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 214' ' ' VAL . . . . . . . . . . . . . 35.4 m -71.38 -3.68 3.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.719 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.71 102.03 0.23 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.066 0.46 . . . . 0.0 111.333 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 3.7 p -141.56 102.02 4.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.316 178.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -91.72 68.85 5.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.701 -177.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 218' ' ' SER . . . . . . . . . . . . . 47.9 m -160.68 179.86 8.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.673 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 17.0 m 76.44 113.75 0.07 Allowed 'General case' 0 CA--C 1.532 0.285 0 O-C-N 123.644 0.59 . . . . 0.0 112.107 174.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 5.1 tt -124.54 98.7 5.85 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 175.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -99.44 -9.49 23.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.792 -173.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -85.03 88.97 7.5 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.731 -177.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . 0.571 ' HA ' ' HH ' ' A' ' 72' ' ' TYR . 11.0 tp10 -164.97 135.72 3.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.213 -177.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 224' ' ' GLN . . . . . 0.432 ' HB2' ' O ' ' B' ' 223' ' ' GLU . 0.0 OUTLIER 170.76 139.98 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.811 0.694 . . . . 0.0 110.588 -179.827 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 17.8 m -109.33 132.18 58.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.943 172.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 226' ' ' SER . . . . . 0.554 ' O ' HG13 ' B' ' 230' ' ' ILE . 5.8 m -88.69 172.8 8.99 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.846 0.355 . . . . 0.0 111.068 -175.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . 0.522 ' HA ' HD13 ' B' ' 230' ' ' ILE . 5.5 mmtt -57.47 -32.65 67.18 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.76 -174.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -68.56 -51.5 42.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.334 -177.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -63.24 -35.52 80.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.015 -177.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.554 HG13 ' O ' ' B' ' 226' ' ' SER . 82.3 mt -57.08 -52.29 58.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.846 178.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 18.3 m -74.18 -24.32 59.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.785 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 20.0 t-160 -75.17 -48.71 22.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.34 -175.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -96.72 -3.16 43.0 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.047 -177.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm 62.92 72.27 0.49 Allowed 'General case' 0 N--CA 1.463 0.224 0 O-C-N 123.67 0.606 . . . . 0.0 111.59 176.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . 0.514 HD11 HG12 ' B' ' 230' ' ' ILE . 69.6 mt -73.35 174.4 8.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.997 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . 0.555 HG22 ' HA ' ' B' ' 294' ' ' ALA . 69.5 t -93.11 -49.19 13.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.644 -176.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 237' ' ' LYS . . . . . 0.574 ' HA ' ' HA ' ' B' ' 291' ' ' TYR . 60.0 tttm 69.97 139.92 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 O-C-N 123.877 0.735 . . . . 0.0 111.734 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 238' ' ' VAL . . . . . 0.524 HG12 ' HB2' ' B' ' 292' ' ' ASN . 3.3 m -111.15 -50.83 6.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . -178.65 -142.08 4.64 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.011 -1.09 . . . . 0.0 113.056 -177.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 63.4 m -134.38 145.36 48.89 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 122.621 0.368 . . . . 0.0 110.716 -176.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 20.5 pt -117.91 131.59 70.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 170.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -123.05 114.44 20.38 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.06 0.457 . . . . 0.0 110.338 -175.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 243' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 82.0 t -94.0 115.19 32.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.433 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 19.2 m -110.69 87.41 2.52 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 174.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 245' ' ' GLN . . . . . 0.488 ' HB3' ' HB3' ' B' ' 284' ' ' PHE . 0.0 OUTLIER -107.55 179.61 4.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.57 0.7 . . . . 0.0 111.53 -172.451 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 33.2 t -108.63 153.31 23.58 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 166.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -58.23 -29.07 62.38 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 121.17 -0.538 . . . . 0.0 113.768 -175.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -73.49 -11.83 80.16 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 121.043 -0.599 . . . . 0.0 113.908 -174.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -94.02 -6.81 44.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 117.482 0.641 . . . . 0.0 111.158 -178.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 47.2 mm -119.73 108.09 22.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.248 -178.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 23.7 t -121.72 -47.62 2.19 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.267 0.556 . . . . 0.0 109.998 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 3.9 m -113.28 156.6 42.87 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.435 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -57.89 -30.31 89.19 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.393 2.062 . . . . 0.0 111.748 176.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 254' ' ' SER . . . . . 0.486 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 18.8 m -63.16 -33.83 76.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.15 177.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -64.62 -45.89 84.95 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.137 0.494 . . . . 0.0 110.222 -178.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 54.3 tp -66.62 -39.39 88.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.941 177.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 257' ' ' ARG . . . . . 0.428 HH11 ' CD ' ' A' ' 23' ' ' GLU . 7.5 tmm_? -58.05 -42.07 84.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.076 178.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 258' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' B' ' 254' ' ' SER . 69.7 mm-40 -57.94 -29.54 65.24 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.57 178.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -85.64 -47.95 9.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.945 0.402 . . . . 0.0 110.658 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 96.0 mt -66.1 -49.72 66.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.119 -174.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 14.6 m -66.88 -33.23 75.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.825 0.345 . . . . 0.0 110.857 -176.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -62.48 -45.68 91.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.264 0.554 . . . . 0.0 110.287 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 263' ' ' LEU . . . . . 0.618 ' O ' ' HG2' ' B' ' 267' ' ' LYS . 92.3 mt -74.39 -44.88 50.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.002 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -59.02 -48.92 79.83 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -175.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -66.87 -31.47 72.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.873 0.368 . . . . 0.0 110.547 -178.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -69.3 -19.23 63.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.9 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 267' ' ' LYS . . . . . 0.618 ' HG2' ' O ' ' B' ' 263' ' ' LEU . 74.2 mmtt -84.76 -20.48 30.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.083 0.468 . . . . 0.0 110.141 177.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 107.23 -3.94 35.29 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.548 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -90.25 153.26 22.7 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.157 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -111.98 -9.98 13.98 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -177.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 271' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -135.79 162.22 33.4 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 272' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -151.24 167.48 27.69 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.414 170.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 273' ' ' HIS . . . . . 0.453 ' CD2' ' HA ' ' B' ' 226' ' ' SER . 47.5 t-80 -135.47 108.55 7.68 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 172.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 274' ' ' ILE . . . . . 0.555 ' HB ' ' HG ' ' A' ' 26' ' ' SER . 62.3 mt -65.21 130.54 30.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 29.4 pt -108.58 -21.29 5.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.658 -175.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -159.76 112.84 2.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.973 -179.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 277' ' ' ALA . . . . . 0.4 ' HB3' ' HG3' ' A' ' 29' ' ' GLU . . . -133.46 103.49 5.96 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 176.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -147.22 175.1 11.01 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.482 -171.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.19 108.47 19.11 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.17 -178.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 33.8 t-80 -90.64 69.83 6.71 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 175.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 75.67 -122.38 6.68 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 -174.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -79.71 -3.81 13.09 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.568 2.179 . . . . 0.0 112.19 175.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -94.99 140.92 29.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.419 -177.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 284' ' ' PHE . . . . . 0.488 ' HB3' ' HB3' ' B' ' 245' ' ' GLN . 71.3 t80 -113.53 110.23 19.92 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 174.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 285' ' ' GLU . . . . . 0.505 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 18.2 mm-40 -105.58 110.98 23.5 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.922 -178.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 286' ' ' ALA . . . . . 0.533 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -111.95 115.13 28.45 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.981 0.42 . . . . 0.0 110.062 172.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 24.4 t -114.12 119.77 62.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.759 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 288' ' ' ALA . . . . . 0.433 ' HB1' HG12 ' B' ' 274' ' ' ILE . . . -131.5 141.64 49.8 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.866 0.365 . . . . 0.0 110.869 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -91.36 124.96 35.94 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 290' ' ' VAL . . . . . 0.441 ' HB ' HG23 ' B' ' 238' ' ' VAL . 11.2 t -89.63 123.44 41.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.028 0.442 . . . . 0.0 109.997 -176.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 291' ' ' TYR . . . . . 0.574 ' HA ' ' HA ' ' B' ' 237' ' ' LYS . 98.3 m-85 -112.3 124.22 51.99 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.905 -176.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 292' ' ' ASN . . . . . 0.524 ' HB2' HG12 ' B' ' 238' ' ' VAL . 10.6 t-20 -91.86 156.47 17.47 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 174.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -59.13 158.28 9.07 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 123.48 0.488 . . . . 0.0 110.953 -177.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 294' ' ' ALA . . . . . 0.555 ' HA ' HG22 ' B' ' 236' ' ' VAL . . . -76.96 -11.25 59.78 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -172.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 295' ' ' THR . . . . . 0.416 ' O ' ' HB2' ' B' ' 296' ' ' LYS . 12.0 t -140.78 -28.97 0.69 Allowed 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.406 -177.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 296' ' ' LYS . . . . . 0.536 ' HE3' HG21 ' B' ' 236' ' ' VAL . 0.3 OUTLIER 71.87 150.81 0.1 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.129 0.572 . . . . 0.0 111.091 179.758 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 297' ' ' LEU . . . . . . . . . . . . . 85.1 mt 72.92 155.1 0.16 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.359 173.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 298' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 71.07 123.55 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.411 175.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 299' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -78.64 51.53 1.09 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.182 174.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 300' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -59.63 143.9 49.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.666 -173.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 301' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -126.36 -174.2 3.05 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.968 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 302' ' ' HIS . . . . . 0.589 ' HA ' ' HB2' ' A' ' 51' ' ' SER . 41.7 p-80 -60.12 164.79 3.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.388 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -68.64 130.94 44.29 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.77 177.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 20.0 p-80 . . . . . 0 C--N 1.322 -0.594 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.739 174.352 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 mpp? . . . . . 0 N--CA 1.477 0.892 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -79.37 89.71 4.99 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.108 0.48 . . . . 0.0 110.103 178.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -119.02 117.01 27.62 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.081 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -120.53 160.41 23.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.503 -178.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.402 HD13 ' N ' ' A' ' 5' ' ' ILE . 4.0 mp -87.33 129.95 37.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.46 HD11 ' O ' ' A' ' 6' ' ' ILE . 1.8 pp -71.81 144.36 13.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.111 0.481 . . . . 0.0 111.946 -178.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -174.28 144.29 0.93 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.608 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -79.15 90.69 4.88 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.142 0.496 . . . . 0.0 110.977 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -99.93 99.93 10.77 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.046 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 62.8 tp -113.65 102.95 10.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.155 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.605 HD12 ' HB3' ' B' ' 244' ' ' SER . 1.0 OUTLIER -154.38 137.47 15.57 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.338 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.48 ' N ' HD11 ' A' ' 11' ' ' LEU . . . -137.52 109.35 7.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.248 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.8 m -90.87 97.54 11.24 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.732 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.3 m -131.04 96.65 2.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.576 0.703 . . . . 0.0 111.605 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.08 61.88 0.41 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.902 176.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.437 ' HA ' ' CD ' ' B' ' 262' ' ' GLU . 22.7 t -70.98 113.04 7.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.019 -171.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -91.03 -25.15 19.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.474 172.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.1 m 60.73 32.03 20.18 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.514 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.9 m -100.39 119.77 38.96 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.064 178.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -80.73 131.34 35.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.025 -176.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.762 ' HB3' ' HB2' ' B' ' 265' ' ' ASP . . . -120.62 -66.52 1.05 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.636 177.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' B' ' 223' ' ' GLU . . . -148.37 -174.17 4.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.911 -177.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.91 ' HA ' ' HH ' ' B' ' 272' ' ' TYR . 16.2 pt-20 -177.39 141.44 0.31 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.629 ' HB3' ' HG3' ' B' ' 224' ' ' GLN . 0.0 OUTLIER -179.67 151.37 0.45 Allowed 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.31 174.264 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.499 ' HB ' ' CG ' ' A' ' 29' ' ' GLU . 11.6 m -112.58 146.35 17.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.77 0.319 . . . . 0.0 110.443 178.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.9 p -89.77 -156.67 0.42 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.438 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.472 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 12.8 tmtt? -80.01 -35.95 36.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.82 0.343 . . . . 0.0 110.676 -175.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -60.0 -50.42 73.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.213 -170.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.499 ' CG ' ' HB ' ' A' ' 25' ' ' VAL . 3.2 pm0 -76.15 -29.16 57.67 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.506 -174.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.548 HG12 HD13 ' A' ' 35' ' ' LEU . 69.2 mt -61.8 -43.68 97.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.011 0.434 . . . . 0.0 109.848 177.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.4 m -73.05 -34.16 66.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.191 177.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 35.1 t-80 -80.04 -36.33 35.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.778 -172.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -103.13 -10.46 18.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.47 0.176 . . . . 0.0 111.341 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt 58.55 83.96 0.11 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.339 -177.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.993 HD12 ' HH ' ' A' ' 71' ' ' TYR . 92.3 mt -93.53 155.37 17.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.8 -178.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.5 t -87.77 117.91 32.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.148 -176.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -82.24 115.15 21.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.025 177.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.421 ' CG1' ' HB2' ' A' ' 92' ' ' ASN . 6.4 m -97.12 15.0 3.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.075 0.464 . . . . 0.0 111.279 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 128.48 -158.1 21.59 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.65 -0.785 . . . . 0.0 113.006 174.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.5 m -144.96 139.74 27.74 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -178.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.6 pt -117.82 150.3 19.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.532 ' HB2' ' HB3' ' B' ' 211' ' ' LEU . 20.5 m120 -130.79 132.71 45.43 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.164 0.507 . . . . 0.0 111.486 -175.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 73.0 t -95.09 123.82 47.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.963 172.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.2 p -151.32 75.92 1.2 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.011 0.434 . . . . 0.0 111.23 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 14.9 mp0 -111.7 156.83 21.27 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.976 0.417 . . . . 0.0 111.084 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 64.4 m -89.47 67.76 7.7 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.975 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.6 -78.18 1.03 Allowed Glycine 0 CA--C 1.521 0.428 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.801 175.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.93 51.55 3.16 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 114.86 0.704 . . . . 0.0 114.86 -169.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -137.62 1.32 2.34 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 168.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.558 HD12 ' HA ' ' A' ' 56' ' ' LEU . 49.7 mm -126.62 107.64 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.081 174.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.3 p -95.55 -29.54 14.31 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.58 -174.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.4 m -147.83 165.88 17.37 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.847 -174.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.49 -46.4 21.18 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.207 1.938 . . . . 0.0 111.325 174.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.461 ' O ' ' HG3' ' A' ' 58' ' ' GLU . 48.4 t -59.49 -34.82 73.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.666 175.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.4 ' OD2' ' HA ' ' A' ' 50' ' ' ILE . 34.9 t70 -66.98 -41.0 87.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.949 0.404 . . . . 0.0 110.002 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.558 ' HA ' HD12 ' A' ' 50' ' ' ILE . 58.5 tp -59.69 -44.61 93.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.317 0.58 . . . . 0.0 109.789 173.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.39 -34.15 77.1 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.003 178.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 54' ' ' SER . 50.2 mt-10 -59.87 -45.49 92.3 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.779 -0.191 . . . . 0.0 110.577 177.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -60.92 -43.54 98.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.918 0.389 . . . . 0.0 110.821 176.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.47 -48.18 76.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.52 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.48 ' HB3' ' O ' ' B' ' 222' ' ' ALA . 18.8 p -70.29 -33.08 71.14 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.075 -176.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -60.95 -48.74 80.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.561 177.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.8 mt -65.46 -35.09 79.88 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.613 178.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.16 -41.99 80.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.863 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -62.13 -38.15 87.84 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.577 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.28 -39.02 85.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.923 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.4 mmtp -74.64 -29.38 61.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.001 0.429 . . . . 0.0 110.74 176.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.31 26.77 11.64 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.759 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -101.03 147.56 17.86 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.131 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 67.6 mttt -93.18 -4.16 52.59 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.825 0.345 . . . . 0.0 111.501 -172.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.993 ' HH ' HD12 ' A' ' 35' ' ' LEU . 22.3 p90 -165.32 164.6 19.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.486 -177.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.413 ' O ' ' HG3' ' A' ' 24' ' ' GLN . 25.3 p90 -131.78 133.06 44.33 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.508 -178.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.409 ' HB3' ' HB2' ' A' ' 89' ' ' GLU . 17.0 t-80 -100.22 102.5 13.8 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.494 -175.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.414 ' H ' HD13 ' A' ' 74' ' ' ILE . 5.3 mp -72.3 122.94 25.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 30.7 pt -111.49 -24.02 4.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.089 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -155.72 125.19 6.32 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.001 0.429 . . . . 0.0 111.202 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.16 119.68 23.36 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 175.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -139.62 155.1 47.63 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.463 0.649 . . . . 0.0 111.973 -171.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -110.54 112.11 23.8 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.538 177.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -78.12 -27.01 48.21 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 123.28 -85.16 0.37 Allowed Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -176.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.91 -20.42 29.42 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.456 2.104 . . . . 0.0 111.474 173.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -123.12 145.7 48.36 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.825 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -102.88 124.85 49.17 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 170.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.542 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 51.6 mt-10 -123.28 115.91 22.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.062 0.458 . . . . 0.0 111.099 -171.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.532 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . . . -127.85 134.37 49.41 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.042 179.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.8 t -114.36 116.27 52.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.155 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -131.65 137.79 48.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.089 0.471 . . . . 0.0 111.087 -178.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.409 ' HB2' ' HB3' ' A' ' 73' ' ' HIS . 30.0 mt-10 -91.48 150.61 21.15 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 17.6 t -113.06 130.64 66.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 177.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.753 ' HB2' ' CE1' ' A' ' 71' ' ' TYR . 52.3 m-85 -121.21 147.71 45.25 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.128 0.489 . . . . 0.0 110.107 177.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.421 ' HB2' ' CG1' ' A' ' 38' ' ' VAL . 1.5 t-20 -95.35 18.73 11.94 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.583 -168.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 45.2 t0 59.88 23.02 12.03 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.672 0.749 . . . . 0.0 110.299 -178.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 64.07 11.04 5.86 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.426 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.4 t -126.53 120.16 28.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.792 0.806 . . . . 0.0 111.222 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.662 ' HB2' ' HZ2' ' A' ' 96' ' ' LYS . 3.5 ttmp? -111.38 11.99 21.55 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.87 -178.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 35.4 mt -87.71 9.38 21.75 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.649 -170.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -99.39 -49.57 4.4 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.343 0.592 . . . . 0.0 110.166 176.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 12.6 p-80 -131.44 138.17 48.94 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.056 -177.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -129.83 -168.69 1.99 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.483 -169.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 65.31 64.09 0.62 Allowed 'General case' 0 N--CA 1.465 0.301 0 O-C-N 123.93 0.769 . . . . 0.0 110.89 -176.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.5 m170 -156.7 133.09 9.94 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.558 173.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -78.77 -77.11 0.18 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.313 178.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 69.4 m-70 . . . . . 0 C--N 1.324 -0.514 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.48 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 4.6 mpp? . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 121.095 0.474 . . . . 0.0 110.475 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -162.0 117.17 1.95 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.394 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -79.79 86.53 5.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.99 0.424 . . . . 0.0 111.826 -174.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -155.6 101.97 2.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.501 172.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 41.4 pt -85.84 -5.48 9.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.603 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 53.6 mt -79.61 83.97 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.378 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -146.99 23.21 1.21 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.816 176.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -81.24 90.42 6.1 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.692 -173.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -89.02 129.14 35.71 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 169.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 210' ' ' LEU . . . . . . . . . . . . . 83.6 mt -104.77 126.27 51.68 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.152 0.501 . . . . 0.0 111.615 -174.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . 0.532 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 58.2 tp -142.66 119.75 11.41 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.224 176.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.53 131.29 45.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.358 -177.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 213' ' ' THR . . . . . . . . . . . . . 19.0 p -81.35 97.44 7.71 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.241 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 214' ' ' VAL . . . . . . . . . . . . . 3.7 m -78.18 78.41 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.566 0.698 . . . . 0.0 110.001 175.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -66.02 144.58 56.65 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.549 -172.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 216' ' ' SER . . . . . 0.411 ' O ' ' HB3' ' B' ' 217' ' ' PHE . 17.6 m -138.22 -100.52 0.18 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.25 175.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 217' ' ' PHE . . . . . 0.411 ' HB3' ' O ' ' B' ' 216' ' ' SER . 31.0 p90 176.06 128.47 0.04 OUTLIER 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 173.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 218' ' ' SER . . . . . . . . . . . . . 67.5 m -143.27 174.2 10.93 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.823 0.344 . . . . 0.0 110.999 -177.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 3.5 p -77.35 157.33 30.72 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.115 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.438 HD11 ' O ' ' B' ' 220' ' ' LEU . 1.6 pp -70.89 109.6 5.13 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.359 0.6 . . . . 0.0 110.025 177.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -116.64 -7.22 11.58 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.333 -178.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . 0.48 ' O ' ' HB3' ' A' ' 61' ' ' SER . . . -165.94 149.06 7.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.29 -177.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . 0.464 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 7.2 pt-20 -168.54 122.69 0.89 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.062 0.458 . . . . 0.0 111.513 178.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 224' ' ' GLN . . . . . 0.629 ' HG3' ' HB3' ' A' ' 24' ' ' GLN . 0.7 OUTLIER -171.07 154.24 4.02 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.352 179.615 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 23.8 m -131.94 130.69 61.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.71 0.29 . . . . 0.0 111.032 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 226' ' ' SER . . . . . 0.66 ' HA ' ' HD2' ' B' ' 273' ' ' HIS . 77.3 p -88.87 179.8 6.12 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.45 -28.72 70.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.441 0.162 . . . . 0.0 111.312 -172.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -64.28 -50.65 67.08 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -61.65 -46.14 91.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.317 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.424 HG12 HD12 ' B' ' 235' ' ' LEU . 90.9 mt -55.8 -48.82 77.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.273 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 14.7 m -73.25 -35.11 66.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.88 0.371 . . . . 0.0 111.433 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -77.95 -33.53 51.53 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.37 -174.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -99.05 -9.41 23.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.399 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt 58.64 70.75 0.63 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.263 0.554 . . . . 0.0 110.691 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . 0.424 HD12 HG12 ' B' ' 230' ' ' ILE . 74.0 mt -82.99 -177.94 6.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.946 -175.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . 0.511 HG21 ' HA ' ' B' ' 294' ' ' ALA . 57.0 t -105.88 123.65 60.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.599 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -86.89 123.34 31.91 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 177.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 18.9 t -96.09 -38.82 8.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.444 -173.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 165.74 154.04 7.95 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.168 -1.015 . . . . 0.0 112.582 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 240' ' ' THR . . . . . 0.509 HG22 ' HG2' ' B' ' 289' ' ' GLU . 17.9 m -92.01 136.62 33.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.549 0.214 . . . . 0.0 110.542 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 36.5 pt -120.17 168.44 12.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.008 0.432 . . . . 0.0 110.949 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -144.72 133.13 21.9 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.19 174.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 243' ' ' VAL . . . . . 0.534 HG22 HD13 ' B' ' 263' ' ' LEU . 43.9 t -104.49 108.53 25.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.16 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 244' ' ' SER . . . . . 0.605 ' HB3' HD12 ' A' ' 11' ' ' LEU . 8.2 t -139.36 106.79 5.54 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.113 0.482 . . . . 0.0 110.115 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 245' ' ' GLN . . . . . 0.541 ' HB3' ' OE1' ' B' ' 249' ' ' GLN . 1.0 OUTLIER -132.1 -177.25 4.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.327 178.306 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 246' ' ' SER . . . . . 0.444 ' HB3' ' HG3' ' B' ' 249' ' ' GLN . 47.4 t -72.42 150.71 43.12 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.655 173.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -65.1 -16.26 61.86 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.727 177.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -77.56 -16.2 80.52 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.14 175.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . 0.541 ' OE1' ' HB3' ' B' ' 245' ' ' GLN . 38.9 mt-30 -92.03 -45.16 8.46 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 50.3 mm -97.33 93.22 3.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.814 0.816 . . . . 0.0 109.842 175.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 20.1 m -118.68 -15.7 9.47 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.049 -176.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 19.9 m -127.72 142.7 45.04 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.75 -39.64 80.18 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.536 2.157 . . . . 0.0 111.828 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 254' ' ' SER . . . . . 0.427 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 4.7 m -62.47 -29.85 70.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.17 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -74.84 -34.78 62.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.004 0.431 . . . . 0.0 110.632 -176.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . 0.42 ' O ' ' HG ' ' B' ' 260' ' ' LEU . 66.1 tp -61.86 -42.5 99.13 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.953 176.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -58.4 -35.56 72.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.981 178.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 258' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' B' ' 254' ' ' SER . 25.1 mm-40 -57.98 -50.87 71.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.333 177.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -66.87 -39.38 87.51 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.337 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 260' ' ' LEU . . . . . 0.485 ' HB3' ' CZ ' ' B' ' 272' ' ' TYR . 97.6 mt -58.11 -45.9 86.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.082 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 22.9 t -66.06 -44.16 85.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.298 0.571 . . . . 0.0 110.27 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 262' ' ' GLU . . . . . 0.437 ' CD ' ' HA ' ' A' ' 16' ' ' SER . 39.1 tt0 -58.43 -42.78 88.05 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.642 -177.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 263' ' ' LEU . . . . . 0.534 HD13 HG22 ' B' ' 243' ' ' VAL . 83.7 mt -73.09 -30.33 63.58 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.866 -178.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -65.88 -50.98 62.55 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.717 0.294 . . . . 0.0 110.915 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 265' ' ' ASP . . . . . 0.762 ' HB2' ' HB3' ' A' ' 21' ' ' ALA . 16.0 t70 -59.86 -38.1 81.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.949 0.404 . . . . 0.0 110.777 176.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -64.21 -22.31 66.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.496 -178.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 267' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' B' ' 267' ' ' LYS . 63.3 mmtt -87.48 -14.61 39.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.504 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 90.95 19.39 43.35 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.423 -175.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -117.63 -166.12 13.84 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . 0.416 ' O ' ' HB1' ' A' ' 22' ' ' ALA . 50.4 mttp -130.19 -66.51 0.77 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.722 0.296 . . . . 0.0 110.533 -178.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 271' ' ' TYR . . . . . 0.515 ' HB3' ' HA ' ' B' ' 224' ' ' GLN . 5.7 m-85 -90.56 153.65 20.19 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -175.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 272' ' ' TYR . . . . . 0.91 ' HH ' ' HA ' ' A' ' 23' ' ' GLU . 27.5 p90 -132.85 129.42 38.42 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.264 0.554 . . . . 0.0 110.759 178.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 273' ' ' HIS . . . . . 0.66 ' HD2' ' HA ' ' B' ' 226' ' ' SER . 55.9 t-80 -101.87 103.19 13.86 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.845 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 274' ' ' ILE . . . . . . . . . . . . . 59.1 mt -67.5 135.7 28.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.408 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 17.8 pt -115.52 -26.51 2.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -157.21 136.96 12.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.532 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -148.11 129.37 14.69 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.512 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.72 173.61 14.41 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.5 149.73 40.81 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.955 0.407 . . . . 0.0 110.318 171.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -95.51 -0.8 51.77 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.657 -178.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 113.86 -90.5 0.54 Allowed Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.323 -174.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.59 -14.62 22.14 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.852 2.368 . . . . 0.0 112.166 177.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -135.03 156.52 48.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.976 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 284' ' ' PHE . . . . . 0.546 ' O ' ' HA ' ' B' ' 244' ' ' SER . 82.7 t80 -110.83 145.63 37.85 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 285' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -138.67 110.1 6.99 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.924 0.393 . . . . 0.0 111.497 -177.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 286' ' ' ALA . . . . . 0.463 ' HB2' ' HB ' ' B' ' 243' ' ' VAL . . . -125.16 145.03 50.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.75 175.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 88.3 t -127.56 131.76 69.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.912 0.387 . . . . 0.0 110.347 177.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -142.57 156.28 45.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.246 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 289' ' ' GLU . . . . . 0.509 ' HG2' HG22 ' B' ' 240' ' ' THR . 35.5 mt-10 -112.76 128.28 56.38 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 58.4 t -89.02 131.42 36.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.943 0.402 . . . . 0.0 110.979 -176.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -125.23 159.7 30.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.284 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 292' ' ' ASN . . . . . 0.475 ' ND2' ' HA ' ' B' ' 296' ' ' LYS . 10.9 t-20 -118.52 161.79 19.44 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 293' ' ' ASP . . . . . 0.541 ' HB3' HG23 ' B' ' 295' ' ' THR . 4.6 t70 -76.69 21.98 0.19 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -170.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 294' ' ' ALA . . . . . 0.511 ' HA ' HG21 ' B' ' 236' ' ' VAL . . . 68.56 -8.88 0.58 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.53 0.732 . . . . 0.0 112.108 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 295' ' ' THR . . . . . 0.541 HG23 ' HB3' ' B' ' 293' ' ' ASP . 15.0 t -93.93 -22.27 18.7 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.249 175.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 296' ' ' LYS . . . . . 0.475 ' HA ' ' ND2' ' B' ' 292' ' ' ASN . 28.9 mtpp 71.04 -61.34 0.48 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 114.844 -1.071 . . . . 0.0 112.189 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 297' ' ' LEU . . . . . . . . . . . . . 48.2 mt -63.91 176.43 0.95 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.842 -174.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 298' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -76.01 78.68 2.87 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -171.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 299' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -83.22 61.27 6.01 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 166.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 300' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -152.82 18.29 0.59 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.359 -1.291 . . . . 0.0 107.847 -173.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 301' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -74.69 93.64 2.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.504 -1.225 . . . . 0.0 111.72 -171.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 302' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -154.43 109.77 3.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.37 172.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -86.36 -39.0 16.87 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -178.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 36.4 m80 . . . . . 0 C--N 1.326 -0.441 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 172.769 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 120.797 0.332 . . . . 0.0 110.765 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -164.08 166.11 21.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.346 175.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -97.35 105.98 18.22 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 65.4 mtm180 -101.71 161.72 13.44 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.271 -177.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.1 pt -123.56 155.7 30.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.314 178.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.1 pt -88.07 162.04 2.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.12 -179.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -147.52 153.37 39.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.949 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -133.22 151.88 51.94 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.546 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.07 98.95 3.56 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.578 178.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 60.2 tp -72.37 105.44 4.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.079 177.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.07 95.05 1.57 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.77 -177.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.31 72.17 10.74 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.255 177.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.2 t -151.92 153.19 33.63 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.384 -178.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 52.6 t -103.59 114.72 43.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.005 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.33 107.05 0.84 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.277 177.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.8 m -84.94 93.21 8.5 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.254 -174.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -82.05 155.37 25.15 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.116 176.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.1 m -155.31 157.41 37.15 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.653 0.263 . . . . 0.0 110.877 -174.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.8 m -68.05 93.52 0.44 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.968 0.413 . . . . 0.0 110.705 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 77.0 mt -142.38 23.62 1.98 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.52 178.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -169.69 -49.03 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.288 -178.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.482 ' HB2' ' HA ' ' B' ' 261' ' ' SER . . . -73.03 100.13 2.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.859 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -151.72 179.41 8.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.612 -176.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.575 ' HA ' ' HB2' ' A' ' 71' ' ' TYR . 0.0 OUTLIER 81.79 167.78 0.13 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.791 0.836 . . . . 0.0 111.765 171.919 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.419 HG13 ' CZ ' ' B' ' 257' ' ' ARG . 31.0 m -126.4 171.97 14.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.47 -178.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.514 ' HB2' ' HB ' ' B' ' 274' ' ' ILE . 10.8 t -112.66 -149.73 0.45 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.519 ' HA ' HD11 ' A' ' 30' ' ' ILE . 18.2 ttpt -97.86 -17.15 19.46 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 122.088 -0.382 . . . . 0.0 110.44 178.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -62.95 -42.53 99.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.951 -176.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.635 ' HG2' HH22 ' B' ' 257' ' ' ARG . 3.4 mp0 -68.83 -31.18 69.97 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.495 178.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.519 HD11 ' HA ' ' A' ' 27' ' ' LYS . 62.7 mt -64.68 -51.29 69.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.443 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.8 m -69.44 -27.87 65.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.407 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 22.2 m170 -84.1 -58.11 2.91 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.979 0.362 . . . . 0.0 111.979 -178.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -99.17 -11.75 21.08 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -169.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.434 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 3.8 mppt? 60.12 84.56 0.12 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.233 0.54 . . . . 0.0 110.799 -177.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 90.4 mt -73.81 151.44 40.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.031 -177.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 63.1 t -91.22 108.86 20.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.025 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -83.61 130.48 34.98 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.208 0.528 . . . . 0.0 110.836 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.472 HG12 ' HB2' ' A' ' 92' ' ' ASN . 6.4 m -92.03 -20.94 6.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.847 178.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.27 171.27 22.39 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.608 178.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 35.0 m -106.43 129.57 54.38 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.8 pt -102.92 151.46 6.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -128.49 123.77 34.43 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.095 0.474 . . . . 0.0 110.663 -171.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.746 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 57.3 t -93.54 109.05 21.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 174.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.6 t -141.38 78.71 1.65 Allowed 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -106.7 138.52 42.73 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.984 -177.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.0 m -83.66 94.15 8.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.865 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.89 -169.72 13.06 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.521 178.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.28 55.64 4.36 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.412 -0.423 . . . . 0.0 113.383 -176.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -75.94 -21.23 57.26 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.406 0.622 . . . . 0.0 109.421 173.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.1 mm -119.46 98.63 6.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.148 -0.933 . . . . 0.0 108.65 172.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 77.2 p -111.56 -40.93 4.21 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.229 -173.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.409 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 12.6 m -119.54 161.72 36.08 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.65 -177.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 52' ' ' SER . 9.3 Cg_endo -53.38 -29.47 48.36 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.728 2.285 . . . . 0.0 111.78 176.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.528 ' HA ' ' NE ' ' A' ' 57' ' ' ARG . 23.7 m -59.04 -38.92 80.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.621 177.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.453 ' O ' ' HD3' ' A' ' 59' ' ' LYS . 59.5 m-20 -63.54 -53.23 55.07 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -174.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 23.1 tp -54.92 -49.71 70.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.258 -173.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.528 ' NE ' ' HA ' ' A' ' 54' ' ' SER . 25.7 ptt180 -63.34 -42.68 98.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.355 -178.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 54' ' ' SER . 43.3 mt-10 -69.54 -46.89 65.42 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.672 0.272 . . . . 0.0 111.161 -176.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.453 ' HD3' ' O ' ' A' ' 55' ' ' ASP . 14.5 mptt -59.77 -45.86 90.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.527 178.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.528 HD22 ' CG2' ' A' ' 43' ' ' VAL . 79.7 mt -75.04 -30.82 61.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.146 -175.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.7 m -60.48 -41.43 94.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.023 0.439 . . . . 0.0 110.312 174.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -63.66 -46.94 83.31 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.402 177.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 88.6 mt -69.5 -48.48 60.49 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.862 -177.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.2 -50.93 68.35 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -174.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.574 ' OD2' ' HA ' ' B' ' 218' ' ' SER . 23.9 t70 -63.88 -37.36 87.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.909 0.385 . . . . 0.0 111.004 -176.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.95 -19.34 62.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.439 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -85.04 -5.73 59.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.955 0.407 . . . . 0.0 110.866 177.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.884 ' HA2' ' HA ' ' B' ' 216' ' ' SER . . . 106.97 -28.45 13.04 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.351 177.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.513 ' HA3' HG13 ' A' ' 90' ' ' VAL . . . -79.84 179.42 53.2 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.911 -0.662 . . . . 0.0 111.789 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.826 ' HA ' ' HZ1' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -112.43 -72.85 0.69 Allowed 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.162 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.575 ' HB2' ' HA ' ' A' ' 24' ' ' GLN . 0.6 OUTLIER -96.5 155.65 16.68 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.845 -176.349 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.744 ' CD1' ' HB1' ' B' ' 222' ' ' ALA . 3.9 p90 -109.34 170.94 7.74 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.259 -177.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 23.6 t-80 -141.0 103.38 4.46 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.419 HD11 ' H ' ' A' ' 74' ' ' ILE . 2.9 mp -65.12 132.01 30.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.029 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 32.1 pt -133.02 -5.76 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.686 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.403 ' HB1' ' HB ' ' A' ' 87' ' ' VAL . . . -165.92 144.73 5.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.739 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -158.56 137.9 11.64 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 177.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.444 HH11 ' HD2' ' A' ' 78' ' ' ARG . 7.4 ptp180 -166.15 141.15 4.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.945 0.402 . . . . 0.0 111.363 -178.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -77.93 96.19 4.97 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 170.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -90.44 77.5 6.52 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.677 -177.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.1 -120.42 13.68 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -175.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -86.33 -0.68 8.34 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.518 2.145 . . . . 0.0 111.869 176.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -107.96 110.41 22.13 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.57 -176.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -79.44 104.33 9.98 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 173.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.746 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 23.3 mt-10 -104.06 123.14 46.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.191 0.519 . . . . 0.0 111.484 -175.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.496 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -130.82 126.84 37.33 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.856 176.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.403 ' HB ' ' HB1' ' A' ' 76' ' ' ALA . 41.9 t -105.62 121.53 57.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.428 -176.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.47 135.95 32.49 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.794 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 40' ' ' THR . 29.3 mt-10 -96.35 150.17 20.88 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.513 HG13 ' HA3' ' A' ' 69' ' ' GLY . 8.2 t -110.56 133.59 55.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 -179.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.478 ' HB2' ' HE1' ' A' ' 71' ' ' TYR . 54.1 m-85 -116.77 151.1 37.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.25 0.547 . . . . 0.0 110.889 -178.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.472 ' HB2' HG12 ' A' ' 38' ' ' VAL . 8.2 t-20 -106.13 21.96 16.49 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.926 -177.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.2 t70 66.11 -155.03 0.25 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.174 -175.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -115.34 10.88 15.97 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.069 0.462 . . . . 0.0 110.076 177.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.6 t -159.33 172.73 17.45 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.94 -178.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -109.91 160.77 16.1 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.828 0.347 . . . . 0.0 110.216 178.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.9 pp -68.15 150.23 48.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.057 178.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.04 -168.34 2.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.643 -178.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 61.8 m80 -96.09 90.92 5.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.093 0.473 . . . . 0.0 111.766 -174.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.84 104.25 11.23 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 170.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 28.5 m170 -65.71 112.21 3.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.072 -172.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 38.7 p-80 -155.12 134.15 12.26 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.449 176.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 70.0 m-70 -92.16 -19.77 21.91 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.26 173.777 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 4.2 mpp? . . . . . 0 N--CA 1.483 1.205 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 60.6 tptt -80.3 96.78 6.74 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.166 177.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt 68.02 165.26 0.23 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.143 -179.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 74.0 mtm180 -117.0 88.79 2.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.966 0.413 . . . . 0.0 110.481 176.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 59.4 mt -119.32 96.07 4.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.794 177.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 42.8 mt -102.17 93.68 2.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.733 -178.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -107.09 86.03 2.24 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.164 177.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -148.2 37.94 0.87 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.419 -176.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -75.63 77.57 2.62 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.794 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 210' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -162.86 131.94 4.13 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 2.2 pp -132.79 161.83 33.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.566 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -129.5 -54.25 1.17 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.072 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 213' ' ' THR . . . . . . . . . . . . . 3.0 m 60.65 75.59 0.4 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.906 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 214' ' ' VAL . . . . . 0.55 HG11 ' H ' ' B' ' 215' ' ' ALA . 3.4 p -84.29 -62.47 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.803 -176.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . 0.55 ' H ' HG11 ' B' ' 214' ' ' VAL . . . -158.2 174.35 15.32 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -178.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 216' ' ' SER . . . . . 0.884 ' HA ' ' HA2' ' A' ' 68' ' ' GLY . 4.5 p -125.35 128.38 48.09 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.896 0.379 . . . . 0.0 111.019 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -137.86 133.83 34.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.916 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 218' ' ' SER . . . . . 0.574 ' HA ' ' OD2' ' A' ' 65' ' ' ASP . 16.4 m -77.59 115.99 17.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.133 -177.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 219' ' ' THR . . . . . 0.658 HG21 ' H ' ' B' ' 220' ' ' LEU . 1.3 m -150.03 -152.86 0.46 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.658 ' H ' HG21 ' B' ' 219' ' ' THR . 89.4 mt -59.2 141.05 55.24 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 173.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -113.03 -112.84 0.34 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -169.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . 0.744 ' HB1' ' CD1' ' A' ' 72' ' ' TYR . . . -129.8 106.15 8.49 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -164.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . 0.842 ' HB3' ' HE1' ' B' ' 271' ' ' TYR . 30.0 mt-10 -143.98 105.63 4.3 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 224' ' ' GLN . . . . . 0.573 ' HB2' ' HB2' ' A' ' 24' ' ' GLN . 0.0 OUTLIER 173.56 179.87 0.09 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.298 0.639 . . . . 0.0 109.287 172.273 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . 0.523 HG13 HD11 ' B' ' 235' ' ' LEU . 15.8 m -138.84 157.86 29.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 120.622 0.248 . . . . 0.0 110.774 178.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 226' ' ' SER . . . . . 0.503 ' HA ' ' CD2' ' B' ' 273' ' ' HIS . 81.2 p -110.2 -92.88 0.44 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.072 178.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . 0.487 ' C ' ' HD3' ' B' ' 227' ' ' LYS . 8.1 tmtm? -133.42 -52.99 0.89 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.813 0.34 . . . . 0.0 110.959 -176.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 228' ' ' GLN . . . . . 0.43 ' NE2' ' H ' ' B' ' 228' ' ' GLN . 1.9 mp0 -59.96 -45.43 92.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.278 -172.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 229' ' ' GLU . . . . . 0.538 ' H ' ' CD ' ' B' ' 229' ' ' GLU . 2.0 mp0 -60.58 -45.12 95.14 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.991 -177.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.521 HG12 HD13 ' B' ' 235' ' ' LEU . 49.1 mt -60.72 -49.77 83.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.119 -176.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 25.4 m -67.21 -21.26 65.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.465 -177.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -94.21 -44.07 8.15 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.597 -174.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -92.34 -8.73 44.21 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -175.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 10.6 mmmm 63.03 75.62 0.39 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.088 0.471 . . . . 0.0 111.042 176.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . 0.523 HD11 HG13 ' B' ' 225' ' ' VAL . 68.6 mt -83.77 161.68 20.9 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.293 0.568 . . . . 0.0 111.574 -177.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 65.2 t -95.63 129.18 46.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.348 176.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -102.32 146.07 28.57 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 238' ' ' VAL . . . . . 0.495 HG13 ' HB2' ' B' ' 292' ' ' ASN . 2.5 m -127.4 9.36 3.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 133.62 -161.92 24.32 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 119.942 -1.123 . . . . 0.0 113.191 174.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 240' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' B' ' 289' ' ' GLU . 29.2 m -140.18 133.35 29.63 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 33.3 pt -109.49 147.37 13.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.214 0.531 . . . . 0.0 111.031 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -112.82 118.06 33.89 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.25 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 243' ' ' VAL . . . . . 0.586 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 22.1 t -93.83 113.46 28.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 176.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 47.7 t -125.38 100.97 6.74 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.72 0.295 . . . . 0.0 110.228 -176.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 245' ' ' GLN . . . . . 0.573 ' HB3' ' HB2' ' B' ' 249' ' ' GLN . 9.2 mm-40 -90.63 -175.94 4.57 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.611 0.72 . . . . 0.0 111.453 -177.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 68.6 m -143.49 113.45 7.18 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.699 176.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 66.3 -118.85 11.6 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.135 177.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -98.3 42.2 2.11 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.181 -0.533 . . . . 0.0 113.49 -172.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . 0.83 HE21 ' HA ' ' B' ' 249' ' ' GLN . 0.0 OUTLIER -77.78 -22.19 50.56 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 173.687 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 250' ' ' ILE . . . . . 0.551 HG12 ' HG3' ' B' ' 245' ' ' GLN . 43.8 mm -121.51 96.36 4.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.34 175.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 39.4 t -96.64 -24.31 16.06 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.321 0.581 . . . . 0.0 109.583 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 73.8 p -138.23 162.85 51.4 Favored Pre-proline 0 N--CA 1.447 -0.625 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.65 -179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.93 -22.59 74.61 Favored 'Trans proline' 0 C--O 1.238 0.482 0 C-N-CA 122.019 1.813 . . . . 0.0 111.263 173.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 254' ' ' SER . . . . . . . . . . . . . 2.3 m -66.09 -42.79 88.83 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.566 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.466 ' O ' ' HG2' ' B' ' 259' ' ' LYS . 30.1 m-20 -54.92 -39.01 68.37 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.013 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . 0.414 ' O ' ' HG ' ' B' ' 260' ' ' LEU . 45.2 tp -58.83 -42.58 89.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.848 -178.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 257' ' ' ARG . . . . . 0.635 HH22 ' HG2' ' A' ' 29' ' ' GLU . 0.1 OUTLIER -67.92 -31.37 71.1 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.154 0.502 . . . . 0.0 110.028 -179.161 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 258' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' B' ' 255' ' ' ASP . 52.7 mm-40 -61.18 -41.45 96.83 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.424 178.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 259' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' B' ' 255' ' ' ASP . 16.0 mmmt -77.15 -42.04 39.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.766 -179.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 260' ' ' LEU . . . . . 0.452 HD11 ' CE2' ' B' ' 272' ' ' TYR . 97.3 mt -60.33 -42.96 96.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.768 -177.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 261' ' ' SER . . . . . 0.482 ' HA ' ' HB2' ' A' ' 22' ' ' ALA . 67.8 m -58.32 -48.97 78.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.955 0.407 . . . . 0.0 110.988 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -64.33 -41.89 96.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.023 -177.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 263' ' ' LEU . . . . . 0.442 ' O ' ' HG2' ' B' ' 267' ' ' LYS . 94.0 mt -74.12 -51.04 16.88 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -176.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -66.99 -48.14 69.36 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -172.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -67.09 -32.37 73.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.944 0.402 . . . . 0.0 110.62 -174.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -82.68 -9.91 59.16 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.245 -177.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 267' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' B' ' 263' ' ' LEU . 67.6 mmtt -87.48 -2.41 58.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.677 0.275 . . . . 0.0 111.279 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 91.98 7.85 63.88 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.031 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -108.75 -174.45 21.53 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 176.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . 0.614 ' HE2' ' HA ' ' B' ' 270' ' ' LYS . 8.4 mmpt? -127.41 -62.91 1.07 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.942 0.401 . . . . 0.0 110.876 -178.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 271' ' ' TYR . . . . . 0.842 ' HE1' ' HB3' ' B' ' 223' ' ' GLU . 90.1 m-85 -102.43 173.33 6.4 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.125 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 272' ' ' TYR . . . . . 0.452 ' CE2' HD11 ' B' ' 260' ' ' LEU . 17.6 p90 -149.87 169.4 21.21 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.519 -178.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 273' ' ' HIS . . . . . 0.503 ' CD2' ' HA ' ' B' ' 226' ' ' SER . 11.2 t-160 -139.63 110.01 6.59 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.813 0.34 . . . . 0.0 110.622 174.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 274' ' ' ILE . . . . . 0.514 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 47.6 mt -70.69 113.19 6.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.063 175.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 25.2 pt -100.04 -23.56 4.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.814 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -160.52 146.6 15.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.358 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 277' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' B' ' 285' ' ' GLU . . . -157.03 111.03 2.66 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 177.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.31 150.46 50.67 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.651 -174.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -84.81 95.8 9.09 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 172.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 17.3 t-80 -91.61 84.85 5.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.055 0.455 . . . . 0.0 109.932 -177.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 66.76 -125.48 25.61 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.386 -175.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -85.15 -8.56 8.83 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.598 2.199 . . . . 0.0 111.965 175.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 283' ' ' ASN . . . . . 0.409 ' HA ' ' O ' ' B' ' 245' ' ' GLN . 15.1 m120 -103.81 109.98 21.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.676 -177.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 284' ' ' PHE . . . . . 0.494 ' HB3' ' HB2' ' B' ' 245' ' ' GLN . 78.3 t80 -78.76 120.02 22.81 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 175.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 285' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' B' ' 277' ' ' ALA . 97.2 mt-10 -108.72 110.92 22.45 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.41 0.444 . . . . 0.0 111.155 -176.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 286' ' ' ALA . . . . . 0.586 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -111.53 123.14 49.61 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 172.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 28.5 t -105.12 113.31 41.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.312 -178.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -130.84 128.81 41.4 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.678 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 289' ' ' GLU . . . . . 0.538 ' HA ' ' HA ' ' B' ' 240' ' ' THR . 17.2 mt-10 -92.38 135.46 34.02 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 23.6 t -97.67 137.84 24.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.142 0.496 . . . . 0.0 111.496 -170.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -118.3 149.5 41.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.159 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 292' ' ' ASN . . . . . 0.548 ' OD1' ' HG2' ' B' ' 296' ' ' LYS . 8.0 t-20 -95.37 21.95 7.48 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.881 -171.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 293' ' ' ASP . . . . . 0.443 ' HB3' ' O ' ' B' ' 292' ' ' ASN . 10.8 t70 78.36 -28.92 0.16 Allowed 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.562 172.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 294' ' ' ALA . . . . . 0.418 ' H ' ' C ' ' B' ' 292' ' ' ASN . . . 82.36 -9.4 1.17 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.507 1.123 . . . . 0.0 111.085 -178.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 295' ' ' THR . . . . . . . . . . . . . 8.9 m -107.25 -21.76 12.84 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.455 174.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 296' ' ' LYS . . . . . 0.548 ' HG2' ' OD1' ' B' ' 292' ' ' ASN . 68.2 mttm 69.79 -80.98 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.335 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 297' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -175.84 -168.79 0.3 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.744 -175.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 298' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.34 111.63 5.36 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 176.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 299' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -142.41 48.23 1.56 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.369 0.604 . . . . 0.0 110.276 -176.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 300' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -53.39 128.88 30.17 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.373 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 301' ' ' HIS . . . . . . . . . . . . . 20.5 m80 61.39 86.35 0.11 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.943 177.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 302' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -140.43 94.91 2.79 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -81.22 -49.08 11.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.539 -177.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 78.9 t60 . . . . . 0 C--N 1.325 -0.483 0 C-N-CA 120.605 -0.438 . . . . 0.0 109.85 177.479 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.414 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.7 mpt? . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -78.33 146.97 34.41 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -152.82 154.09 34.44 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.269 -174.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 10.9 ptp85 -138.11 150.73 47.12 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 177.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.7 tt -99.58 113.7 35.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.371 0.605 . . . . 0.0 110.425 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 34.6 pt -117.68 140.06 42.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.033 -177.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -128.61 100.05 5.6 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.76 175.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.9 -71.66 0.18 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.445 -176.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -138.36 132.64 31.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.078 -178.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.712 ' H ' HD23 ' A' ' 10' ' ' LEU . 1.6 pt? -100.46 95.98 7.09 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.261 0.553 . . . . 0.0 110.45 178.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.7 mt -133.63 118.57 18.36 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.499 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.55 103.23 6.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.07 0.462 . . . . 0.0 109.824 176.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.8 t -70.26 -21.96 62.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.432 -176.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.0 t 62.46 82.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.094 0 CA-C-O 121.543 0.687 . . . . 0.0 109.865 -175.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -122.42 76.79 1.35 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.885 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.3 m -86.13 111.58 20.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.257 -175.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -140.37 -60.96 0.52 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.06 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.9 p -166.11 126.34 1.71 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.627 -178.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.761 HG22 ' HB2' ' B' ' 265' ' ' ASP . 0.1 OUTLIER -78.16 42.99 0.42 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -176.266 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.3 mt -78.23 73.15 4.79 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 176.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 173.96 -28.56 0.0 OUTLIER 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.829 -174.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.63 112.71 18.3 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -170.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 178.95 104.65 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.584 178.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.592 ' HB2' ' HB3' ' B' ' 224' ' ' GLN . 0.0 OUTLIER -162.14 155.64 20.87 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 122.052 -0.405 . . . . 0.0 110.873 -179.341 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.8 m -115.75 143.93 24.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.966 174.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.617 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 11.8 t -108.05 -90.45 0.44 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -174.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.413 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 10.7 tmtt? -145.88 -45.73 0.21 Allowed 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -173.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.413 ' CB ' ' HB1' ' B' ' 277' ' ' ALA . 27.7 mm-40 -54.58 -49.85 69.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.996 -174.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.477 ' H ' ' CD ' ' A' ' 29' ' ' GLU . 0.9 OUTLIER -68.85 -43.75 74.8 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.713 -176.129 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.525 HG12 HD11 ' A' ' 35' ' ' LEU . 54.7 mt -62.1 -43.64 98.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.66 -175.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.4 m -72.6 -24.38 61.07 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.928 0.394 . . . . 0.0 111.274 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -91.56 -32.85 15.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.533 -173.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.455 ' HA ' ' HB2' ' A' ' 103' ' ' HIS . 80.4 m-85 -110.1 -12.5 14.5 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -177.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt 65.93 82.98 0.17 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.165 0.507 . . . . 0.0 111.719 -178.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.525 HD11 HG12 ' A' ' 30' ' ' ILE . 22.0 mt -89.88 147.91 23.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.2 177.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.1 m -85.03 122.36 38.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.711 -177.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.1 ttmm -85.54 117.53 24.5 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 177.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.1 t -78.39 -28.08 14.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.155 0.502 . . . . 0.0 109.939 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 167.45 -175.99 42.35 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.854 179.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.486 HG21 ' HB3' ' B' ' 207' ' ' ALA . 26.6 m -130.28 123.47 30.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.055 0.455 . . . . 0.0 110.243 178.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.422 HD12 HD11 ' A' ' 63' ' ' LEU . 25.3 pt -120.28 166.07 15.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.413 -176.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.44 HD22 HD12 ' B' ' 210' ' ' LEU . 25.7 p30 -145.77 147.53 31.98 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.491 0.663 . . . . 0.0 111.169 176.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.609 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 75.0 t -94.56 142.64 13.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.551 177.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.6 t -159.6 79.73 0.72 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.189 0.519 . . . . 0.0 109.765 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -113.8 150.04 34.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.358 178.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.7 t -111.61 112.73 24.65 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.622 -175.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.61 -144.93 17.45 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.226 176.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.3 74.54 1.68 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 121.603 -0.332 . . . . 0.0 113.781 -173.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -121.65 -36.73 2.99 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.154 0.502 . . . . 0.0 109.796 169.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.435 HG22 ' HB2' ' A' ' 55' ' ' ASP . 72.1 mt -133.52 123.01 45.35 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.493 176.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.7 m -143.64 -27.98 0.54 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.0 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.3 p -113.73 154.87 45.68 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 175.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.74 -25.0 58.28 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.824 2.349 . . . . 0.0 112.879 -176.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.612 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 11.8 p -67.24 -40.9 86.35 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.92 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.435 ' HB2' HG22 ' A' ' 50' ' ' ILE . 37.3 m-20 -58.63 -41.78 86.76 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.117 0.485 . . . . 0.0 110.624 -176.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 45.2 tp -63.23 -45.76 90.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.307 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.482 ' HD2' ' OE2' ' B' ' 223' ' ' GLU . 42.9 ttp180 -61.32 -40.5 94.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.983 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.612 ' HG2' ' O ' ' A' ' 54' ' ' SER . 9.4 mm-40 -59.18 -30.98 68.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.454 -177.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.421 ' O ' ' HB3' ' A' ' 62' ' ' GLU . 4.3 mptp? -93.86 -37.09 11.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.775 -177.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 86.5 mt -70.42 -39.7 74.27 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.019 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.0 t -69.2 -34.7 75.29 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 176.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.421 ' HB3' ' O ' ' A' ' 59' ' ' LYS . 34.4 tt0 -56.8 -49.32 75.68 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.87 177.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.422 HD11 HD12 ' A' ' 41' ' ' ILE . 73.8 mt -74.43 -30.36 61.88 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.742 -178.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.82 -50.98 53.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.433 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -68.23 -25.43 65.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.158 0.504 . . . . 0.0 110.41 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.45 -42.29 59.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.13 178.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.445 ' HE2' ' HA ' ' B' ' 212' ' ' ALA . 59.0 mmtt -77.13 -35.66 56.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.394 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.57 59.94 0.63 Allowed Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.605 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.638 ' HA2' ' HA ' ' A' ' 92' ' ' ASN . . . -143.93 160.87 27.82 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 177.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -107.63 -15.71 14.52 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.777 0.289 . . . . 0.0 111.267 -175.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -140.47 145.63 37.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.642 0.258 . . . . 0.0 110.362 -177.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.445 ' O ' ' HG2' ' A' ' 24' ' ' GLN . 21.4 p90 -116.53 168.08 10.48 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 171.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.617 ' CD2' ' HA ' ' A' ' 26' ' ' SER . 10.0 t-160 -140.0 108.21 5.79 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.204 178.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 76.6 mt -71.76 118.59 16.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.188 177.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.9 pt -114.89 -18.58 7.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -152.92 100.42 2.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.826 0.345 . . . . 0.0 111.235 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -115.31 115.12 26.11 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -138.08 160.3 39.74 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.252 0.548 . . . . 0.0 111.614 -172.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -104.7 103.93 13.65 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.738 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.487 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 2.6 t-160 -94.75 56.88 2.09 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -176.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.67 -122.82 5.83 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.769 -0.933 . . . . 0.0 110.769 -175.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -83.94 10.52 3.66 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.372 2.048 . . . . 0.0 111.7 174.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.487 ' HB2' ' HB3' ' A' ' 80' ' ' HIS . 17.3 m-80 -113.48 127.27 56.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.282 -176.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -97.67 111.88 23.98 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.609 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 42.0 mt-10 -116.12 119.83 37.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.04 0.448 . . . . 0.0 110.957 -177.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -130.12 118.25 21.19 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.507 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.1 t -95.27 127.74 47.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 73' ' ' HIS . . . -136.62 144.72 44.23 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.389 -175.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -91.57 147.27 23.13 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 176.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 43.9 t -106.46 122.02 59.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -121.31 139.1 53.87 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.817 0.342 . . . . 0.0 110.079 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.638 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 26.2 t-20 -77.4 -89.42 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.202 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.5 t70 172.62 -48.77 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 70.29 1.0 3.4 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 114.338 -1.301 . . . . 0.0 113.601 169.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.434 ' OG1' ' HG2' ' B' ' 253' ' ' PRO . 32.2 m -66.16 -44.68 83.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.717 0.294 . . . . 0.0 110.918 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -83.72 -6.33 59.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.955 0.407 . . . . 0.0 110.843 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 93.6 mt -101.17 179.65 4.31 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.195 -173.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -76.1 65.67 2.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.075 -176.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -86.1 87.55 7.44 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.776 0.798 . . . . 0.0 110.227 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -86.96 24.89 1.41 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.41 0.624 . . . . 0.0 110.328 177.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -103.01 118.59 37.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.861 171.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -83.47 149.3 26.73 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.455 ' HB2' ' HA ' ' A' ' 33' ' ' PHE . 31.6 p-80 -89.51 161.3 16.29 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.102 -178.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 56.2 t60 . . . . . 0 C--N 1.32 -0.695 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.789 177.405 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 83.9 mtp . . . . . 0 N--CA 1.485 1.275 0 CA-C-O 120.595 0.236 . . . . 0.0 110.392 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt 69.88 -67.69 0.22 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.374 0.67 . . . . 0.0 111.917 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . 0.444 ' HB3' HD11 ' B' ' 205' ' ' ILE . 62.0 mttp -76.55 102.4 6.06 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.466 -175.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 65.1 mtm180 -115.67 94.55 4.74 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 172.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 205' ' ' ILE . . . . . 0.444 HD11 ' HB3' ' B' ' 203' ' ' LYS . 4.8 mp -100.38 120.34 49.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.817 0.341 . . . . 0.0 110.754 -175.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 1.4 pp -122.78 62.03 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.564 0.697 . . . . 0.0 110.563 177.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 207' ' ' ALA . . . . . 0.486 ' HB3' HG21 ' A' ' 40' ' ' THR . . . -75.43 123.5 25.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.498 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -111.97 110.24 20.45 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.938 0.399 . . . . 0.0 111.827 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -109.91 -50.03 3.02 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 172.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 210' ' ' LEU . . . . . 0.44 HD12 HD22 ' A' ' 42' ' ' ASN . 10.6 mp 66.88 -172.3 0.19 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.642 172.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . 0.425 HD21 ' HA ' ' B' ' 211' ' ' LEU . 0.3 OUTLIER 65.17 90.53 0.09 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.982 -179.213 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 212' ' ' ALA . . . . . 0.445 ' HA ' ' HE2' ' A' ' 67' ' ' LYS . . . -135.16 147.98 49.58 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.982 178.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 213' ' ' THR . . . . . . . . . . . . . 12.3 p -90.71 -171.12 2.93 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.973 -178.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 214' ' ' VAL . . . . . . . . . . . . . 3.0 p -124.51 114.58 41.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.14 0.495 . . . . 0.0 110.768 -178.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -148.8 150.29 32.81 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 8.9 t -156.95 77.79 0.89 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.27 0.557 . . . . 0.0 109.765 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -110.46 -30.16 7.78 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.516 178.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 218' ' ' SER . . . . . . . . . . . . . 32.3 t -89.05 98.25 11.66 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 174.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 1.7 p -62.48 -30.49 71.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.326 -178.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 60.4 tp -106.55 100.04 9.59 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 173.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -168.41 105.68 0.46 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.162 -178.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . 0.413 ' HB3' ' HD2' ' A' ' 72' ' ' TYR . . . 68.71 97.95 0.06 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 123.993 0.808 . . . . 0.0 112.656 171.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . 0.519 ' O ' ' HB2' ' A' ' 24' ' ' GLN . 34.7 mt-10 -139.98 -156.46 0.68 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.631 -178.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 224' ' ' GLN . . . . . 0.592 ' HB3' ' HB2' ' A' ' 24' ' ' GLN . 0.8 OUTLIER 68.76 144.32 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.034 0.534 . . . . 0.0 112.352 176.503 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 2.4 m -118.87 172.87 5.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.686 -177.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 226' ' ' SER . . . . . 0.529 ' HA ' ' CD2' ' B' ' 273' ' ' HIS . 13.4 t -101.8 -96.02 0.28 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -176.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -142.53 -41.21 0.33 Allowed 'General case' 0 C--O 1.233 0.236 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -173.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -62.78 -30.7 71.66 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.76 0.79 . . . . 0.0 110.023 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -70.99 -34.52 71.46 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.625 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.499 HG22 ' HB2' ' B' ' 235' ' ' LEU . 56.4 mt -59.27 -43.38 89.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.153 0.502 . . . . 0.0 109.988 177.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 42.6 t -63.48 -30.15 71.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.668 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -84.54 -46.49 11.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.96 -176.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -93.89 -14.28 26.22 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -171.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? 62.52 88.91 0.09 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.289 0.566 . . . . 0.0 110.798 -176.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . 0.585 HD13 ' HE1' ' B' ' 271' ' ' TYR . 81.6 mt -108.9 155.43 20.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.08 -177.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 73.3 t -115.19 113.02 42.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.535 -172.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.2 140.05 58.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.91 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 1.9 m -122.85 5.78 5.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 138.62 -160.17 25.54 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.173 -1.013 . . . . 0.0 112.788 176.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 240' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' B' ' 289' ' ' GLU . 8.8 m -140.54 146.14 37.7 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -176.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 241' ' ' ILE . . . . . 0.51 ' HB ' HD13 ' B' ' 263' ' ' LEU . 26.4 pt -113.19 143.98 21.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 174.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -127.15 123.05 35.82 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.223 0.535 . . . . 0.0 110.684 -174.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 243' ' ' VAL . . . . . 0.582 ' HB ' ' HB2' ' B' ' 286' ' ' ALA . 75.3 t -100.15 116.14 42.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.448 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 72.7 m -135.96 87.87 2.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.332 177.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 245' ' ' GLN . . . . . 0.402 HE22 HG12 ' B' ' 243' ' ' VAL . 0.0 OUTLIER -142.43 163.11 33.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.575 179.714 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 37.7 t -78.14 174.68 10.9 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.208 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -70.4 4.6 8.52 Favored Glycine 0 CA--C 1.521 0.408 0 CA-C-N 116.363 -0.38 . . . . 0.0 113.041 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -80.55 -35.54 25.55 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.453 174.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -94.66 -21.5 18.75 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.924 0.393 . . . . 0.0 110.581 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 42.0 mm -119.45 99.29 7.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 176.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 16.7 t -130.9 -52.94 1.05 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.851 0.358 . . . . 0.0 110.524 -177.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 252' ' ' SER . . . . . 0.438 ' HB3' ' HD2' ' B' ' 253' ' ' PRO . 23.1 m -109.9 159.71 30.77 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.213 178.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' B' ' 252' ' ' SER . 11.1 Cg_endo -55.87 -39.78 89.08 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.826 2.351 . . . . 0.0 112.841 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 254' ' ' SER . . . . . 0.495 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 66.7 m -60.98 -31.87 71.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.211 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -64.13 -50.19 69.22 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.061 0.458 . . . . 0.0 110.249 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 48.6 tp -62.05 -38.38 88.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.541 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -56.99 -51.03 70.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.754 178.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 258' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' B' ' 254' ' ' SER . 10.2 mm-40 -63.9 -38.9 92.81 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.934 -178.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -63.99 -46.36 84.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.628 178.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 94.6 mt -65.89 -38.88 89.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.711 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 47.3 t -62.42 -40.08 95.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.432 176.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -60.85 -43.24 98.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.42 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 263' ' ' LEU . . . . . 0.51 HD13 ' HB ' ' B' ' 241' ' ' ILE . 94.1 mt -74.06 -39.49 63.44 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.392 -178.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -64.67 -44.56 90.0 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.73 0.3 . . . . 0.0 111.447 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 265' ' ' ASP . . . . . 0.761 ' HB2' HG22 ' A' ' 19' ' ' THR . 38.9 t70 -68.72 -31.73 71.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.078 0.466 . . . . 0.0 110.174 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -67.06 -35.78 80.59 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.779 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -75.57 -37.21 60.08 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.024 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 89.25 31.98 11.13 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.374 -176.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -94.3 -176.9 38.98 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.568 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . 0.403 ' HG2' HD21 ' B' ' 292' ' ' ASN . 30.1 mmtp -112.1 -12.94 13.62 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.426 -177.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 271' ' ' TYR . . . . . 0.585 ' HE1' HD13 ' B' ' 235' ' ' LEU . 43.5 p90 -167.52 175.71 6.97 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 173.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 272' ' ' TYR . . . . . 0.486 ' H ' ' HG3' ' B' ' 224' ' ' GLN . 43.9 p90 -133.04 123.93 26.71 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 273' ' ' HIS . . . . . 0.529 ' CD2' ' HA ' ' B' ' 226' ' ' SER . 6.1 t-160 -95.04 102.12 13.91 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.095 -0.642 . . . . 0.0 110.257 -177.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 274' ' ' ILE . . . . . . . . . . . . . 62.1 mt -66.36 111.63 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.185 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 20.0 pt -103.2 -35.66 3.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -178.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -159.76 113.86 2.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.003 0.43 . . . . 0.0 111.365 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 277' ' ' ALA . . . . . 0.53 ' HA ' ' HA ' ' B' ' 286' ' ' ALA . . . -122.37 107.43 12.07 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 174.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -128.18 138.54 52.52 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.644 0.735 . . . . 0.0 111.55 -169.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -78.88 133.63 36.96 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.363 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -134.08 101.1 4.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.009 0.433 . . . . 0.0 110.704 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 64.46 -129.49 36.84 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.858 -178.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -88.71 8.38 3.99 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.235 2.624 . . . . 0.0 112.489 178.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -124.57 155.77 38.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.965 0.412 . . . . 0.0 110.726 -177.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 284' ' ' PHE . . . . . 0.498 ' CE2' ' HB3' ' B' ' 286' ' ' ALA . 83.2 t80 -111.62 125.17 53.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.241 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 285' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 8.3 mm-40 -109.7 110.86 22.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.282 -178.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 286' ' ' ALA . . . . . 0.582 ' HB2' ' HB ' ' B' ' 243' ' ' VAL . . . -119.82 125.51 48.73 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.329 179.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 25.8 t -111.65 118.62 57.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.364 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -135.19 135.92 41.39 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.868 177.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 289' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' B' ' 240' ' ' THR . 2.4 mt-10 -98.3 140.43 32.59 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -178.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 40.3 t -101.4 129.66 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -176.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 291' ' ' TYR . . . . . 0.556 ' HB2' ' CZ ' ' B' ' 271' ' ' TYR . 50.4 m-85 -120.14 150.51 40.5 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.403 0.62 . . . . 0.0 110.512 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 292' ' ' ASN . . . . . 0.403 HD21 ' HG2' ' B' ' 270' ' ' LYS . 3.1 t-20 -120.74 179.45 4.34 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.75 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -82.2 175.72 10.07 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 174.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 294' ' ' ALA . . . . . . . . . . . . . . . -107.25 10.91 29.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.892 0.377 . . . . 0.0 111.141 -176.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 295' ' ' THR . . . . . . . . . . . . . 8.8 t -109.11 -31.55 7.56 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.743 -176.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt 63.85 -87.69 0.03 OUTLIER 'General case' 0 C--O 1.233 0.215 0 O-C-N 123.77 0.668 . . . . 0.0 111.88 173.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 297' ' ' LEU . . . . . 0.503 HD21 ' HB2' ' B' ' 301' ' ' HIS . 0.9 OUTLIER 175.55 156.89 0.2 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.132 -177.021 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 298' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.36 -40.15 8.86 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 168.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 299' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -177.31 -3.43 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.928 172.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 300' ' ' HIS . . . . . . . . . . . . . 52.9 m170 -80.46 21.23 0.64 Allowed 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 301' ' ' HIS . . . . . 0.503 ' HB2' HD21 ' B' ' 297' ' ' LEU . 75.7 t60 -65.38 -55.34 18.66 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 178.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 302' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -178.62 110.01 0.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -82.38 147.71 28.65 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 121.049 -0.261 . . . . 0.0 110.342 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 . . . . . 0 C--N 1.32 -0.69 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.345 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.446 ' O ' ' HB2' ' A' ' 2' ' ' LYS . 26.3 ptt? . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.368 0.128 . . . . 0.0 110.913 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 1' ' ' MET . 3.7 mptp? 69.66 168.44 0.29 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 122.993 0.517 . . . . 0.0 110.9 -174.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.519 ' C ' ' HD2' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -162.75 162.96 26.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.718 174.514 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.519 ' HD2' ' C ' ' A' ' 3' ' ' LYS . 3.4 mpt_? -122.45 104.92 9.71 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 176.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.476 HD11 ' O ' ' A' ' 5' ' ' ILE . 2.3 pp -84.62 126.82 40.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.07 0.462 . . . . 0.0 110.673 -179.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.9 mm -133.45 123.9 47.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.84 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -114.33 93.8 4.51 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 177.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -93.85 102.72 14.85 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.641 -177.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -110.59 141.55 43.63 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.887 177.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.0 mt -88.49 -41.18 12.9 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 -173.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 58.83 -92.71 0.04 OUTLIER 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.778 -177.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 66.31 -77.85 0.04 OUTLIER 'General case' 0 C--O 1.232 0.166 0 O-C-N 123.891 0.745 . . . . 0.0 110.146 -171.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.3 m 54.88 86.38 0.05 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.523 0.678 . . . . 0.0 111.6 178.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.5 t -131.22 117.86 38.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.827 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -98.73 98.72 9.81 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.972 0.415 . . . . 0.0 110.194 177.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.0 p -78.1 177.41 8.36 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.398 -177.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -118.36 138.46 52.4 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 174.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.7 m -45.52 106.2 0.07 Allowed 'General case' 0 C--O 1.234 0.254 0 O-C-N 123.947 0.779 . . . . 0.0 112.242 -174.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.3 t -82.02 37.59 0.49 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.148 -176.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.6 mt 58.35 75.85 0.37 Allowed 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.385 -177.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -159.52 158.41 31.78 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.848 -175.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.445 ' CB ' ' HA ' ' B' ' 261' ' ' SER . . . 68.87 99.93 0.06 Allowed 'General case' 0 N--CA 1.466 0.365 0 O-C-N 124.299 0.999 . . . . 0.0 112.351 176.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.51 ' HG2' ' HA ' ' B' ' 222' ' ' ALA . 8.6 tp10 -155.51 165.51 36.37 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.161 -179.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.469 ' HB3' ' HB2' ' B' ' 224' ' ' GLN . 0.0 OUTLIER 76.23 156.47 0.18 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.662 0.785 . . . . 0.0 111.168 176.876 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.9 m -117.92 174.42 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 121.157 0.503 . . . . 0.0 111.636 -174.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.42 ' HB3' ' HB ' ' B' ' 274' ' ' ILE . 69.0 p -79.4 -172.4 3.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.232 0.539 . . . . 0.0 111.542 -173.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.47 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 14.2 tmtt? -86.11 -29.37 23.38 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 171.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.453 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 1.0 OUTLIER -58.25 -50.1 74.77 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.287 179.875 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.548 ' HA ' ' HB3' ' A' ' 32' ' ' HIS . 0.4 OUTLIER -61.66 -26.99 68.36 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.315 -177.181 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.482 HG12 ' OH ' ' A' ' 71' ' ' TYR . 57.8 mt -61.0 -54.66 32.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.011 0.434 . . . . 0.0 110.047 176.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.2 m -73.48 -26.99 61.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.684 177.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.548 ' HB3' ' HA ' ' A' ' 29' ' ' GLU . 12.2 t-160 -68.31 -48.48 64.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.336 -175.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -104.52 -5.06 21.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.793 -176.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt 58.75 78.04 0.27 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.337 0.589 . . . . 0.0 110.77 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.8 mt -92.72 168.47 11.18 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.937 -176.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.9 t -96.99 138.23 22.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.792 -176.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -97.34 127.09 43.0 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.417 HG13 ' HB2' ' A' ' 92' ' ' ASN . 6.8 m -101.53 -45.78 11.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -175.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -174.66 175.0 46.88 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 119.689 -1.243 . . . . 0.0 113.362 -178.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.543 HG23 ' HG2' ' A' ' 89' ' ' GLU . 15.6 m -112.6 141.44 46.37 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 122.617 0.367 . . . . 0.0 110.421 -178.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.6 pt -120.14 144.64 28.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.816 0.341 . . . . 0.0 110.688 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -115.14 118.95 34.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.408 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.569 ' HB ' ' HB1' ' A' ' 86' ' ' ALA . 61.2 t -95.18 109.5 22.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.695 176.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.8 m -138.4 96.14 3.12 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.479 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -129.01 134.43 48.14 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.637 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.9 t -78.93 64.26 3.83 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.09 0.471 . . . . 0.0 111.126 -177.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.65 -69.93 2.3 Favored Glycine 0 CA--C 1.521 0.459 0 CA-C-N 115.86 -0.609 . . . . 0.0 114.412 172.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -50.83 -30.34 21.59 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 115.831 1.092 . . . . 0.0 115.831 -167.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -78.17 -27.01 47.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.831 0.816 . . . . 0.0 112.178 -175.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.496 HD13 ' HA ' ' A' ' 56' ' ' LEU . 49.7 mm -125.28 117.08 48.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 110.555 -0.165 . . . . 0.0 110.555 -175.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.6 t -119.19 -54.56 2.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.02 0.438 . . . . 0.0 110.329 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.503 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 4.9 m -105.85 164.35 15.19 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.817 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.557 ' HG3' HD21 ' B' ' 235' ' ' LEU . 18.4 Cg_endo -60.52 -28.26 86.35 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.482 2.121 . . . . 0.0 111.57 177.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.416 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -68.82 -28.81 67.07 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.2 178.62 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.765 ' HA ' ' HB2' ' B' ' 299' ' ' HIS . 31.0 m-20 -70.76 -44.9 65.78 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.337 0.589 . . . . 0.0 109.444 175.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.496 ' HA ' HD13 ' A' ' 50' ' ' ILE . 55.5 tp -65.35 -40.0 93.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.542 -175.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.416 ' HG3' ' O ' ' A' ' 54' ' ' SER . 3.0 ppt_? -61.28 -37.02 81.64 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -175.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -67.64 -37.98 83.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.945 0.402 . . . . 0.0 110.277 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -67.92 -40.18 83.41 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.215 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.571 HD11 ' CE2' ' A' ' 72' ' ' TYR . 81.6 mt -71.89 -39.21 69.75 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.102 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.5 t -65.29 -39.13 92.15 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -57.11 -42.71 81.35 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.009 177.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 97.9 mt -71.68 -46.02 60.12 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.411 -178.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.81 -42.32 86.11 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -175.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.516 ' HB2' ' HB1' ' B' ' 221' ' ' ALA . 33.1 t70 -63.37 -24.06 67.68 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.796 0.331 . . . . 0.0 111.623 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.23 -13.79 37.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.906 0.384 . . . . 0.0 111.335 178.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -90.02 -42.68 11.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.094 0.473 . . . . 0.0 110.409 178.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.67 65.27 0.65 Allowed Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.724 -178.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -145.35 169.65 26.9 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.067 177.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.416 ' HD2' HH12 ' B' ' 257' ' ' ARG . 31.7 mmtp -92.17 -15.13 28.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.716 0.293 . . . . 0.0 111.087 -178.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.635 ' HA ' ' CB ' ' B' ' 222' ' ' ALA . 31.6 p90 -165.26 175.79 8.93 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -177.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.571 ' CE2' HD11 ' A' ' 60' ' ' LEU . 54.6 p90 -135.36 136.54 41.57 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 175.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -110.54 115.83 30.31 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.489 -177.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.431 HD13 ' H ' ' A' ' 74' ' ' ILE . 4.8 mp -72.53 136.03 26.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 32.2 pt -117.26 -21.78 4.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.736 0.303 . . . . 0.0 111.196 178.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -159.4 147.89 17.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.714 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -162.06 141.5 9.71 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -166.77 154.81 9.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.036 0.446 . . . . 0.0 111.403 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -88.6 118.32 28.17 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 168.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -107.15 91.93 3.87 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.19 -120.09 12.91 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -172.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -94.43 6.6 2.43 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.074 2.516 . . . . 0.0 112.341 175.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.489 ' N ' HD21 ' A' ' 83' ' ' ASN . 0.8 OUTLIER -103.55 143.51 32.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.705 0.288 . . . . 0.0 110.679 -178.241 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -103.06 114.25 28.39 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -111.91 127.34 55.82 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.842 -177.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.569 ' HB1' ' HB ' ' A' ' 43' ' ' VAL . . . -141.08 133.48 28.3 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.924 0.392 . . . . 0.0 110.126 175.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.3 t -116.16 118.03 57.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.072 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -133.5 145.54 50.27 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.851 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.543 ' HG2' HG23 ' A' ' 40' ' ' THR . 10.4 mt-10 -117.5 136.77 53.0 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 26.0 t -95.52 135.95 28.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.676 -171.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 71' ' ' TYR . 79.5 m-85 -119.2 149.06 42.38 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.211 0.529 . . . . 0.0 110.41 178.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.417 ' HB2' HG13 ' A' ' 38' ' ' VAL . 18.1 t-20 -95.74 167.36 11.32 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.482 -176.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -66.4 -12.63 58.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.298 -178.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 74.66 7.04 4.47 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.494 -176.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.2 m -115.18 -29.89 6.48 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.852 176.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 96.2 mttt 66.91 -89.74 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.93 178.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 40.0 mt 71.96 170.8 0.32 Allowed 'General case' 0 N--CA 1.467 0.422 0 O-C-N 123.792 0.683 . . . . 0.0 112.468 176.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 43.12 68.75 0.46 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 114.646 -1.161 . . . . 0.0 113.487 174.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -95.08 95.35 8.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.534 173.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -90.03 157.07 17.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.824 0.345 . . . . 0.0 110.713 -176.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 31.6 t60 -71.18 132.21 44.67 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.467 -175.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 -145.53 159.59 42.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.187 -175.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 31.1 t60 -155.08 122.17 5.51 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.992 0.425 . . . . 0.0 110.546 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.32 -0.71 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.101 177.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 67.4 mtt . . . . . 0 N--CA 1.483 1.188 0 N-CA-C 111.522 0.193 . . . . 0.0 111.522 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -71.68 -58.44 3.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.171 0.51 . . . . 0.0 111.576 -174.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -122.23 126.61 48.58 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.799 -175.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 204' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' B' ' 204' ' ' ARG . 0.0 OUTLIER -154.01 88.28 1.24 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.536 0.684 . . . . 0.0 110.633 177.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 60.6 mt -113.05 101.54 12.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.424 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 7.9 tt -153.72 96.82 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.584 0.706 . . . . 0.0 110.447 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -131.38 98.7 4.6 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.236 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -80.39 146.29 31.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.959 -177.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -99.38 112.71 24.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.558 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 210' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -95.4 81.42 3.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.992 0.425 . . . . 0.0 110.693 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 95.5 mt -132.14 131.0 41.87 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.229 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -129.52 113.04 14.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.017 0.437 . . . . 0.0 110.57 178.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 213' ' ' THR . . . . . . . . . . . . . 23.2 m -95.19 86.81 4.67 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.16 0.505 . . . . 0.0 110.447 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 214' ' ' VAL . . . . . . . . . . . . . 7.2 p -147.45 4.26 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.346 0.593 . . . . 0.0 110.412 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.26 112.25 1.66 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.367 -176.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 3.0 p -135.84 -177.31 4.63 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.877 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -148.18 156.09 42.17 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.391 -0.225 . . . . 0.0 110.391 -177.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 218' ' ' SER . . . . . . . . . . . . . 21.9 t -130.66 -81.4 0.54 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.405 177.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 84.9 m -174.55 -64.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -176.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 96.1 mt -128.23 136.65 51.35 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.122 -1.399 . . . . 0.0 107.467 171.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . 0.516 ' HB1' ' HB2' ' A' ' 65' ' ' ASP . . . -88.68 -75.7 0.42 Allowed 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.87 -174.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . 0.635 ' CB ' ' HA ' ' A' ' 71' ' ' TYR . . . -169.59 -179.64 3.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.23 -171.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . 0.523 ' HA ' ' OH ' ' A' ' 72' ' ' TYR . 10.2 pt-20 177.54 133.46 0.06 Allowed 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.896 0.747 . . . . 0.0 111.941 -177.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 224' ' ' GLN . . . . . 0.469 ' HB2' ' HB3' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -172.22 157.86 4.32 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.657 0.783 . . . . 0.0 109.064 179.789 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . 0.444 HG21 HD12 ' B' ' 235' ' ' LEU . 18.6 m -109.55 133.09 55.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.729 0.3 . . . . 0.0 111.109 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 226' ' ' SER . . . . . 0.519 ' O ' HG13 ' B' ' 230' ' ' ILE . 83.3 p -90.56 -174.28 4.05 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 178.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -56.46 -37.42 70.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.397 -177.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -64.8 -50.45 66.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.702 -177.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -60.82 -41.06 94.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.171 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.519 HG13 ' O ' ' B' ' 226' ' ' SER . 83.5 mt -55.52 -51.79 53.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.921 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 35.3 m -72.09 -28.76 63.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.382 -178.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -78.26 -47.99 16.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.708 -175.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -92.04 4.33 53.31 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -173.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm 57.75 41.0 25.82 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.101 0.477 . . . . 0.0 111.022 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . 0.557 HD21 ' HG3' ' A' ' 53' ' ' PRO . 89.4 mt -63.01 125.66 24.75 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.838 -176.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . 0.46 HG23 ' HB3' ' B' ' 294' ' ' ALA . 17.0 m -78.79 132.94 31.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.569 -175.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 41.9 tttm -78.4 117.58 19.75 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.44 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 27.0 t -84.3 -35.92 11.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.003 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 164.91 -178.65 39.94 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.226 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 42.1 m -109.69 135.46 50.6 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 18.4 pt -110.05 134.31 52.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.99 0.424 . . . . 0.0 110.511 175.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -120.5 114.33 21.61 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.952 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 243' ' ' VAL . . . . . 0.527 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 5.3 t -102.4 113.38 38.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.15 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 23.3 t -111.72 103.11 11.38 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.938 0.399 . . . . 0.0 110.032 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 245' ' ' GLN . . . . . 0.536 ' HG2' HG12 ' B' ' 250' ' ' ILE . 0.6 OUTLIER -99.96 143.38 30.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.784 -177.247 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 41.1 t -97.69 72.88 2.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.991 0.424 . . . . 0.0 110.859 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 69.43 -92.36 0.33 Allowed Glycine 0 CA--C 1.518 0.269 0 CA-C-N 115.676 -0.693 . . . . 0.0 114.158 172.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -79.89 50.86 3.97 Favored Glycine 0 CA--C 1.517 0.21 0 N-CA-C 114.195 0.438 . . . . 0.0 114.195 -169.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . 0.463 ' HB2' ' HG3' ' B' ' 245' ' ' GLN . 78.7 mt-30 -131.66 -0.07 3.93 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.17 0.51 . . . . 0.0 109.761 173.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 250' ' ' ILE . . . . . 0.536 HG12 ' HG2' ' B' ' 245' ' ' GLN . 45.0 mm -132.01 119.74 41.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.551 178.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 3.4 m -135.08 -50.68 0.76 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.227 -177.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.25 163.68 16.43 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.305 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.27 -37.75 94.21 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.342 2.028 . . . . 0.0 111.954 176.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 254' ' ' SER . . . . . . . . . . . . . 54.8 m -68.31 -25.9 65.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.831 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -64.42 -32.01 73.46 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.616 0.246 . . . . 0.0 110.581 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 56.3 tp -86.93 -38.51 16.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.929 0.395 . . . . 0.0 109.981 176.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 257' ' ' ARG . . . . . 0.416 HH12 ' HD2' ' A' ' 70' ' ' LYS . 77.6 ttt180 -50.72 -43.53 57.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.799 179.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 258' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -55.48 -48.57 74.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.657 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -72.9 -32.42 65.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.815 0.341 . . . . 0.0 111.041 -174.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 92.0 mt -65.22 -46.23 81.5 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.871 -178.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 261' ' ' SER . . . . . 0.445 ' HA ' ' CB ' ' A' ' 22' ' ' ALA . 17.6 m -67.18 -36.77 82.48 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.871 177.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -57.56 -52.13 66.68 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.169 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 263' ' ' LEU . . . . . 0.404 HD11 HG21 ' B' ' 243' ' ' VAL . 89.8 mt -73.21 -30.82 63.78 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -174.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.5 -38.51 68.12 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 121.149 -0.22 . . . . 0.0 111.33 -176.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -70.35 -32.89 70.79 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.989 0.423 . . . . 0.0 110.07 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -68.65 -22.73 64.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.321 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -96.36 -11.18 26.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.672 0.272 . . . . 0.0 111.004 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 80.03 53.35 4.24 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.634 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.04 -178.88 18.74 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.012 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 22.3 mmmt -117.22 -46.87 2.69 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.922 0.391 . . . . 0.0 110.722 177.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 271' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -138.23 164.82 28.25 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 272' ' ' TYR . . . . . 0.429 ' HE1' ' N ' ' A' ' 23' ' ' GLU . 11.1 p90 -144.49 142.14 30.04 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.564 -174.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 22.0 t-80 -114.36 104.85 12.47 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.85 -178.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 274' ' ' ILE . . . . . 0.42 ' HB ' ' HB3' ' A' ' 26' ' ' SER . 57.4 mt -68.03 105.37 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.228 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 19.1 pt -77.98 -40.49 26.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.393 -176.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -153.45 131.45 11.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.126 0.489 . . . . 0.0 111.51 -177.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -120.58 103.56 9.25 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 174.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -127.23 126.82 43.4 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.331 0.586 . . . . 0.0 110.603 -172.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -88.89 126.55 35.43 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.308 0.575 . . . . 0.0 110.487 -176.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -97.39 81.2 2.96 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.121 -176.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 61.16 -120.18 21.7 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.057 -176.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . 0.473 ' C ' HD21 ' B' ' 283' ' ' ASN . 89.2 Cg_endo -83.06 10.55 3.6 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.799 2.332 . . . . 0.0 112.211 177.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 283' ' ' ASN . . . . . 0.473 HD21 ' C ' ' B' ' 282' ' ' PRO . 1.0 OUTLIER -121.08 166.53 13.78 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.893 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 284' ' ' PHE . . . . . 0.448 ' CE2' ' HB1' ' B' ' 286' ' ' ALA . 51.1 t80 -131.7 127.47 36.95 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.425 0.155 . . . . 0.0 110.686 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 285' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -111.26 110.51 21.03 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.443 -178.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 286' ' ' ALA . . . . . 0.527 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -107.29 120.24 41.61 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.612 0.244 . . . . 0.0 110.788 176.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 17.7 t -116.13 123.12 70.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.816 0.341 . . . . 0.0 110.577 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -136.6 144.47 44.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.945 0.402 . . . . 0.0 111.588 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -92.98 123.66 36.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.705 176.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 48.9 t -91.13 128.33 42.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.75 0.31 . . . . 0.0 110.467 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -123.48 156.34 35.78 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.11 0.481 . . . . 0.0 111.032 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 292' ' ' ASN . . . . . 0.435 ' HB3' ' CG2' ' B' ' 236' ' ' VAL . 6.9 t-20 -117.21 159.35 22.79 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -72.03 -27.95 63.04 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 123.102 0.251 . . . . 0.0 111.161 -177.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 294' ' ' ALA . . . . . 0.46 ' HB3' HG23 ' B' ' 236' ' ' VAL . . . 66.04 13.88 9.32 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 173.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 295' ' ' THR . . . . . . . . . . . . . 9.5 t -124.57 -26.69 3.81 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.042 178.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 296' ' ' LYS . . . . . 0.507 ' HE2' ' HA ' ' B' ' 296' ' ' LYS . 5.5 mmpt? 64.7 30.38 12.49 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 123.139 0.576 . . . . 0.0 111.271 177.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 297' ' ' LEU . . . . . . . . . . . . . 96.6 mt -127.97 118.66 23.96 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.904 178.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 298' ' ' GLU . . . . . 0.408 ' HA ' ' HB2' ' A' ' 54' ' ' SER . 41.1 mm-40 -84.44 177.31 8.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.488 177.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 299' ' ' HIS . . . . . 0.765 ' HB2' ' HA ' ' A' ' 55' ' ' ASP . 13.3 t-80 -62.22 122.09 14.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.268 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 300' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -80.26 107.98 13.5 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.032 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 301' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -64.41 94.73 0.12 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.823 177.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 302' ' ' HIS . . . . . . . . . . . . . 24.6 t-80 -146.96 123.08 10.81 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.618 -175.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -156.59 -178.56 7.44 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.241 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 . . . . . 0 C--N 1.317 -0.825 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 173.604 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.482 ' O ' ' HE2' ' B' ' 227' ' ' LYS . 23.4 mmt . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 120.511 0.196 . . . . 0.0 111.351 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.84 157.75 28.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.245 0.545 . . . . 0.0 111.971 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.505 ' HB3' ' HE3' ' B' ' 227' ' ' LYS . 23.6 tptm -161.52 98.08 1.11 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.532 178.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 19.6 mtm180 -119.13 -23.2 6.89 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.773 -173.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.4 mp -93.81 98.95 8.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.124 0.488 . . . . 0.0 110.299 178.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.1 mp -112.0 101.69 12.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 175.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.01 101.48 13.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.614 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -78.84 116.64 19.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.581 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.545 ' H ' ' HB ' ' B' ' 240' ' ' THR . . . -106.04 123.67 48.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.565 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.9 tp -93.38 96.0 9.66 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.366 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 22.1 tp -153.58 93.87 1.73 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 175.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.25 173.62 10.23 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.348 0.594 . . . . 0.0 112.038 -171.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.584 ' HB ' HD22 ' B' ' 263' ' ' LEU . 25.3 m -142.82 131.35 22.4 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.64 178.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.5 p -89.75 -36.22 8.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.899 -178.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.94 130.08 1.18 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.773 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.2 t -150.69 -82.16 0.1 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.579 ' O ' ' HA ' ' B' ' 262' ' ' GLU . 88.8 m-85 -148.97 172.55 14.55 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.0 t -119.21 -68.79 0.89 Allowed 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.773 -175.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 55.9 m 66.23 126.72 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.724 0.773 . . . . 0.0 111.721 -178.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.0 mt -85.69 91.3 8.25 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.272 179.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.484 ' HA ' ' OE2' ' B' ' 223' ' ' GLU . . . -155.12 5.39 0.22 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.241 175.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.524 ' HB3' ' CD2' ' B' ' 272' ' ' TYR . . . -134.22 97.88 3.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.916 -175.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.611 ' HB3' ' HE1' ' A' ' 71' ' ' TYR . 10.8 mt-10 -160.33 110.97 1.85 Allowed 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -177.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.632 ' HB2' ' HB3' ' B' ' 224' ' ' GLN . 0.9 OUTLIER -173.58 141.35 0.86 Allowed 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.469 174.501 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.2 m -105.76 116.11 48.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.081 0.467 . . . . 0.0 110.929 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.656 ' HA ' ' HD2' ' A' ' 73' ' ' HIS . 15.9 t -82.13 172.76 12.82 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.778 0.323 . . . . 0.0 110.147 -177.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.527 ' HA ' ' HB ' ' A' ' 30' ' ' ILE . 29.1 mmmt -67.3 -19.33 65.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.26 -173.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 17.7 mp0 -65.47 -51.57 59.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.902 0.382 . . . . 0.0 110.31 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.512 ' OE2' ' HB3' ' A' ' 26' ' ' SER . 2.3 pm0 -76.84 -28.03 55.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.087 177.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.527 ' HB ' ' HA ' ' A' ' 27' ' ' LYS . 77.7 mt -60.0 -46.59 93.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.725 0.298 . . . . 0.0 110.204 174.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.6 m -73.8 -21.83 60.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.207 178.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -86.72 -46.17 10.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.423 -175.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -94.49 -13.87 25.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.07 -178.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm 62.01 76.06 0.38 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.525 0.679 . . . . 0.0 110.579 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.454 HD13 HG12 ' A' ' 30' ' ' ILE . 71.6 mt -87.52 177.01 7.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.869 -172.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.471 ' HB ' ' HB2' ' A' ' 92' ' ' ASN . 28.9 t -104.0 115.34 45.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.472 -174.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.1 ttmm -80.88 121.16 25.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.654 0.264 . . . . 0.0 110.588 177.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.6 HG23 ' OD1' ' A' ' 92' ' ' ASN . 2.2 t -78.78 -34.42 17.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.572 0.701 . . . . 0.0 109.344 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 160.32 -159.51 30.89 Favored Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.961 -177.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.5 m -137.5 126.44 24.19 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.5 pt -103.96 136.46 37.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.087 0.47 . . . . 0.0 111.089 -177.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -117.01 122.58 44.62 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.974 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 88.3 t -94.25 138.11 21.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.345 175.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.4 t -156.99 80.37 0.92 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.195 0.522 . . . . 0.0 110.247 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -125.4 159.75 31.1 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 176.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.536 ' HA ' ' HA ' ' A' ' 83' ' ' ASN . 22.6 t -64.59 158.95 22.94 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 176.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.88 50.82 1.9 Allowed Glycine 0 C--N 1.333 0.363 0 CA-C-N 116.358 -0.383 . . . . 0.0 112.843 -178.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -142.17 -36.84 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 177.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -69.66 -30.13 67.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.291 0.567 . . . . 0.0 110.036 175.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.3 mm -108.24 96.1 4.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 173.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.3 t -106.28 -2.03 22.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.954 0.407 . . . . 0.0 110.991 -174.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 93.4 p -162.19 164.4 17.33 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.213 -178.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.74 -25.86 81.88 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.237 1.958 . . . . 0.0 111.213 172.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.464 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 17.1 m -66.65 -45.4 79.09 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.6 178.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.483 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 26.5 m-20 -57.61 -45.54 85.2 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.227 0.537 . . . . 0.0 109.945 177.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 54.4 tp -64.57 -39.58 94.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.048 -178.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -60.32 -46.21 90.69 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.702 -178.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 54' ' ' SER . 8.5 mm-40 -63.53 -26.99 68.96 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.927 -177.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.508 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 29.3 mmmt -78.2 -53.67 7.08 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.524 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.0 mt -63.67 -41.86 98.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.72 -174.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.9 p -63.23 -45.71 90.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.668 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -60.61 -45.26 94.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.911 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 59' ' ' LYS . 92.1 mt -63.75 -40.27 96.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.066 -178.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.1 -43.85 77.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.863 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -63.2 -44.99 93.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.404 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.8 -22.25 61.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.976 -177.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -80.04 -12.17 59.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.691 0.281 . . . . 0.0 110.911 176.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 94.92 16.65 40.78 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.404 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.424 ' HA3' HG21 ' A' ' 38' ' ' VAL . . . -112.53 -158.15 13.65 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.875 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.815 ' HD2' ' HB2' ' A' ' 93' ' ' ASP . 93.2 mttt -138.92 -61.46 0.56 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.096 0.474 . . . . 0.0 110.795 177.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.611 ' HE1' ' HB3' ' A' ' 23' ' ' GLU . 56.8 m-85 -97.8 156.98 16.33 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.901 -171.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.47 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 26.3 p90 -142.81 123.24 13.94 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.191 178.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.656 ' HD2' ' HA ' ' A' ' 26' ' ' SER . 48.2 t-80 -96.06 109.07 21.55 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.14 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.437 HD11 ' H ' ' A' ' 74' ' ' ILE . 4.5 mp -73.69 104.8 2.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 30.0 pt -85.65 -20.55 8.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.723 -178.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -160.0 120.78 3.05 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.12 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -124.7 96.2 4.8 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 175.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.1 -178.99 4.25 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.292 -174.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.83 157.41 17.49 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 176.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.537 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 4.3 t-160 -124.08 63.16 1.08 Allowed 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 174.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.48 -114.6 4.5 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.213 -175.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -83.76 20.9 1.12 Allowed 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.684 2.256 . . . . 0.0 112.015 174.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.537 ' HB2' ' HB3' ' A' ' 80' ' ' HIS . 31.0 m-80 -131.27 164.21 26.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.116 -177.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -124.1 129.96 51.74 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 175.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 81.8 mt-10 -127.86 116.89 20.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.129 0.49 . . . . 0.0 111.465 -176.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -114.31 128.79 56.53 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.312 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.0 t -108.76 115.86 50.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.905 179.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.433 ' HB2' ' HB2' ' A' ' 72' ' ' TYR . . . -125.99 136.65 53.23 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.933 0.397 . . . . 0.0 111.544 -176.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' A' ' 72' ' ' TYR . 45.9 mt-10 -91.76 118.63 30.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.82 177.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.5 t -86.3 128.65 39.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.434 -178.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -124.92 147.36 48.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.09 0.472 . . . . 0.0 110.608 178.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.6 ' OD1' HG23 ' A' ' 38' ' ' VAL . 21.5 m120 -82.52 163.1 21.76 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.139 178.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.815 ' HB2' ' HD2' ' A' ' 70' ' ' LYS . 38.0 t0 -74.39 135.51 42.42 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 169.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.88 83.09 0.92 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.273 0.559 . . . . 0.0 109.81 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.0 t -177.85 -30.95 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.655 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 60.7 tttm 70.66 170.14 0.31 Allowed 'General case' 0 CA--C 1.536 0.442 0 O-C-N 123.776 0.673 . . . . 0.0 110.743 176.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 72.2 mt 63.62 -148.05 0.32 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 122.552 0.341 . . . . 0.0 110.835 178.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 70.66 -68.84 0.2 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.542 0.737 . . . . 0.0 111.719 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.29 74.02 7.13 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.312 -173.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -135.26 25.11 3.53 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.58 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 32.9 m170 69.44 160.03 0.19 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.442 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 24.2 t-80 63.07 23.24 13.87 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.374 173.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -89.77 2.06 55.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.036 0.446 . . . . 0.0 110.792 -176.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 24.6 t60 . . . . . 0 C--N 1.32 -0.681 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 177.876 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 66.2 mtm . . . . . 0 N--CA 1.483 1.218 0 CA-C-O 120.793 0.33 . . . . 0.0 110.545 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 5.3 ptmm? -85.19 177.35 7.9 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 176.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -67.02 134.43 51.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.049 0.452 . . . . 0.0 111.024 -173.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -138.39 173.7 11.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.411 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 8.1 tp -128.19 144.08 38.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.965 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 7.3 tt -119.13 106.06 18.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.357 0.599 . . . . 0.0 110.463 178.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -79.56 146.55 32.54 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.041 177.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . 59.24 71.44 0.58 Allowed 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.209 0.528 . . . . 0.0 110.826 -177.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -93.04 166.06 12.55 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.875 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 210' ' ' LEU . . . . . . . . . . . . . 7.3 mp -106.67 163.52 12.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.259 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 61.4 tp -124.14 108.86 12.76 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 177.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -124.43 114.99 20.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.062 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 213' ' ' THR . . . . . . . . . . . . . 2.9 m -111.85 30.0 7.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.817 0.818 . . . . 0.0 109.152 175.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 214' ' ' VAL . . . . . . . . . . . . . 32.7 t -68.95 120.34 16.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.236 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -128.0 153.32 46.88 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.64 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 55.0 m -95.4 -61.5 1.46 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 177.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -177.9 -63.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.613 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 218' ' ' SER . . . . . . . . . . . . . 67.1 p -168.77 108.52 0.48 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.012 177.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 15.0 t -85.62 -174.3 5.09 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.747 0.308 . . . . 0.0 110.378 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -116.69 -45.57 2.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.657 -175.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -110.67 -151.48 0.48 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.35 -173.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . 73.51 94.5 0.07 Allowed 'General case' 0 N--CA 1.467 0.381 0 O-C-N 124.089 0.868 . . . . 0.0 110.269 -176.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . 0.484 ' OE2' ' HA ' ' A' ' 21' ' ' ALA . 46.9 mt-10 -151.43 -156.66 0.73 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.126 -168.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 224' ' ' GLN . . . . . 0.674 ' HA ' ' HB3' ' B' ' 271' ' ' TYR . 0.0 OUTLIER 82.23 145.79 0.08 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.899 0.88 . . . . 0.0 111.495 172.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 23.7 m -115.97 154.36 17.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.208 -176.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 19.7 m -99.03 -102.79 0.22 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.883 -178.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . 0.505 ' HE3' ' HB3' ' A' ' 3' ' ' LYS . 1.7 tmtp? -124.16 -57.54 1.59 Allowed 'General case' 0 C--N 1.326 -0.413 0 O-C-N 122.011 -0.43 . . . . 0.0 111.31 -170.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -62.04 -38.08 87.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.025 0.44 . . . . 0.0 110.878 -175.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -61.72 -36.08 79.91 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.01 -177.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.416 HD13 ' CZ ' ' B' ' 291' ' ' TYR . 66.7 mt -60.49 -53.08 53.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.79 -178.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 23.2 t -72.85 -21.33 60.96 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.171 -176.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -87.87 -44.48 11.04 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -176.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -95.32 -18.43 20.8 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.582 0.216 . . . . 0.0 111.582 -177.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 5.7 mmmm 63.17 77.29 0.33 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.501 0.667 . . . . 0.0 111.489 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 87.9 mt -93.94 140.75 29.32 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.502 175.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 27.2 m -76.88 127.07 38.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.106 0.479 . . . . 0.0 111.0 -177.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 237' ' ' LYS . . . . . 0.516 ' HE2' ' HB3' ' B' ' 289' ' ' GLU . 57.9 tttm -84.95 107.12 16.93 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.936 178.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 48.8 t -67.28 -35.19 73.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.607 -177.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 168.79 -149.32 13.61 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.313 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 240' ' ' THR . . . . . 0.545 ' HB ' ' H ' ' A' ' 9' ' ' ALA . 38.3 m -139.74 140.81 36.83 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 -178.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 18.2 pt -121.14 139.01 49.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.097 0.475 . . . . 0.0 110.677 178.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -127.68 113.59 16.23 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 243' ' ' VAL . . . . . 0.405 ' HB ' ' HB2' ' B' ' 286' ' ' ALA . 2.3 t -100.69 108.41 23.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.21 -175.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 26.5 t -99.32 109.42 22.04 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 177.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 245' ' ' GLN . . . . . 0.609 ' CA ' HE21 ' B' ' 245' ' ' GLN . 0.0 OUTLIER -99.71 158.25 15.91 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 121.358 0.599 . . . . 0.0 110.669 179.302 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 1.5 p -91.48 11.04 25.31 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.539 175.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 94.83 -61.02 1.68 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.796 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -78.29 50.57 3.47 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 121.2 -0.524 . . . . 0.0 113.103 -178.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -137.03 -14.48 1.57 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.828 0.346 . . . . 0.0 110.533 177.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 39.5 mm -125.56 99.15 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.73 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 23.1 t -98.38 -25.47 14.81 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.355 0.597 . . . . 0.0 109.65 178.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 252' ' ' SER . . . . . 0.527 ' HB3' ' HD2' ' B' ' 253' ' ' PRO . 49.8 m -151.49 165.7 16.81 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.747 178.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . 0.527 ' HD2' ' HB3' ' B' ' 252' ' ' SER . 11.3 Cg_endo -55.41 -25.69 49.63 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.756 2.304 . . . . 0.0 112.113 177.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 254' ' ' SER . . . . . 0.544 ' O ' ' HG3' ' B' ' 258' ' ' GLU . 30.0 t -54.15 -36.29 63.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.142 174.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -74.32 -40.16 62.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.905 0.383 . . . . 0.0 110.614 -177.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 42.7 tp -60.9 -45.45 94.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.211 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 257' ' ' ARG . . . . . 0.497 ' HD3' ' OH ' ' A' ' 71' ' ' TYR . 13.1 ptt180 -63.72 -30.99 72.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.796 0.331 . . . . 0.0 111.158 -178.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 258' ' ' GLU . . . . . 0.544 ' HG3' ' O ' ' B' ' 254' ' ' SER . 56.5 mt-10 -72.41 -36.49 68.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.854 0.359 . . . . 0.0 110.462 -179.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -74.67 -40.1 61.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.966 178.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 93.3 mt -66.35 -43.89 84.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.746 -177.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 22.0 p -68.15 -34.15 75.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.751 0.31 . . . . 0.0 110.521 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 262' ' ' GLU . . . . . 0.579 ' HA ' ' O ' ' A' ' 17' ' ' PHE . 7.9 tp10 -54.93 -44.76 74.57 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.573 0.701 . . . . 0.0 109.966 176.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 263' ' ' LEU . . . . . 0.584 HD22 ' HB ' ' A' ' 13' ' ' THR . 68.9 mt -74.69 -41.73 59.69 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.995 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -60.17 -47.86 84.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.271 -174.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -70.7 -29.96 66.39 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.624 -177.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -66.49 -23.53 66.27 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.373 0.606 . . . . 0.0 110.538 176.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 267' ' ' LYS . . . . . 0.578 ' HG2' ' O ' ' B' ' 263' ' ' LEU . 73.3 mmtt -89.43 -21.76 22.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.869 176.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 88.27 25.3 31.47 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.802 -177.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -100.14 -165.28 28.82 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.124 -179.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 22.2 mmtp -132.66 -67.56 0.64 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.194 0.521 . . . . 0.0 109.708 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 271' ' ' TYR . . . . . 0.674 ' HB3' ' HA ' ' B' ' 224' ' ' GLN . 7.7 m-85 -101.23 145.29 29.02 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.165 -176.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 272' ' ' TYR . . . . . 0.524 ' CD2' ' HB3' ' A' ' 22' ' ' ALA . 10.9 p90 -104.46 169.47 8.45 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 175.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 273' ' ' HIS . . . . . 0.438 ' HB3' ' HB2' ' B' ' 289' ' ' GLU . 10.7 t-160 -138.03 101.47 4.43 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.402 172.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 274' ' ' ILE . . . . . 0.454 HD11 ' OE1' ' A' ' 29' ' ' GLU . 63.3 mt -71.33 123.02 24.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.155 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 22.5 pt -114.08 -28.67 2.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.592 -176.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -152.06 107.13 3.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.954 0.407 . . . . 0.0 111.531 -178.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -105.37 96.65 6.66 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 173.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -127.38 137.51 52.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.206 0.527 . . . . 0.0 111.331 -170.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -88.06 119.75 28.74 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.095 0.474 . . . . 0.0 110.707 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -98.62 78.65 2.39 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 69.5 -126.42 18.78 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 -175.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.74 6.47 4.5 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 122.614 2.209 . . . . 0.0 112.257 177.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -112.34 151.49 29.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.184 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 284' ' ' PHE . . . . . 0.453 ' HB3' ' HB2' ' B' ' 245' ' ' GLN . 52.0 t80 -115.67 113.0 22.93 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 175.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 285' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -102.37 110.39 22.32 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.293 -0.412 . . . . 0.0 109.993 -177.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 286' ' ' ALA . . . . . 0.405 ' HB2' ' HB ' ' B' ' 243' ' ' VAL . . . -102.35 114.91 29.49 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.79 0.328 . . . . 0.0 110.52 176.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 29.4 t -105.75 120.93 57.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.218 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -138.83 152.21 47.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.019 0.438 . . . . 0.0 111.364 -178.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 289' ' ' GLU . . . . . 0.516 ' HB3' ' HE2' ' B' ' 237' ' ' LYS . 31.1 mt-10 -91.74 157.99 16.61 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 175.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 39.9 t -115.11 125.43 72.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 177.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 291' ' ' TYR . . . . . 0.416 ' CZ ' HD13 ' B' ' 230' ' ' ILE . 93.5 m-85 -125.02 155.34 39.87 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.236 0.541 . . . . 0.0 110.716 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 292' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -118.91 156.62 29.2 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 293' ' ' ASP . . . . . 0.435 ' OD1' ' HG3' ' B' ' 296' ' ' LYS . 2.3 p30 -65.14 -23.44 67.13 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.662 0.267 . . . . 0.0 110.897 -178.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 294' ' ' ALA . . . . . . . . . . . . . . . 70.79 13.02 7.19 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.544 173.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 295' ' ' THR . . . . . 0.558 ' O ' ' HE1' ' B' ' 300' ' ' HIS . 1.7 t -140.84 -70.4 0.38 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 178.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 296' ' ' LYS . . . . . 0.742 ' O ' ' HG ' ' B' ' 297' ' ' LEU . 41.5 mtmt 68.23 130.11 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 122.916 0.486 . . . . 0.0 112.21 -175.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 297' ' ' LEU . . . . . 0.742 ' HG ' ' O ' ' B' ' 296' ' ' LYS . 3.1 pp 60.9 135.31 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.274 1.43 . . . . 0.0 114.313 171.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 298' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' B' ' 299' ' ' HIS . 43.9 mt-10 -73.5 168.14 19.87 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.599 177.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 299' ' ' HIS . . . . . 0.437 ' HB2' ' O ' ' B' ' 298' ' ' GLU . 16.3 m170 70.58 -55.12 0.63 Allowed 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.743 0.652 . . . . 0.0 110.514 -175.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 300' ' ' HIS . . . . . 0.558 ' HE1' ' O ' ' B' ' 295' ' ' THR . 2.5 t60 71.12 165.57 0.29 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.413 0.685 . . . . 0.0 111.284 174.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 301' ' ' HIS . . . . . . . . . . . . . 40.6 m80 70.52 -171.72 0.17 Allowed 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.593 179.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 302' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 71.18 109.31 0.06 Allowed 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.789 0.681 . . . . 0.0 112.477 176.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 9.8 m80 -139.26 122.02 16.46 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.817 173.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 . . . . . 0 C--N 1.322 -0.63 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 -178.979 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.2 ttm . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 120.72 0.295 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -157.24 -94.52 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 175.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -147.28 138.83 24.03 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -130.7 112.31 12.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.705 0.764 . . . . 0.0 110.933 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.8 pt -113.47 123.66 69.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.959 177.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.48 ' O ' HD13 ' A' ' 6' ' ' ILE . 2.4 pp -98.42 130.5 47.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.311 0.577 . . . . 0.0 111.336 -177.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -161.74 90.41 0.78 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.034 178.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -149.92 -158.9 0.96 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.54 -177.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 70.4 76.52 0.2 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 123.917 0.761 . . . . 0.0 111.076 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 94.9 mt -142.99 160.73 39.8 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.774 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.4 pp -160.16 159.09 31.26 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 176.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.5 -60.79 0.51 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.984 0.421 . . . . 0.0 110.764 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.4 m -151.07 122.06 7.65 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.435 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.1 m -84.01 152.79 3.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 176.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.545 ' HB2' ' HA3' ' B' ' 268' ' ' GLY . . . -126.01 -162.44 1.13 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.74 0.305 . . . . 0.0 111.114 -175.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.9 t -118.99 -172.23 2.26 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.568 -178.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -72.49 162.34 29.61 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.663 -175.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.3 m -147.49 -55.34 0.23 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.775 173.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 75.7 m -162.46 141.33 9.04 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 177.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 34.9 tp -62.95 98.04 0.12 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.974 0.416 . . . . 0.0 110.19 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -137.26 -151.12 0.38 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.106 -177.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.587 ' HA ' ' OE2' ' B' ' 223' ' ' GLU . . . 73.54 111.07 0.07 Allowed 'General case' 0 N--CA 1.464 0.241 0 O-C-N 123.994 0.809 . . . . 0.0 109.984 -175.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.713 ' O ' ' HB3' ' A' ' 24' ' ' GLN . 9.2 tp10 -133.74 178.75 6.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.349 -171.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.713 ' HB3' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER 96.45 134.9 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.95 1.3 . . . . 0.0 111.985 176.851 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.43 ' N ' ' HG2' ' A' ' 24' ' ' GLN . 21.2 m -109.98 155.74 11.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.07 -0.968 . . . . 0.0 108.721 172.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.621 ' HB3' ' OE1' ' A' ' 28' ' ' GLN . 7.0 t -98.29 -176.85 3.52 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.26 -178.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.578 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 5.0 tmtt? -65.08 -27.87 69.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.464 -169.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.621 ' OE1' ' HB3' ' A' ' 26' ' ' SER . 15.8 mp0 -59.34 -49.51 77.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.021 0.439 . . . . 0.0 110.356 -178.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.593 ' HA ' ' HB3' ' A' ' 32' ' ' HIS . 12.8 mm-40 -75.25 -25.62 58.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.102 -173.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.528 HD11 ' HA ' ' A' ' 27' ' ' LYS . 63.8 mt -57.53 -52.93 51.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.204 0.526 . . . . 0.0 109.912 175.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.8 m -73.87 -24.02 59.68 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.001 177.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.593 ' HB3' ' HA ' ' A' ' 29' ' ' GLU . 21.8 t-160 -69.72 -52.58 24.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.136 -177.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -97.59 2.95 50.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.301 -176.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt 56.17 59.05 3.9 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 123.624 0.577 . . . . 0.0 111.03 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.3 mt -62.44 138.04 58.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.654 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.8 t -65.09 -37.17 79.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.541 -174.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.0 tttm 66.28 114.94 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 O-C-N 124.227 0.954 . . . . 0.0 111.118 -178.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.2 m -82.66 -39.45 15.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.859 -0.337 . . . . 0.0 111.741 -177.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 173.12 -155.67 23.12 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.266 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.487 HG23 ' HG2' ' A' ' 89' ' ' GLU . 46.8 m -141.97 131.06 23.25 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.706 0.289 . . . . 0.0 110.337 -178.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.9 pt -120.91 173.3 6.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -150.29 152.2 34.13 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.558 0.694 . . . . 0.0 112.112 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.607 HG12 ' NE2' ' A' ' 45' ' ' GLN . 69.2 t -94.64 128.67 45.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.521 171.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.4 t -143.34 46.11 1.52 Allowed 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.607 ' NE2' HG12 ' A' ' 43' ' ' VAL . 1.0 OUTLIER -93.42 145.05 24.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.033 -175.089 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.3 m -82.1 80.97 8.2 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.956 -174.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.23 -77.29 0.58 Allowed Glycine 0 CA--C 1.521 0.434 0 N-CA-C 114.872 0.709 . . . . 0.0 114.872 168.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -58.56 -19.85 43.5 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 114.743 0.657 . . . . 0.0 114.743 -168.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.416 ' HB2' ' HB3' ' A' ' 45' ' ' GLN . 15.9 mm-40 -79.35 -21.77 45.37 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 117.356 0.578 . . . . 0.0 111.169 -178.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 40.3 mm -123.44 88.22 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.7 t -105.76 -30.64 9.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.635 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.7 m -127.47 158.38 69.92 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.373 -177.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.28 -32.52 81.31 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.726 2.284 . . . . 0.0 112.088 176.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.579 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 11.5 p -64.28 -40.68 96.45 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.145 178.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -54.96 -30.97 60.13 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.733 0.301 . . . . 0.0 111.457 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 40.4 tp -56.59 -55.91 27.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.774 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -73.21 -29.8 63.06 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.047 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.579 ' HG2' ' O ' ' A' ' 54' ' ' SER . 22.8 mm-40 -62.05 -48.31 80.83 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.214 0.531 . . . . 0.0 110.837 179.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -73.12 -37.94 66.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.336 -178.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.462 HD13 ' CE1' ' A' ' 72' ' ' TYR . 37.6 mt -72.08 -35.51 69.25 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.732 -178.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.9 m -62.6 -42.74 99.75 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 120.874 -0.331 . . . . 0.0 110.31 173.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.747 ' HG3' ' HA ' ' B' ' 216' ' ' SER . 9.2 tp10 -56.18 -39.65 72.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.356 -178.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 86.6 mt -76.42 -51.34 12.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.669 178.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.86 -32.16 72.48 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.294 -171.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -58.03 -49.49 76.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.946 0.403 . . . . 0.0 110.611 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.474 ' HB1' ' HB2' ' B' ' 217' ' ' PHE . . . -70.49 -25.25 63.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.612 -178.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -75.87 -19.62 58.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.023 0.439 . . . . 0.0 110.581 178.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.55 38.46 9.7 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.291 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -105.51 161.62 14.56 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.414 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.577 ' HG3' ' OD2' ' A' ' 93' ' ' ASP . 35.4 mmtp -98.73 -48.66 4.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.276 0.56 . . . . 0.0 110.387 178.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.527 ' HE2' ' HD2' ' B' ' 257' ' ' ARG . 1.5 p90 -147.63 168.28 22.42 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.39 -178.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.462 ' CE1' HD13 ' A' ' 60' ' ' LEU . 45.8 p90 -142.14 166.96 23.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.901 -178.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -137.7 109.43 7.08 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.313 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.509 HG12 ' HB1' ' A' ' 88' ' ' ALA . 83.6 mt -69.62 130.31 34.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 176.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.9 pt -109.55 -25.88 3.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.29 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -150.0 129.37 12.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.628 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -144.28 138.12 27.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.255 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.492 ' HD3' ' HB2' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -166.52 157.77 12.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.547 179.848 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -91.47 122.68 34.28 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 168.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -115.35 96.73 5.8 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.82 -125.25 9.0 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -172.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.444 ' HD2' ' ND2' ' A' ' 83' ' ' ASN . 94.9 Cg_endo -94.83 14.94 1.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.019 2.479 . . . . 0.0 112.497 175.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.444 ' ND2' ' HD2' ' A' ' 82' ' ' PRO . 12.6 m-80 -114.87 150.69 35.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.704 0.288 . . . . 0.0 110.947 -176.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -109.43 108.17 18.59 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 174.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.52 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 5.0 mm-40 -100.62 112.34 24.71 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.057 -175.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.459 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -130.57 116.55 18.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.855 0.359 . . . . 0.0 111.318 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.2 t -96.55 123.35 48.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.782 0.325 . . . . 0.0 110.649 -177.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.509 ' HB1' HG12 ' A' ' 74' ' ' ILE . . . -135.35 129.0 32.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.007 0.432 . . . . 0.0 111.307 -177.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.487 ' HG2' HG23 ' A' ' 40' ' ' THR . 21.1 mt-10 -92.34 137.01 32.73 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 23.1 t -99.89 134.5 39.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 120.896 0.379 . . . . 0.0 110.33 -176.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -124.69 149.35 47.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.237 -177.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.565 ' OD1' ' HG2' ' A' ' 70' ' ' LYS . 18.2 m-20 -123.53 150.85 43.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.393 176.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.577 ' OD2' ' HG3' ' A' ' 70' ' ' LYS . 5.8 m-20 -60.94 152.66 27.05 Favored 'General case' 0 C--O 1.238 0.464 0 O-C-N 123.687 0.617 . . . . 0.0 110.359 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.97 85.72 0.52 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.021 0.439 . . . . 0.0 110.098 176.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.433 HG23 ' HB2' ' A' ' 93' ' ' ASP . 7.1 t -174.6 -29.64 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.532 -176.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 95' ' ' THR . 31.0 mmtp 72.27 4.81 5.13 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 122.981 0.512 . . . . 0.0 111.976 177.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.41 ' H ' HG22 ' A' ' 95' ' ' THR . 93.8 mt -105.6 134.96 47.86 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.044 0.45 . . . . 0.0 110.906 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.404 ' OE1' ' HB2' ' A' ' 100' ' ' HIS . 1.1 pp20? -125.98 170.43 11.71 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.393 177.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 20.9 t60 -114.15 36.3 3.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.065 0.459 . . . . 0.0 110.995 -174.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.404 ' HB2' ' OE1' ' A' ' 98' ' ' GLU . 30.2 m80 -96.0 15.93 19.27 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.024 0.44 . . . . 0.0 109.935 175.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 54.1 m170 -68.01 163.07 23.09 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.927 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 69.76 31.46 3.52 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.158 0.504 . . . . 0.0 110.428 -175.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.41 ' HB2' ' HZ ' ' B' ' 217' ' ' PHE . 15.2 p80 -105.41 178.42 4.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.61 -177.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 34.8 m80 . . . . . 0 C--N 1.321 -0.665 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 170.413 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 79.4 mtp . . . . . 0 N--CA 1.482 1.13 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -73.3 79.0 1.33 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 121.687 0.756 . . . . 0.0 111.444 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -171.52 87.21 0.09 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.486 174.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -81.48 97.27 7.7 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.883 178.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 205' ' ' ILE . . . . . 0.738 HG13 ' H ' ' B' ' 207' ' ' ALA . 7.3 tp -60.45 128.25 21.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.55 -178.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 31.3 pt -83.1 4.6 2.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.542 -177.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 207' ' ' ALA . . . . . 0.738 ' H ' HG13 ' B' ' 205' ' ' ILE . . . 64.14 35.35 10.37 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 123.605 0.565 . . . . 0.0 111.539 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -116.1 124.21 49.81 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.889 176.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.05 160.05 25.79 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.924 0.392 . . . . 0.0 111.186 -178.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 210' ' ' LEU . . . . . . . . . . . . . 37.4 tp -114.29 138.31 50.66 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 6.1 tt -72.31 116.51 12.83 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -93.35 131.29 38.65 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.851 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 213' ' ' THR . . . . . . . . . . . . . 53.9 m -101.43 130.05 47.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.147 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 214' ' ' VAL . . . . . . . . . . . . . 49.5 t -56.05 122.13 4.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.146 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -101.64 -53.55 2.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.579 -177.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 216' ' ' SER . . . . . 0.747 ' HA ' ' HG3' ' A' ' 62' ' ' GLU . 47.1 m 70.05 120.86 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 O-C-N 123.671 0.607 . . . . 0.0 111.448 -178.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 217' ' ' PHE . . . . . 0.474 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 10.1 t80 -157.32 -69.08 0.1 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.038 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 218' ' ' SER . . . . . . . . . . . . . 5.9 m -135.63 150.74 49.73 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 175.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 4.0 m -99.22 12.78 35.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.626 0.727 . . . . 0.0 110.519 -178.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 95.7 mt -123.07 93.36 3.93 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.107 179.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -138.55 -62.53 0.56 Allowed 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 121.117 -0.233 . . . . 0.0 111.526 -178.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -158.35 170.04 23.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.951 0.405 . . . . 0.0 111.65 -173.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . 0.587 ' OE2' ' HA ' ' A' ' 22' ' ' ALA . 8.7 pt-20 -150.78 169.58 21.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.502 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 224' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' B' ' 223' ' ' GLU . 0.8 OUTLIER 177.4 137.08 0.07 Allowed 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.781 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 5.7 m -133.55 107.28 10.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.07 0.462 . . . . 0.0 110.195 173.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 226' ' ' SER . . . . . 0.5 ' O ' HG13 ' B' ' 230' ' ' ILE . 8.5 t -89.71 171.08 9.9 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -178.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -66.45 -18.18 65.22 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -171.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -72.07 -47.56 50.64 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 176.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 229' ' ' GLU . . . . . 0.438 ' OE1' ' HB3' ' B' ' 226' ' ' SER . 2.0 mp0 -67.4 -41.04 85.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.159 176.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.525 HG12 HD12 ' B' ' 235' ' ' LEU . 98.1 mt -59.01 -48.01 88.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.448 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 35.5 p -72.78 -25.01 61.01 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.007 0.432 . . . . 0.0 110.959 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 26.4 t-80 -75.71 -50.17 16.12 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.284 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -88.62 -16.89 31.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.319 -177.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 60.06 79.77 0.23 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.543 0.687 . . . . 0.0 110.177 -177.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . 0.525 HD12 HG12 ' B' ' 230' ' ' ILE . 82.9 mt -82.57 177.48 8.69 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.002 -175.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . 0.46 HG22 ' HA ' ' B' ' 294' ' ' ALA . 61.3 t -105.96 138.8 29.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.727 -178.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 237' ' ' LYS . . . . . 0.422 ' HE2' ' O ' ' B' ' 239' ' ' GLY . 20.2 tptm -104.74 128.9 53.0 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.774 -179.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 238' ' ' VAL . . . . . 0.406 HG11 ' HB2' ' B' ' 292' ' ' ASN . 2.6 m -91.3 -45.33 14.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.297 176.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 239' ' ' GLY . . . . . 0.422 ' O ' ' HE2' ' B' ' 237' ' ' LYS . . . 166.02 -178.7 40.57 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.115 -177.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 34.9 m -106.69 137.93 43.81 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.466 -0.198 . . . . 0.0 110.466 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 29.7 pt -105.53 137.44 35.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.878 0.37 . . . . 0.0 110.435 175.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -115.64 114.17 24.53 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.431 -177.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 243' ' ' VAL . . . . . 0.518 ' HB ' ' HB2' ' B' ' 286' ' ' ALA . 54.9 t -101.9 125.4 56.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.901 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 23.1 t -146.91 106.4 3.92 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.874 0.369 . . . . 0.0 110.44 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 245' ' ' GLN . . . . . 0.489 ' HG3' ' HB2' ' B' ' 249' ' ' GLN . 0.0 OUTLIER -156.33 168.05 28.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.391 178.363 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 22.6 t -92.16 -174.3 3.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.828 0.347 . . . . 0.0 110.413 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -69.64 -3.1 39.67 Favored Glycine 0 C--N 1.33 0.2 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.771 -178.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -74.45 -27.59 65.29 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.701 -0.762 . . . . 0.0 111.613 174.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . 0.489 ' HB2' ' HG3' ' B' ' 245' ' ' GLN . 64.7 mt-30 -102.16 -36.79 8.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.56 0.219 . . . . 0.0 110.586 177.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 250' ' ' ILE . . . . . 0.401 HG12 ' HG3' ' B' ' 245' ' ' GLN . 47.6 mm -115.4 99.97 9.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.857 0.36 . . . . 0.0 110.791 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 21.5 t -122.68 -42.74 2.3 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.999 175.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 252' ' ' SER . . . . . 0.521 ' HB3' ' HD2' ' B' ' 253' ' ' PRO . 32.3 m -111.23 162.33 21.35 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.776 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . 0.521 ' HD2' ' HB3' ' B' ' 252' ' ' SER . 13.1 Cg_endo -57.83 -35.25 98.88 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.775 2.316 . . . . 0.0 112.754 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 254' ' ' SER . . . . . 0.404 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 5.3 p -63.27 -34.39 77.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.149 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -58.84 -51.57 69.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.662 -176.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 55.4 tp -63.66 -37.92 89.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.029 -177.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 257' ' ' ARG . . . . . 0.527 ' HD2' ' HE2' ' A' ' 71' ' ' TYR . 81.3 mtp180 -59.43 -39.92 85.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.719 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 258' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' B' ' 254' ' ' SER . 21.2 mm-40 -65.46 -30.98 71.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.857 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -79.74 -48.36 13.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.113 -177.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.69 -46.25 86.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.904 -174.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 18.4 p -61.28 -41.18 96.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.224 0.535 . . . . 0.0 110.763 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -61.5 -51.0 70.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.156 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 263' ' ' LEU . . . . . . . . . . . . . 95.9 mt -67.65 -31.42 71.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.68 -175.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.88 -50.75 47.05 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -175.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -71.98 -25.31 61.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.872 0.368 . . . . 0.0 110.106 -177.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -67.8 -34.24 76.37 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.287 0.565 . . . . 0.0 110.552 176.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -81.79 -9.68 59.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.362 177.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 268' ' ' GLY . . . . . 0.545 ' HA3' ' HB2' ' A' ' 15' ' ' ALA . . . 96.37 5.92 58.94 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.168 175.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . 0.456 ' HA3' HG12 ' B' ' 290' ' ' VAL . . . -89.45 154.94 24.58 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.685 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . 0.472 ' HE2' ' O ' ' B' ' 268' ' ' GLY . 48.6 mmtt -119.74 -2.54 10.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.951 0.405 . . . . 0.0 110.55 -175.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 271' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -143.55 154.6 43.77 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 175.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 272' ' ' TYR . . . . . 0.419 ' CD1' ' HB1' ' A' ' 22' ' ' ALA . 7.3 p90 -151.31 157.85 43.05 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.994 174.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -138.89 112.13 8.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.865 -178.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 274' ' ' ILE . . . . . 0.555 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 55.6 mt -69.24 120.76 17.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.536 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 22.0 pt -97.87 -36.94 6.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.149 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -145.45 100.44 3.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.925 0.393 . . . . 0.0 111.598 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -104.57 100.57 10.24 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 174.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 278' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' B' ' 285' ' ' GLU . 10.0 ptm180 -118.68 111.96 19.19 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.838 0.827 . . . . 0.0 111.787 -169.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -77.75 96.78 4.99 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.666 173.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 17.1 t-160 -96.62 97.83 9.7 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.691 -175.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 77.39 -137.26 20.1 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -174.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -83.08 -4.36 11.17 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.462 2.108 . . . . 0.0 111.872 174.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -103.66 154.33 19.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.173 -176.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 284' ' ' PHE . . . . . 0.458 ' CE2' ' HB3' ' B' ' 286' ' ' ALA . 84.1 t80 -114.74 124.75 52.58 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.913 0.387 . . . . 0.0 110.238 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 285' ' ' GLU . . . . . 0.461 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 36.2 mt-10 -123.72 116.65 23.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.151 -179.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 286' ' ' ALA . . . . . 0.518 ' HB2' ' HB ' ' B' ' 243' ' ' VAL . . . -118.07 130.15 55.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.119 0.485 . . . . 0.0 111.722 -175.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 35.2 t -110.93 120.73 62.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.031 174.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -133.13 140.86 47.84 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.11 0.481 . . . . 0.0 111.517 -177.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -91.75 119.27 31.43 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.497 177.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 290' ' ' VAL . . . . . 0.456 HG12 ' HA3' ' B' ' 269' ' ' GLY . 15.4 t -94.98 130.41 43.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -117.35 157.81 25.49 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.375 0.607 . . . . 0.0 110.634 -176.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 292' ' ' ASN . . . . . 0.406 ' HB2' HG11 ' B' ' 238' ' ' VAL . 6.3 t-20 -120.37 164.38 16.43 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 174.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -67.53 157.16 34.99 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -176.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 294' ' ' ALA . . . . . 0.46 ' HA ' HG22 ' B' ' 236' ' ' VAL . . . -72.64 -6.21 42.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.118 0.485 . . . . 0.0 111.708 -173.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 295' ' ' THR . . . . . . . . . . . . . 14.8 t -105.47 -6.11 19.72 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.132 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 65.22 -167.18 0.22 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.04 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 297' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.88 159.13 15.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.995 -176.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 298' ' ' GLU . . . . . 0.496 ' HB3' ' CE1' ' B' ' 301' ' ' HIS . 34.7 tt0 63.62 99.95 0.03 OUTLIER 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.748 -176.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 299' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -82.83 22.3 0.93 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.744 -178.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 300' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -138.54 70.9 1.38 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.559 175.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 301' ' ' HIS . . . . . 0.496 ' CE1' ' HB3' ' B' ' 298' ' ' GLU . 3.4 m-70 -93.03 105.74 17.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.947 175.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 302' ' ' HIS . . . . . 0.435 ' HB2' ' O ' ' B' ' 301' ' ' HIS . 41.0 m170 73.7 152.54 0.13 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.73 0.776 . . . . 0.0 112.304 178.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -144.01 -34.92 0.38 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.572 170.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 11.5 t60 . . . . . 0 C--N 1.333 -0.144 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.394 172.401 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -151.3 82.69 1.31 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.173 0.511 . . . . 0.0 110.287 178.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.6 tttt 68.51 152.39 0.09 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.168 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -94.75 -168.15 1.77 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.435 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.6 pt -73.08 165.34 3.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.844 0.354 . . . . 0.0 111.128 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 64.8 mt -74.4 109.11 6.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.5 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.1 96.28 7.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.842 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -156.89 -176.77 6.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.62 179.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -95.89 101.9 13.63 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 110.151 -0.315 . . . . 0.0 110.151 176.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -136.89 149.17 47.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.549 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.31 -57.4 2.25 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 176.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 57.84 -158.91 0.27 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.317 177.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.9 t -150.48 137.71 19.47 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 174.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.7 m -112.15 141.89 26.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.581 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -111.26 82.06 1.54 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.354 177.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.4 p -118.38 91.12 3.48 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.596 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 93.7 t80 -122.78 123.35 40.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.032 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.6 m -123.18 119.56 30.58 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.318 177.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.0 t -73.16 -10.24 59.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.828 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.1 mp -85.16 95.85 9.28 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 177.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -129.87 -74.33 0.55 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.09 -178.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.683 ' HB1' ' CD1' ' B' ' 272' ' ' TYR . . . -126.54 138.32 53.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.931 -176.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.733 ' HG2' ' HB1' ' B' ' 221' ' ' ALA . 0.0 OUTLIER -138.23 -171.67 3.09 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.883 -171.116 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.551 ' CD ' ' HG3' ' B' ' 224' ' ' GLN . 0.0 OUTLIER 75.24 154.69 0.16 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.627 0.771 . . . . 0.0 111.615 176.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.8 m -114.77 164.56 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.854 -176.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.546 ' HB2' ' HB ' ' B' ' 274' ' ' ILE . 16.8 t -74.95 164.32 26.69 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.005 0.431 . . . . 0.0 111.267 -174.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -66.61 -28.91 68.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.281 176.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -60.67 -37.97 83.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.403 176.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.581 ' HA ' ' HB3' ' A' ' 32' ' ' HIS . 15.4 mm-40 -72.52 -26.21 61.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.908 -175.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.432 ' HA ' HD13 ' A' ' 35' ' ' LEU . 56.5 mt -60.79 -48.09 90.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 173.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.2 m -73.92 -21.15 60.16 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.1 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.581 ' HB3' ' HA ' ' A' ' 29' ' ' GLU . 22.8 t-160 -80.89 -54.21 5.79 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.402 -175.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -93.24 -20.05 20.81 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -176.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.85 84.99 0.13 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.191 0.519 . . . . 0.0 110.513 -175.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.552 HD23 ' HE1' ' A' ' 71' ' ' TYR . 5.8 mp -91.08 175.48 6.93 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.433 -176.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.633 HG11 ' HZ3' ' A' ' 96' ' ' LYS . 45.6 t -99.38 129.51 49.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.253 -173.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.448 ' HZ2' ' CD ' ' A' ' 89' ' ' GLU . 35.3 tptt -70.48 126.46 29.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.416 179.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.94 8.88 5.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.952 0.406 . . . . 0.0 111.483 175.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.75 -170.0 15.97 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.8 174.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 53.3 m -133.38 131.05 39.58 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.616 HG13 ' HB1' ' A' ' 88' ' ' ALA . 26.1 pt -104.23 132.33 51.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 176.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -123.28 127.72 48.96 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.136 0.493 . . . . 0.0 110.686 -175.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.655 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 88.7 t -93.01 123.26 45.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.171 175.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.5 t -146.35 74.4 1.36 Allowed 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 176.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -124.37 178.75 5.22 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.051 -178.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.8 t -86.27 168.47 13.88 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.85 176.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.26 -16.52 54.07 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.492 178.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.24 -17.83 74.45 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.123 -0.561 . . . . 0.0 112.349 177.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -111.61 -26.85 8.81 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.12 0.486 . . . . 0.0 110.353 176.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.469 HD12 ' HA ' ' A' ' 56' ' ' LEU . 43.1 mm -117.41 92.13 2.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.34 175.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.8 t -113.79 -62.33 1.61 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.347 -177.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.8 m -101.56 165.02 14.8 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.827 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -53.0 -38.4 79.98 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.423 2.082 . . . . 0.0 111.567 174.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.8 p -67.71 -38.53 83.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.448 177.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -59.88 -46.89 87.89 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.154 0.502 . . . . 0.0 109.932 176.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.469 ' HA ' HD12 ' A' ' 50' ' ' ILE . 60.4 tp -61.28 -45.74 93.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.19 176.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.672 ' HD2' ' OE2' ' B' ' 223' ' ' GLU . 3.7 ttp180 -53.41 -48.36 68.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.203 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -55.52 -45.76 77.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.14 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -70.74 -35.23 72.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.06 -178.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.7 mt -66.04 -48.65 70.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.062 0.458 . . . . 0.0 110.635 176.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.5 t -64.03 -38.11 89.87 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.226 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -58.17 -43.88 87.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.95 178.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 93.5 mt -70.32 -38.03 74.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.277 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.95 93.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.063 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.813 ' HB2' HD11 ' B' ' 220' ' ' LEU . 20.1 t70 -63.11 -31.94 73.2 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.099 178.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.47 -24.01 61.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.32 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 28.3 mmtm -100.17 -13.42 18.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.557 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.09 38.82 73.47 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.108 -179.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.1 146.3 18.19 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.567 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.613 ' O ' ' HB2' ' B' ' 221' ' ' ALA . 0.0 OUTLIER -89.89 -2.18 58.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.633 0.254 . . . . 0.0 111.442 -176.497 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.552 ' HE1' HD23 ' A' ' 35' ' ' LEU . 10.4 p90 -167.4 174.88 7.61 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 169.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.532 ' O ' ' HG3' ' A' ' 24' ' ' GLN . 44.0 p90 -148.25 130.74 15.77 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 175.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -111.43 109.67 19.75 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.385 -0.526 . . . . 0.0 109.97 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.542 ' HA ' ' HA ' ' A' ' 88' ' ' ALA . 68.2 mt -68.75 127.15 30.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 177.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 26.8 pt -102.3 -37.24 4.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.03 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.23 136.03 36.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.241 -178.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -147.69 134.12 19.68 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.454 ' HD3' ' HB2' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -154.72 147.34 24.21 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.999 0.428 . . . . 0.0 110.286 179.192 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -94.11 92.6 7.37 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 177.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -87.59 80.13 8.1 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.44 -173.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.62 -121.92 16.05 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.961 -178.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -86.2 -1.46 8.56 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.951 2.434 . . . . 0.0 112.442 177.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -117.45 122.42 43.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.318 -178.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.44 ' CD2' HG23 ' A' ' 50' ' ' ILE . 88.5 t80 -92.53 128.04 38.23 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 177.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.655 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 48.4 mt-10 -112.22 117.09 31.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.708 -179.107 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.517 ' HB1' ' HB ' ' A' ' 43' ' ' VAL . . . -120.99 118.67 30.44 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.194 175.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.6 t -100.95 111.5 30.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.616 ' HB1' HG13 ' A' ' 41' ' ' ILE . . . -117.38 132.45 56.58 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.05 0.452 . . . . 0.0 110.957 -177.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.475 ' HB3' ' CE2' ' A' ' 91' ' ' TYR . 11.0 mm-40 -92.14 128.23 37.91 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.116 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.1 t -102.37 125.86 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -178.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.527 ' HB2' ' HH ' ' A' ' 71' ' ' TYR . 92.9 m-85 -129.54 142.67 50.71 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.0 0.429 . . . . 0.0 110.386 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -111.85 170.32 8.23 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.014 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.46 ' OD2' ' HG2' ' A' ' 70' ' ' LYS . 13.2 m-20 -76.04 167.03 22.61 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.085 0.469 . . . . 0.0 111.006 -176.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -87.36 23.57 1.84 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.231 178.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.9 t -129.5 117.46 20.52 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.643 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.633 ' HZ3' HG11 ' A' ' 36' ' ' VAL . 33.8 mtmt -149.88 20.74 0.89 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.115 177.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 71.6 mt -107.83 92.4 4.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.957 -177.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -115.4 -74.45 0.61 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -119.82 105.06 10.75 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.28 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 14.3 m80 -120.33 162.09 20.05 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.222 176.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 64.8 t60 -81.54 -38.5 26.1 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.588 -177.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -124.07 137.55 54.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.906 0.384 . . . . 0.0 110.419 178.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 62.6 m80 -104.11 -24.46 13.18 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 175.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.039 174.695 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 66.2 mtt . . . . . 0 N--CA 1.482 1.175 0 CA-C-O 120.452 0.168 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . 0.523 ' HB2' ' HZ3' ' B' ' 202' ' ' LYS . 10.4 mtmp? -147.39 168.73 21.1 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 82.5 tttt 71.81 135.61 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 O-C-N 124.285 0.991 . . . . 0.0 111.709 177.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -89.16 125.75 35.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.394 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 15.3 tt -146.05 150.09 15.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.571 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 60.7 mt -116.43 -61.18 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.561 0.22 . . . . 0.0 110.542 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -169.17 156.97 7.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 -177.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -146.16 76.66 1.46 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.753 177.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -175.32 173.64 2.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.108 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 210' ' ' LEU . . . . . . . . . . . . . 6.9 mp -77.63 145.76 36.54 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.636 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 42.9 tp -70.17 159.11 34.55 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.434 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.67 93.84 5.55 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.849 0.357 . . . . 0.0 110.86 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 213' ' ' THR . . . . . . . . . . . . . 9.8 p -89.66 -32.41 17.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.967 178.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 214' ' ' VAL . . . . . . . . . . . . . 19.6 m -91.34 33.15 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.172 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -73.81 92.24 2.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.784 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 52.9 m -151.22 100.35 2.75 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.542 178.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -163.0 144.27 9.78 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 218' ' ' SER . . . . . . . . . . . . . 15.4 m -78.76 66.05 4.15 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.172 0.51 . . . . 0.0 111.403 -178.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 96.7 m -153.75 94.58 1.79 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.961 174.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.813 HD11 ' HB2' ' A' ' 65' ' ' ASP . 1.1 pt? -116.95 96.37 5.43 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.829 177.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . 0.733 ' HB1' ' HG2' ' A' ' 23' ' ' GLU . . . -84.65 64.12 8.33 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.613 0.721 . . . . 0.0 110.12 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -106.45 102.46 11.85 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.141 -175.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . 0.672 ' OE2' ' HD2' ' A' ' 57' ' ' ARG . 9.8 tp10 -162.04 120.45 2.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.818 -178.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 224' ' ' GLN . . . . . 0.551 ' HG3' ' CD ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -169.95 139.29 1.86 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.041 0.448 . . . . 0.0 112.067 -179.093 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 14.1 m -113.84 128.83 70.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.032 170.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 226' ' ' SER . . . . . 0.463 ' HB2' ' HG2' ' B' ' 229' ' ' GLU . 12.5 m -77.59 157.42 30.29 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.683 -178.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -68.31 -30.39 69.36 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -62.22 -35.75 79.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.687 176.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 229' ' ' GLU . . . . . 0.463 ' HG2' ' HB2' ' B' ' 226' ' ' SER . 36.6 mm-40 -71.34 -25.3 62.34 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.405 -178.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.497 HG12 HD12 ' B' ' 235' ' ' LEU . 56.8 mt -60.97 -45.17 98.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.828 175.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 5.1 m -73.07 -21.66 60.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.568 176.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -78.11 -52.04 9.35 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.579 -173.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -113.22 -4.59 13.72 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -175.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.88 84.92 0.12 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.421 0.629 . . . . 0.0 110.119 -171.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . 0.497 HD12 HG12 ' B' ' 230' ' ' ILE . 87.9 mt -79.32 138.84 37.87 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.031 -176.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . 0.41 HG13 ' HE2' ' B' ' 296' ' ' LYS . 57.2 t -72.92 106.4 2.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.626 -178.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -79.23 116.88 19.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.105 0.478 . . . . 0.0 110.317 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 3.0 t -81.36 -40.89 18.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.825 -178.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 169.05 -149.98 14.73 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.47 -178.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 41.6 m -139.42 127.63 22.58 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 241' ' ' ILE . . . . . 0.443 HG21 HG21 ' B' ' 290' ' ' VAL . 2.4 pp -103.32 131.96 50.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.123 0.487 . . . . 0.0 109.931 178.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -116.19 120.19 38.19 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.058 -177.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 243' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' B' ' 285' ' ' GLU . 57.9 t -94.16 132.2 38.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.408 178.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 46.5 m -127.87 88.55 2.79 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 172.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 245' ' ' GLN . . . . . 0.556 ' HG2' HG12 ' B' ' 250' ' ' ILE . 0.7 OUTLIER -80.88 107.82 14.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.076 -173.474 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 53.1 p -84.99 102.74 13.42 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.853 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 92.52 -163.73 27.58 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.798 176.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -85.61 64.67 4.09 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 121.275 -0.488 . . . . 0.0 113.443 -172.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . 0.527 ' HB2' ' HG3' ' B' ' 245' ' ' GLN . 64.8 mt-30 -93.95 -3.06 52.28 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.01 0.433 . . . . 0.0 110.195 173.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 250' ' ' ILE . . . . . 0.556 HG12 ' HG2' ' B' ' 245' ' ' GLN . 38.7 mm -125.68 99.22 5.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.091 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 33.0 t -93.58 -46.36 7.32 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.098 0.475 . . . . 0.0 109.799 175.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 20.0 m -123.64 167.63 14.58 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.212 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.13 -26.77 61.89 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.574 2.183 . . . . 0.0 112.01 173.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 254' ' ' SER . . . . . . . . . . . . . 19.9 m -64.78 -39.45 93.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.625 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.04 -46.76 82.17 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.301 177.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 55.3 tp -57.58 -43.85 84.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.701 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 257' ' ' ARG . . . . . 0.483 ' HD2' ' CD ' ' A' ' 23' ' ' GLU . 10.7 ttp180 -53.71 -52.32 60.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.266 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 258' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -60.29 -27.1 67.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.814 -173.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 259' ' ' LYS . . . . . 0.416 ' O ' ' HG ' ' B' ' 263' ' ' LEU . 14.4 mptt -80.47 -39.65 27.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.976 0.417 . . . . 0.0 110.851 176.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 95.6 mt -71.28 -47.34 57.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.73 -175.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 2.8 m -58.93 -34.83 72.18 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.314 0.578 . . . . 0.0 110.658 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -66.39 -47.81 72.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.421 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 263' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' B' ' 259' ' ' LYS . 90.6 mt -64.96 -32.41 74.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.629 -175.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -60.86 -42.58 98.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.597 -177.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -61.29 -49.39 77.22 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.43 -177.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -68.92 -15.12 63.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.852 -175.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 267' ' ' LYS . . . . . 0.437 ' HD3' ' HA ' ' B' ' 267' ' ' LYS . 31.4 mmtp -100.87 -0.86 36.07 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.088 178.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 74.42 28.11 64.35 Favored Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.218 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -101.27 162.76 17.98 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.066 -178.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . 0.586 ' HZ1' ' CD ' ' B' ' 298' ' ' GLU . 0.0 OUTLIER -117.15 -59.94 1.89 Allowed 'General case' 0 C--N 1.32 -0.716 0 O-C-N 122.66 -0.317 . . . . 0.0 110.754 179.426 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 271' ' ' TYR . . . . . 0.618 ' HE2' ' HB2' ' B' ' 293' ' ' ASP . 6.0 m-85 -117.19 162.94 17.06 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 272' ' ' TYR . . . . . 0.683 ' CD1' ' HB1' ' A' ' 22' ' ' ALA . 0.1 OUTLIER -148.74 158.75 44.37 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.183 0.516 . . . . 0.0 110.994 -179.123 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -128.17 107.78 10.07 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.256 -178.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 274' ' ' ILE . . . . . 0.546 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 4.5 mp -77.46 120.47 28.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.611 -174.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 14.4 pt -111.42 -26.45 3.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -176.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . 0.56 ' HB1' ' HB ' ' B' ' 287' ' ' VAL . . . -134.9 145.74 48.52 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.192 -177.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 277' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' B' ' 285' ' ' GLU . . . -169.47 117.66 0.62 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.856 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.13 139.11 15.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.83 0.348 . . . . 0.0 110.992 -178.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 279' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' B' ' 284' ' ' PHE . 3.3 mp0 -76.7 91.08 3.43 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 174.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -87.01 89.31 7.95 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 -176.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 66.44 -118.76 11.33 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.511 -174.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -90.54 -2.12 5.18 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.896 2.398 . . . . 0.0 112.733 177.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 283' ' ' ASN . . . . . 0.547 ' HA ' ' O ' ' B' ' 245' ' ' GLN . 59.1 m-80 -118.87 115.87 25.3 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.018 0.437 . . . . 0.0 111.127 -176.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 284' ' ' PHE . . . . . 0.434 ' HA ' ' HA ' ' B' ' 279' ' ' GLU . 70.0 t80 -79.06 113.92 17.57 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 175.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 285' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 48.3 mt-10 -99.27 114.13 26.79 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.853 -176.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 286' ' ' ALA . . . . . 0.471 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -114.26 135.09 54.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.473 174.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 287' ' ' VAL . . . . . 0.56 ' HB ' ' HB1' ' B' ' 276' ' ' ALA . 37.4 t -125.41 128.48 72.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 110.081 -0.341 . . . . 0.0 110.081 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -134.74 151.13 50.74 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.965 0.412 . . . . 0.0 111.54 -178.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 289' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' B' ' 272' ' ' TYR . 21.8 mt-10 -90.62 119.92 31.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.141 178.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 290' ' ' VAL . . . . . 0.443 HG21 HG21 ' B' ' 241' ' ' ILE . 39.1 t -94.15 124.15 46.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.511 0.196 . . . . 0.0 111.211 -175.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -129.27 151.29 50.09 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.469 0.652 . . . . 0.0 111.658 -178.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 292' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -106.76 155.19 19.96 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.949 173.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 293' ' ' ASP . . . . . 0.618 ' HB2' ' HE2' ' B' ' 271' ' ' TYR . 25.7 t70 -77.77 160.23 28.52 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 165.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 294' ' ' ALA . . . . . . . . . . . . . . . -75.29 41.29 0.18 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.963 0.411 . . . . 0.0 111.77 -176.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 295' ' ' THR . . . . . 0.407 ' H ' ' C ' ' B' ' 293' ' ' ASP . 10.0 t -126.49 -41.79 1.85 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.41 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 296' ' ' LYS . . . . . 0.41 ' HE2' HG13 ' B' ' 236' ' ' VAL . 43.4 mttm 56.28 32.0 19.57 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 177.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 297' ' ' LEU . . . . . . . . . . . . . 95.7 mt -107.52 112.5 25.28 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 176.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 298' ' ' GLU . . . . . 0.586 ' CD ' ' HZ1' ' B' ' 270' ' ' LYS . 7.4 tp10 -105.62 4.09 29.87 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.914 -174.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 299' ' ' HIS . . . . . . . . . . . . . 40.4 m170 -108.38 133.26 52.81 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.333 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 300' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 66.77 82.42 0.18 Allowed 'General case' 0 C--N 1.331 -0.237 0 O-C-N 123.832 0.708 . . . . 0.0 110.894 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 301' ' ' HIS . . . . . . . . . . . . . 50.5 m80 -84.32 -40.43 17.95 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 302' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -145.27 -56.02 0.32 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 174.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -120.03 -44.38 2.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.205 168.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 45.2 m80 . . . . . 0 C--N 1.325 -0.494 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.622 177.984 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.6 mmt . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -136.94 124.97 22.82 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.428 -0.805 . . . . 0.0 108.904 175.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.834 ' HD3' ' H ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -81.62 90.08 6.27 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.548 0.69 . . . . 0.0 111.015 -173.501 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.539 ' HD3' ' H ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -81.85 56.11 2.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.776 0.798 . . . . 0.0 110.055 177.663 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.9 pt -79.88 -170.84 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.945 -178.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.5 tt -139.76 130.94 32.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.893 0.378 . . . . 0.0 110.799 178.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -138.57 18.54 2.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.375 0.607 . . . . 0.0 110.077 176.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -96.73 142.49 28.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.436 178.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -136.07 94.48 3.05 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.173 0.511 . . . . 0.0 111.132 -176.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 53.9 tp -122.35 122.38 38.92 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.738 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 56.8 tp -119.23 110.42 16.99 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.925 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.97 -177.5 4.91 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.158 0.504 . . . . 0.0 111.024 -177.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.4 m -145.69 106.87 4.17 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.12 177.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.6 m -130.62 -166.83 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.267 -175.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.457 ' HB3' ' HA2' ' B' ' 268' ' ' GLY . . . 69.18 171.11 0.3 Allowed 'General case' 0 N--CA 1.463 0.184 0 O-C-N 123.825 0.703 . . . . 0.0 111.967 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.0 t -167.81 -39.3 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.959 -177.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -115.74 106.06 13.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.051 174.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.46 ' C ' ' HG1' ' A' ' 19' ' ' THR . 69.3 m -145.45 -77.91 0.19 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.693 -0.23 . . . . 0.0 110.483 175.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.46 ' HG1' ' C ' ' A' ' 18' ' ' SER . 0.7 OUTLIER 55.84 -66.31 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.321 1.048 . . . . 0.0 113.624 -177.972 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.566 HD13 HD12 ' B' ' 220' ' ' LEU . 2.2 mm? -83.0 81.9 8.47 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -163.5 167.37 21.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.669 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.454 ' O ' ' HD3' ' B' ' 257' ' ' ARG . . . 72.35 117.57 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 O-C-N 124.281 0.988 . . . . 0.0 112.002 176.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.695 ' HG2' ' H ' ' B' ' 222' ' ' ALA . 9.8 tp10 -150.17 179.74 7.85 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.361 -178.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.765 ' HA ' ' HB2' ' A' ' 71' ' ' TYR . 0.0 OUTLIER 85.44 140.08 0.06 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.074 0.95 . . . . 0.0 111.529 176.712 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.495 HG21 ' CZ ' ' A' ' 71' ' ' TYR . 5.0 m -117.06 173.35 4.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.48 176.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.551 ' HB3' ' HB ' ' B' ' 274' ' ' ILE . 92.3 p -97.99 -175.75 3.24 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.097 0.475 . . . . 0.0 111.039 -175.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.0 tmmt? -71.48 -19.74 62.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.099 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -66.51 -45.91 77.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.6 -178.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -65.64 -44.69 85.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.502 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.0 mt -53.77 -46.47 62.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.688 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.3 m -68.4 -38.4 81.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.549 -176.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 25.8 m80 -80.86 -44.99 17.53 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -174.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.429 ' CD1' ' HD3' ' B' ' 253' ' ' PRO . 97.8 m-85 -93.22 -19.9 20.97 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -173.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm 61.35 82.72 0.16 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.184 0.516 . . . . 0.0 110.617 -177.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.572 HD21 ' HG3' ' B' ' 253' ' ' PRO . 96.5 mt -85.31 173.38 10.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.415 -176.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.1 t -95.97 124.78 48.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.608 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -84.58 115.49 22.65 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.161 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -94.68 -3.84 10.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.157 0.503 . . . . 0.0 111.141 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 120.83 155.25 9.51 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.976 174.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 27.4 m -81.16 150.3 28.75 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 177.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.3 pt -116.35 134.22 60.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.001 0.429 . . . . 0.0 110.006 172.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -124.12 116.04 22.11 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.122 -178.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 3.2 t -109.87 109.51 28.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.513 -178.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.8 p -92.48 91.92 7.84 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 175.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.559 ' HG2' HG12 ' A' ' 50' ' ' ILE . 0.9 OUTLIER -97.58 147.66 24.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.669 -170.641 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.9 t -96.84 154.8 17.08 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 172.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.92 78.32 0.39 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.338 178.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -175.76 -37.83 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 121.146 -0.549 . . . . 0.0 112.553 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -81.73 -23.85 36.48 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 122.57 -0.37 . . . . 0.0 111.255 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.559 HG12 ' HG2' ' A' ' 45' ' ' GLN . 49.3 mm -112.7 109.71 29.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.6 t -107.12 -45.94 4.02 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.204 0.526 . . . . 0.0 109.711 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.533 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 22.0 m -126.06 165.96 24.32 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.837 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.533 ' HD2' ' HB3' ' A' ' 52' ' ' SER . 10.7 Cg_endo -54.69 -26.4 46.65 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.631 2.221 . . . . 0.0 111.981 177.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.588 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 2.3 m -55.67 -51.86 65.8 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.752 176.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -59.62 -42.17 92.07 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.234 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 56.9 tp -61.5 -46.58 89.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.908 -177.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 21.5 ttp180 -58.66 -44.51 90.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.455 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.588 ' HG2' ' O ' ' A' ' 54' ' ' SER . 19.0 mm-40 -62.32 -45.35 93.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.854 -178.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -67.33 -36.86 82.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.362 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.0 mt -68.26 -43.0 78.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.977 0.418 . . . . 0.0 110.515 177.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.4 m -68.49 -30.53 69.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.575 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -58.01 -46.67 84.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.055 0.455 . . . . 0.0 110.46 177.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 98.5 mt -74.55 -37.0 63.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.898 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.72 -32.64 74.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.091 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -60.33 -41.72 94.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.917 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.05 -16.62 56.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.078 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.681 ' HE3' ' HB1' ' B' ' 212' ' ' ALA . 28.0 mmtp -89.52 -15.22 33.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.548 177.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 57.68 48.98 77.83 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 -175.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -92.66 171.14 32.97 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.877 -175.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.467 ' CB ' ' HA ' ' A' ' 92' ' ' ASN . 56.7 tptt -99.89 -47.18 5.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.535 0.683 . . . . 0.0 109.811 178.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.765 ' HB2' ' HA ' ' A' ' 24' ' ' GLN . 35.1 p90 -150.96 177.15 10.43 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.794 -178.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -142.62 126.05 16.69 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.247 0.546 . . . . 0.0 110.166 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -106.61 101.0 10.48 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.281 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.569 ' HB ' ' HB2' ' B' ' 226' ' ' SER . 69.7 mt -72.44 120.11 20.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.139 0.495 . . . . 0.0 110.514 -176.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.6 pt -94.99 -35.38 6.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.22 -178.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.97 110.88 5.02 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.995 0.426 . . . . 0.0 111.601 -177.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -107.86 88.43 2.73 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 172.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.521 ' CG ' ' HB2' ' A' ' 85' ' ' GLU . 6.2 ptp180 -95.86 121.49 37.64 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.874 0.845 . . . . 0.0 112.196 -166.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -70.64 100.47 1.85 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.71 172.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 23.8 t-80 -88.16 14.74 8.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.062 0.458 . . . . 0.0 110.46 -177.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.85 -106.5 3.18 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.75 -5.9 16.39 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.579 2.186 . . . . 0.0 111.193 173.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -123.02 156.8 34.09 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.172 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -128.49 120.97 27.83 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.521 ' HB2' ' CG ' ' A' ' 78' ' ' ARG . 41.3 mt-10 -110.3 110.94 21.94 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.787 -177.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.36 118.12 32.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.035 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.9 t -112.82 112.79 41.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.934 176.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.507 ' HB1' HG12 ' A' ' 74' ' ' ILE . . . -127.76 141.71 51.51 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.962 0.41 . . . . 0.0 111.895 -176.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -91.85 116.47 28.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.79 177.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.6 t -100.34 125.01 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-O 121.117 0.484 . . . . 0.0 110.067 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.517 ' HB2' ' CE1' ' A' ' 71' ' ' TYR . 64.7 m-85 -123.84 159.51 29.43 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.911 177.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.467 ' HA ' ' CB ' ' A' ' 70' ' ' LYS . 10.3 t-20 -120.52 174.07 6.78 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 175.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -55.89 157.11 4.59 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.764 0.316 . . . . 0.0 110.222 176.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.49 ' C ' ' HG1' ' A' ' 95' ' ' THR . . . -75.75 64.86 1.81 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.994 0.426 . . . . 0.0 110.702 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.49 ' HG1' ' C ' ' A' ' 94' ' ' ALA . 16.0 m -152.78 -107.17 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.547 178.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 57.7 mttt 44.38 -94.57 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -174.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 90.0 mt -85.13 76.98 10.15 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.135 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 51.76 77.11 0.15 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.41 -0.813 . . . . 0.0 112.24 175.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.437 ' O ' ' HA ' ' A' ' 95' ' ' THR . 33.1 m80 -147.27 127.16 13.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.122 177.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -142.24 102.58 4.13 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.298 170.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -130.22 71.52 1.46 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.324 0.583 . . . . 0.0 110.29 -178.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -83.63 103.17 12.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.371 179.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 65.4 t-80 -87.64 134.84 33.57 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.767 178.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 4.7 p80 . . . . . 0 C--N 1.324 -0.523 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.847 178.965 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -119.33 16.56 13.07 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.34 0.59 . . . . 0.0 109.622 172.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -71.04 139.69 50.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.322 173.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -84.66 -45.36 12.55 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 59.7 mt 58.61 92.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.168 176.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 25.5 pt -114.38 144.95 20.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.271 174.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -166.24 -47.35 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.61 0.243 . . . . 0.0 111.236 -175.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . 65.06 -156.61 0.29 Allowed 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.833 -178.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . 69.61 40.24 1.42 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.371 0.605 . . . . 0.0 110.665 -178.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 210' ' ' LEU . . . . . . . . . . . . . 91.5 mt -101.55 111.79 24.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.53 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 8.2 mp -93.99 146.21 24.1 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.868 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 212' ' ' ALA . . . . . 0.681 ' HB1' ' HE3' ' A' ' 67' ' ' LYS . . . -139.87 93.88 2.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.481 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 213' ' ' THR . . . . . . . . . . . . . 47.6 m -152.94 90.63 1.47 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.3 0.571 . . . . 0.0 110.977 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 214' ' ' VAL . . . . . . . . . . . . . 11.0 p -162.46 141.16 2.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.646 176.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -79.89 -57.38 3.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.418 -177.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 22.8 m 64.04 -161.65 0.28 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.353 -178.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -102.81 129.5 49.49 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 218' ' ' SER . . . . . . . . . . . . . 15.5 m -85.94 76.46 9.84 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.461 0.648 . . . . 0.0 110.813 -178.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 11.2 m -104.02 163.19 12.54 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.85 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.593 ' H ' HD21 ' B' ' 220' ' ' LEU . 1.2 pt? -60.34 114.99 3.21 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 176.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 70' ' ' LYS . . . -166.83 178.38 5.9 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.328 -177.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . 0.695 ' H ' ' HG2' ' A' ' 23' ' ' GLU . . . 61.8 87.65 0.1 Allowed 'General case' 0 N--CA 1.465 0.321 0 O-C-N 124.004 0.815 . . . . 0.0 112.706 177.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -167.61 110.57 0.65 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.926 174.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 224' ' ' GLN . . . . . 0.519 ' HG3' ' CD ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -161.94 148.09 13.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.033 -175.817 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . 0.435 HG22 ' HB3' ' B' ' 271' ' ' TYR . 18.7 m -126.78 128.69 71.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 166.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 226' ' ' SER . . . . . 0.569 ' HB2' ' HB ' ' A' ' 74' ' ' ILE . 6.3 t -87.86 178.98 6.55 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.776 0.322 . . . . 0.0 110.158 -177.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . 0.408 ' HA ' HD13 ' B' ' 230' ' ' ILE . 23.0 tptp -66.98 -23.91 65.99 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.293 -170.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -72.0 -50.32 29.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.939 0.399 . . . . 0.0 110.127 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -65.06 -38.64 91.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.784 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.494 HG13 ' O ' ' B' ' 226' ' ' SER . 97.4 mt -54.88 -54.0 27.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.032 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 56.8 m -73.44 -22.08 60.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.76 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -79.88 -44.5 20.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.693 0.282 . . . . 0.0 110.547 -177.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -89.48 -8.59 52.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.97 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt 60.28 51.72 5.32 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.528 -178.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.42 149.66 47.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.874 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . 0.438 HG21 ' HB3' ' B' ' 292' ' ' ASN . 16.0 m -86.46 124.34 40.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.375 0.607 . . . . 0.0 111.491 -177.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -75.6 128.13 34.58 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.511 176.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 40.5 t -92.69 -44.44 13.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.253 0.549 . . . . 0.0 110.337 -179.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 177.11 -157.35 22.21 Favored Glycine 0 N--CA 1.442 -0.94 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.442 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 59.3 m -135.22 137.47 42.65 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 22.7 pt -117.61 142.61 31.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 175.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -132.9 138.5 47.0 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.692 0.758 . . . . 0.0 111.772 -177.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 243' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' B' ' 285' ' ' GLU . 59.7 t -102.75 134.68 43.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.221 177.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 7.2 t -149.21 47.82 0.98 Allowed 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 245' ' ' GLN . . . . . 0.513 ' NE2' HG11 ' B' ' 243' ' ' VAL . 0.9 OUTLIER -103.63 159.22 15.8 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.738 -177.071 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 246' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' B' ' 283' ' ' ASN . 19.1 m -89.18 171.06 10.09 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.247 -177.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -54.61 115.4 5.35 Favored Glycine 0 C--N 1.333 0.389 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.084 176.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . 134.31 -43.57 1.25 Allowed Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 -176.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . 0.459 ' HB2' ' HB3' ' B' ' 245' ' ' GLN . 11.5 mm100 -73.29 -23.81 60.33 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 49.9 mm -114.29 111.63 36.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 171.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 19.7 m -104.03 -19.09 14.31 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.612 -175.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 252' ' ' SER . . . . . 0.483 ' HB3' ' HD2' ' B' ' 253' ' ' PRO . 38.6 m -154.99 163.51 24.21 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -176.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . 0.572 ' HG3' HD21 ' A' ' 35' ' ' LEU . 19.1 Cg_endo -61.64 -41.98 35.7 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.256 1.971 . . . . 0.0 111.246 175.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 254' ' ' SER . . . . . 0.423 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 27.5 m -75.28 -18.74 60.0 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.762 177.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' B' ' 258' ' ' GLU . 35.2 t70 -71.56 -33.57 69.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.204 0.526 . . . . 0.0 109.723 176.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 63.2 tp -59.44 -43.22 93.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.461 172.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 257' ' ' ARG . . . . . 0.454 ' HD3' ' O ' ' A' ' 22' ' ' ALA . 1.8 tmm_? -62.24 -39.12 91.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.807 178.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 258' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' B' ' 254' ' ' SER . 13.5 mm-40 -52.43 -52.32 54.59 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.911 0.386 . . . . 0.0 110.328 176.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -62.31 -42.86 99.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.128 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 260' ' ' LEU . . . . . 0.495 HD12 ' CE2' ' B' ' 272' ' ' TYR . 96.0 mt -67.9 -43.82 78.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.82 -176.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 17.0 p -64.7 -31.23 72.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.999 0.428 . . . . 0.0 110.683 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -65.73 -42.42 91.04 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.21 178.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 263' ' ' LEU . . . . . . . . . . . . . 94.6 mt -73.21 -37.71 66.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.128 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -59.5 -39.31 83.4 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.575 -178.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -61.29 -40.0 92.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.182 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -74.7 -19.15 60.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.657 -176.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -93.25 -36.18 12.72 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.946 0.403 . . . . 0.0 110.904 179.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 268' ' ' GLY . . . . . 0.457 ' HA2' ' HB3' ' A' ' 15' ' ' ALA . . . 106.13 55.91 0.67 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.559 177.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -142.64 150.8 22.53 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.366 -0.921 . . . . 0.0 111.857 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . 0.907 ' HD3' ' HB2' ' B' ' 293' ' ' ASP . 45.6 mtpt -94.52 -37.81 11.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.426 0.632 . . . . 0.0 110.268 177.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 271' ' ' TYR . . . . . 0.435 ' HB3' HG22 ' B' ' 225' ' ' VAL . 16.7 m-85 -117.75 150.31 39.33 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.747 -172.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 272' ' ' TYR . . . . . 0.495 ' CE2' HD12 ' B' ' 260' ' ' LEU . 21.6 p90 -145.2 155.02 43.01 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 175.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -136.49 109.79 7.85 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -177.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 274' ' ' ILE . . . . . 0.551 ' HB ' ' HB3' ' A' ' 26' ' ' SER . 60.8 mt -65.4 127.2 26.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.076 177.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 22.7 pt -108.25 -28.26 2.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.777 0.322 . . . . 0.0 111.769 -177.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -152.71 108.84 3.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.922 -178.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 277' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' B' ' 286' ' ' ALA . . . -124.53 102.89 7.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.091 0.472 . . . . 0.0 109.921 178.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.53 132.02 54.47 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.543 0.687 . . . . 0.0 111.311 -174.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.1 115.53 15.9 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 171.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 280' ' ' HIS . . . . . 0.457 ' HB2' ' HG3' ' B' ' 285' ' ' GLU . 7.1 t-160 -103.54 25.51 9.6 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.189 0.519 . . . . 0.0 110.109 -171.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 103.35 -106.44 2.86 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.982 -0.627 . . . . 0.0 111.732 -177.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -75.45 -24.57 12.0 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.993 2.462 . . . . 0.0 112.045 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 283' ' ' ASN . . . . . 0.465 ' HA ' ' HA ' ' B' ' 246' ' ' SER . 53.2 m-80 -116.18 148.21 40.61 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.944 -177.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -107.22 115.31 29.94 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.58 176.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 285' ' ' GLU . . . . . 0.551 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 1.0 OUTLIER -101.52 110.85 22.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.959 -175.095 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 286' ' ' ALA . . . . . 0.455 ' HB2' ' HB ' ' B' ' 243' ' ' VAL . . . -125.95 116.52 21.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.782 0.325 . . . . 0.0 111.604 -177.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 46.3 t -103.46 124.47 57.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.328 178.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -130.08 141.2 50.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.929 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -92.47 133.42 35.93 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.046 178.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 44.8 t -98.0 125.06 51.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.622 -178.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -123.68 142.98 50.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.1 0.476 . . . . 0.0 110.581 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 292' ' ' ASN . . . . . 0.438 ' HB3' HG21 ' B' ' 236' ' ' VAL . 14.8 t-20 -92.2 167.33 12.11 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 293' ' ' ASP . . . . . 0.907 ' HB2' ' HD3' ' B' ' 270' ' ' LYS . 13.6 t70 -64.27 -25.14 67.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.143 0.497 . . . . 0.0 110.093 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 294' ' ' ALA . . . . . . . . . . . . . . . 75.14 -53.77 0.66 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.334 175.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 295' ' ' THR . . . . . 0.442 HG21 ' HB3' ' A' ' 52' ' ' SER . 12.0 t -92.69 -29.09 16.26 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.035 -177.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 296' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' B' ' 295' ' ' THR . 23.0 mtmt 71.4 -66.77 0.28 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.259 0.624 . . . . 0.0 110.543 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 297' ' ' LEU . . . . . . . . . . . . . 4.0 pp -157.24 150.44 23.78 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.077 174.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 298' ' ' GLU . . . . . 0.624 ' CD ' ' H ' ' B' ' 299' ' ' HIS . 0.0 OUTLIER -89.62 -66.57 0.91 Allowed 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.088 0.47 . . . . 0.0 110.333 -178.306 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 299' ' ' HIS . . . . . 0.624 ' H ' ' CD ' ' B' ' 298' ' ' GLU . 13.2 p-80 -152.09 18.5 0.67 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 300' ' ' HIS . . . . . 0.421 ' HB2' ' O ' ' B' ' 299' ' ' HIS . 2.6 m80 74.91 109.54 0.07 Allowed 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.478 -178.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 301' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -63.38 108.53 1.35 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 173.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 302' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -60.53 117.51 5.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.319 0.58 . . . . 0.0 112.439 -170.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -133.99 100.17 4.65 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.862 176.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 . . . . . 0 C--N 1.322 -0.624 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.672 179.878 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.771 0.32 . . . . 0.0 111.229 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -87.68 106.56 18.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.211 0.529 . . . . 0.0 112.101 -172.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.6 ttpp -112.63 81.92 1.56 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 170.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -110.98 14.38 22.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.432 -172.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.5 mt -102.79 110.77 30.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.505 -178.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.603 ' HA ' HD13 ' B' ' 275' ' ' ILE . 8.4 pt -139.35 84.5 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.202 0.525 . . . . 0.0 110.488 173.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -107.88 93.45 4.55 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.263 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.36 131.95 35.22 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.821 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.415 ' HB1' ' HG1' ' B' ' 240' ' ' THR . . . -150.1 154.35 37.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.01 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 87.7 mt 64.97 175.24 0.2 Allowed 'General case' 0 N--CA 1.465 0.319 0 O-C-N 123.917 0.761 . . . . 0.0 112.054 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.628 ' HA ' HD22 ' B' ' 242' ' ' ASN . 43.9 tp -168.04 142.28 3.45 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.46 178.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.59 67.71 0.97 Allowed 'General case' 0 C--O 1.234 0.266 0 O-C-N 123.761 0.663 . . . . 0.0 110.768 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.568 HG23 HD22 ' B' ' 263' ' ' LEU . 5.2 t -84.5 133.22 34.47 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.319 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.3 m -97.43 151.3 4.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.162 -177.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.9 108.2 4.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.903 -176.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.8 m -109.15 14.13 24.08 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.25 0.547 . . . . 0.0 110.674 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -145.89 127.99 15.62 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.5 p -136.42 98.27 3.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.069 0.461 . . . . 0.0 112.183 -172.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.4 m -113.16 141.98 46.31 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.001 173.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 79.9 mt -72.09 100.36 2.51 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -138.21 19.66 2.78 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.566 -174.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.486 ' O ' ' HD3' ' B' ' 257' ' ' ARG . . . -170.32 144.02 2.45 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.241 0.338 . . . . 0.0 110.456 -178.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.493 ' CD ' ' HA ' ' B' ' 221' ' ' ALA . 8.4 pt-20 -176.46 114.71 0.11 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.107 0.48 . . . . 0.0 112.289 178.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.774 ' HB3' ' CB ' ' B' ' 224' ' ' GLN . 22.2 tm0? 173.81 141.0 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.136 176.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.46 HG23 HD13 ' A' ' 35' ' ' LEU . 31.3 m -120.7 155.08 24.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 121.099 0.476 . . . . 0.0 111.883 -174.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 72.6 p -96.33 -93.09 0.21 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.429 -174.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.473 ' C ' ' HD3' ' A' ' 27' ' ' LYS . 10.8 tmtt? -123.12 -66.61 1.0 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 122.168 -0.333 . . . . 0.0 111.873 -174.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.5 -28.53 69.9 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -170.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -65.32 -42.78 92.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.968 0.414 . . . . 0.0 110.064 176.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.417 HG12 ' CD1' ' A' ' 35' ' ' LEU . 28.0 mt -64.57 -44.94 96.81 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.897 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.3 m -67.35 -30.47 70.3 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.846 -0.341 . . . . 0.0 111.335 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -72.45 -48.25 42.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.583 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.407 ' C ' ' H ' ' A' ' 35' ' ' LEU . 87.0 m-85 -98.68 4.16 47.85 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.324 -176.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt 71.85 -45.95 0.63 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.978 0.911 . . . . 0.0 112.028 177.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.514 HD21 ' HA ' ' A' ' 93' ' ' ASP . 19.3 mt 58.71 164.25 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.208 1.003 . . . . 0.0 112.604 -172.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 76.3 t -97.5 -47.68 12.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.658 -175.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.57 ' HA ' ' HA ' ' A' ' 91' ' ' TYR . 63.5 tttm 70.39 126.49 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 O-C-N 124.159 0.912 . . . . 0.0 111.082 -177.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.0 m -114.28 -30.06 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -175.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 169.47 -161.99 35.51 Favored Glycine 0 C--O 1.227 -0.305 0 C-N-CA 119.303 -1.427 . . . . 0.0 113.656 -178.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.534 HG22 ' HG2' ' A' ' 89' ' ' GLU . 6.4 m -123.07 143.88 49.66 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 122.473 0.309 . . . . 0.0 110.441 -176.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.9 pt -118.92 139.5 46.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 172.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -122.02 114.4 20.9 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.724 -175.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.579 ' HB ' ' HB1' ' A' ' 86' ' ' ALA . 43.0 t -105.63 115.33 47.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 68.7 p -148.28 99.27 3.02 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.731 0.301 . . . . 0.0 110.996 -174.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -142.15 157.11 45.25 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.064 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.583 ' HA ' ' HA ' ' A' ' 83' ' ' ASN . 19.9 t -71.38 173.44 7.85 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 120.666 0.27 . . . . 0.0 110.313 178.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.78 55.16 2.57 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 113.165 -176.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -141.52 -37.3 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 176.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -83.41 -14.81 51.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.09 0.471 . . . . 0.0 110.59 177.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.1 mm -130.34 132.57 64.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 176.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.3 m -134.84 -35.03 0.88 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.055 0.455 . . . . 0.0 111.584 -177.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.583 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 28.1 m -142.11 168.48 13.49 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -177.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.583 ' HD2' ' HB3' ' A' ' 52' ' ' SER . 10.8 Cg_endo -54.55 -31.05 67.93 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.543 2.162 . . . . 0.0 112.637 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.4 m -61.87 -34.51 76.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.664 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -62.88 -52.81 61.65 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.338 0.59 . . . . 0.0 109.881 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 57.4 tp -63.4 -30.37 71.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.276 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -62.08 -31.79 72.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.955 -178.302 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -74.93 -46.87 32.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.8 0.333 . . . . 0.0 110.358 175.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.543 ' HA ' ' HG2' ' A' ' 62' ' ' GLU . 1.9 mptp? -62.97 -40.39 97.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.195 -175.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.3 mt -61.6 -37.12 82.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.824 0.345 . . . . 0.0 110.748 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.534 ' HA ' ' HB3' ' B' ' 222' ' ' ALA . 19.5 m -75.95 -43.28 45.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.45 -178.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.543 ' HG2' ' HA ' ' A' ' 59' ' ' LYS . 16.8 pt-20 -69.44 -36.72 76.93 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 121.151 -0.219 . . . . 0.0 111.221 -175.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 87.4 mt -74.9 -49.36 20.59 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -178.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.24 -44.1 89.27 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -174.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -65.68 -34.9 79.29 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.997 0.427 . . . . 0.0 110.72 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.572 ' HA ' ' CE2' ' B' ' 217' ' ' PHE . . . -73.11 -8.86 57.65 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.428 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -106.48 2.24 26.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.804 176.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.05 58.57 4.31 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.967 178.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -131.17 -178.04 15.23 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.28 178.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -130.29 -37.07 1.45 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.165 0.507 . . . . 0.0 110.007 177.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.551 ' HB3' ' HA ' ' A' ' 24' ' ' GLN . 11.4 m-85 -127.23 169.53 13.39 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.417 ' O ' ' HG2' ' A' ' 24' ' ' GLN . 25.7 p90 -142.63 167.28 22.47 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 173.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -134.45 109.26 8.62 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.818 175.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 54.2 mt -68.65 129.81 33.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.833 176.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.5 pt -123.33 -14.78 5.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.741 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -157.45 107.3 2.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.505 0.193 . . . . 0.0 111.191 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -132.6 105.35 7.16 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.785 0.326 . . . . 0.0 110.187 176.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.439 HH11 ' HD3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -153.47 146.9 24.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.942 -177.529 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -77.79 109.07 11.48 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.636 174.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -101.84 87.95 3.25 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.74 -134.66 13.6 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -175.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -83.61 1.2 9.06 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.65 2.233 . . . . 0.0 112.386 176.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.583 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 44.6 m-80 -115.08 143.15 45.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.051 0.453 . . . . 0.0 111.491 -177.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.505 ' O ' ' HA ' ' A' ' 44' ' ' SER . 66.6 t80 -93.99 120.11 33.79 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.783 176.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -105.26 118.8 37.46 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.512 -177.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.579 ' HB1' ' HB ' ' A' ' 43' ' ' VAL . . . -132.34 115.73 15.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.166 0.507 . . . . 0.0 110.696 176.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 44.6 t -111.81 122.58 66.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.019 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.28 142.09 33.9 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.413 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.534 ' HG2' HG22 ' A' ' 40' ' ' THR . 10.9 mt-10 -103.75 140.24 37.9 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.68 -0.408 . . . . 0.0 109.977 176.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 36.5 t -90.52 125.05 43.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.054 0.454 . . . . 0.0 110.369 -175.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 37' ' ' LYS . 54.9 m-85 -111.5 114.23 27.19 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.657 -178.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -86.36 146.47 26.46 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 171.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.514 ' HA ' HD21 ' A' ' 35' ' ' LEU . 2.7 p-10 -84.51 -179.5 7.17 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 121.13 -0.228 . . . . 0.0 110.494 -174.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.73 12.52 0.49 Allowed 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -175.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.42 ' H ' ' C ' ' A' ' 93' ' ' ASP . 86.6 m -95.43 -36.91 11.16 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 177.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.495 ' HG2' ' HG ' ' A' ' 97' ' ' LEU . 82.7 tttt 66.71 -74.32 0.07 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.547 -177.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.495 ' HG ' ' HG2' ' A' ' 96' ' ' LYS . 0.7 OUTLIER -147.1 -179.96 7.19 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.583 176.795 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -64.39 -36.48 84.28 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -174.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 37.3 m170 -73.37 112.36 9.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.121 0.486 . . . . 0.0 111.365 -176.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 13.6 m170 -112.18 118.3 34.97 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.956 0.408 . . . . 0.0 110.3 177.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -126.45 124.75 40.84 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.532 -175.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 70.91 109.1 0.06 Allowed 'General case' 0 N--CA 1.467 0.407 0 O-C-N 124.062 0.851 . . . . 0.0 111.073 178.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 31.8 p80 -138.32 174.92 10.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.422 -176.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 63.4 t-80 . . . . . 0 C--N 1.323 -0.559 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 175.727 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 201' ' ' MET . . . . . 0.741 ' HE1' ' HA ' ' B' ' 201' ' ' MET . 1.2 tpt . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp 67.88 99.2 0.05 Allowed 'General case' 0 N--CA 1.468 0.448 0 O-C-N 123.462 0.476 . . . . 0.0 111.69 176.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . 0.565 ' HE2' ' HB ' ' B' ' 205' ' ' ILE . 22.2 ptmt -90.5 -21.93 21.6 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.054 175.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 204' ' ' ARG . . . . . 0.464 ' O ' ' HG3' ' B' ' 204' ' ' ARG . 0.6 OUTLIER 68.68 16.18 9.01 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.856 171.232 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 205' ' ' ILE . . . . . 0.565 ' HB ' ' HE2' ' B' ' 203' ' ' LYS . 48.3 mm -91.41 97.01 6.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.092 0.472 . . . . 0.0 110.476 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 55.0 mt -98.7 81.76 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.756 177.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -95.91 78.8 3.24 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.564 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -97.96 104.06 16.05 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.252 176.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -149.1 -152.0 0.42 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.435 -173.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 210' ' ' LEU . . . . . . . . . . . . . 94.2 mt 73.94 -49.82 0.68 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.53 0.732 . . . . 0.0 112.224 176.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 97.2 mt 65.76 -178.41 0.19 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 122.833 0.453 . . . . 0.0 110.8 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -86.04 -59.84 2.18 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 213' ' ' THR . . . . . 0.48 HG21 HG22 ' B' ' 214' ' ' VAL . 2.5 m 66.59 -80.1 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.445 177.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 214' ' ' VAL . . . . . 0.48 HG22 HG21 ' B' ' 213' ' ' THR . 45.3 t -129.84 -22.68 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.032 0.444 . . . . 0.0 110.244 -177.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . 60.85 -176.64 0.11 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.085 -175.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 72.5 m -158.42 146.26 18.24 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.359 -0.238 . . . . 0.0 110.359 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 217' ' ' PHE . . . . . 0.572 ' CE2' ' HA ' ' A' ' 66' ' ' ALA . 19.3 m-85 -58.65 150.98 21.85 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 123.626 0.579 . . . . 0.0 110.463 177.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 218' ' ' SER . . . . . . . . . . . . . 15.8 m -116.64 9.97 14.26 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.252 -178.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 31.6 m 74.08 -59.03 0.57 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.64 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 43.5 tp -155.1 99.78 2.12 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 174.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . 0.493 ' HA ' ' CD ' ' A' ' 23' ' ' GLU . . . -155.73 83.87 1.03 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.254 -177.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . 0.534 ' HB3' ' HA ' ' A' ' 61' ' ' SER . . . 170.54 91.05 0.0 OUTLIER 'General case' 0 C--O 1.236 0.359 0 O-C-N 123.851 0.719 . . . . 0.0 110.523 177.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -170.55 116.65 0.49 Allowed 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 224' ' ' GLN . . . . . 0.774 ' CB ' ' HB3' ' A' ' 24' ' ' GLN . 0.0 OUTLIER 177.31 167.46 0.6 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.449 -1.25 . . . . 0.0 107.96 176.95 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . 0.466 ' H ' ' CD ' ' B' ' 224' ' ' GLN . 27.9 m -121.54 147.17 25.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.3 0.571 . . . . 0.0 111.508 -177.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 84.1 p -105.89 -157.47 0.61 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.487 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . 0.489 ' C ' ' HD3' ' B' ' 227' ' ' LYS . 12.1 tmtt? -67.07 -40.8 87.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.753 0.311 . . . . 0.0 110.277 -178.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -59.19 -49.26 78.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.631 -173.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -63.46 -39.42 94.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.574 -177.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 77.8 mt -59.25 -56.9 14.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.652 0.263 . . . . 0.0 111.358 -177.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 5.7 p -73.31 -21.59 60.53 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -174.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -98.09 -38.76 9.22 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.429 -0.508 . . . . 0.0 112.198 -176.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . 0.482 ' CD1' ' HD3' ' A' ' 53' ' ' PRO . 57.7 m-85 -99.4 4.64 46.32 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -174.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt 58.63 40.52 23.39 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.302 0.376 . . . . 0.0 110.915 174.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . 0.455 HD12 HG22 ' B' ' 225' ' ' VAL . 84.7 mt -55.44 150.5 11.64 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.278 0.561 . . . . 0.0 112.456 -173.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 22.1 t -94.08 110.31 23.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.838 -176.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -83.29 114.99 21.77 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 177.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -86.06 -28.93 6.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.457 -178.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 178.44 -170.17 42.11 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.423 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 240' ' ' THR . . . . . 0.415 ' HG1' ' HB1' ' A' ' 9' ' ' ALA . 7.5 m -133.71 140.46 47.03 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 28.1 pt -124.1 148.06 28.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.941 0.401 . . . . 0.0 110.416 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 242' ' ' ASN . . . . . 0.628 HD22 ' HA ' ' A' ' 11' ' ' LEU . 6.1 p30 -134.74 142.36 46.73 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.477 0.656 . . . . 0.0 111.533 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 243' ' ' VAL . . . . . 0.627 HG11 ' NE2' ' B' ' 245' ' ' GLN . 67.9 t -106.66 123.64 61.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.695 -178.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 10.6 t -143.05 69.6 1.31 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 176.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 245' ' ' GLN . . . . . 0.627 ' NE2' HG11 ' B' ' 243' ' ' VAL . 1.3 mp0 -109.42 153.43 24.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.97 -174.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 57.8 m -83.06 43.32 0.86 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.49 -174.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . 0.445 ' C ' ' H ' ' B' ' 249' ' ' GLN . . . 78.47 -41.25 2.06 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.922 -0.656 . . . . 0.0 113.731 174.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -73.57 27.63 0.88 Allowed Glycine 0 CA--C 1.519 0.34 0 CA-C-N 116.888 0.344 . . . . 0.0 113.652 -176.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . 0.52 ' HG3' ' HG2' ' B' ' 245' ' ' GLN . 23.8 mm-40 -130.85 -3.62 4.07 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 176.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 44.9 mm -133.71 132.3 56.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.337 -179.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 23.2 m -133.45 -58.26 0.88 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.24 -177.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 252' ' ' SER . . . . . 0.535 ' HB3' ' HD2' ' B' ' 253' ' ' PRO . 7.2 m -113.72 168.87 7.18 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . 0.535 ' HD2' ' HB3' ' B' ' 252' ' ' SER . 11.6 Cg_endo -57.1 -24.47 58.5 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.293 1.996 . . . . 0.0 112.213 175.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 254' ' ' SER . . . . . 0.545 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 1.5 p -70.2 -37.12 75.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.139 176.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -61.93 -37.43 84.66 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.792 0.329 . . . . 0.0 110.895 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 51.9 tp -59.02 -42.01 89.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.52 177.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 257' ' ' ARG . . . . . 0.56 ' C ' ' HD2' ' B' ' 257' ' ' ARG . 3.9 tmm_? -64.13 -47.07 81.39 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.859 177.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 258' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' B' ' 254' ' ' SER . 28.8 mm-40 -54.02 -48.85 70.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.349 -176.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -70.17 -35.25 73.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.732 0.301 . . . . 0.0 111.24 -177.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 81.9 mt -72.66 -40.5 66.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.178 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 17.0 t -68.54 -31.97 71.58 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 177.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -57.36 -51.65 68.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.242 175.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 263' ' ' LEU . . . . . 0.568 HD22 HG23 ' A' ' 13' ' ' THR . 74.5 mt -71.17 -41.18 70.71 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.958 -179.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -63.52 -44.39 94.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.721 -177.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -66.31 -34.21 77.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.896 0.379 . . . . 0.0 110.48 -178.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -68.94 -20.09 64.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.285 0.565 . . . . 0.0 110.821 176.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 4.8 mmpm? -94.81 -2.41 50.93 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.664 176.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 77.35 16.06 80.84 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.168 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . 0.553 ' HA3' ' CG1' ' B' ' 290' ' ' VAL . . . -93.85 148.99 19.24 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.017 -178.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -110.73 3.42 19.15 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.247 0.546 . . . . 0.0 110.073 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 271' ' ' TYR . . . . . 0.696 ' HD1' ' HA ' ' B' ' 224' ' ' GLN . 9.2 m-85 -147.75 141.45 25.61 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 -177.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 272' ' ' TYR . . . . . 0.451 ' CE2' HD13 ' B' ' 274' ' ' ILE . 34.2 p90 -126.66 111.11 13.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.472 0.654 . . . . 0.0 110.06 178.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -92.1 101.75 14.28 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.171 -174.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 274' ' ' ILE . . . . . 0.451 HD13 ' CE2' ' B' ' 272' ' ' TYR . 4.6 mp -72.35 131.59 34.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.82 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 275' ' ' ILE . . . . . 0.603 HD13 ' HA ' ' A' ' 6' ' ' ILE . 28.4 pt -117.64 -28.45 2.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.727 0.299 . . . . 0.0 111.511 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -156.97 137.84 13.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.832 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -155.51 120.81 4.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.506 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 278' ' ' ARG . . . . . 0.468 ' HE ' ' HB3' ' B' ' 278' ' ' ARG . 0.0 OUTLIER -145.04 155.02 43.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.0 0.428 . . . . 0.0 110.942 -178.853 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -79.19 134.87 36.68 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.208 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -122.01 72.68 1.05 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.001 0.429 . . . . 0.0 110.059 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 64.11 -120.38 19.54 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.659 -177.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.11 -2.3 12.27 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.737 2.292 . . . . 0.0 112.259 176.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -114.41 166.08 12.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.28 -177.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -129.39 122.28 29.12 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.936 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 285' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -105.28 119.7 39.72 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.32 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 286' ' ' ALA . . . . . 0.525 ' HB1' ' HB ' ' B' ' 243' ' ' VAL . . . -136.68 146.83 46.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.692 0.282 . . . . 0.0 111.154 177.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 37.0 t -128.79 128.86 68.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 177.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -137.27 144.92 42.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.004 0.43 . . . . 0.0 110.988 -179.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 289' ' ' GLU . . . . . 0.41 ' HB2' ' HE1' ' B' ' 291' ' ' TYR . 25.5 mt-10 -96.1 150.09 20.89 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.891 178.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 290' ' ' VAL . . . . . 0.553 ' CG1' ' HA3' ' B' ' 269' ' ' GLY . 12.8 t -111.93 123.97 68.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 291' ' ' TYR . . . . . 0.41 ' HE1' ' HB2' ' B' ' 289' ' ' GLU . 65.9 m-85 -124.29 151.69 43.94 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.229 0.538 . . . . 0.0 111.618 -177.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 292' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -117.65 161.4 19.72 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.105 170.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.56 136.97 49.76 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.439 0.462 . . . . 0.0 111.551 175.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 294' ' ' ALA . . . . . . . . . . . . . . . -99.79 98.11 8.95 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.422 177.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 295' ' ' THR . . . . . . . . . . . . . 71.7 m 69.59 119.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.225 -177.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -77.24 104.8 7.95 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.039 -177.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 297' ' ' LEU . . . . . 0.533 ' HA ' ' HB2' ' A' ' 52' ' ' SER . 0.7 OUTLIER 34.03 98.8 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 O-C-N 124.779 1.299 . . . . 0.0 113.747 174.466 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 298' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -55.65 156.73 4.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.459 0.647 . . . . 0.0 112.234 -179.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 299' ' ' HIS . . . . . . . . . . . . . 58.0 m80 -127.05 16.24 7.3 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.378 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 300' ' ' HIS . . . . . . . . . . . . . 14.3 m80 -61.68 100.08 0.14 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.743 176.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 301' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -80.37 100.32 8.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.098 -176.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 302' ' ' HIS . . . . . 0.44 ' C ' ' H ' ' B' ' 304' ' ' HIS . 48.8 m-70 -105.25 168.58 8.98 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.672 -177.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 55.8 t60 71.66 -8.05 1.14 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.568 0.747 . . . . 0.0 111.283 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 304' ' ' HIS . . . . . 0.44 ' H ' ' C ' ' B' ' 302' ' ' HIS . 50.6 t-80 . . . . . 0 C--N 1.325 -0.467 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.542 ' O ' ' HB3' ' B' ' 261' ' ' SER . . . . . . . . 0 N--CA 1.465 0.282 0 CA-C-O 121.134 0.492 . . . . 0.0 110.823 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.458 ' CD ' ' HD3' ' B' ' 257' ' ' ARG . 2.2 tp10 -147.0 -138.88 0.09 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -176.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.721 ' HB2' ' H ' ' B' ' 223' ' ' GLU . 1.4 tm0? 72.73 156.73 0.17 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 122.6 0.36 . . . . 0.0 111.64 176.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.3 m -114.5 147.72 17.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 121.055 0.455 . . . . 0.0 110.905 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.411 ' O ' HG13 ' A' ' 30' ' ' ILE . 19.9 t -100.29 -166.79 1.36 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.28 0.562 . . . . 0.0 111.017 -177.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -66.5 -44.1 83.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.535 -173.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.641 ' HG2' ' OE1' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -63.59 -44.72 93.19 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.891 -173.736 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.641 ' OE1' ' HG2' ' A' ' 28' ' ' GLN . 2.3 mp0 -62.98 -40.95 99.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.619 0.247 . . . . 0.0 110.846 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 26' ' ' SER . 97.4 mt -59.01 -49.9 81.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.841 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.3 t -73.43 -24.85 60.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.362 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.452 ' HB2' ' O ' ' A' ' 28' ' ' GLN . 33.7 t-80 -85.92 -57.81 2.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.686 0.279 . . . . 0.0 111.287 -174.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -81.77 -10.74 59.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.193 -175.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt 59.54 76.43 0.36 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.338 0.59 . . . . 0.0 110.113 -175.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.405 HD12 HG12 ' A' ' 30' ' ' ILE . 95.1 mt -82.39 159.39 23.01 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.892 -176.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.1 t -81.88 111.71 18.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.081 -176.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.552 ' HD3' ' CE2' ' A' ' 91' ' ' TYR . 15.0 tptm -71.5 111.19 6.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.67 175.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.421 HG23 ' HB ' ' A' ' 90' ' ' VAL . 3.2 m -104.66 6.95 10.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.871 0.367 . . . . 0.0 111.667 -176.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 133.37 -168.44 23.08 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.549 175.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 47.7 m -136.54 132.93 35.88 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.4 pt -111.43 134.22 54.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.257 0.551 . . . . 0.0 110.861 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -114.62 121.05 42.22 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.565 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.619 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 24.3 t -93.35 107.51 19.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.8 t -110.62 110.54 21.28 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.549 -176.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.524 ' HG2' HG12 ' A' ' 50' ' ' ILE . 1.7 tp60 -116.79 152.63 33.99 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.236 -176.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.8 t -126.03 124.79 41.46 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.875 -0.416 . . . . 0.0 109.875 175.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.33 -145.92 25.79 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.456 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.84 52.53 0.72 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.877 -175.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.464 ' HB2' ' CG ' ' A' ' 45' ' ' GLN . 14.5 mm100 -71.96 -41.79 67.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.298 0.571 . . . . 0.0 109.619 175.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.566 HG23 ' HB2' ' A' ' 55' ' ' ASP . 49.3 mm -97.93 125.4 51.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.73 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.1 m -103.26 -39.74 6.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.199 -176.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.423 ' HB2' ' HD2' ' A' ' 53' ' ' PRO . 51.4 p -131.87 162.56 55.72 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.462 -176.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.423 ' HD2' ' HB2' ' A' ' 52' ' ' SER . 17.0 Cg_endo -57.49 -27.02 74.53 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.633 2.222 . . . . 0.0 111.44 176.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.594 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 2.5 m -59.08 -45.92 89.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.545 177.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.566 ' HB2' HG23 ' A' ' 50' ' ' ILE . 36.2 m-20 -64.85 -35.84 82.43 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.561 -178.229 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 67.2 tp -61.46 -47.2 86.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.847 175.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -58.08 -41.12 82.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.068 177.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.594 ' HG2' ' O ' ' A' ' 54' ' ' SER . 14.1 mm-40 -55.6 -50.47 70.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.281 0.562 . . . . 0.0 110.68 177.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.41 ' HA ' ' HD3' ' A' ' 59' ' ' LYS . 73.2 mmtt -69.71 -35.14 74.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.323 -177.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.2 mt -62.58 -44.32 96.61 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.54 176.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.7 t -66.6 -39.83 88.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.068 0.461 . . . . 0.0 110.237 177.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -57.03 -48.72 77.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.905 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 87.4 mt -71.83 -40.49 69.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.618 -176.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.62 -38.11 89.89 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -176.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -59.56 -42.71 93.05 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.271 0.558 . . . . 0.0 110.336 178.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.73 -7.78 58.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.425 -177.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.431 ' HD3' ' HA ' ' A' ' 67' ' ' LYS . 30.2 mmtm -97.38 -19.98 18.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.788 0.328 . . . . 0.0 111.408 178.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.79 34.47 9.06 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.335 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.468 ' HA3' HG12 ' A' ' 90' ' ' VAL . . . -129.32 138.49 10.28 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 177.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.426 ' O ' ' HB2' ' B' ' 222' ' ' ALA . 87.9 mttt -85.01 -28.99 25.35 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.74 0.27 . . . . 0.0 111.463 -174.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -129.56 141.3 51.0 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -176.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.611 ' CD2' ' HB1' ' B' ' 222' ' ' ALA . 13.8 p90 -105.07 168.0 9.34 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 171.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.404 ' CD2' ' HA ' ' A' ' 26' ' ' SER . 9.7 t-80 -138.94 105.84 5.41 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.907 172.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 33.5 mt -69.96 124.5 26.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.238 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 31.4 pt -110.94 -17.59 8.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.989 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -171.89 101.22 0.18 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.509 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.58 ' HA ' ' HA ' ' A' ' 86' ' ' ALA . . . -107.69 101.64 10.93 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 171.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -136.96 167.1 22.13 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.104 0.478 . . . . 0.0 111.373 -172.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -90.37 145.58 24.84 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.821 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -129.35 80.53 1.97 Allowed 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 173.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.5 -117.73 9.2 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.827 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -83.12 -2.2 10.64 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.812 2.341 . . . . 0.0 112.045 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -112.42 165.04 12.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.989 -177.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -125.89 121.92 34.57 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.046 175.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -117.23 111.01 18.83 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.866 0.365 . . . . 0.0 110.579 -176.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.619 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -110.59 116.32 31.15 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.08 0.467 . . . . 0.0 110.495 176.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.6 t -102.39 118.17 48.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.311 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -135.94 136.65 40.6 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.592 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.55 ' HB3' ' HE3' ' A' ' 37' ' ' LYS . 40.9 mt-10 -91.83 149.87 21.36 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.468 HG12 ' HA3' ' A' ' 69' ' ' GLY . 5.6 t -107.48 132.72 54.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.35 -177.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.552 ' CE2' ' HD3' ' A' ' 37' ' ' LYS . 95.8 m-85 -133.21 146.3 51.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.162 0.506 . . . . 0.0 111.196 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -123.31 160.47 26.62 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.402 176.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 . . . . . 0 C--O 1.237 0.442 0 CA-C-O 120.673 0.273 . . . . 0.0 110.814 -177.698 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 222' ' ' ALA . . . . . 0.611 ' HB1' ' CD2' ' A' ' 72' ' ' TYR . . . . . . . . 0 CA--C 1.517 -0.314 0 N-CA-C 110.585 -0.154 . . . . 0.0 110.585 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 223' ' ' GLU . . . . . 0.721 ' H ' ' HB2' ' A' ' 24' ' ' GLN . 40.5 tt0 -172.88 101.83 0.13 Allowed 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -176.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 224' ' ' GLN . . . . . 0.602 ' HA ' ' HD1' ' B' ' 271' ' ' TYR . 1.5 tm0? -174.04 158.71 3.15 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 122.919 0.488 . . . . 0.0 109.807 175.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 225' ' ' VAL . . . . . 0.484 HG21 ' CD1' ' B' ' 235' ' ' LEU . 24.1 m -117.03 146.11 21.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 120.543 0.211 . . . . 0.0 110.672 178.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 78.1 p -91.49 -166.8 1.65 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.952 0.406 . . . . 0.0 110.67 -177.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -67.13 -29.17 68.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.173 -176.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -73.02 -50.87 20.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.072 -174.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 229' ' ' GLU . . . . . 0.413 ' HB2' ' HB ' ' B' ' 225' ' ' VAL . 2.2 mp0 -59.8 -39.11 83.89 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.048 -177.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 87.8 mt -60.4 -49.22 85.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.781 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 15.2 m -72.82 -32.2 65.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.093 -177.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -78.76 -55.18 5.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.455 -175.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -83.23 -23.44 32.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.562 -174.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm 64.34 80.81 0.22 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.424 0.631 . . . . 0.0 110.308 -176.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 235' ' ' LEU . . . . . 0.484 ' CD1' HG21 ' B' ' 225' ' ' VAL . 63.1 mt -83.79 -178.41 7.0 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.108 -175.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 44.5 t -100.12 109.71 25.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.11 178.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 52.6 tttm -82.0 114.01 20.28 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 238' ' ' VAL . . . . . 0.519 HG23 ' HB ' ' B' ' 290' ' ' VAL . 14.5 m -104.36 7.57 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -170.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 131.34 -153.38 20.37 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 119.934 -1.127 . . . . 0.0 113.499 175.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 240' ' ' THR . . . . . 0.469 HG23 ' HG2' ' B' ' 289' ' ' GLU . 6.9 m -137.95 141.43 40.54 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 122.205 0.202 . . . . 0.0 110.846 -175.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 37.4 pt -127.67 148.65 32.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 171.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -144.54 141.0 29.18 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.559 0.695 . . . . 0.0 111.717 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 243' ' ' VAL . . . . . 0.613 ' O ' ' HA ' ' B' ' 285' ' ' GLU . 61.3 t -92.99 129.54 43.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.284 176.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 5.8 t -153.07 74.99 1.06 Allowed 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 245' ' ' GLN . . . . . 0.569 ' HB3' ' HG3' ' B' ' 249' ' ' GLN . 0.8 OUTLIER -116.7 168.36 10.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.646 -177.803 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 246' ' ' SER . . . . . 0.428 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 21.0 p -83.77 101.12 11.37 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.727 -177.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 42.62 -92.04 0.01 OUTLIER Glycine 0 N--CA 1.463 0.48 0 N-CA-C 115.817 1.087 . . . . 0.0 115.817 167.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -71.71 10.92 3.66 Favored Glycine 0 CA--C 1.519 0.329 0 N-CA-C 114.809 0.683 . . . . 0.0 114.809 -168.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 249' ' ' GLN . . . . . 0.569 ' HG3' ' HB3' ' B' ' 245' ' ' GLN . 74.9 mm-40 -73.24 -21.1 60.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.664 0.732 . . . . 0.0 110.012 175.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 250' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' B' ' 256' ' ' LEU . 46.9 mm -114.89 103.08 14.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.49 178.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 41.2 t -88.97 -16.9 30.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.653 0.264 . . . . 0.0 111.416 -177.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 252' ' ' SER . . . . . 0.554 ' HB2' ' HD2' ' B' ' 253' ' ' PRO . 89.4 p -163.92 165.78 13.07 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -178.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 253' ' ' PRO . . . . . 0.554 ' HD2' ' HB2' ' B' ' 252' ' ' SER . 9.4 Cg_endo -52.56 -32.0 51.79 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.821 2.347 . . . . 0.0 112.243 176.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 254' ' ' SER . . . . . 0.492 ' O ' ' HG3' ' B' ' 258' ' ' GLU . 5.1 m -59.28 -47.43 85.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.35 177.092 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 255' ' ' ASP . . . . . 0.406 ' O ' ' HG2' ' B' ' 259' ' ' LYS . 0.9 OUTLIER -55.07 -43.71 74.15 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.879 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.403 ' HA ' HD12 ' B' ' 250' ' ' ILE . 57.4 tp -57.7 -56.17 25.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.426 -175.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 257' ' ' ARG . . . . . 0.542 ' HA ' HD12 ' B' ' 260' ' ' LEU . 6.3 ppt_? -66.69 -31.18 71.68 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.34 -176.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 258' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' B' ' 254' ' ' SER . 44.2 mt-10 -63.14 -26.78 68.98 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.868 0.366 . . . . 0.0 111.03 177.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 259' ' ' LYS . . . . . 0.425 ' O ' ' HG ' ' B' ' 263' ' ' LEU . 66.1 mmtt -88.28 -22.91 23.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.93 0.395 . . . . 0.0 110.52 177.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 260' ' ' LEU . . . . . 0.542 HD12 ' HA ' ' B' ' 257' ' ' ARG . 89.2 mt -74.13 -48.42 29.57 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.501 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 261' ' ' SER . . . . . 0.542 ' HB3' ' O ' ' A' ' 22' ' ' ALA . 2.7 p -65.78 -30.99 71.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.862 0.363 . . . . 0.0 110.542 176.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -56.48 -45.4 80.96 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.053 175.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 263' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' B' ' 259' ' ' LYS . 84.1 mt -74.74 -34.52 62.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.843 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -64.31 -38.7 91.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.214 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -62.95 -43.86 97.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.694 177.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -64.01 -34.38 77.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.635 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 12.8 mmtt -73.03 -46.94 49.03 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.852 177.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 99.23 32.8 5.67 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -176.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -104.48 171.99 19.89 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.568 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -111.83 -24.86 9.76 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.851 0.358 . . . . 0.0 111.423 -177.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 271' ' ' TYR . . . . . 0.602 ' HD1' ' HA ' ' B' ' 224' ' ' GLN . 24.0 m-85 -144.01 160.52 40.72 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 272' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -137.55 129.17 28.41 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.047 0.451 . . . . 0.0 110.068 173.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -98.46 102.59 14.38 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.914 -177.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 274' ' ' ILE . . . . . 0.514 HG12 ' HB2' ' B' ' 288' ' ' ALA . 57.0 mt -67.25 129.74 32.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.821 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 19.0 pt -116.97 -26.84 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.807 -176.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -144.49 139.95 28.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.157 -177.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -154.79 117.5 4.34 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.222 177.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 278' ' ' ARG . . . . . 0.421 ' HD3' ' HB2' ' B' ' 285' ' ' GLU . 0.0 OUTLIER -154.91 156.77 36.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.928 0.394 . . . . 0.0 110.78 -177.789 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -88.8 117.43 27.79 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 167.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -92.77 14.48 17.15 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.492 0.663 . . . . 0.0 109.976 -175.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 129.93 -119.96 2.98 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 -175.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.93 -13.3 15.92 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.445 2.097 . . . . 0.0 111.765 173.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -106.82 142.96 35.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.665 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -104.1 130.8 51.82 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 285' ' ' GLU . . . . . 0.613 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 52.1 mt-10 -118.96 122.06 41.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.278 -176.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 286' ' ' ALA . . . . . 0.484 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -132.67 116.25 16.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.167 174.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 40.4 t -109.02 127.53 65.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.81 0.338 . . . . 0.0 111.067 -174.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 288' ' ' ALA . . . . . 0.514 ' HB2' HG12 ' B' ' 274' ' ' ILE . . . -139.25 133.53 31.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.957 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 289' ' ' GLU . . . . . 0.469 ' HG2' HG23 ' B' ' 240' ' ' THR . 31.9 mt-10 -93.06 135.39 34.28 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 290' ' ' VAL . . . . . 0.519 ' HB ' HG23 ' B' ' 238' ' ' VAL . 3.8 t -92.96 138.87 19.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.037 0.446 . . . . 0.0 111.27 -168.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -130.02 149.38 51.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.478 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 292' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -114.68 159.78 20.11 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 171.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 . . . . . 0 N--CA 1.474 0.747 0 CA-C-O 121.492 0.663 . . . . 0.0 112.116 -174.609 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.641 ' HB1' ' CD2' ' B' ' 272' ' ' TYR . . . . . . . . 0 C--O 1.234 0.268 0 CA-C-O 120.9 0.381 . . . . 0.0 111.942 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.933 ' HB3' ' HE1' ' A' ' 71' ' ' TYR . 26.8 mt-10 -149.28 105.28 3.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.683 -179.358 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.57 ' HB2' ' HB2' ' B' ' 224' ' ' GLN . 1.5 tt0 -162.3 156.1 21.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.262 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.0 m -101.69 128.32 54.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.037 0.446 . . . . 0.0 110.887 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.537 ' O ' HG13 ' A' ' 30' ' ' ILE . 1.5 m -64.99 151.33 46.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.877 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.446 ' HA ' HD12 ' A' ' 30' ' ' ILE . 88.7 tttt -57.85 -40.52 80.31 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.128 0.489 . . . . 0.0 109.724 176.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -61.14 -39.06 88.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.408 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.581 ' HA ' ' HB3' ' A' ' 32' ' ' HIS . 20.6 mm-40 -76.94 -26.98 54.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.503 -177.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.537 HG13 ' O ' ' A' ' 26' ' ' SER . 86.0 mt -60.88 -45.07 98.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 173.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.4 m -73.42 -31.83 64.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.879 175.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.581 ' HB3' ' HA ' ' A' ' 29' ' ' GLU . 23.7 t-160 -65.82 -54.86 21.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.286 -177.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -92.67 -8.74 43.16 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.376 -177.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm 59.31 70.56 0.64 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.452 0.644 . . . . 0.0 110.592 -178.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 94.1 mt -76.31 163.0 27.44 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.306 -176.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 85.1 t -93.37 126.42 45.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.271 -177.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.546 ' HE3' ' HB3' ' A' ' 89' ' ' GLU . 21.7 tptm -70.12 116.76 10.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.651 175.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.41 HG11 HD22 ' A' ' 92' ' ' ASN . 4.2 m -122.84 26.0 3.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -174.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.12 -175.36 16.94 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.109 -1.043 . . . . 0.0 113.252 174.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 61.7 m -135.29 129.55 33.72 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 30.5 pt -104.48 138.62 28.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 175.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -135.02 122.23 21.54 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.197 0.522 . . . . 0.0 111.092 -173.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 59.0 t -93.45 121.69 44.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.062 176.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.2 t -141.23 30.79 1.76 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.752 0.786 . . . . 0.0 109.134 -177.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -91.24 160.55 15.47 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.773 -175.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.2 t -64.06 157.84 24.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.075 176.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.06 -20.14 33.5 Favored Glycine 0 C--O 1.228 -0.271 0 CA-C-N 116.039 -0.528 . . . . 0.0 113.314 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.26 -20.64 75.28 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.884 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -101.46 -2.04 31.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.893 0.377 . . . . 0.0 110.88 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.1 mm -130.8 75.23 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 171.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.0 t -96.46 -14.01 22.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.875 -168.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.1 m -155.43 160.0 31.22 Favored Pre-proline 0 C--N 1.322 -0.598 0 O-C-N 122.365 -0.209 . . . . 0.0 110.784 -176.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.5 -36.26 86.98 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.589 2.193 . . . . 0.0 111.623 175.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.573 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 0.1 OUTLIER -63.27 -44.36 95.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.648 0.737 . . . . 0.0 109.698 174.071 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -64.38 -27.74 69.21 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.136 -177.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.6 tp -61.59 -52.68 63.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.683 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -65.79 -28.13 68.79 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.432 -176.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.573 ' HG2' ' O ' ' A' ' 54' ' ' SER . 38.8 mm-40 -62.6 -34.62 77.38 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.974 0.416 . . . . 0.0 110.223 -178.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -83.25 -38.33 22.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.764 176.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.3 mt -61.78 -48.48 80.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.255 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.2 p -64.52 -36.4 84.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.021 0.439 . . . . 0.0 110.473 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -64.29 -40.38 95.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.193 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 86.2 mt -69.54 -44.79 70.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.9 177.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.61 -37.33 83.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.99 0.424 . . . . 0.0 110.652 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -66.68 -37.78 85.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.808 177.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.9 -34.96 78.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.772 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -80.65 -45.03 17.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.177 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 118.24 41.88 0.62 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.534 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.512 ' HA3' ' CG1' ' A' ' 90' ' ' VAL . . . -124.38 151.68 17.26 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.413 -0.899 . . . . 0.0 113.043 -177.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -81.04 -43.58 19.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.834 0.35 . . . . 0.0 110.44 176.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.933 ' HE1' ' HB3' ' A' ' 23' ' ' GLU . 78.9 m-85 -137.96 175.61 9.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.264 -174.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.442 ' HD2' ' CB ' ' A' ' 88' ' ' ALA . 0.6 OUTLIER -149.85 168.25 24.28 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -177.13 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -135.05 126.1 27.79 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.49 -0.484 . . . . 0.0 109.812 172.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.534 ' H ' HD12 ' A' ' 74' ' ' ILE . 5.0 mp -72.77 123.37 27.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.017 -178.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 33.1 pt -104.88 -31.13 2.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.386 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.479 ' HB1' ' NH1' ' A' ' 78' ' ' ARG . . . -161.82 117.9 2.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.025 -177.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -131.92 122.28 25.37 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.385 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.479 ' NH1' ' HB1' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -156.46 142.24 17.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.044 0.449 . . . . 0.0 110.888 -178.983 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -72.07 145.62 48.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.905 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -139.6 100.38 3.95 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 61.97 -123.87 32.57 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.991 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -88.29 6.6 4.8 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.994 2.463 . . . . 0.0 112.569 178.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -119.76 158.92 25.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.046 0.45 . . . . 0.0 111.123 -176.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -113.57 111.65 22.23 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.564 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.559 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 25.9 mm-40 -96.26 111.45 23.51 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.612 -176.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.534 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -124.99 115.17 20.13 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.754 177.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.2 t -105.64 124.86 60.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.499 -178.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.442 ' CB ' ' HD2' ' A' ' 72' ' ' TYR . . . -141.0 149.2 41.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.2 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.546 ' HB3' ' HE3' ' A' ' 37' ' ' LYS . 7.4 mt-10 -108.67 143.61 37.54 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.263 -178.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.512 ' CG1' ' HA3' ' A' ' 69' ' ' GLY . 11.4 t -95.04 137.57 23.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.642 -172.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -133.71 136.98 45.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.894 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.41 HD22 HG11 ' A' ' 38' ' ' VAL . 74.5 m-20 -122.42 172.78 8.09 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.578 176.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.673 177.301 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 222' ' ' ALA . . . . . 0.416 ' HB1' ' CD1' ' A' ' 72' ' ' TYR . . . . . . . . 0 N--CA 1.463 0.222 0 CA-C-O 121.237 0.542 . . . . 0.0 111.588 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -161.12 125.5 3.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.839 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 224' ' ' GLN . . . . . 0.57 ' HB2' ' HB2' ' A' ' 24' ' ' GLN . 1.2 tt0 -159.3 167.97 27.59 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.782 176.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 225' ' ' VAL . . . . . 0.44 HG11 HD11 ' B' ' 235' ' ' LEU . 6.8 m -135.18 123.63 39.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.984 0.421 . . . . 0.0 110.353 174.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 226' ' ' SER . . . . . 0.409 ' O ' HG13 ' B' ' 230' ' ' ILE . 9.3 t -105.72 -171.72 1.96 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.581 178.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 227' ' ' LYS . . . . . 0.426 ' HE2' ' CA ' ' B' ' 227' ' ' LYS . 0.0 OUTLIER -55.33 -33.83 63.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.769 -175.092 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -70.74 -49.65 44.56 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.264 0.554 . . . . 0.0 110.365 -176.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 229' ' ' GLU . . . . . 0.401 ' O ' ' HD1' ' B' ' 233' ' ' PHE . 1.8 mp0 -72.13 -48.44 43.66 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.459 -176.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.531 HG12 HD12 ' B' ' 235' ' ' LEU . 89.9 mt -54.54 -49.68 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 -174.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 59.1 m -72.56 -21.17 61.2 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -176.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -89.12 -35.92 16.01 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.893 -177.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 233' ' ' PHE . . . . . 0.401 ' HD1' ' O ' ' B' ' 229' ' ' GLU . 81.7 m-85 -89.9 -15.02 32.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.377 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 234' ' ' LYS . . . . . 0.434 ' HB3' ' HE3' ' B' ' 234' ' ' LYS . 25.9 mmmt 59.79 77.55 0.31 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.225 0.536 . . . . 0.0 111.545 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 235' ' ' LEU . . . . . 0.531 HD12 HG12 ' B' ' 230' ' ' ILE . 94.4 mt -88.21 163.46 16.13 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.389 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 47.4 t -96.28 118.36 42.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.82 178.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -91.29 111.97 23.69 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 238' ' ' VAL . . . . . 0.434 HG23 ' HB ' ' B' ' 290' ' ' VAL . 2.6 m -90.28 -25.01 5.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -176.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 161.8 -156.29 27.78 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.046 -1.073 . . . . 0.0 112.863 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 87.4 m -139.7 131.45 27.43 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 122.476 0.311 . . . . 0.0 110.353 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 22.3 pt -103.98 143.11 16.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.008 0.432 . . . . 0.0 110.13 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -116.02 128.76 55.97 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.881 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 243' ' ' VAL . . . . . 0.587 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 58.0 t -96.8 124.31 49.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.613 177.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 23.2 t -153.35 88.77 1.31 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.895 0.379 . . . . 0.0 110.138 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 245' ' ' GLN . . . . . . . . . . . . . 11.2 mp0 -142.4 157.65 44.55 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 246' ' ' SER . . . . . 0.58 ' HA ' ' HA ' ' B' ' 283' ' ' ASN . 25.8 t -62.48 153.18 32.38 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.694 0.283 . . . . 0.0 110.385 177.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -60.51 -17.54 48.31 Favored Glycine 0 C--N 1.332 0.353 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.807 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.04 -23.33 69.5 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.362 176.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -88.98 -47.65 7.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.098 0.475 . . . . 0.0 110.547 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 44.9 mm -107.55 100.42 10.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.968 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 22.3 t -112.11 -11.43 13.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.993 0.425 . . . . 0.0 111.085 -175.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 78.8 p -149.33 163.66 24.23 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.399 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.72 -31.63 94.43 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.476 2.117 . . . . 0.0 111.639 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 254' ' ' SER . . . . . 0.561 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 8.1 t -65.49 -40.12 92.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.106 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -64.48 -38.46 91.11 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.297 0.57 . . . . 0.0 109.978 177.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 48.5 tp -60.24 -44.69 95.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.847 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 257' ' ' ARG . . . . . 0.471 ' HD3' ' OE1' ' A' ' 23' ' ' GLU . 0.3 OUTLIER -66.44 -34.76 78.66 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.787 -0.188 . . . . 0.0 110.712 -177.032 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 258' ' ' GLU . . . . . 0.561 ' HG2' ' O ' ' B' ' 254' ' ' SER . 67.7 mm-40 -59.54 -45.56 91.44 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-O 121.311 0.576 . . . . 0.0 109.604 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 259' ' ' LYS . . . . . 0.481 ' O ' ' HG ' ' B' ' 263' ' ' LEU . 38.8 tptt -72.91 -40.18 65.71 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.834 -178.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 81.1 mt -64.53 -48.73 73.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.346 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 49.4 m -64.56 -29.8 70.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.706 0.289 . . . . 0.0 110.541 178.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -64.34 -51.44 63.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.997 0.427 . . . . 0.0 110.248 174.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 263' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' B' ' 259' ' ' LYS . 86.8 mt -65.45 -36.58 84.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.922 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.53 -39.51 81.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.856 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -62.54 -35.54 79.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.149 0.5 . . . . 0.0 110.626 177.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -76.37 -11.35 59.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.932 -177.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -114.99 -27.04 7.5 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.817 0.341 . . . . 0.0 111.372 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 91.61 64.93 1.15 Allowed Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.5 176.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -137.82 156.94 23.99 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.611 175.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 270' ' ' LYS . . . . . 0.876 ' HD3' ' HB2' ' B' ' 293' ' ' ASP . 10.3 mtpm? -104.39 -12.67 16.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.824 0.312 . . . . 0.0 111.321 -178.052 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 271' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -146.37 159.96 42.69 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 272' ' ' TYR . . . . . 0.641 ' CD2' ' HB1' ' A' ' 22' ' ' ALA . 0.3 OUTLIER -132.37 163.52 28.51 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.165 171.42 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -128.58 101.93 6.38 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 175.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 274' ' ' ILE . . . . . 0.577 HG12 ' HB2' ' B' ' 288' ' ' ALA . 49.6 mt -82.23 118.04 29.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.083 0.468 . . . . 0.0 110.267 -177.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 16.9 pt -103.19 -39.27 5.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.457 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 276' ' ' ALA . . . . . 0.562 ' HB3' ' HB ' ' B' ' 287' ' ' VAL . . . -119.92 143.95 47.7 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.783 0.325 . . . . 0.0 111.417 -175.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -157.98 114.52 2.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.421 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 278' ' ' ARG . . . . . 0.465 ' HG2' ' HB2' ' B' ' 285' ' ' GLU . 0.0 OUTLIER -151.35 150.91 31.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.949 0.404 . . . . 0.0 111.147 -175.639 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -93.4 109.56 21.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.846 176.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 280' ' ' HIS . . . . . 0.431 ' HB2' ' CG ' ' B' ' 285' ' ' GLU . 4.7 t60 -69.26 -22.96 63.8 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 150.15 -110.66 0.48 Allowed Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -69.52 -15.82 38.19 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 122.319 2.013 . . . . 0.0 111.43 171.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 283' ' ' ASN . . . . . 0.58 ' HA ' ' HA ' ' B' ' 246' ' ' SER . 41.1 m-80 -111.85 151.82 28.65 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.464 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -107.88 133.78 51.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.41 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 285' ' ' GLU . . . . . 0.465 ' HB2' ' HG2' ' B' ' 278' ' ' ARG . 50.4 mm-40 -117.67 122.23 42.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.941 -175.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 286' ' ' ALA . . . . . 0.587 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -136.55 145.86 45.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.811 0.339 . . . . 0.0 110.673 177.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 287' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' B' ' 276' ' ' ALA . 59.2 t -126.29 118.06 50.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.445 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 288' ' ' ALA . . . . . 0.577 ' HB2' HG12 ' B' ' 274' ' ' ILE . . . -129.09 136.16 49.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.054 -177.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -91.21 136.83 32.82 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 290' ' ' VAL . . . . . 0.434 ' HB ' HG23 ' B' ' 238' ' ' VAL . 12.7 t -97.91 127.36 50.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.748 0.309 . . . . 0.0 110.411 -176.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -120.75 134.5 55.28 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.265 0.555 . . . . 0.0 110.998 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 292' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -95.33 159.15 15.14 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 176.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 293' ' ' ASP . . . . . 0.876 ' HB2' ' HD3' ' B' ' 270' ' ' LYS . 3.2 t70 . . . . . 0 C--N 1.32 -0.696 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.492 -174.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.29 0 CA-C-O 120.591 0.234 . . . . 0.0 110.603 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.547 ' HB3' ' HG3' ' B' ' 257' ' ' ARG . 6.1 pt-20 -161.4 124.86 3.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.693 0.759 . . . . 0.0 111.796 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.804 ' HG3' ' HG3' ' B' ' 224' ' ' GLN . 0.9 OUTLIER -141.35 143.5 34.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.769 -173.54 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.562 HG23 ' HB2' ' A' ' 73' ' ' HIS . 3.5 m -103.19 126.84 57.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.364 0.602 . . . . 0.0 111.401 176.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.674 ' HB2' ' OE1' ' A' ' 28' ' ' GLN . 1.3 p -92.5 159.12 15.67 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.478 178.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.522 ' HA ' HD12 ' A' ' 30' ' ' ILE . 15.9 ttpp -69.67 -26.19 64.26 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.153 0.502 . . . . 0.0 109.688 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.674 ' OE1' ' HB2' ' A' ' 26' ' ' SER . 19.6 mp0 -59.9 -49.53 77.34 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.078 175.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.612 ' HA ' ' HB3' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -71.23 -25.76 62.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.948 -1.023 . . . . 0.0 112.347 -177.043 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.546 HG12 HD12 ' A' ' 35' ' ' LEU . 72.6 mt -52.93 -55.69 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.778 0.323 . . . . 0.0 110.503 177.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.9 t -73.59 -31.53 63.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.082 0.468 . . . . 0.0 110.564 176.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.612 ' HB3' ' HA ' ' A' ' 29' ' ' GLU . 15.1 t-160 -63.55 -51.37 65.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.901 -173.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -111.38 4.53 19.05 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 121.208 -0.197 . . . . 0.0 111.494 -176.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm 56.64 79.01 0.19 Allowed 'General case' 0 N--CA 1.465 0.29 0 O-C-N 123.696 0.622 . . . . 0.0 110.841 -177.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.546 HD12 HG12 ' A' ' 30' ' ' ILE . 91.0 mt -75.55 152.9 37.68 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.934 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.9 t -92.14 101.1 12.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.452 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.528 ' HE3' ' HB3' ' A' ' 89' ' ' GLU . 22.9 tptm -75.1 113.66 12.69 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.691 178.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.8 m -99.55 -9.37 8.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.134 0.492 . . . . 0.0 111.31 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 142.75 -179.75 20.16 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.432 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 21.3 m -131.09 126.69 36.43 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.1 pt -106.8 160.62 6.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.031 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -141.56 141.6 33.52 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.731 0.777 . . . . 0.0 111.8 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.672 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 53.5 t -94.13 135.33 28.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.943 179.004 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 10.0 t -150.38 86.7 1.42 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.121 0.486 . . . . 0.0 109.972 178.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.83 148.44 42.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.97 178.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.7 t -100.7 124.91 46.97 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.62 -177.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.45 -157.72 22.59 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.272 175.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.27 50.5 4.1 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.344 -0.455 . . . . 0.0 113.755 -172.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -75.42 -38.32 59.89 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 172.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.532 HD12 ' HA ' ' A' ' 56' ' ' LEU . 47.4 mm -105.24 95.03 3.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.541 176.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.3 t -108.58 -36.39 6.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.394 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.431 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 19.8 m -107.46 144.38 29.11 Favored Pre-proline 0 N--CA 1.448 -0.568 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.408 -177.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.641 ' HG3' ' HB3' ' B' ' 233' ' ' PHE . 34.8 Cg_exo -56.99 -39.92 87.86 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.908 2.405 . . . . 0.0 111.707 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.1 t -62.37 -40.54 96.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.834 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -67.31 -34.79 78.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.941 -174.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.532 ' HA ' HD12 ' A' ' 50' ' ' ILE . 58.4 tp -57.89 -55.89 29.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.472 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.481 ' HA ' HD12 ' A' ' 60' ' ' LEU . 7.8 ppt_? -70.84 -24.55 62.55 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.285 -177.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -58.67 -34.82 71.68 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.95 0.405 . . . . 0.0 110.495 171.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -78.51 -36.55 44.76 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.41 175.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.502 HD13 HD11 ' A' ' 74' ' ' ILE . 97.0 mt -62.24 -48.77 78.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.146 -178.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 65' ' ' ASP . 5.4 p -68.68 -42.15 78.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.741 0.305 . . . . 0.0 110.781 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -54.41 -42.83 70.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.988 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 94.2 mt -76.06 -51.06 13.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.883 178.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.47 -45.34 69.25 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -172.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 61' ' ' SER . 0.4 OUTLIER -64.87 -42.63 94.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.113 0.482 . . . . 0.0 110.053 -176.954 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.41 -12.84 60.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.457 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -78.05 -22.99 48.31 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 175.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.72 59.98 0.7 Allowed Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.842 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.474 ' HA2' ' OD1' ' A' ' 92' ' ' ASN . . . -135.56 176.25 20.25 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.851 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -116.69 -30.18 5.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 117.04 0.42 . . . . 0.0 111.331 176.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -142.2 163.72 32.11 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.505 ' CE1' ' HB3' ' B' ' 224' ' ' GLN . 12.1 p90 -136.71 152.45 50.38 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.946 172.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.562 ' HB2' HG23 ' A' ' 25' ' ' VAL . 46.9 t-80 -131.53 108.88 9.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.166 -174.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.555 HD12 ' HB2' ' B' ' 226' ' ' SER . 69.0 mt -79.56 127.59 39.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.829 0.347 . . . . 0.0 110.672 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.4 pt -101.03 -29.37 3.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.49 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -159.84 141.46 12.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.905 0.383 . . . . 0.0 111.299 -177.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -142.95 126.53 16.87 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.49 147.45 34.54 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.373 0.606 . . . . 0.0 112.223 -175.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -93.71 104.81 16.89 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 169.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -87.55 11.45 14.89 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.314 0.578 . . . . 0.0 110.484 -171.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 120.27 -113.42 2.42 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 111.309 -0.717 . . . . 0.0 111.309 -178.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -73.79 -11.19 23.8 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.449 2.1 . . . . 0.0 112.172 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -122.17 140.54 52.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.92 0.391 . . . . 0.0 110.758 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 44' ' ' SER . 84.0 t80 -103.15 130.5 50.35 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 175.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.672 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 63.0 mt-10 -124.57 114.86 19.95 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.278 -175.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -121.18 121.24 37.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.325 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.6 t -105.34 120.46 56.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.659 0.266 . . . . 0.0 110.821 -176.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.552 ' HB2' HG12 ' A' ' 74' ' ' ILE . . . -131.57 137.73 48.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.082 0.468 . . . . 0.0 111.274 -177.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.528 ' HB3' ' HE3' ' A' ' 37' ' ' LYS . 30.4 mt-10 -91.73 145.68 24.38 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.586 177.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 18.3 t -105.25 129.84 57.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -125.38 134.96 51.97 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.496 0.665 . . . . 0.0 112.024 -177.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.474 ' OD1' ' HA2' ' A' ' 69' ' ' GLY . 56.0 m-20 -109.72 179.45 4.12 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.234 169.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 39.9 p30 . . . . . 0 C--N 1.317 -0.821 0 CA-C-O 120.812 0.339 . . . . 0.0 110.191 175.828 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.189 0 CA-C-O 120.235 0.064 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 223' ' ' GLU . . . . . 0.477 ' OE2' ' HD3' ' A' ' 57' ' ' ARG . 4.7 mm-40 -147.34 125.54 12.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.998 0.428 . . . . 0.0 111.282 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 224' ' ' GLN . . . . . 0.804 ' HG3' ' HG3' ' A' ' 24' ' ' GLN . 0.9 OUTLIER -147.38 138.56 23.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.782 -174.431 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 225' ' ' VAL . . . . . 0.437 HG13 ' HB2' ' B' ' 271' ' ' TYR . 12.3 m -94.95 136.03 27.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.226 0.536 . . . . 0.0 110.414 175.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 226' ' ' SER . . . . . 0.555 ' HB2' HD12 ' A' ' 74' ' ' ILE . 28.4 t -82.78 148.01 28.06 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.229 -175.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 227' ' ' LYS . . . . . 0.523 ' HD3' ' O ' ' B' ' 227' ' ' LYS . 12.6 tmtt? -69.57 -36.69 76.54 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -65.16 -36.11 83.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.458 177.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 229' ' ' GLU . . . . . 0.625 ' HA ' ' HB3' ' B' ' 232' ' ' HIS . 0.0 OUTLIER -68.66 -25.63 64.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.649 -178.557 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 73.8 mt -56.15 -53.06 43.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 174.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 46.2 t -73.62 -31.19 63.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.059 177.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 232' ' ' HIS . . . . . 0.625 ' HB3' ' HA ' ' B' ' 229' ' ' GLU . 22.1 t-160 -72.57 -46.82 52.5 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.658 -173.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 233' ' ' PHE . . . . . 0.641 ' HB3' ' HG3' ' A' ' 53' ' ' PRO . 82.5 m-85 -111.49 6.45 20.19 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -175.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm 56.25 51.68 11.31 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.36 0.412 . . . . 0.0 110.587 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 89.9 mt -57.2 140.2 50.37 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.693 -176.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 75.0 t -79.86 117.72 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.635 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -81.41 105.68 12.77 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.806 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 238' ' ' VAL . . . . . 0.454 HG22 ' O ' ' B' ' 290' ' ' VAL . 36.0 m -87.05 -16.11 9.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.799 -0.361 . . . . 0.0 111.792 -175.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 160.98 145.09 4.19 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 119.883 -1.151 . . . . 0.0 113.077 177.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 240' ' ' THR . . . . . 0.58 HG23 ' HG2' ' B' ' 289' ' ' GLU . 24.8 m -97.78 122.32 40.74 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 174.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 24.0 pt -103.58 131.71 51.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.303 0.573 . . . . 0.0 110.849 -177.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -102.27 112.48 25.18 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.628 176.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 243' ' ' VAL . . . . . 0.576 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 87.6 t -95.55 108.92 21.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.199 176.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 244' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' B' ' 284' ' ' PHE . 7.9 t -127.9 94.19 3.87 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.323 0.582 . . . . 0.0 109.632 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 245' ' ' GLN . . . . . 0.555 ' HB2' ' HB3' ' B' ' 284' ' ' PHE . 0.0 OUTLIER -86.28 147.45 26.07 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.396 -177.204 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 22.8 t -101.31 102.48 13.34 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 177.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 94.65 177.25 38.4 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.441 -0.663 . . . . 0.0 111.441 -174.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -79.3 66.28 3.49 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.819 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -76.2 -21.02 56.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.163 0.506 . . . . 0.0 110.879 -177.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 50.0 mm -98.75 122.17 50.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 176.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 1.9 m -109.94 -53.8 2.63 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.287 0.565 . . . . 0.0 110.231 -176.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 16.0 m -114.91 163.08 20.74 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.493 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.6 -29.14 59.26 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.463 2.109 . . . . 0.0 111.979 176.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 254' ' ' SER . . . . . 0.563 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 1.6 p -60.52 -44.09 96.43 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.568 177.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -56.43 -45.33 80.79 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.24 0.543 . . . . 0.0 110.225 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 46.6 tp -68.32 -39.41 81.98 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.55 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 257' ' ' ARG . . . . . 0.547 ' HG3' ' HB3' ' A' ' 23' ' ' GLU . 6.7 ttp85 -60.33 -46.8 88.63 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.759 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 258' ' ' GLU . . . . . 0.563 ' HG2' ' O ' ' B' ' 254' ' ' SER . 33.7 mm-40 -57.99 -42.98 86.28 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.598 -178.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 259' ' ' LYS . . . . . 0.548 ' O ' ' HG ' ' B' ' 263' ' ' LEU . 75.4 mmtt -64.12 -48.25 76.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.446 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 97.6 mt -66.67 -38.75 87.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.414 -176.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 29.5 t -65.35 -38.92 91.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.841 0.353 . . . . 0.0 110.095 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -63.16 -47.11 84.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.254 0.55 . . . . 0.0 110.145 177.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 263' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' B' ' 259' ' ' LYS . 85.1 mt -64.05 -42.62 96.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.967 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -58.9 -48.29 81.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.335 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -62.83 -43.98 97.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.256 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -68.1 -37.79 81.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.925 0.393 . . . . 0.0 111.338 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -78.86 -3.73 46.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.408 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 76.17 48.5 9.56 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.141 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 269' ' ' GLY . . . . . 0.46 ' HA3' HG12 ' B' ' 290' ' ' VAL . . . -128.47 -179.66 16.03 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.681 178.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 270' ' ' LYS . . . . . 0.707 ' HB3' ' HZ3' ' B' ' 270' ' ' LYS . 7.9 mtpm? -115.88 -63.57 1.43 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.723 0.296 . . . . 0.0 110.608 -178.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 271' ' ' TYR . . . . . 0.437 ' HB2' HG13 ' B' ' 225' ' ' VAL . 13.9 m-85 -122.99 174.38 7.22 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 272' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -139.01 166.79 23.57 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.663 -175.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -141.49 125.49 17.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.849 175.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 274' ' ' ILE . . . . . 0.469 ' H ' HE22 ' A' ' 24' ' ' GLN . 84.9 mt -82.75 140.11 16.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.412 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 19.1 pt -125.12 -22.29 2.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -152.66 109.1 3.41 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.738 0.304 . . . . 0.0 110.596 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -132.23 121.17 23.21 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.832 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 278' ' ' ARG . . . . . 0.41 ' HD2' ' N ' ' B' ' 278' ' ' ARG . 0.0 OUTLIER -141.64 130.76 23.35 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.334 0.587 . . . . 0.0 111.256 -178.025 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -75.39 106.24 6.82 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 174.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -80.73 -24.93 38.39 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.458 -172.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 113.12 -89.75 0.53 Allowed Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -70.28 -12.65 32.28 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.42 2.08 . . . . 0.0 111.353 174.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -140.29 170.54 15.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.562 177.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 284' ' ' PHE . . . . . 0.555 ' HB3' ' HB2' ' B' ' 245' ' ' GLN . 72.9 t80 -131.89 119.87 21.77 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.108 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 285' ' ' GLU . . . . . 0.403 ' HB2' ' HD3' ' B' ' 278' ' ' ARG . 11.3 mm-40 -109.45 111.21 22.62 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 123.108 0.255 . . . . 0.0 110.395 -175.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 286' ' ' ALA . . . . . 0.576 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -123.83 117.16 24.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.983 0.42 . . . . 0.0 110.838 174.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 38.3 t -105.21 118.28 52.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.277 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -140.36 150.1 43.53 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.148 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 289' ' ' GLU . . . . . 0.58 ' HG2' HG23 ' B' ' 240' ' ' THR . 32.6 mt-10 -109.85 143.18 40.1 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 177.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 290' ' ' VAL . . . . . 0.46 HG12 ' HA3' ' B' ' 269' ' ' GLY . 17.2 t -102.42 141.09 19.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 291' ' ' TYR . . . . . 0.424 ' CD2' HG21 ' B' ' 225' ' ' VAL . 71.6 m-85 -128.04 149.62 50.3 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.776 0.322 . . . . 0.0 110.346 -178.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 292' ' ' ASN . . . . . 0.446 ' HB2' ' CG1' ' B' ' 238' ' ' VAL . 5.5 t-20 -104.7 24.58 11.56 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.245 0.545 . . . . 0.0 111.163 -176.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 . . . . . 0 C--N 1.317 -0.807 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.31 179.997 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.099 0 CA-C-O 121.021 0.439 . . . . 0.0 111.515 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.543 ' H ' ' HB2' ' B' ' 223' ' ' GLU . 33.7 mt-10 -150.4 99.37 2.77 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.574 -175.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.8 156.21 5.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.649 176.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.483 ' HB ' ' HB2' ' A' ' 29' ' ' GLU . 19.6 m -122.79 143.38 35.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.185 177.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.49 ' O ' HG13 ' A' ' 30' ' ' ILE . 94.9 p -93.78 -167.6 1.72 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.918 0.39 . . . . 0.0 110.738 -176.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -62.18 -38.53 89.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.624 -174.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.536 ' HB2' ' OE2' ' A' ' 29' ' ' GLU . 0.9 OUTLIER -62.17 -49.98 73.66 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.096 0.474 . . . . 0.0 110.601 -176.416 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.536 ' OE2' ' HB2' ' A' ' 28' ' ' GLN . 1.8 mp0 -62.32 -40.86 97.72 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.251 -177.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.557 HG12 HD12 ' A' ' 35' ' ' LEU . 80.8 mt -55.35 -48.28 77.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 121.048 0.452 . . . . 0.0 110.712 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.9 m -73.28 -41.61 63.4 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.749 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 12.6 t60 -76.99 -32.28 57.09 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.79 0.292 . . . . 0.0 111.79 -171.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -101.87 -2.78 29.15 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 121.352 -0.139 . . . . 0.0 111.257 -178.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt 44.68 100.02 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 122.294 1.045 . . . . 0.0 113.76 -171.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.557 HD12 HG12 ' A' ' 30' ' ' ILE . 91.7 mt -104.67 152.82 22.02 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.106 -1.406 . . . . 0.0 111.368 -176.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.1 t -88.09 105.66 15.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.932 -175.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.4 tttp -73.87 118.49 16.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.956 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 26.8 m -100.05 -21.9 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -178.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.58 -171.83 34.23 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.43 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 27.2 m -125.17 139.49 53.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.666 0.269 . . . . 0.0 110.659 -178.025 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.3 pt -114.7 143.88 23.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 175.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -126.18 131.12 52.07 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.105 0.479 . . . . 0.0 111.359 -173.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.686 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 95.9 t -93.89 125.67 46.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.084 173.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -153.16 88.96 1.33 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.863 0.364 . . . . 0.0 110.135 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 13.5 mp0 -138.46 163.45 31.91 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.884 177.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.567 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 4.0 p -66.05 148.92 51.07 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.122 0.487 . . . . 0.0 111.835 -178.126 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.88 114.42 6.03 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.934 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 137.62 -39.38 1.61 Allowed Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 -175.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -70.24 -29.29 66.06 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.465 0.65 . . . . 0.0 109.632 175.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.442 HD11 ' HG3' ' A' ' 59' ' ' LYS . 46.1 mm -118.38 109.19 26.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.728 174.147 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.5 t -116.18 -44.53 2.89 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.041 0.448 . . . . 0.0 110.23 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.2 m -104.06 157.14 34.61 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.073 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.953 ' HG3' HD21 ' B' ' 235' ' ' LEU . 22.1 Cg_endo -61.08 -28.79 86.3 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.411 2.074 . . . . 0.0 110.857 175.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.642 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 0.8 OUTLIER -60.34 -45.29 93.99 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.118 176.12 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.501 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 71.8 m-20 -54.93 -46.88 75.0 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.117 0.484 . . . . 0.0 110.25 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 59.2 tp -57.14 -47.82 80.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.898 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.51 -31.49 68.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.91 -176.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.642 ' HG2' ' O ' ' A' ' 54' ' ' SER . 57.7 mm-40 -63.2 -43.16 98.95 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.982 0.42 . . . . 0.0 110.013 176.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 55' ' ' ASP . 31.5 mmmt -67.24 -45.6 76.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.562 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 87.5 mt -65.24 -38.82 91.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.509 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.4 t -63.47 -35.75 81.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.96 0.409 . . . . 0.0 110.316 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -59.75 -42.88 94.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.251 176.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 87.3 mt -74.74 -33.68 62.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.936 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.93 -40.17 94.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.449 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -61.21 -35.82 78.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.373 176.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.59 2.49 29.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.579 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.427 ' HD3' ' HA ' ' A' ' 67' ' ' LYS . 42.9 mmtm -122.08 -0.05 9.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.911 0.386 . . . . 0.0 110.687 176.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 60.73 40.5 98.17 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.631 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -108.2 135.56 12.91 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.007 -178.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -77.68 -25.7 49.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.365 0.602 . . . . 0.0 110.021 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -152.93 175.44 12.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.215 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -147.65 170.22 17.98 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.925 -176.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -135.42 114.23 11.95 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 119.994 -0.683 . . . . 0.0 110.915 174.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.477 ' HA ' ' HA ' ' A' ' 88' ' ' ALA . 55.8 mt -78.39 127.53 38.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.777 177.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 23.2 pt -100.92 -35.2 4.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.585 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -156.32 144.86 20.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.817 0.341 . . . . 0.0 111.424 -177.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -147.14 124.67 11.7 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.07 152.21 40.68 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.888 0.375 . . . . 0.0 111.213 -174.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -86.0 118.88 25.75 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.488 170.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -80.11 -22.13 42.5 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 128.4 -86.28 0.32 Allowed Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 -175.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.567 ' O ' ' HA ' ' A' ' 46' ' ' SER . 70.1 Cg_endo -74.73 -24.0 13.86 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.16 1.907 . . . . 0.0 111.374 172.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.467 ' OD1' ' HG2' ' A' ' 82' ' ' PRO . 1.1 m120 -119.57 150.15 40.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.323 -176.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -108.13 121.67 45.33 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 170.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.686 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 46.2 mt-10 -117.71 118.98 33.57 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.206 0.527 . . . . 0.0 111.782 -174.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -121.36 132.13 54.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.992 176.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.1 t -111.54 112.85 42.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.997 0.427 . . . . 0.0 110.421 -178.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 74' ' ' ILE . . . -125.13 135.57 52.78 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.223 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 40' ' ' THR . 33.2 mt-10 -106.0 134.96 48.29 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 26.2 t -90.66 132.19 35.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -175.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -123.25 125.73 45.61 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.167 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -87.68 147.39 25.26 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 174.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.061 -178.769 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.317 0 CA-C-O 121.264 0.554 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 223' ' ' GLU . . . . . 0.543 ' HB2' ' H ' ' A' ' 23' ' ' GLU . 4.2 mm-40 -127.07 89.14 2.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.274 -173.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 224' ' ' GLN . . . . . 0.619 ' HA ' ' HB3' ' B' ' 271' ' ' TYR . 0.0 OUTLIER -176.62 155.73 1.38 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.285 169.264 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 20.3 m -125.88 150.85 31.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.272 175.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 226' ' ' SER . . . . . 0.442 ' O ' HG13 ' B' ' 230' ' ' ILE . 12.7 t -83.74 171.61 13.02 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 227' ' ' LYS . . . . . 0.494 ' HA ' HD12 ' B' ' 230' ' ' ILE . 74.3 tttt -68.74 -19.55 64.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.343 -173.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 228' ' ' GLN . . . . . 0.44 ' HB2' ' OE1' ' B' ' 229' ' ' GLU . 0.6 OUTLIER -65.75 -50.36 65.07 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 177.315 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 229' ' ' GLU . . . . . 0.44 ' OE1' ' HB2' ' B' ' 228' ' ' GLN . 1.9 mp0 -64.58 -41.33 96.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.444 178.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.494 HD12 ' HA ' ' B' ' 227' ' ' LYS . 87.4 mt -56.84 -46.46 83.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.898 178.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 16.5 m -73.14 -21.29 60.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.458 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 -85.48 -48.03 9.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.806 -176.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -91.19 -7.81 50.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.033 -177.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 57.95 64.56 1.5 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.082 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 235' ' ' LEU . . . . . 0.953 HD21 ' HG3' ' A' ' 53' ' ' PRO . 60.4 mt -75.21 147.26 40.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.236 -178.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 46.8 t -88.55 119.09 35.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.08 -175.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -80.53 117.56 21.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.12 175.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 238' ' ' VAL . . . . . 0.416 HG23 ' HB ' ' B' ' 290' ' ' VAL . 2.0 m -80.26 -39.48 19.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.841 177.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 179.37 -173.27 45.26 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.991 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 33.3 m -115.22 129.81 56.74 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.245 -0.279 . . . . 0.0 110.245 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 24.2 pt -104.08 132.66 50.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.006 0.431 . . . . 0.0 110.177 175.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -117.55 123.08 45.38 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.582 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 243' ' ' VAL . . . . . 0.701 ' O ' ' HA ' ' B' ' 285' ' ' GLU . 41.9 t -92.6 120.42 41.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 173.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 15.9 t -150.97 87.16 1.39 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.345 0.593 . . . . 0.0 109.511 -177.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 245' ' ' GLN . . . . . 0.561 ' HG3' ' HB2' ' B' ' 249' ' ' GLN . 6.3 pm0 -138.62 173.62 11.39 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.734 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 8.6 t -85.39 176.21 8.41 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.735 0.302 . . . . 0.0 110.275 -176.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.69 52.42 1.57 Allowed Glycine 0 CA--C 1.521 0.439 0 CA-C-N 116.098 -0.501 . . . . 0.0 113.246 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -141.28 -39.78 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 176.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 249' ' ' GLN . . . . . 0.561 ' HB2' ' HG3' ' B' ' 245' ' ' GLN . 77.3 mt-30 -80.03 -15.13 57.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.587 -0.306 . . . . 0.0 110.518 175.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 250' ' ' ILE . . . . . 0.547 ' HA ' ' OD2' ' B' ' 255' ' ' ASP . 47.4 mm -131.76 110.22 16.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 175.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 8.5 t -118.25 -27.98 5.91 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.606 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 252' ' ' SER . . . . . 0.522 ' HB3' ' HD2' ' B' ' 253' ' ' PRO . 50.6 m -152.22 164.72 19.36 Favored Pre-proline 0 C--N 1.327 -0.383 0 O-C-N 122.357 -0.214 . . . . 0.0 110.62 -175.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 253' ' ' PRO . . . . . 0.522 ' HD2' ' HB3' ' B' ' 252' ' ' SER . 12.3 Cg_endo -56.95 -43.9 49.76 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.8 2.333 . . . . 0.0 112.503 178.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 254' ' ' SER . . . . . 0.405 ' O ' ' HG3' ' B' ' 257' ' ' ARG . 4.3 p -64.14 -30.46 71.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.361 0.6 . . . . 0.0 110.726 177.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 255' ' ' ASP . . . . . 0.547 ' OD2' ' HA ' ' B' ' 250' ' ' ILE . 28.1 t70 -75.75 -37.1 59.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.458 177.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 60.6 tp -61.64 -47.54 84.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.945 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 257' ' ' ARG . . . . . 0.513 ' HA ' HD12 ' B' ' 260' ' ' LEU . 2.0 ppt_? -59.19 -25.38 63.9 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -175.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 258' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -63.0 -47.5 82.86 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.169 0.509 . . . . 0.0 110.372 176.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 259' ' ' LYS . . . . . 0.529 ' HD2' ' N ' ' B' ' 259' ' ' LYS . 12.2 mptt -74.16 -26.23 60.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.559 -175.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 260' ' ' LEU . . . . . 0.513 HD12 ' HA ' ' B' ' 257' ' ' ARG . 95.9 mt -67.79 -48.21 66.94 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.479 176.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 14.4 t -66.1 -37.59 86.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.891 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -51.2 -49.4 61.09 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.083 176.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 263' ' ' LEU . . . . . . . . . . . . . 87.7 mt -74.48 -30.39 61.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.547 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.42 -40.95 81.01 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -177.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -63.48 -35.48 80.58 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.24 0.543 . . . . 0.0 110.42 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -74.59 -6.74 50.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.471 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -116.16 -2.84 12.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.84 176.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 66.29 51.09 46.28 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.158 -0.544 . . . . 0.0 112.854 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -138.92 169.35 24.46 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.172 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 270' ' ' LYS . . . . . 0.443 ' HB3' ' OE1' ' B' ' 223' ' ' GLU . 46.0 mtmt -105.56 -66.56 0.98 Allowed 'General case' 0 C--O 1.223 -0.334 0 CA-C-O 121.017 0.437 . . . . 0.0 110.923 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 271' ' ' TYR . . . . . 0.619 ' HB3' ' HA ' ' B' ' 224' ' ' GLN . 16.0 m-85 -92.41 152.66 19.6 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -174.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 272' ' ' TYR . . . . . 0.592 ' HB2' ' HB1' ' B' ' 288' ' ' ALA . 2.8 p90 -134.69 118.28 16.96 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.352 0.596 . . . . 0.0 110.203 175.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 273' ' ' HIS . . . . . 0.518 ' HA ' ' OE1' ' B' ' 224' ' ' GLN . 32.7 t-80 -87.84 101.21 13.49 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 274' ' ' ILE . . . . . 0.597 HG12 ' HB2' ' B' ' 288' ' ' ALA . 58.5 mt -74.17 106.44 4.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.314 -178.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 19.4 pt -85.66 -33.36 7.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.588 -175.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -151.58 124.13 8.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.703 0.287 . . . . 0.0 111.193 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -130.47 118.43 21.12 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 174.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -133.67 164.96 26.05 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.384 0.612 . . . . 0.0 111.064 -175.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -99.14 123.28 43.31 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.027 178.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 280' ' ' HIS . . . . . 0.478 ' HB3' ' HB2' ' B' ' 283' ' ' ASN . 12.1 t-80 -103.07 28.95 5.82 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.198 0.523 . . . . 0.0 110.067 -174.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 93.0 -108.3 3.64 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -178.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -83.23 4.3 7.16 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.666 2.244 . . . . 0.0 111.518 175.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 283' ' ' ASN . . . . . 0.478 ' HB2' ' HB3' ' B' ' 280' ' ' HIS . 87.0 m-20 -126.16 142.02 51.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.484 -177.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -103.61 129.03 50.81 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 173.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 285' ' ' GLU . . . . . 0.701 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 31.2 mt-10 -121.95 113.97 20.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.787 0.327 . . . . 0.0 111.651 -178.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 286' ' ' ALA . . . . . 0.538 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -117.59 127.97 54.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.554 175.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 32.1 t -110.09 116.43 52.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.23 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 288' ' ' ALA . . . . . 0.597 ' HB2' HG12 ' B' ' 274' ' ' ILE . . . -128.31 139.24 52.52 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.131 0.491 . . . . 0.0 111.783 -177.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -91.9 123.46 35.29 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.352 177.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 290' ' ' VAL . . . . . 0.416 ' HB ' HG23 ' B' ' 238' ' ' VAL . 16.5 t -90.78 127.4 43.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.461 -176.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -123.49 139.83 53.62 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.018 -177.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 292' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -106.39 165.77 11.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.106 172.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 . . . . . 0 C--O 1.236 0.38 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 175.98 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.332 0 CA-C-O 121.387 0.613 . . . . 0.0 111.369 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.7 ' HB3' ' HE2' ' A' ' 71' ' ' TYR . 42.8 mt-10 -133.88 160.67 36.95 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.38 176.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.587 ' CG ' ' HG3' ' B' ' 224' ' ' GLN . 1.3 tm0? 174.66 142.88 0.05 Allowed 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.539 0.525 . . . . 0.0 110.424 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.2 m -123.97 125.2 70.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 169.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.456 ' HB2' ' HB ' ' B' ' 274' ' ' ILE . 8.2 t -99.38 -167.93 1.54 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.025 0.44 . . . . 0.0 110.915 -175.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.407 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -71.26 -36.62 71.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.321 -175.169 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -64.54 -50.33 67.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.058 -173.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -59.17 -36.07 74.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.426 -177.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 26' ' ' SER . 79.2 mt -57.19 -56.05 17.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.93 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.6 m -73.77 -30.51 62.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.749 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 17.6 t-160 -79.08 -51.84 9.01 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -174.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -93.03 -7.81 44.7 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 121.18 -0.208 . . . . 0.0 111.467 -174.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt 59.66 65.12 1.19 Allowed 'General case' 0 N--CA 1.463 0.212 0 O-C-N 123.555 0.534 . . . . 0.0 110.656 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.4 mt -65.47 144.49 57.0 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.54 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.511 ' HB ' ' HB3' ' A' ' 92' ' ' ASN . 95.3 t -73.23 112.56 9.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.06 0.457 . . . . 0.0 110.477 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.617 ' HD3' ' CE1' ' A' ' 91' ' ' TYR . 19.3 tptm -78.75 112.98 16.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.125 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.501 HG21 ' HA3' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -97.99 -13.19 8.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.816 -178.675 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 145.48 -170.81 26.71 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.293 -0.956 . . . . 0.0 112.571 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.504 HG23 ' HG2' ' A' ' 89' ' ' GLU . 52.2 m -137.17 139.38 41.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.632 0.253 . . . . 0.0 110.432 -178.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 34.5 pt -121.97 155.65 26.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.743 0.306 . . . . 0.0 110.201 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -141.18 140.53 34.05 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.218 0.533 . . . . 0.0 110.728 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 44.1 t -94.6 126.31 47.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.313 -0.858 . . . . 0.0 108.775 173.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.7 p -138.69 35.83 2.21 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.848 0.832 . . . . 0.0 108.894 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -99.75 159.73 14.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.942 -175.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' A' ' 83' ' ' ASN . 22.7 t -73.31 172.09 11.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.829 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.96 22.07 1.55 Allowed Glycine 0 CA--C 1.52 0.363 0 CA-C-N 116.178 -0.464 . . . . 0.0 113.366 -177.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -103.96 -21.78 9.33 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 173.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -102.41 -20.22 14.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.339 0.59 . . . . 0.0 109.63 178.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.3 mm -125.58 98.05 4.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.17 172.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.8 m -103.26 -66.54 0.93 Allowed 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.651 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.534 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 23.5 m -108.24 165.0 13.51 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.534 ' HD2' ' HB3' ' A' ' 52' ' ' SER . 11.2 Cg_endo -55.14 -32.49 80.2 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.581 2.188 . . . . 0.0 111.88 178.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.6 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 7.9 m -60.76 -43.25 98.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.896 177.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.52 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 18.3 m-20 -63.39 -36.49 83.88 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.536 -178.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.7 tp -60.86 -46.73 89.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.496 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.45 ' HD2' ' HG2' ' B' ' 223' ' ' GLU . 23.5 ttp180 -60.63 -42.65 97.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.44 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.6 ' HG2' ' O ' ' A' ' 54' ' ' SER . 31.3 mm-40 -63.05 -34.84 78.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.841 -179.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 55' ' ' ASP . 42.9 mmtm -75.29 -43.54 50.6 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.806 0.336 . . . . 0.0 110.707 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.1 mt -62.69 -46.38 88.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.066 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.7 p -64.76 -40.05 94.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.994 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -58.8 -44.15 90.71 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.797 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.7 mt -74.49 -36.03 63.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.511 -179.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.38 -47.09 74.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.815 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -64.35 -35.36 80.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.069 0.462 . . . . 0.0 110.487 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -78.64 4.78 12.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.55 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.7 mmtm -119.45 3.95 11.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.779 0.323 . . . . 0.0 111.563 176.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.46 -17.46 58.41 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.215 174.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.501 ' HA3' HG21 ' A' ' 38' ' ' VAL . . . -92.47 179.73 40.51 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.846 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.582 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 9.2 mmpt? -122.18 -59.13 1.67 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.672 0.272 . . . . 0.0 110.456 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.7 ' HE2' ' HB3' ' A' ' 23' ' ' GLU . 95.2 m-85 -91.67 167.35 12.26 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.545 -175.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.439 ' HE2' ' HB1' ' B' ' 222' ' ' ALA . 8.8 p90 -146.3 157.65 43.82 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.794 0.33 . . . . 0.0 110.912 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -127.48 102.88 7.06 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.098 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.442 ' HA ' ' HA ' ' A' ' 88' ' ' ALA . 63.9 mt -63.81 127.24 23.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.466 176.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.4 pt -113.45 -14.6 10.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.857 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.484 ' HB3' ' HB ' ' A' ' 87' ' ' VAL . . . -150.2 123.83 9.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.733 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.461 ' HB3' ' HB2' ' B' ' 228' ' ' GLN . . . -135.34 108.34 7.63 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.457 HH11 ' HD3' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -149.6 171.98 15.77 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.578 -174.668 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -119.5 140.1 51.04 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -130.36 96.69 4.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.017 0.437 . . . . 0.0 110.08 -178.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 60.8 -125.36 38.09 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -175.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -90.6 20.51 0.97 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.852 2.368 . . . . 0.0 112.348 175.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.582 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 38.4 m-80 -123.86 151.88 42.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.361 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.416 ' CE2' ' HB2' ' A' ' 86' ' ' ALA . 83.6 t80 -111.21 120.45 42.32 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.049 178.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.578 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 26.2 mm-40 -102.03 110.62 22.64 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.403 -177.053 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.416 ' HB2' ' CE2' ' A' ' 84' ' ' PHE . . . -128.38 114.99 17.55 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.808 0.337 . . . . 0.0 110.768 177.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.484 ' HB ' ' HB3' ' A' ' 76' ' ' ALA . 48.3 t -105.68 117.37 51.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 120.77 0.319 . . . . 0.0 110.344 -178.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.442 ' HA ' ' HA ' ' A' ' 74' ' ' ILE . . . -131.84 133.09 44.29 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.455 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.581 ' HB3' ' HE3' ' A' ' 37' ' ' LYS . 29.8 mt-10 -92.0 135.26 34.09 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.9 t -91.42 127.72 43.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -175.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.617 ' CE1' ' HD3' ' A' ' 37' ' ' LYS . 77.1 m-85 -128.14 136.98 51.89 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.336 0.589 . . . . 0.0 110.879 -178.064 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.511 ' HB3' ' HB ' ' A' ' 36' ' ' VAL . 8.0 t-20 -95.15 -176.86 3.94 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 174.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.4 t70 . . . . . 0 CA--C 1.538 0.498 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.609 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 222' ' ' ALA . . . . . 0.439 ' HB1' ' HE2' ' A' ' 72' ' ' TYR . . . . . . . . 0 C--O 1.234 0.242 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 223' ' ' GLU . . . . . 0.45 ' HG2' ' HD2' ' A' ' 57' ' ' ARG . 28.9 mt-10 -138.8 164.96 28.25 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 173.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 224' ' ' GLN . . . . . 0.587 ' HG3' ' CG ' ' A' ' 24' ' ' GLN . 26.1 tt0 179.6 146.99 0.22 Allowed 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.405 0.441 . . . . 0.0 111.247 175.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 225' ' ' VAL . . . . . 0.515 ' N ' ' HG2' ' B' ' 224' ' ' GLN . 17.2 m -141.94 139.73 30.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 167.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 226' ' ' SER . . . . . 0.721 ' HA ' ' CD2' ' B' ' 273' ' ' HIS . 4.5 m -109.21 -89.81 0.47 Allowed 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.954 -0.299 . . . . 0.0 111.658 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 14.5 mmtm -154.66 -41.83 0.09 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.079 0.466 . . . . 0.0 109.774 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 228' ' ' GLN . . . . . 0.475 ' CD ' ' H ' ' B' ' 228' ' ' GLN . 0.0 OUTLIER -63.39 -44.19 95.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.191 -178.254 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -65.62 -40.0 92.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.6 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.552 HG23 ' HB2' ' B' ' 235' ' ' LEU . 77.6 mt -66.82 -38.05 80.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.497 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 30.7 t -71.38 -25.66 62.46 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.956 177.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -87.86 -46.69 9.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.983 -175.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 233' ' ' PHE . . . . . 0.459 ' CD1' ' HD3' ' A' ' 53' ' ' PRO . 68.6 m-85 -94.09 -7.39 42.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.401 -177.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt 61.08 74.1 0.46 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.523 174.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 235' ' ' LEU . . . . . 0.552 ' HB2' HG23 ' B' ' 230' ' ' ILE . 68.1 mt -88.89 176.41 7.04 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.808 0.337 . . . . 0.0 111.211 -177.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 59.4 t -101.89 123.71 55.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.057 -177.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 237' ' ' LYS . . . . . 0.656 ' HD3' ' CZ ' ' B' ' 291' ' ' TYR . 18.9 tptm -82.74 111.85 19.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.763 177.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 238' ' ' VAL . . . . . 0.454 HG23 HG12 ' B' ' 290' ' ' VAL . 0.4 OUTLIER -104.84 14.37 7.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -176.113 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 128.2 -162.53 21.94 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.279 -0.963 . . . . 0.0 113.216 173.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 89.4 m -149.08 135.61 19.46 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 26.7 pt -110.18 146.07 15.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.311 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -130.56 114.94 16.09 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.715 -178.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 243' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 76.7 t -94.4 109.34 21.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.287 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 10.2 p -119.71 105.34 11.06 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 176.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 245' ' ' GLN . . . . . 0.508 HE22 HD11 ' B' ' 250' ' ' ILE . 75.3 mt-30 -111.5 -174.78 2.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.865 -172.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 23.4 m -151.79 102.8 2.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.426 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 102.93 -164.48 16.02 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.423 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -83.85 58.45 5.01 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.228 -0.511 . . . . 0.0 112.704 -176.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 249' ' ' GLN . . . . . 0.433 ' OE1' ' HB3' ' B' ' 245' ' ' GLN . 53.9 mt-30 -80.27 -15.81 56.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.875 0.369 . . . . 0.0 110.395 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 250' ' ' ILE . . . . . 0.581 HD12 ' HA ' ' B' ' 256' ' ' LEU . 47.9 mm -113.59 114.34 46.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 173.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 16.3 t -108.07 -13.95 14.83 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.146 -176.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 252' ' ' SER . . . . . 0.45 ' O ' ' HB3' ' B' ' 255' ' ' ASP . 46.7 m -152.71 158.65 33.11 Favored Pre-proline 0 C--N 1.326 -0.415 0 O-C-N 122.382 -0.199 . . . . 0.0 110.617 -177.023 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -58.66 -50.49 9.2 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.809 2.34 . . . . 0.0 111.876 175.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 254' ' ' SER . . . . . 0.696 ' O ' ' HG3' ' B' ' 257' ' ' ARG . 41.4 t -58.31 -36.35 73.22 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.02 0.438 . . . . 0.0 110.629 174.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 255' ' ' ASP . . . . . 0.45 ' HB3' ' O ' ' B' ' 252' ' ' SER . 20.2 t0 -60.78 -43.62 97.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.355 178.075 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.581 ' HA ' HD12 ' B' ' 250' ' ' ILE . 55.3 tp -61.51 -44.4 97.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.278 178.045 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 257' ' ' ARG . . . . . 0.696 ' HG3' ' O ' ' B' ' 254' ' ' SER . 0.7 OUTLIER -66.26 -30.91 71.43 Favored 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 120.411 -0.515 . . . . 0.0 110.372 -177.346 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 258' ' ' GLU . . . . . 0.501 ' HG3' ' O ' ' B' ' 254' ' ' SER . 49.5 mt-10 -68.76 -27.06 65.57 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.946 0.403 . . . . 0.0 110.651 178.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 259' ' ' LYS . . . . . 0.407 ' HD3' ' O ' ' B' ' 255' ' ' ASP . 14.2 mptt -75.01 -34.35 61.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.27 0.557 . . . . 0.0 110.273 174.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 260' ' ' LEU . . . . . 0.455 ' CD1' HD11 ' B' ' 274' ' ' ILE . 79.1 mt -74.04 -46.71 41.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.421 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 25.0 m -60.39 -34.21 73.58 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.108 175.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -54.81 -48.64 72.5 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.085 0.469 . . . . 0.0 110.589 176.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 263' ' ' LEU . . . . . . . . . . . . . 86.6 mt -73.82 -38.13 64.65 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.171 -178.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.59 -44.68 61.7 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -177.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -67.77 -39.65 84.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.275 -178.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -72.36 -24.03 61.21 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.03 177.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 11.8 mmtt -78.21 -50.35 12.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.591 177.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 118.88 33.09 1.2 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.686 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -132.66 133.07 6.88 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 176.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -93.52 8.5 40.46 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -167.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 271' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -146.78 146.67 30.34 Favored 'General case' 0 C--N 1.33 -0.239 0 O-C-N 122.312 -0.242 . . . . 0.0 110.675 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 272' ' ' TYR . . . . . 0.461 ' CE1' ' HB3' ' A' ' 24' ' ' GLN . 37.1 p90 -141.19 159.87 41.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.877 0.37 . . . . 0.0 110.965 177.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 273' ' ' HIS . . . . . 0.721 ' CD2' ' HA ' ' B' ' 226' ' ' SER . 12.4 t-80 -136.14 111.97 9.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.567 -178.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 274' ' ' ILE . . . . . 0.585 ' H ' ' NE2' ' A' ' 24' ' ' GLN . 77.4 mt -78.26 113.29 17.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.872 0.368 . . . . 0.0 110.456 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 9.0 pt -97.09 -27.2 3.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.294 -178.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -150.07 130.71 14.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.467 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 277' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' B' ' 285' ' ' GLU . . . -153.37 117.9 4.95 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -157.56 175.48 13.88 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.064 0.459 . . . . 0.0 110.795 -178.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -109.24 124.75 51.38 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.325 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -112.74 87.67 2.64 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 173.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 69.84 -124.71 15.14 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 -175.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -84.37 -3.28 10.11 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.656 2.237 . . . . 0.0 112.036 175.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -100.2 116.5 32.35 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.082 -174.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -90.52 126.44 35.93 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 175.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 285' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' B' ' 277' ' ' ALA . 9.2 mm-40 -116.02 110.54 19.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.781 -176.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 286' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -118.86 115.72 24.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.857 0.361 . . . . 0.0 111.092 174.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 27.2 t -110.21 124.34 66.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.268 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -135.93 148.08 48.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.236 0.541 . . . . 0.0 111.673 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 289' ' ' GLU . . . . . 0.532 ' HB3' ' HE3' ' B' ' 237' ' ' LYS . 31.8 mt-10 -89.73 143.58 26.69 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 290' ' ' VAL . . . . . 0.454 HG12 HG23 ' B' ' 238' ' ' VAL . 10.6 t -107.79 123.31 63.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 291' ' ' TYR . . . . . 0.656 ' CZ ' ' HD3' ' B' ' 237' ' ' LYS . 77.0 m-85 -127.31 148.88 50.23 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.253 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 292' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -124.12 162.64 23.14 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 11.9 p30 . . . . . 0 C--N 1.329 -0.326 0 CA-C-O 121.584 0.707 . . . . 0.0 112.336 -174.578 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.403 ' HB3' ' HA ' ' B' ' 261' ' ' SER . . . . . . . . 0 CA--C 1.519 -0.219 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.508 ' HB2' ' CE1' ' A' ' 71' ' ' TYR . 8.7 pt-20 -165.29 125.43 1.86 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -169.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.622 ' HA ' ' HB3' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -161.71 159.08 26.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.506 174.522 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.503 HG22 ' HB2' ' A' ' 71' ' ' TYR . 17.1 m -128.32 130.91 69.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.353 174.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.479 ' O ' HG13 ' A' ' 30' ' ' ILE . 15.4 m -97.56 173.95 6.89 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.382 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -66.58 -15.16 63.22 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.556 -174.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.452 ' HB2' ' OE1' ' A' ' 29' ' ' GLU . 41.9 mt-30 -71.57 -50.81 27.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.405 0.621 . . . . 0.0 109.527 177.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.464 ' OE1' ' HB2' ' A' ' 26' ' ' SER . 1.9 mp0 -70.44 -41.28 73.05 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.901 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 26' ' ' SER . 94.7 mt -56.21 -48.67 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.353 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.1 m -72.34 -30.12 64.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.08 0.467 . . . . 0.0 110.727 -177.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -74.87 -40.85 60.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.498 -177.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -96.88 -0.01 48.43 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -175.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm 57.87 51.45 9.08 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.03 0.443 . . . . 0.0 110.033 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.873 HD21 ' HG2' ' B' ' 253' ' ' PRO . 56.4 mt -68.62 169.58 10.83 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.622 0.725 . . . . 0.0 112.78 -172.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.7 t -100.04 117.88 45.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.293 -175.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.424 ' HE2' ' OE1' ' A' ' 89' ' ' GLU . 60.8 tttm -83.14 107.65 15.85 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 176.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.5 m -90.69 -11.68 9.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -175.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 138.07 -168.02 24.71 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 119.892 -1.147 . . . . 0.0 113.092 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 24.0 m -123.55 144.54 49.5 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -178.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.6 pt -110.84 157.54 11.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.674 0.273 . . . . 0.0 110.439 178.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -117.98 136.71 53.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.126 0.489 . . . . 0.0 111.921 -171.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.662 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 85.5 t -122.45 113.45 38.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.849 169.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.0 t -150.85 77.2 1.27 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.186 0.517 . . . . 0.0 110.053 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.416 HE22 HG13 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -137.73 163.64 30.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.992 -179.565 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.525 ' HA ' ' HA ' ' A' ' 83' ' ' ASN . 26.4 t -73.18 163.83 27.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.643 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.97 -16.97 58.02 Favored Glycine 0 C--N 1.333 0.393 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.48 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.46 -19.63 68.95 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.215 176.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -102.0 -28.37 12.41 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.676 0.274 . . . . 0.0 111.01 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 43.5 mm -119.35 107.33 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-O 121.219 0.533 . . . . 0.0 110.479 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.8 m -128.98 -28.64 2.38 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.967 -178.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.8 m -121.68 156.08 59.16 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.192 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.441 ' HG2' ' HB2' ' B' ' 293' ' ' ASP . 32.5 Cg_exo -59.88 -24.43 76.08 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.729 2.286 . . . . 0.0 112.087 177.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.514 ' O ' ' HG3' ' A' ' 58' ' ' GLU . 24.1 p -62.76 -39.91 95.63 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.471 177.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.57 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 16.3 m-20 -61.69 -51.79 66.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.304 -175.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.443 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 57.6 tp -57.03 -44.82 83.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.653 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.403 ' HD2' HH11 ' A' ' 57' ' ' ARG . 7.5 ttp180 -53.25 -53.59 48.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.516 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.514 ' HG3' ' O ' ' A' ' 54' ' ' SER . 72.4 mt-10 -67.5 -27.27 66.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.021 -171.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.57 ' HG2' ' O ' ' A' ' 55' ' ' ASP . 46.9 mmtt -71.05 -45.64 63.47 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 56' ' ' LEU . 82.1 mt -65.53 -43.86 88.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.227 -176.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.9 p -62.88 -41.47 99.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.74 0.305 . . . . 0.0 111.383 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -64.67 -46.36 82.76 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.173 0.511 . . . . 0.0 110.223 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 59' ' ' LYS . 81.2 mt -67.87 -34.74 77.26 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.464 -178.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.72 -46.73 77.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.693 -178.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -67.38 -25.81 66.15 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.84 0.352 . . . . 0.0 110.992 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.77 -28.96 68.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.261 0.553 . . . . 0.0 110.237 176.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -86.18 -13.43 47.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.742 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.76 -9.04 73.8 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.914 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.24 172.5 54.41 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 121.221 -0.514 . . . . 0.0 112.146 -178.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -117.35 -62.8 1.52 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.966 0.412 . . . . 0.0 110.671 -176.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.622 ' HB3' ' HA ' ' A' ' 24' ' ' GLN . 4.5 m-85 -98.17 148.1 23.91 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -176.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.454 ' CE2' ' HA ' ' B' ' 223' ' ' GLU . 32.7 p90 -121.8 156.98 32.04 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 177.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 48.1 t60 -135.25 115.93 13.85 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.569 -177.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.466 ' H ' HD12 ' A' ' 74' ' ' ILE . 4.6 mp -73.31 132.06 33.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 26.6 pt -117.37 -27.74 2.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.589 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -152.96 133.53 13.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.616 0.245 . . . . 0.0 110.684 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.517 ' HB3' ' HG3' ' B' ' 228' ' ' GLN . . . -150.55 142.74 24.14 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -164.87 147.99 8.56 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.033 0.444 . . . . 0.0 111.048 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -78.29 111.33 14.16 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 169.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -115.06 82.14 1.69 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.049 0.452 . . . . 0.0 110.349 -174.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.04 -128.75 8.74 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.6 -178.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -81.43 -6.15 12.7 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.572 2.181 . . . . 0.0 112.893 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.525 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 81.9 m-20 -121.07 154.52 36.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.079 0.466 . . . . 0.0 111.276 -175.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -104.29 118.39 36.51 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.585 176.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -102.4 124.92 48.83 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.05 -176.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.662 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -137.36 129.8 29.72 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.231 0.539 . . . . 0.0 110.917 178.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.9 t -113.24 118.83 59.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.973 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.59 138.24 39.34 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.121 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 40' ' ' THR . 51.1 mt-10 -98.96 153.91 18.47 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 178.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.9 t -112.27 138.45 41.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -125.26 148.57 48.61 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.086 0.47 . . . . 0.0 110.595 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -118.27 164.73 14.76 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.508 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.6 t0 . . . . . 0 C--N 1.329 -0.317 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.591 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.301 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 223' ' ' GLU . . . . . 0.454 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 10.8 pt-20 -173.0 140.65 0.92 Allowed 'General case' 0 C--O 1.235 0.31 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -167.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 224' ' ' GLN . . . . . 0.472 ' HA ' ' HB3' ' B' ' 271' ' ' TYR . 0.0 OUTLIER -175.57 156.73 1.97 Allowed 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.612 173.365 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 28.3 m -116.45 141.51 33.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.769 0.319 . . . . 0.0 110.811 177.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 226' ' ' SER . . . . . 0.417 ' HA ' ' CE1' ' B' ' 273' ' ' HIS . 47.9 t -83.83 -92.96 0.07 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.111 -176.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 227' ' ' LYS . . . . . 0.416 ' HA ' HD12 ' B' ' 230' ' ' ILE . 26.2 ttpt -151.48 -39.68 0.12 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.962 0.411 . . . . 0.0 110.895 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 228' ' ' GLN . . . . . 0.517 ' HG3' ' HB3' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -63.75 -35.09 79.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.424 179.876 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 229' ' ' GLU . . . . . 0.467 ' OE1' ' HG2' ' B' ' 228' ' ' GLN . 2.4 mp0 -69.68 -37.93 76.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.831 176.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.559 HG12 HD12 ' B' ' 235' ' ' LEU . 63.3 mt -59.05 -45.18 92.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.642 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 16.5 m -73.13 -37.68 66.57 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.861 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -70.37 -48.54 55.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.435 -176.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -94.45 5.43 51.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.438 -175.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt 55.68 45.13 25.22 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.92 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 235' ' ' LEU . . . . . 0.617 HD22 ' HA ' ' B' ' 293' ' ' ASP . 72.7 mt -58.27 148.82 26.04 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.509 -175.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 61.9 t -97.29 117.92 42.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.01 -174.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -80.82 113.63 19.15 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.14 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 18.9 m -85.89 -34.94 8.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -176.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 166.02 179.77 39.72 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.637 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 240' ' ' THR . . . . . 0.494 HG23 ' HG2' ' B' ' 289' ' ' GLU . 54.3 m -113.45 135.84 53.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.698 0.285 . . . . 0.0 110.583 -178.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 30.1 pt -107.77 131.19 58.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 171.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -120.19 113.79 20.96 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.997 -174.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 243' ' ' VAL . . . . . 0.571 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 84.2 t -95.12 119.61 43.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.353 -177.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 22.6 t -115.64 86.1 2.4 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 170.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 245' ' ' GLN . . . . . 0.565 ' HG2' HG12 ' B' ' 250' ' ' ILE . 0.3 OUTLIER -81.63 106.47 13.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.946 -173.22 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 13.9 m -88.13 103.69 15.98 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.68 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 94.69 -162.69 24.42 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.146 174.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -82.54 63.73 4.39 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.554 -0.355 . . . . 0.0 113.591 -173.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 249' ' ' GLN . . . . . 0.524 ' HB2' ' HG3' ' B' ' 245' ' ' GLN . 72.6 mt-30 -96.09 -2.8 45.88 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.126 0.488 . . . . 0.0 109.911 172.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 250' ' ' ILE . . . . . 0.565 HG12 ' HG2' ' B' ' 245' ' ' GLN . 48.9 mm -128.36 125.54 64.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.116 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 251' ' ' SER . . . . . 0.4 ' H ' ' CG ' ' B' ' 255' ' ' ASP . 1.1 m -112.09 -57.79 2.22 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.457 0.646 . . . . 0.0 109.668 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 252' ' ' SER . . . . . 0.522 ' HB3' ' HD2' ' B' ' 253' ' ' PRO . 50.7 m -127.01 175.12 3.55 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.362 176.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 253' ' ' PRO . . . . . 0.873 ' HG2' HD21 ' A' ' 35' ' ' LEU . 52.2 Cg_exo -55.09 -28.63 61.56 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.288 1.992 . . . . 0.0 112.315 175.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 254' ' ' SER . . . . . 0.576 ' O ' ' HB3' ' B' ' 257' ' ' ARG . 56.3 m -65.74 -26.19 67.62 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.777 178.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 255' ' ' ASP . . . . . 0.588 ' O ' ' HD3' ' B' ' 259' ' ' LYS . 2.6 m-20 -70.82 -49.39 46.84 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.154 0.502 . . . . 0.0 109.661 176.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 41.2 tp -62.5 -31.31 72.04 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.024 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 257' ' ' ARG . . . . . 0.576 ' HB3' ' O ' ' B' ' 254' ' ' SER . 50.7 ttt85 -51.19 -51.4 54.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.117 175.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 258' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -59.72 -51.99 67.41 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.138 0.494 . . . . 0.0 110.317 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 259' ' ' LYS . . . . . 0.588 ' HD3' ' O ' ' B' ' 255' ' ' ASP . 12.1 mptt -59.56 -43.7 93.5 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.245 -174.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 260' ' ' LEU . . . . . 0.485 HD13 ' CE2' ' B' ' 272' ' ' TYR . 96.5 mt -74.26 -43.62 56.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.179 -177.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 261' ' ' SER . . . . . 0.403 ' HA ' ' HB3' ' A' ' 22' ' ' ALA . 32.9 t -63.39 -37.97 89.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.677 0.275 . . . . 0.0 110.482 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -60.95 -52.96 62.8 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.46 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 263' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' B' ' 259' ' ' LYS . 81.1 mt -68.84 -40.19 79.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.282 -176.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -61.25 -52.53 64.36 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -175.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -69.48 -32.25 71.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.875 0.369 . . . . 0.0 110.413 -176.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -68.1 -24.23 65.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.007 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -84.96 0.4 51.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.531 176.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 74.82 34.16 53.78 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.798 -178.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 269' ' ' GLY . . . . . 0.43 ' HA2' ' OD1' ' B' ' 292' ' ' ASN . . . -127.79 163.83 21.35 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 121.051 -0.595 . . . . 0.0 111.957 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 270' ' ' LYS . . . . . 0.616 ' HA ' ' NZ ' ' B' ' 270' ' ' LYS . 1.0 OUTLIER -108.34 -66.55 1.03 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.782 0.325 . . . . 0.0 111.276 178.427 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 271' ' ' TYR . . . . . 0.472 ' HB3' ' HA ' ' B' ' 224' ' ' GLN . 4.9 m-85 -92.61 140.79 29.18 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -173.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 272' ' ' TYR . . . . . 0.485 ' CE2' HD13 ' B' ' 260' ' ' LEU . 55.0 p90 -125.17 131.38 53.23 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 176.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 273' ' ' HIS . . . . . 0.417 ' CE1' ' HA ' ' B' ' 226' ' ' SER . 21.7 t60 -104.34 107.91 19.06 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.114 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 274' ' ' ILE . . . . . . . . . . . . . 69.6 mt -70.21 123.14 23.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.191 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 34.0 pt -100.17 -26.55 3.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.706 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -153.76 123.71 6.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.826 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -143.58 117.97 9.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.261 178.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.8 159.02 13.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.948 0.404 . . . . 0.0 111.404 -177.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -84.65 138.58 32.6 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 172.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -114.7 26.84 9.87 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 173.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 115.49 -125.94 6.92 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -175.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.16 -10.5 22.69 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.457 2.104 . . . . 0.0 111.481 175.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 283' ' ' ASN . . . . . 0.454 ' HA ' ' O ' ' B' ' 245' ' ' GLN . 80.3 m-20 -109.64 125.54 52.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.817 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 284' ' ' PHE . . . . . 0.477 ' HB3' ' HB3' ' B' ' 245' ' ' GLN . 71.6 t80 -101.46 121.99 42.95 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.387 178.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 285' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -98.13 113.82 25.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.096 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 286' ' ' ALA . . . . . 0.571 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -125.63 116.02 21.05 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.867 0.365 . . . . 0.0 110.158 172.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 21.4 t -113.3 114.68 47.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.247 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -129.35 133.65 47.52 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.451 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 289' ' ' GLU . . . . . 0.494 ' HG2' HG23 ' B' ' 240' ' ' THR . 14.1 mt-10 -106.48 128.17 53.87 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 290' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' B' ' 272' ' ' TYR . 25.0 t -90.31 135.63 25.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.102 0.477 . . . . 0.0 111.202 -171.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -127.26 133.68 50.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.676 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 292' ' ' ASN . . . . . 0.43 ' OD1' ' HA2' ' B' ' 269' ' ' GLY . 54.2 m-20 -106.16 161.6 14.38 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.305 174.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 293' ' ' ASP . . . . . 0.617 ' HA ' HD22 ' B' ' 235' ' ' LEU . 9.3 p-10 . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.618 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.139 0 CA-C-O 121.295 0.569 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.51 ' O ' ' HB2' ' A' ' 24' ' ' GLN . 30.9 mt-10 -140.42 165.64 26.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.54 176.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.58 ' HG2' HE21 ' B' ' 224' ' ' GLN . 0.0 OUTLIER 174.69 136.63 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 O-C-N 123.791 0.682 . . . . 0.0 109.775 171.017 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.0 m -128.24 116.0 40.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.167 0.508 . . . . 0.0 110.479 173.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.429 ' O ' HG13 ' A' ' 30' ' ' ILE . 0.7 OUTLIER -91.29 169.89 10.44 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.099 -178.91 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.45 ' HD3' ' HA ' ' A' ' 27' ' ' LYS . 21.5 mmtp -68.99 -20.24 64.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.472 -177.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.11 -49.8 66.25 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 177.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -66.39 -43.89 84.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.317 176.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.542 HG12 HD12 ' A' ' 35' ' ' LEU . 90.2 mt -58.6 -46.84 89.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.437 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.9 t -72.88 -26.63 61.51 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.999 0.428 . . . . 0.0 110.611 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -73.83 -51.37 16.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.08 -177.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -85.47 -13.52 48.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.95 -178.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt 62.74 68.17 0.66 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.989 -176.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.578 HD21 ' HG2' ' B' ' 253' ' ' PRO . 63.0 mt -79.79 162.63 24.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.463 -176.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.6 m -96.29 131.28 43.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.947 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -85.12 118.51 24.72 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.89 177.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.41 HG12 ' HD2' ' A' ' 67' ' ' LYS . 20.8 t -78.76 -26.73 13.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 157.48 164.88 14.3 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.705 176.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 88.4 m -107.27 118.2 36.08 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 173.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.6 pt -107.52 170.44 2.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -178.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -143.42 143.85 31.79 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.924 0.868 . . . . 0.0 111.682 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.548 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 82.2 t -93.55 128.79 44.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 114.323 -1.308 . . . . 0.0 108.668 174.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -156.12 72.4 0.77 Allowed 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -178.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.44 HE22 HG13 ' A' ' 43' ' ' VAL . 0.6 OUTLIER -103.11 148.37 25.82 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.097 -176.432 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.7 p -105.67 112.2 25.19 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.338 -176.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.28 -147.04 18.28 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.73 -0.747 . . . . 0.0 113.116 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -90.26 38.09 3.27 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.133 -0.556 . . . . 0.0 112.823 -173.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -76.4 -31.26 57.86 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.446 HD12 ' HA ' ' A' ' 56' ' ' LEU . 44.7 mm -114.43 95.23 3.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 171.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.8 t -103.41 -43.48 5.4 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.211 0.529 . . . . 0.0 109.831 -177.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 17.8 m -113.74 159.17 36.76 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.385 176.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -57.18 -26.35 69.14 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.386 2.057 . . . . 0.0 111.947 177.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.406 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 3.8 p -73.24 -22.72 60.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.508 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -71.45 -34.54 70.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.326 0.584 . . . . 0.0 109.715 177.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.446 ' HA ' HD12 ' A' ' 50' ' ' ILE . 51.6 tp -66.25 -48.19 71.32 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.57 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.515 ' HD3' ' OE1' ' B' ' 223' ' ' GLU . 0.2 OUTLIER -64.21 -30.52 71.57 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.223 -178.217 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.458 ' HG3' ' NE ' ' A' ' 57' ' ' ARG . 36.1 mt-10 -67.64 -41.25 84.18 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.1 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -66.81 -45.34 78.65 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.823 0.344 . . . . 0.0 110.635 177.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.4 mt -64.48 -41.34 96.54 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.033 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.6 t -65.94 -39.04 90.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.154 0.502 . . . . 0.0 110.256 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -63.4 -42.67 98.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.883 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 97.5 mt -69.64 -32.69 71.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.804 178.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.87 -40.54 95.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.039 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -63.0 -40.38 97.61 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.912 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.79 -44.01 87.01 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.823 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.41 ' HD2' HG12 ' A' ' 38' ' ' VAL . 40.7 mmtt -74.11 -33.44 63.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.813 177.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 94.2 36.46 5.69 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.08 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -100.38 166.68 19.85 Favored Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -123.12 2.75 9.28 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.96 0.38 . . . . 0.0 111.587 -176.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.518 ' HE2' ' HB2' ' A' ' 93' ' ' ASP . 6.9 m-85 -153.96 166.02 34.28 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 177.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -150.65 157.46 43.0 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 171.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -146.1 117.64 8.03 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.041 -176.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.515 HG13 ' HB2' ' A' ' 88' ' ' ALA . 3.7 mp -83.64 131.35 34.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 178.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 9.9 pt -107.62 -21.63 5.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.592 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -150.52 139.26 20.75 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.171 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -151.15 113.01 4.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.749 0.309 . . . . 0.0 110.561 -178.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.59 150.7 51.62 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.415 0.626 . . . . 0.0 111.194 -177.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -93.99 102.72 14.81 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.272 176.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -102.54 77.32 1.61 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.367 -175.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.83 -125.6 35.27 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.292 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -82.67 5.46 6.38 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.874 2.383 . . . . 0.0 112.734 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' ' 45' ' ' GLN . 58.5 m-80 -122.51 120.03 32.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.961 0.41 . . . . 0.0 110.628 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -85.32 116.42 23.65 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 177.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.529 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 19.3 mm-40 -106.94 114.49 28.61 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.833 -175.017 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.548 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -135.26 121.16 19.78 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.617 0.246 . . . . 0.0 110.96 176.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.6 t -95.77 120.42 45.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -177.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.515 ' HB2' HG13 ' A' ' 74' ' ' ILE . . . -126.05 143.62 51.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.198 0.523 . . . . 0.0 111.349 -175.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.471 ' HB3' ' CE1' ' A' ' 91' ' ' TYR . 41.4 mt-10 -103.3 140.71 37.05 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.547 178.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.3 t -107.81 119.21 57.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 176.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.471 ' CE1' ' HB3' ' A' ' 89' ' ' GLU . 72.1 m-85 -123.77 152.81 41.78 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.193 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -115.69 155.87 26.95 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.063 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.518 ' HB2' ' HE2' ' A' ' 71' ' ' TYR . 19.7 t70 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.078 -177.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.292 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 223' ' ' GLU . . . . . 0.84 ' HG2' ' HE1' ' B' ' 271' ' ' TYR . 12.7 tt0 -164.43 125.27 2.12 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.371 0.605 . . . . 0.0 111.076 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 224' ' ' GLN . . . . . 0.58 HE21 ' HG2' ' A' ' 24' ' ' GLN . 1.1 tm0? -164.93 150.61 9.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.571 -170.235 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 225' ' ' VAL . . . . . 0.552 HG22 ' HB3' ' B' ' 271' ' ' TYR . 17.9 m -127.02 128.84 71.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 172.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 226' ' ' SER . . . . . 0.611 ' HA ' ' ND1' ' B' ' 273' ' ' HIS . 11.5 t -92.84 173.17 7.89 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.089 0.471 . . . . 0.0 110.547 -178.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 227' ' ' LYS . . . . . 0.517 ' HA ' HD12 ' B' ' 230' ' ' ILE . 47.4 tttm -64.16 -28.64 69.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.874 -172.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -66.49 -50.46 63.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.291 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 229' ' ' GLU . . . . . 0.486 ' OE1' ' HB3' ' B' ' 226' ' ' SER . 1.9 mp0 -65.36 -38.0 88.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.651 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.539 HG12 HD12 ' B' ' 235' ' ' LEU . 97.1 mt -55.86 -53.92 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.232 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 68.6 m -73.45 -21.01 60.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.713 0.292 . . . . 0.0 111.517 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 65.5 t-80 -75.04 -45.05 44.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.564 0.221 . . . . 0.0 110.99 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -100.75 -12.42 19.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.347 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? 64.41 91.15 0.08 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.139 -175.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 235' ' ' LEU . . . . . 0.539 HD12 HG12 ' B' ' 230' ' ' ILE . 88.6 mt -96.87 166.24 11.72 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.43 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 52.1 t -93.22 115.06 31.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.582 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -84.77 111.76 19.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.081 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 238' ' ' VAL . . . . . 0.431 HG23 ' HB ' ' B' ' 290' ' ' VAL . 1.2 m -88.35 -30.15 5.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -176.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 168.21 -147.53 11.58 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 119.964 -1.112 . . . . 0.0 113.085 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 29.0 m -141.17 138.1 33.16 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 122.598 0.359 . . . . 0.0 110.377 -176.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 241' ' ' ILE . . . . . 0.493 HG13 ' HB3' ' B' ' 288' ' ' ALA . 2.4 pt -105.29 137.61 34.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.139 0.495 . . . . 0.0 110.514 177.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -109.69 123.23 49.14 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.707 -172.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 243' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' B' ' 285' ' ' GLU . 89.2 t -100.95 117.4 46.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 172.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 34.4 m -155.37 76.61 0.97 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.787 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 245' ' ' GLN . . . . . 0.415 ' O ' ' HA ' ' B' ' 283' ' ' ASN . 0.9 OUTLIER -103.79 142.77 33.8 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.834 -177.706 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 246' ' ' SER . . . . . 0.578 ' HA ' ' O ' ' B' ' 282' ' ' PRO . 17.2 m -80.97 117.74 21.85 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.06 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 90.53 -165.71 31.27 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.582 176.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -87.08 53.12 4.45 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.319 -0.467 . . . . 0.0 112.454 -177.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -72.21 -25.32 61.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.252 0.549 . . . . 0.0 109.797 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 39.4 mm -105.91 90.84 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 175.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 9.4 t -92.94 -23.63 18.67 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.219 0.533 . . . . 0.0 109.961 -176.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 7.1 p -141.14 157.2 67.3 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.141 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 253' ' ' PRO . . . . . 0.578 ' HG2' HD21 ' A' ' 35' ' ' LEU . 68.5 Cg_exo -53.22 -30.78 52.7 Favored 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 123.017 2.478 . . . . 0.0 113.08 178.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 254' ' ' SER . . . . . 0.592 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 6.9 p -59.44 -41.22 89.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.833 -0.167 . . . . 0.0 110.902 176.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -58.36 -44.19 88.7 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.427 0.632 . . . . 0.0 109.764 176.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 49.2 tp -61.48 -44.57 96.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.272 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 257' ' ' ARG . . . . . 0.433 ' HD2' ' HG2' ' A' ' 23' ' ' GLU . 3.1 ttp180 -61.71 -46.67 88.69 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.549 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 258' ' ' GLU . . . . . 0.592 ' HG2' ' O ' ' B' ' 254' ' ' SER . 9.9 mm-40 -58.12 -47.08 84.38 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.959 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -66.39 -47.86 71.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.13 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 53.2 mt -62.86 -47.63 82.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.841 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 35.0 p -63.98 -39.07 93.29 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.84 0.352 . . . . 0.0 110.707 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -62.09 -48.46 80.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.433 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 263' ' ' LEU . . . . . 0.591 ' O ' ' HG2' ' B' ' 267' ' ' LYS . 96.2 mt -65.44 -37.35 86.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.055 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -69.07 -49.45 57.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.286 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -63.51 -33.29 75.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.878 0.37 . . . . 0.0 110.815 -178.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -66.79 -29.31 69.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.737 178.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 267' ' ' LYS . . . . . 0.591 ' HG2' ' O ' ' B' ' 263' ' ' LEU . 48.3 mmtm -82.07 -25.06 34.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.137 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 113.41 -5.68 24.85 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.866 -178.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 269' ' ' GLY . . . . . 0.503 ' HA2' ' OD1' ' B' ' 292' ' ' ASN . . . -77.41 145.69 30.79 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.183 -0.532 . . . . 0.0 111.812 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 270' ' ' LYS . . . . . 0.606 ' HA ' ' HE2' ' B' ' 270' ' ' LYS . 9.7 mmpt? -107.5 -23.64 12.09 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.854 0.359 . . . . 0.0 110.893 -177.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 271' ' ' TYR . . . . . 0.84 ' HE1' ' HG2' ' B' ' 223' ' ' GLU . 99.4 m-85 -133.46 157.06 46.54 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.348 -178.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 272' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -151.07 167.46 27.61 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.688 174.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 273' ' ' HIS . . . . . 0.611 ' ND1' ' HA ' ' B' ' 226' ' ' SER . 50.6 t60 -143.15 117.27 9.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.863 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 274' ' ' ILE . . . . . 0.451 ' HA ' ' HA ' ' B' ' 288' ' ' ALA . 61.8 mt -67.4 137.1 25.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.191 178.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 25.8 pt -110.91 -26.74 3.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.129 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -158.55 140.44 13.78 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.842 0.354 . . . . 0.0 111.016 -178.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -140.25 129.35 23.58 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 278' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' B' ' 278' ' ' ARG . 1.4 ptm180 -137.53 150.81 47.8 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.394 0.616 . . . . 0.0 111.195 -175.068 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -101.72 123.76 46.24 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.479 -175.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 280' ' ' HIS . . . . . 0.462 ' HB2' ' O ' ' B' ' 283' ' ' ASN . 10.1 m170 -125.33 154.72 41.36 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 163.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . -65.92 -57.59 10.59 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.715 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 282' ' ' PRO . . . . . 0.578 ' O ' ' HA ' ' B' ' 246' ' ' SER . 60.4 Cg_endo -72.07 -29.73 14.38 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.136 1.891 . . . . 0.0 112.958 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 283' ' ' ASN . . . . . 0.462 ' O ' ' HB2' ' B' ' 280' ' ' HIS . 6.9 m-20 -132.49 129.38 39.1 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 122.326 -0.234 . . . . 0.0 111.126 -175.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -91.17 120.46 32.12 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 171.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 285' ' ' GLU . . . . . 0.518 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 46.6 mt-10 -118.61 130.82 56.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.288 0.566 . . . . 0.0 112.411 -170.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 286' ' ' ALA . . . . . 0.425 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -149.27 143.7 26.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.128 176.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 41.0 t -123.38 124.91 70.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.397 -178.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 288' ' ' ALA . . . . . 0.493 ' HB3' HG13 ' B' ' 241' ' ' ILE . . . -132.24 141.48 49.05 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.941 0.401 . . . . 0.0 111.153 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -92.01 132.52 36.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.64 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 290' ' ' VAL . . . . . 0.431 ' HB ' HG23 ' B' ' 238' ' ' VAL . 6.0 t -97.99 131.89 44.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 120.832 0.349 . . . . 0.0 110.455 -176.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -127.99 143.91 51.09 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.32 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 292' ' ' ASN . . . . . 0.503 ' OD1' ' HA2' ' B' ' 269' ' ' GLY . 1.5 m120 -112.14 179.71 3.92 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.559 0.695 . . . . 0.0 112.157 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.322 -0.599 0 CA-C-N 114.014 -1.448 . . . . 0.0 110.032 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.211 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -133.94 104.11 6.12 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.176 -170.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.659 ' HA ' ' HB3' ' A' ' 71' ' ' TYR . 0.0 OUTLIER 175.13 167.64 0.3 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.816 0.341 . . . . 0.0 111.27 176.217 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.411 ' H ' ' CD ' ' A' ' 24' ' ' GLN . 28.3 m -127.51 139.77 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.068 0.547 . . . . 0.0 110.174 175.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.423 ' HA ' ' CE1' ' A' ' 73' ' ' HIS . 79.9 p -89.46 -93.65 0.11 Allowed 'General case' 0 C--N 1.322 -0.611 0 O-C-N 121.768 -0.582 . . . . 0.0 112.29 -174.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -131.68 -46.75 0.96 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.757 0.313 . . . . 0.0 111.044 -175.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -64.85 -47.39 78.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.516 -177.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.42 ' H ' ' CD ' ' A' ' 29' ' ' GLU . 1.7 mp0 -55.12 -47.81 74.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.608 -176.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.484 HG12 HD12 ' A' ' 35' ' ' LEU . 59.8 mt -58.02 -48.55 83.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.08 0.467 . . . . 0.0 111.147 -178.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.9 m -72.8 -33.83 66.51 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.344 -177.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -81.97 -34.88 29.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.956 -173.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.776 ' HB3' ' HG3' ' B' ' 253' ' ' PRO . 71.1 m-85 -101.77 -8.14 21.96 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.708 -176.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm 60.71 70.44 0.62 Allowed 'General case' 0 N--CA 1.466 0.343 0 O-C-N 123.559 0.537 . . . . 0.0 110.367 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.489 HD21 ' HB3' ' B' ' 253' ' ' PRO . 87.5 mt -82.12 163.16 22.18 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.799 -175.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 51.8 t -91.74 108.69 20.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.818 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -81.64 105.19 12.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.761 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.453 HG23 ' HB ' ' A' ' 90' ' ' VAL . 4.8 m -86.72 -20.4 7.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -172.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.59 -151.0 22.58 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 119.622 -1.275 . . . . 0.0 113.181 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.401 HG23 ' HG2' ' A' ' 89' ' ' GLU . 4.7 m -137.5 145.84 43.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.656 0.265 . . . . 0.0 110.73 -174.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.2 pt -127.83 144.95 35.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 174.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -125.95 138.62 53.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.084 0.469 . . . . 0.0 111.797 -175.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.632 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 90.4 t -97.57 110.26 25.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.198 171.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.4 p -138.46 74.99 1.5 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.361 0.601 . . . . 0.0 109.65 175.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.0 mp0 -134.65 166.54 22.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.307 -177.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.1 t -73.78 164.65 26.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.75 -177.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.06 5.24 6.7 Favored Glycine 0 CA--C 1.519 0.324 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.729 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.49 -5.27 55.75 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.927 174.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -108.35 -15.75 14.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.819 0.342 . . . . 0.0 110.81 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.578 HD12 ' HA ' ' A' ' 56' ' ' LEU . 45.1 mm -125.43 107.72 18.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.1 m -101.58 -42.01 6.38 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.015 -174.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.51 ' H ' ' HB3' ' A' ' 55' ' ' ASP . 80.5 p -138.94 169.46 12.45 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.288 -175.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.85 ' HG2' HD21 ' B' ' 235' ' ' LEU . 42.1 Cg_exo -58.54 -36.02 97.91 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.354 2.036 . . . . 0.0 111.639 174.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.573 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -64.76 -44.59 89.59 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.6 175.212 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.534 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 38.9 t0 -66.88 -30.66 70.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.312 0.577 . . . . 0.0 110.179 179.035 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.578 ' HA ' HD12 ' A' ' 50' ' ' ILE . 63.9 tp -63.5 -51.16 66.74 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.933 176.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.573 ' HG3' ' O ' ' A' ' 54' ' ' SER . 6.2 ppt_? -68.45 -25.71 65.14 Favored 'General case' 0 C--O 1.225 -0.202 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.452 -178.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.534 ' HB2' ' O ' ' A' ' 55' ' ' ASP . 6.0 mm-40 -51.77 -51.5 55.86 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.295 0.569 . . . . 0.0 110.698 174.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.499 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 12.4 mptt -65.03 -45.11 86.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.204 -176.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.457 HD21 HG23 ' A' ' 43' ' ' VAL . 86.7 mt -71.45 -36.03 71.1 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.517 -177.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.522 ' HA ' ' HB3' ' B' ' 222' ' ' ALA . 6.9 t -62.94 -44.16 96.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.254 0.55 . . . . 0.0 109.523 176.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -63.39 -40.7 97.93 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.699 177.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 59' ' ' LYS . 84.7 mt -66.68 -44.68 81.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.079 178.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.7 -47.48 85.49 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.856 0.36 . . . . 0.0 110.673 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -58.24 -40.57 82.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.277 178.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.03 -25.29 58.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.817 -177.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -83.77 -47.55 11.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.935 0.398 . . . . 0.0 111.238 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 125.6 34.93 0.63 Allowed Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.498 -175.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.454 ' HA2' ' OD1' ' A' ' 92' ' ' ASN . . . -134.13 161.34 24.37 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -108.3 -71.74 0.75 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.866 0.333 . . . . 0.0 111.409 -178.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.659 ' HB3' ' HA ' ' A' ' 24' ' ' GLN . 2.3 m-85 -93.22 157.23 16.37 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 -173.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.543 ' CD2' ' HB1' ' B' ' 222' ' ' ALA . 45.6 p90 -146.45 133.68 20.55 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.293 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.423 ' CE1' ' HA ' ' A' ' 26' ' ' SER . 18.7 t60 -102.62 119.11 38.27 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.159 -178.031 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.514 ' H ' HD12 ' A' ' 74' ' ' ILE . 4.9 mp -77.04 124.53 35.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 30.3 pt -105.99 -21.71 5.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.925 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -152.61 135.92 15.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.696 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -149.03 111.4 4.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.163 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -149.86 173.63 13.56 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.918 0.389 . . . . 0.0 111.073 -176.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.84 148.76 26.3 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.242 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -100.92 -20.47 15.44 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.508 0.671 . . . . 0.0 109.212 175.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 143.06 -99.4 0.22 Allowed Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -176.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -74.28 -18.78 20.39 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.772 2.315 . . . . 0.0 111.232 171.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -116.47 159.64 21.75 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.623 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -115.74 138.31 51.24 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.632 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 42.1 mt-10 -123.98 117.4 24.66 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.209 0.528 . . . . 0.0 111.24 -176.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.546 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -129.03 139.46 52.05 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.629 178.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.7 t -118.77 119.44 61.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.128 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.42 ' HB1' ' HD1' ' A' ' 72' ' ' TYR . . . -135.78 138.82 43.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.782 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.401 ' HG2' HG23 ' A' ' 40' ' ' THR . 3.2 mt-10 -104.0 139.53 39.0 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.453 ' HB ' HG23 ' A' ' 38' ' ' VAL . 8.5 t -97.5 134.83 34.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.144 -170.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -130.4 139.08 50.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.28 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.454 ' OD1' ' HA2' ' A' ' 69' ' ' GLY . 78.9 m-20 -101.37 -178.99 3.9 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.161 173.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.721 174.635 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 222' ' ' ALA . . . . . 0.543 ' HB1' ' CD2' ' A' ' 72' ' ' TYR . . . . . . . . 0 N--CA 1.451 -0.425 0 CA-C-O 121.804 0.812 . . . . 0.0 108.813 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 223' ' ' GLU . . . . . 0.515 ' HG3' ' HD3' ' A' ' 57' ' ' ARG . 4.4 mp0 -124.37 96.55 4.95 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.389 -166.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 224' ' ' GLN . . . . . 0.653 ' HB3' ' HG3' ' A' ' 24' ' ' GLN . 18.4 tm0? -173.02 148.65 1.76 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.246 -178.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 225' ' ' VAL . . . . . 0.502 HG21 ' CD1' ' B' ' 235' ' ' LEU . 16.6 m -128.7 137.34 57.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.046 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 226' ' ' SER . . . . . 0.538 ' HA ' ' CD2' ' B' ' 273' ' ' HIS . 8.7 t -96.24 176.78 5.94 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 120.976 0.417 . . . . 0.0 110.301 -178.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -65.31 -28.93 69.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.437 -173.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.18 -50.32 68.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.043 0.449 . . . . 0.0 110.283 -178.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -65.44 -42.72 92.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.459 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.535 HG12 HD12 ' B' ' 235' ' ' LEU . 88.5 mt -63.34 -34.36 66.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.965 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 31.4 t -69.57 -21.24 63.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.0 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 29.2 t-80 -98.17 -45.73 6.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.836 0.351 . . . . 0.0 110.921 -177.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -86.2 -20.95 27.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.835 -176.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm 59.57 80.76 0.19 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.351 0.596 . . . . 0.0 111.612 -177.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 235' ' ' LEU . . . . . 0.85 HD21 ' HG2' ' A' ' 53' ' ' PRO . 40.9 mt -83.24 -168.92 2.28 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.754 178.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 59.0 t -109.82 109.21 27.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.088 0.471 . . . . 0.0 111.089 -178.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 237' ' ' LYS . . . . . 0.567 ' HE3' ' HB3' ' B' ' 289' ' ' GLU . 23.1 tptm -73.97 112.67 10.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.789 175.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 3.8 m -100.05 -4.41 9.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -175.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 136.07 -171.82 22.62 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 119.979 -1.105 . . . . 0.0 112.999 176.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 240' ' ' THR . . . . . 0.559 HG23 ' HG2' ' B' ' 289' ' ' GLU . 29.8 m -128.63 134.26 48.51 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -178.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 32.8 pt -107.86 137.62 38.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.945 0.402 . . . . 0.0 110.386 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -111.58 115.12 28.63 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.839 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 243' ' ' VAL . . . . . 0.526 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 34.9 t -94.05 109.35 21.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.108 -178.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 23.1 t -110.06 98.36 7.65 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 245' ' ' GLN . . . . . 0.637 ' O ' ' HA ' ' B' ' 283' ' ' ASN . 0.5 OUTLIER -87.89 148.39 24.64 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.946 -177.892 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 51.1 m -126.32 107.04 9.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.209 0.528 . . . . 0.0 111.056 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 101.05 -141.38 15.32 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.322 177.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -107.85 42.29 1.98 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.329 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -63.51 -46.44 86.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.752 0.311 . . . . 0.0 110.365 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 250' ' ' ILE . . . . . 0.588 HG12 ' HG2' ' B' ' 245' ' ' GLN . 47.2 mm -77.56 99.89 2.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.392 0.615 . . . . 0.0 109.585 177.143 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 5.7 m -100.68 -26.01 13.95 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.691 -174.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 1.9 m -136.52 162.36 56.65 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -177.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 253' ' ' PRO . . . . . 0.776 ' HG3' ' HB3' ' A' ' 33' ' ' PHE . 48.0 Cg_exo -56.06 -36.38 96.08 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.241 1.961 . . . . 0.0 111.537 175.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 254' ' ' SER . . . . . . . . . . . . . 4.3 m -69.25 -24.26 63.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.653 -178.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.17 -34.93 74.27 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.013 0.435 . . . . 0.0 111.523 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.471 ' O ' ' HG ' ' B' ' 260' ' ' LEU . 22.3 tp -65.11 -38.52 90.96 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.749 -177.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 257' ' ' ARG . . . . . 0.438 HH21 ' CD ' ' B' ' 258' ' ' GLU . 2.9 ttp85 -63.83 -35.82 81.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.996 0.427 . . . . 0.0 110.424 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 258' ' ' GLU . . . . . 0.438 ' CD ' HH21 ' B' ' 257' ' ' ARG . 17.0 mm-40 -62.27 -43.06 99.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.249 -178.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -71.79 -34.74 69.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.041 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 260' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' B' ' 256' ' ' LEU . 95.2 mt -69.18 -46.2 68.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.003 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 24.2 p -65.47 -34.75 79.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.802 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -54.18 -51.11 65.39 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.247 0.546 . . . . 0.0 110.439 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 263' ' ' LEU . . . . . 0.483 ' O ' ' HG2' ' B' ' 267' ' ' LYS . 98.2 mt -71.79 -41.69 68.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.172 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -63.84 -32.12 73.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.822 0.344 . . . . 0.0 111.486 -178.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -71.9 -44.27 64.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.814 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -67.0 -30.82 71.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.265 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 267' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' B' ' 263' ' ' LEU . 74.3 mmtt -79.52 -55.82 4.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.002 0.43 . . . . 0.0 110.095 176.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 114.64 48.08 0.56 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.252 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -97.95 -169.63 32.3 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.478 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 270' ' ' LYS . . . . . 0.47 ' HB2' ' HA ' ' B' ' 292' ' ' ASN . 4.4 tptp -131.53 -29.9 1.72 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.709 0.29 . . . . 0.0 110.882 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 271' ' ' TYR . . . . . 0.437 ' HB3' ' HA ' ' B' ' 224' ' ' GLN . 6.4 m-85 -147.95 173.53 12.78 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 177.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 272' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.65 167.18 22.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.766 0.317 . . . . 0.0 110.796 174.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 273' ' ' HIS . . . . . 0.538 ' CD2' ' HA ' ' B' ' 226' ' ' SER . 19.5 t-80 -148.04 103.5 3.48 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.184 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 274' ' ' ILE . . . . . 0.519 HG13 ' HB2' ' B' ' 288' ' ' ALA . 4.2 mp -70.25 135.23 28.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 31.2 pt -113.99 -28.87 2.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.699 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -157.7 146.97 19.8 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.645 0.259 . . . . 0.0 110.956 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -156.37 139.26 15.29 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 278' ' ' ARG . . . . . 0.435 ' HD2' ' N ' ' B' ' 278' ' ' ARG . 0.0 OUTLIER -155.92 136.39 13.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.969 0.414 . . . . 0.0 111.214 -179.157 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -88.72 102.64 15.18 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 171.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -114.84 103.72 11.23 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 73.6 -134.49 19.24 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.667 -176.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -82.95 -9.16 10.86 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.589 2.193 . . . . 0.0 111.877 176.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 283' ' ' ASN . . . . . 0.637 ' HA ' ' O ' ' B' ' 245' ' ' GLN . 93.4 m-20 -101.37 113.48 26.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.463 -175.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -87.4 107.47 18.55 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 170.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 285' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -100.8 113.67 26.78 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.06 -175.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 286' ' ' ALA . . . . . 0.526 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -117.94 124.24 47.76 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.49 178.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 24.5 t -106.27 112.81 41.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.159 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 288' ' ' ALA . . . . . 0.519 ' HB2' HG13 ' B' ' 274' ' ' ILE . . . -125.63 132.54 52.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.274 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 289' ' ' GLU . . . . . 0.567 ' HB3' ' HE3' ' B' ' 237' ' ' LYS . 18.1 mt-10 -94.83 138.88 32.05 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 21.9 t -103.64 138.93 26.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.972 0.415 . . . . 0.0 110.408 -174.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -128.15 152.18 48.34 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.336 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 292' ' ' ASN . . . . . 0.47 ' HA ' ' HB2' ' B' ' 270' ' ' LYS . 12.2 t-20 -120.01 163.4 17.68 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 174.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 16.1 t70 . . . . . 0 C--N 1.326 -0.42 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -176.875 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.379 0 CA-C-O 120.508 0.194 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.437 ' HA ' ' OH ' ' B' ' 272' ' ' TYR . 0.5 OUTLIER -161.23 121.98 2.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.051 0.453 . . . . 0.0 111.84 -178.812 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 1.05 ' HG3' ' HG3' ' B' ' 224' ' ' GLN . 6.4 tm0? -150.35 144.34 25.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.777 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.2 m -126.78 152.27 34.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 172.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.627 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 6.9 m -108.38 -79.77 0.58 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.074 0.464 . . . . 0.0 110.746 -178.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -165.68 -48.25 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -176.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.422 ' HG3' ' CD ' ' A' ' 29' ' ' GLU . 5.2 pt20 -56.95 -36.44 70.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.058 176.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.422 ' CD ' ' HG3' ' A' ' 28' ' ' GLN . 25.6 mp0 -72.73 -40.1 66.37 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.563 HG23 ' HB2' ' A' ' 35' ' ' LEU . 87.8 mt -61.72 -48.58 88.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.247 -178.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.4 m -68.44 -21.37 64.65 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.259 -177.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -92.97 -43.57 8.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.529 -176.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.545 ' HB3' ' HD3' ' B' ' 253' ' ' PRO . 82.9 m-85 -98.61 -2.91 37.38 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -175.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.7 mptt 65.06 90.1 0.09 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.394 0.616 . . . . 0.0 111.894 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.563 ' HB2' HG23 ' A' ' 30' ' ' ILE . 97.2 mt -121.54 147.86 45.24 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.804 176.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.3 t -103.38 125.09 57.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.912 0.387 . . . . 0.0 111.399 -174.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -69.67 111.57 5.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.092 173.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.1 m -94.8 -8.29 9.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.874 -177.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.34 -160.2 29.36 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.179 -1.01 . . . . 0.0 112.785 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 64.6 m -145.15 135.94 24.56 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 122.596 0.358 . . . . 0.0 110.247 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.7 pt -104.68 143.28 16.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 176.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -122.88 123.51 41.15 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.013 0.435 . . . . 0.0 111.346 -175.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.687 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 67.4 t -97.26 130.72 45.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.294 174.148 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.9 t -157.68 40.97 0.29 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.5 ' NE2' HG13 ' A' ' 43' ' ' VAL . 0.9 OUTLIER -81.57 158.32 24.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.646 -172.119 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.8 t -99.7 87.12 3.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.932 -172.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.61 -84.19 0.55 Allowed Glycine 0 C--O 1.224 -0.524 0 N-CA-C 114.582 0.593 . . . . 0.0 114.582 170.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -49.94 -42.35 38.43 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 114.923 0.729 . . . . 0.0 114.923 -168.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.438 ' OE1' ' HG2' ' A' ' 45' ' ' GLN . 63.8 mt-30 -71.03 -18.03 62.6 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -174.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.7 mm -129.43 123.93 58.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.62 0.248 . . . . 0.0 110.79 -175.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.7 t -140.25 -51.47 0.49 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.017 0.437 . . . . 0.0 110.814 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.547 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 46.4 m -128.41 172.63 6.64 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 178.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.794 ' HD3' ' HB3' ' B' ' 233' ' ' PHE . 59.3 Cg_exo -51.7 -34.96 55.98 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.49 2.126 . . . . 0.0 111.97 178.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.55 ' O ' ' HG3' ' A' ' 58' ' ' GLU . 16.7 p -58.34 -56.72 18.42 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.072 179.208 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -58.7 -37.67 76.6 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.876 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 61.9 tp -64.12 -52.55 58.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.121 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.427 ' HG3' ' O ' ' A' ' 53' ' ' PRO . 7.4 ppt_? -69.85 -25.91 63.96 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.501 -177.074 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.55 ' HG3' ' O ' ' A' ' 54' ' ' SER . 38.8 mt-10 -62.61 -40.84 98.21 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 120.835 0.35 . . . . 0.0 110.24 173.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -74.31 -38.52 63.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.611 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.6 mt -64.5 -48.88 73.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.707 -177.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.487 ' HB2' ' HG2' ' B' ' 223' ' ' GLU . 17.0 t -65.92 -35.55 80.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.858 0.361 . . . . 0.0 110.483 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -60.74 -42.12 96.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.15 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 93.4 mt -75.02 -32.71 61.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.293 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.57 -41.7 68.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.281 -178.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -58.93 -41.72 88.02 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 176.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.75 -4.99 30.8 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.855 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -104.71 -9.36 18.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.191 0.52 . . . . 0.0 110.178 174.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.54 26.12 72.49 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.312 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -112.53 146.65 18.26 Favored Glycine 0 C--O 1.225 -0.447 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.764 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -97.19 -14.17 21.61 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -172.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.16 144.12 32.07 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -176.08 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.519 ' CD2' ' HB1' ' B' ' 222' ' ' ALA . 15.5 p90 -129.91 157.51 42.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.82 0.343 . . . . 0.0 110.13 172.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.627 ' CD2' ' HA ' ' A' ' 26' ' ' SER . 8.1 t-160 -128.74 109.34 11.22 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.868 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.598 HG12 ' HB2' ' A' ' 88' ' ' ALA . 57.6 mt -75.95 116.68 19.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.314 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.4 pt -107.15 -15.54 8.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.803 -176.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -153.25 142.5 21.51 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.616 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 85' ' ' GLU . . . -162.77 139.35 7.52 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.9 152.12 22.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.753 0.311 . . . . 0.0 110.701 178.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -89.9 107.54 19.17 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 171.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -112.51 84.91 2.06 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.092 0.473 . . . . 0.0 110.301 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.18 -123.29 20.74 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.264 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -84.28 -3.57 10.2 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.845 2.363 . . . . 0.0 112.864 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 58.8 m-20 -119.26 128.9 54.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.748 0.309 . . . . 0.0 110.611 -176.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -93.14 123.46 36.42 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 173.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.687 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 43.1 mt-10 -108.5 129.07 55.29 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.879 0.371 . . . . 0.0 111.066 -176.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.519 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -138.28 132.58 31.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.231 177.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.3 t -114.21 112.87 41.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.012 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.598 ' HB2' HG12 ' A' ' 74' ' ' ILE . . . -128.04 129.09 46.12 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.724 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 40' ' ' THR . 26.5 mt-10 -91.88 139.15 30.95 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.6 t -100.39 136.76 30.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -176.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -124.19 150.88 44.7 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.291 0.567 . . . . 0.0 111.127 -177.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -130.33 158.64 39.25 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.464 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 120.766 0.317 . . . . 0.0 110.317 178.717 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 222' ' ' ALA . . . . . 0.519 ' HB1' ' CD2' ' A' ' 72' ' ' TYR . . . . . . . . 0 C--O 1.231 0.117 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 223' ' ' GLU . . . . . 0.935 ' HB3' ' HE2' ' B' ' 271' ' ' TYR . 28.2 mt-10 -144.42 124.36 13.52 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.737 173.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 224' ' ' GLN . . . . . 1.05 ' HG3' ' HG3' ' A' ' 24' ' ' GLN . 0.9 OUTLIER -153.69 146.42 24.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.867 -172.813 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 225' ' ' VAL . . . . . 0.527 ' HB ' HD11 ' B' ' 235' ' ' LEU . 11.6 m -116.26 126.56 73.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 170.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 226' ' ' SER . . . . . 0.429 ' O ' HG13 ' B' ' 230' ' ' ILE . 6.7 t -95.99 -167.33 1.57 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.374 0.607 . . . . 0.0 111.523 -173.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 227' ' ' LYS . . . . . 0.465 ' HA ' HD12 ' B' ' 230' ' ' ILE . 2.2 tmtp? -75.67 -28.91 58.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.831 -172.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -72.86 -43.73 62.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.088 0.47 . . . . 0.0 110.539 -177.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -61.8 -26.94 68.41 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.459 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.504 HG12 HD12 ' B' ' 235' ' ' LEU . 69.9 mt -57.83 -57.23 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.096 0.474 . . . . 0.0 110.253 176.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 11.2 m -73.69 -50.61 20.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.05 -177.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -76.24 -38.59 56.11 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -170.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 233' ' ' PHE . . . . . 0.794 ' HB3' ' HD3' ' A' ' 53' ' ' PRO . 37.7 m-85 -102.71 -5.8 23.35 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -173.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt 67.01 92.01 0.08 Allowed 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.853 0.721 . . . . 0.0 110.996 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 235' ' ' LEU . . . . . 0.527 HD11 ' HB ' ' B' ' 225' ' ' VAL . 28.1 mt -97.23 141.06 30.8 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.023 178.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 21.7 t -66.64 -50.14 68.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.237 -178.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 237' ' ' LYS . . . . . 0.526 ' HA ' ' HA ' ' B' ' 291' ' ' TYR . 50.7 tttm 65.78 120.39 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.901 -175.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 38.1 t -91.14 -46.62 14.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.43 -177.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.73 -152.03 16.57 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.871 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 21.3 m -127.62 140.09 52.32 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 241' ' ' ILE . . . . . 0.434 HG23 HG21 ' B' ' 290' ' ' VAL . 19.2 pt -113.08 141.88 27.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.887 0.375 . . . . 0.0 110.683 176.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -120.21 126.54 50.88 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.835 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 243' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' B' ' 285' ' ' GLU . 88.1 t -94.02 132.25 38.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.061 175.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 11.0 p -152.93 64.3 0.78 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.442 0.639 . . . . 0.0 110.776 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 245' ' ' GLN . . . . . 0.402 HE22 HG13 ' B' ' 243' ' ' VAL . 0.9 OUTLIER -97.95 143.85 28.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.295 -179.698 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 6.2 t -86.62 36.84 0.72 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.357 0.598 . . . . 0.0 110.412 -174.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 88.0 167.94 43.89 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.227 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . 82.35 -49.35 4.13 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.821 176.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -71.26 -18.49 62.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.839 0.352 . . . . 0.0 111.201 -178.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 250' ' ' ILE . . . . . 0.481 ' HA ' ' HB3' ' B' ' 255' ' ' ASP . 40.8 mm -126.61 107.59 17.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 34.7 t -135.52 3.5 3.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.601 0.239 . . . . 0.0 111.129 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 252' ' ' SER . . . . . 0.525 ' HB2' ' HD2' ' B' ' 253' ' ' PRO . 95.7 p -158.38 167.21 14.89 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -178.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 253' ' ' PRO . . . . . 0.545 ' HD3' ' HB3' ' A' ' 33' ' ' PHE . 15.9 Cg_endo -59.14 -37.8 90.13 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.261 1.974 . . . . 0.0 111.019 173.241 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 254' ' ' SER . . . . . 0.573 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 15.3 m -60.75 -46.13 91.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.682 176.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 255' ' ' ASP . . . . . 0.481 ' HB3' ' HA ' ' B' ' 250' ' ' ILE . 24.9 m-20 -55.12 -50.11 70.07 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.663 0.268 . . . . 0.0 110.786 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.483 ' O ' ' HG ' ' B' ' 260' ' ' LEU . 57.0 tp -60.01 -45.94 91.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.068 178.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -57.27 -48.24 79.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.962 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 258' ' ' GLU . . . . . 0.573 ' HG2' ' O ' ' B' ' 254' ' ' SER . 43.8 mm-40 -58.13 -39.49 78.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.475 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 259' ' ' LYS . . . . . 0.436 ' HD3' ' O ' ' B' ' 255' ' ' ASP . 13.5 mptt -77.28 -35.48 55.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.395 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 260' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' B' ' 256' ' ' LEU . 87.7 mt -64.97 -47.41 77.68 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.501 0.191 . . . . 0.0 110.965 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 6.1 m -61.85 -30.79 71.09 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.205 0.526 . . . . 0.0 110.274 177.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -70.07 -52.76 21.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.753 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 263' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' B' ' 259' ' ' LYS . 88.0 mt -64.08 -36.9 85.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.263 -176.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -66.24 -38.3 87.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.279 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -72.38 -36.7 68.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.439 -177.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -63.27 -30.2 71.39 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.806 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -72.2 -32.9 67.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.352 175.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 117.46 -3.59 17.98 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.234 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -99.44 -153.59 27.86 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.594 -177.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm -150.53 -60.17 0.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.771 0.32 . . . . 0.0 111.049 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 271' ' ' TYR . . . . . 0.935 ' HE2' ' HB3' ' B' ' 223' ' ' GLU . 62.1 m-85 -90.41 148.1 23.01 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -172.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 272' ' ' TYR . . . . . 0.437 ' OH ' ' HA ' ' A' ' 23' ' ' GLU . 10.0 p90 -147.08 167.59 23.69 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.906 0.384 . . . . 0.0 111.423 -174.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 273' ' ' HIS . . . . . 0.522 ' HA ' ' OE1' ' A' ' 24' ' ' GLN . 0.6 OUTLIER -139.47 113.35 8.65 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.878 177.529 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 274' ' ' ILE . . . . . 0.438 ' H ' HD12 ' B' ' 274' ' ' ILE . 4.4 mp -70.67 121.63 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 178.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 30.1 pt -102.43 -24.53 4.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.526 -178.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -153.85 140.73 19.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.863 -178.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -144.79 123.51 12.58 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.779 177.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 278' ' ' ARG . . . . . 0.411 ' HE ' ' CD ' ' B' ' 285' ' ' GLU . 6.1 ptt180 -129.2 134.5 48.03 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.084 0.468 . . . . 0.0 110.691 -178.211 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -99.21 89.89 4.39 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 173.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -92.77 85.42 5.21 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.058 -173.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 62.08 -116.1 8.89 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.725 176.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.49 -16.57 21.54 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.716 2.277 . . . . 0.0 112.808 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 -105.99 162.89 13.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.176 0.512 . . . . 0.0 110.952 -175.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -132.12 104.7 6.94 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 171.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 285' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 21.4 mp0 -107.13 134.08 50.78 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.063 0.459 . . . . 0.0 110.843 -176.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 286' ' ' ALA . . . . . 0.416 ' H ' ' HB ' ' B' ' 243' ' ' VAL . . . -137.19 147.08 45.63 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.585 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 32.8 t -123.25 122.53 65.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.947 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -131.84 143.62 50.31 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.937 0.399 . . . . 0.0 111.069 -178.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -91.56 123.94 35.35 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.824 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 290' ' ' VAL . . . . . 0.434 HG21 HG23 ' B' ' 241' ' ' ILE . 53.5 t -94.34 129.36 44.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.884 0.373 . . . . 0.0 110.851 -177.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 291' ' ' TYR . . . . . 0.526 ' HA ' ' HA ' ' B' ' 237' ' ' LYS . 64.0 m-85 -121.79 171.06 9.16 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.058 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 292' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -123.09 157.47 32.79 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 174.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 36.7 t70 . . . . . 0 C--N 1.32 -0.691 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.625 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.771 ' HA ' ' HG3' ' B' ' 223' ' ' GLU . . . . . . . . 0 N--CA 1.453 -0.275 0 CA-C-O 120.446 0.165 . . . . 0.0 110.97 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.559 ' HG3' ' HB2' ' B' ' 257' ' ' ARG . 17.0 tt0 80.9 104.97 0.07 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 124.37 1.043 . . . . 0.0 110.358 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.519 ' HA ' ' HB3' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -162.18 154.11 18.87 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.39 -174.333 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.433 HG22 ' HB2' ' A' ' 71' ' ' TYR . 27.1 m -106.79 139.27 28.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.854 0.359 . . . . 0.0 110.877 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.691 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 7.4 t -93.98 -86.11 0.28 Allowed 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.328 -175.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -157.97 -49.15 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.225 -176.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -58.56 -40.42 83.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.067 0.461 . . . . 0.0 110.53 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.406 ' H ' ' CD ' ' A' ' 29' ' ' GLU . 1.2 mp0 -64.87 -37.89 89.13 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.664 178.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.564 HG12 HD12 ' A' ' 35' ' ' LEU . 58.5 mt -66.72 -39.46 83.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.442 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.9 m -68.81 -35.03 76.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.086 0.47 . . . . 0.0 110.86 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -85.87 -45.17 11.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.416 -174.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -92.24 -19.38 22.26 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -175.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.439 ' HB2' ' NZ ' ' A' ' 34' ' ' LYS . 0.2 OUTLIER 65.83 85.18 0.14 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.127 0.489 . . . . 0.0 111.388 -177.614 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.564 HD12 HG12 ' A' ' 30' ' ' ILE . 67.7 mt -94.35 175.67 6.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.676 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.7 t -105.97 123.6 60.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.33 -175.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.8 tttp -81.4 112.35 18.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.191 176.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.42 HG23 ' HB ' ' A' ' 90' ' ' VAL . 21.2 m -107.48 22.4 3.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -173.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 120.9 -164.8 14.11 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.306 -0.949 . . . . 0.0 112.897 174.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.617 HG23 ' HG2' ' A' ' 89' ' ' GLU . 12.9 m -140.06 134.69 31.71 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 -176.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.7 pt -107.21 151.05 9.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 174.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -125.52 123.04 38.27 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.033 0.444 . . . . 0.0 111.628 -174.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.611 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 73.0 t -99.1 117.68 44.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.348 172.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 63.5 p -145.98 72.81 1.31 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.245 0.545 . . . . 0.0 109.718 176.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.429 HE22 HG13 ' A' ' 43' ' ' VAL . 0.7 OUTLIER -100.5 148.77 24.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.03 -176.706 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.4 m -86.4 56.64 4.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.594 -176.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.82 -71.05 2.79 Favored Glycine 0 C--O 1.227 -0.337 0 C-N-CA 121.261 -0.495 . . . . 0.0 114.129 173.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -54.01 -28.71 41.65 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 115.164 0.825 . . . . 0.0 115.164 -169.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -78.61 -14.57 59.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.59 0.695 . . . . 0.0 111.606 -177.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.0 mm -120.32 107.53 21.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.163 0.506 . . . . 0.0 110.185 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.2 m -114.52 -45.13 3.03 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.576 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 87.7 p -124.78 164.28 32.01 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.739 177.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.783 ' HB2' ' HB2' ' B' ' 293' ' ' ASP . 24.2 Cg_exo -64.34 -20.19 66.27 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.28 1.986 . . . . 0.0 111.644 174.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.506 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 75.2 m -69.06 -42.75 75.85 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.084 173.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -62.87 -39.11 93.41 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.217 0.532 . . . . 0.0 109.717 176.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 61.7 tp -60.36 -41.36 93.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.964 176.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.461 ' HD2' ' OE1' ' B' ' 223' ' ' GLU . 9.5 ttp85 -61.3 -43.86 98.18 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.552 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 54' ' ' SER . 22.9 mm-40 -53.49 -50.78 64.63 Favored 'General case' 0 C--N 1.332 -0.165 0 O-C-N 123.51 0.506 . . . . 0.0 110.616 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.503 ' HA ' ' HG2' ' A' ' 62' ' ' GLU . 4.3 mptp? -67.44 -41.62 84.45 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.573 -178.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 85.0 mt -63.34 -34.16 77.1 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.005 0.431 . . . . 0.0 110.482 177.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.6 t -70.6 -52.46 21.33 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.724 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.503 ' HG2' ' HA ' ' A' ' 59' ' ' LYS . 13.0 pt-20 -65.26 -31.46 72.63 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -175.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 82.9 mt -66.98 -47.07 72.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.84 0.353 . . . . 0.0 111.172 177.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.532 ' O ' ' HG3' ' A' ' 67' ' ' LYS . . . -74.01 -43.9 56.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.608 -177.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -59.57 -51.52 69.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.548 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.9 -18.97 64.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.038 -176.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.532 ' HG3' ' O ' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -91.19 -13.92 32.0 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.439 -179.285 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.64 44.35 4.91 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.212 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -130.07 151.76 19.49 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.097 -0.573 . . . . 0.0 111.813 177.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.459 ' O ' ' HB2' ' B' ' 222' ' ' ALA . 17.7 mmtp -88.4 -72.78 0.52 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.86 0.362 . . . . 0.0 111.543 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.519 ' HB3' ' HA ' ' A' ' 24' ' ' GLN . 0.4 OUTLIER -108.19 169.82 8.39 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -173.128 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -140.68 167.51 22.0 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.691 ' CD2' ' HA ' ' A' ' 26' ' ' SER . 4.8 t-80 -139.08 110.59 7.04 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.753 174.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 59.8 mt -65.89 113.93 2.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.804 176.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 31.8 pt -97.73 -26.31 3.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.966 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -156.21 131.69 9.5 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.328 178.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -135.65 98.81 4.02 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -125.32 165.69 17.9 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.513 -173.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -109.69 129.33 55.61 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.963 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -100.5 18.39 19.21 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.335 0.588 . . . . 0.0 109.647 -178.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 110.25 -98.93 1.13 Allowed Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.463 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.83 -13.86 11.49 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.522 2.148 . . . . 0.0 112.103 176.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -114.34 139.26 49.61 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.019 -176.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -99.83 115.8 30.42 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 172.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 50.5 mt-10 -107.18 111.14 23.42 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.946 0.403 . . . . 0.0 110.73 -175.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.611 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -120.38 117.34 27.49 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.258 177.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.5 t -98.61 112.97 32.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.034 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -126.46 123.89 38.88 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.017 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.617 ' HG2' HG23 ' A' ' 40' ' ' THR . 10.4 mt-10 -93.46 143.99 25.77 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.42 ' HB ' HG23 ' A' ' 38' ' ' VAL . 10.6 t -96.6 130.43 45.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.894 0.378 . . . . 0.0 110.356 -171.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -125.61 133.88 52.09 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.821 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -107.48 161.44 14.83 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.2 t70 . . . . . 0 C--O 1.238 0.476 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -179.37 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 222' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 70' ' ' LYS . . . . . . . . 0 N--CA 1.453 -0.324 0 N-CA-C 110.243 -0.281 . . . . 0.0 110.243 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 223' ' ' GLU . . . . . 0.771 ' HG3' ' HA ' ' A' ' 22' ' ' ALA . 0.9 OUTLIER -170.36 124.7 0.72 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -176.212 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 224' ' ' GLN . . . . . 0.48 ' HA ' ' HB3' ' B' ' 271' ' ' TYR . 1.4 tm0? -171.48 149.26 2.65 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.325 177.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 29.0 m -114.77 151.42 16.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.513 176.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 226' ' ' SER . . . . . 0.532 ' HA ' ' CE1' ' B' ' 273' ' ' HIS . 57.5 p -113.59 -96.21 0.45 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -136.05 -36.05 0.76 Allowed 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 228' ' ' GLN . . . . . 0.402 ' HB2' ' OE2' ' B' ' 229' ' ' GLU . 0.7 OUTLIER -58.61 -43.1 89.5 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.443 0.639 . . . . 0.0 109.98 -178.921 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 229' ' ' GLU . . . . . 0.537 ' CD ' ' H ' ' B' ' 229' ' ' GLU . 3.2 mp0 -58.72 -45.22 90.08 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.448 177.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.542 HG12 HD12 ' B' ' 235' ' ' LEU . 55.7 mt -63.44 -39.3 84.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.528 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 15.2 m -69.82 -23.13 63.26 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.086 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -93.5 -57.6 2.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.602 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -90.05 -14.38 33.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.157 -170.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt 59.07 82.78 0.14 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.252 0.549 . . . . 0.0 110.082 -175.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 235' ' ' LEU . . . . . 0.573 HD22 ' HA ' ' B' ' 293' ' ' ASP . 55.1 mt -80.32 178.8 8.04 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.477 -171.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.574 ' HB ' ' HB2' ' B' ' 292' ' ' ASN . 40.8 t -103.61 109.35 26.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.135 -0.938 . . . . 0.0 110.288 -178.169 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -76.33 125.75 29.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.711 -176.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 238' ' ' VAL . . . . . 0.69 HG12 ' HD2' ' B' ' 267' ' ' LYS . 4.1 t -100.73 -17.53 6.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-O 121.334 0.588 . . . . 0.0 110.847 -176.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 115.81 162.64 13.38 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.391 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.04 145.07 31.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.046 0.45 . . . . 0.0 111.505 -177.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 32.2 pt -126.87 132.04 70.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 169.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -117.45 132.39 56.57 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.993 0.901 . . . . 0.0 111.477 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 243' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 66.5 t -93.99 131.0 42.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 114.528 -1.214 . . . . 0.0 109.999 -177.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 15.4 t -148.06 95.74 2.53 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 176.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 245' ' ' GLN . . . . . . . . . . . . . 8.6 mp0 -136.91 152.37 50.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.124 176.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 246' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' B' ' 283' ' ' ASN . 15.3 m -76.94 162.72 27.36 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.012 -178.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -58.72 106.11 0.8 Allowed Glycine 0 C--N 1.331 0.275 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.916 176.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . 151.92 -50.41 0.52 Allowed Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -174.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -78.13 -28.99 48.59 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 173.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 42.8 mm -121.27 123.43 69.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.675 171.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 22.2 t -149.88 -38.72 0.14 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.95 0.405 . . . . 0.0 110.379 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 252' ' ' SER . . . . . 0.441 ' HB3' ' HD2' ' B' ' 253' ' ' PRO . 16.5 m -113.16 161.53 26.47 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.152 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 253' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' B' ' 252' ' ' SER . 13.7 Cg_endo -57.78 -20.89 45.48 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.675 2.25 . . . . 0.0 112.189 177.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 254' ' ' SER . . . . . 0.625 ' HA ' ' NH1' ' B' ' 257' ' ' ARG . 22.6 t -65.94 -51.08 61.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.522 177.232 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 255' ' ' ASP . . . . . 0.461 ' O ' ' HG2' ' B' ' 259' ' ' LYS . 9.3 m-20 -54.47 -45.4 73.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.383 -173.169 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 49.3 tp -60.3 -60.61 3.54 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.234 -174.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 257' ' ' ARG . . . . . 0.625 ' NH1' ' HA ' ' B' ' 254' ' ' SER . 0.0 OUTLIER -68.03 -25.92 65.62 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -174.636 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 258' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' B' ' 254' ' ' SER . 53.8 mt-10 -70.18 -32.19 70.0 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.398 179.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 259' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' B' ' 255' ' ' ASP . 74.8 mmtt -73.03 -44.21 61.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.986 0.422 . . . . 0.0 109.965 174.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.32 -48.26 82.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.612 -177.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 41.0 m -60.88 -35.34 76.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.677 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -68.37 -41.76 80.15 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.008 0.432 . . . . 0.0 110.529 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 263' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' B' ' 259' ' ' LYS . 98.1 mt -67.46 -44.18 79.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.008 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -61.44 -41.99 98.06 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.158 177.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -54.03 -53.87 47.0 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.306 176.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -64.01 -31.18 72.28 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.048 0.451 . . . . 0.0 111.02 -177.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 267' ' ' LYS . . . . . 0.69 ' HD2' HG12 ' B' ' 238' ' ' VAL . 32.7 mmtt -62.5 -38.7 90.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.21 176.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 94.9 15.33 45.98 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -170.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 269' ' ' GLY . . . . . 0.492 ' HA2' ' ND2' ' B' ' 292' ' ' ASN . . . -106.87 146.76 16.1 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 270' ' ' LYS . . . . . 0.543 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 54.8 mtpt -79.66 -68.28 0.68 Allowed 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 121.133 -0.227 . . . . 0.0 111.415 -176.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 271' ' ' TYR . . . . . 0.593 ' HA ' ' HB2' ' A' ' 22' ' ' ALA . 9.9 m-85 -97.93 154.41 17.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.101 0.477 . . . . 0.0 110.631 -173.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 272' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -122.62 136.42 54.88 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 175.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 273' ' ' HIS . . . . . 0.532 ' CE1' ' HA ' ' B' ' 226' ' ' SER . 36.4 t60 -110.98 101.79 10.32 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.667 0.27 . . . . 0.0 110.745 -176.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 274' ' ' ILE . . . . . . . . . . . . . 68.5 mt -70.16 122.12 21.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 176.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 61.5 mt -97.85 -52.65 8.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.152 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -140.73 147.52 39.31 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.968 -177.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -144.53 138.68 27.7 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -152.38 151.41 30.79 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.038 0.447 . . . . 0.0 110.811 -176.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -97.25 120.24 37.25 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 175.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -129.95 107.54 9.44 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.006 0.432 . . . . 0.0 110.813 -174.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 66.82 -127.62 28.29 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.787 -178.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -92.21 3.54 3.84 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.767 2.311 . . . . 0.0 112.472 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 283' ' ' ASN . . . . . 0.419 ' HA ' ' HA ' ' B' ' 246' ' ' SER . 81.0 m-20 -118.58 149.86 40.63 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.129 0.49 . . . . 0.0 111.415 -174.011 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -99.9 123.3 44.0 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.515 173.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 285' ' ' GLU . . . . . 0.453 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 21.1 mm-40 -107.75 121.21 44.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.457 -176.006 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 286' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -128.75 134.48 48.43 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 121.106 -0.238 . . . . 0.0 110.827 176.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 65.0 t -116.52 117.53 55.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.832 0.349 . . . . 0.0 110.386 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -133.28 142.99 48.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.467 -178.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -99.26 131.43 45.29 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.982 175.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 290' ' ' VAL . . . . . 0.582 ' HB ' ' HB ' ' B' ' 238' ' ' VAL . 32.7 t -90.09 133.81 30.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 176.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 291' ' ' TYR . . . . . 0.415 ' HA ' HG23 ' B' ' 238' ' ' VAL . 73.9 m-85 -132.58 134.12 44.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.993 0.425 . . . . 0.0 111.354 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 292' ' ' ASN . . . . . 0.574 ' HB2' ' HB ' ' B' ' 236' ' ' VAL . 23.2 m120 -90.73 123.71 34.53 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 165.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 293' ' ' ASP . . . . . 0.783 ' HB2' ' HB2' ' A' ' 53' ' ' PRO . 5.3 p-10 . . . . . 0 C--N 1.318 -0.79 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.432 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.448 ' HB3' ' HE1' ' A' ' 71' ' ' TYR . 30.9 mt-10 -144.43 -158.8 0.92 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.691 -175.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.647 ' HA ' ' CD1' ' A' ' 71' ' ' TYR . 1.6 tm0? 86.98 145.62 0.05 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.857 1.263 . . . . 0.0 111.447 178.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.424 HG21 ' CD1' ' A' ' 35' ' ' LEU . 31.1 m -109.82 140.98 26.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.356 -178.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.435 ' HB2' ' OE1' ' A' ' 29' ' ' GLU . 6.3 m -86.81 -174.08 4.78 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.296 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -69.92 -35.3 74.45 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -169.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -73.21 -33.93 65.65 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.561 -177.198 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.435 ' OE1' ' HB2' ' A' ' 26' ' ' SER . 3.0 mp0 -63.58 -45.03 92.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.099 0.476 . . . . 0.0 109.907 175.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.507 HG12 HD12 ' A' ' 35' ' ' LEU . 81.4 mt -56.76 -40.31 69.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.756 177.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.1 m -71.94 -20.74 61.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.305 -178.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -88.29 -42.19 12.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.476 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -89.56 -9.31 50.31 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 121.064 -0.255 . . . . 0.0 111.372 -178.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? 54.84 54.78 8.61 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.293 0.568 . . . . 0.0 110.237 -176.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.507 HD12 HG12 ' A' ' 30' ' ' ILE . 89.6 mt -66.17 145.93 55.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.44 -176.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.7 m -73.71 135.91 26.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.719 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.5 tttm -96.89 122.58 40.02 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.365 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.24 -47.11 20.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.973 0.416 . . . . 0.0 110.237 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 171.45 173.86 38.7 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.066 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 86.9 m -101.26 121.28 41.6 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.619 0.247 . . . . 0.0 110.467 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.1 pt -106.77 144.09 16.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 176.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -128.43 131.57 48.44 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.533 0.682 . . . . 0.0 110.882 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 70.7 t -93.99 128.5 45.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 114.255 -1.339 . . . . 0.0 109.311 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.0 t -150.35 78.17 1.32 Allowed 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.636 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 0.6 OUTLIER -103.1 130.68 50.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.997 -179.141 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.9 t -92.14 102.61 15.14 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.009 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.54 -130.21 10.18 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.055 -0.593 . . . . 0.0 114.405 171.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.91 34.06 2.59 Favored Glycine 0 C--N 1.331 0.26 0 N-CA-C 114.329 0.492 . . . . 0.0 114.329 -167.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.636 ' HB2' ' HB3' ' A' ' 45' ' ' GLN . 15.2 mm100 -82.68 -28.33 30.67 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 172.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.558 HD12 ' HA ' ' A' ' 56' ' ' LEU . 49.6 mm -122.95 112.1 32.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.407 176.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.0 m -118.46 -1.27 11.26 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.311 -176.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 40.4 m -155.93 148.46 17.82 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -58.73 -31.49 95.07 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.426 2.084 . . . . 0.0 111.21 176.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.57 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 2.8 p -69.72 -35.1 74.74 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.212 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -75.76 -32.1 59.81 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.879 0.371 . . . . 0.0 110.422 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.558 ' HA ' HD12 ' A' ' 50' ' ' ILE . 68.4 tp -59.59 -50.21 74.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.049 178.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.568 ' HD2' ' CD ' ' B' ' 223' ' ' GLU . 26.5 ptt85 -67.35 -32.8 73.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.952 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.57 ' HG2' ' O ' ' A' ' 54' ' ' SER . 9.5 mm-40 -55.5 -42.64 74.72 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.162 0.506 . . . . 0.0 110.006 176.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.501 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 13.7 mptt -58.76 -44.91 90.71 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.591 175.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.453 HD13 HD11 ' A' ' 74' ' ' ILE . 74.5 mt -64.89 -41.88 95.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.972 -176.01 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.4 m -60.18 -40.01 88.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.163 0.506 . . . . 0.0 110.168 175.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -69.04 -40.37 78.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.891 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 59' ' ' LYS . 87.9 mt -66.26 -37.49 85.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.221 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.96 -39.08 93.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.885 0.374 . . . . 0.0 110.523 178.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -68.04 -35.77 78.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.849 177.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.12 -32.7 70.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.285 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.416 ' HD3' ' HA ' ' A' ' 67' ' ' LYS . 71.5 mmtt -87.34 -26.54 23.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.882 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.53 43.96 3.3 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.511 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -120.44 -170.84 14.33 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.81 -0.709 . . . . 0.0 111.776 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -123.26 -36.08 2.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.966 0.412 . . . . 0.0 110.591 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.647 ' CD1' ' HA ' ' A' ' 24' ' ' GLN . 71.7 m-85 -132.6 166.74 21.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.007 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -148.96 131.3 15.61 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.609 ' HA ' HE21 ' A' ' 24' ' ' GLN . 56.1 t60 -109.72 105.61 14.93 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.078 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.509 ' HB ' ' OG ' ' B' ' 226' ' ' SER . 60.6 mt -67.77 130.89 33.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.272 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 33.5 pt -114.17 -16.27 9.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.15 -178.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.554 ' HB3' ' HB ' ' A' ' 87' ' ' VAL . . . -147.94 137.31 22.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.056 -176.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -156.51 103.54 2.13 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.41 145.97 35.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.776 0.322 . . . . 0.0 111.032 -176.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -82.14 124.96 30.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.199 0.523 . . . . 0.0 110.816 176.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.0 t-160 -100.19 50.61 0.9 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 175.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.14 -130.83 10.14 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 110.321 -1.111 . . . . 0.0 110.321 -170.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -79.61 6.0 5.47 Favored 'Trans proline' 0 N--CA 1.464 -0.229 0 C-N-CA 122.483 2.122 . . . . 0.0 111.499 173.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -108.96 121.93 46.16 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.284 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.471 ' CE2' ' HB2' ' A' ' 86' ' ' ALA . 70.1 t80 -93.36 122.77 36.11 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.964 -176.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 25.9 mm-40 -112.36 115.3 28.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.249 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.514 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -132.31 134.67 45.51 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.591 0.234 . . . . 0.0 111.057 178.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.554 ' HB ' ' HB3' ' A' ' 76' ' ' ALA . 97.2 t -114.46 121.86 67.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.939 0.4 . . . . 0.0 110.075 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 74' ' ' ILE . . . -125.19 138.07 54.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.165 -177.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.05 116.92 29.4 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.776 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.7 t -86.3 126.02 40.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.833 0.349 . . . . 0.0 110.655 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -123.52 156.51 35.5 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.986 178.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -110.19 172.65 6.74 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 16.8 t70 . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.299 -175.494 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.325 0 CA-C-O 120.517 0.199 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 223' ' ' GLU . . . . . 0.568 ' CD ' ' HD2' ' A' ' 57' ' ' ARG . 11.0 tp10 -164.97 135.72 3.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.213 -177.291 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 224' ' ' GLN . . . . . 0.439 ' HB2' ' O ' ' B' ' 223' ' ' GLU . 1.5 tm0? 170.76 139.98 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.811 0.694 . . . . 0.0 110.588 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 17.8 m -109.33 132.18 58.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.943 172.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 226' ' ' SER . . . . . 0.549 ' O ' HG13 ' B' ' 230' ' ' ILE . 5.8 m -88.69 172.8 8.99 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.846 0.355 . . . . 0.0 111.068 -175.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 227' ' ' LYS . . . . . 0.546 ' HA ' HD12 ' B' ' 230' ' ' ILE . 5.5 mmtt -57.47 -32.65 67.18 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.76 -174.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -68.56 -51.5 42.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.334 -177.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -63.24 -35.52 80.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.015 -177.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.556 HG12 HD12 ' B' ' 235' ' ' LEU . 82.3 mt -57.08 -52.29 58.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.846 178.135 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 18.3 m -74.18 -24.32 59.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.785 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 20.0 t-160 -75.17 -48.71 22.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.34 -175.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -96.72 -3.16 43.0 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.047 -177.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm 62.92 72.27 0.49 Allowed 'General case' 0 N--CA 1.463 0.224 0 O-C-N 123.67 0.606 . . . . 0.0 111.59 176.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 235' ' ' LEU . . . . . 0.556 HD12 HG12 ' B' ' 230' ' ' ILE . 69.6 mt -73.35 174.4 8.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.997 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 69.5 t -93.11 -49.19 13.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.644 -176.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 237' ' ' LYS . . . . . 0.602 ' HA ' ' HA ' ' B' ' 291' ' ' TYR . 60.0 tttm 69.97 139.92 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 O-C-N 123.877 0.735 . . . . 0.0 111.734 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 238' ' ' VAL . . . . . 0.547 HG13 ' HB2' ' B' ' 292' ' ' ASN . 3.3 m -111.15 -50.83 6.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . -178.65 -142.08 4.64 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.011 -1.09 . . . . 0.0 113.056 -177.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 63.4 m -134.38 145.36 48.89 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 122.621 0.368 . . . . 0.0 110.716 -176.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 20.5 pt -117.91 131.59 70.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 170.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -123.05 114.44 20.38 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.06 0.457 . . . . 0.0 110.338 -175.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 243' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 82.0 t -94.0 115.19 32.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.433 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 19.2 m -110.69 87.41 2.52 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 174.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 245' ' ' GLN . . . . . 0.524 ' HB3' ' HB3' ' B' ' 284' ' ' PHE . 0.7 OUTLIER -107.55 179.61 4.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.57 0.7 . . . . 0.0 111.53 -172.451 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 33.2 t -108.63 153.31 23.58 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 166.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -58.23 -29.07 62.38 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 121.17 -0.538 . . . . 0.0 113.768 -175.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -73.49 -11.83 80.16 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 121.043 -0.599 . . . . 0.0 113.908 -174.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -94.02 -6.81 44.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 117.482 0.641 . . . . 0.0 111.158 -178.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 47.2 mm -119.73 108.09 22.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.248 -178.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 23.7 t -121.72 -47.62 2.19 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.267 0.556 . . . . 0.0 109.998 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 3.9 m -113.28 156.6 42.87 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.435 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -57.89 -30.31 89.19 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.393 2.062 . . . . 0.0 111.748 176.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 254' ' ' SER . . . . . 0.494 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 18.8 m -63.16 -33.83 76.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.15 177.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -64.62 -45.89 84.95 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.137 0.494 . . . . 0.0 110.222 -178.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 54.3 tp -66.62 -39.39 88.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.941 177.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 257' ' ' ARG . . . . . 0.433 HH11 ' CD ' ' A' ' 23' ' ' GLU . 7.5 tmm_? -58.05 -42.07 84.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.076 178.031 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 258' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' B' ' 254' ' ' SER . 69.7 mm-40 -57.94 -29.54 65.24 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.57 178.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -85.64 -47.95 9.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.945 0.402 . . . . 0.0 110.658 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 96.0 mt -66.1 -49.72 66.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.119 -174.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 14.6 m -66.88 -33.23 75.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.825 0.345 . . . . 0.0 110.857 -176.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -62.48 -45.68 91.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.264 0.554 . . . . 0.0 110.287 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 263' ' ' LEU . . . . . 0.624 ' O ' ' HG2' ' B' ' 267' ' ' LYS . 92.3 mt -74.39 -44.88 50.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.002 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -59.02 -48.92 79.83 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -175.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -66.87 -31.47 72.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.873 0.368 . . . . 0.0 110.547 -178.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -69.3 -19.23 63.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.9 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 267' ' ' LYS . . . . . 0.624 ' HG2' ' O ' ' B' ' 263' ' ' LEU . 74.2 mmtt -84.76 -20.48 30.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.083 0.468 . . . . 0.0 110.141 177.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 107.23 -3.94 35.29 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.548 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -90.25 153.26 22.7 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.157 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -111.98 -9.98 13.98 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -177.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 271' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -135.79 162.22 33.4 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 272' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -151.24 167.48 27.69 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.414 170.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -135.47 108.55 7.68 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 172.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 274' ' ' ILE . . . . . 0.477 HG12 ' HB2' ' B' ' 288' ' ' ALA . 62.3 mt -65.21 130.54 30.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 29.4 pt -108.58 -21.29 5.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.658 -175.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -159.76 112.84 2.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.973 -179.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 277' ' ' ALA . . . . . 0.406 ' HB3' ' HG3' ' A' ' 29' ' ' GLU . . . -133.46 103.49 5.96 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 176.385 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -147.22 175.1 11.01 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.482 -171.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.19 108.47 19.11 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.17 -178.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 33.8 t-80 -90.64 69.83 6.71 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 175.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 75.67 -122.38 6.68 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 -174.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -79.71 -3.81 13.09 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.568 2.179 . . . . 0.0 112.19 175.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -94.99 140.92 29.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.419 -177.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 284' ' ' PHE . . . . . 0.524 ' HB3' ' HB3' ' B' ' 245' ' ' GLN . 71.3 t80 -113.53 110.23 19.92 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 174.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 285' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 18.2 mm-40 -105.58 110.98 23.5 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.922 -178.422 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 286' ' ' ALA . . . . . 0.569 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -111.95 115.13 28.45 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.981 0.42 . . . . 0.0 110.062 172.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 24.4 t -114.12 119.77 62.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.759 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 288' ' ' ALA . . . . . 0.477 ' HB2' HG12 ' B' ' 274' ' ' ILE . . . -131.5 141.64 49.8 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.866 0.365 . . . . 0.0 110.869 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -91.36 124.96 35.94 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 290' ' ' VAL . . . . . 0.451 ' HB ' HG23 ' B' ' 238' ' ' VAL . 11.2 t -89.63 123.44 41.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.028 0.442 . . . . 0.0 109.997 -176.084 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 291' ' ' TYR . . . . . 0.602 ' HA ' ' HA ' ' B' ' 237' ' ' LYS . 98.3 m-85 -112.3 124.22 51.99 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.905 -176.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 292' ' ' ASN . . . . . 0.547 ' HB2' HG13 ' B' ' 238' ' ' VAL . 10.6 t-20 -91.86 156.47 17.47 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 174.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 19.8 t70 . . . . . 0 C--N 1.323 -0.545 0 O-C-N 123.48 0.488 . . . . 0.0 110.953 -177.053 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.477 ' HB1' ' O ' ' B' ' 223' ' ' GLU . . . . . . . . 0 CA--C 1.521 -0.142 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.716 ' HA ' ' OH ' ' B' ' 272' ' ' TYR . 16.2 pt-20 -177.39 141.44 0.31 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.22 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.635 ' HB3' ' HG3' ' B' ' 224' ' ' GLN . 1.4 tm0? -179.67 151.37 0.45 Allowed 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.31 174.264 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.504 ' HB ' ' CG ' ' A' ' 29' ' ' GLU . 11.6 m -112.58 146.35 17.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.77 0.319 . . . . 0.0 110.443 178.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.9 p -89.77 -156.67 0.42 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.438 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.484 ' HD3' ' O ' ' A' ' 27' ' ' LYS . 12.8 tmtt? -80.01 -35.95 36.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.82 0.343 . . . . 0.0 110.676 -175.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -60.0 -50.42 73.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.213 -170.353 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.504 ' CG ' ' HB ' ' A' ' 25' ' ' VAL . 3.2 pm0 -76.15 -29.16 57.67 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.506 -174.152 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.594 HG12 HD12 ' A' ' 35' ' ' LEU . 69.2 mt -61.8 -43.68 97.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.011 0.434 . . . . 0.0 109.848 177.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.4 m -73.05 -34.16 66.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.191 177.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 35.1 t-80 -80.04 -36.33 35.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.778 -172.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -103.13 -10.46 18.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.47 0.176 . . . . 0.0 111.341 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt 58.55 83.96 0.11 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.339 -177.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.594 HD12 HG12 ' A' ' 30' ' ' ILE . 92.3 mt -93.53 155.37 17.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.8 -178.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.5 t -87.77 117.91 32.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.148 -176.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -82.24 115.15 21.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.025 177.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.457 HG13 ' HB2' ' A' ' 92' ' ' ASN . 6.4 m -97.12 15.0 3.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.075 0.464 . . . . 0.0 111.279 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 128.48 -158.1 21.59 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.65 -0.785 . . . . 0.0 113.006 174.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.5 m -144.96 139.74 27.74 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -178.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.6 pt -117.82 150.3 19.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -130.79 132.71 45.43 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.164 0.507 . . . . 0.0 111.486 -175.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.612 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 73.0 t -95.09 123.82 47.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.963 172.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.2 p -151.32 75.92 1.2 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.011 0.434 . . . . 0.0 111.23 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 14.9 mp0 -111.7 156.83 21.27 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.976 0.417 . . . . 0.0 111.084 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 64.4 m -89.47 67.76 7.7 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.975 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.6 -78.18 1.03 Allowed Glycine 0 CA--C 1.521 0.428 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.801 175.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.93 51.55 3.16 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 114.86 0.704 . . . . 0.0 114.86 -169.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -137.62 1.32 2.34 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 168.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.59 HD12 ' HA ' ' A' ' 56' ' ' LEU . 49.7 mm -126.62 107.64 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.081 174.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.3 p -95.55 -29.54 14.31 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.58 -174.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.475 ' H ' ' HB3' ' A' ' 55' ' ' ASP . 16.4 m -147.83 165.88 17.37 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.847 -174.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.49 -46.4 21.18 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.207 1.938 . . . . 0.0 111.325 174.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.46 ' O ' ' HG3' ' A' ' 58' ' ' GLU . 48.4 t -59.49 -34.82 73.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.666 175.383 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.475 ' HB3' ' H ' ' A' ' 52' ' ' SER . 34.9 t70 -66.98 -41.0 87.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.949 0.404 . . . . 0.0 110.002 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.59 ' HA ' HD12 ' A' ' 50' ' ' ILE . 58.5 tp -59.69 -44.61 93.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.317 0.58 . . . . 0.0 109.789 173.175 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.39 -34.15 77.1 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.003 178.038 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 54' ' ' SER . 50.2 mt-10 -59.87 -45.49 92.3 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.779 -0.191 . . . . 0.0 110.577 177.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -60.92 -43.54 98.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.918 0.389 . . . . 0.0 110.821 176.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.47 -48.18 76.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.52 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.498 ' HB3' ' O ' ' B' ' 222' ' ' ALA . 18.8 p -70.29 -33.08 71.14 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.075 -176.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -60.95 -48.74 80.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.561 177.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.8 mt -65.46 -35.09 79.88 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.613 178.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.16 -41.99 80.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.863 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -62.13 -38.15 87.84 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.577 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.28 -39.02 85.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.923 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.4 mmtp -74.64 -29.38 61.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.001 0.429 . . . . 0.0 110.74 176.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.31 26.77 11.64 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.759 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -101.03 147.56 17.86 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.131 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 67.6 mttt -93.18 -4.16 52.59 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.825 0.345 . . . . 0.0 111.501 -172.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.768 ' CE1' ' HB2' ' A' ' 91' ' ' TYR . 22.3 p90 -165.32 164.6 19.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.486 -177.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.435 ' O ' ' HG3' ' A' ' 24' ' ' GLN . 25.3 p90 -131.78 133.06 44.33 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.508 -178.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.423 ' HB3' ' HB2' ' A' ' 89' ' ' GLU . 17.0 t-80 -100.22 102.5 13.8 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.494 -175.388 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.516 ' H ' HD12 ' A' ' 74' ' ' ILE . 5.3 mp -72.3 122.94 25.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 30.7 pt -111.49 -24.02 4.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.089 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -155.72 125.19 6.32 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.001 0.429 . . . . 0.0 111.202 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.16 119.68 23.36 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 175.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -139.62 155.1 47.63 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.463 0.649 . . . . 0.0 111.973 -171.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -110.54 112.11 23.8 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.538 177.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -78.12 -27.01 48.21 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 123.28 -85.16 0.37 Allowed Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -176.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.91 -20.42 29.42 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.456 2.104 . . . . 0.0 111.474 173.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -123.12 145.7 48.36 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.825 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -102.88 124.85 49.17 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 170.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.562 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 51.6 mt-10 -123.28 115.91 22.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.062 0.458 . . . . 0.0 111.099 -171.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.612 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -127.85 134.37 49.41 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.042 179.088 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.8 t -114.36 116.27 52.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.155 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -131.65 137.79 48.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.089 0.471 . . . . 0.0 111.087 -178.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.423 ' HB2' ' HB3' ' A' ' 73' ' ' HIS . 30.0 mt-10 -91.48 150.61 21.15 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 17.6 t -113.06 130.64 66.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 177.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.768 ' HB2' ' CE1' ' A' ' 71' ' ' TYR . 52.3 m-85 -121.21 147.71 45.25 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.128 0.489 . . . . 0.0 110.107 177.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.457 ' HB2' HG13 ' A' ' 38' ' ' VAL . 60.0 t30 -95.35 18.73 11.94 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.583 -168.172 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 45.2 t0 . . . . . 0 N--CA 1.476 0.866 0 CA-C-O 121.672 0.749 . . . . 0.0 110.299 -178.754 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 222' ' ' ALA . . . . . 0.498 ' O ' ' HB3' ' A' ' 61' ' ' SER . . . . . . . . 0 CA--C 1.521 -0.151 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 223' ' ' GLU . . . . . 0.477 ' O ' ' HB1' ' A' ' 22' ' ' ALA . 7.2 pt-20 -168.54 122.69 0.89 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.062 0.458 . . . . 0.0 111.513 178.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 224' ' ' GLN . . . . . 0.635 ' HG3' ' HB3' ' A' ' 24' ' ' GLN . 25.9 tm0? -171.07 154.24 4.02 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.352 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 23.8 m -131.94 130.69 61.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.71 0.29 . . . . 0.0 111.032 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 226' ' ' SER . . . . . 0.412 ' O ' HG13 ' B' ' 230' ' ' ILE . 77.3 p -88.87 179.8 6.12 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.45 -28.72 70.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.441 0.162 . . . . 0.0 111.312 -172.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -64.28 -50.65 67.08 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -61.65 -46.14 91.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.317 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.459 HG12 HD12 ' B' ' 235' ' ' LEU . 90.9 mt -55.8 -48.82 77.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.273 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 14.7 m -73.25 -35.11 66.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.88 0.371 . . . . 0.0 111.433 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -77.95 -33.53 51.53 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.37 -174.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -99.05 -9.41 23.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.399 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt 58.64 70.75 0.63 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.263 0.554 . . . . 0.0 110.691 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 235' ' ' LEU . . . . . 0.459 HD12 HG12 ' B' ' 230' ' ' ILE . 74.0 mt -82.99 -177.94 6.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.946 -175.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 57.0 t -105.88 123.65 60.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.599 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -86.89 123.34 31.91 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 177.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 18.9 t -96.09 -38.82 8.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.444 -173.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 165.74 154.04 7.95 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.168 -1.015 . . . . 0.0 112.582 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 240' ' ' THR . . . . . 0.528 HG23 ' HG2' ' B' ' 289' ' ' GLU . 17.9 m -92.01 136.62 33.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.549 0.214 . . . . 0.0 110.542 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 36.5 pt -120.17 168.44 12.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.008 0.432 . . . . 0.0 110.949 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -144.72 133.13 21.9 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.19 174.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 243' ' ' VAL . . . . . 0.54 HG22 HD12 ' B' ' 263' ' ' LEU . 43.9 t -104.49 108.53 25.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.16 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 244' ' ' SER . . . . . 0.564 ' HA ' ' O ' ' B' ' 284' ' ' PHE . 8.2 t -139.36 106.79 5.54 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.113 0.482 . . . . 0.0 110.115 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 245' ' ' GLN . . . . . 0.543 ' HB3' ' OE1' ' B' ' 249' ' ' GLN . 1.0 OUTLIER -132.1 -177.25 4.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.327 178.306 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 246' ' ' SER . . . . . 0.448 ' HB3' ' HG3' ' B' ' 249' ' ' GLN . 47.4 t -72.42 150.71 43.12 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.655 173.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -65.1 -16.26 61.86 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.727 177.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -77.56 -16.2 80.52 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.14 175.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 249' ' ' GLN . . . . . 0.543 ' OE1' ' HB3' ' B' ' 245' ' ' GLN . 38.9 mt-30 -92.03 -45.16 8.46 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 50.3 mm -97.33 93.22 3.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.814 0.816 . . . . 0.0 109.842 175.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 20.1 m -118.68 -15.7 9.47 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.049 -176.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 19.9 m -127.72 142.7 45.04 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.75 -39.64 80.18 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.536 2.157 . . . . 0.0 111.828 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 254' ' ' SER . . . . . 0.436 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 4.7 m -62.47 -29.85 70.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.17 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -74.84 -34.78 62.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.004 0.431 . . . . 0.0 110.632 -176.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.433 ' O ' ' HG ' ' B' ' 260' ' ' LEU . 66.1 tp -61.86 -42.5 99.13 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.953 176.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -58.4 -35.56 72.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.981 178.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 258' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' B' ' 254' ' ' SER . 25.1 mm-40 -57.98 -50.87 71.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.333 177.564 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -66.87 -39.38 87.51 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.337 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 260' ' ' LEU . . . . . 0.503 ' HB3' ' CZ ' ' B' ' 272' ' ' TYR . 97.6 mt -58.11 -45.9 86.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.082 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 22.9 t -66.06 -44.16 85.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.298 0.571 . . . . 0.0 110.27 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -58.43 -42.78 88.05 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.642 -177.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 263' ' ' LEU . . . . . 0.54 HD12 HG22 ' B' ' 243' ' ' VAL . 83.7 mt -73.09 -30.33 63.58 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.866 -178.088 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -65.88 -50.98 62.55 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.717 0.294 . . . . 0.0 110.915 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -59.86 -38.1 81.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.949 0.404 . . . . 0.0 110.777 176.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -64.21 -22.31 66.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.496 -178.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 267' ' ' LYS . . . . . 0.41 ' HD3' ' HA ' ' B' ' 267' ' ' LYS . 63.3 mmtt -87.48 -14.61 39.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.504 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 90.95 19.39 43.35 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.423 -175.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -117.63 -166.12 13.84 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 270' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 50.4 mttp -130.19 -66.51 0.77 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.722 0.296 . . . . 0.0 110.533 -178.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 271' ' ' TYR . . . . . 0.528 ' HB3' ' HA ' ' B' ' 224' ' ' GLN . 5.7 m-85 -90.56 153.65 20.19 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -175.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 272' ' ' TYR . . . . . 0.716 ' OH ' ' HA ' ' A' ' 23' ' ' GLU . 27.5 p90 -132.85 129.42 38.42 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.264 0.554 . . . . 0.0 110.759 178.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -101.87 103.19 13.86 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.845 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 274' ' ' ILE . . . . . . . . . . . . . 59.1 mt -67.5 135.7 28.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.408 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 17.8 pt -115.52 -26.51 2.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -157.21 136.96 12.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.532 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -148.11 129.37 14.69 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.512 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.72 173.61 14.41 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.439 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.5 149.73 40.81 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.955 0.407 . . . . 0.0 110.318 171.326 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -95.51 -0.8 51.77 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.657 -178.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 113.86 -90.5 0.54 Allowed Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.323 -174.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.59 -14.62 22.14 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.852 2.368 . . . . 0.0 112.166 177.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -135.03 156.52 48.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.976 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 284' ' ' PHE . . . . . 0.564 ' O ' ' HA ' ' B' ' 244' ' ' SER . 82.7 t80 -110.83 145.63 37.85 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 285' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -138.67 110.1 6.99 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.924 0.393 . . . . 0.0 111.497 -177.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 286' ' ' ALA . . . . . 0.493 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -125.16 145.03 50.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.75 175.002 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 88.3 t -127.56 131.76 69.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.912 0.387 . . . . 0.0 110.347 177.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -142.57 156.28 45.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.246 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 289' ' ' GLU . . . . . 0.528 ' HG2' HG23 ' B' ' 240' ' ' THR . 35.5 mt-10 -112.76 128.28 56.38 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.339 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 58.4 t -89.02 131.42 36.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.943 0.402 . . . . 0.0 110.979 -176.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -125.23 159.7 30.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.284 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 292' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -118.52 161.79 19.44 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 4.6 t70 . . . . . 0 N--CA 1.471 0.608 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -170.395 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.496 ' HB3' ' HA ' ' B' ' 261' ' ' SER . . . . . . . . 0 C--O 1.233 0.203 0 CA-C-O 120.894 0.378 . . . . 0.0 110.859 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -151.72 179.41 8.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.612 -176.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.615 ' HB2' ' HB2' ' B' ' 224' ' ' GLN . 0.0 OUTLIER 81.79 167.78 0.13 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.791 0.836 . . . . 0.0 111.765 171.919 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.424 HG12 ' CZ ' ' B' ' 257' ' ' ARG . 31.0 m -126.4 171.97 14.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.47 -178.228 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.545 ' HB2' ' HB ' ' B' ' 274' ' ' ILE . 10.8 t -112.66 -149.73 0.45 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.093 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.524 ' HA ' HD12 ' A' ' 30' ' ' ILE . 18.2 ttpt -97.86 -17.15 19.46 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 122.088 -0.382 . . . . 0.0 110.44 178.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -62.95 -42.53 99.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.951 -176.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.655 ' HG2' HH22 ' B' ' 257' ' ' ARG . 3.4 mp0 -68.83 -31.18 69.97 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.495 178.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.524 HD12 ' HA ' ' A' ' 27' ' ' LYS . 62.7 mt -64.68 -51.29 69.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.443 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.8 m -69.44 -27.87 65.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.407 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 22.2 m170 -84.1 -58.11 2.91 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.979 0.362 . . . . 0.0 111.979 -178.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -99.17 -11.75 21.08 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -169.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.423 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 3.8 mppt? 60.12 84.56 0.12 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.233 0.54 . . . . 0.0 110.799 -177.341 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 90.4 mt -73.81 151.44 40.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.031 -177.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 63.1 t -91.22 108.86 20.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.025 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -83.61 130.48 34.98 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.208 0.528 . . . . 0.0 110.836 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.483 HG13 ' HB2' ' A' ' 92' ' ' ASN . 6.4 m -92.03 -20.94 6.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.847 178.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.27 171.27 22.39 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.608 178.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 35.0 m -106.43 129.57 54.38 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.8 pt -102.92 151.46 6.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -128.49 123.77 34.43 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.095 0.474 . . . . 0.0 110.663 -171.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.753 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 57.3 t -93.54 109.05 21.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 174.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.6 t -141.38 78.71 1.65 Allowed 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -106.7 138.52 42.73 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.984 -177.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.0 m -83.66 94.15 8.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.865 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.89 -169.72 13.06 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.521 178.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.28 55.64 4.36 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.412 -0.423 . . . . 0.0 113.383 -176.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -75.94 -21.23 57.26 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.406 0.622 . . . . 0.0 109.421 173.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.1 mm -119.46 98.63 6.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.148 -0.933 . . . . 0.0 108.65 172.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 77.2 p -111.56 -40.93 4.21 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.229 -173.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.401 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 12.6 m -119.54 161.72 36.08 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.65 -177.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 52' ' ' SER . 9.3 Cg_endo -53.38 -29.47 48.36 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.728 2.285 . . . . 0.0 111.78 176.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.542 ' HA ' ' NE ' ' A' ' 57' ' ' ARG . 23.7 m -59.04 -38.92 80.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.621 177.153 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.476 ' O ' ' HD3' ' A' ' 59' ' ' LYS . 59.5 m-20 -63.54 -53.23 55.07 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -174.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 23.1 tp -54.92 -49.71 70.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.258 -173.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.542 ' NE ' ' HA ' ' A' ' 54' ' ' SER . 25.7 ptt180 -63.34 -42.68 98.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.355 -178.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 54' ' ' SER . 43.3 mt-10 -69.54 -46.89 65.42 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.672 0.272 . . . . 0.0 111.161 -176.009 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.476 ' HD3' ' O ' ' A' ' 55' ' ' ASP . 14.5 mptt -59.77 -45.86 90.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.527 178.263 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.541 HD21 ' CG2' ' A' ' 43' ' ' VAL . 79.7 mt -75.04 -30.82 61.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.146 -175.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.7 m -60.48 -41.43 94.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.023 0.439 . . . . 0.0 110.312 174.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -63.66 -46.94 83.31 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.402 177.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 88.6 mt -69.5 -48.48 60.49 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.862 -177.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.2 -50.93 68.35 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -174.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -63.88 -37.36 87.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.909 0.385 . . . . 0.0 111.004 -176.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.95 -19.34 62.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.439 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 67' ' ' LYS . 70.3 mmtt -85.04 -5.73 59.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.955 0.407 . . . . 0.0 110.866 177.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.97 -28.45 13.04 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.351 177.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.61 ' HA3' HG12 ' A' ' 90' ' ' VAL . . . -79.84 179.42 53.2 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.911 -0.662 . . . . 0.0 111.789 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.639 ' HA ' ' NZ ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -112.43 -72.85 0.69 Allowed 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.162 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.593 ' HB2' ' HA ' ' A' ' 24' ' ' GLN . 0.6 OUTLIER -96.5 155.65 16.68 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.845 -176.349 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.784 ' CD1' ' HB1' ' B' ' 222' ' ' ALA . 3.9 p90 -109.34 170.94 7.74 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.259 -177.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 23.6 t-80 -141.0 103.38 4.46 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.491 ' H ' HD12 ' A' ' 74' ' ' ILE . 2.9 mp -65.12 132.01 30.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.029 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 32.1 pt -133.02 -5.76 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.686 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.431 ' HB3' ' HB ' ' A' ' 87' ' ' VAL . . . -165.92 144.73 5.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.739 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -158.56 137.9 11.64 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 177.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -166.15 141.15 4.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.945 0.402 . . . . 0.0 111.363 -178.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -77.93 96.19 4.97 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 170.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -90.44 77.5 6.52 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.677 -177.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.1 -120.42 13.68 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -175.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -86.33 -0.68 8.34 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.518 2.145 . . . . 0.0 111.869 176.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -107.96 110.41 22.13 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.57 -176.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -79.44 104.33 9.98 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 173.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.753 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 23.3 mt-10 -104.06 123.14 46.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.191 0.519 . . . . 0.0 111.484 -175.178 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.522 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -130.82 126.84 37.33 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.856 176.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.431 ' HB ' ' HB3' ' A' ' 76' ' ' ALA . 41.9 t -105.62 121.53 57.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.428 -176.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.47 135.95 32.49 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.794 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 40' ' ' THR . 29.3 mt-10 -96.35 150.17 20.88 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.61 HG12 ' HA3' ' A' ' 69' ' ' GLY . 8.2 t -110.56 133.59 55.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 -179.208 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.495 ' HB2' ' HE1' ' A' ' 71' ' ' TYR . 54.1 m-85 -116.77 151.1 37.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.25 0.547 . . . . 0.0 110.889 -178.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.483 ' HB2' HG13 ' A' ' 38' ' ' VAL . 8.2 t-20 -106.13 21.96 16.49 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.926 -177.163 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.403 ' HA ' ' OH ' ' A' ' 71' ' ' TYR . 6.2 t70 . . . . . 0 C--N 1.323 -0.58 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.174 -175.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 222' ' ' ALA . . . . . 0.784 ' HB1' ' CD1' ' A' ' 72' ' ' TYR . . . . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 223' ' ' GLU . . . . . 0.831 ' HB3' ' HE1' ' B' ' 271' ' ' TYR . 30.0 mt-10 -143.98 105.63 4.3 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 224' ' ' GLN . . . . . 0.615 ' HB2' ' HB2' ' A' ' 24' ' ' GLN . 1.2 tt0 173.56 179.87 0.09 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.298 0.639 . . . . 0.0 109.287 172.273 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 225' ' ' VAL . . . . . 0.546 HG11 HD11 ' B' ' 235' ' ' LEU . 15.8 m -138.84 157.86 29.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 120.622 0.248 . . . . 0.0 110.774 178.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 81.2 p -110.2 -92.88 0.44 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.072 178.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 227' ' ' LYS . . . . . 0.489 ' C ' ' HD3' ' B' ' 227' ' ' LYS . 8.1 tmtm? -133.42 -52.99 0.89 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.813 0.34 . . . . 0.0 110.959 -176.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -59.96 -45.43 92.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.278 -172.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 229' ' ' GLU . . . . . 0.604 ' CD ' ' H ' ' B' ' 229' ' ' GLU . 2.0 mp0 -60.58 -45.12 95.14 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.991 -177.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.552 HG12 HD12 ' B' ' 235' ' ' LEU . 49.1 mt -60.72 -49.77 83.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.119 -176.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 25.4 m -67.21 -21.26 65.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.465 -177.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -94.21 -44.07 8.15 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.597 -174.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -92.34 -8.73 44.21 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -175.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 10.6 mmmm 63.03 75.62 0.39 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.088 0.471 . . . . 0.0 111.042 176.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 235' ' ' LEU . . . . . 0.552 HD12 HG12 ' B' ' 230' ' ' ILE . 68.6 mt -83.77 161.68 20.9 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.293 0.568 . . . . 0.0 111.574 -177.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 65.2 t -95.63 129.18 46.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.348 176.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 237' ' ' LYS . . . . . 0.42 ' HE3' ' HB3' ' B' ' 289' ' ' GLU . 85.4 tttt -102.32 146.07 28.57 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -179.351 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 238' ' ' VAL . . . . . 0.55 HG13 ' HB2' ' B' ' 292' ' ' ASN . 2.5 m -127.4 9.36 3.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 239' ' ' GLY . . . . . 0.401 ' H ' ' HG2' ' B' ' 237' ' ' LYS . . . 133.62 -161.92 24.32 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 119.942 -1.123 . . . . 0.0 113.191 174.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 240' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' B' ' 289' ' ' GLU . 29.2 m -140.18 133.35 29.63 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 33.3 pt -109.49 147.37 13.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.214 0.531 . . . . 0.0 111.031 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -112.82 118.06 33.89 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.25 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 243' ' ' VAL . . . . . 0.674 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 22.1 t -93.83 113.46 28.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 176.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 244' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' B' ' 284' ' ' PHE . 47.7 t -125.38 100.97 6.74 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.72 0.295 . . . . 0.0 110.228 -176.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 245' ' ' GLN . . . . . 0.587 ' HG3' HG12 ' B' ' 250' ' ' ILE . 9.2 mm-40 -90.63 -175.94 4.57 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.611 0.72 . . . . 0.0 111.453 -177.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 68.6 m -143.49 113.45 7.18 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.699 176.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 66.3 -118.85 11.6 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.135 177.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -98.3 42.2 2.11 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.181 -0.533 . . . . 0.0 113.49 -172.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 249' ' ' GLN . . . . . 0.57 ' HB2' ' HB3' ' B' ' 245' ' ' GLN . 19.9 mm-40 -77.78 -22.19 50.56 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 173.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 250' ' ' ILE . . . . . 0.587 HG12 ' HG3' ' B' ' 245' ' ' GLN . 43.8 mm -121.51 96.36 4.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.34 175.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 39.4 t -96.64 -24.31 16.06 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.321 0.581 . . . . 0.0 109.583 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 73.8 p -138.23 162.85 51.4 Favored Pre-proline 0 N--CA 1.447 -0.625 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.65 -179.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.93 -22.59 74.61 Favored 'Trans proline' 0 C--O 1.238 0.482 0 C-N-CA 122.019 1.813 . . . . 0.0 111.263 173.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 254' ' ' SER . . . . . . . . . . . . . 2.3 m -66.09 -42.79 88.83 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.566 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 255' ' ' ASP . . . . . 0.467 ' O ' ' HG2' ' B' ' 259' ' ' LYS . 30.1 m-20 -54.92 -39.01 68.37 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.013 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.429 ' O ' ' HG ' ' B' ' 260' ' ' LEU . 45.2 tp -58.83 -42.58 89.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.848 -178.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 257' ' ' ARG . . . . . 0.655 HH22 ' HG2' ' A' ' 29' ' ' GLU . 0.1 OUTLIER -67.92 -31.37 71.1 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.154 0.502 . . . . 0.0 110.028 -179.161 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 258' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' B' ' 255' ' ' ASP . 52.7 mm-40 -61.18 -41.45 96.83 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.424 178.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 259' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' B' ' 255' ' ' ASP . 16.0 mmmt -77.15 -42.04 39.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.766 -179.383 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 260' ' ' LEU . . . . . 0.455 HD13 ' CE2' ' B' ' 272' ' ' TYR . 97.3 mt -60.33 -42.96 96.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.768 -177.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 261' ' ' SER . . . . . 0.496 ' HA ' ' HB3' ' A' ' 22' ' ' ALA . 67.8 m -58.32 -48.97 78.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.955 0.407 . . . . 0.0 110.988 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -64.33 -41.89 96.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.023 -177.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 263' ' ' LEU . . . . . 0.459 ' O ' ' HG2' ' B' ' 267' ' ' LYS . 94.0 mt -74.12 -51.04 16.88 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -176.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -66.99 -48.14 69.36 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -172.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -67.09 -32.37 73.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.944 0.402 . . . . 0.0 110.62 -174.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -82.68 -9.91 59.16 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.245 -177.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 267' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' B' ' 263' ' ' LEU . 67.6 mmtt -87.48 -2.41 58.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.677 0.275 . . . . 0.0 111.279 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 91.98 7.85 63.88 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.031 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -108.75 -174.45 21.53 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 176.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 270' ' ' LYS . . . . . 0.652 ' HA ' ' HE2' ' B' ' 270' ' ' LYS . 8.4 mmpt? -127.41 -62.91 1.07 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.942 0.401 . . . . 0.0 110.876 -178.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 271' ' ' TYR . . . . . 0.831 ' HE1' ' HB3' ' B' ' 223' ' ' GLU . 90.1 m-85 -102.43 173.33 6.4 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.125 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 272' ' ' TYR . . . . . 0.455 ' CE2' HD13 ' B' ' 260' ' ' LEU . 17.6 p90 -149.87 169.4 21.21 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.519 -178.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -139.63 110.01 6.59 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.813 0.34 . . . . 0.0 110.622 174.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 274' ' ' ILE . . . . . 0.545 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 47.6 mt -70.69 113.19 6.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.063 175.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 25.2 pt -100.04 -23.56 4.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.814 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -160.52 146.6 15.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.358 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 277' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' B' ' 285' ' ' GLU . . . -157.03 111.03 2.66 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 177.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 278' ' ' ARG . . . . . 0.442 ' HD2' ' H ' ' B' ' 278' ' ' ARG . 0.0 OUTLIER -129.31 150.46 50.67 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.651 -174.818 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -84.81 95.8 9.09 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 172.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 17.3 t-80 -91.61 84.85 5.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.055 0.455 . . . . 0.0 109.932 -177.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 66.76 -125.48 25.61 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.386 -175.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -85.15 -8.56 8.83 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.598 2.199 . . . . 0.0 111.965 175.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 283' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' B' ' 245' ' ' GLN . 15.1 m120 -103.81 109.98 21.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.676 -177.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 284' ' ' PHE . . . . . 0.51 ' HB3' ' HB2' ' B' ' 245' ' ' GLN . 78.3 t80 -78.76 120.02 22.81 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 175.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 285' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' B' ' 277' ' ' ALA . 97.2 mt-10 -108.72 110.92 22.45 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.41 0.444 . . . . 0.0 111.155 -176.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 286' ' ' ALA . . . . . 0.674 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -111.53 123.14 49.61 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 172.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 28.5 t -105.12 113.31 41.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.312 -178.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -130.84 128.81 41.4 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.678 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 289' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' B' ' 240' ' ' THR . 17.2 mt-10 -92.38 135.46 34.02 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.051 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 23.6 t -97.67 137.84 24.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.142 0.496 . . . . 0.0 111.496 -170.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -118.3 149.5 41.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.159 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 292' ' ' ASN . . . . . 0.55 ' HB2' HG13 ' B' ' 238' ' ' VAL . 10.2 t30 -95.37 21.95 7.48 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.881 -171.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 293' ' ' ASP . . . . . 0.455 ' HB3' ' O ' ' B' ' 292' ' ' ASN . 10.8 t70 . . . . . 0 N--CA 1.474 0.775 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.562 172.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.127 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 178.95 104.65 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.584 178.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.622 ' HB2' ' HB3' ' B' ' 224' ' ' GLN . 1.4 tm0? -162.14 155.64 20.87 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 122.052 -0.405 . . . . 0.0 110.873 -179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.8 m -115.75 143.93 24.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.966 174.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.634 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 11.8 t -108.05 -90.45 0.44 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -174.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.424 ' HD3' ' O ' ' A' ' 27' ' ' LYS . 10.7 tmtt? -145.88 -45.73 0.21 Allowed 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -173.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.42 ' CB ' ' HB3' ' B' ' 277' ' ' ALA . 27.7 mm-40 -54.58 -49.85 69.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.996 -174.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' A' ' 29' ' ' GLU . 0.9 OUTLIER -68.85 -43.75 74.8 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.713 -176.129 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.553 HG12 HD12 ' A' ' 35' ' ' LEU . 54.7 mt -62.1 -43.64 98.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.66 -175.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.4 m -72.6 -24.38 61.07 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.928 0.394 . . . . 0.0 111.274 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -91.56 -32.85 15.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.533 -173.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -110.1 -12.5 14.5 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -177.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt 65.93 82.98 0.17 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.165 0.507 . . . . 0.0 111.719 -178.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.553 HD12 HG12 ' A' ' 30' ' ' ILE . 22.0 mt -89.88 147.91 23.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.2 177.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.1 m -85.03 122.36 38.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.711 -177.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.1 ttmm -85.54 117.53 24.5 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 177.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.1 t -78.39 -28.08 14.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.155 0.502 . . . . 0.0 109.939 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 167.45 -175.99 42.35 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.854 179.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.6 m -130.28 123.47 30.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.055 0.455 . . . . 0.0 110.243 178.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.419 HD12 HD12 ' A' ' 63' ' ' LEU . 25.3 pt -120.28 166.07 15.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.413 -176.32 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.7 p30 -145.77 147.53 31.98 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.491 0.663 . . . . 0.0 111.169 176.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 75.0 t -94.56 142.64 13.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.551 177.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.6 t -159.6 79.73 0.72 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.189 0.519 . . . . 0.0 109.765 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.403 HE22 HG13 ' A' ' 43' ' ' VAL . 0.9 OUTLIER -113.8 150.04 34.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.358 178.365 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.7 t -111.61 112.73 24.65 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.622 -175.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.61 -144.93 17.45 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.226 176.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.3 74.54 1.68 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 121.603 -0.332 . . . . 0.0 113.781 -173.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -121.65 -36.73 2.99 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.154 0.502 . . . . 0.0 109.796 169.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.458 HG23 ' HB2' ' A' ' 55' ' ' ASP . 72.1 mt -133.52 123.01 45.35 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.493 176.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.7 m -143.64 -27.98 0.54 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.0 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.3 p -113.73 154.87 45.68 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 175.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.74 -25.0 58.28 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.824 2.349 . . . . 0.0 112.879 -176.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.628 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 11.8 p -67.24 -40.9 86.35 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.92 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.458 ' HB2' HG23 ' A' ' 50' ' ' ILE . 37.3 m-20 -58.63 -41.78 86.76 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.117 0.485 . . . . 0.0 110.624 -176.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 45.2 tp -63.23 -45.76 90.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.307 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.503 ' HD2' ' OE2' ' B' ' 223' ' ' GLU . 42.9 ttp180 -61.32 -40.5 94.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.983 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.628 ' HG2' ' O ' ' A' ' 54' ' ' SER . 9.4 mm-40 -59.18 -30.98 68.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.454 -177.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.433 ' O ' ' HB3' ' A' ' 62' ' ' GLU . 4.3 mptp? -93.86 -37.09 11.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.775 -177.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 86.5 mt -70.42 -39.7 74.27 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.019 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.0 t -69.2 -34.7 75.29 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 176.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.433 ' HB3' ' O ' ' A' ' 59' ' ' LYS . 34.4 tt0 -56.8 -49.32 75.68 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.87 177.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.419 HD12 HD12 ' A' ' 41' ' ' ILE . 73.8 mt -74.43 -30.36 61.88 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.742 -178.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.82 -50.98 53.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.433 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -68.23 -25.43 65.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.158 0.504 . . . . 0.0 110.41 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.45 -42.29 59.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.13 178.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.453 ' HD3' ' HA ' ' A' ' 67' ' ' LYS . 59.0 mmtt -77.13 -35.66 56.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.394 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.57 59.94 0.63 Allowed Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.605 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.672 ' HA2' ' HA ' ' A' ' 92' ' ' ASN . . . -143.93 160.87 27.82 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 177.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -107.63 -15.71 14.52 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.777 0.289 . . . . 0.0 111.267 -175.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.403 ' OH ' ' HD3' ' B' ' 257' ' ' ARG . 2.9 m-85 -140.47 145.63 37.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.642 0.258 . . . . 0.0 110.362 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.61 ' HD2' ' HB1' ' B' ' 222' ' ' ALA . 21.4 p90 -116.53 168.08 10.48 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 171.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.634 ' CD2' ' HA ' ' A' ' 26' ' ' SER . 10.0 t-160 -140.0 108.21 5.79 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.204 178.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 76.6 mt -71.76 118.59 16.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.188 177.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.9 pt -114.89 -18.58 7.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -152.92 100.42 2.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.826 0.345 . . . . 0.0 111.235 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -115.31 115.12 26.11 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -138.08 160.3 39.74 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.252 0.548 . . . . 0.0 111.614 -172.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -104.7 103.93 13.65 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.738 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.513 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 2.6 t-160 -94.75 56.88 2.09 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -176.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.67 -122.82 5.83 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.769 -0.933 . . . . 0.0 110.769 -175.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -83.94 10.52 3.66 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.372 2.048 . . . . 0.0 111.7 174.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.513 ' HB2' ' HB3' ' A' ' 80' ' ' HIS . 17.3 m-80 -113.48 127.27 56.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.282 -176.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -97.67 111.88 23.98 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.622 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 42.0 mt-10 -116.12 119.83 37.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.04 0.448 . . . . 0.0 110.957 -177.166 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -130.12 118.25 21.19 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.507 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.1 t -95.27 127.74 47.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 73' ' ' HIS . . . -136.62 144.72 44.23 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.389 -175.388 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -91.57 147.27 23.13 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 176.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 43.9 t -106.46 122.02 59.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -121.31 139.1 53.87 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.817 0.342 . . . . 0.0 110.079 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.672 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 26.2 t-20 -77.4 -89.42 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.202 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.5 t70 . . . . . 0 C--N 1.327 -0.404 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 178.417 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 222' ' ' ALA . . . . . 0.61 ' HB1' ' HD2' ' A' ' 72' ' ' TYR . . . . . . . . 0 C--O 1.234 0.257 0 CA-C-O 121.72 0.772 . . . . 0.0 112.656 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 223' ' ' GLU . . . . . 0.522 ' O ' ' HB2' ' A' ' 24' ' ' GLN . 34.7 mt-10 -139.98 -156.46 0.68 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.631 -178.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 224' ' ' GLN . . . . . 0.622 ' HB3' ' HB2' ' A' ' 24' ' ' GLN . 0.8 OUTLIER 68.76 144.32 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.034 0.534 . . . . 0.0 112.352 176.503 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 2.4 m -118.87 172.87 5.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.686 -177.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 226' ' ' SER . . . . . 0.543 ' HA ' ' CD2' ' B' ' 273' ' ' HIS . 13.4 t -101.8 -96.02 0.28 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -176.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -142.53 -41.21 0.33 Allowed 'General case' 0 C--O 1.233 0.236 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -173.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -62.78 -30.7 71.66 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.76 0.79 . . . . 0.0 110.023 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -70.99 -34.52 71.46 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.625 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.506 HG23 ' HB2' ' B' ' 235' ' ' LEU . 56.4 mt -59.27 -43.38 89.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.153 0.502 . . . . 0.0 109.988 177.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 42.6 t -63.48 -30.15 71.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.668 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -84.54 -46.49 11.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.96 -176.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -93.89 -14.28 26.22 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -171.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? 62.52 88.91 0.09 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.289 0.566 . . . . 0.0 110.798 -176.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 235' ' ' LEU . . . . . 0.597 HD13 ' HE1' ' B' ' 271' ' ' TYR . 81.6 mt -108.9 155.43 20.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.08 -177.151 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 73.3 t -115.19 113.02 42.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.535 -172.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.2 140.05 58.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.91 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 1.9 m -122.85 5.78 5.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 138.62 -160.17 25.54 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.173 -1.013 . . . . 0.0 112.788 176.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 240' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' B' ' 289' ' ' GLU . 8.8 m -140.54 146.14 37.7 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -176.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 241' ' ' ILE . . . . . 0.524 ' HB ' HD13 ' B' ' 263' ' ' LEU . 26.4 pt -113.19 143.98 21.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 174.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -127.15 123.05 35.82 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.223 0.535 . . . . 0.0 110.684 -174.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 243' ' ' VAL . . . . . 0.674 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 75.3 t -100.15 116.14 42.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.448 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 72.7 m -135.96 87.87 2.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.332 177.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 245' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -142.43 163.11 33.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.575 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 37.7 t -78.14 174.68 10.9 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.208 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -70.4 4.6 8.52 Favored Glycine 0 CA--C 1.521 0.408 0 CA-C-N 116.363 -0.38 . . . . 0.0 113.041 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -80.55 -35.54 25.55 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.453 174.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -94.66 -21.5 18.75 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.924 0.393 . . . . 0.0 110.581 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 42.0 mm -119.45 99.29 7.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 176.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 16.7 t -130.9 -52.94 1.05 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.851 0.358 . . . . 0.0 110.524 -177.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 252' ' ' SER . . . . . 0.427 ' HB3' ' HD2' ' B' ' 253' ' ' PRO . 23.1 m -109.9 159.71 30.77 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.213 178.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 253' ' ' PRO . . . . . 0.452 ' HB3' HD21 ' A' ' 35' ' ' LEU . 11.1 Cg_endo -55.87 -39.78 89.08 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.826 2.351 . . . . 0.0 112.841 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 254' ' ' SER . . . . . 0.508 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 66.7 m -60.98 -31.87 71.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.211 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -64.13 -50.19 69.22 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.061 0.458 . . . . 0.0 110.249 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 48.6 tp -62.05 -38.38 88.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.541 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 257' ' ' ARG . . . . . 0.403 ' HD3' ' OH ' ' A' ' 71' ' ' TYR . 43.7 ttp180 -56.99 -51.03 70.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.754 178.224 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 258' ' ' GLU . . . . . 0.508 ' HG2' ' O ' ' B' ' 254' ' ' SER . 10.2 mm-40 -63.9 -38.9 92.81 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.934 -178.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -63.99 -46.36 84.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.628 178.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 94.6 mt -65.89 -38.88 89.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.711 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 47.3 t -62.42 -40.08 95.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.432 176.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -60.85 -43.24 98.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.42 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 263' ' ' LEU . . . . . 0.524 HD13 ' HB ' ' B' ' 241' ' ' ILE . 94.1 mt -74.06 -39.49 63.44 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.392 -178.403 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -64.67 -44.56 90.0 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.73 0.3 . . . . 0.0 111.447 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -68.72 -31.73 71.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.078 0.466 . . . . 0.0 110.174 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -67.06 -35.78 80.59 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.779 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -75.57 -37.21 60.08 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.024 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 89.25 31.98 11.13 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.374 -176.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -94.3 -176.9 38.98 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.568 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -112.1 -12.94 13.62 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.426 -177.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 271' ' ' TYR . . . . . 0.597 ' HE1' HD13 ' B' ' 235' ' ' LEU . 43.5 p90 -167.52 175.71 6.97 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 173.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 272' ' ' TYR . . . . . 0.544 ' H ' ' HG3' ' B' ' 224' ' ' GLN . 43.9 p90 -133.04 123.93 26.71 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 273' ' ' HIS . . . . . 0.543 ' CD2' ' HA ' ' B' ' 226' ' ' SER . 6.1 t-160 -95.04 102.12 13.91 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.095 -0.642 . . . . 0.0 110.257 -177.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 274' ' ' ILE . . . . . . . . . . . . . 62.1 mt -66.36 111.63 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.185 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 20.0 pt -103.2 -35.66 3.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -178.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -159.76 113.86 2.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.003 0.43 . . . . 0.0 111.365 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 277' ' ' ALA . . . . . 0.56 ' HA ' ' HA ' ' B' ' 286' ' ' ALA . . . -122.37 107.43 12.07 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 174.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -128.18 138.54 52.52 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.644 0.735 . . . . 0.0 111.55 -169.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -78.88 133.63 36.96 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.363 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -134.08 101.1 4.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.009 0.433 . . . . 0.0 110.704 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 64.46 -129.49 36.84 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.858 -178.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -88.71 8.38 3.99 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.235 2.624 . . . . 0.0 112.489 178.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -124.57 155.77 38.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.965 0.412 . . . . 0.0 110.726 -177.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 284' ' ' PHE . . . . . 0.493 ' CE2' ' HB2' ' B' ' 286' ' ' ALA . 83.2 t80 -111.62 125.17 53.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.241 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 285' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 8.3 mm-40 -109.7 110.86 22.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.282 -178.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 286' ' ' ALA . . . . . 0.674 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -119.82 125.51 48.73 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.329 179.238 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 25.8 t -111.65 118.62 57.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.364 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -135.19 135.92 41.39 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.868 177.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 289' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' B' ' 240' ' ' THR . 2.4 mt-10 -98.3 140.43 32.59 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -178.322 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 40.3 t -101.4 129.66 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -176.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 291' ' ' TYR . . . . . 0.552 ' HB2' ' CZ ' ' B' ' 271' ' ' TYR . 50.4 m-85 -120.14 150.51 40.5 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.403 0.62 . . . . 0.0 110.512 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 292' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -120.74 179.45 4.34 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.75 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 2.1 p30 . . . . . 0 C--N 1.318 -0.774 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 174.928 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.454 ' CB ' ' HA ' ' B' ' 261' ' ' SER . . . . . . . . 0 N--CA 1.466 0.365 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.55 ' HG2' ' HA ' ' B' ' 222' ' ' ALA . 8.6 tp10 -155.51 165.51 36.37 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.161 -179.134 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.503 ' HB3' ' HB2' ' B' ' 224' ' ' GLN . 1.5 tm0? 76.23 156.47 0.18 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.662 0.785 . . . . 0.0 111.168 176.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.9 m -117.92 174.42 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 121.157 0.503 . . . . 0.0 111.636 -174.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.45 ' HB3' ' HB ' ' B' ' 274' ' ' ILE . 69.0 p -79.4 -172.4 3.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.232 0.539 . . . . 0.0 111.542 -173.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.472 ' HD3' ' O ' ' A' ' 27' ' ' LYS . 14.2 tmtt? -86.11 -29.37 23.38 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 171.046 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.476 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 1.0 OUTLIER -58.25 -50.1 74.77 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.287 179.875 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.59 ' HA ' ' HB3' ' A' ' 32' ' ' HIS . 0.4 OUTLIER -61.66 -26.99 68.36 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.315 -177.181 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.483 HG12 ' OH ' ' A' ' 71' ' ' TYR . 57.8 mt -61.0 -54.66 32.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.011 0.434 . . . . 0.0 110.047 176.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.2 m -73.48 -26.99 61.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.684 177.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.59 ' HB3' ' HA ' ' A' ' 29' ' ' GLU . 12.2 t-160 -68.31 -48.48 64.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.336 -175.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -104.52 -5.06 21.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.793 -176.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt 58.75 78.04 0.27 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.337 0.589 . . . . 0.0 110.77 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.8 mt -92.72 168.47 11.18 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.937 -176.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.9 t -96.99 138.23 22.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.792 -176.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -97.34 127.09 43.0 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.44 HG13 ' HB2' ' A' ' 92' ' ' ASN . 6.8 m -101.53 -45.78 11.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -175.26 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -174.66 175.0 46.88 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 119.689 -1.243 . . . . 0.0 113.362 -178.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.556 HG23 ' HG2' ' A' ' 89' ' ' GLU . 15.6 m -112.6 141.44 46.37 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 122.617 0.367 . . . . 0.0 110.421 -178.445 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.6 pt -120.14 144.64 28.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.816 0.341 . . . . 0.0 110.688 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -115.14 118.95 34.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.408 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.598 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 61.2 t -95.18 109.5 22.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.695 176.37 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.8 m -138.4 96.14 3.12 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.479 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.402 HE22 HG13 ' A' ' 43' ' ' VAL . 0.6 OUTLIER -129.01 134.43 48.14 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.637 -179.807 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.9 t -78.93 64.26 3.83 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.09 0.471 . . . . 0.0 111.126 -177.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.65 -69.93 2.3 Favored Glycine 0 CA--C 1.521 0.459 0 CA-C-N 115.86 -0.609 . . . . 0.0 114.412 172.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -50.83 -30.34 21.59 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 115.831 1.092 . . . . 0.0 115.831 -167.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -78.17 -27.01 47.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.831 0.816 . . . . 0.0 112.178 -175.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' A' ' 56' ' ' LEU . 49.7 mm -125.28 117.08 48.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 110.555 -0.165 . . . . 0.0 110.555 -175.141 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.6 t -119.19 -54.56 2.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.02 0.438 . . . . 0.0 110.329 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.511 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 4.9 m -105.85 164.35 15.19 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.817 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.572 ' HG3' HD21 ' B' ' 235' ' ' LEU . 18.4 Cg_endo -60.52 -28.26 86.35 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.482 2.121 . . . . 0.0 111.57 177.146 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.438 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -68.82 -28.81 67.07 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.2 178.62 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -70.76 -44.9 65.78 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.337 0.589 . . . . 0.0 109.444 175.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.505 ' HA ' HD12 ' A' ' 50' ' ' ILE . 55.5 tp -65.35 -40.0 93.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.542 -175.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 54' ' ' SER . 3.0 ppt_? -61.28 -37.02 81.64 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -175.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -67.64 -37.98 83.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.945 0.402 . . . . 0.0 110.277 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -67.92 -40.18 83.41 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.215 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.578 HD13 ' CE2' ' A' ' 72' ' ' TYR . 81.6 mt -71.89 -39.21 69.75 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.102 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.5 t -65.29 -39.13 92.15 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -57.11 -42.71 81.35 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.009 177.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 97.9 mt -71.68 -46.02 60.12 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.411 -178.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.81 -42.32 86.11 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -175.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -63.37 -24.06 67.68 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.796 0.331 . . . . 0.0 111.623 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.23 -13.79 37.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.906 0.384 . . . . 0.0 111.335 178.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -90.02 -42.68 11.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.094 0.473 . . . . 0.0 110.409 178.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.67 65.27 0.65 Allowed Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.724 -178.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -145.35 169.65 26.9 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.067 177.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.446 ' HD2' HH12 ' B' ' 257' ' ' ARG . 31.7 mmtp -92.17 -15.13 28.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.716 0.293 . . . . 0.0 111.087 -178.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.639 ' HA ' ' CB ' ' B' ' 222' ' ' ALA . 31.6 p90 -165.26 175.79 8.93 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -177.043 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.578 ' CE2' HD13 ' A' ' 60' ' ' LEU . 54.6 p90 -135.36 136.54 41.57 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 175.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -110.54 115.83 30.31 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.489 -177.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.526 ' H ' HD12 ' A' ' 74' ' ' ILE . 4.8 mp -72.53 136.03 26.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 32.2 pt -117.26 -21.78 4.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.736 0.303 . . . . 0.0 111.196 178.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -159.4 147.89 17.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.714 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -162.06 141.5 9.71 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -166.77 154.81 9.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.036 0.446 . . . . 0.0 111.403 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -88.6 118.32 28.17 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 168.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -107.15 91.93 3.87 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.19 -120.09 12.91 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -172.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -94.43 6.6 2.43 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.074 2.516 . . . . 0.0 112.341 175.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -103.55 143.51 32.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.705 0.288 . . . . 0.0 110.679 -178.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -103.06 114.25 28.39 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -111.91 127.34 55.82 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.842 -177.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.598 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -141.08 133.48 28.3 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.924 0.392 . . . . 0.0 110.126 175.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.3 t -116.16 118.03 57.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.072 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -133.5 145.54 50.27 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.851 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.556 ' HG2' HG23 ' A' ' 40' ' ' THR . 10.4 mt-10 -117.5 136.77 53.0 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.109 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 26.0 t -95.52 135.95 28.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.676 -171.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.492 ' HB2' ' CZ ' ' A' ' 71' ' ' TYR . 79.5 m-85 -119.2 149.06 42.38 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.211 0.529 . . . . 0.0 110.41 178.559 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.44 ' HB2' HG13 ' A' ' 38' ' ' VAL . 18.1 t-20 -95.74 167.36 11.32 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.482 -176.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.7 t70 . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.298 -178.994 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 222' ' ' ALA . . . . . 0.639 ' CB ' ' HA ' ' A' ' 71' ' ' TYR . . . . . . . . 0 N--CA 1.45 -0.425 0 CA-C-O 120.419 0.152 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 223' ' ' GLU . . . . . 0.526 ' HA ' ' OH ' ' A' ' 72' ' ' TYR . 10.2 pt-20 177.54 133.46 0.06 Allowed 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.896 0.747 . . . . 0.0 111.941 -177.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 224' ' ' GLN . . . . . 0.503 ' HB2' ' HB3' ' A' ' 24' ' ' GLN . 1.4 tm0? -172.22 157.86 4.32 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.657 0.783 . . . . 0.0 109.064 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 225' ' ' VAL . . . . . 0.46 HG21 HD13 ' B' ' 235' ' ' LEU . 18.6 m -109.55 133.09 55.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.729 0.3 . . . . 0.0 111.109 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 226' ' ' SER . . . . . 0.514 ' O ' HG13 ' B' ' 230' ' ' ILE . 83.3 p -90.56 -174.28 4.05 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 178.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -56.46 -37.42 70.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.397 -177.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -64.8 -50.45 66.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.702 -177.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -60.82 -41.06 94.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.171 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.541 ' HA ' HD12 ' B' ' 235' ' ' LEU . 83.5 mt -55.52 -51.79 53.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.921 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 35.3 m -72.09 -28.76 63.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.382 -178.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -78.26 -47.99 16.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.708 -175.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -92.04 4.33 53.31 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -173.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm 57.75 41.0 25.82 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.101 0.477 . . . . 0.0 111.022 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 235' ' ' LEU . . . . . 0.572 HD21 ' HG3' ' A' ' 53' ' ' PRO . 89.4 mt -63.01 125.66 24.75 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.838 -176.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.457 ' CG2' ' HB3' ' B' ' 292' ' ' ASN . 17.0 m -78.79 132.94 31.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.569 -175.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 41.9 tttm -78.4 117.58 19.75 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.44 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 27.0 t -84.3 -35.92 11.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.003 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 164.91 -178.65 39.94 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.226 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 42.1 m -109.69 135.46 50.6 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 18.4 pt -110.05 134.31 52.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.99 0.424 . . . . 0.0 110.511 175.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -120.5 114.33 21.61 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.952 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 243' ' ' VAL . . . . . 0.592 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 5.3 t -102.4 113.38 38.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.15 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 23.3 t -111.72 103.11 11.38 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.938 0.399 . . . . 0.0 110.032 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 245' ' ' GLN . . . . . 0.554 ' HG2' HG12 ' B' ' 250' ' ' ILE . 0.2 OUTLIER -99.96 143.38 30.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.784 -177.247 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 41.1 t -97.69 72.88 2.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.991 0.424 . . . . 0.0 110.859 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 69.43 -92.36 0.33 Allowed Glycine 0 CA--C 1.518 0.269 0 CA-C-N 115.676 -0.693 . . . . 0.0 114.158 172.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -79.89 50.86 3.97 Favored Glycine 0 CA--C 1.517 0.21 0 N-CA-C 114.195 0.438 . . . . 0.0 114.195 -169.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 249' ' ' GLN . . . . . 0.5 ' HB2' ' HG3' ' B' ' 245' ' ' GLN . 78.7 mt-30 -131.66 -0.07 3.93 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.17 0.51 . . . . 0.0 109.761 173.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 250' ' ' ILE . . . . . 0.554 HG12 ' HG2' ' B' ' 245' ' ' GLN . 45.0 mm -132.01 119.74 41.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.551 178.169 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 3.4 m -135.08 -50.68 0.76 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.227 -177.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.25 163.68 16.43 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.305 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.27 -37.75 94.21 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.342 2.028 . . . . 0.0 111.954 176.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 254' ' ' SER . . . . . 0.434 ' HA ' ' HB3' ' B' ' 257' ' ' ARG . 54.8 m -68.31 -25.9 65.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.831 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -64.42 -32.01 73.46 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.616 0.246 . . . . 0.0 110.581 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 56.3 tp -86.93 -38.51 16.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.929 0.395 . . . . 0.0 109.981 176.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 257' ' ' ARG . . . . . 0.446 HH12 ' HD2' ' A' ' 70' ' ' LYS . 77.6 ttt180 -50.72 -43.53 57.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.799 179.138 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 258' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -55.48 -48.57 74.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.657 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -72.9 -32.42 65.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.815 0.341 . . . . 0.0 111.041 -174.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 92.0 mt -65.22 -46.23 81.5 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.871 -178.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 261' ' ' SER . . . . . 0.454 ' HA ' ' CB ' ' A' ' 22' ' ' ALA . 17.6 m -67.18 -36.77 82.48 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.871 177.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -57.56 -52.13 66.68 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.169 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 263' ' ' LEU . . . . . 0.436 HD12 HG22 ' B' ' 243' ' ' VAL . 89.8 mt -73.21 -30.82 63.78 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -174.287 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.5 -38.51 68.12 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 121.149 -0.22 . . . . 0.0 111.33 -176.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -70.35 -32.89 70.79 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.989 0.423 . . . . 0.0 110.07 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -68.65 -22.73 64.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.321 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -96.36 -11.18 26.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.672 0.272 . . . . 0.0 111.004 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 80.03 53.35 4.24 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.634 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.04 -178.88 18.74 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.012 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 270' ' ' LYS . . . . . 0.412 ' HG3' ' OD2' ' B' ' 293' ' ' ASP . 22.3 mmmt -117.22 -46.87 2.69 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.922 0.391 . . . . 0.0 110.722 177.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 271' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -138.23 164.82 28.25 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 272' ' ' TYR . . . . . 0.427 ' HE1' ' N ' ' A' ' 23' ' ' GLU . 11.1 p90 -144.49 142.14 30.04 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.564 -174.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 22.0 t-80 -114.36 104.85 12.47 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.85 -178.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 274' ' ' ILE . . . . . 0.45 ' HB ' ' HB3' ' A' ' 26' ' ' SER . 57.4 mt -68.03 105.37 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.228 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 19.1 pt -77.98 -40.49 26.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.393 -176.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -153.45 131.45 11.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.126 0.489 . . . . 0.0 111.51 -177.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -120.58 103.56 9.25 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 174.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -127.23 126.82 43.4 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.331 0.586 . . . . 0.0 110.603 -172.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -88.89 126.55 35.43 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.308 0.575 . . . . 0.0 110.487 -176.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -97.39 81.2 2.96 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.121 -176.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 61.16 -120.18 21.7 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.057 -176.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -83.06 10.55 3.6 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.799 2.332 . . . . 0.0 112.211 177.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -121.08 166.53 13.78 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 284' ' ' PHE . . . . . 0.448 ' CE2' ' HB2' ' B' ' 286' ' ' ALA . 51.1 t80 -131.7 127.47 36.95 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.425 0.155 . . . . 0.0 110.686 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 285' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -111.26 110.51 21.03 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.443 -178.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 286' ' ' ALA . . . . . 0.592 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -107.29 120.24 41.61 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.612 0.244 . . . . 0.0 110.788 176.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 17.7 t -116.13 123.12 70.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.816 0.341 . . . . 0.0 110.577 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -136.6 144.47 44.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.945 0.402 . . . . 0.0 111.588 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -92.98 123.66 36.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.705 176.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 48.9 t -91.13 128.33 42.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.75 0.31 . . . . 0.0 110.467 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -123.48 156.34 35.78 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.11 0.481 . . . . 0.0 111.032 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 292' ' ' ASN . . . . . 0.457 ' HB3' ' CG2' ' B' ' 236' ' ' VAL . 6.9 t-20 -117.21 159.35 22.79 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.345 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 293' ' ' ASP . . . . . 0.412 ' OD2' ' HG3' ' B' ' 270' ' ' LYS . 4.1 p30 . . . . . 0 C--N 1.327 -0.408 0 O-C-N 123.102 0.251 . . . . 0.0 111.161 -177.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.539 ' HB1' ' CD2' ' B' ' 272' ' ' TYR . . . . . . . . 0 N--CA 1.453 -0.301 0 CA-C-O 120.36 0.124 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.602 ' HB3' ' HE1' ' A' ' 71' ' ' TYR . 10.8 mt-10 -160.33 110.97 1.85 Allowed 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -177.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.666 ' HB2' ' HB3' ' B' ' 224' ' ' GLN . 24.8 tm0? -173.58 141.35 0.86 Allowed 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.469 174.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.2 m -105.76 116.11 48.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.081 0.467 . . . . 0.0 110.929 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.517 ' HB3' ' OE2' ' A' ' 29' ' ' GLU . 15.9 t -82.13 172.76 12.82 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.778 0.323 . . . . 0.0 110.147 -177.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.553 ' HA ' ' HB ' ' A' ' 30' ' ' ILE . 29.1 mmmt -67.3 -19.33 65.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.26 -173.202 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 17.7 mp0 -65.47 -51.57 59.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.902 0.382 . . . . 0.0 110.31 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.517 ' OE2' ' HB3' ' A' ' 26' ' ' SER . 2.3 pm0 -76.84 -28.03 55.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.087 177.254 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.553 ' HB ' ' HA ' ' A' ' 27' ' ' LYS . 77.7 mt -60.0 -46.59 93.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.725 0.298 . . . . 0.0 110.204 174.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.6 m -73.8 -21.83 60.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.207 178.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -86.72 -46.17 10.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.423 -175.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -94.49 -13.87 25.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.07 -178.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm 62.01 76.06 0.38 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.525 0.679 . . . . 0.0 110.579 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.485 HD12 HG12 ' A' ' 30' ' ' ILE . 71.6 mt -87.52 177.01 7.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.869 -172.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 92' ' ' ASN . 28.9 t -104.0 115.34 45.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.472 -174.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.1 ttmm -80.88 121.16 25.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.654 0.264 . . . . 0.0 110.588 177.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.613 HG22 ' OD1' ' A' ' 92' ' ' ASN . 2.2 t -78.78 -34.42 17.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.572 0.701 . . . . 0.0 109.344 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 160.32 -159.51 30.89 Favored Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.961 -177.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.5 m -137.5 126.44 24.19 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.5 pt -103.96 136.46 37.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.087 0.47 . . . . 0.0 111.089 -177.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -117.01 122.58 44.62 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.974 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.49 ' HB ' ' H ' ' A' ' 86' ' ' ALA . 88.3 t -94.25 138.11 21.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.345 175.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.4 t -156.99 80.37 0.92 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.195 0.522 . . . . 0.0 110.247 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -125.4 159.75 31.1 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 176.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.557 ' HA ' ' HA ' ' A' ' 83' ' ' ASN . 22.6 t -64.59 158.95 22.94 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 176.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.88 50.82 1.9 Allowed Glycine 0 C--N 1.333 0.363 0 CA-C-N 116.358 -0.383 . . . . 0.0 112.843 -178.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -142.17 -36.84 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 177.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -69.66 -30.13 67.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.291 0.567 . . . . 0.0 110.036 175.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.3 mm -108.24 96.1 4.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 173.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.3 t -106.28 -2.03 22.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.954 0.407 . . . . 0.0 110.991 -174.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 93.4 p -162.19 164.4 17.33 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.213 -178.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.74 -25.86 81.88 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.237 1.958 . . . . 0.0 111.213 172.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.473 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 17.1 m -66.65 -45.4 79.09 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.6 178.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.503 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 26.5 m-20 -57.61 -45.54 85.2 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.227 0.537 . . . . 0.0 109.945 177.233 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 54.4 tp -64.57 -39.58 94.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.048 -178.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -60.32 -46.21 90.69 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.702 -178.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 54' ' ' SER . 8.5 mm-40 -63.53 -26.99 68.96 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.927 -177.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.521 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 29.3 mmmt -78.2 -53.67 7.08 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.524 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.0 mt -63.67 -41.86 98.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.72 -174.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.9 p -63.23 -45.71 90.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.668 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -60.61 -45.26 94.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.911 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 59' ' ' LYS . 92.1 mt -63.75 -40.27 96.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.066 -178.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.1 -43.85 77.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.863 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -63.2 -44.99 93.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.404 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.8 -22.25 61.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.976 -177.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -80.04 -12.17 59.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.691 0.281 . . . . 0.0 110.911 176.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 94.92 16.65 40.78 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.404 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.451 ' HA3' HG21 ' A' ' 38' ' ' VAL . . . -112.53 -158.15 13.65 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.875 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.822 ' HD2' ' HB2' ' A' ' 93' ' ' ASP . 93.2 mttt -138.92 -61.46 0.56 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.096 0.474 . . . . 0.0 110.795 177.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.602 ' HE1' ' HB3' ' A' ' 23' ' ' GLU . 56.8 m-85 -97.8 156.98 16.33 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.901 -171.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.49 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 26.3 p90 -142.81 123.24 13.94 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.191 178.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.471 ' ND1' ' HA ' ' A' ' 26' ' ' SER . 32.7 t60 -96.06 109.07 21.55 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.14 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.596 ' H ' HD12 ' A' ' 74' ' ' ILE . 4.5 mp -73.69 104.8 2.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 30.0 pt -85.65 -20.55 8.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.723 -178.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -160.0 120.78 3.05 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.12 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -124.7 96.2 4.8 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 175.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.1 -178.99 4.25 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.292 -174.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.83 157.41 17.49 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 176.02 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.563 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 4.3 t-160 -124.08 63.16 1.08 Allowed 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 174.195 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.48 -114.6 4.5 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.213 -175.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -83.76 20.9 1.12 Allowed 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.684 2.256 . . . . 0.0 112.015 174.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.563 ' HB2' ' HB3' ' A' ' 80' ' ' HIS . 31.0 m-80 -131.27 164.21 26.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.116 -177.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -124.1 129.96 51.74 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 175.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.461 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 81.8 mt-10 -127.86 116.89 20.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.129 0.49 . . . . 0.0 111.465 -176.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.49 ' H ' ' HB ' ' A' ' 43' ' ' VAL . . . -114.31 128.79 56.53 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.312 178.068 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.0 t -108.76 115.86 50.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.905 179.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 72' ' ' TYR . . . -125.99 136.65 53.23 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.933 0.397 . . . . 0.0 111.544 -176.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 72' ' ' TYR . 45.9 mt-10 -91.76 118.63 30.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.82 177.029 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.5 t -86.3 128.65 39.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.434 -178.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -124.92 147.36 48.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.09 0.472 . . . . 0.0 110.608 178.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.613 ' OD1' HG22 ' A' ' 38' ' ' VAL . 21.5 m120 -82.52 163.1 21.76 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.139 178.077 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.822 ' HB2' ' HD2' ' A' ' 70' ' ' LYS . 38.0 t0 . . . . . 0 C--N 1.319 -0.757 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 169.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.381 0 CA-C-O 121.033 0.444 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -151.43 -156.66 0.73 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.126 -168.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 224' ' ' GLN . . . . . 0.687 ' HA ' ' HB3' ' B' ' 271' ' ' TYR . 1.6 tm0? 82.23 145.79 0.08 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.899 0.88 . . . . 0.0 111.495 172.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 225' ' ' VAL . . . . . 0.402 HG21 HD12 ' B' ' 235' ' ' LEU . 23.7 m -115.97 154.36 17.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.208 -176.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 19.7 m -99.03 -102.79 0.22 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.883 -178.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -124.16 -57.54 1.59 Allowed 'General case' 0 C--N 1.326 -0.413 0 O-C-N 122.011 -0.43 . . . . 0.0 111.31 -170.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -62.04 -38.08 87.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.025 0.44 . . . . 0.0 110.878 -175.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -61.72 -36.08 79.91 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.01 -177.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.415 HD13 ' CZ ' ' B' ' 291' ' ' TYR . 66.7 mt -60.49 -53.08 53.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.79 -178.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 23.2 t -72.85 -21.33 60.96 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.171 -176.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -87.87 -44.48 11.04 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -176.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -95.32 -18.43 20.8 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.582 0.216 . . . . 0.0 111.582 -177.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 5.7 mmmm 63.17 77.29 0.33 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.501 0.667 . . . . 0.0 111.489 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 235' ' ' LEU . . . . . 0.402 HD12 HG21 ' B' ' 225' ' ' VAL . 87.9 mt -93.94 140.75 29.32 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.502 175.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 27.2 m -76.88 127.07 38.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.106 0.479 . . . . 0.0 111.0 -177.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 237' ' ' LYS . . . . . 0.532 ' HE2' ' HB3' ' B' ' 289' ' ' GLU . 57.9 tttm -84.95 107.12 16.93 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.936 178.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 48.8 t -67.28 -35.19 73.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.607 -177.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 168.79 -149.32 13.61 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.313 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 38.3 m -139.74 140.81 36.83 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 -178.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 18.2 pt -121.14 139.01 49.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.097 0.475 . . . . 0.0 110.677 178.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -127.68 113.59 16.23 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 243' ' ' VAL . . . . . 0.468 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 2.3 t -100.69 108.41 23.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.21 -175.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 26.5 t -99.32 109.42 22.04 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 177.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 245' ' ' GLN . . . . . 0.554 HE21 HD11 ' B' ' 250' ' ' ILE . 3.9 mm-40 -99.71 158.25 15.91 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 121.358 0.599 . . . . 0.0 110.669 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 1.5 p -91.48 11.04 25.31 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.539 175.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 94.83 -61.02 1.68 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.796 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -78.29 50.57 3.47 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 121.2 -0.524 . . . . 0.0 113.103 -178.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -137.03 -14.48 1.57 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.828 0.346 . . . . 0.0 110.533 177.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 250' ' ' ILE . . . . . 0.554 HD11 HE21 ' B' ' 245' ' ' GLN . 39.5 mm -125.56 99.15 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.73 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 23.1 t -98.38 -25.47 14.81 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.355 0.597 . . . . 0.0 109.65 178.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 252' ' ' SER . . . . . 0.522 ' HB3' ' HD2' ' B' ' 253' ' ' PRO . 49.8 m -151.49 165.7 16.81 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.747 178.345 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 253' ' ' PRO . . . . . 0.522 ' HD2' ' HB3' ' B' ' 252' ' ' SER . 11.3 Cg_endo -55.41 -25.69 49.63 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.756 2.304 . . . . 0.0 112.113 177.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 254' ' ' SER . . . . . 0.548 ' O ' ' HG3' ' B' ' 258' ' ' GLU . 30.0 t -54.15 -36.29 63.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.142 174.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -74.32 -40.16 62.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.905 0.383 . . . . 0.0 110.614 -177.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 42.7 tp -60.9 -45.45 94.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.211 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 257' ' ' ARG . . . . . 0.519 ' HD3' ' OH ' ' A' ' 71' ' ' TYR . 13.1 ptt180 -63.72 -30.99 72.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.796 0.331 . . . . 0.0 111.158 -178.004 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 258' ' ' GLU . . . . . 0.548 ' HG3' ' O ' ' B' ' 254' ' ' SER . 56.5 mt-10 -72.41 -36.49 68.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.854 0.359 . . . . 0.0 110.462 -179.175 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 259' ' ' LYS . . . . . 0.551 ' HG2' HE22 ' B' ' 245' ' ' GLN . 14.2 mptt -74.67 -40.1 61.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.966 178.056 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 93.3 mt -66.35 -43.89 84.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.746 -177.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 22.0 p -68.15 -34.15 75.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.751 0.31 . . . . 0.0 110.521 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -54.93 -44.76 74.57 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.573 0.701 . . . . 0.0 109.966 176.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 263' ' ' LEU . . . . . 0.587 ' O ' ' HG2' ' B' ' 267' ' ' LYS . 68.9 mt -74.69 -41.73 59.69 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.995 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -60.17 -47.86 84.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.271 -174.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -70.7 -29.96 66.39 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.624 -177.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -66.49 -23.53 66.27 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.373 0.606 . . . . 0.0 110.538 176.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 267' ' ' LYS . . . . . 0.587 ' HG2' ' O ' ' B' ' 263' ' ' LEU . 73.3 mmtt -89.43 -21.76 22.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.869 176.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 88.27 25.3 31.47 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.802 -177.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -100.14 -165.28 28.82 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.124 -179.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 270' ' ' LYS . . . . . 0.513 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 22.2 mmtp -132.66 -67.56 0.64 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.194 0.521 . . . . 0.0 109.708 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 271' ' ' TYR . . . . . 0.687 ' HB3' ' HA ' ' B' ' 224' ' ' GLN . 7.7 m-85 -101.23 145.29 29.02 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.165 -176.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 272' ' ' TYR . . . . . 0.539 ' CD2' ' HB1' ' A' ' 22' ' ' ALA . 10.9 p90 -104.46 169.47 8.45 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 175.07 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 273' ' ' HIS . . . . . 0.455 ' HB3' ' HB2' ' B' ' 289' ' ' GLU . 10.7 t-160 -138.03 101.47 4.43 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.402 172.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 274' ' ' ILE . . . . . 0.46 HG21 ' OE1' ' A' ' 29' ' ' GLU . 63.3 mt -71.33 123.02 24.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.155 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 22.5 pt -114.08 -28.67 2.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.592 -176.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -152.06 107.13 3.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.954 0.407 . . . . 0.0 111.531 -178.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -105.37 96.65 6.66 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 173.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -127.38 137.51 52.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.206 0.527 . . . . 0.0 111.331 -170.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -88.06 119.75 28.74 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.095 0.474 . . . . 0.0 110.707 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -98.62 78.65 2.39 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 69.5 -126.42 18.78 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 -175.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.74 6.47 4.5 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 122.614 2.209 . . . . 0.0 112.257 177.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -112.34 151.49 29.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.184 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 284' ' ' PHE . . . . . 0.464 ' HB3' ' HB2' ' B' ' 245' ' ' GLN . 52.0 t80 -115.67 113.0 22.93 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 175.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 285' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -102.37 110.39 22.32 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.293 -0.412 . . . . 0.0 109.993 -177.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 286' ' ' ALA . . . . . 0.468 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -102.35 114.91 29.49 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.79 0.328 . . . . 0.0 110.52 176.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 29.4 t -105.75 120.93 57.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.218 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -138.83 152.21 47.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.019 0.438 . . . . 0.0 111.364 -178.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 289' ' ' GLU . . . . . 0.532 ' HB3' ' HE2' ' B' ' 237' ' ' LYS . 31.1 mt-10 -91.74 157.99 16.61 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 175.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 39.9 t -115.11 125.43 72.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 177.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 291' ' ' TYR . . . . . 0.415 ' CZ ' HD13 ' B' ' 230' ' ' ILE . 93.5 m-85 -125.02 155.34 39.87 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.236 0.541 . . . . 0.0 110.716 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 292' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -118.91 156.62 29.2 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 2.3 p30 . . . . . 0 N--CA 1.466 0.325 0 CA-C-O 120.662 0.267 . . . . 0.0 110.897 -178.871 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.589 ' HA ' ' OE2' ' B' ' 223' ' ' GLU . . . . . . . . 0 N--CA 1.464 0.241 0 CA-C-O 121.277 0.561 . . . . 0.0 109.984 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.717 ' O ' ' HB3' ' A' ' 24' ' ' GLN . 9.2 tp10 -133.74 178.75 6.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.349 -171.174 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.717 ' HB3' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER 96.45 134.9 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.95 1.3 . . . . 0.0 111.985 176.851 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.435 ' N ' ' HG2' ' A' ' 24' ' ' GLN . 21.2 m -109.98 155.74 11.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.07 -0.968 . . . . 0.0 108.721 172.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.623 ' HB3' ' OE1' ' A' ' 28' ' ' GLN . 7.0 t -98.29 -176.85 3.52 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.26 -178.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.594 ' HA ' HD12 ' A' ' 30' ' ' ILE . 5.0 tmtt? -65.08 -27.87 69.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.464 -169.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.623 ' OE1' ' HB3' ' A' ' 26' ' ' SER . 15.8 mp0 -59.34 -49.51 77.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.021 0.439 . . . . 0.0 110.356 -178.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.638 ' HA ' ' HB3' ' A' ' 32' ' ' HIS . 12.8 mm-40 -75.25 -25.62 58.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.102 -173.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.594 HD12 ' HA ' ' A' ' 27' ' ' LYS . 63.8 mt -57.53 -52.93 51.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.204 0.526 . . . . 0.0 109.912 175.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.8 m -73.87 -24.02 59.68 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.001 177.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.638 ' HB3' ' HA ' ' A' ' 29' ' ' GLU . 21.8 t-160 -69.72 -52.58 24.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.136 -177.506 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -97.59 2.95 50.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.301 -176.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt 56.17 59.05 3.9 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 123.624 0.577 . . . . 0.0 111.03 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.3 mt -62.44 138.04 58.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.654 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.8 t -65.09 -37.17 79.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.541 -174.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.0 tttm 66.28 114.94 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 O-C-N 124.227 0.954 . . . . 0.0 111.118 -178.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.2 m -82.66 -39.45 15.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.859 -0.337 . . . . 0.0 111.741 -177.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 173.12 -155.67 23.12 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.266 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.55 HG23 ' HG2' ' A' ' 89' ' ' GLU . 46.8 m -141.97 131.06 23.25 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.706 0.289 . . . . 0.0 110.337 -178.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.9 pt -120.91 173.3 6.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -150.29 152.2 34.13 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.558 0.694 . . . . 0.0 112.112 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.616 HG13 ' NE2' ' A' ' 45' ' ' GLN . 69.2 t -94.64 128.67 45.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.521 171.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.4 t -143.34 46.11 1.52 Allowed 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.616 ' NE2' HG13 ' A' ' 43' ' ' VAL . 1.0 OUTLIER -93.42 145.05 24.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.033 -175.089 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.3 m -82.1 80.97 8.2 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.956 -174.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.23 -77.29 0.58 Allowed Glycine 0 CA--C 1.521 0.434 0 N-CA-C 114.872 0.709 . . . . 0.0 114.872 168.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -58.56 -19.85 43.5 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 114.743 0.657 . . . . 0.0 114.743 -168.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.431 ' HB2' ' HB3' ' A' ' 45' ' ' GLN . 15.9 mm-40 -79.35 -21.77 45.37 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 117.356 0.578 . . . . 0.0 111.169 -178.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 40.3 mm -123.44 88.22 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.7 t -105.76 -30.64 9.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.635 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.7 m -127.47 158.38 69.92 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.373 -177.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.28 -32.52 81.31 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.726 2.284 . . . . 0.0 112.088 176.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.591 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 11.5 p -64.28 -40.68 96.45 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.145 178.045 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -54.96 -30.97 60.13 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.733 0.301 . . . . 0.0 111.457 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 40.4 tp -56.59 -55.91 27.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.774 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -73.21 -29.8 63.06 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.047 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.591 ' HG2' ' O ' ' A' ' 54' ' ' SER . 22.8 mm-40 -62.05 -48.31 80.83 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.214 0.531 . . . . 0.0 110.837 179.121 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -73.12 -37.94 66.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.336 -178.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.479 HD13 ' CE1' ' A' ' 72' ' ' TYR . 37.6 mt -72.08 -35.51 69.25 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.732 -178.012 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.515 ' HG ' ' N ' ' B' ' 222' ' ' ALA . 24.9 m -62.6 -42.74 99.75 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 120.874 -0.331 . . . . 0.0 110.31 173.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -56.18 -39.65 72.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.356 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.402 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 86.6 mt -76.42 -51.34 12.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.669 178.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.86 -32.16 72.48 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.294 -171.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -58.03 -49.49 76.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.946 0.403 . . . . 0.0 110.611 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.49 -25.25 63.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.612 -178.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 63' ' ' LEU . 74.9 mmtt -75.87 -19.62 58.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.023 0.439 . . . . 0.0 110.581 178.071 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.55 38.46 9.7 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.291 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -105.51 161.62 14.56 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.414 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.584 ' HG3' ' OD2' ' A' ' 93' ' ' ASP . 35.4 mmtp -98.73 -48.66 4.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.276 0.56 . . . . 0.0 110.387 178.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.537 ' HE2' ' HD2' ' B' ' 257' ' ' ARG . 1.5 p90 -147.63 168.28 22.42 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.39 -178.359 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.479 ' CE1' HD13 ' A' ' 60' ' ' LEU . 45.8 p90 -142.14 166.96 23.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.901 -178.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -137.7 109.43 7.08 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.313 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.575 HG12 ' HB2' ' A' ' 88' ' ' ALA . 83.6 mt -69.62 130.31 34.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 176.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.9 pt -109.55 -25.88 3.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.29 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -150.0 129.37 12.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.628 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -144.28 138.12 27.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.255 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.531 ' HD3' ' HB2' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -166.52 157.77 12.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.547 179.848 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -91.47 122.68 34.28 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 168.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -115.35 96.73 5.8 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.82 -125.25 9.0 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -172.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -94.83 14.94 1.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.019 2.479 . . . . 0.0 112.497 175.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -114.87 150.69 35.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.704 0.288 . . . . 0.0 110.947 -176.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -109.43 108.17 18.59 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 174.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.532 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 5.0 mm-40 -100.62 112.34 24.71 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.057 -175.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.495 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -130.57 116.55 18.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.855 0.359 . . . . 0.0 111.318 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.2 t -96.55 123.35 48.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.782 0.325 . . . . 0.0 110.649 -177.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.575 ' HB2' HG12 ' A' ' 74' ' ' ILE . . . -135.35 129.0 32.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.007 0.432 . . . . 0.0 111.307 -177.127 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.55 ' HG2' HG23 ' A' ' 40' ' ' THR . 21.1 mt-10 -92.34 137.01 32.73 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 23.1 t -99.89 134.5 39.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 120.896 0.379 . . . . 0.0 110.33 -176.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -124.69 149.35 47.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.237 -177.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.574 ' OD1' ' HG2' ' A' ' 70' ' ' LYS . 18.2 m-20 -123.53 150.85 43.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.393 176.143 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.584 ' OD2' ' HG3' ' A' ' 70' ' ' LYS . 5.8 m-20 . . . . . 0 C--O 1.238 0.464 0 O-C-N 123.687 0.617 . . . . 0.0 110.359 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 222' ' ' ALA . . . . . 0.515 ' N ' ' HG ' ' A' ' 61' ' ' SER . . . . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.951 0.405 . . . . 0.0 111.65 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 223' ' ' GLU . . . . . 0.589 ' OE2' ' HA ' ' A' ' 22' ' ' ALA . 8.7 pt-20 -150.78 169.58 21.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.502 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 224' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' B' ' 223' ' ' GLU . 0.8 OUTLIER 177.4 137.08 0.07 Allowed 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.781 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 5.7 m -133.55 107.28 10.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.07 0.462 . . . . 0.0 110.195 173.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 226' ' ' SER . . . . . 0.495 ' O ' HG13 ' B' ' 230' ' ' ILE . 8.5 t -89.71 171.08 9.9 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -178.591 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 227' ' ' LYS . . . . . 0.419 ' HB3' ' HE2' ' B' ' 227' ' ' LYS . 43.5 mtpt -66.45 -18.18 65.22 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -171.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -72.07 -47.56 50.64 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 176.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 229' ' ' GLU . . . . . 0.449 ' OE1' ' HB3' ' B' ' 226' ' ' SER . 2.0 mp0 -67.4 -41.04 85.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.159 176.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.571 HG12 HD12 ' B' ' 235' ' ' LEU . 98.1 mt -59.01 -48.01 88.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.448 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 35.5 p -72.78 -25.01 61.01 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.007 0.432 . . . . 0.0 110.959 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 26.4 t-80 -75.71 -50.17 16.12 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.284 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -88.62 -16.89 31.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.319 -177.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 60.06 79.77 0.23 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.543 0.687 . . . . 0.0 110.177 -177.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 235' ' ' LEU . . . . . 0.571 HD12 HG12 ' B' ' 230' ' ' ILE . 82.9 mt -82.57 177.48 8.69 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.002 -175.002 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 61.3 t -105.96 138.8 29.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.727 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 237' ' ' LYS . . . . . 0.438 ' HE2' ' O ' ' B' ' 239' ' ' GLY . 20.2 tptm -104.74 128.9 53.0 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.774 -179.29 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 238' ' ' VAL . . . . . 0.418 HG13 ' HB2' ' B' ' 292' ' ' ASN . 2.6 m -91.3 -45.33 14.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.297 176.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 239' ' ' GLY . . . . . 0.438 ' O ' ' HE2' ' B' ' 237' ' ' LYS . . . 166.02 -178.7 40.57 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.115 -177.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 34.9 m -106.69 137.93 43.81 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.466 -0.198 . . . . 0.0 110.466 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 29.7 pt -105.53 137.44 35.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.878 0.37 . . . . 0.0 110.435 175.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -115.64 114.17 24.53 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.431 -177.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 243' ' ' VAL . . . . . 0.585 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 54.9 t -101.9 125.4 56.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.901 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 23.1 t -146.91 106.4 3.92 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.874 0.369 . . . . 0.0 110.44 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 245' ' ' GLN . . . . . 0.507 ' HG3' ' HB2' ' B' ' 249' ' ' GLN . 0.0 OUTLIER -156.33 168.05 28.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.391 178.363 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 22.6 t -92.16 -174.3 3.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.828 0.347 . . . . 0.0 110.413 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -69.64 -3.1 39.67 Favored Glycine 0 C--N 1.33 0.2 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.771 -178.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -74.45 -27.59 65.29 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.701 -0.762 . . . . 0.0 111.613 174.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 249' ' ' GLN . . . . . 0.507 ' HB2' ' HG3' ' B' ' 245' ' ' GLN . 64.7 mt-30 -102.16 -36.79 8.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.56 0.219 . . . . 0.0 110.586 177.317 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 250' ' ' ILE . . . . . 0.433 HG12 ' HG3' ' B' ' 245' ' ' GLN . 47.6 mm -115.4 99.97 9.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.857 0.36 . . . . 0.0 110.791 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 21.5 t -122.68 -42.74 2.3 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.999 175.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 252' ' ' SER . . . . . 0.51 ' HB3' ' HD2' ' B' ' 253' ' ' PRO . 32.3 m -111.23 162.33 21.35 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.776 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 253' ' ' PRO . . . . . 0.51 ' HD2' ' HB3' ' B' ' 252' ' ' SER . 13.1 Cg_endo -57.83 -35.25 98.88 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.775 2.316 . . . . 0.0 112.754 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 254' ' ' SER . . . . . 0.417 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 5.3 p -63.27 -34.39 77.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.149 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -58.84 -51.57 69.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.662 -176.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 55.4 tp -63.66 -37.92 89.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.029 -177.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 257' ' ' ARG . . . . . 0.537 ' HD2' ' HE2' ' A' ' 71' ' ' TYR . 81.3 mtp180 -59.43 -39.92 85.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.719 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 258' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' B' ' 254' ' ' SER . 21.2 mm-40 -65.46 -30.98 71.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.857 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -79.74 -48.36 13.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.113 -177.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.69 -46.25 86.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.904 -174.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 18.4 p -61.28 -41.18 96.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.224 0.535 . . . . 0.0 110.763 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -61.5 -51.0 70.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.156 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 263' ' ' LEU . . . . . . . . . . . . . 95.9 mt -67.65 -31.42 71.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.68 -175.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.88 -50.75 47.05 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -175.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -71.98 -25.31 61.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.872 0.368 . . . . 0.0 110.106 -177.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -67.8 -34.24 76.37 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.287 0.565 . . . . 0.0 110.552 176.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -81.79 -9.68 59.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.362 177.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 268' ' ' GLY . . . . . 0.484 ' O ' ' HE2' ' B' ' 270' ' ' LYS . . . 96.37 5.92 58.94 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.168 175.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 269' ' ' GLY . . . . . 0.485 ' HA3' HG12 ' B' ' 290' ' ' VAL . . . -89.45 154.94 24.58 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.685 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 270' ' ' LYS . . . . . 0.484 ' HE2' ' O ' ' B' ' 268' ' ' GLY . 48.6 mmtt -119.74 -2.54 10.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.951 0.405 . . . . 0.0 110.55 -175.162 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 271' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -143.55 154.6 43.77 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 175.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 272' ' ' TYR . . . . . 0.443 ' CD1' ' HB1' ' A' ' 22' ' ' ALA . 7.3 p90 -151.31 157.85 43.05 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.994 174.575 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -138.89 112.13 8.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.865 -178.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 274' ' ' ILE . . . . . 0.591 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 55.6 mt -69.24 120.76 17.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.536 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 22.0 pt -97.87 -36.94 6.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.149 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -145.45 100.44 3.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.925 0.393 . . . . 0.0 111.598 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -104.57 100.57 10.24 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 174.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 278' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' B' ' 285' ' ' GLU . 10.0 ptm180 -118.68 111.96 19.19 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.838 0.827 . . . . 0.0 111.787 -169.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -77.75 96.78 4.99 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.666 173.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 17.1 t-160 -96.62 97.83 9.7 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.691 -175.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 77.39 -137.26 20.1 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -174.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -83.08 -4.36 11.17 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.462 2.108 . . . . 0.0 111.872 174.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -103.66 154.33 19.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.173 -176.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 284' ' ' PHE . . . . . 0.438 ' CE2' ' HB2' ' B' ' 286' ' ' ALA . 84.1 t80 -114.74 124.75 52.58 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.913 0.387 . . . . 0.0 110.238 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 285' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 36.2 mt-10 -123.72 116.65 23.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.151 -179.311 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 286' ' ' ALA . . . . . 0.585 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -118.07 130.15 55.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.119 0.485 . . . . 0.0 111.722 -175.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 35.2 t -110.93 120.73 62.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.031 174.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -133.13 140.86 47.84 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.11 0.481 . . . . 0.0 111.517 -177.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -91.75 119.27 31.43 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.497 177.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 290' ' ' VAL . . . . . 0.485 HG12 ' HA3' ' B' ' 269' ' ' GLY . 15.4 t -94.98 130.41 43.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -117.35 157.81 25.49 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.375 0.607 . . . . 0.0 110.634 -176.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 292' ' ' ASN . . . . . 0.418 ' HB2' HG13 ' B' ' 238' ' ' VAL . 6.3 t-20 -120.37 164.38 16.43 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 174.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 9.5 t70 . . . . . 0 C--N 1.32 -0.688 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -176.985 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.697 ' HB1' ' CD1' ' B' ' 272' ' ' TYR . . . . . . . . 0 CA--C 1.519 -0.248 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.497 ' O ' ' HE1' ' B' ' 272' ' ' TYR . 0.0 OUTLIER -138.23 -171.67 3.09 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.883 -171.116 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.554 ' CD ' ' HG3' ' B' ' 224' ' ' GLN . 0.0 OUTLIER 75.24 154.69 0.16 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.627 0.771 . . . . 0.0 111.615 176.985 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.8 m -114.77 164.56 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.854 -176.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.525 ' HB2' ' HB ' ' B' ' 274' ' ' ILE . 16.8 t -74.95 164.32 26.69 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.005 0.431 . . . . 0.0 111.267 -174.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -66.61 -28.91 68.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.281 176.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -60.67 -37.97 83.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.403 176.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.622 ' HA ' ' HB3' ' A' ' 32' ' ' HIS . 15.4 mm-40 -72.52 -26.21 61.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.908 -175.252 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.457 ' HA ' HD13 ' A' ' 35' ' ' LEU . 56.5 mt -60.79 -48.09 90.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 173.203 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.2 m -73.92 -21.15 60.16 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.1 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.622 ' HB3' ' HA ' ' A' ' 29' ' ' GLU . 22.8 t-160 -80.89 -54.21 5.79 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.402 -175.284 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -93.24 -20.05 20.81 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -176.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.85 84.99 0.13 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.191 0.519 . . . . 0.0 110.513 -175.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.565 HD22 ' HE1' ' A' ' 71' ' ' TYR . 5.8 mp -91.08 175.48 6.93 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.433 -176.323 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -99.38 129.51 49.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.253 -173.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.474 ' HZ1' ' CD ' ' A' ' 89' ' ' GLU . 35.3 tptt -70.48 126.46 29.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.416 179.078 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.94 8.88 5.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.952 0.406 . . . . 0.0 111.483 175.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.75 -170.0 15.97 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.8 174.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 53.3 m -133.38 131.05 39.58 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.629 HG13 ' HB3' ' A' ' 88' ' ' ALA . 26.1 pt -104.23 132.33 51.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 176.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -123.28 127.72 48.96 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.136 0.493 . . . . 0.0 110.686 -175.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.662 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 88.7 t -93.01 123.26 45.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.171 175.008 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.5 t -146.35 74.4 1.36 Allowed 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 176.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -124.37 178.75 5.22 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.051 -178.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.8 t -86.27 168.47 13.88 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.85 176.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.26 -16.52 54.07 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.492 178.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.24 -17.83 74.45 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.123 -0.561 . . . . 0.0 112.349 177.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -111.61 -26.85 8.81 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.12 0.486 . . . . 0.0 110.353 176.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.494 HD12 ' HA ' ' A' ' 56' ' ' LEU . 43.1 mm -117.41 92.13 2.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.34 175.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.8 t -113.79 -62.33 1.61 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.347 -177.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.8 m -101.56 165.02 14.8 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.827 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -53.0 -38.4 79.98 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.423 2.082 . . . . 0.0 111.567 174.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.8 p -67.71 -38.53 83.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.448 177.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -59.88 -46.89 87.89 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.154 0.502 . . . . 0.0 109.932 176.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.494 ' HA ' HD12 ' A' ' 50' ' ' ILE . 60.4 tp -61.28 -45.74 93.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.19 176.611 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.69 ' HD2' ' OE2' ' B' ' 223' ' ' GLU . 3.7 ttp180 -53.41 -48.36 68.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.203 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -55.52 -45.76 77.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.14 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -70.74 -35.23 72.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.06 -178.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.7 mt -66.04 -48.65 70.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.062 0.458 . . . . 0.0 110.635 176.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.5 t -64.03 -38.11 89.87 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.226 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -58.17 -43.88 87.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.95 178.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 93.5 mt -70.32 -38.03 74.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.277 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.95 93.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.063 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -63.11 -31.94 73.2 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.099 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.47 -24.01 61.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.32 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 28.3 mmtm -100.17 -13.42 18.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.557 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.09 38.82 73.47 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.108 -179.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.1 146.3 18.19 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.567 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.471 ' HG2' ' OD2' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -89.89 -2.18 58.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.633 0.254 . . . . 0.0 111.442 -176.497 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.565 ' HE1' HD22 ' A' ' 35' ' ' LEU . 10.4 p90 -167.4 174.88 7.61 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 169.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.547 ' O ' ' HG3' ' A' ' 24' ' ' GLN . 44.0 p90 -148.25 130.74 15.77 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 175.611 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -111.43 109.67 19.75 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.385 -0.526 . . . . 0.0 109.97 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.555 ' HA ' ' HA ' ' A' ' 88' ' ' ALA . 68.2 mt -68.75 127.15 30.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 177.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 26.8 pt -102.3 -37.24 4.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.03 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.23 136.03 36.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.241 -178.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -147.69 134.12 19.68 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.493 ' HD3' ' HB2' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -154.72 147.34 24.21 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.999 0.428 . . . . 0.0 110.286 179.192 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -94.11 92.6 7.37 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 177.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -87.59 80.13 8.1 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.44 -173.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.62 -121.92 16.05 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.961 -178.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -86.2 -1.46 8.56 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.951 2.434 . . . . 0.0 112.442 177.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -117.45 122.42 43.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.318 -178.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.45 ' CD2' HG21 ' A' ' 50' ' ' ILE . 88.5 t80 -92.53 128.04 38.23 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 177.193 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.662 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 48.4 mt-10 -112.22 117.09 31.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.708 -179.107 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.525 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -120.99 118.67 30.44 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.194 175.117 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.6 t -100.95 111.5 30.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.629 ' HB3' HG13 ' A' ' 41' ' ' ILE . . . -117.38 132.45 56.58 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.05 0.452 . . . . 0.0 110.957 -177.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.496 ' HB3' ' CE2' ' A' ' 91' ' ' TYR . 11.0 mm-40 -92.14 128.23 37.91 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.116 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.1 t -102.37 125.86 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -178.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.496 ' CE2' ' HB3' ' A' ' 89' ' ' GLU . 92.9 m-85 -129.54 142.67 50.71 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.0 0.429 . . . . 0.0 110.386 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -111.85 170.32 8.23 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.014 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.471 ' OD2' ' HG2' ' A' ' 70' ' ' LYS . 13.2 m-20 . . . . . 0 C--N 1.322 -0.608 0 CA-C-O 121.085 0.469 . . . . 0.0 111.006 -176.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.503 0 CA-C-O 120.769 0.319 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 223' ' ' GLU . . . . . 0.69 ' OE2' ' HD2' ' A' ' 57' ' ' ARG . 9.8 tp10 -162.04 120.45 2.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.818 -178.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 224' ' ' GLN . . . . . 0.554 ' HG3' ' CD ' ' A' ' 24' ' ' GLN . 1.5 tm0? -169.95 139.29 1.86 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.041 0.448 . . . . 0.0 112.067 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 14.1 m -113.84 128.83 70.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.032 170.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 226' ' ' SER . . . . . 0.464 ' HB2' ' HG2' ' B' ' 229' ' ' GLU . 12.5 m -77.59 157.42 30.29 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.683 -178.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -68.31 -30.39 69.36 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -62.22 -35.75 79.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.687 176.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 229' ' ' GLU . . . . . 0.464 ' HG2' ' HB2' ' B' ' 226' ' ' SER . 36.6 mm-40 -71.34 -25.3 62.34 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.405 -178.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.532 HG12 HD12 ' B' ' 235' ' ' LEU . 56.8 mt -60.97 -45.17 98.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.828 175.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 5.1 m -73.07 -21.66 60.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.568 176.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 232' ' ' HIS . . . . . 0.421 ' HB3' ' HA ' ' B' ' 229' ' ' GLU . 23.1 t-160 -78.11 -52.04 9.35 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.579 -173.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -113.22 -4.59 13.72 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -175.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.88 84.92 0.12 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.421 0.629 . . . . 0.0 110.119 -171.109 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 235' ' ' LEU . . . . . 0.532 HD12 HG12 ' B' ' 230' ' ' ILE . 87.9 mt -79.32 138.84 37.87 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.031 -176.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 57.2 t -72.92 106.4 2.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.626 -178.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -79.23 116.88 19.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.105 0.478 . . . . 0.0 110.317 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 3.0 t -81.36 -40.89 18.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.825 -178.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 169.05 -149.98 14.73 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.47 -178.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 41.6 m -139.42 127.63 22.58 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 241' ' ' ILE . . . . . 0.466 HG23 HG21 ' B' ' 290' ' ' VAL . 2.4 pp -103.32 131.96 50.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.123 0.487 . . . . 0.0 109.931 178.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -116.19 120.19 38.19 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.058 -177.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 243' ' ' VAL . . . . . 0.588 ' O ' ' HA ' ' B' ' 285' ' ' GLU . 57.9 t -94.16 132.2 38.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.408 178.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 46.5 m -127.87 88.55 2.79 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 172.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 245' ' ' GLN . . . . . 0.594 ' HG2' HG12 ' B' ' 250' ' ' ILE . 1.1 tp60 -80.88 107.82 14.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.076 -173.474 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 53.1 p -84.99 102.74 13.42 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.853 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 92.52 -163.73 27.58 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.798 176.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -85.61 64.67 4.09 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 121.275 -0.488 . . . . 0.0 113.443 -172.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 249' ' ' GLN . . . . . 0.556 ' HB2' ' HG3' ' B' ' 245' ' ' GLN . 64.8 mt-30 -93.95 -3.06 52.28 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.01 0.433 . . . . 0.0 110.195 173.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 250' ' ' ILE . . . . . 0.594 HG12 ' HG2' ' B' ' 245' ' ' GLN . 38.7 mm -125.68 99.22 5.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.091 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 33.0 t -93.58 -46.36 7.32 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.098 0.475 . . . . 0.0 109.799 175.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 20.0 m -123.64 167.63 14.58 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.212 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.13 -26.77 61.89 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.574 2.183 . . . . 0.0 112.01 173.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 254' ' ' SER . . . . . 0.404 ' O ' ' HG3' ' B' ' 258' ' ' GLU . 19.9 m -64.78 -39.45 93.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.625 177.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.04 -46.76 82.17 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.301 177.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 55.3 tp -57.58 -43.85 84.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.701 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 257' ' ' ARG . . . . . 0.49 ' HD2' ' CD ' ' A' ' 23' ' ' GLU . 10.7 ttp180 -53.71 -52.32 60.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.266 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 258' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' B' ' 254' ' ' SER . 68.7 mt-10 -60.29 -27.1 67.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.814 -173.302 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 259' ' ' LYS . . . . . 0.427 ' O ' ' HG ' ' B' ' 263' ' ' LEU . 14.4 mptt -80.47 -39.65 27.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.976 0.417 . . . . 0.0 110.851 176.383 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 95.6 mt -71.28 -47.34 57.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.73 -175.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 2.8 m -58.93 -34.83 72.18 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.314 0.578 . . . . 0.0 110.658 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -66.39 -47.81 72.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.421 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 263' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' B' ' 259' ' ' LYS . 90.6 mt -64.96 -32.41 74.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.629 -175.198 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -60.86 -42.58 98.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.597 -177.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -61.29 -49.39 77.22 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.43 -177.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -68.92 -15.12 63.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.852 -175.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 267' ' ' LYS . . . . . 0.444 ' HD3' ' HA ' ' B' ' 267' ' ' LYS . 31.4 mmtp -100.87 -0.86 36.07 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.088 178.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 74.42 28.11 64.35 Favored Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.218 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -101.27 162.76 17.98 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.066 -178.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 270' ' ' LYS . . . . . 0.496 ' HA ' ' CE ' ' B' ' 270' ' ' LYS . 0.0 OUTLIER -117.15 -59.94 1.89 Allowed 'General case' 0 C--N 1.32 -0.716 0 O-C-N 122.66 -0.317 . . . . 0.0 110.754 179.426 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 271' ' ' TYR . . . . . 0.622 ' HE2' ' HB2' ' B' ' 293' ' ' ASP . 6.0 m-85 -117.19 162.94 17.06 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 272' ' ' TYR . . . . . 0.697 ' CD1' ' HB1' ' A' ' 22' ' ' ALA . 0.1 OUTLIER -148.74 158.75 44.37 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.183 0.516 . . . . 0.0 110.994 -179.123 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -128.17 107.78 10.07 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.256 -178.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 274' ' ' ILE . . . . . 0.525 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 4.5 mp -77.46 120.47 28.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.611 -174.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 14.4 pt -111.42 -26.45 3.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -176.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 276' ' ' ALA . . . . . 0.659 ' HB3' ' HB ' ' B' ' 287' ' ' VAL . . . -134.9 145.74 48.52 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.192 -177.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 277' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' B' ' 285' ' ' GLU . . . -169.47 117.66 0.62 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.856 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.13 139.11 15.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.83 0.348 . . . . 0.0 110.992 -178.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 279' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' B' ' 284' ' ' PHE . 3.3 mp0 -76.7 91.08 3.43 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 174.305 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -87.01 89.31 7.95 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 -176.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 66.44 -118.76 11.33 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.511 -174.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -90.54 -2.12 5.18 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.896 2.398 . . . . 0.0 112.733 177.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 283' ' ' ASN . . . . . 0.551 ' HA ' ' O ' ' B' ' 245' ' ' GLN . 59.1 m-80 -118.87 115.87 25.3 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.018 0.437 . . . . 0.0 111.127 -176.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 284' ' ' PHE . . . . . 0.449 ' HA ' ' HA ' ' B' ' 279' ' ' GLU . 70.0 t80 -79.06 113.92 17.57 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 175.014 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 285' ' ' GLU . . . . . 0.588 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 48.3 mt-10 -99.27 114.13 26.79 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.853 -176.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 286' ' ' ALA . . . . . 0.498 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -114.26 135.09 54.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.473 174.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 287' ' ' VAL . . . . . 0.659 ' HB ' ' HB3' ' B' ' 276' ' ' ALA . 37.4 t -125.41 128.48 72.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 110.081 -0.341 . . . . 0.0 110.081 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -134.74 151.13 50.74 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.965 0.412 . . . . 0.0 111.54 -178.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 289' ' ' GLU . . . . . 0.455 ' O ' ' HA ' ' B' ' 272' ' ' TYR . 21.8 mt-10 -90.62 119.92 31.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.141 178.112 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 290' ' ' VAL . . . . . 0.466 HG21 HG23 ' B' ' 241' ' ' ILE . 39.1 t -94.15 124.15 46.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.511 0.196 . . . . 0.0 111.211 -175.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -129.27 151.29 50.09 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.469 0.652 . . . . 0.0 111.658 -178.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 292' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -106.76 155.19 19.96 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.949 173.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 293' ' ' ASP . . . . . 0.622 ' HB2' ' HE2' ' B' ' 271' ' ' TYR . 25.7 t70 . . . . . 0 C--N 1.322 -0.59 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 165.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.467 ' O ' ' HD3' ' B' ' 257' ' ' ARG . . . . . . . . 0 N--CA 1.467 0.382 0 CA-C-O 121.276 0.56 . . . . 0.0 112.002 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.593 ' HG2' ' N ' ' B' ' 222' ' ' ALA . 9.8 tp10 -150.17 179.74 7.85 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.361 -178.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.778 ' HA ' ' HB2' ' A' ' 71' ' ' TYR . 0.0 OUTLIER 85.44 140.08 0.06 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.074 0.95 . . . . 0.0 111.529 176.712 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.503 HG22 ' CZ ' ' A' ' 71' ' ' TYR . 5.0 m -117.06 173.35 4.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.48 176.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.57 ' HB3' ' HB ' ' B' ' 274' ' ' ILE . 92.3 p -97.99 -175.75 3.24 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.097 0.475 . . . . 0.0 111.039 -175.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.0 tmmt? -71.48 -19.74 62.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.099 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' B' ' 277' ' ' ALA . 1.8 mp0 -66.51 -45.91 77.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.6 -178.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -65.64 -44.69 85.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.502 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.0 mt -53.77 -46.47 62.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.688 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.3 m -68.4 -38.4 81.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.549 -176.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 25.8 m80 -80.86 -44.99 17.53 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -174.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.429 ' CD1' ' HD3' ' B' ' 253' ' ' PRO . 97.8 m-85 -93.22 -19.9 20.97 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -173.35 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm 61.35 82.72 0.16 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.184 0.516 . . . . 0.0 110.617 -177.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.573 HD21 ' HG3' ' B' ' 253' ' ' PRO . 96.5 mt -85.31 173.38 10.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.415 -176.131 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.1 t -95.97 124.78 48.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.608 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -84.58 115.49 22.65 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.161 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -94.68 -3.84 10.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.157 0.503 . . . . 0.0 111.141 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 120.83 155.25 9.51 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.976 174.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 27.4 m -81.16 150.3 28.75 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 177.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.3 pt -116.35 134.22 60.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.001 0.429 . . . . 0.0 110.006 172.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -124.12 116.04 22.11 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.122 -178.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 3.2 t -109.87 109.51 28.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.513 -178.369 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.8 p -92.48 91.92 7.84 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 175.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.606 ' HG2' HG12 ' A' ' 50' ' ' ILE . 0.9 OUTLIER -97.58 147.66 24.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.669 -170.641 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.9 t -96.84 154.8 17.08 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 172.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.92 78.32 0.39 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.338 178.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -175.76 -37.83 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 121.146 -0.549 . . . . 0.0 112.553 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -81.73 -23.85 36.48 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 122.57 -0.37 . . . . 0.0 111.255 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.606 HG12 ' HG2' ' A' ' 45' ' ' GLN . 49.3 mm -112.7 109.71 29.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.447 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.6 t -107.12 -45.94 4.02 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.204 0.526 . . . . 0.0 109.711 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.518 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 22.0 m -126.06 165.96 24.32 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.837 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' A' ' 52' ' ' SER . 10.7 Cg_endo -54.69 -26.4 46.65 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.631 2.221 . . . . 0.0 111.981 177.036 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.598 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 2.3 m -55.67 -51.86 65.8 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.752 176.132 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -59.62 -42.17 92.07 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.234 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 56.9 tp -61.5 -46.58 89.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.908 -177.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 21.5 ttp180 -58.66 -44.51 90.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.455 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.598 ' HG2' ' O ' ' A' ' 54' ' ' SER . 19.0 mm-40 -62.32 -45.35 93.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.854 -178.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -67.33 -36.86 82.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.362 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.0 mt -68.26 -43.0 78.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.977 0.418 . . . . 0.0 110.515 177.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.4 m -68.49 -30.53 69.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.575 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -58.01 -46.67 84.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.055 0.455 . . . . 0.0 110.46 177.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 98.5 mt -74.55 -37.0 63.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.898 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.72 -32.64 74.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.091 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -60.33 -41.72 94.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.917 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.05 -16.62 56.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.078 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -89.52 -15.22 33.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.548 177.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 57.68 48.98 77.83 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 -175.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -92.66 171.14 32.97 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.877 -175.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.477 ' CB ' ' HA ' ' A' ' 92' ' ' ASN . 56.7 tptt -99.89 -47.18 5.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.535 0.683 . . . . 0.0 109.811 178.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.778 ' HB2' ' HA ' ' A' ' 24' ' ' GLN . 35.1 p90 -150.96 177.15 10.43 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.794 -178.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -142.62 126.05 16.69 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.247 0.546 . . . . 0.0 110.166 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -106.61 101.0 10.48 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.281 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.626 HG12 ' HB2' ' A' ' 88' ' ' ALA . 69.7 mt -72.44 120.11 20.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.139 0.495 . . . . 0.0 110.514 -176.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.6 pt -94.99 -35.38 6.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.22 -178.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.97 110.88 5.02 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.995 0.426 . . . . 0.0 111.601 -177.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -107.86 88.43 2.73 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 172.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.532 ' CG ' ' HB2' ' A' ' 85' ' ' GLU . 6.2 ptp180 -95.86 121.49 37.64 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.874 0.845 . . . . 0.0 112.196 -166.331 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -70.64 100.47 1.85 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.71 172.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 23.8 t-80 -88.16 14.74 8.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.062 0.458 . . . . 0.0 110.46 -177.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.85 -106.5 3.18 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.75 -5.9 16.39 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.579 2.186 . . . . 0.0 111.193 173.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -123.02 156.8 34.09 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.172 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -128.49 120.97 27.83 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.532 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 41.3 mt-10 -110.3 110.94 21.94 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.787 -177.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.36 118.12 32.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.035 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.9 t -112.82 112.79 41.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.934 176.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.626 ' HB2' HG12 ' A' ' 74' ' ' ILE . . . -127.76 141.71 51.51 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.962 0.41 . . . . 0.0 111.895 -176.233 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -91.85 116.47 28.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.79 177.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.6 t -100.34 125.01 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-O 121.117 0.484 . . . . 0.0 110.067 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.536 ' HB2' ' CE1' ' A' ' 71' ' ' TYR . 64.7 m-85 -123.84 159.51 29.43 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.911 177.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.477 ' HA ' ' CB ' ' A' ' 70' ' ' LYS . 10.3 t-20 -120.52 174.07 6.78 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 175.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 . . . . . 0 C--O 1.235 0.335 0 CA-C-O 120.764 0.316 . . . . 0.0 110.222 176.427 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 222' ' ' ALA . . . . . 0.593 ' N ' ' HG2' ' A' ' 23' ' ' GLU . . . . . . . . 0 N--CA 1.465 0.321 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -167.61 110.57 0.65 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.926 174.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 224' ' ' GLN . . . . . 0.53 ' HG3' ' CD ' ' A' ' 24' ' ' GLN . 1.1 tm0? -161.94 148.09 13.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.033 -175.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 225' ' ' VAL . . . . . 0.454 HG22 ' HB3' ' B' ' 271' ' ' TYR . 18.7 m -126.78 128.69 71.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 166.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 226' ' ' SER . . . . . 0.6 ' HB2' ' HB ' ' A' ' 74' ' ' ILE . 6.3 t -87.86 178.98 6.55 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.776 0.322 . . . . 0.0 110.158 -177.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 227' ' ' LYS . . . . . 0.426 ' HA ' HD12 ' B' ' 230' ' ' ILE . 23.0 tptp -66.98 -23.91 65.99 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.293 -170.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -72.0 -50.32 29.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.939 0.399 . . . . 0.0 110.127 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -65.06 -38.64 91.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.784 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.49 HG13 ' O ' ' B' ' 226' ' ' SER . 97.4 mt -54.88 -54.0 27.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.032 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 56.8 m -73.44 -22.08 60.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.76 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -79.88 -44.5 20.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.693 0.282 . . . . 0.0 110.547 -177.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -89.48 -8.59 52.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.97 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt 60.28 51.72 5.32 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.528 -178.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.42 149.66 47.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.874 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.459 HG23 ' HB3' ' B' ' 292' ' ' ASN . 16.0 m -86.46 124.34 40.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.375 0.607 . . . . 0.0 111.491 -177.445 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -75.6 128.13 34.58 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.511 176.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 40.5 t -92.69 -44.44 13.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.253 0.549 . . . . 0.0 110.337 -179.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 177.11 -157.35 22.21 Favored Glycine 0 N--CA 1.442 -0.94 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.442 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 59.3 m -135.22 137.47 42.65 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 22.7 pt -117.61 142.61 31.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 175.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -132.9 138.5 47.0 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.692 0.758 . . . . 0.0 111.772 -177.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 243' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' B' ' 285' ' ' GLU . 59.7 t -102.75 134.68 43.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.221 177.377 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 7.2 t -149.21 47.82 0.98 Allowed 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 245' ' ' GLN . . . . . 0.522 ' NE2' HG13 ' B' ' 243' ' ' VAL . 0.9 OUTLIER -103.63 159.22 15.8 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.738 -177.071 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 246' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' B' ' 283' ' ' ASN . 19.1 m -89.18 171.06 10.09 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.247 -177.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -54.61 115.4 5.35 Favored Glycine 0 C--N 1.333 0.389 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.084 176.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . 134.31 -43.57 1.25 Allowed Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 -176.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 249' ' ' GLN . . . . . 0.472 ' HB2' ' HB3' ' B' ' 245' ' ' GLN . 11.5 mm100 -73.29 -23.81 60.33 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.009 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 49.9 mm -114.29 111.63 36.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 171.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 19.7 m -104.03 -19.09 14.31 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.612 -175.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 252' ' ' SER . . . . . 0.478 ' H ' ' HB3' ' B' ' 255' ' ' ASP . 38.6 m -154.99 163.51 24.21 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -176.187 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 253' ' ' PRO . . . . . 0.573 ' HG3' HD21 ' A' ' 35' ' ' LEU . 19.1 Cg_endo -61.64 -41.98 35.7 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.256 1.971 . . . . 0.0 111.246 175.211 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 254' ' ' SER . . . . . 0.44 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 27.5 m -75.28 -18.74 60.0 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.762 177.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 255' ' ' ASP . . . . . 0.478 ' HB3' ' H ' ' B' ' 252' ' ' SER . 35.2 t70 -71.56 -33.57 69.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.204 0.526 . . . . 0.0 109.723 176.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.409 ' O ' ' HG ' ' B' ' 260' ' ' LEU . 63.2 tp -59.44 -43.22 93.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.461 172.23 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 257' ' ' ARG . . . . . 0.467 ' HD3' ' O ' ' A' ' 22' ' ' ALA . 1.8 tmm_? -62.24 -39.12 91.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.807 178.398 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 258' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' B' ' 254' ' ' SER . 13.5 mm-40 -52.43 -52.32 54.59 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.911 0.386 . . . . 0.0 110.328 176.091 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -62.31 -42.86 99.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.128 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 260' ' ' LEU . . . . . 0.493 HD13 ' CE2' ' B' ' 272' ' ' TYR . 96.0 mt -67.9 -43.82 78.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.82 -176.194 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 17.0 p -64.7 -31.23 72.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.999 0.428 . . . . 0.0 110.683 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -65.73 -42.42 91.04 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.21 178.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 263' ' ' LEU . . . . . . . . . . . . . 94.6 mt -73.21 -37.71 66.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.128 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -59.5 -39.31 83.4 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.575 -178.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -61.29 -40.0 92.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.182 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -74.7 -19.15 60.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.657 -176.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 267' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' B' ' 267' ' ' LYS . 42.7 mmtm -93.25 -36.18 12.72 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.946 0.403 . . . . 0.0 110.904 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 106.13 55.91 0.67 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.559 177.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -142.64 150.8 22.53 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.366 -0.921 . . . . 0.0 111.857 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 270' ' ' LYS . . . . . 0.918 ' HD3' ' HB2' ' B' ' 293' ' ' ASP . 45.6 mtpt -94.52 -37.81 11.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.426 0.632 . . . . 0.0 110.268 177.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 271' ' ' TYR . . . . . 0.454 ' HB3' HG22 ' B' ' 225' ' ' VAL . 16.7 m-85 -117.75 150.31 39.33 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.747 -172.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 272' ' ' TYR . . . . . 0.493 ' CE2' HD13 ' B' ' 260' ' ' LEU . 21.6 p90 -145.2 155.02 43.01 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 175.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -136.49 109.79 7.85 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -177.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 274' ' ' ILE . . . . . 0.57 ' HB ' ' HB3' ' A' ' 26' ' ' SER . 60.8 mt -65.4 127.2 26.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.076 177.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 22.7 pt -108.25 -28.26 2.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.777 0.322 . . . . 0.0 111.769 -177.268 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -152.71 108.84 3.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.922 -178.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 277' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' B' ' 286' ' ' ALA . . . -124.53 102.89 7.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.091 0.472 . . . . 0.0 109.921 178.174 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.53 132.02 54.47 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.543 0.687 . . . . 0.0 111.311 -174.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.1 115.53 15.9 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 171.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 280' ' ' HIS . . . . . 0.485 ' HB2' ' HG3' ' B' ' 285' ' ' GLU . 7.1 t-160 -103.54 25.51 9.6 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.189 0.519 . . . . 0.0 110.109 -171.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 281' ' ' GLY . . . . . 0.403 ' HA3' ' HD3' ' B' ' 282' ' ' PRO . . . 103.35 -106.44 2.86 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.982 -0.627 . . . . 0.0 111.732 -177.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 282' ' ' PRO . . . . . 0.403 ' HD3' ' HA3' ' B' ' 281' ' ' GLY . 3.6 Cg_exo -75.45 -24.57 12.0 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.993 2.462 . . . . 0.0 112.045 178.394 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 283' ' ' ASN . . . . . 0.48 ' HA ' ' HA ' ' B' ' 246' ' ' SER . 53.2 m-80 -116.18 148.21 40.61 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.944 -177.31 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -107.22 115.31 29.94 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.58 176.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 285' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 1.0 OUTLIER -101.52 110.85 22.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.959 -175.095 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 286' ' ' ALA . . . . . 0.499 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -125.95 116.52 21.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.782 0.325 . . . . 0.0 111.604 -177.667 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 46.3 t -103.46 124.47 57.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.328 178.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -130.08 141.2 50.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.929 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -92.47 133.42 35.93 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.046 178.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 44.8 t -98.0 125.06 51.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.622 -178.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -123.68 142.98 50.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.1 0.476 . . . . 0.0 110.581 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 292' ' ' ASN . . . . . 0.459 ' HB3' HG23 ' B' ' 236' ' ' VAL . 14.8 t-20 -92.2 167.33 12.11 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.279 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 293' ' ' ASP . . . . . 0.918 ' HB2' ' HD3' ' B' ' 270' ' ' LYS . 13.6 t70 . . . . . 0 C--N 1.328 -0.346 0 CA-C-O 121.143 0.497 . . . . 0.0 110.093 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.495 ' O ' ' HD3' ' B' ' 257' ' ' ARG . . . . . . . . 0 C--O 1.234 0.28 0 N-CA-C 110.456 -0.202 . . . . 0.0 110.456 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 24' ' ' GLN . 8.4 pt-20 -176.46 114.71 0.11 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.107 0.48 . . . . 0.0 112.289 178.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.788 ' HB3' ' CB ' ' B' ' 224' ' ' GLN . 22.2 tm0? 173.81 141.0 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.136 176.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.48 HG21 HD11 ' A' ' 35' ' ' LEU . 31.3 m -120.7 155.08 24.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 121.099 0.476 . . . . 0.0 111.883 -174.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.404 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 72.6 p -96.33 -93.09 0.21 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.429 -174.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.482 ' C ' ' HD3' ' A' ' 27' ' ' LYS . 10.8 tmtt? -123.12 -66.61 1.0 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 122.168 -0.333 . . . . 0.0 111.873 -174.008 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.44 ' H ' ' NE2' ' A' ' 28' ' ' GLN . 0.6 OUTLIER -62.5 -28.53 69.9 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -170.122 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -65.32 -42.78 92.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.968 0.414 . . . . 0.0 110.064 176.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.437 HG12 HD12 ' A' ' 35' ' ' LEU . 28.0 mt -64.57 -44.94 96.81 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.897 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.3 m -67.35 -30.47 70.3 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.846 -0.341 . . . . 0.0 111.335 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -72.45 -48.25 42.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.583 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -98.68 4.16 47.85 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.324 -176.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt 71.85 -45.95 0.63 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.978 0.911 . . . . 0.0 112.028 177.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.561 HD22 ' HA ' ' A' ' 93' ' ' ASP . 19.3 mt 58.71 164.25 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.208 1.003 . . . . 0.0 112.604 -172.619 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 76.3 t -97.5 -47.68 12.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.658 -175.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.592 ' HA ' ' HA ' ' A' ' 91' ' ' TYR . 63.5 tttm 70.39 126.49 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 O-C-N 124.159 0.912 . . . . 0.0 111.082 -177.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.0 m -114.28 -30.06 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -175.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 169.47 -161.99 35.51 Favored Glycine 0 C--O 1.227 -0.305 0 C-N-CA 119.303 -1.427 . . . . 0.0 113.656 -178.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.574 HG23 ' HG2' ' A' ' 89' ' ' GLU . 6.4 m -123.07 143.88 49.66 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 122.473 0.309 . . . . 0.0 110.441 -176.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.9 pt -118.92 139.5 46.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 172.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -122.02 114.4 20.9 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.724 -175.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.59 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 43.0 t -105.63 115.33 47.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.516 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 68.7 p -148.28 99.27 3.02 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.731 0.301 . . . . 0.0 110.996 -174.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 18.7 mp0 -142.15 157.11 45.25 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.064 179.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.599 ' HA ' ' HA ' ' A' ' 83' ' ' ASN . 19.9 t -71.38 173.44 7.85 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 120.666 0.27 . . . . 0.0 110.313 178.309 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.78 55.16 2.57 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 113.165 -176.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -141.52 -37.3 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 176.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -83.41 -14.81 51.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.09 0.471 . . . . 0.0 110.59 177.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.1 mm -130.34 132.57 64.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 176.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.3 m -134.84 -35.03 0.88 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.055 0.455 . . . . 0.0 111.584 -177.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.599 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 28.1 m -142.11 168.48 13.49 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -177.253 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.599 ' HD2' ' HB3' ' A' ' 52' ' ' SER . 10.8 Cg_endo -54.55 -31.05 67.93 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.543 2.162 . . . . 0.0 112.637 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.4 m -61.87 -34.51 76.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.664 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -62.88 -52.81 61.65 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.338 0.59 . . . . 0.0 109.881 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 57.4 tp -63.4 -30.37 71.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.276 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -62.08 -31.79 72.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.955 -178.302 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -74.93 -46.87 32.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.8 0.333 . . . . 0.0 110.358 175.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.565 ' HA ' ' HG2' ' A' ' 62' ' ' GLU . 1.9 mptp? -62.97 -40.39 97.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.195 -175.395 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.3 mt -61.6 -37.12 82.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.824 0.345 . . . . 0.0 110.748 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.523 ' HA ' ' HB3' ' B' ' 222' ' ' ALA . 19.5 m -75.95 -43.28 45.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.45 -178.232 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.565 ' HG2' ' HA ' ' A' ' 59' ' ' LYS . 16.8 pt-20 -69.44 -36.72 76.93 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 121.151 -0.219 . . . . 0.0 111.221 -175.002 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 87.4 mt -74.9 -49.36 20.59 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -178.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.24 -44.1 89.27 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -174.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -65.68 -34.9 79.29 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.997 0.427 . . . . 0.0 110.72 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.11 -8.86 57.65 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.428 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -106.48 2.24 26.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.804 176.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.05 58.57 4.31 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.967 178.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -131.17 -178.04 15.23 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.28 178.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -130.29 -37.07 1.45 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.165 0.507 . . . . 0.0 110.007 177.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.558 ' HB3' ' HA ' ' A' ' 24' ' ' GLN . 11.4 m-85 -127.23 169.53 13.39 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.569 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.43 ' O ' ' HG2' ' A' ' 24' ' ' GLN . 25.7 p90 -142.63 167.28 22.47 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 173.506 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.404 ' CD2' ' HA ' ' A' ' 26' ' ' SER . 4.0 t-160 -134.45 109.26 8.62 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.818 175.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 54.2 mt -68.65 129.81 33.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.833 176.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.5 pt -123.33 -14.78 5.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.741 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -157.45 107.3 2.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.505 0.193 . . . . 0.0 111.191 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -132.6 105.35 7.16 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.785 0.326 . . . . 0.0 110.187 176.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.405 ' HD3' HH11 ' A' ' 78' ' ' ARG . 0.0 OUTLIER -153.47 146.9 24.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.942 -177.529 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -77.79 109.07 11.48 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.636 174.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -101.84 87.95 3.25 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.74 -134.66 13.6 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -175.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -83.61 1.2 9.06 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.65 2.233 . . . . 0.0 112.386 176.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.599 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 44.6 m-80 -115.08 143.15 45.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.051 0.453 . . . . 0.0 111.491 -177.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.516 ' O ' ' HA ' ' A' ' 44' ' ' SER . 66.6 t80 -93.99 120.11 33.79 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.783 176.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -105.26 118.8 37.46 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.512 -177.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.59 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -132.34 115.73 15.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.166 0.507 . . . . 0.0 110.696 176.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 44.6 t -111.81 122.58 66.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.019 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.28 142.09 33.9 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.413 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.574 ' HG2' HG23 ' A' ' 40' ' ' THR . 10.9 mt-10 -103.75 140.24 37.9 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.68 -0.408 . . . . 0.0 109.977 176.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 36.5 t -90.52 125.05 43.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.054 0.454 . . . . 0.0 110.369 -175.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.592 ' HA ' ' HA ' ' A' ' 37' ' ' LYS . 54.9 m-85 -111.5 114.23 27.19 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.657 -178.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -86.36 146.47 26.46 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 171.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.561 ' HA ' HD22 ' A' ' 35' ' ' LEU . 2.7 p-10 . . . . . 0 C--N 1.318 -0.788 0 C-N-CA 121.13 -0.228 . . . . 0.0 110.494 -174.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 222' ' ' ALA . . . . . 0.523 ' HB3' ' HA ' ' A' ' 61' ' ' SER . . . . . . . . 0 C--O 1.236 0.359 0 N-CA-C 110.523 -0.177 . . . . 0.0 110.523 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -170.55 116.65 0.49 Allowed 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 224' ' ' GLN . . . . . 0.788 ' CB ' ' HB3' ' A' ' 24' ' ' GLN . 0.0 OUTLIER 177.31 167.46 0.6 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.449 -1.25 . . . . 0.0 107.96 176.95 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 225' ' ' VAL . . . . . 0.456 HG21 HD13 ' B' ' 235' ' ' LEU . 27.9 m -121.54 147.17 25.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.3 0.571 . . . . 0.0 111.508 -177.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 84.1 p -105.89 -157.47 0.61 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.487 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 227' ' ' LYS . . . . . 0.494 ' C ' ' HD3' ' B' ' 227' ' ' LYS . 12.1 tmtt? -67.07 -40.8 87.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.753 0.311 . . . . 0.0 110.277 -178.292 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -59.19 -49.26 78.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.631 -173.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -63.46 -39.42 94.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.574 -177.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 77.8 mt -59.25 -56.9 14.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.652 0.263 . . . . 0.0 111.358 -177.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 5.7 p -73.31 -21.59 60.53 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -174.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -98.09 -38.76 9.22 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.429 -0.508 . . . . 0.0 112.198 -176.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 233' ' ' PHE . . . . . 0.476 ' CD1' ' HD3' ' A' ' 53' ' ' PRO . 57.7 m-85 -99.4 4.64 46.32 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -174.47 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt 58.63 40.52 23.39 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.302 0.376 . . . . 0.0 110.915 174.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 235' ' ' LEU . . . . . 0.456 HD13 HG21 ' B' ' 225' ' ' VAL . 84.7 mt -55.44 150.5 11.64 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.278 0.561 . . . . 0.0 112.456 -173.413 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 22.1 t -94.08 110.31 23.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.838 -176.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -83.29 114.99 21.77 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 177.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -86.06 -28.93 6.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.457 -178.32 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 178.44 -170.17 42.11 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.423 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 7.5 m -133.71 140.46 47.03 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 28.1 pt -124.1 148.06 28.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.941 0.401 . . . . 0.0 110.416 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -134.74 142.36 46.73 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.477 0.656 . . . . 0.0 111.533 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 243' ' ' VAL . . . . . 0.621 HG13 ' NE2' ' B' ' 245' ' ' GLN . 67.9 t -106.66 123.64 61.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.695 -178.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 10.6 t -143.05 69.6 1.31 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 176.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 245' ' ' GLN . . . . . 0.621 ' NE2' HG13 ' B' ' 243' ' ' VAL . 1.3 mp0 -109.42 153.43 24.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.97 -174.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 57.8 m -83.06 43.32 0.86 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.49 -174.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 247' ' ' GLY . . . . . 0.417 ' C ' ' H ' ' B' ' 249' ' ' GLN . . . 78.47 -41.25 2.06 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.922 -0.656 . . . . 0.0 113.731 174.545 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -73.57 27.63 0.88 Allowed Glycine 0 CA--C 1.519 0.34 0 CA-C-N 116.888 0.344 . . . . 0.0 113.652 -176.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 249' ' ' GLN . . . . . 0.544 ' HG3' ' HG2' ' B' ' 245' ' ' GLN . 23.8 mm-40 -130.85 -3.62 4.07 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 176.361 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 44.9 mm -133.71 132.3 56.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.337 -179.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 23.2 m -133.45 -58.26 0.88 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.24 -177.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 252' ' ' SER . . . . . 0.542 ' HB3' ' HD2' ' B' ' 253' ' ' PRO . 7.2 m -113.72 168.87 7.18 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 253' ' ' PRO . . . . . 0.542 ' HD2' ' HB3' ' B' ' 252' ' ' SER . 11.6 Cg_endo -57.1 -24.47 58.5 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.293 1.996 . . . . 0.0 112.213 175.3 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 254' ' ' SER . . . . . 0.546 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 1.5 p -70.2 -37.12 75.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.139 176.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -61.93 -37.43 84.66 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.792 0.329 . . . . 0.0 110.895 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 51.9 tp -59.02 -42.01 89.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.52 177.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 257' ' ' ARG . . . . . 0.553 ' C ' ' HD2' ' B' ' 257' ' ' ARG . 3.9 tmm_? -64.13 -47.07 81.39 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.859 177.072 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 258' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' B' ' 254' ' ' SER . 28.8 mm-40 -54.02 -48.85 70.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.349 -176.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -70.17 -35.25 73.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.732 0.301 . . . . 0.0 111.24 -177.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 81.9 mt -72.66 -40.5 66.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.178 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 17.0 t -68.54 -31.97 71.58 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 177.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -57.36 -51.65 68.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.242 175.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 263' ' ' LEU . . . . . . . . . . . . . 74.5 mt -71.17 -41.18 70.71 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.958 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -63.52 -44.39 94.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.721 -177.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -66.31 -34.21 77.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.896 0.379 . . . . 0.0 110.48 -178.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -68.94 -20.09 64.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.285 0.565 . . . . 0.0 110.821 176.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 4.8 mmpm? -94.81 -2.41 50.93 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.664 176.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 77.35 16.06 80.84 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.168 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 269' ' ' GLY . . . . . 0.567 ' HA3' ' CG1' ' B' ' 290' ' ' VAL . . . -93.85 148.99 19.24 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.017 -178.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -110.73 3.42 19.15 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.247 0.546 . . . . 0.0 110.073 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 271' ' ' TYR . . . . . 0.654 ' HD1' ' HA ' ' B' ' 224' ' ' GLN . 9.2 m-85 -147.75 141.45 25.61 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 -177.184 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 272' ' ' TYR . . . . . 0.51 ' CE2' HD11 ' B' ' 274' ' ' ILE . 34.2 p90 -126.66 111.11 13.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.472 0.654 . . . . 0.0 110.06 178.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -92.1 101.75 14.28 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.171 -174.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 274' ' ' ILE . . . . . 0.534 ' H ' HD12 ' B' ' 274' ' ' ILE . 4.6 mp -72.35 131.59 34.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.82 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 28.4 pt -117.64 -28.45 2.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.727 0.299 . . . . 0.0 111.511 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -156.97 137.84 13.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.832 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -155.51 120.81 4.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.506 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 278' ' ' ARG . . . . . 0.472 ' HE ' ' HB3' ' B' ' 278' ' ' ARG . 0.0 OUTLIER -145.04 155.02 43.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.0 0.428 . . . . 0.0 110.942 -178.853 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -79.19 134.87 36.68 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.208 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -122.01 72.68 1.05 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.001 0.429 . . . . 0.0 110.059 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 64.11 -120.38 19.54 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.659 -177.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.11 -2.3 12.27 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.737 2.292 . . . . 0.0 112.259 176.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -114.41 166.08 12.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.28 -177.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -129.39 122.28 29.12 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.936 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 285' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -105.28 119.7 39.72 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.32 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 286' ' ' ALA . . . . . 0.574 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -136.68 146.83 46.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.692 0.282 . . . . 0.0 111.154 177.072 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 37.0 t -128.79 128.86 68.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 177.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -137.27 144.92 42.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.004 0.43 . . . . 0.0 110.988 -179.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 289' ' ' GLU . . . . . 0.429 ' HB2' ' HE1' ' B' ' 291' ' ' TYR . 25.5 mt-10 -96.1 150.09 20.89 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.891 178.266 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 290' ' ' VAL . . . . . 0.567 ' CG1' ' HA3' ' B' ' 269' ' ' GLY . 12.8 t -111.93 123.97 68.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 291' ' ' TYR . . . . . 0.429 ' HE1' ' HB2' ' B' ' 289' ' ' GLU . 65.9 m-85 -124.29 151.69 43.94 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.229 0.538 . . . . 0.0 111.618 -177.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 292' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -117.65 161.4 19.72 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.105 170.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.467 0.402 0 O-C-N 123.439 0.462 . . . . 0.0 111.551 175.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.48 1.069 0 CA-C-O 120.584 0.23 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -83.64 100.91 11.14 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -92.98 109.35 20.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.009 -175.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 70.5 mtt-85 -124.36 108.67 12.43 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.883 176.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 pp -73.36 95.09 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.685 0.755 . . . . 0.0 111.277 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 27.6 pt -128.5 -176.72 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.22 -175.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 68.39 107.88 0.05 Allowed 'General case' 0 N--CA 1.465 0.293 0 O-C-N 124.09 0.869 . . . . 0.0 112.274 175.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -144.43 109.37 5.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.069 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -116.3 113.15 22.58 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.963 0.411 . . . . 0.0 111.22 -175.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -102.15 34.67 2.64 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.318 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.3 mt -65.4 124.92 23.55 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.723 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -147.32 143.32 27.96 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.278 -177.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.6 m 73.62 115.61 0.06 Allowed 'General case' 0 C--O 1.233 0.22 0 O-C-N 124.048 0.843 . . . . 0.0 112.656 175.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.3 p -143.78 88.42 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.109 172.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.486 ' HB1' ' CE2' ' A' ' 17' ' ' PHE . . . -93.84 119.83 33.3 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.293 -172.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.1 p -103.57 88.71 3.15 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.423 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.486 ' CE2' ' HB1' ' A' ' 15' ' ' ALA . 71.8 m-85 -108.17 -80.45 0.57 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.399 177.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.5 m 54.92 22.12 4.1 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 123.722 0.639 . . . . 0.0 111.689 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.7 m -83.64 90.64 7.31 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.012 0.434 . . . . 0.0 110.221 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 61.6 mt -99.64 -163.73 1.06 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.635 -176.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -135.5 159.81 40.43 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 177.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.542 ' O ' ' HB3' ' B' ' 261' ' ' SER . . . 70.65 108.31 0.06 Allowed 'General case' 0 N--CA 1.465 0.282 0 O-C-N 124.085 0.866 . . . . 0.0 110.823 -177.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.51 ' HG2' ' HB1' ' B' ' 221' ' ' ALA . 2.2 tp10 -147.0 -138.88 0.09 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -176.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.721 ' HB2' ' H ' ' B' ' 223' ' ' GLU . 1.4 tm0? 72.73 156.73 0.17 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 122.6 0.36 . . . . 0.0 111.64 176.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.3 m -114.5 147.72 17.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 121.055 0.455 . . . . 0.0 110.905 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.411 ' O ' HG13 ' A' ' 30' ' ' ILE . 19.9 t -100.29 -166.79 1.36 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.28 0.562 . . . . 0.0 111.017 -177.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -66.5 -44.1 83.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.535 -173.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.641 ' HG2' ' OE1' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -63.59 -44.72 93.19 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.891 -173.736 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.641 ' OE1' ' HG2' ' A' ' 28' ' ' GLN . 2.3 mp0 -62.98 -40.95 99.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.619 0.247 . . . . 0.0 110.846 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 26' ' ' SER . 97.4 mt -59.01 -49.9 81.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.841 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.3 t -73.43 -24.85 60.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.362 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.452 ' HB2' ' O ' ' A' ' 28' ' ' GLN . 33.7 t-80 -85.92 -57.81 2.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.686 0.279 . . . . 0.0 111.287 -174.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -81.77 -10.74 59.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.193 -175.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt 59.54 76.43 0.36 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.338 0.59 . . . . 0.0 110.113 -175.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.405 HD12 HG12 ' A' ' 30' ' ' ILE . 95.1 mt -82.39 159.39 23.01 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.892 -176.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.548 HG11 ' HE3' ' A' ' 96' ' ' LYS . 48.1 t -81.88 111.71 18.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.081 -176.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.552 ' HD3' ' CE2' ' A' ' 91' ' ' TYR . 15.0 tptm -71.5 111.19 6.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.67 175.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.421 HG23 ' HB ' ' A' ' 90' ' ' VAL . 3.2 m -104.66 6.95 10.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.871 0.367 . . . . 0.0 111.667 -176.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 133.37 -168.44 23.08 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.549 175.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 47.7 m -136.54 132.93 35.88 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.4 pt -111.43 134.22 54.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.257 0.551 . . . . 0.0 110.861 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -114.62 121.05 42.22 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.565 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.619 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 24.3 t -93.35 107.51 19.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.8 t -110.62 110.54 21.28 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.549 -176.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.524 ' HG2' HG12 ' A' ' 50' ' ' ILE . 1.7 tp60 -116.79 152.63 33.99 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.236 -176.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.8 t -126.03 124.79 41.46 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.875 -0.416 . . . . 0.0 109.875 175.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.33 -145.92 25.79 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.456 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.84 52.53 0.72 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.877 -175.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.464 ' HB2' ' CG ' ' A' ' 45' ' ' GLN . 14.5 mm100 -71.96 -41.79 67.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.298 0.571 . . . . 0.0 109.619 175.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.566 HG23 ' HB2' ' A' ' 55' ' ' ASP . 49.3 mm -97.93 125.4 51.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.73 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.1 m -103.26 -39.74 6.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.199 -176.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.423 ' HB2' ' HD2' ' A' ' 53' ' ' PRO . 51.4 p -131.87 162.56 55.72 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.462 -176.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.423 ' HD2' ' HB2' ' A' ' 52' ' ' SER . 17.0 Cg_endo -57.49 -27.02 74.53 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.633 2.222 . . . . 0.0 111.44 176.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.594 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 2.5 m -59.08 -45.92 89.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.545 177.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.566 ' HB2' HG23 ' A' ' 50' ' ' ILE . 36.2 m-20 -64.85 -35.84 82.43 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.561 -178.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 67.2 tp -61.46 -47.2 86.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.847 175.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.424 HH22 ' HB3' ' B' ' 298' ' ' GLU . 7.4 ttm180 -58.08 -41.12 82.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.068 177.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.594 ' HG2' ' O ' ' A' ' 54' ' ' SER . 14.1 mm-40 -55.6 -50.47 70.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.281 0.562 . . . . 0.0 110.68 177.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.41 ' HA ' ' HD3' ' A' ' 59' ' ' LYS . 73.2 mmtt -69.71 -35.14 74.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.323 -177.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.2 mt -62.58 -44.32 96.61 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.54 176.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.7 t -66.6 -39.83 88.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.068 0.461 . . . . 0.0 110.237 177.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -57.03 -48.72 77.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.905 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 87.4 mt -71.83 -40.49 69.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.618 -176.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.62 -38.11 89.89 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -176.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -59.56 -42.71 93.05 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.271 0.558 . . . . 0.0 110.336 178.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.73 -7.78 58.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.425 -177.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.431 ' HD3' ' HA ' ' A' ' 67' ' ' LYS . 30.2 mmtm -97.38 -19.98 18.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.788 0.328 . . . . 0.0 111.408 178.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.79 34.47 9.06 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.335 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.468 ' HA3' HG12 ' A' ' 90' ' ' VAL . . . -129.32 138.49 10.28 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 177.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.735 ' HA ' ' HB2' ' B' ' 220' ' ' LEU . 87.9 mttt -85.01 -28.99 25.35 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.74 0.27 . . . . 0.0 111.463 -174.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -129.56 141.3 51.0 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -176.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.611 ' CD2' ' HB1' ' B' ' 222' ' ' ALA . 13.8 p90 -105.07 168.0 9.34 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 171.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.404 ' CD2' ' HA ' ' A' ' 26' ' ' SER . 9.7 t-80 -138.94 105.84 5.41 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.907 172.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 33.5 mt -69.96 124.5 26.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.238 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 31.4 pt -110.94 -17.59 8.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.989 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -171.89 101.22 0.18 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.509 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.58 ' HA ' ' HA ' ' A' ' 86' ' ' ALA . . . -107.69 101.64 10.93 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 171.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -136.96 167.1 22.13 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.104 0.478 . . . . 0.0 111.373 -172.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -90.37 145.58 24.84 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.821 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -129.35 80.53 1.97 Allowed 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 173.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.5 -117.73 9.2 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.827 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -83.12 -2.2 10.64 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.812 2.341 . . . . 0.0 112.045 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -112.42 165.04 12.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.989 -177.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -125.89 121.92 34.57 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.046 175.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -117.23 111.01 18.83 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.866 0.365 . . . . 0.0 110.579 -176.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.619 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -110.59 116.32 31.15 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.08 0.467 . . . . 0.0 110.495 176.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.6 t -102.39 118.17 48.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.311 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -135.94 136.65 40.6 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.592 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.55 ' HB3' ' HE3' ' A' ' 37' ' ' LYS . 40.9 mt-10 -91.83 149.87 21.36 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.468 HG12 ' HA3' ' A' ' 69' ' ' GLY . 5.6 t -107.48 132.72 54.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.35 -177.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.552 ' CE2' ' HD3' ' A' ' 37' ' ' LYS . 95.8 m-85 -133.21 146.3 51.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.162 0.506 . . . . 0.0 111.196 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -123.31 160.47 26.62 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.402 176.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -56.46 145.74 26.73 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 120.673 0.273 . . . . 0.0 110.814 -177.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.56 70.75 1.32 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.279 0.561 . . . . 0.0 110.39 177.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.454 HG23 ' H ' ' A' ' 97' ' ' LEU . 8.7 t -175.26 -26.37 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.42 -177.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.548 ' HE3' HG11 ' A' ' 36' ' ' VAL . 28.4 mmtp 73.49 -0.83 3.25 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 122.996 0.519 . . . . 0.0 112.371 175.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.454 ' H ' HG23 ' A' ' 95' ' ' THR . 87.7 mt -99.88 -169.82 1.8 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.731 0.301 . . . . 0.0 110.441 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.622 ' CD ' ' H ' ' A' ' 99' ' ' HIS . 0.6 OUTLIER -139.46 -172.21 3.31 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -178.382 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.622 ' H ' ' CD ' ' A' ' 98' ' ' GLU . 32.8 t60 -82.77 1.61 38.06 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.228 0.537 . . . . 0.0 109.738 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -115.04 155.85 26.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.284 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -115.5 117.42 30.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.63 0.252 . . . . 0.0 110.997 -178.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 72.69 125.77 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.366 -0.834 . . . . 0.0 113.131 174.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -140.84 -42.29 0.39 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 168.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 . . . . . 0 C--N 1.324 -0.527 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.699 174.281 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 202' ' ' LYS . . . . . 0.522 ' HG3' ' H ' ' B' ' 203' ' ' LYS . 38.7 tptt 66.56 177.13 0.23 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.24 -178.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 203' ' ' LYS . . . . . 0.522 ' H ' ' HG3' ' B' ' 202' ' ' LYS . 56.2 mtpt -121.11 171.69 8.5 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 177.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 62.09 95.41 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.931 0.769 . . . . 0.0 110.207 -176.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 10.4 tt -104.41 -36.31 3.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.132 -176.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 48.7 mm 68.74 109.04 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 O-C-N 123.563 0.539 . . . . 0.0 111.004 -177.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -77.14 176.66 8.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.036 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -82.96 30.84 0.44 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.981 0.42 . . . . 0.0 111.322 -177.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -79.84 -24.58 41.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.143 177.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 210' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -82.68 113.71 20.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.349 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 87.7 mt -67.79 -29.02 68.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.356 -175.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -119.26 102.34 8.63 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.932 0.396 . . . . 0.0 111.141 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 213' ' ' THR . . . . . . . . . . . . . 33.4 p -110.5 102.93 11.5 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.831 175.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 214' ' ' VAL . . . . . . . . . . . . . 28.9 m -112.85 135.62 51.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.167 0.508 . . . . 0.0 111.624 -175.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -139.88 120.29 14.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.466 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 50.8 m -96.05 -175.81 3.5 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.182 176.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 217' ' ' PHE . . . . . 0.537 ' HD2' ' H ' ' B' ' 218' ' ' SER . 2.5 p90 41.54 -99.38 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.772 0.829 . . . . 0.0 112.734 -176.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 218' ' ' SER . . . . . 0.537 ' H ' ' HD2' ' B' ' 217' ' ' PHE . 45.6 m 62.22 27.43 16.46 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 122.74 0.416 . . . . 0.0 111.673 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 6.4 t 39.5 87.81 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.274 1.029 . . . . 0.0 113.282 178.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.735 ' HB2' ' HA ' ' A' ' 70' ' ' LYS . 2.4 pt? -68.71 165.94 18.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.351 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 221' ' ' ALA . . . . . 0.51 ' HB1' ' HG2' ' A' ' 23' ' ' GLU . . . -135.47 69.17 1.44 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.444 176.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 222' ' ' ALA . . . . . 0.611 ' HB1' ' CD2' ' A' ' 72' ' ' TYR . . . -113.08 118.32 34.44 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.585 -175.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 223' ' ' GLU . . . . . 0.721 ' H ' ' HB2' ' A' ' 24' ' ' GLN . 40.5 tt0 -172.88 101.83 0.13 Allowed 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -176.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 224' ' ' GLN . . . . . 0.602 ' HA ' ' HD1' ' B' ' 271' ' ' TYR . 1.5 tm0? -174.04 158.71 3.15 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 122.919 0.488 . . . . 0.0 109.807 175.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 225' ' ' VAL . . . . . 0.484 HG21 ' CD1' ' B' ' 235' ' ' LEU . 24.1 m -117.03 146.11 21.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 120.543 0.211 . . . . 0.0 110.672 178.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 78.1 p -91.49 -166.8 1.65 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.952 0.406 . . . . 0.0 110.67 -177.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -67.13 -29.17 68.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.173 -176.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -73.02 -50.87 20.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.072 -174.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 229' ' ' GLU . . . . . 0.413 ' HB2' ' HB ' ' B' ' 225' ' ' VAL . 2.2 mp0 -59.8 -39.11 83.89 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.048 -177.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 87.8 mt -60.4 -49.22 85.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.781 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 15.2 m -72.82 -32.2 65.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.093 -177.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -78.76 -55.18 5.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.455 -175.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -83.23 -23.44 32.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.562 -174.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm 64.34 80.81 0.22 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.424 0.631 . . . . 0.0 110.308 -176.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 235' ' ' LEU . . . . . 0.484 ' CD1' HG21 ' B' ' 225' ' ' VAL . 63.1 mt -83.79 -178.41 7.0 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.108 -175.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 44.5 t -100.12 109.71 25.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.11 178.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 52.6 tttm -82.0 114.01 20.28 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 238' ' ' VAL . . . . . 0.519 HG23 ' HB ' ' B' ' 290' ' ' VAL . 14.5 m -104.36 7.57 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -170.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 131.34 -153.38 20.37 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 119.934 -1.127 . . . . 0.0 113.499 175.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 240' ' ' THR . . . . . 0.469 HG23 ' HG2' ' B' ' 289' ' ' GLU . 6.9 m -137.95 141.43 40.54 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 122.205 0.202 . . . . 0.0 110.846 -175.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 37.4 pt -127.67 148.65 32.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 171.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -144.54 141.0 29.18 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.559 0.695 . . . . 0.0 111.717 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 243' ' ' VAL . . . . . 0.613 ' O ' ' HA ' ' B' ' 285' ' ' GLU . 61.3 t -92.99 129.54 43.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.284 176.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 5.8 t -153.07 74.99 1.06 Allowed 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 245' ' ' GLN . . . . . 0.569 ' HB3' ' HG3' ' B' ' 249' ' ' GLN . 0.8 OUTLIER -116.7 168.36 10.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.646 -177.803 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 246' ' ' SER . . . . . 0.428 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 21.0 p -83.77 101.12 11.37 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.727 -177.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 42.62 -92.04 0.01 OUTLIER Glycine 0 N--CA 1.463 0.48 0 N-CA-C 115.817 1.087 . . . . 0.0 115.817 167.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -71.71 10.92 3.66 Favored Glycine 0 CA--C 1.519 0.329 0 N-CA-C 114.809 0.683 . . . . 0.0 114.809 -168.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 249' ' ' GLN . . . . . 0.569 ' HG3' ' HB3' ' B' ' 245' ' ' GLN . 74.9 mm-40 -73.24 -21.1 60.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.664 0.732 . . . . 0.0 110.012 175.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 250' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' B' ' 256' ' ' LEU . 46.9 mm -114.89 103.08 14.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.49 178.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 41.2 t -88.97 -16.9 30.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.653 0.264 . . . . 0.0 111.416 -177.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 252' ' ' SER . . . . . 0.554 ' HB2' ' HD2' ' B' ' 253' ' ' PRO . 89.4 p -163.92 165.78 13.07 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -178.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 253' ' ' PRO . . . . . 0.554 ' HD2' ' HB2' ' B' ' 252' ' ' SER . 9.4 Cg_endo -52.56 -32.0 51.79 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.821 2.347 . . . . 0.0 112.243 176.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 254' ' ' SER . . . . . 0.492 ' O ' ' HG3' ' B' ' 258' ' ' GLU . 5.1 m -59.28 -47.43 85.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.35 177.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.406 ' O ' ' HG2' ' B' ' 259' ' ' LYS . 0.9 OUTLIER -55.07 -43.71 74.15 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.879 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.403 ' HA ' HD12 ' B' ' 250' ' ' ILE . 57.4 tp -57.7 -56.17 25.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.426 -175.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 257' ' ' ARG . . . . . 0.542 ' HA ' HD12 ' B' ' 260' ' ' LEU . 6.3 ppt_? -66.69 -31.18 71.68 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.34 -176.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 258' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' B' ' 254' ' ' SER . 44.2 mt-10 -63.14 -26.78 68.98 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.868 0.366 . . . . 0.0 111.03 177.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 259' ' ' LYS . . . . . 0.425 ' O ' ' HG ' ' B' ' 263' ' ' LEU . 66.1 mmtt -88.28 -22.91 23.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.93 0.395 . . . . 0.0 110.52 177.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 260' ' ' LEU . . . . . 0.542 HD12 ' HA ' ' B' ' 257' ' ' ARG . 89.2 mt -74.13 -48.42 29.57 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.501 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 261' ' ' SER . . . . . 0.542 ' HB3' ' O ' ' A' ' 22' ' ' ALA . 2.7 p -65.78 -30.99 71.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.862 0.363 . . . . 0.0 110.542 176.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -56.48 -45.4 80.96 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.053 175.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 263' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' B' ' 259' ' ' LYS . 84.1 mt -74.74 -34.52 62.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.843 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -64.31 -38.7 91.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.214 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -62.95 -43.86 97.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.694 177.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -64.01 -34.38 77.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.635 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 12.8 mmtt -73.03 -46.94 49.03 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.852 177.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 99.23 32.8 5.67 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -176.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -104.48 171.99 19.89 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.568 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -111.83 -24.86 9.76 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.851 0.358 . . . . 0.0 111.423 -177.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 271' ' ' TYR . . . . . 0.602 ' HD1' ' HA ' ' B' ' 224' ' ' GLN . 24.0 m-85 -144.01 160.52 40.72 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 272' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -137.55 129.17 28.41 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.047 0.451 . . . . 0.0 110.068 173.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -98.46 102.59 14.38 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.914 -177.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 274' ' ' ILE . . . . . 0.514 HG12 ' HB2' ' B' ' 288' ' ' ALA . 57.0 mt -67.25 129.74 32.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.821 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 19.0 pt -116.97 -26.84 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.807 -176.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -144.49 139.95 28.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.157 -177.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -154.79 117.5 4.34 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.222 177.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 278' ' ' ARG . . . . . 0.421 ' HD3' ' HB2' ' B' ' 285' ' ' GLU . 0.0 OUTLIER -154.91 156.77 36.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.928 0.394 . . . . 0.0 110.78 -177.789 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -88.8 117.43 27.79 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 167.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -92.77 14.48 17.15 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.492 0.663 . . . . 0.0 109.976 -175.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 129.93 -119.96 2.98 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 -175.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.93 -13.3 15.92 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.445 2.097 . . . . 0.0 111.765 173.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -106.82 142.96 35.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.665 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -104.1 130.8 51.82 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 285' ' ' GLU . . . . . 0.613 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 52.1 mt-10 -118.96 122.06 41.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.278 -176.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 286' ' ' ALA . . . . . 0.484 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -132.67 116.25 16.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.167 174.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 40.4 t -109.02 127.53 65.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.81 0.338 . . . . 0.0 111.067 -174.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 288' ' ' ALA . . . . . 0.514 ' HB2' HG12 ' B' ' 274' ' ' ILE . . . -139.25 133.53 31.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.957 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 289' ' ' GLU . . . . . 0.469 ' HG2' HG23 ' B' ' 240' ' ' THR . 31.9 mt-10 -93.06 135.39 34.28 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 290' ' ' VAL . . . . . 0.519 ' HB ' HG23 ' B' ' 238' ' ' VAL . 3.8 t -92.96 138.87 19.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.037 0.446 . . . . 0.0 111.27 -168.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -130.02 149.38 51.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.478 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 292' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -114.68 159.78 20.11 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 171.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -57.61 -95.16 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.492 0.663 . . . . 0.0 112.116 -174.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 294' ' ' ALA . . . . . . . . . . . . . . . -130.8 4.94 4.58 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.799 0.809 . . . . 0.0 109.147 176.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 295' ' ' THR . . . . . . . . . . . . . 14.5 t -161.49 -176.43 5.34 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.151 -1.386 . . . . 0.0 107.611 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 29.7 ttpp -86.47 99.46 11.67 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.308 -176.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 297' ' ' LEU . . . . . . . . . . . . . 94.7 mt 71.76 107.58 0.07 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.993 171.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 298' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' B' ' 299' ' ' HIS . 4.4 tm-20 -86.29 157.72 19.85 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 172.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 299' ' ' HIS . . . . . 0.458 ' HB2' ' O ' ' B' ' 298' ' ' GLU . 47.0 m-70 71.9 87.76 0.11 Allowed 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.344 0.658 . . . . 0.0 110.279 -172.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 300' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -78.72 37.17 0.28 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.747 -1.115 . . . . 0.0 113.218 -171.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 301' ' ' HIS . . . . . . . . . . . . . 23.4 t60 -147.53 78.19 1.46 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.948 0.404 . . . . 0.0 110.107 171.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 302' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -153.71 18.72 0.53 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.065 177.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -80.24 137.44 36.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.476 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 15.5 p80 . . . . . 0 C--N 1.322 -0.621 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.349 -177.997 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.1 tpp . . . . . 0 N--CA 1.482 1.144 0 CA-C-O 120.626 0.251 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.423 ' HE2' ' HB3' ' A' ' 2' ' ' LYS . 45.6 mtpt -113.21 -38.53 4.41 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 175.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -74.52 93.3 2.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.099 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -68.57 119.45 13.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.879 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.465 ' H ' HG13 ' A' ' 5' ' ' ILE . 2.4 pp -84.49 165.67 2.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.323 174.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.2 pt -106.41 100.47 10.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.407 0.623 . . . . 0.0 111.513 -177.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -138.54 134.46 33.91 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.068 178.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -81.05 -35.61 31.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.036 -176.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 60.16 69.89 0.67 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.04 -178.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 36.7 tp -84.83 96.54 9.33 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.114 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.3 mt -76.4 -44.97 33.78 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.339 -177.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.07 72.59 0.46 Allowed 'General case' 0 N--CA 1.465 0.318 0 O-C-N 123.761 0.663 . . . . 0.0 111.02 -177.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.5 m -125.76 140.93 52.27 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.842 -175.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.6 p -61.97 141.47 17.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.15 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.61 108.76 4.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.058 177.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.3 m -84.15 -37.35 22.04 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.225 -176.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -156.18 154.8 31.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.455 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.8 m -124.56 109.57 13.38 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.613 177.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.1 p -76.93 -41.04 44.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.069 0.461 . . . . 0.0 110.957 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 54.1 tp -132.47 107.68 8.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.54 176.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.648 ' HB1' ' HA ' ' B' ' 270' ' ' LYS . . . -168.12 133.1 1.78 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.235 -178.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.641 ' HB1' ' CD2' ' B' ' 272' ' ' TYR . . . 64.04 86.89 0.12 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.942 173.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.933 ' HB3' ' HE1' ' A' ' 71' ' ' TYR . 26.8 mt-10 -149.28 105.28 3.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.683 -179.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.57 ' HB2' ' HB2' ' B' ' 224' ' ' GLN . 1.5 tt0 -162.3 156.1 21.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.262 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.0 m -101.69 128.32 54.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.037 0.446 . . . . 0.0 110.887 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.537 ' O ' HG13 ' A' ' 30' ' ' ILE . 1.5 m -64.99 151.33 46.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.877 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.446 ' HA ' HD12 ' A' ' 30' ' ' ILE . 88.7 tttt -57.85 -40.52 80.31 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.128 0.489 . . . . 0.0 109.724 176.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -61.14 -39.06 88.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.408 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.581 ' HA ' ' HB3' ' A' ' 32' ' ' HIS . 20.6 mm-40 -76.94 -26.98 54.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.503 -177.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.537 HG13 ' O ' ' A' ' 26' ' ' SER . 86.0 mt -60.88 -45.07 98.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 173.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.4 m -73.42 -31.83 64.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.879 175.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.581 ' HB3' ' HA ' ' A' ' 29' ' ' GLU . 23.7 t-160 -65.82 -54.86 21.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.286 -177.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -92.67 -8.74 43.16 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.376 -177.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm 59.31 70.56 0.64 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.452 0.644 . . . . 0.0 110.592 -178.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 94.1 mt -76.31 163.0 27.44 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.306 -176.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.449 HG23 ' HA ' ' A' ' 94' ' ' ALA . 85.1 t -93.37 126.42 45.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.271 -177.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.546 ' HE3' ' HB3' ' A' ' 89' ' ' GLU . 21.7 tptm -70.12 116.76 10.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.651 175.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.41 HG11 HD22 ' A' ' 92' ' ' ASN . 4.2 m -122.84 26.0 3.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -174.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.12 -175.36 16.94 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.109 -1.043 . . . . 0.0 113.252 174.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 61.7 m -135.29 129.55 33.72 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 30.5 pt -104.48 138.62 28.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 175.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -135.02 122.23 21.54 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.197 0.522 . . . . 0.0 111.092 -173.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 59.0 t -93.45 121.69 44.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.062 176.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.2 t -141.23 30.79 1.76 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.752 0.786 . . . . 0.0 109.134 -177.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -91.24 160.55 15.47 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.773 -175.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.2 t -64.06 157.84 24.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.075 176.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.06 -20.14 33.5 Favored Glycine 0 C--O 1.228 -0.271 0 CA-C-N 116.039 -0.528 . . . . 0.0 113.314 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.26 -20.64 75.28 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.884 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -101.46 -2.04 31.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.893 0.377 . . . . 0.0 110.88 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.1 mm -130.8 75.23 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 171.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.0 t -96.46 -14.01 22.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.875 -168.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.1 m -155.43 160.0 31.22 Favored Pre-proline 0 C--N 1.322 -0.598 0 O-C-N 122.365 -0.209 . . . . 0.0 110.784 -176.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.5 -36.26 86.98 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.589 2.193 . . . . 0.0 111.623 175.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.573 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 0.1 OUTLIER -63.27 -44.36 95.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.648 0.737 . . . . 0.0 109.698 174.071 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -64.38 -27.74 69.21 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.136 -177.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.6 tp -61.59 -52.68 63.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.683 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -65.79 -28.13 68.79 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.432 -176.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.573 ' HG2' ' O ' ' A' ' 54' ' ' SER . 38.8 mm-40 -62.6 -34.62 77.38 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.974 0.416 . . . . 0.0 110.223 -178.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -83.25 -38.33 22.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.764 176.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.3 mt -61.78 -48.48 80.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.255 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.2 p -64.52 -36.4 84.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.021 0.439 . . . . 0.0 110.473 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -64.29 -40.38 95.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.193 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 86.2 mt -69.54 -44.79 70.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.9 177.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.61 -37.33 83.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.99 0.424 . . . . 0.0 110.652 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.754 ' HA ' HG21 ' B' ' 219' ' ' THR . 22.8 t70 -66.68 -37.78 85.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.808 177.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.9 -34.96 78.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.772 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -80.65 -45.03 17.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.177 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 118.24 41.88 0.62 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.534 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.512 ' HA3' ' CG1' ' A' ' 90' ' ' VAL . . . -124.38 151.68 17.26 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.413 -0.899 . . . . 0.0 113.043 -177.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -81.04 -43.58 19.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.834 0.35 . . . . 0.0 110.44 176.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.933 ' HE1' ' HB3' ' A' ' 23' ' ' GLU . 78.9 m-85 -137.96 175.61 9.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.264 -174.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.442 ' HD2' ' CB ' ' A' ' 88' ' ' ALA . 0.6 OUTLIER -149.85 168.25 24.28 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -177.13 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -135.05 126.1 27.79 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.49 -0.484 . . . . 0.0 109.812 172.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.534 ' H ' HD12 ' A' ' 74' ' ' ILE . 5.0 mp -72.77 123.37 27.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.017 -178.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 33.1 pt -104.88 -31.13 2.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.386 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.479 ' HB1' ' NH1' ' A' ' 78' ' ' ARG . . . -161.82 117.9 2.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.025 -177.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -131.92 122.28 25.37 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.385 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.479 ' NH1' ' HB1' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -156.46 142.24 17.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.044 0.449 . . . . 0.0 110.888 -178.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -72.07 145.62 48.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.905 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -139.6 100.38 3.95 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 61.97 -123.87 32.57 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.991 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -88.29 6.6 4.8 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.994 2.463 . . . . 0.0 112.569 178.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -119.76 158.92 25.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.046 0.45 . . . . 0.0 111.123 -176.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -113.57 111.65 22.23 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.564 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.559 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 25.9 mm-40 -96.26 111.45 23.51 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.612 -176.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.534 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -124.99 115.17 20.13 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.754 177.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.2 t -105.64 124.86 60.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.499 -178.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.442 ' CB ' ' HD2' ' A' ' 72' ' ' TYR . . . -141.0 149.2 41.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.2 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.546 ' HB3' ' HE3' ' A' ' 37' ' ' LYS . 7.4 mt-10 -108.67 143.61 37.54 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.263 -178.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.512 ' CG1' ' HA3' ' A' ' 69' ' ' GLY . 11.4 t -95.04 137.57 23.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.642 -172.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -133.71 136.98 45.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.894 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.41 HD22 HG11 ' A' ' 38' ' ' VAL . 74.5 m-20 -122.42 172.78 8.09 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.578 176.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -61.16 161.4 8.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.673 177.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.449 ' HA ' HG23 ' A' ' 36' ' ' VAL . . . -83.4 14.79 3.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.684 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.8 t -131.95 139.07 48.57 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.269 -178.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.523 ' HB3' ' HB3' ' B' ' 215' ' ' ALA . 0.1 OUTLIER -124.82 125.09 43.45 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 17.3 mt -139.55 6.68 2.3 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.41 -0.516 . . . . 0.0 112.328 -168.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.577 ' OE2' ' HB1' ' B' ' 215' ' ' ALA . 5.3 pm0 -90.35 79.33 6.32 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 122.173 0.987 . . . . 0.0 110.389 176.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -66.99 123.82 21.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.467 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -144.11 -178.61 6.03 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.091 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -56.14 133.12 51.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.698 -176.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -73.88 80.44 1.64 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.562 175.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 31.4 t-80 -80.49 143.35 33.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.939 -176.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 7.0 p-80 . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.857 173.985 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 201' ' ' MET . . . . . 0.425 ' N ' ' SD ' ' B' ' 201' ' ' MET . 1.6 mpt? . . . . . 0 N--CA 1.48 1.054 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -131.49 22.3 4.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.182 0.515 . . . . 0.0 110.544 -173.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -71.97 103.57 3.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.515 0.674 . . . . 0.0 110.668 178.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -147.16 105.37 3.76 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.285 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 8.1 tp -120.01 132.65 69.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.337 0.589 . . . . 0.0 111.079 -174.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 21.3 pt -121.67 129.26 75.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.753 176.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -96.37 8.16 44.68 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.349 -176.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -62.95 133.33 54.46 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.639 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -87.3 -175.28 5.22 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.926 -177.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 210' ' ' LEU . . . . . 0.892 ' HG ' ' H ' ' B' ' 211' ' ' LEU . 21.1 tp 66.71 -169.25 0.2 Allowed 'General case' 0 CA--C 1.534 0.344 0 O-C-N 123.699 0.624 . . . . 0.0 110.294 178.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 211' ' ' LEU . . . . . 0.892 ' H ' ' HG ' ' B' ' 210' ' ' LEU . 83.2 mt 60.01 43.88 14.0 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.158 0.504 . . . . 0.0 110.964 -178.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -84.23 144.15 29.12 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 173.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 213' ' ' THR . . . . . . . . . . . . . 19.0 m -148.92 -68.91 0.22 Allowed 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.725 -176.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 214' ' ' VAL . . . . . . . . . . . . . 30.6 m -109.07 171.99 2.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.266 0.555 . . . . 0.0 111.756 -174.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 215' ' ' ALA . . . . . 0.577 ' HB1' ' OE2' ' A' ' 98' ' ' GLU . . . -101.27 -169.29 1.67 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.491 176.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 50.9 m -157.16 -81.4 0.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -177.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -143.93 162.92 34.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.762 0.315 . . . . 0.0 111.063 -175.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 218' ' ' SER . . . . . . . . . . . . . 71.1 m -150.28 129.74 12.99 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.168 176.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 219' ' ' THR . . . . . 0.754 HG21 ' HA ' ' A' ' 65' ' ' ASP . 57.9 p -101.38 157.28 16.91 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.651 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 26.2 tp -143.27 -74.52 0.27 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.272 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -144.95 -78.47 0.19 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 121.266 -0.173 . . . . 0.0 111.359 -177.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 222' ' ' ALA . . . . . 0.416 ' HB1' ' CD1' ' A' ' 72' ' ' TYR . . . 71.03 92.69 0.08 Allowed 'General case' 0 N--CA 1.463 0.222 0 O-C-N 124.008 0.817 . . . . 0.0 111.588 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -161.12 125.5 3.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.839 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 224' ' ' GLN . . . . . 0.57 ' HB2' ' HB2' ' A' ' 24' ' ' GLN . 1.2 tt0 -159.3 167.97 27.59 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.782 176.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 225' ' ' VAL . . . . . 0.44 HG11 HD11 ' B' ' 235' ' ' LEU . 6.8 m -135.18 123.63 39.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.984 0.421 . . . . 0.0 110.353 174.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 226' ' ' SER . . . . . 0.409 ' O ' HG13 ' B' ' 230' ' ' ILE . 9.3 t -105.72 -171.72 1.96 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.581 178.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 227' ' ' LYS . . . . . 0.426 ' HE2' ' CA ' ' B' ' 227' ' ' LYS . 0.0 OUTLIER -55.33 -33.83 63.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.769 -175.092 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -70.74 -49.65 44.56 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.264 0.554 . . . . 0.0 110.365 -176.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 229' ' ' GLU . . . . . 0.401 ' O ' ' HD1' ' B' ' 233' ' ' PHE . 1.8 mp0 -72.13 -48.44 43.66 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.459 -176.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.531 HG12 HD12 ' B' ' 235' ' ' LEU . 89.9 mt -54.54 -49.68 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 -174.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 59.1 m -72.56 -21.17 61.2 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -176.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -89.12 -35.92 16.01 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.893 -177.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 233' ' ' PHE . . . . . 0.401 ' HD1' ' O ' ' B' ' 229' ' ' GLU . 81.7 m-85 -89.9 -15.02 32.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.377 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 234' ' ' LYS . . . . . 0.434 ' HB3' ' HE3' ' B' ' 234' ' ' LYS . 25.9 mmmt 59.79 77.55 0.31 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.225 0.536 . . . . 0.0 111.545 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 235' ' ' LEU . . . . . 0.531 HD12 HG12 ' B' ' 230' ' ' ILE . 94.4 mt -88.21 163.46 16.13 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.389 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 47.4 t -96.28 118.36 42.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.82 178.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -91.29 111.97 23.69 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 238' ' ' VAL . . . . . 0.434 HG23 ' HB ' ' B' ' 290' ' ' VAL . 2.6 m -90.28 -25.01 5.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -176.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 161.8 -156.29 27.78 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.046 -1.073 . . . . 0.0 112.863 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 87.4 m -139.7 131.45 27.43 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 122.476 0.311 . . . . 0.0 110.353 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 22.3 pt -103.98 143.11 16.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.008 0.432 . . . . 0.0 110.13 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -116.02 128.76 55.97 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.881 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 243' ' ' VAL . . . . . 0.587 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 58.0 t -96.8 124.31 49.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.613 177.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 23.2 t -153.35 88.77 1.31 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.895 0.379 . . . . 0.0 110.138 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 245' ' ' GLN . . . . . . . . . . . . . 11.2 mp0 -142.4 157.65 44.55 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 246' ' ' SER . . . . . 0.58 ' HA ' ' HA ' ' B' ' 283' ' ' ASN . 25.8 t -62.48 153.18 32.38 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.694 0.283 . . . . 0.0 110.385 177.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -60.51 -17.54 48.31 Favored Glycine 0 C--N 1.332 0.353 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.807 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.04 -23.33 69.5 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.362 176.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -88.98 -47.65 7.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.098 0.475 . . . . 0.0 110.547 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 44.9 mm -107.55 100.42 10.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.968 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 22.3 t -112.11 -11.43 13.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.993 0.425 . . . . 0.0 111.085 -175.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 78.8 p -149.33 163.66 24.23 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.399 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.72 -31.63 94.43 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.476 2.117 . . . . 0.0 111.639 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 254' ' ' SER . . . . . 0.561 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 8.1 t -65.49 -40.12 92.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.106 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -64.48 -38.46 91.11 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.297 0.57 . . . . 0.0 109.978 177.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 48.5 tp -60.24 -44.69 95.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.847 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 257' ' ' ARG . . . . . 0.471 ' HD3' ' OE1' ' A' ' 23' ' ' GLU . 0.3 OUTLIER -66.44 -34.76 78.66 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.787 -0.188 . . . . 0.0 110.712 -177.032 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 258' ' ' GLU . . . . . 0.561 ' HG2' ' O ' ' B' ' 254' ' ' SER . 67.7 mm-40 -59.54 -45.56 91.44 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-O 121.311 0.576 . . . . 0.0 109.604 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 259' ' ' LYS . . . . . 0.481 ' O ' ' HG ' ' B' ' 263' ' ' LEU . 38.8 tptt -72.91 -40.18 65.71 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.834 -178.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 81.1 mt -64.53 -48.73 73.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.346 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 49.4 m -64.56 -29.8 70.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.706 0.289 . . . . 0.0 110.541 178.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -64.34 -51.44 63.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.997 0.427 . . . . 0.0 110.248 174.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 263' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' B' ' 259' ' ' LYS . 86.8 mt -65.45 -36.58 84.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.922 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.53 -39.51 81.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.856 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -62.54 -35.54 79.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.149 0.5 . . . . 0.0 110.626 177.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -76.37 -11.35 59.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.932 -177.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -114.99 -27.04 7.5 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.817 0.341 . . . . 0.0 111.372 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 91.61 64.93 1.15 Allowed Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.5 176.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -137.82 156.94 23.99 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.611 175.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 270' ' ' LYS . . . . . 0.876 ' HD3' ' HB2' ' B' ' 293' ' ' ASP . 10.3 mtpm? -104.39 -12.67 16.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.824 0.312 . . . . 0.0 111.321 -178.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 271' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -146.37 159.96 42.69 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 272' ' ' TYR . . . . . 0.641 ' CD2' ' HB1' ' A' ' 22' ' ' ALA . 0.3 OUTLIER -132.37 163.52 28.51 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.165 171.42 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -128.58 101.93 6.38 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 175.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 274' ' ' ILE . . . . . 0.577 HG12 ' HB2' ' B' ' 288' ' ' ALA . 49.6 mt -82.23 118.04 29.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.083 0.468 . . . . 0.0 110.267 -177.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 16.9 pt -103.19 -39.27 5.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.457 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 276' ' ' ALA . . . . . 0.562 ' HB3' ' HB ' ' B' ' 287' ' ' VAL . . . -119.92 143.95 47.7 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.783 0.325 . . . . 0.0 111.417 -175.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -157.98 114.52 2.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.421 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 278' ' ' ARG . . . . . 0.465 ' HG2' ' HB2' ' B' ' 285' ' ' GLU . 0.0 OUTLIER -151.35 150.91 31.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.949 0.404 . . . . 0.0 111.147 -175.639 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -93.4 109.56 21.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.846 176.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 280' ' ' HIS . . . . . 0.431 ' HB2' ' CG ' ' B' ' 285' ' ' GLU . 4.7 t60 -69.26 -22.96 63.8 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 150.15 -110.66 0.48 Allowed Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -69.52 -15.82 38.19 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 122.319 2.013 . . . . 0.0 111.43 171.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 283' ' ' ASN . . . . . 0.58 ' HA ' ' HA ' ' B' ' 246' ' ' SER . 41.1 m-80 -111.85 151.82 28.65 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.464 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -107.88 133.78 51.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.41 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 285' ' ' GLU . . . . . 0.465 ' HB2' ' HG2' ' B' ' 278' ' ' ARG . 50.4 mm-40 -117.67 122.23 42.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.941 -175.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 286' ' ' ALA . . . . . 0.587 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -136.55 145.86 45.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.811 0.339 . . . . 0.0 110.673 177.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 287' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' B' ' 276' ' ' ALA . 59.2 t -126.29 118.06 50.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.445 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 288' ' ' ALA . . . . . 0.577 ' HB2' HG12 ' B' ' 274' ' ' ILE . . . -129.09 136.16 49.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.054 -177.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -91.21 136.83 32.82 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 290' ' ' VAL . . . . . 0.434 ' HB ' HG23 ' B' ' 238' ' ' VAL . 12.7 t -97.91 127.36 50.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.748 0.309 . . . . 0.0 110.411 -176.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -120.75 134.5 55.28 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.265 0.555 . . . . 0.0 110.998 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 292' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -95.33 159.15 15.14 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 176.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 293' ' ' ASP . . . . . 0.876 ' HB2' ' HD3' ' B' ' 270' ' ' LYS . 3.2 t70 -82.56 150.89 26.66 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.492 -174.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 294' ' ' ALA . . . . . . . . . . . . . . . -78.66 73.51 5.21 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.218 0.532 . . . . 0.0 110.401 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 295' ' ' THR . . . . . . . . . . . . . 6.4 t -174.93 -41.07 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.101 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt 60.92 20.92 11.19 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.502 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 297' ' ' LEU . . . . . . . . . . . . . 90.1 mt -114.26 111.96 22.35 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.993 0.425 . . . . 0.0 110.98 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 298' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -76.92 158.55 30.63 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 299' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -63.69 -62.35 1.71 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -176.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 300' ' ' HIS . . . . . . . . . . . . . 34.2 p-80 -169.3 128.89 1.04 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.912 0.387 . . . . 0.0 111.37 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 301' ' ' HIS . . . . . . . . . . . . . 36.0 p-80 -170.59 143.43 2.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.111 176.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 302' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -97.01 121.77 39.26 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 174.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -123.72 77.91 1.56 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -178.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 5.7 t60 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.527 -179.691 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.606 ' HG3' ' H ' ' A' ' 2' ' ' LYS . 11.5 tpt . . . . . 0 N--CA 1.482 1.163 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.606 ' H ' ' HG3' ' A' ' 1' ' ' MET . 11.7 mptt -83.51 -84.28 0.13 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.103 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt 47.47 52.87 11.81 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 122.176 0.989 . . . . 0.0 108.436 -170.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -76.83 4.07 10.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.198 -1.365 . . . . 0.0 113.184 -164.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 58.4 mt -90.23 92.11 3.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.026 0.441 . . . . 0.0 110.324 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.5 pt -127.1 126.85 68.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.467 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.409 ' C ' ' H ' ' A' ' 9' ' ' ALA . . . -161.58 -73.35 0.06 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.733 -178.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 70.1 -35.87 0.33 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.632 0.773 . . . . 0.0 112.368 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.409 ' H ' ' C ' ' A' ' 7' ' ' ALA . . . -73.95 95.9 2.56 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.841 0.353 . . . . 0.0 111.394 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 59.6 tp -104.39 96.66 6.77 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 174.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.46 122.34 33.96 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.736 -176.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.35 90.07 7.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.319 0.581 . . . . 0.0 111.037 -178.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.8 m -107.43 98.8 8.37 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.23 172.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.0 p -138.91 140.51 38.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.981 0.42 . . . . 0.0 110.556 -175.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.52 145.03 28.31 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.44 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.6 m -76.79 90.19 3.45 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.178 178.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.452 ' CE2' ' HB3' ' B' ' 304' ' ' HIS . 56.1 t80 -80.19 146.57 31.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.05 -176.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.8 m -61.3 167.5 3.16 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.227 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.406 ' C ' HD12 ' A' ' 20' ' ' LEU . 8.8 t -98.21 140.7 32.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.129 0.49 . . . . 0.0 111.014 -175.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.406 HD12 ' C ' ' A' ' 19' ' ' THR . 8.6 mp -125.64 28.38 6.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.037 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' B' ' 223' ' ' GLU . . . -98.2 22.22 9.83 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.826 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.3 97.12 8.14 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.603 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.547 ' HB3' ' HG3' ' B' ' 257' ' ' ARG . 6.1 pt-20 -161.4 124.86 3.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.693 0.759 . . . . 0.0 111.796 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.804 ' HG3' ' HG3' ' B' ' 224' ' ' GLN . 0.9 OUTLIER -141.35 143.5 34.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.769 -173.54 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.562 HG23 ' HB2' ' A' ' 73' ' ' HIS . 3.5 m -103.19 126.84 57.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.364 0.602 . . . . 0.0 111.401 176.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.674 ' HB2' ' OE1' ' A' ' 28' ' ' GLN . 1.3 p -92.5 159.12 15.67 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.478 178.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.522 ' HA ' HD12 ' A' ' 30' ' ' ILE . 15.9 ttpp -69.67 -26.19 64.26 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.153 0.502 . . . . 0.0 109.688 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.674 ' OE1' ' HB2' ' A' ' 26' ' ' SER . 19.6 mp0 -59.9 -49.53 77.34 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.078 175.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.612 ' HA ' ' HB3' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -71.23 -25.76 62.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.948 -1.023 . . . . 0.0 112.347 -177.043 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.546 HG12 HD12 ' A' ' 35' ' ' LEU . 72.6 mt -52.93 -55.69 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.778 0.323 . . . . 0.0 110.503 177.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.9 t -73.59 -31.53 63.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.082 0.468 . . . . 0.0 110.564 176.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.612 ' HB3' ' HA ' ' A' ' 29' ' ' GLU . 15.1 t-160 -63.55 -51.37 65.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.901 -173.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -111.38 4.53 19.05 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 121.208 -0.197 . . . . 0.0 111.494 -176.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm 56.64 79.01 0.19 Allowed 'General case' 0 N--CA 1.465 0.29 0 O-C-N 123.696 0.622 . . . . 0.0 110.841 -177.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.546 HD12 HG12 ' A' ' 30' ' ' ILE . 91.0 mt -75.55 152.9 37.68 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.934 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.466 HG11 ' HG3' ' A' ' 98' ' ' GLU . 57.9 t -92.14 101.1 12.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.452 -178.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.528 ' HE3' ' HB3' ' A' ' 89' ' ' GLU . 22.9 tptm -75.1 113.66 12.69 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.691 178.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.8 m -99.55 -9.37 8.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.134 0.492 . . . . 0.0 111.31 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 142.75 -179.75 20.16 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.432 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 21.3 m -131.09 126.69 36.43 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.1 pt -106.8 160.62 6.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.031 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -141.56 141.6 33.52 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.731 0.777 . . . . 0.0 111.8 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.672 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 53.5 t -94.13 135.33 28.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.943 179.004 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 10.0 t -150.38 86.7 1.42 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.121 0.486 . . . . 0.0 109.972 178.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.83 148.44 42.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.97 178.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.7 t -100.7 124.91 46.97 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.62 -177.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.45 -157.72 22.59 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.272 175.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.27 50.5 4.1 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.344 -0.455 . . . . 0.0 113.755 -172.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -75.42 -38.32 59.89 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 172.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.532 HD12 ' HA ' ' A' ' 56' ' ' LEU . 47.4 mm -105.24 95.03 3.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.541 176.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.3 t -108.58 -36.39 6.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.394 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.431 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 19.8 m -107.46 144.38 29.11 Favored Pre-proline 0 N--CA 1.448 -0.568 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.408 -177.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.641 ' HG3' ' HB3' ' B' ' 233' ' ' PHE . 34.8 Cg_exo -56.99 -39.92 87.86 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.908 2.405 . . . . 0.0 111.707 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.1 t -62.37 -40.54 96.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.834 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -67.31 -34.79 78.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.941 -174.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.532 ' HA ' HD12 ' A' ' 50' ' ' ILE . 58.4 tp -57.89 -55.89 29.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.472 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.481 ' HA ' HD12 ' A' ' 60' ' ' LEU . 7.8 ppt_? -70.84 -24.55 62.55 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.285 -177.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -58.67 -34.82 71.68 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.95 0.405 . . . . 0.0 110.495 171.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -78.51 -36.55 44.76 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.41 175.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.502 HD13 HD11 ' A' ' 74' ' ' ILE . 97.0 mt -62.24 -48.77 78.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.146 -178.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 65' ' ' ASP . 5.4 p -68.68 -42.15 78.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.741 0.305 . . . . 0.0 110.781 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.85 ' HG2' ' HB1' ' B' ' 215' ' ' ALA . 37.7 tt0 -54.41 -42.83 70.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.988 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.514 HD23 ' HB2' ' B' ' 215' ' ' ALA . 94.2 mt -76.06 -51.06 13.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.883 178.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.47 -45.34 69.25 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -172.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 61' ' ' SER . 0.4 OUTLIER -64.87 -42.63 94.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.113 0.482 . . . . 0.0 110.053 -176.954 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.41 -12.84 60.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.457 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.648 ' HG2' HG21 ' B' ' 213' ' ' THR . 5.4 tmtt? -78.05 -22.99 48.31 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 175.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.72 59.98 0.7 Allowed Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.842 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.474 ' HA2' ' OD1' ' A' ' 92' ' ' ASN . . . -135.56 176.25 20.25 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.851 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -116.69 -30.18 5.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 117.04 0.42 . . . . 0.0 111.331 176.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -142.2 163.72 32.11 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.505 ' CE1' ' HB3' ' B' ' 224' ' ' GLN . 12.1 p90 -136.71 152.45 50.38 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.946 172.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.562 ' HB2' HG23 ' A' ' 25' ' ' VAL . 46.9 t-80 -131.53 108.88 9.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.166 -174.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.555 HD12 ' HB2' ' B' ' 226' ' ' SER . 69.0 mt -79.56 127.59 39.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.829 0.347 . . . . 0.0 110.672 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.4 pt -101.03 -29.37 3.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.49 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -159.84 141.46 12.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.905 0.383 . . . . 0.0 111.299 -177.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -142.95 126.53 16.87 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.49 147.45 34.54 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.373 0.606 . . . . 0.0 112.223 -175.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -93.71 104.81 16.89 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 169.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -87.55 11.45 14.89 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.314 0.578 . . . . 0.0 110.484 -171.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 120.27 -113.42 2.42 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 111.309 -0.717 . . . . 0.0 111.309 -178.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -73.79 -11.19 23.8 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.449 2.1 . . . . 0.0 112.172 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -122.17 140.54 52.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.92 0.391 . . . . 0.0 110.758 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 44' ' ' SER . 84.0 t80 -103.15 130.5 50.35 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 175.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.672 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 63.0 mt-10 -124.57 114.86 19.95 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.278 -175.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -121.18 121.24 37.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.325 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.6 t -105.34 120.46 56.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.659 0.266 . . . . 0.0 110.821 -176.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.552 ' HB2' HG12 ' A' ' 74' ' ' ILE . . . -131.57 137.73 48.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.082 0.468 . . . . 0.0 111.274 -177.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.528 ' HB3' ' HE3' ' A' ' 37' ' ' LYS . 30.4 mt-10 -91.73 145.68 24.38 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.586 177.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 18.3 t -105.25 129.84 57.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -125.38 134.96 51.97 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.496 0.665 . . . . 0.0 112.024 -177.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.474 ' OD1' ' HA2' ' A' ' 69' ' ' GLY . 56.0 m-20 -109.72 179.45 4.12 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.234 169.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.416 ' OD1' HG22 ' A' ' 95' ' ' THR . 39.9 p30 -124.23 174.56 7.61 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.812 0.339 . . . . 0.0 110.191 175.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.85 21.77 0.11 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -173.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.416 HG22 ' OD1' ' A' ' 93' ' ' ASP . 6.9 t -122.77 3.53 9.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.706 0.765 . . . . 0.0 109.987 178.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -80.73 -170.57 2.7 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.836 175.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.411 ' H ' ' HG ' ' A' ' 97' ' ' LEU . 3.3 pp -96.02 19.92 10.89 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.2 0.524 . . . . 0.0 111.047 -174.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.466 ' HG3' HG11 ' A' ' 36' ' ' VAL . 1.6 mm-40 -81.24 34.65 0.37 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.336 -174.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 41.75 85.35 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.955 0.883 . . . . 0.0 111.708 -173.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -77.97 148.26 34.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.965 -1.016 . . . . 0.0 112.112 -171.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -73.84 144.11 45.63 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.882 169.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 -59.26 120.1 8.62 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 65.7 t-80 -139.99 143.94 36.73 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.638 -172.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 38.0 m80 . . . . . 0 C--N 1.326 -0.419 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 171.008 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 201' ' ' MET . . . . . 0.441 ' HA ' ' HD3' ' A' ' 27' ' ' LYS . 72.9 mtm . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 202' ' ' LYS . . . . . 0.524 ' HB3' HD11 ' B' ' 205' ' ' ILE . 32.3 mmmt -101.84 111.74 24.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.811 0.339 . . . . 0.0 110.878 -178.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -112.2 172.28 7.01 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.177 177.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 68.9 mtp180 64.51 18.51 11.4 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.492 0.495 . . . . 0.0 112.243 174.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 205' ' ' ILE . . . . . 0.524 HD11 ' HB3' ' B' ' 202' ' ' LYS . 71.4 mt -71.38 -51.62 32.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.131 0.491 . . . . 0.0 110.452 177.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 43.9 pt -99.42 153.2 4.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.18 -178.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -145.25 -47.55 0.23 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.777 175.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -87.55 83.54 7.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.187 177.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -162.97 130.44 3.63 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.695 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 210' ' ' LEU . . . . . . . . . . . . . 50.1 tp -153.91 97.36 2.07 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 86.7 mt -120.18 100.06 6.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.034 0.445 . . . . 0.0 111.823 -171.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.57 95.02 6.18 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 171.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 213' ' ' THR . . . . . 0.648 HG21 ' HG2' ' A' ' 67' ' ' LYS . 13.5 p -79.13 160.74 26.88 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.534 -175.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 214' ' ' VAL . . . . . . . . . . . . . 40.5 t -70.57 100.61 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.897 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 215' ' ' ALA . . . . . 0.85 ' HB1' ' HG2' ' A' ' 62' ' ' GLU . . . -70.76 129.55 39.4 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.042 -177.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 50.1 m -84.01 161.13 20.84 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 175.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -71.75 88.04 0.99 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.793 0.33 . . . . 0.0 111.768 -174.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 218' ' ' SER . . . . . . . . . . . . . 3.1 t 60.98 89.94 0.07 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.051 174.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 9.3 m -115.49 119.03 34.86 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 39.7 tp -116.95 110.45 18.31 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -169.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -153.35 -58.01 0.13 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.577 170.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -80.38 118.76 22.3 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.906 177.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 223' ' ' GLU . . . . . 0.477 ' OE2' ' HD3' ' A' ' 57' ' ' ARG . 4.7 mm-40 -147.34 125.54 12.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.998 0.428 . . . . 0.0 111.282 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 224' ' ' GLN . . . . . 0.804 ' HG3' ' HG3' ' A' ' 24' ' ' GLN . 0.9 OUTLIER -147.38 138.56 23.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.782 -174.431 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 225' ' ' VAL . . . . . 0.437 HG13 ' HB2' ' B' ' 271' ' ' TYR . 12.3 m -94.95 136.03 27.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.226 0.536 . . . . 0.0 110.414 175.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 226' ' ' SER . . . . . 0.555 ' HB2' HD12 ' A' ' 74' ' ' ILE . 28.4 t -82.78 148.01 28.06 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.229 -175.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 227' ' ' LYS . . . . . 0.523 ' HD3' ' O ' ' B' ' 227' ' ' LYS . 12.6 tmtt? -69.57 -36.69 76.54 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -65.16 -36.11 83.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.458 177.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 229' ' ' GLU . . . . . 0.625 ' HA ' ' HB3' ' B' ' 232' ' ' HIS . 0.0 OUTLIER -68.66 -25.63 64.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.649 -178.557 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 73.8 mt -56.15 -53.06 43.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 174.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 46.2 t -73.62 -31.19 63.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.059 177.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 232' ' ' HIS . . . . . 0.625 ' HB3' ' HA ' ' B' ' 229' ' ' GLU . 22.1 t-160 -72.57 -46.82 52.5 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.658 -173.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 233' ' ' PHE . . . . . 0.641 ' HB3' ' HG3' ' A' ' 53' ' ' PRO . 82.5 m-85 -111.49 6.45 20.19 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -175.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm 56.25 51.68 11.31 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.36 0.412 . . . . 0.0 110.587 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 235' ' ' LEU . . . . . 0.821 ' HA ' ' HB2' ' B' ' 294' ' ' ALA . 89.9 mt -57.2 140.2 50.37 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.693 -176.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.587 HG23 ' HA ' ' B' ' 294' ' ' ALA . 75.0 t -79.86 117.72 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.635 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -81.41 105.68 12.77 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.806 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 238' ' ' VAL . . . . . 0.454 HG22 ' O ' ' B' ' 290' ' ' VAL . 36.0 m -87.05 -16.11 9.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.799 -0.361 . . . . 0.0 111.792 -175.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 160.98 145.09 4.19 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 119.883 -1.151 . . . . 0.0 113.077 177.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 240' ' ' THR . . . . . 0.58 HG23 ' HG2' ' B' ' 289' ' ' GLU . 24.8 m -97.78 122.32 40.74 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 174.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 24.0 pt -103.58 131.71 51.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.303 0.573 . . . . 0.0 110.849 -177.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -102.27 112.48 25.18 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.628 176.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 243' ' ' VAL . . . . . 0.576 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 87.6 t -95.55 108.92 21.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.199 176.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 244' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' B' ' 284' ' ' PHE . 7.9 t -127.9 94.19 3.87 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.323 0.582 . . . . 0.0 109.632 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 245' ' ' GLN . . . . . 0.555 ' HB2' ' HB3' ' B' ' 284' ' ' PHE . 0.0 OUTLIER -86.28 147.45 26.07 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.396 -177.204 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 22.8 t -101.31 102.48 13.34 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 177.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 94.65 177.25 38.4 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.441 -0.663 . . . . 0.0 111.441 -174.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -79.3 66.28 3.49 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.819 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -76.2 -21.02 56.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.163 0.506 . . . . 0.0 110.879 -177.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 50.0 mm -98.75 122.17 50.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 176.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 1.9 m -109.94 -53.8 2.63 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.287 0.565 . . . . 0.0 110.231 -176.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 16.0 m -114.91 163.08 20.74 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.493 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.6 -29.14 59.26 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.463 2.109 . . . . 0.0 111.979 176.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 254' ' ' SER . . . . . 0.563 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 1.6 p -60.52 -44.09 96.43 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.568 177.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -56.43 -45.33 80.79 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.24 0.543 . . . . 0.0 110.225 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 46.6 tp -68.32 -39.41 81.98 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.55 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 257' ' ' ARG . . . . . 0.547 ' HG3' ' HB3' ' A' ' 23' ' ' GLU . 6.7 ttp85 -60.33 -46.8 88.63 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.759 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 258' ' ' GLU . . . . . 0.563 ' HG2' ' O ' ' B' ' 254' ' ' SER . 33.7 mm-40 -57.99 -42.98 86.28 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.598 -178.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 259' ' ' LYS . . . . . 0.548 ' O ' ' HG ' ' B' ' 263' ' ' LEU . 75.4 mmtt -64.12 -48.25 76.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.446 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 97.6 mt -66.67 -38.75 87.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.414 -176.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 29.5 t -65.35 -38.92 91.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.841 0.353 . . . . 0.0 110.095 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -63.16 -47.11 84.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.254 0.55 . . . . 0.0 110.145 177.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 263' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' B' ' 259' ' ' LYS . 85.1 mt -64.05 -42.62 96.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.967 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -58.9 -48.29 81.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.335 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -62.83 -43.98 97.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.256 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -68.1 -37.79 81.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.925 0.393 . . . . 0.0 111.338 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -78.86 -3.73 46.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.408 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 76.17 48.5 9.56 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.141 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 269' ' ' GLY . . . . . 0.46 ' HA3' HG12 ' B' ' 290' ' ' VAL . . . -128.47 -179.66 16.03 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.681 178.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 270' ' ' LYS . . . . . 0.707 ' HB3' ' HZ3' ' B' ' 270' ' ' LYS . 7.9 mtpm? -115.88 -63.57 1.43 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.723 0.296 . . . . 0.0 110.608 -178.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 271' ' ' TYR . . . . . 0.437 ' HB2' HG13 ' B' ' 225' ' ' VAL . 13.9 m-85 -122.99 174.38 7.22 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 272' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -139.01 166.79 23.57 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.663 -175.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -141.49 125.49 17.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.849 175.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 274' ' ' ILE . . . . . 0.469 ' H ' HE22 ' A' ' 24' ' ' GLN . 84.9 mt -82.75 140.11 16.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.412 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 19.1 pt -125.12 -22.29 2.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -152.66 109.1 3.41 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.738 0.304 . . . . 0.0 110.596 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -132.23 121.17 23.21 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.832 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 278' ' ' ARG . . . . . 0.41 ' HD2' ' N ' ' B' ' 278' ' ' ARG . 0.0 OUTLIER -141.64 130.76 23.35 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.334 0.587 . . . . 0.0 111.256 -178.025 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -75.39 106.24 6.82 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 174.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -80.73 -24.93 38.39 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.458 -172.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 113.12 -89.75 0.53 Allowed Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -70.28 -12.65 32.28 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.42 2.08 . . . . 0.0 111.353 174.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -140.29 170.54 15.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.562 177.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 284' ' ' PHE . . . . . 0.555 ' HB3' ' HB2' ' B' ' 245' ' ' GLN . 72.9 t80 -131.89 119.87 21.77 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 285' ' ' GLU . . . . . 0.403 ' HB2' ' HD3' ' B' ' 278' ' ' ARG . 11.3 mm-40 -109.45 111.21 22.62 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 123.108 0.255 . . . . 0.0 110.395 -175.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 286' ' ' ALA . . . . . 0.576 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -123.83 117.16 24.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.983 0.42 . . . . 0.0 110.838 174.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 38.3 t -105.21 118.28 52.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.277 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -140.36 150.1 43.53 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.148 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 289' ' ' GLU . . . . . 0.58 ' HG2' HG23 ' B' ' 240' ' ' THR . 32.6 mt-10 -109.85 143.18 40.1 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 177.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 290' ' ' VAL . . . . . 0.46 HG12 ' HA3' ' B' ' 269' ' ' GLY . 17.2 t -102.42 141.09 19.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 291' ' ' TYR . . . . . 0.424 ' CD2' HG21 ' B' ' 225' ' ' VAL . 71.6 m-85 -128.04 149.62 50.3 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.776 0.322 . . . . 0.0 110.346 -178.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 292' ' ' ASN . . . . . 0.446 ' HB2' ' CG1' ' B' ' 238' ' ' VAL . 5.5 t-20 -104.7 24.58 11.56 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.245 0.545 . . . . 0.0 111.163 -176.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 64.58 9.45 5.11 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.31 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 294' ' ' ALA . . . . . 0.821 ' HB2' ' HA ' ' B' ' 235' ' ' LEU . . . 68.76 18.65 8.64 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.373 0.669 . . . . 0.0 112.514 178.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 295' ' ' THR . . . . . 0.453 ' C ' ' H ' ' B' ' 297' ' ' LEU . 6.3 t -112.21 -34.28 5.97 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.371 -0.531 . . . . 0.0 112.044 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 296' ' ' LYS . . . . . 0.524 ' HD3' ' O ' ' B' ' 296' ' ' LYS . 1.7 tmtp? 73.99 -20.68 0.3 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.632 0.773 . . . . 0.0 110.834 -177.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 297' ' ' LEU . . . . . 0.453 ' H ' ' C ' ' B' ' 295' ' ' THR . 74.4 mt -105.17 -167.52 1.35 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.977 178.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 298' ' ' GLU . . . . . 0.849 ' HG2' ' H ' ' B' ' 299' ' ' HIS . 9.2 tt0 68.92 -179.22 0.23 Allowed 'General case' 0 CA--C 1.536 0.416 0 O-C-N 123.642 0.589 . . . . 0.0 110.843 177.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 299' ' ' HIS . . . . . 0.849 ' H ' ' HG2' ' B' ' 298' ' ' GLU . 4.7 p80 -172.97 -36.31 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.556 176.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 300' ' ' HIS . . . . . . . . . . . . . 16.1 m170 47.96 72.32 0.28 Allowed 'General case' 0 N--CA 1.471 0.585 0 O-C-N 123.602 0.564 . . . . 0.0 111.504 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 301' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -179.32 103.43 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -178.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 302' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -72.74 -42.55 63.96 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.157 -171.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -154.2 -165.09 2.0 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.996 -176.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 304' ' ' HIS . . . . . 0.452 ' HB3' ' CE2' ' A' ' 17' ' ' PHE . 5.1 p80 . . . . . 0 C--N 1.325 -0.478 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.1 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.574 ' O ' ' HG2' ' A' ' 2' ' ' LYS . 14.7 tpt . . . . . 0 N--CA 1.481 1.081 0 N-CA-C 110.803 -0.073 . . . . 0.0 110.803 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.574 ' HG2' ' O ' ' A' ' 1' ' ' MET . 12.8 ptpt 65.15 141.26 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.76 1.224 . . . . 0.0 112.087 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -142.49 -26.9 0.62 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.778 175.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 64.53 -171.07 0.18 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.295 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.4 tt -156.5 115.31 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.505 0.669 . . . . 0.0 110.76 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.413 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.0 mp -101.62 99.03 7.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 176.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -93.45 134.11 36.04 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.644 -177.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 72.07 163.56 0.27 Allowed 'General case' 0 C--O 1.234 0.262 0 O-C-N 124.202 0.939 . . . . 0.0 111.157 -177.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -169.74 170.36 7.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.149 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.431 ' HG ' HD13 ' B' ' 297' ' ' LEU . 27.2 tp -100.03 86.28 3.22 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.0 mp -74.44 -37.13 63.37 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.159 -176.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.778 ' HB2' HD11 ' B' ' 297' ' ' LEU . . . 70.91 155.08 0.14 Allowed 'General case' 0 N--CA 1.467 0.406 0 O-C-N 124.272 0.983 . . . . 0.0 110.321 -170.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.6 m -75.74 74.12 2.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.342 0.591 . . . . 0.0 110.984 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.8 t -138.6 -59.68 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.192 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 62.44 -168.6 0.19 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.846 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.7 m -114.89 -62.81 1.55 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 174.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 47.6 t80 48.46 -89.04 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.136 0.974 . . . . 0.0 112.895 177.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.7 t -81.64 -17.88 46.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.853 0.359 . . . . 0.0 110.578 -175.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.0 m -77.69 107.04 9.89 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.128 178.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.8 mt -69.13 104.27 2.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.042 0.449 . . . . 0.0 110.06 178.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.506 ' HA ' ' HG3' ' B' ' 223' ' ' GLU . . . -151.5 -175.03 5.02 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.645 -178.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 61.25 66.62 0.86 Allowed 'General case' 0 C--N 1.332 -0.175 0 O-C-N 123.695 0.622 . . . . 0.0 111.515 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.543 ' H ' ' HB2' ' B' ' 223' ' ' GLU . 33.7 mt-10 -150.4 99.37 2.77 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.574 -175.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.8 156.21 5.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.649 176.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.483 ' HB ' ' HB2' ' A' ' 29' ' ' GLU . 19.6 m -122.79 143.38 35.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.185 177.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.49 ' O ' HG13 ' A' ' 30' ' ' ILE . 94.9 p -93.78 -167.6 1.72 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.918 0.39 . . . . 0.0 110.738 -176.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -62.18 -38.53 89.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.624 -174.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.536 ' HB2' ' OE2' ' A' ' 29' ' ' GLU . 0.9 OUTLIER -62.17 -49.98 73.66 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.096 0.474 . . . . 0.0 110.601 -176.416 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.536 ' OE2' ' HB2' ' A' ' 28' ' ' GLN . 1.8 mp0 -62.32 -40.86 97.72 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.251 -177.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.557 HG12 HD12 ' A' ' 35' ' ' LEU . 80.8 mt -55.35 -48.28 77.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 121.048 0.452 . . . . 0.0 110.712 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.9 m -73.28 -41.61 63.4 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.749 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 12.6 t60 -76.99 -32.28 57.09 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.79 0.292 . . . . 0.0 111.79 -171.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -101.87 -2.78 29.15 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 121.352 -0.139 . . . . 0.0 111.257 -178.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt 44.68 100.02 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 122.294 1.045 . . . . 0.0 113.76 -171.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.557 HD12 HG12 ' A' ' 30' ' ' ILE . 91.7 mt -104.67 152.82 22.02 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.106 -1.406 . . . . 0.0 111.368 -176.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.1 t -88.09 105.66 15.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.932 -175.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.4 tttp -73.87 118.49 16.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.956 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 26.8 m -100.05 -21.9 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -178.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.58 -171.83 34.23 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.43 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 27.2 m -125.17 139.49 53.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.666 0.269 . . . . 0.0 110.659 -178.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.3 pt -114.7 143.88 23.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 175.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -126.18 131.12 52.07 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.105 0.479 . . . . 0.0 111.359 -173.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.686 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 95.9 t -93.89 125.67 46.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.084 173.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -153.16 88.96 1.33 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.863 0.364 . . . . 0.0 110.135 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 13.5 mp0 -138.46 163.45 31.91 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.884 177.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.567 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 4.0 p -66.05 148.92 51.07 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.122 0.487 . . . . 0.0 111.835 -178.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.88 114.42 6.03 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.934 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 137.62 -39.38 1.61 Allowed Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 -175.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -70.24 -29.29 66.06 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.465 0.65 . . . . 0.0 109.632 175.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.442 HD11 ' HG3' ' A' ' 59' ' ' LYS . 46.1 mm -118.38 109.19 26.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.728 174.147 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.5 t -116.18 -44.53 2.89 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.041 0.448 . . . . 0.0 110.23 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.2 m -104.06 157.14 34.61 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.073 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.953 ' HG3' HD21 ' B' ' 235' ' ' LEU . 22.1 Cg_endo -61.08 -28.79 86.3 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.411 2.074 . . . . 0.0 110.857 175.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.642 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 0.8 OUTLIER -60.34 -45.29 93.99 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.118 176.12 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.501 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 71.8 m-20 -54.93 -46.88 75.0 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.117 0.484 . . . . 0.0 110.25 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 59.2 tp -57.14 -47.82 80.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.898 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.51 -31.49 68.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.91 -176.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.642 ' HG2' ' O ' ' A' ' 54' ' ' SER . 57.7 mm-40 -63.2 -43.16 98.95 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.982 0.42 . . . . 0.0 110.013 176.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 55' ' ' ASP . 31.5 mmmt -67.24 -45.6 76.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.562 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 87.5 mt -65.24 -38.82 91.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.509 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.4 t -63.47 -35.75 81.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.96 0.409 . . . . 0.0 110.316 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -59.75 -42.88 94.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.251 176.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 87.3 mt -74.74 -33.68 62.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.936 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.93 -40.17 94.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.449 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -61.21 -35.82 78.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.373 176.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.59 2.49 29.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.579 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.427 ' HD3' ' HA ' ' A' ' 67' ' ' LYS . 42.9 mmtm -122.08 -0.05 9.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.911 0.386 . . . . 0.0 110.687 176.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 60.73 40.5 98.17 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.631 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -108.2 135.56 12.91 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.007 -178.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.818 ' HD3' HG21 ' B' ' 219' ' ' THR . 74.6 mmtt -77.68 -25.7 49.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.365 0.602 . . . . 0.0 110.021 177.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -152.93 175.44 12.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.215 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -147.65 170.22 17.98 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.925 -176.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -135.42 114.23 11.95 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 119.994 -0.683 . . . . 0.0 110.915 174.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.477 ' HA ' ' HA ' ' A' ' 88' ' ' ALA . 55.8 mt -78.39 127.53 38.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.777 177.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 23.2 pt -100.92 -35.2 4.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.585 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -156.32 144.86 20.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.817 0.341 . . . . 0.0 111.424 -177.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -147.14 124.67 11.7 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.07 152.21 40.68 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.888 0.375 . . . . 0.0 111.213 -174.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -86.0 118.88 25.75 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.488 170.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -80.11 -22.13 42.5 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 128.4 -86.28 0.32 Allowed Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 -175.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.567 ' O ' ' HA ' ' A' ' 46' ' ' SER . 70.1 Cg_endo -74.73 -24.0 13.86 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.16 1.907 . . . . 0.0 111.374 172.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.467 ' OD1' ' HG2' ' A' ' 82' ' ' PRO . 1.1 m120 -119.57 150.15 40.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.323 -176.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -108.13 121.67 45.33 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 170.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.686 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 46.2 mt-10 -117.71 118.98 33.57 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.206 0.527 . . . . 0.0 111.782 -174.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -121.36 132.13 54.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.992 176.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.1 t -111.54 112.85 42.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.997 0.427 . . . . 0.0 110.421 -178.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 74' ' ' ILE . . . -125.13 135.57 52.78 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.223 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 40' ' ' THR . 33.2 mt-10 -106.0 134.96 48.29 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 26.2 t -90.66 132.19 35.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -175.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -123.25 125.73 45.61 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.167 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.68 147.39 25.26 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 174.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.456 ' C ' ' H ' ' A' ' 95' ' ' THR . 2.1 m-20 -53.5 147.82 10.27 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.061 -178.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.455 ' O ' ' HB3' ' A' ' 104' ' ' HIS . . . -73.49 46.84 0.21 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 166.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.456 ' H ' ' C ' ' A' ' 93' ' ' ASP . 31.1 m -151.43 -50.11 0.12 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.947 -172.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -69.66 -32.74 71.58 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.235 -178.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 78.2 mt -116.32 24.13 11.6 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.286 0.565 . . . . 0.0 110.294 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.28 141.27 48.37 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 35.1 t-80 -146.72 75.61 1.4 Allowed 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.547 -175.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 14.5 m80 -90.52 -49.84 6.28 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 169.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -112.53 -84.0 0.59 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 176.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 14.5 t-160 -128.97 -41.63 1.44 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -143.09 161.15 38.95 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.964 -1.016 . . . . 0.0 108.53 170.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.455 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 57.5 t-80 . . . . . 0 C--N 1.311 -1.068 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 171.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 201' ' ' MET . . . . . 0.427 ' HG3' ' HG3' ' B' ' 202' ' ' LYS . 15.7 tpt . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 120.574 0.226 . . . . 0.0 110.756 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 202' ' ' LYS . . . . . 0.427 ' HG3' ' HG3' ' B' ' 201' ' ' MET . 98.4 mttt -133.57 122.12 23.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.594 0.235 . . . . 0.0 110.619 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 92.8 mttt 60.2 67.96 0.81 Allowed 'General case' 0 N--CA 1.465 0.301 0 O-C-N 124.037 0.836 . . . . 0.0 112.802 177.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -135.1 101.87 5.01 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 170.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 205' ' ' ILE . . . . . 0.62 HG22 HG23 ' B' ' 206' ' ' ILE . 4.4 mp -119.93 -73.04 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.722 -178.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 206' ' ' ILE . . . . . 0.62 HG23 HG22 ' B' ' 205' ' ' ILE . 32.2 pt -128.41 174.55 11.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.825 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -118.33 -11.85 9.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.597 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . 63.86 18.42 11.16 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.425 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -89.87 140.85 29.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.097 -178.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 210' ' ' LEU . . . . . . . . . . . . . 8.7 mp 65.79 24.7 11.4 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.248 176.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 97.9 mt -64.76 -58.69 5.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.283 0.563 . . . . 0.0 109.488 173.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -132.21 -60.79 0.89 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.4 -0.818 . . . . 0.0 108.84 171.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 213' ' ' THR . . . . . 0.736 HG22 ' H ' ' B' ' 214' ' ' VAL . 1.2 m 64.91 -160.64 0.28 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.438 172.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 214' ' ' VAL . . . . . 0.736 ' H ' HG22 ' B' ' 213' ' ' THR . 47.8 t 67.51 94.03 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-O 121.262 0.554 . . . . 0.0 111.225 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -155.18 85.87 1.09 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.73 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 15.0 m -78.4 84.12 4.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.109 -173.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -107.33 151.94 24.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.349 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 218' ' ' SER . . . . . . . . . . . . . 8.4 t -91.58 124.73 35.97 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.786 0.327 . . . . 0.0 110.845 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 219' ' ' THR . . . . . 0.818 HG21 ' HD3' ' A' ' 70' ' ' LYS . 89.1 m -159.2 109.43 1.97 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.379 175.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 6.3 mp -86.31 96.18 9.89 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.658 -0.417 . . . . 0.0 109.91 173.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -140.14 -139.99 0.13 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.041 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . 68.73 91.12 0.09 Allowed 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.64 0.588 . . . . 0.0 111.154 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 223' ' ' GLU . . . . . 0.543 ' HB2' ' H ' ' A' ' 23' ' ' GLU . 4.2 mm-40 -127.07 89.14 2.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.274 -173.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 224' ' ' GLN . . . . . 0.619 ' HA ' ' HB3' ' B' ' 271' ' ' TYR . 0.0 OUTLIER -176.62 155.73 1.38 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.285 169.264 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 20.3 m -125.88 150.85 31.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.272 175.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 226' ' ' SER . . . . . 0.442 ' O ' HG13 ' B' ' 230' ' ' ILE . 12.7 t -83.74 171.61 13.02 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 227' ' ' LYS . . . . . 0.494 ' HA ' HD12 ' B' ' 230' ' ' ILE . 74.3 tttt -68.74 -19.55 64.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.343 -173.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 228' ' ' GLN . . . . . 0.44 ' HB2' ' OE1' ' B' ' 229' ' ' GLU . 0.6 OUTLIER -65.75 -50.36 65.07 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 177.315 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 229' ' ' GLU . . . . . 0.44 ' OE1' ' HB2' ' B' ' 228' ' ' GLN . 1.9 mp0 -64.58 -41.33 96.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.444 178.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.494 HD12 ' HA ' ' B' ' 227' ' ' LYS . 87.4 mt -56.84 -46.46 83.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.898 178.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 16.5 m -73.14 -21.29 60.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.458 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 -85.48 -48.03 9.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.806 -176.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -91.19 -7.81 50.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.033 -177.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 57.95 64.56 1.5 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.082 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 235' ' ' LEU . . . . . 0.953 HD21 ' HG3' ' A' ' 53' ' ' PRO . 60.4 mt -75.21 147.26 40.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.236 -178.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 46.8 t -88.55 119.09 35.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.08 -175.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -80.53 117.56 21.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.12 175.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 238' ' ' VAL . . . . . 0.416 HG23 ' HB ' ' B' ' 290' ' ' VAL . 2.0 m -80.26 -39.48 19.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.841 177.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 179.37 -173.27 45.26 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.991 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 33.3 m -115.22 129.81 56.74 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.245 -0.279 . . . . 0.0 110.245 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 24.2 pt -104.08 132.66 50.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.006 0.431 . . . . 0.0 110.177 175.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -117.55 123.08 45.38 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.582 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 243' ' ' VAL . . . . . 0.701 ' O ' ' HA ' ' B' ' 285' ' ' GLU . 41.9 t -92.6 120.42 41.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 173.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 15.9 t -150.97 87.16 1.39 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.345 0.593 . . . . 0.0 109.511 -177.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 245' ' ' GLN . . . . . 0.561 ' HG3' ' HB2' ' B' ' 249' ' ' GLN . 6.3 pm0 -138.62 173.62 11.39 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.734 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 8.6 t -85.39 176.21 8.41 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.735 0.302 . . . . 0.0 110.275 -176.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.69 52.42 1.57 Allowed Glycine 0 CA--C 1.521 0.439 0 CA-C-N 116.098 -0.501 . . . . 0.0 113.246 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -141.28 -39.78 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 176.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 249' ' ' GLN . . . . . 0.561 ' HB2' ' HG3' ' B' ' 245' ' ' GLN . 77.3 mt-30 -80.03 -15.13 57.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.587 -0.306 . . . . 0.0 110.518 175.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 250' ' ' ILE . . . . . 0.547 ' HA ' ' OD2' ' B' ' 255' ' ' ASP . 47.4 mm -131.76 110.22 16.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 175.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 8.5 t -118.25 -27.98 5.91 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.606 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 252' ' ' SER . . . . . 0.522 ' HB3' ' HD2' ' B' ' 253' ' ' PRO . 50.6 m -152.22 164.72 19.36 Favored Pre-proline 0 C--N 1.327 -0.383 0 O-C-N 122.357 -0.214 . . . . 0.0 110.62 -175.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 253' ' ' PRO . . . . . 0.522 ' HD2' ' HB3' ' B' ' 252' ' ' SER . 12.3 Cg_endo -56.95 -43.9 49.76 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.8 2.333 . . . . 0.0 112.503 178.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 254' ' ' SER . . . . . 0.405 ' O ' ' HG3' ' B' ' 257' ' ' ARG . 4.3 p -64.14 -30.46 71.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.361 0.6 . . . . 0.0 110.726 177.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.547 ' OD2' ' HA ' ' B' ' 250' ' ' ILE . 28.1 t70 -75.75 -37.1 59.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.458 177.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 60.6 tp -61.64 -47.54 84.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.945 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 257' ' ' ARG . . . . . 0.513 ' HA ' HD12 ' B' ' 260' ' ' LEU . 2.0 ppt_? -59.19 -25.38 63.9 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -175.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 258' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -63.0 -47.5 82.86 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.169 0.509 . . . . 0.0 110.372 176.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 259' ' ' LYS . . . . . 0.529 ' HD2' ' N ' ' B' ' 259' ' ' LYS . 12.2 mptt -74.16 -26.23 60.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.559 -175.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 260' ' ' LEU . . . . . 0.513 HD12 ' HA ' ' B' ' 257' ' ' ARG . 95.9 mt -67.79 -48.21 66.94 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.479 176.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 14.4 t -66.1 -37.59 86.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.891 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -51.2 -49.4 61.09 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.083 176.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 263' ' ' LEU . . . . . . . . . . . . . 87.7 mt -74.48 -30.39 61.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.547 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.42 -40.95 81.01 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -177.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -63.48 -35.48 80.58 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.24 0.543 . . . . 0.0 110.42 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -74.59 -6.74 50.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.471 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -116.16 -2.84 12.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.84 176.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 66.29 51.09 46.28 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.158 -0.544 . . . . 0.0 112.854 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -138.92 169.35 24.46 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.172 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 270' ' ' LYS . . . . . 0.443 ' HB3' ' OE1' ' B' ' 223' ' ' GLU . 46.0 mtmt -105.56 -66.56 0.98 Allowed 'General case' 0 C--O 1.223 -0.334 0 CA-C-O 121.017 0.437 . . . . 0.0 110.923 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 271' ' ' TYR . . . . . 0.619 ' HB3' ' HA ' ' B' ' 224' ' ' GLN . 16.0 m-85 -92.41 152.66 19.6 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -174.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 272' ' ' TYR . . . . . 0.592 ' HB2' ' HB1' ' B' ' 288' ' ' ALA . 2.8 p90 -134.69 118.28 16.96 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.352 0.596 . . . . 0.0 110.203 175.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 273' ' ' HIS . . . . . 0.518 ' HA ' ' OE1' ' B' ' 224' ' ' GLN . 32.7 t-80 -87.84 101.21 13.49 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 274' ' ' ILE . . . . . 0.597 HG12 ' HB2' ' B' ' 288' ' ' ALA . 58.5 mt -74.17 106.44 4.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.314 -178.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 19.4 pt -85.66 -33.36 7.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.588 -175.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -151.58 124.13 8.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.703 0.287 . . . . 0.0 111.193 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -130.47 118.43 21.12 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 174.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -133.67 164.96 26.05 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.384 0.612 . . . . 0.0 111.064 -175.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -99.14 123.28 43.31 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.027 178.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 280' ' ' HIS . . . . . 0.478 ' HB3' ' HB2' ' B' ' 283' ' ' ASN . 12.1 t-80 -103.07 28.95 5.82 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.198 0.523 . . . . 0.0 110.067 -174.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 93.0 -108.3 3.64 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -178.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -83.23 4.3 7.16 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.666 2.244 . . . . 0.0 111.518 175.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 283' ' ' ASN . . . . . 0.478 ' HB2' ' HB3' ' B' ' 280' ' ' HIS . 87.0 m-20 -126.16 142.02 51.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.484 -177.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -103.61 129.03 50.81 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 173.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 285' ' ' GLU . . . . . 0.701 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 31.2 mt-10 -121.95 113.97 20.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.787 0.327 . . . . 0.0 111.651 -178.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 286' ' ' ALA . . . . . 0.538 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -117.59 127.97 54.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.554 175.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 32.1 t -110.09 116.43 52.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.23 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 288' ' ' ALA . . . . . 0.597 ' HB2' HG12 ' B' ' 274' ' ' ILE . . . -128.31 139.24 52.52 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.131 0.491 . . . . 0.0 111.783 -177.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -91.9 123.46 35.29 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.352 177.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 290' ' ' VAL . . . . . 0.416 ' HB ' HG23 ' B' ' 238' ' ' VAL . 16.5 t -90.78 127.4 43.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.461 -176.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -123.49 139.83 53.62 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.018 -177.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 292' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -106.39 165.77 11.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.106 172.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -60.48 152.1 26.65 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 175.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 294' ' ' ALA . . . . . . . . . . . . . . . -73.03 77.05 1.21 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.076 0.465 . . . . 0.0 110.534 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 295' ' ' THR . . . . . . . . . . . . . 11.2 t 179.72 -28.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.695 -178.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 296' ' ' LYS . . . . . 0.737 ' HD2' ' HG ' ' B' ' 297' ' ' LEU . 2.1 tmmm? -80.07 91.78 5.54 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 297' ' ' LEU . . . . . 0.778 HD11 ' HB2' ' A' ' 12' ' ' ALA . 75.4 mt 74.17 91.72 0.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.644 -1.162 . . . . 0.0 112.995 172.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 298' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -100.99 35.74 2.14 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 166.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 299' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -63.96 136.45 57.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.352 -1.294 . . . . 0.0 110.406 -175.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 300' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -69.52 103.95 2.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.081 0.467 . . . . 0.0 110.157 -179.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 301' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -69.78 99.88 1.43 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.606 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 302' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -85.39 -13.19 50.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.847 176.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -120.48 104.11 9.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.559 175.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 60.6 t60 . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.071 -177.164 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.868 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.1 mttm 61.85 84.14 0.14 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.584 0.707 . . . . 0.0 111.548 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -98.04 108.77 21.55 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.917 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.0 tpt180 -125.03 115.51 20.65 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 177.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 60.3 mt 64.42 92.71 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.272 0 O-C-N 123.701 0.625 . . . . 0.0 110.737 -174.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 40.7 pt -138.37 179.03 3.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.708 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 56.26 50.7 12.88 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.923 175.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -113.22 145.87 40.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.36 178.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -141.93 110.97 6.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.832 0.348 . . . . 0.0 111.53 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 24.7 tp -137.6 41.86 2.35 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.735 0.779 . . . . 0.0 109.437 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.516 HD23 ' H ' ' B' ' 242' ' ' ASN . 0.3 OUTLIER -79.35 94.61 5.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.013 -177.696 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.42 116.47 4.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.417 177.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.6 t -173.47 134.39 0.51 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.162 177.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 56.4 t -107.94 101.79 13.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.869 0.366 . . . . 0.0 110.404 177.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -164.82 170.49 15.37 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.865 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.5 p -120.16 78.76 1.38 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.332 0.587 . . . . 0.0 110.484 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.618 ' HB3' ' OD2' ' B' ' 265' ' ' ASP . 65.8 m-85 -131.25 146.99 52.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.142 178.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.897 ' HA ' ' HA ' ' B' ' 262' ' ' GLU . 34.5 m -155.53 -25.34 0.11 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -177.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.4 p -141.36 116.88 10.22 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -174.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 59.4 tp -165.77 -53.56 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.329 176.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -153.67 -165.01 2.02 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.236 177.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 73.5 91.53 0.08 Allowed 'General case' 0 C--O 1.235 0.332 0 O-C-N 123.756 0.66 . . . . 0.0 111.369 176.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.7 ' HB3' ' HE2' ' A' ' 71' ' ' TYR . 42.8 mt-10 -133.88 160.67 36.95 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.38 176.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.587 ' CG ' ' HG3' ' B' ' 224' ' ' GLN . 1.3 tm0? 174.66 142.88 0.05 Allowed 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.539 0.525 . . . . 0.0 110.424 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.2 m -123.97 125.2 70.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 169.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.456 ' HB2' ' HB ' ' B' ' 274' ' ' ILE . 8.2 t -99.38 -167.93 1.54 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.025 0.44 . . . . 0.0 110.915 -175.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.407 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -71.26 -36.62 71.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.321 -175.169 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -64.54 -50.33 67.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.058 -173.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -59.17 -36.07 74.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.426 -177.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 26' ' ' SER . 79.2 mt -57.19 -56.05 17.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.93 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.6 m -73.77 -30.51 62.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.749 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 17.6 t-160 -79.08 -51.84 9.01 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -174.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -93.03 -7.81 44.7 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 121.18 -0.208 . . . . 0.0 111.467 -174.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt 59.66 65.12 1.19 Allowed 'General case' 0 N--CA 1.463 0.212 0 O-C-N 123.555 0.534 . . . . 0.0 110.656 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.4 mt -65.47 144.49 57.0 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.54 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.511 ' HB ' ' HB3' ' A' ' 92' ' ' ASN . 95.3 t -73.23 112.56 9.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.06 0.457 . . . . 0.0 110.477 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.617 ' HD3' ' CE1' ' A' ' 91' ' ' TYR . 19.3 tptm -78.75 112.98 16.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.125 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.501 HG21 ' HA3' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -97.99 -13.19 8.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.816 -178.675 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 145.48 -170.81 26.71 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.293 -0.956 . . . . 0.0 112.571 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.504 HG23 ' HG2' ' A' ' 89' ' ' GLU . 52.2 m -137.17 139.38 41.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.632 0.253 . . . . 0.0 110.432 -178.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 34.5 pt -121.97 155.65 26.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.743 0.306 . . . . 0.0 110.201 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -141.18 140.53 34.05 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.218 0.533 . . . . 0.0 110.728 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 44.1 t -94.6 126.31 47.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.313 -0.858 . . . . 0.0 108.775 173.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.7 p -138.69 35.83 2.21 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.848 0.832 . . . . 0.0 108.894 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -99.75 159.73 14.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.942 -175.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' A' ' 83' ' ' ASN . 22.7 t -73.31 172.09 11.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.829 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.96 22.07 1.55 Allowed Glycine 0 CA--C 1.52 0.363 0 CA-C-N 116.178 -0.464 . . . . 0.0 113.366 -177.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -103.96 -21.78 9.33 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 173.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -102.41 -20.22 14.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.339 0.59 . . . . 0.0 109.63 178.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.3 mm -125.58 98.05 4.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.17 172.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.8 m -103.26 -66.54 0.93 Allowed 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.651 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.534 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 23.5 m -108.24 165.0 13.51 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.534 ' HD2' ' HB3' ' A' ' 52' ' ' SER . 11.2 Cg_endo -55.14 -32.49 80.2 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.581 2.188 . . . . 0.0 111.88 178.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.6 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 7.9 m -60.76 -43.25 98.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.896 177.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.52 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 18.3 m-20 -63.39 -36.49 83.88 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.536 -178.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.7 tp -60.86 -46.73 89.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.496 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.45 ' HD2' ' HG2' ' B' ' 223' ' ' GLU . 23.5 ttp180 -60.63 -42.65 97.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.44 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.6 ' HG2' ' O ' ' A' ' 54' ' ' SER . 31.3 mm-40 -63.05 -34.84 78.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.841 -179.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 55' ' ' ASP . 42.9 mmtm -75.29 -43.54 50.6 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.806 0.336 . . . . 0.0 110.707 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.1 mt -62.69 -46.38 88.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.066 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.7 p -64.76 -40.05 94.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.994 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -58.8 -44.15 90.71 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.797 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.7 mt -74.49 -36.03 63.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.511 -179.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.38 -47.09 74.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.815 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -64.35 -35.36 80.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.069 0.462 . . . . 0.0 110.487 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -78.64 4.78 12.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.55 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.7 mmtm -119.45 3.95 11.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.779 0.323 . . . . 0.0 111.563 176.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.46 -17.46 58.41 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.215 174.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.501 ' HA3' HG21 ' A' ' 38' ' ' VAL . . . -92.47 179.73 40.51 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.846 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.582 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 9.2 mmpt? -122.18 -59.13 1.67 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.672 0.272 . . . . 0.0 110.456 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.7 ' HE2' ' HB3' ' A' ' 23' ' ' GLU . 95.2 m-85 -91.67 167.35 12.26 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.545 -175.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.439 ' HE2' ' HB1' ' B' ' 222' ' ' ALA . 8.8 p90 -146.3 157.65 43.82 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.794 0.33 . . . . 0.0 110.912 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -127.48 102.88 7.06 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.098 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.442 ' HA ' ' HA ' ' A' ' 88' ' ' ALA . 63.9 mt -63.81 127.24 23.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.466 176.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.4 pt -113.45 -14.6 10.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.857 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.484 ' HB3' ' HB ' ' A' ' 87' ' ' VAL . . . -150.2 123.83 9.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.733 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.461 ' HB3' ' HB2' ' B' ' 228' ' ' GLN . . . -135.34 108.34 7.63 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.457 HH11 ' HD3' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -149.6 171.98 15.77 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.578 -174.668 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -119.5 140.1 51.04 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -130.36 96.69 4.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.017 0.437 . . . . 0.0 110.08 -178.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 60.8 -125.36 38.09 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -175.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -90.6 20.51 0.97 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.852 2.368 . . . . 0.0 112.348 175.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.582 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 38.4 m-80 -123.86 151.88 42.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.361 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.416 ' CE2' ' HB2' ' A' ' 86' ' ' ALA . 83.6 t80 -111.21 120.45 42.32 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.049 178.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.578 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 26.2 mm-40 -102.03 110.62 22.64 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.403 -177.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.416 ' HB2' ' CE2' ' A' ' 84' ' ' PHE . . . -128.38 114.99 17.55 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.808 0.337 . . . . 0.0 110.768 177.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.484 ' HB ' ' HB3' ' A' ' 76' ' ' ALA . 48.3 t -105.68 117.37 51.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 120.77 0.319 . . . . 0.0 110.344 -178.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.442 ' HA ' ' HA ' ' A' ' 74' ' ' ILE . . . -131.84 133.09 44.29 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.455 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.581 ' HB3' ' HE3' ' A' ' 37' ' ' LYS . 29.8 mt-10 -92.0 135.26 34.09 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.9 t -91.42 127.72 43.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -175.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.617 ' CE1' ' HD3' ' A' ' 37' ' ' LYS . 77.1 m-85 -128.14 136.98 51.89 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.336 0.589 . . . . 0.0 110.879 -178.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.511 ' HB3' ' HB ' ' A' ' 36' ' ' VAL . 8.0 t-20 -95.15 -176.86 3.94 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 174.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -71.82 -166.97 0.24 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -98.42 6.95 46.81 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 121.844 -0.535 . . . . 0.0 110.563 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.7 t -112.5 159.96 18.27 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.545 -178.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -131.77 9.14 4.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.744 177.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 85.8 mt -101.95 101.99 12.48 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.045 -173.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -117.38 -98.81 0.45 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 56.4 m80 -155.38 -47.48 0.08 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 175.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -129.3 95.17 3.96 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.358 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.403 ' O ' ' HB2' ' A' ' 102' ' ' HIS . 51.0 p-80 -124.71 38.65 4.15 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.119 -173.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.403 ' HB2' ' O ' ' A' ' 101' ' ' HIS . 91.9 m-70 70.38 -170.94 0.17 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.654 -177.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 22.6 p-80 -116.66 159.81 21.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.708 0.289 . . . . 0.0 110.321 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 . . . . . 0 C--N 1.322 -0.626 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.762 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 51.4 ttm . . . . . 0 N--CA 1.477 0.889 0 CA-C-O 120.99 0.424 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -125.4 -28.36 3.35 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 175.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -74.2 110.81 8.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.632 176.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -161.42 99.14 1.16 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.834 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 205' ' ' ILE . . . . . 0.782 HG12 HG13 ' B' ' 206' ' ' ILE . 14.7 tt -91.59 143.65 10.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.893 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 206' ' ' ILE . . . . . 0.782 HG13 HG12 ' B' ' 205' ' ' ILE . 73.8 mt 71.85 114.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 123.383 0.673 . . . . 0.0 112.19 177.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -140.05 108.56 5.88 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.14 175.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -90.63 102.9 15.64 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.354 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -89.76 -45.99 8.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.738 -174.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 210' ' ' LEU . . . . . . . . . . . . . 31.6 tp -83.99 74.61 10.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.292 0.568 . . . . 0.0 111.003 -176.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 67.8 mt -131.86 104.48 6.89 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.06 175.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -83.24 139.69 32.96 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.099 176.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 213' ' ' THR . . . . . 0.71 HG22 ' H ' ' B' ' 215' ' ' ALA . 29.0 m -133.48 130.78 39.04 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.986 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 214' ' ' VAL . . . . . . . . . . . . . 26.9 m -87.41 10.83 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.122 0.487 . . . . 0.0 110.979 -178.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 215' ' ' ALA . . . . . 0.71 ' H ' HG22 ' B' ' 213' ' ' THR . . . -80.34 99.91 8.15 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.979 176.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 49.8 m -145.03 98.75 3.22 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.787 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -133.19 149.71 52.02 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 218' ' ' SER . . . . . . . . . . . . . 9.5 m -66.32 92.93 0.2 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.052 0.453 . . . . 0.0 110.023 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 14.9 t -101.01 141.99 33.12 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.798 -175.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 59.5 tp -106.47 83.02 1.81 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 177.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 221' ' ' ALA . . . . . 0.596 ' HA ' ' OE2' ' A' ' 23' ' ' GLU . . . -172.16 34.56 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.922 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 222' ' ' ALA . . . . . 0.439 ' HB1' ' HE2' ' A' ' 72' ' ' TYR . . . -157.71 82.01 0.88 Allowed 'General case' 0 C--O 1.234 0.242 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -171.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 223' ' ' GLU . . . . . 0.45 ' HG2' ' HD2' ' A' ' 57' ' ' ARG . 28.9 mt-10 -138.8 164.96 28.25 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 173.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 224' ' ' GLN . . . . . 0.587 ' HG3' ' CG ' ' A' ' 24' ' ' GLN . 26.1 tt0 179.6 146.99 0.22 Allowed 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.405 0.441 . . . . 0.0 111.247 175.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 225' ' ' VAL . . . . . 0.515 ' N ' ' HG2' ' B' ' 224' ' ' GLN . 17.2 m -141.94 139.73 30.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 167.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 226' ' ' SER . . . . . 0.721 ' HA ' ' CD2' ' B' ' 273' ' ' HIS . 4.5 m -109.21 -89.81 0.47 Allowed 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.954 -0.299 . . . . 0.0 111.658 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 14.5 mmtm -154.66 -41.83 0.09 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.079 0.466 . . . . 0.0 109.774 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 228' ' ' GLN . . . . . 0.475 ' CD ' ' H ' ' B' ' 228' ' ' GLN . 0.0 OUTLIER -63.39 -44.19 95.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.191 -178.254 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -65.62 -40.0 92.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.6 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.552 HG23 ' HB2' ' B' ' 235' ' ' LEU . 77.6 mt -66.82 -38.05 80.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.497 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 30.7 t -71.38 -25.66 62.46 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.956 177.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -87.86 -46.69 9.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.983 -175.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 233' ' ' PHE . . . . . 0.459 ' CD1' ' HD3' ' A' ' 53' ' ' PRO . 68.6 m-85 -94.09 -7.39 42.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.401 -177.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt 61.08 74.1 0.46 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.523 174.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 235' ' ' LEU . . . . . 0.552 ' HB2' HG23 ' B' ' 230' ' ' ILE . 68.1 mt -88.89 176.41 7.04 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.808 0.337 . . . . 0.0 111.211 -177.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 59.4 t -101.89 123.71 55.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.057 -177.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 237' ' ' LYS . . . . . 0.656 ' HD3' ' CZ ' ' B' ' 291' ' ' TYR . 18.9 tptm -82.74 111.85 19.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.763 177.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 238' ' ' VAL . . . . . 0.454 HG23 HG12 ' B' ' 290' ' ' VAL . 0.4 OUTLIER -104.84 14.37 7.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -176.113 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 128.2 -162.53 21.94 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.279 -0.963 . . . . 0.0 113.216 173.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 89.4 m -149.08 135.61 19.46 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 26.7 pt -110.18 146.07 15.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.311 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 242' ' ' ASN . . . . . 0.516 ' H ' HD23 ' A' ' 11' ' ' LEU . 37.6 t-20 -130.56 114.94 16.09 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.715 -178.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 243' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 76.7 t -94.4 109.34 21.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.287 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 10.2 p -119.71 105.34 11.06 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 176.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 245' ' ' GLN . . . . . 0.508 HE22 HD11 ' B' ' 250' ' ' ILE . 75.3 mt-30 -111.5 -174.78 2.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.865 -172.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 23.4 m -151.79 102.8 2.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.426 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 102.93 -164.48 16.02 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.423 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -83.85 58.45 5.01 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.228 -0.511 . . . . 0.0 112.704 -176.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 249' ' ' GLN . . . . . 0.433 ' OE1' ' HB3' ' B' ' 245' ' ' GLN . 53.9 mt-30 -80.27 -15.81 56.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.875 0.369 . . . . 0.0 110.395 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 250' ' ' ILE . . . . . 0.581 HD12 ' HA ' ' B' ' 256' ' ' LEU . 47.9 mm -113.59 114.34 46.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 173.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 16.3 t -108.07 -13.95 14.83 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.146 -176.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 252' ' ' SER . . . . . 0.45 ' O ' ' HB3' ' B' ' 255' ' ' ASP . 46.7 m -152.71 158.65 33.11 Favored Pre-proline 0 C--N 1.326 -0.415 0 O-C-N 122.382 -0.199 . . . . 0.0 110.617 -177.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -58.66 -50.49 9.2 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.809 2.34 . . . . 0.0 111.876 175.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 254' ' ' SER . . . . . 0.696 ' O ' ' HG3' ' B' ' 257' ' ' ARG . 41.4 t -58.31 -36.35 73.22 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.02 0.438 . . . . 0.0 110.629 174.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.45 ' HB3' ' O ' ' B' ' 252' ' ' SER . 20.2 t0 -60.78 -43.62 97.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.355 178.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.581 ' HA ' HD12 ' B' ' 250' ' ' ILE . 55.3 tp -61.51 -44.4 97.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.278 178.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 257' ' ' ARG . . . . . 0.696 ' HG3' ' O ' ' B' ' 254' ' ' SER . 0.7 OUTLIER -66.26 -30.91 71.43 Favored 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 120.411 -0.515 . . . . 0.0 110.372 -177.346 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 258' ' ' GLU . . . . . 0.501 ' HG3' ' O ' ' B' ' 254' ' ' SER . 49.5 mt-10 -68.76 -27.06 65.57 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.946 0.403 . . . . 0.0 110.651 178.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 259' ' ' LYS . . . . . 0.407 ' HD3' ' O ' ' B' ' 255' ' ' ASP . 14.2 mptt -75.01 -34.35 61.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.27 0.557 . . . . 0.0 110.273 174.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 260' ' ' LEU . . . . . 0.455 ' CD1' HD11 ' B' ' 274' ' ' ILE . 79.1 mt -74.04 -46.71 41.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.421 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 25.0 m -60.39 -34.21 73.58 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.108 175.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 262' ' ' GLU . . . . . 0.897 ' HA ' ' HA ' ' A' ' 18' ' ' SER . 34.6 tt0 -54.81 -48.64 72.5 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.085 0.469 . . . . 0.0 110.589 176.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 263' ' ' LEU . . . . . . . . . . . . . 86.6 mt -73.82 -38.13 64.65 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.171 -178.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.59 -44.68 61.7 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -177.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 265' ' ' ASP . . . . . 0.618 ' OD2' ' HB3' ' A' ' 17' ' ' PHE . 25.0 t0 -67.77 -39.65 84.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.275 -178.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -72.36 -24.03 61.21 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.03 177.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 11.8 mmtt -78.21 -50.35 12.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.591 177.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 268' ' ' GLY . . . . . 0.444 ' HA3' ' NE2' ' B' ' 302' ' ' HIS . . . 118.88 33.09 1.2 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.686 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -132.66 133.07 6.88 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 176.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -93.52 8.5 40.46 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -167.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 271' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -146.78 146.67 30.34 Favored 'General case' 0 C--N 1.33 -0.239 0 O-C-N 122.312 -0.242 . . . . 0.0 110.675 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 272' ' ' TYR . . . . . 0.461 ' CE1' ' HB3' ' A' ' 24' ' ' GLN . 37.1 p90 -141.19 159.87 41.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.877 0.37 . . . . 0.0 110.965 177.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 273' ' ' HIS . . . . . 0.721 ' CD2' ' HA ' ' B' ' 226' ' ' SER . 12.4 t-80 -136.14 111.97 9.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.567 -178.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 274' ' ' ILE . . . . . 0.585 ' H ' ' NE2' ' A' ' 24' ' ' GLN . 77.4 mt -78.26 113.29 17.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.872 0.368 . . . . 0.0 110.456 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 9.0 pt -97.09 -27.2 3.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.294 -178.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -150.07 130.71 14.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.467 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 277' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' B' ' 285' ' ' GLU . . . -153.37 117.9 4.95 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -157.56 175.48 13.88 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.064 0.459 . . . . 0.0 110.795 -178.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -109.24 124.75 51.38 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.325 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -112.74 87.67 2.64 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 173.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 69.84 -124.71 15.14 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 -175.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -84.37 -3.28 10.11 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.656 2.237 . . . . 0.0 112.036 175.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -100.2 116.5 32.35 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.082 -174.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -90.52 126.44 35.93 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 175.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 285' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' B' ' 277' ' ' ALA . 9.2 mm-40 -116.02 110.54 19.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.781 -176.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 286' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -118.86 115.72 24.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.857 0.361 . . . . 0.0 111.092 174.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 27.2 t -110.21 124.34 66.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.268 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -135.93 148.08 48.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.236 0.541 . . . . 0.0 111.673 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 289' ' ' GLU . . . . . 0.532 ' HB3' ' HE3' ' B' ' 237' ' ' LYS . 31.8 mt-10 -89.73 143.58 26.69 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 290' ' ' VAL . . . . . 0.454 HG12 HG23 ' B' ' 238' ' ' VAL . 10.6 t -107.79 123.31 63.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 291' ' ' TYR . . . . . 0.656 ' CZ ' ' HD3' ' B' ' 237' ' ' LYS . 77.0 m-85 -127.31 148.88 50.23 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.253 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 292' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -124.12 162.64 23.14 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 11.9 p30 -63.95 151.54 42.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.584 0.707 . . . . 0.0 112.336 -174.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 294' ' ' ALA . . . . . 0.489 ' HB2' ' HA ' ' B' ' 235' ' ' LEU . . . -85.25 58.57 5.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.595 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 295' ' ' THR . . . . . . . . . . . . . 7.3 t -161.89 -25.44 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.578 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 97.3 mttt 73.21 72.44 0.13 Allowed 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.682 170.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 297' ' ' LEU . . . . . . . . . . . . . 71.9 mt -134.01 96.7 3.69 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.611 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 298' ' ' GLU . . . . . 0.639 ' HG3' ' HB2' ' B' ' 302' ' ' HIS . 2.5 tm-20 -90.3 156.71 18.08 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 299' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -69.99 -29.04 66.03 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.012 0.434 . . . . 0.0 110.605 -172.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 300' ' ' HIS . . . . . 0.466 ' H ' ' CD ' ' B' ' 298' ' ' GLU . 2.7 m-70 -107.03 -104.61 0.34 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.346 -0.388 . . . . 0.0 109.987 170.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 301' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -156.02 97.27 1.79 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 302' ' ' HIS . . . . . 0.639 ' HB2' ' HG3' ' B' ' 298' ' ' GLU . 28.6 t-80 -81.4 141.14 34.23 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.872 0.368 . . . . 0.0 111.329 -172.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 34.9 t60 -71.45 120.75 17.48 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.012 175.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 33.8 p-80 . . . . . 0 C--N 1.321 -0.654 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.038 177.746 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.481 1.079 0 CA-C-O 120.641 0.258 . . . . 0.0 110.601 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -127.6 158.92 36.2 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 -177.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.705 ' HD3' HG21 ' B' ' 287' ' ' VAL . 52.0 mttp -121.25 -77.4 0.58 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.588 ' HB3' ' HB2' ' A' ' 7' ' ' ALA . 29.1 mmt180 -141.82 -33.08 0.51 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.11 177.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 63.4 mt 64.18 88.17 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.317 -177.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 72.2 mt 66.82 -81.06 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.271 -175.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.588 ' HB2' ' HB3' ' A' ' 4' ' ' ARG . . . 66.1 147.56 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.839 0.828 . . . . 0.0 112.899 177.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -106.89 101.05 10.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.261 173.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.94 137.53 41.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.57 -175.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -90.31 143.8 26.42 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.573 176.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.2 tp -123.07 141.99 51.36 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.757 0.313 . . . . 0.0 110.343 -177.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -93.46 110.93 22.49 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.317 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.9 p -83.91 86.63 7.14 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.35 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.0 m -132.84 -169.6 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.311 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.01 67.48 1.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.249 0.547 . . . . 0.0 111.56 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.1 m -119.23 111.02 17.7 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.891 176.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -135.62 -76.25 0.44 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.534 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.506 ' O ' ' HB ' ' A' ' 19' ' ' THR . 20.3 m 56.26 -103.38 0.18 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.552 -175.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.506 ' HB ' ' O ' ' A' ' 18' ' ' SER . 8.8 t 163.9 -41.03 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 123.504 0.722 . . . . 0.0 109.062 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.556 HD13 HH21 ' B' ' 257' ' ' ARG . 83.9 mt -147.24 -125.46 0.06 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 62.68 49.07 3.97 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.268 0.556 . . . . 0.0 110.906 176.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.403 ' HB3' ' HA ' ' B' ' 261' ' ' SER . . . -177.96 90.59 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.594 -1.184 . . . . 0.0 108.626 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.508 ' HB2' ' CE1' ' A' ' 71' ' ' TYR . 8.7 pt-20 -165.29 125.43 1.86 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -169.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.622 ' HA ' ' HB3' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -161.71 159.08 26.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.506 174.522 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.503 HG22 ' HB2' ' A' ' 71' ' ' TYR . 17.1 m -128.32 130.91 69.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.353 174.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.479 ' O ' HG13 ' A' ' 30' ' ' ILE . 15.4 m -97.56 173.95 6.89 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.382 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -66.58 -15.16 63.22 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.556 -174.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.452 ' HB2' ' OE1' ' A' ' 29' ' ' GLU . 41.9 mt-30 -71.57 -50.81 27.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.405 0.621 . . . . 0.0 109.527 177.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.464 ' OE1' ' HB2' ' A' ' 26' ' ' SER . 1.9 mp0 -70.44 -41.28 73.05 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.901 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 26' ' ' SER . 94.7 mt -56.21 -48.67 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.353 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.1 m -72.34 -30.12 64.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.08 0.467 . . . . 0.0 110.727 -177.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -74.87 -40.85 60.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.498 -177.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -96.88 -0.01 48.43 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -175.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm 57.87 51.45 9.08 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.03 0.443 . . . . 0.0 110.033 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.873 HD21 ' HG2' ' B' ' 253' ' ' PRO . 56.4 mt -68.62 169.58 10.83 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.622 0.725 . . . . 0.0 112.78 -172.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.7 t -100.04 117.88 45.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.293 -175.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.424 ' HE2' ' OE1' ' A' ' 89' ' ' GLU . 60.8 tttm -83.14 107.65 15.85 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 176.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.5 m -90.69 -11.68 9.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -175.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 138.07 -168.02 24.71 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 119.892 -1.147 . . . . 0.0 113.092 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 24.0 m -123.55 144.54 49.5 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -178.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.6 pt -110.84 157.54 11.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.674 0.273 . . . . 0.0 110.439 178.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -117.98 136.71 53.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.126 0.489 . . . . 0.0 111.921 -171.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.662 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 85.5 t -122.45 113.45 38.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.849 169.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.0 t -150.85 77.2 1.27 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.186 0.517 . . . . 0.0 110.053 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.416 HE22 HG13 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -137.73 163.64 30.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.992 -179.565 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.525 ' HA ' ' HA ' ' A' ' 83' ' ' ASN . 26.4 t -73.18 163.83 27.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.643 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.97 -16.97 58.02 Favored Glycine 0 C--N 1.333 0.393 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.48 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.46 -19.63 68.95 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.215 176.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -102.0 -28.37 12.41 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.676 0.274 . . . . 0.0 111.01 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 43.5 mm -119.35 107.33 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-O 121.219 0.533 . . . . 0.0 110.479 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.8 m -128.98 -28.64 2.38 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.967 -178.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.8 m -121.68 156.08 59.16 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.192 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.441 ' HG2' ' HB2' ' B' ' 293' ' ' ASP . 32.5 Cg_exo -59.88 -24.43 76.08 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.729 2.286 . . . . 0.0 112.087 177.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.514 ' O ' ' HG3' ' A' ' 58' ' ' GLU . 24.1 p -62.76 -39.91 95.63 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.471 177.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.57 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 16.3 m-20 -61.69 -51.79 66.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.304 -175.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.443 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 57.6 tp -57.03 -44.82 83.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.653 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.403 ' HD2' HH11 ' A' ' 57' ' ' ARG . 7.5 ttp180 -53.25 -53.59 48.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.516 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.514 ' HG3' ' O ' ' A' ' 54' ' ' SER . 72.4 mt-10 -67.5 -27.27 66.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.021 -171.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.57 ' HG2' ' O ' ' A' ' 55' ' ' ASP . 46.9 mmtt -71.05 -45.64 63.47 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 56' ' ' LEU . 82.1 mt -65.53 -43.86 88.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.227 -176.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.9 p -62.88 -41.47 99.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.74 0.305 . . . . 0.0 111.383 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -64.67 -46.36 82.76 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.173 0.511 . . . . 0.0 110.223 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 59' ' ' LYS . 81.2 mt -67.87 -34.74 77.26 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.464 -178.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.72 -46.73 77.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.693 -178.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -67.38 -25.81 66.15 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.84 0.352 . . . . 0.0 110.992 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.77 -28.96 68.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.261 0.553 . . . . 0.0 110.237 176.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -86.18 -13.43 47.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.742 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.76 -9.04 73.8 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.914 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.24 172.5 54.41 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 121.221 -0.514 . . . . 0.0 112.146 -178.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -117.35 -62.8 1.52 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.966 0.412 . . . . 0.0 110.671 -176.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.622 ' HB3' ' HA ' ' A' ' 24' ' ' GLN . 4.5 m-85 -98.17 148.1 23.91 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -176.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.454 ' CE2' ' HA ' ' B' ' 223' ' ' GLU . 32.7 p90 -121.8 156.98 32.04 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 177.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 48.1 t60 -135.25 115.93 13.85 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.569 -177.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.466 ' H ' HD12 ' A' ' 74' ' ' ILE . 4.6 mp -73.31 132.06 33.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.518 HD12 ' HA ' ' B' ' 205' ' ' ILE . 26.6 pt -117.37 -27.74 2.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.589 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -152.96 133.53 13.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.616 0.245 . . . . 0.0 110.684 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.517 ' HB3' ' HG3' ' B' ' 228' ' ' GLN . . . -150.55 142.74 24.14 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -164.87 147.99 8.56 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.033 0.444 . . . . 0.0 111.048 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -78.29 111.33 14.16 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 169.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -115.06 82.14 1.69 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.049 0.452 . . . . 0.0 110.349 -174.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.04 -128.75 8.74 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.6 -178.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -81.43 -6.15 12.7 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.572 2.181 . . . . 0.0 112.893 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.525 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 81.9 m-20 -121.07 154.52 36.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.079 0.466 . . . . 0.0 111.276 -175.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -104.29 118.39 36.51 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.585 176.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -102.4 124.92 48.83 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.05 -176.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.662 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -137.36 129.8 29.72 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.231 0.539 . . . . 0.0 110.917 178.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.9 t -113.24 118.83 59.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.973 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.59 138.24 39.34 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.121 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 40' ' ' THR . 51.1 mt-10 -98.96 153.91 18.47 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 178.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.9 t -112.27 138.45 41.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -125.26 148.57 48.61 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.086 0.47 . . . . 0.0 110.595 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -118.27 164.73 14.76 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.508 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -74.44 150.8 39.77 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.41 25.85 0.59 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.774 0.321 . . . . 0.0 111.845 -171.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.1 t -103.11 -12.72 17.18 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.09 0.471 . . . . 0.0 111.128 -176.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -86.12 179.45 6.95 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.407 -176.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.402 ' H ' ' HG ' ' A' ' 97' ' ' LEU . 2.4 pp -86.15 -1.79 57.75 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 113.099 0.778 . . . . 0.0 113.099 -167.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -55.41 126.26 24.34 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 63.7 m80 -66.5 106.22 1.7 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.994 -171.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 56.2 p-80 -139.62 -16.78 1.01 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.772 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 43.2 m80 65.87 177.33 0.21 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.848 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -143.64 98.02 3.17 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.483 0.659 . . . . 0.0 109.992 173.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 63.1 t60 -55.61 127.81 31.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.767 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 . . . . . 0 C--N 1.325 -0.496 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.883 175.633 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 201' ' ' MET . . . . . 0.697 ' SD ' ' HG3' ' B' ' 202' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 202' ' ' LYS . . . . . 0.697 ' HG3' ' SD ' ' B' ' 201' ' ' MET . 85.6 mttt 72.27 134.65 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 O-C-N 124.058 0.849 . . . . 0.0 111.981 -176.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -105.82 68.1 0.77 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.678 170.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 38.9 ptt85 -75.81 145.79 40.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.992 177.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 205' ' ' ILE . . . . . 0.518 ' HA ' HD12 ' A' ' 75' ' ' ILE . 24.0 pt -125.21 136.99 59.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.017 0.437 . . . . 0.0 111.234 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 60.5 mt -121.54 90.89 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 173.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -93.25 80.72 4.45 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.034 0.445 . . . . 0.0 110.867 -176.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -116.77 93.99 4.42 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.043 177.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -115.18 107.77 15.73 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.234 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 210' ' ' LEU . . . . . . . . . . . . . 31.7 tp -126.74 100.33 6.14 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.361 -175.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 11.0 mp 70.2 143.02 0.05 Allowed 'General case' 0 N--CA 1.469 0.522 0 O-C-N 124.03 0.831 . . . . 0.0 112.223 177.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -85.75 176.61 8.04 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.898 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 213' ' ' THR . . . . . . . . . . . . . 12.5 t -115.68 169.86 8.88 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 214' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.2 134.65 29.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 177.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -73.86 88.66 1.82 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.236 0.541 . . . . 0.0 111.327 -175.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 36.0 m -143.74 152.9 41.84 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.151 176.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -151.28 150.81 30.99 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.924 0.392 . . . . 0.0 110.576 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 218' ' ' SER . . . . . . . . . . . . . 3.1 m -118.22 159.49 23.23 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.981 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 2.8 p -76.54 79.31 3.23 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.317 0.58 . . . . 0.0 110.642 176.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 86.8 mt -104.76 179.63 4.21 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.492 -177.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -126.11 107.1 10.07 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.567 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . 178.71 109.37 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 223' ' ' GLU . . . . . 0.454 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 10.8 pt-20 -173.0 140.65 0.92 Allowed 'General case' 0 C--O 1.235 0.31 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -167.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 224' ' ' GLN . . . . . 0.472 ' HA ' ' HB3' ' B' ' 271' ' ' TYR . 0.0 OUTLIER -175.57 156.73 1.97 Allowed 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.612 173.365 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 28.3 m -116.45 141.51 33.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.769 0.319 . . . . 0.0 110.811 177.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 226' ' ' SER . . . . . 0.417 ' HA ' ' CE1' ' B' ' 273' ' ' HIS . 47.9 t -83.83 -92.96 0.07 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.111 -176.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 227' ' ' LYS . . . . . 0.416 ' HA ' HD12 ' B' ' 230' ' ' ILE . 26.2 ttpt -151.48 -39.68 0.12 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.962 0.411 . . . . 0.0 110.895 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 228' ' ' GLN . . . . . 0.517 ' HG3' ' HB3' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -63.75 -35.09 79.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.424 179.876 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 229' ' ' GLU . . . . . 0.467 ' OE1' ' HG2' ' B' ' 228' ' ' GLN . 2.4 mp0 -69.68 -37.93 76.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.831 176.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.559 HG12 HD12 ' B' ' 235' ' ' LEU . 63.3 mt -59.05 -45.18 92.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.642 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 16.5 m -73.13 -37.68 66.57 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.861 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -70.37 -48.54 55.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.435 -176.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -94.45 5.43 51.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.438 -175.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt 55.68 45.13 25.22 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.92 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 235' ' ' LEU . . . . . 0.617 HD22 ' HA ' ' B' ' 293' ' ' ASP . 72.7 mt -58.27 148.82 26.04 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.509 -175.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 61.9 t -97.29 117.92 42.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.01 -174.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -80.82 113.63 19.15 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.14 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 18.9 m -85.89 -34.94 8.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -176.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 166.02 179.77 39.72 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.637 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 240' ' ' THR . . . . . 0.494 HG23 ' HG2' ' B' ' 289' ' ' GLU . 54.3 m -113.45 135.84 53.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.698 0.285 . . . . 0.0 110.583 -178.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 30.1 pt -107.77 131.19 58.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 171.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -120.19 113.79 20.96 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.997 -174.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 243' ' ' VAL . . . . . 0.571 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 84.2 t -95.12 119.61 43.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.353 -177.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 22.6 t -115.64 86.1 2.4 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 170.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 245' ' ' GLN . . . . . 0.565 ' HG2' HG12 ' B' ' 250' ' ' ILE . 0.3 OUTLIER -81.63 106.47 13.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.946 -173.22 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 13.9 m -88.13 103.69 15.98 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.68 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 94.69 -162.69 24.42 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.146 174.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -82.54 63.73 4.39 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.554 -0.355 . . . . 0.0 113.591 -173.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 249' ' ' GLN . . . . . 0.524 ' HB2' ' HG3' ' B' ' 245' ' ' GLN . 72.6 mt-30 -96.09 -2.8 45.88 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.126 0.488 . . . . 0.0 109.911 172.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 250' ' ' ILE . . . . . 0.565 HG12 ' HG2' ' B' ' 245' ' ' GLN . 48.9 mm -128.36 125.54 64.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.116 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 251' ' ' SER . . . . . 0.4 ' H ' ' CG ' ' B' ' 255' ' ' ASP . 1.1 m -112.09 -57.79 2.22 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.457 0.646 . . . . 0.0 109.668 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 252' ' ' SER . . . . . 0.522 ' HB3' ' HD2' ' B' ' 253' ' ' PRO . 50.7 m -127.01 175.12 3.55 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.362 176.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 253' ' ' PRO . . . . . 0.873 ' HG2' HD21 ' A' ' 35' ' ' LEU . 52.2 Cg_exo -55.09 -28.63 61.56 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.288 1.992 . . . . 0.0 112.315 175.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 254' ' ' SER . . . . . 0.576 ' O ' ' HB3' ' B' ' 257' ' ' ARG . 56.3 m -65.74 -26.19 67.62 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.777 178.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.588 ' O ' ' HD3' ' B' ' 259' ' ' LYS . 2.6 m-20 -70.82 -49.39 46.84 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.154 0.502 . . . . 0.0 109.661 176.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 41.2 tp -62.5 -31.31 72.04 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.024 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 257' ' ' ARG . . . . . 0.576 ' HB3' ' O ' ' B' ' 254' ' ' SER . 50.7 ttt85 -51.19 -51.4 54.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.117 175.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 258' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -59.72 -51.99 67.41 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.138 0.494 . . . . 0.0 110.317 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 259' ' ' LYS . . . . . 0.588 ' HD3' ' O ' ' B' ' 255' ' ' ASP . 12.1 mptt -59.56 -43.7 93.5 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.245 -174.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 260' ' ' LEU . . . . . 0.485 HD13 ' CE2' ' B' ' 272' ' ' TYR . 96.5 mt -74.26 -43.62 56.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.179 -177.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 261' ' ' SER . . . . . 0.403 ' HA ' ' HB3' ' A' ' 22' ' ' ALA . 32.9 t -63.39 -37.97 89.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.677 0.275 . . . . 0.0 110.482 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -60.95 -52.96 62.8 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.46 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 263' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' B' ' 259' ' ' LYS . 81.1 mt -68.84 -40.19 79.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.282 -176.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -61.25 -52.53 64.36 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -175.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -69.48 -32.25 71.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.875 0.369 . . . . 0.0 110.413 -176.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -68.1 -24.23 65.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.007 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -84.96 0.4 51.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.531 176.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 74.82 34.16 53.78 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.798 -178.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 269' ' ' GLY . . . . . 0.43 ' HA2' ' OD1' ' B' ' 292' ' ' ASN . . . -127.79 163.83 21.35 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 121.051 -0.595 . . . . 0.0 111.957 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 270' ' ' LYS . . . . . 0.616 ' HA ' ' NZ ' ' B' ' 270' ' ' LYS . 1.0 OUTLIER -108.34 -66.55 1.03 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.782 0.325 . . . . 0.0 111.276 178.427 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 271' ' ' TYR . . . . . 0.472 ' HB3' ' HA ' ' B' ' 224' ' ' GLN . 4.9 m-85 -92.61 140.79 29.18 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -173.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 272' ' ' TYR . . . . . 0.485 ' CE2' HD13 ' B' ' 260' ' ' LEU . 55.0 p90 -125.17 131.38 53.23 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 176.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 273' ' ' HIS . . . . . 0.417 ' CE1' ' HA ' ' B' ' 226' ' ' SER . 21.7 t60 -104.34 107.91 19.06 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.114 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 274' ' ' ILE . . . . . . . . . . . . . 69.6 mt -70.21 123.14 23.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.191 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 34.0 pt -100.17 -26.55 3.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.706 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -153.76 123.71 6.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.826 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -143.58 117.97 9.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.261 178.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.8 159.02 13.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.948 0.404 . . . . 0.0 111.404 -177.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -84.65 138.58 32.6 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 172.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -114.7 26.84 9.87 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 173.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 115.49 -125.94 6.92 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -175.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.16 -10.5 22.69 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.457 2.104 . . . . 0.0 111.481 175.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 283' ' ' ASN . . . . . 0.454 ' HA ' ' O ' ' B' ' 245' ' ' GLN . 80.3 m-20 -109.64 125.54 52.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.817 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 284' ' ' PHE . . . . . 0.477 ' HB3' ' HB3' ' B' ' 245' ' ' GLN . 71.6 t80 -101.46 121.99 42.95 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.387 178.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 285' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -98.13 113.82 25.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.096 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 286' ' ' ALA . . . . . 0.571 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -125.63 116.02 21.05 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.867 0.365 . . . . 0.0 110.158 172.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 287' ' ' VAL . . . . . 0.705 HG21 ' HD3' ' A' ' 3' ' ' LYS . 21.4 t -113.3 114.68 47.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.247 -178.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -129.35 133.65 47.52 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.451 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 289' ' ' GLU . . . . . 0.494 ' HG2' HG23 ' B' ' 240' ' ' THR . 14.1 mt-10 -106.48 128.17 53.87 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 290' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' B' ' 272' ' ' TYR . 25.0 t -90.31 135.63 25.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.102 0.477 . . . . 0.0 111.202 -171.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -127.26 133.68 50.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.676 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 292' ' ' ASN . . . . . 0.43 ' OD1' ' HA2' ' B' ' 269' ' ' GLY . 54.2 m-20 -106.16 161.6 14.38 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.305 174.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 293' ' ' ASP . . . . . 0.617 ' HA ' HD22 ' B' ' 235' ' ' LEU . 9.3 p-10 -64.2 -62.2 1.76 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.618 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 294' ' ' ALA . . . . . 0.406 ' H ' ' CG ' ' B' ' 293' ' ' ASP . . . 176.22 6.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.208 0.603 . . . . 0.0 112.236 177.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 295' ' ' THR . . . . . 0.553 HG22 ' OD1' ' B' ' 293' ' ' ASP . 8.9 t -96.04 -47.76 5.96 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.815 -0.553 . . . . 0.0 112.213 -174.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 12.2 mmmt 68.83 -52.24 0.57 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.957 0.503 . . . . 0.0 111.513 -174.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 297' ' ' LEU . . . . . . . . . . . . . 73.9 mt -85.57 -179.56 6.92 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.434 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 298' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 61.65 90.09 0.07 Allowed 'General case' 0 C--N 1.331 -0.212 0 O-C-N 123.882 0.739 . . . . 0.0 110.367 -174.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 299' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -80.23 72.24 7.05 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 176.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 300' ' ' HIS . . . . . . . . . . . . . 5.5 t60 74.24 -52.97 0.69 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.055 -175.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 301' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -154.2 110.06 3.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.736 0.303 . . . . 0.0 110.805 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 302' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -149.88 81.83 1.39 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 174.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 62.54 81.31 0.2 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.15 -174.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 . . . . . 0 C--N 1.322 -0.589 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.006 -177.533 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.7 ttp . . . . . 0 N--CA 1.481 1.084 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -75.5 14.62 0.58 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -149.9 119.59 7.02 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.53 -172.21 2.04 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.912 176.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.62 137.67 56.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.048 0.452 . . . . 0.0 110.186 -176.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.8 tt -129.97 114.91 31.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.345 0.593 . . . . 0.0 110.06 177.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -119.09 -174.01 2.62 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.305 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 60.84 63.05 1.35 Allowed 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.92 0.762 . . . . 0.0 111.236 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.01 128.11 35.19 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.766 178.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 80.5 mt -80.34 73.22 7.22 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.711 -177.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 98.2 mt -119.81 128.97 54.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.054 178.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.81 118.28 23.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.491 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.1 p -58.0 134.87 56.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.917 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.1 m -88.51 174.36 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.251 176.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.65 104.68 2.04 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.073 0.463 . . . . 0.0 110.319 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.1 p -128.57 154.14 46.49 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.981 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -84.62 150.92 24.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.971 0.415 . . . . 0.0 111.253 -174.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.2 m -100.53 174.73 5.95 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 173.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.427 HG21 ' NH1' ' A' ' 57' ' ' ARG . 18.8 p -78.39 141.16 38.55 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.044 0.449 . . . . 0.0 110.997 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.658 HD21 HH22 ' B' ' 257' ' ' ARG . 51.4 tp -82.71 80.28 8.86 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 175.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.495 ' HB2' ' OE2' ' B' ' 223' ' ' GLU . . . -95.54 -159.07 0.69 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.508 -174.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 67.6 73.6 0.32 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.968 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.51 ' O ' ' HB2' ' A' ' 24' ' ' GLN . 30.9 mt-10 -140.42 165.64 26.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.54 176.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.58 ' HG2' HE21 ' B' ' 224' ' ' GLN . 0.0 OUTLIER 174.69 136.63 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 O-C-N 123.791 0.682 . . . . 0.0 109.775 171.017 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.0 m -128.24 116.0 40.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.167 0.508 . . . . 0.0 110.479 173.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.429 ' O ' HG13 ' A' ' 30' ' ' ILE . 0.7 OUTLIER -91.29 169.89 10.44 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.099 -178.91 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.45 ' HD3' ' HA ' ' A' ' 27' ' ' LYS . 21.5 mmtp -68.99 -20.24 64.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.472 -177.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.11 -49.8 66.25 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 177.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -66.39 -43.89 84.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.317 176.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.542 HG12 HD12 ' A' ' 35' ' ' LEU . 90.2 mt -58.6 -46.84 89.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.437 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.9 t -72.88 -26.63 61.51 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.999 0.428 . . . . 0.0 110.611 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -73.83 -51.37 16.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.08 -177.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -85.47 -13.52 48.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.95 -178.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt 62.74 68.17 0.66 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.989 -176.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.578 HD21 ' HG2' ' B' ' 253' ' ' PRO . 63.0 mt -79.79 162.63 24.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.463 -176.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.471 HG11 ' HE2' ' A' ' 96' ' ' LYS . 15.6 m -96.29 131.28 43.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.947 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -85.12 118.51 24.72 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.89 177.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.41 HG12 ' HD2' ' A' ' 67' ' ' LYS . 20.8 t -78.76 -26.73 13.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 157.48 164.88 14.3 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.705 176.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 88.4 m -107.27 118.2 36.08 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 173.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.6 pt -107.52 170.44 2.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -178.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -143.42 143.85 31.79 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.924 0.868 . . . . 0.0 111.682 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.548 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 82.2 t -93.55 128.79 44.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 114.323 -1.308 . . . . 0.0 108.668 174.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -156.12 72.4 0.77 Allowed 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -178.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.44 HE22 HG13 ' A' ' 43' ' ' VAL . 0.6 OUTLIER -103.11 148.37 25.82 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.097 -176.432 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.7 p -105.67 112.2 25.19 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.338 -176.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.28 -147.04 18.28 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.73 -0.747 . . . . 0.0 113.116 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -90.26 38.09 3.27 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.133 -0.556 . . . . 0.0 112.823 -173.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -76.4 -31.26 57.86 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.446 HD12 ' HA ' ' A' ' 56' ' ' LEU . 44.7 mm -114.43 95.23 3.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 171.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.8 t -103.41 -43.48 5.4 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.211 0.529 . . . . 0.0 109.831 -177.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 17.8 m -113.74 159.17 36.76 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.385 176.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -57.18 -26.35 69.14 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.386 2.057 . . . . 0.0 111.947 177.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.406 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 3.8 p -73.24 -22.72 60.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.508 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -71.45 -34.54 70.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.326 0.584 . . . . 0.0 109.715 177.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.446 ' HA ' HD12 ' A' ' 50' ' ' ILE . 51.6 tp -66.25 -48.19 71.32 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.57 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.515 ' HD3' ' OE1' ' B' ' 223' ' ' GLU . 0.2 OUTLIER -64.21 -30.52 71.57 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.223 -178.217 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.458 ' HG3' ' NE ' ' A' ' 57' ' ' ARG . 36.1 mt-10 -67.64 -41.25 84.18 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.1 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -66.81 -45.34 78.65 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.823 0.344 . . . . 0.0 110.635 177.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.4 mt -64.48 -41.34 96.54 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.033 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.6 t -65.94 -39.04 90.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.154 0.502 . . . . 0.0 110.256 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -63.4 -42.67 98.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.883 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 97.5 mt -69.64 -32.69 71.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.804 178.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.87 -40.54 95.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.039 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -63.0 -40.38 97.61 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.912 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.79 -44.01 87.01 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.823 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.41 ' HD2' HG12 ' A' ' 38' ' ' VAL . 40.7 mmtt -74.11 -33.44 63.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.813 177.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.49 ' HA3' ' CE1' ' A' ' 99' ' ' HIS . . . 94.2 36.46 5.69 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.08 -179.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -100.38 166.68 19.85 Favored Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -123.12 2.75 9.28 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.96 0.38 . . . . 0.0 111.587 -176.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.518 ' HE2' ' HB2' ' A' ' 93' ' ' ASP . 6.9 m-85 -153.96 166.02 34.28 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 177.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -150.65 157.46 43.0 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 171.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -146.1 117.64 8.03 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.041 -176.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.515 HG13 ' HB2' ' A' ' 88' ' ' ALA . 3.7 mp -83.64 131.35 34.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 178.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.419 HD12 HG22 ' B' ' 205' ' ' ILE . 9.9 pt -107.62 -21.63 5.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.592 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -150.52 139.26 20.75 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.171 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -151.15 113.01 4.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.749 0.309 . . . . 0.0 110.561 -178.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.59 150.7 51.62 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.415 0.626 . . . . 0.0 111.194 -177.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -93.99 102.72 14.81 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.272 176.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -102.54 77.32 1.61 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.367 -175.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.83 -125.6 35.27 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.292 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -82.67 5.46 6.38 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.874 2.383 . . . . 0.0 112.734 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' ' 45' ' ' GLN . 58.5 m-80 -122.51 120.03 32.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.961 0.41 . . . . 0.0 110.628 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -85.32 116.42 23.65 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 177.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.529 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 19.3 mm-40 -106.94 114.49 28.61 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.833 -175.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.548 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -135.26 121.16 19.78 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.617 0.246 . . . . 0.0 110.96 176.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.6 t -95.77 120.42 45.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -177.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.515 ' HB2' HG13 ' A' ' 74' ' ' ILE . . . -126.05 143.62 51.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.198 0.523 . . . . 0.0 111.349 -175.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.471 ' HB3' ' CE1' ' A' ' 91' ' ' TYR . 41.4 mt-10 -103.3 140.71 37.05 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.547 178.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.3 t -107.81 119.21 57.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 176.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.471 ' CE1' ' HB3' ' A' ' 89' ' ' GLU . 72.1 m-85 -123.77 152.81 41.78 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.193 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.531 ' HB3' ' HB ' ' A' ' 95' ' ' THR . 2.1 m-20 -115.69 155.87 26.95 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.063 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.518 ' HB2' ' HE2' ' A' ' 71' ' ' TYR . 19.7 t70 -79.44 67.66 5.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.078 -177.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 56.63 22.29 6.6 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.596 -175.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.563 HG23 ' CB ' ' A' ' 98' ' ' GLU . 72.0 m -62.84 112.52 2.59 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 121.889 0.852 . . . . 0.0 112.261 -175.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.471 ' HE2' HG11 ' A' ' 36' ' ' VAL . 73.4 mmtt -131.67 103.44 6.37 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.328 -1.306 . . . . 0.0 109.158 174.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 93.6 mt 67.3 16.85 10.18 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.145 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.563 ' CB ' HG23 ' A' ' 95' ' ' THR . 47.6 tt0 -53.76 -53.89 45.91 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 172.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.49 ' CE1' ' HA3' ' A' ' 68' ' ' GLY . 10.4 p80 -116.6 129.49 56.2 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 166.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 60.5 m-70 -80.9 -28.05 36.02 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -167.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 61.78 96.08 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -174.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -67.86 72.96 0.17 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.478 -175.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 169.12 -37.49 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.067 0.947 . . . . 0.0 108.945 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 6.1 t60 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.271 -170.855 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.126 0 CA-C-O 120.7 0.286 . . . . 0.0 110.306 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -83.94 100.67 11.17 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 174.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -114.73 108.61 17.01 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.541 0.686 . . . . 0.0 111.052 -177.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -86.09 107.54 17.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.238 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 205' ' ' ILE . . . . . 0.419 HG22 HD12 ' A' ' 75' ' ' ILE . 2.9 pp -70.27 153.09 8.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.402 -176.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 8.6 tt -145.19 107.68 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.477 0.656 . . . . 0.0 110.853 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -108.8 93.68 4.65 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.198 177.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -143.94 66.63 1.28 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.002 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -136.4 111.14 8.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.883 175.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 210' ' ' LEU . . . . . . . . . . . . . 6.0 mp -110.88 -3.2 15.76 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.409 -174.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -114.09 112.86 23.9 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.076 0.465 . . . . 0.0 111.353 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -104.98 -167.0 1.29 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.048 174.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 213' ' ' THR . . . . . . . . . . . . . 14.7 t -166.57 151.08 7.55 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 177.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 214' ' ' VAL . . . . . . . . . . . . . 60.2 t -110.26 107.99 24.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.02 0.438 . . . . 0.0 110.839 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 215' ' ' ALA . . . . . 0.433 ' HB1' ' HE1' ' B' ' 217' ' ' PHE . . . -144.64 85.91 1.79 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.028 175.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 49.0 m -91.38 109.61 20.89 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.907 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 217' ' ' PHE . . . . . 0.433 ' HE1' ' HB1' ' B' ' 215' ' ' ALA . 79.5 m-85 -117.09 -72.57 0.68 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.688 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 218' ' ' SER . . . . . . . . . . . . . 47.8 t -179.96 128.04 0.08 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.255 -177.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 9.0 t -67.04 158.59 30.65 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.403 176.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 60.6 tp -157.97 -49.64 0.07 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.989 -177.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -135.79 100.94 4.6 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.019 178.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . 178.43 85.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 O-C-N 123.856 0.723 . . . . 0.0 110.169 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 223' ' ' GLU . . . . . 0.84 ' HG2' ' HE1' ' B' ' 271' ' ' TYR . 12.7 tt0 -164.43 125.27 2.12 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.371 0.605 . . . . 0.0 111.076 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 224' ' ' GLN . . . . . 0.58 HE21 ' HG2' ' A' ' 24' ' ' GLN . 1.1 tm0? -164.93 150.61 9.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.571 -170.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 225' ' ' VAL . . . . . 0.552 HG22 ' HB3' ' B' ' 271' ' ' TYR . 17.9 m -127.02 128.84 71.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 172.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 226' ' ' SER . . . . . 0.611 ' HA ' ' ND1' ' B' ' 273' ' ' HIS . 11.5 t -92.84 173.17 7.89 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.089 0.471 . . . . 0.0 110.547 -178.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 227' ' ' LYS . . . . . 0.517 ' HA ' HD12 ' B' ' 230' ' ' ILE . 47.4 tttm -64.16 -28.64 69.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.874 -172.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -66.49 -50.46 63.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.291 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 229' ' ' GLU . . . . . 0.486 ' OE1' ' HB3' ' B' ' 226' ' ' SER . 1.9 mp0 -65.36 -38.0 88.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.651 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.539 HG12 HD12 ' B' ' 235' ' ' LEU . 97.1 mt -55.86 -53.92 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.232 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 68.6 m -73.45 -21.01 60.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.713 0.292 . . . . 0.0 111.517 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 65.5 t-80 -75.04 -45.05 44.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.564 0.221 . . . . 0.0 110.99 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -100.75 -12.42 19.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.347 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? 64.41 91.15 0.08 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.139 -175.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 235' ' ' LEU . . . . . 0.539 HD12 HG12 ' B' ' 230' ' ' ILE . 88.6 mt -96.87 166.24 11.72 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.43 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 52.1 t -93.22 115.06 31.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.582 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -84.77 111.76 19.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.081 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 238' ' ' VAL . . . . . 0.431 HG23 ' HB ' ' B' ' 290' ' ' VAL . 1.2 m -88.35 -30.15 5.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -176.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 168.21 -147.53 11.58 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 119.964 -1.112 . . . . 0.0 113.085 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 29.0 m -141.17 138.1 33.16 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 122.598 0.359 . . . . 0.0 110.377 -176.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 241' ' ' ILE . . . . . 0.493 HG13 ' HB3' ' B' ' 288' ' ' ALA . 2.4 pt -105.29 137.61 34.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.139 0.495 . . . . 0.0 110.514 177.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -109.69 123.23 49.14 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.707 -172.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 243' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' B' ' 285' ' ' GLU . 89.2 t -100.95 117.4 46.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 172.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 34.4 m -155.37 76.61 0.97 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.787 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 245' ' ' GLN . . . . . 0.415 ' O ' ' HA ' ' B' ' 283' ' ' ASN . 0.9 OUTLIER -103.79 142.77 33.8 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.834 -177.706 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 246' ' ' SER . . . . . 0.578 ' HA ' ' O ' ' B' ' 282' ' ' PRO . 17.2 m -80.97 117.74 21.85 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.06 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 90.53 -165.71 31.27 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.582 176.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -87.08 53.12 4.45 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.319 -0.467 . . . . 0.0 112.454 -177.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -72.21 -25.32 61.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.252 0.549 . . . . 0.0 109.797 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 39.4 mm -105.91 90.84 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 175.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 9.4 t -92.94 -23.63 18.67 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.219 0.533 . . . . 0.0 109.961 -176.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 7.1 p -141.14 157.2 67.3 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.141 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 253' ' ' PRO . . . . . 0.578 ' HG2' HD21 ' A' ' 35' ' ' LEU . 68.5 Cg_exo -53.22 -30.78 52.7 Favored 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 123.017 2.478 . . . . 0.0 113.08 178.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 254' ' ' SER . . . . . 0.592 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 6.9 p -59.44 -41.22 89.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.833 -0.167 . . . . 0.0 110.902 176.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -58.36 -44.19 88.7 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.427 0.632 . . . . 0.0 109.764 176.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 49.2 tp -61.48 -44.57 96.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.272 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 257' ' ' ARG . . . . . 0.658 HH22 HD21 ' A' ' 20' ' ' LEU . 3.1 ttp180 -61.71 -46.67 88.69 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.549 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 258' ' ' GLU . . . . . 0.592 ' HG2' ' O ' ' B' ' 254' ' ' SER . 9.9 mm-40 -58.12 -47.08 84.38 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.959 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -66.39 -47.86 71.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.13 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 53.2 mt -62.86 -47.63 82.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.841 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 35.0 p -63.98 -39.07 93.29 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.84 0.352 . . . . 0.0 110.707 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -62.09 -48.46 80.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.433 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 263' ' ' LEU . . . . . 0.591 ' O ' ' HG2' ' B' ' 267' ' ' LYS . 96.2 mt -65.44 -37.35 86.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.055 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -69.07 -49.45 57.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.286 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -63.51 -33.29 75.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.878 0.37 . . . . 0.0 110.815 -178.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -66.79 -29.31 69.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.737 178.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 267' ' ' LYS . . . . . 0.591 ' HG2' ' O ' ' B' ' 263' ' ' LEU . 48.3 mmtm -82.07 -25.06 34.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.137 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 113.41 -5.68 24.85 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.866 -178.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 269' ' ' GLY . . . . . 0.503 ' HA2' ' OD1' ' B' ' 292' ' ' ASN . . . -77.41 145.69 30.79 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.183 -0.532 . . . . 0.0 111.812 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 270' ' ' LYS . . . . . 0.606 ' HA ' ' HE2' ' B' ' 270' ' ' LYS . 9.7 mmpt? -107.5 -23.64 12.09 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.854 0.359 . . . . 0.0 110.893 -177.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 271' ' ' TYR . . . . . 0.84 ' HE1' ' HG2' ' B' ' 223' ' ' GLU . 99.4 m-85 -133.46 157.06 46.54 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.348 -178.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 272' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -151.07 167.46 27.61 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.688 174.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 273' ' ' HIS . . . . . 0.611 ' ND1' ' HA ' ' B' ' 226' ' ' SER . 50.6 t60 -143.15 117.27 9.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.863 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 274' ' ' ILE . . . . . 0.451 ' HA ' ' HA ' ' B' ' 288' ' ' ALA . 61.8 mt -67.4 137.1 25.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.191 178.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 25.8 pt -110.91 -26.74 3.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.129 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -158.55 140.44 13.78 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.842 0.354 . . . . 0.0 111.016 -178.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -140.25 129.35 23.58 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 278' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' B' ' 278' ' ' ARG . 1.4 ptm180 -137.53 150.81 47.8 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.394 0.616 . . . . 0.0 111.195 -175.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -101.72 123.76 46.24 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.479 -175.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 280' ' ' HIS . . . . . 0.462 ' HB2' ' O ' ' B' ' 283' ' ' ASN . 10.1 m170 -125.33 154.72 41.36 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 163.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . -65.92 -57.59 10.59 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.715 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 282' ' ' PRO . . . . . 0.578 ' O ' ' HA ' ' B' ' 246' ' ' SER . 60.4 Cg_endo -72.07 -29.73 14.38 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.136 1.891 . . . . 0.0 112.958 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 283' ' ' ASN . . . . . 0.462 ' O ' ' HB2' ' B' ' 280' ' ' HIS . 6.9 m-20 -132.49 129.38 39.1 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 122.326 -0.234 . . . . 0.0 111.126 -175.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -91.17 120.46 32.12 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 171.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 285' ' ' GLU . . . . . 0.518 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 46.6 mt-10 -118.61 130.82 56.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.288 0.566 . . . . 0.0 112.411 -170.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 286' ' ' ALA . . . . . 0.425 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -149.27 143.7 26.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.128 176.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 41.0 t -123.38 124.91 70.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.397 -178.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 288' ' ' ALA . . . . . 0.493 ' HB3' HG13 ' B' ' 241' ' ' ILE . . . -132.24 141.48 49.05 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.941 0.401 . . . . 0.0 111.153 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -92.01 132.52 36.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.64 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 290' ' ' VAL . . . . . 0.431 ' HB ' HG23 ' B' ' 238' ' ' VAL . 6.0 t -97.99 131.89 44.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 120.832 0.349 . . . . 0.0 110.455 -176.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -127.99 143.91 51.09 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.32 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 292' ' ' ASN . . . . . 0.503 ' OD1' ' HA2' ' B' ' 269' ' ' GLY . 1.5 m120 -112.14 179.71 3.92 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.559 0.695 . . . . 0.0 112.157 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.21 133.55 44.5 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.014 -1.448 . . . . 0.0 110.032 177.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 294' ' ' ALA . . . . . 0.49 ' O ' ' HB ' ' B' ' 295' ' ' THR . . . -73.19 70.17 1.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.052 0.453 . . . . 0.0 110.323 178.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 295' ' ' THR . . . . . 0.49 ' HB ' ' O ' ' B' ' 294' ' ' ALA . 9.3 t 166.47 -21.01 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.173 -175.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 296' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' B' ' 295' ' ' THR . 98.5 mttt 71.15 -173.49 0.17 Allowed 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.128 0.571 . . . . 0.0 110.413 -176.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 297' ' ' LEU . . . . . . . . . . . . . 96.1 mt 63.18 -171.46 0.17 Allowed 'General case' 0 N--CA 1.464 0.261 0 O-C-N 123.486 0.491 . . . . 0.0 109.989 -173.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 298' ' ' GLU . . . . . 0.477 ' HB3' ' CG ' ' B' ' 302' ' ' HIS . 11.4 mm-40 51.28 32.25 8.01 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 176.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 299' ' ' HIS . . . . . . . . . . . . . 22.8 m170 -63.76 -29.49 70.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.21 0.528 . . . . 0.0 110.282 177.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 300' ' ' HIS . . . . . . . . . . . . . 11.2 p80 -135.0 157.27 47.37 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.473 -0.785 . . . . 0.0 108.968 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 301' ' ' HIS . . . . . . . . . . . . . 31.5 t60 65.1 22.94 12.37 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.279 0.562 . . . . 0.0 110.286 175.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 302' ' ' HIS . . . . . 0.477 ' CG ' ' HB3' ' B' ' 298' ' ' GLU . 9.5 t-160 -82.8 82.37 8.14 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.902 -177.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 303' ' ' HIS . . . . . 0.429 ' O ' ' HB2' ' B' ' 304' ' ' HIS . 52.9 t60 -99.63 80.17 2.34 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.968 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 304' ' ' HIS . . . . . 0.429 ' HB2' ' O ' ' B' ' 303' ' ' HIS . 4.9 t-80 . . . . . 0 N--CA 1.462 0.16 0 O-C-N 123.798 0.687 . . . . 0.0 109.776 176.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.3 mtm . . . . . 0 N--CA 1.48 1.039 0 CA-C-O 120.717 0.294 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -78.79 -33.34 46.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.898 0.38 . . . . 0.0 111.144 -176.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -91.23 103.97 16.57 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.37 0.605 . . . . 0.0 111.658 -171.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -108.8 133.86 52.29 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 165.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.8 pt -73.16 148.55 8.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.718 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.933 HD13 ' H ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -73.34 69.2 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.655 0.741 . . . . 0.0 111.574 -176.943 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.35 91.72 7.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.736 175.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.98 3.4 8.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.751 -176.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.12 106.64 2.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.893 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.7 tt -145.08 112.17 6.0 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.494 ' O ' HD12 ' A' ' 11' ' ' LEU . 1.5 pp -143.44 142.7 31.3 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.653 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.17 86.59 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 O-C-N 124.103 0.877 . . . . 0.0 112.538 176.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 63.0 m -88.03 86.6 7.14 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.124 0.487 . . . . 0.0 110.766 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.3 t -95.26 72.14 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.79 177.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -177.94 105.79 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.302 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.3 m -81.15 100.21 8.95 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.168 0.509 . . . . 0.0 110.917 -178.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -132.08 130.56 41.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.517 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.4 m 57.07 67.19 1.02 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.401 0.619 . . . . 0.0 110.192 -174.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.5 p -85.23 69.62 10.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.736 -175.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 1.8 pt? -158.98 88.58 0.9 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.543 174.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -173.2 55.46 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.289 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -175.91 66.58 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.733 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.518 ' HG2' ' HB1' ' B' ' 221' ' ' ALA . 12.4 mp0 -133.94 104.11 6.12 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.176 -170.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.659 ' HA ' ' HB3' ' A' ' 71' ' ' TYR . 0.0 OUTLIER 175.13 167.64 0.3 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.816 0.341 . . . . 0.0 111.27 176.217 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.411 ' H ' ' CD ' ' A' ' 24' ' ' GLN . 28.3 m -127.51 139.77 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.068 0.547 . . . . 0.0 110.174 175.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.423 ' HA ' ' CE1' ' A' ' 73' ' ' HIS . 79.9 p -89.46 -93.65 0.11 Allowed 'General case' 0 C--N 1.322 -0.611 0 O-C-N 121.768 -0.582 . . . . 0.0 112.29 -174.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -131.68 -46.75 0.96 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.757 0.313 . . . . 0.0 111.044 -175.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -64.85 -47.39 78.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.516 -177.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.42 ' H ' ' CD ' ' A' ' 29' ' ' GLU . 1.7 mp0 -55.12 -47.81 74.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.608 -176.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.484 HG12 HD12 ' A' ' 35' ' ' LEU . 59.8 mt -58.02 -48.55 83.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.08 0.467 . . . . 0.0 111.147 -178.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.9 m -72.8 -33.83 66.51 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.344 -177.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -81.97 -34.88 29.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.956 -173.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.776 ' HB3' ' HG3' ' B' ' 253' ' ' PRO . 71.1 m-85 -101.77 -8.14 21.96 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.708 -176.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.578 ' HE3' ' HA ' ' B' ' 205' ' ' ILE . 13.3 mmmm 60.71 70.44 0.62 Allowed 'General case' 0 N--CA 1.466 0.343 0 O-C-N 123.559 0.537 . . . . 0.0 110.367 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.489 HD21 ' HB3' ' B' ' 253' ' ' PRO . 87.5 mt -82.12 163.16 22.18 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.799 -175.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 51.8 t -91.74 108.69 20.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.818 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -81.64 105.19 12.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.761 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.453 HG23 ' HB ' ' A' ' 90' ' ' VAL . 4.8 m -86.72 -20.4 7.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -172.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.59 -151.0 22.58 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 119.622 -1.275 . . . . 0.0 113.181 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.401 HG23 ' HG2' ' A' ' 89' ' ' GLU . 4.7 m -137.5 145.84 43.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.656 0.265 . . . . 0.0 110.73 -174.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.2 pt -127.83 144.95 35.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 174.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -125.95 138.62 53.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.084 0.469 . . . . 0.0 111.797 -175.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.632 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 90.4 t -97.57 110.26 25.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.198 171.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.4 p -138.46 74.99 1.5 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.361 0.601 . . . . 0.0 109.65 175.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.0 mp0 -134.65 166.54 22.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.307 -177.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.1 t -73.78 164.65 26.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.75 -177.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.06 5.24 6.7 Favored Glycine 0 CA--C 1.519 0.324 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.729 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.49 -5.27 55.75 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.927 174.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -108.35 -15.75 14.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.819 0.342 . . . . 0.0 110.81 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.578 HD12 ' HA ' ' A' ' 56' ' ' LEU . 45.1 mm -125.43 107.72 18.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.1 m -101.58 -42.01 6.38 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.015 -174.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.51 ' H ' ' HB3' ' A' ' 55' ' ' ASP . 80.5 p -138.94 169.46 12.45 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.288 -175.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.85 ' HG2' HD21 ' B' ' 235' ' ' LEU . 42.1 Cg_exo -58.54 -36.02 97.91 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.354 2.036 . . . . 0.0 111.639 174.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.573 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -64.76 -44.59 89.59 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.6 175.212 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.534 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 38.9 t0 -66.88 -30.66 70.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.312 0.577 . . . . 0.0 110.179 179.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.578 ' HA ' HD12 ' A' ' 50' ' ' ILE . 63.9 tp -63.5 -51.16 66.74 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.933 176.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.573 ' HG3' ' O ' ' A' ' 54' ' ' SER . 6.2 ppt_? -68.45 -25.71 65.14 Favored 'General case' 0 C--O 1.225 -0.202 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.452 -178.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.534 ' HB2' ' O ' ' A' ' 55' ' ' ASP . 6.0 mm-40 -51.77 -51.5 55.86 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.295 0.569 . . . . 0.0 110.698 174.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.499 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 12.4 mptt -65.03 -45.11 86.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.204 -176.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.457 HD21 HG23 ' A' ' 43' ' ' VAL . 86.7 mt -71.45 -36.03 71.1 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.517 -177.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.522 ' HA ' ' HB3' ' B' ' 222' ' ' ALA . 6.9 t -62.94 -44.16 96.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.254 0.55 . . . . 0.0 109.523 176.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -63.39 -40.7 97.93 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.699 177.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 59' ' ' LYS . 84.7 mt -66.68 -44.68 81.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.079 178.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.7 -47.48 85.49 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.856 0.36 . . . . 0.0 110.673 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.553 ' HB2' ' HB3' ' B' ' 220' ' ' LEU . 10.0 t70 -58.24 -40.57 82.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.277 178.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.03 -25.29 58.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.817 -177.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -83.77 -47.55 11.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.935 0.398 . . . . 0.0 111.238 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.44 ' C ' HD21 ' A' ' 97' ' ' LEU . . . 125.6 34.93 0.63 Allowed Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.498 -175.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.454 ' HA2' ' OD1' ' A' ' 92' ' ' ASN . . . -134.13 161.34 24.37 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.593 ' HE2' ' HB2' ' A' ' 99' ' ' HIS . 24.8 mtpp -108.3 -71.74 0.75 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.866 0.333 . . . . 0.0 111.409 -178.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.659 ' HB3' ' HA ' ' A' ' 24' ' ' GLN . 2.3 m-85 -93.22 157.23 16.37 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 -173.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.543 ' CD2' ' HB1' ' B' ' 222' ' ' ALA . 45.6 p90 -146.45 133.68 20.55 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.293 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.423 ' CE1' ' HA ' ' A' ' 26' ' ' SER . 18.7 t60 -102.62 119.11 38.27 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.159 -178.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.514 ' H ' HD12 ' A' ' 74' ' ' ILE . 4.9 mp -77.04 124.53 35.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 30.3 pt -105.99 -21.71 5.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.925 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -152.61 135.92 15.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.696 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -149.03 111.4 4.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.163 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -149.86 173.63 13.56 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.918 0.389 . . . . 0.0 111.073 -176.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.84 148.76 26.3 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.242 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -100.92 -20.47 15.44 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.508 0.671 . . . . 0.0 109.212 175.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 143.06 -99.4 0.22 Allowed Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -176.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -74.28 -18.78 20.39 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.772 2.315 . . . . 0.0 111.232 171.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -116.47 159.64 21.75 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.623 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -115.74 138.31 51.24 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.632 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 42.1 mt-10 -123.98 117.4 24.66 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.209 0.528 . . . . 0.0 111.24 -176.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.546 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -129.03 139.46 52.05 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.629 178.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.7 t -118.77 119.44 61.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.128 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.42 ' HB1' ' HD1' ' A' ' 72' ' ' TYR . . . -135.78 138.82 43.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.782 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.401 ' HG2' HG23 ' A' ' 40' ' ' THR . 3.2 mt-10 -104.0 139.53 39.0 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.453 ' HB ' HG23 ' A' ' 38' ' ' VAL . 8.5 t -97.5 134.83 34.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.144 -170.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -130.4 139.08 50.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.28 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.454 ' OD1' ' HA2' ' A' ' 69' ' ' GLY . 78.9 m-20 -101.37 -178.99 3.9 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.161 173.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -70.64 -156.05 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.721 174.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -83.33 16.85 2.31 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.408 0.623 . . . . 0.0 109.908 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.2 t -154.31 -162.05 1.34 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.126 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -78.9 -157.57 0.12 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.638 0.256 . . . . 0.0 110.834 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.44 HD21 ' C ' ' A' ' 68' ' ' GLY . 54.5 mt -72.98 40.83 0.09 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 122.964 0.506 . . . . 0.0 111.887 -177.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -90.07 -61.18 1.74 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.148 -175.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.593 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . 21.7 t-80 63.06 -82.86 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 O-C-N 123.602 0.564 . . . . 0.0 109.709 -170.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 28.17 87.64 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.557 1.143 . . . . 0.0 113.33 175.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -77.61 123.11 26.2 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.132 0.491 . . . . 0.0 110.848 -176.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -75.27 142.44 43.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.358 174.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -86.42 137.05 32.87 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.94 0.4 . . . . 0.0 110.761 -178.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.5 t60 . . . . . 0 C--N 1.324 -0.529 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.687 -178.525 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 201' ' ' MET . . . . . 0.451 ' O ' ' HB2' ' B' ' 202' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.93 0 CA-C-O 121.125 0.488 . . . . 0.0 110.509 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 202' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' B' ' 201' ' ' MET . 5.3 mptp? 71.66 160.74 0.23 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.103 -178.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? 66.7 112.85 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.471 -176.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -97.88 142.1 30.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.432 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 205' ' ' ILE . . . . . 0.578 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 12.1 tt -101.95 123.61 55.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.016 0.436 . . . . 0.0 110.29 178.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 7.8 tt -131.45 125.83 57.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.592 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 207' ' ' ALA . . . . . 0.729 ' HB1' HD21 ' B' ' 210' ' ' LEU . . . -81.6 87.64 6.25 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.529 178.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -95.2 131.17 41.53 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.008 -178.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . 61.09 73.57 0.48 Allowed 'General case' 0 C--O 1.234 0.246 0 O-C-N 123.937 0.773 . . . . 0.0 112.033 177.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 210' ' ' LEU . . . . . 0.729 HD21 ' HB1' ' B' ' 207' ' ' ALA . 88.1 mt -85.26 83.68 7.91 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.014 176.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 48.5 tp -110.91 110.77 21.49 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.056 -177.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -158.22 104.04 1.84 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.902 178.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 213' ' ' THR . . . . . 0.456 ' O ' ' HB ' ' B' ' 214' ' ' VAL . 2.3 m -62.81 -74.05 0.1 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.819 -178.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 214' ' ' VAL . . . . . 0.456 ' HB ' ' O ' ' B' ' 213' ' ' THR . 13.8 p 173.92 -34.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.287 0 O-C-N 123.424 0.453 . . . . 0.0 110.27 178.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . 66.19 178.89 0.21 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.611 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 23.2 m -117.96 -37.01 3.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.973 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -102.8 99.8 9.76 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 173.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 218' ' ' SER . . . . . . . . . . . . . 21.6 m -129.37 167.53 17.62 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.354 -174.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 58.9 p -131.45 117.31 18.66 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.984 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.553 ' HB3' ' HB2' ' A' ' 65' ' ' ASP . 0.2 OUTLIER -64.11 -85.89 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.093 177.541 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 221' ' ' ALA . . . . . 0.536 ' H ' ' CD1' ' B' ' 220' ' ' LEU . . . 64.2 65.7 0.66 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.611 0.72 . . . . 0.0 109.818 -174.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 222' ' ' ALA . . . . . 0.543 ' HB1' ' CD2' ' A' ' 72' ' ' TYR . . . -128.19 61.03 1.46 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.456 -1.247 . . . . 0.0 108.813 -175.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 223' ' ' GLU . . . . . 0.515 ' HG3' ' HD3' ' A' ' 57' ' ' ARG . 4.4 mp0 -124.37 96.55 4.95 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.389 -166.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 224' ' ' GLN . . . . . 0.653 ' HB3' ' HG3' ' A' ' 24' ' ' GLN . 18.4 tm0? -173.02 148.65 1.76 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.246 -178.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 225' ' ' VAL . . . . . 0.502 HG21 ' CD1' ' B' ' 235' ' ' LEU . 16.6 m -128.7 137.34 57.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.046 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 226' ' ' SER . . . . . 0.538 ' HA ' ' CD2' ' B' ' 273' ' ' HIS . 8.7 t -96.24 176.78 5.94 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 120.976 0.417 . . . . 0.0 110.301 -178.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -65.31 -28.93 69.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.437 -173.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.18 -50.32 68.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.043 0.449 . . . . 0.0 110.283 -178.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -65.44 -42.72 92.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.459 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.535 HG12 HD12 ' B' ' 235' ' ' LEU . 88.5 mt -63.34 -34.36 66.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.965 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 31.4 t -69.57 -21.24 63.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.0 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 29.2 t-80 -98.17 -45.73 6.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.836 0.351 . . . . 0.0 110.921 -177.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -86.2 -20.95 27.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.835 -176.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm 59.57 80.76 0.19 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.351 0.596 . . . . 0.0 111.612 -177.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 235' ' ' LEU . . . . . 0.85 HD21 ' HG2' ' A' ' 53' ' ' PRO . 40.9 mt -83.24 -168.92 2.28 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.754 178.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 59.0 t -109.82 109.21 27.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.088 0.471 . . . . 0.0 111.089 -178.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 237' ' ' LYS . . . . . 0.567 ' HE3' ' HB3' ' B' ' 289' ' ' GLU . 23.1 tptm -73.97 112.67 10.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.789 175.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 3.8 m -100.05 -4.41 9.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -175.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 136.07 -171.82 22.62 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 119.979 -1.105 . . . . 0.0 112.999 176.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 240' ' ' THR . . . . . 0.559 HG23 ' HG2' ' B' ' 289' ' ' GLU . 29.8 m -128.63 134.26 48.51 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -178.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 32.8 pt -107.86 137.62 38.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.945 0.402 . . . . 0.0 110.386 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -111.58 115.12 28.63 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.839 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 243' ' ' VAL . . . . . 0.526 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 34.9 t -94.05 109.35 21.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.108 -178.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 23.1 t -110.06 98.36 7.65 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 245' ' ' GLN . . . . . 0.637 ' O ' ' HA ' ' B' ' 283' ' ' ASN . 0.5 OUTLIER -87.89 148.39 24.64 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.946 -177.892 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 51.1 m -126.32 107.04 9.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.209 0.528 . . . . 0.0 111.056 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 101.05 -141.38 15.32 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.322 177.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -107.85 42.29 1.98 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.329 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -63.51 -46.44 86.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.752 0.311 . . . . 0.0 110.365 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 250' ' ' ILE . . . . . 0.588 HG12 ' HG2' ' B' ' 245' ' ' GLN . 47.2 mm -77.56 99.89 2.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.392 0.615 . . . . 0.0 109.585 177.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 5.7 m -100.68 -26.01 13.95 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.691 -174.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 1.9 m -136.52 162.36 56.65 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -177.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 253' ' ' PRO . . . . . 0.776 ' HG3' ' HB3' ' A' ' 33' ' ' PHE . 48.0 Cg_exo -56.06 -36.38 96.08 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.241 1.961 . . . . 0.0 111.537 175.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 254' ' ' SER . . . . . 0.418 ' HB3' ' CD2' ' A' ' 99' ' ' HIS . 4.3 m -69.25 -24.26 63.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.653 -178.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.17 -34.93 74.27 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.013 0.435 . . . . 0.0 111.523 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.471 ' O ' ' HG ' ' B' ' 260' ' ' LEU . 22.3 tp -65.11 -38.52 90.96 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.749 -177.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 257' ' ' ARG . . . . . 0.438 HH21 ' CD ' ' B' ' 258' ' ' GLU . 2.9 ttp85 -63.83 -35.82 81.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.996 0.427 . . . . 0.0 110.424 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 258' ' ' GLU . . . . . 0.438 ' CD ' HH21 ' B' ' 257' ' ' ARG . 17.0 mm-40 -62.27 -43.06 99.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.249 -178.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -71.79 -34.74 69.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.041 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 260' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' B' ' 256' ' ' LEU . 95.2 mt -69.18 -46.2 68.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.003 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 24.2 p -65.47 -34.75 79.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.802 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -54.18 -51.11 65.39 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.247 0.546 . . . . 0.0 110.439 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 263' ' ' LEU . . . . . 0.483 ' O ' ' HG2' ' B' ' 267' ' ' LYS . 98.2 mt -71.79 -41.69 68.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.172 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -63.84 -32.12 73.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.822 0.344 . . . . 0.0 111.486 -178.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -71.9 -44.27 64.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.814 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -67.0 -30.82 71.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.265 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 267' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' B' ' 263' ' ' LEU . 74.3 mmtt -79.52 -55.82 4.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.002 0.43 . . . . 0.0 110.095 176.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 114.64 48.08 0.56 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.252 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -97.95 -169.63 32.3 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.478 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 270' ' ' LYS . . . . . 0.47 ' HB2' ' HA ' ' B' ' 292' ' ' ASN . 4.4 tptp -131.53 -29.9 1.72 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.709 0.29 . . . . 0.0 110.882 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 271' ' ' TYR . . . . . 0.437 ' HB3' ' HA ' ' B' ' 224' ' ' GLN . 6.4 m-85 -147.95 173.53 12.78 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 177.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 272' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.65 167.18 22.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.766 0.317 . . . . 0.0 110.796 174.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 273' ' ' HIS . . . . . 0.538 ' CD2' ' HA ' ' B' ' 226' ' ' SER . 19.5 t-80 -148.04 103.5 3.48 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.184 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 274' ' ' ILE . . . . . 0.519 HG13 ' HB2' ' B' ' 288' ' ' ALA . 4.2 mp -70.25 135.23 28.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 31.2 pt -113.99 -28.87 2.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.699 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -157.7 146.97 19.8 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.645 0.259 . . . . 0.0 110.956 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -156.37 139.26 15.29 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 278' ' ' ARG . . . . . 0.435 ' HD2' ' N ' ' B' ' 278' ' ' ARG . 0.0 OUTLIER -155.92 136.39 13.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.969 0.414 . . . . 0.0 111.214 -179.157 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -88.72 102.64 15.18 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 171.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -114.84 103.72 11.23 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 73.6 -134.49 19.24 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.667 -176.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -82.95 -9.16 10.86 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.589 2.193 . . . . 0.0 111.877 176.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 283' ' ' ASN . . . . . 0.637 ' HA ' ' O ' ' B' ' 245' ' ' GLN . 93.4 m-20 -101.37 113.48 26.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.463 -175.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -87.4 107.47 18.55 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 170.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 285' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -100.8 113.67 26.78 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.06 -175.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 286' ' ' ALA . . . . . 0.526 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -117.94 124.24 47.76 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.49 178.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 24.5 t -106.27 112.81 41.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.159 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 288' ' ' ALA . . . . . 0.519 ' HB2' HG13 ' B' ' 274' ' ' ILE . . . -125.63 132.54 52.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.274 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 289' ' ' GLU . . . . . 0.567 ' HB3' ' HE3' ' B' ' 237' ' ' LYS . 18.1 mt-10 -94.83 138.88 32.05 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 21.9 t -103.64 138.93 26.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.972 0.415 . . . . 0.0 110.408 -174.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -128.15 152.18 48.34 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.336 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 292' ' ' ASN . . . . . 0.47 ' HA ' ' HB2' ' B' ' 270' ' ' LYS . 12.2 t-20 -120.01 163.4 17.68 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 174.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -66.38 170.75 5.6 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -176.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 294' ' ' ALA . . . . . . . . . . . . . . . -73.33 9.12 1.4 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.994 0.426 . . . . 0.0 111.815 -174.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 295' ' ' THR . . . . . . . . . . . . . 13.8 t -125.91 -8.73 6.63 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.381 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt 57.22 -162.81 0.19 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.186 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 297' ' ' LEU . . . . . 0.443 HD22 ' CE1' ' B' ' 304' ' ' HIS . 36.8 mt 67.95 -161.97 0.21 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.021 170.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 298' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 54.49 69.46 0.72 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.36 -176.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 299' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 179.75 -53.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.84 175.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 300' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -92.55 102.64 15.08 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 174.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 301' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -70.56 143.35 51.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.227 -177.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 302' ' ' HIS . . . . . . . . . . . . . 9.4 t-80 73.58 170.14 0.31 Allowed 'General case' 0 N--CA 1.468 0.437 0 O-C-N 124.173 0.921 . . . . 0.0 111.508 176.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 71.62 35.25 1.47 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.803 0.841 . . . . 0.0 110.001 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 304' ' ' HIS . . . . . 0.443 ' CE1' HD22 ' B' ' 297' ' ' LEU . 55.2 m-70 . . . . . 0 C--N 1.326 -0.428 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.656 175.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtt . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.814 0.34 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -97.86 6.05 48.28 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -174.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -75.5 112.13 11.51 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 177.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -118.57 101.87 8.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.074 0.464 . . . . 0.0 110.225 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.1 tt -171.21 120.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.315 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.3 pt -125.92 37.36 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.221 0.534 . . . . 0.0 111.243 -177.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.59 90.37 8.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.633 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -139.01 91.46 2.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.52 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -149.83 152.27 34.87 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.585 -178.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 54.2 tp -162.25 129.34 3.77 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.366 177.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 41.3 tp -105.95 97.64 7.43 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 175.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.01 137.65 34.82 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.982 -176.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.6 m 67.48 77.94 0.25 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.695 0.76 . . . . 0.0 110.909 178.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.6 t -107.4 -47.91 8.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.324 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -108.75 100.8 9.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.571 175.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.4 m -83.11 56.99 3.71 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.817 -174.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.5 t80 66.1 -73.43 0.07 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.861 176.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.8 t -146.32 116.57 7.43 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.6 t -136.55 132.81 35.7 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.216 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.1 mt -99.83 142.86 30.74 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.882 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -154.32 66.76 0.71 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.209 -0.905 . . . . 0.0 108.817 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -161.72 84.9 0.62 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.033 -170.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.437 ' HA ' ' OH ' ' B' ' 272' ' ' TYR . 0.5 OUTLIER -161.23 121.98 2.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.051 0.453 . . . . 0.0 111.84 -178.812 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 1.05 ' HG3' ' HG3' ' B' ' 224' ' ' GLN . 6.4 tm0? -150.35 144.34 25.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.777 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.2 m -126.78 152.27 34.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 172.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.627 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 6.9 m -108.38 -79.77 0.58 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.074 0.464 . . . . 0.0 110.746 -178.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -165.68 -48.25 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -176.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.422 ' HG3' ' CD ' ' A' ' 29' ' ' GLU . 5.2 pt20 -56.95 -36.44 70.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.058 176.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.422 ' CD ' ' HG3' ' A' ' 28' ' ' GLN . 25.6 mp0 -72.73 -40.1 66.37 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.563 HG23 ' HB2' ' A' ' 35' ' ' LEU . 87.8 mt -61.72 -48.58 88.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.247 -178.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.4 m -68.44 -21.37 64.65 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.259 -177.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -92.97 -43.57 8.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.529 -176.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.545 ' HB3' ' HD3' ' B' ' 253' ' ' PRO . 82.9 m-85 -98.61 -2.91 37.38 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -175.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.7 mptt 65.06 90.1 0.09 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.394 0.616 . . . . 0.0 111.894 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.563 ' HB2' HG23 ' A' ' 30' ' ' ILE . 97.2 mt -121.54 147.86 45.24 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.804 176.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.3 t -103.38 125.09 57.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.912 0.387 . . . . 0.0 111.399 -174.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -69.67 111.57 5.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.092 173.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.1 m -94.8 -8.29 9.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.874 -177.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.34 -160.2 29.36 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.179 -1.01 . . . . 0.0 112.785 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 64.6 m -145.15 135.94 24.56 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 122.596 0.358 . . . . 0.0 110.247 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.7 pt -104.68 143.28 16.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 176.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -122.88 123.51 41.15 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.013 0.435 . . . . 0.0 111.346 -175.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.687 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 67.4 t -97.26 130.72 45.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.294 174.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.9 t -157.68 40.97 0.29 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.5 ' NE2' HG13 ' A' ' 43' ' ' VAL . 0.9 OUTLIER -81.57 158.32 24.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.646 -172.119 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.8 t -99.7 87.12 3.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.932 -172.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.61 -84.19 0.55 Allowed Glycine 0 C--O 1.224 -0.524 0 N-CA-C 114.582 0.593 . . . . 0.0 114.582 170.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -49.94 -42.35 38.43 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 114.923 0.729 . . . . 0.0 114.923 -168.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.438 ' OE1' ' HG2' ' A' ' 45' ' ' GLN . 63.8 mt-30 -71.03 -18.03 62.6 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -174.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.7 mm -129.43 123.93 58.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.62 0.248 . . . . 0.0 110.79 -175.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.7 t -140.25 -51.47 0.49 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.017 0.437 . . . . 0.0 110.814 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.547 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 46.4 m -128.41 172.63 6.64 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 178.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.794 ' HD3' ' HB3' ' B' ' 233' ' ' PHE . 59.3 Cg_exo -51.7 -34.96 55.98 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.49 2.126 . . . . 0.0 111.97 178.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.55 ' O ' ' HG3' ' A' ' 58' ' ' GLU . 16.7 p -58.34 -56.72 18.42 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.072 179.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -58.7 -37.67 76.6 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.876 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 61.9 tp -64.12 -52.55 58.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.121 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.427 ' HG3' ' O ' ' A' ' 53' ' ' PRO . 7.4 ppt_? -69.85 -25.91 63.96 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.501 -177.074 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.55 ' HG3' ' O ' ' A' ' 54' ' ' SER . 38.8 mt-10 -62.61 -40.84 98.21 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 120.835 0.35 . . . . 0.0 110.24 173.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -74.31 -38.52 63.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.611 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.6 mt -64.5 -48.88 73.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.707 -177.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.487 ' HB2' ' HG2' ' B' ' 223' ' ' GLU . 17.0 t -65.92 -35.55 80.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.858 0.361 . . . . 0.0 110.483 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -60.74 -42.12 96.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.15 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 93.4 mt -75.02 -32.71 61.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.293 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.57 -41.7 68.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.281 -178.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.596 ' OD2' ' HB2' ' B' ' 218' ' ' SER . 9.2 t0 -58.93 -41.72 88.02 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 176.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.523 ' HA ' ' OG ' ' B' ' 216' ' ' SER . . . -71.75 -4.99 30.8 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.855 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -104.71 -9.36 18.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.191 0.52 . . . . 0.0 110.178 174.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.54 26.12 72.49 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.312 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.491 ' O ' ' HB1' ' B' ' 221' ' ' ALA . . . -112.53 146.65 18.26 Favored Glycine 0 C--O 1.225 -0.447 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.764 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -97.19 -14.17 21.61 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -172.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.16 144.12 32.07 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -176.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.519 ' CD2' ' HB1' ' B' ' 222' ' ' ALA . 15.5 p90 -129.91 157.51 42.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.82 0.343 . . . . 0.0 110.13 172.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.627 ' CD2' ' HA ' ' A' ' 26' ' ' SER . 8.1 t-160 -128.74 109.34 11.22 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.868 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.598 HG12 ' HB2' ' A' ' 88' ' ' ALA . 57.6 mt -75.95 116.68 19.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.314 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.4 pt -107.15 -15.54 8.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.803 -176.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -153.25 142.5 21.51 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.616 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 85' ' ' GLU . . . -162.77 139.35 7.52 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.9 152.12 22.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.753 0.311 . . . . 0.0 110.701 178.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -89.9 107.54 19.17 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 171.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -112.51 84.91 2.06 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.092 0.473 . . . . 0.0 110.301 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.18 -123.29 20.74 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.264 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -84.28 -3.57 10.2 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.845 2.363 . . . . 0.0 112.864 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 58.8 m-20 -119.26 128.9 54.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.748 0.309 . . . . 0.0 110.611 -176.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -93.14 123.46 36.42 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 173.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.687 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 43.1 mt-10 -108.5 129.07 55.29 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.879 0.371 . . . . 0.0 111.066 -176.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.519 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -138.28 132.58 31.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.231 177.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.3 t -114.21 112.87 41.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.012 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.598 ' HB2' HG12 ' A' ' 74' ' ' ILE . . . -128.04 129.09 46.12 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.724 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 40' ' ' THR . 26.5 mt-10 -91.88 139.15 30.95 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.6 t -100.39 136.76 30.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -176.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -124.19 150.88 44.7 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.291 0.567 . . . . 0.0 111.127 -177.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -130.33 158.64 39.25 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.464 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -69.49 169.12 13.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.766 0.317 . . . . 0.0 110.317 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -77.1 73.48 3.68 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.259 0.552 . . . . 0.0 110.674 178.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.9 t -170.05 -35.63 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.717 179.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm 67.59 -72.34 0.09 Allowed 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.622 0.576 . . . . 0.0 112.198 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 96.1 mt -137.36 -174.18 3.68 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.479 -176.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -91.62 -29.67 16.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.286 0.565 . . . . 0.0 109.482 175.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.455 ' O ' ' HB2' ' A' ' 100' ' ' HIS . 3.4 t60 -81.3 115.47 20.69 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.455 ' HB2' ' O ' ' A' ' 99' ' ' HIS . 33.7 m170 73.13 165.66 0.3 Allowed 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.916 0.76 . . . . 0.0 110.156 -168.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 62.8 t60 -157.84 126.42 5.58 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -122.59 125.72 46.25 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.451 -173.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -100.35 175.69 5.62 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 173.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 84.2 t60 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.73 -0.214 . . . . 0.0 110.469 177.985 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 47.9 ttm . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 120.541 0.21 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -77.61 98.94 5.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.769 0.318 . . . . 0.0 110.277 177.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 203' ' ' LYS . . . . . 0.443 ' HA ' ' HD3' ' B' ' 203' ' ' LYS . 27.4 mmtp -135.29 135.59 40.95 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.014 175.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -77.0 168.52 19.96 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.848 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 67.8 mt -77.33 105.85 6.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.033 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 50.7 mm -92.81 105.22 16.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.887 177.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -107.27 9.01 30.16 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.012 -176.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -81.32 80.61 7.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.165 0.507 . . . . 0.0 111.161 -178.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -140.1 141.78 36.13 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.132 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 210' ' ' LEU . . . . . . . . . . . . . 95.9 mt -121.29 140.08 52.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.782 0.325 . . . . 0.0 110.695 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 211' ' ' LEU . . . . . 0.844 ' H ' HD23 ' B' ' 211' ' ' LEU . 1.7 pt? -87.7 110.94 20.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.104 0.478 . . . . 0.0 110.108 177.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -153.44 115.79 4.39 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.885 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 213' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.14 95.91 4.88 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.458 178.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 214' ' ' VAL . . . . . . . . . . . . . 27.3 m -86.94 163.75 2.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.452 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.39 91.65 0.12 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.962 0.41 . . . . 0.0 110.77 178.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 216' ' ' SER . . . . . 0.523 ' OG ' ' HA ' ' A' ' 66' ' ' ALA . 13.9 m -95.2 159.52 14.97 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.363 -178.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -160.4 32.12 0.16 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -173.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 218' ' ' SER . . . . . 0.596 ' HB2' ' OD2' ' A' ' 65' ' ' ASP . 4.8 m -71.75 -77.87 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 119.329 -0.367 . . . . 0.0 110.666 -175.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 2.3 m 146.39 -58.33 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.118 1.367 . . . . 0.0 109.113 178.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -149.82 106.34 3.51 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 221' ' ' ALA . . . . . 0.491 ' HB1' ' O ' ' A' ' 69' ' ' GLY . . . -126.14 117.3 22.85 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.947 -175.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 222' ' ' ALA . . . . . 0.519 ' HB1' ' CD2' ' A' ' 72' ' ' TYR . . . 68.52 109.93 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 O-C-N 124.187 0.93 . . . . 0.0 112.814 174.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 223' ' ' GLU . . . . . 0.935 ' HB3' ' HE2' ' B' ' 271' ' ' TYR . 28.2 mt-10 -144.42 124.36 13.52 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.737 173.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 224' ' ' GLN . . . . . 1.05 ' HG3' ' HG3' ' A' ' 24' ' ' GLN . 0.9 OUTLIER -153.69 146.42 24.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.867 -172.813 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 225' ' ' VAL . . . . . 0.527 ' HB ' HD11 ' B' ' 235' ' ' LEU . 11.6 m -116.26 126.56 73.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 170.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 226' ' ' SER . . . . . 0.429 ' O ' HG13 ' B' ' 230' ' ' ILE . 6.7 t -95.99 -167.33 1.57 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.374 0.607 . . . . 0.0 111.523 -173.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 227' ' ' LYS . . . . . 0.465 ' HA ' HD12 ' B' ' 230' ' ' ILE . 2.2 tmtp? -75.67 -28.91 58.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.831 -172.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -72.86 -43.73 62.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.088 0.47 . . . . 0.0 110.539 -177.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -61.8 -26.94 68.41 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.459 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.504 HG12 HD12 ' B' ' 235' ' ' LEU . 69.9 mt -57.83 -57.23 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.096 0.474 . . . . 0.0 110.253 176.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 11.2 m -73.69 -50.61 20.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.05 -177.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -76.24 -38.59 56.11 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -170.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 233' ' ' PHE . . . . . 0.794 ' HB3' ' HD3' ' A' ' 53' ' ' PRO . 37.7 m-85 -102.71 -5.8 23.35 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -173.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt 67.01 92.01 0.08 Allowed 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.853 0.721 . . . . 0.0 110.996 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 235' ' ' LEU . . . . . 0.527 HD11 ' HB ' ' B' ' 225' ' ' VAL . 28.1 mt -97.23 141.06 30.8 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.023 178.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 21.7 t -66.64 -50.14 68.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.237 -178.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 237' ' ' LYS . . . . . 0.526 ' HA ' ' HA ' ' B' ' 291' ' ' TYR . 50.7 tttm 65.78 120.39 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.901 -175.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 38.1 t -91.14 -46.62 14.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.43 -177.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.73 -152.03 16.57 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.871 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 21.3 m -127.62 140.09 52.32 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 241' ' ' ILE . . . . . 0.434 HG23 HG21 ' B' ' 290' ' ' VAL . 19.2 pt -113.08 141.88 27.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.887 0.375 . . . . 0.0 110.683 176.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -120.21 126.54 50.88 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.835 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 243' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' B' ' 285' ' ' GLU . 88.1 t -94.02 132.25 38.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.061 175.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 11.0 p -152.93 64.3 0.78 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.442 0.639 . . . . 0.0 110.776 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 245' ' ' GLN . . . . . 0.402 HE22 HG13 ' B' ' 243' ' ' VAL . 0.9 OUTLIER -97.95 143.85 28.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.295 -179.698 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 6.2 t -86.62 36.84 0.72 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.357 0.598 . . . . 0.0 110.412 -174.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 88.0 167.94 43.89 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.227 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . 82.35 -49.35 4.13 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.821 176.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -71.26 -18.49 62.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.839 0.352 . . . . 0.0 111.201 -178.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 250' ' ' ILE . . . . . 0.481 ' HA ' ' HB3' ' B' ' 255' ' ' ASP . 40.8 mm -126.61 107.59 17.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 34.7 t -135.52 3.5 3.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.601 0.239 . . . . 0.0 111.129 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 252' ' ' SER . . . . . 0.525 ' HB2' ' HD2' ' B' ' 253' ' ' PRO . 95.7 p -158.38 167.21 14.89 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -178.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 253' ' ' PRO . . . . . 0.545 ' HD3' ' HB3' ' A' ' 33' ' ' PHE . 15.9 Cg_endo -59.14 -37.8 90.13 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.261 1.974 . . . . 0.0 111.019 173.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 254' ' ' SER . . . . . 0.573 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 15.3 m -60.75 -46.13 91.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.682 176.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.481 ' HB3' ' HA ' ' B' ' 250' ' ' ILE . 24.9 m-20 -55.12 -50.11 70.07 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.663 0.268 . . . . 0.0 110.786 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.483 ' O ' ' HG ' ' B' ' 260' ' ' LEU . 57.0 tp -60.01 -45.94 91.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.068 178.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -57.27 -48.24 79.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.962 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 258' ' ' GLU . . . . . 0.573 ' HG2' ' O ' ' B' ' 254' ' ' SER . 43.8 mm-40 -58.13 -39.49 78.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.475 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 259' ' ' LYS . . . . . 0.436 ' HD3' ' O ' ' B' ' 255' ' ' ASP . 13.5 mptt -77.28 -35.48 55.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.395 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 260' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' B' ' 256' ' ' LEU . 87.7 mt -64.97 -47.41 77.68 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.501 0.191 . . . . 0.0 110.965 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 6.1 m -61.85 -30.79 71.09 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.205 0.526 . . . . 0.0 110.274 177.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -70.07 -52.76 21.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.753 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 263' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' B' ' 259' ' ' LYS . 88.0 mt -64.08 -36.9 85.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.263 -176.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -66.24 -38.3 87.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.279 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -72.38 -36.7 68.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.439 -177.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -63.27 -30.2 71.39 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.806 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -72.2 -32.9 67.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.352 175.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 117.46 -3.59 17.98 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.234 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -99.44 -153.59 27.86 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.594 -177.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm -150.53 -60.17 0.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.771 0.32 . . . . 0.0 111.049 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 271' ' ' TYR . . . . . 0.935 ' HE2' ' HB3' ' B' ' 223' ' ' GLU . 62.1 m-85 -90.41 148.1 23.01 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -172.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 272' ' ' TYR . . . . . 0.437 ' OH ' ' HA ' ' A' ' 23' ' ' GLU . 10.0 p90 -147.08 167.59 23.69 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.906 0.384 . . . . 0.0 111.423 -174.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 273' ' ' HIS . . . . . 0.522 ' HA ' ' OE1' ' A' ' 24' ' ' GLN . 0.6 OUTLIER -139.47 113.35 8.65 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.878 177.529 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 274' ' ' ILE . . . . . 0.438 ' H ' HD12 ' B' ' 274' ' ' ILE . 4.4 mp -70.67 121.63 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 178.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 30.1 pt -102.43 -24.53 4.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.526 -178.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -153.85 140.73 19.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.863 -178.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -144.79 123.51 12.58 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.779 177.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 278' ' ' ARG . . . . . 0.411 ' HE ' ' CD ' ' B' ' 285' ' ' GLU . 6.1 ptt180 -129.2 134.5 48.03 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.084 0.468 . . . . 0.0 110.691 -178.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -99.21 89.89 4.39 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 173.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -92.77 85.42 5.21 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.058 -173.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 62.08 -116.1 8.89 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.725 176.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.49 -16.57 21.54 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.716 2.277 . . . . 0.0 112.808 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 -105.99 162.89 13.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.176 0.512 . . . . 0.0 110.952 -175.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -132.12 104.7 6.94 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 171.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 285' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 21.4 mp0 -107.13 134.08 50.78 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.063 0.459 . . . . 0.0 110.843 -176.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 286' ' ' ALA . . . . . 0.416 ' H ' ' HB ' ' B' ' 243' ' ' VAL . . . -137.19 147.08 45.63 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.585 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 32.8 t -123.25 122.53 65.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.947 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -131.84 143.62 50.31 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.937 0.399 . . . . 0.0 111.069 -178.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -91.56 123.94 35.35 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.824 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 290' ' ' VAL . . . . . 0.434 HG21 HG23 ' B' ' 241' ' ' ILE . 53.5 t -94.34 129.36 44.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.884 0.373 . . . . 0.0 110.851 -177.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 291' ' ' TYR . . . . . 0.526 ' HA ' ' HA ' ' B' ' 237' ' ' LYS . 64.0 m-85 -121.79 171.06 9.16 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.058 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 292' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -123.09 157.47 32.79 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 174.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -72.84 141.57 47.98 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 294' ' ' ALA . . . . . 0.459 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . . . -74.08 79.71 1.73 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.343 0.592 . . . . 0.0 111.081 -175.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 295' ' ' THR . . . . . . . . . . . . . 8.9 t -166.7 -34.86 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.142 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -81.91 89.22 6.35 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.051 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 297' ' ' LEU . . . . . . . . . . . . . 56.4 mt -149.5 160.23 43.64 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.779 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 298' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -72.51 -61.01 1.95 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.95 0.405 . . . . 0.0 110.05 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 299' ' ' HIS . . . . . . . . . . . . . 37.5 m-70 -92.79 118.46 31.12 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.833 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 300' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -80.52 112.82 18.22 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.331 0.586 . . . . 0.0 110.909 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 301' ' ' HIS . . . . . 0.41 ' O ' ' HB3' ' B' ' 302' ' ' HIS . 18.0 p80 -137.16 143.87 42.65 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 175.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 302' ' ' HIS . . . . . 0.41 ' HB3' ' O ' ' B' ' 301' ' ' HIS . 57.2 t-80 70.36 96.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 O-C-N 124.019 0.825 . . . . 0.0 110.502 -176.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 13.4 t60 75.91 91.27 0.07 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.35 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.337 178.498 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.413 ' HD2' ' HA ' ' A' ' 2' ' ' LYS . 33.2 tptt -89.49 147.66 23.87 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -179.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.07 69.17 3.32 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.05 0.452 . . . . 0.0 112.129 -176.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -100.54 -35.59 9.48 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.72 0.295 . . . . 0.0 111.21 179.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.401 ' H ' HG13 ' A' ' 5' ' ' ILE . 1.1 pp -83.4 117.28 28.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.459 0.647 . . . . 0.0 112.593 -171.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.2 pp -134.05 156.47 40.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.237 174.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -121.58 153.43 38.06 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.887 0.375 . . . . 0.0 111.011 -177.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.01 101.56 13.03 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.544 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.0 137.82 32.02 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.686 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.2 mp -91.76 147.24 23.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.993 0.425 . . . . 0.0 110.55 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -83.46 159.47 21.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.913 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -158.18 154.61 27.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.615 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 33.9 p -84.01 -83.53 0.15 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.964 0.165 . . . . 0.0 111.174 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.57 HG11 HG13 ' B' ' 238' ' ' VAL . 59.1 t 64.34 108.32 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 121.632 0.73 . . . . 0.0 112.029 178.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -118.91 97.27 5.62 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.167 175.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.684 ' HB3' ' HA3' ' B' ' 268' ' ' GLY . 23.0 t -112.62 -179.7 3.74 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.933 -178.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -62.06 124.59 21.22 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.96 0.41 . . . . 0.0 110.781 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' B' ' 265' ' ' ASP . 3.8 p -75.18 110.69 9.72 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.372 -178.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.8 t -158.96 87.43 0.86 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.965 175.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.759 ' HB3' ' HB2' ' B' ' 265' ' ' ASP . 3.8 pp -58.2 140.64 52.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.108 -178.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -156.14 78.85 0.97 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.104 176.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.771 ' HA ' ' HG3' ' B' ' 223' ' ' GLU . . . -163.35 -135.21 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.97 -171.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.559 ' HG3' ' HB2' ' B' ' 257' ' ' ARG . 17.0 tt0 80.9 104.97 0.07 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 124.37 1.043 . . . . 0.0 110.358 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.519 ' HA ' ' HB3' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -162.18 154.11 18.87 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.39 -174.333 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.433 HG22 ' HB2' ' A' ' 71' ' ' TYR . 27.1 m -106.79 139.27 28.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.854 0.359 . . . . 0.0 110.877 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.691 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 7.4 t -93.98 -86.11 0.28 Allowed 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.328 -175.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -157.97 -49.15 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.225 -176.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -58.56 -40.42 83.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.067 0.461 . . . . 0.0 110.53 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.406 ' H ' ' CD ' ' A' ' 29' ' ' GLU . 1.2 mp0 -64.87 -37.89 89.13 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.664 178.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.564 HG12 HD12 ' A' ' 35' ' ' LEU . 58.5 mt -66.72 -39.46 83.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.442 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.9 m -68.81 -35.03 76.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.086 0.47 . . . . 0.0 110.86 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -85.87 -45.17 11.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.416 -174.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -92.24 -19.38 22.26 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -175.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.439 ' HB2' ' NZ ' ' A' ' 34' ' ' LYS . 0.2 OUTLIER 65.83 85.18 0.14 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.127 0.489 . . . . 0.0 111.388 -177.614 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.564 HD12 HG12 ' A' ' 30' ' ' ILE . 67.7 mt -94.35 175.67 6.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.676 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.678 HG21 ' HE3' ' A' ' 96' ' ' LYS . 40.7 t -105.97 123.6 60.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.33 -175.37 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.8 tttp -81.4 112.35 18.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.191 176.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.42 HG23 ' HB ' ' A' ' 90' ' ' VAL . 21.2 m -107.48 22.4 3.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -173.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 120.9 -164.8 14.11 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.306 -0.949 . . . . 0.0 112.897 174.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.617 HG23 ' HG2' ' A' ' 89' ' ' GLU . 12.9 m -140.06 134.69 31.71 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 -176.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.7 pt -107.21 151.05 9.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 174.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -125.52 123.04 38.27 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.033 0.444 . . . . 0.0 111.628 -174.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.611 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 73.0 t -99.1 117.68 44.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.348 172.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 63.5 p -145.98 72.81 1.31 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.245 0.545 . . . . 0.0 109.718 176.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.429 HE22 HG13 ' A' ' 43' ' ' VAL . 0.7 OUTLIER -100.5 148.77 24.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.03 -176.706 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.4 m -86.4 56.64 4.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.594 -176.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.82 -71.05 2.79 Favored Glycine 0 C--O 1.227 -0.337 0 C-N-CA 121.261 -0.495 . . . . 0.0 114.129 173.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -54.01 -28.71 41.65 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 115.164 0.825 . . . . 0.0 115.164 -169.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -78.61 -14.57 59.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.59 0.695 . . . . 0.0 111.606 -177.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.0 mm -120.32 107.53 21.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.163 0.506 . . . . 0.0 110.185 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.2 m -114.52 -45.13 3.03 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.576 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 87.7 p -124.78 164.28 32.01 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.739 177.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.783 ' HB2' ' HB2' ' B' ' 293' ' ' ASP . 24.2 Cg_exo -64.34 -20.19 66.27 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.28 1.986 . . . . 0.0 111.644 174.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.506 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 75.2 m -69.06 -42.75 75.85 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.084 173.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -62.87 -39.11 93.41 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.217 0.532 . . . . 0.0 109.717 176.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 61.7 tp -60.36 -41.36 93.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.964 176.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.461 ' HD2' ' OE1' ' B' ' 223' ' ' GLU . 9.5 ttp85 -61.3 -43.86 98.18 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.552 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 54' ' ' SER . 22.9 mm-40 -53.49 -50.78 64.63 Favored 'General case' 0 C--N 1.332 -0.165 0 O-C-N 123.51 0.506 . . . . 0.0 110.616 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.503 ' HA ' ' HG2' ' A' ' 62' ' ' GLU . 4.3 mptp? -67.44 -41.62 84.45 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.573 -178.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 85.0 mt -63.34 -34.16 77.1 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.005 0.431 . . . . 0.0 110.482 177.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.6 t -70.6 -52.46 21.33 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.724 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.734 ' HA ' ' O ' ' B' ' 217' ' ' PHE . 13.0 pt-20 -65.26 -31.46 72.63 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -175.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 82.9 mt -66.98 -47.07 72.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.84 0.353 . . . . 0.0 111.172 177.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.532 ' O ' ' HG3' ' A' ' 67' ' ' LYS . . . -74.01 -43.9 56.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.608 -177.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -59.57 -51.52 69.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.548 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.9 -18.97 64.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.038 -176.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.532 ' HG3' ' O ' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -91.19 -13.92 32.0 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.439 -179.285 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.64 44.35 4.91 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.212 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -130.07 151.76 19.49 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.097 -0.573 . . . . 0.0 111.813 177.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.459 ' O ' ' HB2' ' B' ' 222' ' ' ALA . 17.7 mmtp -88.4 -72.78 0.52 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.86 0.362 . . . . 0.0 111.543 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.519 ' HB3' ' HA ' ' A' ' 24' ' ' GLN . 0.4 OUTLIER -108.19 169.82 8.39 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -173.128 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -140.68 167.51 22.0 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.691 ' CD2' ' HA ' ' A' ' 26' ' ' SER . 4.8 t-80 -139.08 110.59 7.04 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.753 174.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 59.8 mt -65.89 113.93 2.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.804 176.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 31.8 pt -97.73 -26.31 3.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.966 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -156.21 131.69 9.5 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.328 178.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -135.65 98.81 4.02 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.512 HH11 ' HB2' ' B' ' 207' ' ' ALA . 13.3 ptm180 -125.32 165.69 17.9 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.513 -173.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -109.69 129.33 55.61 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.963 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -100.5 18.39 19.21 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.335 0.588 . . . . 0.0 109.647 -178.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 110.25 -98.93 1.13 Allowed Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.463 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.83 -13.86 11.49 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.522 2.148 . . . . 0.0 112.103 176.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -114.34 139.26 49.61 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.019 -176.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -99.83 115.8 30.42 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 172.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 50.5 mt-10 -107.18 111.14 23.42 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.946 0.403 . . . . 0.0 110.73 -175.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.611 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -120.38 117.34 27.49 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.258 177.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.5 t -98.61 112.97 32.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.034 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -126.46 123.89 38.88 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.017 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.617 ' HG2' HG23 ' A' ' 40' ' ' THR . 10.4 mt-10 -93.46 143.99 25.77 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.42 ' HB ' HG23 ' A' ' 38' ' ' VAL . 10.6 t -96.6 130.43 45.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.894 0.378 . . . . 0.0 110.356 -171.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -125.61 133.88 52.09 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.821 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -107.48 161.44 14.83 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -64.84 164.04 13.14 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.459 ' O ' ' HB ' ' A' ' 95' ' ' THR . . . -75.92 65.37 1.99 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.153 0.501 . . . . 0.0 110.549 -177.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.459 ' HB ' ' O ' ' A' ' 94' ' ' ALA . 9.6 t 168.82 -21.4 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.438 -177.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.678 ' HE3' HG21 ' A' ' 36' ' ' VAL . 7.8 mptt 60.92 -117.5 0.73 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.959 -177.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 95' ' ' THR . 83.4 mt 70.81 151.96 0.11 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 122.057 0.932 . . . . 0.0 113.191 174.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.464 ' OE1' ' HB2' ' A' ' 100' ' ' HIS . 1.7 tm-20 -147.63 138.4 23.35 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -73.93 -20.39 60.39 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -168.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.464 ' HB2' ' OE1' ' A' ' 98' ' ' GLU . 47.1 m80 -93.84 -2.89 52.84 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 173.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 58.44 90.93 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.158 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -140.46 141.93 35.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.911 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -152.67 148.01 26.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.977 170.127 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 . . . . . 0 C--N 1.321 -0.633 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -179.651 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 201' ' ' MET . . . . . 0.431 ' N ' ' SD ' ' B' ' 201' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 56.5 mmtt -148.93 -65.97 0.23 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.293 0.568 . . . . 0.0 110.721 -178.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 45.2 pttt -102.68 114.07 28.0 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.878 -173.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -118.34 27.49 8.92 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.386 175.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 44.1 mm -84.28 -64.66 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.712 -174.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 47.0 mm -68.97 128.04 31.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.31 -174.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 207' ' ' ALA . . . . . 0.512 ' HB2' HH11 ' A' ' 78' ' ' ARG . . . -164.82 102.27 0.79 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.299 178.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -148.15 126.89 12.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.505 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -109.89 106.46 16.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.166 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 210' ' ' LEU . . . . . . . . . . . . . 5.5 tt -96.02 -46.23 6.59 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 177.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 90.2 mt 73.27 146.95 0.08 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.625 175.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -154.91 179.12 9.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.914 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 213' ' ' THR . . . . . . . . . . . . . 39.4 p -67.55 138.76 56.74 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 177.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 214' ' ' VAL . . . . . . . . . . . . . 43.6 t -95.84 -48.87 12.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.177 -175.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . 59.34 -156.98 0.33 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.446 -175.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 16.1 t -151.03 83.35 1.33 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.099 0.475 . . . . 0.0 110.547 177.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 217' ' ' PHE . . . . . 0.734 ' O ' ' HA ' ' A' ' 62' ' ' GLU . 91.8 m-85 -140.73 111.11 6.73 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 175.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 218' ' ' SER . . . . . . . . . . . . . 3.3 p -125.66 116.5 21.78 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.105 0.478 . . . . 0.0 111.512 -176.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 4.2 m -121.76 149.41 43.33 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.702 176.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.405 ' HA ' ' OE2' ' B' ' 223' ' ' GLU . 6.6 mp -71.45 106.88 4.11 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . 178.65 -19.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.961 -174.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 222' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 70' ' ' LYS . . . -129.16 92.2 3.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.243 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 223' ' ' GLU . . . . . 0.771 ' HG3' ' HA ' ' A' ' 22' ' ' ALA . 0.9 OUTLIER -170.36 124.7 0.72 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -176.212 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 224' ' ' GLN . . . . . 0.48 ' HA ' ' HB3' ' B' ' 271' ' ' TYR . 1.4 tm0? -171.48 149.26 2.65 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.325 177.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 29.0 m -114.77 151.42 16.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.513 176.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 226' ' ' SER . . . . . 0.532 ' HA ' ' CE1' ' B' ' 273' ' ' HIS . 57.5 p -113.59 -96.21 0.45 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -136.05 -36.05 0.76 Allowed 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 228' ' ' GLN . . . . . 0.402 ' HB2' ' OE2' ' B' ' 229' ' ' GLU . 0.7 OUTLIER -58.61 -43.1 89.5 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.443 0.639 . . . . 0.0 109.98 -178.921 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 229' ' ' GLU . . . . . 0.537 ' CD ' ' H ' ' B' ' 229' ' ' GLU . 3.2 mp0 -58.72 -45.22 90.08 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.448 177.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.542 HG12 HD12 ' B' ' 235' ' ' LEU . 55.7 mt -63.44 -39.3 84.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.528 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 15.2 m -69.82 -23.13 63.26 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.086 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -93.5 -57.6 2.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.602 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -90.05 -14.38 33.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.157 -170.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt 59.07 82.78 0.14 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.252 0.549 . . . . 0.0 110.082 -175.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 235' ' ' LEU . . . . . 0.573 HD22 ' HA ' ' B' ' 293' ' ' ASP . 55.1 mt -80.32 178.8 8.04 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.477 -171.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.574 ' HB ' ' HB2' ' B' ' 292' ' ' ASN . 40.8 t -103.61 109.35 26.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.135 -0.938 . . . . 0.0 110.288 -178.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -76.33 125.75 29.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.711 -176.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 238' ' ' VAL . . . . . 0.69 HG12 ' HD2' ' B' ' 267' ' ' LYS . 4.1 t -100.73 -17.53 6.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-O 121.334 0.588 . . . . 0.0 110.847 -176.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 115.81 162.64 13.38 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.391 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.04 145.07 31.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.046 0.45 . . . . 0.0 111.505 -177.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 32.2 pt -126.87 132.04 70.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 169.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -117.45 132.39 56.57 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.993 0.901 . . . . 0.0 111.477 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 243' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 66.5 t -93.99 131.0 42.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 114.528 -1.214 . . . . 0.0 109.999 -177.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 15.4 t -148.06 95.74 2.53 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 176.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 245' ' ' GLN . . . . . . . . . . . . . 8.6 mp0 -136.91 152.37 50.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.124 176.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 246' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' B' ' 283' ' ' ASN . 15.3 m -76.94 162.72 27.36 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.012 -178.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -58.72 106.11 0.8 Allowed Glycine 0 C--N 1.331 0.275 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.916 176.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . 151.92 -50.41 0.52 Allowed Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -174.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -78.13 -28.99 48.59 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 173.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 42.8 mm -121.27 123.43 69.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.675 171.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 22.2 t -149.88 -38.72 0.14 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.95 0.405 . . . . 0.0 110.379 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 252' ' ' SER . . . . . 0.441 ' HB3' ' HD2' ' B' ' 253' ' ' PRO . 16.5 m -113.16 161.53 26.47 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.152 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 253' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' B' ' 252' ' ' SER . 13.7 Cg_endo -57.78 -20.89 45.48 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.675 2.25 . . . . 0.0 112.189 177.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 254' ' ' SER . . . . . 0.625 ' HA ' ' NH1' ' B' ' 257' ' ' ARG . 22.6 t -65.94 -51.08 61.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.522 177.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.461 ' O ' ' HG2' ' B' ' 259' ' ' LYS . 9.3 m-20 -54.47 -45.4 73.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.383 -173.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 49.3 tp -60.3 -60.61 3.54 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.234 -174.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 257' ' ' ARG . . . . . 0.625 ' NH1' ' HA ' ' B' ' 254' ' ' SER . 0.0 OUTLIER -68.03 -25.92 65.62 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -174.636 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 258' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' B' ' 254' ' ' SER . 53.8 mt-10 -70.18 -32.19 70.0 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.398 179.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 259' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' B' ' 255' ' ' ASP . 74.8 mmtt -73.03 -44.21 61.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.986 0.422 . . . . 0.0 109.965 174.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.32 -48.26 82.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.612 -177.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 41.0 m -60.88 -35.34 76.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.677 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -68.37 -41.76 80.15 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.008 0.432 . . . . 0.0 110.529 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 263' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' B' ' 259' ' ' LYS . 98.1 mt -67.46 -44.18 79.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.008 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -61.44 -41.99 98.06 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.158 177.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 265' ' ' ASP . . . . . 0.759 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 26.6 t70 -54.03 -53.87 47.0 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.306 176.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -64.01 -31.18 72.28 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.048 0.451 . . . . 0.0 111.02 -177.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 267' ' ' LYS . . . . . 0.69 ' HD2' HG12 ' B' ' 238' ' ' VAL . 32.7 mmtt -62.5 -38.7 90.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.21 176.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 268' ' ' GLY . . . . . 0.684 ' HA3' ' HB3' ' A' ' 16' ' ' SER . . . 94.9 15.33 45.98 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -170.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 269' ' ' GLY . . . . . 0.492 ' HA2' ' ND2' ' B' ' 292' ' ' ASN . . . -106.87 146.76 16.1 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 270' ' ' LYS . . . . . 0.543 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 54.8 mtpt -79.66 -68.28 0.68 Allowed 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 121.133 -0.227 . . . . 0.0 111.415 -176.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 271' ' ' TYR . . . . . 0.593 ' HA ' ' HB2' ' A' ' 22' ' ' ALA . 9.9 m-85 -97.93 154.41 17.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.101 0.477 . . . . 0.0 110.631 -173.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 272' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -122.62 136.42 54.88 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 175.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 273' ' ' HIS . . . . . 0.532 ' CE1' ' HA ' ' B' ' 226' ' ' SER . 36.4 t60 -110.98 101.79 10.32 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.667 0.27 . . . . 0.0 110.745 -176.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 274' ' ' ILE . . . . . . . . . . . . . 68.5 mt -70.16 122.12 21.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 176.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 61.5 mt -97.85 -52.65 8.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.152 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -140.73 147.52 39.31 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.968 -177.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -144.53 138.68 27.7 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -152.38 151.41 30.79 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.038 0.447 . . . . 0.0 110.811 -176.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -97.25 120.24 37.25 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 175.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -129.95 107.54 9.44 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.006 0.432 . . . . 0.0 110.813 -174.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 66.82 -127.62 28.29 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.787 -178.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -92.21 3.54 3.84 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.767 2.311 . . . . 0.0 112.472 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 283' ' ' ASN . . . . . 0.419 ' HA ' ' HA ' ' B' ' 246' ' ' SER . 81.0 m-20 -118.58 149.86 40.63 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.129 0.49 . . . . 0.0 111.415 -174.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -99.9 123.3 44.0 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.515 173.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 285' ' ' GLU . . . . . 0.453 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 21.1 mm-40 -107.75 121.21 44.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.457 -176.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 286' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -128.75 134.48 48.43 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 121.106 -0.238 . . . . 0.0 110.827 176.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 65.0 t -116.52 117.53 55.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.832 0.349 . . . . 0.0 110.386 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -133.28 142.99 48.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.467 -178.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -99.26 131.43 45.29 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.982 175.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 290' ' ' VAL . . . . . 0.582 ' HB ' ' HB ' ' B' ' 238' ' ' VAL . 32.7 t -90.09 133.81 30.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 176.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 291' ' ' TYR . . . . . 0.415 ' HA ' HG23 ' B' ' 238' ' ' VAL . 73.9 m-85 -132.58 134.12 44.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.993 0.425 . . . . 0.0 111.354 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 292' ' ' ASN . . . . . 0.574 ' HB2' ' HB ' ' B' ' 236' ' ' VAL . 23.2 m120 -90.73 123.71 34.53 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 165.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 293' ' ' ASP . . . . . 0.783 ' HB2' ' HB2' ' A' ' 53' ' ' PRO . 5.3 p-10 -71.45 163.91 26.8 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 294' ' ' ALA . . . . . 0.501 ' H ' ' HG2' ' A' ' 53' ' ' PRO . . . -71.73 77.99 0.85 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.975 0.417 . . . . 0.0 111.063 -177.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 295' ' ' THR . . . . . . . . . . . . . 8.5 t -133.72 105.16 6.67 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 122.485 1.136 . . . . 0.0 110.998 176.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -151.44 15.37 0.69 Allowed 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.079 -1.418 . . . . 0.0 108.375 177.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 297' ' ' LEU . . . . . . . . . . . . . 74.3 mt -114.47 141.22 47.97 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.523 -173.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 298' ' ' GLU . . . . . 0.482 ' CD ' ' H ' ' B' ' 299' ' ' HIS . 0.5 OUTLIER -77.72 163.85 25.79 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.099 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 299' ' ' HIS . . . . . 0.482 ' H ' ' CD ' ' B' ' 298' ' ' GLU . 77.9 m-70 -75.72 -25.61 56.76 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 176.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 300' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 64.64 34.46 9.79 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.174 170.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 301' ' ' HIS . . . . . . . . . . . . . 42.6 t-80 -167.24 -53.54 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.388 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 302' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -144.44 102.66 3.86 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.092 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -70.91 -53.12 16.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.487 -175.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 20.6 t-80 . . . . . 0 C--N 1.324 -0.515 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 -178.645 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.0 tpp . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -144.97 111.25 5.6 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -60.27 -44.52 95.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.375 -176.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 61.47 -170.02 0.16 Allowed 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.476 0.485 . . . . 0.0 110.699 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 51.4 mm 71.25 -69.49 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.227 172.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.9 mt 64.25 94.09 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.573 0.701 . . . . 0.0 110.044 -172.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -138.58 -142.93 0.16 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.078 -176.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 68.92 30.83 4.47 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 122.989 0.515 . . . . 0.0 110.944 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.91 133.43 39.25 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.678 177.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.5 tp -102.73 109.9 21.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.932 0.396 . . . . 0.0 111.248 -176.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' A' ' 11' ' ' LEU . 0.4 OUTLIER -101.57 122.23 43.45 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 175.89 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -98.49 107.16 19.55 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.859 0.361 . . . . 0.0 111.121 -175.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.3 m -123.8 98.39 5.79 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.128 0.489 . . . . 0.0 110.605 178.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.9 m -102.92 -174.15 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.049 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -151.55 166.54 30.85 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.201 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.9 t -84.5 117.98 24.02 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 177.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -81.02 -83.33 0.11 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -171.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 71.8 m 59.18 27.88 17.02 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.488 0.661 . . . . 0.0 110.574 -172.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.485 ' HB ' HD23 ' A' ' 20' ' ' LEU . 44.6 p -104.64 -157.39 0.61 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.755 177.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.526 HD23 ' H ' ' A' ' 20' ' ' LEU . 2.0 pt? -52.75 125.68 17.55 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 171.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -130.67 149.79 52.16 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.644 -177.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.76 92.52 2.49 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 176.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.448 ' HB3' ' HE1' ' A' ' 71' ' ' TYR . 30.9 mt-10 -144.43 -158.8 0.92 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.691 -175.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.647 ' HA ' ' CD1' ' A' ' 71' ' ' TYR . 1.6 tm0? 86.98 145.62 0.05 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.857 1.263 . . . . 0.0 111.447 178.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.424 HG21 ' CD1' ' A' ' 35' ' ' LEU . 31.1 m -109.82 140.98 26.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.356 -178.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.435 ' HB2' ' OE1' ' A' ' 29' ' ' GLU . 6.3 m -86.81 -174.08 4.78 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.296 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -69.92 -35.3 74.45 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -169.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -73.21 -33.93 65.65 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.561 -177.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.435 ' OE1' ' HB2' ' A' ' 26' ' ' SER . 3.0 mp0 -63.58 -45.03 92.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.099 0.476 . . . . 0.0 109.907 175.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.507 HG12 HD12 ' A' ' 35' ' ' LEU . 81.4 mt -56.76 -40.31 69.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.756 177.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.1 m -71.94 -20.74 61.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.305 -178.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -88.29 -42.19 12.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.476 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -89.56 -9.31 50.31 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 121.064 -0.255 . . . . 0.0 111.372 -178.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? 54.84 54.78 8.61 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.293 0.568 . . . . 0.0 110.237 -176.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.507 HD12 HG12 ' A' ' 30' ' ' ILE . 89.6 mt -66.17 145.93 55.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.44 -176.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.474 ' H ' ' HB2' ' A' ' 94' ' ' ALA . 15.7 m -73.71 135.91 26.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.719 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.5 tttm -96.89 122.58 40.02 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.365 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.24 -47.11 20.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.973 0.416 . . . . 0.0 110.237 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 171.45 173.86 38.7 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.066 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 86.9 m -101.26 121.28 41.6 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.619 0.247 . . . . 0.0 110.467 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.1 pt -106.77 144.09 16.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 176.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -128.43 131.57 48.44 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.533 0.682 . . . . 0.0 110.882 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 70.7 t -93.99 128.5 45.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 114.255 -1.339 . . . . 0.0 109.311 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.0 t -150.35 78.17 1.32 Allowed 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.636 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 0.6 OUTLIER -103.1 130.68 50.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.997 -179.141 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.9 t -92.14 102.61 15.14 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.009 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.54 -130.21 10.18 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.055 -0.593 . . . . 0.0 114.405 171.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.91 34.06 2.59 Favored Glycine 0 C--N 1.331 0.26 0 N-CA-C 114.329 0.492 . . . . 0.0 114.329 -167.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.636 ' HB2' ' HB3' ' A' ' 45' ' ' GLN . 15.2 mm100 -82.68 -28.33 30.67 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 172.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.558 HD12 ' HA ' ' A' ' 56' ' ' LEU . 49.6 mm -122.95 112.1 32.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.407 176.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.598 ' HB2' ' HA ' ' B' ' 302' ' ' HIS . 15.0 m -118.46 -1.27 11.26 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.311 -176.189 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 40.4 m -155.93 148.46 17.82 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -58.73 -31.49 95.07 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.426 2.084 . . . . 0.0 111.21 176.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.57 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 2.8 p -69.72 -35.1 74.74 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.212 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -75.76 -32.1 59.81 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.879 0.371 . . . . 0.0 110.422 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.558 ' HA ' HD12 ' A' ' 50' ' ' ILE . 68.4 tp -59.59 -50.21 74.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.049 178.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.568 ' HD2' ' CD ' ' B' ' 223' ' ' GLU . 26.5 ptt85 -67.35 -32.8 73.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.952 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.57 ' HG2' ' O ' ' A' ' 54' ' ' SER . 9.5 mm-40 -55.5 -42.64 74.72 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.162 0.506 . . . . 0.0 110.006 176.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.501 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 13.7 mptt -58.76 -44.91 90.71 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.591 175.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.453 HD13 HD11 ' A' ' 74' ' ' ILE . 74.5 mt -64.89 -41.88 95.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.972 -176.01 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.4 m -60.18 -40.01 88.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.163 0.506 . . . . 0.0 110.168 175.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -69.04 -40.37 78.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.891 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 59' ' ' LYS . 87.9 mt -66.26 -37.49 85.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.221 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.96 -39.08 93.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.885 0.374 . . . . 0.0 110.523 178.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -68.04 -35.77 78.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.849 177.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.12 -32.7 70.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.285 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.416 ' HD3' ' HA ' ' A' ' 67' ' ' LYS . 71.5 mmtt -87.34 -26.54 23.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.882 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.53 43.96 3.3 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.511 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -120.44 -170.84 14.33 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.81 -0.709 . . . . 0.0 111.776 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -123.26 -36.08 2.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.966 0.412 . . . . 0.0 110.591 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.647 ' CD1' ' HA ' ' A' ' 24' ' ' GLN . 71.7 m-85 -132.6 166.74 21.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.007 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -148.96 131.3 15.61 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.609 ' HA ' HE21 ' A' ' 24' ' ' GLN . 56.1 t60 -109.72 105.61 14.93 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.078 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.509 ' HB ' ' OG ' ' B' ' 226' ' ' SER . 60.6 mt -67.77 130.89 33.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.272 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 33.5 pt -114.17 -16.27 9.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.15 -178.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.554 ' HB3' ' HB ' ' A' ' 87' ' ' VAL . . . -147.94 137.31 22.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.056 -176.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -156.51 103.54 2.13 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.41 145.97 35.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.776 0.322 . . . . 0.0 111.032 -176.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -82.14 124.96 30.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.199 0.523 . . . . 0.0 110.816 176.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.0 t-160 -100.19 50.61 0.9 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 175.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.14 -130.83 10.14 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 110.321 -1.111 . . . . 0.0 110.321 -170.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -79.61 6.0 5.47 Favored 'Trans proline' 0 N--CA 1.464 -0.229 0 C-N-CA 122.483 2.122 . . . . 0.0 111.499 173.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -108.96 121.93 46.16 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.284 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.471 ' CE2' ' HB2' ' A' ' 86' ' ' ALA . 70.1 t80 -93.36 122.77 36.11 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.964 -176.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 25.9 mm-40 -112.36 115.3 28.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.249 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.514 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -132.31 134.67 45.51 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.591 0.234 . . . . 0.0 111.057 178.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.554 ' HB ' ' HB3' ' A' ' 76' ' ' ALA . 97.2 t -114.46 121.86 67.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.939 0.4 . . . . 0.0 110.075 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 74' ' ' ILE . . . -125.19 138.07 54.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.165 -177.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.05 116.92 29.4 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.776 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.7 t -86.3 126.02 40.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.833 0.349 . . . . 0.0 110.655 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -123.52 156.51 35.5 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.986 178.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -110.19 172.65 6.74 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.428 ' C ' ' H ' ' A' ' 95' ' ' THR . 16.8 t70 -61.24 -31.94 71.73 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.299 -175.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.474 ' HB2' ' H ' ' A' ' 36' ' ' VAL . . . 71.08 -9.78 0.83 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.565 0.746 . . . . 0.0 112.178 178.153 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.428 ' H ' ' C ' ' A' ' 93' ' ' ASP . 6.9 m -118.76 -39.94 2.92 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.122 175.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 97.0 mttt 70.03 35.21 2.27 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.783 176.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 96.5 mt -122.98 97.46 5.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.22 173.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.457 ' OE2' ' HD2' ' A' ' 99' ' ' HIS . 11.4 tm-20 -97.28 -73.62 0.6 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.572 -176.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.457 ' HD2' ' OE2' ' A' ' 98' ' ' GLU . 27.9 m-70 -151.78 146.21 25.56 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 173.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -79.95 78.23 6.58 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 174.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -143.05 117.76 9.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.595 0.712 . . . . 0.0 111.418 -178.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 41.8 t60 -99.1 102.74 14.53 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.873 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 69.4 t60 -103.92 85.48 2.42 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.811 0.338 . . . . 0.0 110.263 178.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 83.6 t60 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.928 178.229 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 120.834 0.35 . . . . 0.0 110.507 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -136.32 103.63 5.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.938 -177.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 203' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' B' ' 203' ' ' LYS . 71.0 mmtt -132.78 150.41 52.16 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.952 175.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? 70.67 -83.16 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.994 0.809 . . . . 0.0 111.581 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 64.0 mt 60.54 84.23 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -169.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 21.7 pt -91.06 128.82 42.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.419 -174.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -89.27 86.13 6.77 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 175.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -148.14 160.65 42.69 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.213 -176.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 209' ' ' ALA . . . . . 0.436 ' HB1' ' HB ' ' B' ' 213' ' ' THR . . . -143.31 -50.68 0.34 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.66 177.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 210' ' ' LEU . . . . . . . . . . . . . 6.8 mp 55.91 28.52 12.69 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.045 -178.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 95.0 mt 71.68 -5.87 1.56 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.651 0.781 . . . . 0.0 111.679 -178.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -93.54 20.87 6.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.236 0.541 . . . . 0.0 110.76 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 213' ' ' THR . . . . . 0.436 ' HB ' ' HB1' ' B' ' 209' ' ' ALA . 11.1 t -65.79 -11.28 44.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.482 -177.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 214' ' ' VAL . . . . . . . . . . . . . 35.4 m -71.38 -3.68 3.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.719 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.71 102.03 0.23 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.066 0.46 . . . . 0.0 111.333 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 3.7 p -141.56 102.02 4.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.316 178.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -91.72 68.85 5.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.701 -177.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 218' ' ' SER . . . . . . . . . . . . . 47.9 m -160.68 179.86 8.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.673 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 17.0 m 76.44 113.75 0.07 Allowed 'General case' 0 CA--C 1.532 0.285 0 O-C-N 123.644 0.59 . . . . 0.0 112.107 174.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 5.1 tt -124.54 98.7 5.85 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 175.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -99.44 -9.49 23.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.792 -173.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -85.03 88.97 7.5 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.731 -177.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 223' ' ' GLU . . . . . 0.568 ' CD ' ' HD2' ' A' ' 57' ' ' ARG . 11.0 tp10 -164.97 135.72 3.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.213 -177.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 224' ' ' GLN . . . . . 0.439 ' HB2' ' O ' ' B' ' 223' ' ' GLU . 1.5 tm0? 170.76 139.98 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.811 0.694 . . . . 0.0 110.588 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 17.8 m -109.33 132.18 58.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.943 172.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 226' ' ' SER . . . . . 0.549 ' O ' HG13 ' B' ' 230' ' ' ILE . 5.8 m -88.69 172.8 8.99 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.846 0.355 . . . . 0.0 111.068 -175.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 227' ' ' LYS . . . . . 0.546 ' HA ' HD12 ' B' ' 230' ' ' ILE . 5.5 mmtt -57.47 -32.65 67.18 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.76 -174.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -68.56 -51.5 42.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.334 -177.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -63.24 -35.52 80.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.015 -177.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.556 HG12 HD12 ' B' ' 235' ' ' LEU . 82.3 mt -57.08 -52.29 58.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.846 178.135 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 18.3 m -74.18 -24.32 59.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.785 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 20.0 t-160 -75.17 -48.71 22.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.34 -175.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -96.72 -3.16 43.0 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.047 -177.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm 62.92 72.27 0.49 Allowed 'General case' 0 N--CA 1.463 0.224 0 O-C-N 123.67 0.606 . . . . 0.0 111.59 176.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 235' ' ' LEU . . . . . 0.556 HD12 HG12 ' B' ' 230' ' ' ILE . 69.6 mt -73.35 174.4 8.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.997 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.597 HG23 ' HA ' ' B' ' 294' ' ' ALA . 69.5 t -93.11 -49.19 13.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.644 -176.341 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 237' ' ' LYS . . . . . 0.602 ' HA ' ' HA ' ' B' ' 291' ' ' TYR . 60.0 tttm 69.97 139.92 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 O-C-N 123.877 0.735 . . . . 0.0 111.734 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 238' ' ' VAL . . . . . 0.547 HG13 ' HB2' ' B' ' 292' ' ' ASN . 3.3 m -111.15 -50.83 6.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . -178.65 -142.08 4.64 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.011 -1.09 . . . . 0.0 113.056 -177.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 63.4 m -134.38 145.36 48.89 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 122.621 0.368 . . . . 0.0 110.716 -176.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 20.5 pt -117.91 131.59 70.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 170.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -123.05 114.44 20.38 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.06 0.457 . . . . 0.0 110.338 -175.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 243' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 82.0 t -94.0 115.19 32.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.433 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 19.2 m -110.69 87.41 2.52 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 174.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 245' ' ' GLN . . . . . 0.524 ' HB3' ' HB3' ' B' ' 284' ' ' PHE . 0.7 OUTLIER -107.55 179.61 4.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.57 0.7 . . . . 0.0 111.53 -172.451 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 33.2 t -108.63 153.31 23.58 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 166.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -58.23 -29.07 62.38 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 121.17 -0.538 . . . . 0.0 113.768 -175.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -73.49 -11.83 80.16 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 121.043 -0.599 . . . . 0.0 113.908 -174.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -94.02 -6.81 44.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 117.482 0.641 . . . . 0.0 111.158 -178.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 47.2 mm -119.73 108.09 22.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.248 -178.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 23.7 t -121.72 -47.62 2.19 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.267 0.556 . . . . 0.0 109.998 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 3.9 m -113.28 156.6 42.87 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.435 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -57.89 -30.31 89.19 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.393 2.062 . . . . 0.0 111.748 176.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 254' ' ' SER . . . . . 0.494 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 18.8 m -63.16 -33.83 76.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.15 177.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -64.62 -45.89 84.95 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.137 0.494 . . . . 0.0 110.222 -178.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 54.3 tp -66.62 -39.39 88.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.941 177.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 257' ' ' ARG . . . . . 0.433 HH11 ' CD ' ' A' ' 23' ' ' GLU . 7.5 tmm_? -58.05 -42.07 84.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.076 178.031 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 258' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' B' ' 254' ' ' SER . 69.7 mm-40 -57.94 -29.54 65.24 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.57 178.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -85.64 -47.95 9.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.945 0.402 . . . . 0.0 110.658 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 96.0 mt -66.1 -49.72 66.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.119 -174.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 14.6 m -66.88 -33.23 75.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.825 0.345 . . . . 0.0 110.857 -176.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -62.48 -45.68 91.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.264 0.554 . . . . 0.0 110.287 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 263' ' ' LEU . . . . . 0.624 ' O ' ' HG2' ' B' ' 267' ' ' LYS . 92.3 mt -74.39 -44.88 50.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.002 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -59.02 -48.92 79.83 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -175.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -66.87 -31.47 72.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.873 0.368 . . . . 0.0 110.547 -178.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -69.3 -19.23 63.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.9 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 267' ' ' LYS . . . . . 0.624 ' HG2' ' O ' ' B' ' 263' ' ' LEU . 74.2 mmtt -84.76 -20.48 30.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.083 0.468 . . . . 0.0 110.141 177.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 107.23 -3.94 35.29 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.548 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -90.25 153.26 22.7 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.157 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -111.98 -9.98 13.98 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -177.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 271' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -135.79 162.22 33.4 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 272' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -151.24 167.48 27.69 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.414 170.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -135.47 108.55 7.68 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 172.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 274' ' ' ILE . . . . . 0.477 HG12 ' HB2' ' B' ' 288' ' ' ALA . 62.3 mt -65.21 130.54 30.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 29.4 pt -108.58 -21.29 5.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.658 -175.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -159.76 112.84 2.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.973 -179.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 277' ' ' ALA . . . . . 0.406 ' HB3' ' HG3' ' A' ' 29' ' ' GLU . . . -133.46 103.49 5.96 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 176.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -147.22 175.1 11.01 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.482 -171.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.19 108.47 19.11 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.17 -178.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 33.8 t-80 -90.64 69.83 6.71 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 175.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 75.67 -122.38 6.68 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 -174.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -79.71 -3.81 13.09 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.568 2.179 . . . . 0.0 112.19 175.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -94.99 140.92 29.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.419 -177.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 284' ' ' PHE . . . . . 0.524 ' HB3' ' HB3' ' B' ' 245' ' ' GLN . 71.3 t80 -113.53 110.23 19.92 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 174.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 285' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 18.2 mm-40 -105.58 110.98 23.5 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.922 -178.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 286' ' ' ALA . . . . . 0.569 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -111.95 115.13 28.45 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.981 0.42 . . . . 0.0 110.062 172.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 24.4 t -114.12 119.77 62.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.759 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 288' ' ' ALA . . . . . 0.477 ' HB2' HG12 ' B' ' 274' ' ' ILE . . . -131.5 141.64 49.8 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.866 0.365 . . . . 0.0 110.869 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -91.36 124.96 35.94 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 290' ' ' VAL . . . . . 0.451 ' HB ' HG23 ' B' ' 238' ' ' VAL . 11.2 t -89.63 123.44 41.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.028 0.442 . . . . 0.0 109.997 -176.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 291' ' ' TYR . . . . . 0.602 ' HA ' ' HA ' ' B' ' 237' ' ' LYS . 98.3 m-85 -112.3 124.22 51.99 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.905 -176.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 292' ' ' ASN . . . . . 0.547 ' HB2' HG13 ' B' ' 238' ' ' VAL . 10.6 t-20 -91.86 156.47 17.47 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 174.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -59.13 158.28 9.07 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 123.48 0.488 . . . . 0.0 110.953 -177.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 294' ' ' ALA . . . . . 0.597 ' HA ' HG23 ' B' ' 236' ' ' VAL . . . -76.96 -11.25 59.78 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -172.216 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 295' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' B' ' 296' ' ' LYS . 12.0 t -140.78 -28.97 0.69 Allowed 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.406 -177.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 296' ' ' LYS . . . . . 0.561 ' HE3' HG21 ' B' ' 236' ' ' VAL . 0.3 OUTLIER 71.87 150.81 0.1 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.129 0.572 . . . . 0.0 111.091 179.758 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 297' ' ' LEU . . . . . . . . . . . . . 85.1 mt 72.92 155.1 0.16 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.359 173.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 298' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 71.07 123.55 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.411 175.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 299' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -78.64 51.53 1.09 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.182 174.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 300' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -59.63 143.9 49.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.666 -173.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 301' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -126.36 -174.2 3.05 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.968 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 302' ' ' HIS . . . . . 0.598 ' HA ' ' HB2' ' A' ' 51' ' ' SER . 41.7 p-80 -60.12 164.79 3.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.388 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -68.64 130.94 44.29 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.77 177.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 20.0 p-80 . . . . . 0 C--N 1.322 -0.594 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.739 174.352 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 mpp? . . . . . 0 N--CA 1.477 0.892 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -79.37 89.71 4.99 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.108 0.48 . . . . 0.0 110.103 178.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -119.02 117.01 27.62 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.081 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -120.53 160.41 23.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.503 -178.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.432 ' N ' HD12 ' A' ' 5' ' ' ILE . 4.0 mp -87.33 129.95 37.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.195 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.467 ' H ' HG13 ' A' ' 6' ' ' ILE . 1.8 pp -71.81 144.36 13.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.111 0.481 . . . . 0.0 111.946 -178.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -174.28 144.29 0.93 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.608 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -79.15 90.69 4.88 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.142 0.496 . . . . 0.0 110.977 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -99.93 99.93 10.77 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.046 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 62.8 tp -113.65 102.95 10.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.155 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.629 HD12 ' HB3' ' B' ' 244' ' ' SER . 1.0 OUTLIER -154.38 137.47 15.57 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.338 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.494 ' N ' HD13 ' A' ' 11' ' ' LEU . . . -137.52 109.35 7.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.248 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.8 m -90.87 97.54 11.24 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.732 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.3 m -131.04 96.65 2.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.576 0.703 . . . . 0.0 111.605 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.08 61.88 0.41 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.902 176.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.446 ' HA ' ' CD ' ' B' ' 262' ' ' GLU . 22.7 t -70.98 113.04 7.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.019 -171.016 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -91.03 -25.15 19.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.474 172.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.1 m 60.73 32.03 20.18 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.514 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.9 m -100.39 119.77 38.96 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.064 178.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -80.73 131.34 35.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.025 -176.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.774 ' HB2' ' HB2' ' B' ' 265' ' ' ASP . . . -120.62 -66.52 1.05 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.636 177.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.477 ' HB1' ' O ' ' B' ' 223' ' ' GLU . . . -148.37 -174.17 4.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.911 -177.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.716 ' HA ' ' OH ' ' B' ' 272' ' ' TYR . 16.2 pt-20 -177.39 141.44 0.31 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.635 ' HB3' ' HG3' ' B' ' 224' ' ' GLN . 1.4 tm0? -179.67 151.37 0.45 Allowed 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.31 174.264 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.504 ' HB ' ' CG ' ' A' ' 29' ' ' GLU . 11.6 m -112.58 146.35 17.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.77 0.319 . . . . 0.0 110.443 178.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.9 p -89.77 -156.67 0.42 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.438 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.484 ' HD3' ' O ' ' A' ' 27' ' ' LYS . 12.8 tmtt? -80.01 -35.95 36.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.82 0.343 . . . . 0.0 110.676 -175.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -60.0 -50.42 73.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.213 -170.353 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.504 ' CG ' ' HB ' ' A' ' 25' ' ' VAL . 3.2 pm0 -76.15 -29.16 57.67 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.506 -174.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.594 HG12 HD12 ' A' ' 35' ' ' LEU . 69.2 mt -61.8 -43.68 97.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.011 0.434 . . . . 0.0 109.848 177.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.4 m -73.05 -34.16 66.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.191 177.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 35.1 t-80 -80.04 -36.33 35.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.778 -172.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -103.13 -10.46 18.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.47 0.176 . . . . 0.0 111.341 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt 58.55 83.96 0.11 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.339 -177.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.594 HD12 HG12 ' A' ' 30' ' ' ILE . 92.3 mt -93.53 155.37 17.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.8 -178.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.5 t -87.77 117.91 32.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.148 -176.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -82.24 115.15 21.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.025 177.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.457 HG13 ' HB2' ' A' ' 92' ' ' ASN . 6.4 m -97.12 15.0 3.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.075 0.464 . . . . 0.0 111.279 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 128.48 -158.1 21.59 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.65 -0.785 . . . . 0.0 113.006 174.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.5 m -144.96 139.74 27.74 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -178.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.6 pt -117.82 150.3 19.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.541 ' HB2' ' HB3' ' B' ' 211' ' ' LEU . 45.8 m-80 -130.79 132.71 45.43 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.164 0.507 . . . . 0.0 111.486 -175.239 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.612 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 73.0 t -95.09 123.82 47.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.963 172.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.2 p -151.32 75.92 1.2 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.011 0.434 . . . . 0.0 111.23 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 14.9 mp0 -111.7 156.83 21.27 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.976 0.417 . . . . 0.0 111.084 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 64.4 m -89.47 67.76 7.7 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.975 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.6 -78.18 1.03 Allowed Glycine 0 CA--C 1.521 0.428 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.801 175.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.93 51.55 3.16 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 114.86 0.704 . . . . 0.0 114.86 -169.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -137.62 1.32 2.34 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 168.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.59 HD12 ' HA ' ' A' ' 56' ' ' LEU . 49.7 mm -126.62 107.64 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.081 174.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.3 p -95.55 -29.54 14.31 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.58 -174.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.475 ' H ' ' HB3' ' A' ' 55' ' ' ASP . 16.4 m -147.83 165.88 17.37 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.847 -174.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.49 -46.4 21.18 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.207 1.938 . . . . 0.0 111.325 174.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.46 ' O ' ' HG3' ' A' ' 58' ' ' GLU . 48.4 t -59.49 -34.82 73.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.666 175.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.475 ' HB3' ' H ' ' A' ' 52' ' ' SER . 34.9 t70 -66.98 -41.0 87.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.949 0.404 . . . . 0.0 110.002 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.59 ' HA ' HD12 ' A' ' 50' ' ' ILE . 58.5 tp -59.69 -44.61 93.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.317 0.58 . . . . 0.0 109.789 173.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.39 -34.15 77.1 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.003 178.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 54' ' ' SER . 50.2 mt-10 -59.87 -45.49 92.3 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.779 -0.191 . . . . 0.0 110.577 177.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -60.92 -43.54 98.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.918 0.389 . . . . 0.0 110.821 176.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.47 -48.18 76.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.52 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.498 ' HB3' ' O ' ' B' ' 222' ' ' ALA . 18.8 p -70.29 -33.08 71.14 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.075 -176.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -60.95 -48.74 80.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.561 177.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.405 HD11 HG22 ' B' ' 213' ' ' THR . 95.8 mt -65.46 -35.09 79.88 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.613 178.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.16 -41.99 80.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.863 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -62.13 -38.15 87.84 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.577 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.28 -39.02 85.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.923 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.4 mmtp -74.64 -29.38 61.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.001 0.429 . . . . 0.0 110.74 176.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.31 26.77 11.64 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.759 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -101.03 147.56 17.86 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.131 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 67.6 mttt -93.18 -4.16 52.59 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.825 0.345 . . . . 0.0 111.501 -172.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.768 ' CE1' ' HB2' ' A' ' 91' ' ' TYR . 22.3 p90 -165.32 164.6 19.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.486 -177.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.435 ' O ' ' HG3' ' A' ' 24' ' ' GLN . 25.3 p90 -131.78 133.06 44.33 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.508 -178.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.423 ' HB3' ' HB2' ' A' ' 89' ' ' GLU . 17.0 t-80 -100.22 102.5 13.8 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.494 -175.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.516 ' H ' HD12 ' A' ' 74' ' ' ILE . 5.3 mp -72.3 122.94 25.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 30.7 pt -111.49 -24.02 4.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.089 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -155.72 125.19 6.32 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.001 0.429 . . . . 0.0 111.202 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.16 119.68 23.36 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 175.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -139.62 155.1 47.63 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.463 0.649 . . . . 0.0 111.973 -171.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -110.54 112.11 23.8 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.538 177.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -78.12 -27.01 48.21 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 123.28 -85.16 0.37 Allowed Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -176.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.91 -20.42 29.42 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.456 2.104 . . . . 0.0 111.474 173.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -123.12 145.7 48.36 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.825 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -102.88 124.85 49.17 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 170.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.562 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 51.6 mt-10 -123.28 115.91 22.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.062 0.458 . . . . 0.0 111.099 -171.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.612 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -127.85 134.37 49.41 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.042 179.088 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.8 t -114.36 116.27 52.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.155 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -131.65 137.79 48.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.089 0.471 . . . . 0.0 111.087 -178.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.423 ' HB2' ' HB3' ' A' ' 73' ' ' HIS . 30.0 mt-10 -91.48 150.61 21.15 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 17.6 t -113.06 130.64 66.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 177.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.768 ' HB2' ' CE1' ' A' ' 71' ' ' TYR . 52.3 m-85 -121.21 147.71 45.25 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.128 0.489 . . . . 0.0 110.107 177.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.457 ' HB2' HG13 ' A' ' 38' ' ' VAL . 60.0 t30 -95.35 18.73 11.94 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.583 -168.172 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 45.2 t0 59.88 23.02 12.03 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.672 0.749 . . . . 0.0 110.299 -178.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 64.07 11.04 5.86 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.426 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.4 t -126.53 120.16 28.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.792 0.806 . . . . 0.0 111.222 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.432 ' HB2' ' NZ ' ' A' ' 96' ' ' LYS . 3.5 ttmp? -111.38 11.99 21.55 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.87 -178.179 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 35.4 mt -87.71 9.38 21.75 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.649 -170.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -99.39 -49.57 4.4 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.343 0.592 . . . . 0.0 110.166 176.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 12.6 p-80 -131.44 138.17 48.94 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.056 -177.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -129.83 -168.69 1.99 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.483 -169.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 65.31 64.09 0.62 Allowed 'General case' 0 N--CA 1.465 0.301 0 O-C-N 123.93 0.769 . . . . 0.0 110.89 -176.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.5 m170 -156.7 133.09 9.94 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.558 173.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -78.77 -77.11 0.18 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.313 178.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 69.4 m-70 . . . . . 0 C--N 1.324 -0.514 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.48 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 4.6 mpp? . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 121.095 0.474 . . . . 0.0 110.475 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -162.0 117.17 1.95 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.394 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -79.79 86.53 5.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.99 0.424 . . . . 0.0 111.826 -174.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -155.6 101.97 2.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.501 172.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 41.4 pt -85.84 -5.48 9.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.603 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 53.6 mt -79.61 83.97 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.378 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -146.99 23.21 1.21 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.816 176.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -81.24 90.42 6.1 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.692 -173.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -89.02 129.14 35.71 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 169.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 210' ' ' LEU . . . . . . . . . . . . . 83.6 mt -104.77 126.27 51.68 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.152 0.501 . . . . 0.0 111.615 -174.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 211' ' ' LEU . . . . . 0.541 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 58.2 tp -142.66 119.75 11.41 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.224 176.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.53 131.29 45.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.358 -177.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 213' ' ' THR . . . . . 0.405 HG22 HD11 ' A' ' 63' ' ' LEU . 19.0 p -81.35 97.44 7.71 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.241 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 214' ' ' VAL . . . . . . . . . . . . . 3.7 m -78.18 78.41 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.566 0.698 . . . . 0.0 110.001 175.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -66.02 144.58 56.65 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.549 -172.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 216' ' ' SER . . . . . 0.411 ' O ' ' HB3' ' B' ' 217' ' ' PHE . 17.6 m -138.22 -100.52 0.18 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.25 175.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 217' ' ' PHE . . . . . 0.411 ' HB3' ' O ' ' B' ' 216' ' ' SER . 31.0 p90 176.06 128.47 0.04 OUTLIER 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 173.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 218' ' ' SER . . . . . . . . . . . . . 67.5 m -143.27 174.2 10.93 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.823 0.344 . . . . 0.0 110.999 -177.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 3.5 p -77.35 157.33 30.72 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.115 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.445 ' O ' HD12 ' B' ' 220' ' ' LEU . 1.6 pp -70.89 109.6 5.13 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.359 0.6 . . . . 0.0 110.025 177.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -116.64 -7.22 11.58 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.333 -178.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 222' ' ' ALA . . . . . 0.498 ' O ' ' HB3' ' A' ' 61' ' ' SER . . . -165.94 149.06 7.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.29 -177.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 223' ' ' GLU . . . . . 0.477 ' O ' ' HB1' ' A' ' 22' ' ' ALA . 7.2 pt-20 -168.54 122.69 0.89 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.062 0.458 . . . . 0.0 111.513 178.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 224' ' ' GLN . . . . . 0.635 ' HG3' ' HB3' ' A' ' 24' ' ' GLN . 25.9 tm0? -171.07 154.24 4.02 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.352 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 23.8 m -131.94 130.69 61.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.71 0.29 . . . . 0.0 111.032 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 226' ' ' SER . . . . . 0.412 ' O ' HG13 ' B' ' 230' ' ' ILE . 77.3 p -88.87 179.8 6.12 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.45 -28.72 70.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.441 0.162 . . . . 0.0 111.312 -172.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -64.28 -50.65 67.08 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -61.65 -46.14 91.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.317 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.459 HG12 HD12 ' B' ' 235' ' ' LEU . 90.9 mt -55.8 -48.82 77.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.273 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 14.7 m -73.25 -35.11 66.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.88 0.371 . . . . 0.0 111.433 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -77.95 -33.53 51.53 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.37 -174.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -99.05 -9.41 23.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.399 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt 58.64 70.75 0.63 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.263 0.554 . . . . 0.0 110.691 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 235' ' ' LEU . . . . . 0.459 HD12 HG12 ' B' ' 230' ' ' ILE . 74.0 mt -82.99 -177.94 6.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.946 -175.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.59 HG23 ' HA ' ' B' ' 294' ' ' ALA . 57.0 t -105.88 123.65 60.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.599 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -86.89 123.34 31.91 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 177.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 18.9 t -96.09 -38.82 8.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.444 -173.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 165.74 154.04 7.95 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.168 -1.015 . . . . 0.0 112.582 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 240' ' ' THR . . . . . 0.528 HG23 ' HG2' ' B' ' 289' ' ' GLU . 17.9 m -92.01 136.62 33.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.549 0.214 . . . . 0.0 110.542 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 36.5 pt -120.17 168.44 12.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.008 0.432 . . . . 0.0 110.949 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -144.72 133.13 21.9 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.19 174.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 243' ' ' VAL . . . . . 0.54 HG22 HD12 ' B' ' 263' ' ' LEU . 43.9 t -104.49 108.53 25.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.16 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 244' ' ' SER . . . . . 0.629 ' HB3' HD12 ' A' ' 11' ' ' LEU . 8.2 t -139.36 106.79 5.54 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.113 0.482 . . . . 0.0 110.115 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 245' ' ' GLN . . . . . 0.543 ' HB3' ' OE1' ' B' ' 249' ' ' GLN . 1.0 OUTLIER -132.1 -177.25 4.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.327 178.306 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 246' ' ' SER . . . . . 0.448 ' HB3' ' HG3' ' B' ' 249' ' ' GLN . 47.4 t -72.42 150.71 43.12 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.655 173.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -65.1 -16.26 61.86 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.727 177.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -77.56 -16.2 80.52 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.14 175.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 249' ' ' GLN . . . . . 0.543 ' OE1' ' HB3' ' B' ' 245' ' ' GLN . 38.9 mt-30 -92.03 -45.16 8.46 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 50.3 mm -97.33 93.22 3.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.814 0.816 . . . . 0.0 109.842 175.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 20.1 m -118.68 -15.7 9.47 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.049 -176.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 19.9 m -127.72 142.7 45.04 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.75 -39.64 80.18 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.536 2.157 . . . . 0.0 111.828 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 254' ' ' SER . . . . . 0.436 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 4.7 m -62.47 -29.85 70.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.17 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -74.84 -34.78 62.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.004 0.431 . . . . 0.0 110.632 -176.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.433 ' O ' ' HG ' ' B' ' 260' ' ' LEU . 66.1 tp -61.86 -42.5 99.13 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.953 176.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -58.4 -35.56 72.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.981 178.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 258' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' B' ' 254' ' ' SER . 25.1 mm-40 -57.98 -50.87 71.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.333 177.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -66.87 -39.38 87.51 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.337 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 260' ' ' LEU . . . . . 0.503 ' HB3' ' CZ ' ' B' ' 272' ' ' TYR . 97.6 mt -58.11 -45.9 86.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.082 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 22.9 t -66.06 -44.16 85.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.298 0.571 . . . . 0.0 110.27 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 262' ' ' GLU . . . . . 0.446 ' CD ' ' HA ' ' A' ' 16' ' ' SER . 39.1 tt0 -58.43 -42.78 88.05 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.642 -177.008 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 263' ' ' LEU . . . . . 0.54 HD12 HG22 ' B' ' 243' ' ' VAL . 83.7 mt -73.09 -30.33 63.58 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.866 -178.088 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -65.88 -50.98 62.55 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.717 0.294 . . . . 0.0 110.915 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 265' ' ' ASP . . . . . 0.774 ' HB2' ' HB2' ' A' ' 21' ' ' ALA . 16.0 t70 -59.86 -38.1 81.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.949 0.404 . . . . 0.0 110.777 176.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -64.21 -22.31 66.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.496 -178.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 267' ' ' LYS . . . . . 0.41 ' HD3' ' HA ' ' B' ' 267' ' ' LYS . 63.3 mmtt -87.48 -14.61 39.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.504 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 90.95 19.39 43.35 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.423 -175.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -117.63 -166.12 13.84 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 270' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 50.4 mttp -130.19 -66.51 0.77 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.722 0.296 . . . . 0.0 110.533 -178.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 271' ' ' TYR . . . . . 0.528 ' HB3' ' HA ' ' B' ' 224' ' ' GLN . 5.7 m-85 -90.56 153.65 20.19 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -175.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 272' ' ' TYR . . . . . 0.716 ' OH ' ' HA ' ' A' ' 23' ' ' GLU . 27.5 p90 -132.85 129.42 38.42 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.264 0.554 . . . . 0.0 110.759 178.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -101.87 103.19 13.86 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.845 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 274' ' ' ILE . . . . . . . . . . . . . 59.1 mt -67.5 135.7 28.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.408 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 17.8 pt -115.52 -26.51 2.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -157.21 136.96 12.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.532 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -148.11 129.37 14.69 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.512 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.72 173.61 14.41 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.5 149.73 40.81 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.955 0.407 . . . . 0.0 110.318 171.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -95.51 -0.8 51.77 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.657 -178.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 113.86 -90.5 0.54 Allowed Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.323 -174.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.59 -14.62 22.14 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.852 2.368 . . . . 0.0 112.166 177.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -135.03 156.52 48.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.976 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 284' ' ' PHE . . . . . 0.564 ' O ' ' HA ' ' B' ' 244' ' ' SER . 82.7 t80 -110.83 145.63 37.85 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 285' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -138.67 110.1 6.99 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.924 0.393 . . . . 0.0 111.497 -177.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 286' ' ' ALA . . . . . 0.493 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -125.16 145.03 50.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.75 175.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 88.3 t -127.56 131.76 69.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.912 0.387 . . . . 0.0 110.347 177.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -142.57 156.28 45.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.246 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 289' ' ' GLU . . . . . 0.528 ' HG2' HG23 ' B' ' 240' ' ' THR . 35.5 mt-10 -112.76 128.28 56.38 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.339 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 58.4 t -89.02 131.42 36.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.943 0.402 . . . . 0.0 110.979 -176.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -125.23 159.7 30.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.284 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 292' ' ' ASN . . . . . 0.487 ' ND2' ' HA ' ' B' ' 296' ' ' LYS . 10.9 t-20 -118.52 161.79 19.44 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.041 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 293' ' ' ASP . . . . . 0.568 ' HB3' HG22 ' B' ' 295' ' ' THR . 4.6 t70 -76.69 21.98 0.19 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -170.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 294' ' ' ALA . . . . . 0.59 ' HA ' HG23 ' B' ' 236' ' ' VAL . . . 68.56 -8.88 0.58 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.53 0.732 . . . . 0.0 112.108 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 295' ' ' THR . . . . . 0.568 HG22 ' HB3' ' B' ' 293' ' ' ASP . 15.0 t -93.93 -22.27 18.7 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.249 175.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 296' ' ' LYS . . . . . 0.487 ' HA ' ' ND2' ' B' ' 292' ' ' ASN . 28.9 mtpp 71.04 -61.34 0.48 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 114.844 -1.071 . . . . 0.0 112.189 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 297' ' ' LEU . . . . . . . . . . . . . 48.2 mt -63.91 176.43 0.95 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.842 -174.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 298' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -76.01 78.68 2.87 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -171.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 299' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -83.22 61.27 6.01 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 166.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 300' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -152.82 18.29 0.59 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.359 -1.291 . . . . 0.0 107.847 -173.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 301' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -74.69 93.64 2.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.504 -1.225 . . . . 0.0 111.72 -171.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 302' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -154.43 109.77 3.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.37 172.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -86.36 -39.0 16.87 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -178.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 36.4 m80 . . . . . 0 C--N 1.326 -0.441 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 172.769 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 120.797 0.332 . . . . 0.0 110.765 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -164.08 166.11 21.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.346 175.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -97.35 105.98 18.22 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 65.4 mtm180 -101.71 161.72 13.44 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.271 -177.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.1 pt -123.56 155.7 30.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.314 178.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.1 pt -88.07 162.04 2.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.12 -179.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -147.52 153.37 39.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.949 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -133.22 151.88 51.94 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.546 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.07 98.95 3.56 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.578 178.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 60.2 tp -72.37 105.44 4.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.079 177.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.444 ' H ' ' HG ' ' A' ' 11' ' ' LEU . 0.3 OUTLIER -72.07 95.05 1.57 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.77 -177.946 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.31 72.17 10.74 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.255 177.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.2 t -151.92 153.19 33.63 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.384 -178.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 52.6 t -103.59 114.72 43.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.005 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.33 107.05 0.84 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.277 177.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.8 m -84.94 93.21 8.5 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.254 -174.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -82.05 155.37 25.15 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.116 176.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.1 m -155.31 157.41 37.15 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.653 0.263 . . . . 0.0 110.877 -174.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.8 m -68.05 93.52 0.44 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.968 0.413 . . . . 0.0 110.705 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 77.0 mt -142.38 23.62 1.98 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.52 178.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -169.69 -49.03 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.288 -178.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.496 ' HB3' ' HA ' ' B' ' 261' ' ' SER . . . -73.03 100.13 2.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.859 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -151.72 179.41 8.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.612 -176.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.615 ' HB2' ' HB2' ' B' ' 224' ' ' GLN . 0.0 OUTLIER 81.79 167.78 0.13 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.791 0.836 . . . . 0.0 111.765 171.919 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.424 HG12 ' CZ ' ' B' ' 257' ' ' ARG . 31.0 m -126.4 171.97 14.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.47 -178.228 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.545 ' HB2' ' HB ' ' B' ' 274' ' ' ILE . 10.8 t -112.66 -149.73 0.45 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.093 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.524 ' HA ' HD12 ' A' ' 30' ' ' ILE . 18.2 ttpt -97.86 -17.15 19.46 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 122.088 -0.382 . . . . 0.0 110.44 178.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -62.95 -42.53 99.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.951 -176.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.655 ' HG2' HH22 ' B' ' 257' ' ' ARG . 3.4 mp0 -68.83 -31.18 69.97 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.495 178.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.524 HD12 ' HA ' ' A' ' 27' ' ' LYS . 62.7 mt -64.68 -51.29 69.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.443 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.8 m -69.44 -27.87 65.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.407 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 22.2 m170 -84.1 -58.11 2.91 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.979 0.362 . . . . 0.0 111.979 -178.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -99.17 -11.75 21.08 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -169.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.423 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 3.8 mppt? 60.12 84.56 0.12 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.233 0.54 . . . . 0.0 110.799 -177.341 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 90.4 mt -73.81 151.44 40.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.031 -177.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 63.1 t -91.22 108.86 20.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.025 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -83.61 130.48 34.98 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.208 0.528 . . . . 0.0 110.836 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.483 HG13 ' HB2' ' A' ' 92' ' ' ASN . 6.4 m -92.03 -20.94 6.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.847 178.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.27 171.27 22.39 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.608 178.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 35.0 m -106.43 129.57 54.38 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.8 pt -102.92 151.46 6.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -128.49 123.77 34.43 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.095 0.474 . . . . 0.0 110.663 -171.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.753 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 57.3 t -93.54 109.05 21.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 174.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.6 t -141.38 78.71 1.65 Allowed 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -106.7 138.52 42.73 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.984 -177.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.0 m -83.66 94.15 8.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.865 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.89 -169.72 13.06 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.521 178.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.28 55.64 4.36 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.412 -0.423 . . . . 0.0 113.383 -176.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -75.94 -21.23 57.26 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.406 0.622 . . . . 0.0 109.421 173.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.1 mm -119.46 98.63 6.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.148 -0.933 . . . . 0.0 108.65 172.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 77.2 p -111.56 -40.93 4.21 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.229 -173.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.401 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 12.6 m -119.54 161.72 36.08 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.65 -177.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 52' ' ' SER . 9.3 Cg_endo -53.38 -29.47 48.36 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.728 2.285 . . . . 0.0 111.78 176.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.542 ' HA ' ' NE ' ' A' ' 57' ' ' ARG . 23.7 m -59.04 -38.92 80.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.621 177.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.476 ' O ' ' HD3' ' A' ' 59' ' ' LYS . 59.5 m-20 -63.54 -53.23 55.07 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -174.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 23.1 tp -54.92 -49.71 70.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.258 -173.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.542 ' NE ' ' HA ' ' A' ' 54' ' ' SER . 25.7 ptt180 -63.34 -42.68 98.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.355 -178.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 54' ' ' SER . 43.3 mt-10 -69.54 -46.89 65.42 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.672 0.272 . . . . 0.0 111.161 -176.009 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.476 ' HD3' ' O ' ' A' ' 55' ' ' ASP . 14.5 mptt -59.77 -45.86 90.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.527 178.263 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.541 HD21 ' CG2' ' A' ' 43' ' ' VAL . 79.7 mt -75.04 -30.82 61.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.146 -175.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.7 m -60.48 -41.43 94.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.023 0.439 . . . . 0.0 110.312 174.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -63.66 -46.94 83.31 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.402 177.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 88.6 mt -69.5 -48.48 60.49 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.862 -177.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.2 -50.93 68.35 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -174.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.578 ' OD2' ' HA ' ' B' ' 218' ' ' SER . 23.9 t70 -63.88 -37.36 87.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.909 0.385 . . . . 0.0 111.004 -176.023 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.95 -19.34 62.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.439 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 67' ' ' LYS . 70.3 mmtt -85.04 -5.73 59.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.955 0.407 . . . . 0.0 110.866 177.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.906 ' HA2' ' HA ' ' B' ' 216' ' ' SER . . . 106.97 -28.45 13.04 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.351 177.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.61 ' HA3' HG12 ' A' ' 90' ' ' VAL . . . -79.84 179.42 53.2 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.911 -0.662 . . . . 0.0 111.789 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.639 ' HA ' ' NZ ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -112.43 -72.85 0.69 Allowed 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.162 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.593 ' HB2' ' HA ' ' A' ' 24' ' ' GLN . 0.6 OUTLIER -96.5 155.65 16.68 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.845 -176.349 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.784 ' CD1' ' HB1' ' B' ' 222' ' ' ALA . 3.9 p90 -109.34 170.94 7.74 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.259 -177.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 23.6 t-80 -141.0 103.38 4.46 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.491 ' H ' HD12 ' A' ' 74' ' ' ILE . 2.9 mp -65.12 132.01 30.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.029 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 32.1 pt -133.02 -5.76 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.686 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.431 ' HB3' ' HB ' ' A' ' 87' ' ' VAL . . . -165.92 144.73 5.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.739 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -158.56 137.9 11.64 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 177.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -166.15 141.15 4.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.945 0.402 . . . . 0.0 111.363 -178.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -77.93 96.19 4.97 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 170.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -90.44 77.5 6.52 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.677 -177.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.1 -120.42 13.68 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -175.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -86.33 -0.68 8.34 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.518 2.145 . . . . 0.0 111.869 176.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -107.96 110.41 22.13 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.57 -176.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -79.44 104.33 9.98 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 173.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.753 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 23.3 mt-10 -104.06 123.14 46.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.191 0.519 . . . . 0.0 111.484 -175.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.522 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -130.82 126.84 37.33 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.856 176.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.431 ' HB ' ' HB3' ' A' ' 76' ' ' ALA . 41.9 t -105.62 121.53 57.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.428 -176.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.47 135.95 32.49 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.794 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 40' ' ' THR . 29.3 mt-10 -96.35 150.17 20.88 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.61 HG12 ' HA3' ' A' ' 69' ' ' GLY . 8.2 t -110.56 133.59 55.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 -179.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.495 ' HB2' ' HE1' ' A' ' 71' ' ' TYR . 54.1 m-85 -116.77 151.1 37.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.25 0.547 . . . . 0.0 110.889 -178.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.483 ' HB2' HG13 ' A' ' 38' ' ' VAL . 8.2 t-20 -106.13 21.96 16.49 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.926 -177.163 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.403 ' HA ' ' OH ' ' A' ' 71' ' ' TYR . 6.2 t70 66.11 -155.03 0.25 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.174 -175.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -115.34 10.88 15.97 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.069 0.462 . . . . 0.0 110.076 177.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.6 t -159.33 172.73 17.45 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.94 -178.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -109.91 160.77 16.1 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.828 0.347 . . . . 0.0 110.216 178.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.414 ' H ' ' HG ' ' A' ' 97' ' ' LEU . 2.9 pp -68.15 150.23 48.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.057 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.04 -168.34 2.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.643 -178.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 61.8 m80 -96.09 90.92 5.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.093 0.473 . . . . 0.0 111.766 -174.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.84 104.25 11.23 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 170.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 28.5 m170 -65.71 112.21 3.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.072 -172.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 38.7 p-80 -155.12 134.15 12.26 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.449 176.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 70.0 m-70 -92.16 -19.77 21.91 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.26 173.777 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 4.2 mpp? . . . . . 0 N--CA 1.483 1.205 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 60.6 tptt -80.3 96.78 6.74 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.166 177.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt 68.02 165.26 0.23 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.143 -179.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 74.0 mtm180 -117.0 88.79 2.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.966 0.413 . . . . 0.0 110.481 176.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 59.4 mt -119.32 96.07 4.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.794 177.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 42.8 mt -102.17 93.68 2.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.733 -178.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -107.09 86.03 2.24 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.164 177.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -148.2 37.94 0.87 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.419 -176.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -75.63 77.57 2.62 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.794 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 210' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -162.86 131.94 4.13 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 2.2 pp -132.79 161.83 33.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.566 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -129.5 -54.25 1.17 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.072 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 213' ' ' THR . . . . . . . . . . . . . 3.0 m 60.65 75.59 0.4 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.906 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 214' ' ' VAL . . . . . 0.576 HG13 ' H ' ' B' ' 215' ' ' ALA . 3.4 p -84.29 -62.47 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.803 -176.277 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 215' ' ' ALA . . . . . 0.576 ' H ' HG13 ' B' ' 214' ' ' VAL . . . -158.2 174.35 15.32 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -178.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 216' ' ' SER . . . . . 0.906 ' HA ' ' HA2' ' A' ' 68' ' ' GLY . 4.5 p -125.35 128.38 48.09 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.896 0.379 . . . . 0.0 111.019 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -137.86 133.83 34.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.916 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 218' ' ' SER . . . . . 0.578 ' HA ' ' OD2' ' A' ' 65' ' ' ASP . 16.4 m -77.59 115.99 17.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.133 -177.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 219' ' ' THR . . . . . 0.649 HG22 ' H ' ' B' ' 220' ' ' LEU . 1.3 m -150.03 -152.86 0.46 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.137 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.649 ' H ' HG22 ' B' ' 219' ' ' THR . 89.4 mt -59.2 141.05 55.24 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 173.101 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -113.03 -112.84 0.34 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -169.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 222' ' ' ALA . . . . . 0.784 ' HB1' ' CD1' ' A' ' 72' ' ' TYR . . . -129.8 106.15 8.49 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -164.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 223' ' ' GLU . . . . . 0.831 ' HB3' ' HE1' ' B' ' 271' ' ' TYR . 30.0 mt-10 -143.98 105.63 4.3 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 224' ' ' GLN . . . . . 0.615 ' HB2' ' HB2' ' A' ' 24' ' ' GLN . 1.2 tt0 173.56 179.87 0.09 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.298 0.639 . . . . 0.0 109.287 172.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 225' ' ' VAL . . . . . 0.546 HG11 HD11 ' B' ' 235' ' ' LEU . 15.8 m -138.84 157.86 29.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 120.622 0.248 . . . . 0.0 110.774 178.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 81.2 p -110.2 -92.88 0.44 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.072 178.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 227' ' ' LYS . . . . . 0.489 ' C ' ' HD3' ' B' ' 227' ' ' LYS . 8.1 tmtm? -133.42 -52.99 0.89 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.813 0.34 . . . . 0.0 110.959 -176.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -59.96 -45.43 92.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.278 -172.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 229' ' ' GLU . . . . . 0.604 ' CD ' ' H ' ' B' ' 229' ' ' GLU . 2.0 mp0 -60.58 -45.12 95.14 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.991 -177.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.552 HG12 HD12 ' B' ' 235' ' ' LEU . 49.1 mt -60.72 -49.77 83.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.119 -176.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 25.4 m -67.21 -21.26 65.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.465 -177.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -94.21 -44.07 8.15 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.597 -174.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -92.34 -8.73 44.21 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -175.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 10.6 mmmm 63.03 75.62 0.39 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.088 0.471 . . . . 0.0 111.042 176.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 235' ' ' LEU . . . . . 0.552 HD12 HG12 ' B' ' 230' ' ' ILE . 68.6 mt -83.77 161.68 20.9 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.293 0.568 . . . . 0.0 111.574 -177.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 65.2 t -95.63 129.18 46.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.348 176.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 237' ' ' LYS . . . . . 0.42 ' HE3' ' HB3' ' B' ' 289' ' ' GLU . 85.4 tttt -102.32 146.07 28.57 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -179.351 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 238' ' ' VAL . . . . . 0.55 HG13 ' HB2' ' B' ' 292' ' ' ASN . 2.5 m -127.4 9.36 3.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 239' ' ' GLY . . . . . 0.401 ' H ' ' HG2' ' B' ' 237' ' ' LYS . . . 133.62 -161.92 24.32 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 119.942 -1.123 . . . . 0.0 113.191 174.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 240' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' B' ' 289' ' ' GLU . 29.2 m -140.18 133.35 29.63 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 33.3 pt -109.49 147.37 13.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.214 0.531 . . . . 0.0 111.031 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -112.82 118.06 33.89 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.25 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 243' ' ' VAL . . . . . 0.674 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 22.1 t -93.83 113.46 28.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 176.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 244' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' B' ' 284' ' ' PHE . 47.7 t -125.38 100.97 6.74 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.72 0.295 . . . . 0.0 110.228 -176.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 245' ' ' GLN . . . . . 0.587 ' HG3' HG12 ' B' ' 250' ' ' ILE . 9.2 mm-40 -90.63 -175.94 4.57 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.611 0.72 . . . . 0.0 111.453 -177.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 68.6 m -143.49 113.45 7.18 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.699 176.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 66.3 -118.85 11.6 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.135 177.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -98.3 42.2 2.11 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.181 -0.533 . . . . 0.0 113.49 -172.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 249' ' ' GLN . . . . . 0.57 ' HB2' ' HB3' ' B' ' 245' ' ' GLN . 19.9 mm-40 -77.78 -22.19 50.56 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 173.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 250' ' ' ILE . . . . . 0.587 HG12 ' HG3' ' B' ' 245' ' ' GLN . 43.8 mm -121.51 96.36 4.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.34 175.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 39.4 t -96.64 -24.31 16.06 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.321 0.581 . . . . 0.0 109.583 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 73.8 p -138.23 162.85 51.4 Favored Pre-proline 0 N--CA 1.447 -0.625 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.65 -179.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.93 -22.59 74.61 Favored 'Trans proline' 0 C--O 1.238 0.482 0 C-N-CA 122.019 1.813 . . . . 0.0 111.263 173.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 254' ' ' SER . . . . . . . . . . . . . 2.3 m -66.09 -42.79 88.83 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.566 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.467 ' O ' ' HG2' ' B' ' 259' ' ' LYS . 30.1 m-20 -54.92 -39.01 68.37 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.013 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.429 ' O ' ' HG ' ' B' ' 260' ' ' LEU . 45.2 tp -58.83 -42.58 89.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.848 -178.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 257' ' ' ARG . . . . . 0.655 HH22 ' HG2' ' A' ' 29' ' ' GLU . 0.1 OUTLIER -67.92 -31.37 71.1 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.154 0.502 . . . . 0.0 110.028 -179.161 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 258' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' B' ' 255' ' ' ASP . 52.7 mm-40 -61.18 -41.45 96.83 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.424 178.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 259' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' B' ' 255' ' ' ASP . 16.0 mmmt -77.15 -42.04 39.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.766 -179.383 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 260' ' ' LEU . . . . . 0.455 HD13 ' CE2' ' B' ' 272' ' ' TYR . 97.3 mt -60.33 -42.96 96.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.768 -177.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 261' ' ' SER . . . . . 0.496 ' HA ' ' HB3' ' A' ' 22' ' ' ALA . 67.8 m -58.32 -48.97 78.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.955 0.407 . . . . 0.0 110.988 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -64.33 -41.89 96.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.023 -177.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 263' ' ' LEU . . . . . 0.459 ' O ' ' HG2' ' B' ' 267' ' ' LYS . 94.0 mt -74.12 -51.04 16.88 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -176.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -66.99 -48.14 69.36 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -172.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -67.09 -32.37 73.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.944 0.402 . . . . 0.0 110.62 -174.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -82.68 -9.91 59.16 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.245 -177.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 267' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' B' ' 263' ' ' LEU . 67.6 mmtt -87.48 -2.41 58.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.677 0.275 . . . . 0.0 111.279 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 91.98 7.85 63.88 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.031 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -108.75 -174.45 21.53 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 176.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 270' ' ' LYS . . . . . 0.652 ' HA ' ' HE2' ' B' ' 270' ' ' LYS . 8.4 mmpt? -127.41 -62.91 1.07 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.942 0.401 . . . . 0.0 110.876 -178.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 271' ' ' TYR . . . . . 0.831 ' HE1' ' HB3' ' B' ' 223' ' ' GLU . 90.1 m-85 -102.43 173.33 6.4 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.125 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 272' ' ' TYR . . . . . 0.455 ' CE2' HD13 ' B' ' 260' ' ' LEU . 17.6 p90 -149.87 169.4 21.21 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.519 -178.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -139.63 110.01 6.59 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.813 0.34 . . . . 0.0 110.622 174.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 274' ' ' ILE . . . . . 0.545 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 47.6 mt -70.69 113.19 6.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.063 175.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 25.2 pt -100.04 -23.56 4.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.814 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -160.52 146.6 15.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.358 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 277' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' B' ' 285' ' ' GLU . . . -157.03 111.03 2.66 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 177.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 278' ' ' ARG . . . . . 0.442 ' HD2' ' H ' ' B' ' 278' ' ' ARG . 0.0 OUTLIER -129.31 150.46 50.67 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.651 -174.818 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -84.81 95.8 9.09 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 172.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 17.3 t-80 -91.61 84.85 5.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.055 0.455 . . . . 0.0 109.932 -177.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 66.76 -125.48 25.61 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.386 -175.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -85.15 -8.56 8.83 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.598 2.199 . . . . 0.0 111.965 175.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 283' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' B' ' 245' ' ' GLN . 15.1 m120 -103.81 109.98 21.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.676 -177.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 284' ' ' PHE . . . . . 0.51 ' HB3' ' HB2' ' B' ' 245' ' ' GLN . 78.3 t80 -78.76 120.02 22.81 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 175.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 285' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' B' ' 277' ' ' ALA . 97.2 mt-10 -108.72 110.92 22.45 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.41 0.444 . . . . 0.0 111.155 -176.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 286' ' ' ALA . . . . . 0.674 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -111.53 123.14 49.61 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 172.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 28.5 t -105.12 113.31 41.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.312 -178.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -130.84 128.81 41.4 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.678 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 289' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' B' ' 240' ' ' THR . 17.2 mt-10 -92.38 135.46 34.02 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 23.6 t -97.67 137.84 24.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.142 0.496 . . . . 0.0 111.496 -170.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -118.3 149.5 41.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.159 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 292' ' ' ASN . . . . . 0.56 ' OD1' ' HG2' ' B' ' 296' ' ' LYS . 8.0 t-20 -95.37 21.95 7.48 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.881 -171.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 293' ' ' ASP . . . . . 0.455 ' HB3' ' O ' ' B' ' 292' ' ' ASN . 10.8 t70 78.36 -28.92 0.16 Allowed 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.562 172.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 294' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' B' ' 293' ' ' ASP . . . 82.36 -9.4 1.17 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.507 1.123 . . . . 0.0 111.085 -178.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 295' ' ' THR . . . . . . . . . . . . . 8.9 m -107.25 -21.76 12.84 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.455 174.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 296' ' ' LYS . . . . . 0.56 ' HG2' ' OD1' ' B' ' 292' ' ' ASN . 68.2 mttm 69.79 -80.98 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.335 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 297' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -175.84 -168.79 0.3 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.744 -175.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 298' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.34 111.63 5.36 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 176.074 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 299' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -142.41 48.23 1.56 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.369 0.604 . . . . 0.0 110.276 -176.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 300' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.39 128.88 30.17 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.373 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 301' ' ' HIS . . . . . . . . . . . . . 20.5 m80 61.39 86.35 0.11 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.943 177.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 302' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -140.43 94.91 2.79 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -81.22 -49.08 11.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.539 -177.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 78.9 t60 . . . . . 0 C--N 1.325 -0.483 0 C-N-CA 120.605 -0.438 . . . . 0.0 109.85 177.479 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -78.33 146.97 34.41 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.169 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -152.82 154.09 34.44 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.269 -174.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 10.9 ptp85 -138.11 150.73 47.12 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 177.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.7 tt -99.58 113.7 35.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.371 0.605 . . . . 0.0 110.425 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 34.6 pt -117.68 140.06 42.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.033 -177.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -128.61 100.05 5.6 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.76 175.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.9 -71.66 0.18 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.445 -176.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -138.36 132.64 31.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.078 -178.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.789 ' H ' HD23 ' A' ' 10' ' ' LEU . 1.6 pt? -100.46 95.98 7.09 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.261 0.553 . . . . 0.0 110.45 178.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.7 mt -133.63 118.57 18.36 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.499 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.55 103.23 6.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.07 0.462 . . . . 0.0 109.824 176.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.8 t -70.26 -21.96 62.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.432 -176.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.0 t 62.46 82.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.094 0 CA-C-O 121.543 0.687 . . . . 0.0 109.865 -175.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -122.42 76.79 1.35 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.885 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.3 m -86.13 111.58 20.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.257 -175.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -140.37 -60.96 0.52 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.06 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.9 p -166.11 126.34 1.71 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.627 -178.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.765 HG23 ' HB2' ' B' ' 265' ' ' ASP . 0.1 OUTLIER -78.16 42.99 0.42 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -176.266 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.403 HD23 HD13 ' B' ' 220' ' ' LEU . 96.3 mt -78.23 73.15 4.79 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 176.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 173.96 -28.56 0.0 OUTLIER 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.829 -174.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.63 112.71 18.3 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -170.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 178.95 104.65 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.584 178.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.622 ' HB2' ' HB3' ' B' ' 224' ' ' GLN . 1.4 tm0? -162.14 155.64 20.87 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 122.052 -0.405 . . . . 0.0 110.873 -179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.8 m -115.75 143.93 24.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.966 174.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.634 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 11.8 t -108.05 -90.45 0.44 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -174.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.424 ' HD3' ' O ' ' A' ' 27' ' ' LYS . 10.7 tmtt? -145.88 -45.73 0.21 Allowed 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -173.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.42 ' CB ' ' HB3' ' B' ' 277' ' ' ALA . 27.7 mm-40 -54.58 -49.85 69.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.996 -174.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' A' ' 29' ' ' GLU . 0.9 OUTLIER -68.85 -43.75 74.8 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.713 -176.129 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.553 HG12 HD12 ' A' ' 35' ' ' LEU . 54.7 mt -62.1 -43.64 98.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.66 -175.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.4 m -72.6 -24.38 61.07 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.928 0.394 . . . . 0.0 111.274 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -91.56 -32.85 15.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.533 -173.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.493 ' HA ' ' HB2' ' A' ' 103' ' ' HIS . 80.4 m-85 -110.1 -12.5 14.5 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -177.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt 65.93 82.98 0.17 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.165 0.507 . . . . 0.0 111.719 -178.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.553 HD12 HG12 ' A' ' 30' ' ' ILE . 22.0 mt -89.88 147.91 23.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.2 177.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.1 m -85.03 122.36 38.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.711 -177.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.1 ttmm -85.54 117.53 24.5 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 177.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.1 t -78.39 -28.08 14.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.155 0.502 . . . . 0.0 109.939 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 167.45 -175.99 42.35 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.854 179.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.486 HG21 ' HB3' ' B' ' 207' ' ' ALA . 26.6 m -130.28 123.47 30.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.055 0.455 . . . . 0.0 110.243 178.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.419 HD12 HD12 ' A' ' 63' ' ' LEU . 25.3 pt -120.28 166.07 15.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.413 -176.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -145.77 147.53 31.98 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.491 0.663 . . . . 0.0 111.169 176.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 75.0 t -94.56 142.64 13.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.551 177.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.6 t -159.6 79.73 0.72 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.189 0.519 . . . . 0.0 109.765 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.403 HE22 HG13 ' A' ' 43' ' ' VAL . 0.9 OUTLIER -113.8 150.04 34.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.358 178.365 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.7 t -111.61 112.73 24.65 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.622 -175.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.61 -144.93 17.45 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.226 176.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.3 74.54 1.68 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 121.603 -0.332 . . . . 0.0 113.781 -173.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -121.65 -36.73 2.99 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.154 0.502 . . . . 0.0 109.796 169.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.458 HG23 ' HB2' ' A' ' 55' ' ' ASP . 72.1 mt -133.52 123.01 45.35 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.493 176.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.7 m -143.64 -27.98 0.54 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.0 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.3 p -113.73 154.87 45.68 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 175.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.74 -25.0 58.28 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.824 2.349 . . . . 0.0 112.879 -176.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.628 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 11.8 p -67.24 -40.9 86.35 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.92 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.458 ' HB2' HG23 ' A' ' 50' ' ' ILE . 37.3 m-20 -58.63 -41.78 86.76 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.117 0.485 . . . . 0.0 110.624 -176.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 45.2 tp -63.23 -45.76 90.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.307 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.503 ' HD2' ' OE2' ' B' ' 223' ' ' GLU . 42.9 ttp180 -61.32 -40.5 94.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.983 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.628 ' HG2' ' O ' ' A' ' 54' ' ' SER . 9.4 mm-40 -59.18 -30.98 68.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.454 -177.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.433 ' O ' ' HB3' ' A' ' 62' ' ' GLU . 4.3 mptp? -93.86 -37.09 11.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.775 -177.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 86.5 mt -70.42 -39.7 74.27 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.019 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.0 t -69.2 -34.7 75.29 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 176.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.433 ' HB3' ' O ' ' A' ' 59' ' ' LYS . 34.4 tt0 -56.8 -49.32 75.68 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.87 177.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.419 HD12 HD12 ' A' ' 41' ' ' ILE . 73.8 mt -74.43 -30.36 61.88 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.742 -178.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.82 -50.98 53.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.433 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -68.23 -25.43 65.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.158 0.504 . . . . 0.0 110.41 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.45 -42.29 59.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.13 178.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.461 ' HE2' ' HA ' ' B' ' 212' ' ' ALA . 59.0 mmtt -77.13 -35.66 56.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.394 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.57 59.94 0.63 Allowed Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.605 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.672 ' HA2' ' HA ' ' A' ' 92' ' ' ASN . . . -143.93 160.87 27.82 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 177.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -107.63 -15.71 14.52 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.777 0.289 . . . . 0.0 111.267 -175.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.403 ' OH ' ' HD3' ' B' ' 257' ' ' ARG . 2.9 m-85 -140.47 145.63 37.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.642 0.258 . . . . 0.0 110.362 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.61 ' HD2' ' HB1' ' B' ' 222' ' ' ALA . 21.4 p90 -116.53 168.08 10.48 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 171.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.634 ' CD2' ' HA ' ' A' ' 26' ' ' SER . 10.0 t-160 -140.0 108.21 5.79 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.204 178.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 76.6 mt -71.76 118.59 16.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.188 177.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.9 pt -114.89 -18.58 7.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -152.92 100.42 2.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.826 0.345 . . . . 0.0 111.235 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -115.31 115.12 26.11 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -138.08 160.3 39.74 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.252 0.548 . . . . 0.0 111.614 -172.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -104.7 103.93 13.65 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.738 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.513 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 2.6 t-160 -94.75 56.88 2.09 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -176.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.67 -122.82 5.83 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.769 -0.933 . . . . 0.0 110.769 -175.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -83.94 10.52 3.66 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.372 2.048 . . . . 0.0 111.7 174.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.513 ' HB2' ' HB3' ' A' ' 80' ' ' HIS . 17.3 m-80 -113.48 127.27 56.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.282 -176.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -97.67 111.88 23.98 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.622 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 42.0 mt-10 -116.12 119.83 37.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.04 0.448 . . . . 0.0 110.957 -177.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -130.12 118.25 21.19 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.507 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.1 t -95.27 127.74 47.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 73' ' ' HIS . . . -136.62 144.72 44.23 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.389 -175.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -91.57 147.27 23.13 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 176.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 43.9 t -106.46 122.02 59.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -121.31 139.1 53.87 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.817 0.342 . . . . 0.0 110.079 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.672 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 26.2 t-20 -77.4 -89.42 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.202 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.5 t70 172.62 -48.77 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 70.29 1.0 3.4 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 114.338 -1.301 . . . . 0.0 113.601 169.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.446 ' OG1' ' HG2' ' B' ' 253' ' ' PRO . 32.2 m -66.16 -44.68 83.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.717 0.294 . . . . 0.0 110.918 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -83.72 -6.33 59.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.955 0.407 . . . . 0.0 110.843 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 93.6 mt -101.17 179.65 4.31 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.195 -173.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -76.1 65.67 2.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.075 -176.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -86.1 87.55 7.44 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.776 0.798 . . . . 0.0 110.227 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -86.96 24.89 1.41 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.41 0.624 . . . . 0.0 110.328 177.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -103.01 118.59 37.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.861 171.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -83.47 149.3 26.73 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.493 ' HB2' ' HA ' ' A' ' 33' ' ' PHE . 31.6 p-80 -89.51 161.3 16.29 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.102 -178.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 56.2 t60 . . . . . 0 C--N 1.32 -0.695 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.789 177.405 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 201' ' ' MET . . . . . 0.4 ' O ' ' HB2' ' B' ' 202' ' ' LYS . 83.9 mtp . . . . . 0 N--CA 1.485 1.275 0 CA-C-O 120.595 0.236 . . . . 0.0 110.392 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 202' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' B' ' 201' ' ' MET . 27.6 mmmt 69.88 -67.69 0.22 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.374 0.67 . . . . 0.0 111.917 -178.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 203' ' ' LYS . . . . . 0.455 ' HB3' HD11 ' B' ' 205' ' ' ILE . 62.0 mttp -76.55 102.4 6.06 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.466 -175.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 65.1 mtm180 -115.67 94.55 4.74 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 172.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 205' ' ' ILE . . . . . 0.455 HD11 ' HB3' ' B' ' 203' ' ' LYS . 4.8 mp -100.38 120.34 49.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.817 0.341 . . . . 0.0 110.754 -175.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 1.4 pp -122.78 62.03 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.564 0.697 . . . . 0.0 110.563 177.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 207' ' ' ALA . . . . . 0.486 ' HB3' HG21 ' A' ' 40' ' ' THR . . . -75.43 123.5 25.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.498 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -111.97 110.24 20.45 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.938 0.399 . . . . 0.0 111.827 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -109.91 -50.03 3.02 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 172.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 210' ' ' LEU . . . . . . . . . . . . . 10.6 mp 66.88 -172.3 0.19 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.642 172.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 211' ' ' LEU . . . . . 0.441 HD22 ' HA ' ' B' ' 211' ' ' LEU . 0.3 OUTLIER 65.17 90.53 0.09 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.982 -179.213 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 212' ' ' ALA . . . . . 0.461 ' HA ' ' HE2' ' A' ' 67' ' ' LYS . . . -135.16 147.98 49.58 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.982 178.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 213' ' ' THR . . . . . . . . . . . . . 12.3 p -90.71 -171.12 2.93 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.973 -178.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 214' ' ' VAL . . . . . . . . . . . . . 3.0 p -124.51 114.58 41.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.14 0.495 . . . . 0.0 110.768 -178.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -148.8 150.29 32.81 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 8.9 t -156.95 77.79 0.89 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.27 0.557 . . . . 0.0 109.765 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -110.46 -30.16 7.78 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.516 178.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 218' ' ' SER . . . . . . . . . . . . . 32.3 t -89.05 98.25 11.66 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 174.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 1.7 p -62.48 -30.49 71.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.326 -178.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.403 HD13 HD23 ' A' ' 20' ' ' LEU . 60.4 tp -106.55 100.04 9.59 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 173.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -168.41 105.68 0.46 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.162 -178.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 222' ' ' ALA . . . . . 0.61 ' HB1' ' HD2' ' A' ' 72' ' ' TYR . . . 68.71 97.95 0.06 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 123.993 0.808 . . . . 0.0 112.656 171.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 223' ' ' GLU . . . . . 0.522 ' O ' ' HB2' ' A' ' 24' ' ' GLN . 34.7 mt-10 -139.98 -156.46 0.68 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.631 -178.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 224' ' ' GLN . . . . . 0.622 ' HB3' ' HB2' ' A' ' 24' ' ' GLN . 0.8 OUTLIER 68.76 144.32 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.034 0.534 . . . . 0.0 112.352 176.503 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 2.4 m -118.87 172.87 5.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.686 -177.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 226' ' ' SER . . . . . 0.543 ' HA ' ' CD2' ' B' ' 273' ' ' HIS . 13.4 t -101.8 -96.02 0.28 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -176.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -142.53 -41.21 0.33 Allowed 'General case' 0 C--O 1.233 0.236 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -173.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -62.78 -30.7 71.66 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.76 0.79 . . . . 0.0 110.023 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -70.99 -34.52 71.46 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.625 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.506 HG23 ' HB2' ' B' ' 235' ' ' LEU . 56.4 mt -59.27 -43.38 89.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.153 0.502 . . . . 0.0 109.988 177.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 42.6 t -63.48 -30.15 71.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.668 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -84.54 -46.49 11.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.96 -176.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -93.89 -14.28 26.22 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -171.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? 62.52 88.91 0.09 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.289 0.566 . . . . 0.0 110.798 -176.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 235' ' ' LEU . . . . . 0.597 HD13 ' HE1' ' B' ' 271' ' ' TYR . 81.6 mt -108.9 155.43 20.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.08 -177.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 73.3 t -115.19 113.02 42.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.535 -172.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.2 140.05 58.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.91 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 1.9 m -122.85 5.78 5.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 138.62 -160.17 25.54 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.173 -1.013 . . . . 0.0 112.788 176.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 240' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' B' ' 289' ' ' GLU . 8.8 m -140.54 146.14 37.7 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -176.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 241' ' ' ILE . . . . . 0.524 ' HB ' HD13 ' B' ' 263' ' ' LEU . 26.4 pt -113.19 143.98 21.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 174.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -127.15 123.05 35.82 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.223 0.535 . . . . 0.0 110.684 -174.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 243' ' ' VAL . . . . . 0.674 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 75.3 t -100.15 116.14 42.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.448 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 72.7 m -135.96 87.87 2.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.332 177.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 245' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -142.43 163.11 33.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.575 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 37.7 t -78.14 174.68 10.9 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.208 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -70.4 4.6 8.52 Favored Glycine 0 CA--C 1.521 0.408 0 CA-C-N 116.363 -0.38 . . . . 0.0 113.041 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -80.55 -35.54 25.55 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.453 174.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -94.66 -21.5 18.75 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.924 0.393 . . . . 0.0 110.581 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 42.0 mm -119.45 99.29 7.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 176.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 16.7 t -130.9 -52.94 1.05 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.851 0.358 . . . . 0.0 110.524 -177.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 252' ' ' SER . . . . . 0.427 ' HB3' ' HD2' ' B' ' 253' ' ' PRO . 23.1 m -109.9 159.71 30.77 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.213 178.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 253' ' ' PRO . . . . . 0.452 ' HB3' HD21 ' A' ' 35' ' ' LEU . 11.1 Cg_endo -55.87 -39.78 89.08 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.826 2.351 . . . . 0.0 112.841 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 254' ' ' SER . . . . . 0.508 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 66.7 m -60.98 -31.87 71.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.211 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -64.13 -50.19 69.22 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.061 0.458 . . . . 0.0 110.249 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 48.6 tp -62.05 -38.38 88.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.541 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 257' ' ' ARG . . . . . 0.403 ' HD3' ' OH ' ' A' ' 71' ' ' TYR . 43.7 ttp180 -56.99 -51.03 70.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.754 178.224 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 258' ' ' GLU . . . . . 0.508 ' HG2' ' O ' ' B' ' 254' ' ' SER . 10.2 mm-40 -63.9 -38.9 92.81 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.934 -178.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -63.99 -46.36 84.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.628 178.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 94.6 mt -65.89 -38.88 89.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.711 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 47.3 t -62.42 -40.08 95.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.432 176.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -60.85 -43.24 98.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.42 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 263' ' ' LEU . . . . . 0.524 HD13 ' HB ' ' B' ' 241' ' ' ILE . 94.1 mt -74.06 -39.49 63.44 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.392 -178.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -64.67 -44.56 90.0 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.73 0.3 . . . . 0.0 111.447 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 265' ' ' ASP . . . . . 0.765 ' HB2' HG23 ' A' ' 19' ' ' THR . 38.9 t70 -68.72 -31.73 71.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.078 0.466 . . . . 0.0 110.174 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -67.06 -35.78 80.59 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.779 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -75.57 -37.21 60.08 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.024 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 89.25 31.98 11.13 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.374 -176.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -94.3 -176.9 38.98 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.568 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 270' ' ' LYS . . . . . 0.468 ' HG2' HD22 ' B' ' 292' ' ' ASN . 30.1 mmtp -112.1 -12.94 13.62 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.426 -177.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 271' ' ' TYR . . . . . 0.597 ' HE1' HD13 ' B' ' 235' ' ' LEU . 43.5 p90 -167.52 175.71 6.97 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 173.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 272' ' ' TYR . . . . . 0.544 ' H ' ' HG3' ' B' ' 224' ' ' GLN . 43.9 p90 -133.04 123.93 26.71 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 273' ' ' HIS . . . . . 0.543 ' CD2' ' HA ' ' B' ' 226' ' ' SER . 6.1 t-160 -95.04 102.12 13.91 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.095 -0.642 . . . . 0.0 110.257 -177.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 274' ' ' ILE . . . . . . . . . . . . . 62.1 mt -66.36 111.63 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.185 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 20.0 pt -103.2 -35.66 3.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -178.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -159.76 113.86 2.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.003 0.43 . . . . 0.0 111.365 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 277' ' ' ALA . . . . . 0.56 ' HA ' ' HA ' ' B' ' 286' ' ' ALA . . . -122.37 107.43 12.07 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 174.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -128.18 138.54 52.52 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.644 0.735 . . . . 0.0 111.55 -169.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -78.88 133.63 36.96 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.363 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -134.08 101.1 4.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.009 0.433 . . . . 0.0 110.704 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 64.46 -129.49 36.84 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.858 -178.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -88.71 8.38 3.99 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.235 2.624 . . . . 0.0 112.489 178.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -124.57 155.77 38.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.965 0.412 . . . . 0.0 110.726 -177.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 284' ' ' PHE . . . . . 0.493 ' CE2' ' HB2' ' B' ' 286' ' ' ALA . 83.2 t80 -111.62 125.17 53.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.241 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 285' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 8.3 mm-40 -109.7 110.86 22.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.282 -178.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 286' ' ' ALA . . . . . 0.674 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -119.82 125.51 48.73 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.329 179.238 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 25.8 t -111.65 118.62 57.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.364 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -135.19 135.92 41.39 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.868 177.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 289' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' B' ' 240' ' ' THR . 2.4 mt-10 -98.3 140.43 32.59 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -178.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 40.3 t -101.4 129.66 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -176.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 291' ' ' TYR . . . . . 0.552 ' HB2' ' CZ ' ' B' ' 271' ' ' TYR . 50.4 m-85 -120.14 150.51 40.5 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.403 0.62 . . . . 0.0 110.512 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 292' ' ' ASN . . . . . 0.468 HD22 ' HG2' ' B' ' 270' ' ' LYS . 3.1 t-20 -120.74 179.45 4.34 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.75 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -82.2 175.72 10.07 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 174.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 294' ' ' ALA . . . . . . . . . . . . . . . -107.25 10.91 29.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.892 0.377 . . . . 0.0 111.141 -176.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 295' ' ' THR . . . . . . . . . . . . . 8.8 t -109.11 -31.55 7.56 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.743 -176.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt 63.85 -87.69 0.03 OUTLIER 'General case' 0 C--O 1.233 0.215 0 O-C-N 123.77 0.668 . . . . 0.0 111.88 173.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 297' ' ' LEU . . . . . 0.506 HD22 ' HB2' ' B' ' 301' ' ' HIS . 0.9 OUTLIER 175.55 156.89 0.2 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.132 -177.021 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 298' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.36 -40.15 8.86 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 168.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 299' ' ' HIS . . . . . 0.447 ' H ' ' H ' ' B' ' 300' ' ' HIS . 11.4 t-80 -177.31 -3.43 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.928 172.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 300' ' ' HIS . . . . . 0.447 ' H ' ' H ' ' B' ' 299' ' ' HIS . 52.9 m170 -80.46 21.23 0.64 Allowed 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.098 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 301' ' ' HIS . . . . . 0.506 ' HB2' HD22 ' B' ' 297' ' ' LEU . 75.7 t60 -65.38 -55.34 18.66 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 178.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 302' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -178.62 110.01 0.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -82.38 147.71 28.65 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 121.049 -0.261 . . . . 0.0 110.342 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 . . . . . 0 C--N 1.32 -0.69 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.345 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.45 ' O ' ' HB2' ' A' ' 2' ' ' LYS . 26.3 ptt? . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.368 0.128 . . . . 0.0 110.913 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 1' ' ' MET . 3.7 mptp? 69.66 168.44 0.29 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 122.993 0.517 . . . . 0.0 110.9 -174.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.534 ' C ' ' HD2' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -162.75 162.96 26.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.718 174.514 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.534 ' HD2' ' C ' ' A' ' 3' ' ' LYS . 3.4 mpt_? -122.45 104.92 9.71 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 176.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.484 ' O ' HD12 ' A' ' 5' ' ' ILE . 2.3 pp -84.62 126.82 40.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.07 0.462 . . . . 0.0 110.673 -179.143 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.9 mm -133.45 123.9 47.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.84 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -114.33 93.8 4.51 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 177.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -93.85 102.72 14.85 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.641 -177.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -110.59 141.55 43.63 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.887 177.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.0 mt -88.49 -41.18 12.9 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 -173.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 58.83 -92.71 0.04 OUTLIER 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.778 -177.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 66.31 -77.85 0.04 OUTLIER 'General case' 0 C--O 1.232 0.166 0 O-C-N 123.891 0.745 . . . . 0.0 110.146 -171.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.3 m 54.88 86.38 0.05 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.523 0.678 . . . . 0.0 111.6 178.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.5 t -131.22 117.86 38.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.827 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -98.73 98.72 9.81 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.972 0.415 . . . . 0.0 110.194 177.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.0 p -78.1 177.41 8.36 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.398 -177.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -118.36 138.46 52.4 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 174.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.41 ' HA ' ' OD1' ' B' ' 265' ' ' ASP . 17.7 m -45.52 106.2 0.07 Allowed 'General case' 0 C--O 1.234 0.254 0 O-C-N 123.947 0.779 . . . . 0.0 112.242 -174.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.3 t -82.02 37.59 0.49 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.148 -176.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.6 mt 58.35 75.85 0.37 Allowed 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.385 -177.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -159.52 158.41 31.78 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.848 -175.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.454 ' CB ' ' HA ' ' B' ' 261' ' ' SER . . . 68.87 99.93 0.06 Allowed 'General case' 0 N--CA 1.466 0.365 0 O-C-N 124.299 0.999 . . . . 0.0 112.351 176.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.55 ' HG2' ' HA ' ' B' ' 222' ' ' ALA . 8.6 tp10 -155.51 165.51 36.37 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.161 -179.134 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.503 ' HB3' ' HB2' ' B' ' 224' ' ' GLN . 1.5 tm0? 76.23 156.47 0.18 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.662 0.785 . . . . 0.0 111.168 176.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.9 m -117.92 174.42 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 121.157 0.503 . . . . 0.0 111.636 -174.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.45 ' HB3' ' HB ' ' B' ' 274' ' ' ILE . 69.0 p -79.4 -172.4 3.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.232 0.539 . . . . 0.0 111.542 -173.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.472 ' HD3' ' O ' ' A' ' 27' ' ' LYS . 14.2 tmtt? -86.11 -29.37 23.38 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 171.046 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.476 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 1.0 OUTLIER -58.25 -50.1 74.77 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.287 179.875 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.59 ' HA ' ' HB3' ' A' ' 32' ' ' HIS . 0.4 OUTLIER -61.66 -26.99 68.36 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.315 -177.181 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.483 HG12 ' OH ' ' A' ' 71' ' ' TYR . 57.8 mt -61.0 -54.66 32.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.011 0.434 . . . . 0.0 110.047 176.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.2 m -73.48 -26.99 61.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.684 177.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.59 ' HB3' ' HA ' ' A' ' 29' ' ' GLU . 12.2 t-160 -68.31 -48.48 64.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.336 -175.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -104.52 -5.06 21.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.793 -176.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt 58.75 78.04 0.27 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.337 0.589 . . . . 0.0 110.77 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.8 mt -92.72 168.47 11.18 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.937 -176.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.9 t -96.99 138.23 22.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.792 -176.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -97.34 127.09 43.0 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.44 HG13 ' HB2' ' A' ' 92' ' ' ASN . 6.8 m -101.53 -45.78 11.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -175.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -174.66 175.0 46.88 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 119.689 -1.243 . . . . 0.0 113.362 -178.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.556 HG23 ' HG2' ' A' ' 89' ' ' GLU . 15.6 m -112.6 141.44 46.37 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 122.617 0.367 . . . . 0.0 110.421 -178.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.6 pt -120.14 144.64 28.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.816 0.341 . . . . 0.0 110.688 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -115.14 118.95 34.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.408 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.598 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 61.2 t -95.18 109.5 22.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.695 176.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.8 m -138.4 96.14 3.12 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.479 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.402 HE22 HG13 ' A' ' 43' ' ' VAL . 0.6 OUTLIER -129.01 134.43 48.14 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.637 -179.807 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.9 t -78.93 64.26 3.83 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.09 0.471 . . . . 0.0 111.126 -177.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.65 -69.93 2.3 Favored Glycine 0 CA--C 1.521 0.459 0 CA-C-N 115.86 -0.609 . . . . 0.0 114.412 172.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -50.83 -30.34 21.59 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 115.831 1.092 . . . . 0.0 115.831 -167.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -78.17 -27.01 47.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.831 0.816 . . . . 0.0 112.178 -175.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' A' ' 56' ' ' LEU . 49.7 mm -125.28 117.08 48.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 110.555 -0.165 . . . . 0.0 110.555 -175.141 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.6 t -119.19 -54.56 2.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.02 0.438 . . . . 0.0 110.329 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.511 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 4.9 m -105.85 164.35 15.19 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.817 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.572 ' HG3' HD21 ' B' ' 235' ' ' LEU . 18.4 Cg_endo -60.52 -28.26 86.35 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.482 2.121 . . . . 0.0 111.57 177.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.438 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -68.82 -28.81 67.07 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.2 178.62 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.777 ' HA ' ' HB2' ' B' ' 299' ' ' HIS . 31.0 m-20 -70.76 -44.9 65.78 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.337 0.589 . . . . 0.0 109.444 175.097 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.505 ' HA ' HD12 ' A' ' 50' ' ' ILE . 55.5 tp -65.35 -40.0 93.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.542 -175.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 54' ' ' SER . 3.0 ppt_? -61.28 -37.02 81.64 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -175.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -67.64 -37.98 83.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.945 0.402 . . . . 0.0 110.277 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -67.92 -40.18 83.41 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.215 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.578 HD13 ' CE2' ' A' ' 72' ' ' TYR . 81.6 mt -71.89 -39.21 69.75 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.102 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.5 t -65.29 -39.13 92.15 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -57.11 -42.71 81.35 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.009 177.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 97.9 mt -71.68 -46.02 60.12 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.411 -178.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.81 -42.32 86.11 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -175.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.489 ' HB2' ' HB2' ' B' ' 221' ' ' ALA . 33.1 t70 -63.37 -24.06 67.68 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.796 0.331 . . . . 0.0 111.623 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.23 -13.79 37.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.906 0.384 . . . . 0.0 111.335 178.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -90.02 -42.68 11.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.094 0.473 . . . . 0.0 110.409 178.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.67 65.27 0.65 Allowed Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.724 -178.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -145.35 169.65 26.9 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.067 177.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.446 ' HD2' HH12 ' B' ' 257' ' ' ARG . 31.7 mmtp -92.17 -15.13 28.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.716 0.293 . . . . 0.0 111.087 -178.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.639 ' HA ' ' CB ' ' B' ' 222' ' ' ALA . 31.6 p90 -165.26 175.79 8.93 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -177.043 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.578 ' CE2' HD13 ' A' ' 60' ' ' LEU . 54.6 p90 -135.36 136.54 41.57 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 175.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -110.54 115.83 30.31 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.489 -177.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.526 ' H ' HD12 ' A' ' 74' ' ' ILE . 4.8 mp -72.53 136.03 26.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 32.2 pt -117.26 -21.78 4.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.736 0.303 . . . . 0.0 111.196 178.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -159.4 147.89 17.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.714 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -162.06 141.5 9.71 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -166.77 154.81 9.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.036 0.446 . . . . 0.0 111.403 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -88.6 118.32 28.17 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 168.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -107.15 91.93 3.87 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.19 -120.09 12.91 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -172.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -94.43 6.6 2.43 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.074 2.516 . . . . 0.0 112.341 175.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -103.55 143.51 32.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.705 0.288 . . . . 0.0 110.679 -178.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -103.06 114.25 28.39 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -111.91 127.34 55.82 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.842 -177.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.598 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -141.08 133.48 28.3 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.924 0.392 . . . . 0.0 110.126 175.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.3 t -116.16 118.03 57.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.072 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -133.5 145.54 50.27 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.851 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.556 ' HG2' HG23 ' A' ' 40' ' ' THR . 10.4 mt-10 -117.5 136.77 53.0 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.109 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 26.0 t -95.52 135.95 28.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.676 -171.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.492 ' HB2' ' CZ ' ' A' ' 71' ' ' TYR . 79.5 m-85 -119.2 149.06 42.38 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.211 0.529 . . . . 0.0 110.41 178.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.44 ' HB2' HG13 ' A' ' 38' ' ' VAL . 18.1 t-20 -95.74 167.36 11.32 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.482 -176.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -66.4 -12.63 58.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.298 -178.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 74.66 7.04 4.47 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.494 -176.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.2 m -115.18 -29.89 6.48 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.852 176.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 96.2 mttt 66.91 -89.74 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.93 178.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 40.0 mt 71.96 170.8 0.32 Allowed 'General case' 0 N--CA 1.467 0.422 0 O-C-N 123.792 0.683 . . . . 0.0 112.468 176.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 43.12 68.75 0.46 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 114.646 -1.161 . . . . 0.0 113.487 174.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -95.08 95.35 8.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.534 173.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -90.03 157.07 17.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.824 0.345 . . . . 0.0 110.713 -176.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 31.6 t60 -71.18 132.21 44.67 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.467 -175.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 -145.53 159.59 42.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.187 -175.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 31.1 t60 -155.08 122.17 5.51 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.992 0.425 . . . . 0.0 110.546 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.32 -0.71 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.101 177.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 67.4 mtt . . . . . 0 N--CA 1.483 1.188 0 N-CA-C 111.522 0.193 . . . . 0.0 111.522 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -71.68 -58.44 3.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.171 0.51 . . . . 0.0 111.576 -174.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -122.23 126.61 48.58 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.799 -175.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 204' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' B' ' 204' ' ' ARG . 0.0 OUTLIER -154.01 88.28 1.24 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.536 0.684 . . . . 0.0 110.633 177.987 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 60.6 mt -113.05 101.54 12.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.424 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 7.9 tt -153.72 96.82 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.584 0.706 . . . . 0.0 110.447 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -131.38 98.7 4.6 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.236 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -80.39 146.29 31.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.959 -177.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -99.38 112.71 24.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.558 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 210' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -95.4 81.42 3.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.992 0.425 . . . . 0.0 110.693 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 95.5 mt -132.14 131.0 41.87 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.229 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -129.52 113.04 14.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.017 0.437 . . . . 0.0 110.57 178.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 213' ' ' THR . . . . . . . . . . . . . 23.2 m -95.19 86.81 4.67 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.16 0.505 . . . . 0.0 110.447 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 214' ' ' VAL . . . . . . . . . . . . . 7.2 p -147.45 4.26 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.346 0.593 . . . . 0.0 110.412 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.26 112.25 1.66 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.367 -176.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 3.0 p -135.84 -177.31 4.63 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.877 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -148.18 156.09 42.17 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.391 -0.225 . . . . 0.0 110.391 -177.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 218' ' ' SER . . . . . . . . . . . . . 21.9 t -130.66 -81.4 0.54 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.405 177.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 84.9 m -174.55 -64.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -176.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 96.1 mt -128.23 136.65 51.35 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.122 -1.399 . . . . 0.0 107.467 171.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 221' ' ' ALA . . . . . 0.489 ' HB2' ' HB2' ' A' ' 65' ' ' ASP . . . -88.68 -75.7 0.42 Allowed 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.87 -174.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 222' ' ' ALA . . . . . 0.639 ' CB ' ' HA ' ' A' ' 71' ' ' TYR . . . -169.59 -179.64 3.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.23 -171.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 223' ' ' GLU . . . . . 0.526 ' HA ' ' OH ' ' A' ' 72' ' ' TYR . 10.2 pt-20 177.54 133.46 0.06 Allowed 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.896 0.747 . . . . 0.0 111.941 -177.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 224' ' ' GLN . . . . . 0.503 ' HB2' ' HB3' ' A' ' 24' ' ' GLN . 1.4 tm0? -172.22 157.86 4.32 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.657 0.783 . . . . 0.0 109.064 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 225' ' ' VAL . . . . . 0.46 HG21 HD13 ' B' ' 235' ' ' LEU . 18.6 m -109.55 133.09 55.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.729 0.3 . . . . 0.0 111.109 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 226' ' ' SER . . . . . 0.514 ' O ' HG13 ' B' ' 230' ' ' ILE . 83.3 p -90.56 -174.28 4.05 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 178.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -56.46 -37.42 70.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.397 -177.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -64.8 -50.45 66.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.702 -177.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -60.82 -41.06 94.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.171 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.541 ' HA ' HD12 ' B' ' 235' ' ' LEU . 83.5 mt -55.52 -51.79 53.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.921 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 35.3 m -72.09 -28.76 63.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.382 -178.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -78.26 -47.99 16.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.708 -175.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -92.04 4.33 53.31 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -173.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm 57.75 41.0 25.82 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.101 0.477 . . . . 0.0 111.022 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 235' ' ' LEU . . . . . 0.572 HD21 ' HG3' ' A' ' 53' ' ' PRO . 89.4 mt -63.01 125.66 24.75 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.838 -176.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.48 HG22 ' HB2' ' B' ' 294' ' ' ALA . 17.0 m -78.79 132.94 31.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.569 -175.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 41.9 tttm -78.4 117.58 19.75 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.44 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 27.0 t -84.3 -35.92 11.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.003 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 164.91 -178.65 39.94 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.226 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 42.1 m -109.69 135.46 50.6 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 18.4 pt -110.05 134.31 52.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.99 0.424 . . . . 0.0 110.511 175.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -120.5 114.33 21.61 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.952 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 243' ' ' VAL . . . . . 0.592 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 5.3 t -102.4 113.38 38.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.15 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 23.3 t -111.72 103.11 11.38 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.938 0.399 . . . . 0.0 110.032 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 245' ' ' GLN . . . . . 0.554 ' HG2' HG12 ' B' ' 250' ' ' ILE . 0.2 OUTLIER -99.96 143.38 30.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.784 -177.247 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 41.1 t -97.69 72.88 2.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.991 0.424 . . . . 0.0 110.859 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 69.43 -92.36 0.33 Allowed Glycine 0 CA--C 1.518 0.269 0 CA-C-N 115.676 -0.693 . . . . 0.0 114.158 172.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -79.89 50.86 3.97 Favored Glycine 0 CA--C 1.517 0.21 0 N-CA-C 114.195 0.438 . . . . 0.0 114.195 -169.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 249' ' ' GLN . . . . . 0.5 ' HB2' ' HG3' ' B' ' 245' ' ' GLN . 78.7 mt-30 -131.66 -0.07 3.93 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.17 0.51 . . . . 0.0 109.761 173.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 250' ' ' ILE . . . . . 0.554 HG12 ' HG2' ' B' ' 245' ' ' GLN . 45.0 mm -132.01 119.74 41.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.551 178.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 3.4 m -135.08 -50.68 0.76 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.227 -177.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.25 163.68 16.43 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.305 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.27 -37.75 94.21 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.342 2.028 . . . . 0.0 111.954 176.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 254' ' ' SER . . . . . 0.434 ' HA ' ' HB3' ' B' ' 257' ' ' ARG . 54.8 m -68.31 -25.9 65.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.831 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -64.42 -32.01 73.46 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.616 0.246 . . . . 0.0 110.581 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 56.3 tp -86.93 -38.51 16.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.929 0.395 . . . . 0.0 109.981 176.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 257' ' ' ARG . . . . . 0.446 HH12 ' HD2' ' A' ' 70' ' ' LYS . 77.6 ttt180 -50.72 -43.53 57.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.799 179.138 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 258' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -55.48 -48.57 74.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.657 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -72.9 -32.42 65.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.815 0.341 . . . . 0.0 111.041 -174.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 92.0 mt -65.22 -46.23 81.5 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.871 -178.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 261' ' ' SER . . . . . 0.454 ' HA ' ' CB ' ' A' ' 22' ' ' ALA . 17.6 m -67.18 -36.77 82.48 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.871 177.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -57.56 -52.13 66.68 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.169 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 263' ' ' LEU . . . . . 0.436 HD12 HG22 ' B' ' 243' ' ' VAL . 89.8 mt -73.21 -30.82 63.78 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -174.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.5 -38.51 68.12 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 121.149 -0.22 . . . . 0.0 111.33 -176.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 265' ' ' ASP . . . . . 0.41 ' OD1' ' HA ' ' A' ' 18' ' ' SER . 26.5 t70 -70.35 -32.89 70.79 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.989 0.423 . . . . 0.0 110.07 178.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -68.65 -22.73 64.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.321 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -96.36 -11.18 26.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.672 0.272 . . . . 0.0 111.004 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 80.03 53.35 4.24 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.634 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.04 -178.88 18.74 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.012 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 270' ' ' LYS . . . . . 0.412 ' HG3' ' OD2' ' B' ' 293' ' ' ASP . 22.3 mmmt -117.22 -46.87 2.69 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.922 0.391 . . . . 0.0 110.722 177.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 271' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -138.23 164.82 28.25 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 272' ' ' TYR . . . . . 0.427 ' HE1' ' N ' ' A' ' 23' ' ' GLU . 11.1 p90 -144.49 142.14 30.04 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.564 -174.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 22.0 t-80 -114.36 104.85 12.47 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.85 -178.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 274' ' ' ILE . . . . . 0.45 ' HB ' ' HB3' ' A' ' 26' ' ' SER . 57.4 mt -68.03 105.37 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.228 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 19.1 pt -77.98 -40.49 26.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.393 -176.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -153.45 131.45 11.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.126 0.489 . . . . 0.0 111.51 -177.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -120.58 103.56 9.25 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 174.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -127.23 126.82 43.4 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.331 0.586 . . . . 0.0 110.603 -172.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -88.89 126.55 35.43 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.308 0.575 . . . . 0.0 110.487 -176.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -97.39 81.2 2.96 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.121 -176.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 61.16 -120.18 21.7 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.057 -176.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -83.06 10.55 3.6 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.799 2.332 . . . . 0.0 112.211 177.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -121.08 166.53 13.78 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 284' ' ' PHE . . . . . 0.448 ' CE2' ' HB2' ' B' ' 286' ' ' ALA . 51.1 t80 -131.7 127.47 36.95 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.425 0.155 . . . . 0.0 110.686 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 285' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -111.26 110.51 21.03 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.443 -178.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 286' ' ' ALA . . . . . 0.592 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -107.29 120.24 41.61 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.612 0.244 . . . . 0.0 110.788 176.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 17.7 t -116.13 123.12 70.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.816 0.341 . . . . 0.0 110.577 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -136.6 144.47 44.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.945 0.402 . . . . 0.0 111.588 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -92.98 123.66 36.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.705 176.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 48.9 t -91.13 128.33 42.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.75 0.31 . . . . 0.0 110.467 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -123.48 156.34 35.78 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.11 0.481 . . . . 0.0 111.032 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 292' ' ' ASN . . . . . 0.457 ' HB3' ' CG2' ' B' ' 236' ' ' VAL . 6.9 t-20 -117.21 159.35 22.79 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.345 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 293' ' ' ASP . . . . . 0.412 ' OD2' ' HG3' ' B' ' 270' ' ' LYS . 4.1 p30 -72.03 -27.95 63.04 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 123.102 0.251 . . . . 0.0 111.161 -177.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 294' ' ' ALA . . . . . 0.48 ' HB2' HG22 ' B' ' 236' ' ' VAL . . . 66.04 13.88 9.32 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 173.278 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 295' ' ' THR . . . . . 0.444 HG23 ' H ' ' B' ' 297' ' ' LEU . 9.5 t -124.57 -26.69 3.81 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.042 178.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 296' ' ' LYS . . . . . 0.495 ' HE2' ' CA ' ' B' ' 296' ' ' LYS . 5.5 mmpt? 64.7 30.38 12.49 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 123.139 0.576 . . . . 0.0 111.271 177.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 297' ' ' LEU . . . . . 0.444 ' H ' HG23 ' B' ' 295' ' ' THR . 96.6 mt -127.97 118.66 23.96 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.904 178.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 298' ' ' GLU . . . . . 0.429 ' HA ' ' HB2' ' A' ' 54' ' ' SER . 41.1 mm-40 -84.44 177.31 8.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.488 177.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 299' ' ' HIS . . . . . 0.777 ' HB2' ' HA ' ' A' ' 55' ' ' ASP . 13.3 t-80 -62.22 122.09 14.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.268 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 300' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -80.26 107.98 13.5 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.032 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 301' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -64.41 94.73 0.12 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.823 177.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 302' ' ' HIS . . . . . . . . . . . . . 24.6 t-80 -146.96 123.08 10.81 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.618 -175.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -156.59 -178.56 7.44 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.241 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 . . . . . 0 C--N 1.317 -0.825 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 173.604 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.487 ' O ' ' HE2' ' B' ' 227' ' ' LYS . 23.4 mmt . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 120.511 0.196 . . . . 0.0 111.351 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.84 157.75 28.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.245 0.545 . . . . 0.0 111.971 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.541 ' HB3' ' HE3' ' B' ' 227' ' ' LYS . 23.6 tptm -161.52 98.08 1.11 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.532 178.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 19.6 mtm180 -119.13 -23.2 6.89 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.773 -173.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.413 ' N ' HD12 ' A' ' 5' ' ' ILE . 3.4 mp -93.81 98.95 8.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.124 0.488 . . . . 0.0 110.299 178.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.1 mp -112.0 101.69 12.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 175.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.01 101.48 13.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.614 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.413 ' HA ' HG21 ' B' ' 240' ' ' THR . . . -78.84 116.64 19.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.581 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.605 ' H ' ' HB ' ' B' ' 240' ' ' THR . . . -106.04 123.67 48.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.565 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.9 tp -93.38 96.0 9.66 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.366 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 22.1 tp -153.58 93.87 1.73 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 175.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.25 173.62 10.23 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.348 0.594 . . . . 0.0 112.038 -171.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.596 ' HB ' HD23 ' B' ' 263' ' ' LEU . 25.3 m -142.82 131.35 22.4 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.64 178.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.5 p -89.75 -36.22 8.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.899 -178.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.94 130.08 1.18 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.773 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.2 t -150.69 -82.16 0.1 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.592 ' O ' ' HA ' ' B' ' 262' ' ' GLU . 88.8 m-85 -148.97 172.55 14.55 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.01 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.0 t -119.21 -68.79 0.89 Allowed 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.773 -175.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 55.9 m 66.23 126.72 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.724 0.773 . . . . 0.0 111.721 -178.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.0 mt -85.69 91.3 8.25 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.272 179.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.494 ' HA ' ' OE2' ' B' ' 223' ' ' GLU . . . -155.12 5.39 0.22 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.241 175.273 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.539 ' HB1' ' CD2' ' B' ' 272' ' ' TYR . . . -134.22 97.88 3.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.916 -175.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.602 ' HB3' ' HE1' ' A' ' 71' ' ' TYR . 10.8 mt-10 -160.33 110.97 1.85 Allowed 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -177.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.666 ' HB2' ' HB3' ' B' ' 224' ' ' GLN . 24.8 tm0? -173.58 141.35 0.86 Allowed 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.469 174.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.2 m -105.76 116.11 48.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.081 0.467 . . . . 0.0 110.929 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.517 ' HB3' ' OE2' ' A' ' 29' ' ' GLU . 15.9 t -82.13 172.76 12.82 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.778 0.323 . . . . 0.0 110.147 -177.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.553 ' HA ' ' HB ' ' A' ' 30' ' ' ILE . 29.1 mmmt -67.3 -19.33 65.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.26 -173.202 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 17.7 mp0 -65.47 -51.57 59.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.902 0.382 . . . . 0.0 110.31 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.517 ' OE2' ' HB3' ' A' ' 26' ' ' SER . 2.3 pm0 -76.84 -28.03 55.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.087 177.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.553 ' HB ' ' HA ' ' A' ' 27' ' ' LYS . 77.7 mt -60.0 -46.59 93.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.725 0.298 . . . . 0.0 110.204 174.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.6 m -73.8 -21.83 60.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.207 178.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -86.72 -46.17 10.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.423 -175.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -94.49 -13.87 25.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.07 -178.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm 62.01 76.06 0.38 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.525 0.679 . . . . 0.0 110.579 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.485 HD12 HG12 ' A' ' 30' ' ' ILE . 71.6 mt -87.52 177.01 7.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.869 -172.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 92' ' ' ASN . 28.9 t -104.0 115.34 45.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.472 -174.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.1 ttmm -80.88 121.16 25.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.654 0.264 . . . . 0.0 110.588 177.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.613 HG22 ' OD1' ' A' ' 92' ' ' ASN . 2.2 t -78.78 -34.42 17.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.572 0.701 . . . . 0.0 109.344 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 160.32 -159.51 30.89 Favored Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.961 -177.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.5 m -137.5 126.44 24.19 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.5 pt -103.96 136.46 37.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.087 0.47 . . . . 0.0 111.089 -177.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -117.01 122.58 44.62 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.974 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.49 ' HB ' ' H ' ' A' ' 86' ' ' ALA . 88.3 t -94.25 138.11 21.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.345 175.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.4 t -156.99 80.37 0.92 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.195 0.522 . . . . 0.0 110.247 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -125.4 159.75 31.1 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 176.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.557 ' HA ' ' HA ' ' A' ' 83' ' ' ASN . 22.6 t -64.59 158.95 22.94 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 176.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.88 50.82 1.9 Allowed Glycine 0 C--N 1.333 0.363 0 CA-C-N 116.358 -0.383 . . . . 0.0 112.843 -178.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -142.17 -36.84 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 177.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -69.66 -30.13 67.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.291 0.567 . . . . 0.0 110.036 175.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.3 mm -108.24 96.1 4.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 173.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.3 t -106.28 -2.03 22.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.954 0.407 . . . . 0.0 110.991 -174.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 93.4 p -162.19 164.4 17.33 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.213 -178.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.74 -25.86 81.88 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.237 1.958 . . . . 0.0 111.213 172.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.473 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 17.1 m -66.65 -45.4 79.09 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.6 178.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.503 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 26.5 m-20 -57.61 -45.54 85.2 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.227 0.537 . . . . 0.0 109.945 177.233 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 54.4 tp -64.57 -39.58 94.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.048 -178.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -60.32 -46.21 90.69 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.702 -178.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 54' ' ' SER . 8.5 mm-40 -63.53 -26.99 68.96 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.927 -177.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.521 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 29.3 mmmt -78.2 -53.67 7.08 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.524 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.0 mt -63.67 -41.86 98.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.72 -174.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.9 p -63.23 -45.71 90.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.668 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -60.61 -45.26 94.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.911 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 59' ' ' LYS . 92.1 mt -63.75 -40.27 96.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.066 -178.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.1 -43.85 77.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.863 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -63.2 -44.99 93.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.404 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.431 ' HB1' HG12 ' B' ' 214' ' ' VAL . . . -71.8 -22.25 61.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.976 -177.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -80.04 -12.17 59.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.691 0.281 . . . . 0.0 110.911 176.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 94.92 16.65 40.78 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.404 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.451 ' HA3' HG21 ' A' ' 38' ' ' VAL . . . -112.53 -158.15 13.65 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.875 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.822 ' HD2' ' HB2' ' A' ' 93' ' ' ASP . 93.2 mttt -138.92 -61.46 0.56 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.096 0.474 . . . . 0.0 110.795 177.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.602 ' HE1' ' HB3' ' A' ' 23' ' ' GLU . 56.8 m-85 -97.8 156.98 16.33 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.901 -171.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.49 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 26.3 p90 -142.81 123.24 13.94 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.191 178.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.471 ' ND1' ' HA ' ' A' ' 26' ' ' SER . 32.7 t60 -96.06 109.07 21.55 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.14 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.596 ' H ' HD12 ' A' ' 74' ' ' ILE . 4.5 mp -73.69 104.8 2.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 30.0 pt -85.65 -20.55 8.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.723 -178.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -160.0 120.78 3.05 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.12 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -124.7 96.2 4.8 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 175.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.1 -178.99 4.25 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.292 -174.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.83 157.41 17.49 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 176.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.563 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 4.3 t-160 -124.08 63.16 1.08 Allowed 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 174.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.48 -114.6 4.5 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.213 -175.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -83.76 20.9 1.12 Allowed 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.684 2.256 . . . . 0.0 112.015 174.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.563 ' HB2' ' HB3' ' A' ' 80' ' ' HIS . 31.0 m-80 -131.27 164.21 26.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.116 -177.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -124.1 129.96 51.74 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 175.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.461 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 81.8 mt-10 -127.86 116.89 20.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.129 0.49 . . . . 0.0 111.465 -176.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.49 ' H ' ' HB ' ' A' ' 43' ' ' VAL . . . -114.31 128.79 56.53 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.312 178.068 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.0 t -108.76 115.86 50.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.905 179.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 72' ' ' TYR . . . -125.99 136.65 53.23 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.933 0.397 . . . . 0.0 111.544 -176.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 72' ' ' TYR . 45.9 mt-10 -91.76 118.63 30.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.82 177.029 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.5 t -86.3 128.65 39.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.434 -178.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -124.92 147.36 48.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.09 0.472 . . . . 0.0 110.608 178.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.613 ' OD1' HG22 ' A' ' 38' ' ' VAL . 21.5 m120 -82.52 163.1 21.76 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.139 178.077 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.822 ' HB2' ' HD2' ' A' ' 70' ' ' LYS . 38.0 t0 -74.39 135.51 42.42 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 169.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.88 83.09 0.92 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.273 0.559 . . . . 0.0 109.81 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.0 t -177.85 -30.95 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.655 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 60.7 tttm 70.66 170.14 0.31 Allowed 'General case' 0 CA--C 1.536 0.442 0 O-C-N 123.776 0.673 . . . . 0.0 110.743 176.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 72.2 mt 63.62 -148.05 0.32 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 122.552 0.341 . . . . 0.0 110.835 178.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 70.66 -68.84 0.2 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.542 0.737 . . . . 0.0 111.719 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.29 74.02 7.13 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.312 -173.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -135.26 25.11 3.53 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.58 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 32.9 m170 69.44 160.03 0.19 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.442 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 24.2 t-80 63.07 23.24 13.87 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.374 173.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -89.77 2.06 55.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.036 0.446 . . . . 0.0 110.792 -176.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 24.6 t60 . . . . . 0 C--N 1.32 -0.681 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 177.876 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 66.2 mtm . . . . . 0 N--CA 1.483 1.218 0 CA-C-O 120.793 0.33 . . . . 0.0 110.545 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 5.3 ptmm? -85.19 177.35 7.9 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 176.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -67.02 134.43 51.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.049 0.452 . . . . 0.0 111.024 -173.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -138.39 173.7 11.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.411 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 8.1 tp -128.19 144.08 38.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.965 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 7.3 tt -119.13 106.06 18.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.357 0.599 . . . . 0.0 110.463 178.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -79.56 146.55 32.54 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.041 177.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . 59.24 71.44 0.58 Allowed 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.209 0.528 . . . . 0.0 110.826 -177.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -93.04 166.06 12.55 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.875 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 210' ' ' LEU . . . . . . . . . . . . . 7.3 mp -106.67 163.52 12.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.259 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 61.4 tp -124.14 108.86 12.76 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 177.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -124.43 114.99 20.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.062 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 213' ' ' THR . . . . . . . . . . . . . 2.9 m -111.85 30.0 7.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.817 0.818 . . . . 0.0 109.152 175.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 214' ' ' VAL . . . . . 0.431 HG12 ' HB1' ' A' ' 66' ' ' ALA . 32.7 t -68.95 120.34 16.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.236 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -128.0 153.32 46.88 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.64 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 55.0 m -95.4 -61.5 1.46 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 177.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -177.9 -63.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.613 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 218' ' ' SER . . . . . . . . . . . . . 67.1 p -168.77 108.52 0.48 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.012 177.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 15.0 t -85.62 -174.3 5.09 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.747 0.308 . . . . 0.0 110.378 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -116.69 -45.57 2.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.657 -175.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -110.67 -151.48 0.48 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.35 -173.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . 73.51 94.5 0.07 Allowed 'General case' 0 N--CA 1.467 0.381 0 O-C-N 124.089 0.868 . . . . 0.0 110.269 -176.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 223' ' ' GLU . . . . . 0.494 ' OE2' ' HA ' ' A' ' 21' ' ' ALA . 46.9 mt-10 -151.43 -156.66 0.73 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.126 -168.364 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 224' ' ' GLN . . . . . 0.687 ' HA ' ' HB3' ' B' ' 271' ' ' TYR . 1.6 tm0? 82.23 145.79 0.08 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.899 0.88 . . . . 0.0 111.495 172.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 225' ' ' VAL . . . . . 0.402 HG21 HD12 ' B' ' 235' ' ' LEU . 23.7 m -115.97 154.36 17.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.208 -176.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 19.7 m -99.03 -102.79 0.22 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.883 -178.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 227' ' ' LYS . . . . . 0.541 ' HE3' ' HB3' ' A' ' 3' ' ' LYS . 1.7 tmtp? -124.16 -57.54 1.59 Allowed 'General case' 0 C--N 1.326 -0.413 0 O-C-N 122.011 -0.43 . . . . 0.0 111.31 -170.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -62.04 -38.08 87.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.025 0.44 . . . . 0.0 110.878 -175.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -61.72 -36.08 79.91 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.01 -177.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.415 HD13 ' CZ ' ' B' ' 291' ' ' TYR . 66.7 mt -60.49 -53.08 53.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.79 -178.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 23.2 t -72.85 -21.33 60.96 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.171 -176.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -87.87 -44.48 11.04 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -176.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -95.32 -18.43 20.8 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.582 0.216 . . . . 0.0 111.582 -177.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 5.7 mmmm 63.17 77.29 0.33 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.501 0.667 . . . . 0.0 111.489 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 235' ' ' LEU . . . . . 0.402 HD12 HG21 ' B' ' 225' ' ' VAL . 87.9 mt -93.94 140.75 29.32 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.502 175.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 27.2 m -76.88 127.07 38.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.106 0.479 . . . . 0.0 111.0 -177.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 237' ' ' LYS . . . . . 0.532 ' HE2' ' HB3' ' B' ' 289' ' ' GLU . 57.9 tttm -84.95 107.12 16.93 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.936 178.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 48.8 t -67.28 -35.19 73.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.607 -177.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 168.79 -149.32 13.61 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.313 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 240' ' ' THR . . . . . 0.605 ' HB ' ' H ' ' A' ' 9' ' ' ALA . 38.3 m -139.74 140.81 36.83 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 -178.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 18.2 pt -121.14 139.01 49.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.097 0.475 . . . . 0.0 110.677 178.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -127.68 113.59 16.23 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 243' ' ' VAL . . . . . 0.468 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 2.3 t -100.69 108.41 23.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.21 -175.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 26.5 t -99.32 109.42 22.04 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 177.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 245' ' ' GLN . . . . . 0.554 HE21 HD11 ' B' ' 250' ' ' ILE . 3.9 mm-40 -99.71 158.25 15.91 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 121.358 0.599 . . . . 0.0 110.669 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 1.5 p -91.48 11.04 25.31 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.539 175.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 94.83 -61.02 1.68 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.796 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -78.29 50.57 3.47 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 121.2 -0.524 . . . . 0.0 113.103 -178.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -137.03 -14.48 1.57 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.828 0.346 . . . . 0.0 110.533 177.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 250' ' ' ILE . . . . . 0.554 HD11 HE21 ' B' ' 245' ' ' GLN . 39.5 mm -125.56 99.15 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.73 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 23.1 t -98.38 -25.47 14.81 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.355 0.597 . . . . 0.0 109.65 178.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 252' ' ' SER . . . . . 0.522 ' HB3' ' HD2' ' B' ' 253' ' ' PRO . 49.8 m -151.49 165.7 16.81 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.747 178.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 253' ' ' PRO . . . . . 0.522 ' HD2' ' HB3' ' B' ' 252' ' ' SER . 11.3 Cg_endo -55.41 -25.69 49.63 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.756 2.304 . . . . 0.0 112.113 177.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 254' ' ' SER . . . . . 0.548 ' O ' ' HG3' ' B' ' 258' ' ' GLU . 30.0 t -54.15 -36.29 63.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.142 174.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -74.32 -40.16 62.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.905 0.383 . . . . 0.0 110.614 -177.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 42.7 tp -60.9 -45.45 94.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.211 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 257' ' ' ARG . . . . . 0.519 ' HD3' ' OH ' ' A' ' 71' ' ' TYR . 13.1 ptt180 -63.72 -30.99 72.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.796 0.331 . . . . 0.0 111.158 -178.004 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 258' ' ' GLU . . . . . 0.548 ' HG3' ' O ' ' B' ' 254' ' ' SER . 56.5 mt-10 -72.41 -36.49 68.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.854 0.359 . . . . 0.0 110.462 -179.175 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 259' ' ' LYS . . . . . 0.551 ' HG2' HE22 ' B' ' 245' ' ' GLN . 14.2 mptt -74.67 -40.1 61.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.966 178.056 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 93.3 mt -66.35 -43.89 84.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.746 -177.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 22.0 p -68.15 -34.15 75.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.751 0.31 . . . . 0.0 110.521 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 262' ' ' GLU . . . . . 0.592 ' HA ' ' O ' ' A' ' 17' ' ' PHE . 7.9 tp10 -54.93 -44.76 74.57 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.573 0.701 . . . . 0.0 109.966 176.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 263' ' ' LEU . . . . . 0.596 HD23 ' HB ' ' A' ' 13' ' ' THR . 68.9 mt -74.69 -41.73 59.69 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.995 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -60.17 -47.86 84.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.271 -174.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -70.7 -29.96 66.39 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.624 -177.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -66.49 -23.53 66.27 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.373 0.606 . . . . 0.0 110.538 176.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 267' ' ' LYS . . . . . 0.587 ' HG2' ' O ' ' B' ' 263' ' ' LEU . 73.3 mmtt -89.43 -21.76 22.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.869 176.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 88.27 25.3 31.47 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.802 -177.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -100.14 -165.28 28.82 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.124 -179.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 270' ' ' LYS . . . . . 0.513 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 22.2 mmtp -132.66 -67.56 0.64 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.194 0.521 . . . . 0.0 109.708 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 271' ' ' TYR . . . . . 0.687 ' HB3' ' HA ' ' B' ' 224' ' ' GLN . 7.7 m-85 -101.23 145.29 29.02 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.165 -176.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 272' ' ' TYR . . . . . 0.539 ' CD2' ' HB1' ' A' ' 22' ' ' ALA . 10.9 p90 -104.46 169.47 8.45 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 175.07 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 273' ' ' HIS . . . . . 0.455 ' HB3' ' HB2' ' B' ' 289' ' ' GLU . 10.7 t-160 -138.03 101.47 4.43 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.402 172.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 274' ' ' ILE . . . . . 0.46 HG21 ' OE1' ' A' ' 29' ' ' GLU . 63.3 mt -71.33 123.02 24.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.155 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 22.5 pt -114.08 -28.67 2.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.592 -176.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -152.06 107.13 3.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.954 0.407 . . . . 0.0 111.531 -178.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -105.37 96.65 6.66 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 173.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -127.38 137.51 52.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.206 0.527 . . . . 0.0 111.331 -170.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -88.06 119.75 28.74 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.095 0.474 . . . . 0.0 110.707 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -98.62 78.65 2.39 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 69.5 -126.42 18.78 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 -175.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.74 6.47 4.5 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 122.614 2.209 . . . . 0.0 112.257 177.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -112.34 151.49 29.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.184 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 284' ' ' PHE . . . . . 0.464 ' HB3' ' HB2' ' B' ' 245' ' ' GLN . 52.0 t80 -115.67 113.0 22.93 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 175.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 285' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -102.37 110.39 22.32 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.293 -0.412 . . . . 0.0 109.993 -177.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 286' ' ' ALA . . . . . 0.468 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -102.35 114.91 29.49 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.79 0.328 . . . . 0.0 110.52 176.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 29.4 t -105.75 120.93 57.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.218 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -138.83 152.21 47.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.019 0.438 . . . . 0.0 111.364 -178.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 289' ' ' GLU . . . . . 0.532 ' HB3' ' HE2' ' B' ' 237' ' ' LYS . 31.1 mt-10 -91.74 157.99 16.61 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 175.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 39.9 t -115.11 125.43 72.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 177.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 291' ' ' TYR . . . . . 0.415 ' CZ ' HD13 ' B' ' 230' ' ' ILE . 93.5 m-85 -125.02 155.34 39.87 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.236 0.541 . . . . 0.0 110.716 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 292' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -118.91 156.62 29.2 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 293' ' ' ASP . . . . . 0.447 ' OD1' ' HG3' ' B' ' 296' ' ' LYS . 2.3 p30 -65.14 -23.44 67.13 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.662 0.267 . . . . 0.0 110.897 -178.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 294' ' ' ALA . . . . . . . . . . . . . . . 70.79 13.02 7.19 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.544 173.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 295' ' ' THR . . . . . 0.624 HG23 ' H ' ' B' ' 296' ' ' LYS . 1.7 t -140.84 -70.4 0.38 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 178.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 296' ' ' LYS . . . . . 0.761 ' O ' ' HG ' ' B' ' 297' ' ' LEU . 41.5 mtmt 68.23 130.11 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 122.916 0.486 . . . . 0.0 112.21 -175.422 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 297' ' ' LEU . . . . . 0.761 ' HG ' ' O ' ' B' ' 296' ' ' LYS . 3.1 pp 60.9 135.31 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.274 1.43 . . . . 0.0 114.313 171.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 298' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' B' ' 299' ' ' HIS . 43.9 mt-10 -73.5 168.14 19.87 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.599 177.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 299' ' ' HIS . . . . . 0.446 ' HB2' ' O ' ' B' ' 298' ' ' GLU . 16.3 m170 70.58 -55.12 0.63 Allowed 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.743 0.652 . . . . 0.0 110.514 -175.274 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 300' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 71.12 165.57 0.29 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.413 0.685 . . . . 0.0 111.284 174.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 301' ' ' HIS . . . . . . . . . . . . . 40.6 m80 70.52 -171.72 0.17 Allowed 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.593 179.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 302' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 71.18 109.31 0.06 Allowed 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.789 0.681 . . . . 0.0 112.477 176.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 9.8 m80 -139.26 122.02 16.46 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.817 173.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 . . . . . 0 C--N 1.322 -0.63 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 -178.979 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.2 ttm . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 120.72 0.295 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -157.24 -94.52 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 175.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -147.28 138.83 24.03 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -130.7 112.31 12.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.705 0.764 . . . . 0.0 110.933 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.8 pt -113.47 123.66 69.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.959 177.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.486 ' O ' HD12 ' A' ' 6' ' ' ILE . 2.4 pp -98.42 130.5 47.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.311 0.577 . . . . 0.0 111.336 -177.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -161.74 90.41 0.78 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.034 178.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -149.92 -158.9 0.96 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.54 -177.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 70.4 76.52 0.2 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 123.917 0.761 . . . . 0.0 111.076 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 94.9 mt -142.99 160.73 39.8 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.774 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.4 pp -160.16 159.09 31.26 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 176.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.5 -60.79 0.51 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.984 0.421 . . . . 0.0 110.764 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.4 m -151.07 122.06 7.65 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.435 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.1 m -84.01 152.79 3.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 176.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.559 ' HB3' ' HA3' ' B' ' 268' ' ' GLY . . . -126.01 -162.44 1.13 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.74 0.305 . . . . 0.0 111.114 -175.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.9 t -118.99 -172.23 2.26 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.568 -178.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -72.49 162.34 29.61 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.663 -175.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.3 m -147.49 -55.34 0.23 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.775 173.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 75.7 m -162.46 141.33 9.04 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 177.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 34.9 tp -62.95 98.04 0.12 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.974 0.416 . . . . 0.0 110.19 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -137.26 -151.12 0.38 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.106 -177.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.589 ' HA ' ' OE2' ' B' ' 223' ' ' GLU . . . 73.54 111.07 0.07 Allowed 'General case' 0 N--CA 1.464 0.241 0 O-C-N 123.994 0.809 . . . . 0.0 109.984 -175.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.717 ' O ' ' HB3' ' A' ' 24' ' ' GLN . 9.2 tp10 -133.74 178.75 6.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.349 -171.174 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.717 ' HB3' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER 96.45 134.9 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.95 1.3 . . . . 0.0 111.985 176.851 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.435 ' N ' ' HG2' ' A' ' 24' ' ' GLN . 21.2 m -109.98 155.74 11.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.07 -0.968 . . . . 0.0 108.721 172.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.623 ' HB3' ' OE1' ' A' ' 28' ' ' GLN . 7.0 t -98.29 -176.85 3.52 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.26 -178.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.594 ' HA ' HD12 ' A' ' 30' ' ' ILE . 5.0 tmtt? -65.08 -27.87 69.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.464 -169.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.623 ' OE1' ' HB3' ' A' ' 26' ' ' SER . 15.8 mp0 -59.34 -49.51 77.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.021 0.439 . . . . 0.0 110.356 -178.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.638 ' HA ' ' HB3' ' A' ' 32' ' ' HIS . 12.8 mm-40 -75.25 -25.62 58.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.102 -173.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.594 HD12 ' HA ' ' A' ' 27' ' ' LYS . 63.8 mt -57.53 -52.93 51.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.204 0.526 . . . . 0.0 109.912 175.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.8 m -73.87 -24.02 59.68 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.001 177.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.638 ' HB3' ' HA ' ' A' ' 29' ' ' GLU . 21.8 t-160 -69.72 -52.58 24.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.136 -177.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -97.59 2.95 50.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.301 -176.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt 56.17 59.05 3.9 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 123.624 0.577 . . . . 0.0 111.03 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.3 mt -62.44 138.04 58.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.654 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.8 t -65.09 -37.17 79.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.541 -174.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.0 tttm 66.28 114.94 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 O-C-N 124.227 0.954 . . . . 0.0 111.118 -178.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.2 m -82.66 -39.45 15.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.859 -0.337 . . . . 0.0 111.741 -177.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 173.12 -155.67 23.12 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.266 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.55 HG23 ' HG2' ' A' ' 89' ' ' GLU . 46.8 m -141.97 131.06 23.25 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.706 0.289 . . . . 0.0 110.337 -178.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.9 pt -120.91 173.3 6.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -150.29 152.2 34.13 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.558 0.694 . . . . 0.0 112.112 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.616 HG13 ' NE2' ' A' ' 45' ' ' GLN . 69.2 t -94.64 128.67 45.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.521 171.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.4 t -143.34 46.11 1.52 Allowed 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.616 ' NE2' HG13 ' A' ' 43' ' ' VAL . 1.0 OUTLIER -93.42 145.05 24.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.033 -175.089 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.3 m -82.1 80.97 8.2 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.956 -174.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.23 -77.29 0.58 Allowed Glycine 0 CA--C 1.521 0.434 0 N-CA-C 114.872 0.709 . . . . 0.0 114.872 168.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -58.56 -19.85 43.5 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 114.743 0.657 . . . . 0.0 114.743 -168.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.431 ' HB2' ' HB3' ' A' ' 45' ' ' GLN . 15.9 mm-40 -79.35 -21.77 45.37 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 117.356 0.578 . . . . 0.0 111.169 -178.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 40.3 mm -123.44 88.22 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.7 t -105.76 -30.64 9.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.635 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.7 m -127.47 158.38 69.92 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.373 -177.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.28 -32.52 81.31 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.726 2.284 . . . . 0.0 112.088 176.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.591 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 11.5 p -64.28 -40.68 96.45 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.145 178.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -54.96 -30.97 60.13 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.733 0.301 . . . . 0.0 111.457 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 40.4 tp -56.59 -55.91 27.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.774 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -73.21 -29.8 63.06 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.047 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.591 ' HG2' ' O ' ' A' ' 54' ' ' SER . 22.8 mm-40 -62.05 -48.31 80.83 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.214 0.531 . . . . 0.0 110.837 179.121 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -73.12 -37.94 66.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.336 -178.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.479 HD13 ' CE1' ' A' ' 72' ' ' TYR . 37.6 mt -72.08 -35.51 69.25 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.732 -178.012 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.426 ' HA ' ' HB3' ' B' ' 221' ' ' ALA . 24.9 m -62.6 -42.74 99.75 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 120.874 -0.331 . . . . 0.0 110.31 173.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.767 ' HG3' ' HA ' ' B' ' 216' ' ' SER . 9.2 tp10 -56.18 -39.65 72.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.356 -178.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.402 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 86.6 mt -76.42 -51.34 12.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.669 178.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.86 -32.16 72.48 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.294 -171.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -58.03 -49.49 76.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.946 0.403 . . . . 0.0 110.611 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.525 ' HB2' ' HB2' ' B' ' 217' ' ' PHE . . . -70.49 -25.25 63.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.612 -178.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 63' ' ' LEU . 74.9 mmtt -75.87 -19.62 58.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.023 0.439 . . . . 0.0 110.581 178.071 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.55 38.46 9.7 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.291 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -105.51 161.62 14.56 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.414 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.584 ' HG3' ' OD2' ' A' ' 93' ' ' ASP . 35.4 mmtp -98.73 -48.66 4.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.276 0.56 . . . . 0.0 110.387 178.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.537 ' HE2' ' HD2' ' B' ' 257' ' ' ARG . 1.5 p90 -147.63 168.28 22.42 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.39 -178.359 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.479 ' CE1' HD13 ' A' ' 60' ' ' LEU . 45.8 p90 -142.14 166.96 23.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.901 -178.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -137.7 109.43 7.08 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.313 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.575 HG12 ' HB2' ' A' ' 88' ' ' ALA . 83.6 mt -69.62 130.31 34.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 176.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.9 pt -109.55 -25.88 3.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.29 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -150.0 129.37 12.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.628 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -144.28 138.12 27.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.255 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.531 ' HD3' ' HB2' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -166.52 157.77 12.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.547 179.848 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -91.47 122.68 34.28 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 168.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -115.35 96.73 5.8 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.82 -125.25 9.0 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -172.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -94.83 14.94 1.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.019 2.479 . . . . 0.0 112.497 175.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -114.87 150.69 35.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.704 0.288 . . . . 0.0 110.947 -176.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -109.43 108.17 18.59 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 174.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.532 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 5.0 mm-40 -100.62 112.34 24.71 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.057 -175.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.495 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -130.57 116.55 18.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.855 0.359 . . . . 0.0 111.318 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.2 t -96.55 123.35 48.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.782 0.325 . . . . 0.0 110.649 -177.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.575 ' HB2' HG12 ' A' ' 74' ' ' ILE . . . -135.35 129.0 32.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.007 0.432 . . . . 0.0 111.307 -177.127 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.55 ' HG2' HG23 ' A' ' 40' ' ' THR . 21.1 mt-10 -92.34 137.01 32.73 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 23.1 t -99.89 134.5 39.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 120.896 0.379 . . . . 0.0 110.33 -176.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -124.69 149.35 47.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.237 -177.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.574 ' OD1' ' HG2' ' A' ' 70' ' ' LYS . 18.2 m-20 -123.53 150.85 43.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.393 176.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.584 ' OD2' ' HG3' ' A' ' 70' ' ' LYS . 5.8 m-20 -60.94 152.66 27.05 Favored 'General case' 0 C--O 1.238 0.464 0 O-C-N 123.687 0.617 . . . . 0.0 110.359 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.97 85.72 0.52 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.021 0.439 . . . . 0.0 110.098 176.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.474 HG23 ' H ' ' A' ' 97' ' ' LEU . 7.1 t -174.6 -29.64 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.532 -176.186 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 95' ' ' THR . 31.0 mmtp 72.27 4.81 5.13 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 122.981 0.512 . . . . 0.0 111.976 177.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.474 ' H ' HG23 ' A' ' 95' ' ' THR . 93.8 mt -105.6 134.96 47.86 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.044 0.45 . . . . 0.0 110.906 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.402 ' OE1' ' HB2' ' A' ' 100' ' ' HIS . 1.1 pp20? -125.98 170.43 11.71 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.393 177.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 20.9 t60 -114.15 36.3 3.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.065 0.459 . . . . 0.0 110.995 -174.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.402 ' HB2' ' OE1' ' A' ' 98' ' ' GLU . 30.2 m80 -96.0 15.93 19.27 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.024 0.44 . . . . 0.0 109.935 175.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 54.1 m170 -68.01 163.07 23.09 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.927 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 69.76 31.46 3.52 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.158 0.504 . . . . 0.0 110.428 -175.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.401 ' HB2' ' HZ ' ' B' ' 217' ' ' PHE . 15.2 p80 -105.41 178.42 4.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.61 -177.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 34.8 m80 . . . . . 0 C--N 1.321 -0.665 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 170.413 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 79.4 mtp . . . . . 0 N--CA 1.482 1.13 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -73.3 79.0 1.33 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 121.687 0.756 . . . . 0.0 111.444 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -171.52 87.21 0.09 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.486 174.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -81.48 97.27 7.7 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.883 178.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 205' ' ' ILE . . . . . 0.807 HG13 ' H ' ' B' ' 207' ' ' ALA . 7.3 tp -60.45 128.25 21.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.55 -178.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 31.3 pt -83.1 4.6 2.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.542 -177.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 207' ' ' ALA . . . . . 0.807 ' H ' HG13 ' B' ' 205' ' ' ILE . . . 64.14 35.35 10.37 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 123.605 0.565 . . . . 0.0 111.539 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -116.1 124.21 49.81 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.889 176.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.05 160.05 25.79 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.924 0.392 . . . . 0.0 111.186 -178.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 210' ' ' LEU . . . . . . . . . . . . . 37.4 tp -114.29 138.31 50.66 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 6.1 tt -72.31 116.51 12.83 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -93.35 131.29 38.65 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.851 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 213' ' ' THR . . . . . . . . . . . . . 53.9 m -101.43 130.05 47.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.147 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 214' ' ' VAL . . . . . . . . . . . . . 49.5 t -56.05 122.13 4.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.146 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -101.64 -53.55 2.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.579 -177.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 216' ' ' SER . . . . . 0.767 ' HA ' ' HG3' ' A' ' 62' ' ' GLU . 47.1 m 70.05 120.86 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 O-C-N 123.671 0.607 . . . . 0.0 111.448 -178.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 217' ' ' PHE . . . . . 0.525 ' HB2' ' HB2' ' A' ' 66' ' ' ALA . 10.1 t80 -157.32 -69.08 0.1 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.038 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 218' ' ' SER . . . . . . . . . . . . . 5.9 m -135.63 150.74 49.73 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 175.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 4.0 m -99.22 12.78 35.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.626 0.727 . . . . 0.0 110.519 -178.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 95.7 mt -123.07 93.36 3.93 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.107 179.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 221' ' ' ALA . . . . . 0.426 ' HB3' ' HA ' ' A' ' 61' ' ' SER . . . -138.55 -62.53 0.56 Allowed 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 121.117 -0.233 . . . . 0.0 111.526 -178.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -158.35 170.04 23.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.951 0.405 . . . . 0.0 111.65 -173.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 223' ' ' GLU . . . . . 0.589 ' OE2' ' HA ' ' A' ' 22' ' ' ALA . 8.7 pt-20 -150.78 169.58 21.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.502 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 224' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' B' ' 223' ' ' GLU . 0.8 OUTLIER 177.4 137.08 0.07 Allowed 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.781 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 5.7 m -133.55 107.28 10.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.07 0.462 . . . . 0.0 110.195 173.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 226' ' ' SER . . . . . 0.495 ' O ' HG13 ' B' ' 230' ' ' ILE . 8.5 t -89.71 171.08 9.9 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -178.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 227' ' ' LYS . . . . . 0.419 ' HB3' ' HE2' ' B' ' 227' ' ' LYS . 43.5 mtpt -66.45 -18.18 65.22 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -171.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -72.07 -47.56 50.64 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 176.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 229' ' ' GLU . . . . . 0.449 ' OE1' ' HB3' ' B' ' 226' ' ' SER . 2.0 mp0 -67.4 -41.04 85.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.159 176.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.571 HG12 HD12 ' B' ' 235' ' ' LEU . 98.1 mt -59.01 -48.01 88.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.448 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 35.5 p -72.78 -25.01 61.01 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.007 0.432 . . . . 0.0 110.959 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 26.4 t-80 -75.71 -50.17 16.12 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.284 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -88.62 -16.89 31.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.319 -177.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 60.06 79.77 0.23 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.543 0.687 . . . . 0.0 110.177 -177.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 235' ' ' LEU . . . . . 0.571 HD12 HG12 ' B' ' 230' ' ' ILE . 82.9 mt -82.57 177.48 8.69 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.002 -175.002 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.476 HG23 ' HA ' ' B' ' 294' ' ' ALA . 61.3 t -105.96 138.8 29.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.727 -178.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 237' ' ' LYS . . . . . 0.438 ' HE2' ' O ' ' B' ' 239' ' ' GLY . 20.2 tptm -104.74 128.9 53.0 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.774 -179.29 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 238' ' ' VAL . . . . . 0.418 HG13 ' HB2' ' B' ' 292' ' ' ASN . 2.6 m -91.3 -45.33 14.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.297 176.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 239' ' ' GLY . . . . . 0.438 ' O ' ' HE2' ' B' ' 237' ' ' LYS . . . 166.02 -178.7 40.57 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.115 -177.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 34.9 m -106.69 137.93 43.81 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.466 -0.198 . . . . 0.0 110.466 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 29.7 pt -105.53 137.44 35.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.878 0.37 . . . . 0.0 110.435 175.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -115.64 114.17 24.53 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.431 -177.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 243' ' ' VAL . . . . . 0.585 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 54.9 t -101.9 125.4 56.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.901 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 23.1 t -146.91 106.4 3.92 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.874 0.369 . . . . 0.0 110.44 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 245' ' ' GLN . . . . . 0.507 ' HG3' ' HB2' ' B' ' 249' ' ' GLN . 0.0 OUTLIER -156.33 168.05 28.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.391 178.363 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 22.6 t -92.16 -174.3 3.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.828 0.347 . . . . 0.0 110.413 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -69.64 -3.1 39.67 Favored Glycine 0 C--N 1.33 0.2 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.771 -178.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -74.45 -27.59 65.29 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.701 -0.762 . . . . 0.0 111.613 174.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 249' ' ' GLN . . . . . 0.507 ' HB2' ' HG3' ' B' ' 245' ' ' GLN . 64.7 mt-30 -102.16 -36.79 8.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.56 0.219 . . . . 0.0 110.586 177.317 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 250' ' ' ILE . . . . . 0.433 HG12 ' HG3' ' B' ' 245' ' ' GLN . 47.6 mm -115.4 99.97 9.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.857 0.36 . . . . 0.0 110.791 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 21.5 t -122.68 -42.74 2.3 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.999 175.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 252' ' ' SER . . . . . 0.51 ' HB3' ' HD2' ' B' ' 253' ' ' PRO . 32.3 m -111.23 162.33 21.35 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.776 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 253' ' ' PRO . . . . . 0.51 ' HD2' ' HB3' ' B' ' 252' ' ' SER . 13.1 Cg_endo -57.83 -35.25 98.88 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.775 2.316 . . . . 0.0 112.754 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 254' ' ' SER . . . . . 0.417 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 5.3 p -63.27 -34.39 77.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.149 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -58.84 -51.57 69.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.662 -176.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 55.4 tp -63.66 -37.92 89.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.029 -177.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 257' ' ' ARG . . . . . 0.537 ' HD2' ' HE2' ' A' ' 71' ' ' TYR . 81.3 mtp180 -59.43 -39.92 85.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.719 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 258' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' B' ' 254' ' ' SER . 21.2 mm-40 -65.46 -30.98 71.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.857 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -79.74 -48.36 13.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.113 -177.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.69 -46.25 86.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.904 -174.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 18.4 p -61.28 -41.18 96.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.224 0.535 . . . . 0.0 110.763 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -61.5 -51.0 70.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.156 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 263' ' ' LEU . . . . . . . . . . . . . 95.9 mt -67.65 -31.42 71.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.68 -175.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.88 -50.75 47.05 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -175.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -71.98 -25.31 61.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.872 0.368 . . . . 0.0 110.106 -177.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -67.8 -34.24 76.37 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.287 0.565 . . . . 0.0 110.552 176.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -81.79 -9.68 59.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.362 177.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 268' ' ' GLY . . . . . 0.559 ' HA3' ' HB3' ' A' ' 15' ' ' ALA . . . 96.37 5.92 58.94 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.168 175.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 269' ' ' GLY . . . . . 0.485 ' HA3' HG12 ' B' ' 290' ' ' VAL . . . -89.45 154.94 24.58 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.685 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 270' ' ' LYS . . . . . 0.484 ' HE2' ' O ' ' B' ' 268' ' ' GLY . 48.6 mmtt -119.74 -2.54 10.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.951 0.405 . . . . 0.0 110.55 -175.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 271' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -143.55 154.6 43.77 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 175.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 272' ' ' TYR . . . . . 0.443 ' CD1' ' HB1' ' A' ' 22' ' ' ALA . 7.3 p90 -151.31 157.85 43.05 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.994 174.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -138.89 112.13 8.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.865 -178.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 274' ' ' ILE . . . . . 0.591 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 55.6 mt -69.24 120.76 17.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.536 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 22.0 pt -97.87 -36.94 6.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.149 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -145.45 100.44 3.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.925 0.393 . . . . 0.0 111.598 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -104.57 100.57 10.24 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 174.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 278' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' B' ' 285' ' ' GLU . 10.0 ptm180 -118.68 111.96 19.19 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.838 0.827 . . . . 0.0 111.787 -169.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -77.75 96.78 4.99 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.666 173.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 17.1 t-160 -96.62 97.83 9.7 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.691 -175.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 77.39 -137.26 20.1 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -174.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -83.08 -4.36 11.17 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.462 2.108 . . . . 0.0 111.872 174.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -103.66 154.33 19.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.173 -176.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 284' ' ' PHE . . . . . 0.438 ' CE2' ' HB2' ' B' ' 286' ' ' ALA . 84.1 t80 -114.74 124.75 52.58 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.913 0.387 . . . . 0.0 110.238 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 285' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 36.2 mt-10 -123.72 116.65 23.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.151 -179.311 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 286' ' ' ALA . . . . . 0.585 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -118.07 130.15 55.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.119 0.485 . . . . 0.0 111.722 -175.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 35.2 t -110.93 120.73 62.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.031 174.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -133.13 140.86 47.84 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.11 0.481 . . . . 0.0 111.517 -177.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -91.75 119.27 31.43 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.497 177.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 290' ' ' VAL . . . . . 0.485 HG12 ' HA3' ' B' ' 269' ' ' GLY . 15.4 t -94.98 130.41 43.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -117.35 157.81 25.49 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.375 0.607 . . . . 0.0 110.634 -176.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 292' ' ' ASN . . . . . 0.418 ' HB2' HG13 ' B' ' 238' ' ' VAL . 6.3 t-20 -120.37 164.38 16.43 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 174.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -67.53 157.16 34.99 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -176.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 294' ' ' ALA . . . . . 0.476 ' HA ' HG23 ' B' ' 236' ' ' VAL . . . -72.64 -6.21 42.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.118 0.485 . . . . 0.0 111.708 -173.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 295' ' ' THR . . . . . . . . . . . . . 14.8 t -105.47 -6.11 19.72 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.132 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 65.22 -167.18 0.22 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.04 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 297' ' ' LEU . . . . . 0.464 HD23 ' H ' ' B' ' 297' ' ' LEU . 0.4 OUTLIER -94.88 159.13 15.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.995 -176.34 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 298' ' ' GLU . . . . . 0.504 ' HB3' ' CE1' ' B' ' 301' ' ' HIS . 34.7 tt0 63.62 99.95 0.03 OUTLIER 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.748 -176.366 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 299' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -82.83 22.3 0.93 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.744 -178.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 300' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -138.54 70.9 1.38 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.559 175.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 301' ' ' HIS . . . . . 0.504 ' CE1' ' HB3' ' B' ' 298' ' ' GLU . 3.4 m-70 -93.03 105.74 17.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.947 175.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 302' ' ' HIS . . . . . 0.436 ' HB2' ' O ' ' B' ' 301' ' ' HIS . 41.0 m170 73.7 152.54 0.13 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.73 0.776 . . . . 0.0 112.304 178.199 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -144.01 -34.92 0.38 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.572 170.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 11.5 t60 . . . . . 0 C--N 1.333 -0.144 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.394 172.401 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -151.3 82.69 1.31 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.173 0.511 . . . . 0.0 110.287 178.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.6 tttt 68.51 152.39 0.09 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.168 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 4' ' ' ARG . 8.4 ptp180 -94.75 -168.15 1.77 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.435 -179.143 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.6 pt -73.08 165.34 3.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.844 0.354 . . . . 0.0 111.128 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 64.8 mt -74.4 109.11 6.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.5 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.1 96.28 7.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.842 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -156.89 -176.77 6.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.62 179.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -95.89 101.9 13.63 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 110.151 -0.315 . . . . 0.0 110.151 176.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -136.89 149.17 47.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.549 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.31 -57.4 2.25 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 176.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 57.84 -158.91 0.27 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.317 177.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.9 t -150.48 137.71 19.47 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 174.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.7 m -112.15 141.89 26.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.581 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -111.26 82.06 1.54 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.354 177.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.4 p -118.38 91.12 3.48 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.596 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 93.7 t80 -122.78 123.35 40.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.032 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.6 m -123.18 119.56 30.58 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.318 177.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.0 t -73.16 -10.24 59.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.828 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.1 mp -85.16 95.85 9.28 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 177.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -129.87 -74.33 0.55 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.09 -178.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.697 ' HB1' ' CD1' ' B' ' 272' ' ' TYR . . . -126.54 138.32 53.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.931 -176.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.765 ' HG2' ' HB1' ' B' ' 221' ' ' ALA . 0.0 OUTLIER -138.23 -171.67 3.09 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.883 -171.116 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.554 ' CD ' ' HG3' ' B' ' 224' ' ' GLN . 0.0 OUTLIER 75.24 154.69 0.16 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.627 0.771 . . . . 0.0 111.615 176.985 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.8 m -114.77 164.56 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.854 -176.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.525 ' HB2' ' HB ' ' B' ' 274' ' ' ILE . 16.8 t -74.95 164.32 26.69 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.005 0.431 . . . . 0.0 111.267 -174.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -66.61 -28.91 68.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.281 176.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -60.67 -37.97 83.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.403 176.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.622 ' HA ' ' HB3' ' A' ' 32' ' ' HIS . 15.4 mm-40 -72.52 -26.21 61.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.908 -175.252 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.457 ' HA ' HD13 ' A' ' 35' ' ' LEU . 56.5 mt -60.79 -48.09 90.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 173.203 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.2 m -73.92 -21.15 60.16 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.1 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.622 ' HB3' ' HA ' ' A' ' 29' ' ' GLU . 22.8 t-160 -80.89 -54.21 5.79 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.402 -175.284 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -93.24 -20.05 20.81 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -176.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.85 84.99 0.13 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.191 0.519 . . . . 0.0 110.513 -175.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.565 HD22 ' HE1' ' A' ' 71' ' ' TYR . 5.8 mp -91.08 175.48 6.93 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.433 -176.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.415 HG11 ' HZ3' ' A' ' 96' ' ' LYS . 45.6 t -99.38 129.51 49.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.253 -173.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.474 ' HZ1' ' CD ' ' A' ' 89' ' ' GLU . 35.3 tptt -70.48 126.46 29.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.416 179.078 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.94 8.88 5.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.952 0.406 . . . . 0.0 111.483 175.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.75 -170.0 15.97 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.8 174.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 53.3 m -133.38 131.05 39.58 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.629 HG13 ' HB3' ' A' ' 88' ' ' ALA . 26.1 pt -104.23 132.33 51.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 176.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -123.28 127.72 48.96 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.136 0.493 . . . . 0.0 110.686 -175.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.662 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 88.7 t -93.01 123.26 45.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.171 175.008 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.5 t -146.35 74.4 1.36 Allowed 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 176.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -124.37 178.75 5.22 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.051 -178.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.8 t -86.27 168.47 13.88 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.85 176.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.26 -16.52 54.07 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.492 178.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.24 -17.83 74.45 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.123 -0.561 . . . . 0.0 112.349 177.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -111.61 -26.85 8.81 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.12 0.486 . . . . 0.0 110.353 176.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.494 HD12 ' HA ' ' A' ' 56' ' ' LEU . 43.1 mm -117.41 92.13 2.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.34 175.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.8 t -113.79 -62.33 1.61 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.347 -177.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.8 m -101.56 165.02 14.8 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.827 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -53.0 -38.4 79.98 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.423 2.082 . . . . 0.0 111.567 174.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.8 p -67.71 -38.53 83.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.448 177.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -59.88 -46.89 87.89 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.154 0.502 . . . . 0.0 109.932 176.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.494 ' HA ' HD12 ' A' ' 50' ' ' ILE . 60.4 tp -61.28 -45.74 93.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.19 176.611 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.69 ' HD2' ' OE2' ' B' ' 223' ' ' GLU . 3.7 ttp180 -53.41 -48.36 68.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.203 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -55.52 -45.76 77.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.14 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -70.74 -35.23 72.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.06 -178.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.7 mt -66.04 -48.65 70.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.062 0.458 . . . . 0.0 110.635 176.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.5 t -64.03 -38.11 89.87 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.226 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -58.17 -43.88 87.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.95 178.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 93.5 mt -70.32 -38.03 74.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.277 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.95 93.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.063 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.825 ' HB2' HD13 ' B' ' 220' ' ' LEU . 20.1 t70 -63.11 -31.94 73.2 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.099 178.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.47 -24.01 61.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.32 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 28.3 mmtm -100.17 -13.42 18.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.557 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.09 38.82 73.47 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.108 -179.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.1 146.3 18.19 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.567 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.612 ' O ' ' HB3' ' B' ' 221' ' ' ALA . 0.0 OUTLIER -89.89 -2.18 58.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.633 0.254 . . . . 0.0 111.442 -176.497 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.565 ' HE1' HD22 ' A' ' 35' ' ' LEU . 10.4 p90 -167.4 174.88 7.61 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 169.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.547 ' O ' ' HG3' ' A' ' 24' ' ' GLN . 44.0 p90 -148.25 130.74 15.77 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 175.611 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -111.43 109.67 19.75 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.385 -0.526 . . . . 0.0 109.97 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.555 ' HA ' ' HA ' ' A' ' 88' ' ' ALA . 68.2 mt -68.75 127.15 30.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 177.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 26.8 pt -102.3 -37.24 4.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.03 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.23 136.03 36.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.241 -178.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -147.69 134.12 19.68 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.493 ' HD3' ' HB2' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -154.72 147.34 24.21 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.999 0.428 . . . . 0.0 110.286 179.192 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -94.11 92.6 7.37 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 177.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -87.59 80.13 8.1 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.44 -173.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.62 -121.92 16.05 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.961 -178.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -86.2 -1.46 8.56 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.951 2.434 . . . . 0.0 112.442 177.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -117.45 122.42 43.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.318 -178.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.45 ' CD2' HG21 ' A' ' 50' ' ' ILE . 88.5 t80 -92.53 128.04 38.23 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 177.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.662 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 48.4 mt-10 -112.22 117.09 31.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.708 -179.107 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.525 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -120.99 118.67 30.44 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.194 175.117 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.6 t -100.95 111.5 30.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.629 ' HB3' HG13 ' A' ' 41' ' ' ILE . . . -117.38 132.45 56.58 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.05 0.452 . . . . 0.0 110.957 -177.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.496 ' HB3' ' CE2' ' A' ' 91' ' ' TYR . 11.0 mm-40 -92.14 128.23 37.91 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.116 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.1 t -102.37 125.86 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -178.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.496 ' CE2' ' HB3' ' A' ' 89' ' ' GLU . 92.9 m-85 -129.54 142.67 50.71 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.0 0.429 . . . . 0.0 110.386 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -111.85 170.32 8.23 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.014 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.471 ' OD2' ' HG2' ' A' ' 70' ' ' LYS . 13.2 m-20 -76.04 167.03 22.61 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.085 0.469 . . . . 0.0 111.006 -176.135 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -87.36 23.57 1.84 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.231 178.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.9 t -129.5 117.46 20.52 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.643 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.415 ' HZ3' HG11 ' A' ' 36' ' ' VAL . 33.8 mtmt -149.88 20.74 0.89 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.115 177.182 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 71.6 mt -107.83 92.4 4.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.957 -177.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -115.4 -74.45 0.61 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -119.82 105.06 10.75 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.28 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 14.3 m80 -120.33 162.09 20.05 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.222 176.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 64.8 t60 -81.54 -38.5 26.1 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.588 -177.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -124.07 137.55 54.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.906 0.384 . . . . 0.0 110.419 178.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 62.6 m80 -104.11 -24.46 13.18 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 175.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.039 174.695 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 66.2 mtt . . . . . 0 N--CA 1.482 1.175 0 CA-C-O 120.452 0.168 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? -147.39 168.73 21.1 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 82.5 tttt 71.81 135.61 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 O-C-N 124.285 0.991 . . . . 0.0 111.709 177.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -89.16 125.75 35.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.394 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 15.3 tt -146.05 150.09 15.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.571 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 60.7 mt -116.43 -61.18 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.561 0.22 . . . . 0.0 110.542 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 207' ' ' ALA . . . . . 0.409 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . . . -169.17 156.97 7.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 -177.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -146.16 76.66 1.46 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.753 177.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -175.32 173.64 2.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.108 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 210' ' ' LEU . . . . . . . . . . . . . 6.9 mp -77.63 145.76 36.54 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.636 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 42.9 tp -70.17 159.11 34.55 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.434 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.67 93.84 5.55 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.849 0.357 . . . . 0.0 110.86 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 213' ' ' THR . . . . . . . . . . . . . 9.8 p -89.66 -32.41 17.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.967 178.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 214' ' ' VAL . . . . . . . . . . . . . 19.6 m -91.34 33.15 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.172 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -73.81 92.24 2.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.784 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 52.9 m -151.22 100.35 2.75 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.542 178.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -163.0 144.27 9.78 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 218' ' ' SER . . . . . . . . . . . . . 15.4 m -78.76 66.05 4.15 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.172 0.51 . . . . 0.0 111.403 -178.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 96.7 m -153.75 94.58 1.79 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.961 174.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.825 HD13 ' HB2' ' A' ' 65' ' ' ASP . 1.1 pt? -116.95 96.37 5.43 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.829 177.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 221' ' ' ALA . . . . . 0.765 ' HB1' ' HG2' ' A' ' 23' ' ' GLU . . . -84.65 64.12 8.33 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.613 0.721 . . . . 0.0 110.12 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -106.45 102.46 11.85 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.141 -175.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 223' ' ' GLU . . . . . 0.69 ' OE2' ' HD2' ' A' ' 57' ' ' ARG . 9.8 tp10 -162.04 120.45 2.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.818 -178.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 224' ' ' GLN . . . . . 0.554 ' HG3' ' CD ' ' A' ' 24' ' ' GLN . 1.5 tm0? -169.95 139.29 1.86 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.041 0.448 . . . . 0.0 112.067 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 14.1 m -113.84 128.83 70.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.032 170.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 226' ' ' SER . . . . . 0.464 ' HB2' ' HG2' ' B' ' 229' ' ' GLU . 12.5 m -77.59 157.42 30.29 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.683 -178.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -68.31 -30.39 69.36 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -62.22 -35.75 79.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.687 176.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 229' ' ' GLU . . . . . 0.464 ' HG2' ' HB2' ' B' ' 226' ' ' SER . 36.6 mm-40 -71.34 -25.3 62.34 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.405 -178.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.532 HG12 HD12 ' B' ' 235' ' ' LEU . 56.8 mt -60.97 -45.17 98.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.828 175.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 5.1 m -73.07 -21.66 60.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.568 176.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 232' ' ' HIS . . . . . 0.421 ' HB3' ' HA ' ' B' ' 229' ' ' GLU . 23.1 t-160 -78.11 -52.04 9.35 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.579 -173.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -113.22 -4.59 13.72 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -175.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.88 84.92 0.12 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.421 0.629 . . . . 0.0 110.119 -171.109 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 235' ' ' LEU . . . . . 0.532 HD12 HG12 ' B' ' 230' ' ' ILE . 87.9 mt -79.32 138.84 37.87 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.031 -176.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.43 HG11 ' HE2' ' B' ' 296' ' ' LYS . 57.2 t -72.92 106.4 2.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.626 -178.56 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -79.23 116.88 19.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.105 0.478 . . . . 0.0 110.317 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 3.0 t -81.36 -40.89 18.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.825 -178.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 169.05 -149.98 14.73 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.47 -178.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 41.6 m -139.42 127.63 22.58 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 241' ' ' ILE . . . . . 0.466 HG23 HG21 ' B' ' 290' ' ' VAL . 2.4 pp -103.32 131.96 50.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.123 0.487 . . . . 0.0 109.931 178.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -116.19 120.19 38.19 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.058 -177.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 243' ' ' VAL . . . . . 0.588 ' O ' ' HA ' ' B' ' 285' ' ' GLU . 57.9 t -94.16 132.2 38.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.408 178.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 46.5 m -127.87 88.55 2.79 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 172.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 245' ' ' GLN . . . . . 0.594 ' HG2' HG12 ' B' ' 250' ' ' ILE . 1.1 tp60 -80.88 107.82 14.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.076 -173.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 53.1 p -84.99 102.74 13.42 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.853 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 92.52 -163.73 27.58 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.798 176.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -85.61 64.67 4.09 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 121.275 -0.488 . . . . 0.0 113.443 -172.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 249' ' ' GLN . . . . . 0.556 ' HB2' ' HG3' ' B' ' 245' ' ' GLN . 64.8 mt-30 -93.95 -3.06 52.28 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.01 0.433 . . . . 0.0 110.195 173.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 250' ' ' ILE . . . . . 0.594 HG12 ' HG2' ' B' ' 245' ' ' GLN . 38.7 mm -125.68 99.22 5.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.091 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 33.0 t -93.58 -46.36 7.32 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.098 0.475 . . . . 0.0 109.799 175.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 20.0 m -123.64 167.63 14.58 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.212 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.13 -26.77 61.89 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.574 2.183 . . . . 0.0 112.01 173.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 254' ' ' SER . . . . . 0.404 ' O ' ' HG3' ' B' ' 258' ' ' GLU . 19.9 m -64.78 -39.45 93.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.625 177.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.04 -46.76 82.17 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.301 177.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 55.3 tp -57.58 -43.85 84.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.701 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 257' ' ' ARG . . . . . 0.49 ' HD2' ' CD ' ' A' ' 23' ' ' GLU . 10.7 ttp180 -53.71 -52.32 60.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.266 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 258' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' B' ' 254' ' ' SER . 68.7 mt-10 -60.29 -27.1 67.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.814 -173.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 259' ' ' LYS . . . . . 0.427 ' O ' ' HG ' ' B' ' 263' ' ' LEU . 14.4 mptt -80.47 -39.65 27.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.976 0.417 . . . . 0.0 110.851 176.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 95.6 mt -71.28 -47.34 57.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.73 -175.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 2.8 m -58.93 -34.83 72.18 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.314 0.578 . . . . 0.0 110.658 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -66.39 -47.81 72.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.421 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 263' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' B' ' 259' ' ' LYS . 90.6 mt -64.96 -32.41 74.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.629 -175.198 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -60.86 -42.58 98.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.597 -177.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -61.29 -49.39 77.22 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.43 -177.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -68.92 -15.12 63.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.852 -175.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 267' ' ' LYS . . . . . 0.444 ' HD3' ' HA ' ' B' ' 267' ' ' LYS . 31.4 mmtp -100.87 -0.86 36.07 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.088 178.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 74.42 28.11 64.35 Favored Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.218 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -101.27 162.76 17.98 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.066 -178.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 270' ' ' LYS . . . . . 0.496 ' HA ' ' CE ' ' B' ' 270' ' ' LYS . 0.0 OUTLIER -117.15 -59.94 1.89 Allowed 'General case' 0 C--N 1.32 -0.716 0 O-C-N 122.66 -0.317 . . . . 0.0 110.754 179.426 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 271' ' ' TYR . . . . . 0.622 ' HE2' ' HB2' ' B' ' 293' ' ' ASP . 6.0 m-85 -117.19 162.94 17.06 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 272' ' ' TYR . . . . . 0.697 ' CD1' ' HB1' ' A' ' 22' ' ' ALA . 0.1 OUTLIER -148.74 158.75 44.37 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.183 0.516 . . . . 0.0 110.994 -179.123 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -128.17 107.78 10.07 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.256 -178.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 274' ' ' ILE . . . . . 0.525 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 4.5 mp -77.46 120.47 28.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.611 -174.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 14.4 pt -111.42 -26.45 3.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -176.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 276' ' ' ALA . . . . . 0.659 ' HB3' ' HB ' ' B' ' 287' ' ' VAL . . . -134.9 145.74 48.52 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.192 -177.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 277' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' B' ' 285' ' ' GLU . . . -169.47 117.66 0.62 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.856 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.13 139.11 15.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.83 0.348 . . . . 0.0 110.992 -178.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 279' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' B' ' 284' ' ' PHE . 3.3 mp0 -76.7 91.08 3.43 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 174.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -87.01 89.31 7.95 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 -176.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 66.44 -118.76 11.33 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.511 -174.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -90.54 -2.12 5.18 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.896 2.398 . . . . 0.0 112.733 177.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 283' ' ' ASN . . . . . 0.551 ' HA ' ' O ' ' B' ' 245' ' ' GLN . 59.1 m-80 -118.87 115.87 25.3 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.018 0.437 . . . . 0.0 111.127 -176.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 284' ' ' PHE . . . . . 0.449 ' HA ' ' HA ' ' B' ' 279' ' ' GLU . 70.0 t80 -79.06 113.92 17.57 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 175.014 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 285' ' ' GLU . . . . . 0.588 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 48.3 mt-10 -99.27 114.13 26.79 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.853 -176.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 286' ' ' ALA . . . . . 0.498 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -114.26 135.09 54.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.473 174.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 287' ' ' VAL . . . . . 0.659 ' HB ' ' HB3' ' B' ' 276' ' ' ALA . 37.4 t -125.41 128.48 72.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 110.081 -0.341 . . . . 0.0 110.081 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -134.74 151.13 50.74 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.965 0.412 . . . . 0.0 111.54 -178.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 289' ' ' GLU . . . . . 0.455 ' O ' ' HA ' ' B' ' 272' ' ' TYR . 21.8 mt-10 -90.62 119.92 31.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.141 178.112 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 290' ' ' VAL . . . . . 0.466 HG21 HG23 ' B' ' 241' ' ' ILE . 39.1 t -94.15 124.15 46.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.511 0.196 . . . . 0.0 111.211 -175.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -129.27 151.29 50.09 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.469 0.652 . . . . 0.0 111.658 -178.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 292' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -106.76 155.19 19.96 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.949 173.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 293' ' ' ASP . . . . . 0.622 ' HB2' ' HE2' ' B' ' 271' ' ' TYR . 25.7 t70 -77.77 160.23 28.52 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 165.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 294' ' ' ALA . . . . . . . . . . . . . . . -75.29 41.29 0.18 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.963 0.411 . . . . 0.0 111.77 -176.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 295' ' ' THR . . . . . . . . . . . . . 10.0 t -126.49 -41.79 1.85 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.41 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 296' ' ' LYS . . . . . 0.43 ' HE2' HG11 ' B' ' 236' ' ' VAL . 43.4 mttm 56.28 32.0 19.57 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 177.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 297' ' ' LEU . . . . . . . . . . . . . 95.7 mt -107.52 112.5 25.28 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 176.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 298' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -105.62 4.09 29.87 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.914 -174.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 299' ' ' HIS . . . . . . . . . . . . . 40.4 m170 -108.38 133.26 52.81 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.333 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 300' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 66.77 82.42 0.18 Allowed 'General case' 0 C--N 1.331 -0.237 0 O-C-N 123.832 0.708 . . . . 0.0 110.894 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 301' ' ' HIS . . . . . . . . . . . . . 50.5 m80 -84.32 -40.43 17.95 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 302' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -145.27 -56.02 0.32 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 174.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -120.03 -44.38 2.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.205 168.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 45.2 m80 . . . . . 0 C--N 1.325 -0.494 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.622 177.984 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.471 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 18.6 mmt . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.471 ' H ' ' HB2' ' A' ' 1' ' ' MET . 95.2 mttt -136.94 124.97 22.82 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.428 -0.805 . . . . 0.0 108.904 175.357 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.887 ' H ' ' HD3' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -81.62 90.08 6.27 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.548 0.69 . . . . 0.0 111.015 -173.501 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.637 ' H ' ' HD3' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -81.85 56.11 2.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.776 0.798 . . . . 0.0 110.055 177.663 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.9 pt -79.88 -170.84 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.945 -178.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.5 tt -139.76 130.94 32.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.893 0.378 . . . . 0.0 110.799 178.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -138.57 18.54 2.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.375 0.607 . . . . 0.0 110.077 176.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -96.73 142.49 28.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.436 178.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -136.07 94.48 3.05 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.173 0.511 . . . . 0.0 111.132 -176.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 53.9 tp -122.35 122.38 38.92 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.738 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 56.8 tp -119.23 110.42 16.99 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.925 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.97 -177.5 4.91 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.158 0.504 . . . . 0.0 111.024 -177.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.4 m -145.69 106.87 4.17 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.12 177.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.6 m -130.62 -166.83 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.267 -175.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.539 ' HB3' ' HA2' ' B' ' 268' ' ' GLY . . . 69.18 171.11 0.3 Allowed 'General case' 0 N--CA 1.463 0.184 0 O-C-N 123.825 0.703 . . . . 0.0 111.967 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.0 t -167.81 -39.3 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.959 -177.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -115.74 106.06 13.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.051 174.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 69.3 m -145.45 -77.91 0.19 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.693 -0.23 . . . . 0.0 110.483 175.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 55.84 -66.31 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.321 1.048 . . . . 0.0 113.624 -177.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.599 HD12 HD13 ' B' ' 220' ' ' LEU . 2.2 mm? -83.0 81.9 8.47 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -163.5 167.37 21.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.669 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.467 ' O ' ' HD3' ' B' ' 257' ' ' ARG . . . 72.35 117.57 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 O-C-N 124.281 0.988 . . . . 0.0 112.002 176.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.733 ' HG2' ' H ' ' B' ' 222' ' ' ALA . 9.8 tp10 -150.17 179.74 7.85 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.361 -178.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.778 ' HA ' ' HB2' ' A' ' 71' ' ' TYR . 0.0 OUTLIER 85.44 140.08 0.06 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.074 0.95 . . . . 0.0 111.529 176.712 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.503 HG22 ' CZ ' ' A' ' 71' ' ' TYR . 5.0 m -117.06 173.35 4.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.48 176.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.57 ' HB3' ' HB ' ' B' ' 274' ' ' ILE . 92.3 p -97.99 -175.75 3.24 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.097 0.475 . . . . 0.0 111.039 -175.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.0 tmmt? -71.48 -19.74 62.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.099 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' B' ' 277' ' ' ALA . 1.8 mp0 -66.51 -45.91 77.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.6 -178.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -65.64 -44.69 85.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.502 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.0 mt -53.77 -46.47 62.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.688 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.3 m -68.4 -38.4 81.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.549 -176.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 25.8 m80 -80.86 -44.99 17.53 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -174.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.429 ' CD1' ' HD3' ' B' ' 253' ' ' PRO . 97.8 m-85 -93.22 -19.9 20.97 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -173.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm 61.35 82.72 0.16 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.184 0.516 . . . . 0.0 110.617 -177.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.573 HD21 ' HG3' ' B' ' 253' ' ' PRO . 96.5 mt -85.31 173.38 10.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.415 -176.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.1 t -95.97 124.78 48.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.608 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -84.58 115.49 22.65 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.161 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -94.68 -3.84 10.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.157 0.503 . . . . 0.0 111.141 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 120.83 155.25 9.51 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.976 174.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 27.4 m -81.16 150.3 28.75 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 177.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.3 pt -116.35 134.22 60.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.001 0.429 . . . . 0.0 110.006 172.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -124.12 116.04 22.11 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.122 -178.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 3.2 t -109.87 109.51 28.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.513 -178.369 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.8 p -92.48 91.92 7.84 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 175.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.606 ' HG2' HG12 ' A' ' 50' ' ' ILE . 0.9 OUTLIER -97.58 147.66 24.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.669 -170.641 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.9 t -96.84 154.8 17.08 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 172.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.92 78.32 0.39 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.338 178.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -175.76 -37.83 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 121.146 -0.549 . . . . 0.0 112.553 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -81.73 -23.85 36.48 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 122.57 -0.37 . . . . 0.0 111.255 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.606 HG12 ' HG2' ' A' ' 45' ' ' GLN . 49.3 mm -112.7 109.71 29.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.6 t -107.12 -45.94 4.02 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.204 0.526 . . . . 0.0 109.711 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.518 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 22.0 m -126.06 165.96 24.32 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.837 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' A' ' 52' ' ' SER . 10.7 Cg_endo -54.69 -26.4 46.65 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.631 2.221 . . . . 0.0 111.981 177.036 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.598 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 2.3 m -55.67 -51.86 65.8 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.752 176.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -59.62 -42.17 92.07 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.234 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 56.9 tp -61.5 -46.58 89.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.908 -177.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 21.5 ttp180 -58.66 -44.51 90.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.455 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.598 ' HG2' ' O ' ' A' ' 54' ' ' SER . 19.0 mm-40 -62.32 -45.35 93.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.854 -178.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -67.33 -36.86 82.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.362 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.0 mt -68.26 -43.0 78.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.977 0.418 . . . . 0.0 110.515 177.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.4 m -68.49 -30.53 69.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.575 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -58.01 -46.67 84.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.055 0.455 . . . . 0.0 110.46 177.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 98.5 mt -74.55 -37.0 63.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.898 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.72 -32.64 74.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.091 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -60.33 -41.72 94.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.917 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.05 -16.62 56.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.078 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.707 ' HE3' ' HB2' ' B' ' 212' ' ' ALA . 28.0 mmtp -89.52 -15.22 33.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.548 177.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 57.68 48.98 77.83 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 -175.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -92.66 171.14 32.97 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.877 -175.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.477 ' CB ' ' HA ' ' A' ' 92' ' ' ASN . 56.7 tptt -99.89 -47.18 5.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.535 0.683 . . . . 0.0 109.811 178.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.778 ' HB2' ' HA ' ' A' ' 24' ' ' GLN . 35.1 p90 -150.96 177.15 10.43 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.794 -178.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -142.62 126.05 16.69 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.247 0.546 . . . . 0.0 110.166 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -106.61 101.0 10.48 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.281 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.626 HG12 ' HB2' ' A' ' 88' ' ' ALA . 69.7 mt -72.44 120.11 20.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.139 0.495 . . . . 0.0 110.514 -176.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.6 pt -94.99 -35.38 6.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.22 -178.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.97 110.88 5.02 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.995 0.426 . . . . 0.0 111.601 -177.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -107.86 88.43 2.73 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 172.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.532 ' CG ' ' HB2' ' A' ' 85' ' ' GLU . 6.2 ptp180 -95.86 121.49 37.64 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.874 0.845 . . . . 0.0 112.196 -166.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -70.64 100.47 1.85 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.71 172.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 23.8 t-80 -88.16 14.74 8.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.062 0.458 . . . . 0.0 110.46 -177.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.85 -106.5 3.18 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.75 -5.9 16.39 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.579 2.186 . . . . 0.0 111.193 173.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -123.02 156.8 34.09 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.172 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -128.49 120.97 27.83 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.532 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 41.3 mt-10 -110.3 110.94 21.94 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.787 -177.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.36 118.12 32.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.035 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.9 t -112.82 112.79 41.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.934 176.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.626 ' HB2' HG12 ' A' ' 74' ' ' ILE . . . -127.76 141.71 51.51 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.962 0.41 . . . . 0.0 111.895 -176.233 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -91.85 116.47 28.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.79 177.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.6 t -100.34 125.01 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-O 121.117 0.484 . . . . 0.0 110.067 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.536 ' HB2' ' CE1' ' A' ' 71' ' ' TYR . 64.7 m-85 -123.84 159.51 29.43 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.911 177.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.477 ' HA ' ' CB ' ' A' ' 70' ' ' LYS . 10.3 t-20 -120.52 174.07 6.78 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 175.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -55.89 157.11 4.59 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.764 0.316 . . . . 0.0 110.222 176.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.75 64.86 1.81 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.994 0.426 . . . . 0.0 110.702 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 99' ' ' HIS . 16.0 m -152.78 -107.17 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.547 178.032 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 57.7 mttt 44.38 -94.57 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -174.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 90.0 mt -85.13 76.98 10.15 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.135 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 51.76 77.11 0.15 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.41 -0.813 . . . . 0.0 112.24 175.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.447 ' O ' ' HA ' ' A' ' 95' ' ' THR . 33.1 m80 -147.27 127.16 13.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.122 177.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -142.24 102.58 4.13 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.298 170.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -130.22 71.52 1.46 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.324 0.583 . . . . 0.0 110.29 -178.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 36.0 t60 -83.63 103.17 12.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.371 179.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 65.4 t-80 -87.64 134.84 33.57 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.767 178.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 4.7 p80 . . . . . 0 C--N 1.324 -0.523 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.847 178.965 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -119.33 16.56 13.07 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.34 0.59 . . . . 0.0 109.622 172.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -71.04 139.69 50.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.322 173.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -84.66 -45.36 12.55 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 59.7 mt 58.61 92.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.168 176.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 25.5 pt -114.38 144.95 20.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.271 174.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -166.24 -47.35 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.61 0.243 . . . . 0.0 111.236 -175.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . 65.06 -156.61 0.29 Allowed 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.833 -178.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . 69.61 40.24 1.42 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.371 0.605 . . . . 0.0 110.665 -178.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 210' ' ' LEU . . . . . . . . . . . . . 91.5 mt -101.55 111.79 24.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.53 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 8.2 mp -93.99 146.21 24.1 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.868 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 212' ' ' ALA . . . . . 0.707 ' HB2' ' HE3' ' A' ' 67' ' ' LYS . . . -139.87 93.88 2.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.481 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 213' ' ' THR . . . . . . . . . . . . . 47.6 m -152.94 90.63 1.47 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.3 0.571 . . . . 0.0 110.977 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 214' ' ' VAL . . . . . . . . . . . . . 11.0 p -162.46 141.16 2.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.646 176.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -79.89 -57.38 3.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.418 -177.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 22.8 m 64.04 -161.65 0.28 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.353 -178.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -102.81 129.5 49.49 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 218' ' ' SER . . . . . . . . . . . . . 15.5 m -85.94 76.46 9.84 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.461 0.648 . . . . 0.0 110.813 -178.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 11.2 m -104.02 163.19 12.54 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.85 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.644 ' H ' HD23 ' B' ' 220' ' ' LEU . 1.2 pt? -60.34 114.99 3.21 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 176.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 221' ' ' ALA . . . . . 0.47 ' HB1' ' O ' ' A' ' 70' ' ' LYS . . . -166.83 178.38 5.9 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.328 -177.237 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 222' ' ' ALA . . . . . 0.733 ' H ' ' HG2' ' A' ' 23' ' ' GLU . . . 61.8 87.65 0.1 Allowed 'General case' 0 N--CA 1.465 0.321 0 O-C-N 124.004 0.815 . . . . 0.0 112.706 177.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -167.61 110.57 0.65 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.926 174.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 224' ' ' GLN . . . . . 0.53 ' HG3' ' CD ' ' A' ' 24' ' ' GLN . 1.1 tm0? -161.94 148.09 13.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.033 -175.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 225' ' ' VAL . . . . . 0.454 HG22 ' HB3' ' B' ' 271' ' ' TYR . 18.7 m -126.78 128.69 71.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 166.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 226' ' ' SER . . . . . 0.6 ' HB2' ' HB ' ' A' ' 74' ' ' ILE . 6.3 t -87.86 178.98 6.55 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.776 0.322 . . . . 0.0 110.158 -177.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 227' ' ' LYS . . . . . 0.426 ' HA ' HD12 ' B' ' 230' ' ' ILE . 23.0 tptp -66.98 -23.91 65.99 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.293 -170.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -72.0 -50.32 29.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.939 0.399 . . . . 0.0 110.127 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -65.06 -38.64 91.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.784 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.49 HG13 ' O ' ' B' ' 226' ' ' SER . 97.4 mt -54.88 -54.0 27.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.032 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 56.8 m -73.44 -22.08 60.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.76 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -79.88 -44.5 20.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.693 0.282 . . . . 0.0 110.547 -177.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -89.48 -8.59 52.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.97 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt 60.28 51.72 5.32 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.528 -178.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.42 149.66 47.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.874 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.459 HG23 ' HB3' ' B' ' 292' ' ' ASN . 16.0 m -86.46 124.34 40.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.375 0.607 . . . . 0.0 111.491 -177.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -75.6 128.13 34.58 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.511 176.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 40.5 t -92.69 -44.44 13.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.253 0.549 . . . . 0.0 110.337 -179.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 177.11 -157.35 22.21 Favored Glycine 0 N--CA 1.442 -0.94 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.442 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 59.3 m -135.22 137.47 42.65 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 22.7 pt -117.61 142.61 31.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 175.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -132.9 138.5 47.0 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.692 0.758 . . . . 0.0 111.772 -177.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 243' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' B' ' 285' ' ' GLU . 59.7 t -102.75 134.68 43.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.221 177.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 7.2 t -149.21 47.82 0.98 Allowed 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 245' ' ' GLN . . . . . 0.522 ' NE2' HG13 ' B' ' 243' ' ' VAL . 0.9 OUTLIER -103.63 159.22 15.8 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.738 -177.071 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 246' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' B' ' 283' ' ' ASN . 19.1 m -89.18 171.06 10.09 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.247 -177.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -54.61 115.4 5.35 Favored Glycine 0 C--N 1.333 0.389 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.084 176.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . 134.31 -43.57 1.25 Allowed Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 -176.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 249' ' ' GLN . . . . . 0.472 ' HB2' ' HB3' ' B' ' 245' ' ' GLN . 11.5 mm100 -73.29 -23.81 60.33 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.009 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 49.9 mm -114.29 111.63 36.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 171.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 19.7 m -104.03 -19.09 14.31 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.612 -175.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 252' ' ' SER . . . . . 0.478 ' H ' ' HB3' ' B' ' 255' ' ' ASP . 38.6 m -154.99 163.51 24.21 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -176.187 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 253' ' ' PRO . . . . . 0.573 ' HG3' HD21 ' A' ' 35' ' ' LEU . 19.1 Cg_endo -61.64 -41.98 35.7 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.256 1.971 . . . . 0.0 111.246 175.211 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 254' ' ' SER . . . . . 0.44 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 27.5 m -75.28 -18.74 60.0 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.762 177.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.478 ' HB3' ' H ' ' B' ' 252' ' ' SER . 35.2 t70 -71.56 -33.57 69.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.204 0.526 . . . . 0.0 109.723 176.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.409 ' O ' ' HG ' ' B' ' 260' ' ' LEU . 63.2 tp -59.44 -43.22 93.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.461 172.23 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 257' ' ' ARG . . . . . 0.467 ' HD3' ' O ' ' A' ' 22' ' ' ALA . 1.8 tmm_? -62.24 -39.12 91.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.807 178.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 258' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' B' ' 254' ' ' SER . 13.5 mm-40 -52.43 -52.32 54.59 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.911 0.386 . . . . 0.0 110.328 176.091 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -62.31 -42.86 99.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.128 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 260' ' ' LEU . . . . . 0.493 HD13 ' CE2' ' B' ' 272' ' ' TYR . 96.0 mt -67.9 -43.82 78.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.82 -176.194 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 17.0 p -64.7 -31.23 72.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.999 0.428 . . . . 0.0 110.683 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -65.73 -42.42 91.04 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.21 178.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 263' ' ' LEU . . . . . . . . . . . . . 94.6 mt -73.21 -37.71 66.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.128 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -59.5 -39.31 83.4 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.575 -178.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -61.29 -40.0 92.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.182 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -74.7 -19.15 60.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.657 -176.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 267' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' B' ' 267' ' ' LYS . 42.7 mmtm -93.25 -36.18 12.72 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.946 0.403 . . . . 0.0 110.904 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 268' ' ' GLY . . . . . 0.539 ' HA2' ' HB3' ' A' ' 15' ' ' ALA . . . 106.13 55.91 0.67 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.559 177.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -142.64 150.8 22.53 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.366 -0.921 . . . . 0.0 111.857 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 270' ' ' LYS . . . . . 0.918 ' HD3' ' HB2' ' B' ' 293' ' ' ASP . 45.6 mtpt -94.52 -37.81 11.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.426 0.632 . . . . 0.0 110.268 177.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 271' ' ' TYR . . . . . 0.454 ' HB3' HG22 ' B' ' 225' ' ' VAL . 16.7 m-85 -117.75 150.31 39.33 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.747 -172.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 272' ' ' TYR . . . . . 0.493 ' CE2' HD13 ' B' ' 260' ' ' LEU . 21.6 p90 -145.2 155.02 43.01 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 175.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -136.49 109.79 7.85 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -177.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 274' ' ' ILE . . . . . 0.57 ' HB ' ' HB3' ' A' ' 26' ' ' SER . 60.8 mt -65.4 127.2 26.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.076 177.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 22.7 pt -108.25 -28.26 2.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.777 0.322 . . . . 0.0 111.769 -177.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -152.71 108.84 3.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.922 -178.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 277' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' B' ' 286' ' ' ALA . . . -124.53 102.89 7.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.091 0.472 . . . . 0.0 109.921 178.174 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.53 132.02 54.47 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.543 0.687 . . . . 0.0 111.311 -174.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.1 115.53 15.9 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 171.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 280' ' ' HIS . . . . . 0.485 ' HB2' ' HG3' ' B' ' 285' ' ' GLU . 7.1 t-160 -103.54 25.51 9.6 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.189 0.519 . . . . 0.0 110.109 -171.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 281' ' ' GLY . . . . . 0.403 ' HA3' ' HD3' ' B' ' 282' ' ' PRO . . . 103.35 -106.44 2.86 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.982 -0.627 . . . . 0.0 111.732 -177.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 282' ' ' PRO . . . . . 0.403 ' HD3' ' HA3' ' B' ' 281' ' ' GLY . 3.6 Cg_exo -75.45 -24.57 12.0 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.993 2.462 . . . . 0.0 112.045 178.394 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 283' ' ' ASN . . . . . 0.48 ' HA ' ' HA ' ' B' ' 246' ' ' SER . 53.2 m-80 -116.18 148.21 40.61 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.944 -177.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -107.22 115.31 29.94 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.58 176.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 285' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 1.0 OUTLIER -101.52 110.85 22.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.959 -175.095 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 286' ' ' ALA . . . . . 0.499 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -125.95 116.52 21.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.782 0.325 . . . . 0.0 111.604 -177.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 46.3 t -103.46 124.47 57.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.328 178.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -130.08 141.2 50.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.929 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -92.47 133.42 35.93 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.046 178.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 44.8 t -98.0 125.06 51.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.622 -178.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -123.68 142.98 50.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.1 0.476 . . . . 0.0 110.581 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 292' ' ' ASN . . . . . 0.459 ' HB3' HG23 ' B' ' 236' ' ' VAL . 14.8 t-20 -92.2 167.33 12.11 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 293' ' ' ASP . . . . . 0.918 ' HB2' ' HD3' ' B' ' 270' ' ' LYS . 13.6 t70 -64.27 -25.14 67.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.143 0.497 . . . . 0.0 110.093 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 294' ' ' ALA . . . . . . . . . . . . . . . 75.14 -53.77 0.66 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.334 175.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 295' ' ' THR . . . . . 0.459 HG21 ' HB3' ' A' ' 52' ' ' SER . 12.0 t -92.69 -29.09 16.26 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.035 -177.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 296' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' B' ' 295' ' ' THR . 23.0 mtmt 71.4 -66.77 0.28 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.259 0.624 . . . . 0.0 110.543 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 297' ' ' LEU . . . . . . . . . . . . . 4.0 pp -157.24 150.44 23.78 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.077 174.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 298' ' ' GLU . . . . . 0.617 ' CD ' ' H ' ' B' ' 299' ' ' HIS . 0.0 OUTLIER -89.62 -66.57 0.91 Allowed 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.088 0.47 . . . . 0.0 110.333 -178.306 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 299' ' ' HIS . . . . . 0.617 ' H ' ' CD ' ' B' ' 298' ' ' GLU . 13.2 p-80 -152.09 18.5 0.67 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.278 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 300' ' ' HIS . . . . . 0.437 ' HB2' ' O ' ' B' ' 299' ' ' HIS . 2.6 m80 74.91 109.54 0.07 Allowed 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.478 -178.309 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 301' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -63.38 108.53 1.35 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 173.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 302' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -60.53 117.51 5.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.319 0.58 . . . . 0.0 112.439 -170.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -133.99 100.17 4.65 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.862 176.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 . . . . . 0 C--N 1.322 -0.624 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.672 179.878 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.771 0.32 . . . . 0.0 111.229 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -87.68 106.56 18.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.211 0.529 . . . . 0.0 112.101 -172.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.6 ttpp -112.63 81.92 1.56 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 170.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -110.98 14.38 22.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.432 -172.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.5 mt -102.79 110.77 30.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.505 -178.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.588 ' HA ' HD12 ' B' ' 275' ' ' ILE . 8.4 pt -139.35 84.5 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.202 0.525 . . . . 0.0 110.488 173.271 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -107.88 93.45 4.55 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.263 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.36 131.95 35.22 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.821 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -150.1 154.35 37.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.01 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 87.7 mt 64.97 175.24 0.2 Allowed 'General case' 0 N--CA 1.465 0.319 0 O-C-N 123.917 0.761 . . . . 0.0 112.054 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 43.9 tp -168.04 142.28 3.45 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.46 178.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.59 67.71 0.97 Allowed 'General case' 0 C--O 1.234 0.266 0 O-C-N 123.761 0.663 . . . . 0.0 110.768 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.562 HG23 HD22 ' B' ' 263' ' ' LEU . 5.2 t -84.5 133.22 34.47 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.319 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.3 m -97.43 151.3 4.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.162 -177.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.9 108.2 4.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.903 -176.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.8 m -109.15 14.13 24.08 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.25 0.547 . . . . 0.0 110.674 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -145.89 127.99 15.62 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.5 p -136.42 98.27 3.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.069 0.461 . . . . 0.0 112.183 -172.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.4 m -113.16 141.98 46.31 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.001 173.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 79.9 mt -72.09 100.36 2.51 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -138.21 19.66 2.78 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.566 -174.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.495 ' O ' ' HD3' ' B' ' 257' ' ' ARG . . . -170.32 144.02 2.45 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.241 0.338 . . . . 0.0 110.456 -178.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.495 ' CD ' ' HA ' ' B' ' 221' ' ' ALA . 8.4 pt-20 -176.46 114.71 0.11 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.107 0.48 . . . . 0.0 112.289 178.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.788 ' HB3' ' CB ' ' B' ' 224' ' ' GLN . 22.2 tm0? 173.81 141.0 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.136 176.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.48 HG21 HD11 ' A' ' 35' ' ' LEU . 31.3 m -120.7 155.08 24.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 121.099 0.476 . . . . 0.0 111.883 -174.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.404 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 72.6 p -96.33 -93.09 0.21 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.429 -174.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.482 ' C ' ' HD3' ' A' ' 27' ' ' LYS . 10.8 tmtt? -123.12 -66.61 1.0 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 122.168 -0.333 . . . . 0.0 111.873 -174.008 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.44 ' H ' ' NE2' ' A' ' 28' ' ' GLN . 0.6 OUTLIER -62.5 -28.53 69.9 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -170.122 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -65.32 -42.78 92.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.968 0.414 . . . . 0.0 110.064 176.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.437 HG12 HD12 ' A' ' 35' ' ' LEU . 28.0 mt -64.57 -44.94 96.81 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.897 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.3 m -67.35 -30.47 70.3 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.846 -0.341 . . . . 0.0 111.335 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -72.45 -48.25 42.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.583 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -98.68 4.16 47.85 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.324 -176.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt 71.85 -45.95 0.63 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.978 0.911 . . . . 0.0 112.028 177.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.561 HD22 ' HA ' ' A' ' 93' ' ' ASP . 19.3 mt 58.71 164.25 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.208 1.003 . . . . 0.0 112.604 -172.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 76.3 t -97.5 -47.68 12.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.658 -175.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.592 ' HA ' ' HA ' ' A' ' 91' ' ' TYR . 63.5 tttm 70.39 126.49 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 O-C-N 124.159 0.912 . . . . 0.0 111.082 -177.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.0 m -114.28 -30.06 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -175.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 169.47 -161.99 35.51 Favored Glycine 0 C--O 1.227 -0.305 0 C-N-CA 119.303 -1.427 . . . . 0.0 113.656 -178.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.574 HG23 ' HG2' ' A' ' 89' ' ' GLU . 6.4 m -123.07 143.88 49.66 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 122.473 0.309 . . . . 0.0 110.441 -176.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.9 pt -118.92 139.5 46.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 172.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -122.02 114.4 20.9 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.724 -175.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.59 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 43.0 t -105.63 115.33 47.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.516 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 68.7 p -148.28 99.27 3.02 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.731 0.301 . . . . 0.0 110.996 -174.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 18.7 mp0 -142.15 157.11 45.25 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.064 179.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.599 ' HA ' ' HA ' ' A' ' 83' ' ' ASN . 19.9 t -71.38 173.44 7.85 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 120.666 0.27 . . . . 0.0 110.313 178.309 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.78 55.16 2.57 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 113.165 -176.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -141.52 -37.3 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 176.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -83.41 -14.81 51.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.09 0.471 . . . . 0.0 110.59 177.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.1 mm -130.34 132.57 64.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 176.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.3 m -134.84 -35.03 0.88 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.055 0.455 . . . . 0.0 111.584 -177.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.599 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 28.1 m -142.11 168.48 13.49 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -177.253 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.599 ' HD2' ' HB3' ' A' ' 52' ' ' SER . 10.8 Cg_endo -54.55 -31.05 67.93 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.543 2.162 . . . . 0.0 112.637 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.4 m -61.87 -34.51 76.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.664 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -62.88 -52.81 61.65 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.338 0.59 . . . . 0.0 109.881 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 57.4 tp -63.4 -30.37 71.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.276 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -62.08 -31.79 72.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.955 -178.302 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -74.93 -46.87 32.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.8 0.333 . . . . 0.0 110.358 175.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.565 ' HA ' ' HG2' ' A' ' 62' ' ' GLU . 1.9 mptp? -62.97 -40.39 97.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.195 -175.395 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.3 mt -61.6 -37.12 82.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.824 0.345 . . . . 0.0 110.748 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.523 ' HA ' ' HB3' ' B' ' 222' ' ' ALA . 19.5 m -75.95 -43.28 45.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.45 -178.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.565 ' HG2' ' HA ' ' A' ' 59' ' ' LYS . 16.8 pt-20 -69.44 -36.72 76.93 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 121.151 -0.219 . . . . 0.0 111.221 -175.002 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 87.4 mt -74.9 -49.36 20.59 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -178.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.24 -44.1 89.27 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -174.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -65.68 -34.9 79.29 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.997 0.427 . . . . 0.0 110.72 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.579 ' HA ' ' CE2' ' B' ' 217' ' ' PHE . . . -73.11 -8.86 57.65 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.428 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -106.48 2.24 26.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.804 176.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.41 ' HA3' ' HB1' ' B' ' 215' ' ' ALA . . . 74.05 58.57 4.31 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.967 178.228 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -131.17 -178.04 15.23 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.28 178.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.422 ' HA ' ' HB1' ' B' ' 221' ' ' ALA . 62.8 mttp -130.29 -37.07 1.45 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.165 0.507 . . . . 0.0 110.007 177.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.558 ' HB3' ' HA ' ' A' ' 24' ' ' GLN . 11.4 m-85 -127.23 169.53 13.39 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.43 ' O ' ' HG2' ' A' ' 24' ' ' GLN . 25.7 p90 -142.63 167.28 22.47 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 173.506 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.404 ' CD2' ' HA ' ' A' ' 26' ' ' SER . 4.0 t-160 -134.45 109.26 8.62 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.818 175.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 54.2 mt -68.65 129.81 33.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.833 176.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.5 pt -123.33 -14.78 5.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.741 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -157.45 107.3 2.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.505 0.193 . . . . 0.0 111.191 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -132.6 105.35 7.16 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.785 0.326 . . . . 0.0 110.187 176.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.405 ' HD3' HH11 ' A' ' 78' ' ' ARG . 0.0 OUTLIER -153.47 146.9 24.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.942 -177.529 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -77.79 109.07 11.48 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.636 174.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -101.84 87.95 3.25 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.74 -134.66 13.6 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -175.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -83.61 1.2 9.06 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.65 2.233 . . . . 0.0 112.386 176.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.599 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 44.6 m-80 -115.08 143.15 45.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.051 0.453 . . . . 0.0 111.491 -177.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.516 ' O ' ' HA ' ' A' ' 44' ' ' SER . 66.6 t80 -93.99 120.11 33.79 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.783 176.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -105.26 118.8 37.46 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.512 -177.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.59 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -132.34 115.73 15.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.166 0.507 . . . . 0.0 110.696 176.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 44.6 t -111.81 122.58 66.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.019 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.28 142.09 33.9 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.413 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.574 ' HG2' HG23 ' A' ' 40' ' ' THR . 10.9 mt-10 -103.75 140.24 37.9 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.68 -0.408 . . . . 0.0 109.977 176.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 36.5 t -90.52 125.05 43.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.054 0.454 . . . . 0.0 110.369 -175.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.592 ' HA ' ' HA ' ' A' ' 37' ' ' LYS . 54.9 m-85 -111.5 114.23 27.19 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.657 -178.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -86.36 146.47 26.46 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 171.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.561 ' HA ' HD22 ' A' ' 35' ' ' LEU . 2.7 p-10 -84.51 -179.5 7.17 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 121.13 -0.228 . . . . 0.0 110.494 -174.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.73 12.52 0.49 Allowed 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -175.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 86.6 m -95.43 -36.91 11.16 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 177.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.496 ' HG2' ' HG ' ' A' ' 97' ' ' LEU . 82.7 tttt 66.71 -74.32 0.07 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.547 -177.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.496 ' HG ' ' HG2' ' A' ' 96' ' ' LYS . 0.7 OUTLIER -147.1 -179.96 7.19 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.583 176.795 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -64.39 -36.48 84.28 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -174.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 37.3 m170 -73.37 112.36 9.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.121 0.486 . . . . 0.0 111.365 -176.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 13.6 m170 -112.18 118.3 34.97 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.956 0.408 . . . . 0.0 110.3 177.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -126.45 124.75 40.84 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.532 -175.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 70.91 109.1 0.06 Allowed 'General case' 0 N--CA 1.467 0.407 0 O-C-N 124.062 0.851 . . . . 0.0 111.073 178.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 31.8 p80 -138.32 174.92 10.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.422 -176.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 63.4 t-80 . . . . . 0 C--N 1.323 -0.559 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 175.727 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 201' ' ' MET . . . . . 0.415 ' HA ' ' CE ' ' B' ' 201' ' ' MET . 1.2 tpt . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp 67.88 99.2 0.05 Allowed 'General case' 0 N--CA 1.468 0.448 0 O-C-N 123.462 0.476 . . . . 0.0 111.69 176.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 203' ' ' LYS . . . . . 0.575 ' HE2' ' HB ' ' B' ' 205' ' ' ILE . 22.2 ptmt -90.5 -21.93 21.6 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.054 175.104 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 204' ' ' ARG . . . . . 0.484 ' HE ' ' HA ' ' B' ' 204' ' ' ARG . 0.6 OUTLIER 68.68 16.18 9.01 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.856 171.232 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 205' ' ' ILE . . . . . 0.575 ' HB ' ' HE2' ' B' ' 203' ' ' LYS . 48.3 mm -91.41 97.01 6.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.092 0.472 . . . . 0.0 110.476 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 55.0 mt -98.7 81.76 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.756 177.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -95.91 78.8 3.24 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.564 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -97.96 104.06 16.05 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.252 176.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -149.1 -152.0 0.42 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.435 -173.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 210' ' ' LEU . . . . . 0.433 ' HB3' ' HD2' ' A' ' 96' ' ' LYS . 94.2 mt 73.94 -49.82 0.68 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.53 0.732 . . . . 0.0 112.224 176.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 97.2 mt 65.76 -178.41 0.19 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 122.833 0.453 . . . . 0.0 110.8 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -86.04 -59.84 2.18 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 213' ' ' THR . . . . . 0.497 HG22 HG23 ' B' ' 214' ' ' VAL . 2.5 m 66.59 -80.1 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.445 177.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 214' ' ' VAL . . . . . 0.497 HG23 HG22 ' B' ' 213' ' ' THR . 45.3 t -129.84 -22.68 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.032 0.444 . . . . 0.0 110.244 -177.052 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 215' ' ' ALA . . . . . 0.41 ' HB1' ' HA3' ' A' ' 68' ' ' GLY . . . 60.85 -176.64 0.11 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.085 -175.353 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 72.5 m -158.42 146.26 18.24 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.359 -0.238 . . . . 0.0 110.359 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 217' ' ' PHE . . . . . 0.579 ' CE2' ' HA ' ' A' ' 66' ' ' ALA . 19.3 m-85 -58.65 150.98 21.85 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 123.626 0.579 . . . . 0.0 110.463 177.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 218' ' ' SER . . . . . 0.46 ' HB2' ' HB3' ' B' ' 221' ' ' ALA . 15.8 m -116.64 9.97 14.26 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.252 -178.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 31.6 m 74.08 -59.03 0.57 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.64 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 43.5 tp -155.1 99.78 2.12 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 174.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 221' ' ' ALA . . . . . 0.495 ' HA ' ' CD ' ' A' ' 23' ' ' GLU . . . -155.73 83.87 1.03 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.254 -177.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 222' ' ' ALA . . . . . 0.523 ' HB3' ' HA ' ' A' ' 61' ' ' SER . . . 170.54 91.05 0.0 OUTLIER 'General case' 0 C--O 1.236 0.359 0 O-C-N 123.851 0.719 . . . . 0.0 110.523 177.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -170.55 116.65 0.49 Allowed 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 224' ' ' GLN . . . . . 0.788 ' CB ' ' HB3' ' A' ' 24' ' ' GLN . 0.0 OUTLIER 177.31 167.46 0.6 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.449 -1.25 . . . . 0.0 107.96 176.95 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 225' ' ' VAL . . . . . 0.456 HG21 HD13 ' B' ' 235' ' ' LEU . 27.9 m -121.54 147.17 25.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.3 0.571 . . . . 0.0 111.508 -177.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 84.1 p -105.89 -157.47 0.61 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.487 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 227' ' ' LYS . . . . . 0.494 ' C ' ' HD3' ' B' ' 227' ' ' LYS . 12.1 tmtt? -67.07 -40.8 87.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.753 0.311 . . . . 0.0 110.277 -178.292 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -59.19 -49.26 78.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.631 -173.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -63.46 -39.42 94.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.574 -177.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 77.8 mt -59.25 -56.9 14.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.652 0.263 . . . . 0.0 111.358 -177.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 5.7 p -73.31 -21.59 60.53 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -174.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -98.09 -38.76 9.22 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.429 -0.508 . . . . 0.0 112.198 -176.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 233' ' ' PHE . . . . . 0.476 ' CD1' ' HD3' ' A' ' 53' ' ' PRO . 57.7 m-85 -99.4 4.64 46.32 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -174.47 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt 58.63 40.52 23.39 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.302 0.376 . . . . 0.0 110.915 174.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 235' ' ' LEU . . . . . 0.456 HD13 HG21 ' B' ' 225' ' ' VAL . 84.7 mt -55.44 150.5 11.64 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.278 0.561 . . . . 0.0 112.456 -173.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 22.1 t -94.08 110.31 23.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.838 -176.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -83.29 114.99 21.77 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 177.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -86.06 -28.93 6.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.457 -178.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 178.44 -170.17 42.11 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.423 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 7.5 m -133.71 140.46 47.03 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 28.1 pt -124.1 148.06 28.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.941 0.401 . . . . 0.0 110.416 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -134.74 142.36 46.73 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.477 0.656 . . . . 0.0 111.533 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 243' ' ' VAL . . . . . 0.621 HG13 ' NE2' ' B' ' 245' ' ' GLN . 67.9 t -106.66 123.64 61.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.695 -178.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 10.6 t -143.05 69.6 1.31 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 176.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 245' ' ' GLN . . . . . 0.621 ' NE2' HG13 ' B' ' 243' ' ' VAL . 1.3 mp0 -109.42 153.43 24.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.97 -174.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 57.8 m -83.06 43.32 0.86 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.49 -174.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 247' ' ' GLY . . . . . 0.417 ' C ' ' H ' ' B' ' 249' ' ' GLN . . . 78.47 -41.25 2.06 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.922 -0.656 . . . . 0.0 113.731 174.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -73.57 27.63 0.88 Allowed Glycine 0 CA--C 1.519 0.34 0 CA-C-N 116.888 0.344 . . . . 0.0 113.652 -176.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 249' ' ' GLN . . . . . 0.544 ' HG3' ' HG2' ' B' ' 245' ' ' GLN . 23.8 mm-40 -130.85 -3.62 4.07 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 176.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 44.9 mm -133.71 132.3 56.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.337 -179.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 23.2 m -133.45 -58.26 0.88 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.24 -177.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 252' ' ' SER . . . . . 0.542 ' HB3' ' HD2' ' B' ' 253' ' ' PRO . 7.2 m -113.72 168.87 7.18 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 253' ' ' PRO . . . . . 0.542 ' HD2' ' HB3' ' B' ' 252' ' ' SER . 11.6 Cg_endo -57.1 -24.47 58.5 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.293 1.996 . . . . 0.0 112.213 175.3 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 254' ' ' SER . . . . . 0.546 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 1.5 p -70.2 -37.12 75.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.139 176.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -61.93 -37.43 84.66 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.792 0.329 . . . . 0.0 110.895 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 51.9 tp -59.02 -42.01 89.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.52 177.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 257' ' ' ARG . . . . . 0.553 ' C ' ' HD2' ' B' ' 257' ' ' ARG . 3.9 tmm_? -64.13 -47.07 81.39 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.859 177.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 258' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' B' ' 254' ' ' SER . 28.8 mm-40 -54.02 -48.85 70.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.349 -176.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -70.17 -35.25 73.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.732 0.301 . . . . 0.0 111.24 -177.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 81.9 mt -72.66 -40.5 66.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.178 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 17.0 t -68.54 -31.97 71.58 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 177.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -57.36 -51.65 68.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.242 175.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 263' ' ' LEU . . . . . 0.562 HD22 HG23 ' A' ' 13' ' ' THR . 74.5 mt -71.17 -41.18 70.71 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.958 -179.19 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -63.52 -44.39 94.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.721 -177.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -66.31 -34.21 77.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.896 0.379 . . . . 0.0 110.48 -178.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -68.94 -20.09 64.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.285 0.565 . . . . 0.0 110.821 176.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 4.8 mmpm? -94.81 -2.41 50.93 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.664 176.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 77.35 16.06 80.84 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.168 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 269' ' ' GLY . . . . . 0.567 ' HA3' ' CG1' ' B' ' 290' ' ' VAL . . . -93.85 148.99 19.24 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.017 -178.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -110.73 3.42 19.15 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.247 0.546 . . . . 0.0 110.073 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 271' ' ' TYR . . . . . 0.654 ' HD1' ' HA ' ' B' ' 224' ' ' GLN . 9.2 m-85 -147.75 141.45 25.61 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 -177.184 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 272' ' ' TYR . . . . . 0.51 ' CE2' HD11 ' B' ' 274' ' ' ILE . 34.2 p90 -126.66 111.11 13.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.472 0.654 . . . . 0.0 110.06 178.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -92.1 101.75 14.28 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.171 -174.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 274' ' ' ILE . . . . . 0.534 ' H ' HD12 ' B' ' 274' ' ' ILE . 4.6 mp -72.35 131.59 34.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.82 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 275' ' ' ILE . . . . . 0.588 HD12 ' HA ' ' A' ' 6' ' ' ILE . 28.4 pt -117.64 -28.45 2.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.727 0.299 . . . . 0.0 111.511 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -156.97 137.84 13.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.832 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -155.51 120.81 4.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.506 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 278' ' ' ARG . . . . . 0.472 ' HE ' ' HB3' ' B' ' 278' ' ' ARG . 0.0 OUTLIER -145.04 155.02 43.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.0 0.428 . . . . 0.0 110.942 -178.853 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -79.19 134.87 36.68 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.208 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -122.01 72.68 1.05 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.001 0.429 . . . . 0.0 110.059 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 64.11 -120.38 19.54 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.659 -177.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.11 -2.3 12.27 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.737 2.292 . . . . 0.0 112.259 176.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -114.41 166.08 12.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.28 -177.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -129.39 122.28 29.12 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.936 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 285' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -105.28 119.7 39.72 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.32 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 286' ' ' ALA . . . . . 0.574 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -136.68 146.83 46.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.692 0.282 . . . . 0.0 111.154 177.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 37.0 t -128.79 128.86 68.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 177.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -137.27 144.92 42.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.004 0.43 . . . . 0.0 110.988 -179.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 289' ' ' GLU . . . . . 0.429 ' HB2' ' HE1' ' B' ' 291' ' ' TYR . 25.5 mt-10 -96.1 150.09 20.89 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.891 178.266 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 290' ' ' VAL . . . . . 0.567 ' CG1' ' HA3' ' B' ' 269' ' ' GLY . 12.8 t -111.93 123.97 68.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 291' ' ' TYR . . . . . 0.429 ' HE1' ' HB2' ' B' ' 289' ' ' GLU . 65.9 m-85 -124.29 151.69 43.94 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.229 0.538 . . . . 0.0 111.618 -177.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 292' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -117.65 161.4 19.72 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.105 170.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.56 136.97 49.76 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.439 0.462 . . . . 0.0 111.551 175.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 294' ' ' ALA . . . . . . . . . . . . . . . -99.79 98.11 8.95 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.422 177.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 295' ' ' THR . . . . . . . . . . . . . 71.7 m 69.59 119.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.225 -177.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -77.24 104.8 7.95 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.039 -177.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 297' ' ' LEU . . . . . 0.532 ' HA ' ' HB2' ' A' ' 52' ' ' SER . 0.7 OUTLIER 34.03 98.8 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 O-C-N 124.779 1.299 . . . . 0.0 113.747 174.466 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 298' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -55.65 156.73 4.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.459 0.647 . . . . 0.0 112.234 -179.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 299' ' ' HIS . . . . . . . . . . . . . 58.0 m80 -127.05 16.24 7.3 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.378 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 300' ' ' HIS . . . . . . . . . . . . . 14.3 m80 -61.68 100.08 0.14 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.743 176.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 301' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -80.37 100.32 8.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.098 -176.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 302' ' ' HIS . . . . . . . . . . . . . 48.8 m-70 -105.25 168.58 8.98 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.672 -177.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 55.8 t60 71.66 -8.05 1.14 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.568 0.747 . . . . 0.0 111.283 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 . . . . . 0 C--N 1.325 -0.467 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.199 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.542 ' O ' ' HB3' ' B' ' 261' ' ' SER . . . . . . . . 0 N--CA 1.465 0.282 0 CA-C-O 121.134 0.492 . . . . 0.0 110.823 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.458 ' CD ' ' HD3' ' B' ' 257' ' ' ARG . 2.2 tp10 -147.0 -138.88 0.09 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -176.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.721 ' HB2' ' H ' ' B' ' 223' ' ' GLU . 0.0 OUTLIER 72.73 156.73 0.17 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 122.6 0.36 . . . . 0.0 111.64 176.348 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.3 m -114.5 147.72 17.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 121.055 0.455 . . . . 0.0 110.905 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.411 ' O ' HG13 ' A' ' 30' ' ' ILE . 19.9 t -100.29 -166.79 1.36 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.28 0.562 . . . . 0.0 111.017 -177.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -66.5 -44.1 83.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.535 -173.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.641 ' HG2' ' OE1' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -63.59 -44.72 93.19 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.891 -173.736 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.641 ' OE1' ' HG2' ' A' ' 28' ' ' GLN . 2.3 mp0 -62.98 -40.95 99.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.619 0.247 . . . . 0.0 110.846 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 26' ' ' SER . 97.4 mt -59.01 -49.9 81.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.841 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.3 t -73.43 -24.85 60.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.362 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.452 ' HB2' ' O ' ' A' ' 28' ' ' GLN . 33.7 t-80 -85.92 -57.81 2.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.686 0.279 . . . . 0.0 111.287 -174.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -81.77 -10.74 59.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.193 -175.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt 59.54 76.43 0.36 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.338 0.59 . . . . 0.0 110.113 -175.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.405 HD12 HG12 ' A' ' 30' ' ' ILE . 95.1 mt -82.39 159.39 23.01 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.892 -176.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.1 t -81.88 111.71 18.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.081 -176.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.552 ' HD3' ' CE2' ' A' ' 91' ' ' TYR . 15.0 tptm -71.5 111.19 6.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.67 175.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.421 HG23 ' HB ' ' A' ' 90' ' ' VAL . 3.2 m -104.66 6.95 10.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.871 0.367 . . . . 0.0 111.667 -176.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 133.37 -168.44 23.08 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.549 175.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 47.7 m -136.54 132.93 35.88 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.4 pt -111.43 134.22 54.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.257 0.551 . . . . 0.0 110.861 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -114.62 121.05 42.22 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.565 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.619 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 24.3 t -93.35 107.51 19.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.8 t -110.62 110.54 21.28 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.549 -176.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.524 ' HG2' HG12 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -116.79 152.63 33.99 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.236 -176.53 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.8 t -126.03 124.79 41.46 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.875 -0.416 . . . . 0.0 109.875 175.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.33 -145.92 25.79 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.456 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.84 52.53 0.72 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.877 -175.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.464 ' HB2' ' CG ' ' A' ' 45' ' ' GLN . 14.5 mm100 -71.96 -41.79 67.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.298 0.571 . . . . 0.0 109.619 175.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.566 HG23 ' HB2' ' A' ' 55' ' ' ASP . 49.3 mm -97.93 125.4 51.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.73 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.1 m -103.26 -39.74 6.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.199 -176.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.423 ' HB2' ' HD2' ' A' ' 53' ' ' PRO . 51.4 p -131.87 162.56 55.72 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.462 -176.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.423 ' HD2' ' HB2' ' A' ' 52' ' ' SER . 17.0 Cg_endo -57.49 -27.02 74.53 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.633 2.222 . . . . 0.0 111.44 176.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.594 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 2.5 m -59.08 -45.92 89.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.545 177.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.566 ' HB2' HG23 ' A' ' 50' ' ' ILE . 36.2 m-20 -64.85 -35.84 82.43 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.561 -178.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 67.2 tp -61.46 -47.2 86.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.847 175.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -58.08 -41.12 82.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.068 177.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.594 ' HG2' ' O ' ' A' ' 54' ' ' SER . 14.1 mm-40 -55.6 -50.47 70.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.281 0.562 . . . . 0.0 110.68 177.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.41 ' HA ' ' HD3' ' A' ' 59' ' ' LYS . 73.2 mmtt -69.71 -35.14 74.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.323 -177.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.2 mt -62.58 -44.32 96.61 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.54 176.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.7 t -66.6 -39.83 88.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.068 0.461 . . . . 0.0 110.237 177.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -57.03 -48.72 77.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.905 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 87.4 mt -71.83 -40.49 69.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.618 -176.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.62 -38.11 89.89 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -176.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -59.56 -42.71 93.05 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.271 0.558 . . . . 0.0 110.336 178.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.73 -7.78 58.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.425 -177.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.431 ' HD3' ' HA ' ' A' ' 67' ' ' LYS . 30.2 mmtm -97.38 -19.98 18.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.788 0.328 . . . . 0.0 111.408 178.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.79 34.47 9.06 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.335 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.468 ' HA3' HG12 ' A' ' 90' ' ' VAL . . . -129.32 138.49 10.28 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 177.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.426 ' O ' ' HB2' ' B' ' 222' ' ' ALA . 87.9 mttt -85.01 -28.99 25.35 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.74 0.27 . . . . 0.0 111.463 -174.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -129.56 141.3 51.0 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -176.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.611 ' CD2' ' HB1' ' B' ' 222' ' ' ALA . 13.8 p90 -105.07 168.0 9.34 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 171.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.404 ' CD2' ' HA ' ' A' ' 26' ' ' SER . 9.7 t-80 -138.94 105.84 5.41 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.907 172.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 33.5 mt -69.96 124.5 26.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.238 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 31.4 pt -110.94 -17.59 8.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.989 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -171.89 101.22 0.18 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.509 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.58 ' HA ' ' HA ' ' A' ' 86' ' ' ALA . . . -107.69 101.64 10.93 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 171.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -136.96 167.1 22.13 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.104 0.478 . . . . 0.0 111.373 -172.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -90.37 145.58 24.84 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.821 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -129.35 80.53 1.97 Allowed 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 173.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.5 -117.73 9.2 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.827 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -83.12 -2.2 10.64 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.812 2.341 . . . . 0.0 112.045 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -112.42 165.04 12.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.989 -177.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -125.89 121.92 34.57 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.046 175.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -117.23 111.01 18.83 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.866 0.365 . . . . 0.0 110.579 -176.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.619 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -110.59 116.32 31.15 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.08 0.467 . . . . 0.0 110.495 176.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.6 t -102.39 118.17 48.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.311 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -135.94 136.65 40.6 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.592 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.55 ' HB3' ' HE3' ' A' ' 37' ' ' LYS . 40.9 mt-10 -91.83 149.87 21.36 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.468 HG12 ' HA3' ' A' ' 69' ' ' GLY . 5.6 t -107.48 132.72 54.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.35 -177.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.552 ' CE2' ' HD3' ' A' ' 37' ' ' LYS . 95.8 m-85 -133.21 146.3 51.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.162 0.506 . . . . 0.0 111.196 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -123.31 160.47 26.62 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.402 176.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 . . . . . 0 C--O 1.237 0.442 0 CA-C-O 120.673 0.273 . . . . 0.0 110.814 -177.698 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 222' ' ' ALA . . . . . 0.611 ' HB1' ' CD2' ' A' ' 72' ' ' TYR . . . . . . . . 0 CA--C 1.517 -0.314 0 N-CA-C 110.585 -0.154 . . . . 0.0 110.585 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 223' ' ' GLU . . . . . 0.721 ' H ' ' HB2' ' A' ' 24' ' ' GLN . 40.5 tt0 -172.88 101.83 0.13 Allowed 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -176.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 224' ' ' GLN . . . . . 0.602 ' HA ' ' HD1' ' B' ' 271' ' ' TYR . 0.0 OUTLIER -174.04 158.71 3.15 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 122.919 0.488 . . . . 0.0 109.807 175.754 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . 0.484 HG21 ' CD1' ' B' ' 235' ' ' LEU . 24.1 m -117.03 146.11 21.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 120.543 0.211 . . . . 0.0 110.672 178.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 78.1 p -91.49 -166.8 1.65 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.952 0.406 . . . . 0.0 110.67 -177.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -67.13 -29.17 68.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.173 -176.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -73.02 -50.87 20.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.072 -174.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 229' ' ' GLU . . . . . 0.413 ' HB2' ' HB ' ' B' ' 225' ' ' VAL . 2.2 mp0 -59.8 -39.11 83.89 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.048 -177.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 87.8 mt -60.4 -49.22 85.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.781 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 15.2 m -72.82 -32.2 65.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.093 -177.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -78.76 -55.18 5.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.455 -175.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -83.23 -23.44 32.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.562 -174.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm 64.34 80.81 0.22 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.424 0.631 . . . . 0.0 110.308 -176.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . 0.484 ' CD1' HG21 ' B' ' 225' ' ' VAL . 63.1 mt -83.79 -178.41 7.0 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.108 -175.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 44.5 t -100.12 109.71 25.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.11 178.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 52.6 tttm -82.0 114.01 20.28 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 238' ' ' VAL . . . . . 0.519 HG23 ' HB ' ' B' ' 290' ' ' VAL . 14.5 m -104.36 7.57 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -170.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 131.34 -153.38 20.37 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 119.934 -1.127 . . . . 0.0 113.499 175.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . 0.469 HG23 ' HG2' ' B' ' 289' ' ' GLU . 6.9 m -137.95 141.43 40.54 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 122.205 0.202 . . . . 0.0 110.846 -175.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 37.4 pt -127.67 148.65 32.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 171.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -144.54 141.0 29.18 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.559 0.695 . . . . 0.0 111.717 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 243' ' ' VAL . . . . . 0.613 ' O ' ' HA ' ' B' ' 285' ' ' GLU . 61.3 t -92.99 129.54 43.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.284 176.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 5.8 t -153.07 74.99 1.06 Allowed 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 245' ' ' GLN . . . . . 0.569 ' HB3' ' HG3' ' B' ' 249' ' ' GLN . 0.8 OUTLIER -116.7 168.36 10.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.646 -177.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 246' ' ' SER . . . . . 0.428 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 21.0 p -83.77 101.12 11.37 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.727 -177.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 42.62 -92.04 0.01 OUTLIER Glycine 0 N--CA 1.463 0.48 0 N-CA-C 115.817 1.087 . . . . 0.0 115.817 167.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -71.71 10.92 3.66 Favored Glycine 0 CA--C 1.519 0.329 0 N-CA-C 114.809 0.683 . . . . 0.0 114.809 -168.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . 0.569 ' HG3' ' HB3' ' B' ' 245' ' ' GLN . 13.3 mm100 -73.24 -21.1 60.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.664 0.732 . . . . 0.0 110.012 175.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 250' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' B' ' 256' ' ' LEU . 46.9 mm -114.89 103.08 14.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.49 178.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 41.2 t -88.97 -16.9 30.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.653 0.264 . . . . 0.0 111.416 -177.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 252' ' ' SER . . . . . 0.554 ' HB2' ' HD2' ' B' ' 253' ' ' PRO . 89.4 p -163.92 165.78 13.07 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -178.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . 0.554 ' HD2' ' HB2' ' B' ' 252' ' ' SER . 9.4 Cg_endo -52.56 -32.0 51.79 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.821 2.347 . . . . 0.0 112.243 176.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 254' ' ' SER . . . . . 0.492 ' O ' ' HG3' ' B' ' 258' ' ' GLU . 5.1 m -59.28 -47.43 85.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.35 177.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 255' ' ' ASP . . . . . 0.406 ' O ' ' HG2' ' B' ' 259' ' ' LYS . 0.9 OUTLIER -55.07 -43.71 74.15 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.879 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.403 ' HA ' HD12 ' B' ' 250' ' ' ILE . 57.4 tp -57.7 -56.17 25.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.426 -175.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 257' ' ' ARG . . . . . 0.542 ' HA ' HD12 ' B' ' 260' ' ' LEU . 6.3 ppt_? -66.69 -31.18 71.68 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.34 -176.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 258' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' B' ' 254' ' ' SER . 44.2 mt-10 -63.14 -26.78 68.98 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.868 0.366 . . . . 0.0 111.03 177.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 259' ' ' LYS . . . . . 0.425 ' O ' ' HG ' ' B' ' 263' ' ' LEU . 66.1 mmtt -88.28 -22.91 23.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.93 0.395 . . . . 0.0 110.52 177.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 260' ' ' LEU . . . . . 0.542 HD12 ' HA ' ' B' ' 257' ' ' ARG . 89.2 mt -74.13 -48.42 29.57 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.501 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 261' ' ' SER . . . . . 0.542 ' HB3' ' O ' ' A' ' 22' ' ' ALA . 2.7 p -65.78 -30.99 71.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.862 0.363 . . . . 0.0 110.542 176.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -56.48 -45.4 80.96 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.053 175.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 263' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' B' ' 259' ' ' LYS . 84.1 mt -74.74 -34.52 62.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.843 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -64.31 -38.7 91.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.214 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -62.95 -43.86 97.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.694 177.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -64.01 -34.38 77.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.635 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 12.8 mmtt -73.03 -46.94 49.03 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.852 177.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 99.23 32.8 5.67 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -176.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -104.48 171.99 19.89 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.568 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -111.83 -24.86 9.76 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.851 0.358 . . . . 0.0 111.423 -177.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 271' ' ' TYR . . . . . 0.602 ' HD1' ' HA ' ' B' ' 224' ' ' GLN . 24.0 m-85 -144.01 160.52 40.72 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 272' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -137.55 129.17 28.41 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.047 0.451 . . . . 0.0 110.068 173.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -98.46 102.59 14.38 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.914 -177.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 274' ' ' ILE . . . . . 0.514 HG12 ' HB2' ' B' ' 288' ' ' ALA . 57.0 mt -67.25 129.74 32.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.821 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 19.0 pt -116.97 -26.84 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.807 -176.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -144.49 139.95 28.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.157 -177.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -154.79 117.5 4.34 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.222 177.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 278' ' ' ARG . . . . . 0.421 ' HD3' ' HB2' ' B' ' 285' ' ' GLU . 0.0 OUTLIER -154.91 156.77 36.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.928 0.394 . . . . 0.0 110.78 -177.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -88.8 117.43 27.79 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 167.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -92.77 14.48 17.15 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.492 0.663 . . . . 0.0 109.976 -175.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 129.93 -119.96 2.98 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 -175.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.93 -13.3 15.92 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.445 2.097 . . . . 0.0 111.765 173.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -106.82 142.96 35.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.665 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -104.1 130.8 51.82 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 285' ' ' GLU . . . . . 0.613 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 52.1 mt-10 -118.96 122.06 41.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.278 -176.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 286' ' ' ALA . . . . . 0.484 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -132.67 116.25 16.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.167 174.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 40.4 t -109.02 127.53 65.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.81 0.338 . . . . 0.0 111.067 -174.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 288' ' ' ALA . . . . . 0.514 ' HB2' HG12 ' B' ' 274' ' ' ILE . . . -139.25 133.53 31.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.957 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 289' ' ' GLU . . . . . 0.469 ' HG2' HG23 ' B' ' 240' ' ' THR . 31.9 mt-10 -93.06 135.39 34.28 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 290' ' ' VAL . . . . . 0.519 ' HB ' HG23 ' B' ' 238' ' ' VAL . 3.8 t -92.96 138.87 19.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.037 0.446 . . . . 0.0 111.27 -168.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -130.02 149.38 51.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.478 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 292' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -114.68 159.78 20.11 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 171.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 . . . . . 0 N--CA 1.474 0.747 0 CA-C-O 121.492 0.663 . . . . 0.0 112.116 -174.609 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.641 ' HB1' ' CD2' ' B' ' 272' ' ' TYR . . . . . . . . 0 C--O 1.234 0.268 0 CA-C-O 120.9 0.381 . . . . 0.0 111.942 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.933 ' HB3' ' HE1' ' A' ' 71' ' ' TYR . 26.8 mt-10 -149.28 105.28 3.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.683 -179.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.57 ' HB2' ' HB2' ' B' ' 224' ' ' GLN . 0.0 OUTLIER -162.3 156.1 21.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.262 178.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.0 m -101.69 128.32 54.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.037 0.446 . . . . 0.0 110.887 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.537 ' O ' HG13 ' A' ' 30' ' ' ILE . 1.5 m -64.99 151.33 46.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.877 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.534 ' HB2' ' CE1' ' A' ' 73' ' ' HIS . 88.7 tttt -57.85 -40.52 80.31 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.128 0.489 . . . . 0.0 109.724 176.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -61.14 -39.06 88.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.408 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.581 ' HA ' ' HB3' ' A' ' 32' ' ' HIS . 20.6 mm-40 -76.94 -26.98 54.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.503 -177.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.537 HG13 ' O ' ' A' ' 26' ' ' SER . 86.0 mt -60.88 -45.07 98.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 173.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.4 m -73.42 -31.83 64.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.879 175.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.581 ' HB3' ' HA ' ' A' ' 29' ' ' GLU . 23.7 t-160 -65.82 -54.86 21.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.286 -177.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -92.67 -8.74 43.16 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.376 -177.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm 59.31 70.56 0.64 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.452 0.644 . . . . 0.0 110.592 -178.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 94.1 mt -76.31 163.0 27.44 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.306 -176.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 85.1 t -93.37 126.42 45.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.271 -177.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.546 ' HE3' ' HB3' ' A' ' 89' ' ' GLU . 21.7 tptm -70.12 116.76 10.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.651 175.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.41 HG11 HD22 ' A' ' 92' ' ' ASN . 4.2 m -122.84 26.0 3.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -174.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.12 -175.36 16.94 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.109 -1.043 . . . . 0.0 113.252 174.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 61.7 m -135.29 129.55 33.72 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 30.5 pt -104.48 138.62 28.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 175.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -135.02 122.23 21.54 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.197 0.522 . . . . 0.0 111.092 -173.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 59.0 t -93.45 121.69 44.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.062 176.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.2 t -141.23 30.79 1.76 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.752 0.786 . . . . 0.0 109.134 -177.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -91.24 160.55 15.47 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.773 -175.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.2 t -64.06 157.84 24.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.075 176.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.06 -20.14 33.5 Favored Glycine 0 C--O 1.228 -0.271 0 CA-C-N 116.039 -0.528 . . . . 0.0 113.314 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.26 -20.64 75.28 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.884 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -101.46 -2.04 31.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.893 0.377 . . . . 0.0 110.88 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.1 mm -130.8 75.23 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 171.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.0 t -96.46 -14.01 22.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.875 -168.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.1 m -155.43 160.0 31.22 Favored Pre-proline 0 C--N 1.322 -0.598 0 O-C-N 122.365 -0.209 . . . . 0.0 110.784 -176.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.5 -36.26 86.98 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.589 2.193 . . . . 0.0 111.623 175.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.573 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 0.1 OUTLIER -63.27 -44.36 95.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.648 0.737 . . . . 0.0 109.698 174.071 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -64.38 -27.74 69.21 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.136 -177.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.6 tp -61.59 -52.68 63.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.683 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -65.79 -28.13 68.79 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.432 -176.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.573 ' HG2' ' O ' ' A' ' 54' ' ' SER . 38.8 mm-40 -62.6 -34.62 77.38 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.974 0.416 . . . . 0.0 110.223 -178.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -83.25 -38.33 22.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.764 176.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.3 mt -61.78 -48.48 80.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.255 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.2 p -64.52 -36.4 84.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.021 0.439 . . . . 0.0 110.473 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -64.29 -40.38 95.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.193 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 86.2 mt -69.54 -44.79 70.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.9 177.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.61 -37.33 83.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.99 0.424 . . . . 0.0 110.652 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -66.68 -37.78 85.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.808 177.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.9 -34.96 78.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.772 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -80.65 -45.03 17.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.177 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 118.24 41.88 0.62 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.534 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.512 ' HA3' ' CG1' ' A' ' 90' ' ' VAL . . . -124.38 151.68 17.26 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.413 -0.899 . . . . 0.0 113.043 -177.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -81.04 -43.58 19.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.834 0.35 . . . . 0.0 110.44 176.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.933 ' HE1' ' HB3' ' A' ' 23' ' ' GLU . 78.9 m-85 -137.96 175.61 9.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.264 -174.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.442 ' HD2' ' CB ' ' A' ' 88' ' ' ALA . 0.6 OUTLIER -149.85 168.25 24.28 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -177.13 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.534 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 19.2 t-80 -135.05 126.1 27.79 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.49 -0.484 . . . . 0.0 109.812 172.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.534 ' H ' HD12 ' A' ' 74' ' ' ILE . 5.0 mp -72.77 123.37 27.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.017 -178.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 33.1 pt -104.88 -31.13 2.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.386 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.479 ' HB1' ' NH1' ' A' ' 78' ' ' ARG . . . -161.82 117.9 2.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.025 -177.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -131.92 122.28 25.37 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.385 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.479 ' NH1' ' HB1' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -156.46 142.24 17.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.044 0.449 . . . . 0.0 110.888 -178.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -72.07 145.62 48.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.905 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -139.6 100.38 3.95 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 61.97 -123.87 32.57 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.991 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -88.29 6.6 4.8 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.994 2.463 . . . . 0.0 112.569 178.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -119.76 158.92 25.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.046 0.45 . . . . 0.0 111.123 -176.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -113.57 111.65 22.23 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.564 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.559 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 25.9 mm-40 -96.26 111.45 23.51 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.612 -176.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.534 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -124.99 115.17 20.13 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.754 177.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.2 t -105.64 124.86 60.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.499 -178.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.442 ' CB ' ' HD2' ' A' ' 72' ' ' TYR . . . -141.0 149.2 41.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.2 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.546 ' HB3' ' HE3' ' A' ' 37' ' ' LYS . 7.4 mt-10 -108.67 143.61 37.54 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.263 -178.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.512 ' CG1' ' HA3' ' A' ' 69' ' ' GLY . 11.4 t -95.04 137.57 23.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.642 -172.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -133.71 136.98 45.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.894 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.41 HD22 HG11 ' A' ' 38' ' ' VAL . 74.5 m-20 -122.42 172.78 8.09 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.578 176.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.673 177.301 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 222' ' ' ALA . . . . . 0.416 ' HB1' ' CD1' ' A' ' 72' ' ' TYR . . . . . . . . 0 N--CA 1.463 0.222 0 CA-C-O 121.237 0.542 . . . . 0.0 111.588 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -161.12 125.5 3.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.839 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 224' ' ' GLN . . . . . 0.57 ' HB2' ' HB2' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -159.3 167.97 27.59 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.782 176.845 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . 0.44 HG11 HD11 ' B' ' 235' ' ' LEU . 6.8 m -135.18 123.63 39.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.984 0.421 . . . . 0.0 110.353 174.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . 0.409 ' O ' HG13 ' B' ' 230' ' ' ILE . 9.3 t -105.72 -171.72 1.96 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.581 178.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . 0.426 ' HE2' ' CA ' ' B' ' 227' ' ' LYS . 0.0 OUTLIER -55.33 -33.83 63.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.769 -175.092 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -70.74 -49.65 44.56 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.264 0.554 . . . . 0.0 110.365 -176.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 229' ' ' GLU . . . . . 0.401 ' O ' ' HD1' ' B' ' 233' ' ' PHE . 1.8 mp0 -72.13 -48.44 43.66 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.459 -176.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.531 HG12 HD12 ' B' ' 235' ' ' LEU . 89.9 mt -54.54 -49.68 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 -174.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 59.1 m -72.56 -21.17 61.2 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -176.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -89.12 -35.92 16.01 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.893 -177.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 233' ' ' PHE . . . . . 0.401 ' HD1' ' O ' ' B' ' 229' ' ' GLU . 81.7 m-85 -89.9 -15.02 32.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.377 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 234' ' ' LYS . . . . . 0.434 ' HB3' ' HE3' ' B' ' 234' ' ' LYS . 25.9 mmmt 59.79 77.55 0.31 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.225 0.536 . . . . 0.0 111.545 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . 0.531 HD12 HG12 ' B' ' 230' ' ' ILE . 94.4 mt -88.21 163.46 16.13 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.389 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 47.4 t -96.28 118.36 42.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.82 178.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -91.29 111.97 23.69 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 238' ' ' VAL . . . . . 0.434 HG23 ' HB ' ' B' ' 290' ' ' VAL . 2.6 m -90.28 -25.01 5.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -176.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 161.8 -156.29 27.78 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.046 -1.073 . . . . 0.0 112.863 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 87.4 m -139.7 131.45 27.43 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 122.476 0.311 . . . . 0.0 110.353 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 22.3 pt -103.98 143.11 16.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.008 0.432 . . . . 0.0 110.13 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -116.02 128.76 55.97 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.881 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 243' ' ' VAL . . . . . 0.587 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 58.0 t -96.8 124.31 49.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.613 177.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 23.2 t -153.35 88.77 1.31 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.895 0.379 . . . . 0.0 110.138 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 245' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -142.4 157.65 44.55 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 246' ' ' SER . . . . . 0.58 ' HA ' ' HA ' ' B' ' 283' ' ' ASN . 25.8 t -62.48 153.18 32.38 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.694 0.283 . . . . 0.0 110.385 177.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -60.51 -17.54 48.31 Favored Glycine 0 C--N 1.332 0.353 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.807 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.04 -23.33 69.5 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.362 176.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -88.98 -47.65 7.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.098 0.475 . . . . 0.0 110.547 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 44.9 mm -107.55 100.42 10.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.968 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 22.3 t -112.11 -11.43 13.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.993 0.425 . . . . 0.0 111.085 -175.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 78.8 p -149.33 163.66 24.23 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.399 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.72 -31.63 94.43 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.476 2.117 . . . . 0.0 111.639 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 254' ' ' SER . . . . . 0.561 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 8.1 t -65.49 -40.12 92.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.106 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -64.48 -38.46 91.11 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.297 0.57 . . . . 0.0 109.978 177.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 48.5 tp -60.24 -44.69 95.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.847 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 257' ' ' ARG . . . . . 0.471 ' HD3' ' OE1' ' A' ' 23' ' ' GLU . 0.3 OUTLIER -66.44 -34.76 78.66 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.787 -0.188 . . . . 0.0 110.712 -177.032 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 258' ' ' GLU . . . . . 0.561 ' HG2' ' O ' ' B' ' 254' ' ' SER . 67.7 mm-40 -59.54 -45.56 91.44 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-O 121.311 0.576 . . . . 0.0 109.604 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 259' ' ' LYS . . . . . 0.481 ' O ' ' HG ' ' B' ' 263' ' ' LEU . 38.8 tptt -72.91 -40.18 65.71 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.834 -178.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 81.1 mt -64.53 -48.73 73.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.346 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 49.4 m -64.56 -29.8 70.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.706 0.289 . . . . 0.0 110.541 178.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -64.34 -51.44 63.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.997 0.427 . . . . 0.0 110.248 174.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 263' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' B' ' 259' ' ' LYS . 86.8 mt -65.45 -36.58 84.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.922 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.53 -39.51 81.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.856 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -62.54 -35.54 79.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.149 0.5 . . . . 0.0 110.626 177.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -76.37 -11.35 59.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.932 -177.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -114.99 -27.04 7.5 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.817 0.341 . . . . 0.0 111.372 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 91.61 64.93 1.15 Allowed Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.5 176.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -137.82 156.94 23.99 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.611 175.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . 0.876 ' HD3' ' HB2' ' B' ' 293' ' ' ASP . 10.3 mtpm? -104.39 -12.67 16.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.824 0.312 . . . . 0.0 111.321 -178.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 271' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -146.37 159.96 42.69 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 272' ' ' TYR . . . . . 0.641 ' CD2' ' HB1' ' A' ' 22' ' ' ALA . 0.3 OUTLIER -132.37 163.52 28.51 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.165 171.42 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -128.58 101.93 6.38 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 175.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 274' ' ' ILE . . . . . 0.577 HG12 ' HB2' ' B' ' 288' ' ' ALA . 49.6 mt -82.23 118.04 29.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.083 0.468 . . . . 0.0 110.267 -177.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 16.9 pt -103.19 -39.27 5.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.457 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 276' ' ' ALA . . . . . 0.562 ' HB3' ' HB ' ' B' ' 287' ' ' VAL . . . -119.92 143.95 47.7 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.783 0.325 . . . . 0.0 111.417 -175.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -157.98 114.52 2.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.421 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 278' ' ' ARG . . . . . 0.465 ' HG2' ' HB2' ' B' ' 285' ' ' GLU . 0.0 OUTLIER -151.35 150.91 31.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.949 0.404 . . . . 0.0 111.147 -175.639 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -93.4 109.56 21.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.846 176.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 280' ' ' HIS . . . . . 0.431 ' HB2' ' CG ' ' B' ' 285' ' ' GLU . 4.7 t60 -69.26 -22.96 63.8 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 150.15 -110.66 0.48 Allowed Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -69.52 -15.82 38.19 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 122.319 2.013 . . . . 0.0 111.43 171.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 283' ' ' ASN . . . . . 0.58 ' HA ' ' HA ' ' B' ' 246' ' ' SER . 41.1 m-80 -111.85 151.82 28.65 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.464 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -107.88 133.78 51.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.41 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 285' ' ' GLU . . . . . 0.465 ' HB2' ' HG2' ' B' ' 278' ' ' ARG . 50.4 mm-40 -117.67 122.23 42.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.941 -175.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 286' ' ' ALA . . . . . 0.587 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -136.55 145.86 45.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.811 0.339 . . . . 0.0 110.673 177.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 287' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' B' ' 276' ' ' ALA . 59.2 t -126.29 118.06 50.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.445 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 288' ' ' ALA . . . . . 0.577 ' HB2' HG12 ' B' ' 274' ' ' ILE . . . -129.09 136.16 49.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.054 -177.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -91.21 136.83 32.82 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 290' ' ' VAL . . . . . 0.434 ' HB ' HG23 ' B' ' 238' ' ' VAL . 12.7 t -97.91 127.36 50.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.748 0.309 . . . . 0.0 110.411 -176.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -120.75 134.5 55.28 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.265 0.555 . . . . 0.0 110.998 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 292' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -95.33 159.15 15.14 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 176.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 293' ' ' ASP . . . . . 0.876 ' HB2' ' HD3' ' B' ' 270' ' ' LYS . 3.2 t70 . . . . . 0 C--N 1.32 -0.696 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.492 -174.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.29 0 CA-C-O 120.591 0.234 . . . . 0.0 110.603 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.547 ' HB3' ' HG3' ' B' ' 257' ' ' ARG . 6.1 pt-20 -161.4 124.86 3.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.693 0.759 . . . . 0.0 111.796 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.804 ' HG3' ' HG3' ' B' ' 224' ' ' GLN . 0.0 OUTLIER -141.35 143.5 34.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.769 -173.54 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.562 HG23 ' HB2' ' A' ' 73' ' ' HIS . 3.5 m -103.19 126.84 57.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.364 0.602 . . . . 0.0 111.401 176.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.674 ' HB2' ' OE1' ' A' ' 28' ' ' GLN . 1.3 p -92.5 159.12 15.67 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.478 178.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.522 ' HA ' HD12 ' A' ' 30' ' ' ILE . 15.9 ttpp -69.67 -26.19 64.26 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.153 0.502 . . . . 0.0 109.688 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.674 ' OE1' ' HB2' ' A' ' 26' ' ' SER . 19.6 mp0 -59.9 -49.53 77.34 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.078 175.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.612 ' HA ' ' HB3' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -71.23 -25.76 62.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.948 -1.023 . . . . 0.0 112.347 -177.043 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.546 HG12 HD12 ' A' ' 35' ' ' LEU . 72.6 mt -52.93 -55.69 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.778 0.323 . . . . 0.0 110.503 177.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.9 t -73.59 -31.53 63.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.082 0.468 . . . . 0.0 110.564 176.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.612 ' HB3' ' HA ' ' A' ' 29' ' ' GLU . 15.1 t-160 -63.55 -51.37 65.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.901 -173.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -111.38 4.53 19.05 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 121.208 -0.197 . . . . 0.0 111.494 -176.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm 56.64 79.01 0.19 Allowed 'General case' 0 N--CA 1.465 0.29 0 O-C-N 123.696 0.622 . . . . 0.0 110.841 -177.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.546 HD12 HG12 ' A' ' 30' ' ' ILE . 91.0 mt -75.55 152.9 37.68 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.934 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.9 t -92.14 101.1 12.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.452 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.528 ' HE3' ' HB3' ' A' ' 89' ' ' GLU . 22.9 tptm -75.1 113.66 12.69 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.691 178.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.8 m -99.55 -9.37 8.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.134 0.492 . . . . 0.0 111.31 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 142.75 -179.75 20.16 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.432 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 21.3 m -131.09 126.69 36.43 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.1 pt -106.8 160.62 6.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.031 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -141.56 141.6 33.52 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.731 0.777 . . . . 0.0 111.8 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.672 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 53.5 t -94.13 135.33 28.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.943 179.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 10.0 t -150.38 86.7 1.42 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.121 0.486 . . . . 0.0 109.972 178.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.83 148.44 42.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.97 178.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.7 t -100.7 124.91 46.97 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.62 -177.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.45 -157.72 22.59 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.272 175.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.27 50.5 4.1 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.344 -0.455 . . . . 0.0 113.755 -172.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -75.42 -38.32 59.89 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 172.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.532 HD12 ' HA ' ' A' ' 56' ' ' LEU . 47.4 mm -105.24 95.03 3.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.541 176.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.3 t -108.58 -36.39 6.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.394 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.431 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 19.8 m -107.46 144.38 29.11 Favored Pre-proline 0 N--CA 1.448 -0.568 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.408 -177.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.641 ' HG3' ' HB3' ' B' ' 233' ' ' PHE . 34.8 Cg_exo -56.99 -39.92 87.86 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.908 2.405 . . . . 0.0 111.707 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.1 t -62.37 -40.54 96.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.834 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -67.31 -34.79 78.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.941 -174.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.532 ' HA ' HD12 ' A' ' 50' ' ' ILE . 58.4 tp -57.89 -55.89 29.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.472 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.481 ' HA ' HD12 ' A' ' 60' ' ' LEU . 7.8 ppt_? -70.84 -24.55 62.55 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.285 -177.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -58.67 -34.82 71.68 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.95 0.405 . . . . 0.0 110.495 171.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -78.51 -36.55 44.76 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.41 175.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.502 HD13 HD11 ' A' ' 74' ' ' ILE . 97.0 mt -62.24 -48.77 78.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.146 -178.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 65' ' ' ASP . 5.4 p -68.68 -42.15 78.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.741 0.305 . . . . 0.0 110.781 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -54.41 -42.83 70.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.988 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 94.2 mt -76.06 -51.06 13.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.883 178.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.47 -45.34 69.25 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -172.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 61' ' ' SER . 0.4 OUTLIER -64.87 -42.63 94.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.113 0.482 . . . . 0.0 110.053 -176.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.41 -12.84 60.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.457 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -78.05 -22.99 48.31 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 175.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.72 59.98 0.7 Allowed Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.842 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.474 ' HA2' ' OD1' ' A' ' 92' ' ' ASN . . . -135.56 176.25 20.25 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.851 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -116.69 -30.18 5.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 117.04 0.42 . . . . 0.0 111.331 176.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -142.2 163.72 32.11 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.505 ' CE1' ' HB3' ' B' ' 224' ' ' GLN . 12.1 p90 -136.71 152.45 50.38 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.946 172.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.562 ' HB2' HG23 ' A' ' 25' ' ' VAL . 46.9 t-80 -131.53 108.88 9.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.166 -174.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.555 HD12 ' HB2' ' B' ' 226' ' ' SER . 69.0 mt -79.56 127.59 39.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.829 0.347 . . . . 0.0 110.672 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.4 pt -101.03 -29.37 3.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.49 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -159.84 141.46 12.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.905 0.383 . . . . 0.0 111.299 -177.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -142.95 126.53 16.87 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.49 147.45 34.54 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.373 0.606 . . . . 0.0 112.223 -175.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -93.71 104.81 16.89 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 169.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -87.55 11.45 14.89 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.314 0.578 . . . . 0.0 110.484 -171.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 120.27 -113.42 2.42 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 111.309 -0.717 . . . . 0.0 111.309 -178.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -73.79 -11.19 23.8 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.449 2.1 . . . . 0.0 112.172 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -122.17 140.54 52.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.92 0.391 . . . . 0.0 110.758 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 44' ' ' SER . 84.0 t80 -103.15 130.5 50.35 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 175.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.672 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 63.0 mt-10 -124.57 114.86 19.95 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.278 -175.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -121.18 121.24 37.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.325 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.6 t -105.34 120.46 56.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.659 0.266 . . . . 0.0 110.821 -176.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.552 ' HB2' HG12 ' A' ' 74' ' ' ILE . . . -131.57 137.73 48.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.082 0.468 . . . . 0.0 111.274 -177.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.528 ' HB3' ' HE3' ' A' ' 37' ' ' LYS . 30.4 mt-10 -91.73 145.68 24.38 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.586 177.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 18.3 t -105.25 129.84 57.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -125.38 134.96 51.97 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.496 0.665 . . . . 0.0 112.024 -177.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.474 ' OD1' ' HA2' ' A' ' 69' ' ' GLY . 56.0 m-20 -109.72 179.45 4.12 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.234 169.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 39.9 p30 . . . . . 0 C--N 1.317 -0.821 0 CA-C-O 120.812 0.339 . . . . 0.0 110.191 175.828 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.189 0 CA-C-O 120.235 0.064 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 223' ' ' GLU . . . . . 0.477 ' OE2' ' HD3' ' A' ' 57' ' ' ARG . 4.7 mm-40 -147.34 125.54 12.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.998 0.428 . . . . 0.0 111.282 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 224' ' ' GLN . . . . . 0.804 ' HG3' ' HG3' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -147.38 138.56 23.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.782 -174.431 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . 0.437 HG13 ' HB2' ' B' ' 271' ' ' TYR . 12.3 m -94.95 136.03 27.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.226 0.536 . . . . 0.0 110.414 175.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . 0.555 ' HB2' HD12 ' A' ' 74' ' ' ILE . 28.4 t -82.78 148.01 28.06 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.229 -175.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . 0.523 ' HD3' ' O ' ' B' ' 227' ' ' LYS . 12.6 tmtt? -69.57 -36.69 76.54 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -65.16 -36.11 83.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.458 177.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 229' ' ' GLU . . . . . 0.625 ' HA ' ' HB3' ' B' ' 232' ' ' HIS . 0.0 OUTLIER -68.66 -25.63 64.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.649 -178.557 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 73.8 mt -56.15 -53.06 43.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 174.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 46.2 t -73.62 -31.19 63.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.059 177.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 232' ' ' HIS . . . . . 0.625 ' HB3' ' HA ' ' B' ' 229' ' ' GLU . 22.1 t-160 -72.57 -46.82 52.5 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.658 -173.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 233' ' ' PHE . . . . . 0.641 ' HB3' ' HG3' ' A' ' 53' ' ' PRO . 82.5 m-85 -111.49 6.45 20.19 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -175.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm 56.25 51.68 11.31 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.36 0.412 . . . . 0.0 110.587 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 89.9 mt -57.2 140.2 50.37 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.693 -176.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 75.0 t -79.86 117.72 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.635 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -81.41 105.68 12.77 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.806 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 238' ' ' VAL . . . . . 0.454 HG22 ' O ' ' B' ' 290' ' ' VAL . 36.0 m -87.05 -16.11 9.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.799 -0.361 . . . . 0.0 111.792 -175.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 160.98 145.09 4.19 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 119.883 -1.151 . . . . 0.0 113.077 177.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . 0.58 HG23 ' HG2' ' B' ' 289' ' ' GLU . 24.8 m -97.78 122.32 40.74 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 174.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 24.0 pt -103.58 131.71 51.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.303 0.573 . . . . 0.0 110.849 -177.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -102.27 112.48 25.18 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.628 176.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 243' ' ' VAL . . . . . 0.576 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 87.6 t -95.55 108.92 21.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.199 176.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 244' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' B' ' 284' ' ' PHE . 7.9 t -127.9 94.19 3.87 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.323 0.582 . . . . 0.0 109.632 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 245' ' ' GLN . . . . . 0.555 ' HB2' ' HB3' ' B' ' 284' ' ' PHE . 0.0 OUTLIER -86.28 147.45 26.07 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.396 -177.204 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 22.8 t -101.31 102.48 13.34 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 177.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 94.65 177.25 38.4 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.441 -0.663 . . . . 0.0 111.441 -174.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -79.3 66.28 3.49 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.819 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -76.2 -21.02 56.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.163 0.506 . . . . 0.0 110.879 -177.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 50.0 mm -98.75 122.17 50.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 176.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 1.9 m -109.94 -53.8 2.63 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.287 0.565 . . . . 0.0 110.231 -176.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 16.0 m -114.91 163.08 20.74 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.493 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.6 -29.14 59.26 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.463 2.109 . . . . 0.0 111.979 176.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 254' ' ' SER . . . . . 0.563 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 1.6 p -60.52 -44.09 96.43 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.568 177.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -56.43 -45.33 80.79 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.24 0.543 . . . . 0.0 110.225 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 46.6 tp -68.32 -39.41 81.98 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.55 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 257' ' ' ARG . . . . . 0.547 ' HG3' ' HB3' ' A' ' 23' ' ' GLU . 6.7 ttp85 -60.33 -46.8 88.63 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.759 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 258' ' ' GLU . . . . . 0.563 ' HG2' ' O ' ' B' ' 254' ' ' SER . 33.7 mm-40 -57.99 -42.98 86.28 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.598 -178.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 259' ' ' LYS . . . . . 0.548 ' O ' ' HG ' ' B' ' 263' ' ' LEU . 75.4 mmtt -64.12 -48.25 76.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.446 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 97.6 mt -66.67 -38.75 87.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.414 -176.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 29.5 t -65.35 -38.92 91.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.841 0.353 . . . . 0.0 110.095 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -63.16 -47.11 84.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.254 0.55 . . . . 0.0 110.145 177.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 263' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' B' ' 259' ' ' LYS . 85.1 mt -64.05 -42.62 96.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.967 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -58.9 -48.29 81.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.335 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -62.83 -43.98 97.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.256 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -68.1 -37.79 81.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.925 0.393 . . . . 0.0 111.338 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -78.86 -3.73 46.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.408 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 76.17 48.5 9.56 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.141 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . 0.46 ' HA3' HG12 ' B' ' 290' ' ' VAL . . . -128.47 -179.66 16.03 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.681 178.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . 0.707 ' HZ3' ' HB3' ' B' ' 270' ' ' LYS . 7.9 mtpm? -115.88 -63.57 1.43 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.723 0.296 . . . . 0.0 110.608 -178.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 271' ' ' TYR . . . . . 0.437 ' HB2' HG13 ' B' ' 225' ' ' VAL . 13.9 m-85 -122.99 174.38 7.22 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 272' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -139.01 166.79 23.57 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.663 -175.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -141.49 125.49 17.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.849 175.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 274' ' ' ILE . . . . . . . . . . . . . 84.9 mt -82.75 140.11 16.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.412 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 19.1 pt -125.12 -22.29 2.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -152.66 109.1 3.41 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.738 0.304 . . . . 0.0 110.596 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -132.23 121.17 23.21 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.832 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 278' ' ' ARG . . . . . 0.41 ' N ' ' HD2' ' B' ' 278' ' ' ARG . 0.0 OUTLIER -141.64 130.76 23.35 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.334 0.587 . . . . 0.0 111.256 -178.025 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -75.39 106.24 6.82 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 174.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -80.73 -24.93 38.39 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.458 -172.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 113.12 -89.75 0.53 Allowed Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -70.28 -12.65 32.28 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.42 2.08 . . . . 0.0 111.353 174.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -140.29 170.54 15.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.562 177.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 284' ' ' PHE . . . . . 0.555 ' HB3' ' HB2' ' B' ' 245' ' ' GLN . 72.9 t80 -131.89 119.87 21.77 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 285' ' ' GLU . . . . . 0.403 ' HB2' ' HD3' ' B' ' 278' ' ' ARG . 11.3 mm-40 -109.45 111.21 22.62 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 123.108 0.255 . . . . 0.0 110.395 -175.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 286' ' ' ALA . . . . . 0.576 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -123.83 117.16 24.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.983 0.42 . . . . 0.0 110.838 174.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 38.3 t -105.21 118.28 52.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.277 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -140.36 150.1 43.53 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.148 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 289' ' ' GLU . . . . . 0.58 ' HG2' HG23 ' B' ' 240' ' ' THR . 32.6 mt-10 -109.85 143.18 40.1 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 177.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 290' ' ' VAL . . . . . 0.46 HG12 ' HA3' ' B' ' 269' ' ' GLY . 17.2 t -102.42 141.09 19.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 291' ' ' TYR . . . . . 0.424 ' CD2' HG21 ' B' ' 225' ' ' VAL . 71.6 m-85 -128.04 149.62 50.3 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.776 0.322 . . . . 0.0 110.346 -178.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 292' ' ' ASN . . . . . 0.446 ' HB2' ' CG1' ' B' ' 238' ' ' VAL . 5.5 t-20 -104.7 24.58 11.56 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.245 0.545 . . . . 0.0 111.163 -176.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 . . . . . 0 C--N 1.317 -0.807 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.31 179.997 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.099 0 CA-C-O 121.021 0.439 . . . . 0.0 111.515 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.543 ' H ' ' HB2' ' B' ' 223' ' ' GLU . 33.7 mt-10 -150.4 99.37 2.77 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.574 -175.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.8 156.21 5.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.649 176.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.483 ' HB ' ' HB2' ' A' ' 29' ' ' GLU . 19.6 m -122.79 143.38 35.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.185 177.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.49 ' O ' HG13 ' A' ' 30' ' ' ILE . 94.9 p -93.78 -167.6 1.72 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.918 0.39 . . . . 0.0 110.738 -176.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -62.18 -38.53 89.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.624 -174.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.536 ' HB2' ' OE2' ' A' ' 29' ' ' GLU . 0.9 OUTLIER -62.17 -49.98 73.66 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.096 0.474 . . . . 0.0 110.601 -176.416 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.536 ' OE2' ' HB2' ' A' ' 28' ' ' GLN . 1.8 mp0 -62.32 -40.86 97.72 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.251 -177.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.557 HG12 HD12 ' A' ' 35' ' ' LEU . 80.8 mt -55.35 -48.28 77.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 121.048 0.452 . . . . 0.0 110.712 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.9 m -73.28 -41.61 63.4 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.749 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 12.6 t60 -76.99 -32.28 57.09 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.79 0.292 . . . . 0.0 111.79 -171.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -101.87 -2.78 29.15 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 121.352 -0.139 . . . . 0.0 111.257 -178.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt 44.68 100.02 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 122.294 1.045 . . . . 0.0 113.76 -171.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.557 HD12 HG12 ' A' ' 30' ' ' ILE . 91.7 mt -104.67 152.82 22.02 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.106 -1.406 . . . . 0.0 111.368 -176.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.1 t -88.09 105.66 15.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.932 -175.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.4 tttp -73.87 118.49 16.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.956 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 26.8 m -100.05 -21.9 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -178.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.58 -171.83 34.23 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.43 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 27.2 m -125.17 139.49 53.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.666 0.269 . . . . 0.0 110.659 -178.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.3 pt -114.7 143.88 23.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 175.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -126.18 131.12 52.07 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.105 0.479 . . . . 0.0 111.359 -173.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.686 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 95.9 t -93.89 125.67 46.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.084 173.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -153.16 88.96 1.33 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.863 0.364 . . . . 0.0 110.135 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.406 HE22 HG13 ' A' ' 43' ' ' VAL . 0.5 OUTLIER -138.46 163.45 31.91 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.884 177.586 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.567 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 4.0 p -66.05 148.92 51.07 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.122 0.487 . . . . 0.0 111.835 -178.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.88 114.42 6.03 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.934 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 137.62 -39.38 1.61 Allowed Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 -175.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -70.24 -29.29 66.06 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.465 0.65 . . . . 0.0 109.632 175.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.442 HD11 ' HG3' ' A' ' 59' ' ' LYS . 46.1 mm -118.38 109.19 26.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.728 174.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.5 t -116.18 -44.53 2.89 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.041 0.448 . . . . 0.0 110.23 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.2 m -104.06 157.14 34.61 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.073 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.953 ' HG3' HD21 ' B' ' 235' ' ' LEU . 22.1 Cg_endo -61.08 -28.79 86.3 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.411 2.074 . . . . 0.0 110.857 175.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.642 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 0.8 OUTLIER -60.34 -45.29 93.99 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.118 176.12 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.501 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 71.8 m-20 -54.93 -46.88 75.0 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.117 0.484 . . . . 0.0 110.25 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 59.2 tp -57.14 -47.82 80.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.898 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.51 -31.49 68.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.91 -176.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.642 ' HG2' ' O ' ' A' ' 54' ' ' SER . 57.7 mm-40 -63.2 -43.16 98.95 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.982 0.42 . . . . 0.0 110.013 176.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 55' ' ' ASP . 31.5 mmmt -67.24 -45.6 76.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.562 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 87.5 mt -65.24 -38.82 91.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.509 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.4 t -63.47 -35.75 81.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.96 0.409 . . . . 0.0 110.316 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -59.75 -42.88 94.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.251 176.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 87.3 mt -74.74 -33.68 62.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.936 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.93 -40.17 94.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.449 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -61.21 -35.82 78.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.373 176.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.59 2.49 29.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.579 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.427 ' HD3' ' HA ' ' A' ' 67' ' ' LYS . 42.9 mmtm -122.08 -0.05 9.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.911 0.386 . . . . 0.0 110.687 176.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 60.73 40.5 98.17 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.631 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -108.2 135.56 12.91 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.007 -178.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -77.68 -25.7 49.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.365 0.602 . . . . 0.0 110.021 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -152.93 175.44 12.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.215 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -147.65 170.22 17.98 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.925 -176.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -135.42 114.23 11.95 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 119.994 -0.683 . . . . 0.0 110.915 174.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.477 ' HA ' ' HA ' ' A' ' 88' ' ' ALA . 55.8 mt -78.39 127.53 38.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.777 177.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 23.2 pt -100.92 -35.2 4.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.585 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -156.32 144.86 20.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.817 0.341 . . . . 0.0 111.424 -177.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -147.14 124.67 11.7 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.07 152.21 40.68 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.888 0.375 . . . . 0.0 111.213 -174.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -86.0 118.88 25.75 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.488 170.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -80.11 -22.13 42.5 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 128.4 -86.28 0.32 Allowed Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 -175.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.567 ' O ' ' HA ' ' A' ' 46' ' ' SER . 70.1 Cg_endo -74.73 -24.0 13.86 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.16 1.907 . . . . 0.0 111.374 172.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.467 ' OD1' ' HG2' ' A' ' 82' ' ' PRO . 1.1 m120 -119.57 150.15 40.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.323 -176.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -108.13 121.67 45.33 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 170.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.686 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 46.2 mt-10 -117.71 118.98 33.57 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.206 0.527 . . . . 0.0 111.782 -174.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -121.36 132.13 54.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.992 176.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.1 t -111.54 112.85 42.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.997 0.427 . . . . 0.0 110.421 -178.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 74' ' ' ILE . . . -125.13 135.57 52.78 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.223 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 40' ' ' THR . 33.2 mt-10 -106.0 134.96 48.29 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 26.2 t -90.66 132.19 35.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -175.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -123.25 125.73 45.61 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.167 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.68 147.39 25.26 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 174.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.061 -178.769 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.317 0 CA-C-O 121.264 0.554 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 223' ' ' GLU . . . . . 0.543 ' HB2' ' H ' ' A' ' 23' ' ' GLU . 4.2 mm-40 -127.07 89.14 2.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.274 -173.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 224' ' ' GLN . . . . . 0.619 ' HA ' ' HB3' ' B' ' 271' ' ' TYR . 0.0 OUTLIER -176.62 155.73 1.38 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.285 169.264 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 20.3 m -125.88 150.85 31.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.272 175.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . 0.442 ' O ' HG13 ' B' ' 230' ' ' ILE . 12.7 t -83.74 171.61 13.02 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . 0.494 ' HA ' HD12 ' B' ' 230' ' ' ILE . 74.3 tttt -68.74 -19.55 64.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.343 -173.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 228' ' ' GLN . . . . . 0.44 ' HB2' ' OE1' ' B' ' 229' ' ' GLU . 0.6 OUTLIER -65.75 -50.36 65.07 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 177.315 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 229' ' ' GLU . . . . . 0.44 ' OE1' ' HB2' ' B' ' 228' ' ' GLN . 1.9 mp0 -64.58 -41.33 96.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.444 178.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.494 HD12 ' HA ' ' B' ' 227' ' ' LYS . 87.4 mt -56.84 -46.46 83.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.898 178.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 16.5 m -73.14 -21.29 60.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.458 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 -85.48 -48.03 9.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.806 -176.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -91.19 -7.81 50.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.033 -177.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 57.95 64.56 1.5 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.082 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . 0.953 HD21 ' HG3' ' A' ' 53' ' ' PRO . 60.4 mt -75.21 147.26 40.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.236 -178.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 46.8 t -88.55 119.09 35.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.08 -175.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -80.53 117.56 21.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.12 175.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 238' ' ' VAL . . . . . 0.416 HG23 ' HB ' ' B' ' 290' ' ' VAL . 2.0 m -80.26 -39.48 19.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.841 177.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 179.37 -173.27 45.26 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.991 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 33.3 m -115.22 129.81 56.74 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.245 -0.279 . . . . 0.0 110.245 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 24.2 pt -104.08 132.66 50.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.006 0.431 . . . . 0.0 110.177 175.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -117.55 123.08 45.38 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.582 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 243' ' ' VAL . . . . . 0.701 ' O ' ' HA ' ' B' ' 285' ' ' GLU . 41.9 t -92.6 120.42 41.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 173.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 15.9 t -150.97 87.16 1.39 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.345 0.593 . . . . 0.0 109.511 -177.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 245' ' ' GLN . . . . . 0.561 ' HG3' ' HB2' ' B' ' 249' ' ' GLN . 6.3 pm0 -138.62 173.62 11.39 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.734 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 246' ' ' SER . . . . . 0.434 ' HA ' HD22 ' B' ' 283' ' ' ASN . 8.6 t -85.39 176.21 8.41 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.735 0.302 . . . . 0.0 110.275 -176.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.69 52.42 1.57 Allowed Glycine 0 CA--C 1.521 0.439 0 CA-C-N 116.098 -0.501 . . . . 0.0 113.246 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -141.28 -39.78 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 176.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . 0.561 ' HB2' ' HG3' ' B' ' 245' ' ' GLN . 77.3 mt-30 -80.03 -15.13 57.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.587 -0.306 . . . . 0.0 110.518 175.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 250' ' ' ILE . . . . . 0.547 ' HA ' ' OD2' ' B' ' 255' ' ' ASP . 47.4 mm -131.76 110.22 16.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 175.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 8.5 t -118.25 -27.98 5.91 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.606 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 252' ' ' SER . . . . . 0.522 ' HB3' ' HD2' ' B' ' 253' ' ' PRO . 50.6 m -152.22 164.72 19.36 Favored Pre-proline 0 C--N 1.327 -0.383 0 O-C-N 122.357 -0.214 . . . . 0.0 110.62 -175.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . 0.522 ' HD2' ' HB3' ' B' ' 252' ' ' SER . 12.3 Cg_endo -56.95 -43.9 49.76 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.8 2.333 . . . . 0.0 112.503 178.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 254' ' ' SER . . . . . 0.405 ' O ' ' HG3' ' B' ' 257' ' ' ARG . 4.3 p -64.14 -30.46 71.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.361 0.6 . . . . 0.0 110.726 177.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 255' ' ' ASP . . . . . 0.547 ' OD2' ' HA ' ' B' ' 250' ' ' ILE . 28.1 t70 -75.75 -37.1 59.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.458 177.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 60.6 tp -61.64 -47.54 84.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.945 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 257' ' ' ARG . . . . . 0.513 ' HA ' HD12 ' B' ' 260' ' ' LEU . 2.0 ppt_? -59.19 -25.38 63.9 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -175.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 258' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -63.0 -47.5 82.86 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.169 0.509 . . . . 0.0 110.372 176.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 259' ' ' LYS . . . . . 0.529 ' N ' ' HD2' ' B' ' 259' ' ' LYS . 12.2 mptt -74.16 -26.23 60.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.559 -175.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 260' ' ' LEU . . . . . 0.513 HD12 ' HA ' ' B' ' 257' ' ' ARG . 95.9 mt -67.79 -48.21 66.94 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.479 176.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 14.4 t -66.1 -37.59 86.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.891 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -51.2 -49.4 61.09 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.083 176.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 263' ' ' LEU . . . . . . . . . . . . . 87.7 mt -74.48 -30.39 61.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.547 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.42 -40.95 81.01 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -177.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -63.48 -35.48 80.58 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.24 0.543 . . . . 0.0 110.42 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -74.59 -6.74 50.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.471 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -116.16 -2.84 12.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.84 176.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 66.29 51.09 46.28 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.158 -0.544 . . . . 0.0 112.854 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -138.92 169.35 24.46 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.172 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . 0.443 ' HB3' ' OE1' ' B' ' 223' ' ' GLU . 46.0 mtmt -105.56 -66.56 0.98 Allowed 'General case' 0 C--O 1.223 -0.334 0 CA-C-O 121.017 0.437 . . . . 0.0 110.923 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 271' ' ' TYR . . . . . 0.619 ' HB3' ' HA ' ' B' ' 224' ' ' GLN . 16.0 m-85 -92.41 152.66 19.6 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -174.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 272' ' ' TYR . . . . . 0.592 ' HB2' ' HB1' ' B' ' 288' ' ' ALA . 2.8 p90 -134.69 118.28 16.96 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.352 0.596 . . . . 0.0 110.203 175.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 273' ' ' HIS . . . . . 0.518 ' HA ' ' OE1' ' B' ' 224' ' ' GLN . 32.7 t-80 -87.84 101.21 13.49 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 274' ' ' ILE . . . . . 0.597 HG12 ' HB2' ' B' ' 288' ' ' ALA . 58.5 mt -74.17 106.44 4.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.314 -178.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 19.4 pt -85.66 -33.36 7.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.588 -175.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -151.58 124.13 8.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.703 0.287 . . . . 0.0 111.193 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -130.47 118.43 21.12 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 174.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -133.67 164.96 26.05 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.384 0.612 . . . . 0.0 111.064 -175.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -99.14 123.28 43.31 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.027 178.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 280' ' ' HIS . . . . . 0.478 ' HB3' ' HB2' ' B' ' 283' ' ' ASN . 12.1 t-80 -103.07 28.95 5.82 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.198 0.523 . . . . 0.0 110.067 -174.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 93.0 -108.3 3.64 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -178.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -83.23 4.3 7.16 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.666 2.244 . . . . 0.0 111.518 175.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 283' ' ' ASN . . . . . 0.478 ' HB2' ' HB3' ' B' ' 280' ' ' HIS . 15.6 m120 -126.16 142.02 51.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.484 -177.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -103.61 129.03 50.81 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 173.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 285' ' ' GLU . . . . . 0.701 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 31.2 mt-10 -121.95 113.97 20.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.787 0.327 . . . . 0.0 111.651 -178.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 286' ' ' ALA . . . . . 0.538 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -117.59 127.97 54.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.554 175.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 32.1 t -110.09 116.43 52.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.23 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 288' ' ' ALA . . . . . 0.597 ' HB2' HG12 ' B' ' 274' ' ' ILE . . . -128.31 139.24 52.52 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.131 0.491 . . . . 0.0 111.783 -177.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -91.9 123.46 35.29 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.352 177.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 290' ' ' VAL . . . . . 0.416 ' HB ' HG23 ' B' ' 238' ' ' VAL . 16.5 t -90.78 127.4 43.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.461 -176.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -123.49 139.83 53.62 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.018 -177.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 292' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -106.39 165.77 11.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.106 172.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 . . . . . 0 C--O 1.236 0.38 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 175.98 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.332 0 CA-C-O 121.387 0.613 . . . . 0.0 111.369 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.7 ' HB3' ' HE2' ' A' ' 71' ' ' TYR . 42.8 mt-10 -133.88 160.67 36.95 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.38 176.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.587 ' CG ' ' HG3' ' B' ' 224' ' ' GLN . 0.0 OUTLIER 174.66 142.88 0.05 Allowed 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.539 0.525 . . . . 0.0 110.424 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.2 m -123.97 125.2 70.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 169.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.456 ' HB2' ' HB ' ' B' ' 274' ' ' ILE . 8.2 t -99.38 -167.93 1.54 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.025 0.44 . . . . 0.0 110.915 -175.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.407 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -71.26 -36.62 71.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.321 -175.169 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -64.54 -50.33 67.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.058 -173.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -59.17 -36.07 74.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.426 -177.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 26' ' ' SER . 79.2 mt -57.19 -56.05 17.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.93 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.6 m -73.77 -30.51 62.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.749 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 17.6 t-160 -79.08 -51.84 9.01 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -174.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -93.03 -7.81 44.7 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 121.18 -0.208 . . . . 0.0 111.467 -174.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt 59.66 65.12 1.19 Allowed 'General case' 0 N--CA 1.463 0.212 0 O-C-N 123.555 0.534 . . . . 0.0 110.656 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.4 mt -65.47 144.49 57.0 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.54 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.511 ' HB ' ' HB3' ' A' ' 92' ' ' ASN . 95.3 t -73.23 112.56 9.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.06 0.457 . . . . 0.0 110.477 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.617 ' HD3' ' CE1' ' A' ' 91' ' ' TYR . 19.3 tptm -78.75 112.98 16.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.125 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.501 HG21 ' HA3' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -97.99 -13.19 8.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.816 -178.675 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 145.48 -170.81 26.71 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.293 -0.956 . . . . 0.0 112.571 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.504 HG23 ' HG2' ' A' ' 89' ' ' GLU . 52.2 m -137.17 139.38 41.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.632 0.253 . . . . 0.0 110.432 -178.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 34.5 pt -121.97 155.65 26.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.743 0.306 . . . . 0.0 110.201 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -141.18 140.53 34.05 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.218 0.533 . . . . 0.0 110.728 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 44.1 t -94.6 126.31 47.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.313 -0.858 . . . . 0.0 108.775 173.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.7 p -138.69 35.83 2.21 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.848 0.832 . . . . 0.0 108.894 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -99.75 159.73 14.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.942 -175.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' A' ' 83' ' ' ASN . 22.7 t -73.31 172.09 11.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.829 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.96 22.07 1.55 Allowed Glycine 0 CA--C 1.52 0.363 0 CA-C-N 116.178 -0.464 . . . . 0.0 113.366 -177.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -103.96 -21.78 9.33 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 173.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -102.41 -20.22 14.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.339 0.59 . . . . 0.0 109.63 178.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.3 mm -125.58 98.05 4.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.17 172.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.8 m -103.26 -66.54 0.93 Allowed 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.651 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.534 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 23.5 m -108.24 165.0 13.51 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.534 ' HD2' ' HB3' ' A' ' 52' ' ' SER . 11.2 Cg_endo -55.14 -32.49 80.2 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.581 2.188 . . . . 0.0 111.88 178.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.6 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 7.9 m -60.76 -43.25 98.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.896 177.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.52 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 18.3 m-20 -63.39 -36.49 83.88 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.536 -178.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.7 tp -60.86 -46.73 89.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.496 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.45 ' HD2' ' HG2' ' B' ' 223' ' ' GLU . 23.5 ttp180 -60.63 -42.65 97.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.44 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.6 ' HG2' ' O ' ' A' ' 54' ' ' SER . 31.3 mm-40 -63.05 -34.84 78.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.841 -179.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 55' ' ' ASP . 42.9 mmtm -75.29 -43.54 50.6 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.806 0.336 . . . . 0.0 110.707 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.1 mt -62.69 -46.38 88.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.066 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.7 p -64.76 -40.05 94.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.994 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -58.8 -44.15 90.71 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.797 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.7 mt -74.49 -36.03 63.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.511 -179.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.38 -47.09 74.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.815 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -64.35 -35.36 80.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.069 0.462 . . . . 0.0 110.487 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -78.64 4.78 12.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.55 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.7 mmtm -119.45 3.95 11.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.779 0.323 . . . . 0.0 111.563 176.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.46 -17.46 58.41 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.215 174.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.501 ' HA3' HG21 ' A' ' 38' ' ' VAL . . . -92.47 179.73 40.51 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.846 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.582 ' HE2' ' HA ' ' A' ' 70' ' ' LYS . 9.2 mmpt? -122.18 -59.13 1.67 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.672 0.272 . . . . 0.0 110.456 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.7 ' HE2' ' HB3' ' A' ' 23' ' ' GLU . 95.2 m-85 -91.67 167.35 12.26 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.545 -175.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.439 ' HE2' ' HB1' ' B' ' 222' ' ' ALA . 8.8 p90 -146.3 157.65 43.82 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.794 0.33 . . . . 0.0 110.912 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.444 ' CD2' ' HA ' ' A' ' 26' ' ' SER . 40.6 t-80 -127.48 102.88 7.06 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.098 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.442 ' HA ' ' HA ' ' A' ' 88' ' ' ALA . 63.9 mt -63.81 127.24 23.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.466 176.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.4 pt -113.45 -14.6 10.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.857 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.484 ' HB3' ' HB ' ' A' ' 87' ' ' VAL . . . -150.2 123.83 9.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.733 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.461 ' HB3' ' HB2' ' B' ' 228' ' ' GLN . . . -135.34 108.34 7.63 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.457 HH11 ' HD3' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -149.6 171.98 15.77 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.578 -174.668 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -119.5 140.1 51.04 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -130.36 96.69 4.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.017 0.437 . . . . 0.0 110.08 -178.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 60.8 -125.36 38.09 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -175.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -90.6 20.51 0.97 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.852 2.368 . . . . 0.0 112.348 175.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.582 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 38.4 m-80 -123.86 151.88 42.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.361 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.416 ' CE2' ' HB2' ' A' ' 86' ' ' ALA . 83.6 t80 -111.21 120.45 42.32 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.049 178.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.578 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 26.2 mm-40 -102.03 110.62 22.64 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.403 -177.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.416 ' HB2' ' CE2' ' A' ' 84' ' ' PHE . . . -128.38 114.99 17.55 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.808 0.337 . . . . 0.0 110.768 177.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.484 ' HB ' ' HB3' ' A' ' 76' ' ' ALA . 48.3 t -105.68 117.37 51.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 120.77 0.319 . . . . 0.0 110.344 -178.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.442 ' HA ' ' HA ' ' A' ' 74' ' ' ILE . . . -131.84 133.09 44.29 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.455 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.581 ' HB3' ' HE3' ' A' ' 37' ' ' LYS . 29.8 mt-10 -92.0 135.26 34.09 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.9 t -91.42 127.72 43.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -175.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.617 ' CE1' ' HD3' ' A' ' 37' ' ' LYS . 77.1 m-85 -128.14 136.98 51.89 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.336 0.589 . . . . 0.0 110.879 -178.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.511 ' HB3' ' HB ' ' A' ' 36' ' ' VAL . 8.0 t-20 -95.15 -176.86 3.94 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 174.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.4 t70 . . . . . 0 CA--C 1.538 0.498 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.609 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 222' ' ' ALA . . . . . 0.439 ' HB1' ' HE2' ' A' ' 72' ' ' TYR . . . . . . . . 0 C--O 1.234 0.242 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 223' ' ' GLU . . . . . 0.45 ' HG2' ' HD2' ' A' ' 57' ' ' ARG . 28.9 mt-10 -138.8 164.96 28.25 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 173.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 224' ' ' GLN . . . . . 0.587 ' HG3' ' CG ' ' A' ' 24' ' ' GLN . 26.1 tt0 179.6 146.99 0.22 Allowed 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.405 0.441 . . . . 0.0 111.247 175.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . 0.515 ' N ' ' HG2' ' B' ' 224' ' ' GLN . 17.2 m -141.94 139.73 30.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 167.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . 0.721 ' HA ' ' CD2' ' B' ' 273' ' ' HIS . 4.5 m -109.21 -89.81 0.47 Allowed 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.954 -0.299 . . . . 0.0 111.658 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 14.5 mmtm -154.66 -41.83 0.09 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.079 0.466 . . . . 0.0 109.774 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 228' ' ' GLN . . . . . 0.475 ' CD ' ' H ' ' B' ' 228' ' ' GLN . 0.0 OUTLIER -63.39 -44.19 95.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.191 -178.254 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -65.62 -40.0 92.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.6 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.552 HG23 ' HB2' ' B' ' 235' ' ' LEU . 77.6 mt -66.82 -38.05 80.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.497 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 30.7 t -71.38 -25.66 62.46 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.956 177.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -87.86 -46.69 9.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.983 -175.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 233' ' ' PHE . . . . . 0.459 ' CD1' ' HD3' ' A' ' 53' ' ' PRO . 68.6 m-85 -94.09 -7.39 42.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.401 -177.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt 61.08 74.1 0.46 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.523 174.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . 0.552 ' HB2' HG23 ' B' ' 230' ' ' ILE . 68.1 mt -88.89 176.41 7.04 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.808 0.337 . . . . 0.0 111.211 -177.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 59.4 t -101.89 123.71 55.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.057 -177.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 237' ' ' LYS . . . . . 0.656 ' HD3' ' CZ ' ' B' ' 291' ' ' TYR . 18.9 tptm -82.74 111.85 19.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.763 177.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 238' ' ' VAL . . . . . 0.454 HG23 HG12 ' B' ' 290' ' ' VAL . 0.4 OUTLIER -104.84 14.37 7.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -176.113 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 128.2 -162.53 21.94 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.279 -0.963 . . . . 0.0 113.216 173.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 89.4 m -149.08 135.61 19.46 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 26.7 pt -110.18 146.07 15.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.311 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -130.56 114.94 16.09 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.715 -178.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 243' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 76.7 t -94.4 109.34 21.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.287 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 10.2 p -119.71 105.34 11.06 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 176.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 245' ' ' GLN . . . . . 0.508 HE22 HD11 ' B' ' 250' ' ' ILE . 75.3 mt-30 -111.5 -174.78 2.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.865 -172.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 23.4 m -151.79 102.8 2.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.426 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 102.93 -164.48 16.02 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.423 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -83.85 58.45 5.01 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.228 -0.511 . . . . 0.0 112.704 -176.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . 0.433 ' OE1' ' HB3' ' B' ' 245' ' ' GLN . 53.9 mt-30 -80.27 -15.81 56.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.875 0.369 . . . . 0.0 110.395 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 250' ' ' ILE . . . . . 0.581 HD12 ' HA ' ' B' ' 256' ' ' LEU . 47.9 mm -113.59 114.34 46.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 173.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 16.3 t -108.07 -13.95 14.83 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.146 -176.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 252' ' ' SER . . . . . 0.45 ' O ' ' HB3' ' B' ' 255' ' ' ASP . 46.7 m -152.71 158.65 33.11 Favored Pre-proline 0 C--N 1.326 -0.415 0 O-C-N 122.382 -0.199 . . . . 0.0 110.617 -177.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -58.66 -50.49 9.2 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.809 2.34 . . . . 0.0 111.876 175.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 254' ' ' SER . . . . . 0.696 ' O ' ' HG3' ' B' ' 257' ' ' ARG . 41.4 t -58.31 -36.35 73.22 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.02 0.438 . . . . 0.0 110.629 174.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 255' ' ' ASP . . . . . 0.45 ' HB3' ' O ' ' B' ' 252' ' ' SER . 20.2 t0 -60.78 -43.62 97.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.355 178.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.581 ' HA ' HD12 ' B' ' 250' ' ' ILE . 55.3 tp -61.51 -44.4 97.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.278 178.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 257' ' ' ARG . . . . . 0.696 ' HG3' ' O ' ' B' ' 254' ' ' SER . 0.7 OUTLIER -66.26 -30.91 71.43 Favored 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 120.411 -0.515 . . . . 0.0 110.372 -177.346 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 258' ' ' GLU . . . . . 0.501 ' HG3' ' O ' ' B' ' 254' ' ' SER . 49.5 mt-10 -68.76 -27.06 65.57 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.946 0.403 . . . . 0.0 110.651 178.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 259' ' ' LYS . . . . . 0.407 ' HD3' ' O ' ' B' ' 255' ' ' ASP . 14.2 mptt -75.01 -34.35 61.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.27 0.557 . . . . 0.0 110.273 174.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 260' ' ' LEU . . . . . 0.455 ' CD1' HD11 ' B' ' 274' ' ' ILE . 79.1 mt -74.04 -46.71 41.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.421 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 25.0 m -60.39 -34.21 73.58 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.108 175.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -54.81 -48.64 72.5 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.085 0.469 . . . . 0.0 110.589 176.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 263' ' ' LEU . . . . . . . . . . . . . 86.6 mt -73.82 -38.13 64.65 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.171 -178.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.59 -44.68 61.7 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -177.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -67.77 -39.65 84.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.275 -178.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -72.36 -24.03 61.21 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.03 177.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 11.8 mmtt -78.21 -50.35 12.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.591 177.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 118.88 33.09 1.2 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.686 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -132.66 133.07 6.88 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 176.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -93.52 8.5 40.46 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -167.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 271' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -146.78 146.67 30.34 Favored 'General case' 0 C--N 1.33 -0.239 0 O-C-N 122.312 -0.242 . . . . 0.0 110.675 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 272' ' ' TYR . . . . . 0.461 ' CE1' ' HB3' ' A' ' 24' ' ' GLN . 37.1 p90 -141.19 159.87 41.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.877 0.37 . . . . 0.0 110.965 177.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 273' ' ' HIS . . . . . 0.721 ' CD2' ' HA ' ' B' ' 226' ' ' SER . 12.4 t-80 -136.14 111.97 9.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.567 -178.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 274' ' ' ILE . . . . . 0.456 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 77.4 mt -78.26 113.29 17.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.872 0.368 . . . . 0.0 110.456 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 9.0 pt -97.09 -27.2 3.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.294 -178.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -150.07 130.71 14.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.467 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 277' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' B' ' 285' ' ' GLU . . . -153.37 117.9 4.95 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -157.56 175.48 13.88 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.064 0.459 . . . . 0.0 110.795 -178.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -109.24 124.75 51.38 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.325 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -112.74 87.67 2.64 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 173.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 69.84 -124.71 15.14 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 -175.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -84.37 -3.28 10.11 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.656 2.237 . . . . 0.0 112.036 175.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -100.2 116.5 32.35 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.082 -174.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -90.52 126.44 35.93 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 175.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 285' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' B' ' 277' ' ' ALA . 9.2 mm-40 -116.02 110.54 19.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.781 -176.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 286' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -118.86 115.72 24.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.857 0.361 . . . . 0.0 111.092 174.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 27.2 t -110.21 124.34 66.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.268 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -135.93 148.08 48.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.236 0.541 . . . . 0.0 111.673 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 289' ' ' GLU . . . . . 0.532 ' HB3' ' HE3' ' B' ' 237' ' ' LYS . 31.8 mt-10 -89.73 143.58 26.69 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 290' ' ' VAL . . . . . 0.454 HG12 HG23 ' B' ' 238' ' ' VAL . 10.6 t -107.79 123.31 63.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 291' ' ' TYR . . . . . 0.656 ' CZ ' ' HD3' ' B' ' 237' ' ' LYS . 77.0 m-85 -127.31 148.88 50.23 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.253 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 292' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -124.12 162.64 23.14 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 11.9 p30 . . . . . 0 C--N 1.329 -0.326 0 CA-C-O 121.584 0.707 . . . . 0.0 112.336 -174.578 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.403 ' HB3' ' HA ' ' B' ' 261' ' ' SER . . . . . . . . 0 CA--C 1.519 -0.219 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.508 ' HB2' ' CE1' ' A' ' 71' ' ' TYR . 8.7 pt-20 -165.29 125.43 1.86 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -169.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.622 ' HA ' ' HB3' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -161.71 159.08 26.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.506 174.522 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.503 HG22 ' HB2' ' A' ' 71' ' ' TYR . 17.1 m -128.32 130.91 69.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.353 174.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.479 ' O ' HG13 ' A' ' 30' ' ' ILE . 15.4 m -97.56 173.95 6.89 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.382 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -66.58 -15.16 63.22 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.556 -174.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.452 ' HB2' ' OE1' ' A' ' 29' ' ' GLU . 41.9 mt-30 -71.57 -50.81 27.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.405 0.621 . . . . 0.0 109.527 177.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.464 ' OE1' ' HB2' ' A' ' 26' ' ' SER . 1.9 mp0 -70.44 -41.28 73.05 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.901 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 26' ' ' SER . 94.7 mt -56.21 -48.67 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.353 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.1 m -72.34 -30.12 64.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.08 0.467 . . . . 0.0 110.727 -177.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -74.87 -40.85 60.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.498 -177.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -96.88 -0.01 48.43 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -175.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm 57.87 51.45 9.08 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.03 0.443 . . . . 0.0 110.033 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.873 HD21 ' HG2' ' B' ' 253' ' ' PRO . 56.4 mt -68.62 169.58 10.83 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.622 0.725 . . . . 0.0 112.78 -172.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.7 t -100.04 117.88 45.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.293 -175.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.424 ' HE2' ' OE1' ' A' ' 89' ' ' GLU . 60.8 tttm -83.14 107.65 15.85 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 176.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.5 m -90.69 -11.68 9.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -175.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 138.07 -168.02 24.71 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 119.892 -1.147 . . . . 0.0 113.092 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 24.0 m -123.55 144.54 49.5 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -178.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.6 pt -110.84 157.54 11.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.674 0.273 . . . . 0.0 110.439 178.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -117.98 136.71 53.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.126 0.489 . . . . 0.0 111.921 -171.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.662 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 85.5 t -122.45 113.45 38.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.849 169.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.0 t -150.85 77.2 1.27 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.186 0.517 . . . . 0.0 110.053 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.416 HE22 HG13 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -137.73 163.64 30.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.992 -179.565 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.525 ' HA ' ' HA ' ' A' ' 83' ' ' ASN . 26.4 t -73.18 163.83 27.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.643 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.97 -16.97 58.02 Favored Glycine 0 C--N 1.333 0.393 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.48 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.46 -19.63 68.95 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.215 176.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -102.0 -28.37 12.41 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.676 0.274 . . . . 0.0 111.01 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 43.5 mm -119.35 107.33 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-O 121.219 0.533 . . . . 0.0 110.479 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.8 m -128.98 -28.64 2.38 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.967 -178.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.8 m -121.68 156.08 59.16 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.192 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.441 ' HG2' ' HB2' ' B' ' 293' ' ' ASP . 32.5 Cg_exo -59.88 -24.43 76.08 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.729 2.286 . . . . 0.0 112.087 177.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.514 ' O ' ' HG3' ' A' ' 58' ' ' GLU . 24.1 p -62.76 -39.91 95.63 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.471 177.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.57 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 16.3 m-20 -61.69 -51.79 66.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.304 -175.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.443 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 57.6 tp -57.03 -44.82 83.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.653 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.403 ' HD2' HH11 ' A' ' 57' ' ' ARG . 7.5 ttp180 -53.25 -53.59 48.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.516 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.514 ' HG3' ' O ' ' A' ' 54' ' ' SER . 72.4 mt-10 -67.5 -27.27 66.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.021 -171.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.57 ' HG2' ' O ' ' A' ' 55' ' ' ASP . 46.9 mmtt -71.05 -45.64 63.47 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 56' ' ' LEU . 82.1 mt -65.53 -43.86 88.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.227 -176.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.9 p -62.88 -41.47 99.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.74 0.305 . . . . 0.0 111.383 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -64.67 -46.36 82.76 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.173 0.511 . . . . 0.0 110.223 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 59' ' ' LYS . 81.2 mt -67.87 -34.74 77.26 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.464 -178.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.72 -46.73 77.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.693 -178.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -67.38 -25.81 66.15 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.84 0.352 . . . . 0.0 110.992 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.77 -28.96 68.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.261 0.553 . . . . 0.0 110.237 176.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -86.18 -13.43 47.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.742 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.76 -9.04 73.8 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.914 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.24 172.5 54.41 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 121.221 -0.514 . . . . 0.0 112.146 -178.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -117.35 -62.8 1.52 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.966 0.412 . . . . 0.0 110.671 -176.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.622 ' HB3' ' HA ' ' A' ' 24' ' ' GLN . 4.5 m-85 -98.17 148.1 23.91 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -176.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.454 ' CE2' ' HA ' ' B' ' 223' ' ' GLU . 32.7 p90 -121.8 156.98 32.04 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 177.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -135.25 115.93 13.85 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.569 -177.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.466 ' H ' HD12 ' A' ' 74' ' ' ILE . 4.6 mp -73.31 132.06 33.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 26.6 pt -117.37 -27.74 2.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.589 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -152.96 133.53 13.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.616 0.245 . . . . 0.0 110.684 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.517 ' HB3' ' HG3' ' B' ' 228' ' ' GLN . . . -150.55 142.74 24.14 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -164.87 147.99 8.56 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.033 0.444 . . . . 0.0 111.048 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -78.29 111.33 14.16 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 169.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -115.06 82.14 1.69 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.049 0.452 . . . . 0.0 110.349 -174.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.04 -128.75 8.74 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.6 -178.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -81.43 -6.15 12.7 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.572 2.181 . . . . 0.0 112.893 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.525 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 81.9 m-20 -121.07 154.52 36.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.079 0.466 . . . . 0.0 111.276 -175.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -104.29 118.39 36.51 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.585 176.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -102.4 124.92 48.83 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.05 -176.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.662 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -137.36 129.8 29.72 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.231 0.539 . . . . 0.0 110.917 178.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.9 t -113.24 118.83 59.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.973 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.59 138.24 39.34 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.121 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 40' ' ' THR . 51.1 mt-10 -98.96 153.91 18.47 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 178.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.9 t -112.27 138.45 41.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -125.26 148.57 48.61 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.086 0.47 . . . . 0.0 110.595 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -118.27 164.73 14.76 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.508 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.6 t0 . . . . . 0 C--N 1.329 -0.317 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.591 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.301 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 223' ' ' GLU . . . . . 0.454 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 10.8 pt-20 -173.0 140.65 0.92 Allowed 'General case' 0 C--O 1.235 0.31 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -167.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 224' ' ' GLN . . . . . 0.472 ' HA ' ' HB3' ' B' ' 271' ' ' TYR . 0.0 OUTLIER -175.57 156.73 1.97 Allowed 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.612 173.365 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 28.3 m -116.45 141.51 33.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.769 0.319 . . . . 0.0 110.811 177.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 47.9 t -83.83 -92.96 0.07 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.111 -176.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . 0.416 ' HA ' HD12 ' B' ' 230' ' ' ILE . 26.2 ttpt -151.48 -39.68 0.12 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.962 0.411 . . . . 0.0 110.895 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 228' ' ' GLN . . . . . 0.517 ' HG3' ' HB3' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -63.75 -35.09 79.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.424 179.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 229' ' ' GLU . . . . . 0.467 ' OE1' ' HG2' ' B' ' 228' ' ' GLN . 2.4 mp0 -69.68 -37.93 76.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.831 176.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.559 HG12 HD12 ' B' ' 235' ' ' LEU . 63.3 mt -59.05 -45.18 92.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.642 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 16.5 m -73.13 -37.68 66.57 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.861 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -70.37 -48.54 55.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.435 -176.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -94.45 5.43 51.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.438 -175.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt 55.68 45.13 25.22 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.92 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . 0.617 HD22 ' HA ' ' B' ' 293' ' ' ASP . 72.7 mt -58.27 148.82 26.04 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.509 -175.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 61.9 t -97.29 117.92 42.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.01 -174.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -80.82 113.63 19.15 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.14 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 18.9 m -85.89 -34.94 8.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -176.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 166.02 179.77 39.72 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.637 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . 0.494 HG23 ' HG2' ' B' ' 289' ' ' GLU . 54.3 m -113.45 135.84 53.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.698 0.285 . . . . 0.0 110.583 -178.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 30.1 pt -107.77 131.19 58.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 171.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -120.19 113.79 20.96 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.997 -174.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 243' ' ' VAL . . . . . 0.571 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 84.2 t -95.12 119.61 43.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.353 -177.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 22.6 t -115.64 86.1 2.4 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 170.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 245' ' ' GLN . . . . . 0.565 ' HG2' HG12 ' B' ' 250' ' ' ILE . 0.3 OUTLIER -81.63 106.47 13.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.946 -173.22 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 13.9 m -88.13 103.69 15.98 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.68 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 94.69 -162.69 24.42 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.146 174.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -82.54 63.73 4.39 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.554 -0.355 . . . . 0.0 113.591 -173.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . 0.524 ' HB2' ' HG3' ' B' ' 245' ' ' GLN . 72.6 mt-30 -96.09 -2.8 45.88 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.126 0.488 . . . . 0.0 109.911 172.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 250' ' ' ILE . . . . . 0.565 HG12 ' HG2' ' B' ' 245' ' ' GLN . 48.9 mm -128.36 125.54 64.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.116 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 251' ' ' SER . . . . . 0.4 ' H ' ' CG ' ' B' ' 255' ' ' ASP . 1.1 m -112.09 -57.79 2.22 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.457 0.646 . . . . 0.0 109.668 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 252' ' ' SER . . . . . 0.522 ' HB3' ' HD2' ' B' ' 253' ' ' PRO . 50.7 m -127.01 175.12 3.55 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.362 176.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . 0.873 ' HG2' HD21 ' A' ' 35' ' ' LEU . 52.2 Cg_exo -55.09 -28.63 61.56 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.288 1.992 . . . . 0.0 112.315 175.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 254' ' ' SER . . . . . 0.576 ' O ' ' HB3' ' B' ' 257' ' ' ARG . 56.3 m -65.74 -26.19 67.62 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.777 178.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 255' ' ' ASP . . . . . 0.588 ' O ' ' HD3' ' B' ' 259' ' ' LYS . 2.6 m-20 -70.82 -49.39 46.84 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.154 0.502 . . . . 0.0 109.661 176.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 41.2 tp -62.5 -31.31 72.04 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.024 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 257' ' ' ARG . . . . . 0.576 ' HB3' ' O ' ' B' ' 254' ' ' SER . 50.7 ttt85 -51.19 -51.4 54.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.117 175.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 258' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -59.72 -51.99 67.41 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.138 0.494 . . . . 0.0 110.317 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 259' ' ' LYS . . . . . 0.588 ' HD3' ' O ' ' B' ' 255' ' ' ASP . 12.1 mptt -59.56 -43.7 93.5 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.245 -174.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 260' ' ' LEU . . . . . 0.485 HD13 ' CE2' ' B' ' 272' ' ' TYR . 96.5 mt -74.26 -43.62 56.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.179 -177.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 261' ' ' SER . . . . . 0.403 ' HA ' ' HB3' ' A' ' 22' ' ' ALA . 32.9 t -63.39 -37.97 89.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.677 0.275 . . . . 0.0 110.482 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -60.95 -52.96 62.8 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.46 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 263' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' B' ' 259' ' ' LYS . 81.1 mt -68.84 -40.19 79.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.282 -176.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -61.25 -52.53 64.36 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -175.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -69.48 -32.25 71.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.875 0.369 . . . . 0.0 110.413 -176.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -68.1 -24.23 65.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.007 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -84.96 0.4 51.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.531 176.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 74.82 34.16 53.78 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.798 -178.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . 0.43 ' HA2' ' OD1' ' B' ' 292' ' ' ASN . . . -127.79 163.83 21.35 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 121.051 -0.595 . . . . 0.0 111.957 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . 0.616 ' NZ ' ' HA ' ' B' ' 270' ' ' LYS . 1.0 OUTLIER -108.34 -66.55 1.03 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.782 0.325 . . . . 0.0 111.276 178.427 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 271' ' ' TYR . . . . . 0.472 ' HB3' ' HA ' ' B' ' 224' ' ' GLN . 4.9 m-85 -92.61 140.79 29.18 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -173.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 272' ' ' TYR . . . . . 0.485 ' CE2' HD13 ' B' ' 260' ' ' LEU . 55.0 p90 -125.17 131.38 53.23 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 176.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -104.34 107.91 19.06 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.114 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 274' ' ' ILE . . . . . . . . . . . . . 69.6 mt -70.21 123.14 23.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.191 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 34.0 pt -100.17 -26.55 3.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.706 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -153.76 123.71 6.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.826 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -143.58 117.97 9.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.261 178.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.8 159.02 13.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.948 0.404 . . . . 0.0 111.404 -177.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -84.65 138.58 32.6 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 172.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -114.7 26.84 9.87 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 173.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 115.49 -125.94 6.92 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -175.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.16 -10.5 22.69 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.457 2.104 . . . . 0.0 111.481 175.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 283' ' ' ASN . . . . . 0.454 ' HA ' ' O ' ' B' ' 245' ' ' GLN . 80.3 m-20 -109.64 125.54 52.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.817 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 284' ' ' PHE . . . . . 0.477 ' HB3' ' HB3' ' B' ' 245' ' ' GLN . 71.6 t80 -101.46 121.99 42.95 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.387 178.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 285' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -98.13 113.82 25.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.096 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 286' ' ' ALA . . . . . 0.571 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -125.63 116.02 21.05 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.867 0.365 . . . . 0.0 110.158 172.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 21.4 t -113.3 114.68 47.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.247 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -129.35 133.65 47.52 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.451 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 289' ' ' GLU . . . . . 0.494 ' HG2' HG23 ' B' ' 240' ' ' THR . 14.1 mt-10 -106.48 128.17 53.87 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 290' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' B' ' 272' ' ' TYR . 25.0 t -90.31 135.63 25.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.102 0.477 . . . . 0.0 111.202 -171.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -127.26 133.68 50.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.676 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 292' ' ' ASN . . . . . 0.43 ' OD1' ' HA2' ' B' ' 269' ' ' GLY . 54.2 m-20 -106.16 161.6 14.38 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.305 174.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 293' ' ' ASP . . . . . 0.617 ' HA ' HD22 ' B' ' 235' ' ' LEU . 9.3 p-10 . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.618 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.139 0 CA-C-O 121.295 0.569 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.51 ' O ' ' HB2' ' A' ' 24' ' ' GLN . 30.9 mt-10 -140.42 165.64 26.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.54 176.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.51 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER 174.69 136.63 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 O-C-N 123.791 0.682 . . . . 0.0 109.775 171.017 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.0 m -128.24 116.0 40.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.167 0.508 . . . . 0.0 110.479 173.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.429 ' O ' HG13 ' A' ' 30' ' ' ILE . 0.7 OUTLIER -91.29 169.89 10.44 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.099 -178.91 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.45 ' HD3' ' HA ' ' A' ' 27' ' ' LYS . 21.5 mmtp -68.99 -20.24 64.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.472 -177.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.11 -49.8 66.25 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 177.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -66.39 -43.89 84.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.317 176.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.542 HG12 HD12 ' A' ' 35' ' ' LEU . 90.2 mt -58.6 -46.84 89.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.437 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.9 t -72.88 -26.63 61.51 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.999 0.428 . . . . 0.0 110.611 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -73.83 -51.37 16.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.08 -177.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -85.47 -13.52 48.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.95 -178.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt 62.74 68.17 0.66 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.989 -176.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.578 HD21 ' HG2' ' B' ' 253' ' ' PRO . 63.0 mt -79.79 162.63 24.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.463 -176.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.6 m -96.29 131.28 43.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.947 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -85.12 118.51 24.72 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.89 177.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.41 HG12 ' HD2' ' A' ' 67' ' ' LYS . 20.8 t -78.76 -26.73 13.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 157.48 164.88 14.3 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.705 176.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 88.4 m -107.27 118.2 36.08 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 173.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.6 pt -107.52 170.44 2.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -178.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -143.42 143.85 31.79 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.924 0.868 . . . . 0.0 111.682 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.548 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 82.2 t -93.55 128.79 44.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 114.323 -1.308 . . . . 0.0 108.668 174.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -156.12 72.4 0.77 Allowed 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -178.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.44 HE22 HG13 ' A' ' 43' ' ' VAL . 0.6 OUTLIER -103.11 148.37 25.82 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.097 -176.432 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.7 p -105.67 112.2 25.19 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.338 -176.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.28 -147.04 18.28 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.73 -0.747 . . . . 0.0 113.116 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -90.26 38.09 3.27 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.133 -0.556 . . . . 0.0 112.823 -173.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -76.4 -31.26 57.86 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.446 HD12 ' HA ' ' A' ' 56' ' ' LEU . 44.7 mm -114.43 95.23 3.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 171.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.8 t -103.41 -43.48 5.4 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.211 0.529 . . . . 0.0 109.831 -177.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 17.8 m -113.74 159.17 36.76 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.385 176.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -57.18 -26.35 69.14 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.386 2.057 . . . . 0.0 111.947 177.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.406 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 3.8 p -73.24 -22.72 60.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.508 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -71.45 -34.54 70.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.326 0.584 . . . . 0.0 109.715 177.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.446 ' HA ' HD12 ' A' ' 50' ' ' ILE . 51.6 tp -66.25 -48.19 71.32 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.57 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.515 ' HD3' ' OE1' ' B' ' 223' ' ' GLU . 0.2 OUTLIER -64.21 -30.52 71.57 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.223 -178.217 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.458 ' HG3' ' NE ' ' A' ' 57' ' ' ARG . 36.1 mt-10 -67.64 -41.25 84.18 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.1 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -66.81 -45.34 78.65 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.823 0.344 . . . . 0.0 110.635 177.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.4 mt -64.48 -41.34 96.54 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.033 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.6 t -65.94 -39.04 90.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.154 0.502 . . . . 0.0 110.256 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -63.4 -42.67 98.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.883 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 97.5 mt -69.64 -32.69 71.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.804 178.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.87 -40.54 95.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.039 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -63.0 -40.38 97.61 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.912 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.79 -44.01 87.01 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.823 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.41 ' HD2' HG12 ' A' ' 38' ' ' VAL . 40.7 mmtt -74.11 -33.44 63.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.813 177.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 94.2 36.46 5.69 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.08 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -100.38 166.68 19.85 Favored Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -123.12 2.75 9.28 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.96 0.38 . . . . 0.0 111.587 -176.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.518 ' HE2' ' HB2' ' A' ' 93' ' ' ASP . 6.9 m-85 -153.96 166.02 34.28 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 177.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -150.65 157.46 43.0 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 171.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -146.1 117.64 8.03 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.041 -176.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.515 HG13 ' HB2' ' A' ' 88' ' ' ALA . 3.7 mp -83.64 131.35 34.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 178.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 9.9 pt -107.62 -21.63 5.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.592 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -150.52 139.26 20.75 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.171 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -151.15 113.01 4.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.749 0.309 . . . . 0.0 110.561 -178.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.59 150.7 51.62 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.415 0.626 . . . . 0.0 111.194 -177.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -93.99 102.72 14.81 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.272 176.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -102.54 77.32 1.61 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.367 -175.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.83 -125.6 35.27 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.292 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -82.67 5.46 6.38 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.874 2.383 . . . . 0.0 112.734 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' ' 45' ' ' GLN . 58.5 m-80 -122.51 120.03 32.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.961 0.41 . . . . 0.0 110.628 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -85.32 116.42 23.65 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 177.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.529 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 19.3 mm-40 -106.94 114.49 28.61 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.833 -175.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.548 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -135.26 121.16 19.78 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.617 0.246 . . . . 0.0 110.96 176.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.6 t -95.77 120.42 45.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -177.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.515 ' HB2' HG13 ' A' ' 74' ' ' ILE . . . -126.05 143.62 51.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.198 0.523 . . . . 0.0 111.349 -175.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.471 ' HB3' ' CE1' ' A' ' 91' ' ' TYR . 41.4 mt-10 -103.3 140.71 37.05 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.547 178.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.3 t -107.81 119.21 57.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 176.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.471 ' CE1' ' HB3' ' A' ' 89' ' ' GLU . 72.1 m-85 -123.77 152.81 41.78 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.193 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -115.69 155.87 26.95 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.063 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.518 ' HB2' ' HE2' ' A' ' 71' ' ' TYR . 19.7 t70 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.078 -177.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.292 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 223' ' ' GLU . . . . . 0.84 ' HG2' ' HE1' ' B' ' 271' ' ' TYR . 12.7 tt0 -164.43 125.27 2.12 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.371 0.605 . . . . 0.0 111.076 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 224' ' ' GLN . . . . . 0.426 HE21 ' C ' ' B' ' 224' ' ' GLN . 0.0 OUTLIER -164.93 150.61 9.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.571 -170.235 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . 0.552 HG22 ' HB3' ' B' ' 271' ' ' TYR . 17.9 m -127.02 128.84 71.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 172.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . 0.811 ' HA ' ' CD2' ' B' ' 273' ' ' HIS . 11.5 t -92.84 173.17 7.89 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.089 0.471 . . . . 0.0 110.547 -178.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . 0.517 ' HA ' HD12 ' B' ' 230' ' ' ILE . 47.4 tttm -64.16 -28.64 69.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.874 -172.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -66.49 -50.46 63.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.291 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 229' ' ' GLU . . . . . 0.486 ' OE1' ' HB3' ' B' ' 226' ' ' SER . 1.9 mp0 -65.36 -38.0 88.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.651 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.539 HG12 HD12 ' B' ' 235' ' ' LEU . 97.1 mt -55.86 -53.92 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.232 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 68.6 m -73.45 -21.01 60.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.713 0.292 . . . . 0.0 111.517 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -75.04 -45.05 44.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.564 0.221 . . . . 0.0 110.99 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -100.75 -12.42 19.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.347 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? 64.41 91.15 0.08 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.139 -175.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . 0.539 HD12 HG12 ' B' ' 230' ' ' ILE . 88.6 mt -96.87 166.24 11.72 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.43 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 52.1 t -93.22 115.06 31.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.582 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -84.77 111.76 19.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.081 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 238' ' ' VAL . . . . . 0.431 HG23 ' HB ' ' B' ' 290' ' ' VAL . 1.2 m -88.35 -30.15 5.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -176.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 168.21 -147.53 11.58 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 119.964 -1.112 . . . . 0.0 113.085 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 29.0 m -141.17 138.1 33.16 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 122.598 0.359 . . . . 0.0 110.377 -176.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 241' ' ' ILE . . . . . 0.493 HG13 ' HB3' ' B' ' 288' ' ' ALA . 2.4 pt -105.29 137.61 34.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.139 0.495 . . . . 0.0 110.514 177.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -109.69 123.23 49.14 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.707 -172.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 243' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' B' ' 285' ' ' GLU . 89.2 t -100.95 117.4 46.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 172.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 34.4 m -155.37 76.61 0.97 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.787 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 245' ' ' GLN . . . . . 0.415 ' O ' ' HA ' ' B' ' 283' ' ' ASN . 0.9 OUTLIER -103.79 142.77 33.8 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.834 -177.706 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 246' ' ' SER . . . . . 0.578 ' HA ' ' O ' ' B' ' 282' ' ' PRO . 17.2 m -80.97 117.74 21.85 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.06 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 90.53 -165.71 31.27 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.582 176.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -87.08 53.12 4.45 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.319 -0.467 . . . . 0.0 112.454 -177.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -72.21 -25.32 61.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.252 0.549 . . . . 0.0 109.797 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 39.4 mm -105.91 90.84 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 175.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 9.4 t -92.94 -23.63 18.67 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.219 0.533 . . . . 0.0 109.961 -176.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 7.1 p -141.14 157.2 67.3 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.141 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . 0.578 ' HG2' HD21 ' A' ' 35' ' ' LEU . 68.5 Cg_exo -53.22 -30.78 52.7 Favored 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 123.017 2.478 . . . . 0.0 113.08 178.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 254' ' ' SER . . . . . 0.592 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 6.9 p -59.44 -41.22 89.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.833 -0.167 . . . . 0.0 110.902 176.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -58.36 -44.19 88.7 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.427 0.632 . . . . 0.0 109.764 176.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 49.2 tp -61.48 -44.57 96.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.272 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 257' ' ' ARG . . . . . 0.433 ' HD2' ' HG2' ' A' ' 23' ' ' GLU . 3.1 ttp180 -61.71 -46.67 88.69 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.549 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 258' ' ' GLU . . . . . 0.592 ' HG2' ' O ' ' B' ' 254' ' ' SER . 9.9 mm-40 -58.12 -47.08 84.38 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.959 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -66.39 -47.86 71.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.13 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 53.2 mt -62.86 -47.63 82.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.841 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 35.0 p -63.98 -39.07 93.29 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.84 0.352 . . . . 0.0 110.707 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -62.09 -48.46 80.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.433 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 263' ' ' LEU . . . . . 0.591 ' O ' ' HG2' ' B' ' 267' ' ' LYS . 96.2 mt -65.44 -37.35 86.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.055 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -69.07 -49.45 57.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.286 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -63.51 -33.29 75.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.878 0.37 . . . . 0.0 110.815 -178.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -66.79 -29.31 69.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.737 178.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 267' ' ' LYS . . . . . 0.591 ' HG2' ' O ' ' B' ' 263' ' ' LEU . 48.3 mmtm -82.07 -25.06 34.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.137 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 113.41 -5.68 24.85 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.866 -178.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . 0.503 ' HA2' ' OD1' ' B' ' 292' ' ' ASN . . . -77.41 145.69 30.79 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.183 -0.532 . . . . 0.0 111.812 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . 0.606 ' HE2' ' HA ' ' B' ' 270' ' ' LYS . 9.7 mmpt? -107.5 -23.64 12.09 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.854 0.359 . . . . 0.0 110.893 -177.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 271' ' ' TYR . . . . . 0.84 ' HE1' ' HG2' ' B' ' 223' ' ' GLU . 99.4 m-85 -133.46 157.06 46.54 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.348 -178.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 272' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -151.07 167.46 27.61 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.688 174.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 273' ' ' HIS . . . . . 0.811 ' CD2' ' HA ' ' B' ' 226' ' ' SER . 49.1 t-80 -143.15 117.27 9.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.863 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 274' ' ' ILE . . . . . 0.451 ' HA ' ' HA ' ' B' ' 288' ' ' ALA . 61.8 mt -67.4 137.1 25.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.191 178.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 25.8 pt -110.91 -26.74 3.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.129 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -158.55 140.44 13.78 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.842 0.354 . . . . 0.0 111.016 -178.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -140.25 129.35 23.58 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 278' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' B' ' 278' ' ' ARG . 1.4 ptm180 -137.53 150.81 47.8 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.394 0.616 . . . . 0.0 111.195 -175.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -101.72 123.76 46.24 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.479 -175.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 280' ' ' HIS . . . . . 0.462 ' HB2' ' O ' ' B' ' 283' ' ' ASN . 10.1 m170 -125.33 154.72 41.36 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 163.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . -65.92 -57.59 10.59 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.715 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 282' ' ' PRO . . . . . 0.578 ' O ' ' HA ' ' B' ' 246' ' ' SER . 60.4 Cg_endo -72.07 -29.73 14.38 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.136 1.891 . . . . 0.0 112.958 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 283' ' ' ASN . . . . . 0.544 HD22 ' C ' ' B' ' 282' ' ' PRO . 0.9 OUTLIER -132.49 129.38 39.1 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 122.326 -0.234 . . . . 0.0 111.126 -175.609 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -91.17 120.46 32.12 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 171.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 285' ' ' GLU . . . . . 0.518 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 46.6 mt-10 -118.61 130.82 56.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.288 0.566 . . . . 0.0 112.411 -170.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 286' ' ' ALA . . . . . 0.425 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -149.27 143.7 26.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.128 176.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 41.0 t -123.38 124.91 70.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.397 -178.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 288' ' ' ALA . . . . . 0.493 ' HB3' HG13 ' B' ' 241' ' ' ILE . . . -132.24 141.48 49.05 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.941 0.401 . . . . 0.0 111.153 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -92.01 132.52 36.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.64 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 290' ' ' VAL . . . . . 0.431 ' HB ' HG23 ' B' ' 238' ' ' VAL . 6.0 t -97.99 131.89 44.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 120.832 0.349 . . . . 0.0 110.455 -176.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -127.99 143.91 51.09 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.32 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 292' ' ' ASN . . . . . 0.503 ' OD1' ' HA2' ' B' ' 269' ' ' GLY . 1.5 m120 -112.14 179.71 3.92 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.559 0.695 . . . . 0.0 112.157 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.322 -0.599 0 CA-C-N 114.014 -1.448 . . . . 0.0 110.032 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.211 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -133.94 104.11 6.12 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.176 -170.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.659 ' HA ' ' HB3' ' A' ' 71' ' ' TYR . 0.0 OUTLIER 175.13 167.64 0.3 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.816 0.341 . . . . 0.0 111.27 176.217 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.411 ' H ' ' CD ' ' A' ' 24' ' ' GLN . 28.3 m -127.51 139.77 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.068 0.547 . . . . 0.0 110.174 175.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.9 p -89.46 -93.65 0.11 Allowed 'General case' 0 C--N 1.322 -0.611 0 O-C-N 121.768 -0.582 . . . . 0.0 112.29 -174.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -131.68 -46.75 0.96 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.757 0.313 . . . . 0.0 111.044 -175.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -64.85 -47.39 78.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.516 -177.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.42 ' H ' ' CD ' ' A' ' 29' ' ' GLU . 1.7 mp0 -55.12 -47.81 74.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.608 -176.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.484 HG12 HD12 ' A' ' 35' ' ' LEU . 59.8 mt -58.02 -48.55 83.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.08 0.467 . . . . 0.0 111.147 -178.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.9 m -72.8 -33.83 66.51 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.344 -177.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -81.97 -34.88 29.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.956 -173.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.776 ' HB3' ' HG3' ' B' ' 253' ' ' PRO . 71.1 m-85 -101.77 -8.14 21.96 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.708 -176.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm 60.71 70.44 0.62 Allowed 'General case' 0 N--CA 1.466 0.343 0 O-C-N 123.559 0.537 . . . . 0.0 110.367 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.489 HD21 ' HB3' ' B' ' 253' ' ' PRO . 87.5 mt -82.12 163.16 22.18 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.799 -175.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 51.8 t -91.74 108.69 20.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.818 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -81.64 105.19 12.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.761 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.453 HG23 ' HB ' ' A' ' 90' ' ' VAL . 4.8 m -86.72 -20.4 7.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -172.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.59 -151.0 22.58 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 119.622 -1.275 . . . . 0.0 113.181 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.401 HG23 ' HG2' ' A' ' 89' ' ' GLU . 4.7 m -137.5 145.84 43.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.656 0.265 . . . . 0.0 110.73 -174.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.2 pt -127.83 144.95 35.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 174.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -125.95 138.62 53.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.084 0.469 . . . . 0.0 111.797 -175.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.632 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 90.4 t -97.57 110.26 25.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.198 171.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.4 p -138.46 74.99 1.5 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.361 0.601 . . . . 0.0 109.65 175.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.65 166.54 22.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.307 -177.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.1 t -73.78 164.65 26.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.75 -177.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.06 5.24 6.7 Favored Glycine 0 CA--C 1.519 0.324 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.729 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.49 -5.27 55.75 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.927 174.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -108.35 -15.75 14.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.819 0.342 . . . . 0.0 110.81 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.578 HD12 ' HA ' ' A' ' 56' ' ' LEU . 45.1 mm -125.43 107.72 18.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.1 m -101.58 -42.01 6.38 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.015 -174.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.51 ' H ' ' HB3' ' A' ' 55' ' ' ASP . 80.5 p -138.94 169.46 12.45 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.288 -175.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.85 ' HG2' HD21 ' B' ' 235' ' ' LEU . 42.1 Cg_exo -58.54 -36.02 97.91 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.354 2.036 . . . . 0.0 111.639 174.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.573 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -64.76 -44.59 89.59 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.6 175.212 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.534 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 38.9 t0 -66.88 -30.66 70.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.312 0.577 . . . . 0.0 110.179 179.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.578 ' HA ' HD12 ' A' ' 50' ' ' ILE . 63.9 tp -63.5 -51.16 66.74 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.933 176.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.573 ' HG3' ' O ' ' A' ' 54' ' ' SER . 6.2 ppt_? -68.45 -25.71 65.14 Favored 'General case' 0 C--O 1.225 -0.202 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.452 -178.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.534 ' HB2' ' O ' ' A' ' 55' ' ' ASP . 6.0 mm-40 -51.77 -51.5 55.86 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.295 0.569 . . . . 0.0 110.698 174.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.499 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 12.4 mptt -65.03 -45.11 86.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.204 -176.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.457 HD21 HG23 ' A' ' 43' ' ' VAL . 86.7 mt -71.45 -36.03 71.1 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.517 -177.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.522 ' HA ' ' HB3' ' B' ' 222' ' ' ALA . 6.9 t -62.94 -44.16 96.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.254 0.55 . . . . 0.0 109.523 176.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -63.39 -40.7 97.93 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.699 177.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 59' ' ' LYS . 84.7 mt -66.68 -44.68 81.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.079 178.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.7 -47.48 85.49 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.856 0.36 . . . . 0.0 110.673 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -58.24 -40.57 82.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.277 178.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.03 -25.29 58.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.817 -177.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -83.77 -47.55 11.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.935 0.398 . . . . 0.0 111.238 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 125.6 34.93 0.63 Allowed Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.498 -175.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.454 ' HA2' ' OD1' ' A' ' 92' ' ' ASN . . . -134.13 161.34 24.37 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -108.3 -71.74 0.75 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.866 0.333 . . . . 0.0 111.409 -178.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.659 ' HB3' ' HA ' ' A' ' 24' ' ' GLN . 2.3 m-85 -93.22 157.23 16.37 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 -173.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.543 ' CD2' ' HB1' ' B' ' 222' ' ' ALA . 45.6 p90 -146.45 133.68 20.55 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.293 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -102.62 119.11 38.27 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.159 -178.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.514 ' H ' HD12 ' A' ' 74' ' ' ILE . 4.9 mp -77.04 124.53 35.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 30.3 pt -105.99 -21.71 5.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.925 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -152.61 135.92 15.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.696 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -149.03 111.4 4.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.163 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -149.86 173.63 13.56 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.918 0.389 . . . . 0.0 111.073 -176.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.84 148.76 26.3 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.242 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -100.92 -20.47 15.44 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.508 0.671 . . . . 0.0 109.212 175.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 143.06 -99.4 0.22 Allowed Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -176.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -74.28 -18.78 20.39 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.772 2.315 . . . . 0.0 111.232 171.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -116.47 159.64 21.75 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.623 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -115.74 138.31 51.24 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.632 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 42.1 mt-10 -123.98 117.4 24.66 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.209 0.528 . . . . 0.0 111.24 -176.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.546 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -129.03 139.46 52.05 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.629 178.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.7 t -118.77 119.44 61.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.128 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.42 ' HB1' ' HD1' ' A' ' 72' ' ' TYR . . . -135.78 138.82 43.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.782 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.401 ' HG2' HG23 ' A' ' 40' ' ' THR . 3.2 mt-10 -104.0 139.53 39.0 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.453 ' HB ' HG23 ' A' ' 38' ' ' VAL . 8.5 t -97.5 134.83 34.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.144 -170.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -130.4 139.08 50.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.28 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.454 ' OD1' ' HA2' ' A' ' 69' ' ' GLY . 78.9 m-20 -101.37 -178.99 3.9 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.161 173.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.721 174.635 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 222' ' ' ALA . . . . . 0.543 ' HB1' ' CD2' ' A' ' 72' ' ' TYR . . . . . . . . 0 N--CA 1.451 -0.425 0 CA-C-O 121.804 0.812 . . . . 0.0 108.813 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 223' ' ' GLU . . . . . 0.515 ' HG3' ' HD3' ' A' ' 57' ' ' ARG . 4.4 mp0 -124.37 96.55 4.95 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.389 -166.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 224' ' ' GLN . . . . . 0.653 ' HB3' ' HG3' ' A' ' 24' ' ' GLN . 0.6 OUTLIER -173.02 148.65 1.76 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.246 -178.557 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . 0.502 HG21 ' CD1' ' B' ' 235' ' ' LEU . 16.6 m -128.7 137.34 57.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.046 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . 0.538 ' HA ' ' CD2' ' B' ' 273' ' ' HIS . 8.7 t -96.24 176.78 5.94 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 120.976 0.417 . . . . 0.0 110.301 -178.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -65.31 -28.93 69.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.437 -173.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.18 -50.32 68.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.043 0.449 . . . . 0.0 110.283 -178.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -65.44 -42.72 92.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.459 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.535 HG12 HD12 ' B' ' 235' ' ' LEU . 88.5 mt -63.34 -34.36 66.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.965 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 31.4 t -69.57 -21.24 63.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.0 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 29.2 t-80 -98.17 -45.73 6.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.836 0.351 . . . . 0.0 110.921 -177.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -86.2 -20.95 27.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.835 -176.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm 59.57 80.76 0.19 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.351 0.596 . . . . 0.0 111.612 -177.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . 0.85 HD21 ' HG2' ' A' ' 53' ' ' PRO . 40.9 mt -83.24 -168.92 2.28 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.754 178.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 59.0 t -109.82 109.21 27.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.088 0.471 . . . . 0.0 111.089 -178.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 237' ' ' LYS . . . . . 0.567 ' HE3' ' HB3' ' B' ' 289' ' ' GLU . 23.1 tptm -73.97 112.67 10.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.789 175.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 3.8 m -100.05 -4.41 9.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -175.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 136.07 -171.82 22.62 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 119.979 -1.105 . . . . 0.0 112.999 176.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . 0.559 HG23 ' HG2' ' B' ' 289' ' ' GLU . 29.8 m -128.63 134.26 48.51 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -178.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 32.8 pt -107.86 137.62 38.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.945 0.402 . . . . 0.0 110.386 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -111.58 115.12 28.63 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.839 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 243' ' ' VAL . . . . . 0.526 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 34.9 t -94.05 109.35 21.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.108 -178.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 23.1 t -110.06 98.36 7.65 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 245' ' ' GLN . . . . . 0.637 ' O ' ' HA ' ' B' ' 283' ' ' ASN . 0.7 OUTLIER -87.89 148.39 24.64 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.946 -177.892 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 51.1 m -126.32 107.04 9.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.209 0.528 . . . . 0.0 111.056 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 101.05 -141.38 15.32 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.322 177.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -107.85 42.29 1.98 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.329 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -63.51 -46.44 86.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.752 0.311 . . . . 0.0 110.365 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 250' ' ' ILE . . . . . 0.588 HG12 ' HG2' ' B' ' 245' ' ' GLN . 47.2 mm -77.56 99.89 2.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.392 0.615 . . . . 0.0 109.585 177.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 5.7 m -100.68 -26.01 13.95 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.691 -174.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 1.9 m -136.52 162.36 56.65 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -177.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . 0.776 ' HG3' ' HB3' ' A' ' 33' ' ' PHE . 48.0 Cg_exo -56.06 -36.38 96.08 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.241 1.961 . . . . 0.0 111.537 175.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 254' ' ' SER . . . . . . . . . . . . . 4.3 m -69.25 -24.26 63.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.653 -178.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.17 -34.93 74.27 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.013 0.435 . . . . 0.0 111.523 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.471 ' O ' ' HG ' ' B' ' 260' ' ' LEU . 22.3 tp -65.11 -38.52 90.96 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.749 -177.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 257' ' ' ARG . . . . . 0.438 HH21 ' CD ' ' B' ' 258' ' ' GLU . 2.9 ttp85 -63.83 -35.82 81.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.996 0.427 . . . . 0.0 110.424 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 258' ' ' GLU . . . . . 0.438 ' CD ' HH21 ' B' ' 257' ' ' ARG . 17.0 mm-40 -62.27 -43.06 99.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.249 -178.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -71.79 -34.74 69.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.041 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 260' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' B' ' 256' ' ' LEU . 95.2 mt -69.18 -46.2 68.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.003 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 24.2 p -65.47 -34.75 79.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.802 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -54.18 -51.11 65.39 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.247 0.546 . . . . 0.0 110.439 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 263' ' ' LEU . . . . . 0.483 ' O ' ' HG2' ' B' ' 267' ' ' LYS . 98.2 mt -71.79 -41.69 68.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.172 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -63.84 -32.12 73.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.822 0.344 . . . . 0.0 111.486 -178.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -71.9 -44.27 64.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.814 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -67.0 -30.82 71.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.265 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 267' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' B' ' 263' ' ' LEU . 74.3 mmtt -79.52 -55.82 4.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.002 0.43 . . . . 0.0 110.095 176.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 114.64 48.08 0.56 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.252 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -97.95 -169.63 32.3 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.478 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . 0.47 ' HB2' ' HA ' ' B' ' 292' ' ' ASN . 4.4 tptp -131.53 -29.9 1.72 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.709 0.29 . . . . 0.0 110.882 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 271' ' ' TYR . . . . . 0.437 ' HB3' ' HA ' ' B' ' 224' ' ' GLN . 6.4 m-85 -147.95 173.53 12.78 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 177.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 272' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.65 167.18 22.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.766 0.317 . . . . 0.0 110.796 174.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 273' ' ' HIS . . . . . 0.538 ' CD2' ' HA ' ' B' ' 226' ' ' SER . 19.5 t-80 -148.04 103.5 3.48 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.184 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 274' ' ' ILE . . . . . 0.519 HG13 ' HB2' ' B' ' 288' ' ' ALA . 4.2 mp -70.25 135.23 28.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 31.2 pt -113.99 -28.87 2.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.699 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -157.7 146.97 19.8 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.645 0.259 . . . . 0.0 110.956 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -156.37 139.26 15.29 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 278' ' ' ARG . . . . . 0.435 ' N ' ' HD2' ' B' ' 278' ' ' ARG . 0.0 OUTLIER -155.92 136.39 13.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.969 0.414 . . . . 0.0 111.214 -179.157 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -88.72 102.64 15.18 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 171.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -114.84 103.72 11.23 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 73.6 -134.49 19.24 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.667 -176.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -82.95 -9.16 10.86 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.589 2.193 . . . . 0.0 111.877 176.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 283' ' ' ASN . . . . . 0.637 ' HA ' ' O ' ' B' ' 245' ' ' GLN . 93.4 m-20 -101.37 113.48 26.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.463 -175.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -87.4 107.47 18.55 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 170.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 285' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -100.8 113.67 26.78 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.06 -175.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 286' ' ' ALA . . . . . 0.526 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -117.94 124.24 47.76 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.49 178.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 24.5 t -106.27 112.81 41.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.159 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 288' ' ' ALA . . . . . 0.519 ' HB2' HG13 ' B' ' 274' ' ' ILE . . . -125.63 132.54 52.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.274 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 289' ' ' GLU . . . . . 0.567 ' HB3' ' HE3' ' B' ' 237' ' ' LYS . 18.1 mt-10 -94.83 138.88 32.05 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 21.9 t -103.64 138.93 26.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.972 0.415 . . . . 0.0 110.408 -174.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -128.15 152.18 48.34 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.336 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 292' ' ' ASN . . . . . 0.47 ' HA ' ' HB2' ' B' ' 270' ' ' LYS . 12.2 t-20 -120.01 163.4 17.68 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 174.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 16.1 t70 . . . . . 0 C--N 1.326 -0.42 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -176.875 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.379 0 CA-C-O 120.508 0.194 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.437 ' HA ' ' OH ' ' B' ' 272' ' ' TYR . 0.5 OUTLIER -161.23 121.98 2.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.051 0.453 . . . . 0.0 111.84 -178.812 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 1.05 ' HG3' ' HG3' ' B' ' 224' ' ' GLN . 6.4 tm0? -150.35 144.34 25.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.777 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.2 m -126.78 152.27 34.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 172.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.627 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 6.9 m -108.38 -79.77 0.58 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.074 0.464 . . . . 0.0 110.746 -178.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -165.68 -48.25 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -176.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.422 ' HG3' ' CD ' ' A' ' 29' ' ' GLU . 5.2 pt20 -56.95 -36.44 70.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.058 176.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.422 ' CD ' ' HG3' ' A' ' 28' ' ' GLN . 25.6 mp0 -72.73 -40.1 66.37 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.563 HG23 ' HB2' ' A' ' 35' ' ' LEU . 87.8 mt -61.72 -48.58 88.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.247 -178.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.4 m -68.44 -21.37 64.65 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.259 -177.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -92.97 -43.57 8.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.529 -176.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.545 ' HB3' ' HD3' ' B' ' 253' ' ' PRO . 82.9 m-85 -98.61 -2.91 37.38 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -175.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.7 mptt 65.06 90.1 0.09 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.394 0.616 . . . . 0.0 111.894 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.563 ' HB2' HG23 ' A' ' 30' ' ' ILE . 97.2 mt -121.54 147.86 45.24 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.804 176.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.3 t -103.38 125.09 57.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.912 0.387 . . . . 0.0 111.399 -174.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -69.67 111.57 5.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.092 173.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.1 m -94.8 -8.29 9.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.874 -177.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.34 -160.2 29.36 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.179 -1.01 . . . . 0.0 112.785 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 64.6 m -145.15 135.94 24.56 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 122.596 0.358 . . . . 0.0 110.247 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.7 pt -104.68 143.28 16.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 176.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -122.88 123.51 41.15 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.013 0.435 . . . . 0.0 111.346 -175.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.687 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 67.4 t -97.26 130.72 45.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.294 174.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.9 t -157.68 40.97 0.29 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.5 ' NE2' HG13 ' A' ' 43' ' ' VAL . 0.9 OUTLIER -81.57 158.32 24.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.646 -172.119 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.462 ' HA ' HD22 ' A' ' 83' ' ' ASN . 10.8 t -99.7 87.12 3.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.932 -172.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.61 -84.19 0.55 Allowed Glycine 0 C--O 1.224 -0.524 0 N-CA-C 114.582 0.593 . . . . 0.0 114.582 170.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -49.94 -42.35 38.43 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 114.923 0.729 . . . . 0.0 114.923 -168.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.438 ' OE1' ' HG2' ' A' ' 45' ' ' GLN . 63.8 mt-30 -71.03 -18.03 62.6 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -174.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.7 mm -129.43 123.93 58.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.62 0.248 . . . . 0.0 110.79 -175.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.7 t -140.25 -51.47 0.49 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.017 0.437 . . . . 0.0 110.814 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.547 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 46.4 m -128.41 172.63 6.64 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 178.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.794 ' HD3' ' HB3' ' B' ' 233' ' ' PHE . 59.3 Cg_exo -51.7 -34.96 55.98 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.49 2.126 . . . . 0.0 111.97 178.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.55 ' O ' ' HG3' ' A' ' 58' ' ' GLU . 16.7 p -58.34 -56.72 18.42 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.072 179.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -58.7 -37.67 76.6 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.876 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 61.9 tp -64.12 -52.55 58.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.121 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.427 ' HG3' ' O ' ' A' ' 53' ' ' PRO . 7.4 ppt_? -69.85 -25.91 63.96 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.501 -177.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.55 ' HG3' ' O ' ' A' ' 54' ' ' SER . 38.8 mt-10 -62.61 -40.84 98.21 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 120.835 0.35 . . . . 0.0 110.24 173.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -74.31 -38.52 63.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.611 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.6 mt -64.5 -48.88 73.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.707 -177.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.487 ' HB2' ' HG2' ' B' ' 223' ' ' GLU . 17.0 t -65.92 -35.55 80.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.858 0.361 . . . . 0.0 110.483 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -60.74 -42.12 96.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.15 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 93.4 mt -75.02 -32.71 61.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.293 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.57 -41.7 68.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.281 -178.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -58.93 -41.72 88.02 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 176.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.75 -4.99 30.8 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.855 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -104.71 -9.36 18.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.191 0.52 . . . . 0.0 110.178 174.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.54 26.12 72.49 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.312 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -112.53 146.65 18.26 Favored Glycine 0 C--O 1.225 -0.447 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.764 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -97.19 -14.17 21.61 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -172.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.16 144.12 32.07 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -176.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.519 ' CD2' ' HB1' ' B' ' 222' ' ' ALA . 15.5 p90 -129.91 157.51 42.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.82 0.343 . . . . 0.0 110.13 172.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.627 ' CD2' ' HA ' ' A' ' 26' ' ' SER . 8.1 t-160 -128.74 109.34 11.22 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.868 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.598 HG12 ' HB2' ' A' ' 88' ' ' ALA . 57.6 mt -75.95 116.68 19.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.314 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.4 pt -107.15 -15.54 8.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.803 -176.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -153.25 142.5 21.51 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.616 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 85' ' ' GLU . . . -162.77 139.35 7.52 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.9 152.12 22.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.753 0.311 . . . . 0.0 110.701 178.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -89.9 107.54 19.17 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 171.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -112.51 84.91 2.06 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.092 0.473 . . . . 0.0 110.301 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.18 -123.29 20.74 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.264 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -84.28 -3.57 10.2 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.845 2.363 . . . . 0.0 112.864 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.462 HD22 ' HA ' ' A' ' 46' ' ' SER . 10.7 m120 -119.26 128.9 54.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.748 0.309 . . . . 0.0 110.611 -176.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -93.14 123.46 36.42 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 173.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.687 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 43.1 mt-10 -108.5 129.07 55.29 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.879 0.371 . . . . 0.0 111.066 -176.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.519 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -138.28 132.58 31.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.231 177.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.3 t -114.21 112.87 41.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.012 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.598 ' HB2' HG12 ' A' ' 74' ' ' ILE . . . -128.04 129.09 46.12 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.724 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 40' ' ' THR . 26.5 mt-10 -91.88 139.15 30.95 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.6 t -100.39 136.76 30.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -176.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -124.19 150.88 44.7 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.291 0.567 . . . . 0.0 111.127 -177.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -130.33 158.64 39.25 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.464 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 120.766 0.317 . . . . 0.0 110.317 178.717 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 222' ' ' ALA . . . . . 0.519 ' HB1' ' CD2' ' A' ' 72' ' ' TYR . . . . . . . . 0 C--O 1.231 0.117 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 223' ' ' GLU . . . . . 0.935 ' HB3' ' HE2' ' B' ' 271' ' ' TYR . 28.2 mt-10 -144.42 124.36 13.52 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.737 173.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 224' ' ' GLN . . . . . 1.05 ' HG3' ' HG3' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -153.69 146.42 24.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.867 -172.813 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . 0.527 ' HB ' HD11 ' B' ' 235' ' ' LEU . 11.6 m -116.26 126.56 73.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 170.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . 0.429 ' O ' HG13 ' B' ' 230' ' ' ILE . 6.7 t -95.99 -167.33 1.57 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.374 0.607 . . . . 0.0 111.523 -173.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . 0.465 ' HA ' HD12 ' B' ' 230' ' ' ILE . 2.2 tmtp? -75.67 -28.91 58.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.831 -172.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -72.86 -43.73 62.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.088 0.47 . . . . 0.0 110.539 -177.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -61.8 -26.94 68.41 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.459 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.504 HG12 HD12 ' B' ' 235' ' ' LEU . 69.9 mt -57.83 -57.23 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.096 0.474 . . . . 0.0 110.253 176.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 11.2 m -73.69 -50.61 20.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.05 -177.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -76.24 -38.59 56.11 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -170.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 233' ' ' PHE . . . . . 0.794 ' HB3' ' HD3' ' A' ' 53' ' ' PRO . 37.7 m-85 -102.71 -5.8 23.35 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -173.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt 67.01 92.01 0.08 Allowed 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.853 0.721 . . . . 0.0 110.996 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . 0.527 HD11 ' HB ' ' B' ' 225' ' ' VAL . 28.1 mt -97.23 141.06 30.8 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.023 178.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 21.7 t -66.64 -50.14 68.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.237 -178.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 237' ' ' LYS . . . . . 0.526 ' HA ' ' HA ' ' B' ' 291' ' ' TYR . 50.7 tttm 65.78 120.39 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.901 -175.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 38.1 t -91.14 -46.62 14.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.43 -177.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.73 -152.03 16.57 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.871 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 21.3 m -127.62 140.09 52.32 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 241' ' ' ILE . . . . . 0.434 HG23 HG21 ' B' ' 290' ' ' VAL . 19.2 pt -113.08 141.88 27.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.887 0.375 . . . . 0.0 110.683 176.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -120.21 126.54 50.88 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.835 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 243' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' B' ' 285' ' ' GLU . 88.1 t -94.02 132.25 38.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.061 175.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 11.0 p -152.93 64.3 0.78 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.442 0.639 . . . . 0.0 110.776 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 245' ' ' GLN . . . . . 0.402 HE22 HG13 ' B' ' 243' ' ' VAL . 0.9 OUTLIER -97.95 143.85 28.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.295 -179.698 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 6.2 t -86.62 36.84 0.72 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.357 0.598 . . . . 0.0 110.412 -174.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 88.0 167.94 43.89 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.227 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . 82.35 -49.35 4.13 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.821 176.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -71.26 -18.49 62.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.839 0.352 . . . . 0.0 111.201 -178.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 250' ' ' ILE . . . . . 0.481 ' HA ' ' HB3' ' B' ' 255' ' ' ASP . 40.8 mm -126.61 107.59 17.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 34.7 t -135.52 3.5 3.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.601 0.239 . . . . 0.0 111.129 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 252' ' ' SER . . . . . 0.525 ' HB2' ' HD2' ' B' ' 253' ' ' PRO . 95.7 p -158.38 167.21 14.89 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -178.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . 0.545 ' HD3' ' HB3' ' A' ' 33' ' ' PHE . 15.9 Cg_endo -59.14 -37.8 90.13 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.261 1.974 . . . . 0.0 111.019 173.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 254' ' ' SER . . . . . 0.573 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 15.3 m -60.75 -46.13 91.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.682 176.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 255' ' ' ASP . . . . . 0.481 ' HB3' ' HA ' ' B' ' 250' ' ' ILE . 24.9 m-20 -55.12 -50.11 70.07 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.663 0.268 . . . . 0.0 110.786 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.483 ' O ' ' HG ' ' B' ' 260' ' ' LEU . 57.0 tp -60.01 -45.94 91.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.068 178.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -57.27 -48.24 79.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.962 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 258' ' ' GLU . . . . . 0.573 ' HG2' ' O ' ' B' ' 254' ' ' SER . 43.8 mm-40 -58.13 -39.49 78.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.475 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 259' ' ' LYS . . . . . 0.436 ' HD3' ' O ' ' B' ' 255' ' ' ASP . 13.5 mptt -77.28 -35.48 55.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.395 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 260' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' B' ' 256' ' ' LEU . 87.7 mt -64.97 -47.41 77.68 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.501 0.191 . . . . 0.0 110.965 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 6.1 m -61.85 -30.79 71.09 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.205 0.526 . . . . 0.0 110.274 177.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -70.07 -52.76 21.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.753 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 263' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' B' ' 259' ' ' LYS . 88.0 mt -64.08 -36.9 85.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.263 -176.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -66.24 -38.3 87.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.279 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -72.38 -36.7 68.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.439 -177.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -63.27 -30.2 71.39 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.806 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -72.2 -32.9 67.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.352 175.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 117.46 -3.59 17.98 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.234 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -99.44 -153.59 27.86 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.594 -177.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm -150.53 -60.17 0.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.771 0.32 . . . . 0.0 111.049 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 271' ' ' TYR . . . . . 0.935 ' HE2' ' HB3' ' B' ' 223' ' ' GLU . 62.1 m-85 -90.41 148.1 23.01 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -172.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 272' ' ' TYR . . . . . 0.437 ' OH ' ' HA ' ' A' ' 23' ' ' GLU . 10.0 p90 -147.08 167.59 23.69 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.906 0.384 . . . . 0.0 111.423 -174.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 273' ' ' HIS . . . . . 0.522 ' HA ' ' OE1' ' A' ' 24' ' ' GLN . 0.6 OUTLIER -139.47 113.35 8.65 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.878 177.529 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 274' ' ' ILE . . . . . 0.438 ' H ' HD12 ' B' ' 274' ' ' ILE . 4.4 mp -70.67 121.63 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 178.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 30.1 pt -102.43 -24.53 4.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.526 -178.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -153.85 140.73 19.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.863 -178.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -144.79 123.51 12.58 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.779 177.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 278' ' ' ARG . . . . . 0.411 ' HE ' ' CD ' ' B' ' 285' ' ' GLU . 6.1 ptt180 -129.2 134.5 48.03 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.084 0.468 . . . . 0.0 110.691 -178.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -99.21 89.89 4.39 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 173.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -92.77 85.42 5.21 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.058 -173.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 62.08 -116.1 8.89 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.725 176.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.49 -16.57 21.54 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.716 2.277 . . . . 0.0 112.808 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 -105.99 162.89 13.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.176 0.512 . . . . 0.0 110.952 -175.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -132.12 104.7 6.94 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 171.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 285' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 21.4 mp0 -107.13 134.08 50.78 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.063 0.459 . . . . 0.0 110.843 -176.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 286' ' ' ALA . . . . . 0.416 ' H ' ' HB ' ' B' ' 243' ' ' VAL . . . -137.19 147.08 45.63 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.585 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 32.8 t -123.25 122.53 65.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.947 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -131.84 143.62 50.31 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.937 0.399 . . . . 0.0 111.069 -178.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -91.56 123.94 35.35 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.824 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 290' ' ' VAL . . . . . 0.434 HG21 HG23 ' B' ' 241' ' ' ILE . 53.5 t -94.34 129.36 44.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.884 0.373 . . . . 0.0 110.851 -177.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 291' ' ' TYR . . . . . 0.526 ' HA ' ' HA ' ' B' ' 237' ' ' LYS . 64.0 m-85 -121.79 171.06 9.16 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.058 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 292' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -123.09 157.47 32.79 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 174.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 36.7 t70 . . . . . 0 C--N 1.32 -0.691 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.625 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.771 ' HA ' ' HG3' ' B' ' 223' ' ' GLU . . . . . . . . 0 N--CA 1.453 -0.275 0 CA-C-O 120.446 0.165 . . . . 0.0 110.97 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.559 ' HG3' ' HB2' ' B' ' 257' ' ' ARG . 17.0 tt0 80.9 104.97 0.07 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 124.37 1.043 . . . . 0.0 110.358 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.519 ' HA ' ' HB3' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -162.18 154.11 18.87 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.39 -174.333 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.433 HG22 ' HB2' ' A' ' 71' ' ' TYR . 27.1 m -106.79 139.27 28.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.854 0.359 . . . . 0.0 110.877 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.691 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 7.4 t -93.98 -86.11 0.28 Allowed 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.328 -175.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -157.97 -49.15 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.225 -176.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -58.56 -40.42 83.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.067 0.461 . . . . 0.0 110.53 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.406 ' H ' ' CD ' ' A' ' 29' ' ' GLU . 1.2 mp0 -64.87 -37.89 89.13 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.664 178.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.564 HG12 HD12 ' A' ' 35' ' ' LEU . 58.5 mt -66.72 -39.46 83.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.442 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.9 m -68.81 -35.03 76.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.086 0.47 . . . . 0.0 110.86 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -85.87 -45.17 11.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.416 -174.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -92.24 -19.38 22.26 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -175.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.439 ' NZ ' ' HB2' ' A' ' 34' ' ' LYS . 0.2 OUTLIER 65.83 85.18 0.14 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.127 0.489 . . . . 0.0 111.388 -177.614 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.564 HD12 HG12 ' A' ' 30' ' ' ILE . 67.7 mt -94.35 175.67 6.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.676 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.7 t -105.97 123.6 60.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.33 -175.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.8 tttp -81.4 112.35 18.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.191 176.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.42 HG23 ' HB ' ' A' ' 90' ' ' VAL . 21.2 m -107.48 22.4 3.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -173.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 120.9 -164.8 14.11 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.306 -0.949 . . . . 0.0 112.897 174.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.617 HG23 ' HG2' ' A' ' 89' ' ' GLU . 12.9 m -140.06 134.69 31.71 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 -176.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.7 pt -107.21 151.05 9.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 174.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -125.52 123.04 38.27 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.033 0.444 . . . . 0.0 111.628 -174.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.611 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 73.0 t -99.1 117.68 44.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.348 172.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 63.5 p -145.98 72.81 1.31 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.245 0.545 . . . . 0.0 109.718 176.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.429 HE22 HG13 ' A' ' 43' ' ' VAL . 0.7 OUTLIER -100.5 148.77 24.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.03 -176.706 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.454 ' HA ' HD22 ' A' ' 83' ' ' ASN . 17.4 m -86.4 56.64 4.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.594 -176.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.82 -71.05 2.79 Favored Glycine 0 C--O 1.227 -0.337 0 C-N-CA 121.261 -0.495 . . . . 0.0 114.129 173.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -54.01 -28.71 41.65 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 115.164 0.825 . . . . 0.0 115.164 -169.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -78.61 -14.57 59.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.59 0.695 . . . . 0.0 111.606 -177.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.0 mm -120.32 107.53 21.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.163 0.506 . . . . 0.0 110.185 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.2 m -114.52 -45.13 3.03 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.576 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 87.7 p -124.78 164.28 32.01 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.739 177.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.783 ' HB2' ' HB2' ' B' ' 293' ' ' ASP . 24.2 Cg_exo -64.34 -20.19 66.27 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.28 1.986 . . . . 0.0 111.644 174.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.506 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 75.2 m -69.06 -42.75 75.85 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.084 173.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -62.87 -39.11 93.41 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.217 0.532 . . . . 0.0 109.717 176.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 61.7 tp -60.36 -41.36 93.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.964 176.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.461 ' HD2' ' OE1' ' B' ' 223' ' ' GLU . 9.5 ttp85 -61.3 -43.86 98.18 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.552 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 54' ' ' SER . 22.9 mm-40 -53.49 -50.78 64.63 Favored 'General case' 0 C--N 1.332 -0.165 0 O-C-N 123.51 0.506 . . . . 0.0 110.616 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.503 ' HA ' ' HG2' ' A' ' 62' ' ' GLU . 4.3 mptp? -67.44 -41.62 84.45 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.573 -178.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 85.0 mt -63.34 -34.16 77.1 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.005 0.431 . . . . 0.0 110.482 177.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.6 t -70.6 -52.46 21.33 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.724 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.503 ' HG2' ' HA ' ' A' ' 59' ' ' LYS . 13.0 pt-20 -65.26 -31.46 72.63 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -175.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 82.9 mt -66.98 -47.07 72.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.84 0.353 . . . . 0.0 111.172 177.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.532 ' O ' ' HG3' ' A' ' 67' ' ' LYS . . . -74.01 -43.9 56.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.608 -177.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -59.57 -51.52 69.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.548 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.9 -18.97 64.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.038 -176.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.532 ' HG3' ' O ' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -91.19 -13.92 32.0 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.439 -179.285 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.64 44.35 4.91 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.212 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -130.07 151.76 19.49 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.097 -0.573 . . . . 0.0 111.813 177.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.459 ' O ' ' HB2' ' B' ' 222' ' ' ALA . 17.7 mmtp -88.4 -72.78 0.52 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.86 0.362 . . . . 0.0 111.543 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.519 ' HB3' ' HA ' ' A' ' 24' ' ' GLN . 0.4 OUTLIER -108.19 169.82 8.39 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -173.128 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -140.68 167.51 22.0 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.691 ' CD2' ' HA ' ' A' ' 26' ' ' SER . 4.8 t-80 -139.08 110.59 7.04 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.753 174.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 59.8 mt -65.89 113.93 2.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.804 176.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 31.8 pt -97.73 -26.31 3.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.966 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -156.21 131.69 9.5 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.328 178.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -135.65 98.81 4.02 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -125.32 165.69 17.9 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.513 -173.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -109.69 129.33 55.61 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.963 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -100.5 18.39 19.21 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.335 0.588 . . . . 0.0 109.647 -178.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 110.25 -98.93 1.13 Allowed Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.463 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.83 -13.86 11.49 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.522 2.148 . . . . 0.0 112.103 176.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.454 HD22 ' HA ' ' A' ' 46' ' ' SER . 13.5 m120 -114.34 139.26 49.61 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.019 -176.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -99.83 115.8 30.42 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 172.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 50.5 mt-10 -107.18 111.14 23.42 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.946 0.403 . . . . 0.0 110.73 -175.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.611 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -120.38 117.34 27.49 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.258 177.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.5 t -98.61 112.97 32.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.034 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -126.46 123.89 38.88 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.017 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.617 ' HG2' HG23 ' A' ' 40' ' ' THR . 10.4 mt-10 -93.46 143.99 25.77 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.42 ' HB ' HG23 ' A' ' 38' ' ' VAL . 10.6 t -96.6 130.43 45.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.894 0.378 . . . . 0.0 110.356 -171.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -125.61 133.88 52.09 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.821 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -107.48 161.44 14.83 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.2 t70 . . . . . 0 C--O 1.238 0.476 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -179.37 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 222' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 70' ' ' LYS . . . . . . . . 0 N--CA 1.453 -0.324 0 N-CA-C 110.243 -0.281 . . . . 0.0 110.243 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 223' ' ' GLU . . . . . 0.771 ' HG3' ' HA ' ' A' ' 22' ' ' ALA . 0.9 OUTLIER -170.36 124.7 0.72 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -176.212 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 224' ' ' GLN . . . . . 0.48 ' HA ' ' HB3' ' B' ' 271' ' ' TYR . 0.0 OUTLIER -171.48 149.26 2.65 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.325 177.463 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 29.0 m -114.77 151.42 16.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.513 176.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . 0.623 ' HA ' ' CD2' ' B' ' 273' ' ' HIS . 57.5 p -113.59 -96.21 0.45 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -136.05 -36.05 0.76 Allowed 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 228' ' ' GLN . . . . . 0.402 ' HB2' ' OE2' ' B' ' 229' ' ' GLU . 0.7 OUTLIER -58.61 -43.1 89.5 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.443 0.639 . . . . 0.0 109.98 -178.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 229' ' ' GLU . . . . . 0.537 ' H ' ' CD ' ' B' ' 229' ' ' GLU . 3.2 mp0 -58.72 -45.22 90.08 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.448 177.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.542 HG12 HD12 ' B' ' 235' ' ' LEU . 55.7 mt -63.44 -39.3 84.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.528 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 15.2 m -69.82 -23.13 63.26 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.086 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -93.5 -57.6 2.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.602 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -90.05 -14.38 33.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.157 -170.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt 59.07 82.78 0.14 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.252 0.549 . . . . 0.0 110.082 -175.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . 0.573 HD22 ' HA ' ' B' ' 293' ' ' ASP . 55.1 mt -80.32 178.8 8.04 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.477 -171.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.574 ' HB ' ' HB2' ' B' ' 292' ' ' ASN . 40.8 t -103.61 109.35 26.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.135 -0.938 . . . . 0.0 110.288 -178.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -76.33 125.75 29.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.711 -176.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 238' ' ' VAL . . . . . 0.69 HG12 ' HD2' ' B' ' 267' ' ' LYS . 4.1 t -100.73 -17.53 6.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-O 121.334 0.588 . . . . 0.0 110.847 -176.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 115.81 162.64 13.38 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.391 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.04 145.07 31.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.046 0.45 . . . . 0.0 111.505 -177.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 32.2 pt -126.87 132.04 70.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 169.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -117.45 132.39 56.57 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.993 0.901 . . . . 0.0 111.477 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 243' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 66.5 t -93.99 131.0 42.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 114.528 -1.214 . . . . 0.0 109.999 -177.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 15.4 t -148.06 95.74 2.53 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 176.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 245' ' ' GLN . . . . . 0.424 HE21 ' HB2' ' B' ' 245' ' ' GLN . 0.0 OUTLIER -136.91 152.37 50.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.124 176.627 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 246' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' B' ' 283' ' ' ASN . 15.3 m -76.94 162.72 27.36 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.012 -178.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -58.72 106.11 0.8 Allowed Glycine 0 C--N 1.331 0.275 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.916 176.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . 151.92 -50.41 0.52 Allowed Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -174.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -78.13 -28.99 48.59 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 173.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 42.8 mm -121.27 123.43 69.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.675 171.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 22.2 t -149.88 -38.72 0.14 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.95 0.405 . . . . 0.0 110.379 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 252' ' ' SER . . . . . 0.441 ' HB3' ' HD2' ' B' ' 253' ' ' PRO . 16.5 m -113.16 161.53 26.47 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.152 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' B' ' 252' ' ' SER . 13.7 Cg_endo -57.78 -20.89 45.48 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.675 2.25 . . . . 0.0 112.189 177.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 254' ' ' SER . . . . . 0.625 ' HA ' ' NH1' ' B' ' 257' ' ' ARG . 22.6 t -65.94 -51.08 61.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.522 177.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 255' ' ' ASP . . . . . 0.461 ' O ' ' HG2' ' B' ' 259' ' ' LYS . 9.3 m-20 -54.47 -45.4 73.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.383 -173.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 49.3 tp -60.3 -60.61 3.54 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.234 -174.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 257' ' ' ARG . . . . . 0.625 ' NH1' ' HA ' ' B' ' 254' ' ' SER . 0.0 OUTLIER -68.03 -25.92 65.62 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -174.636 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 258' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' B' ' 254' ' ' SER . 53.8 mt-10 -70.18 -32.19 70.0 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.398 179.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 259' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' B' ' 255' ' ' ASP . 74.8 mmtt -73.03 -44.21 61.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.986 0.422 . . . . 0.0 109.965 174.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.32 -48.26 82.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.612 -177.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 41.0 m -60.88 -35.34 76.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.677 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -68.37 -41.76 80.15 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.008 0.432 . . . . 0.0 110.529 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 263' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' B' ' 259' ' ' LYS . 98.1 mt -67.46 -44.18 79.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.008 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -61.44 -41.99 98.06 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.158 177.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -54.03 -53.87 47.0 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.306 176.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -64.01 -31.18 72.28 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.048 0.451 . . . . 0.0 111.02 -177.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 267' ' ' LYS . . . . . 0.69 ' HD2' HG12 ' B' ' 238' ' ' VAL . 32.7 mmtt -62.5 -38.7 90.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.21 176.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 94.9 15.33 45.98 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -170.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . 0.492 ' HA2' ' ND2' ' B' ' 292' ' ' ASN . . . -106.87 146.76 16.1 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . 0.543 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 54.8 mtpt -79.66 -68.28 0.68 Allowed 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 121.133 -0.227 . . . . 0.0 111.415 -176.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 271' ' ' TYR . . . . . 0.593 ' HA ' ' HB2' ' A' ' 22' ' ' ALA . 9.9 m-85 -97.93 154.41 17.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.101 0.477 . . . . 0.0 110.631 -173.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 272' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -122.62 136.42 54.88 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 175.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 273' ' ' HIS . . . . . 0.623 ' CD2' ' HA ' ' B' ' 226' ' ' SER . 12.3 t-80 -110.98 101.79 10.32 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.667 0.27 . . . . 0.0 110.745 -176.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 274' ' ' ILE . . . . . . . . . . . . . 68.5 mt -70.16 122.12 21.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 176.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 61.5 mt -97.85 -52.65 8.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.152 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -140.73 147.52 39.31 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.968 -177.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -144.53 138.68 27.7 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -152.38 151.41 30.79 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.038 0.447 . . . . 0.0 110.811 -176.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -97.25 120.24 37.25 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 175.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -129.95 107.54 9.44 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.006 0.432 . . . . 0.0 110.813 -174.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 66.82 -127.62 28.29 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.787 -178.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -92.21 3.54 3.84 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.767 2.311 . . . . 0.0 112.472 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 283' ' ' ASN . . . . . 0.419 ' HA ' ' HA ' ' B' ' 246' ' ' SER . 81.0 m-20 -118.58 149.86 40.63 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.129 0.49 . . . . 0.0 111.415 -174.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -99.9 123.3 44.0 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.515 173.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 285' ' ' GLU . . . . . 0.453 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 21.1 mm-40 -107.75 121.21 44.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.457 -176.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 286' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -128.75 134.48 48.43 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 121.106 -0.238 . . . . 0.0 110.827 176.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 65.0 t -116.52 117.53 55.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.832 0.349 . . . . 0.0 110.386 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -133.28 142.99 48.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.467 -178.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -99.26 131.43 45.29 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.982 175.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 290' ' ' VAL . . . . . 0.582 ' HB ' ' HB ' ' B' ' 238' ' ' VAL . 32.7 t -90.09 133.81 30.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 176.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 291' ' ' TYR . . . . . 0.415 ' HA ' HG23 ' B' ' 238' ' ' VAL . 73.9 m-85 -132.58 134.12 44.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.993 0.425 . . . . 0.0 111.354 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 292' ' ' ASN . . . . . 0.574 ' HB2' ' HB ' ' B' ' 236' ' ' VAL . 23.2 m120 -90.73 123.71 34.53 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 165.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 293' ' ' ASP . . . . . 0.783 ' HB2' ' HB2' ' A' ' 53' ' ' PRO . 5.3 p-10 . . . . . 0 C--N 1.318 -0.79 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.432 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.448 ' HB3' ' HE1' ' A' ' 71' ' ' TYR . 30.9 mt-10 -144.43 -158.8 0.92 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.691 -175.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.647 ' HA ' ' CD1' ' A' ' 71' ' ' TYR . 0.0 OUTLIER 86.98 145.62 0.05 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.857 1.263 . . . . 0.0 111.447 178.437 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.424 HG21 ' CD1' ' A' ' 35' ' ' LEU . 31.1 m -109.82 140.98 26.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.356 -178.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.585 ' HA ' ' HD2' ' A' ' 73' ' ' HIS . 6.3 m -86.81 -174.08 4.78 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.296 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -69.92 -35.3 74.45 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -169.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.531 HE21 ' HB2' ' A' ' 26' ' ' SER . 0.5 OUTLIER -73.21 -33.93 65.65 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.561 -177.198 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.435 ' OE1' ' HB2' ' A' ' 26' ' ' SER . 3.0 mp0 -63.58 -45.03 92.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.099 0.476 . . . . 0.0 109.907 175.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.507 HG12 HD12 ' A' ' 35' ' ' LEU . 81.4 mt -56.76 -40.31 69.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.756 177.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.1 m -71.94 -20.74 61.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.305 -178.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -88.29 -42.19 12.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.476 -178.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -89.56 -9.31 50.31 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 121.064 -0.255 . . . . 0.0 111.372 -178.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? 54.84 54.78 8.61 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.293 0.568 . . . . 0.0 110.237 -176.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.507 HD12 HG12 ' A' ' 30' ' ' ILE . 89.6 mt -66.17 145.93 55.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.44 -176.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.7 m -73.71 135.91 26.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.719 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.5 tttm -96.89 122.58 40.02 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.365 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.24 -47.11 20.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.973 0.416 . . . . 0.0 110.237 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 171.45 173.86 38.7 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.066 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 86.9 m -101.26 121.28 41.6 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.619 0.247 . . . . 0.0 110.467 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.1 pt -106.77 144.09 16.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 176.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -128.43 131.57 48.44 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.533 0.682 . . . . 0.0 110.882 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 70.7 t -93.99 128.5 45.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 114.255 -1.339 . . . . 0.0 109.311 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.0 t -150.35 78.17 1.32 Allowed 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.636 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 0.6 OUTLIER -103.1 130.68 50.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.997 -179.141 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.9 t -92.14 102.61 15.14 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.009 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.54 -130.21 10.18 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.055 -0.593 . . . . 0.0 114.405 171.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.91 34.06 2.59 Favored Glycine 0 C--N 1.331 0.26 0 N-CA-C 114.329 0.492 . . . . 0.0 114.329 -167.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.636 ' HB2' ' HB3' ' A' ' 45' ' ' GLN . 15.2 mm100 -82.68 -28.33 30.67 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 172.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.558 HD12 ' HA ' ' A' ' 56' ' ' LEU . 49.6 mm -122.95 112.1 32.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.407 176.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.0 m -118.46 -1.27 11.26 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.311 -176.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 40.4 m -155.93 148.46 17.82 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -58.73 -31.49 95.07 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.426 2.084 . . . . 0.0 111.21 176.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.57 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 2.8 p -69.72 -35.1 74.74 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.212 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -75.76 -32.1 59.81 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.879 0.371 . . . . 0.0 110.422 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.558 ' HA ' HD12 ' A' ' 50' ' ' ILE . 68.4 tp -59.59 -50.21 74.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.049 178.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.568 ' HD2' ' CD ' ' B' ' 223' ' ' GLU . 26.5 ptt85 -67.35 -32.8 73.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.952 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.57 ' HG2' ' O ' ' A' ' 54' ' ' SER . 9.5 mm-40 -55.5 -42.64 74.72 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.162 0.506 . . . . 0.0 110.006 176.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.501 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 13.7 mptt -58.76 -44.91 90.71 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.591 175.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.453 HD13 HD11 ' A' ' 74' ' ' ILE . 74.5 mt -64.89 -41.88 95.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.972 -176.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.4 m -60.18 -40.01 88.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.163 0.506 . . . . 0.0 110.168 175.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -69.04 -40.37 78.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.891 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 59' ' ' LYS . 87.9 mt -66.26 -37.49 85.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.221 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.96 -39.08 93.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.885 0.374 . . . . 0.0 110.523 178.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -68.04 -35.77 78.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.849 177.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.12 -32.7 70.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.285 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.416 ' HD3' ' HA ' ' A' ' 67' ' ' LYS . 71.5 mmtt -87.34 -26.54 23.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.882 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.53 43.96 3.3 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.511 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -120.44 -170.84 14.33 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.81 -0.709 . . . . 0.0 111.776 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -123.26 -36.08 2.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.966 0.412 . . . . 0.0 110.591 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.647 ' CD1' ' HA ' ' A' ' 24' ' ' GLN . 71.7 m-85 -132.6 166.74 21.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.007 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -148.96 131.3 15.61 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.585 ' HD2' ' HA ' ' A' ' 26' ' ' SER . 58.8 t-80 -109.72 105.61 14.93 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.078 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.509 ' HB ' ' OG ' ' B' ' 226' ' ' SER . 60.6 mt -67.77 130.89 33.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.272 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 33.5 pt -114.17 -16.27 9.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.15 -178.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.554 ' HB3' ' HB ' ' A' ' 87' ' ' VAL . . . -147.94 137.31 22.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.056 -176.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -156.51 103.54 2.13 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.41 145.97 35.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.776 0.322 . . . . 0.0 111.032 -176.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -82.14 124.96 30.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.199 0.523 . . . . 0.0 110.816 176.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.0 t-160 -100.19 50.61 0.9 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 175.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.14 -130.83 10.14 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 110.321 -1.111 . . . . 0.0 110.321 -170.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -79.61 6.0 5.47 Favored 'Trans proline' 0 N--CA 1.464 -0.229 0 C-N-CA 122.483 2.122 . . . . 0.0 111.499 173.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -108.96 121.93 46.16 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.284 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.471 ' CE2' ' HB2' ' A' ' 86' ' ' ALA . 70.1 t80 -93.36 122.77 36.11 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.964 -176.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 25.9 mm-40 -112.36 115.3 28.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.249 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.514 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -132.31 134.67 45.51 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.591 0.234 . . . . 0.0 111.057 178.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.554 ' HB ' ' HB3' ' A' ' 76' ' ' ALA . 97.2 t -114.46 121.86 67.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.939 0.4 . . . . 0.0 110.075 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 74' ' ' ILE . . . -125.19 138.07 54.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.165 -177.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.05 116.92 29.4 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.776 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.7 t -86.3 126.02 40.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.833 0.349 . . . . 0.0 110.655 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -123.52 156.51 35.5 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.986 178.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -110.19 172.65 6.74 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 16.8 t70 . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.299 -175.494 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.325 0 CA-C-O 120.517 0.199 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 223' ' ' GLU . . . . . 0.568 ' CD ' ' HD2' ' A' ' 57' ' ' ARG . 11.0 tp10 -164.97 135.72 3.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.213 -177.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 224' ' ' GLN . . . . . 0.439 ' HB2' ' O ' ' B' ' 223' ' ' GLU . 0.0 OUTLIER 170.76 139.98 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.811 0.694 . . . . 0.0 110.588 -179.827 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 17.8 m -109.33 132.18 58.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.943 172.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . 0.549 ' O ' HG13 ' B' ' 230' ' ' ILE . 5.8 m -88.69 172.8 8.99 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.846 0.355 . . . . 0.0 111.068 -175.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . 0.546 ' HA ' HD12 ' B' ' 230' ' ' ILE . 5.5 mmtt -57.47 -32.65 67.18 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.76 -174.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -68.56 -51.5 42.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.334 -177.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -63.24 -35.52 80.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.015 -177.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.556 HG12 HD12 ' B' ' 235' ' ' LEU . 82.3 mt -57.08 -52.29 58.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.846 178.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 18.3 m -74.18 -24.32 59.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.785 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 20.0 t-160 -75.17 -48.71 22.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.34 -175.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -96.72 -3.16 43.0 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.047 -177.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm 62.92 72.27 0.49 Allowed 'General case' 0 N--CA 1.463 0.224 0 O-C-N 123.67 0.606 . . . . 0.0 111.59 176.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . 0.556 HD12 HG12 ' B' ' 230' ' ' ILE . 69.6 mt -73.35 174.4 8.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.997 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 69.5 t -93.11 -49.19 13.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.644 -176.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 237' ' ' LYS . . . . . 0.602 ' HA ' ' HA ' ' B' ' 291' ' ' TYR . 60.0 tttm 69.97 139.92 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 O-C-N 123.877 0.735 . . . . 0.0 111.734 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 238' ' ' VAL . . . . . 0.547 HG13 ' HB2' ' B' ' 292' ' ' ASN . 3.3 m -111.15 -50.83 6.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . -178.65 -142.08 4.64 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.011 -1.09 . . . . 0.0 113.056 -177.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 63.4 m -134.38 145.36 48.89 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 122.621 0.368 . . . . 0.0 110.716 -176.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 20.5 pt -117.91 131.59 70.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 170.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -123.05 114.44 20.38 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.06 0.457 . . . . 0.0 110.338 -175.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 243' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 82.0 t -94.0 115.19 32.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.433 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 19.2 m -110.69 87.41 2.52 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 174.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 245' ' ' GLN . . . . . 0.524 ' HB3' ' HB3' ' B' ' 284' ' ' PHE . 0.0 OUTLIER -107.55 179.61 4.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.57 0.7 . . . . 0.0 111.53 -172.451 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 33.2 t -108.63 153.31 23.58 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 166.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -58.23 -29.07 62.38 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 121.17 -0.538 . . . . 0.0 113.768 -175.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -73.49 -11.83 80.16 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 121.043 -0.599 . . . . 0.0 113.908 -174.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -94.02 -6.81 44.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 117.482 0.641 . . . . 0.0 111.158 -178.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 47.2 mm -119.73 108.09 22.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.248 -178.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 23.7 t -121.72 -47.62 2.19 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.267 0.556 . . . . 0.0 109.998 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 3.9 m -113.28 156.6 42.87 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.435 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -57.89 -30.31 89.19 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.393 2.062 . . . . 0.0 111.748 176.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 254' ' ' SER . . . . . 0.494 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 18.8 m -63.16 -33.83 76.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.15 177.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -64.62 -45.89 84.95 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.137 0.494 . . . . 0.0 110.222 -178.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 54.3 tp -66.62 -39.39 88.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.941 177.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 257' ' ' ARG . . . . . 0.433 HH11 ' CD ' ' A' ' 23' ' ' GLU . 7.5 tmm_? -58.05 -42.07 84.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.076 178.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 258' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' B' ' 254' ' ' SER . 69.7 mm-40 -57.94 -29.54 65.24 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.57 178.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -85.64 -47.95 9.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.945 0.402 . . . . 0.0 110.658 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 96.0 mt -66.1 -49.72 66.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.119 -174.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 14.6 m -66.88 -33.23 75.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.825 0.345 . . . . 0.0 110.857 -176.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -62.48 -45.68 91.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.264 0.554 . . . . 0.0 110.287 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 263' ' ' LEU . . . . . 0.624 ' O ' ' HG2' ' B' ' 267' ' ' LYS . 92.3 mt -74.39 -44.88 50.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.002 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -59.02 -48.92 79.83 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -175.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -66.87 -31.47 72.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.873 0.368 . . . . 0.0 110.547 -178.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -69.3 -19.23 63.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.9 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 267' ' ' LYS . . . . . 0.624 ' HG2' ' O ' ' B' ' 263' ' ' LEU . 74.2 mmtt -84.76 -20.48 30.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.083 0.468 . . . . 0.0 110.141 177.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 107.23 -3.94 35.29 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.548 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -90.25 153.26 22.7 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.157 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -111.98 -9.98 13.98 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -177.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 271' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -135.79 162.22 33.4 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 272' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -151.24 167.48 27.69 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.414 170.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 273' ' ' HIS . . . . . 0.468 ' CD2' ' HA ' ' B' ' 226' ' ' SER . 47.5 t-80 -135.47 108.55 7.68 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 172.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 274' ' ' ILE . . . . . 0.477 HG12 ' HB2' ' B' ' 288' ' ' ALA . 62.3 mt -65.21 130.54 30.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 29.4 pt -108.58 -21.29 5.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.658 -175.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -159.76 112.84 2.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.973 -179.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 277' ' ' ALA . . . . . 0.406 ' HB3' ' HG3' ' A' ' 29' ' ' GLU . . . -133.46 103.49 5.96 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 176.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -147.22 175.1 11.01 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.482 -171.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.19 108.47 19.11 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.17 -178.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 33.8 t-80 -90.64 69.83 6.71 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 175.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 75.67 -122.38 6.68 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 -174.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -79.71 -3.81 13.09 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.568 2.179 . . . . 0.0 112.19 175.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -94.99 140.92 29.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.419 -177.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 284' ' ' PHE . . . . . 0.524 ' HB3' ' HB3' ' B' ' 245' ' ' GLN . 71.3 t80 -113.53 110.23 19.92 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 174.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 285' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 18.2 mm-40 -105.58 110.98 23.5 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.922 -178.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 286' ' ' ALA . . . . . 0.569 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -111.95 115.13 28.45 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.981 0.42 . . . . 0.0 110.062 172.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 24.4 t -114.12 119.77 62.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.759 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 288' ' ' ALA . . . . . 0.477 ' HB2' HG12 ' B' ' 274' ' ' ILE . . . -131.5 141.64 49.8 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.866 0.365 . . . . 0.0 110.869 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -91.36 124.96 35.94 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 290' ' ' VAL . . . . . 0.451 ' HB ' HG23 ' B' ' 238' ' ' VAL . 11.2 t -89.63 123.44 41.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.028 0.442 . . . . 0.0 109.997 -176.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 291' ' ' TYR . . . . . 0.602 ' HA ' ' HA ' ' B' ' 237' ' ' LYS . 98.3 m-85 -112.3 124.22 51.99 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.905 -176.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 292' ' ' ASN . . . . . 0.547 ' HB2' HG13 ' B' ' 238' ' ' VAL . 10.6 t-20 -91.86 156.47 17.47 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 174.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 19.8 t70 . . . . . 0 C--N 1.323 -0.545 0 O-C-N 123.48 0.488 . . . . 0.0 110.953 -177.053 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.477 ' HB1' ' O ' ' B' ' 223' ' ' GLU . . . . . . . . 0 CA--C 1.521 -0.142 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.716 ' HA ' ' OH ' ' B' ' 272' ' ' TYR . 16.2 pt-20 -177.39 141.44 0.31 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.635 ' HB3' ' HG3' ' B' ' 224' ' ' GLN . 0.0 OUTLIER -179.67 151.37 0.45 Allowed 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.31 174.264 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.504 ' HB ' ' CG ' ' A' ' 29' ' ' GLU . 11.6 m -112.58 146.35 17.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.77 0.319 . . . . 0.0 110.443 178.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.9 p -89.77 -156.67 0.42 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.438 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.484 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 12.8 tmtt? -80.01 -35.95 36.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.82 0.343 . . . . 0.0 110.676 -175.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -60.0 -50.42 73.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.213 -170.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.504 ' CG ' ' HB ' ' A' ' 25' ' ' VAL . 3.2 pm0 -76.15 -29.16 57.67 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.506 -174.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.594 HG12 HD12 ' A' ' 35' ' ' LEU . 69.2 mt -61.8 -43.68 97.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.011 0.434 . . . . 0.0 109.848 177.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.4 m -73.05 -34.16 66.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.191 177.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 35.1 t-80 -80.04 -36.33 35.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.778 -172.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -103.13 -10.46 18.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.47 0.176 . . . . 0.0 111.341 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt 58.55 83.96 0.11 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.339 -177.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.594 HD12 HG12 ' A' ' 30' ' ' ILE . 92.3 mt -93.53 155.37 17.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.8 -178.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.5 t -87.77 117.91 32.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.148 -176.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -82.24 115.15 21.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.025 177.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.457 HG13 ' HB2' ' A' ' 92' ' ' ASN . 6.4 m -97.12 15.0 3.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.075 0.464 . . . . 0.0 111.279 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 128.48 -158.1 21.59 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.65 -0.785 . . . . 0.0 113.006 174.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.5 m -144.96 139.74 27.74 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -178.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.6 pt -117.82 150.3 19.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.416 HD22 HG22 ' A' ' 87' ' ' VAL . 20.5 m120 -130.79 132.71 45.43 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.164 0.507 . . . . 0.0 111.486 -175.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.612 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 73.0 t -95.09 123.82 47.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.963 172.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.2 p -151.32 75.92 1.2 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.011 0.434 . . . . 0.0 111.23 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 14.9 mp0 -111.7 156.83 21.27 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.976 0.417 . . . . 0.0 111.084 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 64.4 m -89.47 67.76 7.7 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.975 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.6 -78.18 1.03 Allowed Glycine 0 CA--C 1.521 0.428 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.801 175.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.93 51.55 3.16 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 114.86 0.704 . . . . 0.0 114.86 -169.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -137.62 1.32 2.34 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 168.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.59 HD12 ' HA ' ' A' ' 56' ' ' LEU . 49.7 mm -126.62 107.64 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.081 174.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.3 p -95.55 -29.54 14.31 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.58 -174.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.475 ' H ' ' HB3' ' A' ' 55' ' ' ASP . 16.4 m -147.83 165.88 17.37 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.847 -174.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.49 -46.4 21.18 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.207 1.938 . . . . 0.0 111.325 174.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.46 ' O ' ' HG3' ' A' ' 58' ' ' GLU . 48.4 t -59.49 -34.82 73.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.666 175.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.475 ' HB3' ' H ' ' A' ' 52' ' ' SER . 34.9 t70 -66.98 -41.0 87.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.949 0.404 . . . . 0.0 110.002 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.59 ' HA ' HD12 ' A' ' 50' ' ' ILE . 58.5 tp -59.69 -44.61 93.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.317 0.58 . . . . 0.0 109.789 173.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.39 -34.15 77.1 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.003 178.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 54' ' ' SER . 50.2 mt-10 -59.87 -45.49 92.3 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.779 -0.191 . . . . 0.0 110.577 177.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -60.92 -43.54 98.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.918 0.389 . . . . 0.0 110.821 176.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.47 -48.18 76.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.52 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.498 ' HB3' ' O ' ' B' ' 222' ' ' ALA . 18.8 p -70.29 -33.08 71.14 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.075 -176.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -60.95 -48.74 80.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.561 177.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.8 mt -65.46 -35.09 79.88 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.613 178.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.16 -41.99 80.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.863 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -62.13 -38.15 87.84 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.577 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.28 -39.02 85.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.923 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.4 mmtp -74.64 -29.38 61.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.001 0.429 . . . . 0.0 110.74 176.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.31 26.77 11.64 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.759 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -101.03 147.56 17.86 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.131 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 67.6 mttt -93.18 -4.16 52.59 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.825 0.345 . . . . 0.0 111.501 -172.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.768 ' CE1' ' HB2' ' A' ' 91' ' ' TYR . 22.3 p90 -165.32 164.6 19.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.486 -177.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.435 ' O ' ' HG3' ' A' ' 24' ' ' GLN . 25.3 p90 -131.78 133.06 44.33 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.508 -178.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.423 ' HB3' ' HB2' ' A' ' 89' ' ' GLU . 17.0 t-80 -100.22 102.5 13.8 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.494 -175.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.516 ' H ' HD12 ' A' ' 74' ' ' ILE . 5.3 mp -72.3 122.94 25.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 30.7 pt -111.49 -24.02 4.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.089 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -155.72 125.19 6.32 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.001 0.429 . . . . 0.0 111.202 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.16 119.68 23.36 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 175.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -139.62 155.1 47.63 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.463 0.649 . . . . 0.0 111.973 -171.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -110.54 112.11 23.8 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.538 177.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -78.12 -27.01 48.21 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 123.28 -85.16 0.37 Allowed Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -176.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.91 -20.42 29.42 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.456 2.104 . . . . 0.0 111.474 173.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -123.12 145.7 48.36 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.825 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -102.88 124.85 49.17 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 170.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.562 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 51.6 mt-10 -123.28 115.91 22.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.062 0.458 . . . . 0.0 111.099 -171.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.612 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -127.85 134.37 49.41 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.042 179.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.416 HG22 HD22 ' A' ' 42' ' ' ASN . 24.8 t -114.36 116.27 52.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.155 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -131.65 137.79 48.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.089 0.471 . . . . 0.0 111.087 -178.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.423 ' HB2' ' HB3' ' A' ' 73' ' ' HIS . 30.0 mt-10 -91.48 150.61 21.15 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 17.6 t -113.06 130.64 66.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 177.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.768 ' HB2' ' CE1' ' A' ' 71' ' ' TYR . 52.3 m-85 -121.21 147.71 45.25 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.128 0.489 . . . . 0.0 110.107 177.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.457 ' HB2' HG13 ' A' ' 38' ' ' VAL . 1.5 t-20 -95.35 18.73 11.94 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.583 -168.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 45.2 t0 . . . . . 0 N--CA 1.476 0.866 0 CA-C-O 121.672 0.749 . . . . 0.0 110.299 -178.754 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 222' ' ' ALA . . . . . 0.498 ' O ' ' HB3' ' A' ' 61' ' ' SER . . . . . . . . 0 CA--C 1.521 -0.151 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 223' ' ' GLU . . . . . 0.477 ' O ' ' HB1' ' A' ' 22' ' ' ALA . 7.2 pt-20 -168.54 122.69 0.89 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.062 0.458 . . . . 0.0 111.513 178.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 224' ' ' GLN . . . . . 0.635 ' HG3' ' HB3' ' A' ' 24' ' ' GLN . 0.7 OUTLIER -171.07 154.24 4.02 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.352 179.615 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 23.8 m -131.94 130.69 61.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.71 0.29 . . . . 0.0 111.032 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . 0.669 ' HA ' ' HD2' ' B' ' 273' ' ' HIS . 77.3 p -88.87 179.8 6.12 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.45 -28.72 70.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.441 0.162 . . . . 0.0 111.312 -172.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -64.28 -50.65 67.08 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -61.65 -46.14 91.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.317 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.459 HG12 HD12 ' B' ' 235' ' ' LEU . 90.9 mt -55.8 -48.82 77.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.273 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 14.7 m -73.25 -35.11 66.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.88 0.371 . . . . 0.0 111.433 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -77.95 -33.53 51.53 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.37 -174.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -99.05 -9.41 23.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.399 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt 58.64 70.75 0.63 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.263 0.554 . . . . 0.0 110.691 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . 0.459 HD12 HG12 ' B' ' 230' ' ' ILE . 74.0 mt -82.99 -177.94 6.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.946 -175.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 57.0 t -105.88 123.65 60.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.599 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -86.89 123.34 31.91 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 177.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 18.9 t -96.09 -38.82 8.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.444 -173.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 165.74 154.04 7.95 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.168 -1.015 . . . . 0.0 112.582 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . 0.528 HG23 ' HG2' ' B' ' 289' ' ' GLU . 17.9 m -92.01 136.62 33.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.549 0.214 . . . . 0.0 110.542 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 36.5 pt -120.17 168.44 12.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.008 0.432 . . . . 0.0 110.949 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -144.72 133.13 21.9 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.19 174.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 243' ' ' VAL . . . . . 0.54 HG22 HD12 ' B' ' 263' ' ' LEU . 43.9 t -104.49 108.53 25.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.16 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 244' ' ' SER . . . . . 0.564 ' HA ' ' O ' ' B' ' 284' ' ' PHE . 8.2 t -139.36 106.79 5.54 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.113 0.482 . . . . 0.0 110.115 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 245' ' ' GLN . . . . . 0.543 ' HB3' ' OE1' ' B' ' 249' ' ' GLN . 1.0 OUTLIER -132.1 -177.25 4.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.327 178.306 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 246' ' ' SER . . . . . 0.448 ' HB3' ' HG3' ' B' ' 249' ' ' GLN . 47.4 t -72.42 150.71 43.12 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.655 173.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -65.1 -16.26 61.86 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.727 177.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -77.56 -16.2 80.52 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.14 175.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . 0.543 ' OE1' ' HB3' ' B' ' 245' ' ' GLN . 38.9 mt-30 -92.03 -45.16 8.46 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 50.3 mm -97.33 93.22 3.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.814 0.816 . . . . 0.0 109.842 175.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 20.1 m -118.68 -15.7 9.47 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.049 -176.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 19.9 m -127.72 142.7 45.04 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.75 -39.64 80.18 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.536 2.157 . . . . 0.0 111.828 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 254' ' ' SER . . . . . 0.436 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 4.7 m -62.47 -29.85 70.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.17 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -74.84 -34.78 62.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.004 0.431 . . . . 0.0 110.632 -176.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.433 ' O ' ' HG ' ' B' ' 260' ' ' LEU . 66.1 tp -61.86 -42.5 99.13 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.953 176.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -58.4 -35.56 72.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.981 178.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 258' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' B' ' 254' ' ' SER . 25.1 mm-40 -57.98 -50.87 71.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.333 177.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -66.87 -39.38 87.51 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.337 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 260' ' ' LEU . . . . . 0.503 ' HB3' ' CZ ' ' B' ' 272' ' ' TYR . 97.6 mt -58.11 -45.9 86.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.082 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 22.9 t -66.06 -44.16 85.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.298 0.571 . . . . 0.0 110.27 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -58.43 -42.78 88.05 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.642 -177.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 263' ' ' LEU . . . . . 0.54 HD12 HG22 ' B' ' 243' ' ' VAL . 83.7 mt -73.09 -30.33 63.58 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.866 -178.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -65.88 -50.98 62.55 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.717 0.294 . . . . 0.0 110.915 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -59.86 -38.1 81.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.949 0.404 . . . . 0.0 110.777 176.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -64.21 -22.31 66.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.496 -178.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 267' ' ' LYS . . . . . 0.41 ' HD3' ' HA ' ' B' ' 267' ' ' LYS . 63.3 mmtt -87.48 -14.61 39.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.504 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 90.95 19.39 43.35 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.423 -175.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -117.63 -166.12 13.84 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 50.4 mttp -130.19 -66.51 0.77 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.722 0.296 . . . . 0.0 110.533 -178.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 271' ' ' TYR . . . . . 0.528 ' HB3' ' HA ' ' B' ' 224' ' ' GLN . 5.7 m-85 -90.56 153.65 20.19 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -175.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 272' ' ' TYR . . . . . 0.716 ' OH ' ' HA ' ' A' ' 23' ' ' GLU . 27.5 p90 -132.85 129.42 38.42 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.264 0.554 . . . . 0.0 110.759 178.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 273' ' ' HIS . . . . . 0.669 ' HD2' ' HA ' ' B' ' 226' ' ' SER . 55.9 t-80 -101.87 103.19 13.86 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.845 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 274' ' ' ILE . . . . . . . . . . . . . 59.1 mt -67.5 135.7 28.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.408 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 17.8 pt -115.52 -26.51 2.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -157.21 136.96 12.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.532 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -148.11 129.37 14.69 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.512 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.72 173.61 14.41 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.5 149.73 40.81 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.955 0.407 . . . . 0.0 110.318 171.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -95.51 -0.8 51.77 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.657 -178.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 113.86 -90.5 0.54 Allowed Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.323 -174.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.59 -14.62 22.14 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.852 2.368 . . . . 0.0 112.166 177.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -135.03 156.52 48.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.976 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 284' ' ' PHE . . . . . 0.564 ' O ' ' HA ' ' B' ' 244' ' ' SER . 82.7 t80 -110.83 145.63 37.85 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 285' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -138.67 110.1 6.99 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.924 0.393 . . . . 0.0 111.497 -177.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 286' ' ' ALA . . . . . 0.493 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -125.16 145.03 50.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.75 175.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 88.3 t -127.56 131.76 69.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.912 0.387 . . . . 0.0 110.347 177.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -142.57 156.28 45.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.246 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 289' ' ' GLU . . . . . 0.528 ' HG2' HG23 ' B' ' 240' ' ' THR . 35.5 mt-10 -112.76 128.28 56.38 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 58.4 t -89.02 131.42 36.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.943 0.402 . . . . 0.0 110.979 -176.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -125.23 159.7 30.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.284 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 292' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -118.52 161.79 19.44 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 4.6 t70 . . . . . 0 N--CA 1.471 0.608 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -170.395 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.496 ' HB3' ' HA ' ' B' ' 261' ' ' SER . . . . . . . . 0 C--O 1.233 0.203 0 CA-C-O 120.894 0.378 . . . . 0.0 110.859 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -151.72 179.41 8.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.612 -176.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.615 ' HB2' ' HB2' ' B' ' 224' ' ' GLN . 0.0 OUTLIER 81.79 167.78 0.13 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.791 0.836 . . . . 0.0 111.765 171.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.424 HG12 ' CZ ' ' B' ' 257' ' ' ARG . 31.0 m -126.4 171.97 14.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.47 -178.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.545 ' HB2' ' HB ' ' B' ' 274' ' ' ILE . 10.8 t -112.66 -149.73 0.45 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.524 ' HA ' HD12 ' A' ' 30' ' ' ILE . 18.2 ttpt -97.86 -17.15 19.46 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 122.088 -0.382 . . . . 0.0 110.44 178.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -62.95 -42.53 99.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.951 -176.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.655 ' HG2' HH22 ' B' ' 257' ' ' ARG . 3.4 mp0 -68.83 -31.18 69.97 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.495 178.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.524 HD12 ' HA ' ' A' ' 27' ' ' LYS . 62.7 mt -64.68 -51.29 69.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.443 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.8 m -69.44 -27.87 65.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.407 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 22.2 m170 -84.1 -58.11 2.91 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.979 0.362 . . . . 0.0 111.979 -178.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -99.17 -11.75 21.08 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -169.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.423 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 3.8 mppt? 60.12 84.56 0.12 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.233 0.54 . . . . 0.0 110.799 -177.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 90.4 mt -73.81 151.44 40.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.031 -177.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 63.1 t -91.22 108.86 20.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.025 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -83.61 130.48 34.98 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.208 0.528 . . . . 0.0 110.836 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.483 HG13 ' HB2' ' A' ' 92' ' ' ASN . 6.4 m -92.03 -20.94 6.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.847 178.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.27 171.27 22.39 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.608 178.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 35.0 m -106.43 129.57 54.38 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.8 pt -102.92 151.46 6.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -128.49 123.77 34.43 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.095 0.474 . . . . 0.0 110.663 -171.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.753 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 57.3 t -93.54 109.05 21.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 174.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.6 t -141.38 78.71 1.65 Allowed 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.422 HE22 HG13 ' A' ' 43' ' ' VAL . 0.9 OUTLIER -106.7 138.52 42.73 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.984 -177.481 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.0 m -83.66 94.15 8.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.865 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.89 -169.72 13.06 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.521 178.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.28 55.64 4.36 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.412 -0.423 . . . . 0.0 113.383 -176.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -75.94 -21.23 57.26 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.406 0.622 . . . . 0.0 109.421 173.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.1 mm -119.46 98.63 6.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.148 -0.933 . . . . 0.0 108.65 172.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 77.2 p -111.56 -40.93 4.21 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.229 -173.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.401 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 12.6 m -119.54 161.72 36.08 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.65 -177.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 52' ' ' SER . 9.3 Cg_endo -53.38 -29.47 48.36 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.728 2.285 . . . . 0.0 111.78 176.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.542 ' HA ' ' NE ' ' A' ' 57' ' ' ARG . 23.7 m -59.04 -38.92 80.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.621 177.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.476 ' O ' ' HD3' ' A' ' 59' ' ' LYS . 59.5 m-20 -63.54 -53.23 55.07 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -174.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 23.1 tp -54.92 -49.71 70.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.258 -173.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.542 ' NE ' ' HA ' ' A' ' 54' ' ' SER . 25.7 ptt180 -63.34 -42.68 98.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.355 -178.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 54' ' ' SER . 43.3 mt-10 -69.54 -46.89 65.42 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.672 0.272 . . . . 0.0 111.161 -176.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.476 ' HD3' ' O ' ' A' ' 55' ' ' ASP . 14.5 mptt -59.77 -45.86 90.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.527 178.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.541 HD21 ' CG2' ' A' ' 43' ' ' VAL . 79.7 mt -75.04 -30.82 61.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.146 -175.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.7 m -60.48 -41.43 94.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.023 0.439 . . . . 0.0 110.312 174.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -63.66 -46.94 83.31 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.402 177.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 88.6 mt -69.5 -48.48 60.49 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.862 -177.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.2 -50.93 68.35 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -174.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -63.88 -37.36 87.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.909 0.385 . . . . 0.0 111.004 -176.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.95 -19.34 62.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.439 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 67' ' ' LYS . 70.3 mmtt -85.04 -5.73 59.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.955 0.407 . . . . 0.0 110.866 177.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.97 -28.45 13.04 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.351 177.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.61 ' HA3' HG12 ' A' ' 90' ' ' VAL . . . -79.84 179.42 53.2 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.911 -0.662 . . . . 0.0 111.789 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.639 ' NZ ' ' HA ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -112.43 -72.85 0.69 Allowed 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.162 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.593 ' HB2' ' HA ' ' A' ' 24' ' ' GLN . 0.6 OUTLIER -96.5 155.65 16.68 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.845 -176.349 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.784 ' CD1' ' HB1' ' B' ' 222' ' ' ALA . 3.9 p90 -109.34 170.94 7.74 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.259 -177.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 23.6 t-80 -141.0 103.38 4.46 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.491 ' H ' HD12 ' A' ' 74' ' ' ILE . 2.9 mp -65.12 132.01 30.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.029 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 32.1 pt -133.02 -5.76 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.686 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.431 ' HB3' ' HB ' ' A' ' 87' ' ' VAL . . . -165.92 144.73 5.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.739 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -158.56 137.9 11.64 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 177.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -166.15 141.15 4.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.945 0.402 . . . . 0.0 111.363 -178.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -77.93 96.19 4.97 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 170.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -90.44 77.5 6.52 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.677 -177.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.1 -120.42 13.68 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -175.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -86.33 -0.68 8.34 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.518 2.145 . . . . 0.0 111.869 176.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -107.96 110.41 22.13 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.57 -176.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -79.44 104.33 9.98 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 173.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.753 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 23.3 mt-10 -104.06 123.14 46.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.191 0.519 . . . . 0.0 111.484 -175.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.522 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -130.82 126.84 37.33 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.856 176.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.431 ' HB ' ' HB3' ' A' ' 76' ' ' ALA . 41.9 t -105.62 121.53 57.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.428 -176.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.47 135.95 32.49 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.794 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 40' ' ' THR . 29.3 mt-10 -96.35 150.17 20.88 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.61 HG12 ' HA3' ' A' ' 69' ' ' GLY . 8.2 t -110.56 133.59 55.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 -179.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.495 ' HB2' ' HE1' ' A' ' 71' ' ' TYR . 54.1 m-85 -116.77 151.1 37.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.25 0.547 . . . . 0.0 110.889 -178.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.483 ' HB2' HG13 ' A' ' 38' ' ' VAL . 8.2 t-20 -106.13 21.96 16.49 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.926 -177.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.403 ' HA ' ' OH ' ' A' ' 71' ' ' TYR . 6.2 t70 . . . . . 0 C--N 1.323 -0.58 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.174 -175.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 222' ' ' ALA . . . . . 0.784 ' HB1' ' CD1' ' A' ' 72' ' ' TYR . . . . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 223' ' ' GLU . . . . . 0.831 ' HB3' ' HE1' ' B' ' 271' ' ' TYR . 30.0 mt-10 -143.98 105.63 4.3 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 224' ' ' GLN . . . . . 0.615 ' HB2' ' HB2' ' A' ' 24' ' ' GLN . 0.0 OUTLIER 173.56 179.87 0.09 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.298 0.639 . . . . 0.0 109.287 172.273 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . 0.546 HG11 HD11 ' B' ' 235' ' ' LEU . 15.8 m -138.84 157.86 29.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 120.622 0.248 . . . . 0.0 110.774 178.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . 0.516 ' HA ' ' CD2' ' B' ' 273' ' ' HIS . 81.2 p -110.2 -92.88 0.44 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.072 178.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . 0.489 ' C ' ' HD3' ' B' ' 227' ' ' LYS . 8.1 tmtm? -133.42 -52.99 0.89 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.813 0.34 . . . . 0.0 110.959 -176.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 228' ' ' GLN . . . . . 0.503 ' NE2' ' H ' ' B' ' 228' ' ' GLN . 1.9 mp0 -59.96 -45.43 92.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.278 -172.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 229' ' ' GLU . . . . . 0.604 ' H ' ' CD ' ' B' ' 229' ' ' GLU . 2.0 mp0 -60.58 -45.12 95.14 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.991 -177.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.552 HG12 HD12 ' B' ' 235' ' ' LEU . 49.1 mt -60.72 -49.77 83.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.119 -176.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 25.4 m -67.21 -21.26 65.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.465 -177.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -94.21 -44.07 8.15 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.597 -174.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -92.34 -8.73 44.21 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -175.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 10.6 mmmm 63.03 75.62 0.39 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.088 0.471 . . . . 0.0 111.042 176.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . 0.552 HD12 HG12 ' B' ' 230' ' ' ILE . 68.6 mt -83.77 161.68 20.9 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.293 0.568 . . . . 0.0 111.574 -177.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 65.2 t -95.63 129.18 46.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.348 176.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 237' ' ' LYS . . . . . 0.42 ' HE3' ' HB3' ' B' ' 289' ' ' GLU . 85.4 tttt -102.32 146.07 28.57 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -179.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 238' ' ' VAL . . . . . 0.55 HG13 ' HB2' ' B' ' 292' ' ' ASN . 2.5 m -127.4 9.36 3.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 239' ' ' GLY . . . . . 0.401 ' H ' ' HG2' ' B' ' 237' ' ' LYS . . . 133.62 -161.92 24.32 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 119.942 -1.123 . . . . 0.0 113.191 174.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' B' ' 289' ' ' GLU . 29.2 m -140.18 133.35 29.63 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 33.3 pt -109.49 147.37 13.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.214 0.531 . . . . 0.0 111.031 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -112.82 118.06 33.89 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.25 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 243' ' ' VAL . . . . . 0.674 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 22.1 t -93.83 113.46 28.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 176.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 244' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' B' ' 284' ' ' PHE . 47.7 t -125.38 100.97 6.74 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.72 0.295 . . . . 0.0 110.228 -176.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 245' ' ' GLN . . . . . 0.587 ' HG3' HG12 ' B' ' 250' ' ' ILE . 9.2 mm-40 -90.63 -175.94 4.57 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.611 0.72 . . . . 0.0 111.453 -177.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 68.6 m -143.49 113.45 7.18 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.699 176.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 66.3 -118.85 11.6 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.135 177.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -98.3 42.2 2.11 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.181 -0.533 . . . . 0.0 113.49 -172.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . 0.884 HE21 ' HA ' ' B' ' 249' ' ' GLN . 0.0 OUTLIER -77.78 -22.19 50.56 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 173.687 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 250' ' ' ILE . . . . . 0.587 HG12 ' HG3' ' B' ' 245' ' ' GLN . 43.8 mm -121.51 96.36 4.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.34 175.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 39.4 t -96.64 -24.31 16.06 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.321 0.581 . . . . 0.0 109.583 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 73.8 p -138.23 162.85 51.4 Favored Pre-proline 0 N--CA 1.447 -0.625 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.65 -179.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.93 -22.59 74.61 Favored 'Trans proline' 0 C--O 1.238 0.482 0 C-N-CA 122.019 1.813 . . . . 0.0 111.263 173.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 254' ' ' SER . . . . . . . . . . . . . 2.3 m -66.09 -42.79 88.83 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.566 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 255' ' ' ASP . . . . . 0.467 ' O ' ' HG2' ' B' ' 259' ' ' LYS . 30.1 m-20 -54.92 -39.01 68.37 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.013 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.429 ' O ' ' HG ' ' B' ' 260' ' ' LEU . 45.2 tp -58.83 -42.58 89.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.848 -178.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 257' ' ' ARG . . . . . 0.655 HH22 ' HG2' ' A' ' 29' ' ' GLU . 0.1 OUTLIER -67.92 -31.37 71.1 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.154 0.502 . . . . 0.0 110.028 -179.161 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 258' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' B' ' 255' ' ' ASP . 52.7 mm-40 -61.18 -41.45 96.83 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.424 178.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 259' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' B' ' 255' ' ' ASP . 16.0 mmmt -77.15 -42.04 39.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.766 -179.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 260' ' ' LEU . . . . . 0.455 HD13 ' CE2' ' B' ' 272' ' ' TYR . 97.3 mt -60.33 -42.96 96.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.768 -177.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 261' ' ' SER . . . . . 0.496 ' HA ' ' HB3' ' A' ' 22' ' ' ALA . 67.8 m -58.32 -48.97 78.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.955 0.407 . . . . 0.0 110.988 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -64.33 -41.89 96.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.023 -177.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 263' ' ' LEU . . . . . 0.459 ' O ' ' HG2' ' B' ' 267' ' ' LYS . 94.0 mt -74.12 -51.04 16.88 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -176.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -66.99 -48.14 69.36 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -172.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -67.09 -32.37 73.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.944 0.402 . . . . 0.0 110.62 -174.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -82.68 -9.91 59.16 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.245 -177.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 267' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' B' ' 263' ' ' LEU . 67.6 mmtt -87.48 -2.41 58.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.677 0.275 . . . . 0.0 111.279 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 91.98 7.85 63.88 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.031 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -108.75 -174.45 21.53 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 176.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . 0.652 ' HE2' ' HA ' ' B' ' 270' ' ' LYS . 8.4 mmpt? -127.41 -62.91 1.07 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.942 0.401 . . . . 0.0 110.876 -178.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 271' ' ' TYR . . . . . 0.831 ' HE1' ' HB3' ' B' ' 223' ' ' GLU . 90.1 m-85 -102.43 173.33 6.4 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.125 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 272' ' ' TYR . . . . . 0.455 ' CE2' HD13 ' B' ' 260' ' ' LEU . 17.6 p90 -149.87 169.4 21.21 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.519 -178.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 273' ' ' HIS . . . . . 0.516 ' CD2' ' HA ' ' B' ' 226' ' ' SER . 11.2 t-160 -139.63 110.01 6.59 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.813 0.34 . . . . 0.0 110.622 174.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 274' ' ' ILE . . . . . 0.545 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 47.6 mt -70.69 113.19 6.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.063 175.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 25.2 pt -100.04 -23.56 4.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.814 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -160.52 146.6 15.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.358 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 277' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' B' ' 285' ' ' GLU . . . -157.03 111.03 2.66 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 177.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 278' ' ' ARG . . . . . 0.442 ' H ' ' HD2' ' B' ' 278' ' ' ARG . 0.0 OUTLIER -129.31 150.46 50.67 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.651 -174.818 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -84.81 95.8 9.09 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 172.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 17.3 t-80 -91.61 84.85 5.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.055 0.455 . . . . 0.0 109.932 -177.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 66.76 -125.48 25.61 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.386 -175.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -85.15 -8.56 8.83 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.598 2.199 . . . . 0.0 111.965 175.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 283' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' B' ' 245' ' ' GLN . 15.1 m120 -103.81 109.98 21.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.676 -177.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 284' ' ' PHE . . . . . 0.51 ' HB3' ' HB2' ' B' ' 245' ' ' GLN . 78.3 t80 -78.76 120.02 22.81 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 175.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 285' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' B' ' 277' ' ' ALA . 97.2 mt-10 -108.72 110.92 22.45 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.41 0.444 . . . . 0.0 111.155 -176.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 286' ' ' ALA . . . . . 0.674 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -111.53 123.14 49.61 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 172.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 28.5 t -105.12 113.31 41.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.312 -178.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -130.84 128.81 41.4 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.678 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 289' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' B' ' 240' ' ' THR . 17.2 mt-10 -92.38 135.46 34.02 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 23.6 t -97.67 137.84 24.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.142 0.496 . . . . 0.0 111.496 -170.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -118.3 149.5 41.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.159 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 292' ' ' ASN . . . . . 0.55 ' HB2' HG13 ' B' ' 238' ' ' VAL . 8.0 t-20 -95.37 21.95 7.48 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.881 -171.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 293' ' ' ASP . . . . . 0.455 ' HB3' ' O ' ' B' ' 292' ' ' ASN . 10.8 t70 . . . . . 0 N--CA 1.474 0.775 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.562 172.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.127 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 178.95 104.65 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.584 178.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.622 ' HB2' ' HB3' ' B' ' 224' ' ' GLN . 0.0 OUTLIER -162.14 155.64 20.87 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 122.052 -0.405 . . . . 0.0 110.873 -179.341 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.8 m -115.75 143.93 24.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.966 174.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.634 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 11.8 t -108.05 -90.45 0.44 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -174.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.424 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 10.7 tmtt? -145.88 -45.73 0.21 Allowed 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -173.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.42 ' CB ' ' HB3' ' B' ' 277' ' ' ALA . 27.7 mm-40 -54.58 -49.85 69.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.996 -174.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.5 ' H ' ' CD ' ' A' ' 29' ' ' GLU . 0.9 OUTLIER -68.85 -43.75 74.8 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.713 -176.129 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.553 HG12 HD12 ' A' ' 35' ' ' LEU . 54.7 mt -62.1 -43.64 98.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.66 -175.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.4 m -72.6 -24.38 61.07 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.928 0.394 . . . . 0.0 111.274 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -91.56 -32.85 15.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.533 -173.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -110.1 -12.5 14.5 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -177.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt 65.93 82.98 0.17 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.165 0.507 . . . . 0.0 111.719 -178.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.553 HD12 HG12 ' A' ' 30' ' ' ILE . 22.0 mt -89.88 147.91 23.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.2 177.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.1 m -85.03 122.36 38.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.711 -177.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.1 ttmm -85.54 117.53 24.5 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 177.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.1 t -78.39 -28.08 14.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.155 0.502 . . . . 0.0 109.939 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 167.45 -175.99 42.35 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.854 179.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.6 m -130.28 123.47 30.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.055 0.455 . . . . 0.0 110.243 178.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.419 HD12 HD12 ' A' ' 63' ' ' LEU . 25.3 pt -120.28 166.07 15.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.413 -176.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.7 p30 -145.77 147.53 31.98 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.491 0.663 . . . . 0.0 111.169 176.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 75.0 t -94.56 142.64 13.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.551 177.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.6 t -159.6 79.73 0.72 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.189 0.519 . . . . 0.0 109.765 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.403 HE22 HG13 ' A' ' 43' ' ' VAL . 0.9 OUTLIER -113.8 150.04 34.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.358 178.365 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.7 t -111.61 112.73 24.65 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.622 -175.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.61 -144.93 17.45 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.226 176.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.3 74.54 1.68 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 121.603 -0.332 . . . . 0.0 113.781 -173.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -121.65 -36.73 2.99 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.154 0.502 . . . . 0.0 109.796 169.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.458 HG23 ' HB2' ' A' ' 55' ' ' ASP . 72.1 mt -133.52 123.01 45.35 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.493 176.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.7 m -143.64 -27.98 0.54 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.0 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.3 p -113.73 154.87 45.68 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 175.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.74 -25.0 58.28 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.824 2.349 . . . . 0.0 112.879 -176.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.628 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 11.8 p -67.24 -40.9 86.35 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.92 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.458 ' HB2' HG23 ' A' ' 50' ' ' ILE . 37.3 m-20 -58.63 -41.78 86.76 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.117 0.485 . . . . 0.0 110.624 -176.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 45.2 tp -63.23 -45.76 90.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.307 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.503 ' HD2' ' OE2' ' B' ' 223' ' ' GLU . 42.9 ttp180 -61.32 -40.5 94.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.983 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.628 ' HG2' ' O ' ' A' ' 54' ' ' SER . 9.4 mm-40 -59.18 -30.98 68.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.454 -177.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.433 ' O ' ' HB3' ' A' ' 62' ' ' GLU . 4.3 mptp? -93.86 -37.09 11.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.775 -177.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 86.5 mt -70.42 -39.7 74.27 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.019 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.0 t -69.2 -34.7 75.29 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 176.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.433 ' HB3' ' O ' ' A' ' 59' ' ' LYS . 34.4 tt0 -56.8 -49.32 75.68 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.87 177.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.419 HD12 HD12 ' A' ' 41' ' ' ILE . 73.8 mt -74.43 -30.36 61.88 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.742 -178.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.82 -50.98 53.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.433 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -68.23 -25.43 65.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.158 0.504 . . . . 0.0 110.41 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.45 -42.29 59.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.13 178.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.453 ' HD3' ' HA ' ' A' ' 67' ' ' LYS . 59.0 mmtt -77.13 -35.66 56.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.394 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.57 59.94 0.63 Allowed Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.605 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.672 ' HA2' ' HA ' ' A' ' 92' ' ' ASN . . . -143.93 160.87 27.82 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 177.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -107.63 -15.71 14.52 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.777 0.289 . . . . 0.0 111.267 -175.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.403 ' OH ' ' HD3' ' B' ' 257' ' ' ARG . 2.9 m-85 -140.47 145.63 37.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.642 0.258 . . . . 0.0 110.362 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.61 ' HD2' ' HB1' ' B' ' 222' ' ' ALA . 21.4 p90 -116.53 168.08 10.48 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 171.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.634 ' CD2' ' HA ' ' A' ' 26' ' ' SER . 10.0 t-160 -140.0 108.21 5.79 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.204 178.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 76.6 mt -71.76 118.59 16.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.188 177.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.9 pt -114.89 -18.58 7.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -152.92 100.42 2.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.826 0.345 . . . . 0.0 111.235 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -115.31 115.12 26.11 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -138.08 160.3 39.74 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.252 0.548 . . . . 0.0 111.614 -172.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -104.7 103.93 13.65 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.738 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.513 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 2.6 t-160 -94.75 56.88 2.09 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -176.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.67 -122.82 5.83 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.769 -0.933 . . . . 0.0 110.769 -175.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -83.94 10.52 3.66 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.372 2.048 . . . . 0.0 111.7 174.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.513 ' HB2' ' HB3' ' A' ' 80' ' ' HIS . 17.3 m-80 -113.48 127.27 56.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.282 -176.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -97.67 111.88 23.98 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.622 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 42.0 mt-10 -116.12 119.83 37.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.04 0.448 . . . . 0.0 110.957 -177.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -130.12 118.25 21.19 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.507 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.1 t -95.27 127.74 47.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 73' ' ' HIS . . . -136.62 144.72 44.23 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.389 -175.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -91.57 147.27 23.13 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 176.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 43.9 t -106.46 122.02 59.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -121.31 139.1 53.87 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.817 0.342 . . . . 0.0 110.079 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.672 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 26.2 t-20 -77.4 -89.42 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.202 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.5 t70 . . . . . 0 C--N 1.327 -0.404 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 178.417 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 222' ' ' ALA . . . . . 0.61 ' HB1' ' HD2' ' A' ' 72' ' ' TYR . . . . . . . . 0 C--O 1.234 0.257 0 CA-C-O 121.72 0.772 . . . . 0.0 112.656 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 223' ' ' GLU . . . . . 0.522 ' O ' ' HB2' ' A' ' 24' ' ' GLN . 34.7 mt-10 -139.98 -156.46 0.68 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.631 -178.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 224' ' ' GLN . . . . . 0.622 ' HB3' ' HB2' ' A' ' 24' ' ' GLN . 0.8 OUTLIER 68.76 144.32 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.034 0.534 . . . . 0.0 112.352 176.503 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 2.4 m -118.87 172.87 5.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.686 -177.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . 0.543 ' HA ' ' CD2' ' B' ' 273' ' ' HIS . 13.4 t -101.8 -96.02 0.28 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -176.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -142.53 -41.21 0.33 Allowed 'General case' 0 C--O 1.233 0.236 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -173.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -62.78 -30.7 71.66 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.76 0.79 . . . . 0.0 110.023 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -70.99 -34.52 71.46 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.625 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.506 HG23 ' HB2' ' B' ' 235' ' ' LEU . 56.4 mt -59.27 -43.38 89.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.153 0.502 . . . . 0.0 109.988 177.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 42.6 t -63.48 -30.15 71.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.668 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -84.54 -46.49 11.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.96 -176.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -93.89 -14.28 26.22 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -171.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? 62.52 88.91 0.09 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.289 0.566 . . . . 0.0 110.798 -176.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . 0.597 HD13 ' HE1' ' B' ' 271' ' ' TYR . 81.6 mt -108.9 155.43 20.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.08 -177.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 73.3 t -115.19 113.02 42.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.535 -172.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.2 140.05 58.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.91 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 1.9 m -122.85 5.78 5.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 138.62 -160.17 25.54 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.173 -1.013 . . . . 0.0 112.788 176.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' B' ' 289' ' ' GLU . 8.8 m -140.54 146.14 37.7 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -176.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 241' ' ' ILE . . . . . 0.524 ' HB ' HD13 ' B' ' 263' ' ' LEU . 26.4 pt -113.19 143.98 21.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 174.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -127.15 123.05 35.82 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.223 0.535 . . . . 0.0 110.684 -174.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 243' ' ' VAL . . . . . 0.674 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 75.3 t -100.15 116.14 42.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.448 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 72.7 m -135.96 87.87 2.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.332 177.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 245' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.43 163.11 33.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.575 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 37.7 t -78.14 174.68 10.9 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.208 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -70.4 4.6 8.52 Favored Glycine 0 CA--C 1.521 0.408 0 CA-C-N 116.363 -0.38 . . . . 0.0 113.041 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -80.55 -35.54 25.55 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.453 174.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -94.66 -21.5 18.75 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.924 0.393 . . . . 0.0 110.581 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 42.0 mm -119.45 99.29 7.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 176.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 16.7 t -130.9 -52.94 1.05 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.851 0.358 . . . . 0.0 110.524 -177.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 252' ' ' SER . . . . . 0.427 ' HB3' ' HD2' ' B' ' 253' ' ' PRO . 23.1 m -109.9 159.71 30.77 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.213 178.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . 0.452 ' HB3' HD21 ' A' ' 35' ' ' LEU . 11.1 Cg_endo -55.87 -39.78 89.08 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.826 2.351 . . . . 0.0 112.841 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 254' ' ' SER . . . . . 0.508 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 66.7 m -60.98 -31.87 71.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.211 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -64.13 -50.19 69.22 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.061 0.458 . . . . 0.0 110.249 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 48.6 tp -62.05 -38.38 88.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.541 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 257' ' ' ARG . . . . . 0.403 ' HD3' ' OH ' ' A' ' 71' ' ' TYR . 43.7 ttp180 -56.99 -51.03 70.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.754 178.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 258' ' ' GLU . . . . . 0.508 ' HG2' ' O ' ' B' ' 254' ' ' SER . 10.2 mm-40 -63.9 -38.9 92.81 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.934 -178.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -63.99 -46.36 84.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.628 178.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 94.6 mt -65.89 -38.88 89.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.711 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 47.3 t -62.42 -40.08 95.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.432 176.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -60.85 -43.24 98.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.42 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 263' ' ' LEU . . . . . 0.524 HD13 ' HB ' ' B' ' 241' ' ' ILE . 94.1 mt -74.06 -39.49 63.44 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.392 -178.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -64.67 -44.56 90.0 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.73 0.3 . . . . 0.0 111.447 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -68.72 -31.73 71.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.078 0.466 . . . . 0.0 110.174 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -67.06 -35.78 80.59 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.779 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -75.57 -37.21 60.08 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.024 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 89.25 31.98 11.13 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.374 -176.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -94.3 -176.9 38.98 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.568 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . 0.468 ' HG2' HD22 ' B' ' 292' ' ' ASN . 30.1 mmtp -112.1 -12.94 13.62 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.426 -177.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 271' ' ' TYR . . . . . 0.597 ' HE1' HD13 ' B' ' 235' ' ' LEU . 43.5 p90 -167.52 175.71 6.97 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 173.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 272' ' ' TYR . . . . . 0.544 ' H ' ' HG3' ' B' ' 224' ' ' GLN . 43.9 p90 -133.04 123.93 26.71 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 273' ' ' HIS . . . . . 0.543 ' CD2' ' HA ' ' B' ' 226' ' ' SER . 6.1 t-160 -95.04 102.12 13.91 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.095 -0.642 . . . . 0.0 110.257 -177.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 274' ' ' ILE . . . . . . . . . . . . . 62.1 mt -66.36 111.63 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.185 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 20.0 pt -103.2 -35.66 3.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -178.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -159.76 113.86 2.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.003 0.43 . . . . 0.0 111.365 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 277' ' ' ALA . . . . . 0.56 ' HA ' ' HA ' ' B' ' 286' ' ' ALA . . . -122.37 107.43 12.07 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 174.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -128.18 138.54 52.52 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.644 0.735 . . . . 0.0 111.55 -169.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -78.88 133.63 36.96 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.363 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -134.08 101.1 4.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.009 0.433 . . . . 0.0 110.704 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 64.46 -129.49 36.84 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.858 -178.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -88.71 8.38 3.99 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.235 2.624 . . . . 0.0 112.489 178.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -124.57 155.77 38.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.965 0.412 . . . . 0.0 110.726 -177.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 284' ' ' PHE . . . . . 0.493 ' CE2' ' HB2' ' B' ' 286' ' ' ALA . 83.2 t80 -111.62 125.17 53.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.241 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 285' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 8.3 mm-40 -109.7 110.86 22.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.282 -178.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 286' ' ' ALA . . . . . 0.674 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -119.82 125.51 48.73 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.329 179.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 25.8 t -111.65 118.62 57.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.364 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -135.19 135.92 41.39 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.868 177.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 289' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' B' ' 240' ' ' THR . 2.4 mt-10 -98.3 140.43 32.59 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -178.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 40.3 t -101.4 129.66 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -176.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 291' ' ' TYR . . . . . 0.552 ' HB2' ' CZ ' ' B' ' 271' ' ' TYR . 50.4 m-85 -120.14 150.51 40.5 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.403 0.62 . . . . 0.0 110.512 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 292' ' ' ASN . . . . . 0.468 HD22 ' HG2' ' B' ' 270' ' ' LYS . 3.1 t-20 -120.74 179.45 4.34 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.75 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 2.1 p30 . . . . . 0 C--N 1.318 -0.774 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 174.928 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.454 ' CB ' ' HA ' ' B' ' 261' ' ' SER . . . . . . . . 0 N--CA 1.466 0.365 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.55 ' HG2' ' HA ' ' B' ' 222' ' ' ALA . 8.6 tp10 -155.51 165.51 36.37 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.161 -179.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.503 ' HB3' ' HB2' ' B' ' 224' ' ' GLN . 0.0 OUTLIER 76.23 156.47 0.18 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.662 0.785 . . . . 0.0 111.168 176.876 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.9 m -117.92 174.42 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 121.157 0.503 . . . . 0.0 111.636 -174.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.45 ' HB3' ' HB ' ' B' ' 274' ' ' ILE . 69.0 p -79.4 -172.4 3.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.232 0.539 . . . . 0.0 111.542 -173.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.472 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 14.2 tmtt? -86.11 -29.37 23.38 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 171.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.476 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 1.0 OUTLIER -58.25 -50.1 74.77 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.287 179.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.59 ' HA ' ' HB3' ' A' ' 32' ' ' HIS . 0.4 OUTLIER -61.66 -26.99 68.36 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.315 -177.181 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.483 HG12 ' OH ' ' A' ' 71' ' ' TYR . 57.8 mt -61.0 -54.66 32.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.011 0.434 . . . . 0.0 110.047 176.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.2 m -73.48 -26.99 61.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.684 177.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.59 ' HB3' ' HA ' ' A' ' 29' ' ' GLU . 12.2 t-160 -68.31 -48.48 64.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.336 -175.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -104.52 -5.06 21.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.793 -176.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt 58.75 78.04 0.27 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.337 0.589 . . . . 0.0 110.77 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.8 mt -92.72 168.47 11.18 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.937 -176.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.9 t -96.99 138.23 22.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.792 -176.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -97.34 127.09 43.0 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.44 HG13 ' HB2' ' A' ' 92' ' ' ASN . 6.8 m -101.53 -45.78 11.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -175.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -174.66 175.0 46.88 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 119.689 -1.243 . . . . 0.0 113.362 -178.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.556 HG23 ' HG2' ' A' ' 89' ' ' GLU . 15.6 m -112.6 141.44 46.37 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 122.617 0.367 . . . . 0.0 110.421 -178.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.6 pt -120.14 144.64 28.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.816 0.341 . . . . 0.0 110.688 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -115.14 118.95 34.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.408 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.598 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 61.2 t -95.18 109.5 22.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.695 176.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.8 m -138.4 96.14 3.12 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.479 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.402 HE22 HG13 ' A' ' 43' ' ' VAL . 0.6 OUTLIER -129.01 134.43 48.14 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.637 -179.807 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.9 t -78.93 64.26 3.83 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.09 0.471 . . . . 0.0 111.126 -177.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.65 -69.93 2.3 Favored Glycine 0 CA--C 1.521 0.459 0 CA-C-N 115.86 -0.609 . . . . 0.0 114.412 172.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -50.83 -30.34 21.59 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 115.831 1.092 . . . . 0.0 115.831 -167.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -78.17 -27.01 47.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.831 0.816 . . . . 0.0 112.178 -175.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' A' ' 56' ' ' LEU . 49.7 mm -125.28 117.08 48.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 110.555 -0.165 . . . . 0.0 110.555 -175.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.6 t -119.19 -54.56 2.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.02 0.438 . . . . 0.0 110.329 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.511 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 4.9 m -105.85 164.35 15.19 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.817 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.572 ' HG3' HD21 ' B' ' 235' ' ' LEU . 18.4 Cg_endo -60.52 -28.26 86.35 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.482 2.121 . . . . 0.0 111.57 177.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.438 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -68.82 -28.81 67.07 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.2 178.62 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -70.76 -44.9 65.78 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.337 0.589 . . . . 0.0 109.444 175.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.505 ' HA ' HD12 ' A' ' 50' ' ' ILE . 55.5 tp -65.35 -40.0 93.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.542 -175.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 54' ' ' SER . 3.0 ppt_? -61.28 -37.02 81.64 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -175.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -67.64 -37.98 83.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.945 0.402 . . . . 0.0 110.277 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -67.92 -40.18 83.41 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.215 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.578 HD13 ' CE2' ' A' ' 72' ' ' TYR . 81.6 mt -71.89 -39.21 69.75 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.102 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.5 t -65.29 -39.13 92.15 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -57.11 -42.71 81.35 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.009 177.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 97.9 mt -71.68 -46.02 60.12 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.411 -178.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.81 -42.32 86.11 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -175.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -63.37 -24.06 67.68 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.796 0.331 . . . . 0.0 111.623 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.23 -13.79 37.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.906 0.384 . . . . 0.0 111.335 178.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -90.02 -42.68 11.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.094 0.473 . . . . 0.0 110.409 178.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.67 65.27 0.65 Allowed Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.724 -178.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -145.35 169.65 26.9 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.067 177.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.446 ' HD2' HH12 ' B' ' 257' ' ' ARG . 31.7 mmtp -92.17 -15.13 28.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.716 0.293 . . . . 0.0 111.087 -178.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.639 ' HA ' ' CB ' ' B' ' 222' ' ' ALA . 31.6 p90 -165.26 175.79 8.93 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -177.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.578 ' CE2' HD13 ' A' ' 60' ' ' LEU . 54.6 p90 -135.36 136.54 41.57 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 175.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -110.54 115.83 30.31 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.489 -177.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.526 ' H ' HD12 ' A' ' 74' ' ' ILE . 4.8 mp -72.53 136.03 26.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 32.2 pt -117.26 -21.78 4.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.736 0.303 . . . . 0.0 111.196 178.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -159.4 147.89 17.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.714 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -162.06 141.5 9.71 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -166.77 154.81 9.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.036 0.446 . . . . 0.0 111.403 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -88.6 118.32 28.17 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 168.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -107.15 91.93 3.87 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.19 -120.09 12.91 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -172.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -94.43 6.6 2.43 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.074 2.516 . . . . 0.0 112.341 175.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.495 ' N ' HD22 ' A' ' 83' ' ' ASN . 0.8 OUTLIER -103.55 143.51 32.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.705 0.288 . . . . 0.0 110.679 -178.241 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -103.06 114.25 28.39 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -111.91 127.34 55.82 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.842 -177.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.598 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -141.08 133.48 28.3 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.924 0.392 . . . . 0.0 110.126 175.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.3 t -116.16 118.03 57.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.072 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -133.5 145.54 50.27 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.851 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.556 ' HG2' HG23 ' A' ' 40' ' ' THR . 10.4 mt-10 -117.5 136.77 53.0 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 26.0 t -95.52 135.95 28.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.676 -171.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.492 ' HB2' ' CZ ' ' A' ' 71' ' ' TYR . 79.5 m-85 -119.2 149.06 42.38 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.211 0.529 . . . . 0.0 110.41 178.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.44 ' HB2' HG13 ' A' ' 38' ' ' VAL . 18.1 t-20 -95.74 167.36 11.32 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.482 -176.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.7 t70 . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.298 -178.994 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 222' ' ' ALA . . . . . 0.639 ' CB ' ' HA ' ' A' ' 71' ' ' TYR . . . . . . . . 0 N--CA 1.45 -0.425 0 CA-C-O 120.419 0.152 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 223' ' ' GLU . . . . . 0.526 ' HA ' ' OH ' ' A' ' 72' ' ' TYR . 10.2 pt-20 177.54 133.46 0.06 Allowed 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.896 0.747 . . . . 0.0 111.941 -177.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 224' ' ' GLN . . . . . 0.503 ' HB2' ' HB3' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -172.22 157.86 4.32 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.657 0.783 . . . . 0.0 109.064 179.789 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . 0.46 HG21 HD13 ' B' ' 235' ' ' LEU . 18.6 m -109.55 133.09 55.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.729 0.3 . . . . 0.0 111.109 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . 0.514 ' O ' HG13 ' B' ' 230' ' ' ILE . 83.3 p -90.56 -174.28 4.05 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 178.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -56.46 -37.42 70.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.397 -177.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -64.8 -50.45 66.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.702 -177.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -60.82 -41.06 94.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.171 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.541 ' HA ' HD12 ' B' ' 235' ' ' LEU . 83.5 mt -55.52 -51.79 53.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.921 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 35.3 m -72.09 -28.76 63.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.382 -178.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -78.26 -47.99 16.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.708 -175.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -92.04 4.33 53.31 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -173.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm 57.75 41.0 25.82 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.101 0.477 . . . . 0.0 111.022 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . 0.572 HD21 ' HG3' ' A' ' 53' ' ' PRO . 89.4 mt -63.01 125.66 24.75 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.838 -176.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.457 ' CG2' ' HB3' ' B' ' 292' ' ' ASN . 17.0 m -78.79 132.94 31.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.569 -175.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 41.9 tttm -78.4 117.58 19.75 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.44 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 27.0 t -84.3 -35.92 11.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.003 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 164.91 -178.65 39.94 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.226 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 42.1 m -109.69 135.46 50.6 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 18.4 pt -110.05 134.31 52.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.99 0.424 . . . . 0.0 110.511 175.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -120.5 114.33 21.61 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.952 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 243' ' ' VAL . . . . . 0.592 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 5.3 t -102.4 113.38 38.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.15 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 23.3 t -111.72 103.11 11.38 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.938 0.399 . . . . 0.0 110.032 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 245' ' ' GLN . . . . . 0.554 ' HG2' HG12 ' B' ' 250' ' ' ILE . 0.6 OUTLIER -99.96 143.38 30.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.784 -177.247 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 41.1 t -97.69 72.88 2.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.991 0.424 . . . . 0.0 110.859 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 69.43 -92.36 0.33 Allowed Glycine 0 CA--C 1.518 0.269 0 CA-C-N 115.676 -0.693 . . . . 0.0 114.158 172.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -79.89 50.86 3.97 Favored Glycine 0 CA--C 1.517 0.21 0 N-CA-C 114.195 0.438 . . . . 0.0 114.195 -169.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . 0.5 ' HB2' ' HG3' ' B' ' 245' ' ' GLN . 78.7 mt-30 -131.66 -0.07 3.93 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.17 0.51 . . . . 0.0 109.761 173.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 250' ' ' ILE . . . . . 0.554 HG12 ' HG2' ' B' ' 245' ' ' GLN . 45.0 mm -132.01 119.74 41.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.551 178.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 3.4 m -135.08 -50.68 0.76 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.227 -177.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.25 163.68 16.43 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.305 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.27 -37.75 94.21 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.342 2.028 . . . . 0.0 111.954 176.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 254' ' ' SER . . . . . 0.434 ' HA ' ' HB3' ' B' ' 257' ' ' ARG . 54.8 m -68.31 -25.9 65.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.831 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -64.42 -32.01 73.46 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.616 0.246 . . . . 0.0 110.581 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 56.3 tp -86.93 -38.51 16.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.929 0.395 . . . . 0.0 109.981 176.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 257' ' ' ARG . . . . . 0.446 HH12 ' HD2' ' A' ' 70' ' ' LYS . 77.6 ttt180 -50.72 -43.53 57.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.799 179.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 258' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -55.48 -48.57 74.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.657 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -72.9 -32.42 65.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.815 0.341 . . . . 0.0 111.041 -174.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 92.0 mt -65.22 -46.23 81.5 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.871 -178.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 261' ' ' SER . . . . . 0.454 ' HA ' ' CB ' ' A' ' 22' ' ' ALA . 17.6 m -67.18 -36.77 82.48 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.871 177.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -57.56 -52.13 66.68 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.169 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 263' ' ' LEU . . . . . 0.436 HD12 HG22 ' B' ' 243' ' ' VAL . 89.8 mt -73.21 -30.82 63.78 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -174.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.5 -38.51 68.12 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 121.149 -0.22 . . . . 0.0 111.33 -176.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -70.35 -32.89 70.79 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.989 0.423 . . . . 0.0 110.07 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -68.65 -22.73 64.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.321 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -96.36 -11.18 26.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.672 0.272 . . . . 0.0 111.004 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 80.03 53.35 4.24 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.634 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.04 -178.88 18.74 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.012 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . 0.412 ' HG3' ' OD2' ' B' ' 293' ' ' ASP . 22.3 mmmt -117.22 -46.87 2.69 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.922 0.391 . . . . 0.0 110.722 177.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 271' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -138.23 164.82 28.25 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 272' ' ' TYR . . . . . 0.427 ' HE1' ' N ' ' A' ' 23' ' ' GLU . 11.1 p90 -144.49 142.14 30.04 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.564 -174.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 22.0 t-80 -114.36 104.85 12.47 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.85 -178.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 274' ' ' ILE . . . . . 0.45 ' HB ' ' HB3' ' A' ' 26' ' ' SER . 57.4 mt -68.03 105.37 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.228 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 19.1 pt -77.98 -40.49 26.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.393 -176.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -153.45 131.45 11.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.126 0.489 . . . . 0.0 111.51 -177.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -120.58 103.56 9.25 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 174.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -127.23 126.82 43.4 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.331 0.586 . . . . 0.0 110.603 -172.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -88.89 126.55 35.43 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.308 0.575 . . . . 0.0 110.487 -176.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -97.39 81.2 2.96 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.121 -176.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 61.16 -120.18 21.7 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.057 -176.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 282' ' ' PRO . . . . . 0.506 ' C ' HD22 ' B' ' 283' ' ' ASN . 89.2 Cg_endo -83.06 10.55 3.6 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.799 2.332 . . . . 0.0 112.211 177.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 283' ' ' ASN . . . . . 0.506 HD22 ' C ' ' B' ' 282' ' ' PRO . 1.0 OUTLIER -121.08 166.53 13.78 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.893 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 284' ' ' PHE . . . . . 0.448 ' CE2' ' HB2' ' B' ' 286' ' ' ALA . 51.1 t80 -131.7 127.47 36.95 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.425 0.155 . . . . 0.0 110.686 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 285' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -111.26 110.51 21.03 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.443 -178.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 286' ' ' ALA . . . . . 0.592 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -107.29 120.24 41.61 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.612 0.244 . . . . 0.0 110.788 176.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 17.7 t -116.13 123.12 70.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.816 0.341 . . . . 0.0 110.577 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -136.6 144.47 44.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.945 0.402 . . . . 0.0 111.588 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -92.98 123.66 36.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.705 176.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 48.9 t -91.13 128.33 42.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.75 0.31 . . . . 0.0 110.467 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -123.48 156.34 35.78 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.11 0.481 . . . . 0.0 111.032 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 292' ' ' ASN . . . . . 0.457 ' HB3' ' CG2' ' B' ' 236' ' ' VAL . 6.9 t-20 -117.21 159.35 22.79 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 293' ' ' ASP . . . . . 0.412 ' OD2' ' HG3' ' B' ' 270' ' ' LYS . 4.1 p30 . . . . . 0 C--N 1.327 -0.408 0 O-C-N 123.102 0.251 . . . . 0.0 111.161 -177.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.539 ' HB1' ' CD2' ' B' ' 272' ' ' TYR . . . . . . . . 0 N--CA 1.453 -0.301 0 CA-C-O 120.36 0.124 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.602 ' HB3' ' HE1' ' A' ' 71' ' ' TYR . 10.8 mt-10 -160.33 110.97 1.85 Allowed 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -177.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.666 ' HB2' ' HB3' ' B' ' 224' ' ' GLN . 0.9 OUTLIER -173.58 141.35 0.86 Allowed 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.469 174.501 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.2 m -105.76 116.11 48.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.081 0.467 . . . . 0.0 110.929 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.673 ' HA ' ' HD2' ' A' ' 73' ' ' HIS . 15.9 t -82.13 172.76 12.82 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.778 0.323 . . . . 0.0 110.147 -177.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.553 ' HA ' ' HB ' ' A' ' 30' ' ' ILE . 29.1 mmmt -67.3 -19.33 65.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.26 -173.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 17.7 mp0 -65.47 -51.57 59.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.902 0.382 . . . . 0.0 110.31 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.517 ' OE2' ' HB3' ' A' ' 26' ' ' SER . 2.3 pm0 -76.84 -28.03 55.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.087 177.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.553 ' HB ' ' HA ' ' A' ' 27' ' ' LYS . 77.7 mt -60.0 -46.59 93.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.725 0.298 . . . . 0.0 110.204 174.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.6 m -73.8 -21.83 60.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.207 178.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -86.72 -46.17 10.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.423 -175.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -94.49 -13.87 25.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.07 -178.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm 62.01 76.06 0.38 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.525 0.679 . . . . 0.0 110.579 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.485 HD12 HG12 ' A' ' 30' ' ' ILE . 71.6 mt -87.52 177.01 7.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.869 -172.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 92' ' ' ASN . 28.9 t -104.0 115.34 45.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.472 -174.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.1 ttmm -80.88 121.16 25.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.654 0.264 . . . . 0.0 110.588 177.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.613 HG22 ' OD1' ' A' ' 92' ' ' ASN . 2.2 t -78.78 -34.42 17.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.572 0.701 . . . . 0.0 109.344 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 160.32 -159.51 30.89 Favored Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.961 -177.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.5 m -137.5 126.44 24.19 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.5 pt -103.96 136.46 37.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.087 0.47 . . . . 0.0 111.089 -177.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -117.01 122.58 44.62 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.974 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.49 ' HB ' ' H ' ' A' ' 86' ' ' ALA . 88.3 t -94.25 138.11 21.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.345 175.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.4 t -156.99 80.37 0.92 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.195 0.522 . . . . 0.0 110.247 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -125.4 159.75 31.1 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 176.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.557 ' HA ' ' HA ' ' A' ' 83' ' ' ASN . 22.6 t -64.59 158.95 22.94 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 176.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.88 50.82 1.9 Allowed Glycine 0 C--N 1.333 0.363 0 CA-C-N 116.358 -0.383 . . . . 0.0 112.843 -178.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -142.17 -36.84 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 177.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -69.66 -30.13 67.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.291 0.567 . . . . 0.0 110.036 175.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.3 mm -108.24 96.1 4.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 173.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.3 t -106.28 -2.03 22.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.954 0.407 . . . . 0.0 110.991 -174.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 93.4 p -162.19 164.4 17.33 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.213 -178.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.74 -25.86 81.88 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.237 1.958 . . . . 0.0 111.213 172.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.473 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 17.1 m -66.65 -45.4 79.09 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.6 178.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.503 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 26.5 m-20 -57.61 -45.54 85.2 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.227 0.537 . . . . 0.0 109.945 177.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 54.4 tp -64.57 -39.58 94.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.048 -178.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -60.32 -46.21 90.69 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.702 -178.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 54' ' ' SER . 8.5 mm-40 -63.53 -26.99 68.96 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.927 -177.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.521 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 29.3 mmmt -78.2 -53.67 7.08 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.524 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.0 mt -63.67 -41.86 98.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.72 -174.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.9 p -63.23 -45.71 90.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.668 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -60.61 -45.26 94.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.911 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 59' ' ' LYS . 92.1 mt -63.75 -40.27 96.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.066 -178.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.1 -43.85 77.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.863 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -63.2 -44.99 93.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.404 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.8 -22.25 61.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.976 -177.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -80.04 -12.17 59.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.691 0.281 . . . . 0.0 110.911 176.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 94.92 16.65 40.78 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.404 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.451 ' HA3' HG21 ' A' ' 38' ' ' VAL . . . -112.53 -158.15 13.65 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.875 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.822 ' HD2' ' HB2' ' A' ' 93' ' ' ASP . 93.2 mttt -138.92 -61.46 0.56 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.096 0.474 . . . . 0.0 110.795 177.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.602 ' HE1' ' HB3' ' A' ' 23' ' ' GLU . 56.8 m-85 -97.8 156.98 16.33 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.901 -171.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.49 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 26.3 p90 -142.81 123.24 13.94 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.191 178.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.673 ' HD2' ' HA ' ' A' ' 26' ' ' SER . 48.2 t-80 -96.06 109.07 21.55 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.14 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.596 ' H ' HD12 ' A' ' 74' ' ' ILE . 4.5 mp -73.69 104.8 2.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 30.0 pt -85.65 -20.55 8.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.723 -178.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -160.0 120.78 3.05 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.12 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -124.7 96.2 4.8 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 175.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.1 -178.99 4.25 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.292 -174.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.83 157.41 17.49 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 176.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.563 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 4.3 t-160 -124.08 63.16 1.08 Allowed 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 174.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.48 -114.6 4.5 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.213 -175.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -83.76 20.9 1.12 Allowed 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.684 2.256 . . . . 0.0 112.015 174.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.563 ' HB2' ' HB3' ' A' ' 80' ' ' HIS . 31.0 m-80 -131.27 164.21 26.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.116 -177.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -124.1 129.96 51.74 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 175.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.461 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 81.8 mt-10 -127.86 116.89 20.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.129 0.49 . . . . 0.0 111.465 -176.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.49 ' H ' ' HB ' ' A' ' 43' ' ' VAL . . . -114.31 128.79 56.53 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.312 178.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.0 t -108.76 115.86 50.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.905 179.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 72' ' ' TYR . . . -125.99 136.65 53.23 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.933 0.397 . . . . 0.0 111.544 -176.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 72' ' ' TYR . 45.9 mt-10 -91.76 118.63 30.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.82 177.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.5 t -86.3 128.65 39.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.434 -178.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -124.92 147.36 48.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.09 0.472 . . . . 0.0 110.608 178.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.613 ' OD1' HG22 ' A' ' 38' ' ' VAL . 21.5 m120 -82.52 163.1 21.76 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.139 178.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.822 ' HB2' ' HD2' ' A' ' 70' ' ' LYS . 38.0 t0 . . . . . 0 C--N 1.319 -0.757 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 169.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.381 0 CA-C-O 121.033 0.444 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -151.43 -156.66 0.73 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.126 -168.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 224' ' ' GLN . . . . . 0.687 ' HA ' ' HB3' ' B' ' 271' ' ' TYR . 0.0 OUTLIER 82.23 145.79 0.08 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.899 0.88 . . . . 0.0 111.495 172.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . 0.402 HG21 HD12 ' B' ' 235' ' ' LEU . 23.7 m -115.97 154.36 17.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.208 -176.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 19.7 m -99.03 -102.79 0.22 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.883 -178.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -124.16 -57.54 1.59 Allowed 'General case' 0 C--N 1.326 -0.413 0 O-C-N 122.011 -0.43 . . . . 0.0 111.31 -170.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -62.04 -38.08 87.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.025 0.44 . . . . 0.0 110.878 -175.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -61.72 -36.08 79.91 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.01 -177.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.415 HD13 ' CZ ' ' B' ' 291' ' ' TYR . 66.7 mt -60.49 -53.08 53.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.79 -178.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 23.2 t -72.85 -21.33 60.96 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.171 -176.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -87.87 -44.48 11.04 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -176.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -95.32 -18.43 20.8 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.582 0.216 . . . . 0.0 111.582 -177.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 5.7 mmmm 63.17 77.29 0.33 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.501 0.667 . . . . 0.0 111.489 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . 0.402 HD12 HG21 ' B' ' 225' ' ' VAL . 87.9 mt -93.94 140.75 29.32 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.502 175.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 27.2 m -76.88 127.07 38.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.106 0.479 . . . . 0.0 111.0 -177.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 237' ' ' LYS . . . . . 0.532 ' HE2' ' HB3' ' B' ' 289' ' ' GLU . 57.9 tttm -84.95 107.12 16.93 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.936 178.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 48.8 t -67.28 -35.19 73.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.607 -177.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 168.79 -149.32 13.61 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.313 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 38.3 m -139.74 140.81 36.83 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 -178.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 18.2 pt -121.14 139.01 49.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.097 0.475 . . . . 0.0 110.677 178.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -127.68 113.59 16.23 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 243' ' ' VAL . . . . . 0.468 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 2.3 t -100.69 108.41 23.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.21 -175.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 26.5 t -99.32 109.42 22.04 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 177.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 245' ' ' GLN . . . . . 0.698 ' HA ' HE21 ' B' ' 245' ' ' GLN . 0.0 OUTLIER -99.71 158.25 15.91 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 121.358 0.599 . . . . 0.0 110.669 179.302 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 1.5 p -91.48 11.04 25.31 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.539 175.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 94.83 -61.02 1.68 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.796 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -78.29 50.57 3.47 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 121.2 -0.524 . . . . 0.0 113.103 -178.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -137.03 -14.48 1.57 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.828 0.346 . . . . 0.0 110.533 177.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 39.5 mm -125.56 99.15 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.73 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 23.1 t -98.38 -25.47 14.81 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.355 0.597 . . . . 0.0 109.65 178.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 252' ' ' SER . . . . . 0.522 ' HB3' ' HD2' ' B' ' 253' ' ' PRO . 49.8 m -151.49 165.7 16.81 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.747 178.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . 0.522 ' HD2' ' HB3' ' B' ' 252' ' ' SER . 11.3 Cg_endo -55.41 -25.69 49.63 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.756 2.304 . . . . 0.0 112.113 177.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 254' ' ' SER . . . . . 0.548 ' O ' ' HG3' ' B' ' 258' ' ' GLU . 30.0 t -54.15 -36.29 63.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.142 174.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -74.32 -40.16 62.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.905 0.383 . . . . 0.0 110.614 -177.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 42.7 tp -60.9 -45.45 94.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.211 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 257' ' ' ARG . . . . . 0.519 ' HD3' ' OH ' ' A' ' 71' ' ' TYR . 13.1 ptt180 -63.72 -30.99 72.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.796 0.331 . . . . 0.0 111.158 -178.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 258' ' ' GLU . . . . . 0.548 ' HG3' ' O ' ' B' ' 254' ' ' SER . 56.5 mt-10 -72.41 -36.49 68.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.854 0.359 . . . . 0.0 110.462 -179.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -74.67 -40.1 61.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.966 178.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 93.3 mt -66.35 -43.89 84.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.746 -177.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 22.0 p -68.15 -34.15 75.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.751 0.31 . . . . 0.0 110.521 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -54.93 -44.76 74.57 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.573 0.701 . . . . 0.0 109.966 176.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 263' ' ' LEU . . . . . 0.587 ' O ' ' HG2' ' B' ' 267' ' ' LYS . 68.9 mt -74.69 -41.73 59.69 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.995 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -60.17 -47.86 84.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.271 -174.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -70.7 -29.96 66.39 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.624 -177.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -66.49 -23.53 66.27 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.373 0.606 . . . . 0.0 110.538 176.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 267' ' ' LYS . . . . . 0.587 ' HG2' ' O ' ' B' ' 263' ' ' LEU . 73.3 mmtt -89.43 -21.76 22.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.869 176.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 88.27 25.3 31.47 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.802 -177.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -100.14 -165.28 28.82 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.124 -179.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . 0.513 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 22.2 mmtp -132.66 -67.56 0.64 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.194 0.521 . . . . 0.0 109.708 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 271' ' ' TYR . . . . . 0.687 ' HB3' ' HA ' ' B' ' 224' ' ' GLN . 7.7 m-85 -101.23 145.29 29.02 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.165 -176.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 272' ' ' TYR . . . . . 0.539 ' CD2' ' HB1' ' A' ' 22' ' ' ALA . 10.9 p90 -104.46 169.47 8.45 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 175.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 273' ' ' HIS . . . . . 0.455 ' HB3' ' HB2' ' B' ' 289' ' ' GLU . 10.7 t-160 -138.03 101.47 4.43 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.402 172.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 274' ' ' ILE . . . . . 0.46 HG21 ' OE1' ' A' ' 29' ' ' GLU . 63.3 mt -71.33 123.02 24.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.155 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 22.5 pt -114.08 -28.67 2.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.592 -176.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -152.06 107.13 3.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.954 0.407 . . . . 0.0 111.531 -178.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -105.37 96.65 6.66 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 173.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -127.38 137.51 52.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.206 0.527 . . . . 0.0 111.331 -170.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -88.06 119.75 28.74 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.095 0.474 . . . . 0.0 110.707 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -98.62 78.65 2.39 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 69.5 -126.42 18.78 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 -175.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.74 6.47 4.5 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 122.614 2.209 . . . . 0.0 112.257 177.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -112.34 151.49 29.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.184 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 284' ' ' PHE . . . . . 0.464 ' HB3' ' HB2' ' B' ' 245' ' ' GLN . 52.0 t80 -115.67 113.0 22.93 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 175.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 285' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -102.37 110.39 22.32 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.293 -0.412 . . . . 0.0 109.993 -177.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 286' ' ' ALA . . . . . 0.468 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -102.35 114.91 29.49 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.79 0.328 . . . . 0.0 110.52 176.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 29.4 t -105.75 120.93 57.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.218 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -138.83 152.21 47.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.019 0.438 . . . . 0.0 111.364 -178.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 289' ' ' GLU . . . . . 0.532 ' HB3' ' HE2' ' B' ' 237' ' ' LYS . 31.1 mt-10 -91.74 157.99 16.61 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 175.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 39.9 t -115.11 125.43 72.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 177.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 291' ' ' TYR . . . . . 0.415 ' CZ ' HD13 ' B' ' 230' ' ' ILE . 93.5 m-85 -125.02 155.34 39.87 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.236 0.541 . . . . 0.0 110.716 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 292' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -118.91 156.62 29.2 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 2.3 p30 . . . . . 0 N--CA 1.466 0.325 0 CA-C-O 120.662 0.267 . . . . 0.0 110.897 -178.871 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.589 ' HA ' ' OE2' ' B' ' 223' ' ' GLU . . . . . . . . 0 N--CA 1.464 0.241 0 CA-C-O 121.277 0.561 . . . . 0.0 109.984 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.717 ' O ' ' HB3' ' A' ' 24' ' ' GLN . 9.2 tp10 -133.74 178.75 6.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.349 -171.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.717 ' HB3' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER 96.45 134.9 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.95 1.3 . . . . 0.0 111.985 176.851 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.435 ' N ' ' HG2' ' A' ' 24' ' ' GLN . 21.2 m -109.98 155.74 11.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.07 -0.968 . . . . 0.0 108.721 172.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.623 ' HB3' ' OE1' ' A' ' 28' ' ' GLN . 7.0 t -98.29 -176.85 3.52 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.26 -178.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.594 ' HA ' HD12 ' A' ' 30' ' ' ILE . 5.0 tmtt? -65.08 -27.87 69.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.464 -169.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.623 ' OE1' ' HB3' ' A' ' 26' ' ' SER . 15.8 mp0 -59.34 -49.51 77.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.021 0.439 . . . . 0.0 110.356 -178.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.638 ' HA ' ' HB3' ' A' ' 32' ' ' HIS . 12.8 mm-40 -75.25 -25.62 58.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.102 -173.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.594 HD12 ' HA ' ' A' ' 27' ' ' LYS . 63.8 mt -57.53 -52.93 51.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.204 0.526 . . . . 0.0 109.912 175.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.8 m -73.87 -24.02 59.68 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.001 177.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.638 ' HB3' ' HA ' ' A' ' 29' ' ' GLU . 21.8 t-160 -69.72 -52.58 24.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.136 -177.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -97.59 2.95 50.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.301 -176.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt 56.17 59.05 3.9 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 123.624 0.577 . . . . 0.0 111.03 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.3 mt -62.44 138.04 58.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.654 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.8 t -65.09 -37.17 79.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.541 -174.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.0 tttm 66.28 114.94 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 O-C-N 124.227 0.954 . . . . 0.0 111.118 -178.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.2 m -82.66 -39.45 15.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.859 -0.337 . . . . 0.0 111.741 -177.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 173.12 -155.67 23.12 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.266 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.55 HG23 ' HG2' ' A' ' 89' ' ' GLU . 46.8 m -141.97 131.06 23.25 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.706 0.289 . . . . 0.0 110.337 -178.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.9 pt -120.91 173.3 6.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -150.29 152.2 34.13 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.558 0.694 . . . . 0.0 112.112 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.616 HG13 ' NE2' ' A' ' 45' ' ' GLN . 69.2 t -94.64 128.67 45.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.521 171.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.4 t -143.34 46.11 1.52 Allowed 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.616 ' NE2' HG13 ' A' ' 43' ' ' VAL . 1.0 OUTLIER -93.42 145.05 24.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.033 -175.089 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.3 m -82.1 80.97 8.2 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.956 -174.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.23 -77.29 0.58 Allowed Glycine 0 CA--C 1.521 0.434 0 N-CA-C 114.872 0.709 . . . . 0.0 114.872 168.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -58.56 -19.85 43.5 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 114.743 0.657 . . . . 0.0 114.743 -168.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.431 ' HB2' ' HB3' ' A' ' 45' ' ' GLN . 15.9 mm-40 -79.35 -21.77 45.37 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 117.356 0.578 . . . . 0.0 111.169 -178.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 40.3 mm -123.44 88.22 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.7 t -105.76 -30.64 9.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.635 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.7 m -127.47 158.38 69.92 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.373 -177.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.28 -32.52 81.31 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.726 2.284 . . . . 0.0 112.088 176.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.591 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 11.5 p -64.28 -40.68 96.45 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.145 178.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -54.96 -30.97 60.13 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.733 0.301 . . . . 0.0 111.457 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 40.4 tp -56.59 -55.91 27.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.774 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -73.21 -29.8 63.06 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.047 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.591 ' HG2' ' O ' ' A' ' 54' ' ' SER . 22.8 mm-40 -62.05 -48.31 80.83 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.214 0.531 . . . . 0.0 110.837 179.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -73.12 -37.94 66.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.336 -178.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.479 HD13 ' CE1' ' A' ' 72' ' ' TYR . 37.6 mt -72.08 -35.51 69.25 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.732 -178.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.515 ' HG ' ' N ' ' B' ' 222' ' ' ALA . 24.9 m -62.6 -42.74 99.75 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 120.874 -0.331 . . . . 0.0 110.31 173.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -56.18 -39.65 72.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.356 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.402 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 86.6 mt -76.42 -51.34 12.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.669 178.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.86 -32.16 72.48 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.294 -171.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -58.03 -49.49 76.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.946 0.403 . . . . 0.0 110.611 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.49 -25.25 63.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.612 -178.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 63' ' ' LEU . 74.9 mmtt -75.87 -19.62 58.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.023 0.439 . . . . 0.0 110.581 178.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.55 38.46 9.7 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.291 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -105.51 161.62 14.56 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.414 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.584 ' HG3' ' OD2' ' A' ' 93' ' ' ASP . 35.4 mmtp -98.73 -48.66 4.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.276 0.56 . . . . 0.0 110.387 178.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.537 ' HE2' ' HD2' ' B' ' 257' ' ' ARG . 1.5 p90 -147.63 168.28 22.42 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.39 -178.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.479 ' CE1' HD13 ' A' ' 60' ' ' LEU . 45.8 p90 -142.14 166.96 23.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.901 -178.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -137.7 109.43 7.08 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.313 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.575 HG12 ' HB2' ' A' ' 88' ' ' ALA . 83.6 mt -69.62 130.31 34.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 176.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.9 pt -109.55 -25.88 3.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.29 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -150.0 129.37 12.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.628 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -144.28 138.12 27.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.255 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.531 ' HD3' ' HB2' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -166.52 157.77 12.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.547 179.848 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -91.47 122.68 34.28 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 168.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -115.35 96.73 5.8 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.82 -125.25 9.0 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -172.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.44 ' HD2' ' ND2' ' A' ' 83' ' ' ASN . 94.9 Cg_endo -94.83 14.94 1.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.019 2.479 . . . . 0.0 112.497 175.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.44 ' ND2' ' HD2' ' A' ' 82' ' ' PRO . 12.6 m-80 -114.87 150.69 35.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.704 0.288 . . . . 0.0 110.947 -176.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -109.43 108.17 18.59 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 174.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.532 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 5.0 mm-40 -100.62 112.34 24.71 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.057 -175.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.495 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -130.57 116.55 18.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.855 0.359 . . . . 0.0 111.318 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.2 t -96.55 123.35 48.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.782 0.325 . . . . 0.0 110.649 -177.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.575 ' HB2' HG12 ' A' ' 74' ' ' ILE . . . -135.35 129.0 32.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.007 0.432 . . . . 0.0 111.307 -177.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.55 ' HG2' HG23 ' A' ' 40' ' ' THR . 21.1 mt-10 -92.34 137.01 32.73 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 23.1 t -99.89 134.5 39.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 120.896 0.379 . . . . 0.0 110.33 -176.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -124.69 149.35 47.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.237 -177.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.574 ' OD1' ' HG2' ' A' ' 70' ' ' LYS . 18.2 m-20 -123.53 150.85 43.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.393 176.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.584 ' OD2' ' HG3' ' A' ' 70' ' ' LYS . 5.8 m-20 . . . . . 0 C--O 1.238 0.464 0 O-C-N 123.687 0.617 . . . . 0.0 110.359 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 222' ' ' ALA . . . . . 0.515 ' N ' ' HG ' ' A' ' 61' ' ' SER . . . . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.951 0.405 . . . . 0.0 111.65 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 223' ' ' GLU . . . . . 0.589 ' OE2' ' HA ' ' A' ' 22' ' ' ALA . 8.7 pt-20 -150.78 169.58 21.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.502 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 224' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' B' ' 223' ' ' GLU . 0.8 OUTLIER 177.4 137.08 0.07 Allowed 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.781 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 5.7 m -133.55 107.28 10.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.07 0.462 . . . . 0.0 110.195 173.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . 0.495 ' O ' HG13 ' B' ' 230' ' ' ILE . 8.5 t -89.71 171.08 9.9 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -178.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . 0.419 ' HB3' ' HE2' ' B' ' 227' ' ' LYS . 43.5 mtpt -66.45 -18.18 65.22 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -171.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -72.07 -47.56 50.64 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 176.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 229' ' ' GLU . . . . . 0.449 ' OE1' ' HB3' ' B' ' 226' ' ' SER . 2.0 mp0 -67.4 -41.04 85.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.159 176.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.571 HG12 HD12 ' B' ' 235' ' ' LEU . 98.1 mt -59.01 -48.01 88.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.448 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 35.5 p -72.78 -25.01 61.01 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.007 0.432 . . . . 0.0 110.959 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 26.4 t-80 -75.71 -50.17 16.12 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.284 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -88.62 -16.89 31.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.319 -177.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 60.06 79.77 0.23 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.543 0.687 . . . . 0.0 110.177 -177.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . 0.571 HD12 HG12 ' B' ' 230' ' ' ILE . 82.9 mt -82.57 177.48 8.69 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.002 -175.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 61.3 t -105.96 138.8 29.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.727 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 237' ' ' LYS . . . . . 0.438 ' HE2' ' O ' ' B' ' 239' ' ' GLY . 20.2 tptm -104.74 128.9 53.0 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.774 -179.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 238' ' ' VAL . . . . . 0.418 HG13 ' HB2' ' B' ' 292' ' ' ASN . 2.6 m -91.3 -45.33 14.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.297 176.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 239' ' ' GLY . . . . . 0.438 ' O ' ' HE2' ' B' ' 237' ' ' LYS . . . 166.02 -178.7 40.57 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.115 -177.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 34.9 m -106.69 137.93 43.81 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.466 -0.198 . . . . 0.0 110.466 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 29.7 pt -105.53 137.44 35.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.878 0.37 . . . . 0.0 110.435 175.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -115.64 114.17 24.53 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.431 -177.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 243' ' ' VAL . . . . . 0.585 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 54.9 t -101.9 125.4 56.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.901 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 23.1 t -146.91 106.4 3.92 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.874 0.369 . . . . 0.0 110.44 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 245' ' ' GLN . . . . . 0.507 ' HG3' ' HB2' ' B' ' 249' ' ' GLN . 0.0 OUTLIER -156.33 168.05 28.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.391 178.363 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 22.6 t -92.16 -174.3 3.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.828 0.347 . . . . 0.0 110.413 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -69.64 -3.1 39.67 Favored Glycine 0 C--N 1.33 0.2 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.771 -178.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -74.45 -27.59 65.29 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.701 -0.762 . . . . 0.0 111.613 174.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . 0.507 ' HB2' ' HG3' ' B' ' 245' ' ' GLN . 64.7 mt-30 -102.16 -36.79 8.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.56 0.219 . . . . 0.0 110.586 177.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 250' ' ' ILE . . . . . 0.433 HG12 ' HG3' ' B' ' 245' ' ' GLN . 47.6 mm -115.4 99.97 9.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.857 0.36 . . . . 0.0 110.791 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 21.5 t -122.68 -42.74 2.3 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.999 175.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 252' ' ' SER . . . . . 0.51 ' HB3' ' HD2' ' B' ' 253' ' ' PRO . 32.3 m -111.23 162.33 21.35 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.776 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . 0.51 ' HD2' ' HB3' ' B' ' 252' ' ' SER . 13.1 Cg_endo -57.83 -35.25 98.88 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.775 2.316 . . . . 0.0 112.754 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 254' ' ' SER . . . . . 0.417 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 5.3 p -63.27 -34.39 77.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.149 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -58.84 -51.57 69.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.662 -176.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 55.4 tp -63.66 -37.92 89.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.029 -177.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 257' ' ' ARG . . . . . 0.537 ' HD2' ' HE2' ' A' ' 71' ' ' TYR . 81.3 mtp180 -59.43 -39.92 85.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.719 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 258' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' B' ' 254' ' ' SER . 21.2 mm-40 -65.46 -30.98 71.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.857 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -79.74 -48.36 13.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.113 -177.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.69 -46.25 86.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.904 -174.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 18.4 p -61.28 -41.18 96.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.224 0.535 . . . . 0.0 110.763 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -61.5 -51.0 70.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.156 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 263' ' ' LEU . . . . . . . . . . . . . 95.9 mt -67.65 -31.42 71.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.68 -175.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.88 -50.75 47.05 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -175.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -71.98 -25.31 61.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.872 0.368 . . . . 0.0 110.106 -177.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -67.8 -34.24 76.37 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.287 0.565 . . . . 0.0 110.552 176.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -81.79 -9.68 59.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.362 177.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 268' ' ' GLY . . . . . 0.484 ' O ' ' HE2' ' B' ' 270' ' ' LYS . . . 96.37 5.92 58.94 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.168 175.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . 0.485 ' HA3' HG12 ' B' ' 290' ' ' VAL . . . -89.45 154.94 24.58 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.685 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . 0.484 ' HE2' ' O ' ' B' ' 268' ' ' GLY . 48.6 mmtt -119.74 -2.54 10.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.951 0.405 . . . . 0.0 110.55 -175.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 271' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -143.55 154.6 43.77 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 175.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 272' ' ' TYR . . . . . 0.443 ' CD1' ' HB1' ' A' ' 22' ' ' ALA . 7.3 p90 -151.31 157.85 43.05 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.994 174.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -138.89 112.13 8.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.865 -178.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 274' ' ' ILE . . . . . 0.591 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 55.6 mt -69.24 120.76 17.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.536 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 22.0 pt -97.87 -36.94 6.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.149 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -145.45 100.44 3.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.925 0.393 . . . . 0.0 111.598 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -104.57 100.57 10.24 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 174.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 278' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' B' ' 285' ' ' GLU . 10.0 ptm180 -118.68 111.96 19.19 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.838 0.827 . . . . 0.0 111.787 -169.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -77.75 96.78 4.99 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.666 173.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 17.1 t-160 -96.62 97.83 9.7 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.691 -175.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 77.39 -137.26 20.1 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -174.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -83.08 -4.36 11.17 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.462 2.108 . . . . 0.0 111.872 174.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -103.66 154.33 19.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.173 -176.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 284' ' ' PHE . . . . . 0.438 ' CE2' ' HB2' ' B' ' 286' ' ' ALA . 84.1 t80 -114.74 124.75 52.58 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.913 0.387 . . . . 0.0 110.238 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 285' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 36.2 mt-10 -123.72 116.65 23.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.151 -179.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 286' ' ' ALA . . . . . 0.585 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -118.07 130.15 55.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.119 0.485 . . . . 0.0 111.722 -175.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 35.2 t -110.93 120.73 62.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.031 174.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -133.13 140.86 47.84 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.11 0.481 . . . . 0.0 111.517 -177.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -91.75 119.27 31.43 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.497 177.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 290' ' ' VAL . . . . . 0.485 HG12 ' HA3' ' B' ' 269' ' ' GLY . 15.4 t -94.98 130.41 43.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -117.35 157.81 25.49 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.375 0.607 . . . . 0.0 110.634 -176.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 292' ' ' ASN . . . . . 0.418 ' HB2' HG13 ' B' ' 238' ' ' VAL . 6.3 t-20 -120.37 164.38 16.43 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 174.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 9.5 t70 . . . . . 0 C--N 1.32 -0.688 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -176.985 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.697 ' HB1' ' CD1' ' B' ' 272' ' ' TYR . . . . . . . . 0 CA--C 1.519 -0.248 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.497 ' O ' ' HE1' ' B' ' 272' ' ' TYR . 0.0 OUTLIER -138.23 -171.67 3.09 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.883 -171.116 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.554 ' CD ' ' HG3' ' B' ' 224' ' ' GLN . 0.0 OUTLIER 75.24 154.69 0.16 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.627 0.771 . . . . 0.0 111.615 176.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.8 m -114.77 164.56 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.854 -176.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.525 ' HB2' ' HB ' ' B' ' 274' ' ' ILE . 16.8 t -74.95 164.32 26.69 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.005 0.431 . . . . 0.0 111.267 -174.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -66.61 -28.91 68.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.281 176.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -60.67 -37.97 83.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.403 176.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.622 ' HA ' ' HB3' ' A' ' 32' ' ' HIS . 15.4 mm-40 -72.52 -26.21 61.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.908 -175.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.457 ' HA ' HD13 ' A' ' 35' ' ' LEU . 56.5 mt -60.79 -48.09 90.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 173.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.2 m -73.92 -21.15 60.16 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.1 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.622 ' HB3' ' HA ' ' A' ' 29' ' ' GLU . 22.8 t-160 -80.89 -54.21 5.79 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.402 -175.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -93.24 -20.05 20.81 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -176.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.85 84.99 0.13 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.191 0.519 . . . . 0.0 110.513 -175.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.565 HD22 ' HE1' ' A' ' 71' ' ' TYR . 5.8 mp -91.08 175.48 6.93 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.433 -176.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -99.38 129.51 49.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.253 -173.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.474 ' HZ1' ' CD ' ' A' ' 89' ' ' GLU . 35.3 tptt -70.48 126.46 29.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.416 179.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.94 8.88 5.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.952 0.406 . . . . 0.0 111.483 175.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.75 -170.0 15.97 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.8 174.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 53.3 m -133.38 131.05 39.58 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.629 HG13 ' HB3' ' A' ' 88' ' ' ALA . 26.1 pt -104.23 132.33 51.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 176.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -123.28 127.72 48.96 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.136 0.493 . . . . 0.0 110.686 -175.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.662 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 88.7 t -93.01 123.26 45.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.171 175.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.5 t -146.35 74.4 1.36 Allowed 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 176.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -124.37 178.75 5.22 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.051 -178.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.8 t -86.27 168.47 13.88 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.85 176.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.26 -16.52 54.07 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.492 178.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.24 -17.83 74.45 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.123 -0.561 . . . . 0.0 112.349 177.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -111.61 -26.85 8.81 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.12 0.486 . . . . 0.0 110.353 176.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.494 HD12 ' HA ' ' A' ' 56' ' ' LEU . 43.1 mm -117.41 92.13 2.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.34 175.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.8 t -113.79 -62.33 1.61 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.347 -177.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.8 m -101.56 165.02 14.8 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.827 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -53.0 -38.4 79.98 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.423 2.082 . . . . 0.0 111.567 174.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.8 p -67.71 -38.53 83.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.448 177.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -59.88 -46.89 87.89 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.154 0.502 . . . . 0.0 109.932 176.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.494 ' HA ' HD12 ' A' ' 50' ' ' ILE . 60.4 tp -61.28 -45.74 93.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.19 176.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.69 ' HD2' ' OE2' ' B' ' 223' ' ' GLU . 3.7 ttp180 -53.41 -48.36 68.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.203 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -55.52 -45.76 77.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.14 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -70.74 -35.23 72.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.06 -178.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.7 mt -66.04 -48.65 70.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.062 0.458 . . . . 0.0 110.635 176.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.5 t -64.03 -38.11 89.87 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.226 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -58.17 -43.88 87.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.95 178.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 93.5 mt -70.32 -38.03 74.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.277 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.95 93.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.063 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -63.11 -31.94 73.2 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.099 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.47 -24.01 61.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.32 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 28.3 mmtm -100.17 -13.42 18.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.557 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.09 38.82 73.47 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.108 -179.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.1 146.3 18.19 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.567 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.471 ' HG2' ' OD2' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -89.89 -2.18 58.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.633 0.254 . . . . 0.0 111.442 -176.497 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.565 ' HE1' HD22 ' A' ' 35' ' ' LEU . 10.4 p90 -167.4 174.88 7.61 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 169.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.547 ' O ' ' HG3' ' A' ' 24' ' ' GLN . 44.0 p90 -148.25 130.74 15.77 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 175.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -111.43 109.67 19.75 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.385 -0.526 . . . . 0.0 109.97 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.555 ' HA ' ' HA ' ' A' ' 88' ' ' ALA . 68.2 mt -68.75 127.15 30.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 177.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 26.8 pt -102.3 -37.24 4.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.03 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.23 136.03 36.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.241 -178.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -147.69 134.12 19.68 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.493 ' HD3' ' HB2' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -154.72 147.34 24.21 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.999 0.428 . . . . 0.0 110.286 179.192 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -94.11 92.6 7.37 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 177.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -87.59 80.13 8.1 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.44 -173.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.62 -121.92 16.05 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.961 -178.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -86.2 -1.46 8.56 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.951 2.434 . . . . 0.0 112.442 177.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -117.45 122.42 43.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.318 -178.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.45 ' CD2' HG21 ' A' ' 50' ' ' ILE . 88.5 t80 -92.53 128.04 38.23 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 177.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.662 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 48.4 mt-10 -112.22 117.09 31.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.708 -179.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.525 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -120.99 118.67 30.44 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.194 175.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.6 t -100.95 111.5 30.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.629 ' HB3' HG13 ' A' ' 41' ' ' ILE . . . -117.38 132.45 56.58 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.05 0.452 . . . . 0.0 110.957 -177.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.496 ' HB3' ' CE2' ' A' ' 91' ' ' TYR . 11.0 mm-40 -92.14 128.23 37.91 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.116 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.1 t -102.37 125.86 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -178.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.496 ' CE2' ' HB3' ' A' ' 89' ' ' GLU . 92.9 m-85 -129.54 142.67 50.71 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.0 0.429 . . . . 0.0 110.386 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -111.85 170.32 8.23 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.014 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.471 ' OD2' ' HG2' ' A' ' 70' ' ' LYS . 13.2 m-20 . . . . . 0 C--N 1.322 -0.608 0 CA-C-O 121.085 0.469 . . . . 0.0 111.006 -176.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.503 0 CA-C-O 120.769 0.319 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 223' ' ' GLU . . . . . 0.69 ' OE2' ' HD2' ' A' ' 57' ' ' ARG . 9.8 tp10 -162.04 120.45 2.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.818 -178.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 224' ' ' GLN . . . . . 0.554 ' HG3' ' CD ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -169.95 139.29 1.86 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.041 0.448 . . . . 0.0 112.067 -179.093 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 14.1 m -113.84 128.83 70.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.032 170.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . 0.464 ' HB2' ' HG2' ' B' ' 229' ' ' GLU . 12.5 m -77.59 157.42 30.29 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.683 -178.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -68.31 -30.39 69.36 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -62.22 -35.75 79.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.687 176.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 229' ' ' GLU . . . . . 0.464 ' HG2' ' HB2' ' B' ' 226' ' ' SER . 36.6 mm-40 -71.34 -25.3 62.34 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.405 -178.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.532 HG12 HD12 ' B' ' 235' ' ' LEU . 56.8 mt -60.97 -45.17 98.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.828 175.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 5.1 m -73.07 -21.66 60.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.568 176.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 232' ' ' HIS . . . . . 0.421 ' HB3' ' HA ' ' B' ' 229' ' ' GLU . 23.1 t-160 -78.11 -52.04 9.35 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.579 -173.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -113.22 -4.59 13.72 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -175.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.88 84.92 0.12 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.421 0.629 . . . . 0.0 110.119 -171.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . 0.532 HD12 HG12 ' B' ' 230' ' ' ILE . 87.9 mt -79.32 138.84 37.87 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.031 -176.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 57.2 t -72.92 106.4 2.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.626 -178.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -79.23 116.88 19.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.105 0.478 . . . . 0.0 110.317 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 3.0 t -81.36 -40.89 18.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.825 -178.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 169.05 -149.98 14.73 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.47 -178.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 41.6 m -139.42 127.63 22.58 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 241' ' ' ILE . . . . . 0.466 HG23 HG21 ' B' ' 290' ' ' VAL . 2.4 pp -103.32 131.96 50.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.123 0.487 . . . . 0.0 109.931 178.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -116.19 120.19 38.19 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.058 -177.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 243' ' ' VAL . . . . . 0.588 ' O ' ' HA ' ' B' ' 285' ' ' GLU . 57.9 t -94.16 132.2 38.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.408 178.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 46.5 m -127.87 88.55 2.79 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 172.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 245' ' ' GLN . . . . . 0.594 ' HG2' HG12 ' B' ' 250' ' ' ILE . 0.7 OUTLIER -80.88 107.82 14.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.076 -173.474 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 53.1 p -84.99 102.74 13.42 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.853 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 92.52 -163.73 27.58 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.798 176.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -85.61 64.67 4.09 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 121.275 -0.488 . . . . 0.0 113.443 -172.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . 0.556 ' HB2' ' HG3' ' B' ' 245' ' ' GLN . 64.8 mt-30 -93.95 -3.06 52.28 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.01 0.433 . . . . 0.0 110.195 173.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 250' ' ' ILE . . . . . 0.594 HG12 ' HG2' ' B' ' 245' ' ' GLN . 38.7 mm -125.68 99.22 5.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.091 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 33.0 t -93.58 -46.36 7.32 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.098 0.475 . . . . 0.0 109.799 175.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 20.0 m -123.64 167.63 14.58 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.212 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.13 -26.77 61.89 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.574 2.183 . . . . 0.0 112.01 173.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 254' ' ' SER . . . . . 0.404 ' O ' ' HG3' ' B' ' 258' ' ' GLU . 19.9 m -64.78 -39.45 93.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.625 177.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.04 -46.76 82.17 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.301 177.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 55.3 tp -57.58 -43.85 84.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.701 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 257' ' ' ARG . . . . . 0.49 ' HD2' ' CD ' ' A' ' 23' ' ' GLU . 10.7 ttp180 -53.71 -52.32 60.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.266 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 258' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' B' ' 254' ' ' SER . 68.7 mt-10 -60.29 -27.1 67.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.814 -173.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 259' ' ' LYS . . . . . 0.427 ' O ' ' HG ' ' B' ' 263' ' ' LEU . 14.4 mptt -80.47 -39.65 27.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.976 0.417 . . . . 0.0 110.851 176.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 95.6 mt -71.28 -47.34 57.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.73 -175.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 2.8 m -58.93 -34.83 72.18 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.314 0.578 . . . . 0.0 110.658 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -66.39 -47.81 72.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.421 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 263' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' B' ' 259' ' ' LYS . 90.6 mt -64.96 -32.41 74.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.629 -175.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -60.86 -42.58 98.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.597 -177.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -61.29 -49.39 77.22 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.43 -177.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -68.92 -15.12 63.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.852 -175.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 267' ' ' LYS . . . . . 0.444 ' HD3' ' HA ' ' B' ' 267' ' ' LYS . 31.4 mmtp -100.87 -0.86 36.07 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.088 178.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 74.42 28.11 64.35 Favored Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.218 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -101.27 162.76 17.98 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.066 -178.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . 0.496 ' HA ' ' CE ' ' B' ' 270' ' ' LYS . 0.0 OUTLIER -117.15 -59.94 1.89 Allowed 'General case' 0 C--N 1.32 -0.716 0 O-C-N 122.66 -0.317 . . . . 0.0 110.754 179.426 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 271' ' ' TYR . . . . . 0.622 ' HE2' ' HB2' ' B' ' 293' ' ' ASP . 6.0 m-85 -117.19 162.94 17.06 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 272' ' ' TYR . . . . . 0.697 ' CD1' ' HB1' ' A' ' 22' ' ' ALA . 0.1 OUTLIER -148.74 158.75 44.37 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.183 0.516 . . . . 0.0 110.994 -179.123 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -128.17 107.78 10.07 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.256 -178.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 274' ' ' ILE . . . . . 0.525 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 4.5 mp -77.46 120.47 28.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.611 -174.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 14.4 pt -111.42 -26.45 3.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -176.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 276' ' ' ALA . . . . . 0.659 ' HB3' ' HB ' ' B' ' 287' ' ' VAL . . . -134.9 145.74 48.52 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.192 -177.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 277' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' B' ' 285' ' ' GLU . . . -169.47 117.66 0.62 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.856 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.13 139.11 15.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.83 0.348 . . . . 0.0 110.992 -178.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 279' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' B' ' 284' ' ' PHE . 3.3 mp0 -76.7 91.08 3.43 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 174.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -87.01 89.31 7.95 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 -176.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 66.44 -118.76 11.33 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.511 -174.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -90.54 -2.12 5.18 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.896 2.398 . . . . 0.0 112.733 177.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 283' ' ' ASN . . . . . 0.551 ' HA ' ' O ' ' B' ' 245' ' ' GLN . 59.1 m-80 -118.87 115.87 25.3 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.018 0.437 . . . . 0.0 111.127 -176.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 284' ' ' PHE . . . . . 0.449 ' HA ' ' HA ' ' B' ' 279' ' ' GLU . 70.0 t80 -79.06 113.92 17.57 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 175.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 285' ' ' GLU . . . . . 0.588 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 48.3 mt-10 -99.27 114.13 26.79 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.853 -176.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 286' ' ' ALA . . . . . 0.498 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -114.26 135.09 54.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.473 174.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 287' ' ' VAL . . . . . 0.659 ' HB ' ' HB3' ' B' ' 276' ' ' ALA . 37.4 t -125.41 128.48 72.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 110.081 -0.341 . . . . 0.0 110.081 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -134.74 151.13 50.74 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.965 0.412 . . . . 0.0 111.54 -178.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 289' ' ' GLU . . . . . 0.455 ' O ' ' HA ' ' B' ' 272' ' ' TYR . 21.8 mt-10 -90.62 119.92 31.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.141 178.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 290' ' ' VAL . . . . . 0.466 HG21 HG23 ' B' ' 241' ' ' ILE . 39.1 t -94.15 124.15 46.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.511 0.196 . . . . 0.0 111.211 -175.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -129.27 151.29 50.09 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.469 0.652 . . . . 0.0 111.658 -178.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 292' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -106.76 155.19 19.96 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.949 173.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 293' ' ' ASP . . . . . 0.622 ' HB2' ' HE2' ' B' ' 271' ' ' TYR . 25.7 t70 . . . . . 0 C--N 1.322 -0.59 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 165.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.467 ' O ' ' HD3' ' B' ' 257' ' ' ARG . . . . . . . . 0 N--CA 1.467 0.382 0 CA-C-O 121.276 0.56 . . . . 0.0 112.002 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.593 ' HG2' ' N ' ' B' ' 222' ' ' ALA . 9.8 tp10 -150.17 179.74 7.85 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.361 -178.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.778 ' HA ' ' HB2' ' A' ' 71' ' ' TYR . 0.0 OUTLIER 85.44 140.08 0.06 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.074 0.95 . . . . 0.0 111.529 176.712 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.503 HG22 ' CZ ' ' A' ' 71' ' ' TYR . 5.0 m -117.06 173.35 4.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.48 176.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.57 ' HB3' ' HB ' ' B' ' 274' ' ' ILE . 92.3 p -97.99 -175.75 3.24 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.097 0.475 . . . . 0.0 111.039 -175.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.0 tmmt? -71.48 -19.74 62.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.099 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' B' ' 277' ' ' ALA . 1.8 mp0 -66.51 -45.91 77.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.6 -178.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -65.64 -44.69 85.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.502 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.0 mt -53.77 -46.47 62.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.688 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.3 m -68.4 -38.4 81.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.549 -176.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 25.8 m80 -80.86 -44.99 17.53 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -174.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.429 ' CD1' ' HD3' ' B' ' 253' ' ' PRO . 97.8 m-85 -93.22 -19.9 20.97 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -173.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm 61.35 82.72 0.16 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.184 0.516 . . . . 0.0 110.617 -177.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.573 HD21 ' HG3' ' B' ' 253' ' ' PRO . 96.5 mt -85.31 173.38 10.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.415 -176.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.1 t -95.97 124.78 48.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.608 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -84.58 115.49 22.65 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.161 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -94.68 -3.84 10.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.157 0.503 . . . . 0.0 111.141 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 120.83 155.25 9.51 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.976 174.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 27.4 m -81.16 150.3 28.75 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 177.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.3 pt -116.35 134.22 60.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.001 0.429 . . . . 0.0 110.006 172.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -124.12 116.04 22.11 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.122 -178.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 3.2 t -109.87 109.51 28.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.513 -178.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.8 p -92.48 91.92 7.84 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 175.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.606 ' HG2' HG12 ' A' ' 50' ' ' ILE . 0.9 OUTLIER -97.58 147.66 24.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.669 -170.641 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.444 ' HA ' HD22 ' A' ' 83' ' ' ASN . 47.9 t -96.84 154.8 17.08 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 172.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.92 78.32 0.39 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.338 178.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -175.76 -37.83 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 121.146 -0.549 . . . . 0.0 112.553 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -81.73 -23.85 36.48 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 122.57 -0.37 . . . . 0.0 111.255 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.606 HG12 ' HG2' ' A' ' 45' ' ' GLN . 49.3 mm -112.7 109.71 29.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.6 t -107.12 -45.94 4.02 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.204 0.526 . . . . 0.0 109.711 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.518 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 22.0 m -126.06 165.96 24.32 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.837 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' A' ' 52' ' ' SER . 10.7 Cg_endo -54.69 -26.4 46.65 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.631 2.221 . . . . 0.0 111.981 177.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.598 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 2.3 m -55.67 -51.86 65.8 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.752 176.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -59.62 -42.17 92.07 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.234 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 56.9 tp -61.5 -46.58 89.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.908 -177.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 21.5 ttp180 -58.66 -44.51 90.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.455 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.598 ' HG2' ' O ' ' A' ' 54' ' ' SER . 19.0 mm-40 -62.32 -45.35 93.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.854 -178.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -67.33 -36.86 82.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.362 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.0 mt -68.26 -43.0 78.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.977 0.418 . . . . 0.0 110.515 177.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.4 m -68.49 -30.53 69.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.575 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -58.01 -46.67 84.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.055 0.455 . . . . 0.0 110.46 177.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 98.5 mt -74.55 -37.0 63.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.898 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.72 -32.64 74.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.091 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -60.33 -41.72 94.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.917 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.05 -16.62 56.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.078 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -89.52 -15.22 33.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.548 177.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 57.68 48.98 77.83 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 -175.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -92.66 171.14 32.97 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.877 -175.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.477 ' CB ' ' HA ' ' A' ' 92' ' ' ASN . 56.7 tptt -99.89 -47.18 5.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.535 0.683 . . . . 0.0 109.811 178.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.778 ' HB2' ' HA ' ' A' ' 24' ' ' GLN . 35.1 p90 -150.96 177.15 10.43 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.794 -178.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -142.62 126.05 16.69 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.247 0.546 . . . . 0.0 110.166 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -106.61 101.0 10.48 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.281 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.626 HG12 ' HB2' ' A' ' 88' ' ' ALA . 69.7 mt -72.44 120.11 20.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.139 0.495 . . . . 0.0 110.514 -176.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.6 pt -94.99 -35.38 6.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.22 -178.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.97 110.88 5.02 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.995 0.426 . . . . 0.0 111.601 -177.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -107.86 88.43 2.73 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 172.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.532 ' CG ' ' HB2' ' A' ' 85' ' ' GLU . 6.2 ptp180 -95.86 121.49 37.64 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.874 0.845 . . . . 0.0 112.196 -166.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -70.64 100.47 1.85 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.71 172.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 23.8 t-80 -88.16 14.74 8.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.062 0.458 . . . . 0.0 110.46 -177.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.85 -106.5 3.18 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.75 -5.9 16.39 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.579 2.186 . . . . 0.0 111.193 173.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.444 HD22 ' HA ' ' A' ' 46' ' ' SER . 13.3 m120 -123.02 156.8 34.09 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.172 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -128.49 120.97 27.83 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.532 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 41.3 mt-10 -110.3 110.94 21.94 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.787 -177.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.36 118.12 32.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.035 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.9 t -112.82 112.79 41.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.934 176.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.626 ' HB2' HG12 ' A' ' 74' ' ' ILE . . . -127.76 141.71 51.51 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.962 0.41 . . . . 0.0 111.895 -176.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -91.85 116.47 28.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.79 177.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.6 t -100.34 125.01 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-O 121.117 0.484 . . . . 0.0 110.067 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.536 ' HB2' ' CE1' ' A' ' 71' ' ' TYR . 64.7 m-85 -123.84 159.51 29.43 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.911 177.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.477 ' HA ' ' CB ' ' A' ' 70' ' ' LYS . 10.3 t-20 -120.52 174.07 6.78 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 175.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 . . . . . 0 C--O 1.235 0.335 0 CA-C-O 120.764 0.316 . . . . 0.0 110.222 176.427 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 222' ' ' ALA . . . . . 0.593 ' N ' ' HG2' ' A' ' 23' ' ' GLU . . . . . . . . 0 N--CA 1.465 0.321 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -167.61 110.57 0.65 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.926 174.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 224' ' ' GLN . . . . . 0.53 ' HG3' ' CD ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -161.94 148.09 13.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.033 -175.817 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . 0.454 HG22 ' HB3' ' B' ' 271' ' ' TYR . 18.7 m -126.78 128.69 71.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 166.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . 0.6 ' HB2' ' HB ' ' A' ' 74' ' ' ILE . 6.3 t -87.86 178.98 6.55 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.776 0.322 . . . . 0.0 110.158 -177.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . 0.426 ' HA ' HD12 ' B' ' 230' ' ' ILE . 23.0 tptp -66.98 -23.91 65.99 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.293 -170.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -72.0 -50.32 29.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.939 0.399 . . . . 0.0 110.127 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -65.06 -38.64 91.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.784 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.49 HG13 ' O ' ' B' ' 226' ' ' SER . 97.4 mt -54.88 -54.0 27.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.032 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 56.8 m -73.44 -22.08 60.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.76 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -79.88 -44.5 20.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.693 0.282 . . . . 0.0 110.547 -177.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -89.48 -8.59 52.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.97 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt 60.28 51.72 5.32 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.528 -178.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.42 149.66 47.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.874 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.459 HG23 ' HB3' ' B' ' 292' ' ' ASN . 16.0 m -86.46 124.34 40.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.375 0.607 . . . . 0.0 111.491 -177.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -75.6 128.13 34.58 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.511 176.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 40.5 t -92.69 -44.44 13.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.253 0.549 . . . . 0.0 110.337 -179.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 177.11 -157.35 22.21 Favored Glycine 0 N--CA 1.442 -0.94 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.442 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 59.3 m -135.22 137.47 42.65 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 22.7 pt -117.61 142.61 31.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 175.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -132.9 138.5 47.0 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.692 0.758 . . . . 0.0 111.772 -177.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 243' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' B' ' 285' ' ' GLU . 59.7 t -102.75 134.68 43.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.221 177.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 7.2 t -149.21 47.82 0.98 Allowed 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 245' ' ' GLN . . . . . 0.522 ' NE2' HG13 ' B' ' 243' ' ' VAL . 0.9 OUTLIER -103.63 159.22 15.8 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.738 -177.071 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 246' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' B' ' 283' ' ' ASN . 19.1 m -89.18 171.06 10.09 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.247 -177.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -54.61 115.4 5.35 Favored Glycine 0 C--N 1.333 0.389 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.084 176.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . 134.31 -43.57 1.25 Allowed Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 -176.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . 0.472 ' HB2' ' HB3' ' B' ' 245' ' ' GLN . 11.5 mm100 -73.29 -23.81 60.33 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 49.9 mm -114.29 111.63 36.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 171.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 19.7 m -104.03 -19.09 14.31 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.612 -175.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 252' ' ' SER . . . . . 0.478 ' H ' ' HB3' ' B' ' 255' ' ' ASP . 38.6 m -154.99 163.51 24.21 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -176.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . 0.573 ' HG3' HD21 ' A' ' 35' ' ' LEU . 19.1 Cg_endo -61.64 -41.98 35.7 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.256 1.971 . . . . 0.0 111.246 175.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 254' ' ' SER . . . . . 0.44 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 27.5 m -75.28 -18.74 60.0 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.762 177.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 255' ' ' ASP . . . . . 0.478 ' HB3' ' H ' ' B' ' 252' ' ' SER . 35.2 t70 -71.56 -33.57 69.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.204 0.526 . . . . 0.0 109.723 176.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.409 ' O ' ' HG ' ' B' ' 260' ' ' LEU . 63.2 tp -59.44 -43.22 93.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.461 172.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 257' ' ' ARG . . . . . 0.467 ' HD3' ' O ' ' A' ' 22' ' ' ALA . 1.8 tmm_? -62.24 -39.12 91.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.807 178.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 258' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' B' ' 254' ' ' SER . 13.5 mm-40 -52.43 -52.32 54.59 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.911 0.386 . . . . 0.0 110.328 176.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -62.31 -42.86 99.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.128 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 260' ' ' LEU . . . . . 0.493 HD13 ' CE2' ' B' ' 272' ' ' TYR . 96.0 mt -67.9 -43.82 78.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.82 -176.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 17.0 p -64.7 -31.23 72.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.999 0.428 . . . . 0.0 110.683 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -65.73 -42.42 91.04 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.21 178.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 263' ' ' LEU . . . . . . . . . . . . . 94.6 mt -73.21 -37.71 66.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.128 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -59.5 -39.31 83.4 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.575 -178.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -61.29 -40.0 92.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.182 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -74.7 -19.15 60.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.657 -176.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 267' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' B' ' 267' ' ' LYS . 42.7 mmtm -93.25 -36.18 12.72 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.946 0.403 . . . . 0.0 110.904 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 106.13 55.91 0.67 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.559 177.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -142.64 150.8 22.53 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.366 -0.921 . . . . 0.0 111.857 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . 0.918 ' HD3' ' HB2' ' B' ' 293' ' ' ASP . 45.6 mtpt -94.52 -37.81 11.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.426 0.632 . . . . 0.0 110.268 177.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 271' ' ' TYR . . . . . 0.454 ' HB3' HG22 ' B' ' 225' ' ' VAL . 16.7 m-85 -117.75 150.31 39.33 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.747 -172.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 272' ' ' TYR . . . . . 0.493 ' CE2' HD13 ' B' ' 260' ' ' LEU . 21.6 p90 -145.2 155.02 43.01 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 175.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -136.49 109.79 7.85 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -177.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 274' ' ' ILE . . . . . 0.57 ' HB ' ' HB3' ' A' ' 26' ' ' SER . 60.8 mt -65.4 127.2 26.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.076 177.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 22.7 pt -108.25 -28.26 2.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.777 0.322 . . . . 0.0 111.769 -177.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -152.71 108.84 3.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.922 -178.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 277' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' B' ' 286' ' ' ALA . . . -124.53 102.89 7.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.091 0.472 . . . . 0.0 109.921 178.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.53 132.02 54.47 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.543 0.687 . . . . 0.0 111.311 -174.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.1 115.53 15.9 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 171.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 280' ' ' HIS . . . . . 0.485 ' HB2' ' HG3' ' B' ' 285' ' ' GLU . 7.1 t-160 -103.54 25.51 9.6 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.189 0.519 . . . . 0.0 110.109 -171.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 281' ' ' GLY . . . . . 0.403 ' HA3' ' HD3' ' B' ' 282' ' ' PRO . . . 103.35 -106.44 2.86 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.982 -0.627 . . . . 0.0 111.732 -177.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 282' ' ' PRO . . . . . 0.403 ' HD3' ' HA3' ' B' ' 281' ' ' GLY . 3.6 Cg_exo -75.45 -24.57 12.0 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.993 2.462 . . . . 0.0 112.045 178.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 283' ' ' ASN . . . . . 0.48 ' HA ' ' HA ' ' B' ' 246' ' ' SER . 53.2 m-80 -116.18 148.21 40.61 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.944 -177.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -107.22 115.31 29.94 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.58 176.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 285' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 1.0 OUTLIER -101.52 110.85 22.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.959 -175.095 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 286' ' ' ALA . . . . . 0.499 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -125.95 116.52 21.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.782 0.325 . . . . 0.0 111.604 -177.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 46.3 t -103.46 124.47 57.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.328 178.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -130.08 141.2 50.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.929 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -92.47 133.42 35.93 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.046 178.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 44.8 t -98.0 125.06 51.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.622 -178.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -123.68 142.98 50.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.1 0.476 . . . . 0.0 110.581 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 292' ' ' ASN . . . . . 0.459 ' HB3' HG23 ' B' ' 236' ' ' VAL . 14.8 t-20 -92.2 167.33 12.11 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 293' ' ' ASP . . . . . 0.918 ' HB2' ' HD3' ' B' ' 270' ' ' LYS . 13.6 t70 . . . . . 0 C--N 1.328 -0.346 0 CA-C-O 121.143 0.497 . . . . 0.0 110.093 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.495 ' O ' ' HD3' ' B' ' 257' ' ' ARG . . . . . . . . 0 C--O 1.234 0.28 0 N-CA-C 110.456 -0.202 . . . . 0.0 110.456 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 24' ' ' GLN . 8.4 pt-20 -176.46 114.71 0.11 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.107 0.48 . . . . 0.0 112.289 178.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.788 ' HB3' ' CB ' ' B' ' 224' ' ' GLN . 22.2 tm0? 173.81 141.0 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.136 176.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.48 HG21 HD11 ' A' ' 35' ' ' LEU . 31.3 m -120.7 155.08 24.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 121.099 0.476 . . . . 0.0 111.883 -174.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.404 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 72.6 p -96.33 -93.09 0.21 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.429 -174.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.482 ' C ' ' HD3' ' A' ' 27' ' ' LYS . 10.8 tmtt? -123.12 -66.61 1.0 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 122.168 -0.333 . . . . 0.0 111.873 -174.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.44 ' NE2' ' H ' ' A' ' 28' ' ' GLN . 0.6 OUTLIER -62.5 -28.53 69.9 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -170.122 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -65.32 -42.78 92.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.968 0.414 . . . . 0.0 110.064 176.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.437 HG12 HD12 ' A' ' 35' ' ' LEU . 28.0 mt -64.57 -44.94 96.81 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.897 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.3 m -67.35 -30.47 70.3 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.846 -0.341 . . . . 0.0 111.335 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -72.45 -48.25 42.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.583 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -98.68 4.16 47.85 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.324 -176.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt 71.85 -45.95 0.63 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.978 0.911 . . . . 0.0 112.028 177.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.561 HD22 ' HA ' ' A' ' 93' ' ' ASP . 19.3 mt 58.71 164.25 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.208 1.003 . . . . 0.0 112.604 -172.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 76.3 t -97.5 -47.68 12.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.658 -175.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.592 ' HA ' ' HA ' ' A' ' 91' ' ' TYR . 63.5 tttm 70.39 126.49 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 O-C-N 124.159 0.912 . . . . 0.0 111.082 -177.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.0 m -114.28 -30.06 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -175.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 169.47 -161.99 35.51 Favored Glycine 0 C--O 1.227 -0.305 0 C-N-CA 119.303 -1.427 . . . . 0.0 113.656 -178.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.574 HG23 ' HG2' ' A' ' 89' ' ' GLU . 6.4 m -123.07 143.88 49.66 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 122.473 0.309 . . . . 0.0 110.441 -176.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.9 pt -118.92 139.5 46.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 172.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -122.02 114.4 20.9 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.724 -175.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.59 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 43.0 t -105.63 115.33 47.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.516 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 68.7 p -148.28 99.27 3.02 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.731 0.301 . . . . 0.0 110.996 -174.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -142.15 157.11 45.25 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.064 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.599 ' HA ' ' HA ' ' A' ' 83' ' ' ASN . 19.9 t -71.38 173.44 7.85 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 120.666 0.27 . . . . 0.0 110.313 178.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.78 55.16 2.57 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 113.165 -176.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -141.52 -37.3 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 176.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -83.41 -14.81 51.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.09 0.471 . . . . 0.0 110.59 177.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.1 mm -130.34 132.57 64.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 176.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.3 m -134.84 -35.03 0.88 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.055 0.455 . . . . 0.0 111.584 -177.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.599 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 28.1 m -142.11 168.48 13.49 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -177.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.599 ' HD2' ' HB3' ' A' ' 52' ' ' SER . 10.8 Cg_endo -54.55 -31.05 67.93 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.543 2.162 . . . . 0.0 112.637 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.4 m -61.87 -34.51 76.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.664 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -62.88 -52.81 61.65 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.338 0.59 . . . . 0.0 109.881 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 57.4 tp -63.4 -30.37 71.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.276 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -62.08 -31.79 72.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.955 -178.302 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -74.93 -46.87 32.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.8 0.333 . . . . 0.0 110.358 175.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.565 ' HA ' ' HG2' ' A' ' 62' ' ' GLU . 1.9 mptp? -62.97 -40.39 97.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.195 -175.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.3 mt -61.6 -37.12 82.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.824 0.345 . . . . 0.0 110.748 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.523 ' HA ' ' HB3' ' B' ' 222' ' ' ALA . 19.5 m -75.95 -43.28 45.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.45 -178.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.565 ' HG2' ' HA ' ' A' ' 59' ' ' LYS . 16.8 pt-20 -69.44 -36.72 76.93 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 121.151 -0.219 . . . . 0.0 111.221 -175.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 87.4 mt -74.9 -49.36 20.59 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -178.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.24 -44.1 89.27 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -174.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -65.68 -34.9 79.29 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.997 0.427 . . . . 0.0 110.72 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.11 -8.86 57.65 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.428 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -106.48 2.24 26.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.804 176.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.05 58.57 4.31 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.967 178.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -131.17 -178.04 15.23 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.28 178.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -130.29 -37.07 1.45 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.165 0.507 . . . . 0.0 110.007 177.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.558 ' HB3' ' HA ' ' A' ' 24' ' ' GLN . 11.4 m-85 -127.23 169.53 13.39 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.43 ' O ' ' HG2' ' A' ' 24' ' ' GLN . 25.7 p90 -142.63 167.28 22.47 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 173.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.404 ' CD2' ' HA ' ' A' ' 26' ' ' SER . 4.0 t-160 -134.45 109.26 8.62 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.818 175.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 54.2 mt -68.65 129.81 33.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.833 176.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.5 pt -123.33 -14.78 5.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.741 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -157.45 107.3 2.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.505 0.193 . . . . 0.0 111.191 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -132.6 105.35 7.16 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.785 0.326 . . . . 0.0 110.187 176.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.405 ' HD3' HH11 ' A' ' 78' ' ' ARG . 0.0 OUTLIER -153.47 146.9 24.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.942 -177.529 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -77.79 109.07 11.48 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.636 174.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -101.84 87.95 3.25 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.74 -134.66 13.6 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -175.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -83.61 1.2 9.06 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.65 2.233 . . . . 0.0 112.386 176.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.599 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 44.6 m-80 -115.08 143.15 45.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.051 0.453 . . . . 0.0 111.491 -177.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.516 ' O ' ' HA ' ' A' ' 44' ' ' SER . 66.6 t80 -93.99 120.11 33.79 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.783 176.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -105.26 118.8 37.46 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.512 -177.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.59 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -132.34 115.73 15.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.166 0.507 . . . . 0.0 110.696 176.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 44.6 t -111.81 122.58 66.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.019 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.28 142.09 33.9 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.413 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.574 ' HG2' HG23 ' A' ' 40' ' ' THR . 10.9 mt-10 -103.75 140.24 37.9 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.68 -0.408 . . . . 0.0 109.977 176.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 36.5 t -90.52 125.05 43.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.054 0.454 . . . . 0.0 110.369 -175.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.592 ' HA ' ' HA ' ' A' ' 37' ' ' LYS . 54.9 m-85 -111.5 114.23 27.19 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.657 -178.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -86.36 146.47 26.46 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 171.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.561 ' HA ' HD22 ' A' ' 35' ' ' LEU . 2.7 p-10 . . . . . 0 C--N 1.318 -0.788 0 C-N-CA 121.13 -0.228 . . . . 0.0 110.494 -174.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 222' ' ' ALA . . . . . 0.523 ' HB3' ' HA ' ' A' ' 61' ' ' SER . . . . . . . . 0 C--O 1.236 0.359 0 N-CA-C 110.523 -0.177 . . . . 0.0 110.523 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -170.55 116.65 0.49 Allowed 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 224' ' ' GLN . . . . . 0.788 ' CB ' ' HB3' ' A' ' 24' ' ' GLN . 0.0 OUTLIER 177.31 167.46 0.6 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.449 -1.25 . . . . 0.0 107.96 176.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . 0.456 HG21 HD13 ' B' ' 235' ' ' LEU . 27.9 m -121.54 147.17 25.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.3 0.571 . . . . 0.0 111.508 -177.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 84.1 p -105.89 -157.47 0.61 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.487 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . 0.494 ' C ' ' HD3' ' B' ' 227' ' ' LYS . 12.1 tmtt? -67.07 -40.8 87.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.753 0.311 . . . . 0.0 110.277 -178.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -59.19 -49.26 78.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.631 -173.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -63.46 -39.42 94.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.574 -177.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 77.8 mt -59.25 -56.9 14.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.652 0.263 . . . . 0.0 111.358 -177.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 5.7 p -73.31 -21.59 60.53 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -174.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -98.09 -38.76 9.22 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.429 -0.508 . . . . 0.0 112.198 -176.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 233' ' ' PHE . . . . . 0.476 ' CD1' ' HD3' ' A' ' 53' ' ' PRO . 57.7 m-85 -99.4 4.64 46.32 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -174.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt 58.63 40.52 23.39 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.302 0.376 . . . . 0.0 110.915 174.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . 0.456 HD13 HG21 ' B' ' 225' ' ' VAL . 84.7 mt -55.44 150.5 11.64 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.278 0.561 . . . . 0.0 112.456 -173.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 22.1 t -94.08 110.31 23.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.838 -176.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -83.29 114.99 21.77 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 177.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -86.06 -28.93 6.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.457 -178.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 178.44 -170.17 42.11 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.423 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 7.5 m -133.71 140.46 47.03 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 28.1 pt -124.1 148.06 28.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.941 0.401 . . . . 0.0 110.416 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -134.74 142.36 46.73 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.477 0.656 . . . . 0.0 111.533 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 243' ' ' VAL . . . . . 0.621 HG13 ' NE2' ' B' ' 245' ' ' GLN . 67.9 t -106.66 123.64 61.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.695 -178.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 10.6 t -143.05 69.6 1.31 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 176.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 245' ' ' GLN . . . . . 0.621 ' NE2' HG13 ' B' ' 243' ' ' VAL . 1.3 mp0 -109.42 153.43 24.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.97 -174.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 57.8 m -83.06 43.32 0.86 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.49 -174.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . 0.417 ' C ' ' H ' ' B' ' 249' ' ' GLN . . . 78.47 -41.25 2.06 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.922 -0.656 . . . . 0.0 113.731 174.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -73.57 27.63 0.88 Allowed Glycine 0 CA--C 1.519 0.34 0 CA-C-N 116.888 0.344 . . . . 0.0 113.652 -176.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . 0.544 ' HG3' ' HG2' ' B' ' 245' ' ' GLN . 23.8 mm-40 -130.85 -3.62 4.07 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 176.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 44.9 mm -133.71 132.3 56.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.337 -179.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 23.2 m -133.45 -58.26 0.88 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.24 -177.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 252' ' ' SER . . . . . 0.542 ' HB3' ' HD2' ' B' ' 253' ' ' PRO . 7.2 m -113.72 168.87 7.18 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . 0.542 ' HD2' ' HB3' ' B' ' 252' ' ' SER . 11.6 Cg_endo -57.1 -24.47 58.5 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.293 1.996 . . . . 0.0 112.213 175.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 254' ' ' SER . . . . . 0.546 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 1.5 p -70.2 -37.12 75.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.139 176.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -61.93 -37.43 84.66 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.792 0.329 . . . . 0.0 110.895 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 51.9 tp -59.02 -42.01 89.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.52 177.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 257' ' ' ARG . . . . . 0.553 ' C ' ' HD2' ' B' ' 257' ' ' ARG . 3.9 tmm_? -64.13 -47.07 81.39 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.859 177.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 258' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' B' ' 254' ' ' SER . 28.8 mm-40 -54.02 -48.85 70.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.349 -176.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -70.17 -35.25 73.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.732 0.301 . . . . 0.0 111.24 -177.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 81.9 mt -72.66 -40.5 66.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.178 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 17.0 t -68.54 -31.97 71.58 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 177.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -57.36 -51.65 68.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.242 175.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 263' ' ' LEU . . . . . . . . . . . . . 74.5 mt -71.17 -41.18 70.71 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.958 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -63.52 -44.39 94.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.721 -177.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -66.31 -34.21 77.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.896 0.379 . . . . 0.0 110.48 -178.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -68.94 -20.09 64.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.285 0.565 . . . . 0.0 110.821 176.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 4.8 mmpm? -94.81 -2.41 50.93 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.664 176.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 77.35 16.06 80.84 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.168 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . 0.567 ' HA3' ' CG1' ' B' ' 290' ' ' VAL . . . -93.85 148.99 19.24 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.017 -178.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -110.73 3.42 19.15 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.247 0.546 . . . . 0.0 110.073 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 271' ' ' TYR . . . . . 0.654 ' HD1' ' HA ' ' B' ' 224' ' ' GLN . 9.2 m-85 -147.75 141.45 25.61 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 -177.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 272' ' ' TYR . . . . . 0.51 ' CE2' HD11 ' B' ' 274' ' ' ILE . 34.2 p90 -126.66 111.11 13.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.472 0.654 . . . . 0.0 110.06 178.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -92.1 101.75 14.28 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.171 -174.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 274' ' ' ILE . . . . . 0.534 ' H ' HD12 ' B' ' 274' ' ' ILE . 4.6 mp -72.35 131.59 34.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.82 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 28.4 pt -117.64 -28.45 2.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.727 0.299 . . . . 0.0 111.511 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -156.97 137.84 13.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.832 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -155.51 120.81 4.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.506 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 278' ' ' ARG . . . . . 0.472 ' HE ' ' HB3' ' B' ' 278' ' ' ARG . 0.0 OUTLIER -145.04 155.02 43.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.0 0.428 . . . . 0.0 110.942 -178.853 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -79.19 134.87 36.68 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.208 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -122.01 72.68 1.05 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.001 0.429 . . . . 0.0 110.059 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 64.11 -120.38 19.54 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.659 -177.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.11 -2.3 12.27 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.737 2.292 . . . . 0.0 112.259 176.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -114.41 166.08 12.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.28 -177.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -129.39 122.28 29.12 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.936 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 285' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -105.28 119.7 39.72 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.32 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 286' ' ' ALA . . . . . 0.574 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -136.68 146.83 46.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.692 0.282 . . . . 0.0 111.154 177.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 37.0 t -128.79 128.86 68.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 177.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -137.27 144.92 42.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.004 0.43 . . . . 0.0 110.988 -179.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 289' ' ' GLU . . . . . 0.429 ' HB2' ' HE1' ' B' ' 291' ' ' TYR . 25.5 mt-10 -96.1 150.09 20.89 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.891 178.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 290' ' ' VAL . . . . . 0.567 ' CG1' ' HA3' ' B' ' 269' ' ' GLY . 12.8 t -111.93 123.97 68.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 291' ' ' TYR . . . . . 0.429 ' HE1' ' HB2' ' B' ' 289' ' ' GLU . 65.9 m-85 -124.29 151.69 43.94 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.229 0.538 . . . . 0.0 111.618 -177.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 292' ' ' ASN . . . . . 0.411 HD22 ' HA ' ' B' ' 292' ' ' ASN . 7.2 m120 -117.65 161.4 19.72 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.105 170.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.467 0.402 0 O-C-N 123.439 0.462 . . . . 0.0 111.551 175.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.48 1.069 0 CA-C-O 120.584 0.23 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -83.64 100.91 11.14 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -92.98 109.35 20.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.009 -175.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 70.5 mtt-85 -124.36 108.67 12.43 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.883 176.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 pp -73.36 95.09 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.685 0.755 . . . . 0.0 111.277 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 27.6 pt -128.5 -176.72 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.22 -175.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 68.39 107.88 0.05 Allowed 'General case' 0 N--CA 1.465 0.293 0 O-C-N 124.09 0.869 . . . . 0.0 112.274 175.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -144.43 109.37 5.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.069 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -116.3 113.15 22.58 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.963 0.411 . . . . 0.0 111.22 -175.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -102.15 34.67 2.64 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.318 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.3 mt -65.4 124.92 23.55 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.723 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -147.32 143.32 27.96 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.278 -177.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.6 m 73.62 115.61 0.06 Allowed 'General case' 0 C--O 1.233 0.22 0 O-C-N 124.048 0.843 . . . . 0.0 112.656 175.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.3 p -143.78 88.42 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.109 172.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.486 ' HB1' ' CE2' ' A' ' 17' ' ' PHE . . . -93.84 119.83 33.3 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.293 -172.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.1 p -103.57 88.71 3.15 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.423 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.486 ' CE2' ' HB1' ' A' ' 15' ' ' ALA . 71.8 m-85 -108.17 -80.45 0.57 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.399 177.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.5 m 54.92 22.12 4.1 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 123.722 0.639 . . . . 0.0 111.689 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.7 m -83.64 90.64 7.31 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.012 0.434 . . . . 0.0 110.221 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 61.6 mt -99.64 -163.73 1.06 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.635 -176.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -135.5 159.81 40.43 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 177.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.542 ' O ' ' HB3' ' B' ' 261' ' ' SER . . . 70.65 108.31 0.06 Allowed 'General case' 0 N--CA 1.465 0.282 0 O-C-N 124.085 0.866 . . . . 0.0 110.823 -177.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.51 ' HG2' ' HB1' ' B' ' 221' ' ' ALA . 2.2 tp10 -147.0 -138.88 0.09 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -176.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.721 ' HB2' ' H ' ' B' ' 223' ' ' GLU . 0.0 OUTLIER 72.73 156.73 0.17 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 122.6 0.36 . . . . 0.0 111.64 176.348 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.3 m -114.5 147.72 17.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 121.055 0.455 . . . . 0.0 110.905 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.411 ' O ' HG13 ' A' ' 30' ' ' ILE . 19.9 t -100.29 -166.79 1.36 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.28 0.562 . . . . 0.0 111.017 -177.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -66.5 -44.1 83.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.535 -173.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.641 ' HG2' ' OE1' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -63.59 -44.72 93.19 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.891 -173.736 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.641 ' OE1' ' HG2' ' A' ' 28' ' ' GLN . 2.3 mp0 -62.98 -40.95 99.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.619 0.247 . . . . 0.0 110.846 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 26' ' ' SER . 97.4 mt -59.01 -49.9 81.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.841 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.3 t -73.43 -24.85 60.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.362 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.452 ' HB2' ' O ' ' A' ' 28' ' ' GLN . 33.7 t-80 -85.92 -57.81 2.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.686 0.279 . . . . 0.0 111.287 -174.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -81.77 -10.74 59.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.193 -175.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt 59.54 76.43 0.36 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.338 0.59 . . . . 0.0 110.113 -175.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.405 HD12 HG12 ' A' ' 30' ' ' ILE . 95.1 mt -82.39 159.39 23.01 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.892 -176.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.548 HG11 ' HE3' ' A' ' 96' ' ' LYS . 48.1 t -81.88 111.71 18.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.081 -176.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.552 ' HD3' ' CE2' ' A' ' 91' ' ' TYR . 15.0 tptm -71.5 111.19 6.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.67 175.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.421 HG23 ' HB ' ' A' ' 90' ' ' VAL . 3.2 m -104.66 6.95 10.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.871 0.367 . . . . 0.0 111.667 -176.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 133.37 -168.44 23.08 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.549 175.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 47.7 m -136.54 132.93 35.88 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.4 pt -111.43 134.22 54.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.257 0.551 . . . . 0.0 110.861 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -114.62 121.05 42.22 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.565 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.619 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 24.3 t -93.35 107.51 19.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.8 t -110.62 110.54 21.28 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.549 -176.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.524 ' HG2' HG12 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -116.79 152.63 33.99 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.236 -176.53 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.8 t -126.03 124.79 41.46 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.875 -0.416 . . . . 0.0 109.875 175.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.33 -145.92 25.79 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.456 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.84 52.53 0.72 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.877 -175.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.464 ' HB2' ' CG ' ' A' ' 45' ' ' GLN . 14.5 mm100 -71.96 -41.79 67.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.298 0.571 . . . . 0.0 109.619 175.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.566 HG23 ' HB2' ' A' ' 55' ' ' ASP . 49.3 mm -97.93 125.4 51.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.73 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.1 m -103.26 -39.74 6.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.199 -176.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.423 ' HB2' ' HD2' ' A' ' 53' ' ' PRO . 51.4 p -131.87 162.56 55.72 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.462 -176.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.423 ' HD2' ' HB2' ' A' ' 52' ' ' SER . 17.0 Cg_endo -57.49 -27.02 74.53 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.633 2.222 . . . . 0.0 111.44 176.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.594 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 2.5 m -59.08 -45.92 89.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.545 177.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.566 ' HB2' HG23 ' A' ' 50' ' ' ILE . 36.2 m-20 -64.85 -35.84 82.43 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.561 -178.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 67.2 tp -61.46 -47.2 86.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.847 175.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.424 HH22 ' HB3' ' B' ' 298' ' ' GLU . 7.4 ttm180 -58.08 -41.12 82.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.068 177.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.594 ' HG2' ' O ' ' A' ' 54' ' ' SER . 14.1 mm-40 -55.6 -50.47 70.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.281 0.562 . . . . 0.0 110.68 177.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.41 ' HA ' ' HD3' ' A' ' 59' ' ' LYS . 73.2 mmtt -69.71 -35.14 74.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.323 -177.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.2 mt -62.58 -44.32 96.61 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.54 176.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.7 t -66.6 -39.83 88.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.068 0.461 . . . . 0.0 110.237 177.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -57.03 -48.72 77.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.905 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 87.4 mt -71.83 -40.49 69.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.618 -176.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.62 -38.11 89.89 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -176.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -59.56 -42.71 93.05 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.271 0.558 . . . . 0.0 110.336 178.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.73 -7.78 58.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.425 -177.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.431 ' HD3' ' HA ' ' A' ' 67' ' ' LYS . 30.2 mmtm -97.38 -19.98 18.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.788 0.328 . . . . 0.0 111.408 178.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.79 34.47 9.06 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.335 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.468 ' HA3' HG12 ' A' ' 90' ' ' VAL . . . -129.32 138.49 10.28 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 177.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.735 ' HA ' ' HB2' ' B' ' 220' ' ' LEU . 87.9 mttt -85.01 -28.99 25.35 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.74 0.27 . . . . 0.0 111.463 -174.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -129.56 141.3 51.0 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -176.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.611 ' CD2' ' HB1' ' B' ' 222' ' ' ALA . 13.8 p90 -105.07 168.0 9.34 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 171.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.404 ' CD2' ' HA ' ' A' ' 26' ' ' SER . 9.7 t-80 -138.94 105.84 5.41 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.907 172.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 33.5 mt -69.96 124.5 26.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.238 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 31.4 pt -110.94 -17.59 8.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.989 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -171.89 101.22 0.18 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.509 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.58 ' HA ' ' HA ' ' A' ' 86' ' ' ALA . . . -107.69 101.64 10.93 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 171.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -136.96 167.1 22.13 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.104 0.478 . . . . 0.0 111.373 -172.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -90.37 145.58 24.84 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.821 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -129.35 80.53 1.97 Allowed 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 173.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.5 -117.73 9.2 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.827 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -83.12 -2.2 10.64 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.812 2.341 . . . . 0.0 112.045 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -112.42 165.04 12.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.989 -177.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -125.89 121.92 34.57 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.046 175.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -117.23 111.01 18.83 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.866 0.365 . . . . 0.0 110.579 -176.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.619 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -110.59 116.32 31.15 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.08 0.467 . . . . 0.0 110.495 176.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.6 t -102.39 118.17 48.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.311 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -135.94 136.65 40.6 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.592 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.55 ' HB3' ' HE3' ' A' ' 37' ' ' LYS . 40.9 mt-10 -91.83 149.87 21.36 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.468 HG12 ' HA3' ' A' ' 69' ' ' GLY . 5.6 t -107.48 132.72 54.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.35 -177.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.552 ' CE2' ' HD3' ' A' ' 37' ' ' LYS . 95.8 m-85 -133.21 146.3 51.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.162 0.506 . . . . 0.0 111.196 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -123.31 160.47 26.62 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.402 176.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -56.46 145.74 26.73 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 120.673 0.273 . . . . 0.0 110.814 -177.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.56 70.75 1.32 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.279 0.561 . . . . 0.0 110.39 177.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.454 HG23 ' H ' ' A' ' 97' ' ' LEU . 8.7 t -175.26 -26.37 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.42 -177.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.548 ' HE3' HG11 ' A' ' 36' ' ' VAL . 28.4 mmtp 73.49 -0.83 3.25 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 122.996 0.519 . . . . 0.0 112.371 175.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.454 ' H ' HG23 ' A' ' 95' ' ' THR . 87.7 mt -99.88 -169.82 1.8 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.731 0.301 . . . . 0.0 110.441 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.622 ' CD ' ' H ' ' A' ' 99' ' ' HIS . 0.6 OUTLIER -139.46 -172.21 3.31 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -178.382 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.622 ' H ' ' CD ' ' A' ' 98' ' ' GLU . 32.8 t60 -82.77 1.61 38.06 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.228 0.537 . . . . 0.0 109.738 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -115.04 155.85 26.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.284 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -115.5 117.42 30.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.63 0.252 . . . . 0.0 110.997 -178.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 72.69 125.77 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.366 -0.834 . . . . 0.0 113.131 174.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -140.84 -42.29 0.39 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 168.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 . . . . . 0 C--N 1.324 -0.527 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.699 174.281 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . 0.522 ' HG3' ' H ' ' B' ' 203' ' ' LYS . 38.7 tptt 66.56 177.13 0.23 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.24 -178.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . 0.522 ' H ' ' HG3' ' B' ' 202' ' ' LYS . 56.2 mtpt -121.11 171.69 8.5 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 177.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 62.09 95.41 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.931 0.769 . . . . 0.0 110.207 -176.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 10.4 tt -104.41 -36.31 3.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.132 -176.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 48.7 mm 68.74 109.04 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 O-C-N 123.563 0.539 . . . . 0.0 111.004 -177.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -77.14 176.66 8.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.036 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -82.96 30.84 0.44 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.981 0.42 . . . . 0.0 111.322 -177.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -79.84 -24.58 41.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.143 177.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 210' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -82.68 113.71 20.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.349 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 87.7 mt -67.79 -29.02 68.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.356 -175.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -119.26 102.34 8.63 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.932 0.396 . . . . 0.0 111.141 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 213' ' ' THR . . . . . . . . . . . . . 33.4 p -110.5 102.93 11.5 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.831 175.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 214' ' ' VAL . . . . . . . . . . . . . 28.9 m -112.85 135.62 51.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.167 0.508 . . . . 0.0 111.624 -175.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -139.88 120.29 14.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.466 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 50.8 m -96.05 -175.81 3.5 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.182 176.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 217' ' ' PHE . . . . . 0.537 ' HD2' ' H ' ' B' ' 218' ' ' SER . 2.5 p90 41.54 -99.38 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.772 0.829 . . . . 0.0 112.734 -176.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 218' ' ' SER . . . . . 0.537 ' H ' ' HD2' ' B' ' 217' ' ' PHE . 45.6 m 62.22 27.43 16.46 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 122.74 0.416 . . . . 0.0 111.673 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 6.4 t 39.5 87.81 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.274 1.029 . . . . 0.0 113.282 178.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.735 ' HB2' ' HA ' ' A' ' 70' ' ' LYS . 2.4 pt? -68.71 165.94 18.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.351 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . 0.51 ' HB1' ' HG2' ' A' ' 23' ' ' GLU . . . -135.47 69.17 1.44 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.444 176.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . 0.611 ' HB1' ' CD2' ' A' ' 72' ' ' TYR . . . -113.08 118.32 34.44 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.585 -175.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . 0.721 ' H ' ' HB2' ' A' ' 24' ' ' GLN . 40.5 tt0 -172.88 101.83 0.13 Allowed 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -176.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 224' ' ' GLN . . . . . 0.602 ' HA ' ' HD1' ' B' ' 271' ' ' TYR . 0.0 OUTLIER -174.04 158.71 3.15 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 122.919 0.488 . . . . 0.0 109.807 175.754 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . 0.484 HG21 ' CD1' ' B' ' 235' ' ' LEU . 24.1 m -117.03 146.11 21.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 120.543 0.211 . . . . 0.0 110.672 178.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 78.1 p -91.49 -166.8 1.65 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.952 0.406 . . . . 0.0 110.67 -177.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -67.13 -29.17 68.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.173 -176.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -73.02 -50.87 20.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.072 -174.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 229' ' ' GLU . . . . . 0.413 ' HB2' ' HB ' ' B' ' 225' ' ' VAL . 2.2 mp0 -59.8 -39.11 83.89 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.048 -177.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 87.8 mt -60.4 -49.22 85.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.781 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 15.2 m -72.82 -32.2 65.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.093 -177.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -78.76 -55.18 5.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.455 -175.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -83.23 -23.44 32.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.562 -174.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm 64.34 80.81 0.22 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.424 0.631 . . . . 0.0 110.308 -176.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . 0.484 ' CD1' HG21 ' B' ' 225' ' ' VAL . 63.1 mt -83.79 -178.41 7.0 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.108 -175.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 44.5 t -100.12 109.71 25.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.11 178.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 52.6 tttm -82.0 114.01 20.28 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 238' ' ' VAL . . . . . 0.519 HG23 ' HB ' ' B' ' 290' ' ' VAL . 14.5 m -104.36 7.57 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -170.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 131.34 -153.38 20.37 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 119.934 -1.127 . . . . 0.0 113.499 175.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . 0.469 HG23 ' HG2' ' B' ' 289' ' ' GLU . 6.9 m -137.95 141.43 40.54 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 122.205 0.202 . . . . 0.0 110.846 -175.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 37.4 pt -127.67 148.65 32.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 171.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -144.54 141.0 29.18 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.559 0.695 . . . . 0.0 111.717 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 243' ' ' VAL . . . . . 0.613 ' O ' ' HA ' ' B' ' 285' ' ' GLU . 61.3 t -92.99 129.54 43.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.284 176.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 5.8 t -153.07 74.99 1.06 Allowed 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 245' ' ' GLN . . . . . 0.569 ' HB3' ' HG3' ' B' ' 249' ' ' GLN . 0.8 OUTLIER -116.7 168.36 10.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.646 -177.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 246' ' ' SER . . . . . 0.428 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 21.0 p -83.77 101.12 11.37 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.727 -177.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 42.62 -92.04 0.01 OUTLIER Glycine 0 N--CA 1.463 0.48 0 N-CA-C 115.817 1.087 . . . . 0.0 115.817 167.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -71.71 10.92 3.66 Favored Glycine 0 CA--C 1.519 0.329 0 N-CA-C 114.809 0.683 . . . . 0.0 114.809 -168.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . 0.569 ' HG3' ' HB3' ' B' ' 245' ' ' GLN . 13.3 mm100 -73.24 -21.1 60.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.664 0.732 . . . . 0.0 110.012 175.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 250' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' B' ' 256' ' ' LEU . 46.9 mm -114.89 103.08 14.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.49 178.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 41.2 t -88.97 -16.9 30.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.653 0.264 . . . . 0.0 111.416 -177.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . 0.554 ' HB2' ' HD2' ' B' ' 253' ' ' PRO . 89.4 p -163.92 165.78 13.07 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -178.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . 0.554 ' HD2' ' HB2' ' B' ' 252' ' ' SER . 9.4 Cg_endo -52.56 -32.0 51.79 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.821 2.347 . . . . 0.0 112.243 176.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 254' ' ' SER . . . . . 0.492 ' O ' ' HG3' ' B' ' 258' ' ' GLU . 5.1 m -59.28 -47.43 85.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.35 177.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.406 ' O ' ' HG2' ' B' ' 259' ' ' LYS . 0.9 OUTLIER -55.07 -43.71 74.15 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.879 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.403 ' HA ' HD12 ' B' ' 250' ' ' ILE . 57.4 tp -57.7 -56.17 25.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.426 -175.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 257' ' ' ARG . . . . . 0.542 ' HA ' HD12 ' B' ' 260' ' ' LEU . 6.3 ppt_? -66.69 -31.18 71.68 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.34 -176.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 258' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' B' ' 254' ' ' SER . 44.2 mt-10 -63.14 -26.78 68.98 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.868 0.366 . . . . 0.0 111.03 177.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 259' ' ' LYS . . . . . 0.425 ' O ' ' HG ' ' B' ' 263' ' ' LEU . 66.1 mmtt -88.28 -22.91 23.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.93 0.395 . . . . 0.0 110.52 177.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 260' ' ' LEU . . . . . 0.542 HD12 ' HA ' ' B' ' 257' ' ' ARG . 89.2 mt -74.13 -48.42 29.57 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.501 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 261' ' ' SER . . . . . 0.542 ' HB3' ' O ' ' A' ' 22' ' ' ALA . 2.7 p -65.78 -30.99 71.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.862 0.363 . . . . 0.0 110.542 176.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -56.48 -45.4 80.96 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.053 175.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 263' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' B' ' 259' ' ' LYS . 84.1 mt -74.74 -34.52 62.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.843 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -64.31 -38.7 91.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.214 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -62.95 -43.86 97.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.694 177.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -64.01 -34.38 77.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.635 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 12.8 mmtt -73.03 -46.94 49.03 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.852 177.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 99.23 32.8 5.67 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -176.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -104.48 171.99 19.89 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.568 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -111.83 -24.86 9.76 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.851 0.358 . . . . 0.0 111.423 -177.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 271' ' ' TYR . . . . . 0.602 ' HD1' ' HA ' ' B' ' 224' ' ' GLN . 24.0 m-85 -144.01 160.52 40.72 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 272' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -137.55 129.17 28.41 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.047 0.451 . . . . 0.0 110.068 173.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -98.46 102.59 14.38 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.914 -177.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 274' ' ' ILE . . . . . 0.514 HG12 ' HB2' ' B' ' 288' ' ' ALA . 57.0 mt -67.25 129.74 32.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.821 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 19.0 pt -116.97 -26.84 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.807 -176.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -144.49 139.95 28.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.157 -177.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -154.79 117.5 4.34 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.222 177.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 278' ' ' ARG . . . . . 0.421 ' HD3' ' HB2' ' B' ' 285' ' ' GLU . 0.0 OUTLIER -154.91 156.77 36.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.928 0.394 . . . . 0.0 110.78 -177.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -88.8 117.43 27.79 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 167.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -92.77 14.48 17.15 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.492 0.663 . . . . 0.0 109.976 -175.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 129.93 -119.96 2.98 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 -175.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.93 -13.3 15.92 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.445 2.097 . . . . 0.0 111.765 173.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -106.82 142.96 35.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.665 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -104.1 130.8 51.82 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 285' ' ' GLU . . . . . 0.613 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 52.1 mt-10 -118.96 122.06 41.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.278 -176.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 286' ' ' ALA . . . . . 0.484 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -132.67 116.25 16.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.167 174.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 40.4 t -109.02 127.53 65.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.81 0.338 . . . . 0.0 111.067 -174.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 288' ' ' ALA . . . . . 0.514 ' HB2' HG12 ' B' ' 274' ' ' ILE . . . -139.25 133.53 31.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.957 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 289' ' ' GLU . . . . . 0.469 ' HG2' HG23 ' B' ' 240' ' ' THR . 31.9 mt-10 -93.06 135.39 34.28 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 290' ' ' VAL . . . . . 0.519 ' HB ' HG23 ' B' ' 238' ' ' VAL . 3.8 t -92.96 138.87 19.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.037 0.446 . . . . 0.0 111.27 -168.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -130.02 149.38 51.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.478 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 292' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -114.68 159.78 20.11 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 171.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -57.61 -95.16 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.492 0.663 . . . . 0.0 112.116 -174.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 294' ' ' ALA . . . . . . . . . . . . . . . -130.8 4.94 4.58 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.799 0.809 . . . . 0.0 109.147 176.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 295' ' ' THR . . . . . . . . . . . . . 14.5 t -161.49 -176.43 5.34 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.151 -1.386 . . . . 0.0 107.611 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 29.7 ttpp -86.47 99.46 11.67 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.308 -176.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 297' ' ' LEU . . . . . . . . . . . . . 94.7 mt 71.76 107.58 0.07 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.993 171.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 298' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' B' ' 299' ' ' HIS . 4.4 tm-20 -86.29 157.72 19.85 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 172.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 299' ' ' HIS . . . . . 0.458 ' HB2' ' O ' ' B' ' 298' ' ' GLU . 47.0 m-70 71.9 87.76 0.11 Allowed 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.344 0.658 . . . . 0.0 110.279 -172.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 300' ' ' HIS . . . . . . . . . . . . . 11.8 p80 -78.72 37.17 0.28 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.747 -1.115 . . . . 0.0 113.218 -171.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 301' ' ' HIS . . . . . . . . . . . . . 23.4 t60 -147.53 78.19 1.46 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.948 0.404 . . . . 0.0 110.107 171.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 302' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -153.71 18.72 0.53 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.065 177.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -80.24 137.44 36.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.476 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 15.5 p80 . . . . . 0 C--N 1.322 -0.621 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.349 -177.997 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.1 tpp . . . . . 0 N--CA 1.482 1.144 0 CA-C-O 120.626 0.251 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.423 ' HE2' ' HB3' ' A' ' 2' ' ' LYS . 45.6 mtpt -113.21 -38.53 4.41 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 175.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -74.52 93.3 2.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.099 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -68.57 119.45 13.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.879 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.465 HG13 ' H ' ' A' ' 5' ' ' ILE . 2.4 pp -84.49 165.67 2.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.323 174.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.2 pt -106.41 100.47 10.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.407 0.623 . . . . 0.0 111.513 -177.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -138.54 134.46 33.91 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.068 178.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -81.05 -35.61 31.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.036 -176.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 60.16 69.89 0.67 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.04 -178.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 36.7 tp -84.83 96.54 9.33 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.114 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.3 mt -76.4 -44.97 33.78 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.339 -177.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.07 72.59 0.46 Allowed 'General case' 0 N--CA 1.465 0.318 0 O-C-N 123.761 0.663 . . . . 0.0 111.02 -177.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.5 m -125.76 140.93 52.27 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.842 -175.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.6 p -61.97 141.47 17.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.15 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.61 108.76 4.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.058 177.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.3 m -84.15 -37.35 22.04 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.225 -176.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -156.18 154.8 31.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.455 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.8 m -124.56 109.57 13.38 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.613 177.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.1 p -76.93 -41.04 44.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.069 0.461 . . . . 0.0 110.957 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 54.1 tp -132.47 107.68 8.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.54 176.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.648 ' HB1' ' HA ' ' B' ' 270' ' ' LYS . . . -168.12 133.1 1.78 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.235 -178.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.641 ' HB1' ' CD2' ' B' ' 272' ' ' TYR . . . 64.04 86.89 0.12 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.942 173.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.933 ' HB3' ' HE1' ' A' ' 71' ' ' TYR . 26.8 mt-10 -149.28 105.28 3.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.683 -179.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.57 ' HB2' ' HB2' ' B' ' 224' ' ' GLN . 0.0 OUTLIER -162.3 156.1 21.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.262 178.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.0 m -101.69 128.32 54.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.037 0.446 . . . . 0.0 110.887 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.537 ' O ' HG13 ' A' ' 30' ' ' ILE . 1.5 m -64.99 151.33 46.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.877 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.534 ' HB2' ' CE1' ' A' ' 73' ' ' HIS . 88.7 tttt -57.85 -40.52 80.31 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.128 0.489 . . . . 0.0 109.724 176.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -61.14 -39.06 88.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.408 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.581 ' HA ' ' HB3' ' A' ' 32' ' ' HIS . 20.6 mm-40 -76.94 -26.98 54.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.503 -177.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.537 HG13 ' O ' ' A' ' 26' ' ' SER . 86.0 mt -60.88 -45.07 98.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 173.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.4 m -73.42 -31.83 64.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.879 175.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.581 ' HB3' ' HA ' ' A' ' 29' ' ' GLU . 23.7 t-160 -65.82 -54.86 21.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.286 -177.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -92.67 -8.74 43.16 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.376 -177.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm 59.31 70.56 0.64 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.452 0.644 . . . . 0.0 110.592 -178.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 94.1 mt -76.31 163.0 27.44 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.306 -176.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.449 HG23 ' HA ' ' A' ' 94' ' ' ALA . 85.1 t -93.37 126.42 45.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.271 -177.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.546 ' HE3' ' HB3' ' A' ' 89' ' ' GLU . 21.7 tptm -70.12 116.76 10.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.651 175.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.41 HG11 HD22 ' A' ' 92' ' ' ASN . 4.2 m -122.84 26.0 3.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -174.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.12 -175.36 16.94 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.109 -1.043 . . . . 0.0 113.252 174.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 61.7 m -135.29 129.55 33.72 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 30.5 pt -104.48 138.62 28.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 175.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -135.02 122.23 21.54 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.197 0.522 . . . . 0.0 111.092 -173.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 59.0 t -93.45 121.69 44.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.062 176.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.2 t -141.23 30.79 1.76 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.752 0.786 . . . . 0.0 109.134 -177.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -91.24 160.55 15.47 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.773 -175.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.2 t -64.06 157.84 24.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.075 176.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.06 -20.14 33.5 Favored Glycine 0 C--O 1.228 -0.271 0 CA-C-N 116.039 -0.528 . . . . 0.0 113.314 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.26 -20.64 75.28 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.884 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -101.46 -2.04 31.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.893 0.377 . . . . 0.0 110.88 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.1 mm -130.8 75.23 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 171.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.0 t -96.46 -14.01 22.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.875 -168.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.1 m -155.43 160.0 31.22 Favored Pre-proline 0 C--N 1.322 -0.598 0 O-C-N 122.365 -0.209 . . . . 0.0 110.784 -176.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.5 -36.26 86.98 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.589 2.193 . . . . 0.0 111.623 175.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.573 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 0.1 OUTLIER -63.27 -44.36 95.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.648 0.737 . . . . 0.0 109.698 174.071 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -64.38 -27.74 69.21 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.136 -177.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.6 tp -61.59 -52.68 63.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.683 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -65.79 -28.13 68.79 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.432 -176.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.573 ' HG2' ' O ' ' A' ' 54' ' ' SER . 38.8 mm-40 -62.6 -34.62 77.38 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.974 0.416 . . . . 0.0 110.223 -178.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -83.25 -38.33 22.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.764 176.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.3 mt -61.78 -48.48 80.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.255 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.2 p -64.52 -36.4 84.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.021 0.439 . . . . 0.0 110.473 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -64.29 -40.38 95.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.193 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 86.2 mt -69.54 -44.79 70.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.9 177.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.61 -37.33 83.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.99 0.424 . . . . 0.0 110.652 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.754 ' HA ' HG21 ' B' ' 219' ' ' THR . 22.8 t70 -66.68 -37.78 85.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.808 177.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.9 -34.96 78.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.772 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -80.65 -45.03 17.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.177 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 118.24 41.88 0.62 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.534 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.512 ' HA3' ' CG1' ' A' ' 90' ' ' VAL . . . -124.38 151.68 17.26 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.413 -0.899 . . . . 0.0 113.043 -177.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -81.04 -43.58 19.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.834 0.35 . . . . 0.0 110.44 176.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.933 ' HE1' ' HB3' ' A' ' 23' ' ' GLU . 78.9 m-85 -137.96 175.61 9.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.264 -174.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.442 ' HD2' ' CB ' ' A' ' 88' ' ' ALA . 0.6 OUTLIER -149.85 168.25 24.28 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -177.13 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.534 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 19.2 t-80 -135.05 126.1 27.79 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.49 -0.484 . . . . 0.0 109.812 172.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.534 ' H ' HD12 ' A' ' 74' ' ' ILE . 5.0 mp -72.77 123.37 27.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.017 -178.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 33.1 pt -104.88 -31.13 2.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.386 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.479 ' HB1' ' NH1' ' A' ' 78' ' ' ARG . . . -161.82 117.9 2.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.025 -177.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -131.92 122.28 25.37 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.385 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.479 ' NH1' ' HB1' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -156.46 142.24 17.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.044 0.449 . . . . 0.0 110.888 -178.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -72.07 145.62 48.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.905 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -139.6 100.38 3.95 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 61.97 -123.87 32.57 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.991 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -88.29 6.6 4.8 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.994 2.463 . . . . 0.0 112.569 178.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -119.76 158.92 25.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.046 0.45 . . . . 0.0 111.123 -176.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -113.57 111.65 22.23 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.564 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.559 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 25.9 mm-40 -96.26 111.45 23.51 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.612 -176.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.534 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -124.99 115.17 20.13 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.754 177.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.2 t -105.64 124.86 60.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.499 -178.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.442 ' CB ' ' HD2' ' A' ' 72' ' ' TYR . . . -141.0 149.2 41.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.2 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.546 ' HB3' ' HE3' ' A' ' 37' ' ' LYS . 7.4 mt-10 -108.67 143.61 37.54 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.263 -178.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.512 ' CG1' ' HA3' ' A' ' 69' ' ' GLY . 11.4 t -95.04 137.57 23.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.642 -172.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -133.71 136.98 45.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.894 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.41 HD22 HG11 ' A' ' 38' ' ' VAL . 74.5 m-20 -122.42 172.78 8.09 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.578 176.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -61.16 161.4 8.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.673 177.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.449 ' HA ' HG23 ' A' ' 36' ' ' VAL . . . -83.4 14.79 3.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.684 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.8 t -131.95 139.07 48.57 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.269 -178.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.523 ' HB3' ' HB3' ' B' ' 215' ' ' ALA . 0.1 OUTLIER -124.82 125.09 43.45 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 17.3 mt -139.55 6.68 2.3 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.41 -0.516 . . . . 0.0 112.328 -168.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.577 ' OE2' ' HB1' ' B' ' 215' ' ' ALA . 5.3 pm0 -90.35 79.33 6.32 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 122.173 0.987 . . . . 0.0 110.389 176.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -66.99 123.82 21.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.467 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -144.11 -178.61 6.03 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.091 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -56.14 133.12 51.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.698 -176.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -73.88 80.44 1.64 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.562 175.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 31.4 t-80 -80.49 143.35 33.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.939 -176.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 7.0 p-80 . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.857 173.985 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . 0.425 ' N ' ' SD ' ' B' ' 201' ' ' MET . 1.6 mpt? . . . . . 0 N--CA 1.48 1.054 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -131.49 22.3 4.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.182 0.515 . . . . 0.0 110.544 -173.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -71.97 103.57 3.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.515 0.674 . . . . 0.0 110.668 178.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -147.16 105.37 3.76 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.285 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 8.1 tp -120.01 132.65 69.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.337 0.589 . . . . 0.0 111.079 -174.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 21.3 pt -121.67 129.26 75.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.753 176.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -96.37 8.16 44.68 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.349 -176.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -62.95 133.33 54.46 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.639 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -87.3 -175.28 5.22 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.926 -177.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 210' ' ' LEU . . . . . 0.892 ' HG ' ' H ' ' B' ' 211' ' ' LEU . 21.1 tp 66.71 -169.25 0.2 Allowed 'General case' 0 CA--C 1.534 0.344 0 O-C-N 123.699 0.624 . . . . 0.0 110.294 178.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . 0.892 ' H ' ' HG ' ' B' ' 210' ' ' LEU . 83.2 mt 60.01 43.88 14.0 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.158 0.504 . . . . 0.0 110.964 -178.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -84.23 144.15 29.12 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 173.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 213' ' ' THR . . . . . . . . . . . . . 19.0 m -148.92 -68.91 0.22 Allowed 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.725 -176.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 214' ' ' VAL . . . . . . . . . . . . . 30.6 m -109.07 171.99 2.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.266 0.555 . . . . 0.0 111.756 -174.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . 0.577 ' HB1' ' OE2' ' A' ' 98' ' ' GLU . . . -101.27 -169.29 1.67 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.491 176.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 50.9 m -157.16 -81.4 0.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -177.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -143.93 162.92 34.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.762 0.315 . . . . 0.0 111.063 -175.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 218' ' ' SER . . . . . . . . . . . . . 71.1 m -150.28 129.74 12.99 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.168 176.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 219' ' ' THR . . . . . 0.754 HG21 ' HA ' ' A' ' 65' ' ' ASP . 57.9 p -101.38 157.28 16.91 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.651 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 26.2 tp -143.27 -74.52 0.27 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.272 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -144.95 -78.47 0.19 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 121.266 -0.173 . . . . 0.0 111.359 -177.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . 0.416 ' HB1' ' CD1' ' A' ' 72' ' ' TYR . . . 71.03 92.69 0.08 Allowed 'General case' 0 N--CA 1.463 0.222 0 O-C-N 124.008 0.817 . . . . 0.0 111.588 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -161.12 125.5 3.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.839 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 224' ' ' GLN . . . . . 0.57 ' HB2' ' HB2' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -159.3 167.97 27.59 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.782 176.845 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . 0.44 HG11 HD11 ' B' ' 235' ' ' LEU . 6.8 m -135.18 123.63 39.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.984 0.421 . . . . 0.0 110.353 174.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . 0.409 ' O ' HG13 ' B' ' 230' ' ' ILE . 9.3 t -105.72 -171.72 1.96 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.581 178.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . 0.426 ' HE2' ' CA ' ' B' ' 227' ' ' LYS . 0.0 OUTLIER -55.33 -33.83 63.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.769 -175.092 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -70.74 -49.65 44.56 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.264 0.554 . . . . 0.0 110.365 -176.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 229' ' ' GLU . . . . . 0.401 ' O ' ' HD1' ' B' ' 233' ' ' PHE . 1.8 mp0 -72.13 -48.44 43.66 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.459 -176.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.531 HG12 HD12 ' B' ' 235' ' ' LEU . 89.9 mt -54.54 -49.68 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 -174.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 59.1 m -72.56 -21.17 61.2 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -176.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -89.12 -35.92 16.01 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.893 -177.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . 0.401 ' HD1' ' O ' ' B' ' 229' ' ' GLU . 81.7 m-85 -89.9 -15.02 32.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.377 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 234' ' ' LYS . . . . . 0.434 ' HB3' ' HE3' ' B' ' 234' ' ' LYS . 25.9 mmmt 59.79 77.55 0.31 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.225 0.536 . . . . 0.0 111.545 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . 0.531 HD12 HG12 ' B' ' 230' ' ' ILE . 94.4 mt -88.21 163.46 16.13 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.389 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 47.4 t -96.28 118.36 42.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.82 178.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -91.29 111.97 23.69 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 238' ' ' VAL . . . . . 0.434 HG23 ' HB ' ' B' ' 290' ' ' VAL . 2.6 m -90.28 -25.01 5.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -176.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 161.8 -156.29 27.78 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.046 -1.073 . . . . 0.0 112.863 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 87.4 m -139.7 131.45 27.43 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 122.476 0.311 . . . . 0.0 110.353 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 22.3 pt -103.98 143.11 16.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.008 0.432 . . . . 0.0 110.13 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -116.02 128.76 55.97 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.881 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 243' ' ' VAL . . . . . 0.587 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 58.0 t -96.8 124.31 49.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.613 177.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 23.2 t -153.35 88.77 1.31 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.895 0.379 . . . . 0.0 110.138 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 245' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -142.4 157.65 44.55 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 246' ' ' SER . . . . . 0.58 ' HA ' ' HA ' ' B' ' 283' ' ' ASN . 25.8 t -62.48 153.18 32.38 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.694 0.283 . . . . 0.0 110.385 177.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -60.51 -17.54 48.31 Favored Glycine 0 C--N 1.332 0.353 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.807 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -65.04 -23.33 69.5 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.362 176.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -88.98 -47.65 7.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.098 0.475 . . . . 0.0 110.547 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 44.9 mm -107.55 100.42 10.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.968 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 22.3 t -112.11 -11.43 13.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.993 0.425 . . . . 0.0 111.085 -175.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 78.8 p -149.33 163.66 24.23 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.399 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.72 -31.63 94.43 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.476 2.117 . . . . 0.0 111.639 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 254' ' ' SER . . . . . 0.561 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 8.1 t -65.49 -40.12 92.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.106 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -64.48 -38.46 91.11 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.297 0.57 . . . . 0.0 109.978 177.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 48.5 tp -60.24 -44.69 95.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.847 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 257' ' ' ARG . . . . . 0.471 ' HD3' ' OE1' ' A' ' 23' ' ' GLU . 0.3 OUTLIER -66.44 -34.76 78.66 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.787 -0.188 . . . . 0.0 110.712 -177.032 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 258' ' ' GLU . . . . . 0.561 ' HG2' ' O ' ' B' ' 254' ' ' SER . 67.7 mm-40 -59.54 -45.56 91.44 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-O 121.311 0.576 . . . . 0.0 109.604 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 259' ' ' LYS . . . . . 0.481 ' O ' ' HG ' ' B' ' 263' ' ' LEU . 38.8 tptt -72.91 -40.18 65.71 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.834 -178.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 81.1 mt -64.53 -48.73 73.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.346 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 49.4 m -64.56 -29.8 70.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.706 0.289 . . . . 0.0 110.541 178.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -64.34 -51.44 63.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.997 0.427 . . . . 0.0 110.248 174.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 263' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' B' ' 259' ' ' LYS . 86.8 mt -65.45 -36.58 84.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.922 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.53 -39.51 81.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.856 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -62.54 -35.54 79.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.149 0.5 . . . . 0.0 110.626 177.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -76.37 -11.35 59.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.932 -177.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -114.99 -27.04 7.5 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.817 0.341 . . . . 0.0 111.372 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 91.61 64.93 1.15 Allowed Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.5 176.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -137.82 156.94 23.99 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.611 175.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . 0.876 ' HD3' ' HB2' ' B' ' 293' ' ' ASP . 10.3 mtpm? -104.39 -12.67 16.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.824 0.312 . . . . 0.0 111.321 -178.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 271' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -146.37 159.96 42.69 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 272' ' ' TYR . . . . . 0.641 ' CD2' ' HB1' ' A' ' 22' ' ' ALA . 0.3 OUTLIER -132.37 163.52 28.51 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.165 171.42 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -128.58 101.93 6.38 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 175.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 274' ' ' ILE . . . . . 0.577 HG12 ' HB2' ' B' ' 288' ' ' ALA . 49.6 mt -82.23 118.04 29.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.083 0.468 . . . . 0.0 110.267 -177.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 16.9 pt -103.19 -39.27 5.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.457 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . 0.562 ' HB3' ' HB ' ' B' ' 287' ' ' VAL . . . -119.92 143.95 47.7 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.783 0.325 . . . . 0.0 111.417 -175.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -157.98 114.52 2.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.421 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 278' ' ' ARG . . . . . 0.465 ' HG2' ' HB2' ' B' ' 285' ' ' GLU . 0.0 OUTLIER -151.35 150.91 31.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.949 0.404 . . . . 0.0 111.147 -175.639 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -93.4 109.56 21.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.846 176.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 280' ' ' HIS . . . . . 0.431 ' HB2' ' CG ' ' B' ' 285' ' ' GLU . 4.7 t60 -69.26 -22.96 63.8 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 150.15 -110.66 0.48 Allowed Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -69.52 -15.82 38.19 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 122.319 2.013 . . . . 0.0 111.43 171.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 283' ' ' ASN . . . . . 0.58 ' HA ' ' HA ' ' B' ' 246' ' ' SER . 41.1 m-80 -111.85 151.82 28.65 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.464 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -107.88 133.78 51.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.41 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 285' ' ' GLU . . . . . 0.465 ' HB2' ' HG2' ' B' ' 278' ' ' ARG . 50.4 mm-40 -117.67 122.23 42.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.941 -175.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 286' ' ' ALA . . . . . 0.587 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -136.55 145.86 45.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.811 0.339 . . . . 0.0 110.673 177.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 287' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' B' ' 276' ' ' ALA . 59.2 t -126.29 118.06 50.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.445 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 288' ' ' ALA . . . . . 0.577 ' HB2' HG12 ' B' ' 274' ' ' ILE . . . -129.09 136.16 49.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.054 -177.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -91.21 136.83 32.82 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 290' ' ' VAL . . . . . 0.434 ' HB ' HG23 ' B' ' 238' ' ' VAL . 12.7 t -97.91 127.36 50.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.748 0.309 . . . . 0.0 110.411 -176.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -120.75 134.5 55.28 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.265 0.555 . . . . 0.0 110.998 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 292' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -95.33 159.15 15.14 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 176.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 293' ' ' ASP . . . . . 0.876 ' HB2' ' HD3' ' B' ' 270' ' ' LYS . 3.2 t70 -82.56 150.89 26.66 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.492 -174.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 294' ' ' ALA . . . . . . . . . . . . . . . -78.66 73.51 5.21 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.218 0.532 . . . . 0.0 110.401 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 295' ' ' THR . . . . . . . . . . . . . 6.4 t -174.93 -41.07 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.101 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt 60.92 20.92 11.19 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.502 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 297' ' ' LEU . . . . . . . . . . . . . 90.1 mt -114.26 111.96 22.35 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.993 0.425 . . . . 0.0 110.98 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 298' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -76.92 158.55 30.63 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 299' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -63.69 -62.35 1.71 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -176.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 300' ' ' HIS . . . . . . . . . . . . . 34.2 p-80 -169.3 128.89 1.04 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.912 0.387 . . . . 0.0 111.37 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 301' ' ' HIS . . . . . . . . . . . . . 36.0 p-80 -170.59 143.43 2.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.111 176.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 302' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -97.01 121.77 39.26 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 174.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -123.72 77.91 1.56 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -178.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 5.7 t60 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.527 -179.691 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.606 ' HG3' ' H ' ' A' ' 2' ' ' LYS . 11.5 tpt . . . . . 0 N--CA 1.482 1.163 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.606 ' H ' ' HG3' ' A' ' 1' ' ' MET . 11.7 mptt -83.51 -84.28 0.13 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.103 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt 47.47 52.87 11.81 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 122.176 0.989 . . . . 0.0 108.436 -170.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -76.83 4.07 10.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.198 -1.365 . . . . 0.0 113.184 -164.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 58.4 mt -90.23 92.11 3.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.026 0.441 . . . . 0.0 110.324 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.5 pt -127.1 126.85 68.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.467 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.409 ' C ' ' H ' ' A' ' 9' ' ' ALA . . . -161.58 -73.35 0.06 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.733 -178.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 70.1 -35.87 0.33 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.632 0.773 . . . . 0.0 112.368 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.409 ' H ' ' C ' ' A' ' 7' ' ' ALA . . . -73.95 95.9 2.56 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.841 0.353 . . . . 0.0 111.394 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 59.6 tp -104.39 96.66 6.77 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 174.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.46 122.34 33.96 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.736 -176.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.35 90.07 7.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.319 0.581 . . . . 0.0 111.037 -178.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.8 m -107.43 98.8 8.37 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.23 172.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.0 p -138.91 140.51 38.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.981 0.42 . . . . 0.0 110.556 -175.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.52 145.03 28.31 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.44 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.6 m -76.79 90.19 3.45 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.178 178.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.452 ' CE2' ' HB3' ' B' ' 304' ' ' HIS . 56.1 t80 -80.19 146.57 31.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.05 -176.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.8 m -61.3 167.5 3.16 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.227 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.406 ' C ' HD12 ' A' ' 20' ' ' LEU . 8.8 t -98.21 140.7 32.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.129 0.49 . . . . 0.0 111.014 -175.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.406 HD12 ' C ' ' A' ' 19' ' ' THR . 8.6 mp -125.64 28.38 6.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.037 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' B' ' 223' ' ' GLU . . . -98.2 22.22 9.83 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.826 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.3 97.12 8.14 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.603 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.547 ' HB3' ' HG3' ' B' ' 257' ' ' ARG . 6.1 pt-20 -161.4 124.86 3.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.693 0.759 . . . . 0.0 111.796 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.804 ' HG3' ' HG3' ' B' ' 224' ' ' GLN . 0.0 OUTLIER -141.35 143.5 34.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.769 -173.54 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.562 HG23 ' HB2' ' A' ' 73' ' ' HIS . 3.5 m -103.19 126.84 57.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.364 0.602 . . . . 0.0 111.401 176.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.674 ' HB2' ' OE1' ' A' ' 28' ' ' GLN . 1.3 p -92.5 159.12 15.67 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.478 178.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.522 ' HA ' HD12 ' A' ' 30' ' ' ILE . 15.9 ttpp -69.67 -26.19 64.26 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.153 0.502 . . . . 0.0 109.688 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.674 ' OE1' ' HB2' ' A' ' 26' ' ' SER . 19.6 mp0 -59.9 -49.53 77.34 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.078 175.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.612 ' HA ' ' HB3' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -71.23 -25.76 62.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.948 -1.023 . . . . 0.0 112.347 -177.043 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.546 HG12 HD12 ' A' ' 35' ' ' LEU . 72.6 mt -52.93 -55.69 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.778 0.323 . . . . 0.0 110.503 177.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.9 t -73.59 -31.53 63.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.082 0.468 . . . . 0.0 110.564 176.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.612 ' HB3' ' HA ' ' A' ' 29' ' ' GLU . 15.1 t-160 -63.55 -51.37 65.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.901 -173.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -111.38 4.53 19.05 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 121.208 -0.197 . . . . 0.0 111.494 -176.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm 56.64 79.01 0.19 Allowed 'General case' 0 N--CA 1.465 0.29 0 O-C-N 123.696 0.622 . . . . 0.0 110.841 -177.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.546 HD12 HG12 ' A' ' 30' ' ' ILE . 91.0 mt -75.55 152.9 37.68 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.934 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.466 HG11 ' HG3' ' A' ' 98' ' ' GLU . 57.9 t -92.14 101.1 12.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.452 -178.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.528 ' HE3' ' HB3' ' A' ' 89' ' ' GLU . 22.9 tptm -75.1 113.66 12.69 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.691 178.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.8 m -99.55 -9.37 8.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.134 0.492 . . . . 0.0 111.31 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 142.75 -179.75 20.16 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.432 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 21.3 m -131.09 126.69 36.43 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.1 pt -106.8 160.62 6.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.031 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -141.56 141.6 33.52 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.731 0.777 . . . . 0.0 111.8 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.672 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 53.5 t -94.13 135.33 28.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.943 179.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 10.0 t -150.38 86.7 1.42 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.121 0.486 . . . . 0.0 109.972 178.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.83 148.44 42.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.97 178.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.7 t -100.7 124.91 46.97 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.62 -177.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.45 -157.72 22.59 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.272 175.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.27 50.5 4.1 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.344 -0.455 . . . . 0.0 113.755 -172.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -75.42 -38.32 59.89 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 172.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.532 HD12 ' HA ' ' A' ' 56' ' ' LEU . 47.4 mm -105.24 95.03 3.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.541 176.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.3 t -108.58 -36.39 6.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.394 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.431 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 19.8 m -107.46 144.38 29.11 Favored Pre-proline 0 N--CA 1.448 -0.568 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.408 -177.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.641 ' HG3' ' HB3' ' B' ' 233' ' ' PHE . 34.8 Cg_exo -56.99 -39.92 87.86 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.908 2.405 . . . . 0.0 111.707 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.1 t -62.37 -40.54 96.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.834 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -67.31 -34.79 78.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.941 -174.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.532 ' HA ' HD12 ' A' ' 50' ' ' ILE . 58.4 tp -57.89 -55.89 29.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.472 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.481 ' HA ' HD12 ' A' ' 60' ' ' LEU . 7.8 ppt_? -70.84 -24.55 62.55 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.285 -177.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -58.67 -34.82 71.68 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.95 0.405 . . . . 0.0 110.495 171.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -78.51 -36.55 44.76 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.41 175.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.502 HD13 HD11 ' A' ' 74' ' ' ILE . 97.0 mt -62.24 -48.77 78.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.146 -178.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 65' ' ' ASP . 5.4 p -68.68 -42.15 78.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.741 0.305 . . . . 0.0 110.781 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.85 ' HG2' ' HB1' ' B' ' 215' ' ' ALA . 37.7 tt0 -54.41 -42.83 70.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.988 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.514 HD23 ' HB2' ' B' ' 215' ' ' ALA . 94.2 mt -76.06 -51.06 13.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.883 178.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.47 -45.34 69.25 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -172.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 61' ' ' SER . 0.4 OUTLIER -64.87 -42.63 94.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.113 0.482 . . . . 0.0 110.053 -176.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.41 -12.84 60.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.457 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.648 ' HG2' HG21 ' B' ' 213' ' ' THR . 5.4 tmtt? -78.05 -22.99 48.31 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 175.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.72 59.98 0.7 Allowed Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.842 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.474 ' HA2' ' OD1' ' A' ' 92' ' ' ASN . . . -135.56 176.25 20.25 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.851 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -116.69 -30.18 5.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 117.04 0.42 . . . . 0.0 111.331 176.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -142.2 163.72 32.11 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.505 ' CE1' ' HB3' ' B' ' 224' ' ' GLN . 12.1 p90 -136.71 152.45 50.38 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.946 172.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.562 ' HB2' HG23 ' A' ' 25' ' ' VAL . 46.9 t-80 -131.53 108.88 9.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.166 -174.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.555 HD12 ' HB2' ' B' ' 226' ' ' SER . 69.0 mt -79.56 127.59 39.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.829 0.347 . . . . 0.0 110.672 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.4 pt -101.03 -29.37 3.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.49 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -159.84 141.46 12.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.905 0.383 . . . . 0.0 111.299 -177.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -142.95 126.53 16.87 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.49 147.45 34.54 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.373 0.606 . . . . 0.0 112.223 -175.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -93.71 104.81 16.89 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 169.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -87.55 11.45 14.89 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.314 0.578 . . . . 0.0 110.484 -171.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 120.27 -113.42 2.42 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 111.309 -0.717 . . . . 0.0 111.309 -178.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -73.79 -11.19 23.8 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.449 2.1 . . . . 0.0 112.172 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -122.17 140.54 52.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.92 0.391 . . . . 0.0 110.758 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 44' ' ' SER . 84.0 t80 -103.15 130.5 50.35 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 175.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.672 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 63.0 mt-10 -124.57 114.86 19.95 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.278 -175.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -121.18 121.24 37.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.325 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.6 t -105.34 120.46 56.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.659 0.266 . . . . 0.0 110.821 -176.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.552 ' HB2' HG12 ' A' ' 74' ' ' ILE . . . -131.57 137.73 48.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.082 0.468 . . . . 0.0 111.274 -177.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.528 ' HB3' ' HE3' ' A' ' 37' ' ' LYS . 30.4 mt-10 -91.73 145.68 24.38 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.586 177.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 18.3 t -105.25 129.84 57.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -125.38 134.96 51.97 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.496 0.665 . . . . 0.0 112.024 -177.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.474 ' OD1' ' HA2' ' A' ' 69' ' ' GLY . 56.0 m-20 -109.72 179.45 4.12 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.234 169.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.416 ' OD1' HG22 ' A' ' 95' ' ' THR . 39.9 p30 -124.23 174.56 7.61 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.812 0.339 . . . . 0.0 110.191 175.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.85 21.77 0.11 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -173.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.416 HG22 ' OD1' ' A' ' 93' ' ' ASP . 6.9 t -122.77 3.53 9.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.706 0.765 . . . . 0.0 109.987 178.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -80.73 -170.57 2.7 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.836 175.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.411 ' H ' ' HG ' ' A' ' 97' ' ' LEU . 3.3 pp -96.02 19.92 10.89 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.2 0.524 . . . . 0.0 111.047 -174.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.466 ' HG3' HG11 ' A' ' 36' ' ' VAL . 1.6 mm-40 -81.24 34.65 0.37 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.336 -174.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 41.75 85.35 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.955 0.883 . . . . 0.0 111.708 -173.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -77.97 148.26 34.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.965 -1.016 . . . . 0.0 112.112 -171.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -73.84 144.11 45.63 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.882 169.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 -59.26 120.1 8.62 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 65.7 t-80 -139.99 143.94 36.73 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.638 -172.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 38.0 m80 . . . . . 0 C--N 1.326 -0.419 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 171.008 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . 0.441 ' HA ' ' HD3' ' A' ' 27' ' ' LYS . 72.9 mtm . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . 0.524 ' HB3' HD11 ' B' ' 205' ' ' ILE . 32.3 mmmt -101.84 111.74 24.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.811 0.339 . . . . 0.0 110.878 -178.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -112.2 172.28 7.01 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.177 177.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 68.9 mtp180 64.51 18.51 11.4 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.492 0.495 . . . . 0.0 112.243 174.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 205' ' ' ILE . . . . . 0.524 HD11 ' HB3' ' B' ' 202' ' ' LYS . 71.4 mt -71.38 -51.62 32.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.131 0.491 . . . . 0.0 110.452 177.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 43.9 pt -99.42 153.2 4.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.18 -178.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -145.25 -47.55 0.23 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.777 175.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -87.55 83.54 7.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.187 177.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -162.97 130.44 3.63 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.695 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 210' ' ' LEU . . . . . . . . . . . . . 50.1 tp -153.91 97.36 2.07 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 86.7 mt -120.18 100.06 6.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.034 0.445 . . . . 0.0 111.823 -171.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.57 95.02 6.18 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 171.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 213' ' ' THR . . . . . 0.648 HG21 ' HG2' ' A' ' 67' ' ' LYS . 13.5 p -79.13 160.74 26.88 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.534 -175.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 214' ' ' VAL . . . . . . . . . . . . . 40.5 t -70.57 100.61 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.897 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . 0.85 ' HB1' ' HG2' ' A' ' 62' ' ' GLU . . . -70.76 129.55 39.4 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.042 -177.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 50.1 m -84.01 161.13 20.84 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 175.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -71.75 88.04 0.99 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.793 0.33 . . . . 0.0 111.768 -174.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 218' ' ' SER . . . . . . . . . . . . . 3.1 t 60.98 89.94 0.07 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.051 174.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 9.3 m -115.49 119.03 34.86 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 39.7 tp -116.95 110.45 18.31 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -169.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -153.35 -58.01 0.13 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.577 170.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -80.38 118.76 22.3 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.906 177.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . 0.477 ' OE2' ' HD3' ' A' ' 57' ' ' ARG . 4.7 mm-40 -147.34 125.54 12.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.998 0.428 . . . . 0.0 111.282 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 224' ' ' GLN . . . . . 0.804 ' HG3' ' HG3' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -147.38 138.56 23.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.782 -174.431 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . 0.437 HG13 ' HB2' ' B' ' 271' ' ' TYR . 12.3 m -94.95 136.03 27.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.226 0.536 . . . . 0.0 110.414 175.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . 0.555 ' HB2' HD12 ' A' ' 74' ' ' ILE . 28.4 t -82.78 148.01 28.06 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.229 -175.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . 0.523 ' HD3' ' O ' ' B' ' 227' ' ' LYS . 12.6 tmtt? -69.57 -36.69 76.54 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -65.16 -36.11 83.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.458 177.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 229' ' ' GLU . . . . . 0.625 ' HA ' ' HB3' ' B' ' 232' ' ' HIS . 0.0 OUTLIER -68.66 -25.63 64.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.649 -178.557 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 73.8 mt -56.15 -53.06 43.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 174.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 46.2 t -73.62 -31.19 63.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.059 177.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 232' ' ' HIS . . . . . 0.625 ' HB3' ' HA ' ' B' ' 229' ' ' GLU . 22.1 t-160 -72.57 -46.82 52.5 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.658 -173.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . 0.641 ' HB3' ' HG3' ' A' ' 53' ' ' PRO . 82.5 m-85 -111.49 6.45 20.19 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -175.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm 56.25 51.68 11.31 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.36 0.412 . . . . 0.0 110.587 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . 0.821 ' HA ' ' HB2' ' B' ' 294' ' ' ALA . 89.9 mt -57.2 140.2 50.37 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.693 -176.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.587 HG23 ' HA ' ' B' ' 294' ' ' ALA . 75.0 t -79.86 117.72 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.635 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -81.41 105.68 12.77 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.806 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 238' ' ' VAL . . . . . 0.454 HG22 ' O ' ' B' ' 290' ' ' VAL . 36.0 m -87.05 -16.11 9.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.799 -0.361 . . . . 0.0 111.792 -175.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 160.98 145.09 4.19 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 119.883 -1.151 . . . . 0.0 113.077 177.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . 0.58 HG23 ' HG2' ' B' ' 289' ' ' GLU . 24.8 m -97.78 122.32 40.74 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 174.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 24.0 pt -103.58 131.71 51.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.303 0.573 . . . . 0.0 110.849 -177.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -102.27 112.48 25.18 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.628 176.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 243' ' ' VAL . . . . . 0.576 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 87.6 t -95.55 108.92 21.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.199 176.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 244' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' B' ' 284' ' ' PHE . 7.9 t -127.9 94.19 3.87 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.323 0.582 . . . . 0.0 109.632 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 245' ' ' GLN . . . . . 0.555 ' HB2' ' HB3' ' B' ' 284' ' ' PHE . 0.0 OUTLIER -86.28 147.45 26.07 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.396 -177.204 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 22.8 t -101.31 102.48 13.34 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 177.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 94.65 177.25 38.4 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.441 -0.663 . . . . 0.0 111.441 -174.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -79.3 66.28 3.49 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.819 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -76.2 -21.02 56.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.163 0.506 . . . . 0.0 110.879 -177.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 50.0 mm -98.75 122.17 50.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 176.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 1.9 m -109.94 -53.8 2.63 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.287 0.565 . . . . 0.0 110.231 -176.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 16.0 m -114.91 163.08 20.74 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.493 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.6 -29.14 59.26 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.463 2.109 . . . . 0.0 111.979 176.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 254' ' ' SER . . . . . 0.563 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 1.6 p -60.52 -44.09 96.43 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.568 177.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -56.43 -45.33 80.79 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.24 0.543 . . . . 0.0 110.225 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 46.6 tp -68.32 -39.41 81.98 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.55 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 257' ' ' ARG . . . . . 0.547 ' HG3' ' HB3' ' A' ' 23' ' ' GLU . 6.7 ttp85 -60.33 -46.8 88.63 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.759 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 258' ' ' GLU . . . . . 0.563 ' HG2' ' O ' ' B' ' 254' ' ' SER . 33.7 mm-40 -57.99 -42.98 86.28 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.598 -178.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 259' ' ' LYS . . . . . 0.548 ' O ' ' HG ' ' B' ' 263' ' ' LEU . 75.4 mmtt -64.12 -48.25 76.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.446 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 97.6 mt -66.67 -38.75 87.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.414 -176.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 29.5 t -65.35 -38.92 91.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.841 0.353 . . . . 0.0 110.095 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -63.16 -47.11 84.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.254 0.55 . . . . 0.0 110.145 177.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 263' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' B' ' 259' ' ' LYS . 85.1 mt -64.05 -42.62 96.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.967 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -58.9 -48.29 81.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.335 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -62.83 -43.98 97.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.256 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -68.1 -37.79 81.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.925 0.393 . . . . 0.0 111.338 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -78.86 -3.73 46.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.408 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 76.17 48.5 9.56 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.141 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . 0.46 ' HA3' HG12 ' B' ' 290' ' ' VAL . . . -128.47 -179.66 16.03 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.681 178.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . 0.707 ' HZ3' ' HB3' ' B' ' 270' ' ' LYS . 7.9 mtpm? -115.88 -63.57 1.43 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.723 0.296 . . . . 0.0 110.608 -178.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 271' ' ' TYR . . . . . 0.437 ' HB2' HG13 ' B' ' 225' ' ' VAL . 13.9 m-85 -122.99 174.38 7.22 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 272' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -139.01 166.79 23.57 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.663 -175.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -141.49 125.49 17.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.849 175.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 274' ' ' ILE . . . . . . . . . . . . . 84.9 mt -82.75 140.11 16.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.412 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 19.1 pt -125.12 -22.29 2.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -152.66 109.1 3.41 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.738 0.304 . . . . 0.0 110.596 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -132.23 121.17 23.21 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.832 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 278' ' ' ARG . . . . . 0.41 ' N ' ' HD2' ' B' ' 278' ' ' ARG . 0.0 OUTLIER -141.64 130.76 23.35 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.334 0.587 . . . . 0.0 111.256 -178.025 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -75.39 106.24 6.82 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 174.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -80.73 -24.93 38.39 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.458 -172.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 113.12 -89.75 0.53 Allowed Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -70.28 -12.65 32.28 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.42 2.08 . . . . 0.0 111.353 174.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -140.29 170.54 15.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.562 177.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 284' ' ' PHE . . . . . 0.555 ' HB3' ' HB2' ' B' ' 245' ' ' GLN . 72.9 t80 -131.89 119.87 21.77 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 285' ' ' GLU . . . . . 0.403 ' HB2' ' HD3' ' B' ' 278' ' ' ARG . 11.3 mm-40 -109.45 111.21 22.62 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 123.108 0.255 . . . . 0.0 110.395 -175.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 286' ' ' ALA . . . . . 0.576 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -123.83 117.16 24.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.983 0.42 . . . . 0.0 110.838 174.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 38.3 t -105.21 118.28 52.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.277 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -140.36 150.1 43.53 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.148 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 289' ' ' GLU . . . . . 0.58 ' HG2' HG23 ' B' ' 240' ' ' THR . 32.6 mt-10 -109.85 143.18 40.1 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 177.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 290' ' ' VAL . . . . . 0.46 HG12 ' HA3' ' B' ' 269' ' ' GLY . 17.2 t -102.42 141.09 19.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 291' ' ' TYR . . . . . 0.424 ' CD2' HG21 ' B' ' 225' ' ' VAL . 71.6 m-85 -128.04 149.62 50.3 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.776 0.322 . . . . 0.0 110.346 -178.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 292' ' ' ASN . . . . . 0.446 ' HB2' ' CG1' ' B' ' 238' ' ' VAL . 5.5 t-20 -104.7 24.58 11.56 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.245 0.545 . . . . 0.0 111.163 -176.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 64.58 9.45 5.11 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.31 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 294' ' ' ALA . . . . . 0.821 ' HB2' ' HA ' ' B' ' 235' ' ' LEU . . . 68.76 18.65 8.64 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.373 0.669 . . . . 0.0 112.514 178.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 295' ' ' THR . . . . . 0.453 ' C ' ' H ' ' B' ' 297' ' ' LEU . 6.3 t -112.21 -34.28 5.97 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.371 -0.531 . . . . 0.0 112.044 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 296' ' ' LYS . . . . . 0.524 ' HD3' ' O ' ' B' ' 296' ' ' LYS . 1.7 tmtp? 73.99 -20.68 0.3 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.632 0.773 . . . . 0.0 110.834 -177.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 297' ' ' LEU . . . . . 0.453 ' H ' ' C ' ' B' ' 295' ' ' THR . 74.4 mt -105.17 -167.52 1.35 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.977 178.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 298' ' ' GLU . . . . . 0.849 ' HG2' ' H ' ' B' ' 299' ' ' HIS . 9.2 tt0 68.92 -179.22 0.23 Allowed 'General case' 0 CA--C 1.536 0.416 0 O-C-N 123.642 0.589 . . . . 0.0 110.843 177.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 299' ' ' HIS . . . . . 0.849 ' H ' ' HG2' ' B' ' 298' ' ' GLU . 4.7 p80 -172.97 -36.31 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.556 176.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 300' ' ' HIS . . . . . . . . . . . . . 16.1 m170 47.96 72.32 0.28 Allowed 'General case' 0 N--CA 1.471 0.585 0 O-C-N 123.602 0.564 . . . . 0.0 111.504 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 301' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -179.32 103.43 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -178.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 302' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -72.74 -42.55 63.96 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.157 -171.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -154.2 -165.09 2.0 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.996 -176.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 304' ' ' HIS . . . . . 0.452 ' HB3' ' CE2' ' A' ' 17' ' ' PHE . 5.1 p80 . . . . . 0 C--N 1.325 -0.478 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.1 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.574 ' O ' ' HG2' ' A' ' 2' ' ' LYS . 14.7 tpt . . . . . 0 N--CA 1.481 1.081 0 N-CA-C 110.803 -0.073 . . . . 0.0 110.803 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.574 ' HG2' ' O ' ' A' ' 1' ' ' MET . 12.8 ptpt 65.15 141.26 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.76 1.224 . . . . 0.0 112.087 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -142.49 -26.9 0.62 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.778 175.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 64.53 -171.07 0.18 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.295 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.4 tt -156.5 115.31 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.505 0.669 . . . . 0.0 110.76 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.413 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.0 mp -101.62 99.03 7.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 176.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -93.45 134.11 36.04 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.644 -177.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 72.07 163.56 0.27 Allowed 'General case' 0 C--O 1.234 0.262 0 O-C-N 124.202 0.939 . . . . 0.0 111.157 -177.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -169.74 170.36 7.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.149 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.431 ' HG ' HD13 ' B' ' 297' ' ' LEU . 27.2 tp -100.03 86.28 3.22 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.0 mp -74.44 -37.13 63.37 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.159 -176.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.778 ' HB2' HD11 ' B' ' 297' ' ' LEU . . . 70.91 155.08 0.14 Allowed 'General case' 0 N--CA 1.467 0.406 0 O-C-N 124.272 0.983 . . . . 0.0 110.321 -170.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.6 m -75.74 74.12 2.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.342 0.591 . . . . 0.0 110.984 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.8 t -138.6 -59.68 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.192 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 62.44 -168.6 0.19 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.846 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.7 m -114.89 -62.81 1.55 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 174.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 47.6 t80 48.46 -89.04 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.136 0.974 . . . . 0.0 112.895 177.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.7 t -81.64 -17.88 46.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.853 0.359 . . . . 0.0 110.578 -175.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.0 m -77.69 107.04 9.89 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.128 178.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.8 mt -69.13 104.27 2.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.042 0.449 . . . . 0.0 110.06 178.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.506 ' HA ' ' HG3' ' B' ' 223' ' ' GLU . . . -151.5 -175.03 5.02 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.645 -178.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 61.25 66.62 0.86 Allowed 'General case' 0 C--N 1.332 -0.175 0 O-C-N 123.695 0.622 . . . . 0.0 111.515 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.543 ' H ' ' HB2' ' B' ' 223' ' ' GLU . 33.7 mt-10 -150.4 99.37 2.77 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.574 -175.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.8 156.21 5.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.649 176.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.483 ' HB ' ' HB2' ' A' ' 29' ' ' GLU . 19.6 m -122.79 143.38 35.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.185 177.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.49 ' O ' HG13 ' A' ' 30' ' ' ILE . 94.9 p -93.78 -167.6 1.72 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.918 0.39 . . . . 0.0 110.738 -176.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -62.18 -38.53 89.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.624 -174.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.536 ' HB2' ' OE2' ' A' ' 29' ' ' GLU . 0.9 OUTLIER -62.17 -49.98 73.66 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.096 0.474 . . . . 0.0 110.601 -176.416 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.536 ' OE2' ' HB2' ' A' ' 28' ' ' GLN . 1.8 mp0 -62.32 -40.86 97.72 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.251 -177.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.557 HG12 HD12 ' A' ' 35' ' ' LEU . 80.8 mt -55.35 -48.28 77.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 121.048 0.452 . . . . 0.0 110.712 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.9 m -73.28 -41.61 63.4 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.749 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 12.6 t60 -76.99 -32.28 57.09 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.79 0.292 . . . . 0.0 111.79 -171.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -101.87 -2.78 29.15 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 121.352 -0.139 . . . . 0.0 111.257 -178.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt 44.68 100.02 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 122.294 1.045 . . . . 0.0 113.76 -171.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.557 HD12 HG12 ' A' ' 30' ' ' ILE . 91.7 mt -104.67 152.82 22.02 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.106 -1.406 . . . . 0.0 111.368 -176.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.1 t -88.09 105.66 15.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.932 -175.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.4 tttp -73.87 118.49 16.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.956 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 26.8 m -100.05 -21.9 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -178.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.58 -171.83 34.23 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.43 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 27.2 m -125.17 139.49 53.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.666 0.269 . . . . 0.0 110.659 -178.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.3 pt -114.7 143.88 23.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 175.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -126.18 131.12 52.07 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.105 0.479 . . . . 0.0 111.359 -173.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.686 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 95.9 t -93.89 125.67 46.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.084 173.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -153.16 88.96 1.33 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.863 0.364 . . . . 0.0 110.135 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.406 HE22 HG13 ' A' ' 43' ' ' VAL . 0.5 OUTLIER -138.46 163.45 31.91 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.884 177.586 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.567 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 4.0 p -66.05 148.92 51.07 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.122 0.487 . . . . 0.0 111.835 -178.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.88 114.42 6.03 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.934 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 137.62 -39.38 1.61 Allowed Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 -175.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -70.24 -29.29 66.06 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.465 0.65 . . . . 0.0 109.632 175.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.442 HD11 ' HG3' ' A' ' 59' ' ' LYS . 46.1 mm -118.38 109.19 26.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.728 174.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.5 t -116.18 -44.53 2.89 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.041 0.448 . . . . 0.0 110.23 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.2 m -104.06 157.14 34.61 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.073 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.953 ' HG3' HD21 ' B' ' 235' ' ' LEU . 22.1 Cg_endo -61.08 -28.79 86.3 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.411 2.074 . . . . 0.0 110.857 175.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.642 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 0.8 OUTLIER -60.34 -45.29 93.99 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.118 176.12 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.501 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 71.8 m-20 -54.93 -46.88 75.0 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.117 0.484 . . . . 0.0 110.25 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 59.2 tp -57.14 -47.82 80.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.898 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.51 -31.49 68.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.91 -176.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.642 ' HG2' ' O ' ' A' ' 54' ' ' SER . 57.7 mm-40 -63.2 -43.16 98.95 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.982 0.42 . . . . 0.0 110.013 176.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 55' ' ' ASP . 31.5 mmmt -67.24 -45.6 76.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.562 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 87.5 mt -65.24 -38.82 91.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.509 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.4 t -63.47 -35.75 81.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.96 0.409 . . . . 0.0 110.316 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -59.75 -42.88 94.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.251 176.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 87.3 mt -74.74 -33.68 62.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.936 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.93 -40.17 94.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.449 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -61.21 -35.82 78.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.373 176.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.59 2.49 29.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.579 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.427 ' HD3' ' HA ' ' A' ' 67' ' ' LYS . 42.9 mmtm -122.08 -0.05 9.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.911 0.386 . . . . 0.0 110.687 176.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 60.73 40.5 98.17 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.631 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -108.2 135.56 12.91 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.007 -178.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.818 ' HD3' HG21 ' B' ' 219' ' ' THR . 74.6 mmtt -77.68 -25.7 49.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.365 0.602 . . . . 0.0 110.021 177.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -152.93 175.44 12.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.215 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -147.65 170.22 17.98 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.925 -176.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -135.42 114.23 11.95 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 119.994 -0.683 . . . . 0.0 110.915 174.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.477 ' HA ' ' HA ' ' A' ' 88' ' ' ALA . 55.8 mt -78.39 127.53 38.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.777 177.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 23.2 pt -100.92 -35.2 4.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.585 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -156.32 144.86 20.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.817 0.341 . . . . 0.0 111.424 -177.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -147.14 124.67 11.7 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.07 152.21 40.68 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.888 0.375 . . . . 0.0 111.213 -174.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -86.0 118.88 25.75 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.488 170.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -80.11 -22.13 42.5 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 128.4 -86.28 0.32 Allowed Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 -175.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.567 ' O ' ' HA ' ' A' ' 46' ' ' SER . 70.1 Cg_endo -74.73 -24.0 13.86 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.16 1.907 . . . . 0.0 111.374 172.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.467 ' OD1' ' HG2' ' A' ' 82' ' ' PRO . 1.1 m120 -119.57 150.15 40.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.323 -176.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -108.13 121.67 45.33 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 170.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.686 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 46.2 mt-10 -117.71 118.98 33.57 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.206 0.527 . . . . 0.0 111.782 -174.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -121.36 132.13 54.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.992 176.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.1 t -111.54 112.85 42.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.997 0.427 . . . . 0.0 110.421 -178.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 74' ' ' ILE . . . -125.13 135.57 52.78 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.223 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 40' ' ' THR . 33.2 mt-10 -106.0 134.96 48.29 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 26.2 t -90.66 132.19 35.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -175.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -123.25 125.73 45.61 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.167 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.68 147.39 25.26 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 174.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.456 ' C ' ' H ' ' A' ' 95' ' ' THR . 2.1 m-20 -53.5 147.82 10.27 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.061 -178.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.455 ' O ' ' HB3' ' A' ' 104' ' ' HIS . . . -73.49 46.84 0.21 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 166.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.456 ' H ' ' C ' ' A' ' 93' ' ' ASP . 31.1 m -151.43 -50.11 0.12 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.947 -172.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -69.66 -32.74 71.58 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.235 -178.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 78.2 mt -116.32 24.13 11.6 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.286 0.565 . . . . 0.0 110.294 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.28 141.27 48.37 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 35.1 t-80 -146.72 75.61 1.4 Allowed 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.547 -175.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 14.5 m80 -90.52 -49.84 6.28 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 169.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -112.53 -84.0 0.59 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 176.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 14.5 t-160 -128.97 -41.63 1.44 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -143.09 161.15 38.95 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.964 -1.016 . . . . 0.0 108.53 170.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.455 ' HB3' ' O ' ' A' ' 94' ' ' ALA . 57.5 t-80 . . . . . 0 C--N 1.311 -1.068 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 171.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . 0.427 ' HG3' ' HG3' ' B' ' 202' ' ' LYS . 15.7 tpt . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 120.574 0.226 . . . . 0.0 110.756 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . 0.427 ' HG3' ' HG3' ' B' ' 201' ' ' MET . 98.4 mttt -133.57 122.12 23.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.594 0.235 . . . . 0.0 110.619 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 92.8 mttt 60.2 67.96 0.81 Allowed 'General case' 0 N--CA 1.465 0.301 0 O-C-N 124.037 0.836 . . . . 0.0 112.802 177.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -135.1 101.87 5.01 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 170.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 205' ' ' ILE . . . . . 0.62 HG22 HG23 ' B' ' 206' ' ' ILE . 4.4 mp -119.93 -73.04 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.722 -178.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . 0.62 HG23 HG22 ' B' ' 205' ' ' ILE . 32.2 pt -128.41 174.55 11.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.825 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -118.33 -11.85 9.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.597 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . 63.86 18.42 11.16 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.425 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -89.87 140.85 29.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.097 -178.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 210' ' ' LEU . . . . . . . . . . . . . 8.7 mp 65.79 24.7 11.4 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.248 176.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 97.9 mt -64.76 -58.69 5.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.283 0.563 . . . . 0.0 109.488 173.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -132.21 -60.79 0.89 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.4 -0.818 . . . . 0.0 108.84 171.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 213' ' ' THR . . . . . 0.736 HG22 ' H ' ' B' ' 214' ' ' VAL . 1.2 m 64.91 -160.64 0.28 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.438 172.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 214' ' ' VAL . . . . . 0.736 ' H ' HG22 ' B' ' 213' ' ' THR . 47.8 t 67.51 94.03 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-O 121.262 0.554 . . . . 0.0 111.225 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -155.18 85.87 1.09 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.73 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 15.0 m -78.4 84.12 4.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.109 -173.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -107.33 151.94 24.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.349 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 218' ' ' SER . . . . . . . . . . . . . 8.4 t -91.58 124.73 35.97 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.786 0.327 . . . . 0.0 110.845 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 219' ' ' THR . . . . . 0.818 HG21 ' HD3' ' A' ' 70' ' ' LYS . 89.1 m -159.2 109.43 1.97 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.379 175.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 6.3 mp -86.31 96.18 9.89 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.658 -0.417 . . . . 0.0 109.91 173.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -140.14 -139.99 0.13 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.041 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . 68.73 91.12 0.09 Allowed 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.64 0.588 . . . . 0.0 111.154 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . 0.543 ' HB2' ' H ' ' A' ' 23' ' ' GLU . 4.2 mm-40 -127.07 89.14 2.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.274 -173.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 224' ' ' GLN . . . . . 0.619 ' HA ' ' HB3' ' B' ' 271' ' ' TYR . 0.0 OUTLIER -176.62 155.73 1.38 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.285 169.264 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 20.3 m -125.88 150.85 31.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.272 175.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . 0.442 ' O ' HG13 ' B' ' 230' ' ' ILE . 12.7 t -83.74 171.61 13.02 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . 0.494 ' HA ' HD12 ' B' ' 230' ' ' ILE . 74.3 tttt -68.74 -19.55 64.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.343 -173.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 228' ' ' GLN . . . . . 0.44 ' HB2' ' OE1' ' B' ' 229' ' ' GLU . 0.6 OUTLIER -65.75 -50.36 65.07 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 177.315 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 229' ' ' GLU . . . . . 0.44 ' OE1' ' HB2' ' B' ' 228' ' ' GLN . 1.9 mp0 -64.58 -41.33 96.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.444 178.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.494 HD12 ' HA ' ' B' ' 227' ' ' LYS . 87.4 mt -56.84 -46.46 83.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.898 178.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 16.5 m -73.14 -21.29 60.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.458 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 -85.48 -48.03 9.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.806 -176.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -91.19 -7.81 50.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.033 -177.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 57.95 64.56 1.5 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.082 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . 0.953 HD21 ' HG3' ' A' ' 53' ' ' PRO . 60.4 mt -75.21 147.26 40.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.236 -178.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 46.8 t -88.55 119.09 35.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.08 -175.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -80.53 117.56 21.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.12 175.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 238' ' ' VAL . . . . . 0.416 HG23 ' HB ' ' B' ' 290' ' ' VAL . 2.0 m -80.26 -39.48 19.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.841 177.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 179.37 -173.27 45.26 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.991 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 33.3 m -115.22 129.81 56.74 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.245 -0.279 . . . . 0.0 110.245 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 24.2 pt -104.08 132.66 50.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.006 0.431 . . . . 0.0 110.177 175.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -117.55 123.08 45.38 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.582 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 243' ' ' VAL . . . . . 0.701 ' O ' ' HA ' ' B' ' 285' ' ' GLU . 41.9 t -92.6 120.42 41.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 173.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 15.9 t -150.97 87.16 1.39 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.345 0.593 . . . . 0.0 109.511 -177.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 245' ' ' GLN . . . . . 0.561 ' HG3' ' HB2' ' B' ' 249' ' ' GLN . 6.3 pm0 -138.62 173.62 11.39 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.734 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 246' ' ' SER . . . . . 0.434 ' HA ' HD22 ' B' ' 283' ' ' ASN . 8.6 t -85.39 176.21 8.41 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.735 0.302 . . . . 0.0 110.275 -176.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.69 52.42 1.57 Allowed Glycine 0 CA--C 1.521 0.439 0 CA-C-N 116.098 -0.501 . . . . 0.0 113.246 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -141.28 -39.78 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 176.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . 0.561 ' HB2' ' HG3' ' B' ' 245' ' ' GLN . 77.3 mt-30 -80.03 -15.13 57.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.587 -0.306 . . . . 0.0 110.518 175.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 250' ' ' ILE . . . . . 0.547 ' HA ' ' OD2' ' B' ' 255' ' ' ASP . 47.4 mm -131.76 110.22 16.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 175.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 8.5 t -118.25 -27.98 5.91 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.606 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . 0.522 ' HB3' ' HD2' ' B' ' 253' ' ' PRO . 50.6 m -152.22 164.72 19.36 Favored Pre-proline 0 C--N 1.327 -0.383 0 O-C-N 122.357 -0.214 . . . . 0.0 110.62 -175.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . 0.522 ' HD2' ' HB3' ' B' ' 252' ' ' SER . 12.3 Cg_endo -56.95 -43.9 49.76 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.8 2.333 . . . . 0.0 112.503 178.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 254' ' ' SER . . . . . 0.405 ' O ' ' HG3' ' B' ' 257' ' ' ARG . 4.3 p -64.14 -30.46 71.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.361 0.6 . . . . 0.0 110.726 177.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.547 ' OD2' ' HA ' ' B' ' 250' ' ' ILE . 28.1 t70 -75.75 -37.1 59.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.458 177.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 60.6 tp -61.64 -47.54 84.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.945 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 257' ' ' ARG . . . . . 0.513 ' HA ' HD12 ' B' ' 260' ' ' LEU . 2.0 ppt_? -59.19 -25.38 63.9 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -175.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 258' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -63.0 -47.5 82.86 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.169 0.509 . . . . 0.0 110.372 176.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 259' ' ' LYS . . . . . 0.529 ' N ' ' HD2' ' B' ' 259' ' ' LYS . 12.2 mptt -74.16 -26.23 60.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.559 -175.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 260' ' ' LEU . . . . . 0.513 HD12 ' HA ' ' B' ' 257' ' ' ARG . 95.9 mt -67.79 -48.21 66.94 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.479 176.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 14.4 t -66.1 -37.59 86.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.891 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -51.2 -49.4 61.09 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.083 176.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 263' ' ' LEU . . . . . . . . . . . . . 87.7 mt -74.48 -30.39 61.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.547 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.42 -40.95 81.01 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -177.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -63.48 -35.48 80.58 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.24 0.543 . . . . 0.0 110.42 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -74.59 -6.74 50.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.471 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -116.16 -2.84 12.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.84 176.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 66.29 51.09 46.28 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.158 -0.544 . . . . 0.0 112.854 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -138.92 169.35 24.46 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.172 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . 0.443 ' HB3' ' OE1' ' B' ' 223' ' ' GLU . 46.0 mtmt -105.56 -66.56 0.98 Allowed 'General case' 0 C--O 1.223 -0.334 0 CA-C-O 121.017 0.437 . . . . 0.0 110.923 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 271' ' ' TYR . . . . . 0.619 ' HB3' ' HA ' ' B' ' 224' ' ' GLN . 16.0 m-85 -92.41 152.66 19.6 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -174.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 272' ' ' TYR . . . . . 0.592 ' HB2' ' HB1' ' B' ' 288' ' ' ALA . 2.8 p90 -134.69 118.28 16.96 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.352 0.596 . . . . 0.0 110.203 175.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 273' ' ' HIS . . . . . 0.518 ' HA ' ' OE1' ' B' ' 224' ' ' GLN . 32.7 t-80 -87.84 101.21 13.49 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 274' ' ' ILE . . . . . 0.597 HG12 ' HB2' ' B' ' 288' ' ' ALA . 58.5 mt -74.17 106.44 4.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.314 -178.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 19.4 pt -85.66 -33.36 7.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.588 -175.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -151.58 124.13 8.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.703 0.287 . . . . 0.0 111.193 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -130.47 118.43 21.12 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 174.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -133.67 164.96 26.05 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.384 0.612 . . . . 0.0 111.064 -175.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -99.14 123.28 43.31 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.027 178.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 280' ' ' HIS . . . . . 0.478 ' HB3' ' HB2' ' B' ' 283' ' ' ASN . 12.1 t-80 -103.07 28.95 5.82 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.198 0.523 . . . . 0.0 110.067 -174.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 93.0 -108.3 3.64 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -178.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -83.23 4.3 7.16 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.666 2.244 . . . . 0.0 111.518 175.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 283' ' ' ASN . . . . . 0.478 ' HB2' ' HB3' ' B' ' 280' ' ' HIS . 15.6 m120 -126.16 142.02 51.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.484 -177.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -103.61 129.03 50.81 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 173.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 285' ' ' GLU . . . . . 0.701 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 31.2 mt-10 -121.95 113.97 20.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.787 0.327 . . . . 0.0 111.651 -178.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 286' ' ' ALA . . . . . 0.538 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -117.59 127.97 54.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.554 175.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 32.1 t -110.09 116.43 52.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.23 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 288' ' ' ALA . . . . . 0.597 ' HB2' HG12 ' B' ' 274' ' ' ILE . . . -128.31 139.24 52.52 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.131 0.491 . . . . 0.0 111.783 -177.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -91.9 123.46 35.29 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.352 177.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 290' ' ' VAL . . . . . 0.416 ' HB ' HG23 ' B' ' 238' ' ' VAL . 16.5 t -90.78 127.4 43.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.461 -176.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -123.49 139.83 53.62 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.018 -177.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 292' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -106.39 165.77 11.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.106 172.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -60.48 152.1 26.65 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 175.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 294' ' ' ALA . . . . . . . . . . . . . . . -73.03 77.05 1.21 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.076 0.465 . . . . 0.0 110.534 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 295' ' ' THR . . . . . . . . . . . . . 11.2 t 179.72 -28.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.695 -178.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 296' ' ' LYS . . . . . 0.737 ' HD2' ' HG ' ' B' ' 297' ' ' LEU . 2.1 tmmm? -80.07 91.78 5.54 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 297' ' ' LEU . . . . . 0.778 HD11 ' HB2' ' A' ' 12' ' ' ALA . 75.4 mt 74.17 91.72 0.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.644 -1.162 . . . . 0.0 112.995 172.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 298' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -100.99 35.74 2.14 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 166.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 299' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -63.96 136.45 57.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.352 -1.294 . . . . 0.0 110.406 -175.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 300' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -69.52 103.95 2.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.081 0.467 . . . . 0.0 110.157 -179.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 301' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -69.78 99.88 1.43 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.606 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 302' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -85.39 -13.19 50.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.847 176.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -120.48 104.11 9.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.559 175.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 60.6 t60 . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.071 -177.164 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.868 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.1 mttm 61.85 84.14 0.14 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.584 0.707 . . . . 0.0 111.548 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -98.04 108.77 21.55 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.917 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.0 tpt180 -125.03 115.51 20.65 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 177.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 60.3 mt 64.42 92.71 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.272 0 O-C-N 123.701 0.625 . . . . 0.0 110.737 -174.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 40.7 pt -138.37 179.03 3.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.708 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 56.26 50.7 12.88 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.923 175.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -113.22 145.87 40.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.36 178.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -141.93 110.97 6.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.832 0.348 . . . . 0.0 111.53 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 24.7 tp -137.6 41.86 2.35 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.735 0.779 . . . . 0.0 109.437 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.516 HD23 ' H ' ' B' ' 242' ' ' ASN . 0.3 OUTLIER -79.35 94.61 5.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.013 -177.696 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.42 116.47 4.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.417 177.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.6 t -173.47 134.39 0.51 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.162 177.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 56.4 t -107.94 101.79 13.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.869 0.366 . . . . 0.0 110.404 177.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -164.82 170.49 15.37 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.865 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.5 p -120.16 78.76 1.38 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.332 0.587 . . . . 0.0 110.484 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.618 ' HB3' ' OD2' ' B' ' 265' ' ' ASP . 65.8 m-85 -131.25 146.99 52.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.142 178.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.897 ' HA ' ' HA ' ' B' ' 262' ' ' GLU . 34.5 m -155.53 -25.34 0.11 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -177.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.4 p -141.36 116.88 10.22 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -174.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 59.4 tp -165.77 -53.56 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.329 176.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -153.67 -165.01 2.02 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.236 177.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 73.5 91.53 0.08 Allowed 'General case' 0 C--O 1.235 0.332 0 O-C-N 123.756 0.66 . . . . 0.0 111.369 176.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.7 ' HB3' ' HE2' ' A' ' 71' ' ' TYR . 42.8 mt-10 -133.88 160.67 36.95 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.38 176.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.587 ' CG ' ' HG3' ' B' ' 224' ' ' GLN . 0.0 OUTLIER 174.66 142.88 0.05 Allowed 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.539 0.525 . . . . 0.0 110.424 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.2 m -123.97 125.2 70.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 169.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.456 ' HB2' ' HB ' ' B' ' 274' ' ' ILE . 8.2 t -99.38 -167.93 1.54 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.025 0.44 . . . . 0.0 110.915 -175.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.407 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -71.26 -36.62 71.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.321 -175.169 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -64.54 -50.33 67.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.058 -173.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -59.17 -36.07 74.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.426 -177.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 26' ' ' SER . 79.2 mt -57.19 -56.05 17.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.93 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.6 m -73.77 -30.51 62.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.749 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 17.6 t-160 -79.08 -51.84 9.01 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -174.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -93.03 -7.81 44.7 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 121.18 -0.208 . . . . 0.0 111.467 -174.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt 59.66 65.12 1.19 Allowed 'General case' 0 N--CA 1.463 0.212 0 O-C-N 123.555 0.534 . . . . 0.0 110.656 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.4 mt -65.47 144.49 57.0 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.54 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.511 ' HB ' ' HB3' ' A' ' 92' ' ' ASN . 95.3 t -73.23 112.56 9.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.06 0.457 . . . . 0.0 110.477 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.617 ' HD3' ' CE1' ' A' ' 91' ' ' TYR . 19.3 tptm -78.75 112.98 16.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.125 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.501 HG21 ' HA3' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -97.99 -13.19 8.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.816 -178.675 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 145.48 -170.81 26.71 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.293 -0.956 . . . . 0.0 112.571 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.504 HG23 ' HG2' ' A' ' 89' ' ' GLU . 52.2 m -137.17 139.38 41.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.632 0.253 . . . . 0.0 110.432 -178.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 34.5 pt -121.97 155.65 26.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.743 0.306 . . . . 0.0 110.201 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -141.18 140.53 34.05 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.218 0.533 . . . . 0.0 110.728 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 44.1 t -94.6 126.31 47.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.313 -0.858 . . . . 0.0 108.775 173.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.7 p -138.69 35.83 2.21 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.848 0.832 . . . . 0.0 108.894 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -99.75 159.73 14.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.942 -175.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' A' ' 83' ' ' ASN . 22.7 t -73.31 172.09 11.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.829 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.96 22.07 1.55 Allowed Glycine 0 CA--C 1.52 0.363 0 CA-C-N 116.178 -0.464 . . . . 0.0 113.366 -177.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -103.96 -21.78 9.33 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 173.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -102.41 -20.22 14.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.339 0.59 . . . . 0.0 109.63 178.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.3 mm -125.58 98.05 4.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.17 172.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.8 m -103.26 -66.54 0.93 Allowed 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.651 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.534 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 23.5 m -108.24 165.0 13.51 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.534 ' HD2' ' HB3' ' A' ' 52' ' ' SER . 11.2 Cg_endo -55.14 -32.49 80.2 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.581 2.188 . . . . 0.0 111.88 178.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.6 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 7.9 m -60.76 -43.25 98.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.896 177.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.52 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 18.3 m-20 -63.39 -36.49 83.88 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.536 -178.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.7 tp -60.86 -46.73 89.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.496 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.45 ' HD2' ' HG2' ' B' ' 223' ' ' GLU . 23.5 ttp180 -60.63 -42.65 97.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.44 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.6 ' HG2' ' O ' ' A' ' 54' ' ' SER . 31.3 mm-40 -63.05 -34.84 78.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.841 -179.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 55' ' ' ASP . 42.9 mmtm -75.29 -43.54 50.6 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.806 0.336 . . . . 0.0 110.707 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.1 mt -62.69 -46.38 88.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.066 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.7 p -64.76 -40.05 94.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.994 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -58.8 -44.15 90.71 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.797 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.7 mt -74.49 -36.03 63.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.511 -179.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.38 -47.09 74.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.815 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -64.35 -35.36 80.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.069 0.462 . . . . 0.0 110.487 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -78.64 4.78 12.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.55 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.7 mmtm -119.45 3.95 11.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.779 0.323 . . . . 0.0 111.563 176.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.46 -17.46 58.41 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.215 174.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.501 ' HA3' HG21 ' A' ' 38' ' ' VAL . . . -92.47 179.73 40.51 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.846 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.582 ' HE2' ' HA ' ' A' ' 70' ' ' LYS . 9.2 mmpt? -122.18 -59.13 1.67 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.672 0.272 . . . . 0.0 110.456 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.7 ' HE2' ' HB3' ' A' ' 23' ' ' GLU . 95.2 m-85 -91.67 167.35 12.26 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.545 -175.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.439 ' HE2' ' HB1' ' B' ' 222' ' ' ALA . 8.8 p90 -146.3 157.65 43.82 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.794 0.33 . . . . 0.0 110.912 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.444 ' CD2' ' HA ' ' A' ' 26' ' ' SER . 40.6 t-80 -127.48 102.88 7.06 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.098 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.442 ' HA ' ' HA ' ' A' ' 88' ' ' ALA . 63.9 mt -63.81 127.24 23.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.466 176.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.4 pt -113.45 -14.6 10.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.857 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.484 ' HB3' ' HB ' ' A' ' 87' ' ' VAL . . . -150.2 123.83 9.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.733 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.461 ' HB3' ' HB2' ' B' ' 228' ' ' GLN . . . -135.34 108.34 7.63 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.457 HH11 ' HD3' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -149.6 171.98 15.77 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.578 -174.668 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -119.5 140.1 51.04 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -130.36 96.69 4.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.017 0.437 . . . . 0.0 110.08 -178.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 60.8 -125.36 38.09 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -175.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -90.6 20.51 0.97 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.852 2.368 . . . . 0.0 112.348 175.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.582 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 38.4 m-80 -123.86 151.88 42.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.361 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.416 ' CE2' ' HB2' ' A' ' 86' ' ' ALA . 83.6 t80 -111.21 120.45 42.32 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.049 178.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.578 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 26.2 mm-40 -102.03 110.62 22.64 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.403 -177.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.416 ' HB2' ' CE2' ' A' ' 84' ' ' PHE . . . -128.38 114.99 17.55 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.808 0.337 . . . . 0.0 110.768 177.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.484 ' HB ' ' HB3' ' A' ' 76' ' ' ALA . 48.3 t -105.68 117.37 51.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 120.77 0.319 . . . . 0.0 110.344 -178.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.442 ' HA ' ' HA ' ' A' ' 74' ' ' ILE . . . -131.84 133.09 44.29 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.455 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.581 ' HB3' ' HE3' ' A' ' 37' ' ' LYS . 29.8 mt-10 -92.0 135.26 34.09 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.9 t -91.42 127.72 43.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -175.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.617 ' CE1' ' HD3' ' A' ' 37' ' ' LYS . 77.1 m-85 -128.14 136.98 51.89 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.336 0.589 . . . . 0.0 110.879 -178.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.511 ' HB3' ' HB ' ' A' ' 36' ' ' VAL . 8.0 t-20 -95.15 -176.86 3.94 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 174.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -71.82 -166.97 0.24 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -98.42 6.95 46.81 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 121.844 -0.535 . . . . 0.0 110.563 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.7 t -112.5 159.96 18.27 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.545 -178.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -131.77 9.14 4.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.744 177.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 85.8 mt -101.95 101.99 12.48 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.045 -173.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -117.38 -98.81 0.45 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 56.4 m80 -155.38 -47.48 0.08 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 175.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -129.3 95.17 3.96 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.358 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.403 ' O ' ' HB2' ' A' ' 102' ' ' HIS . 51.0 p-80 -124.71 38.65 4.15 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.119 -173.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.403 ' HB2' ' O ' ' A' ' 101' ' ' HIS . 91.9 m-70 70.38 -170.94 0.17 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.654 -177.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 22.6 p-80 -116.66 159.81 21.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.708 0.289 . . . . 0.0 110.321 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 . . . . . 0 C--N 1.322 -0.626 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.762 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 51.4 ttm . . . . . 0 N--CA 1.477 0.889 0 CA-C-O 120.99 0.424 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -125.4 -28.36 3.35 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 175.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -74.2 110.81 8.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.632 176.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -161.42 99.14 1.16 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.834 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 205' ' ' ILE . . . . . 0.782 HG12 HG13 ' B' ' 206' ' ' ILE . 14.7 tt -91.59 143.65 10.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.893 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . 0.782 HG13 HG12 ' B' ' 205' ' ' ILE . 73.8 mt 71.85 114.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 123.383 0.673 . . . . 0.0 112.19 177.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -140.05 108.56 5.88 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.14 175.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -90.63 102.9 15.64 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.354 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -89.76 -45.99 8.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.738 -174.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 210' ' ' LEU . . . . . . . . . . . . . 31.6 tp -83.99 74.61 10.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.292 0.568 . . . . 0.0 111.003 -176.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 67.8 mt -131.86 104.48 6.89 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.06 175.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -83.24 139.69 32.96 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.099 176.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 213' ' ' THR . . . . . 0.71 HG22 ' H ' ' B' ' 215' ' ' ALA . 29.0 m -133.48 130.78 39.04 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.986 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 214' ' ' VAL . . . . . . . . . . . . . 26.9 m -87.41 10.83 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.122 0.487 . . . . 0.0 110.979 -178.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . 0.71 ' H ' HG22 ' B' ' 213' ' ' THR . . . -80.34 99.91 8.15 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.979 176.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 49.8 m -145.03 98.75 3.22 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.787 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -133.19 149.71 52.02 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 218' ' ' SER . . . . . . . . . . . . . 9.5 m -66.32 92.93 0.2 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.052 0.453 . . . . 0.0 110.023 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 14.9 t -101.01 141.99 33.12 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.798 -175.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 59.5 tp -106.47 83.02 1.81 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 177.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . 0.596 ' HA ' ' OE2' ' A' ' 23' ' ' GLU . . . -172.16 34.56 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.922 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . 0.439 ' HB1' ' HE2' ' A' ' 72' ' ' TYR . . . -157.71 82.01 0.88 Allowed 'General case' 0 C--O 1.234 0.242 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -171.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . 0.45 ' HG2' ' HD2' ' A' ' 57' ' ' ARG . 28.9 mt-10 -138.8 164.96 28.25 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 173.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 224' ' ' GLN . . . . . 0.587 ' HG3' ' CG ' ' A' ' 24' ' ' GLN . 26.1 tt0 179.6 146.99 0.22 Allowed 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.405 0.441 . . . . 0.0 111.247 175.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . 0.515 ' N ' ' HG2' ' B' ' 224' ' ' GLN . 17.2 m -141.94 139.73 30.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 167.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . 0.721 ' HA ' ' CD2' ' B' ' 273' ' ' HIS . 4.5 m -109.21 -89.81 0.47 Allowed 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.954 -0.299 . . . . 0.0 111.658 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 14.5 mmtm -154.66 -41.83 0.09 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.079 0.466 . . . . 0.0 109.774 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 228' ' ' GLN . . . . . 0.475 ' CD ' ' H ' ' B' ' 228' ' ' GLN . 0.0 OUTLIER -63.39 -44.19 95.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.191 -178.254 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -65.62 -40.0 92.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.6 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.552 HG23 ' HB2' ' B' ' 235' ' ' LEU . 77.6 mt -66.82 -38.05 80.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.497 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 30.7 t -71.38 -25.66 62.46 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.956 177.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -87.86 -46.69 9.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.983 -175.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . 0.459 ' CD1' ' HD3' ' A' ' 53' ' ' PRO . 68.6 m-85 -94.09 -7.39 42.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.401 -177.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt 61.08 74.1 0.46 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.523 174.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . 0.552 ' HB2' HG23 ' B' ' 230' ' ' ILE . 68.1 mt -88.89 176.41 7.04 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.808 0.337 . . . . 0.0 111.211 -177.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 59.4 t -101.89 123.71 55.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.057 -177.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 237' ' ' LYS . . . . . 0.656 ' HD3' ' CZ ' ' B' ' 291' ' ' TYR . 18.9 tptm -82.74 111.85 19.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.763 177.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 238' ' ' VAL . . . . . 0.454 HG23 HG12 ' B' ' 290' ' ' VAL . 0.4 OUTLIER -104.84 14.37 7.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -176.113 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 128.2 -162.53 21.94 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.279 -0.963 . . . . 0.0 113.216 173.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 89.4 m -149.08 135.61 19.46 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 26.7 pt -110.18 146.07 15.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.311 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 242' ' ' ASN . . . . . 0.516 ' H ' HD23 ' A' ' 11' ' ' LEU . 37.6 t-20 -130.56 114.94 16.09 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.715 -178.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 243' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 76.7 t -94.4 109.34 21.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.287 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 10.2 p -119.71 105.34 11.06 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 176.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 245' ' ' GLN . . . . . 0.508 HE22 HD11 ' B' ' 250' ' ' ILE . 75.3 mt-30 -111.5 -174.78 2.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.865 -172.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 23.4 m -151.79 102.8 2.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.426 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 102.93 -164.48 16.02 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.423 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -83.85 58.45 5.01 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.228 -0.511 . . . . 0.0 112.704 -176.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . 0.433 ' OE1' ' HB3' ' B' ' 245' ' ' GLN . 53.9 mt-30 -80.27 -15.81 56.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.875 0.369 . . . . 0.0 110.395 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 250' ' ' ILE . . . . . 0.581 HD12 ' HA ' ' B' ' 256' ' ' LEU . 47.9 mm -113.59 114.34 46.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 173.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 16.3 t -108.07 -13.95 14.83 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.146 -176.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . 0.45 ' O ' ' HB3' ' B' ' 255' ' ' ASP . 46.7 m -152.71 158.65 33.11 Favored Pre-proline 0 C--N 1.326 -0.415 0 O-C-N 122.382 -0.199 . . . . 0.0 110.617 -177.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -58.66 -50.49 9.2 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.809 2.34 . . . . 0.0 111.876 175.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 254' ' ' SER . . . . . 0.696 ' O ' ' HG3' ' B' ' 257' ' ' ARG . 41.4 t -58.31 -36.35 73.22 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.02 0.438 . . . . 0.0 110.629 174.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.45 ' HB3' ' O ' ' B' ' 252' ' ' SER . 20.2 t0 -60.78 -43.62 97.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.355 178.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.581 ' HA ' HD12 ' B' ' 250' ' ' ILE . 55.3 tp -61.51 -44.4 97.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.278 178.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 257' ' ' ARG . . . . . 0.696 ' HG3' ' O ' ' B' ' 254' ' ' SER . 0.7 OUTLIER -66.26 -30.91 71.43 Favored 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 120.411 -0.515 . . . . 0.0 110.372 -177.346 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 258' ' ' GLU . . . . . 0.501 ' HG3' ' O ' ' B' ' 254' ' ' SER . 49.5 mt-10 -68.76 -27.06 65.57 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.946 0.403 . . . . 0.0 110.651 178.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 259' ' ' LYS . . . . . 0.407 ' HD3' ' O ' ' B' ' 255' ' ' ASP . 14.2 mptt -75.01 -34.35 61.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.27 0.557 . . . . 0.0 110.273 174.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 260' ' ' LEU . . . . . 0.455 ' CD1' HD11 ' B' ' 274' ' ' ILE . 79.1 mt -74.04 -46.71 41.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.421 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 25.0 m -60.39 -34.21 73.58 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.108 175.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 262' ' ' GLU . . . . . 0.897 ' HA ' ' HA ' ' A' ' 18' ' ' SER . 34.6 tt0 -54.81 -48.64 72.5 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.085 0.469 . . . . 0.0 110.589 176.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 263' ' ' LEU . . . . . . . . . . . . . 86.6 mt -73.82 -38.13 64.65 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.171 -178.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.59 -44.68 61.7 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -177.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 265' ' ' ASP . . . . . 0.618 ' OD2' ' HB3' ' A' ' 17' ' ' PHE . 25.0 t0 -67.77 -39.65 84.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.275 -178.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -72.36 -24.03 61.21 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.03 177.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 11.8 mmtt -78.21 -50.35 12.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.591 177.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 268' ' ' GLY . . . . . 0.444 ' HA3' ' NE2' ' B' ' 302' ' ' HIS . . . 118.88 33.09 1.2 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.686 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -132.66 133.07 6.88 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 176.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -93.52 8.5 40.46 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -167.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 271' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -146.78 146.67 30.34 Favored 'General case' 0 C--N 1.33 -0.239 0 O-C-N 122.312 -0.242 . . . . 0.0 110.675 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 272' ' ' TYR . . . . . 0.461 ' CE1' ' HB3' ' A' ' 24' ' ' GLN . 37.1 p90 -141.19 159.87 41.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.877 0.37 . . . . 0.0 110.965 177.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 273' ' ' HIS . . . . . 0.721 ' CD2' ' HA ' ' B' ' 226' ' ' SER . 12.4 t-80 -136.14 111.97 9.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.567 -178.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 274' ' ' ILE . . . . . 0.456 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 77.4 mt -78.26 113.29 17.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.872 0.368 . . . . 0.0 110.456 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 9.0 pt -97.09 -27.2 3.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.294 -178.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -150.07 130.71 14.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.467 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 277' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' B' ' 285' ' ' GLU . . . -153.37 117.9 4.95 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -157.56 175.48 13.88 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.064 0.459 . . . . 0.0 110.795 -178.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -109.24 124.75 51.38 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.325 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -112.74 87.67 2.64 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 173.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 69.84 -124.71 15.14 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 -175.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -84.37 -3.28 10.11 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.656 2.237 . . . . 0.0 112.036 175.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -100.2 116.5 32.35 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.082 -174.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -90.52 126.44 35.93 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 175.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 285' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' B' ' 277' ' ' ALA . 9.2 mm-40 -116.02 110.54 19.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.781 -176.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 286' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -118.86 115.72 24.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.857 0.361 . . . . 0.0 111.092 174.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 27.2 t -110.21 124.34 66.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.268 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -135.93 148.08 48.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.236 0.541 . . . . 0.0 111.673 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 289' ' ' GLU . . . . . 0.532 ' HB3' ' HE3' ' B' ' 237' ' ' LYS . 31.8 mt-10 -89.73 143.58 26.69 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 290' ' ' VAL . . . . . 0.454 HG12 HG23 ' B' ' 238' ' ' VAL . 10.6 t -107.79 123.31 63.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 291' ' ' TYR . . . . . 0.656 ' CZ ' ' HD3' ' B' ' 237' ' ' LYS . 77.0 m-85 -127.31 148.88 50.23 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.253 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 292' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -124.12 162.64 23.14 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 11.9 p30 -63.95 151.54 42.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.584 0.707 . . . . 0.0 112.336 -174.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 294' ' ' ALA . . . . . 0.489 ' HB2' ' HA ' ' B' ' 235' ' ' LEU . . . -85.25 58.57 5.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.595 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 295' ' ' THR . . . . . . . . . . . . . 7.3 t -161.89 -25.44 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.578 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 97.3 mttt 73.21 72.44 0.13 Allowed 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.682 170.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 297' ' ' LEU . . . . . . . . . . . . . 71.9 mt -134.01 96.7 3.69 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.611 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 298' ' ' GLU . . . . . 0.639 ' HG3' ' HB2' ' B' ' 302' ' ' HIS . 2.5 tm-20 -90.3 156.71 18.08 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 299' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -69.99 -29.04 66.03 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.012 0.434 . . . . 0.0 110.605 -172.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 300' ' ' HIS . . . . . 0.466 ' H ' ' CD ' ' B' ' 298' ' ' GLU . 2.7 m-70 -107.03 -104.61 0.34 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.346 -0.388 . . . . 0.0 109.987 170.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 301' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -156.02 97.27 1.79 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 302' ' ' HIS . . . . . 0.639 ' HB2' ' HG3' ' B' ' 298' ' ' GLU . 28.6 t-80 -81.4 141.14 34.23 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.872 0.368 . . . . 0.0 111.329 -172.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 34.9 t60 -71.45 120.75 17.48 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.012 175.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 7.3 p80 . . . . . 0 C--N 1.321 -0.654 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.038 177.746 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.481 1.079 0 CA-C-O 120.641 0.258 . . . . 0.0 110.601 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -127.6 158.92 36.2 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 -177.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.705 ' HD3' HG21 ' B' ' 287' ' ' VAL . 52.0 mttp -121.25 -77.4 0.58 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.588 ' HB3' ' HB2' ' A' ' 7' ' ' ALA . 29.1 mmt180 -141.82 -33.08 0.51 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.11 177.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 63.4 mt 64.18 88.17 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.317 -177.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 72.2 mt 66.82 -81.06 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.271 -175.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.588 ' HB2' ' HB3' ' A' ' 4' ' ' ARG . . . 66.1 147.56 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.839 0.828 . . . . 0.0 112.899 177.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -106.89 101.05 10.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.261 173.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.94 137.53 41.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.57 -175.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -90.31 143.8 26.42 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.573 176.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.2 tp -123.07 141.99 51.36 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.757 0.313 . . . . 0.0 110.343 -177.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -93.46 110.93 22.49 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.317 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.9 p -83.91 86.63 7.14 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.35 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.0 m -132.84 -169.6 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.311 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.01 67.48 1.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.249 0.547 . . . . 0.0 111.56 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.1 m -119.23 111.02 17.7 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.891 176.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -135.62 -76.25 0.44 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.534 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.506 ' O ' ' HB ' ' A' ' 19' ' ' THR . 20.3 m 56.26 -103.38 0.18 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.552 -175.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.506 ' HB ' ' O ' ' A' ' 18' ' ' SER . 8.8 t 163.9 -41.03 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 123.504 0.722 . . . . 0.0 109.062 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.556 HD13 HH21 ' B' ' 257' ' ' ARG . 83.9 mt -147.24 -125.46 0.06 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 62.68 49.07 3.97 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.268 0.556 . . . . 0.0 110.906 176.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.403 ' HB3' ' HA ' ' B' ' 261' ' ' SER . . . -177.96 90.59 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.594 -1.184 . . . . 0.0 108.626 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.508 ' HB2' ' CE1' ' A' ' 71' ' ' TYR . 8.7 pt-20 -165.29 125.43 1.86 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -169.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.622 ' HA ' ' HB3' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -161.71 159.08 26.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.506 174.522 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.503 HG22 ' HB2' ' A' ' 71' ' ' TYR . 17.1 m -128.32 130.91 69.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.353 174.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.479 ' O ' HG13 ' A' ' 30' ' ' ILE . 15.4 m -97.56 173.95 6.89 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.382 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -66.58 -15.16 63.22 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.556 -174.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.452 ' HB2' ' OE1' ' A' ' 29' ' ' GLU . 41.9 mt-30 -71.57 -50.81 27.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.405 0.621 . . . . 0.0 109.527 177.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.464 ' OE1' ' HB2' ' A' ' 26' ' ' SER . 1.9 mp0 -70.44 -41.28 73.05 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.901 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 26' ' ' SER . 94.7 mt -56.21 -48.67 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.353 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.1 m -72.34 -30.12 64.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.08 0.467 . . . . 0.0 110.727 -177.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -74.87 -40.85 60.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.498 -177.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -96.88 -0.01 48.43 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -175.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm 57.87 51.45 9.08 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.03 0.443 . . . . 0.0 110.033 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.873 HD21 ' HG2' ' B' ' 253' ' ' PRO . 56.4 mt -68.62 169.58 10.83 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.622 0.725 . . . . 0.0 112.78 -172.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.7 t -100.04 117.88 45.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.293 -175.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.424 ' HE2' ' OE1' ' A' ' 89' ' ' GLU . 60.8 tttm -83.14 107.65 15.85 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 176.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.5 m -90.69 -11.68 9.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -175.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 138.07 -168.02 24.71 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 119.892 -1.147 . . . . 0.0 113.092 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 24.0 m -123.55 144.54 49.5 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -178.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.6 pt -110.84 157.54 11.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.674 0.273 . . . . 0.0 110.439 178.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -117.98 136.71 53.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.126 0.489 . . . . 0.0 111.921 -171.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.662 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 85.5 t -122.45 113.45 38.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.849 169.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.0 t -150.85 77.2 1.27 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.186 0.517 . . . . 0.0 110.053 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.416 HE22 HG13 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -137.73 163.64 30.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.992 -179.565 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.525 ' HA ' ' HA ' ' A' ' 83' ' ' ASN . 26.4 t -73.18 163.83 27.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.643 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.97 -16.97 58.02 Favored Glycine 0 C--N 1.333 0.393 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.48 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.46 -19.63 68.95 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.215 176.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -102.0 -28.37 12.41 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.676 0.274 . . . . 0.0 111.01 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 43.5 mm -119.35 107.33 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-O 121.219 0.533 . . . . 0.0 110.479 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.8 m -128.98 -28.64 2.38 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.967 -178.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.8 m -121.68 156.08 59.16 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.192 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.441 ' HG2' ' HB2' ' B' ' 293' ' ' ASP . 32.5 Cg_exo -59.88 -24.43 76.08 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.729 2.286 . . . . 0.0 112.087 177.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.514 ' O ' ' HG3' ' A' ' 58' ' ' GLU . 24.1 p -62.76 -39.91 95.63 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.471 177.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.57 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 16.3 m-20 -61.69 -51.79 66.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.304 -175.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.443 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 57.6 tp -57.03 -44.82 83.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.653 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.403 ' HD2' HH11 ' A' ' 57' ' ' ARG . 7.5 ttp180 -53.25 -53.59 48.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.516 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.514 ' HG3' ' O ' ' A' ' 54' ' ' SER . 72.4 mt-10 -67.5 -27.27 66.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.021 -171.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.57 ' HG2' ' O ' ' A' ' 55' ' ' ASP . 46.9 mmtt -71.05 -45.64 63.47 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 56' ' ' LEU . 82.1 mt -65.53 -43.86 88.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.227 -176.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.9 p -62.88 -41.47 99.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.74 0.305 . . . . 0.0 111.383 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -64.67 -46.36 82.76 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.173 0.511 . . . . 0.0 110.223 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 59' ' ' LYS . 81.2 mt -67.87 -34.74 77.26 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.464 -178.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.72 -46.73 77.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.693 -178.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -67.38 -25.81 66.15 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.84 0.352 . . . . 0.0 110.992 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.77 -28.96 68.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.261 0.553 . . . . 0.0 110.237 176.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -86.18 -13.43 47.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.742 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.76 -9.04 73.8 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.914 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.24 172.5 54.41 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 121.221 -0.514 . . . . 0.0 112.146 -178.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -117.35 -62.8 1.52 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.966 0.412 . . . . 0.0 110.671 -176.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.622 ' HB3' ' HA ' ' A' ' 24' ' ' GLN . 4.5 m-85 -98.17 148.1 23.91 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -176.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.454 ' CE2' ' HA ' ' B' ' 223' ' ' GLU . 32.7 p90 -121.8 156.98 32.04 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 177.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -135.25 115.93 13.85 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.569 -177.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.466 ' H ' HD12 ' A' ' 74' ' ' ILE . 4.6 mp -73.31 132.06 33.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.518 HD12 ' HA ' ' B' ' 205' ' ' ILE . 26.6 pt -117.37 -27.74 2.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.589 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -152.96 133.53 13.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.616 0.245 . . . . 0.0 110.684 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.517 ' HB3' ' HG3' ' B' ' 228' ' ' GLN . . . -150.55 142.74 24.14 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -164.87 147.99 8.56 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.033 0.444 . . . . 0.0 111.048 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -78.29 111.33 14.16 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 169.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -115.06 82.14 1.69 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.049 0.452 . . . . 0.0 110.349 -174.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.04 -128.75 8.74 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.6 -178.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -81.43 -6.15 12.7 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.572 2.181 . . . . 0.0 112.893 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.525 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 81.9 m-20 -121.07 154.52 36.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.079 0.466 . . . . 0.0 111.276 -175.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -104.29 118.39 36.51 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.585 176.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -102.4 124.92 48.83 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.05 -176.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.662 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -137.36 129.8 29.72 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.231 0.539 . . . . 0.0 110.917 178.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.9 t -113.24 118.83 59.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.973 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.59 138.24 39.34 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.121 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 40' ' ' THR . 51.1 mt-10 -98.96 153.91 18.47 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 178.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.9 t -112.27 138.45 41.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -125.26 148.57 48.61 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.086 0.47 . . . . 0.0 110.595 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -118.27 164.73 14.76 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.508 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -74.44 150.8 39.77 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.41 25.85 0.59 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.774 0.321 . . . . 0.0 111.845 -171.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.1 t -103.11 -12.72 17.18 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.09 0.471 . . . . 0.0 111.128 -176.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -86.12 179.45 6.95 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.407 -176.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.402 ' H ' ' HG ' ' A' ' 97' ' ' LEU . 2.4 pp -86.15 -1.79 57.75 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 113.099 0.778 . . . . 0.0 113.099 -167.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -55.41 126.26 24.34 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 63.7 m80 -66.5 106.22 1.7 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.994 -171.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 56.2 p-80 -139.62 -16.78 1.01 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.772 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 43.2 m80 65.87 177.33 0.21 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.848 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -143.64 98.02 3.17 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.483 0.659 . . . . 0.0 109.992 173.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 63.1 t60 -55.61 127.81 31.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.767 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 . . . . . 0 C--N 1.325 -0.496 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.883 175.633 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . 0.697 ' SD ' ' HG3' ' B' ' 202' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . 0.697 ' HG3' ' SD ' ' B' ' 201' ' ' MET . 85.6 mttt 72.27 134.65 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 O-C-N 124.058 0.849 . . . . 0.0 111.981 -176.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -105.82 68.1 0.77 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.678 170.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 38.9 ptt85 -75.81 145.79 40.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.992 177.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 205' ' ' ILE . . . . . 0.518 ' HA ' HD12 ' A' ' 75' ' ' ILE . 24.0 pt -125.21 136.99 59.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.017 0.437 . . . . 0.0 111.234 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 60.5 mt -121.54 90.89 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 173.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -93.25 80.72 4.45 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.034 0.445 . . . . 0.0 110.867 -176.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -116.77 93.99 4.42 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.043 177.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -115.18 107.77 15.73 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.234 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 210' ' ' LEU . . . . . . . . . . . . . 31.7 tp -126.74 100.33 6.14 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.361 -175.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 11.0 mp 70.2 143.02 0.05 Allowed 'General case' 0 N--CA 1.469 0.522 0 O-C-N 124.03 0.831 . . . . 0.0 112.223 177.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -85.75 176.61 8.04 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.898 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 213' ' ' THR . . . . . . . . . . . . . 12.5 t -115.68 169.86 8.88 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 214' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.2 134.65 29.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 177.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -73.86 88.66 1.82 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.236 0.541 . . . . 0.0 111.327 -175.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 36.0 m -143.74 152.9 41.84 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.151 176.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -151.28 150.81 30.99 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.924 0.392 . . . . 0.0 110.576 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 218' ' ' SER . . . . . . . . . . . . . 3.1 m -118.22 159.49 23.23 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.981 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 2.8 p -76.54 79.31 3.23 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.317 0.58 . . . . 0.0 110.642 176.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 86.8 mt -104.76 179.63 4.21 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.492 -177.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -126.11 107.1 10.07 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.567 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . 178.71 109.37 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . 0.454 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 10.8 pt-20 -173.0 140.65 0.92 Allowed 'General case' 0 C--O 1.235 0.31 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -167.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 224' ' ' GLN . . . . . 0.472 ' HA ' ' HB3' ' B' ' 271' ' ' TYR . 0.0 OUTLIER -175.57 156.73 1.97 Allowed 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.612 173.365 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 28.3 m -116.45 141.51 33.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.769 0.319 . . . . 0.0 110.811 177.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 47.9 t -83.83 -92.96 0.07 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.111 -176.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . 0.416 ' HA ' HD12 ' B' ' 230' ' ' ILE . 26.2 ttpt -151.48 -39.68 0.12 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.962 0.411 . . . . 0.0 110.895 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 228' ' ' GLN . . . . . 0.517 ' HG3' ' HB3' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -63.75 -35.09 79.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.424 179.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 229' ' ' GLU . . . . . 0.467 ' OE1' ' HG2' ' B' ' 228' ' ' GLN . 2.4 mp0 -69.68 -37.93 76.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.831 176.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.559 HG12 HD12 ' B' ' 235' ' ' LEU . 63.3 mt -59.05 -45.18 92.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.642 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 16.5 m -73.13 -37.68 66.57 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.861 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -70.37 -48.54 55.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.435 -176.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -94.45 5.43 51.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.438 -175.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt 55.68 45.13 25.22 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.92 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . 0.617 HD22 ' HA ' ' B' ' 293' ' ' ASP . 72.7 mt -58.27 148.82 26.04 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.509 -175.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 61.9 t -97.29 117.92 42.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.01 -174.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -80.82 113.63 19.15 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.14 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 18.9 m -85.89 -34.94 8.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -176.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 166.02 179.77 39.72 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.637 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . 0.494 HG23 ' HG2' ' B' ' 289' ' ' GLU . 54.3 m -113.45 135.84 53.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.698 0.285 . . . . 0.0 110.583 -178.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 30.1 pt -107.77 131.19 58.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 171.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -120.19 113.79 20.96 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.997 -174.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 243' ' ' VAL . . . . . 0.571 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 84.2 t -95.12 119.61 43.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.353 -177.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 22.6 t -115.64 86.1 2.4 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 170.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 245' ' ' GLN . . . . . 0.565 ' HG2' HG12 ' B' ' 250' ' ' ILE . 0.3 OUTLIER -81.63 106.47 13.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.946 -173.22 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 13.9 m -88.13 103.69 15.98 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.68 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 94.69 -162.69 24.42 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.146 174.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -82.54 63.73 4.39 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.554 -0.355 . . . . 0.0 113.591 -173.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . 0.524 ' HB2' ' HG3' ' B' ' 245' ' ' GLN . 72.6 mt-30 -96.09 -2.8 45.88 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.126 0.488 . . . . 0.0 109.911 172.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 250' ' ' ILE . . . . . 0.565 HG12 ' HG2' ' B' ' 245' ' ' GLN . 48.9 mm -128.36 125.54 64.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.116 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 251' ' ' SER . . . . . 0.4 ' H ' ' CG ' ' B' ' 255' ' ' ASP . 1.1 m -112.09 -57.79 2.22 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.457 0.646 . . . . 0.0 109.668 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . 0.522 ' HB3' ' HD2' ' B' ' 253' ' ' PRO . 50.7 m -127.01 175.12 3.55 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.362 176.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . 0.873 ' HG2' HD21 ' A' ' 35' ' ' LEU . 52.2 Cg_exo -55.09 -28.63 61.56 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.288 1.992 . . . . 0.0 112.315 175.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 254' ' ' SER . . . . . 0.576 ' O ' ' HB3' ' B' ' 257' ' ' ARG . 56.3 m -65.74 -26.19 67.62 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.777 178.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.588 ' O ' ' HD3' ' B' ' 259' ' ' LYS . 2.6 m-20 -70.82 -49.39 46.84 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.154 0.502 . . . . 0.0 109.661 176.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 41.2 tp -62.5 -31.31 72.04 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.024 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 257' ' ' ARG . . . . . 0.576 ' HB3' ' O ' ' B' ' 254' ' ' SER . 50.7 ttt85 -51.19 -51.4 54.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.117 175.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 258' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -59.72 -51.99 67.41 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.138 0.494 . . . . 0.0 110.317 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 259' ' ' LYS . . . . . 0.588 ' HD3' ' O ' ' B' ' 255' ' ' ASP . 12.1 mptt -59.56 -43.7 93.5 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.245 -174.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 260' ' ' LEU . . . . . 0.485 HD13 ' CE2' ' B' ' 272' ' ' TYR . 96.5 mt -74.26 -43.62 56.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.179 -177.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 261' ' ' SER . . . . . 0.403 ' HA ' ' HB3' ' A' ' 22' ' ' ALA . 32.9 t -63.39 -37.97 89.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.677 0.275 . . . . 0.0 110.482 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -60.95 -52.96 62.8 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.46 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 263' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' B' ' 259' ' ' LYS . 81.1 mt -68.84 -40.19 79.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.282 -176.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -61.25 -52.53 64.36 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -175.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -69.48 -32.25 71.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.875 0.369 . . . . 0.0 110.413 -176.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -68.1 -24.23 65.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.007 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -84.96 0.4 51.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.531 176.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 74.82 34.16 53.78 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.798 -178.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . 0.43 ' HA2' ' OD1' ' B' ' 292' ' ' ASN . . . -127.79 163.83 21.35 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 121.051 -0.595 . . . . 0.0 111.957 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . 0.616 ' NZ ' ' HA ' ' B' ' 270' ' ' LYS . 1.0 OUTLIER -108.34 -66.55 1.03 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.782 0.325 . . . . 0.0 111.276 178.427 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 271' ' ' TYR . . . . . 0.472 ' HB3' ' HA ' ' B' ' 224' ' ' GLN . 4.9 m-85 -92.61 140.79 29.18 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -173.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 272' ' ' TYR . . . . . 0.485 ' CE2' HD13 ' B' ' 260' ' ' LEU . 55.0 p90 -125.17 131.38 53.23 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 176.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -104.34 107.91 19.06 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.114 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 274' ' ' ILE . . . . . . . . . . . . . 69.6 mt -70.21 123.14 23.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.191 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 34.0 pt -100.17 -26.55 3.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.706 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -153.76 123.71 6.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.826 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -143.58 117.97 9.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.261 178.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.8 159.02 13.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.948 0.404 . . . . 0.0 111.404 -177.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -84.65 138.58 32.6 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 172.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -114.7 26.84 9.87 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 173.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 115.49 -125.94 6.92 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -175.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.16 -10.5 22.69 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.457 2.104 . . . . 0.0 111.481 175.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 283' ' ' ASN . . . . . 0.454 ' HA ' ' O ' ' B' ' 245' ' ' GLN . 80.3 m-20 -109.64 125.54 52.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.817 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 284' ' ' PHE . . . . . 0.477 ' HB3' ' HB3' ' B' ' 245' ' ' GLN . 71.6 t80 -101.46 121.99 42.95 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.387 178.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 285' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -98.13 113.82 25.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.096 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 286' ' ' ALA . . . . . 0.571 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -125.63 116.02 21.05 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.867 0.365 . . . . 0.0 110.158 172.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 287' ' ' VAL . . . . . 0.705 HG21 ' HD3' ' A' ' 3' ' ' LYS . 21.4 t -113.3 114.68 47.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.247 -178.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -129.35 133.65 47.52 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.451 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 289' ' ' GLU . . . . . 0.494 ' HG2' HG23 ' B' ' 240' ' ' THR . 14.1 mt-10 -106.48 128.17 53.87 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 290' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' B' ' 272' ' ' TYR . 25.0 t -90.31 135.63 25.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.102 0.477 . . . . 0.0 111.202 -171.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -127.26 133.68 50.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.676 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 292' ' ' ASN . . . . . 0.43 ' OD1' ' HA2' ' B' ' 269' ' ' GLY . 54.2 m-20 -106.16 161.6 14.38 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.305 174.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 293' ' ' ASP . . . . . 0.617 ' HA ' HD22 ' B' ' 235' ' ' LEU . 9.3 p-10 -64.2 -62.2 1.76 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.618 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 294' ' ' ALA . . . . . 0.406 ' H ' ' CG ' ' B' ' 293' ' ' ASP . . . 176.22 6.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.208 0.603 . . . . 0.0 112.236 177.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 295' ' ' THR . . . . . 0.553 HG22 ' OD1' ' B' ' 293' ' ' ASP . 8.9 t -96.04 -47.76 5.96 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.815 -0.553 . . . . 0.0 112.213 -174.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 12.2 mmmt 68.83 -52.24 0.57 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.957 0.503 . . . . 0.0 111.513 -174.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 297' ' ' LEU . . . . . . . . . . . . . 73.9 mt -85.57 -179.56 6.92 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.434 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 298' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 61.65 90.09 0.07 Allowed 'General case' 0 C--N 1.331 -0.212 0 O-C-N 123.882 0.739 . . . . 0.0 110.367 -174.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 299' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -80.23 72.24 7.05 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 176.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 300' ' ' HIS . . . . . . . . . . . . . 5.5 t60 74.24 -52.97 0.69 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.055 -175.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 301' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -154.2 110.06 3.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.736 0.303 . . . . 0.0 110.805 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 302' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -149.88 81.83 1.39 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 174.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 62.54 81.31 0.2 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.15 -174.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 . . . . . 0 C--N 1.322 -0.589 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.006 -177.533 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.7 ttp . . . . . 0 N--CA 1.481 1.084 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -75.5 14.62 0.58 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -149.9 119.59 7.02 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.53 -172.21 2.04 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.912 176.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.62 137.67 56.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.048 0.452 . . . . 0.0 110.186 -176.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.8 tt -129.97 114.91 31.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.345 0.593 . . . . 0.0 110.06 177.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -119.09 -174.01 2.62 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.305 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 60.84 63.05 1.35 Allowed 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.92 0.762 . . . . 0.0 111.236 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.01 128.11 35.19 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.766 178.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 80.5 mt -80.34 73.22 7.22 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.711 -177.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 98.2 mt -119.81 128.97 54.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.054 178.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.81 118.28 23.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.491 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.464 ' HB ' ' HE1' ' B' ' 301' ' ' HIS . 11.1 p -58.0 134.87 56.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.917 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.1 m -88.51 174.36 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.251 176.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.65 104.68 2.04 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.073 0.463 . . . . 0.0 110.319 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.1 p -128.57 154.14 46.49 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.981 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -84.62 150.92 24.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.971 0.415 . . . . 0.0 111.253 -174.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.2 m -100.53 174.73 5.95 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 173.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.427 HG21 ' NH1' ' A' ' 57' ' ' ARG . 18.8 p -78.39 141.16 38.55 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.044 0.449 . . . . 0.0 110.997 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.658 HD21 HH22 ' B' ' 257' ' ' ARG . 51.4 tp -82.71 80.28 8.86 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 175.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.495 ' HB2' ' OE2' ' B' ' 223' ' ' GLU . . . -95.54 -159.07 0.69 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.508 -174.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 67.6 73.6 0.32 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.968 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.51 ' O ' ' HB2' ' A' ' 24' ' ' GLN . 30.9 mt-10 -140.42 165.64 26.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.54 176.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.51 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER 174.69 136.63 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 O-C-N 123.791 0.682 . . . . 0.0 109.775 171.017 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.0 m -128.24 116.0 40.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.167 0.508 . . . . 0.0 110.479 173.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.429 ' O ' HG13 ' A' ' 30' ' ' ILE . 0.7 OUTLIER -91.29 169.89 10.44 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.099 -178.91 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.45 ' HD3' ' HA ' ' A' ' 27' ' ' LYS . 21.5 mmtp -68.99 -20.24 64.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.472 -177.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.11 -49.8 66.25 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 177.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -66.39 -43.89 84.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.317 176.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.542 HG12 HD12 ' A' ' 35' ' ' LEU . 90.2 mt -58.6 -46.84 89.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.437 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.9 t -72.88 -26.63 61.51 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.999 0.428 . . . . 0.0 110.611 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -73.83 -51.37 16.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.08 -177.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -85.47 -13.52 48.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.95 -178.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt 62.74 68.17 0.66 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.989 -176.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.578 HD21 ' HG2' ' B' ' 253' ' ' PRO . 63.0 mt -79.79 162.63 24.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.463 -176.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.471 HG11 ' HE2' ' A' ' 96' ' ' LYS . 15.6 m -96.29 131.28 43.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.947 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -85.12 118.51 24.72 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.89 177.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.41 HG12 ' HD2' ' A' ' 67' ' ' LYS . 20.8 t -78.76 -26.73 13.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 157.48 164.88 14.3 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.705 176.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 88.4 m -107.27 118.2 36.08 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 173.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.6 pt -107.52 170.44 2.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -178.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -143.42 143.85 31.79 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.924 0.868 . . . . 0.0 111.682 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.548 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 82.2 t -93.55 128.79 44.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 114.323 -1.308 . . . . 0.0 108.668 174.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -156.12 72.4 0.77 Allowed 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -178.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.44 HE22 HG13 ' A' ' 43' ' ' VAL . 0.6 OUTLIER -103.11 148.37 25.82 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.097 -176.432 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.7 p -105.67 112.2 25.19 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.338 -176.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.28 -147.04 18.28 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.73 -0.747 . . . . 0.0 113.116 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -90.26 38.09 3.27 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.133 -0.556 . . . . 0.0 112.823 -173.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -76.4 -31.26 57.86 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.446 HD12 ' HA ' ' A' ' 56' ' ' LEU . 44.7 mm -114.43 95.23 3.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 171.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.8 t -103.41 -43.48 5.4 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.211 0.529 . . . . 0.0 109.831 -177.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 17.8 m -113.74 159.17 36.76 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.385 176.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -57.18 -26.35 69.14 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.386 2.057 . . . . 0.0 111.947 177.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.406 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 3.8 p -73.24 -22.72 60.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.508 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -71.45 -34.54 70.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.326 0.584 . . . . 0.0 109.715 177.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.446 ' HA ' HD12 ' A' ' 50' ' ' ILE . 51.6 tp -66.25 -48.19 71.32 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.57 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.515 ' HD3' ' OE1' ' B' ' 223' ' ' GLU . 0.2 OUTLIER -64.21 -30.52 71.57 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.223 -178.217 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.458 ' HG3' ' NE ' ' A' ' 57' ' ' ARG . 36.1 mt-10 -67.64 -41.25 84.18 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.1 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -66.81 -45.34 78.65 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.823 0.344 . . . . 0.0 110.635 177.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.4 mt -64.48 -41.34 96.54 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.033 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.6 t -65.94 -39.04 90.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.154 0.502 . . . . 0.0 110.256 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -63.4 -42.67 98.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.883 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 97.5 mt -69.64 -32.69 71.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.804 178.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.87 -40.54 95.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.039 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -63.0 -40.38 97.61 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.912 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.79 -44.01 87.01 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.823 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.41 ' HD2' HG12 ' A' ' 38' ' ' VAL . 40.7 mmtt -74.11 -33.44 63.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.813 177.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.49 ' HA3' ' CE1' ' A' ' 99' ' ' HIS . . . 94.2 36.46 5.69 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.08 -179.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -100.38 166.68 19.85 Favored Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -123.12 2.75 9.28 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.96 0.38 . . . . 0.0 111.587 -176.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.518 ' HE2' ' HB2' ' A' ' 93' ' ' ASP . 6.9 m-85 -153.96 166.02 34.28 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 177.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -150.65 157.46 43.0 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 171.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -146.1 117.64 8.03 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.041 -176.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.515 HG13 ' HB2' ' A' ' 88' ' ' ALA . 3.7 mp -83.64 131.35 34.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 178.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.419 HD12 HG22 ' B' ' 205' ' ' ILE . 9.9 pt -107.62 -21.63 5.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.592 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -150.52 139.26 20.75 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.171 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -151.15 113.01 4.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.749 0.309 . . . . 0.0 110.561 -178.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.59 150.7 51.62 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.415 0.626 . . . . 0.0 111.194 -177.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -93.99 102.72 14.81 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.272 176.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -102.54 77.32 1.61 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.367 -175.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.83 -125.6 35.27 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.292 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -82.67 5.46 6.38 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.874 2.383 . . . . 0.0 112.734 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' ' 45' ' ' GLN . 58.5 m-80 -122.51 120.03 32.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.961 0.41 . . . . 0.0 110.628 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -85.32 116.42 23.65 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 177.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.529 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 19.3 mm-40 -106.94 114.49 28.61 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.833 -175.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.548 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -135.26 121.16 19.78 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.617 0.246 . . . . 0.0 110.96 176.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.6 t -95.77 120.42 45.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -177.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.515 ' HB2' HG13 ' A' ' 74' ' ' ILE . . . -126.05 143.62 51.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.198 0.523 . . . . 0.0 111.349 -175.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.471 ' HB3' ' CE1' ' A' ' 91' ' ' TYR . 41.4 mt-10 -103.3 140.71 37.05 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.547 178.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.3 t -107.81 119.21 57.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 176.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.471 ' CE1' ' HB3' ' A' ' 89' ' ' GLU . 72.1 m-85 -123.77 152.81 41.78 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.193 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.531 ' HB3' ' HB ' ' A' ' 95' ' ' THR . 2.1 m-20 -115.69 155.87 26.95 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.063 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.518 ' HB2' ' HE2' ' A' ' 71' ' ' TYR . 19.7 t70 -79.44 67.66 5.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.078 -177.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 56.63 22.29 6.6 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.596 -175.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.563 HG23 ' CB ' ' A' ' 98' ' ' GLU . 72.0 m -62.84 112.52 2.59 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 121.889 0.852 . . . . 0.0 112.261 -175.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.471 ' HE2' HG11 ' A' ' 36' ' ' VAL . 73.4 mmtt -131.67 103.44 6.37 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.328 -1.306 . . . . 0.0 109.158 174.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 93.6 mt 67.3 16.85 10.18 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.145 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.563 ' CB ' HG23 ' A' ' 95' ' ' THR . 47.6 tt0 -53.76 -53.89 45.91 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 172.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.49 ' CE1' ' HA3' ' A' ' 68' ' ' GLY . 10.4 p80 -116.6 129.49 56.2 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 166.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 60.5 m-70 -80.9 -28.05 36.02 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -167.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.442 ' CE1' ' HB2' ' B' ' 215' ' ' ALA . 3.3 t-160 61.78 96.08 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -174.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -67.86 72.96 0.17 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.478 -175.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 169.12 -37.49 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.067 0.947 . . . . 0.0 108.945 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 6.1 t60 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.271 -170.855 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.126 0 CA-C-O 120.7 0.286 . . . . 0.0 110.306 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -83.94 100.67 11.17 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 174.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -114.73 108.61 17.01 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.541 0.686 . . . . 0.0 111.052 -177.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -86.09 107.54 17.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.238 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 205' ' ' ILE . . . . . 0.419 HG22 HD12 ' A' ' 75' ' ' ILE . 2.9 pp -70.27 153.09 8.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.402 -176.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 8.6 tt -145.19 107.68 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.477 0.656 . . . . 0.0 110.853 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -108.8 93.68 4.65 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.198 177.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -143.94 66.63 1.28 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.002 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -136.4 111.14 8.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.883 175.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 210' ' ' LEU . . . . . . . . . . . . . 6.0 mp -110.88 -3.2 15.76 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.409 -174.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -114.09 112.86 23.9 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.076 0.465 . . . . 0.0 111.353 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -104.98 -167.0 1.29 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.048 174.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 213' ' ' THR . . . . . . . . . . . . . 14.7 t -166.57 151.08 7.55 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 177.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 214' ' ' VAL . . . . . . . . . . . . . 60.2 t -110.26 107.99 24.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.02 0.438 . . . . 0.0 110.839 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . 0.442 ' HB2' ' CE1' ' A' ' 101' ' ' HIS . . . -144.64 85.91 1.79 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.028 175.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 49.0 m -91.38 109.61 20.89 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.907 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 217' ' ' PHE . . . . . 0.433 ' HE1' ' HB1' ' B' ' 215' ' ' ALA . 79.5 m-85 -117.09 -72.57 0.68 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.688 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 218' ' ' SER . . . . . . . . . . . . . 47.8 t -179.96 128.04 0.08 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.255 -177.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 9.0 t -67.04 158.59 30.65 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.403 176.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 60.6 tp -157.97 -49.64 0.07 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.989 -177.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -135.79 100.94 4.6 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.019 178.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . 178.43 85.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 O-C-N 123.856 0.723 . . . . 0.0 110.169 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . 0.84 ' HG2' ' HE1' ' B' ' 271' ' ' TYR . 12.7 tt0 -164.43 125.27 2.12 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.371 0.605 . . . . 0.0 111.076 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 224' ' ' GLN . . . . . 0.426 HE21 ' C ' ' B' ' 224' ' ' GLN . 0.0 OUTLIER -164.93 150.61 9.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.571 -170.235 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . 0.552 HG22 ' HB3' ' B' ' 271' ' ' TYR . 17.9 m -127.02 128.84 71.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 172.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . 0.811 ' HA ' ' CD2' ' B' ' 273' ' ' HIS . 11.5 t -92.84 173.17 7.89 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.089 0.471 . . . . 0.0 110.547 -178.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . 0.517 ' HA ' HD12 ' B' ' 230' ' ' ILE . 47.4 tttm -64.16 -28.64 69.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.874 -172.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -66.49 -50.46 63.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.291 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 229' ' ' GLU . . . . . 0.486 ' OE1' ' HB3' ' B' ' 226' ' ' SER . 1.9 mp0 -65.36 -38.0 88.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.651 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.539 HG12 HD12 ' B' ' 235' ' ' LEU . 97.1 mt -55.86 -53.92 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.232 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 68.6 m -73.45 -21.01 60.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.713 0.292 . . . . 0.0 111.517 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -75.04 -45.05 44.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.564 0.221 . . . . 0.0 110.99 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -100.75 -12.42 19.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.347 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? 64.41 91.15 0.08 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.139 -175.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . 0.539 HD12 HG12 ' B' ' 230' ' ' ILE . 88.6 mt -96.87 166.24 11.72 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.43 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 52.1 t -93.22 115.06 31.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.582 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -84.77 111.76 19.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.081 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 238' ' ' VAL . . . . . 0.431 HG23 ' HB ' ' B' ' 290' ' ' VAL . 1.2 m -88.35 -30.15 5.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -176.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 168.21 -147.53 11.58 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 119.964 -1.112 . . . . 0.0 113.085 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 29.0 m -141.17 138.1 33.16 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 122.598 0.359 . . . . 0.0 110.377 -176.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 241' ' ' ILE . . . . . 0.493 HG13 ' HB3' ' B' ' 288' ' ' ALA . 2.4 pt -105.29 137.61 34.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.139 0.495 . . . . 0.0 110.514 177.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -109.69 123.23 49.14 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.707 -172.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 243' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' B' ' 285' ' ' GLU . 89.2 t -100.95 117.4 46.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 172.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 34.4 m -155.37 76.61 0.97 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.787 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 245' ' ' GLN . . . . . 0.415 ' O ' ' HA ' ' B' ' 283' ' ' ASN . 0.9 OUTLIER -103.79 142.77 33.8 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.834 -177.706 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 246' ' ' SER . . . . . 0.578 ' HA ' ' O ' ' B' ' 282' ' ' PRO . 17.2 m -80.97 117.74 21.85 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.06 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 90.53 -165.71 31.27 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.582 176.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -87.08 53.12 4.45 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.319 -0.467 . . . . 0.0 112.454 -177.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -72.21 -25.32 61.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.252 0.549 . . . . 0.0 109.797 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 39.4 mm -105.91 90.84 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 175.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 9.4 t -92.94 -23.63 18.67 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.219 0.533 . . . . 0.0 109.961 -176.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 7.1 p -141.14 157.2 67.3 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.141 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . 0.578 ' HG2' HD21 ' A' ' 35' ' ' LEU . 68.5 Cg_exo -53.22 -30.78 52.7 Favored 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 123.017 2.478 . . . . 0.0 113.08 178.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 254' ' ' SER . . . . . 0.592 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 6.9 p -59.44 -41.22 89.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.833 -0.167 . . . . 0.0 110.902 176.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -58.36 -44.19 88.7 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.427 0.632 . . . . 0.0 109.764 176.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 49.2 tp -61.48 -44.57 96.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.272 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 257' ' ' ARG . . . . . 0.658 HH22 HD21 ' A' ' 20' ' ' LEU . 3.1 ttp180 -61.71 -46.67 88.69 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.549 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 258' ' ' GLU . . . . . 0.592 ' HG2' ' O ' ' B' ' 254' ' ' SER . 9.9 mm-40 -58.12 -47.08 84.38 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.959 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -66.39 -47.86 71.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.13 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 53.2 mt -62.86 -47.63 82.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.841 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 35.0 p -63.98 -39.07 93.29 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.84 0.352 . . . . 0.0 110.707 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -62.09 -48.46 80.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.433 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 263' ' ' LEU . . . . . 0.591 ' O ' ' HG2' ' B' ' 267' ' ' LYS . 96.2 mt -65.44 -37.35 86.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.055 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -69.07 -49.45 57.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.286 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -63.51 -33.29 75.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.878 0.37 . . . . 0.0 110.815 -178.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -66.79 -29.31 69.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.737 178.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 267' ' ' LYS . . . . . 0.591 ' HG2' ' O ' ' B' ' 263' ' ' LEU . 48.3 mmtm -82.07 -25.06 34.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.137 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 113.41 -5.68 24.85 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.866 -178.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . 0.503 ' HA2' ' OD1' ' B' ' 292' ' ' ASN . . . -77.41 145.69 30.79 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.183 -0.532 . . . . 0.0 111.812 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . 0.606 ' HE2' ' HA ' ' B' ' 270' ' ' LYS . 9.7 mmpt? -107.5 -23.64 12.09 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.854 0.359 . . . . 0.0 110.893 -177.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 271' ' ' TYR . . . . . 0.84 ' HE1' ' HG2' ' B' ' 223' ' ' GLU . 99.4 m-85 -133.46 157.06 46.54 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.348 -178.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 272' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -151.07 167.46 27.61 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.688 174.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 273' ' ' HIS . . . . . 0.811 ' CD2' ' HA ' ' B' ' 226' ' ' SER . 49.1 t-80 -143.15 117.27 9.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.863 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 274' ' ' ILE . . . . . 0.451 ' HA ' ' HA ' ' B' ' 288' ' ' ALA . 61.8 mt -67.4 137.1 25.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.191 178.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 25.8 pt -110.91 -26.74 3.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.129 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -158.55 140.44 13.78 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.842 0.354 . . . . 0.0 111.016 -178.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -140.25 129.35 23.58 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 278' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' B' ' 278' ' ' ARG . 1.4 ptm180 -137.53 150.81 47.8 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.394 0.616 . . . . 0.0 111.195 -175.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -101.72 123.76 46.24 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.479 -175.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 280' ' ' HIS . . . . . 0.462 ' HB2' ' O ' ' B' ' 283' ' ' ASN . 10.1 m170 -125.33 154.72 41.36 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 163.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . -65.92 -57.59 10.59 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.715 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . 0.578 ' O ' ' HA ' ' B' ' 246' ' ' SER . 60.4 Cg_endo -72.07 -29.73 14.38 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.136 1.891 . . . . 0.0 112.958 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 283' ' ' ASN . . . . . 0.544 HD22 ' C ' ' B' ' 282' ' ' PRO . 0.9 OUTLIER -132.49 129.38 39.1 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 122.326 -0.234 . . . . 0.0 111.126 -175.609 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -91.17 120.46 32.12 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 171.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 285' ' ' GLU . . . . . 0.518 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 46.6 mt-10 -118.61 130.82 56.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.288 0.566 . . . . 0.0 112.411 -170.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 286' ' ' ALA . . . . . 0.425 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -149.27 143.7 26.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.128 176.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 41.0 t -123.38 124.91 70.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.397 -178.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 288' ' ' ALA . . . . . 0.493 ' HB3' HG13 ' B' ' 241' ' ' ILE . . . -132.24 141.48 49.05 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.941 0.401 . . . . 0.0 111.153 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -92.01 132.52 36.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.64 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 290' ' ' VAL . . . . . 0.431 ' HB ' HG23 ' B' ' 238' ' ' VAL . 6.0 t -97.99 131.89 44.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 120.832 0.349 . . . . 0.0 110.455 -176.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -127.99 143.91 51.09 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.32 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 292' ' ' ASN . . . . . 0.503 ' OD1' ' HA2' ' B' ' 269' ' ' GLY . 1.5 m120 -112.14 179.71 3.92 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.559 0.695 . . . . 0.0 112.157 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.21 133.55 44.5 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.014 -1.448 . . . . 0.0 110.032 177.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 294' ' ' ALA . . . . . 0.49 ' O ' ' HB ' ' B' ' 295' ' ' THR . . . -73.19 70.17 1.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.052 0.453 . . . . 0.0 110.323 178.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 295' ' ' THR . . . . . 0.49 ' HB ' ' O ' ' B' ' 294' ' ' ALA . 9.3 t 166.47 -21.01 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.173 -175.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 296' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' B' ' 295' ' ' THR . 98.5 mttt 71.15 -173.49 0.17 Allowed 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.128 0.571 . . . . 0.0 110.413 -176.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 297' ' ' LEU . . . . . . . . . . . . . 96.1 mt 63.18 -171.46 0.17 Allowed 'General case' 0 N--CA 1.464 0.261 0 O-C-N 123.486 0.491 . . . . 0.0 109.989 -173.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 298' ' ' GLU . . . . . 0.477 ' HB3' ' CG ' ' B' ' 302' ' ' HIS . 11.4 mm-40 51.28 32.25 8.01 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 176.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 299' ' ' HIS . . . . . . . . . . . . . 22.8 m170 -63.76 -29.49 70.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.21 0.528 . . . . 0.0 110.282 177.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 300' ' ' HIS . . . . . . . . . . . . . 11.2 p80 -135.0 157.27 47.37 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.473 -0.785 . . . . 0.0 108.968 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 301' ' ' HIS . . . . . 0.464 ' HE1' ' HB ' ' A' ' 13' ' ' THR . 19.3 t-80 65.1 22.94 12.37 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.279 0.562 . . . . 0.0 110.286 175.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 302' ' ' HIS . . . . . 0.477 ' CG ' ' HB3' ' B' ' 298' ' ' GLU . 9.5 t-160 -82.8 82.37 8.14 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.902 -177.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 303' ' ' HIS . . . . . 0.429 ' O ' ' HB2' ' B' ' 304' ' ' HIS . 52.9 t60 -99.63 80.17 2.34 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.968 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 304' ' ' HIS . . . . . 0.429 ' HB2' ' O ' ' B' ' 303' ' ' HIS . 4.9 t-80 . . . . . 0 N--CA 1.462 0.16 0 O-C-N 123.798 0.687 . . . . 0.0 109.776 176.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.3 mtm . . . . . 0 N--CA 1.48 1.039 0 CA-C-O 120.717 0.294 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -78.79 -33.34 46.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.898 0.38 . . . . 0.0 111.144 -176.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -91.23 103.97 16.57 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.37 0.605 . . . . 0.0 111.658 -171.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -108.8 133.86 52.29 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 165.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.8 pt -73.16 148.55 8.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.718 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.933 HD13 ' H ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -73.34 69.2 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.655 0.741 . . . . 0.0 111.574 -176.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.35 91.72 7.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.736 175.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.98 3.4 8.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.751 -176.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.12 106.64 2.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.893 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.7 tt -145.08 112.17 6.0 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.494 ' O ' HD12 ' A' ' 11' ' ' LEU . 1.5 pp -143.44 142.7 31.3 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.653 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.17 86.59 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 O-C-N 124.103 0.877 . . . . 0.0 112.538 176.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.588 ' HA ' ' HD2' ' B' ' 300' ' ' HIS . 63.0 m -88.03 86.6 7.14 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.124 0.487 . . . . 0.0 110.766 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.3 t -95.26 72.14 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.79 177.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -177.94 105.79 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.302 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.3 m -81.15 100.21 8.95 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.168 0.509 . . . . 0.0 110.917 -178.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -132.08 130.56 41.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.517 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.4 m 57.07 67.19 1.02 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.401 0.619 . . . . 0.0 110.192 -174.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.5 p -85.23 69.62 10.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.736 -175.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.482 ' O ' ' HG ' ' A' ' 20' ' ' LEU . 1.8 pt? -158.98 88.58 0.9 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.543 174.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -173.2 55.46 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.289 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -175.91 66.58 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.733 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.518 ' HG2' ' HB1' ' B' ' 221' ' ' ALA . 12.4 mp0 -133.94 104.11 6.12 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.176 -170.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.659 ' HA ' ' HB3' ' A' ' 71' ' ' TYR . 0.0 OUTLIER 175.13 167.64 0.3 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.816 0.341 . . . . 0.0 111.27 176.217 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.411 ' H ' ' CD ' ' A' ' 24' ' ' GLN . 28.3 m -127.51 139.77 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.068 0.547 . . . . 0.0 110.174 175.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.9 p -89.46 -93.65 0.11 Allowed 'General case' 0 C--N 1.322 -0.611 0 O-C-N 121.768 -0.582 . . . . 0.0 112.29 -174.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -131.68 -46.75 0.96 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.757 0.313 . . . . 0.0 111.044 -175.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -64.85 -47.39 78.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.516 -177.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.42 ' H ' ' CD ' ' A' ' 29' ' ' GLU . 1.7 mp0 -55.12 -47.81 74.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.608 -176.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.484 HG12 HD12 ' A' ' 35' ' ' LEU . 59.8 mt -58.02 -48.55 83.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.08 0.467 . . . . 0.0 111.147 -178.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.9 m -72.8 -33.83 66.51 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.344 -177.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -81.97 -34.88 29.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.956 -173.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.776 ' HB3' ' HG3' ' B' ' 253' ' ' PRO . 71.1 m-85 -101.77 -8.14 21.96 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.708 -176.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.578 ' HE3' ' HA ' ' B' ' 205' ' ' ILE . 13.3 mmmm 60.71 70.44 0.62 Allowed 'General case' 0 N--CA 1.466 0.343 0 O-C-N 123.559 0.537 . . . . 0.0 110.367 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.489 HD21 ' HB3' ' B' ' 253' ' ' PRO . 87.5 mt -82.12 163.16 22.18 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.799 -175.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 51.8 t -91.74 108.69 20.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.818 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -81.64 105.19 12.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.761 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.453 HG23 ' HB ' ' A' ' 90' ' ' VAL . 4.8 m -86.72 -20.4 7.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -172.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.59 -151.0 22.58 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 119.622 -1.275 . . . . 0.0 113.181 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.401 HG23 ' HG2' ' A' ' 89' ' ' GLU . 4.7 m -137.5 145.84 43.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.656 0.265 . . . . 0.0 110.73 -174.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.2 pt -127.83 144.95 35.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 174.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -125.95 138.62 53.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.084 0.469 . . . . 0.0 111.797 -175.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.632 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 90.4 t -97.57 110.26 25.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.198 171.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.4 p -138.46 74.99 1.5 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.361 0.601 . . . . 0.0 109.65 175.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.65 166.54 22.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.307 -177.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.1 t -73.78 164.65 26.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.75 -177.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.06 5.24 6.7 Favored Glycine 0 CA--C 1.519 0.324 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.729 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.49 -5.27 55.75 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.927 174.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -108.35 -15.75 14.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.819 0.342 . . . . 0.0 110.81 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.578 HD12 ' HA ' ' A' ' 56' ' ' LEU . 45.1 mm -125.43 107.72 18.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.1 m -101.58 -42.01 6.38 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.015 -174.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.51 ' H ' ' HB3' ' A' ' 55' ' ' ASP . 80.5 p -138.94 169.46 12.45 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.288 -175.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.85 ' HG2' HD21 ' B' ' 235' ' ' LEU . 42.1 Cg_exo -58.54 -36.02 97.91 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.354 2.036 . . . . 0.0 111.639 174.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.573 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -64.76 -44.59 89.59 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.6 175.212 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.534 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 38.9 t0 -66.88 -30.66 70.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.312 0.577 . . . . 0.0 110.179 179.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.578 ' HA ' HD12 ' A' ' 50' ' ' ILE . 63.9 tp -63.5 -51.16 66.74 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.933 176.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.573 ' HG3' ' O ' ' A' ' 54' ' ' SER . 6.2 ppt_? -68.45 -25.71 65.14 Favored 'General case' 0 C--O 1.225 -0.202 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.452 -178.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.534 ' HB2' ' O ' ' A' ' 55' ' ' ASP . 6.0 mm-40 -51.77 -51.5 55.86 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.295 0.569 . . . . 0.0 110.698 174.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.499 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 12.4 mptt -65.03 -45.11 86.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.204 -176.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.457 HD21 HG23 ' A' ' 43' ' ' VAL . 86.7 mt -71.45 -36.03 71.1 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.517 -177.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.522 ' HA ' ' HB3' ' B' ' 222' ' ' ALA . 6.9 t -62.94 -44.16 96.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.254 0.55 . . . . 0.0 109.523 176.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -63.39 -40.7 97.93 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.699 177.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 59' ' ' LYS . 84.7 mt -66.68 -44.68 81.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.079 178.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.7 -47.48 85.49 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.856 0.36 . . . . 0.0 110.673 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.553 ' HB2' ' HB3' ' B' ' 220' ' ' LEU . 10.0 t70 -58.24 -40.57 82.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.277 178.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.03 -25.29 58.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.817 -177.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -83.77 -47.55 11.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.935 0.398 . . . . 0.0 111.238 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.44 ' C ' HD21 ' A' ' 97' ' ' LEU . . . 125.6 34.93 0.63 Allowed Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.498 -175.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.454 ' HA2' ' OD1' ' A' ' 92' ' ' ASN . . . -134.13 161.34 24.37 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.593 ' HE2' ' HB2' ' A' ' 99' ' ' HIS . 24.8 mtpp -108.3 -71.74 0.75 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.866 0.333 . . . . 0.0 111.409 -178.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.659 ' HB3' ' HA ' ' A' ' 24' ' ' GLN . 2.3 m-85 -93.22 157.23 16.37 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 -173.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.543 ' CD2' ' HB1' ' B' ' 222' ' ' ALA . 45.6 p90 -146.45 133.68 20.55 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.293 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -102.62 119.11 38.27 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.159 -178.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.514 ' H ' HD12 ' A' ' 74' ' ' ILE . 4.9 mp -77.04 124.53 35.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 30.3 pt -105.99 -21.71 5.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.925 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -152.61 135.92 15.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.696 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -149.03 111.4 4.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.163 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -149.86 173.63 13.56 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.918 0.389 . . . . 0.0 111.073 -176.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.84 148.76 26.3 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.242 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -100.92 -20.47 15.44 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.508 0.671 . . . . 0.0 109.212 175.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 143.06 -99.4 0.22 Allowed Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -176.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -74.28 -18.78 20.39 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.772 2.315 . . . . 0.0 111.232 171.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -116.47 159.64 21.75 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.623 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -115.74 138.31 51.24 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.632 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 42.1 mt-10 -123.98 117.4 24.66 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.209 0.528 . . . . 0.0 111.24 -176.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.546 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -129.03 139.46 52.05 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.629 178.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.7 t -118.77 119.44 61.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.128 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.42 ' HB1' ' HD1' ' A' ' 72' ' ' TYR . . . -135.78 138.82 43.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.782 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.401 ' HG2' HG23 ' A' ' 40' ' ' THR . 3.2 mt-10 -104.0 139.53 39.0 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.453 ' HB ' HG23 ' A' ' 38' ' ' VAL . 8.5 t -97.5 134.83 34.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.144 -170.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -130.4 139.08 50.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.28 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.454 ' OD1' ' HA2' ' A' ' 69' ' ' GLY . 78.9 m-20 -101.37 -178.99 3.9 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.161 173.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -70.64 -156.05 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.721 174.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -83.33 16.85 2.31 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.408 0.623 . . . . 0.0 109.908 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.2 t -154.31 -162.05 1.34 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.126 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -78.9 -157.57 0.12 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.638 0.256 . . . . 0.0 110.834 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.44 HD21 ' C ' ' A' ' 68' ' ' GLY . 54.5 mt -72.98 40.83 0.09 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 122.964 0.506 . . . . 0.0 111.887 -177.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -90.07 -61.18 1.74 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.148 -175.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.593 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . 21.7 t-80 63.06 -82.86 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 O-C-N 123.602 0.564 . . . . 0.0 109.709 -170.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 28.17 87.64 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.557 1.143 . . . . 0.0 113.33 175.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -77.61 123.11 26.2 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.132 0.491 . . . . 0.0 110.848 -176.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -75.27 142.44 43.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.358 174.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -86.42 137.05 32.87 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.94 0.4 . . . . 0.0 110.761 -178.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.5 t60 . . . . . 0 C--N 1.324 -0.529 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.687 -178.525 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . 0.451 ' O ' ' HB2' ' B' ' 202' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.93 0 CA-C-O 121.125 0.488 . . . . 0.0 110.509 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' B' ' 201' ' ' MET . 5.3 mptp? 71.66 160.74 0.23 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.103 -178.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? 66.7 112.85 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.471 -176.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -97.88 142.1 30.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.432 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 205' ' ' ILE . . . . . 0.578 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 12.1 tt -101.95 123.61 55.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.016 0.436 . . . . 0.0 110.29 178.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 7.8 tt -131.45 125.83 57.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.592 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 207' ' ' ALA . . . . . 0.729 ' HB1' HD21 ' B' ' 210' ' ' LEU . . . -81.6 87.64 6.25 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.529 178.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -95.2 131.17 41.53 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.008 -178.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . 61.09 73.57 0.48 Allowed 'General case' 0 C--O 1.234 0.246 0 O-C-N 123.937 0.773 . . . . 0.0 112.033 177.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 210' ' ' LEU . . . . . 0.729 HD21 ' HB1' ' B' ' 207' ' ' ALA . 88.1 mt -85.26 83.68 7.91 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.014 176.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 48.5 tp -110.91 110.77 21.49 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.056 -177.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -158.22 104.04 1.84 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.902 178.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 213' ' ' THR . . . . . 0.456 ' O ' ' HB ' ' B' ' 214' ' ' VAL . 2.3 m -62.81 -74.05 0.1 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.819 -178.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 214' ' ' VAL . . . . . 0.456 ' HB ' ' O ' ' B' ' 213' ' ' THR . 13.8 p 173.92 -34.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.287 0 O-C-N 123.424 0.453 . . . . 0.0 110.27 178.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . 66.19 178.89 0.21 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.611 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 23.2 m -117.96 -37.01 3.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.973 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -102.8 99.8 9.76 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 173.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 218' ' ' SER . . . . . . . . . . . . . 21.6 m -129.37 167.53 17.62 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.354 -174.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 58.9 p -131.45 117.31 18.66 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.984 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.553 ' HB3' ' HB2' ' A' ' 65' ' ' ASP . 0.2 OUTLIER -64.11 -85.89 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.093 177.541 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . 0.536 ' H ' ' CD1' ' B' ' 220' ' ' LEU . . . 64.2 65.7 0.66 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.611 0.72 . . . . 0.0 109.818 -174.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . 0.543 ' HB1' ' CD2' ' A' ' 72' ' ' TYR . . . -128.19 61.03 1.46 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.456 -1.247 . . . . 0.0 108.813 -175.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . 0.515 ' HG3' ' HD3' ' A' ' 57' ' ' ARG . 4.4 mp0 -124.37 96.55 4.95 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.389 -166.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 224' ' ' GLN . . . . . 0.653 ' HB3' ' HG3' ' A' ' 24' ' ' GLN . 0.6 OUTLIER -173.02 148.65 1.76 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.246 -178.557 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . 0.502 HG21 ' CD1' ' B' ' 235' ' ' LEU . 16.6 m -128.7 137.34 57.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.046 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . 0.538 ' HA ' ' CD2' ' B' ' 273' ' ' HIS . 8.7 t -96.24 176.78 5.94 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 120.976 0.417 . . . . 0.0 110.301 -178.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -65.31 -28.93 69.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.437 -173.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.18 -50.32 68.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.043 0.449 . . . . 0.0 110.283 -178.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -65.44 -42.72 92.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.459 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.535 HG12 HD12 ' B' ' 235' ' ' LEU . 88.5 mt -63.34 -34.36 66.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.965 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 31.4 t -69.57 -21.24 63.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.0 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 29.2 t-80 -98.17 -45.73 6.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.836 0.351 . . . . 0.0 110.921 -177.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -86.2 -20.95 27.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.835 -176.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm 59.57 80.76 0.19 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.351 0.596 . . . . 0.0 111.612 -177.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . 0.85 HD21 ' HG2' ' A' ' 53' ' ' PRO . 40.9 mt -83.24 -168.92 2.28 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.754 178.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 59.0 t -109.82 109.21 27.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.088 0.471 . . . . 0.0 111.089 -178.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 237' ' ' LYS . . . . . 0.567 ' HE3' ' HB3' ' B' ' 289' ' ' GLU . 23.1 tptm -73.97 112.67 10.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.789 175.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 3.8 m -100.05 -4.41 9.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -175.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 136.07 -171.82 22.62 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 119.979 -1.105 . . . . 0.0 112.999 176.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . 0.559 HG23 ' HG2' ' B' ' 289' ' ' GLU . 29.8 m -128.63 134.26 48.51 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -178.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 32.8 pt -107.86 137.62 38.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.945 0.402 . . . . 0.0 110.386 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -111.58 115.12 28.63 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.839 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 243' ' ' VAL . . . . . 0.526 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 34.9 t -94.05 109.35 21.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.108 -178.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 23.1 t -110.06 98.36 7.65 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 245' ' ' GLN . . . . . 0.637 ' O ' ' HA ' ' B' ' 283' ' ' ASN . 0.7 OUTLIER -87.89 148.39 24.64 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.946 -177.892 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 51.1 m -126.32 107.04 9.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.209 0.528 . . . . 0.0 111.056 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 101.05 -141.38 15.32 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.322 177.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -107.85 42.29 1.98 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.329 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -63.51 -46.44 86.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.752 0.311 . . . . 0.0 110.365 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 250' ' ' ILE . . . . . 0.588 HG12 ' HG2' ' B' ' 245' ' ' GLN . 47.2 mm -77.56 99.89 2.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.392 0.615 . . . . 0.0 109.585 177.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 5.7 m -100.68 -26.01 13.95 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.691 -174.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 1.9 m -136.52 162.36 56.65 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -177.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . 0.776 ' HG3' ' HB3' ' A' ' 33' ' ' PHE . 48.0 Cg_exo -56.06 -36.38 96.08 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.241 1.961 . . . . 0.0 111.537 175.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 254' ' ' SER . . . . . 0.418 ' HB3' ' CD2' ' A' ' 99' ' ' HIS . 4.3 m -69.25 -24.26 63.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.653 -178.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.17 -34.93 74.27 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.013 0.435 . . . . 0.0 111.523 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.471 ' O ' ' HG ' ' B' ' 260' ' ' LEU . 22.3 tp -65.11 -38.52 90.96 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.749 -177.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 257' ' ' ARG . . . . . 0.438 HH21 ' CD ' ' B' ' 258' ' ' GLU . 2.9 ttp85 -63.83 -35.82 81.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.996 0.427 . . . . 0.0 110.424 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 258' ' ' GLU . . . . . 0.438 ' CD ' HH21 ' B' ' 257' ' ' ARG . 17.0 mm-40 -62.27 -43.06 99.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.249 -178.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -71.79 -34.74 69.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.041 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 260' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' B' ' 256' ' ' LEU . 95.2 mt -69.18 -46.2 68.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.003 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 24.2 p -65.47 -34.75 79.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.802 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -54.18 -51.11 65.39 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.247 0.546 . . . . 0.0 110.439 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 263' ' ' LEU . . . . . 0.483 ' O ' ' HG2' ' B' ' 267' ' ' LYS . 98.2 mt -71.79 -41.69 68.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.172 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -63.84 -32.12 73.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.822 0.344 . . . . 0.0 111.486 -178.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -71.9 -44.27 64.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.814 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -67.0 -30.82 71.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.265 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 267' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' B' ' 263' ' ' LEU . 74.3 mmtt -79.52 -55.82 4.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.002 0.43 . . . . 0.0 110.095 176.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 114.64 48.08 0.56 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.252 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -97.95 -169.63 32.3 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.478 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . 0.47 ' HB2' ' HA ' ' B' ' 292' ' ' ASN . 4.4 tptp -131.53 -29.9 1.72 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.709 0.29 . . . . 0.0 110.882 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 271' ' ' TYR . . . . . 0.437 ' HB3' ' HA ' ' B' ' 224' ' ' GLN . 6.4 m-85 -147.95 173.53 12.78 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 177.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 272' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.65 167.18 22.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.766 0.317 . . . . 0.0 110.796 174.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 273' ' ' HIS . . . . . 0.538 ' CD2' ' HA ' ' B' ' 226' ' ' SER . 19.5 t-80 -148.04 103.5 3.48 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.184 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 274' ' ' ILE . . . . . 0.519 HG13 ' HB2' ' B' ' 288' ' ' ALA . 4.2 mp -70.25 135.23 28.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 31.2 pt -113.99 -28.87 2.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.699 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -157.7 146.97 19.8 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.645 0.259 . . . . 0.0 110.956 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -156.37 139.26 15.29 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 278' ' ' ARG . . . . . 0.435 ' N ' ' HD2' ' B' ' 278' ' ' ARG . 0.0 OUTLIER -155.92 136.39 13.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.969 0.414 . . . . 0.0 111.214 -179.157 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -88.72 102.64 15.18 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 171.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -114.84 103.72 11.23 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 73.6 -134.49 19.24 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.667 -176.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -82.95 -9.16 10.86 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.589 2.193 . . . . 0.0 111.877 176.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 283' ' ' ASN . . . . . 0.637 ' HA ' ' O ' ' B' ' 245' ' ' GLN . 93.4 m-20 -101.37 113.48 26.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.463 -175.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -87.4 107.47 18.55 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 170.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 285' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -100.8 113.67 26.78 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.06 -175.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 286' ' ' ALA . . . . . 0.526 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -117.94 124.24 47.76 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.49 178.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 24.5 t -106.27 112.81 41.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.159 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 288' ' ' ALA . . . . . 0.519 ' HB2' HG13 ' B' ' 274' ' ' ILE . . . -125.63 132.54 52.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.274 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 289' ' ' GLU . . . . . 0.567 ' HB3' ' HE3' ' B' ' 237' ' ' LYS . 18.1 mt-10 -94.83 138.88 32.05 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 21.9 t -103.64 138.93 26.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.972 0.415 . . . . 0.0 110.408 -174.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -128.15 152.18 48.34 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.336 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 292' ' ' ASN . . . . . 0.47 ' HA ' ' HB2' ' B' ' 270' ' ' LYS . 12.2 t-20 -120.01 163.4 17.68 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 174.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -66.38 170.75 5.6 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -176.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 294' ' ' ALA . . . . . . . . . . . . . . . -73.33 9.12 1.4 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.994 0.426 . . . . 0.0 111.815 -174.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 295' ' ' THR . . . . . . . . . . . . . 13.8 t -125.91 -8.73 6.63 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.381 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt 57.22 -162.81 0.19 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.186 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 297' ' ' LEU . . . . . 0.443 HD22 ' CE1' ' B' ' 304' ' ' HIS . 36.8 mt 67.95 -161.97 0.21 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.021 170.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 298' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 54.49 69.46 0.72 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.36 -176.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 299' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 179.75 -53.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.84 175.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 300' ' ' HIS . . . . . 0.588 ' HD2' ' HA ' ' A' ' 13' ' ' THR . 61.7 t-80 -92.55 102.64 15.08 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 174.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 301' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -70.56 143.35 51.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.227 -177.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 302' ' ' HIS . . . . . . . . . . . . . 9.4 t-80 73.58 170.14 0.31 Allowed 'General case' 0 N--CA 1.468 0.437 0 O-C-N 124.173 0.921 . . . . 0.0 111.508 176.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 71.62 35.25 1.47 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.803 0.841 . . . . 0.0 110.001 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 304' ' ' HIS . . . . . 0.443 ' CE1' HD22 ' B' ' 297' ' ' LEU . 55.2 m-70 . . . . . 0 C--N 1.326 -0.428 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.656 175.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtt . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.814 0.34 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -97.86 6.05 48.28 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -174.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -75.5 112.13 11.51 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 177.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -118.57 101.87 8.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.074 0.464 . . . . 0.0 110.225 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.1 tt -171.21 120.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.315 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.3 pt -125.92 37.36 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.221 0.534 . . . . 0.0 111.243 -177.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.59 90.37 8.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.633 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -139.01 91.46 2.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.52 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -149.83 152.27 34.87 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.585 -178.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 54.2 tp -162.25 129.34 3.77 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.366 177.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 41.3 tp -105.95 97.64 7.43 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 175.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.01 137.65 34.82 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.982 -176.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.6 m 67.48 77.94 0.25 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.695 0.76 . . . . 0.0 110.909 178.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.6 t -107.4 -47.91 8.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.324 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -108.75 100.8 9.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.571 175.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.4 m -83.11 56.99 3.71 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.817 -174.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.5 t80 66.1 -73.43 0.07 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.861 176.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.8 t -146.32 116.57 7.43 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.6 t -136.55 132.81 35.7 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.216 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.1 mt -99.83 142.86 30.74 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.882 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -154.32 66.76 0.71 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.209 -0.905 . . . . 0.0 108.817 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -161.72 84.9 0.62 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.033 -170.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.437 ' HA ' ' OH ' ' B' ' 272' ' ' TYR . 0.5 OUTLIER -161.23 121.98 2.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.051 0.453 . . . . 0.0 111.84 -178.812 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 1.05 ' HG3' ' HG3' ' B' ' 224' ' ' GLN . 6.4 tm0? -150.35 144.34 25.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.777 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.2 m -126.78 152.27 34.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 172.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.627 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 6.9 m -108.38 -79.77 0.58 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.074 0.464 . . . . 0.0 110.746 -178.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -165.68 -48.25 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -176.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.422 ' HG3' ' CD ' ' A' ' 29' ' ' GLU . 5.2 pt20 -56.95 -36.44 70.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.058 176.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.422 ' CD ' ' HG3' ' A' ' 28' ' ' GLN . 25.6 mp0 -72.73 -40.1 66.37 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.563 HG23 ' HB2' ' A' ' 35' ' ' LEU . 87.8 mt -61.72 -48.58 88.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.247 -178.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.4 m -68.44 -21.37 64.65 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.259 -177.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -92.97 -43.57 8.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.529 -176.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.545 ' HB3' ' HD3' ' B' ' 253' ' ' PRO . 82.9 m-85 -98.61 -2.91 37.38 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -175.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.7 mptt 65.06 90.1 0.09 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.394 0.616 . . . . 0.0 111.894 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.563 ' HB2' HG23 ' A' ' 30' ' ' ILE . 97.2 mt -121.54 147.86 45.24 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.804 176.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.3 t -103.38 125.09 57.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.912 0.387 . . . . 0.0 111.399 -174.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -69.67 111.57 5.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.092 173.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.1 m -94.8 -8.29 9.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.874 -177.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.34 -160.2 29.36 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.179 -1.01 . . . . 0.0 112.785 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 64.6 m -145.15 135.94 24.56 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 122.596 0.358 . . . . 0.0 110.247 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.7 pt -104.68 143.28 16.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 176.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -122.88 123.51 41.15 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.013 0.435 . . . . 0.0 111.346 -175.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.687 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 67.4 t -97.26 130.72 45.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.294 174.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.9 t -157.68 40.97 0.29 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.5 ' NE2' HG13 ' A' ' 43' ' ' VAL . 0.9 OUTLIER -81.57 158.32 24.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.646 -172.119 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.462 ' HA ' HD22 ' A' ' 83' ' ' ASN . 10.8 t -99.7 87.12 3.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.932 -172.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.61 -84.19 0.55 Allowed Glycine 0 C--O 1.224 -0.524 0 N-CA-C 114.582 0.593 . . . . 0.0 114.582 170.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -49.94 -42.35 38.43 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 114.923 0.729 . . . . 0.0 114.923 -168.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.438 ' OE1' ' HG2' ' A' ' 45' ' ' GLN . 63.8 mt-30 -71.03 -18.03 62.6 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -174.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.7 mm -129.43 123.93 58.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.62 0.248 . . . . 0.0 110.79 -175.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.7 t -140.25 -51.47 0.49 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.017 0.437 . . . . 0.0 110.814 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.547 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 46.4 m -128.41 172.63 6.64 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 178.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.794 ' HD3' ' HB3' ' B' ' 233' ' ' PHE . 59.3 Cg_exo -51.7 -34.96 55.98 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.49 2.126 . . . . 0.0 111.97 178.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.55 ' O ' ' HG3' ' A' ' 58' ' ' GLU . 16.7 p -58.34 -56.72 18.42 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.072 179.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -58.7 -37.67 76.6 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.876 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 61.9 tp -64.12 -52.55 58.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.121 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.427 ' HG3' ' O ' ' A' ' 53' ' ' PRO . 7.4 ppt_? -69.85 -25.91 63.96 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.501 -177.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.55 ' HG3' ' O ' ' A' ' 54' ' ' SER . 38.8 mt-10 -62.61 -40.84 98.21 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 120.835 0.35 . . . . 0.0 110.24 173.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -74.31 -38.52 63.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.611 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.6 mt -64.5 -48.88 73.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.707 -177.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.487 ' HB2' ' HG2' ' B' ' 223' ' ' GLU . 17.0 t -65.92 -35.55 80.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.858 0.361 . . . . 0.0 110.483 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -60.74 -42.12 96.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.15 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 93.4 mt -75.02 -32.71 61.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.293 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.57 -41.7 68.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.281 -178.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.596 ' OD2' ' HB2' ' B' ' 218' ' ' SER . 9.2 t0 -58.93 -41.72 88.02 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 176.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.523 ' HA ' ' OG ' ' B' ' 216' ' ' SER . . . -71.75 -4.99 30.8 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.855 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -104.71 -9.36 18.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.191 0.52 . . . . 0.0 110.178 174.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.54 26.12 72.49 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.312 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.491 ' O ' ' HB1' ' B' ' 221' ' ' ALA . . . -112.53 146.65 18.26 Favored Glycine 0 C--O 1.225 -0.447 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.764 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -97.19 -14.17 21.61 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -172.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.16 144.12 32.07 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -176.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.519 ' CD2' ' HB1' ' B' ' 222' ' ' ALA . 15.5 p90 -129.91 157.51 42.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.82 0.343 . . . . 0.0 110.13 172.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.627 ' CD2' ' HA ' ' A' ' 26' ' ' SER . 8.1 t-160 -128.74 109.34 11.22 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.868 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.598 HG12 ' HB2' ' A' ' 88' ' ' ALA . 57.6 mt -75.95 116.68 19.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.314 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.4 pt -107.15 -15.54 8.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.803 -176.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -153.25 142.5 21.51 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.616 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 85' ' ' GLU . . . -162.77 139.35 7.52 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.9 152.12 22.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.753 0.311 . . . . 0.0 110.701 178.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -89.9 107.54 19.17 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 171.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -112.51 84.91 2.06 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.092 0.473 . . . . 0.0 110.301 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.18 -123.29 20.74 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.264 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -84.28 -3.57 10.2 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.845 2.363 . . . . 0.0 112.864 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.462 HD22 ' HA ' ' A' ' 46' ' ' SER . 10.7 m120 -119.26 128.9 54.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.748 0.309 . . . . 0.0 110.611 -176.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -93.14 123.46 36.42 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 173.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.687 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 43.1 mt-10 -108.5 129.07 55.29 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.879 0.371 . . . . 0.0 111.066 -176.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.519 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -138.28 132.58 31.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.231 177.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.3 t -114.21 112.87 41.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.012 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.598 ' HB2' HG12 ' A' ' 74' ' ' ILE . . . -128.04 129.09 46.12 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.724 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 40' ' ' THR . 26.5 mt-10 -91.88 139.15 30.95 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.6 t -100.39 136.76 30.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -176.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -124.19 150.88 44.7 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.291 0.567 . . . . 0.0 111.127 -177.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -130.33 158.64 39.25 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.464 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -69.49 169.12 13.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.766 0.317 . . . . 0.0 110.317 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -77.1 73.48 3.68 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.259 0.552 . . . . 0.0 110.674 178.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.9 t -170.05 -35.63 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.717 179.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm 67.59 -72.34 0.09 Allowed 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.622 0.576 . . . . 0.0 112.198 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 96.1 mt -137.36 -174.18 3.68 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.479 -176.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -91.62 -29.67 16.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.286 0.565 . . . . 0.0 109.482 175.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.455 ' O ' ' HB2' ' A' ' 100' ' ' HIS . 3.4 t60 -81.3 115.47 20.69 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.455 ' HB2' ' O ' ' A' ' 99' ' ' HIS . 33.7 m170 73.13 165.66 0.3 Allowed 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.916 0.76 . . . . 0.0 110.156 -168.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -157.84 126.42 5.58 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -122.59 125.72 46.25 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.451 -173.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -100.35 175.69 5.62 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 173.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 84.2 t60 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.73 -0.214 . . . . 0.0 110.469 177.985 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 47.9 ttm . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 120.541 0.21 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -77.61 98.94 5.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.769 0.318 . . . . 0.0 110.277 177.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . 0.443 ' HD3' ' HA ' ' B' ' 203' ' ' LYS . 27.4 mmtp -135.29 135.59 40.95 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.014 175.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -77.0 168.52 19.96 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.848 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 67.8 mt -77.33 105.85 6.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.033 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 50.7 mm -92.81 105.22 16.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.887 177.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -107.27 9.01 30.16 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.012 -176.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -81.32 80.61 7.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.165 0.507 . . . . 0.0 111.161 -178.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -140.1 141.78 36.13 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.132 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 210' ' ' LEU . . . . . . . . . . . . . 95.9 mt -121.29 140.08 52.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.782 0.325 . . . . 0.0 110.695 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . 0.844 ' H ' HD23 ' B' ' 211' ' ' LEU . 1.7 pt? -87.7 110.94 20.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.104 0.478 . . . . 0.0 110.108 177.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -153.44 115.79 4.39 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.885 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 213' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.14 95.91 4.88 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.458 178.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 214' ' ' VAL . . . . . . . . . . . . . 27.3 m -86.94 163.75 2.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.452 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.39 91.65 0.12 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.962 0.41 . . . . 0.0 110.77 178.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 216' ' ' SER . . . . . 0.523 ' OG ' ' HA ' ' A' ' 66' ' ' ALA . 13.9 m -95.2 159.52 14.97 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.363 -178.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -160.4 32.12 0.16 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -173.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 218' ' ' SER . . . . . 0.596 ' HB2' ' OD2' ' A' ' 65' ' ' ASP . 4.8 m -71.75 -77.87 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 119.329 -0.367 . . . . 0.0 110.666 -175.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 2.3 m 146.39 -58.33 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.118 1.367 . . . . 0.0 109.113 178.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -149.82 106.34 3.51 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . 0.491 ' HB1' ' O ' ' A' ' 69' ' ' GLY . . . -126.14 117.3 22.85 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.947 -175.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . 0.519 ' HB1' ' CD2' ' A' ' 72' ' ' TYR . . . 68.52 109.93 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 O-C-N 124.187 0.93 . . . . 0.0 112.814 174.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . 0.935 ' HB3' ' HE2' ' B' ' 271' ' ' TYR . 28.2 mt-10 -144.42 124.36 13.52 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.737 173.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 224' ' ' GLN . . . . . 1.05 ' HG3' ' HG3' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -153.69 146.42 24.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.867 -172.813 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . 0.527 ' HB ' HD11 ' B' ' 235' ' ' LEU . 11.6 m -116.26 126.56 73.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 170.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . 0.429 ' O ' HG13 ' B' ' 230' ' ' ILE . 6.7 t -95.99 -167.33 1.57 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.374 0.607 . . . . 0.0 111.523 -173.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . 0.465 ' HA ' HD12 ' B' ' 230' ' ' ILE . 2.2 tmtp? -75.67 -28.91 58.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.831 -172.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -72.86 -43.73 62.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.088 0.47 . . . . 0.0 110.539 -177.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -61.8 -26.94 68.41 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.459 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.504 HG12 HD12 ' B' ' 235' ' ' LEU . 69.9 mt -57.83 -57.23 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.096 0.474 . . . . 0.0 110.253 176.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 11.2 m -73.69 -50.61 20.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.05 -177.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -76.24 -38.59 56.11 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -170.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . 0.794 ' HB3' ' HD3' ' A' ' 53' ' ' PRO . 37.7 m-85 -102.71 -5.8 23.35 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -173.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt 67.01 92.01 0.08 Allowed 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.853 0.721 . . . . 0.0 110.996 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . 0.527 HD11 ' HB ' ' B' ' 225' ' ' VAL . 28.1 mt -97.23 141.06 30.8 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.023 178.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 21.7 t -66.64 -50.14 68.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.237 -178.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 237' ' ' LYS . . . . . 0.526 ' HA ' ' HA ' ' B' ' 291' ' ' TYR . 50.7 tttm 65.78 120.39 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.901 -175.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 38.1 t -91.14 -46.62 14.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.43 -177.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.73 -152.03 16.57 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.871 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 21.3 m -127.62 140.09 52.32 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 241' ' ' ILE . . . . . 0.434 HG23 HG21 ' B' ' 290' ' ' VAL . 19.2 pt -113.08 141.88 27.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.887 0.375 . . . . 0.0 110.683 176.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -120.21 126.54 50.88 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.835 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 243' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' B' ' 285' ' ' GLU . 88.1 t -94.02 132.25 38.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.061 175.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 11.0 p -152.93 64.3 0.78 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.442 0.639 . . . . 0.0 110.776 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 245' ' ' GLN . . . . . 0.402 HE22 HG13 ' B' ' 243' ' ' VAL . 0.9 OUTLIER -97.95 143.85 28.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.295 -179.698 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 6.2 t -86.62 36.84 0.72 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.357 0.598 . . . . 0.0 110.412 -174.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 88.0 167.94 43.89 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.227 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . 82.35 -49.35 4.13 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.821 176.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -71.26 -18.49 62.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.839 0.352 . . . . 0.0 111.201 -178.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 250' ' ' ILE . . . . . 0.481 ' HA ' ' HB3' ' B' ' 255' ' ' ASP . 40.8 mm -126.61 107.59 17.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 34.7 t -135.52 3.5 3.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.601 0.239 . . . . 0.0 111.129 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . 0.525 ' HB2' ' HD2' ' B' ' 253' ' ' PRO . 95.7 p -158.38 167.21 14.89 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -178.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . 0.545 ' HD3' ' HB3' ' A' ' 33' ' ' PHE . 15.9 Cg_endo -59.14 -37.8 90.13 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.261 1.974 . . . . 0.0 111.019 173.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 254' ' ' SER . . . . . 0.573 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 15.3 m -60.75 -46.13 91.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.682 176.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.481 ' HB3' ' HA ' ' B' ' 250' ' ' ILE . 24.9 m-20 -55.12 -50.11 70.07 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.663 0.268 . . . . 0.0 110.786 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.483 ' O ' ' HG ' ' B' ' 260' ' ' LEU . 57.0 tp -60.01 -45.94 91.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.068 178.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -57.27 -48.24 79.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.962 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 258' ' ' GLU . . . . . 0.573 ' HG2' ' O ' ' B' ' 254' ' ' SER . 43.8 mm-40 -58.13 -39.49 78.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.475 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 259' ' ' LYS . . . . . 0.436 ' HD3' ' O ' ' B' ' 255' ' ' ASP . 13.5 mptt -77.28 -35.48 55.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.395 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 260' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' B' ' 256' ' ' LEU . 87.7 mt -64.97 -47.41 77.68 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.501 0.191 . . . . 0.0 110.965 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 6.1 m -61.85 -30.79 71.09 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.205 0.526 . . . . 0.0 110.274 177.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -70.07 -52.76 21.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.753 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 263' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' B' ' 259' ' ' LYS . 88.0 mt -64.08 -36.9 85.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.263 -176.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -66.24 -38.3 87.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.279 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -72.38 -36.7 68.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.439 -177.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -63.27 -30.2 71.39 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.806 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -72.2 -32.9 67.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.352 175.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 117.46 -3.59 17.98 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.234 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -99.44 -153.59 27.86 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.594 -177.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm -150.53 -60.17 0.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.771 0.32 . . . . 0.0 111.049 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 271' ' ' TYR . . . . . 0.935 ' HE2' ' HB3' ' B' ' 223' ' ' GLU . 62.1 m-85 -90.41 148.1 23.01 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -172.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 272' ' ' TYR . . . . . 0.437 ' OH ' ' HA ' ' A' ' 23' ' ' GLU . 10.0 p90 -147.08 167.59 23.69 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.906 0.384 . . . . 0.0 111.423 -174.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 273' ' ' HIS . . . . . 0.522 ' HA ' ' OE1' ' A' ' 24' ' ' GLN . 0.6 OUTLIER -139.47 113.35 8.65 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.878 177.529 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 274' ' ' ILE . . . . . 0.438 ' H ' HD12 ' B' ' 274' ' ' ILE . 4.4 mp -70.67 121.63 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 178.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 30.1 pt -102.43 -24.53 4.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.526 -178.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -153.85 140.73 19.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.863 -178.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -144.79 123.51 12.58 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.779 177.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 278' ' ' ARG . . . . . 0.411 ' HE ' ' CD ' ' B' ' 285' ' ' GLU . 6.1 ptt180 -129.2 134.5 48.03 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.084 0.468 . . . . 0.0 110.691 -178.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -99.21 89.89 4.39 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 173.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -92.77 85.42 5.21 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.058 -173.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 62.08 -116.1 8.89 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.725 176.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.49 -16.57 21.54 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.716 2.277 . . . . 0.0 112.808 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 -105.99 162.89 13.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.176 0.512 . . . . 0.0 110.952 -175.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -132.12 104.7 6.94 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 171.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 285' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 21.4 mp0 -107.13 134.08 50.78 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.063 0.459 . . . . 0.0 110.843 -176.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 286' ' ' ALA . . . . . 0.416 ' H ' ' HB ' ' B' ' 243' ' ' VAL . . . -137.19 147.08 45.63 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.585 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 32.8 t -123.25 122.53 65.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.947 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -131.84 143.62 50.31 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.937 0.399 . . . . 0.0 111.069 -178.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -91.56 123.94 35.35 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.824 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 290' ' ' VAL . . . . . 0.434 HG21 HG23 ' B' ' 241' ' ' ILE . 53.5 t -94.34 129.36 44.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.884 0.373 . . . . 0.0 110.851 -177.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 291' ' ' TYR . . . . . 0.526 ' HA ' ' HA ' ' B' ' 237' ' ' LYS . 64.0 m-85 -121.79 171.06 9.16 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.058 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 292' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -123.09 157.47 32.79 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 174.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -72.84 141.57 47.98 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 294' ' ' ALA . . . . . 0.459 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . . . -74.08 79.71 1.73 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.343 0.592 . . . . 0.0 111.081 -175.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 295' ' ' THR . . . . . . . . . . . . . 8.9 t -166.7 -34.86 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.142 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -81.91 89.22 6.35 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.051 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 297' ' ' LEU . . . . . . . . . . . . . 56.4 mt -149.5 160.23 43.64 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.779 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 298' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -72.51 -61.01 1.95 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.95 0.405 . . . . 0.0 110.05 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 299' ' ' HIS . . . . . . . . . . . . . 37.5 m-70 -92.79 118.46 31.12 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.833 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 300' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -80.52 112.82 18.22 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.331 0.586 . . . . 0.0 110.909 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 301' ' ' HIS . . . . . 0.41 ' O ' ' HB3' ' B' ' 302' ' ' HIS . 18.0 p80 -137.16 143.87 42.65 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 175.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 302' ' ' HIS . . . . . 0.41 ' HB3' ' O ' ' B' ' 301' ' ' HIS . 57.2 t-80 70.36 96.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 O-C-N 124.019 0.825 . . . . 0.0 110.502 -176.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 13.4 t60 75.91 91.27 0.07 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.35 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.337 178.498 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.413 ' HD2' ' HA ' ' A' ' 2' ' ' LYS . 33.2 tptt -89.49 147.66 23.87 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -179.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.07 69.17 3.32 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.05 0.452 . . . . 0.0 112.129 -176.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -100.54 -35.59 9.48 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.72 0.295 . . . . 0.0 111.21 179.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.401 ' H ' HG13 ' A' ' 5' ' ' ILE . 1.1 pp -83.4 117.28 28.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.459 0.647 . . . . 0.0 112.593 -171.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.2 pp -134.05 156.47 40.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.237 174.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -121.58 153.43 38.06 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.887 0.375 . . . . 0.0 111.011 -177.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.01 101.56 13.03 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.544 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.0 137.82 32.02 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.686 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.2 mp -91.76 147.24 23.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.993 0.425 . . . . 0.0 110.55 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -83.46 159.47 21.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.913 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -158.18 154.61 27.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.615 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 33.9 p -84.01 -83.53 0.15 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.964 0.165 . . . . 0.0 111.174 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.57 HG11 HG13 ' B' ' 238' ' ' VAL . 59.1 t 64.34 108.32 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 121.632 0.73 . . . . 0.0 112.029 178.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -118.91 97.27 5.62 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.167 175.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.684 ' HB3' ' HA3' ' B' ' 268' ' ' GLY . 23.0 t -112.62 -179.7 3.74 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.933 -178.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -62.06 124.59 21.22 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.96 0.41 . . . . 0.0 110.781 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' B' ' 265' ' ' ASP . 3.8 p -75.18 110.69 9.72 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.372 -178.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.8 t -158.96 87.43 0.86 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.965 175.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.759 ' HB3' ' HB2' ' B' ' 265' ' ' ASP . 3.8 pp -58.2 140.64 52.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.108 -178.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -156.14 78.85 0.97 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.104 176.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.771 ' HA ' ' HG3' ' B' ' 223' ' ' GLU . . . -163.35 -135.21 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.97 -171.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.559 ' HG3' ' HB2' ' B' ' 257' ' ' ARG . 17.0 tt0 80.9 104.97 0.07 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 124.37 1.043 . . . . 0.0 110.358 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.519 ' HA ' ' HB3' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -162.18 154.11 18.87 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.39 -174.333 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.433 HG22 ' HB2' ' A' ' 71' ' ' TYR . 27.1 m -106.79 139.27 28.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.854 0.359 . . . . 0.0 110.877 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.691 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 7.4 t -93.98 -86.11 0.28 Allowed 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.328 -175.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -157.97 -49.15 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.225 -176.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -58.56 -40.42 83.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.067 0.461 . . . . 0.0 110.53 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.406 ' H ' ' CD ' ' A' ' 29' ' ' GLU . 1.2 mp0 -64.87 -37.89 89.13 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.664 178.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.564 HG12 HD12 ' A' ' 35' ' ' LEU . 58.5 mt -66.72 -39.46 83.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.442 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.9 m -68.81 -35.03 76.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.086 0.47 . . . . 0.0 110.86 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -85.87 -45.17 11.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.416 -174.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -92.24 -19.38 22.26 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -175.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.439 ' NZ ' ' HB2' ' A' ' 34' ' ' LYS . 0.2 OUTLIER 65.83 85.18 0.14 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.127 0.489 . . . . 0.0 111.388 -177.614 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.564 HD12 HG12 ' A' ' 30' ' ' ILE . 67.7 mt -94.35 175.67 6.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.676 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.678 HG21 ' HE3' ' A' ' 96' ' ' LYS . 40.7 t -105.97 123.6 60.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.33 -175.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.8 tttp -81.4 112.35 18.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.191 176.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.42 HG23 ' HB ' ' A' ' 90' ' ' VAL . 21.2 m -107.48 22.4 3.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -173.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 120.9 -164.8 14.11 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.306 -0.949 . . . . 0.0 112.897 174.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.617 HG23 ' HG2' ' A' ' 89' ' ' GLU . 12.9 m -140.06 134.69 31.71 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 -176.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.7 pt -107.21 151.05 9.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 174.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -125.52 123.04 38.27 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.033 0.444 . . . . 0.0 111.628 -174.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.611 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 73.0 t -99.1 117.68 44.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.348 172.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 63.5 p -145.98 72.81 1.31 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.245 0.545 . . . . 0.0 109.718 176.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.429 HE22 HG13 ' A' ' 43' ' ' VAL . 0.7 OUTLIER -100.5 148.77 24.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.03 -176.706 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.454 ' HA ' HD22 ' A' ' 83' ' ' ASN . 17.4 m -86.4 56.64 4.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.594 -176.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.82 -71.05 2.79 Favored Glycine 0 C--O 1.227 -0.337 0 C-N-CA 121.261 -0.495 . . . . 0.0 114.129 173.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -54.01 -28.71 41.65 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 115.164 0.825 . . . . 0.0 115.164 -169.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -78.61 -14.57 59.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.59 0.695 . . . . 0.0 111.606 -177.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.0 mm -120.32 107.53 21.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.163 0.506 . . . . 0.0 110.185 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.2 m -114.52 -45.13 3.03 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.576 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 87.7 p -124.78 164.28 32.01 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.739 177.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.783 ' HB2' ' HB2' ' B' ' 293' ' ' ASP . 24.2 Cg_exo -64.34 -20.19 66.27 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.28 1.986 . . . . 0.0 111.644 174.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.506 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 75.2 m -69.06 -42.75 75.85 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.084 173.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -62.87 -39.11 93.41 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.217 0.532 . . . . 0.0 109.717 176.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 61.7 tp -60.36 -41.36 93.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.964 176.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.461 ' HD2' ' OE1' ' B' ' 223' ' ' GLU . 9.5 ttp85 -61.3 -43.86 98.18 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.552 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 54' ' ' SER . 22.9 mm-40 -53.49 -50.78 64.63 Favored 'General case' 0 C--N 1.332 -0.165 0 O-C-N 123.51 0.506 . . . . 0.0 110.616 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.503 ' HA ' ' HG2' ' A' ' 62' ' ' GLU . 4.3 mptp? -67.44 -41.62 84.45 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.573 -178.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 85.0 mt -63.34 -34.16 77.1 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.005 0.431 . . . . 0.0 110.482 177.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.6 t -70.6 -52.46 21.33 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.724 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.734 ' HA ' ' O ' ' B' ' 217' ' ' PHE . 13.0 pt-20 -65.26 -31.46 72.63 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -175.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 82.9 mt -66.98 -47.07 72.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.84 0.353 . . . . 0.0 111.172 177.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.532 ' O ' ' HG3' ' A' ' 67' ' ' LYS . . . -74.01 -43.9 56.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.608 -177.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -59.57 -51.52 69.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.548 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.9 -18.97 64.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.038 -176.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.532 ' HG3' ' O ' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -91.19 -13.92 32.0 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.439 -179.285 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.64 44.35 4.91 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.212 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -130.07 151.76 19.49 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.097 -0.573 . . . . 0.0 111.813 177.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.459 ' O ' ' HB2' ' B' ' 222' ' ' ALA . 17.7 mmtp -88.4 -72.78 0.52 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.86 0.362 . . . . 0.0 111.543 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.519 ' HB3' ' HA ' ' A' ' 24' ' ' GLN . 0.4 OUTLIER -108.19 169.82 8.39 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -173.128 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -140.68 167.51 22.0 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.691 ' CD2' ' HA ' ' A' ' 26' ' ' SER . 4.8 t-80 -139.08 110.59 7.04 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.753 174.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 59.8 mt -65.89 113.93 2.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.804 176.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 31.8 pt -97.73 -26.31 3.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.966 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -156.21 131.69 9.5 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.328 178.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -135.65 98.81 4.02 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.512 HH11 ' HB2' ' B' ' 207' ' ' ALA . 13.3 ptm180 -125.32 165.69 17.9 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.513 -173.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -109.69 129.33 55.61 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.963 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -100.5 18.39 19.21 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.335 0.588 . . . . 0.0 109.647 -178.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 110.25 -98.93 1.13 Allowed Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.463 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.83 -13.86 11.49 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.522 2.148 . . . . 0.0 112.103 176.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.454 HD22 ' HA ' ' A' ' 46' ' ' SER . 13.5 m120 -114.34 139.26 49.61 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.019 -176.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -99.83 115.8 30.42 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 172.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 50.5 mt-10 -107.18 111.14 23.42 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.946 0.403 . . . . 0.0 110.73 -175.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.611 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -120.38 117.34 27.49 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.258 177.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.5 t -98.61 112.97 32.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.034 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -126.46 123.89 38.88 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.017 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.617 ' HG2' HG23 ' A' ' 40' ' ' THR . 10.4 mt-10 -93.46 143.99 25.77 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.42 ' HB ' HG23 ' A' ' 38' ' ' VAL . 10.6 t -96.6 130.43 45.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.894 0.378 . . . . 0.0 110.356 -171.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -125.61 133.88 52.09 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.821 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -107.48 161.44 14.83 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -64.84 164.04 13.14 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.459 ' O ' ' HB ' ' A' ' 95' ' ' THR . . . -75.92 65.37 1.99 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.153 0.501 . . . . 0.0 110.549 -177.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.459 ' HB ' ' O ' ' A' ' 94' ' ' ALA . 9.6 t 168.82 -21.4 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.438 -177.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.678 ' HE3' HG21 ' A' ' 36' ' ' VAL . 7.8 mptt 60.92 -117.5 0.73 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.959 -177.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 95' ' ' THR . 83.4 mt 70.81 151.96 0.11 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 122.057 0.932 . . . . 0.0 113.191 174.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.464 ' OE1' ' HB2' ' A' ' 100' ' ' HIS . 1.7 tm-20 -147.63 138.4 23.35 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -73.93 -20.39 60.39 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -168.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.464 ' HB2' ' OE1' ' A' ' 98' ' ' GLU . 47.1 m80 -93.84 -2.89 52.84 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 173.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 58.44 90.93 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.158 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -140.46 141.93 35.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.911 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -152.67 148.01 26.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.977 170.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 . . . . . 0 C--N 1.321 -0.633 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -179.651 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . 0.431 ' N ' ' SD ' ' B' ' 201' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 56.5 mmtt -148.93 -65.97 0.23 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.293 0.568 . . . . 0.0 110.721 -178.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 45.2 pttt -102.68 114.07 28.0 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.878 -173.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -118.34 27.49 8.92 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.386 175.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 44.1 mm -84.28 -64.66 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.712 -174.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 47.0 mm -68.97 128.04 31.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.31 -174.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 207' ' ' ALA . . . . . 0.512 ' HB2' HH11 ' A' ' 78' ' ' ARG . . . -164.82 102.27 0.79 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.299 178.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -148.15 126.89 12.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.505 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -109.89 106.46 16.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.166 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 210' ' ' LEU . . . . . . . . . . . . . 5.5 tt -96.02 -46.23 6.59 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 177.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 90.2 mt 73.27 146.95 0.08 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.625 175.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -154.91 179.12 9.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.914 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 213' ' ' THR . . . . . . . . . . . . . 39.4 p -67.55 138.76 56.74 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 177.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 214' ' ' VAL . . . . . . . . . . . . . 43.6 t -95.84 -48.87 12.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.177 -175.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . 59.34 -156.98 0.33 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.446 -175.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 16.1 t -151.03 83.35 1.33 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.099 0.475 . . . . 0.0 110.547 177.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 217' ' ' PHE . . . . . 0.734 ' O ' ' HA ' ' A' ' 62' ' ' GLU . 91.8 m-85 -140.73 111.11 6.73 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 175.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 218' ' ' SER . . . . . . . . . . . . . 3.3 p -125.66 116.5 21.78 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.105 0.478 . . . . 0.0 111.512 -176.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 4.2 m -121.76 149.41 43.33 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.702 176.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.405 ' HA ' ' OE2' ' B' ' 223' ' ' GLU . 6.6 mp -71.45 106.88 4.11 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . 178.65 -19.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.961 -174.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 70' ' ' LYS . . . -129.16 92.2 3.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.243 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . 0.771 ' HG3' ' HA ' ' A' ' 22' ' ' ALA . 0.9 OUTLIER -170.36 124.7 0.72 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -176.212 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 224' ' ' GLN . . . . . 0.48 ' HA ' ' HB3' ' B' ' 271' ' ' TYR . 0.0 OUTLIER -171.48 149.26 2.65 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.325 177.463 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 29.0 m -114.77 151.42 16.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.513 176.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . 0.623 ' HA ' ' CD2' ' B' ' 273' ' ' HIS . 57.5 p -113.59 -96.21 0.45 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -136.05 -36.05 0.76 Allowed 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 228' ' ' GLN . . . . . 0.402 ' HB2' ' OE2' ' B' ' 229' ' ' GLU . 0.7 OUTLIER -58.61 -43.1 89.5 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.443 0.639 . . . . 0.0 109.98 -178.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 229' ' ' GLU . . . . . 0.537 ' H ' ' CD ' ' B' ' 229' ' ' GLU . 3.2 mp0 -58.72 -45.22 90.08 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.448 177.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.542 HG12 HD12 ' B' ' 235' ' ' LEU . 55.7 mt -63.44 -39.3 84.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.528 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 15.2 m -69.82 -23.13 63.26 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.086 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -93.5 -57.6 2.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.602 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -90.05 -14.38 33.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.157 -170.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt 59.07 82.78 0.14 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.252 0.549 . . . . 0.0 110.082 -175.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . 0.573 HD22 ' HA ' ' B' ' 293' ' ' ASP . 55.1 mt -80.32 178.8 8.04 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.477 -171.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.574 ' HB ' ' HB2' ' B' ' 292' ' ' ASN . 40.8 t -103.61 109.35 26.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.135 -0.938 . . . . 0.0 110.288 -178.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -76.33 125.75 29.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.711 -176.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 238' ' ' VAL . . . . . 0.69 HG12 ' HD2' ' B' ' 267' ' ' LYS . 4.1 t -100.73 -17.53 6.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-O 121.334 0.588 . . . . 0.0 110.847 -176.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 115.81 162.64 13.38 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.391 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.04 145.07 31.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.046 0.45 . . . . 0.0 111.505 -177.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 32.2 pt -126.87 132.04 70.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 169.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -117.45 132.39 56.57 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.993 0.901 . . . . 0.0 111.477 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 243' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 66.5 t -93.99 131.0 42.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 114.528 -1.214 . . . . 0.0 109.999 -177.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 15.4 t -148.06 95.74 2.53 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 176.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 245' ' ' GLN . . . . . 0.424 HE21 ' HB2' ' B' ' 245' ' ' GLN . 0.0 OUTLIER -136.91 152.37 50.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.124 176.627 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 246' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' B' ' 283' ' ' ASN . 15.3 m -76.94 162.72 27.36 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.012 -178.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -58.72 106.11 0.8 Allowed Glycine 0 C--N 1.331 0.275 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.916 176.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . 151.92 -50.41 0.52 Allowed Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -174.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -78.13 -28.99 48.59 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 173.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 42.8 mm -121.27 123.43 69.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.675 171.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 22.2 t -149.88 -38.72 0.14 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.95 0.405 . . . . 0.0 110.379 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . 0.441 ' HB3' ' HD2' ' B' ' 253' ' ' PRO . 16.5 m -113.16 161.53 26.47 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.152 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' B' ' 252' ' ' SER . 13.7 Cg_endo -57.78 -20.89 45.48 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.675 2.25 . . . . 0.0 112.189 177.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 254' ' ' SER . . . . . 0.625 ' HA ' ' NH1' ' B' ' 257' ' ' ARG . 22.6 t -65.94 -51.08 61.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.522 177.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.461 ' O ' ' HG2' ' B' ' 259' ' ' LYS . 9.3 m-20 -54.47 -45.4 73.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.383 -173.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 49.3 tp -60.3 -60.61 3.54 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.234 -174.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 257' ' ' ARG . . . . . 0.625 ' NH1' ' HA ' ' B' ' 254' ' ' SER . 0.0 OUTLIER -68.03 -25.92 65.62 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -174.636 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 258' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' B' ' 254' ' ' SER . 53.8 mt-10 -70.18 -32.19 70.0 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.398 179.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 259' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' B' ' 255' ' ' ASP . 74.8 mmtt -73.03 -44.21 61.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.986 0.422 . . . . 0.0 109.965 174.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.32 -48.26 82.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.612 -177.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 41.0 m -60.88 -35.34 76.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.677 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -68.37 -41.76 80.15 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.008 0.432 . . . . 0.0 110.529 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 263' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' B' ' 259' ' ' LYS . 98.1 mt -67.46 -44.18 79.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.008 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -61.44 -41.99 98.06 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.158 177.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 265' ' ' ASP . . . . . 0.759 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 26.6 t70 -54.03 -53.87 47.0 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.306 176.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -64.01 -31.18 72.28 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.048 0.451 . . . . 0.0 111.02 -177.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 267' ' ' LYS . . . . . 0.69 ' HD2' HG12 ' B' ' 238' ' ' VAL . 32.7 mmtt -62.5 -38.7 90.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.21 176.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 268' ' ' GLY . . . . . 0.684 ' HA3' ' HB3' ' A' ' 16' ' ' SER . . . 94.9 15.33 45.98 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -170.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . 0.492 ' HA2' ' ND2' ' B' ' 292' ' ' ASN . . . -106.87 146.76 16.1 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . 0.543 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 54.8 mtpt -79.66 -68.28 0.68 Allowed 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 121.133 -0.227 . . . . 0.0 111.415 -176.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 271' ' ' TYR . . . . . 0.593 ' HA ' ' HB2' ' A' ' 22' ' ' ALA . 9.9 m-85 -97.93 154.41 17.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.101 0.477 . . . . 0.0 110.631 -173.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 272' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -122.62 136.42 54.88 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 175.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 273' ' ' HIS . . . . . 0.623 ' CD2' ' HA ' ' B' ' 226' ' ' SER . 12.3 t-80 -110.98 101.79 10.32 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.667 0.27 . . . . 0.0 110.745 -176.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 274' ' ' ILE . . . . . . . . . . . . . 68.5 mt -70.16 122.12 21.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 176.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 61.5 mt -97.85 -52.65 8.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.152 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -140.73 147.52 39.31 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.968 -177.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -144.53 138.68 27.7 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -152.38 151.41 30.79 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.038 0.447 . . . . 0.0 110.811 -176.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -97.25 120.24 37.25 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 175.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -129.95 107.54 9.44 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.006 0.432 . . . . 0.0 110.813 -174.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 66.82 -127.62 28.29 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.787 -178.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -92.21 3.54 3.84 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.767 2.311 . . . . 0.0 112.472 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 283' ' ' ASN . . . . . 0.419 ' HA ' ' HA ' ' B' ' 246' ' ' SER . 81.0 m-20 -118.58 149.86 40.63 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.129 0.49 . . . . 0.0 111.415 -174.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -99.9 123.3 44.0 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.515 173.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 285' ' ' GLU . . . . . 0.453 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 21.1 mm-40 -107.75 121.21 44.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.457 -176.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 286' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -128.75 134.48 48.43 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 121.106 -0.238 . . . . 0.0 110.827 176.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 65.0 t -116.52 117.53 55.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.832 0.349 . . . . 0.0 110.386 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -133.28 142.99 48.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.467 -178.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -99.26 131.43 45.29 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.982 175.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 290' ' ' VAL . . . . . 0.582 ' HB ' ' HB ' ' B' ' 238' ' ' VAL . 32.7 t -90.09 133.81 30.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 176.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 291' ' ' TYR . . . . . 0.415 ' HA ' HG23 ' B' ' 238' ' ' VAL . 73.9 m-85 -132.58 134.12 44.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.993 0.425 . . . . 0.0 111.354 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 292' ' ' ASN . . . . . 0.574 ' HB2' ' HB ' ' B' ' 236' ' ' VAL . 23.2 m120 -90.73 123.71 34.53 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 165.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 293' ' ' ASP . . . . . 0.783 ' HB2' ' HB2' ' A' ' 53' ' ' PRO . 5.3 p-10 -71.45 163.91 26.8 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 294' ' ' ALA . . . . . 0.501 ' H ' ' HG2' ' A' ' 53' ' ' PRO . . . -71.73 77.99 0.85 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.975 0.417 . . . . 0.0 111.063 -177.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 295' ' ' THR . . . . . . . . . . . . . 8.5 t -133.72 105.16 6.67 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 122.485 1.136 . . . . 0.0 110.998 176.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -151.44 15.37 0.69 Allowed 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.079 -1.418 . . . . 0.0 108.375 177.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 297' ' ' LEU . . . . . . . . . . . . . 74.3 mt -114.47 141.22 47.97 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.523 -173.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 298' ' ' GLU . . . . . 0.482 ' CD ' ' H ' ' B' ' 299' ' ' HIS . 0.5 OUTLIER -77.72 163.85 25.79 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.099 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 299' ' ' HIS . . . . . 0.482 ' H ' ' CD ' ' B' ' 298' ' ' GLU . 77.9 m-70 -75.72 -25.61 56.76 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 176.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 300' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 64.64 34.46 9.79 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.174 170.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 301' ' ' HIS . . . . . . . . . . . . . 42.6 t-80 -167.24 -53.54 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.388 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 302' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -144.44 102.66 3.86 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.092 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -70.91 -53.12 16.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.487 -175.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 20.6 t-80 . . . . . 0 C--N 1.324 -0.515 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 -178.645 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.0 tpp . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -144.97 111.25 5.6 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -60.27 -44.52 95.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.375 -176.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 61.47 -170.02 0.16 Allowed 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.476 0.485 . . . . 0.0 110.699 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 51.4 mm 71.25 -69.49 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.227 172.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.9 mt 64.25 94.09 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.573 0.701 . . . . 0.0 110.044 -172.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -138.58 -142.93 0.16 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.078 -176.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 68.92 30.83 4.47 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 122.989 0.515 . . . . 0.0 110.944 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.91 133.43 39.25 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.678 177.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.5 tp -102.73 109.9 21.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.932 0.396 . . . . 0.0 111.248 -176.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' A' ' 11' ' ' LEU . 0.4 OUTLIER -101.57 122.23 43.45 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 175.89 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -98.49 107.16 19.55 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.859 0.361 . . . . 0.0 111.121 -175.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.3 m -123.8 98.39 5.79 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.128 0.489 . . . . 0.0 110.605 178.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.9 m -102.92 -174.15 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.049 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -151.55 166.54 30.85 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.201 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.9 t -84.5 117.98 24.02 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 177.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -81.02 -83.33 0.11 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -171.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 71.8 m 59.18 27.88 17.02 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.488 0.661 . . . . 0.0 110.574 -172.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.485 ' HB ' HD23 ' A' ' 20' ' ' LEU . 44.6 p -104.64 -157.39 0.61 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.755 177.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.526 HD23 ' H ' ' A' ' 20' ' ' LEU . 2.0 pt? -52.75 125.68 17.55 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 171.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -130.67 149.79 52.16 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.644 -177.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.76 92.52 2.49 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 176.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.448 ' HB3' ' HE1' ' A' ' 71' ' ' TYR . 30.9 mt-10 -144.43 -158.8 0.92 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.691 -175.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.647 ' HA ' ' CD1' ' A' ' 71' ' ' TYR . 0.0 OUTLIER 86.98 145.62 0.05 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.857 1.263 . . . . 0.0 111.447 178.437 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.424 HG21 ' CD1' ' A' ' 35' ' ' LEU . 31.1 m -109.82 140.98 26.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.356 -178.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.585 ' HA ' ' HD2' ' A' ' 73' ' ' HIS . 6.3 m -86.81 -174.08 4.78 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.296 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -69.92 -35.3 74.45 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -169.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.531 HE21 ' HB2' ' A' ' 26' ' ' SER . 0.5 OUTLIER -73.21 -33.93 65.65 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.561 -177.198 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.435 ' OE1' ' HB2' ' A' ' 26' ' ' SER . 3.0 mp0 -63.58 -45.03 92.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.099 0.476 . . . . 0.0 109.907 175.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.507 HG12 HD12 ' A' ' 35' ' ' LEU . 81.4 mt -56.76 -40.31 69.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.756 177.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.1 m -71.94 -20.74 61.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.305 -178.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -88.29 -42.19 12.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.476 -178.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -89.56 -9.31 50.31 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 121.064 -0.255 . . . . 0.0 111.372 -178.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? 54.84 54.78 8.61 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.293 0.568 . . . . 0.0 110.237 -176.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.507 HD12 HG12 ' A' ' 30' ' ' ILE . 89.6 mt -66.17 145.93 55.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.44 -176.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.474 ' H ' ' HB2' ' A' ' 94' ' ' ALA . 15.7 m -73.71 135.91 26.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.719 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.5 tttm -96.89 122.58 40.02 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.365 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.24 -47.11 20.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.973 0.416 . . . . 0.0 110.237 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 171.45 173.86 38.7 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.066 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 86.9 m -101.26 121.28 41.6 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.619 0.247 . . . . 0.0 110.467 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.1 pt -106.77 144.09 16.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 176.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -128.43 131.57 48.44 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.533 0.682 . . . . 0.0 110.882 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 70.7 t -93.99 128.5 45.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 114.255 -1.339 . . . . 0.0 109.311 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.0 t -150.35 78.17 1.32 Allowed 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.636 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 0.6 OUTLIER -103.1 130.68 50.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.997 -179.141 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.9 t -92.14 102.61 15.14 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.009 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.54 -130.21 10.18 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.055 -0.593 . . . . 0.0 114.405 171.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.91 34.06 2.59 Favored Glycine 0 C--N 1.331 0.26 0 N-CA-C 114.329 0.492 . . . . 0.0 114.329 -167.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.636 ' HB2' ' HB3' ' A' ' 45' ' ' GLN . 15.2 mm100 -82.68 -28.33 30.67 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 172.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.558 HD12 ' HA ' ' A' ' 56' ' ' LEU . 49.6 mm -122.95 112.1 32.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.407 176.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.598 ' HB2' ' HA ' ' B' ' 302' ' ' HIS . 15.0 m -118.46 -1.27 11.26 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.311 -176.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 40.4 m -155.93 148.46 17.82 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -58.73 -31.49 95.07 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.426 2.084 . . . . 0.0 111.21 176.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.57 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 2.8 p -69.72 -35.1 74.74 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.212 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -75.76 -32.1 59.81 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.879 0.371 . . . . 0.0 110.422 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.558 ' HA ' HD12 ' A' ' 50' ' ' ILE . 68.4 tp -59.59 -50.21 74.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.049 178.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.568 ' HD2' ' CD ' ' B' ' 223' ' ' GLU . 26.5 ptt85 -67.35 -32.8 73.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.952 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.57 ' HG2' ' O ' ' A' ' 54' ' ' SER . 9.5 mm-40 -55.5 -42.64 74.72 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.162 0.506 . . . . 0.0 110.006 176.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.501 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 13.7 mptt -58.76 -44.91 90.71 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.591 175.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.453 HD13 HD11 ' A' ' 74' ' ' ILE . 74.5 mt -64.89 -41.88 95.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.972 -176.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.4 m -60.18 -40.01 88.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.163 0.506 . . . . 0.0 110.168 175.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -69.04 -40.37 78.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.891 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 59' ' ' LYS . 87.9 mt -66.26 -37.49 85.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.221 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.96 -39.08 93.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.885 0.374 . . . . 0.0 110.523 178.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -68.04 -35.77 78.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.849 177.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.12 -32.7 70.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.285 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.416 ' HD3' ' HA ' ' A' ' 67' ' ' LYS . 71.5 mmtt -87.34 -26.54 23.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.882 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.53 43.96 3.3 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.511 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -120.44 -170.84 14.33 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.81 -0.709 . . . . 0.0 111.776 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -123.26 -36.08 2.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.966 0.412 . . . . 0.0 110.591 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.647 ' CD1' ' HA ' ' A' ' 24' ' ' GLN . 71.7 m-85 -132.6 166.74 21.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.007 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -148.96 131.3 15.61 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.585 ' HD2' ' HA ' ' A' ' 26' ' ' SER . 58.8 t-80 -109.72 105.61 14.93 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.078 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.509 ' HB ' ' OG ' ' B' ' 226' ' ' SER . 60.6 mt -67.77 130.89 33.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.272 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 33.5 pt -114.17 -16.27 9.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.15 -178.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.554 ' HB3' ' HB ' ' A' ' 87' ' ' VAL . . . -147.94 137.31 22.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.056 -176.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -156.51 103.54 2.13 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.41 145.97 35.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.776 0.322 . . . . 0.0 111.032 -176.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -82.14 124.96 30.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.199 0.523 . . . . 0.0 110.816 176.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.0 t-160 -100.19 50.61 0.9 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 175.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.14 -130.83 10.14 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 110.321 -1.111 . . . . 0.0 110.321 -170.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -79.61 6.0 5.47 Favored 'Trans proline' 0 N--CA 1.464 -0.229 0 C-N-CA 122.483 2.122 . . . . 0.0 111.499 173.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -108.96 121.93 46.16 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.284 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.471 ' CE2' ' HB2' ' A' ' 86' ' ' ALA . 70.1 t80 -93.36 122.77 36.11 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.964 -176.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 25.9 mm-40 -112.36 115.3 28.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.249 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.514 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -132.31 134.67 45.51 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.591 0.234 . . . . 0.0 111.057 178.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.554 ' HB ' ' HB3' ' A' ' 76' ' ' ALA . 97.2 t -114.46 121.86 67.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.939 0.4 . . . . 0.0 110.075 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 74' ' ' ILE . . . -125.19 138.07 54.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.165 -177.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.05 116.92 29.4 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.776 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.7 t -86.3 126.02 40.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.833 0.349 . . . . 0.0 110.655 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -123.52 156.51 35.5 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.986 178.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -110.19 172.65 6.74 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.428 ' C ' ' H ' ' A' ' 95' ' ' THR . 16.8 t70 -61.24 -31.94 71.73 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.299 -175.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.474 ' HB2' ' H ' ' A' ' 36' ' ' VAL . . . 71.08 -9.78 0.83 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.565 0.746 . . . . 0.0 112.178 178.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.428 ' H ' ' C ' ' A' ' 93' ' ' ASP . 6.9 m -118.76 -39.94 2.92 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.122 175.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 97.0 mttt 70.03 35.21 2.27 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.783 176.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 96.5 mt -122.98 97.46 5.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.22 173.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.457 ' OE2' ' HD2' ' A' ' 99' ' ' HIS . 11.4 tm-20 -97.28 -73.62 0.6 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.572 -176.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.457 ' HD2' ' OE2' ' A' ' 98' ' ' GLU . 27.9 m-70 -151.78 146.21 25.56 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 173.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -79.95 78.23 6.58 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 174.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -143.05 117.76 9.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.595 0.712 . . . . 0.0 111.418 -178.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 41.8 t60 -99.1 102.74 14.53 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.873 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 69.4 t60 -103.92 85.48 2.42 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.811 0.338 . . . . 0.0 110.263 178.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 83.6 t60 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.928 178.229 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 120.834 0.35 . . . . 0.0 110.507 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -136.32 103.63 5.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.938 -177.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' B' ' 203' ' ' LYS . 71.0 mmtt -132.78 150.41 52.16 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.952 175.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? 70.67 -83.16 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.994 0.809 . . . . 0.0 111.581 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 64.0 mt 60.54 84.23 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -169.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 21.7 pt -91.06 128.82 42.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.419 -174.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -89.27 86.13 6.77 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 175.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -148.14 160.65 42.69 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.213 -176.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . 0.436 ' HB1' ' HB ' ' B' ' 213' ' ' THR . . . -143.31 -50.68 0.34 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.66 177.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 210' ' ' LEU . . . . . . . . . . . . . 6.8 mp 55.91 28.52 12.69 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.045 -178.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 95.0 mt 71.68 -5.87 1.56 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.651 0.781 . . . . 0.0 111.679 -178.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -93.54 20.87 6.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.236 0.541 . . . . 0.0 110.76 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 213' ' ' THR . . . . . 0.436 ' HB ' ' HB1' ' B' ' 209' ' ' ALA . 11.1 t -65.79 -11.28 44.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.482 -177.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 214' ' ' VAL . . . . . . . . . . . . . 35.4 m -71.38 -3.68 3.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.719 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.71 102.03 0.23 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.066 0.46 . . . . 0.0 111.333 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 3.7 p -141.56 102.02 4.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.316 178.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -91.72 68.85 5.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.701 -177.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 218' ' ' SER . . . . . . . . . . . . . 47.9 m -160.68 179.86 8.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.673 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 17.0 m 76.44 113.75 0.07 Allowed 'General case' 0 CA--C 1.532 0.285 0 O-C-N 123.644 0.59 . . . . 0.0 112.107 174.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 5.1 tt -124.54 98.7 5.85 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 175.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -99.44 -9.49 23.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.792 -173.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -85.03 88.97 7.5 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.731 -177.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . 0.568 ' CD ' ' HD2' ' A' ' 57' ' ' ARG . 11.0 tp10 -164.97 135.72 3.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.213 -177.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 224' ' ' GLN . . . . . 0.439 ' HB2' ' O ' ' B' ' 223' ' ' GLU . 0.0 OUTLIER 170.76 139.98 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.811 0.694 . . . . 0.0 110.588 -179.827 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 17.8 m -109.33 132.18 58.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.943 172.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . 0.549 ' O ' HG13 ' B' ' 230' ' ' ILE . 5.8 m -88.69 172.8 8.99 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.846 0.355 . . . . 0.0 111.068 -175.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . 0.546 ' HA ' HD12 ' B' ' 230' ' ' ILE . 5.5 mmtt -57.47 -32.65 67.18 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.76 -174.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -68.56 -51.5 42.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.334 -177.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -63.24 -35.52 80.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.015 -177.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.556 HG12 HD12 ' B' ' 235' ' ' LEU . 82.3 mt -57.08 -52.29 58.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.846 178.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 18.3 m -74.18 -24.32 59.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.785 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 20.0 t-160 -75.17 -48.71 22.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.34 -175.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -96.72 -3.16 43.0 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.047 -177.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm 62.92 72.27 0.49 Allowed 'General case' 0 N--CA 1.463 0.224 0 O-C-N 123.67 0.606 . . . . 0.0 111.59 176.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . 0.556 HD12 HG12 ' B' ' 230' ' ' ILE . 69.6 mt -73.35 174.4 8.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.997 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.597 HG23 ' HA ' ' B' ' 294' ' ' ALA . 69.5 t -93.11 -49.19 13.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.644 -176.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 237' ' ' LYS . . . . . 0.602 ' HA ' ' HA ' ' B' ' 291' ' ' TYR . 60.0 tttm 69.97 139.92 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 O-C-N 123.877 0.735 . . . . 0.0 111.734 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 238' ' ' VAL . . . . . 0.547 HG13 ' HB2' ' B' ' 292' ' ' ASN . 3.3 m -111.15 -50.83 6.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . -178.65 -142.08 4.64 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.011 -1.09 . . . . 0.0 113.056 -177.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 63.4 m -134.38 145.36 48.89 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 122.621 0.368 . . . . 0.0 110.716 -176.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 20.5 pt -117.91 131.59 70.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 170.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -123.05 114.44 20.38 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.06 0.457 . . . . 0.0 110.338 -175.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 243' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 82.0 t -94.0 115.19 32.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.433 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 19.2 m -110.69 87.41 2.52 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 174.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 245' ' ' GLN . . . . . 0.524 ' HB3' ' HB3' ' B' ' 284' ' ' PHE . 0.0 OUTLIER -107.55 179.61 4.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.57 0.7 . . . . 0.0 111.53 -172.451 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 33.2 t -108.63 153.31 23.58 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 166.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -58.23 -29.07 62.38 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 121.17 -0.538 . . . . 0.0 113.768 -175.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -73.49 -11.83 80.16 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 121.043 -0.599 . . . . 0.0 113.908 -174.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -94.02 -6.81 44.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 117.482 0.641 . . . . 0.0 111.158 -178.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 47.2 mm -119.73 108.09 22.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.248 -178.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 23.7 t -121.72 -47.62 2.19 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.267 0.556 . . . . 0.0 109.998 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 3.9 m -113.28 156.6 42.87 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.435 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -57.89 -30.31 89.19 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.393 2.062 . . . . 0.0 111.748 176.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 254' ' ' SER . . . . . 0.494 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 18.8 m -63.16 -33.83 76.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.15 177.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -64.62 -45.89 84.95 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.137 0.494 . . . . 0.0 110.222 -178.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 54.3 tp -66.62 -39.39 88.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.941 177.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 257' ' ' ARG . . . . . 0.433 HH11 ' CD ' ' A' ' 23' ' ' GLU . 7.5 tmm_? -58.05 -42.07 84.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.076 178.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 258' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' B' ' 254' ' ' SER . 69.7 mm-40 -57.94 -29.54 65.24 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.57 178.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -85.64 -47.95 9.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.945 0.402 . . . . 0.0 110.658 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 96.0 mt -66.1 -49.72 66.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.119 -174.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 14.6 m -66.88 -33.23 75.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.825 0.345 . . . . 0.0 110.857 -176.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -62.48 -45.68 91.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.264 0.554 . . . . 0.0 110.287 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 263' ' ' LEU . . . . . 0.624 ' O ' ' HG2' ' B' ' 267' ' ' LYS . 92.3 mt -74.39 -44.88 50.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.002 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -59.02 -48.92 79.83 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -175.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -66.87 -31.47 72.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.873 0.368 . . . . 0.0 110.547 -178.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -69.3 -19.23 63.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.9 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 267' ' ' LYS . . . . . 0.624 ' HG2' ' O ' ' B' ' 263' ' ' LEU . 74.2 mmtt -84.76 -20.48 30.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.083 0.468 . . . . 0.0 110.141 177.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 107.23 -3.94 35.29 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.548 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -90.25 153.26 22.7 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.157 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -111.98 -9.98 13.98 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -177.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 271' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -135.79 162.22 33.4 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 272' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -151.24 167.48 27.69 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.414 170.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 273' ' ' HIS . . . . . 0.468 ' CD2' ' HA ' ' B' ' 226' ' ' SER . 47.5 t-80 -135.47 108.55 7.68 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 172.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 274' ' ' ILE . . . . . 0.477 HG12 ' HB2' ' B' ' 288' ' ' ALA . 62.3 mt -65.21 130.54 30.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 29.4 pt -108.58 -21.29 5.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.658 -175.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -159.76 112.84 2.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.973 -179.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 277' ' ' ALA . . . . . 0.406 ' HB3' ' HG3' ' A' ' 29' ' ' GLU . . . -133.46 103.49 5.96 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 176.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -147.22 175.1 11.01 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.482 -171.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.19 108.47 19.11 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.17 -178.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 33.8 t-80 -90.64 69.83 6.71 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 175.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 75.67 -122.38 6.68 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 -174.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -79.71 -3.81 13.09 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.568 2.179 . . . . 0.0 112.19 175.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -94.99 140.92 29.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.419 -177.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 284' ' ' PHE . . . . . 0.524 ' HB3' ' HB3' ' B' ' 245' ' ' GLN . 71.3 t80 -113.53 110.23 19.92 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 174.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 285' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 18.2 mm-40 -105.58 110.98 23.5 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.922 -178.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 286' ' ' ALA . . . . . 0.569 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -111.95 115.13 28.45 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.981 0.42 . . . . 0.0 110.062 172.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 24.4 t -114.12 119.77 62.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.759 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 288' ' ' ALA . . . . . 0.477 ' HB2' HG12 ' B' ' 274' ' ' ILE . . . -131.5 141.64 49.8 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.866 0.365 . . . . 0.0 110.869 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -91.36 124.96 35.94 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 290' ' ' VAL . . . . . 0.451 ' HB ' HG23 ' B' ' 238' ' ' VAL . 11.2 t -89.63 123.44 41.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.028 0.442 . . . . 0.0 109.997 -176.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 291' ' ' TYR . . . . . 0.602 ' HA ' ' HA ' ' B' ' 237' ' ' LYS . 98.3 m-85 -112.3 124.22 51.99 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.905 -176.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 292' ' ' ASN . . . . . 0.547 ' HB2' HG13 ' B' ' 238' ' ' VAL . 10.6 t-20 -91.86 156.47 17.47 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 174.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -59.13 158.28 9.07 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 123.48 0.488 . . . . 0.0 110.953 -177.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 294' ' ' ALA . . . . . 0.597 ' HA ' HG23 ' B' ' 236' ' ' VAL . . . -76.96 -11.25 59.78 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -172.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 295' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' B' ' 296' ' ' LYS . 12.0 t -140.78 -28.97 0.69 Allowed 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.406 -177.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 296' ' ' LYS . . . . . 0.561 ' HE3' HG21 ' B' ' 236' ' ' VAL . 0.3 OUTLIER 71.87 150.81 0.1 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.129 0.572 . . . . 0.0 111.091 179.758 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 297' ' ' LEU . . . . . . . . . . . . . 85.1 mt 72.92 155.1 0.16 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.359 173.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 298' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 71.07 123.55 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.411 175.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 299' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -78.64 51.53 1.09 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.182 174.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 300' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -59.63 143.9 49.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.666 -173.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 301' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -126.36 -174.2 3.05 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.968 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 302' ' ' HIS . . . . . 0.598 ' HA ' ' HB2' ' A' ' 51' ' ' SER . 41.7 p-80 -60.12 164.79 3.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.388 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -68.64 130.94 44.29 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.77 177.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 20.0 p-80 . . . . . 0 C--N 1.322 -0.594 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.739 174.352 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 mpp? . . . . . 0 N--CA 1.477 0.892 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -79.37 89.71 4.99 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.108 0.48 . . . . 0.0 110.103 178.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -119.02 117.01 27.62 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.081 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -120.53 160.41 23.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.503 -178.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.432 ' N ' HD12 ' A' ' 5' ' ' ILE . 4.0 mp -87.33 129.95 37.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.467 ' H ' HG13 ' A' ' 6' ' ' ILE . 1.8 pp -71.81 144.36 13.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.111 0.481 . . . . 0.0 111.946 -178.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -174.28 144.29 0.93 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.608 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -79.15 90.69 4.88 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.142 0.496 . . . . 0.0 110.977 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -99.93 99.93 10.77 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.046 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 62.8 tp -113.65 102.95 10.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.155 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.629 HD12 ' HB3' ' B' ' 244' ' ' SER . 1.0 OUTLIER -154.38 137.47 15.57 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.338 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.494 ' N ' HD13 ' A' ' 11' ' ' LEU . . . -137.52 109.35 7.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.248 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.8 m -90.87 97.54 11.24 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.732 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.3 m -131.04 96.65 2.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.576 0.703 . . . . 0.0 111.605 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.08 61.88 0.41 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.902 176.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.446 ' HA ' ' CD ' ' B' ' 262' ' ' GLU . 22.7 t -70.98 113.04 7.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.019 -171.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -91.03 -25.15 19.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.474 172.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.1 m 60.73 32.03 20.18 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.514 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.9 m -100.39 119.77 38.96 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.064 178.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -80.73 131.34 35.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.025 -176.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.774 ' HB2' ' HB2' ' B' ' 265' ' ' ASP . . . -120.62 -66.52 1.05 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.636 177.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.477 ' HB1' ' O ' ' B' ' 223' ' ' GLU . . . -148.37 -174.17 4.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.911 -177.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.716 ' HA ' ' OH ' ' B' ' 272' ' ' TYR . 16.2 pt-20 -177.39 141.44 0.31 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.635 ' HB3' ' HG3' ' B' ' 224' ' ' GLN . 0.0 OUTLIER -179.67 151.37 0.45 Allowed 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.31 174.264 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.504 ' HB ' ' CG ' ' A' ' 29' ' ' GLU . 11.6 m -112.58 146.35 17.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.77 0.319 . . . . 0.0 110.443 178.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.9 p -89.77 -156.67 0.42 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.438 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.484 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 12.8 tmtt? -80.01 -35.95 36.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.82 0.343 . . . . 0.0 110.676 -175.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -60.0 -50.42 73.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.213 -170.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.504 ' CG ' ' HB ' ' A' ' 25' ' ' VAL . 3.2 pm0 -76.15 -29.16 57.67 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.506 -174.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.594 HG12 HD12 ' A' ' 35' ' ' LEU . 69.2 mt -61.8 -43.68 97.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.011 0.434 . . . . 0.0 109.848 177.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.4 m -73.05 -34.16 66.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.191 177.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 35.1 t-80 -80.04 -36.33 35.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.778 -172.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -103.13 -10.46 18.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.47 0.176 . . . . 0.0 111.341 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt 58.55 83.96 0.11 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.339 -177.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.594 HD12 HG12 ' A' ' 30' ' ' ILE . 92.3 mt -93.53 155.37 17.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.8 -178.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.5 t -87.77 117.91 32.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.148 -176.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -82.24 115.15 21.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.025 177.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.457 HG13 ' HB2' ' A' ' 92' ' ' ASN . 6.4 m -97.12 15.0 3.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.075 0.464 . . . . 0.0 111.279 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 128.48 -158.1 21.59 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.65 -0.785 . . . . 0.0 113.006 174.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.5 m -144.96 139.74 27.74 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -178.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.6 pt -117.82 150.3 19.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.541 ' HB2' ' HB3' ' B' ' 211' ' ' LEU . 20.5 m120 -130.79 132.71 45.43 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.164 0.507 . . . . 0.0 111.486 -175.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.612 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 73.0 t -95.09 123.82 47.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.963 172.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.2 p -151.32 75.92 1.2 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.011 0.434 . . . . 0.0 111.23 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 14.9 mp0 -111.7 156.83 21.27 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.976 0.417 . . . . 0.0 111.084 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 64.4 m -89.47 67.76 7.7 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.975 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.6 -78.18 1.03 Allowed Glycine 0 CA--C 1.521 0.428 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.801 175.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.93 51.55 3.16 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 114.86 0.704 . . . . 0.0 114.86 -169.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -137.62 1.32 2.34 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 168.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.59 HD12 ' HA ' ' A' ' 56' ' ' LEU . 49.7 mm -126.62 107.64 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.081 174.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.3 p -95.55 -29.54 14.31 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.58 -174.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.475 ' H ' ' HB3' ' A' ' 55' ' ' ASP . 16.4 m -147.83 165.88 17.37 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.847 -174.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.49 -46.4 21.18 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.207 1.938 . . . . 0.0 111.325 174.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.46 ' O ' ' HG3' ' A' ' 58' ' ' GLU . 48.4 t -59.49 -34.82 73.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.666 175.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.475 ' HB3' ' H ' ' A' ' 52' ' ' SER . 34.9 t70 -66.98 -41.0 87.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.949 0.404 . . . . 0.0 110.002 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.59 ' HA ' HD12 ' A' ' 50' ' ' ILE . 58.5 tp -59.69 -44.61 93.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.317 0.58 . . . . 0.0 109.789 173.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.39 -34.15 77.1 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.003 178.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 54' ' ' SER . 50.2 mt-10 -59.87 -45.49 92.3 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.779 -0.191 . . . . 0.0 110.577 177.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -60.92 -43.54 98.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.918 0.389 . . . . 0.0 110.821 176.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.47 -48.18 76.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.52 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.498 ' HB3' ' O ' ' B' ' 222' ' ' ALA . 18.8 p -70.29 -33.08 71.14 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.075 -176.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -60.95 -48.74 80.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.561 177.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.405 HD11 HG22 ' B' ' 213' ' ' THR . 95.8 mt -65.46 -35.09 79.88 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.613 178.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.16 -41.99 80.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.863 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -62.13 -38.15 87.84 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.577 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.28 -39.02 85.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.923 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.4 mmtp -74.64 -29.38 61.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.001 0.429 . . . . 0.0 110.74 176.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.31 26.77 11.64 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.759 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -101.03 147.56 17.86 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.131 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 67.6 mttt -93.18 -4.16 52.59 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.825 0.345 . . . . 0.0 111.501 -172.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.768 ' CE1' ' HB2' ' A' ' 91' ' ' TYR . 22.3 p90 -165.32 164.6 19.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.486 -177.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.435 ' O ' ' HG3' ' A' ' 24' ' ' GLN . 25.3 p90 -131.78 133.06 44.33 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.508 -178.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.423 ' HB3' ' HB2' ' A' ' 89' ' ' GLU . 17.0 t-80 -100.22 102.5 13.8 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.494 -175.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.516 ' H ' HD12 ' A' ' 74' ' ' ILE . 5.3 mp -72.3 122.94 25.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 30.7 pt -111.49 -24.02 4.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.089 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -155.72 125.19 6.32 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.001 0.429 . . . . 0.0 111.202 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.16 119.68 23.36 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 175.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -139.62 155.1 47.63 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.463 0.649 . . . . 0.0 111.973 -171.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -110.54 112.11 23.8 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.538 177.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -78.12 -27.01 48.21 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 123.28 -85.16 0.37 Allowed Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -176.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.91 -20.42 29.42 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.456 2.104 . . . . 0.0 111.474 173.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -123.12 145.7 48.36 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.825 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -102.88 124.85 49.17 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 170.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.562 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 51.6 mt-10 -123.28 115.91 22.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.062 0.458 . . . . 0.0 111.099 -171.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.612 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -127.85 134.37 49.41 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.042 179.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.416 HG22 HD22 ' A' ' 42' ' ' ASN . 24.8 t -114.36 116.27 52.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.155 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -131.65 137.79 48.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.089 0.471 . . . . 0.0 111.087 -178.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.423 ' HB2' ' HB3' ' A' ' 73' ' ' HIS . 30.0 mt-10 -91.48 150.61 21.15 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 17.6 t -113.06 130.64 66.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 177.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.768 ' HB2' ' CE1' ' A' ' 71' ' ' TYR . 52.3 m-85 -121.21 147.71 45.25 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.128 0.489 . . . . 0.0 110.107 177.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.457 ' HB2' HG13 ' A' ' 38' ' ' VAL . 1.5 t-20 -95.35 18.73 11.94 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.583 -168.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 45.2 t0 59.88 23.02 12.03 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.672 0.749 . . . . 0.0 110.299 -178.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 64.07 11.04 5.86 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.426 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.4 t -126.53 120.16 28.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.792 0.806 . . . . 0.0 111.222 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.432 ' NZ ' ' HB2' ' A' ' 96' ' ' LYS . 3.5 ttmp? -111.38 11.99 21.55 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.87 -178.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 35.4 mt -87.71 9.38 21.75 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.649 -170.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -99.39 -49.57 4.4 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.343 0.592 . . . . 0.0 110.166 176.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 12.6 p-80 -131.44 138.17 48.94 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.056 -177.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -129.83 -168.69 1.99 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.483 -169.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 65.31 64.09 0.62 Allowed 'General case' 0 N--CA 1.465 0.301 0 O-C-N 123.93 0.769 . . . . 0.0 110.89 -176.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.5 m170 -156.7 133.09 9.94 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.558 173.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -78.77 -77.11 0.18 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.313 178.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 69.4 m-70 . . . . . 0 C--N 1.324 -0.514 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.48 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 4.6 mpp? . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 121.095 0.474 . . . . 0.0 110.475 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -162.0 117.17 1.95 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.394 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -79.79 86.53 5.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.99 0.424 . . . . 0.0 111.826 -174.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -155.6 101.97 2.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.501 172.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 41.4 pt -85.84 -5.48 9.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.603 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 53.6 mt -79.61 83.97 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.378 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -146.99 23.21 1.21 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.816 176.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -81.24 90.42 6.1 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.692 -173.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -89.02 129.14 35.71 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 169.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 210' ' ' LEU . . . . . . . . . . . . . 83.6 mt -104.77 126.27 51.68 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.152 0.501 . . . . 0.0 111.615 -174.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . 0.541 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 58.2 tp -142.66 119.75 11.41 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.224 176.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.53 131.29 45.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.358 -177.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 213' ' ' THR . . . . . 0.405 HG22 HD11 ' A' ' 63' ' ' LEU . 19.0 p -81.35 97.44 7.71 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.241 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 214' ' ' VAL . . . . . . . . . . . . . 3.7 m -78.18 78.41 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.566 0.698 . . . . 0.0 110.001 175.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -66.02 144.58 56.65 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.549 -172.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 216' ' ' SER . . . . . 0.411 ' O ' ' HB3' ' B' ' 217' ' ' PHE . 17.6 m -138.22 -100.52 0.18 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.25 175.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 217' ' ' PHE . . . . . 0.411 ' HB3' ' O ' ' B' ' 216' ' ' SER . 31.0 p90 176.06 128.47 0.04 OUTLIER 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 173.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 218' ' ' SER . . . . . . . . . . . . . 67.5 m -143.27 174.2 10.93 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.823 0.344 . . . . 0.0 110.999 -177.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 3.5 p -77.35 157.33 30.72 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.115 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.445 ' O ' HD12 ' B' ' 220' ' ' LEU . 1.6 pp -70.89 109.6 5.13 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.359 0.6 . . . . 0.0 110.025 177.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -116.64 -7.22 11.58 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.333 -178.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . 0.498 ' O ' ' HB3' ' A' ' 61' ' ' SER . . . -165.94 149.06 7.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.29 -177.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . 0.477 ' O ' ' HB1' ' A' ' 22' ' ' ALA . 7.2 pt-20 -168.54 122.69 0.89 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.062 0.458 . . . . 0.0 111.513 178.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 224' ' ' GLN . . . . . 0.635 ' HG3' ' HB3' ' A' ' 24' ' ' GLN . 0.7 OUTLIER -171.07 154.24 4.02 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.352 179.615 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 23.8 m -131.94 130.69 61.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.71 0.29 . . . . 0.0 111.032 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . 0.669 ' HA ' ' HD2' ' B' ' 273' ' ' HIS . 77.3 p -88.87 179.8 6.12 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.45 -28.72 70.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.441 0.162 . . . . 0.0 111.312 -172.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -64.28 -50.65 67.08 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -61.65 -46.14 91.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.317 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.459 HG12 HD12 ' B' ' 235' ' ' LEU . 90.9 mt -55.8 -48.82 77.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.273 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 14.7 m -73.25 -35.11 66.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.88 0.371 . . . . 0.0 111.433 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -77.95 -33.53 51.53 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.37 -174.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -99.05 -9.41 23.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.399 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt 58.64 70.75 0.63 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.263 0.554 . . . . 0.0 110.691 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . 0.459 HD12 HG12 ' B' ' 230' ' ' ILE . 74.0 mt -82.99 -177.94 6.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.946 -175.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.59 HG23 ' HA ' ' B' ' 294' ' ' ALA . 57.0 t -105.88 123.65 60.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.599 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -86.89 123.34 31.91 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 177.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 18.9 t -96.09 -38.82 8.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.444 -173.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 165.74 154.04 7.95 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.168 -1.015 . . . . 0.0 112.582 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . 0.528 HG23 ' HG2' ' B' ' 289' ' ' GLU . 17.9 m -92.01 136.62 33.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.549 0.214 . . . . 0.0 110.542 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 36.5 pt -120.17 168.44 12.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.008 0.432 . . . . 0.0 110.949 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -144.72 133.13 21.9 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.19 174.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 243' ' ' VAL . . . . . 0.54 HG22 HD12 ' B' ' 263' ' ' LEU . 43.9 t -104.49 108.53 25.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.16 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 244' ' ' SER . . . . . 0.629 ' HB3' HD12 ' A' ' 11' ' ' LEU . 8.2 t -139.36 106.79 5.54 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.113 0.482 . . . . 0.0 110.115 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 245' ' ' GLN . . . . . 0.543 ' HB3' ' OE1' ' B' ' 249' ' ' GLN . 1.0 OUTLIER -132.1 -177.25 4.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.327 178.306 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 246' ' ' SER . . . . . 0.448 ' HB3' ' HG3' ' B' ' 249' ' ' GLN . 47.4 t -72.42 150.71 43.12 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.655 173.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -65.1 -16.26 61.86 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.727 177.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -77.56 -16.2 80.52 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.14 175.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . 0.543 ' OE1' ' HB3' ' B' ' 245' ' ' GLN . 38.9 mt-30 -92.03 -45.16 8.46 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 50.3 mm -97.33 93.22 3.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.814 0.816 . . . . 0.0 109.842 175.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 20.1 m -118.68 -15.7 9.47 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.049 -176.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 19.9 m -127.72 142.7 45.04 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.75 -39.64 80.18 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.536 2.157 . . . . 0.0 111.828 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 254' ' ' SER . . . . . 0.436 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 4.7 m -62.47 -29.85 70.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.17 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -74.84 -34.78 62.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.004 0.431 . . . . 0.0 110.632 -176.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.433 ' O ' ' HG ' ' B' ' 260' ' ' LEU . 66.1 tp -61.86 -42.5 99.13 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.953 176.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -58.4 -35.56 72.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.981 178.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 258' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' B' ' 254' ' ' SER . 25.1 mm-40 -57.98 -50.87 71.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.333 177.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -66.87 -39.38 87.51 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.337 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 260' ' ' LEU . . . . . 0.503 ' HB3' ' CZ ' ' B' ' 272' ' ' TYR . 97.6 mt -58.11 -45.9 86.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.082 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 22.9 t -66.06 -44.16 85.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.298 0.571 . . . . 0.0 110.27 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 262' ' ' GLU . . . . . 0.446 ' CD ' ' HA ' ' A' ' 16' ' ' SER . 39.1 tt0 -58.43 -42.78 88.05 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.642 -177.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 263' ' ' LEU . . . . . 0.54 HD12 HG22 ' B' ' 243' ' ' VAL . 83.7 mt -73.09 -30.33 63.58 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.866 -178.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -65.88 -50.98 62.55 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.717 0.294 . . . . 0.0 110.915 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 265' ' ' ASP . . . . . 0.774 ' HB2' ' HB2' ' A' ' 21' ' ' ALA . 16.0 t70 -59.86 -38.1 81.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.949 0.404 . . . . 0.0 110.777 176.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -64.21 -22.31 66.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.496 -178.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 267' ' ' LYS . . . . . 0.41 ' HD3' ' HA ' ' B' ' 267' ' ' LYS . 63.3 mmtt -87.48 -14.61 39.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.504 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 90.95 19.39 43.35 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.423 -175.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -117.63 -166.12 13.84 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 50.4 mttp -130.19 -66.51 0.77 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.722 0.296 . . . . 0.0 110.533 -178.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 271' ' ' TYR . . . . . 0.528 ' HB3' ' HA ' ' B' ' 224' ' ' GLN . 5.7 m-85 -90.56 153.65 20.19 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -175.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 272' ' ' TYR . . . . . 0.716 ' OH ' ' HA ' ' A' ' 23' ' ' GLU . 27.5 p90 -132.85 129.42 38.42 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.264 0.554 . . . . 0.0 110.759 178.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 273' ' ' HIS . . . . . 0.669 ' HD2' ' HA ' ' B' ' 226' ' ' SER . 55.9 t-80 -101.87 103.19 13.86 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.845 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 274' ' ' ILE . . . . . . . . . . . . . 59.1 mt -67.5 135.7 28.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.408 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 17.8 pt -115.52 -26.51 2.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -157.21 136.96 12.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.532 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -148.11 129.37 14.69 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.512 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.72 173.61 14.41 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.5 149.73 40.81 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.955 0.407 . . . . 0.0 110.318 171.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -95.51 -0.8 51.77 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.657 -178.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 113.86 -90.5 0.54 Allowed Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.323 -174.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.59 -14.62 22.14 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.852 2.368 . . . . 0.0 112.166 177.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -135.03 156.52 48.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.976 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 284' ' ' PHE . . . . . 0.564 ' O ' ' HA ' ' B' ' 244' ' ' SER . 82.7 t80 -110.83 145.63 37.85 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 285' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -138.67 110.1 6.99 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.924 0.393 . . . . 0.0 111.497 -177.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 286' ' ' ALA . . . . . 0.493 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -125.16 145.03 50.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.75 175.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 88.3 t -127.56 131.76 69.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.912 0.387 . . . . 0.0 110.347 177.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -142.57 156.28 45.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.246 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 289' ' ' GLU . . . . . 0.528 ' HG2' HG23 ' B' ' 240' ' ' THR . 35.5 mt-10 -112.76 128.28 56.38 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 58.4 t -89.02 131.42 36.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.943 0.402 . . . . 0.0 110.979 -176.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -125.23 159.7 30.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.284 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 292' ' ' ASN . . . . . 0.487 ' ND2' ' HA ' ' B' ' 296' ' ' LYS . 10.9 t-20 -118.52 161.79 19.44 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 293' ' ' ASP . . . . . 0.568 ' HB3' HG22 ' B' ' 295' ' ' THR . 4.6 t70 -76.69 21.98 0.19 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -170.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 294' ' ' ALA . . . . . 0.59 ' HA ' HG23 ' B' ' 236' ' ' VAL . . . 68.56 -8.88 0.58 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.53 0.732 . . . . 0.0 112.108 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 295' ' ' THR . . . . . 0.568 HG22 ' HB3' ' B' ' 293' ' ' ASP . 15.0 t -93.93 -22.27 18.7 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.249 175.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 296' ' ' LYS . . . . . 0.487 ' HA ' ' ND2' ' B' ' 292' ' ' ASN . 28.9 mtpp 71.04 -61.34 0.48 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 114.844 -1.071 . . . . 0.0 112.189 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 297' ' ' LEU . . . . . . . . . . . . . 48.2 mt -63.91 176.43 0.95 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.842 -174.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 298' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -76.01 78.68 2.87 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -171.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 299' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -83.22 61.27 6.01 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 166.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 300' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -152.82 18.29 0.59 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.359 -1.291 . . . . 0.0 107.847 -173.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 301' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -74.69 93.64 2.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.504 -1.225 . . . . 0.0 111.72 -171.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 302' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -154.43 109.77 3.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.37 172.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -86.36 -39.0 16.87 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -178.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 36.4 m80 . . . . . 0 C--N 1.326 -0.441 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 172.769 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 120.797 0.332 . . . . 0.0 110.765 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -164.08 166.11 21.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.346 175.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -97.35 105.98 18.22 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 65.4 mtm180 -101.71 161.72 13.44 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.271 -177.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.1 pt -123.56 155.7 30.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.314 178.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.1 pt -88.07 162.04 2.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.12 -179.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -147.52 153.37 39.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.949 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -133.22 151.88 51.94 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.546 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.07 98.95 3.56 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.578 178.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 60.2 tp -72.37 105.44 4.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.079 177.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.444 ' H ' ' HG ' ' A' ' 11' ' ' LEU . 0.3 OUTLIER -72.07 95.05 1.57 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.77 -177.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.31 72.17 10.74 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.255 177.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.2 t -151.92 153.19 33.63 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.384 -178.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 52.6 t -103.59 114.72 43.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.005 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.33 107.05 0.84 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.277 177.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.8 m -84.94 93.21 8.5 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.254 -174.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -82.05 155.37 25.15 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.116 176.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.1 m -155.31 157.41 37.15 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.653 0.263 . . . . 0.0 110.877 -174.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.8 m -68.05 93.52 0.44 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.968 0.413 . . . . 0.0 110.705 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 77.0 mt -142.38 23.62 1.98 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.52 178.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -169.69 -49.03 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.288 -178.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.496 ' HB3' ' HA ' ' B' ' 261' ' ' SER . . . -73.03 100.13 2.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.859 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -151.72 179.41 8.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.612 -176.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.615 ' HB2' ' HB2' ' B' ' 224' ' ' GLN . 0.0 OUTLIER 81.79 167.78 0.13 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.791 0.836 . . . . 0.0 111.765 171.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.424 HG12 ' CZ ' ' B' ' 257' ' ' ARG . 31.0 m -126.4 171.97 14.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.47 -178.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.545 ' HB2' ' HB ' ' B' ' 274' ' ' ILE . 10.8 t -112.66 -149.73 0.45 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.524 ' HA ' HD12 ' A' ' 30' ' ' ILE . 18.2 ttpt -97.86 -17.15 19.46 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 122.088 -0.382 . . . . 0.0 110.44 178.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -62.95 -42.53 99.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.951 -176.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.655 ' HG2' HH22 ' B' ' 257' ' ' ARG . 3.4 mp0 -68.83 -31.18 69.97 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.495 178.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.524 HD12 ' HA ' ' A' ' 27' ' ' LYS . 62.7 mt -64.68 -51.29 69.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.443 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.8 m -69.44 -27.87 65.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.407 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 22.2 m170 -84.1 -58.11 2.91 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.979 0.362 . . . . 0.0 111.979 -178.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -99.17 -11.75 21.08 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -169.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.423 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 3.8 mppt? 60.12 84.56 0.12 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.233 0.54 . . . . 0.0 110.799 -177.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 90.4 mt -73.81 151.44 40.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.031 -177.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 63.1 t -91.22 108.86 20.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.025 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -83.61 130.48 34.98 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.208 0.528 . . . . 0.0 110.836 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.483 HG13 ' HB2' ' A' ' 92' ' ' ASN . 6.4 m -92.03 -20.94 6.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.847 178.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.27 171.27 22.39 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.608 178.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 35.0 m -106.43 129.57 54.38 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.8 pt -102.92 151.46 6.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -128.49 123.77 34.43 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.095 0.474 . . . . 0.0 110.663 -171.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.753 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 57.3 t -93.54 109.05 21.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 174.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.6 t -141.38 78.71 1.65 Allowed 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.422 HE22 HG13 ' A' ' 43' ' ' VAL . 0.9 OUTLIER -106.7 138.52 42.73 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.984 -177.481 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.0 m -83.66 94.15 8.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.865 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.89 -169.72 13.06 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.521 178.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.28 55.64 4.36 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.412 -0.423 . . . . 0.0 113.383 -176.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -75.94 -21.23 57.26 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.406 0.622 . . . . 0.0 109.421 173.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.1 mm -119.46 98.63 6.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.148 -0.933 . . . . 0.0 108.65 172.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 77.2 p -111.56 -40.93 4.21 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.229 -173.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.401 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 12.6 m -119.54 161.72 36.08 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.65 -177.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 52' ' ' SER . 9.3 Cg_endo -53.38 -29.47 48.36 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.728 2.285 . . . . 0.0 111.78 176.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.542 ' HA ' ' NE ' ' A' ' 57' ' ' ARG . 23.7 m -59.04 -38.92 80.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.621 177.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.476 ' O ' ' HD3' ' A' ' 59' ' ' LYS . 59.5 m-20 -63.54 -53.23 55.07 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -174.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 23.1 tp -54.92 -49.71 70.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.258 -173.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.542 ' NE ' ' HA ' ' A' ' 54' ' ' SER . 25.7 ptt180 -63.34 -42.68 98.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.355 -178.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 54' ' ' SER . 43.3 mt-10 -69.54 -46.89 65.42 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.672 0.272 . . . . 0.0 111.161 -176.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.476 ' HD3' ' O ' ' A' ' 55' ' ' ASP . 14.5 mptt -59.77 -45.86 90.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.527 178.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.541 HD21 ' CG2' ' A' ' 43' ' ' VAL . 79.7 mt -75.04 -30.82 61.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.146 -175.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.7 m -60.48 -41.43 94.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.023 0.439 . . . . 0.0 110.312 174.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -63.66 -46.94 83.31 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.402 177.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 88.6 mt -69.5 -48.48 60.49 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.862 -177.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.2 -50.93 68.35 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -174.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.578 ' OD2' ' HA ' ' B' ' 218' ' ' SER . 23.9 t70 -63.88 -37.36 87.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.909 0.385 . . . . 0.0 111.004 -176.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.95 -19.34 62.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.439 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 67' ' ' LYS . 70.3 mmtt -85.04 -5.73 59.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.955 0.407 . . . . 0.0 110.866 177.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.906 ' HA2' ' HA ' ' B' ' 216' ' ' SER . . . 106.97 -28.45 13.04 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.351 177.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.61 ' HA3' HG12 ' A' ' 90' ' ' VAL . . . -79.84 179.42 53.2 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.911 -0.662 . . . . 0.0 111.789 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.639 ' NZ ' ' HA ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -112.43 -72.85 0.69 Allowed 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.162 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.593 ' HB2' ' HA ' ' A' ' 24' ' ' GLN . 0.6 OUTLIER -96.5 155.65 16.68 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.845 -176.349 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.784 ' CD1' ' HB1' ' B' ' 222' ' ' ALA . 3.9 p90 -109.34 170.94 7.74 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.259 -177.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 23.6 t-80 -141.0 103.38 4.46 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.491 ' H ' HD12 ' A' ' 74' ' ' ILE . 2.9 mp -65.12 132.01 30.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.029 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 32.1 pt -133.02 -5.76 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.686 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.431 ' HB3' ' HB ' ' A' ' 87' ' ' VAL . . . -165.92 144.73 5.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.739 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -158.56 137.9 11.64 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 177.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -166.15 141.15 4.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.945 0.402 . . . . 0.0 111.363 -178.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -77.93 96.19 4.97 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 170.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -90.44 77.5 6.52 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.677 -177.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.1 -120.42 13.68 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -175.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -86.33 -0.68 8.34 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.518 2.145 . . . . 0.0 111.869 176.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -107.96 110.41 22.13 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.57 -176.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -79.44 104.33 9.98 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 173.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.753 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 23.3 mt-10 -104.06 123.14 46.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.191 0.519 . . . . 0.0 111.484 -175.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.522 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -130.82 126.84 37.33 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.856 176.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.431 ' HB ' ' HB3' ' A' ' 76' ' ' ALA . 41.9 t -105.62 121.53 57.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.428 -176.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.47 135.95 32.49 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.794 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 40' ' ' THR . 29.3 mt-10 -96.35 150.17 20.88 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.61 HG12 ' HA3' ' A' ' 69' ' ' GLY . 8.2 t -110.56 133.59 55.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 -179.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.495 ' HB2' ' HE1' ' A' ' 71' ' ' TYR . 54.1 m-85 -116.77 151.1 37.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.25 0.547 . . . . 0.0 110.889 -178.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.483 ' HB2' HG13 ' A' ' 38' ' ' VAL . 8.2 t-20 -106.13 21.96 16.49 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.926 -177.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.403 ' HA ' ' OH ' ' A' ' 71' ' ' TYR . 6.2 t70 66.11 -155.03 0.25 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.174 -175.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -115.34 10.88 15.97 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.069 0.462 . . . . 0.0 110.076 177.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.6 t -159.33 172.73 17.45 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.94 -178.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -109.91 160.77 16.1 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.828 0.347 . . . . 0.0 110.216 178.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.414 ' H ' ' HG ' ' A' ' 97' ' ' LEU . 2.9 pp -68.15 150.23 48.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.057 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.04 -168.34 2.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.643 -178.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 61.8 m80 -96.09 90.92 5.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.093 0.473 . . . . 0.0 111.766 -174.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.84 104.25 11.23 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 170.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 28.5 m170 -65.71 112.21 3.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.072 -172.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 38.7 p-80 -155.12 134.15 12.26 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.449 176.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 70.0 m-70 -92.16 -19.77 21.91 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.26 173.777 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 4.2 mpp? . . . . . 0 N--CA 1.483 1.205 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 60.6 tptt -80.3 96.78 6.74 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.166 177.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt 68.02 165.26 0.23 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.143 -179.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 74.0 mtm180 -117.0 88.79 2.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.966 0.413 . . . . 0.0 110.481 176.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 59.4 mt -119.32 96.07 4.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.794 177.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 42.8 mt -102.17 93.68 2.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.733 -178.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -107.09 86.03 2.24 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.164 177.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -148.2 37.94 0.87 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.419 -176.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -75.63 77.57 2.62 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.794 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 210' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -162.86 131.94 4.13 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 2.2 pp -132.79 161.83 33.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.566 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -129.5 -54.25 1.17 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.072 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 213' ' ' THR . . . . . . . . . . . . . 3.0 m 60.65 75.59 0.4 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.906 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 214' ' ' VAL . . . . . 0.576 HG13 ' H ' ' B' ' 215' ' ' ALA . 3.4 p -84.29 -62.47 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.803 -176.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . 0.576 ' H ' HG13 ' B' ' 214' ' ' VAL . . . -158.2 174.35 15.32 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -178.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 216' ' ' SER . . . . . 0.906 ' HA ' ' HA2' ' A' ' 68' ' ' GLY . 4.5 p -125.35 128.38 48.09 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.896 0.379 . . . . 0.0 111.019 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -137.86 133.83 34.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.916 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 218' ' ' SER . . . . . 0.578 ' HA ' ' OD2' ' A' ' 65' ' ' ASP . 16.4 m -77.59 115.99 17.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.133 -177.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 219' ' ' THR . . . . . 0.649 HG22 ' H ' ' B' ' 220' ' ' LEU . 1.3 m -150.03 -152.86 0.46 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.649 ' H ' HG22 ' B' ' 219' ' ' THR . 89.4 mt -59.2 141.05 55.24 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 173.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -113.03 -112.84 0.34 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -169.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . 0.784 ' HB1' ' CD1' ' A' ' 72' ' ' TYR . . . -129.8 106.15 8.49 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -164.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . 0.831 ' HB3' ' HE1' ' B' ' 271' ' ' TYR . 30.0 mt-10 -143.98 105.63 4.3 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 224' ' ' GLN . . . . . 0.615 ' HB2' ' HB2' ' A' ' 24' ' ' GLN . 0.0 OUTLIER 173.56 179.87 0.09 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.298 0.639 . . . . 0.0 109.287 172.273 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . 0.546 HG11 HD11 ' B' ' 235' ' ' LEU . 15.8 m -138.84 157.86 29.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 120.622 0.248 . . . . 0.0 110.774 178.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . 0.516 ' HA ' ' CD2' ' B' ' 273' ' ' HIS . 81.2 p -110.2 -92.88 0.44 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.072 178.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . 0.489 ' C ' ' HD3' ' B' ' 227' ' ' LYS . 8.1 tmtm? -133.42 -52.99 0.89 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.813 0.34 . . . . 0.0 110.959 -176.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 228' ' ' GLN . . . . . 0.503 ' NE2' ' H ' ' B' ' 228' ' ' GLN . 1.9 mp0 -59.96 -45.43 92.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.278 -172.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 229' ' ' GLU . . . . . 0.604 ' H ' ' CD ' ' B' ' 229' ' ' GLU . 2.0 mp0 -60.58 -45.12 95.14 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.991 -177.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.552 HG12 HD12 ' B' ' 235' ' ' LEU . 49.1 mt -60.72 -49.77 83.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.119 -176.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 25.4 m -67.21 -21.26 65.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.465 -177.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -94.21 -44.07 8.15 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.597 -174.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -92.34 -8.73 44.21 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -175.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 10.6 mmmm 63.03 75.62 0.39 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.088 0.471 . . . . 0.0 111.042 176.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . 0.552 HD12 HG12 ' B' ' 230' ' ' ILE . 68.6 mt -83.77 161.68 20.9 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.293 0.568 . . . . 0.0 111.574 -177.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 65.2 t -95.63 129.18 46.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.348 176.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 237' ' ' LYS . . . . . 0.42 ' HE3' ' HB3' ' B' ' 289' ' ' GLU . 85.4 tttt -102.32 146.07 28.57 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -179.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 238' ' ' VAL . . . . . 0.55 HG13 ' HB2' ' B' ' 292' ' ' ASN . 2.5 m -127.4 9.36 3.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 239' ' ' GLY . . . . . 0.401 ' H ' ' HG2' ' B' ' 237' ' ' LYS . . . 133.62 -161.92 24.32 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 119.942 -1.123 . . . . 0.0 113.191 174.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' B' ' 289' ' ' GLU . 29.2 m -140.18 133.35 29.63 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 33.3 pt -109.49 147.37 13.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.214 0.531 . . . . 0.0 111.031 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -112.82 118.06 33.89 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.25 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 243' ' ' VAL . . . . . 0.674 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 22.1 t -93.83 113.46 28.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 176.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 244' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' B' ' 284' ' ' PHE . 47.7 t -125.38 100.97 6.74 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.72 0.295 . . . . 0.0 110.228 -176.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 245' ' ' GLN . . . . . 0.587 ' HG3' HG12 ' B' ' 250' ' ' ILE . 9.2 mm-40 -90.63 -175.94 4.57 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.611 0.72 . . . . 0.0 111.453 -177.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 68.6 m -143.49 113.45 7.18 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.699 176.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 66.3 -118.85 11.6 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.135 177.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -98.3 42.2 2.11 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.181 -0.533 . . . . 0.0 113.49 -172.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . 0.884 HE21 ' HA ' ' B' ' 249' ' ' GLN . 0.0 OUTLIER -77.78 -22.19 50.56 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 173.687 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 250' ' ' ILE . . . . . 0.587 HG12 ' HG3' ' B' ' 245' ' ' GLN . 43.8 mm -121.51 96.36 4.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.34 175.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 39.4 t -96.64 -24.31 16.06 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.321 0.581 . . . . 0.0 109.583 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 73.8 p -138.23 162.85 51.4 Favored Pre-proline 0 N--CA 1.447 -0.625 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.65 -179.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.93 -22.59 74.61 Favored 'Trans proline' 0 C--O 1.238 0.482 0 C-N-CA 122.019 1.813 . . . . 0.0 111.263 173.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 254' ' ' SER . . . . . . . . . . . . . 2.3 m -66.09 -42.79 88.83 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.566 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.467 ' O ' ' HG2' ' B' ' 259' ' ' LYS . 30.1 m-20 -54.92 -39.01 68.37 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.013 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.429 ' O ' ' HG ' ' B' ' 260' ' ' LEU . 45.2 tp -58.83 -42.58 89.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.848 -178.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 257' ' ' ARG . . . . . 0.655 HH22 ' HG2' ' A' ' 29' ' ' GLU . 0.1 OUTLIER -67.92 -31.37 71.1 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.154 0.502 . . . . 0.0 110.028 -179.161 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 258' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' B' ' 255' ' ' ASP . 52.7 mm-40 -61.18 -41.45 96.83 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.424 178.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 259' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' B' ' 255' ' ' ASP . 16.0 mmmt -77.15 -42.04 39.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.766 -179.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 260' ' ' LEU . . . . . 0.455 HD13 ' CE2' ' B' ' 272' ' ' TYR . 97.3 mt -60.33 -42.96 96.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.768 -177.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 261' ' ' SER . . . . . 0.496 ' HA ' ' HB3' ' A' ' 22' ' ' ALA . 67.8 m -58.32 -48.97 78.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.955 0.407 . . . . 0.0 110.988 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -64.33 -41.89 96.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.023 -177.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 263' ' ' LEU . . . . . 0.459 ' O ' ' HG2' ' B' ' 267' ' ' LYS . 94.0 mt -74.12 -51.04 16.88 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -176.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -66.99 -48.14 69.36 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -172.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -67.09 -32.37 73.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.944 0.402 . . . . 0.0 110.62 -174.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -82.68 -9.91 59.16 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.245 -177.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 267' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' B' ' 263' ' ' LEU . 67.6 mmtt -87.48 -2.41 58.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.677 0.275 . . . . 0.0 111.279 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 91.98 7.85 63.88 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.031 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -108.75 -174.45 21.53 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 176.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . 0.652 ' HE2' ' HA ' ' B' ' 270' ' ' LYS . 8.4 mmpt? -127.41 -62.91 1.07 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.942 0.401 . . . . 0.0 110.876 -178.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 271' ' ' TYR . . . . . 0.831 ' HE1' ' HB3' ' B' ' 223' ' ' GLU . 90.1 m-85 -102.43 173.33 6.4 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.125 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 272' ' ' TYR . . . . . 0.455 ' CE2' HD13 ' B' ' 260' ' ' LEU . 17.6 p90 -149.87 169.4 21.21 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.519 -178.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 273' ' ' HIS . . . . . 0.516 ' CD2' ' HA ' ' B' ' 226' ' ' SER . 11.2 t-160 -139.63 110.01 6.59 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.813 0.34 . . . . 0.0 110.622 174.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 274' ' ' ILE . . . . . 0.545 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 47.6 mt -70.69 113.19 6.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.063 175.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 25.2 pt -100.04 -23.56 4.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.814 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -160.52 146.6 15.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.358 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 277' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' B' ' 285' ' ' GLU . . . -157.03 111.03 2.66 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 177.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 278' ' ' ARG . . . . . 0.442 ' H ' ' HD2' ' B' ' 278' ' ' ARG . 0.0 OUTLIER -129.31 150.46 50.67 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.651 -174.818 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -84.81 95.8 9.09 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 172.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 17.3 t-80 -91.61 84.85 5.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.055 0.455 . . . . 0.0 109.932 -177.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 66.76 -125.48 25.61 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.386 -175.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -85.15 -8.56 8.83 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.598 2.199 . . . . 0.0 111.965 175.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 283' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' B' ' 245' ' ' GLN . 15.1 m120 -103.81 109.98 21.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.676 -177.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 284' ' ' PHE . . . . . 0.51 ' HB3' ' HB2' ' B' ' 245' ' ' GLN . 78.3 t80 -78.76 120.02 22.81 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 175.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 285' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' B' ' 277' ' ' ALA . 97.2 mt-10 -108.72 110.92 22.45 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.41 0.444 . . . . 0.0 111.155 -176.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 286' ' ' ALA . . . . . 0.674 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -111.53 123.14 49.61 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 172.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 28.5 t -105.12 113.31 41.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.312 -178.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -130.84 128.81 41.4 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.678 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 289' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' B' ' 240' ' ' THR . 17.2 mt-10 -92.38 135.46 34.02 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 23.6 t -97.67 137.84 24.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.142 0.496 . . . . 0.0 111.496 -170.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -118.3 149.5 41.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.159 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 292' ' ' ASN . . . . . 0.56 ' OD1' ' HG2' ' B' ' 296' ' ' LYS . 8.0 t-20 -95.37 21.95 7.48 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.881 -171.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 293' ' ' ASP . . . . . 0.455 ' HB3' ' O ' ' B' ' 292' ' ' ASN . 10.8 t70 78.36 -28.92 0.16 Allowed 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.562 172.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 294' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' B' ' 293' ' ' ASP . . . 82.36 -9.4 1.17 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.507 1.123 . . . . 0.0 111.085 -178.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 295' ' ' THR . . . . . . . . . . . . . 8.9 m -107.25 -21.76 12.84 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.455 174.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 296' ' ' LYS . . . . . 0.56 ' HG2' ' OD1' ' B' ' 292' ' ' ASN . 68.2 mttm 69.79 -80.98 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.335 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 297' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -175.84 -168.79 0.3 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.744 -175.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 298' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.34 111.63 5.36 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 176.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 299' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -142.41 48.23 1.56 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.369 0.604 . . . . 0.0 110.276 -176.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 300' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -53.39 128.88 30.17 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.373 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 301' ' ' HIS . . . . . . . . . . . . . 20.5 m80 61.39 86.35 0.11 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.943 177.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 302' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -140.43 94.91 2.79 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -81.22 -49.08 11.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.539 -177.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 78.9 t60 . . . . . 0 C--N 1.325 -0.483 0 C-N-CA 120.605 -0.438 . . . . 0.0 109.85 177.479 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -78.33 146.97 34.41 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -152.82 154.09 34.44 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.269 -174.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 10.9 ptp85 -138.11 150.73 47.12 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 177.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.7 tt -99.58 113.7 35.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.371 0.605 . . . . 0.0 110.425 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 34.6 pt -117.68 140.06 42.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.033 -177.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -128.61 100.05 5.6 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.76 175.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.9 -71.66 0.18 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.445 -176.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -138.36 132.64 31.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.078 -178.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.789 ' H ' HD23 ' A' ' 10' ' ' LEU . 1.6 pt? -100.46 95.98 7.09 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.261 0.553 . . . . 0.0 110.45 178.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.7 mt -133.63 118.57 18.36 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.499 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.55 103.23 6.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.07 0.462 . . . . 0.0 109.824 176.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.8 t -70.26 -21.96 62.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.432 -176.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.0 t 62.46 82.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.094 0 CA-C-O 121.543 0.687 . . . . 0.0 109.865 -175.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -122.42 76.79 1.35 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.885 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.3 m -86.13 111.58 20.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.257 -175.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -140.37 -60.96 0.52 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.06 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.9 p -166.11 126.34 1.71 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.627 -178.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.765 HG23 ' HB2' ' B' ' 265' ' ' ASP . 0.1 OUTLIER -78.16 42.99 0.42 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -176.266 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.403 HD23 HD13 ' B' ' 220' ' ' LEU . 96.3 mt -78.23 73.15 4.79 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 176.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 173.96 -28.56 0.0 OUTLIER 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.829 -174.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.63 112.71 18.3 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -170.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 178.95 104.65 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.584 178.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.622 ' HB2' ' HB3' ' B' ' 224' ' ' GLN . 0.0 OUTLIER -162.14 155.64 20.87 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 122.052 -0.405 . . . . 0.0 110.873 -179.341 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.8 m -115.75 143.93 24.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.966 174.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.634 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 11.8 t -108.05 -90.45 0.44 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -174.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.424 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 10.7 tmtt? -145.88 -45.73 0.21 Allowed 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -173.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.42 ' CB ' ' HB3' ' B' ' 277' ' ' ALA . 27.7 mm-40 -54.58 -49.85 69.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.996 -174.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.5 ' H ' ' CD ' ' A' ' 29' ' ' GLU . 0.9 OUTLIER -68.85 -43.75 74.8 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.713 -176.129 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.553 HG12 HD12 ' A' ' 35' ' ' LEU . 54.7 mt -62.1 -43.64 98.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.66 -175.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.4 m -72.6 -24.38 61.07 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.928 0.394 . . . . 0.0 111.274 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -91.56 -32.85 15.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.533 -173.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.493 ' HA ' ' HB2' ' A' ' 103' ' ' HIS . 80.4 m-85 -110.1 -12.5 14.5 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -177.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt 65.93 82.98 0.17 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.165 0.507 . . . . 0.0 111.719 -178.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.553 HD12 HG12 ' A' ' 30' ' ' ILE . 22.0 mt -89.88 147.91 23.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.2 177.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.1 m -85.03 122.36 38.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.711 -177.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.1 ttmm -85.54 117.53 24.5 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 177.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.1 t -78.39 -28.08 14.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.155 0.502 . . . . 0.0 109.939 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 167.45 -175.99 42.35 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.854 179.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.486 HG21 ' HB3' ' B' ' 207' ' ' ALA . 26.6 m -130.28 123.47 30.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.055 0.455 . . . . 0.0 110.243 178.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.419 HD12 HD12 ' A' ' 63' ' ' LEU . 25.3 pt -120.28 166.07 15.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.413 -176.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.468 HD21 HD11 ' B' ' 210' ' ' LEU . 25.7 p30 -145.77 147.53 31.98 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.491 0.663 . . . . 0.0 111.169 176.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 75.0 t -94.56 142.64 13.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.551 177.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.6 t -159.6 79.73 0.72 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.189 0.519 . . . . 0.0 109.765 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.403 HE22 HG13 ' A' ' 43' ' ' VAL . 0.9 OUTLIER -113.8 150.04 34.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.358 178.365 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.7 t -111.61 112.73 24.65 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.622 -175.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.61 -144.93 17.45 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.226 176.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.3 74.54 1.68 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 121.603 -0.332 . . . . 0.0 113.781 -173.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -121.65 -36.73 2.99 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.154 0.502 . . . . 0.0 109.796 169.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.458 HG23 ' HB2' ' A' ' 55' ' ' ASP . 72.1 mt -133.52 123.01 45.35 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.493 176.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.7 m -143.64 -27.98 0.54 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.0 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.3 p -113.73 154.87 45.68 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 175.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.74 -25.0 58.28 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.824 2.349 . . . . 0.0 112.879 -176.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.628 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 11.8 p -67.24 -40.9 86.35 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.92 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.458 ' HB2' HG23 ' A' ' 50' ' ' ILE . 37.3 m-20 -58.63 -41.78 86.76 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.117 0.485 . . . . 0.0 110.624 -176.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 45.2 tp -63.23 -45.76 90.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.307 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.503 ' HD2' ' OE2' ' B' ' 223' ' ' GLU . 42.9 ttp180 -61.32 -40.5 94.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.983 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.628 ' HG2' ' O ' ' A' ' 54' ' ' SER . 9.4 mm-40 -59.18 -30.98 68.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.454 -177.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.433 ' O ' ' HB3' ' A' ' 62' ' ' GLU . 4.3 mptp? -93.86 -37.09 11.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.775 -177.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 86.5 mt -70.42 -39.7 74.27 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.019 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.0 t -69.2 -34.7 75.29 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 176.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.433 ' HB3' ' O ' ' A' ' 59' ' ' LYS . 34.4 tt0 -56.8 -49.32 75.68 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.87 177.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.419 HD12 HD12 ' A' ' 41' ' ' ILE . 73.8 mt -74.43 -30.36 61.88 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.742 -178.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.82 -50.98 53.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.433 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -68.23 -25.43 65.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.158 0.504 . . . . 0.0 110.41 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.45 -42.29 59.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.13 178.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.461 ' HE2' ' HA ' ' B' ' 212' ' ' ALA . 59.0 mmtt -77.13 -35.66 56.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.394 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.57 59.94 0.63 Allowed Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.605 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.672 ' HA2' ' HA ' ' A' ' 92' ' ' ASN . . . -143.93 160.87 27.82 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 177.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -107.63 -15.71 14.52 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.777 0.289 . . . . 0.0 111.267 -175.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.403 ' OH ' ' HD3' ' B' ' 257' ' ' ARG . 2.9 m-85 -140.47 145.63 37.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.642 0.258 . . . . 0.0 110.362 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.61 ' HD2' ' HB1' ' B' ' 222' ' ' ALA . 21.4 p90 -116.53 168.08 10.48 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 171.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.634 ' CD2' ' HA ' ' A' ' 26' ' ' SER . 10.0 t-160 -140.0 108.21 5.79 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.204 178.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 76.6 mt -71.76 118.59 16.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.188 177.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.9 pt -114.89 -18.58 7.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -152.92 100.42 2.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.826 0.345 . . . . 0.0 111.235 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -115.31 115.12 26.11 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -138.08 160.3 39.74 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.252 0.548 . . . . 0.0 111.614 -172.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -104.7 103.93 13.65 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.738 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.513 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 2.6 t-160 -94.75 56.88 2.09 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -176.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.67 -122.82 5.83 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.769 -0.933 . . . . 0.0 110.769 -175.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -83.94 10.52 3.66 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.372 2.048 . . . . 0.0 111.7 174.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.513 ' HB2' ' HB3' ' A' ' 80' ' ' HIS . 17.3 m-80 -113.48 127.27 56.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.282 -176.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -97.67 111.88 23.98 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.622 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 42.0 mt-10 -116.12 119.83 37.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.04 0.448 . . . . 0.0 110.957 -177.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -130.12 118.25 21.19 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.507 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.1 t -95.27 127.74 47.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 73' ' ' HIS . . . -136.62 144.72 44.23 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.389 -175.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -91.57 147.27 23.13 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 176.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 43.9 t -106.46 122.02 59.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -121.31 139.1 53.87 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.817 0.342 . . . . 0.0 110.079 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.672 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 26.2 t-20 -77.4 -89.42 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.202 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.5 t70 172.62 -48.77 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 70.29 1.0 3.4 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 114.338 -1.301 . . . . 0.0 113.601 169.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.446 ' OG1' ' HG2' ' B' ' 253' ' ' PRO . 32.2 m -66.16 -44.68 83.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.717 0.294 . . . . 0.0 110.918 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -83.72 -6.33 59.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.955 0.407 . . . . 0.0 110.843 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 93.6 mt -101.17 179.65 4.31 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.195 -173.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -76.1 65.67 2.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.075 -176.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -86.1 87.55 7.44 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.776 0.798 . . . . 0.0 110.227 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -86.96 24.89 1.41 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.41 0.624 . . . . 0.0 110.328 177.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -103.01 118.59 37.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.861 171.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -83.47 149.3 26.73 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.493 ' HB2' ' HA ' ' A' ' 33' ' ' PHE . 31.6 p-80 -89.51 161.3 16.29 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.102 -178.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 56.2 t60 . . . . . 0 C--N 1.32 -0.695 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.789 177.405 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . 0.4 ' O ' ' HB2' ' B' ' 202' ' ' LYS . 83.9 mtp . . . . . 0 N--CA 1.485 1.275 0 CA-C-O 120.595 0.236 . . . . 0.0 110.392 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' B' ' 201' ' ' MET . 27.6 mmmt 69.88 -67.69 0.22 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.374 0.67 . . . . 0.0 111.917 -178.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . 0.455 ' HB3' HD11 ' B' ' 205' ' ' ILE . 62.0 mttp -76.55 102.4 6.06 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.466 -175.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 65.1 mtm180 -115.67 94.55 4.74 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 172.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 205' ' ' ILE . . . . . 0.455 HD11 ' HB3' ' B' ' 203' ' ' LYS . 4.8 mp -100.38 120.34 49.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.817 0.341 . . . . 0.0 110.754 -175.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 1.4 pp -122.78 62.03 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.564 0.697 . . . . 0.0 110.563 177.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 207' ' ' ALA . . . . . 0.486 ' HB3' HG21 ' A' ' 40' ' ' THR . . . -75.43 123.5 25.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.498 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -111.97 110.24 20.45 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.938 0.399 . . . . 0.0 111.827 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -109.91 -50.03 3.02 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 172.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 210' ' ' LEU . . . . . 0.468 HD11 HD21 ' A' ' 42' ' ' ASN . 10.6 mp 66.88 -172.3 0.19 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.642 172.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . 0.441 HD22 ' HA ' ' B' ' 211' ' ' LEU . 0.3 OUTLIER 65.17 90.53 0.09 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.982 -179.213 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 212' ' ' ALA . . . . . 0.461 ' HA ' ' HE2' ' A' ' 67' ' ' LYS . . . -135.16 147.98 49.58 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.982 178.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 213' ' ' THR . . . . . . . . . . . . . 12.3 p -90.71 -171.12 2.93 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.973 -178.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 214' ' ' VAL . . . . . . . . . . . . . 3.0 p -124.51 114.58 41.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.14 0.495 . . . . 0.0 110.768 -178.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -148.8 150.29 32.81 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 8.9 t -156.95 77.79 0.89 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.27 0.557 . . . . 0.0 109.765 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -110.46 -30.16 7.78 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.516 178.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 218' ' ' SER . . . . . . . . . . . . . 32.3 t -89.05 98.25 11.66 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 174.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 1.7 p -62.48 -30.49 71.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.326 -178.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.403 HD13 HD23 ' A' ' 20' ' ' LEU . 60.4 tp -106.55 100.04 9.59 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 173.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -168.41 105.68 0.46 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.162 -178.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . 0.61 ' HB1' ' HD2' ' A' ' 72' ' ' TYR . . . 68.71 97.95 0.06 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 123.993 0.808 . . . . 0.0 112.656 171.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . 0.522 ' O ' ' HB2' ' A' ' 24' ' ' GLN . 34.7 mt-10 -139.98 -156.46 0.68 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.631 -178.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 224' ' ' GLN . . . . . 0.622 ' HB3' ' HB2' ' A' ' 24' ' ' GLN . 0.8 OUTLIER 68.76 144.32 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.034 0.534 . . . . 0.0 112.352 176.503 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 2.4 m -118.87 172.87 5.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.686 -177.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . 0.543 ' HA ' ' CD2' ' B' ' 273' ' ' HIS . 13.4 t -101.8 -96.02 0.28 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -176.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -142.53 -41.21 0.33 Allowed 'General case' 0 C--O 1.233 0.236 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -173.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -62.78 -30.7 71.66 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.76 0.79 . . . . 0.0 110.023 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -70.99 -34.52 71.46 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.625 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.506 HG23 ' HB2' ' B' ' 235' ' ' LEU . 56.4 mt -59.27 -43.38 89.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.153 0.502 . . . . 0.0 109.988 177.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 42.6 t -63.48 -30.15 71.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.668 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -84.54 -46.49 11.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.96 -176.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -93.89 -14.28 26.22 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -171.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? 62.52 88.91 0.09 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.289 0.566 . . . . 0.0 110.798 -176.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . 0.597 HD13 ' HE1' ' B' ' 271' ' ' TYR . 81.6 mt -108.9 155.43 20.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.08 -177.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 73.3 t -115.19 113.02 42.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.535 -172.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.2 140.05 58.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.91 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 1.9 m -122.85 5.78 5.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 138.62 -160.17 25.54 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.173 -1.013 . . . . 0.0 112.788 176.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' B' ' 289' ' ' GLU . 8.8 m -140.54 146.14 37.7 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -176.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 241' ' ' ILE . . . . . 0.524 ' HB ' HD13 ' B' ' 263' ' ' LEU . 26.4 pt -113.19 143.98 21.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 174.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -127.15 123.05 35.82 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.223 0.535 . . . . 0.0 110.684 -174.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 243' ' ' VAL . . . . . 0.674 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 75.3 t -100.15 116.14 42.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.448 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 72.7 m -135.96 87.87 2.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.332 177.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 245' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.43 163.11 33.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.575 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 37.7 t -78.14 174.68 10.9 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.208 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -70.4 4.6 8.52 Favored Glycine 0 CA--C 1.521 0.408 0 CA-C-N 116.363 -0.38 . . . . 0.0 113.041 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -80.55 -35.54 25.55 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.453 174.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -94.66 -21.5 18.75 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.924 0.393 . . . . 0.0 110.581 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 42.0 mm -119.45 99.29 7.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 176.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 16.7 t -130.9 -52.94 1.05 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.851 0.358 . . . . 0.0 110.524 -177.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . 0.427 ' HB3' ' HD2' ' B' ' 253' ' ' PRO . 23.1 m -109.9 159.71 30.77 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.213 178.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . 0.452 ' HB3' HD21 ' A' ' 35' ' ' LEU . 11.1 Cg_endo -55.87 -39.78 89.08 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.826 2.351 . . . . 0.0 112.841 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 254' ' ' SER . . . . . 0.508 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 66.7 m -60.98 -31.87 71.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.211 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -64.13 -50.19 69.22 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.061 0.458 . . . . 0.0 110.249 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 48.6 tp -62.05 -38.38 88.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.541 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 257' ' ' ARG . . . . . 0.403 ' HD3' ' OH ' ' A' ' 71' ' ' TYR . 43.7 ttp180 -56.99 -51.03 70.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.754 178.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 258' ' ' GLU . . . . . 0.508 ' HG2' ' O ' ' B' ' 254' ' ' SER . 10.2 mm-40 -63.9 -38.9 92.81 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.934 -178.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -63.99 -46.36 84.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.628 178.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 94.6 mt -65.89 -38.88 89.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.711 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 47.3 t -62.42 -40.08 95.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.432 176.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -60.85 -43.24 98.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.42 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 263' ' ' LEU . . . . . 0.524 HD13 ' HB ' ' B' ' 241' ' ' ILE . 94.1 mt -74.06 -39.49 63.44 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.392 -178.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -64.67 -44.56 90.0 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.73 0.3 . . . . 0.0 111.447 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 265' ' ' ASP . . . . . 0.765 ' HB2' HG23 ' A' ' 19' ' ' THR . 38.9 t70 -68.72 -31.73 71.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.078 0.466 . . . . 0.0 110.174 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -67.06 -35.78 80.59 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.779 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -75.57 -37.21 60.08 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.024 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 89.25 31.98 11.13 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.374 -176.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -94.3 -176.9 38.98 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.568 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . 0.468 ' HG2' HD22 ' B' ' 292' ' ' ASN . 30.1 mmtp -112.1 -12.94 13.62 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.426 -177.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 271' ' ' TYR . . . . . 0.597 ' HE1' HD13 ' B' ' 235' ' ' LEU . 43.5 p90 -167.52 175.71 6.97 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 173.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 272' ' ' TYR . . . . . 0.544 ' H ' ' HG3' ' B' ' 224' ' ' GLN . 43.9 p90 -133.04 123.93 26.71 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 273' ' ' HIS . . . . . 0.543 ' CD2' ' HA ' ' B' ' 226' ' ' SER . 6.1 t-160 -95.04 102.12 13.91 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.095 -0.642 . . . . 0.0 110.257 -177.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 274' ' ' ILE . . . . . . . . . . . . . 62.1 mt -66.36 111.63 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.185 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 20.0 pt -103.2 -35.66 3.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -178.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -159.76 113.86 2.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.003 0.43 . . . . 0.0 111.365 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 277' ' ' ALA . . . . . 0.56 ' HA ' ' HA ' ' B' ' 286' ' ' ALA . . . -122.37 107.43 12.07 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 174.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -128.18 138.54 52.52 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.644 0.735 . . . . 0.0 111.55 -169.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -78.88 133.63 36.96 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.363 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -134.08 101.1 4.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.009 0.433 . . . . 0.0 110.704 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 64.46 -129.49 36.84 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.858 -178.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -88.71 8.38 3.99 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.235 2.624 . . . . 0.0 112.489 178.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -124.57 155.77 38.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.965 0.412 . . . . 0.0 110.726 -177.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 284' ' ' PHE . . . . . 0.493 ' CE2' ' HB2' ' B' ' 286' ' ' ALA . 83.2 t80 -111.62 125.17 53.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.241 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 285' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 8.3 mm-40 -109.7 110.86 22.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.282 -178.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 286' ' ' ALA . . . . . 0.674 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -119.82 125.51 48.73 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.329 179.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 25.8 t -111.65 118.62 57.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.364 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -135.19 135.92 41.39 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.868 177.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 289' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' B' ' 240' ' ' THR . 2.4 mt-10 -98.3 140.43 32.59 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -178.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 40.3 t -101.4 129.66 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -176.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 291' ' ' TYR . . . . . 0.552 ' HB2' ' CZ ' ' B' ' 271' ' ' TYR . 50.4 m-85 -120.14 150.51 40.5 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.403 0.62 . . . . 0.0 110.512 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 292' ' ' ASN . . . . . 0.468 HD22 ' HG2' ' B' ' 270' ' ' LYS . 3.1 t-20 -120.74 179.45 4.34 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.75 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -82.2 175.72 10.07 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 174.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 294' ' ' ALA . . . . . . . . . . . . . . . -107.25 10.91 29.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.892 0.377 . . . . 0.0 111.141 -176.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 295' ' ' THR . . . . . . . . . . . . . 8.8 t -109.11 -31.55 7.56 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.743 -176.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt 63.85 -87.69 0.03 OUTLIER 'General case' 0 C--O 1.233 0.215 0 O-C-N 123.77 0.668 . . . . 0.0 111.88 173.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 297' ' ' LEU . . . . . 0.506 HD22 ' HB2' ' B' ' 301' ' ' HIS . 0.9 OUTLIER 175.55 156.89 0.2 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.132 -177.021 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 298' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.36 -40.15 8.86 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 168.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 299' ' ' HIS . . . . . 0.447 ' H ' ' H ' ' B' ' 300' ' ' HIS . 11.4 t-80 -177.31 -3.43 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.928 172.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 300' ' ' HIS . . . . . 0.447 ' H ' ' H ' ' B' ' 299' ' ' HIS . 52.9 m170 -80.46 21.23 0.64 Allowed 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 301' ' ' HIS . . . . . 0.506 ' HB2' HD22 ' B' ' 297' ' ' LEU . 75.7 t60 -65.38 -55.34 18.66 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 178.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 302' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -178.62 110.01 0.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -82.38 147.71 28.65 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 121.049 -0.261 . . . . 0.0 110.342 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 . . . . . 0 C--N 1.32 -0.69 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.345 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.45 ' O ' ' HB2' ' A' ' 2' ' ' LYS . 26.3 ptt? . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.368 0.128 . . . . 0.0 110.913 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 1' ' ' MET . 3.7 mptp? 69.66 168.44 0.29 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 122.993 0.517 . . . . 0.0 110.9 -174.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.534 ' C ' ' HD2' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -162.75 162.96 26.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.718 174.514 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.534 ' HD2' ' C ' ' A' ' 3' ' ' LYS . 3.4 mpt_? -122.45 104.92 9.71 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 176.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.484 HD12 ' O ' ' A' ' 5' ' ' ILE . 2.3 pp -84.62 126.82 40.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.07 0.462 . . . . 0.0 110.673 -179.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.9 mm -133.45 123.9 47.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.84 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -114.33 93.8 4.51 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 177.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -93.85 102.72 14.85 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.641 -177.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -110.59 141.55 43.63 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.887 177.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.0 mt -88.49 -41.18 12.9 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 -173.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 58.83 -92.71 0.04 OUTLIER 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.778 -177.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 66.31 -77.85 0.04 OUTLIER 'General case' 0 C--O 1.232 0.166 0 O-C-N 123.891 0.745 . . . . 0.0 110.146 -171.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.3 m 54.88 86.38 0.05 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.523 0.678 . . . . 0.0 111.6 178.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.5 t -131.22 117.86 38.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.827 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -98.73 98.72 9.81 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.972 0.415 . . . . 0.0 110.194 177.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.0 p -78.1 177.41 8.36 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.398 -177.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -118.36 138.46 52.4 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 174.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.41 ' HA ' ' OD1' ' B' ' 265' ' ' ASP . 17.7 m -45.52 106.2 0.07 Allowed 'General case' 0 C--O 1.234 0.254 0 O-C-N 123.947 0.779 . . . . 0.0 112.242 -174.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.3 t -82.02 37.59 0.49 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.148 -176.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.6 mt 58.35 75.85 0.37 Allowed 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.385 -177.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -159.52 158.41 31.78 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.848 -175.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.454 ' CB ' ' HA ' ' B' ' 261' ' ' SER . . . 68.87 99.93 0.06 Allowed 'General case' 0 N--CA 1.466 0.365 0 O-C-N 124.299 0.999 . . . . 0.0 112.351 176.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.55 ' HG2' ' HA ' ' B' ' 222' ' ' ALA . 8.6 tp10 -155.51 165.51 36.37 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.161 -179.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.503 ' HB3' ' HB2' ' B' ' 224' ' ' GLN . 0.0 OUTLIER 76.23 156.47 0.18 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.662 0.785 . . . . 0.0 111.168 176.876 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.9 m -117.92 174.42 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 121.157 0.503 . . . . 0.0 111.636 -174.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.45 ' HB3' ' HB ' ' B' ' 274' ' ' ILE . 69.0 p -79.4 -172.4 3.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.232 0.539 . . . . 0.0 111.542 -173.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.472 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 14.2 tmtt? -86.11 -29.37 23.38 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 171.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.476 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 1.0 OUTLIER -58.25 -50.1 74.77 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.287 179.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.59 ' HA ' ' HB3' ' A' ' 32' ' ' HIS . 0.4 OUTLIER -61.66 -26.99 68.36 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.315 -177.181 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.483 HG12 ' OH ' ' A' ' 71' ' ' TYR . 57.8 mt -61.0 -54.66 32.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.011 0.434 . . . . 0.0 110.047 176.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.2 m -73.48 -26.99 61.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.684 177.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.59 ' HB3' ' HA ' ' A' ' 29' ' ' GLU . 12.2 t-160 -68.31 -48.48 64.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.336 -175.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -104.52 -5.06 21.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.793 -176.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt 58.75 78.04 0.27 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.337 0.589 . . . . 0.0 110.77 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.8 mt -92.72 168.47 11.18 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.937 -176.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.9 t -96.99 138.23 22.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.792 -176.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -97.34 127.09 43.0 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.44 HG13 ' HB2' ' A' ' 92' ' ' ASN . 6.8 m -101.53 -45.78 11.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -175.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -174.66 175.0 46.88 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 119.689 -1.243 . . . . 0.0 113.362 -178.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.556 HG23 ' HG2' ' A' ' 89' ' ' GLU . 15.6 m -112.6 141.44 46.37 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 122.617 0.367 . . . . 0.0 110.421 -178.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.6 pt -120.14 144.64 28.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.816 0.341 . . . . 0.0 110.688 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -115.14 118.95 34.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.408 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.598 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 61.2 t -95.18 109.5 22.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.695 176.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.8 m -138.4 96.14 3.12 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.479 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.402 HE22 HG13 ' A' ' 43' ' ' VAL . 0.6 OUTLIER -129.01 134.43 48.14 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.637 -179.807 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.9 t -78.93 64.26 3.83 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.09 0.471 . . . . 0.0 111.126 -177.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.65 -69.93 2.3 Favored Glycine 0 CA--C 1.521 0.459 0 CA-C-N 115.86 -0.609 . . . . 0.0 114.412 172.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -50.83 -30.34 21.59 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 115.831 1.092 . . . . 0.0 115.831 -167.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -78.17 -27.01 47.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.831 0.816 . . . . 0.0 112.178 -175.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' A' ' 56' ' ' LEU . 49.7 mm -125.28 117.08 48.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 110.555 -0.165 . . . . 0.0 110.555 -175.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.6 t -119.19 -54.56 2.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.02 0.438 . . . . 0.0 110.329 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.511 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 4.9 m -105.85 164.35 15.19 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.817 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.572 ' HG3' HD21 ' B' ' 235' ' ' LEU . 18.4 Cg_endo -60.52 -28.26 86.35 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.482 2.121 . . . . 0.0 111.57 177.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.438 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -68.82 -28.81 67.07 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.2 178.62 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.777 ' HA ' ' HB2' ' B' ' 299' ' ' HIS . 31.0 m-20 -70.76 -44.9 65.78 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.337 0.589 . . . . 0.0 109.444 175.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.505 ' HA ' HD12 ' A' ' 50' ' ' ILE . 55.5 tp -65.35 -40.0 93.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.542 -175.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 54' ' ' SER . 3.0 ppt_? -61.28 -37.02 81.64 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -175.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -67.64 -37.98 83.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.945 0.402 . . . . 0.0 110.277 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -67.92 -40.18 83.41 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.215 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.578 HD13 ' CE2' ' A' ' 72' ' ' TYR . 81.6 mt -71.89 -39.21 69.75 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.102 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.5 t -65.29 -39.13 92.15 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -57.11 -42.71 81.35 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.009 177.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 97.9 mt -71.68 -46.02 60.12 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.411 -178.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.81 -42.32 86.11 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -175.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.489 ' HB2' ' HB2' ' B' ' 221' ' ' ALA . 33.1 t70 -63.37 -24.06 67.68 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.796 0.331 . . . . 0.0 111.623 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.23 -13.79 37.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.906 0.384 . . . . 0.0 111.335 178.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -90.02 -42.68 11.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.094 0.473 . . . . 0.0 110.409 178.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.67 65.27 0.65 Allowed Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.724 -178.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -145.35 169.65 26.9 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.067 177.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.446 ' HD2' HH12 ' B' ' 257' ' ' ARG . 31.7 mmtp -92.17 -15.13 28.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.716 0.293 . . . . 0.0 111.087 -178.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.639 ' HA ' ' CB ' ' B' ' 222' ' ' ALA . 31.6 p90 -165.26 175.79 8.93 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -177.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.578 ' CE2' HD13 ' A' ' 60' ' ' LEU . 54.6 p90 -135.36 136.54 41.57 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 175.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -110.54 115.83 30.31 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.489 -177.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.526 ' H ' HD12 ' A' ' 74' ' ' ILE . 4.8 mp -72.53 136.03 26.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 32.2 pt -117.26 -21.78 4.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.736 0.303 . . . . 0.0 111.196 178.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -159.4 147.89 17.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.714 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -162.06 141.5 9.71 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -166.77 154.81 9.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.036 0.446 . . . . 0.0 111.403 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -88.6 118.32 28.17 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 168.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -107.15 91.93 3.87 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.19 -120.09 12.91 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -172.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -94.43 6.6 2.43 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.074 2.516 . . . . 0.0 112.341 175.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.495 ' N ' HD22 ' A' ' 83' ' ' ASN . 0.8 OUTLIER -103.55 143.51 32.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.705 0.288 . . . . 0.0 110.679 -178.241 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -103.06 114.25 28.39 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -111.91 127.34 55.82 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.842 -177.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.598 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -141.08 133.48 28.3 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.924 0.392 . . . . 0.0 110.126 175.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.3 t -116.16 118.03 57.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.072 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -133.5 145.54 50.27 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.851 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.556 ' HG2' HG23 ' A' ' 40' ' ' THR . 10.4 mt-10 -117.5 136.77 53.0 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 26.0 t -95.52 135.95 28.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.676 -171.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.492 ' HB2' ' CZ ' ' A' ' 71' ' ' TYR . 79.5 m-85 -119.2 149.06 42.38 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.211 0.529 . . . . 0.0 110.41 178.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.44 ' HB2' HG13 ' A' ' 38' ' ' VAL . 18.1 t-20 -95.74 167.36 11.32 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.482 -176.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -66.4 -12.63 58.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.298 -178.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 74.66 7.04 4.47 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.494 -176.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.2 m -115.18 -29.89 6.48 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.852 176.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 96.2 mttt 66.91 -89.74 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.93 178.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 40.0 mt 71.96 170.8 0.32 Allowed 'General case' 0 N--CA 1.467 0.422 0 O-C-N 123.792 0.683 . . . . 0.0 112.468 176.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 43.12 68.75 0.46 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 114.646 -1.161 . . . . 0.0 113.487 174.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -95.08 95.35 8.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.534 173.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -90.03 157.07 17.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.824 0.345 . . . . 0.0 110.713 -176.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 31.6 t60 -71.18 132.21 44.67 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.467 -175.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 -145.53 159.59 42.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.187 -175.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 31.1 t60 -155.08 122.17 5.51 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.992 0.425 . . . . 0.0 110.546 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.32 -0.71 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.101 177.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 67.4 mtt . . . . . 0 N--CA 1.483 1.188 0 N-CA-C 111.522 0.193 . . . . 0.0 111.522 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -71.68 -58.44 3.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.171 0.51 . . . . 0.0 111.576 -174.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -122.23 126.61 48.58 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.799 -175.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 204' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' B' ' 204' ' ' ARG . 0.0 OUTLIER -154.01 88.28 1.24 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.536 0.684 . . . . 0.0 110.633 177.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 60.6 mt -113.05 101.54 12.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.424 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 7.9 tt -153.72 96.82 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.584 0.706 . . . . 0.0 110.447 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -131.38 98.7 4.6 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.236 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -80.39 146.29 31.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.959 -177.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -99.38 112.71 24.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.558 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 210' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -95.4 81.42 3.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.992 0.425 . . . . 0.0 110.693 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 95.5 mt -132.14 131.0 41.87 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.229 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -129.52 113.04 14.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.017 0.437 . . . . 0.0 110.57 178.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 213' ' ' THR . . . . . . . . . . . . . 23.2 m -95.19 86.81 4.67 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.16 0.505 . . . . 0.0 110.447 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 214' ' ' VAL . . . . . . . . . . . . . 7.2 p -147.45 4.26 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.346 0.593 . . . . 0.0 110.412 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.26 112.25 1.66 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.367 -176.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 3.0 p -135.84 -177.31 4.63 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.877 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -148.18 156.09 42.17 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.391 -0.225 . . . . 0.0 110.391 -177.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 218' ' ' SER . . . . . . . . . . . . . 21.9 t -130.66 -81.4 0.54 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.405 177.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 84.9 m -174.55 -64.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -176.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 96.1 mt -128.23 136.65 51.35 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.122 -1.399 . . . . 0.0 107.467 171.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . 0.489 ' HB2' ' HB2' ' A' ' 65' ' ' ASP . . . -88.68 -75.7 0.42 Allowed 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.87 -174.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . 0.639 ' CB ' ' HA ' ' A' ' 71' ' ' TYR . . . -169.59 -179.64 3.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.23 -171.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . 0.526 ' HA ' ' OH ' ' A' ' 72' ' ' TYR . 10.2 pt-20 177.54 133.46 0.06 Allowed 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.896 0.747 . . . . 0.0 111.941 -177.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 224' ' ' GLN . . . . . 0.503 ' HB2' ' HB3' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -172.22 157.86 4.32 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.657 0.783 . . . . 0.0 109.064 179.789 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . 0.46 HG21 HD13 ' B' ' 235' ' ' LEU . 18.6 m -109.55 133.09 55.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.729 0.3 . . . . 0.0 111.109 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . 0.514 ' O ' HG13 ' B' ' 230' ' ' ILE . 83.3 p -90.56 -174.28 4.05 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 178.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -56.46 -37.42 70.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.397 -177.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -64.8 -50.45 66.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.702 -177.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -60.82 -41.06 94.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.171 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.541 ' HA ' HD12 ' B' ' 235' ' ' LEU . 83.5 mt -55.52 -51.79 53.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.921 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 35.3 m -72.09 -28.76 63.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.382 -178.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -78.26 -47.99 16.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.708 -175.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -92.04 4.33 53.31 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -173.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm 57.75 41.0 25.82 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.101 0.477 . . . . 0.0 111.022 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . 0.572 HD21 ' HG3' ' A' ' 53' ' ' PRO . 89.4 mt -63.01 125.66 24.75 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.838 -176.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.48 HG22 ' HB2' ' B' ' 294' ' ' ALA . 17.0 m -78.79 132.94 31.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.569 -175.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 41.9 tttm -78.4 117.58 19.75 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.44 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 27.0 t -84.3 -35.92 11.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.003 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 164.91 -178.65 39.94 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.226 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 42.1 m -109.69 135.46 50.6 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 18.4 pt -110.05 134.31 52.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.99 0.424 . . . . 0.0 110.511 175.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -120.5 114.33 21.61 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.952 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 243' ' ' VAL . . . . . 0.592 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 5.3 t -102.4 113.38 38.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.15 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 23.3 t -111.72 103.11 11.38 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.938 0.399 . . . . 0.0 110.032 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 245' ' ' GLN . . . . . 0.554 ' HG2' HG12 ' B' ' 250' ' ' ILE . 0.6 OUTLIER -99.96 143.38 30.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.784 -177.247 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 41.1 t -97.69 72.88 2.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.991 0.424 . . . . 0.0 110.859 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 69.43 -92.36 0.33 Allowed Glycine 0 CA--C 1.518 0.269 0 CA-C-N 115.676 -0.693 . . . . 0.0 114.158 172.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -79.89 50.86 3.97 Favored Glycine 0 CA--C 1.517 0.21 0 N-CA-C 114.195 0.438 . . . . 0.0 114.195 -169.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . 0.5 ' HB2' ' HG3' ' B' ' 245' ' ' GLN . 78.7 mt-30 -131.66 -0.07 3.93 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.17 0.51 . . . . 0.0 109.761 173.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 250' ' ' ILE . . . . . 0.554 HG12 ' HG2' ' B' ' 245' ' ' GLN . 45.0 mm -132.01 119.74 41.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.551 178.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 3.4 m -135.08 -50.68 0.76 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.227 -177.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.25 163.68 16.43 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.305 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.27 -37.75 94.21 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.342 2.028 . . . . 0.0 111.954 176.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 254' ' ' SER . . . . . 0.434 ' HA ' ' HB3' ' B' ' 257' ' ' ARG . 54.8 m -68.31 -25.9 65.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.831 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -64.42 -32.01 73.46 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.616 0.246 . . . . 0.0 110.581 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 56.3 tp -86.93 -38.51 16.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.929 0.395 . . . . 0.0 109.981 176.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 257' ' ' ARG . . . . . 0.446 HH12 ' HD2' ' A' ' 70' ' ' LYS . 77.6 ttt180 -50.72 -43.53 57.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.799 179.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 258' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -55.48 -48.57 74.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.657 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -72.9 -32.42 65.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.815 0.341 . . . . 0.0 111.041 -174.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 92.0 mt -65.22 -46.23 81.5 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.871 -178.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 261' ' ' SER . . . . . 0.454 ' HA ' ' CB ' ' A' ' 22' ' ' ALA . 17.6 m -67.18 -36.77 82.48 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.871 177.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -57.56 -52.13 66.68 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.169 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 263' ' ' LEU . . . . . 0.436 HD12 HG22 ' B' ' 243' ' ' VAL . 89.8 mt -73.21 -30.82 63.78 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -174.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.5 -38.51 68.12 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 121.149 -0.22 . . . . 0.0 111.33 -176.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 265' ' ' ASP . . . . . 0.41 ' OD1' ' HA ' ' A' ' 18' ' ' SER . 26.5 t70 -70.35 -32.89 70.79 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.989 0.423 . . . . 0.0 110.07 178.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -68.65 -22.73 64.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.321 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -96.36 -11.18 26.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.672 0.272 . . . . 0.0 111.004 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 80.03 53.35 4.24 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.634 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.04 -178.88 18.74 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.012 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . 0.412 ' HG3' ' OD2' ' B' ' 293' ' ' ASP . 22.3 mmmt -117.22 -46.87 2.69 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.922 0.391 . . . . 0.0 110.722 177.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 271' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -138.23 164.82 28.25 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 272' ' ' TYR . . . . . 0.427 ' HE1' ' N ' ' A' ' 23' ' ' GLU . 11.1 p90 -144.49 142.14 30.04 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.564 -174.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 22.0 t-80 -114.36 104.85 12.47 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.85 -178.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 274' ' ' ILE . . . . . 0.45 ' HB ' ' HB3' ' A' ' 26' ' ' SER . 57.4 mt -68.03 105.37 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.228 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 19.1 pt -77.98 -40.49 26.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.393 -176.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -153.45 131.45 11.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.126 0.489 . . . . 0.0 111.51 -177.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -120.58 103.56 9.25 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 174.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -127.23 126.82 43.4 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.331 0.586 . . . . 0.0 110.603 -172.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -88.89 126.55 35.43 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.308 0.575 . . . . 0.0 110.487 -176.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -97.39 81.2 2.96 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.121 -176.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 61.16 -120.18 21.7 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.057 -176.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . 0.506 ' C ' HD22 ' B' ' 283' ' ' ASN . 89.2 Cg_endo -83.06 10.55 3.6 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.799 2.332 . . . . 0.0 112.211 177.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 283' ' ' ASN . . . . . 0.506 HD22 ' C ' ' B' ' 282' ' ' PRO . 1.0 OUTLIER -121.08 166.53 13.78 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.893 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 284' ' ' PHE . . . . . 0.448 ' CE2' ' HB2' ' B' ' 286' ' ' ALA . 51.1 t80 -131.7 127.47 36.95 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.425 0.155 . . . . 0.0 110.686 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 285' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -111.26 110.51 21.03 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.443 -178.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 286' ' ' ALA . . . . . 0.592 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -107.29 120.24 41.61 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.612 0.244 . . . . 0.0 110.788 176.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 17.7 t -116.13 123.12 70.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.816 0.341 . . . . 0.0 110.577 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -136.6 144.47 44.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.945 0.402 . . . . 0.0 111.588 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -92.98 123.66 36.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.705 176.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 48.9 t -91.13 128.33 42.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.75 0.31 . . . . 0.0 110.467 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -123.48 156.34 35.78 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.11 0.481 . . . . 0.0 111.032 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 292' ' ' ASN . . . . . 0.457 ' HB3' ' CG2' ' B' ' 236' ' ' VAL . 6.9 t-20 -117.21 159.35 22.79 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 293' ' ' ASP . . . . . 0.412 ' OD2' ' HG3' ' B' ' 270' ' ' LYS . 4.1 p30 -72.03 -27.95 63.04 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 123.102 0.251 . . . . 0.0 111.161 -177.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 294' ' ' ALA . . . . . 0.48 ' HB2' HG22 ' B' ' 236' ' ' VAL . . . 66.04 13.88 9.32 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 173.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 295' ' ' THR . . . . . 0.444 HG23 ' H ' ' B' ' 297' ' ' LEU . 9.5 t -124.57 -26.69 3.81 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.042 178.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 296' ' ' LYS . . . . . 0.495 ' HE2' ' CA ' ' B' ' 296' ' ' LYS . 5.5 mmpt? 64.7 30.38 12.49 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 123.139 0.576 . . . . 0.0 111.271 177.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 297' ' ' LEU . . . . . 0.444 ' H ' HG23 ' B' ' 295' ' ' THR . 96.6 mt -127.97 118.66 23.96 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.904 178.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 298' ' ' GLU . . . . . 0.429 ' HA ' ' HB2' ' A' ' 54' ' ' SER . 41.1 mm-40 -84.44 177.31 8.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.488 177.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 299' ' ' HIS . . . . . 0.777 ' HB2' ' HA ' ' A' ' 55' ' ' ASP . 13.3 t-80 -62.22 122.09 14.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.268 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 300' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -80.26 107.98 13.5 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.032 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 301' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -64.41 94.73 0.12 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.823 177.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 302' ' ' HIS . . . . . . . . . . . . . 24.6 t-80 -146.96 123.08 10.81 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.618 -175.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -156.59 -178.56 7.44 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.241 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 . . . . . 0 C--N 1.317 -0.825 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 173.604 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.487 ' O ' ' HE2' ' B' ' 227' ' ' LYS . 23.4 mmt . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 120.511 0.196 . . . . 0.0 111.351 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.84 157.75 28.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.245 0.545 . . . . 0.0 111.971 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.541 ' HB3' ' HE3' ' B' ' 227' ' ' LYS . 23.6 tptm -161.52 98.08 1.11 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.532 178.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 19.6 mtm180 -119.13 -23.2 6.89 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.773 -173.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.413 ' N ' HD12 ' A' ' 5' ' ' ILE . 3.4 mp -93.81 98.95 8.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.124 0.488 . . . . 0.0 110.299 178.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.1 mp -112.0 101.69 12.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 175.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.01 101.48 13.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.614 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.413 ' HA ' HG21 ' B' ' 240' ' ' THR . . . -78.84 116.64 19.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.581 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.605 ' H ' ' HB ' ' B' ' 240' ' ' THR . . . -106.04 123.67 48.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.565 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.9 tp -93.38 96.0 9.66 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.366 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 22.1 tp -153.58 93.87 1.73 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 175.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.25 173.62 10.23 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.348 0.594 . . . . 0.0 112.038 -171.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.596 ' HB ' HD23 ' B' ' 263' ' ' LEU . 25.3 m -142.82 131.35 22.4 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.64 178.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.5 p -89.75 -36.22 8.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.899 -178.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.94 130.08 1.18 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.773 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.2 t -150.69 -82.16 0.1 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.592 ' O ' ' HA ' ' B' ' 262' ' ' GLU . 88.8 m-85 -148.97 172.55 14.55 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.0 t -119.21 -68.79 0.89 Allowed 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.773 -175.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 55.9 m 66.23 126.72 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.724 0.773 . . . . 0.0 111.721 -178.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.0 mt -85.69 91.3 8.25 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.272 179.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.494 ' HA ' ' OE2' ' B' ' 223' ' ' GLU . . . -155.12 5.39 0.22 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.241 175.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.539 ' HB1' ' CD2' ' B' ' 272' ' ' TYR . . . -134.22 97.88 3.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.916 -175.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.602 ' HB3' ' HE1' ' A' ' 71' ' ' TYR . 10.8 mt-10 -160.33 110.97 1.85 Allowed 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -177.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.666 ' HB2' ' HB3' ' B' ' 224' ' ' GLN . 0.9 OUTLIER -173.58 141.35 0.86 Allowed 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.469 174.501 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.2 m -105.76 116.11 48.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.081 0.467 . . . . 0.0 110.929 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.673 ' HA ' ' HD2' ' A' ' 73' ' ' HIS . 15.9 t -82.13 172.76 12.82 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.778 0.323 . . . . 0.0 110.147 -177.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.553 ' HA ' ' HB ' ' A' ' 30' ' ' ILE . 29.1 mmmt -67.3 -19.33 65.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.26 -173.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 17.7 mp0 -65.47 -51.57 59.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.902 0.382 . . . . 0.0 110.31 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.517 ' OE2' ' HB3' ' A' ' 26' ' ' SER . 2.3 pm0 -76.84 -28.03 55.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.087 177.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.553 ' HB ' ' HA ' ' A' ' 27' ' ' LYS . 77.7 mt -60.0 -46.59 93.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.725 0.298 . . . . 0.0 110.204 174.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.6 m -73.8 -21.83 60.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.207 178.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -86.72 -46.17 10.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.423 -175.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -94.49 -13.87 25.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.07 -178.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm 62.01 76.06 0.38 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.525 0.679 . . . . 0.0 110.579 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.485 HD12 HG12 ' A' ' 30' ' ' ILE . 71.6 mt -87.52 177.01 7.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.869 -172.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 92' ' ' ASN . 28.9 t -104.0 115.34 45.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.472 -174.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.1 ttmm -80.88 121.16 25.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.654 0.264 . . . . 0.0 110.588 177.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.613 HG22 ' OD1' ' A' ' 92' ' ' ASN . 2.2 t -78.78 -34.42 17.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.572 0.701 . . . . 0.0 109.344 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 160.32 -159.51 30.89 Favored Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.961 -177.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.5 m -137.5 126.44 24.19 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.5 pt -103.96 136.46 37.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.087 0.47 . . . . 0.0 111.089 -177.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -117.01 122.58 44.62 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.974 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.49 ' HB ' ' H ' ' A' ' 86' ' ' ALA . 88.3 t -94.25 138.11 21.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.345 175.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.4 t -156.99 80.37 0.92 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.195 0.522 . . . . 0.0 110.247 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -125.4 159.75 31.1 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 176.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.557 ' HA ' ' HA ' ' A' ' 83' ' ' ASN . 22.6 t -64.59 158.95 22.94 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 176.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.88 50.82 1.9 Allowed Glycine 0 C--N 1.333 0.363 0 CA-C-N 116.358 -0.383 . . . . 0.0 112.843 -178.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -142.17 -36.84 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 177.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -69.66 -30.13 67.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.291 0.567 . . . . 0.0 110.036 175.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.3 mm -108.24 96.1 4.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 173.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.3 t -106.28 -2.03 22.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.954 0.407 . . . . 0.0 110.991 -174.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 93.4 p -162.19 164.4 17.33 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.213 -178.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.74 -25.86 81.88 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.237 1.958 . . . . 0.0 111.213 172.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.473 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 17.1 m -66.65 -45.4 79.09 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.6 178.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.503 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 26.5 m-20 -57.61 -45.54 85.2 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.227 0.537 . . . . 0.0 109.945 177.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 54.4 tp -64.57 -39.58 94.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.048 -178.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -60.32 -46.21 90.69 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.702 -178.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 54' ' ' SER . 8.5 mm-40 -63.53 -26.99 68.96 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.927 -177.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.521 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 29.3 mmmt -78.2 -53.67 7.08 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.524 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.0 mt -63.67 -41.86 98.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.72 -174.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.9 p -63.23 -45.71 90.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.668 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -60.61 -45.26 94.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.911 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 59' ' ' LYS . 92.1 mt -63.75 -40.27 96.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.066 -178.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.1 -43.85 77.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.863 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -63.2 -44.99 93.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.404 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.431 ' HB1' HG12 ' B' ' 214' ' ' VAL . . . -71.8 -22.25 61.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.976 -177.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -80.04 -12.17 59.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.691 0.281 . . . . 0.0 110.911 176.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 94.92 16.65 40.78 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.404 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.451 ' HA3' HG21 ' A' ' 38' ' ' VAL . . . -112.53 -158.15 13.65 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.875 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.822 ' HD2' ' HB2' ' A' ' 93' ' ' ASP . 93.2 mttt -138.92 -61.46 0.56 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.096 0.474 . . . . 0.0 110.795 177.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.602 ' HE1' ' HB3' ' A' ' 23' ' ' GLU . 56.8 m-85 -97.8 156.98 16.33 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.901 -171.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.49 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 26.3 p90 -142.81 123.24 13.94 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.191 178.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.673 ' HD2' ' HA ' ' A' ' 26' ' ' SER . 48.2 t-80 -96.06 109.07 21.55 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.14 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.596 ' H ' HD12 ' A' ' 74' ' ' ILE . 4.5 mp -73.69 104.8 2.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 30.0 pt -85.65 -20.55 8.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.723 -178.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -160.0 120.78 3.05 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.12 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -124.7 96.2 4.8 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 175.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.1 -178.99 4.25 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.292 -174.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.83 157.41 17.49 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 176.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.563 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 4.3 t-160 -124.08 63.16 1.08 Allowed 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 174.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.48 -114.6 4.5 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.213 -175.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -83.76 20.9 1.12 Allowed 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.684 2.256 . . . . 0.0 112.015 174.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.563 ' HB2' ' HB3' ' A' ' 80' ' ' HIS . 31.0 m-80 -131.27 164.21 26.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.116 -177.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -124.1 129.96 51.74 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 175.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.461 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 81.8 mt-10 -127.86 116.89 20.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.129 0.49 . . . . 0.0 111.465 -176.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.49 ' H ' ' HB ' ' A' ' 43' ' ' VAL . . . -114.31 128.79 56.53 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.312 178.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.0 t -108.76 115.86 50.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.905 179.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 72' ' ' TYR . . . -125.99 136.65 53.23 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.933 0.397 . . . . 0.0 111.544 -176.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 72' ' ' TYR . 45.9 mt-10 -91.76 118.63 30.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.82 177.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.5 t -86.3 128.65 39.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.434 -178.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -124.92 147.36 48.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.09 0.472 . . . . 0.0 110.608 178.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.613 ' OD1' HG22 ' A' ' 38' ' ' VAL . 21.5 m120 -82.52 163.1 21.76 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.139 178.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.822 ' HB2' ' HD2' ' A' ' 70' ' ' LYS . 38.0 t0 -74.39 135.51 42.42 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 169.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.88 83.09 0.92 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.273 0.559 . . . . 0.0 109.81 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.0 t -177.85 -30.95 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.655 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 60.7 tttm 70.66 170.14 0.31 Allowed 'General case' 0 CA--C 1.536 0.442 0 O-C-N 123.776 0.673 . . . . 0.0 110.743 176.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 72.2 mt 63.62 -148.05 0.32 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 122.552 0.341 . . . . 0.0 110.835 178.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 70.66 -68.84 0.2 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.542 0.737 . . . . 0.0 111.719 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.29 74.02 7.13 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.312 -173.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -135.26 25.11 3.53 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.58 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 32.9 m170 69.44 160.03 0.19 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.442 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 24.2 t-80 63.07 23.24 13.87 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.374 173.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -89.77 2.06 55.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.036 0.446 . . . . 0.0 110.792 -176.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 24.6 t60 . . . . . 0 C--N 1.32 -0.681 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 177.876 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 66.2 mtm . . . . . 0 N--CA 1.483 1.218 0 CA-C-O 120.793 0.33 . . . . 0.0 110.545 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 5.3 ptmm? -85.19 177.35 7.9 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 176.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -67.02 134.43 51.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.049 0.452 . . . . 0.0 111.024 -173.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -138.39 173.7 11.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.411 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 8.1 tp -128.19 144.08 38.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.965 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 7.3 tt -119.13 106.06 18.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.357 0.599 . . . . 0.0 110.463 178.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -79.56 146.55 32.54 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.041 177.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . 59.24 71.44 0.58 Allowed 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.209 0.528 . . . . 0.0 110.826 -177.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -93.04 166.06 12.55 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.875 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 210' ' ' LEU . . . . . . . . . . . . . 7.3 mp -106.67 163.52 12.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.259 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 61.4 tp -124.14 108.86 12.76 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 177.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -124.43 114.99 20.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.062 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 213' ' ' THR . . . . . . . . . . . . . 2.9 m -111.85 30.0 7.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.817 0.818 . . . . 0.0 109.152 175.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 214' ' ' VAL . . . . . 0.431 HG12 ' HB1' ' A' ' 66' ' ' ALA . 32.7 t -68.95 120.34 16.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.236 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -128.0 153.32 46.88 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.64 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 55.0 m -95.4 -61.5 1.46 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 177.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -177.9 -63.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.613 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 218' ' ' SER . . . . . . . . . . . . . 67.1 p -168.77 108.52 0.48 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.012 177.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 15.0 t -85.62 -174.3 5.09 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.747 0.308 . . . . 0.0 110.378 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -116.69 -45.57 2.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.657 -175.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -110.67 -151.48 0.48 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.35 -173.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . 73.51 94.5 0.07 Allowed 'General case' 0 N--CA 1.467 0.381 0 O-C-N 124.089 0.868 . . . . 0.0 110.269 -176.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . 0.494 ' OE2' ' HA ' ' A' ' 21' ' ' ALA . 46.9 mt-10 -151.43 -156.66 0.73 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.126 -168.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 224' ' ' GLN . . . . . 0.687 ' HA ' ' HB3' ' B' ' 271' ' ' TYR . 0.0 OUTLIER 82.23 145.79 0.08 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.899 0.88 . . . . 0.0 111.495 172.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . 0.402 HG21 HD12 ' B' ' 235' ' ' LEU . 23.7 m -115.97 154.36 17.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.208 -176.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 19.7 m -99.03 -102.79 0.22 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.883 -178.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . 0.541 ' HE3' ' HB3' ' A' ' 3' ' ' LYS . 1.7 tmtp? -124.16 -57.54 1.59 Allowed 'General case' 0 C--N 1.326 -0.413 0 O-C-N 122.011 -0.43 . . . . 0.0 111.31 -170.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -62.04 -38.08 87.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.025 0.44 . . . . 0.0 110.878 -175.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -61.72 -36.08 79.91 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.01 -177.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.415 HD13 ' CZ ' ' B' ' 291' ' ' TYR . 66.7 mt -60.49 -53.08 53.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.79 -178.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 23.2 t -72.85 -21.33 60.96 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.171 -176.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -87.87 -44.48 11.04 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -176.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -95.32 -18.43 20.8 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.582 0.216 . . . . 0.0 111.582 -177.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 5.7 mmmm 63.17 77.29 0.33 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.501 0.667 . . . . 0.0 111.489 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . 0.402 HD12 HG21 ' B' ' 225' ' ' VAL . 87.9 mt -93.94 140.75 29.32 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.502 175.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 27.2 m -76.88 127.07 38.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.106 0.479 . . . . 0.0 111.0 -177.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 237' ' ' LYS . . . . . 0.532 ' HE2' ' HB3' ' B' ' 289' ' ' GLU . 57.9 tttm -84.95 107.12 16.93 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.936 178.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 48.8 t -67.28 -35.19 73.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.607 -177.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 168.79 -149.32 13.61 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.313 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . 0.605 ' HB ' ' H ' ' A' ' 9' ' ' ALA . 38.3 m -139.74 140.81 36.83 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 -178.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 18.2 pt -121.14 139.01 49.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.097 0.475 . . . . 0.0 110.677 178.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -127.68 113.59 16.23 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 243' ' ' VAL . . . . . 0.468 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 2.3 t -100.69 108.41 23.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.21 -175.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 26.5 t -99.32 109.42 22.04 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 177.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 245' ' ' GLN . . . . . 0.698 ' HA ' HE21 ' B' ' 245' ' ' GLN . 0.0 OUTLIER -99.71 158.25 15.91 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 121.358 0.599 . . . . 0.0 110.669 179.302 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 1.5 p -91.48 11.04 25.31 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.539 175.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 94.83 -61.02 1.68 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.796 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -78.29 50.57 3.47 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 121.2 -0.524 . . . . 0.0 113.103 -178.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -137.03 -14.48 1.57 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.828 0.346 . . . . 0.0 110.533 177.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 39.5 mm -125.56 99.15 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.73 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 23.1 t -98.38 -25.47 14.81 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.355 0.597 . . . . 0.0 109.65 178.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . 0.522 ' HB3' ' HD2' ' B' ' 253' ' ' PRO . 49.8 m -151.49 165.7 16.81 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.747 178.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . 0.522 ' HD2' ' HB3' ' B' ' 252' ' ' SER . 11.3 Cg_endo -55.41 -25.69 49.63 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.756 2.304 . . . . 0.0 112.113 177.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 254' ' ' SER . . . . . 0.548 ' O ' ' HG3' ' B' ' 258' ' ' GLU . 30.0 t -54.15 -36.29 63.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.142 174.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -74.32 -40.16 62.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.905 0.383 . . . . 0.0 110.614 -177.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 42.7 tp -60.9 -45.45 94.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.211 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 257' ' ' ARG . . . . . 0.519 ' HD3' ' OH ' ' A' ' 71' ' ' TYR . 13.1 ptt180 -63.72 -30.99 72.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.796 0.331 . . . . 0.0 111.158 -178.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 258' ' ' GLU . . . . . 0.548 ' HG3' ' O ' ' B' ' 254' ' ' SER . 56.5 mt-10 -72.41 -36.49 68.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.854 0.359 . . . . 0.0 110.462 -179.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -74.67 -40.1 61.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.966 178.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 93.3 mt -66.35 -43.89 84.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.746 -177.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 22.0 p -68.15 -34.15 75.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.751 0.31 . . . . 0.0 110.521 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 262' ' ' GLU . . . . . 0.592 ' HA ' ' O ' ' A' ' 17' ' ' PHE . 7.9 tp10 -54.93 -44.76 74.57 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.573 0.701 . . . . 0.0 109.966 176.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 263' ' ' LEU . . . . . 0.596 HD23 ' HB ' ' A' ' 13' ' ' THR . 68.9 mt -74.69 -41.73 59.69 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.995 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -60.17 -47.86 84.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.271 -174.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -70.7 -29.96 66.39 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.624 -177.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -66.49 -23.53 66.27 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.373 0.606 . . . . 0.0 110.538 176.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 267' ' ' LYS . . . . . 0.587 ' HG2' ' O ' ' B' ' 263' ' ' LEU . 73.3 mmtt -89.43 -21.76 22.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.869 176.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 88.27 25.3 31.47 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.802 -177.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -100.14 -165.28 28.82 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.124 -179.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . 0.513 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 22.2 mmtp -132.66 -67.56 0.64 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.194 0.521 . . . . 0.0 109.708 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 271' ' ' TYR . . . . . 0.687 ' HB3' ' HA ' ' B' ' 224' ' ' GLN . 7.7 m-85 -101.23 145.29 29.02 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.165 -176.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 272' ' ' TYR . . . . . 0.539 ' CD2' ' HB1' ' A' ' 22' ' ' ALA . 10.9 p90 -104.46 169.47 8.45 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 175.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 273' ' ' HIS . . . . . 0.455 ' HB3' ' HB2' ' B' ' 289' ' ' GLU . 10.7 t-160 -138.03 101.47 4.43 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.402 172.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 274' ' ' ILE . . . . . 0.46 HG21 ' OE1' ' A' ' 29' ' ' GLU . 63.3 mt -71.33 123.02 24.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.155 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 22.5 pt -114.08 -28.67 2.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.592 -176.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -152.06 107.13 3.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.954 0.407 . . . . 0.0 111.531 -178.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -105.37 96.65 6.66 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 173.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -127.38 137.51 52.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.206 0.527 . . . . 0.0 111.331 -170.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -88.06 119.75 28.74 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.095 0.474 . . . . 0.0 110.707 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -98.62 78.65 2.39 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 69.5 -126.42 18.78 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 -175.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.74 6.47 4.5 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 122.614 2.209 . . . . 0.0 112.257 177.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -112.34 151.49 29.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.184 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 284' ' ' PHE . . . . . 0.464 ' HB3' ' HB2' ' B' ' 245' ' ' GLN . 52.0 t80 -115.67 113.0 22.93 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 175.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 285' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -102.37 110.39 22.32 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.293 -0.412 . . . . 0.0 109.993 -177.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 286' ' ' ALA . . . . . 0.468 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -102.35 114.91 29.49 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.79 0.328 . . . . 0.0 110.52 176.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 29.4 t -105.75 120.93 57.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.218 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -138.83 152.21 47.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.019 0.438 . . . . 0.0 111.364 -178.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 289' ' ' GLU . . . . . 0.532 ' HB3' ' HE2' ' B' ' 237' ' ' LYS . 31.1 mt-10 -91.74 157.99 16.61 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 175.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 39.9 t -115.11 125.43 72.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 177.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 291' ' ' TYR . . . . . 0.415 ' CZ ' HD13 ' B' ' 230' ' ' ILE . 93.5 m-85 -125.02 155.34 39.87 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.236 0.541 . . . . 0.0 110.716 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 292' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -118.91 156.62 29.2 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 293' ' ' ASP . . . . . 0.447 ' OD1' ' HG3' ' B' ' 296' ' ' LYS . 2.3 p30 -65.14 -23.44 67.13 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.662 0.267 . . . . 0.0 110.897 -178.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 294' ' ' ALA . . . . . . . . . . . . . . . 70.79 13.02 7.19 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.544 173.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 295' ' ' THR . . . . . 0.624 HG23 ' H ' ' B' ' 296' ' ' LYS . 1.7 t -140.84 -70.4 0.38 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 178.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 296' ' ' LYS . . . . . 0.761 ' O ' ' HG ' ' B' ' 297' ' ' LEU . 41.5 mtmt 68.23 130.11 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 122.916 0.486 . . . . 0.0 112.21 -175.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 297' ' ' LEU . . . . . 0.761 ' HG ' ' O ' ' B' ' 296' ' ' LYS . 3.1 pp 60.9 135.31 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.274 1.43 . . . . 0.0 114.313 171.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 298' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' B' ' 299' ' ' HIS . 43.9 mt-10 -73.5 168.14 19.87 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.599 177.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 299' ' ' HIS . . . . . 0.446 ' HB2' ' O ' ' B' ' 298' ' ' GLU . 16.3 m170 70.58 -55.12 0.63 Allowed 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.743 0.652 . . . . 0.0 110.514 -175.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 300' ' ' HIS . . . . . 0.56 ' HE1' ' O ' ' B' ' 295' ' ' THR . 2.5 t60 71.12 165.57 0.29 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.413 0.685 . . . . 0.0 111.284 174.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 301' ' ' HIS . . . . . . . . . . . . . 40.6 m80 70.52 -171.72 0.17 Allowed 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.593 179.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 302' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 71.18 109.31 0.06 Allowed 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.789 0.681 . . . . 0.0 112.477 176.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 9.8 m80 -139.26 122.02 16.46 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.817 173.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 . . . . . 0 C--N 1.322 -0.63 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 -178.979 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.2 ttm . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 120.72 0.295 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -157.24 -94.52 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 175.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -147.28 138.83 24.03 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -130.7 112.31 12.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.705 0.764 . . . . 0.0 110.933 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.8 pt -113.47 123.66 69.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.959 177.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.486 HD12 ' O ' ' A' ' 6' ' ' ILE . 2.4 pp -98.42 130.5 47.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.311 0.577 . . . . 0.0 111.336 -177.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -161.74 90.41 0.78 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.034 178.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -149.92 -158.9 0.96 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.54 -177.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 70.4 76.52 0.2 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 123.917 0.761 . . . . 0.0 111.076 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 94.9 mt -142.99 160.73 39.8 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.774 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.4 pp -160.16 159.09 31.26 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 176.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.5 -60.79 0.51 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.984 0.421 . . . . 0.0 110.764 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.4 m -151.07 122.06 7.65 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.435 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.1 m -84.01 152.79 3.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 176.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.559 ' HB3' ' HA3' ' B' ' 268' ' ' GLY . . . -126.01 -162.44 1.13 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.74 0.305 . . . . 0.0 111.114 -175.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.9 t -118.99 -172.23 2.26 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.568 -178.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -72.49 162.34 29.61 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.663 -175.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.3 m -147.49 -55.34 0.23 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.775 173.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 75.7 m -162.46 141.33 9.04 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 177.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 34.9 tp -62.95 98.04 0.12 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.974 0.416 . . . . 0.0 110.19 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -137.26 -151.12 0.38 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.106 -177.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.589 ' HA ' ' OE2' ' B' ' 223' ' ' GLU . . . 73.54 111.07 0.07 Allowed 'General case' 0 N--CA 1.464 0.241 0 O-C-N 123.994 0.809 . . . . 0.0 109.984 -175.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.717 ' O ' ' HB3' ' A' ' 24' ' ' GLN . 9.2 tp10 -133.74 178.75 6.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.349 -171.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.717 ' HB3' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER 96.45 134.9 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.95 1.3 . . . . 0.0 111.985 176.851 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.435 ' N ' ' HG2' ' A' ' 24' ' ' GLN . 21.2 m -109.98 155.74 11.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.07 -0.968 . . . . 0.0 108.721 172.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.623 ' HB3' ' OE1' ' A' ' 28' ' ' GLN . 7.0 t -98.29 -176.85 3.52 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.26 -178.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.594 ' HA ' HD12 ' A' ' 30' ' ' ILE . 5.0 tmtt? -65.08 -27.87 69.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.464 -169.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.623 ' OE1' ' HB3' ' A' ' 26' ' ' SER . 15.8 mp0 -59.34 -49.51 77.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.021 0.439 . . . . 0.0 110.356 -178.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.638 ' HA ' ' HB3' ' A' ' 32' ' ' HIS . 12.8 mm-40 -75.25 -25.62 58.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.102 -173.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.594 HD12 ' HA ' ' A' ' 27' ' ' LYS . 63.8 mt -57.53 -52.93 51.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.204 0.526 . . . . 0.0 109.912 175.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.8 m -73.87 -24.02 59.68 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.001 177.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.638 ' HB3' ' HA ' ' A' ' 29' ' ' GLU . 21.8 t-160 -69.72 -52.58 24.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.136 -177.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -97.59 2.95 50.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.301 -176.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt 56.17 59.05 3.9 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 123.624 0.577 . . . . 0.0 111.03 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.3 mt -62.44 138.04 58.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.654 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.8 t -65.09 -37.17 79.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.541 -174.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.0 tttm 66.28 114.94 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 O-C-N 124.227 0.954 . . . . 0.0 111.118 -178.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.2 m -82.66 -39.45 15.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.859 -0.337 . . . . 0.0 111.741 -177.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 173.12 -155.67 23.12 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.266 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.55 HG23 ' HG2' ' A' ' 89' ' ' GLU . 46.8 m -141.97 131.06 23.25 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.706 0.289 . . . . 0.0 110.337 -178.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.9 pt -120.91 173.3 6.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -150.29 152.2 34.13 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.558 0.694 . . . . 0.0 112.112 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.616 HG13 ' NE2' ' A' ' 45' ' ' GLN . 69.2 t -94.64 128.67 45.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.521 171.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.4 t -143.34 46.11 1.52 Allowed 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.616 ' NE2' HG13 ' A' ' 43' ' ' VAL . 1.0 OUTLIER -93.42 145.05 24.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.033 -175.089 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.3 m -82.1 80.97 8.2 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.956 -174.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.23 -77.29 0.58 Allowed Glycine 0 CA--C 1.521 0.434 0 N-CA-C 114.872 0.709 . . . . 0.0 114.872 168.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -58.56 -19.85 43.5 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 114.743 0.657 . . . . 0.0 114.743 -168.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.431 ' HB2' ' HB3' ' A' ' 45' ' ' GLN . 15.9 mm-40 -79.35 -21.77 45.37 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 117.356 0.578 . . . . 0.0 111.169 -178.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 40.3 mm -123.44 88.22 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.7 t -105.76 -30.64 9.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.635 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.7 m -127.47 158.38 69.92 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.373 -177.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.28 -32.52 81.31 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.726 2.284 . . . . 0.0 112.088 176.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.591 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 11.5 p -64.28 -40.68 96.45 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.145 178.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -54.96 -30.97 60.13 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.733 0.301 . . . . 0.0 111.457 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 40.4 tp -56.59 -55.91 27.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.774 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -73.21 -29.8 63.06 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.047 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.591 ' HG2' ' O ' ' A' ' 54' ' ' SER . 22.8 mm-40 -62.05 -48.31 80.83 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.214 0.531 . . . . 0.0 110.837 179.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -73.12 -37.94 66.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.336 -178.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.479 HD13 ' CE1' ' A' ' 72' ' ' TYR . 37.6 mt -72.08 -35.51 69.25 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.732 -178.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.426 ' HA ' ' HB3' ' B' ' 221' ' ' ALA . 24.9 m -62.6 -42.74 99.75 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 120.874 -0.331 . . . . 0.0 110.31 173.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.767 ' HG3' ' HA ' ' B' ' 216' ' ' SER . 9.2 tp10 -56.18 -39.65 72.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.356 -178.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.402 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 86.6 mt -76.42 -51.34 12.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.669 178.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.86 -32.16 72.48 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.294 -171.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -58.03 -49.49 76.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.946 0.403 . . . . 0.0 110.611 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.525 ' HB2' ' HB2' ' B' ' 217' ' ' PHE . . . -70.49 -25.25 63.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.612 -178.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 63' ' ' LEU . 74.9 mmtt -75.87 -19.62 58.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.023 0.439 . . . . 0.0 110.581 178.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.55 38.46 9.7 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.291 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -105.51 161.62 14.56 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.414 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.584 ' HG3' ' OD2' ' A' ' 93' ' ' ASP . 35.4 mmtp -98.73 -48.66 4.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.276 0.56 . . . . 0.0 110.387 178.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.537 ' HE2' ' HD2' ' B' ' 257' ' ' ARG . 1.5 p90 -147.63 168.28 22.42 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.39 -178.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.479 ' CE1' HD13 ' A' ' 60' ' ' LEU . 45.8 p90 -142.14 166.96 23.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.901 -178.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -137.7 109.43 7.08 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.313 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.575 HG12 ' HB2' ' A' ' 88' ' ' ALA . 83.6 mt -69.62 130.31 34.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 176.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.9 pt -109.55 -25.88 3.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.29 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -150.0 129.37 12.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.628 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -144.28 138.12 27.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.255 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.531 ' HD3' ' HB2' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -166.52 157.77 12.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.547 179.848 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -91.47 122.68 34.28 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 168.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -115.35 96.73 5.8 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.82 -125.25 9.0 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -172.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.44 ' HD2' ' ND2' ' A' ' 83' ' ' ASN . 94.9 Cg_endo -94.83 14.94 1.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.019 2.479 . . . . 0.0 112.497 175.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.44 ' ND2' ' HD2' ' A' ' 82' ' ' PRO . 12.6 m-80 -114.87 150.69 35.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.704 0.288 . . . . 0.0 110.947 -176.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -109.43 108.17 18.59 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 174.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.532 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 5.0 mm-40 -100.62 112.34 24.71 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.057 -175.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.495 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -130.57 116.55 18.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.855 0.359 . . . . 0.0 111.318 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.2 t -96.55 123.35 48.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.782 0.325 . . . . 0.0 110.649 -177.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.575 ' HB2' HG12 ' A' ' 74' ' ' ILE . . . -135.35 129.0 32.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.007 0.432 . . . . 0.0 111.307 -177.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.55 ' HG2' HG23 ' A' ' 40' ' ' THR . 21.1 mt-10 -92.34 137.01 32.73 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 23.1 t -99.89 134.5 39.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 120.896 0.379 . . . . 0.0 110.33 -176.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -124.69 149.35 47.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.237 -177.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.574 ' OD1' ' HG2' ' A' ' 70' ' ' LYS . 18.2 m-20 -123.53 150.85 43.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.393 176.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.584 ' OD2' ' HG3' ' A' ' 70' ' ' LYS . 5.8 m-20 -60.94 152.66 27.05 Favored 'General case' 0 C--O 1.238 0.464 0 O-C-N 123.687 0.617 . . . . 0.0 110.359 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.97 85.72 0.52 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.021 0.439 . . . . 0.0 110.098 176.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.474 HG23 ' H ' ' A' ' 97' ' ' LEU . 7.1 t -174.6 -29.64 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.532 -176.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 95' ' ' THR . 31.0 mmtp 72.27 4.81 5.13 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 122.981 0.512 . . . . 0.0 111.976 177.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.474 ' H ' HG23 ' A' ' 95' ' ' THR . 93.8 mt -105.6 134.96 47.86 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.044 0.45 . . . . 0.0 110.906 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.402 ' OE1' ' HB2' ' A' ' 100' ' ' HIS . 1.1 pp20? -125.98 170.43 11.71 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.393 177.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 20.9 t60 -114.15 36.3 3.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.065 0.459 . . . . 0.0 110.995 -174.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.402 ' HB2' ' OE1' ' A' ' 98' ' ' GLU . 30.2 m80 -96.0 15.93 19.27 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.024 0.44 . . . . 0.0 109.935 175.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 54.1 m170 -68.01 163.07 23.09 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.927 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 69.76 31.46 3.52 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.158 0.504 . . . . 0.0 110.428 -175.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.401 ' HB2' ' HZ ' ' B' ' 217' ' ' PHE . 15.2 p80 -105.41 178.42 4.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.61 -177.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 34.8 m80 . . . . . 0 C--N 1.321 -0.665 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 170.413 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 79.4 mtp . . . . . 0 N--CA 1.482 1.13 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -73.3 79.0 1.33 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 121.687 0.756 . . . . 0.0 111.444 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -171.52 87.21 0.09 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.486 174.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -81.48 97.27 7.7 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.883 178.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 205' ' ' ILE . . . . . 0.807 HG13 ' H ' ' B' ' 207' ' ' ALA . 7.3 tp -60.45 128.25 21.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.55 -178.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 31.3 pt -83.1 4.6 2.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.542 -177.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 207' ' ' ALA . . . . . 0.807 ' H ' HG13 ' B' ' 205' ' ' ILE . . . 64.14 35.35 10.37 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 123.605 0.565 . . . . 0.0 111.539 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -116.1 124.21 49.81 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.889 176.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.05 160.05 25.79 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.924 0.392 . . . . 0.0 111.186 -178.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 210' ' ' LEU . . . . . . . . . . . . . 37.4 tp -114.29 138.31 50.66 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 6.1 tt -72.31 116.51 12.83 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -93.35 131.29 38.65 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.851 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 213' ' ' THR . . . . . . . . . . . . . 53.9 m -101.43 130.05 47.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.147 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 214' ' ' VAL . . . . . . . . . . . . . 49.5 t -56.05 122.13 4.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.146 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -101.64 -53.55 2.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.579 -177.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 216' ' ' SER . . . . . 0.767 ' HA ' ' HG3' ' A' ' 62' ' ' GLU . 47.1 m 70.05 120.86 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 O-C-N 123.671 0.607 . . . . 0.0 111.448 -178.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 217' ' ' PHE . . . . . 0.525 ' HB2' ' HB2' ' A' ' 66' ' ' ALA . 10.1 t80 -157.32 -69.08 0.1 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.038 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 218' ' ' SER . . . . . . . . . . . . . 5.9 m -135.63 150.74 49.73 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 175.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 4.0 m -99.22 12.78 35.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.626 0.727 . . . . 0.0 110.519 -178.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 95.7 mt -123.07 93.36 3.93 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.107 179.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . 0.426 ' HB3' ' HA ' ' A' ' 61' ' ' SER . . . -138.55 -62.53 0.56 Allowed 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 121.117 -0.233 . . . . 0.0 111.526 -178.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -158.35 170.04 23.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.951 0.405 . . . . 0.0 111.65 -173.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . 0.589 ' OE2' ' HA ' ' A' ' 22' ' ' ALA . 8.7 pt-20 -150.78 169.58 21.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.502 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 224' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' B' ' 223' ' ' GLU . 0.8 OUTLIER 177.4 137.08 0.07 Allowed 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.781 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 5.7 m -133.55 107.28 10.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.07 0.462 . . . . 0.0 110.195 173.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . 0.495 ' O ' HG13 ' B' ' 230' ' ' ILE . 8.5 t -89.71 171.08 9.9 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -178.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . 0.419 ' HB3' ' HE2' ' B' ' 227' ' ' LYS . 43.5 mtpt -66.45 -18.18 65.22 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -171.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -72.07 -47.56 50.64 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 176.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 229' ' ' GLU . . . . . 0.449 ' OE1' ' HB3' ' B' ' 226' ' ' SER . 2.0 mp0 -67.4 -41.04 85.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.159 176.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.571 HG12 HD12 ' B' ' 235' ' ' LEU . 98.1 mt -59.01 -48.01 88.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.448 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 35.5 p -72.78 -25.01 61.01 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.007 0.432 . . . . 0.0 110.959 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 26.4 t-80 -75.71 -50.17 16.12 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.284 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -88.62 -16.89 31.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.319 -177.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 60.06 79.77 0.23 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.543 0.687 . . . . 0.0 110.177 -177.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . 0.571 HD12 HG12 ' B' ' 230' ' ' ILE . 82.9 mt -82.57 177.48 8.69 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.002 -175.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.476 HG23 ' HA ' ' B' ' 294' ' ' ALA . 61.3 t -105.96 138.8 29.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.727 -178.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 237' ' ' LYS . . . . . 0.438 ' HE2' ' O ' ' B' ' 239' ' ' GLY . 20.2 tptm -104.74 128.9 53.0 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.774 -179.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 238' ' ' VAL . . . . . 0.418 HG13 ' HB2' ' B' ' 292' ' ' ASN . 2.6 m -91.3 -45.33 14.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.297 176.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 239' ' ' GLY . . . . . 0.438 ' O ' ' HE2' ' B' ' 237' ' ' LYS . . . 166.02 -178.7 40.57 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.115 -177.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 34.9 m -106.69 137.93 43.81 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.466 -0.198 . . . . 0.0 110.466 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 29.7 pt -105.53 137.44 35.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.878 0.37 . . . . 0.0 110.435 175.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -115.64 114.17 24.53 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.431 -177.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 243' ' ' VAL . . . . . 0.585 ' HB ' ' HB3' ' B' ' 286' ' ' ALA . 54.9 t -101.9 125.4 56.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.901 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 23.1 t -146.91 106.4 3.92 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.874 0.369 . . . . 0.0 110.44 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 245' ' ' GLN . . . . . 0.507 ' HG3' ' HB2' ' B' ' 249' ' ' GLN . 0.0 OUTLIER -156.33 168.05 28.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.391 178.363 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 22.6 t -92.16 -174.3 3.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.828 0.347 . . . . 0.0 110.413 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -69.64 -3.1 39.67 Favored Glycine 0 C--N 1.33 0.2 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.771 -178.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -74.45 -27.59 65.29 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.701 -0.762 . . . . 0.0 111.613 174.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . 0.507 ' HB2' ' HG3' ' B' ' 245' ' ' GLN . 64.7 mt-30 -102.16 -36.79 8.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.56 0.219 . . . . 0.0 110.586 177.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 250' ' ' ILE . . . . . 0.433 HG12 ' HG3' ' B' ' 245' ' ' GLN . 47.6 mm -115.4 99.97 9.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.857 0.36 . . . . 0.0 110.791 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 21.5 t -122.68 -42.74 2.3 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.999 175.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . 0.51 ' HB3' ' HD2' ' B' ' 253' ' ' PRO . 32.3 m -111.23 162.33 21.35 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.776 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . 0.51 ' HD2' ' HB3' ' B' ' 252' ' ' SER . 13.1 Cg_endo -57.83 -35.25 98.88 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.775 2.316 . . . . 0.0 112.754 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 254' ' ' SER . . . . . 0.417 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 5.3 p -63.27 -34.39 77.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.149 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -58.84 -51.57 69.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.662 -176.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 55.4 tp -63.66 -37.92 89.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.029 -177.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 257' ' ' ARG . . . . . 0.537 ' HD2' ' HE2' ' A' ' 71' ' ' TYR . 81.3 mtp180 -59.43 -39.92 85.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.719 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 258' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' B' ' 254' ' ' SER . 21.2 mm-40 -65.46 -30.98 71.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.857 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -79.74 -48.36 13.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.113 -177.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.69 -46.25 86.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.904 -174.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 18.4 p -61.28 -41.18 96.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.224 0.535 . . . . 0.0 110.763 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -61.5 -51.0 70.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.156 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 263' ' ' LEU . . . . . . . . . . . . . 95.9 mt -67.65 -31.42 71.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.68 -175.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.88 -50.75 47.05 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -175.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -71.98 -25.31 61.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.872 0.368 . . . . 0.0 110.106 -177.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -67.8 -34.24 76.37 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.287 0.565 . . . . 0.0 110.552 176.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -81.79 -9.68 59.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.362 177.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 268' ' ' GLY . . . . . 0.559 ' HA3' ' HB3' ' A' ' 15' ' ' ALA . . . 96.37 5.92 58.94 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.168 175.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . 0.485 ' HA3' HG12 ' B' ' 290' ' ' VAL . . . -89.45 154.94 24.58 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.685 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . 0.484 ' HE2' ' O ' ' B' ' 268' ' ' GLY . 48.6 mmtt -119.74 -2.54 10.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.951 0.405 . . . . 0.0 110.55 -175.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 271' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -143.55 154.6 43.77 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 175.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 272' ' ' TYR . . . . . 0.443 ' CD1' ' HB1' ' A' ' 22' ' ' ALA . 7.3 p90 -151.31 157.85 43.05 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.994 174.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -138.89 112.13 8.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.865 -178.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 274' ' ' ILE . . . . . 0.591 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 55.6 mt -69.24 120.76 17.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.536 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 22.0 pt -97.87 -36.94 6.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.149 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -145.45 100.44 3.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.925 0.393 . . . . 0.0 111.598 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -104.57 100.57 10.24 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 174.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 278' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' B' ' 285' ' ' GLU . 10.0 ptm180 -118.68 111.96 19.19 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.838 0.827 . . . . 0.0 111.787 -169.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -77.75 96.78 4.99 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.666 173.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 17.1 t-160 -96.62 97.83 9.7 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.691 -175.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 77.39 -137.26 20.1 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -174.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -83.08 -4.36 11.17 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.462 2.108 . . . . 0.0 111.872 174.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -103.66 154.33 19.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.173 -176.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 284' ' ' PHE . . . . . 0.438 ' CE2' ' HB2' ' B' ' 286' ' ' ALA . 84.1 t80 -114.74 124.75 52.58 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.913 0.387 . . . . 0.0 110.238 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 285' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 36.2 mt-10 -123.72 116.65 23.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.151 -179.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 286' ' ' ALA . . . . . 0.585 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -118.07 130.15 55.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.119 0.485 . . . . 0.0 111.722 -175.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 35.2 t -110.93 120.73 62.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.031 174.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -133.13 140.86 47.84 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.11 0.481 . . . . 0.0 111.517 -177.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -91.75 119.27 31.43 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.497 177.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 290' ' ' VAL . . . . . 0.485 HG12 ' HA3' ' B' ' 269' ' ' GLY . 15.4 t -94.98 130.41 43.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -117.35 157.81 25.49 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.375 0.607 . . . . 0.0 110.634 -176.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 292' ' ' ASN . . . . . 0.418 ' HB2' HG13 ' B' ' 238' ' ' VAL . 6.3 t-20 -120.37 164.38 16.43 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 174.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -67.53 157.16 34.99 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -176.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 294' ' ' ALA . . . . . 0.476 ' HA ' HG23 ' B' ' 236' ' ' VAL . . . -72.64 -6.21 42.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.118 0.485 . . . . 0.0 111.708 -173.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 295' ' ' THR . . . . . . . . . . . . . 14.8 t -105.47 -6.11 19.72 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.132 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 65.22 -167.18 0.22 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.04 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 297' ' ' LEU . . . . . 0.464 ' H ' HD23 ' B' ' 297' ' ' LEU . 0.4 OUTLIER -94.88 159.13 15.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.995 -176.34 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 298' ' ' GLU . . . . . 0.504 ' HB3' ' CE1' ' B' ' 301' ' ' HIS . 34.7 tt0 63.62 99.95 0.03 OUTLIER 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.748 -176.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 299' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -82.83 22.3 0.93 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.744 -178.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 300' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -138.54 70.9 1.38 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.559 175.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 301' ' ' HIS . . . . . 0.504 ' CE1' ' HB3' ' B' ' 298' ' ' GLU . 3.4 m-70 -93.03 105.74 17.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.947 175.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 302' ' ' HIS . . . . . 0.436 ' HB2' ' O ' ' B' ' 301' ' ' HIS . 41.0 m170 73.7 152.54 0.13 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.73 0.776 . . . . 0.0 112.304 178.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -144.01 -34.92 0.38 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.572 170.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 11.5 t60 . . . . . 0 C--N 1.333 -0.144 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.394 172.401 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -151.3 82.69 1.31 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.173 0.511 . . . . 0.0 110.287 178.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.6 tttt 68.51 152.39 0.09 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.168 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 4' ' ' ARG . 8.4 ptp180 -94.75 -168.15 1.77 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.435 -179.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.6 pt -73.08 165.34 3.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.844 0.354 . . . . 0.0 111.128 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 64.8 mt -74.4 109.11 6.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.5 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.1 96.28 7.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.842 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -156.89 -176.77 6.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.62 179.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -95.89 101.9 13.63 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 110.151 -0.315 . . . . 0.0 110.151 176.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -136.89 149.17 47.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.549 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.31 -57.4 2.25 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 176.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 57.84 -158.91 0.27 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.317 177.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.9 t -150.48 137.71 19.47 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 174.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.7 m -112.15 141.89 26.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.581 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -111.26 82.06 1.54 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.354 177.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.4 p -118.38 91.12 3.48 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.596 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 93.7 t80 -122.78 123.35 40.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.032 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.6 m -123.18 119.56 30.58 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.318 177.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.0 t -73.16 -10.24 59.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.828 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.1 mp -85.16 95.85 9.28 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 177.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -129.87 -74.33 0.55 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.09 -178.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.697 ' HB1' ' CD1' ' B' ' 272' ' ' TYR . . . -126.54 138.32 53.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.931 -176.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.765 ' HG2' ' HB1' ' B' ' 221' ' ' ALA . 0.0 OUTLIER -138.23 -171.67 3.09 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.883 -171.116 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.554 ' CD ' ' HG3' ' B' ' 224' ' ' GLN . 0.0 OUTLIER 75.24 154.69 0.16 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.627 0.771 . . . . 0.0 111.615 176.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.8 m -114.77 164.56 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.854 -176.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.525 ' HB2' ' HB ' ' B' ' 274' ' ' ILE . 16.8 t -74.95 164.32 26.69 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.005 0.431 . . . . 0.0 111.267 -174.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -66.61 -28.91 68.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.281 176.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -60.67 -37.97 83.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.403 176.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.622 ' HA ' ' HB3' ' A' ' 32' ' ' HIS . 15.4 mm-40 -72.52 -26.21 61.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.908 -175.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.457 ' HA ' HD13 ' A' ' 35' ' ' LEU . 56.5 mt -60.79 -48.09 90.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 173.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.2 m -73.92 -21.15 60.16 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.1 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.622 ' HB3' ' HA ' ' A' ' 29' ' ' GLU . 22.8 t-160 -80.89 -54.21 5.79 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.402 -175.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -93.24 -20.05 20.81 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -176.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.85 84.99 0.13 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.191 0.519 . . . . 0.0 110.513 -175.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.565 HD22 ' HE1' ' A' ' 71' ' ' TYR . 5.8 mp -91.08 175.48 6.93 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.433 -176.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.415 HG11 ' HZ3' ' A' ' 96' ' ' LYS . 45.6 t -99.38 129.51 49.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.253 -173.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.474 ' HZ1' ' CD ' ' A' ' 89' ' ' GLU . 35.3 tptt -70.48 126.46 29.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.416 179.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.94 8.88 5.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.952 0.406 . . . . 0.0 111.483 175.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.75 -170.0 15.97 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.8 174.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 53.3 m -133.38 131.05 39.58 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.629 HG13 ' HB3' ' A' ' 88' ' ' ALA . 26.1 pt -104.23 132.33 51.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 176.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -123.28 127.72 48.96 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.136 0.493 . . . . 0.0 110.686 -175.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.662 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 88.7 t -93.01 123.26 45.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.171 175.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.5 t -146.35 74.4 1.36 Allowed 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 176.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -124.37 178.75 5.22 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.051 -178.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.8 t -86.27 168.47 13.88 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.85 176.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.26 -16.52 54.07 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.492 178.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.24 -17.83 74.45 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.123 -0.561 . . . . 0.0 112.349 177.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -111.61 -26.85 8.81 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.12 0.486 . . . . 0.0 110.353 176.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.494 HD12 ' HA ' ' A' ' 56' ' ' LEU . 43.1 mm -117.41 92.13 2.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.34 175.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.8 t -113.79 -62.33 1.61 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.347 -177.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.8 m -101.56 165.02 14.8 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.827 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -53.0 -38.4 79.98 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.423 2.082 . . . . 0.0 111.567 174.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.8 p -67.71 -38.53 83.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.448 177.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -59.88 -46.89 87.89 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.154 0.502 . . . . 0.0 109.932 176.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.494 ' HA ' HD12 ' A' ' 50' ' ' ILE . 60.4 tp -61.28 -45.74 93.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.19 176.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.69 ' HD2' ' OE2' ' B' ' 223' ' ' GLU . 3.7 ttp180 -53.41 -48.36 68.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.203 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -55.52 -45.76 77.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.14 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -70.74 -35.23 72.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.06 -178.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.7 mt -66.04 -48.65 70.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.062 0.458 . . . . 0.0 110.635 176.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.5 t -64.03 -38.11 89.87 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.226 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -58.17 -43.88 87.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.95 178.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 93.5 mt -70.32 -38.03 74.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.277 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.95 93.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.063 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.825 ' HB2' HD13 ' B' ' 220' ' ' LEU . 20.1 t70 -63.11 -31.94 73.2 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.099 178.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.47 -24.01 61.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.32 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 28.3 mmtm -100.17 -13.42 18.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.557 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.09 38.82 73.47 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.108 -179.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.1 146.3 18.19 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.567 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.612 ' O ' ' HB3' ' B' ' 221' ' ' ALA . 0.0 OUTLIER -89.89 -2.18 58.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.633 0.254 . . . . 0.0 111.442 -176.497 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.565 ' HE1' HD22 ' A' ' 35' ' ' LEU . 10.4 p90 -167.4 174.88 7.61 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 169.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.547 ' O ' ' HG3' ' A' ' 24' ' ' GLN . 44.0 p90 -148.25 130.74 15.77 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 175.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -111.43 109.67 19.75 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.385 -0.526 . . . . 0.0 109.97 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.555 ' HA ' ' HA ' ' A' ' 88' ' ' ALA . 68.2 mt -68.75 127.15 30.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 177.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 26.8 pt -102.3 -37.24 4.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.03 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.23 136.03 36.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.241 -178.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -147.69 134.12 19.68 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.493 ' HD3' ' HB2' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -154.72 147.34 24.21 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.999 0.428 . . . . 0.0 110.286 179.192 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -94.11 92.6 7.37 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 177.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -87.59 80.13 8.1 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.44 -173.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.62 -121.92 16.05 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.961 -178.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -86.2 -1.46 8.56 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.951 2.434 . . . . 0.0 112.442 177.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -117.45 122.42 43.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.318 -178.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.45 ' CD2' HG21 ' A' ' 50' ' ' ILE . 88.5 t80 -92.53 128.04 38.23 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 177.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.662 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 48.4 mt-10 -112.22 117.09 31.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.708 -179.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.525 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -120.99 118.67 30.44 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.194 175.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.6 t -100.95 111.5 30.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.629 ' HB3' HG13 ' A' ' 41' ' ' ILE . . . -117.38 132.45 56.58 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.05 0.452 . . . . 0.0 110.957 -177.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.496 ' HB3' ' CE2' ' A' ' 91' ' ' TYR . 11.0 mm-40 -92.14 128.23 37.91 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.116 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.1 t -102.37 125.86 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -178.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.496 ' CE2' ' HB3' ' A' ' 89' ' ' GLU . 92.9 m-85 -129.54 142.67 50.71 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.0 0.429 . . . . 0.0 110.386 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -111.85 170.32 8.23 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.014 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.471 ' OD2' ' HG2' ' A' ' 70' ' ' LYS . 13.2 m-20 -76.04 167.03 22.61 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.085 0.469 . . . . 0.0 111.006 -176.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -87.36 23.57 1.84 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.231 178.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.9 t -129.5 117.46 20.52 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.643 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.415 ' HZ3' HG11 ' A' ' 36' ' ' VAL . 33.8 mtmt -149.88 20.74 0.89 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.115 177.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 71.6 mt -107.83 92.4 4.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.957 -177.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -115.4 -74.45 0.61 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -119.82 105.06 10.75 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.28 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 14.3 m80 -120.33 162.09 20.05 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.222 176.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 64.8 t60 -81.54 -38.5 26.1 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.588 -177.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -124.07 137.55 54.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.906 0.384 . . . . 0.0 110.419 178.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 62.6 m80 -104.11 -24.46 13.18 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 175.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.039 174.695 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 66.2 mtt . . . . . 0 N--CA 1.482 1.175 0 CA-C-O 120.452 0.168 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? -147.39 168.73 21.1 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 82.5 tttt 71.81 135.61 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 O-C-N 124.285 0.991 . . . . 0.0 111.709 177.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -89.16 125.75 35.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.394 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 15.3 tt -146.05 150.09 15.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.571 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 60.7 mt -116.43 -61.18 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.561 0.22 . . . . 0.0 110.542 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 207' ' ' ALA . . . . . 0.409 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . . . -169.17 156.97 7.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 -177.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -146.16 76.66 1.46 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.753 177.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -175.32 173.64 2.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.108 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 210' ' ' LEU . . . . . . . . . . . . . 6.9 mp -77.63 145.76 36.54 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.636 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 42.9 tp -70.17 159.11 34.55 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.434 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.67 93.84 5.55 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.849 0.357 . . . . 0.0 110.86 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 213' ' ' THR . . . . . . . . . . . . . 9.8 p -89.66 -32.41 17.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.967 178.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 214' ' ' VAL . . . . . . . . . . . . . 19.6 m -91.34 33.15 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.172 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -73.81 92.24 2.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.784 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 52.9 m -151.22 100.35 2.75 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.542 178.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -163.0 144.27 9.78 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 218' ' ' SER . . . . . . . . . . . . . 15.4 m -78.76 66.05 4.15 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.172 0.51 . . . . 0.0 111.403 -178.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 96.7 m -153.75 94.58 1.79 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.961 174.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.825 HD13 ' HB2' ' A' ' 65' ' ' ASP . 1.1 pt? -116.95 96.37 5.43 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.829 177.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . 0.765 ' HB1' ' HG2' ' A' ' 23' ' ' GLU . . . -84.65 64.12 8.33 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.613 0.721 . . . . 0.0 110.12 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -106.45 102.46 11.85 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.141 -175.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . 0.69 ' OE2' ' HD2' ' A' ' 57' ' ' ARG . 9.8 tp10 -162.04 120.45 2.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.818 -178.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 224' ' ' GLN . . . . . 0.554 ' HG3' ' CD ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -169.95 139.29 1.86 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.041 0.448 . . . . 0.0 112.067 -179.093 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 14.1 m -113.84 128.83 70.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.032 170.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . 0.464 ' HB2' ' HG2' ' B' ' 229' ' ' GLU . 12.5 m -77.59 157.42 30.29 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.683 -178.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -68.31 -30.39 69.36 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -62.22 -35.75 79.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.687 176.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 229' ' ' GLU . . . . . 0.464 ' HG2' ' HB2' ' B' ' 226' ' ' SER . 36.6 mm-40 -71.34 -25.3 62.34 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.405 -178.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.532 HG12 HD12 ' B' ' 235' ' ' LEU . 56.8 mt -60.97 -45.17 98.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.828 175.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 5.1 m -73.07 -21.66 60.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.568 176.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 232' ' ' HIS . . . . . 0.421 ' HB3' ' HA ' ' B' ' 229' ' ' GLU . 23.1 t-160 -78.11 -52.04 9.35 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.579 -173.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -113.22 -4.59 13.72 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -175.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.88 84.92 0.12 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.421 0.629 . . . . 0.0 110.119 -171.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . 0.532 HD12 HG12 ' B' ' 230' ' ' ILE . 87.9 mt -79.32 138.84 37.87 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.031 -176.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.43 HG11 ' HE2' ' B' ' 296' ' ' LYS . 57.2 t -72.92 106.4 2.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.626 -178.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -79.23 116.88 19.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.105 0.478 . . . . 0.0 110.317 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 3.0 t -81.36 -40.89 18.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.825 -178.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 169.05 -149.98 14.73 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.47 -178.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 41.6 m -139.42 127.63 22.58 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 241' ' ' ILE . . . . . 0.466 HG23 HG21 ' B' ' 290' ' ' VAL . 2.4 pp -103.32 131.96 50.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.123 0.487 . . . . 0.0 109.931 178.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -116.19 120.19 38.19 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.058 -177.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 243' ' ' VAL . . . . . 0.588 ' O ' ' HA ' ' B' ' 285' ' ' GLU . 57.9 t -94.16 132.2 38.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.408 178.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 46.5 m -127.87 88.55 2.79 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 172.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 245' ' ' GLN . . . . . 0.594 ' HG2' HG12 ' B' ' 250' ' ' ILE . 0.7 OUTLIER -80.88 107.82 14.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.076 -173.474 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 53.1 p -84.99 102.74 13.42 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.853 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 92.52 -163.73 27.58 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.798 176.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -85.61 64.67 4.09 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 121.275 -0.488 . . . . 0.0 113.443 -172.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . 0.556 ' HB2' ' HG3' ' B' ' 245' ' ' GLN . 64.8 mt-30 -93.95 -3.06 52.28 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.01 0.433 . . . . 0.0 110.195 173.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 250' ' ' ILE . . . . . 0.594 HG12 ' HG2' ' B' ' 245' ' ' GLN . 38.7 mm -125.68 99.22 5.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.091 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 33.0 t -93.58 -46.36 7.32 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.098 0.475 . . . . 0.0 109.799 175.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 20.0 m -123.64 167.63 14.58 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.212 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.13 -26.77 61.89 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.574 2.183 . . . . 0.0 112.01 173.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 254' ' ' SER . . . . . 0.404 ' O ' ' HG3' ' B' ' 258' ' ' GLU . 19.9 m -64.78 -39.45 93.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.625 177.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.04 -46.76 82.17 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.301 177.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 55.3 tp -57.58 -43.85 84.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.701 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 257' ' ' ARG . . . . . 0.49 ' HD2' ' CD ' ' A' ' 23' ' ' GLU . 10.7 ttp180 -53.71 -52.32 60.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.266 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 258' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' B' ' 254' ' ' SER . 68.7 mt-10 -60.29 -27.1 67.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.814 -173.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 259' ' ' LYS . . . . . 0.427 ' O ' ' HG ' ' B' ' 263' ' ' LEU . 14.4 mptt -80.47 -39.65 27.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.976 0.417 . . . . 0.0 110.851 176.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 95.6 mt -71.28 -47.34 57.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.73 -175.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 2.8 m -58.93 -34.83 72.18 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.314 0.578 . . . . 0.0 110.658 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -66.39 -47.81 72.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.421 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 263' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' B' ' 259' ' ' LYS . 90.6 mt -64.96 -32.41 74.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.629 -175.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -60.86 -42.58 98.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.597 -177.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -61.29 -49.39 77.22 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.43 -177.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -68.92 -15.12 63.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.852 -175.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 267' ' ' LYS . . . . . 0.444 ' HD3' ' HA ' ' B' ' 267' ' ' LYS . 31.4 mmtp -100.87 -0.86 36.07 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.088 178.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 74.42 28.11 64.35 Favored Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.218 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -101.27 162.76 17.98 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.066 -178.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . 0.496 ' HA ' ' CE ' ' B' ' 270' ' ' LYS . 0.0 OUTLIER -117.15 -59.94 1.89 Allowed 'General case' 0 C--N 1.32 -0.716 0 O-C-N 122.66 -0.317 . . . . 0.0 110.754 179.426 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 271' ' ' TYR . . . . . 0.622 ' HE2' ' HB2' ' B' ' 293' ' ' ASP . 6.0 m-85 -117.19 162.94 17.06 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 272' ' ' TYR . . . . . 0.697 ' CD1' ' HB1' ' A' ' 22' ' ' ALA . 0.1 OUTLIER -148.74 158.75 44.37 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.183 0.516 . . . . 0.0 110.994 -179.123 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -128.17 107.78 10.07 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.256 -178.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 274' ' ' ILE . . . . . 0.525 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 4.5 mp -77.46 120.47 28.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.611 -174.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 14.4 pt -111.42 -26.45 3.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -176.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . 0.659 ' HB3' ' HB ' ' B' ' 287' ' ' VAL . . . -134.9 145.74 48.52 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.192 -177.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 277' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' B' ' 285' ' ' GLU . . . -169.47 117.66 0.62 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.856 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.13 139.11 15.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.83 0.348 . . . . 0.0 110.992 -178.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 279' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' B' ' 284' ' ' PHE . 3.3 mp0 -76.7 91.08 3.43 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 174.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -87.01 89.31 7.95 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 -176.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 66.44 -118.76 11.33 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.511 -174.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -90.54 -2.12 5.18 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.896 2.398 . . . . 0.0 112.733 177.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 283' ' ' ASN . . . . . 0.551 ' HA ' ' O ' ' B' ' 245' ' ' GLN . 59.1 m-80 -118.87 115.87 25.3 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.018 0.437 . . . . 0.0 111.127 -176.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 284' ' ' PHE . . . . . 0.449 ' HA ' ' HA ' ' B' ' 279' ' ' GLU . 70.0 t80 -79.06 113.92 17.57 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 175.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 285' ' ' GLU . . . . . 0.588 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 48.3 mt-10 -99.27 114.13 26.79 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.853 -176.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 286' ' ' ALA . . . . . 0.498 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -114.26 135.09 54.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.473 174.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 287' ' ' VAL . . . . . 0.659 ' HB ' ' HB3' ' B' ' 276' ' ' ALA . 37.4 t -125.41 128.48 72.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 110.081 -0.341 . . . . 0.0 110.081 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -134.74 151.13 50.74 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.965 0.412 . . . . 0.0 111.54 -178.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 289' ' ' GLU . . . . . 0.455 ' O ' ' HA ' ' B' ' 272' ' ' TYR . 21.8 mt-10 -90.62 119.92 31.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.141 178.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 290' ' ' VAL . . . . . 0.466 HG21 HG23 ' B' ' 241' ' ' ILE . 39.1 t -94.15 124.15 46.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.511 0.196 . . . . 0.0 111.211 -175.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -129.27 151.29 50.09 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.469 0.652 . . . . 0.0 111.658 -178.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 292' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -106.76 155.19 19.96 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.949 173.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 293' ' ' ASP . . . . . 0.622 ' HB2' ' HE2' ' B' ' 271' ' ' TYR . 25.7 t70 -77.77 160.23 28.52 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 165.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 294' ' ' ALA . . . . . . . . . . . . . . . -75.29 41.29 0.18 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.963 0.411 . . . . 0.0 111.77 -176.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 295' ' ' THR . . . . . . . . . . . . . 10.0 t -126.49 -41.79 1.85 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.41 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 296' ' ' LYS . . . . . 0.43 ' HE2' HG11 ' B' ' 236' ' ' VAL . 43.4 mttm 56.28 32.0 19.57 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 177.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 297' ' ' LEU . . . . . . . . . . . . . 95.7 mt -107.52 112.5 25.28 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 176.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 298' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -105.62 4.09 29.87 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.914 -174.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 299' ' ' HIS . . . . . . . . . . . . . 40.4 m170 -108.38 133.26 52.81 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.333 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 300' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 66.77 82.42 0.18 Allowed 'General case' 0 C--N 1.331 -0.237 0 O-C-N 123.832 0.708 . . . . 0.0 110.894 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 301' ' ' HIS . . . . . . . . . . . . . 50.5 m80 -84.32 -40.43 17.95 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 302' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -145.27 -56.02 0.32 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 174.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -120.03 -44.38 2.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.205 168.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 45.2 m80 . . . . . 0 C--N 1.325 -0.494 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.622 177.984 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.471 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 18.6 mmt . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.471 ' H ' ' HB2' ' A' ' 1' ' ' MET . 95.2 mttt -136.94 124.97 22.82 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.428 -0.805 . . . . 0.0 108.904 175.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.887 ' HD3' ' H ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -81.62 90.08 6.27 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.548 0.69 . . . . 0.0 111.015 -173.501 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.637 ' HD3' ' H ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -81.85 56.11 2.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.776 0.798 . . . . 0.0 110.055 177.663 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.9 pt -79.88 -170.84 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.945 -178.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.5 tt -139.76 130.94 32.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.893 0.378 . . . . 0.0 110.799 178.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -138.57 18.54 2.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.375 0.607 . . . . 0.0 110.077 176.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -96.73 142.49 28.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.436 178.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -136.07 94.48 3.05 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.173 0.511 . . . . 0.0 111.132 -176.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 53.9 tp -122.35 122.38 38.92 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.738 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 56.8 tp -119.23 110.42 16.99 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.925 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.97 -177.5 4.91 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.158 0.504 . . . . 0.0 111.024 -177.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.4 m -145.69 106.87 4.17 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.12 177.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.6 m -130.62 -166.83 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.267 -175.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.539 ' HB3' ' HA2' ' B' ' 268' ' ' GLY . . . 69.18 171.11 0.3 Allowed 'General case' 0 N--CA 1.463 0.184 0 O-C-N 123.825 0.703 . . . . 0.0 111.967 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.0 t -167.81 -39.3 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.959 -177.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -115.74 106.06 13.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.051 174.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 69.3 m -145.45 -77.91 0.19 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.693 -0.23 . . . . 0.0 110.483 175.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 55.84 -66.31 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.321 1.048 . . . . 0.0 113.624 -177.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.599 HD12 HD13 ' B' ' 220' ' ' LEU . 2.2 mm? -83.0 81.9 8.47 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -163.5 167.37 21.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.669 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.467 ' O ' ' HD3' ' B' ' 257' ' ' ARG . . . 72.35 117.57 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 O-C-N 124.281 0.988 . . . . 0.0 112.002 176.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.733 ' HG2' ' H ' ' B' ' 222' ' ' ALA . 9.8 tp10 -150.17 179.74 7.85 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.361 -178.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.778 ' HA ' ' HB2' ' A' ' 71' ' ' TYR . 0.0 OUTLIER 85.44 140.08 0.06 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.074 0.95 . . . . 0.0 111.529 176.712 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.503 HG22 ' CZ ' ' A' ' 71' ' ' TYR . 5.0 m -117.06 173.35 4.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.48 176.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.57 ' HB3' ' HB ' ' B' ' 274' ' ' ILE . 92.3 p -97.99 -175.75 3.24 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.097 0.475 . . . . 0.0 111.039 -175.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.0 tmmt? -71.48 -19.74 62.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.099 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' B' ' 277' ' ' ALA . 1.8 mp0 -66.51 -45.91 77.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.6 -178.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -65.64 -44.69 85.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.502 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.0 mt -53.77 -46.47 62.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.688 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.3 m -68.4 -38.4 81.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.549 -176.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 25.8 m80 -80.86 -44.99 17.53 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -174.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.429 ' CD1' ' HD3' ' B' ' 253' ' ' PRO . 97.8 m-85 -93.22 -19.9 20.97 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -173.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm 61.35 82.72 0.16 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.184 0.516 . . . . 0.0 110.617 -177.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.573 HD21 ' HG3' ' B' ' 253' ' ' PRO . 96.5 mt -85.31 173.38 10.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.415 -176.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.1 t -95.97 124.78 48.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.608 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -84.58 115.49 22.65 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.161 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -94.68 -3.84 10.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.157 0.503 . . . . 0.0 111.141 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 120.83 155.25 9.51 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.976 174.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 27.4 m -81.16 150.3 28.75 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 177.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.3 pt -116.35 134.22 60.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.001 0.429 . . . . 0.0 110.006 172.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -124.12 116.04 22.11 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.122 -178.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 85' ' ' GLU . 3.2 t -109.87 109.51 28.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.513 -178.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.8 p -92.48 91.92 7.84 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 175.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.606 ' HG2' HG12 ' A' ' 50' ' ' ILE . 0.9 OUTLIER -97.58 147.66 24.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.669 -170.641 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.444 ' HA ' HD22 ' A' ' 83' ' ' ASN . 47.9 t -96.84 154.8 17.08 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 172.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.92 78.32 0.39 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.338 178.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -175.76 -37.83 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 121.146 -0.549 . . . . 0.0 112.553 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -81.73 -23.85 36.48 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 122.57 -0.37 . . . . 0.0 111.255 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.606 HG12 ' HG2' ' A' ' 45' ' ' GLN . 49.3 mm -112.7 109.71 29.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.6 t -107.12 -45.94 4.02 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.204 0.526 . . . . 0.0 109.711 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.518 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 22.0 m -126.06 165.96 24.32 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.837 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' A' ' 52' ' ' SER . 10.7 Cg_endo -54.69 -26.4 46.65 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.631 2.221 . . . . 0.0 111.981 177.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.598 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 2.3 m -55.67 -51.86 65.8 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.752 176.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -59.62 -42.17 92.07 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.234 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 56.9 tp -61.5 -46.58 89.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.908 -177.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 21.5 ttp180 -58.66 -44.51 90.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.455 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.598 ' HG2' ' O ' ' A' ' 54' ' ' SER . 19.0 mm-40 -62.32 -45.35 93.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.854 -178.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -67.33 -36.86 82.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.362 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.0 mt -68.26 -43.0 78.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.977 0.418 . . . . 0.0 110.515 177.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.4 m -68.49 -30.53 69.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.575 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -58.01 -46.67 84.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.055 0.455 . . . . 0.0 110.46 177.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 98.5 mt -74.55 -37.0 63.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.898 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.72 -32.64 74.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.091 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -60.33 -41.72 94.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.917 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.05 -16.62 56.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.078 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.707 ' HE3' ' HB2' ' B' ' 212' ' ' ALA . 28.0 mmtp -89.52 -15.22 33.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.548 177.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 57.68 48.98 77.83 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 -175.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -92.66 171.14 32.97 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.877 -175.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.477 ' CB ' ' HA ' ' A' ' 92' ' ' ASN . 56.7 tptt -99.89 -47.18 5.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.535 0.683 . . . . 0.0 109.811 178.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.778 ' HB2' ' HA ' ' A' ' 24' ' ' GLN . 35.1 p90 -150.96 177.15 10.43 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.794 -178.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -142.62 126.05 16.69 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.247 0.546 . . . . 0.0 110.166 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -106.61 101.0 10.48 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.281 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.626 HG12 ' HB2' ' A' ' 88' ' ' ALA . 69.7 mt -72.44 120.11 20.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.139 0.495 . . . . 0.0 110.514 -176.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.6 pt -94.99 -35.38 6.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.22 -178.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.97 110.88 5.02 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.995 0.426 . . . . 0.0 111.601 -177.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -107.86 88.43 2.73 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 172.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.532 ' CG ' ' HB2' ' A' ' 85' ' ' GLU . 6.2 ptp180 -95.86 121.49 37.64 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.874 0.845 . . . . 0.0 112.196 -166.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -70.64 100.47 1.85 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.71 172.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 23.8 t-80 -88.16 14.74 8.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.062 0.458 . . . . 0.0 110.46 -177.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.85 -106.5 3.18 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.75 -5.9 16.39 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.579 2.186 . . . . 0.0 111.193 173.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.444 HD22 ' HA ' ' A' ' 46' ' ' SER . 13.3 m120 -123.02 156.8 34.09 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.172 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -128.49 120.97 27.83 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.532 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 41.3 mt-10 -110.3 110.94 21.94 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.787 -177.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.36 118.12 32.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.035 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.9 t -112.82 112.79 41.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.934 176.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.626 ' HB2' HG12 ' A' ' 74' ' ' ILE . . . -127.76 141.71 51.51 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.962 0.41 . . . . 0.0 111.895 -176.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -91.85 116.47 28.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.79 177.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.6 t -100.34 125.01 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-O 121.117 0.484 . . . . 0.0 110.067 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.536 ' HB2' ' CE1' ' A' ' 71' ' ' TYR . 64.7 m-85 -123.84 159.51 29.43 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.911 177.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.477 ' HA ' ' CB ' ' A' ' 70' ' ' LYS . 10.3 t-20 -120.52 174.07 6.78 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 175.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -55.89 157.11 4.59 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.764 0.316 . . . . 0.0 110.222 176.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.75 64.86 1.81 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.994 0.426 . . . . 0.0 110.702 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 99' ' ' HIS . 16.0 m -152.78 -107.17 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.547 178.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 57.7 mttt 44.38 -94.57 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -174.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 90.0 mt -85.13 76.98 10.15 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.135 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 51.76 77.11 0.15 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.41 -0.813 . . . . 0.0 112.24 175.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.447 ' O ' ' HA ' ' A' ' 95' ' ' THR . 33.1 m80 -147.27 127.16 13.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.122 177.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -142.24 102.58 4.13 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.298 170.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -130.22 71.52 1.46 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.324 0.583 . . . . 0.0 110.29 -178.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -83.63 103.17 12.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.371 179.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 65.4 t-80 -87.64 134.84 33.57 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.767 178.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 4.7 p80 . . . . . 0 C--N 1.324 -0.523 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.847 178.965 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -119.33 16.56 13.07 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.34 0.59 . . . . 0.0 109.622 172.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -71.04 139.69 50.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.322 173.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 204' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -84.66 -45.36 12.55 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 205' ' ' ILE . . . . . . . . . . . . . 59.7 mt 58.61 92.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.168 176.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 25.5 pt -114.38 144.95 20.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.271 174.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -166.24 -47.35 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.61 0.243 . . . . 0.0 111.236 -175.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . 65.06 -156.61 0.29 Allowed 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.833 -178.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . 69.61 40.24 1.42 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.371 0.605 . . . . 0.0 110.665 -178.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 210' ' ' LEU . . . . . . . . . . . . . 91.5 mt -101.55 111.79 24.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.53 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 8.2 mp -93.99 146.21 24.1 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.868 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 212' ' ' ALA . . . . . 0.707 ' HB2' ' HE3' ' A' ' 67' ' ' LYS . . . -139.87 93.88 2.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.481 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 213' ' ' THR . . . . . . . . . . . . . 47.6 m -152.94 90.63 1.47 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.3 0.571 . . . . 0.0 110.977 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 214' ' ' VAL . . . . . . . . . . . . . 11.0 p -162.46 141.16 2.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.646 176.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -79.89 -57.38 3.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.418 -177.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 22.8 m 64.04 -161.65 0.28 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.353 -178.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -102.81 129.5 49.49 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 218' ' ' SER . . . . . . . . . . . . . 15.5 m -85.94 76.46 9.84 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.461 0.648 . . . . 0.0 110.813 -178.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 11.2 m -104.02 163.19 12.54 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.85 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.644 HD23 ' H ' ' B' ' 220' ' ' LEU . 1.2 pt? -60.34 114.99 3.21 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 176.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . 0.47 ' HB1' ' O ' ' A' ' 70' ' ' LYS . . . -166.83 178.38 5.9 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.328 -177.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . 0.733 ' H ' ' HG2' ' A' ' 23' ' ' GLU . . . 61.8 87.65 0.1 Allowed 'General case' 0 N--CA 1.465 0.321 0 O-C-N 124.004 0.815 . . . . 0.0 112.706 177.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -167.61 110.57 0.65 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.926 174.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 224' ' ' GLN . . . . . 0.53 ' HG3' ' CD ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -161.94 148.09 13.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.033 -175.817 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . 0.454 HG22 ' HB3' ' B' ' 271' ' ' TYR . 18.7 m -126.78 128.69 71.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 166.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . 0.6 ' HB2' ' HB ' ' A' ' 74' ' ' ILE . 6.3 t -87.86 178.98 6.55 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.776 0.322 . . . . 0.0 110.158 -177.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . 0.426 ' HA ' HD12 ' B' ' 230' ' ' ILE . 23.0 tptp -66.98 -23.91 65.99 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.293 -170.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -72.0 -50.32 29.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.939 0.399 . . . . 0.0 110.127 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -65.06 -38.64 91.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.784 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.49 HG13 ' O ' ' B' ' 226' ' ' SER . 97.4 mt -54.88 -54.0 27.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.032 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 56.8 m -73.44 -22.08 60.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.76 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -79.88 -44.5 20.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.693 0.282 . . . . 0.0 110.547 -177.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -89.48 -8.59 52.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.97 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt 60.28 51.72 5.32 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.528 -178.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.42 149.66 47.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.874 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.459 HG23 ' HB3' ' B' ' 292' ' ' ASN . 16.0 m -86.46 124.34 40.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.375 0.607 . . . . 0.0 111.491 -177.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -75.6 128.13 34.58 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.511 176.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 40.5 t -92.69 -44.44 13.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.253 0.549 . . . . 0.0 110.337 -179.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 177.11 -157.35 22.21 Favored Glycine 0 N--CA 1.442 -0.94 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.442 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 59.3 m -135.22 137.47 42.65 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 22.7 pt -117.61 142.61 31.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 175.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -132.9 138.5 47.0 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.692 0.758 . . . . 0.0 111.772 -177.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 243' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' B' ' 285' ' ' GLU . 59.7 t -102.75 134.68 43.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.221 177.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 7.2 t -149.21 47.82 0.98 Allowed 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 245' ' ' GLN . . . . . 0.522 ' NE2' HG13 ' B' ' 243' ' ' VAL . 0.9 OUTLIER -103.63 159.22 15.8 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.738 -177.071 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 246' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' B' ' 283' ' ' ASN . 19.1 m -89.18 171.06 10.09 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.247 -177.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -54.61 115.4 5.35 Favored Glycine 0 C--N 1.333 0.389 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.084 176.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . 134.31 -43.57 1.25 Allowed Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 -176.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . 0.472 ' HB2' ' HB3' ' B' ' 245' ' ' GLN . 11.5 mm100 -73.29 -23.81 60.33 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 49.9 mm -114.29 111.63 36.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 171.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 19.7 m -104.03 -19.09 14.31 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.612 -175.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . 0.478 ' H ' ' HB3' ' B' ' 255' ' ' ASP . 38.6 m -154.99 163.51 24.21 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -176.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . 0.573 ' HG3' HD21 ' A' ' 35' ' ' LEU . 19.1 Cg_endo -61.64 -41.98 35.7 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.256 1.971 . . . . 0.0 111.246 175.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 254' ' ' SER . . . . . 0.44 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 27.5 m -75.28 -18.74 60.0 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.762 177.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.478 ' HB3' ' H ' ' B' ' 252' ' ' SER . 35.2 t70 -71.56 -33.57 69.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.204 0.526 . . . . 0.0 109.723 176.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.409 ' O ' ' HG ' ' B' ' 260' ' ' LEU . 63.2 tp -59.44 -43.22 93.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.461 172.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 257' ' ' ARG . . . . . 0.467 ' HD3' ' O ' ' A' ' 22' ' ' ALA . 1.8 tmm_? -62.24 -39.12 91.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.807 178.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 258' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' B' ' 254' ' ' SER . 13.5 mm-40 -52.43 -52.32 54.59 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.911 0.386 . . . . 0.0 110.328 176.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -62.31 -42.86 99.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.128 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 260' ' ' LEU . . . . . 0.493 HD13 ' CE2' ' B' ' 272' ' ' TYR . 96.0 mt -67.9 -43.82 78.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.82 -176.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 17.0 p -64.7 -31.23 72.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.999 0.428 . . . . 0.0 110.683 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -65.73 -42.42 91.04 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.21 178.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 263' ' ' LEU . . . . . . . . . . . . . 94.6 mt -73.21 -37.71 66.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.128 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -59.5 -39.31 83.4 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.575 -178.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -61.29 -40.0 92.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.182 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -74.7 -19.15 60.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.657 -176.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 267' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' B' ' 267' ' ' LYS . 42.7 mmtm -93.25 -36.18 12.72 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.946 0.403 . . . . 0.0 110.904 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 268' ' ' GLY . . . . . 0.539 ' HA2' ' HB3' ' A' ' 15' ' ' ALA . . . 106.13 55.91 0.67 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.559 177.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -142.64 150.8 22.53 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.366 -0.921 . . . . 0.0 111.857 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . 0.918 ' HD3' ' HB2' ' B' ' 293' ' ' ASP . 45.6 mtpt -94.52 -37.81 11.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.426 0.632 . . . . 0.0 110.268 177.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 271' ' ' TYR . . . . . 0.454 ' HB3' HG22 ' B' ' 225' ' ' VAL . 16.7 m-85 -117.75 150.31 39.33 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.747 -172.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 272' ' ' TYR . . . . . 0.493 ' CE2' HD13 ' B' ' 260' ' ' LEU . 21.6 p90 -145.2 155.02 43.01 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 175.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -136.49 109.79 7.85 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -177.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 274' ' ' ILE . . . . . 0.57 ' HB ' ' HB3' ' A' ' 26' ' ' SER . 60.8 mt -65.4 127.2 26.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.076 177.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 22.7 pt -108.25 -28.26 2.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.777 0.322 . . . . 0.0 111.769 -177.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -152.71 108.84 3.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.922 -178.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 277' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' B' ' 286' ' ' ALA . . . -124.53 102.89 7.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.091 0.472 . . . . 0.0 109.921 178.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 278' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.53 132.02 54.47 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.543 0.687 . . . . 0.0 111.311 -174.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.1 115.53 15.9 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 171.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 280' ' ' HIS . . . . . 0.485 ' HB2' ' HG3' ' B' ' 285' ' ' GLU . 7.1 t-160 -103.54 25.51 9.6 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.189 0.519 . . . . 0.0 110.109 -171.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 281' ' ' GLY . . . . . 0.403 ' HA3' ' HD3' ' B' ' 282' ' ' PRO . . . 103.35 -106.44 2.86 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.982 -0.627 . . . . 0.0 111.732 -177.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . 0.403 ' HD3' ' HA3' ' B' ' 281' ' ' GLY . 3.6 Cg_exo -75.45 -24.57 12.0 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.993 2.462 . . . . 0.0 112.045 178.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 283' ' ' ASN . . . . . 0.48 ' HA ' ' HA ' ' B' ' 246' ' ' SER . 53.2 m-80 -116.18 148.21 40.61 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.944 -177.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -107.22 115.31 29.94 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.58 176.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 285' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' B' ' 243' ' ' VAL . 1.0 OUTLIER -101.52 110.85 22.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.959 -175.095 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 286' ' ' ALA . . . . . 0.499 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -125.95 116.52 21.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.782 0.325 . . . . 0.0 111.604 -177.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 46.3 t -103.46 124.47 57.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.328 178.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -130.08 141.2 50.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.929 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 289' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -92.47 133.42 35.93 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.046 178.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 44.8 t -98.0 125.06 51.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.622 -178.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 291' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -123.68 142.98 50.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.1 0.476 . . . . 0.0 110.581 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 292' ' ' ASN . . . . . 0.459 ' HB3' HG23 ' B' ' 236' ' ' VAL . 14.8 t-20 -92.2 167.33 12.11 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 293' ' ' ASP . . . . . 0.918 ' HB2' ' HD3' ' B' ' 270' ' ' LYS . 13.6 t70 -64.27 -25.14 67.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.143 0.497 . . . . 0.0 110.093 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 294' ' ' ALA . . . . . . . . . . . . . . . 75.14 -53.77 0.66 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.334 175.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 295' ' ' THR . . . . . 0.459 HG21 ' HB3' ' A' ' 52' ' ' SER . 12.0 t -92.69 -29.09 16.26 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.035 -177.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 296' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' B' ' 295' ' ' THR . 23.0 mtmt 71.4 -66.77 0.28 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.259 0.624 . . . . 0.0 110.543 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 297' ' ' LEU . . . . . . . . . . . . . 4.0 pp -157.24 150.44 23.78 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.077 174.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 298' ' ' GLU . . . . . 0.617 ' CD ' ' H ' ' B' ' 299' ' ' HIS . 0.0 OUTLIER -89.62 -66.57 0.91 Allowed 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.088 0.47 . . . . 0.0 110.333 -178.306 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 299' ' ' HIS . . . . . 0.617 ' H ' ' CD ' ' B' ' 298' ' ' GLU . 13.2 p-80 -152.09 18.5 0.67 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 300' ' ' HIS . . . . . 0.437 ' HB2' ' O ' ' B' ' 299' ' ' HIS . 2.6 m80 74.91 109.54 0.07 Allowed 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.478 -178.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 301' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -63.38 108.53 1.35 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 173.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 302' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -60.53 117.51 5.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.319 0.58 . . . . 0.0 112.439 -170.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -133.99 100.17 4.65 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.862 176.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 . . . . . 0 C--N 1.322 -0.624 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.672 179.878 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.771 0.32 . . . . 0.0 111.229 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -87.68 106.56 18.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.211 0.529 . . . . 0.0 112.101 -172.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.6 ttpp -112.63 81.92 1.56 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 170.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -110.98 14.38 22.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.432 -172.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.5 mt -102.79 110.77 30.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.505 -178.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.588 ' HA ' HD12 ' B' ' 275' ' ' ILE . 8.4 pt -139.35 84.5 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.202 0.525 . . . . 0.0 110.488 173.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -107.88 93.45 4.55 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.263 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.36 131.95 35.22 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.821 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -150.1 154.35 37.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.01 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 87.7 mt 64.97 175.24 0.2 Allowed 'General case' 0 N--CA 1.465 0.319 0 O-C-N 123.917 0.761 . . . . 0.0 112.054 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.648 ' HA ' HD21 ' B' ' 242' ' ' ASN . 43.9 tp -168.04 142.28 3.45 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.46 178.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.59 67.71 0.97 Allowed 'General case' 0 C--O 1.234 0.266 0 O-C-N 123.761 0.663 . . . . 0.0 110.768 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.562 HG23 HD22 ' B' ' 263' ' ' LEU . 5.2 t -84.5 133.22 34.47 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.319 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.3 m -97.43 151.3 4.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.162 -177.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.9 108.2 4.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.903 -176.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.8 m -109.15 14.13 24.08 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.25 0.547 . . . . 0.0 110.674 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -145.89 127.99 15.62 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.5 p -136.42 98.27 3.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.069 0.461 . . . . 0.0 112.183 -172.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.4 m -113.16 141.98 46.31 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.001 173.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 79.9 mt -72.09 100.36 2.51 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -138.21 19.66 2.78 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.566 -174.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.495 ' O ' ' HD3' ' B' ' 257' ' ' ARG . . . -170.32 144.02 2.45 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.241 0.338 . . . . 0.0 110.456 -178.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.495 ' CD ' ' HA ' ' B' ' 221' ' ' ALA . 8.4 pt-20 -176.46 114.71 0.11 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.107 0.48 . . . . 0.0 112.289 178.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.788 ' HB3' ' CB ' ' B' ' 224' ' ' GLN . 22.2 tm0? 173.81 141.0 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.136 176.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.48 HG21 HD11 ' A' ' 35' ' ' LEU . 31.3 m -120.7 155.08 24.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 121.099 0.476 . . . . 0.0 111.883 -174.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.404 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 72.6 p -96.33 -93.09 0.21 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.429 -174.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.482 ' C ' ' HD3' ' A' ' 27' ' ' LYS . 10.8 tmtt? -123.12 -66.61 1.0 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 122.168 -0.333 . . . . 0.0 111.873 -174.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.44 ' NE2' ' H ' ' A' ' 28' ' ' GLN . 0.6 OUTLIER -62.5 -28.53 69.9 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -170.122 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -65.32 -42.78 92.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.968 0.414 . . . . 0.0 110.064 176.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.437 HG12 HD12 ' A' ' 35' ' ' LEU . 28.0 mt -64.57 -44.94 96.81 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.897 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.3 m -67.35 -30.47 70.3 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.846 -0.341 . . . . 0.0 111.335 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -72.45 -48.25 42.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.583 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -98.68 4.16 47.85 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.324 -176.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt 71.85 -45.95 0.63 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.978 0.911 . . . . 0.0 112.028 177.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.561 HD22 ' HA ' ' A' ' 93' ' ' ASP . 19.3 mt 58.71 164.25 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.208 1.003 . . . . 0.0 112.604 -172.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 76.3 t -97.5 -47.68 12.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.658 -175.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.592 ' HA ' ' HA ' ' A' ' 91' ' ' TYR . 63.5 tttm 70.39 126.49 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 O-C-N 124.159 0.912 . . . . 0.0 111.082 -177.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.0 m -114.28 -30.06 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -175.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 169.47 -161.99 35.51 Favored Glycine 0 C--O 1.227 -0.305 0 C-N-CA 119.303 -1.427 . . . . 0.0 113.656 -178.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.574 HG23 ' HG2' ' A' ' 89' ' ' GLU . 6.4 m -123.07 143.88 49.66 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 122.473 0.309 . . . . 0.0 110.441 -176.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.9 pt -118.92 139.5 46.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 172.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -122.02 114.4 20.9 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.724 -175.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.59 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 43.0 t -105.63 115.33 47.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.516 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 68.7 p -148.28 99.27 3.02 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.731 0.301 . . . . 0.0 110.996 -174.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -142.15 157.11 45.25 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.064 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.599 ' HA ' ' HA ' ' A' ' 83' ' ' ASN . 19.9 t -71.38 173.44 7.85 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 120.666 0.27 . . . . 0.0 110.313 178.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.78 55.16 2.57 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 113.165 -176.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -141.52 -37.3 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 176.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -83.41 -14.81 51.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.09 0.471 . . . . 0.0 110.59 177.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.1 mm -130.34 132.57 64.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 176.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.3 m -134.84 -35.03 0.88 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.055 0.455 . . . . 0.0 111.584 -177.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.599 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 28.1 m -142.11 168.48 13.49 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -177.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.599 ' HD2' ' HB3' ' A' ' 52' ' ' SER . 10.8 Cg_endo -54.55 -31.05 67.93 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.543 2.162 . . . . 0.0 112.637 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.4 m -61.87 -34.51 76.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.664 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -62.88 -52.81 61.65 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.338 0.59 . . . . 0.0 109.881 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 57.4 tp -63.4 -30.37 71.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.276 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -62.08 -31.79 72.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.955 -178.302 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -74.93 -46.87 32.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.8 0.333 . . . . 0.0 110.358 175.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.565 ' HA ' ' HG2' ' A' ' 62' ' ' GLU . 1.9 mptp? -62.97 -40.39 97.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.195 -175.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.3 mt -61.6 -37.12 82.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.824 0.345 . . . . 0.0 110.748 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.523 ' HA ' ' HB3' ' B' ' 222' ' ' ALA . 19.5 m -75.95 -43.28 45.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.45 -178.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.565 ' HG2' ' HA ' ' A' ' 59' ' ' LYS . 16.8 pt-20 -69.44 -36.72 76.93 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 121.151 -0.219 . . . . 0.0 111.221 -175.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 87.4 mt -74.9 -49.36 20.59 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -178.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.24 -44.1 89.27 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -174.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -65.68 -34.9 79.29 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.997 0.427 . . . . 0.0 110.72 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.579 ' HA ' ' CE2' ' B' ' 217' ' ' PHE . . . -73.11 -8.86 57.65 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.428 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -106.48 2.24 26.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.804 176.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.41 ' HA3' ' HB1' ' B' ' 215' ' ' ALA . . . 74.05 58.57 4.31 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.967 178.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -131.17 -178.04 15.23 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.28 178.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.422 ' HA ' ' HB1' ' B' ' 221' ' ' ALA . 62.8 mttp -130.29 -37.07 1.45 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.165 0.507 . . . . 0.0 110.007 177.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.558 ' HB3' ' HA ' ' A' ' 24' ' ' GLN . 11.4 m-85 -127.23 169.53 13.39 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.43 ' O ' ' HG2' ' A' ' 24' ' ' GLN . 25.7 p90 -142.63 167.28 22.47 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 173.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.404 ' CD2' ' HA ' ' A' ' 26' ' ' SER . 4.0 t-160 -134.45 109.26 8.62 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.818 175.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 54.2 mt -68.65 129.81 33.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.833 176.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.5 pt -123.33 -14.78 5.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.741 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -157.45 107.3 2.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.505 0.193 . . . . 0.0 111.191 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -132.6 105.35 7.16 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.785 0.326 . . . . 0.0 110.187 176.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.405 ' HD3' HH11 ' A' ' 78' ' ' ARG . 0.0 OUTLIER -153.47 146.9 24.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.942 -177.529 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -77.79 109.07 11.48 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.636 174.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -101.84 87.95 3.25 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.74 -134.66 13.6 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -175.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -83.61 1.2 9.06 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.65 2.233 . . . . 0.0 112.386 176.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.599 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 44.6 m-80 -115.08 143.15 45.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.051 0.453 . . . . 0.0 111.491 -177.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.516 ' O ' ' HA ' ' A' ' 44' ' ' SER . 66.6 t80 -93.99 120.11 33.79 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.783 176.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -105.26 118.8 37.46 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.512 -177.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.59 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . . . -132.34 115.73 15.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.166 0.507 . . . . 0.0 110.696 176.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 44.6 t -111.81 122.58 66.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.019 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.28 142.09 33.9 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.413 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.574 ' HG2' HG23 ' A' ' 40' ' ' THR . 10.9 mt-10 -103.75 140.24 37.9 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.68 -0.408 . . . . 0.0 109.977 176.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 36.5 t -90.52 125.05 43.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.054 0.454 . . . . 0.0 110.369 -175.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.592 ' HA ' ' HA ' ' A' ' 37' ' ' LYS . 54.9 m-85 -111.5 114.23 27.19 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.657 -178.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -86.36 146.47 26.46 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 171.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.561 ' HA ' HD22 ' A' ' 35' ' ' LEU . 2.7 p-10 -84.51 -179.5 7.17 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 121.13 -0.228 . . . . 0.0 110.494 -174.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.73 12.52 0.49 Allowed 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -175.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 86.6 m -95.43 -36.91 11.16 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 177.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.496 ' HG2' ' HG ' ' A' ' 97' ' ' LEU . 82.7 tttt 66.71 -74.32 0.07 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.547 -177.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.496 ' HG ' ' HG2' ' A' ' 96' ' ' LYS . 0.7 OUTLIER -147.1 -179.96 7.19 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.583 176.795 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -64.39 -36.48 84.28 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -174.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 37.3 m170 -73.37 112.36 9.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.121 0.486 . . . . 0.0 111.365 -176.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 13.6 m170 -112.18 118.3 34.97 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.956 0.408 . . . . 0.0 110.3 177.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -126.45 124.75 40.84 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.532 -175.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 70.91 109.1 0.06 Allowed 'General case' 0 N--CA 1.467 0.407 0 O-C-N 124.062 0.851 . . . . 0.0 111.073 178.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 31.8 p80 -138.32 174.92 10.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.422 -176.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 63.4 t-80 . . . . . 0 C--N 1.323 -0.559 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 175.727 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . 0.415 ' CE ' ' HA ' ' B' ' 201' ' ' MET . 1.2 tpt . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp 67.88 99.2 0.05 Allowed 'General case' 0 N--CA 1.468 0.448 0 O-C-N 123.462 0.476 . . . . 0.0 111.69 176.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . 0.575 ' HE2' ' HB ' ' B' ' 205' ' ' ILE . 22.2 ptmt -90.5 -21.93 21.6 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.054 175.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 204' ' ' ARG . . . . . 0.484 ' HE ' ' HA ' ' B' ' 204' ' ' ARG . 0.6 OUTLIER 68.68 16.18 9.01 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.856 171.232 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 205' ' ' ILE . . . . . 0.575 ' HB ' ' HE2' ' B' ' 203' ' ' LYS . 48.3 mm -91.41 97.01 6.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.092 0.472 . . . . 0.0 110.476 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 55.0 mt -98.7 81.76 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.756 177.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -95.91 78.8 3.24 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.564 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -97.96 104.06 16.05 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.252 176.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -149.1 -152.0 0.42 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.435 -173.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 210' ' ' LEU . . . . . 0.433 ' HB3' ' HD2' ' A' ' 96' ' ' LYS . 94.2 mt 73.94 -49.82 0.68 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.53 0.732 . . . . 0.0 112.224 176.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 97.2 mt 65.76 -178.41 0.19 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 122.833 0.453 . . . . 0.0 110.8 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -86.04 -59.84 2.18 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 213' ' ' THR . . . . . 0.497 HG22 HG23 ' B' ' 214' ' ' VAL . 2.5 m 66.59 -80.1 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.445 177.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 214' ' ' VAL . . . . . 0.497 HG23 HG22 ' B' ' 213' ' ' THR . 45.3 t -129.84 -22.68 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.032 0.444 . . . . 0.0 110.244 -177.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . 0.41 ' HB1' ' HA3' ' A' ' 68' ' ' GLY . . . 60.85 -176.64 0.11 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.085 -175.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 72.5 m -158.42 146.26 18.24 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.359 -0.238 . . . . 0.0 110.359 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 217' ' ' PHE . . . . . 0.579 ' CE2' ' HA ' ' A' ' 66' ' ' ALA . 19.3 m-85 -58.65 150.98 21.85 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 123.626 0.579 . . . . 0.0 110.463 177.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 218' ' ' SER . . . . . 0.46 ' HB2' ' HB3' ' B' ' 221' ' ' ALA . 15.8 m -116.64 9.97 14.26 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.252 -178.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 31.6 m 74.08 -59.03 0.57 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.64 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 43.5 tp -155.1 99.78 2.12 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 174.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . 0.495 ' HA ' ' CD ' ' A' ' 23' ' ' GLU . . . -155.73 83.87 1.03 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.254 -177.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . 0.523 ' HB3' ' HA ' ' A' ' 61' ' ' SER . . . 170.54 91.05 0.0 OUTLIER 'General case' 0 C--O 1.236 0.359 0 O-C-N 123.851 0.719 . . . . 0.0 110.523 177.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -170.55 116.65 0.49 Allowed 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 224' ' ' GLN . . . . . 0.788 ' CB ' ' HB3' ' A' ' 24' ' ' GLN . 0.0 OUTLIER 177.31 167.46 0.6 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.449 -1.25 . . . . 0.0 107.96 176.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . 0.456 HG21 HD13 ' B' ' 235' ' ' LEU . 27.9 m -121.54 147.17 25.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.3 0.571 . . . . 0.0 111.508 -177.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 84.1 p -105.89 -157.47 0.61 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.487 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . 0.494 ' C ' ' HD3' ' B' ' 227' ' ' LYS . 12.1 tmtt? -67.07 -40.8 87.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.753 0.311 . . . . 0.0 110.277 -178.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 228' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -59.19 -49.26 78.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.631 -173.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 229' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -63.46 -39.42 94.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.574 -177.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 77.8 mt -59.25 -56.9 14.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.652 0.263 . . . . 0.0 111.358 -177.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 5.7 p -73.31 -21.59 60.53 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -174.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -98.09 -38.76 9.22 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.429 -0.508 . . . . 0.0 112.198 -176.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . 0.476 ' CD1' ' HD3' ' A' ' 53' ' ' PRO . 57.7 m-85 -99.4 4.64 46.32 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -174.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt 58.63 40.52 23.39 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.302 0.376 . . . . 0.0 110.915 174.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . 0.456 HD13 HG21 ' B' ' 225' ' ' VAL . 84.7 mt -55.44 150.5 11.64 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.278 0.561 . . . . 0.0 112.456 -173.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 22.1 t -94.08 110.31 23.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.838 -176.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -83.29 114.99 21.77 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 177.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 238' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -86.06 -28.93 6.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.457 -178.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 178.44 -170.17 42.11 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.423 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 7.5 m -133.71 140.46 47.03 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 241' ' ' ILE . . . . . . . . . . . . . 28.1 pt -124.1 148.06 28.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.941 0.401 . . . . 0.0 110.416 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 242' ' ' ASN . . . . . 0.648 HD21 ' HA ' ' A' ' 11' ' ' LEU . 6.1 p30 -134.74 142.36 46.73 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.477 0.656 . . . . 0.0 111.533 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 243' ' ' VAL . . . . . 0.621 HG13 ' NE2' ' B' ' 245' ' ' GLN . 67.9 t -106.66 123.64 61.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.695 -178.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 10.6 t -143.05 69.6 1.31 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 176.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 245' ' ' GLN . . . . . 0.621 ' NE2' HG13 ' B' ' 243' ' ' VAL . 1.3 mp0 -109.42 153.43 24.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.97 -174.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 57.8 m -83.06 43.32 0.86 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.49 -174.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . 0.417 ' C ' ' H ' ' B' ' 249' ' ' GLN . . . 78.47 -41.25 2.06 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.922 -0.656 . . . . 0.0 113.731 174.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -73.57 27.63 0.88 Allowed Glycine 0 CA--C 1.519 0.34 0 CA-C-N 116.888 0.344 . . . . 0.0 113.652 -176.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . 0.544 ' HG3' ' HG2' ' B' ' 245' ' ' GLN . 23.8 mm-40 -130.85 -3.62 4.07 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 176.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 44.9 mm -133.71 132.3 56.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.337 -179.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 251' ' ' SER . . . . . . . . . . . . . 23.2 m -133.45 -58.26 0.88 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.24 -177.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . 0.542 ' HB3' ' HD2' ' B' ' 253' ' ' PRO . 7.2 m -113.72 168.87 7.18 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . 0.542 ' HD2' ' HB3' ' B' ' 252' ' ' SER . 11.6 Cg_endo -57.1 -24.47 58.5 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.293 1.996 . . . . 0.0 112.213 175.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 254' ' ' SER . . . . . 0.546 ' O ' ' HG2' ' B' ' 258' ' ' GLU . 1.5 p -70.2 -37.12 75.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.139 176.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -61.93 -37.43 84.66 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.792 0.329 . . . . 0.0 110.895 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 51.9 tp -59.02 -42.01 89.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.52 177.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 257' ' ' ARG . . . . . 0.553 ' C ' ' HD2' ' B' ' 257' ' ' ARG . 3.9 tmm_? -64.13 -47.07 81.39 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.859 177.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 258' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' B' ' 254' ' ' SER . 28.8 mm-40 -54.02 -48.85 70.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.349 -176.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 259' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -70.17 -35.25 73.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.732 0.301 . . . . 0.0 111.24 -177.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 260' ' ' LEU . . . . . . . . . . . . . 81.9 mt -72.66 -40.5 66.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.178 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 261' ' ' SER . . . . . . . . . . . . . 17.0 t -68.54 -31.97 71.58 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 177.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 262' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -57.36 -51.65 68.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.242 175.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 263' ' ' LEU . . . . . 0.562 HD22 HG23 ' A' ' 13' ' ' THR . 74.5 mt -71.17 -41.18 70.71 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.958 -179.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -63.52 -44.39 94.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.721 -177.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -66.31 -34.21 77.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.896 0.379 . . . . 0.0 110.48 -178.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 266' ' ' ALA . . . . . . . . . . . . . . . -68.94 -20.09 64.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.285 0.565 . . . . 0.0 110.821 176.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 267' ' ' LYS . . . . . . . . . . . . . 4.8 mmpm? -94.81 -2.41 50.93 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.664 176.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 77.35 16.06 80.84 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.168 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . 0.567 ' HA3' ' CG1' ' B' ' 290' ' ' VAL . . . -93.85 148.99 19.24 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.017 -178.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -110.73 3.42 19.15 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.247 0.546 . . . . 0.0 110.073 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 271' ' ' TYR . . . . . 0.654 ' HD1' ' HA ' ' B' ' 224' ' ' GLN . 9.2 m-85 -147.75 141.45 25.61 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 -177.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 272' ' ' TYR . . . . . 0.51 ' CE2' HD11 ' B' ' 274' ' ' ILE . 34.2 p90 -126.66 111.11 13.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.472 0.654 . . . . 0.0 110.06 178.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 273' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -92.1 101.75 14.28 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.171 -174.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 274' ' ' ILE . . . . . 0.534 ' H ' HD12 ' B' ' 274' ' ' ILE . 4.6 mp -72.35 131.59 34.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.82 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 275' ' ' ILE . . . . . 0.588 HD12 ' HA ' ' A' ' 6' ' ' ILE . 28.4 pt -117.64 -28.45 2.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.727 0.299 . . . . 0.0 111.511 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -156.97 137.84 13.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.832 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -155.51 120.81 4.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.506 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 278' ' ' ARG . . . . . 0.472 ' HE ' ' HB3' ' B' ' 278' ' ' ARG . 0.0 OUTLIER -145.04 155.02 43.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.0 0.428 . . . . 0.0 110.942 -178.853 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -79.19 134.87 36.68 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.208 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 280' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -122.01 72.68 1.05 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.001 0.429 . . . . 0.0 110.059 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 281' ' ' GLY . . . . . . . . . . . . . . . 64.11 -120.38 19.54 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.659 -177.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.11 -2.3 12.27 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.737 2.292 . . . . 0.0 112.259 176.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 283' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -114.41 166.08 12.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.28 -177.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 284' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -129.39 122.28 29.12 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.936 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 285' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -105.28 119.7 39.72 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.32 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 286' ' ' ALA . . . . . 0.574 ' HB3' ' HB ' ' B' ' 243' ' ' VAL . . . -136.68 146.83 46.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.692 0.282 . . . . 0.0 111.154 177.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 287' ' ' VAL . . . . . . . . . . . . . 37.0 t -128.79 128.86 68.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 177.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 288' ' ' ALA . . . . . . . . . . . . . . . -137.27 144.92 42.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.004 0.43 . . . . 0.0 110.988 -179.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 289' ' ' GLU . . . . . 0.429 ' HB2' ' HE1' ' B' ' 291' ' ' TYR . 25.5 mt-10 -96.1 150.09 20.89 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.891 178.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 290' ' ' VAL . . . . . 0.567 ' CG1' ' HA3' ' B' ' 269' ' ' GLY . 12.8 t -111.93 123.97 68.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 291' ' ' TYR . . . . . 0.429 ' HE1' ' HB2' ' B' ' 289' ' ' GLU . 65.9 m-85 -124.29 151.69 43.94 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.229 0.538 . . . . 0.0 111.618 -177.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 292' ' ' ASN . . . . . 0.411 HD22 ' HA ' ' B' ' 292' ' ' ASN . 7.2 m120 -117.65 161.4 19.72 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.105 170.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 293' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.56 136.97 49.76 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.439 0.462 . . . . 0.0 111.551 175.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 294' ' ' ALA . . . . . . . . . . . . . . . -99.79 98.11 8.95 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.422 177.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 295' ' ' THR . . . . . . . . . . . . . 71.7 m 69.59 119.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.225 -177.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -77.24 104.8 7.95 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.039 -177.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 297' ' ' LEU . . . . . 0.532 ' HA ' ' HB2' ' A' ' 52' ' ' SER . 0.7 OUTLIER 34.03 98.8 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 O-C-N 124.779 1.299 . . . . 0.0 113.747 174.466 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 298' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -55.65 156.73 4.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.459 0.647 . . . . 0.0 112.234 -179.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 299' ' ' HIS . . . . . . . . . . . . . 58.0 m80 -127.05 16.24 7.3 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.378 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 300' ' ' HIS . . . . . . . . . . . . . 14.3 m80 -61.68 100.08 0.14 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.743 176.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 301' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -80.37 100.32 8.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.098 -176.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 302' ' ' HIS . . . . . . . . . . . . . 48.8 m-70 -105.25 168.58 8.98 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.672 -177.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 303' ' ' HIS . . . . . . . . . . . . . 55.8 t60 71.66 -8.05 1.14 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.568 0.747 . . . . 0.0 111.283 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 . . . . . 0 C--N 1.325 -0.467 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.199 . . . . . . . . 0 0 . 1 stop_ save_